PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Law, DR; Yan, R; Bershady, MA; Bundy, K; Cherinka, B; Drory, N; MacDonald, N; Sanchez-Gallego, JR; Wake, DA; Weijmans, AM; Blanton, MR; Klaene, MA; Moran, SM; Sanchez, SF; Zhang, K				Law, David R.; Yan, Renbin; Bershady, Matthew A.; Bundy, Kevin; Cherinka, Brian; Drory, Niv; MacDonald, Nicholas; Sanchez-Gallego, Jose R.; Wake, David A.; Weijmans, Anne-Marie; Blanton, Michael R.; Klaene, Mark A.; Moran, Sean M.; Sanchez, Sebastian F.; Zhang, Kai			OBSERVING STRATEGY FOR THE SDSS-IV/MaNGA IFU GALAXY SURVEY	ASTRONOMICAL JOURNAL			English	Article						atmospheric effects; methods: observational; surveys; techniques: imaging spectroscopy	OSCILLATION SPECTROSCOPIC SURVEY; INTEGRAL-FIELD SPECTROGRAPH; 2.5 M TELESCOPE; DIFFERENTIAL REFRACTION; PROTOTYPE OBSERVATIONS; SAURON PROJECT; CLASSIFICATION; OBJECTS; SYSTEM	Mapping Nearby Galaxies at Apache Point Observatory (MaNGA) is an integral-field spectroscopic survey that is one of three core programs in the fourth-generation Sloan Digital Sky Survey (SDSS-IV). MaNGA's 17 pluggable optical fiber-bundle integral field units (IFUs) will observe a sample of 10,000 nearby galaxies distributed throughout the SDSS imaging footprint (focusing particularly on the North Galactic Cap). In each pointing these IFUs are deployed across a 3(degrees) field; they yield spectral coverage 3600-10300 angstrom at a typical resolution R similar to 2000, and sample the sky with 2" diameter fiber apertures with a total bundle fill factor of 56%. Observing over such a large field and range of wavelengths is particularly challenging for obtaining uniform and integral spatial coverage and resolution at all wavelengths and across each entire fiber array. Data quality is affected by the IFU construction technique, chromatic and field differential refraction, the adopted dithering strategy, and many other effects. We use numerical simulations to constrain the hardware design and observing strategy for the survey with the aim of ensuring consistent data quality that meets the survey science requirements while permitting maximum observational flexibility. We find that MaNGA science goals are best achieved with IFUs composed of a regular hexagonal grid of optical fibers with rms displacement of 5 mu m or less from their nominal packing position; this goal is met by the MaNGA hardware, which achieves 3 mu m rms fiber placement. We further show that MaNGA observations are best obtained in sets of three 15 minute exposures dithered along the vertices of a 1.44 arcsec equilateral triangle; these sets form the minimum observational unit, and are repeated as needed to achieve a combined signal-to-noise ratio of 5 angstrom(-1) per fiber in the r-band continuum at a surface brightness of 23 AB arcsec(-2). In order to ensure uniform coverage and delivered image quality, we require that the exposures in a given set be obtained within a 60 minute interval of each other in hour angle, and that all exposures be obtained at airmass less than or similar to 1.2 (i.e., within 1-3 hr of transit depending on the declination of a given field).	[Law, David R.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Yan, Renbin; Sanchez-Gallego, Jose R.; Zhang, Kai] Univ Kentucky, Dept Phys & Astron, Lexington, KY 40506 USA; [Bershady, Matthew A.; Wake, David A.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Bundy, Kevin] Univ Tokyo, Kavli Inst Phys & Math Universe, Todai Inst Adv Study, WPI, Kashiwa, Chiba 2778583, Japan; [Cherinka, Brian] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Drory, Niv] Univ Texas Austin, Dept Astron, McDonald Observ, Austin, TX 78712 USA; [MacDonald, Nicholas] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Wake, David A.] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England; [Weijmans, Anne-Marie] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Blanton, Michael R.] NYU, Dept Phys, Ctr Cosmol & Particle Phys, New York, NY 10003 USA; [Klaene, Mark A.] Apache Point Observ, Sunspot, NM 88349 USA; [Moran, Sean M.] Smithsonian Astrophys Observ, Cambridge, MA 02138 USA; [Sanchez, Sebastian F.] Univ Nacl Autonoma Mexico, Inst Astron, Mexico City 04510, DF, Mexico	Law, DR (reprint author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	dlaw@stsci.edu			Summer Undergraduate Research Program at the Dunlap Institute, University of Toronto; Leverhulme Trust; Alfred P. Sloan Foundation; Center for High-Performance Computing at the University of Utah; Carnegie Institution for Science; Carnegie Mellon University; Chilean Participation Group; Harvard-Smithsonian Center for Astrophysics; Instituto de Astrofisica de Canarias; Johns Hopkins University; Kavli Institute for the Physics and Mathematics of the Universe (IPMU)/University of Tokyo; Lawrence Berkeley National Laboratory; Leibniz Institut fur Astrophysik Potsdam (AIP); Max-Planck-Institut fur Astrophysik (MPA Garching); Max-Planck-Institut fur Extraterrestrische Physik (MPE); Max-Planck-Institut fur Astronomie (MPIA Heidelberg); National Astronomical Observatory of China; New Mexico State University; New York University; Ohio State University; Pennsylvania State University; Shanghai Astronomical Observatory; United Kingdom Participation Group; Universidad Nacional Autonoma de Mexico; University of Arizona; University of Colorado Boulder; University of Portsmouth; University of Utah; University of Washington; University of Wisconsin; Vanderbilt University; Yale University	We thank Maryna Tsybulska for early contributions to this project, and acknowledge the Summer Undergraduate Research Program at the Dunlap Institute, University of Toronto for their support. A.W. acknowledges support of a Leverhulme Trust Early Career Fellowship. D.R.L. thanks the anonymous referee whose comments led to an improved version of the manuscript. Funding for the Sloan Digital Sky Survey IV has been provided by the Alfred P. Sloan Foundation and the Participating Institutions. SDSS-IV acknowledges support and resources from the Center for High-Performance Computing at the University of Utah. The SDSS web site is www.sdss.org. SDSS-IV is managed by the Astrophysical Research Consortium for the Participating Institutions of the SDSS Collaboration including the Carnegie Institution for Science, Carnegie Mellon University, the Chilean Participation Group, Harvard- Smithsonian Center for Astrophysics, Instituto de Astrofisica de Canarias, The Johns Hopkins University, Kavli Institute for the Physics and Mathematics of the Universe (IPMU)/University of Tokyo, Lawrence Berkeley National Laboratory, Leibniz Institut fur Astrophysik Potsdam (AIP), Max-Planck-Institut fur Astrophysik (MPA Garching), Max-Planck-Institut fur Extraterrestrische Physik (MPE), Max-Planck-Institut fur Astronomie (MPIA Heidelberg), National Astronomical Observatory of China, New Mexico State University, New York University, The Ohio State University, Pennsylvania State University, Shanghai Astronomical Observatory, United Kingdom Participation Group, Universidad Nacional Autonoma de Mexico, University of Arizona, University of Colorado Boulder, University of Portsmouth, University of Utah, University of Washington, University of Wisconsin, Vanderbilt University, and Yale University.	Eisenhauer F, 2003, P SOC PHOTO-OPT INS, V4841, P1548, DOI 10.1117/12.459468; Belfiore F, 2015, MON NOT R ASTRON SOC, V449, P867, DOI 10.1093/mnras/stv296; Croom SM, 2012, MON NOT R ASTRON SOC, V421, P872, DOI 10.1111/j.1365-2966.2011.20365.x; Bacon R, 2001, MON NOT R ASTRON SOC, V326, P23, DOI 10.1046/j.1365-8711.2001.04612.x; BALDWIN JA, 1981, PUBL ASTRON SOC PAC, V93, P5, DOI 10.1086/130766; Bershady MA, 2010, ASTROPHYS J, V716, P234, DOI 10.1088/0004-637X/716/1/234; Fabricius MH, 2014, MON NOT R ASTRON SOC, V441, P2212, DOI 10.1093/mnras/stu694; Larkin JE, 2003, P SOC PHOTO-OPT INS, V4841, P1600, DOI 10.1117/12.461775; Gunn JE, 2006, ASTRON J, V131, P2332, DOI 10.1086/500975; Bacon R, 2010, PROC SPIE, V7735, DOI 10.1117/12.856027; Bland-Hawthorn J, 2010, PROC SPIE, V7735, DOI 10.1117/12.856345; Bolton AS, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/144; Bryant JJ, 2014, MON NOT R ASTRON SOC, V438, P869, DOI 10.1093/mnras/stt2254; Bundy K, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/7; Cuby JG, 1998, P SOC PHOTO-OPT INS, V3355, P36, DOI 10.1117/12.316769; Dawson KS, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/1/10; Drory N, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/2/77; Emsellem E, 2004, MON NOT R ASTRON SOC, V352, P721, DOI 10.1111/j.1365-2966.2004.07948.x; FILIPPENKO AV, 1982, PUBL ASTRON SOC PAC, V94, P715, DOI 10.1086/131052; Law D. R., 2009, AP J, V697, P421; Li C, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/2/125; Sanchez S. F., 2012, ASTRON ASTROPHYS, V538, pAA8; Sharp R, 2015, MON NOT R ASTRON SOC, V446, P1551, DOI 10.1093/mnras/stu2055; Sharples R.S, 2013, MSNGR, V151, P21; Smee SA, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/32; Weijmans AM, 2014, MON NOT R ASTRON SOC, V444, P3340, DOI 10.1093/mnras/stu1603; Wilkinson DM, 2015, MON NOT R ASTRON SOC, V449, P328, DOI 10.1093/mnras/stv301	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	JUL	2015	150	1							19	10.1088/0004-6256/150/1/19		17	Astronomy & Astrophysics	Astronomy & Astrophysics	CM5QU	WOS:000357744400019		
J	Inatsu, M; Sato, T; Yamada, TJ; Kuno, R; Sugimoto, S; Farukh, MA; Pokhrel, YN; Kure, S				Inatsu, Masaru; Sato, Tomonori; Yamada, Tomohito J.; Kuno, Ryusuke; Sugimoto, Shiori; Farukh, Murad A.; Pokhrel, Yadu N.; Kure, Shuichi			Multi-GCM by multi-RAM experiments for dynamical downscaling on summertime climate change in Hokkaido	ATMOSPHERIC SCIENCE LETTERS			English	Article						dynamical downscaling; regional climate change; multi-GCM by multi-RAM experiments	MODEL; PRECIPITATION	The experiments with three general circulation models (GCMs) by three regional atmospheric models (RAMs) for the dynamical downscaling (DDS) have been performed to evaluate the uncertainty in the global warming response during summertime in Hokkaido, Japan. The results of a 10-year RAM integration nested into GCM under present or future climate conditions were synthesized after applying bias correction. For the target decades during which the global-mean temperature increases by 2 K in each GCM, the DDS results indicate that surface air temperature and precipitation mostly depend on the GCM imposed as the lateral boundary condition.	[Inatsu, Masaru] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Sato, Tomonori] Hokkaido Univ, Fac Earth Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Yamada, Tomohito J.; Farukh, Murad A.] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0600810, Japan; [Kuno, Ryusuke] ARK Informat Syst, Yokohama, Kanagawa, Japan; [Sugimoto, Shiori] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Tokyo, Japan; [Pokhrel, Yadu N.] Michigan State Univ, Dept Civil & Environm Engn, E Lansing, MI 48824 USA; [Kure, Shuichi] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan	Inatsu, M (reprint author), Hokkaido Univ, Fac Sci, Rigaku 8th Bldg,N10W8, Sapporo, Hokkaido 0600810, Japan.	inaz@mail.sci.hokudai.ac.jp	Kure, Shuichi/J-5842-2015		Research Program on Climate Change Adaptation of Ministry of Education, Culture, Sports, Science and Technology; Program for Risk Information on Climate Change of Ministry of Education, Culture, Sports, Science and Technology; Ministry of the Environment [S-8]	The authors thank M. Kimoto, Y. M. Okumura, N. S. Keenlyside, and R. W. Arritt to help MI to obtain GCM datasets, anonymous reviewers and T. Hirota to give us insightful comments, and Japan Weather Associate to provide gridded climatology data. This study is supported by the Research Program on Climate Change Adaptation and the Program for Risk Information on Climate Change of Ministry of Education, Culture, Sports, Science and Technology, and the Global Environmental Research Fund S-8 of the Ministry of the Environment.	Kimoto M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023383; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Piani C, 2010, THEOR APPL CLIMATOL, V99, P187, DOI 10.1007/s00704-009-0134-9; Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1; GIORGI F, 1989, MON WEATHER REV, V117, P2325, DOI 10.1175/1520-0493(1989)117<2325:TCSOAR>2.0.CO;2; Hirota T, 2011, MITIG ADAPT STRAT GL, V16, P791, DOI 10.1007/s11027-011-9296-8; Nishio Z, 2013, CROP SCI, V53, P621, DOI 10.2135/cropsci2012.05.0331; JUANG HMH, 1994, MON WEATHER REV, V122, P3, DOI 10.1175/1520-0493(1994)122<0003:TNNRSM>2.0.CO;2; Sampe T, 2010, J CLIMATE, V23, P113, DOI 10.1175/2009JCLI3128.1; Wang YQ, 2004, J METEOROL SOC JPN, V82, P1599, DOI 10.2151/jmsj.82.1599; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; Sugimoto S, 2013, J APPL METEOROL CLIM, V52, P2226, DOI 10.1175/JAMC-D-12-0192.1; Meehl GA, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Hasumi H, 2004, 1 CCSR U TOK; Horinouchi T, 2014, J METEOROL SOC JPN, V92, P519, DOI 10.2151/jmsj.2014-602; Ishizaki NN, 2012, J METEOROL SOC JPN, V90, P235, DOI 10.2151/jmsj.2012-206; Kosaka Y, 2011, J CLIMATE, V24, P3935, DOI 10.1175/2011JCLI3907.1; Kuno R, 2014, CLIM DYNAM, V43, P375, DOI 10.1007/s00382-014-2060-5; Ohashi Y, 2014, J APPL METEOROL CLIM, V53, P583, DOI 10.1175/JAMC-D-13-0127.1; Roeckner E., 2003, 349 MPI; Skamarock W. C., 2008, 475 NCAR, V475, P113, DOI DOI 10.5065/D68S4MVH; van der Linden P, 2009, ENSEMBLES CLIMATE CH; Wang SY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037930; Yamada TJ, 2012, ATMOS SCI LETT, V13, P133, DOI 10.1002/asl.373	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1530-261X			ATMOS SCI LETT	Atmos. Sci. Lett.	JUL-SEP	2015	16	3					297	304		10.1002/asl2.557		8	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	CM9HW	WOS:000358020000017		
J	Miyamoto, Y; Yoshida, R; Yamaura, T; Yashiro, H; Tomita, H; Kajikawa, Y				Miyamoto, Yoshiaki; Yoshida, Ryuji; Yamaura, Tsuyoshi; Yashiro, Hisashi; Tomita, Hirofumi; Kajikawa, Yoshiyuki			Does convection vary in different cloud disturbances?	ATMOSPHERIC SCIENCE LETTERS			English	Article						global simulation; moist convection; cloudy disturbance	MODEL	Deep moist convection is an element of cloud disturbances such as Madden-Julian oscillation (MJO), tropical cyclones (TCs), mid-latitudinal low depressions (MDL), and fronts (FRT). However, differences in convection characteristics in disturbances remain unclear. We first clarified the statistical features of the convection (structure, intensity, and environmental parameters) in various disturbances simulated by a global simulation with a sub-kilometre grid spacing. The convection in MJO (TC) was tall with a strong (weak) upward motion, and was driven by large convective available potential energy (strong low-level convergence). The convection in MDL and FRT was shorter and characterized by a strong vertical wind shear.	[Miyamoto, Yoshiaki; Yoshida, Ryuji; Yamaura, Tsuyoshi; Yashiro, Hisashi; Tomita, Hirofumi; Kajikawa, Yoshiyuki] RIKEN Adv Inst Computat Sci, Kobe, Hyogo 6500047, Japan; [Tomita, Hirofumi] Japan Agcy Marine Earth Sci & Technol, Seamless Environm Predict Res, Yokohama, Kanagawa, Japan	Miyamoto, Y (reprint author), RIKEN Adv Inst Computat Sci, Chuo Ku, 7-1-26 Minatojima Minami Machi, Kobe, Hyogo 6500047, Japan.	ymiyamoto@riken.jp					Tomita H, 2008, J METEOROL SOC JPN, V86A, P121; Nakanishi M, 2004, BOUND-LAY METEOROL, V112, P1, DOI 10.1023/B:BOUN.0000020164.04146.98; LOUIS JF, 1979, BOUND-LAY METEOROL, V17, P187, DOI 10.1007/BF00117978; Miyamoto Y, 2013, GEOPHYS RES LETT, V40, P4922, DOI 10.1002/grl.50944; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; Tomita H, 2004, FLUID DYN RES, V34, P357, DOI 10.1016/j.fluiddyn.2004.03.003; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Satoh M, 2008, J COMPUT PHYS, V227, P3486, DOI 10.1016/j.jcp.2007.02.006; Noda AT, 2010, ATMOS RES, V96, P208, DOI 10.1016/j.atmosres.2009.05.007; Smith RK, 2000, REV GEOPHYS, V38, P465, DOI 10.1029/1999RG000080; Liebmann B, 1996, B AM METEOROL SOC, V77, P1275; Kikuchi K, 2012, CLIM DYNAM, V38, P1989, DOI 10.1007/s00382-011-1159-1; MADDEN RA, 1994, MON WEATHER REV, V122, P814, DOI 10.1175/1520-0493(1994)122<0814:OOTDTO>2.0.CO;2; Houze Jr RA, 1994, CLOUD DYNAMICS; Miyamoto Y, 2014, MON WEATHER REV, V142, P1908, DOI 10.1175/MWR-D-13-00115.1; Renard R. J., 1965, MON WEA REV, V93, P547, DOI DOI 10.1175/1520-0493(1965)093<0547:EIN0FA>2.3.C0;2; Sekiguchi M, 2009, AIP CONF PROC, V1100, P89, DOI 10.1063/1.3117081	17	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1530-261X			ATMOS SCI LETT	Atmos. Sci. Lett.	JUL-SEP	2015	16	3					305	309		10.1002/asl2.558		5	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	CM9HW	WOS:000358020000018		
J	Wei, K; Takahashi, M; Chen, W				Wei, Ke; Takahashi, Masaaki; Chen, Wen			Long-term changes in the relationship between stratospheric circulation and East Asian winter monsoon	ATMOSPHERIC SCIENCE LETTERS			English	Article						stratospheric circulation; East Asian winter monsoon; climate change	NORTHERN-HEMISPHERE WINTER; SOUTHERN CHINA; REANALYSIS; TEMPERATURE; PROPAGATION; VARIABILITY; TROPOSPHERE; FIELDS; MODES; INDEX	Using two generations of reanalysis datasets from the National Center for Atmospheric Research (NCAR), European Centre for Medium-Range Weather Forecasts (ECMWF), and Japan Meteorological Agency (JMA), we showed that on the interannual timescale the two leading modes of the East Asian winter monsoon (EAWM) are associated with tropospheric annular mode (AM) and stratospheric polar vortex (SPV), respectively. The relationship between AM and the first EAWM mode remained stable during 1958-2013, whereas that between SPV and the second EAWM mode increased suddenly since the late 1980s. The SPV-related circulation and planetary wave activities are intensified in the latter period. We suggested that this change might be caused by the global warming and ozone depletion.	[Wei, Ke; Chen, Wen] Chinese Acad Sci, Inst Atmospher Phys, Ctr Monsoon Syst Res, Beijing 100190, Peoples R China; [Wei, Ke; Takahashi, Masaaki] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Wei, K (reprint author), Chinese Acad Sci, Inst Atmospher Phys, Ctr Monsoon Syst Res, POB 2718, Beijing 100190, Peoples R China.	weike@mail.iap.ac.cn			National Basic Research Program of China (973 Program) [2010CB428603]; National Natural Science Foundation of China [41175041, 41375046]	The first author would like to acknowledge the hospitality of Atmosphere and Ocean Research Institute, University of Tokyo, for providing the visiting researcher program. In this study, the NCEP1 and NCEP2 reanalysis data are provided by the NOAA/OAR/ESRL PSD, and are available online at ftp://ftp.cdc.noaa.gov/Datasets/, the ERA40 and ERAINT data are provided by the ECMWF and are available online at http://apps.ecmwf.int/datasets/data/, and the JRA25 and JRA55 data are provided by JMA and are available online at http://jra.kishou.go.jp/. This research was supported by the National Basic Research Program of China (973 Program) (Grant No. 2010CB428603) and the National Natural Science Foundation of China (Grant Nos 41175041 and 41375046).	Andrews D. G., 1987, INT GEOPHYS SERIES, V40, P489; Li Q, 2007, ATMOS CHEM PHYS, V7, P183; Huang RH, 2012, ADV ATMOS SCI, V29, P910, DOI 10.1007/s00376-012-2015-x; Chen W, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008611; Hu YY, 2002, J CLIMATE, V15, P1659, DOI 10.1175/1520-0442(2002)015<1659:IADVOP>2.0.CO;2; Perlwitz J, 2003, J CLIMATE, V16, P3011, DOI 10.1175/1520-0442(2003)016<3011:OEOASI>2.0.CO;2; Li JP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017441; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/Bams-83-11-1631, 10.1175/BAMS-83-11-1631]; Ebita A, 2011, SOLA, V7, P149, DOI 10.2151/sola.2011-038; Zhang Y, 1997, MON WEATHER REV, V125, P2605, DOI 10.1175/1520-0493(1997)125<2605:CAIVOT>2.0.CO;2; Wei K, 2012, ADV ATMOS SCI, V29, P1200, DOI 10.1007/s00376-012-1226-5; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; MATSUNO T, 1970, J ATMOS SCI, V27, P871, DOI 10.1175/1520-0469(1970)027<0871:VPOSPW>2.0.CO;2; Wang HJ, 2012, CHINESE SCI BULL, V57, P3535, DOI 10.1007/s11434-012-5285-x; Lorenz DJ, 2003, J CLIMATE, V16, P1212, DOI 10.1175/1520-0442(2003)16<1212:EFFITN>2.0.CO;2; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1000:AMITEC>2.0.CO;2; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; EDMON HJ, 1980, J ATMOS SCI, V37, P2600, DOI 10.1175/1520-0469(1980)037<2600:EPCSFT>2.0.CO;2; Zhou W, 2009, MON WEATHER REV, V137, P3978, DOI 10.1175/2009MWR2952.1; Zhou W, 2007, METEOROL ATMOS PHYS, V98, P283, DOI 10.1007/s00703-007-0263-6; Wang B, 2010, J CLIMATE, V23, P1495, DOI 10.1175/2009JCLI3243.1; Bao Q, 2010, MON WEATHER REV, V138, P2375, DOI 10.1175/2009MWR2950.1; BOYLE JS, 1986, MON WEATHER REV, V114, P903, DOI 10.1175/1520-0493(1986)114<0903:COTSCI>2.0.CO;2; [陈文 CHEN Wen], 2009, [地球科学进展, Advance in Earth Sciences], V24, P272; [陈文 Chen Wen], 2013, [大气科学, Chinese Journal of Atmospheric Sciences], V37, P425; Dee DP, 2009, Q J ROY METEOR SOC, V135, P1830, DOI 10.1002/qj.493; DICKINSO.RE, 1968, J ATMOS SCI, V25, P984, DOI 10.1175/1520-0469(1968)025<0984:PRWPVT>2.0.CO;2; DING Y, 1987, MON WEATHER REV, V115, P2428, DOI 10.1175/1520-0493(1987)115<2428:HBOTSH>2.0.CO;2; [顾雷 GU Lei], 2008, [气候与环境研究, Climatic and Environmental Research], V13, P405; He SP, 2013, CHINESE SCI BULL, V58, P1331, DOI 10.1007/s11434-012-5468-5; Huang RH, 1983, SCI CHINA, V26, P940; [陶诗言 TAO ShiYan], 2008, [气候与环境研究, Climatic and Environmental Research], V13, P337; Wang L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035287	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1530-261X			ATMOS SCI LETT	Atmos. Sci. Lett.	JUL-SEP	2015	16	3					359	365		10.1002/asl2.568		7	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	CM9HW	WOS:000358020000026		
J	Yang, C; Ren, Q; Zhang, JC; Hashimoto, K				Yang, Chun; Ren, Qian; Zhang, Ji-Chun; Hashimoto, Kenji			Tropisetron for postoperative cognitive decline	AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY			English	Editorial Material							MICE		[Yang, Chun; Ren, Qian; Zhang, Ji-Chun; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan	Hashimoto, K (reprint author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, 1-8-1 Inohana, Chiba 2608670, Japan.	hashimoto@faculty.chiba-u.jp			Uehara Memorial Foundation (Tokyo, Japan); Otsuka Toshimi Scholarship Foundation (Osaka, Japan); Smoking Research Foundation, Tokyo, Japan	Dr Chun Yang was supported by the Uehara Memorial Foundation (Tokyo, Japan). Dr Qian Ren was supported by the Otsuka Toshimi Scholarship Foundation (Osaka, Japan). This study was supported by Smoking Research Foundation, Tokyo, Japan (to Prof. Kenji Hashimoto).	Wildeboer KM, 2009, BRAIN RES, V1300, P41, DOI 10.1016/j.brainres.2009.08.075; Hashimoto K, 2006, EUR J PHARMACOL, V553, P191, DOI 10.1016/j.ejphar.2006.09.055; Hashimoto K, 2015, EXPERT OPIN THER TAR, V19, P1, DOI 10.1517/14728222.2014.983901; Spilman P, 2014, BRAIN RES, V1551, P25, DOI 10.1016/j.brainres.2013.12.029; Terrando N, 2014, MOL MED, V20, P667, DOI 10.2119/molmed.2014.00143	5	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0004-8674	1440-1614		AUST NZ J PSYCHIAT	Aust. N. Z. J. Psych.	JUL	2015	49	7					662	663		10.1177/0004867415579466		2	Psychiatry	Psychiatry	CM2YF	WOS:000357547600014		
J	Tanaka, R; Saito, T; Hondo, H; Isogai, A				Tanaka, Reina; Saito, Tsuguyuki; Hondo, Hiromasa; Isogai, Akira			Influence of Flexibility and Dimensions of Nanocelluloses on the Flow Properties of Their Aqueous Dispersions	BIOMACROMOLECULES			English	Article							TEMPO-MEDIATED OXIDATION; WALLED CARBON NANOTUBES; VISCOSITY MEASUREMENTS; RHEOLOGICAL PROPERTIES; MECHANICAL-PROPERTIES; FIBER SUSPENSIONS; POLYMER-SOLUTIONS; CELLULOSE; DILUTE; TRANSPARENT	We report that the intrinsic viscosity [eta] of nanocellulose dispersions can be solely expressed as a function of the aspect ratio p of the nanocellulose. Both short rod-like nanocrystalline and long spaghetti-like nanofibrillated celluloses were prepared as dispersions in water. The influence of the flexibility and dimensions of the nanocelluloses on the flow properties of their dispersions was investigated by experimental and theoretical approaches using seven nanocellulose samples with different widths (2.6-14.4 nm) and aspect ratios (23-376). As the aspect ratio of a nanocellulose increases, it becomes more flexible, and its dispersion has higher viscosity. Irrespective of the flexibility and dimensions of these nanocelluloses, the relationship between [eta] and p was rho[eta] = 0.15 x p(1.9), where p is the density of the nanocellulose.	[Tanaka, Reina; Saito, Tsuguyuki; Hondo, Hiromasa; Isogai, Akira] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan	Isogai, A (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan.	aisogai@mail.ecc.u-tokyo.ac.jp			Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency; Japan Society for the Promotion of Science [201307645, 15K14765]	This research was supported by the Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency and Grants-in-Aid for Scientific Research (Grant Numbers 201307645 and 15K14765) from the Japan Society for the Promotion of Science.	Saito T, 2013, BIOMACROMOLECULES, V14, P248, DOI 10.1021/bm301674e; KITANO T, 1981, RHEOL ACTA, V20, P390, DOI 10.1007/BF01547670; Araki J, 1998, COLLOID SURFACE A, V142, P75, DOI 10.1016/S0927-7757(98)00404-X; Lasseuguette E, 2008, CELLULOSE, V15, P425, DOI 10.1007/s10570-007-9184-2; Syverud K, 2009, CELLULOSE, V16, P75, DOI 10.1007/s10570-008-9244-2; FEDORS RF, 1979, POLYMER, V20, P225, DOI 10.1016/0032-3861(79)90226-X; Switzer LH, 2003, J RHEOL, V47, P759, DOI 10.1122/1.1566034; BROERSMA S, 1960, J CHEM PHYS, V32, P1626, DOI 10.1063/1.1730994; Tanaka R, 2014, CELLULOSE, V21, P1581, DOI 10.1007/s10570-014-0196-4; Okita Y, 2010, BIOMACROMOLECULES, V11, P1696, DOI 10.1021/bm100214b; Mansfield ML, 2008, MACROMOLECULES, V41, P5422, DOI 10.1021/ma702839w; Isogai A, 2013, J WOOD SCI, V59, P449, DOI 10.1007/s10086-013-1365-z; Naderi A, 2014, CELLULOSE, V21, P3507, DOI 10.1007/s10570-014-0394-0; Araki J, 1999, J WOOD SCI, V45, P258, DOI 10.1007/BF01177736; Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0; Korhonen JT, 2011, ACS APPL MATER INTER, V3, P1813, DOI 10.1021/am200475b; Naderi A, 2014, CELLULOSE, V21, P2357, DOI 10.1007/s10570-014-0329-9; Koga H, 2013, BIOMACROMOLECULES, V14, P1160, DOI 10.1021/bm400075f; Parra-Vasquez ANG, 2007, MACROMOLECULES, V40, P4043, DOI 10.1021/ma062003n; Naderi A, 2014, CELLULOSE, V21, P1561, DOI 10.1007/s10570-014-0192-8; Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u; Paakko M, 2007, BIOMACROMOLECULES, V8, P1934, DOI 10.1021/bm061215p; KULICKE WM, 1984, RHEOL ACTA, V23, P75, DOI 10.1007/BF01333878; Boluk Y, 2011, COLLOID SURFACE A, V377, P297, DOI 10.1016/j.colsurfa.2011.01.003; Li MC, 2015, ACS SUSTAIN CHEM ENG, V3, P821, DOI 10.1021/acssuschemeng.5b00144; Joung CG, 2002, J NON-NEWTON FLUID, V102, P1, DOI 10.1016/S0377-0257(01)00163-X; Bercea M, 2000, MACROMOLECULES, V33, P6011, DOI 10.1021/ma000417p; GOTO S, 1986, RHEOL ACTA, V25, P119, DOI 10.1007/BF01332131; Doi M, 1986, THEORY POLYM DYNAMIC; Nakagaito AN, 2004, APPL PHYS A-MATER, V78, P547, DOI 10.1007/s00339-003-2453-5; Parra-Vasquez ANG, 2014, AICHE J, V60, P1499, DOI 10.1002/aic.14325; Kobayashi Y, 2014, ANGEW CHEM INT EDIT, V53, P10394, DOI 10.1002/anie.201405123; Salajkova M, 2012, J MATER CHEM, V22, P19798, DOI 10.1039/c2jm34355j; Tozzi EJ, 2008, NORD PULP PAP RES J, V23, P369	34	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	JUL	2015	16	7					2127	2131		10.1021/acs.biomac.5b00539		5	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CM9KD	WOS:000358026400025		
J	Uetani, K; Okada, T; Oyama, HT				Uetani, Kojiro; Okada, Takumi; Oyama, Hideko T.			Crystallite Size Effect on Thermal Conductive Properties of Nonwoven Nanocellulose Sheets	BIOMACROMOLECULES			English	Article							MECHANICAL-PROPERTIES; BACTERIAL CELLULOSE; NATIVE CELLULOSE; POLYETHYLENE; IMPROVEMENT; MODULUS; FIBERS; NANOCOMPOSITES; DIFFRACTION; AEROGELS	The thermal conductive properties, including the thermal diffusivity and resultant thermal conductivity, of nonwoven nanocellulose sheets were investigated by separately measuring the thermal diffusivity of the sheets in the in-plane and thickness directions with a periodic heating method. The cross-sectional area (or width) of the cellulose crystallites was the main determinant of the thermal conductive properties. Thus, the results strongly indicate that there is a crystallite size effect on phonon conduction within the nanocellulose sheets. The results also indicated that there is a large interfacial thermal resistance between the nanocellulose surfaces. The phonon propagation velocity (i.e., the sound velocity) within the nanocellulose sheets was estimated to be similar to 800 m/s based on the relationship between the thermal diffusivities and crystallite widths. The resulting in-plane thermal conductivity of the tunicate nanocellulose sheet was calculated to be similar to 2.5 W/mK, markedly higher than other plastic films available for flexible electronic devices.	[Uetani, Kojiro; Okada, Takumi; Oyama, Hideko T.] Rikkyo Univ, Coll Sci, Toshima Ku, Tokyo 1718501, Japan	Oyama, HT (reprint author), Rikkyo Univ, Coll Sci, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	hideko-oyama@rikkyo.ac.jp			JSPS KAKENHI [26892027]; MEXT; Rikkyo University	The authors thank Dr. K. Hatori, Hudson Laboratory, Bethel, Co. Ltd. for assistance with the thermal diffusivity measurements. This work was supported by the JSPS KAKENHI (grant number 26892027), the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017, and the Rikkyo University Special Fund for Research 2014.	Henriksson M, 2007, J APPL POLYM SCI, V106, P2817, DOI 10.1002/app.26946; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nogi M, 2013, NANOSCALE, V5, P4395, DOI 10.1039/c3nr00231d; Wang XJ, 2013, MACROMOLECULES, V46, P4937, DOI 10.1021/ma400612y; Bahar E, 2012, J APPL POLYM SCI, V125, P2882, DOI 10.1002/app.36445; HATAKEYAMA T, 1982, POLYMER, V23, P1801, DOI 10.1016/0032-3861(82)90125-2; Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s; Chae HG, 2008, SCIENCE, V319, P908, DOI 10.1126/science.1153911; Shimazaki Y, 2007, BIOMACROMOLECULES, V8, P2976, DOI 10.1021/bm7004998; Shen S, 2010, NAT NANOTECHNOL, V5, P251, DOI 10.1038/nnano.2010.27; MERGENTHALER DB, 1992, MACROMOLECULES, V25, P3500, DOI 10.1021/ma00039a030; Iwamoto S, 2009, BIOMACROMOLECULES, V10, P2571, DOI 10.1021/bm900520n; Chen WS, 2014, CHEMSUSCHEM, V7, P154, DOI 10.1002/cssc.201300950; Choy CL, 1999, J POLYM SCI POL PHYS, V37, P3359, DOI 10.1002/(SICI)1099-0488(19991201)37:23<3359::AID-POLB11>3.0.CO;2-S; Kim DY, 2002, CELLULOSE, V9, P361, DOI 10.1023/A:1021140726936; Eichhorn SJ, 2001, CELLULOSE, V8, P197, DOI 10.1023/A:1013181804540; Eichhorn SJ, 2005, J ROY SOC INTERFACE, V2, P309, DOI 10.1098/rsif.2005.0039; Gierlinger N, 2010, J EXP BOT, V61, P587, DOI 10.1093/jxb/erp325; Kim GH, 2015, NAT MATER, V14, P295, DOI [10.1038/nmat4141, 10.1038/NMAT4141]; Huang XP, 2012, ADV MATER, V24, P1482, DOI 10.1002/adma.201104668; Uetani K, 2014, ADV MATER, V26, P5857, DOI 10.1002/adma.201401736; Dufresne A, 2012, NANOCELLULOSE: FROM NATURE TO HIGH PERFORMANCE TAILORED MATERIALS, P1, DOI 10.1515/9783110254600; Elazzoui-Hafraoui S., 2009, BIOMACROMOLECULES, V9, P57; Hsieh T.-C., 2008, CELLULOSE, V15, P507; Kittel C., 2005, INTRO SOLID STATE PH; Matsumoto N, 2015, CARBON, V87, P239, DOI 10.1016/j.carbon.2015.01.042; Morimune S, 2014, CARBON, V70, P38, DOI 10.1016/j.carbon.2013.12.055; NISHI Y, 1990, J MATER SCI, V25, P2997, DOI 10.1007/BF00584917; Nogi M., 2009, ADV MATER, V20, P1; Kobayashi Y, 2014, ANGEW CHEM INT EDIT, V53, P10394, DOI 10.1002/anie.201405123; SUGIYAMA J, 1991, MACROMOLECULES, V24, P4168, DOI 10.1021/ma00014a033; Terao T, 2010, J PHYS CHEM C, V114, P4340, DOI 10.1021/jp911431f	32	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	JUL	2015	16	7					2220	2227		10.1021/acs.biomac.5b00617		8	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CM9KD	WOS:000358026400034		
J	Oda, K; Yamano, K; Otsuka, Y				Oda, Kazuo; Yamano, Katsuhiro; Otsuka, Yukio			In vitro-in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus (FK506) exposure	BIOPHARMACEUTICS & DRUG DISPOSITION			English	Article						drug-drug interaction; microsomes; tacrolimus; FK506; prediction	HUMAN LIVER-MICROSOMES; CLINICAL PHARMACOKINETICS; CYTOCHROME-P450 ENZYMES; TRANSPLANT RECIPIENT; CYCLOSPORINE; INHIBITION; METABOLISM; PREDICTION; TELAPREVIR; CYP3A5	The effect of concomitant drugs having a cytochrome P450 (CYP) 3A inhibitory potency on tacrolimus exposure was predicted from in vitro metabolism results. In this study, the IC50 values of concomitant drugs on the formation of M-I, the major metabolite of tacrolimus, were determined, and the effect on oral exposure (AUC(p.o.)) of tacrolimus was assessed from static models. When an absorbed fraction (F-a) of 0.97, intestinal wall availability (F-g) of 0.27 and fraction metabolized by CYP3A (f(m(CYP3A))) of 0.8 were used, the least bias was observed for the prediction of the AUC(p.o.) of tacrolimus. The relationship of the IC50 values of 11 inhibitors between tacrolimus and typical CYP3A substrates (midazolam and testosterone) was also analysed. A strong correlation was found between the IC50 values of tacrolimus and typical CYP3A substrates (r(2)0.85). The predictability of the effect of inhibitors on tacrolimus AUC(p.o.) was investigated based on the same static models with the use of published IC50 values for midazolam and testosterone. The bias for the prediction of tacrolimus AUC(p.o.) was minimal with the use of IC50 values determined using tacrolimus itself as a substrate. These results suggest that tacrolimus itself is still the best choice for predicting the AUC(p.o.) of tacrolimus, although our findings suggest that midazolam or testosterone may be used instead of tacrolimus to estimate roughly (predicted AUC(p.o.) within an approximately 2-fold range of observed values) the effect of CYP3A inhibitors on the tacrolimus AUC(p.o.). Copyright (c) 2015 John Wiley & Sons, Ltd.	[Oda, Kazuo; Yamano, Katsuhiro; Otsuka, Yukio] Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, Yodogawa Ku, Osaka 5328514, Japan	Oda, K (reprint author), Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, Yodogawa Ku, 1-6 Kashima,2 Chome, Osaka 5328514, Japan.	kazuo.oda@astellas.com					Floren LC, 1997, CLIN PHARMACOL THER, V62, P41, DOI 10.1016/S0009-9236(97)90150-8; Iwasaki K, 2007, DRUG METAB PHARMACOK, V22, P328, DOI 10.2133/dmpk.22.328; Kato M, 2008, PHARM RES-DORDR, V25, P1891, DOI 10.1007/s11095-008-9607-2; Wang YH, 2004, DRUG METAB DISPOS, V32, P259, DOI 10.1124/dmd.32.2.259; SAEKI T, 1993, J BIOL CHEM, V268, P6077; Sansone-Parsons A, 2007, PHARMACOTHERAPY, V27, P825, DOI 10.1592/phco.27.6.825; Turpeinen M, 2005, EUR J PHARM SCI, V24, P123, DOI 10.1016/j.ejps.2004.10.006; Unger M, 2004, RAPID COMMUN MASS SP, V18, P2273, DOI 10.1002/rcm.1621; Saad AH, 2006, PHARMACOTHERAPY, V26, P1730, DOI 10.1592/phco.26.12.1730; Nivoix Y, 2008, CLIN PHARMACOKINET, V47, P779, DOI 10.2165/0003088-200847120-00003; Hebert MF, 1999, ANN PHARMACOTHER, V33, P680, DOI 10.1345/aph.18356; Kohl V, 2010, ANTIMICROB AGENTS CH, V54, P207, DOI 10.1128/AAC.01027-09; Ma B, 2000, DRUG METAB DISPOS, V28, P125; Obach RS, 2007, DRUG METAB DISPOS, V35, P246, DOI 10.1124/dmd.106.012633; Garg V, 2011, HEPATOLOGY, V54, P20, DOI 10.1002/hep.24443; Kiang TKL, 2013, CLIN PHARMACOKINET, V52, P487, DOI 10.1007/s40262-013-0053-x; Amundsen R, 2012, DRUG METAB DISPOS, V40, P655, DOI 10.1124/dmd.111.043018; Patki KC, 2003, DRUG METAB DISPOS, V31, P938, DOI 10.1124/dmd.31.7.938; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Di L, 2007, INT J PHARM, V335, P1, DOI 10.1016/j.ijpharm.2006.10.039; Buckner FS, 2012, ANTIMICROB AGENTS CH, V56, P4914, DOI 10.1128/AAC.06244-11; Emoto C, 2006, XENOBIOTICA, V36, P219, DOI 10.1080/00498250500489968; Fong SYK, 2014, XENOBIOTICA, V44, P417, DOI 10.3109/00498254.2013.851431; Hairhara Y, 1999, TRANSPLANT P, V31, P2767, DOI 10.1016/S0041-1345(99)00560-6; Krahenbuhl S, 1998, TRANSPLANTATION, V66, P1113; Lai YR, 2014, CURR PHARM DESIGN, V20, P1577; Masuda S, 2006, CLIN PHARMACOL THER, V79, P90, DOI 10.1016/j.clpt.2005.09.013; MEKKI Q, 1993, CLIN PHARMACOL THER, V53, P238; MIELES L, 1991, TRANSPLANTATION, V52, P1086, DOI 10.1097/00007890-199112000-00029; Mita A, 2014, TRANSPL P, V46, P794, DOI 10.1016/j.transproceed.2014.01.006; Moller A, 1999, DRUG METAB DISPOS, V27, P633; Nara M, 2013, EUR J CLIN PHARMACOL, V69, P1321, DOI 10.1007/s00228-013-1471-2; Oda K, 2014, BIOPHARM DRUG DISPOS, V35, P501, DOI 10.1002/bdd.1913; Olyaei AJ, 1998, PHARMACOTHERAPY, V18, P1356; Oswald S, 2011, CLIN PHARMACOL THER, V89, P524, DOI 10.1038/clpt.2011.4; Padhi ID, 1997, THER DRUG MONIT, V19, P120; Racha Jagdish K, 2003, Drug Metab Pharmacokinet, V18, P128, DOI 10.2133/dmpk.18.128; Rostami-Hodjegan Amin, 2004, Drug Discov Today Technol, V1, P441, DOI 10.1016/j.ddtec.2004.10.002; Shiraga T, 1999, XENOBIO METAB DISPOS, V14, P277; Zhang SM, 2012, XENOBIOTICA, V42, P409, DOI 10.3109/00498254.2011.631224; Zhou SF, 2004, CURR DRUG METAB, V5, P415, DOI 10.2174/1389200043335450	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2782	1099-081X		BIOPHARM DRUG DISPOS	Biopharm. Drug Dispos.	JUL	2015	36	5					265	274		10.1002/bdd.1938		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CM6QV	WOS:000357814800001		
J	Ranjit, M; Motomura, K; Ohka, F; Wakabayashi, T; Natsume, A				Ranjit, Melissa; Motomura, Kazuya; Ohka, Fumiharu; Wakabayashi, Toshihiko; Natsume, Atsushi			Applicable advances in the molecular pathology of glioblastoma	BRAIN TUMOR PATHOLOGY			English	Review						Glioma mutations; Immunohistochemistry; Classification; Review	GROWTH-FACTOR-RECEPTOR; INTEGRATED GENOMIC ANALYSIS; TERT PROMOTER MUTATIONS; GRADE DIFFUSE GLIOMAS; HUMAN-BRAIN-TUMORS; STEM-CELLS; MALIGNANT GLIOMA; ENHANCED EXPRESSION; SIGNAL-TRANSDUCTION; FREQUENT ATRX	Comprising more than 80 % of malignant brain tumors, glioma has proven to be a daunting cause of mortality in a vast majority of the human population. Progressive and extensive research on malignant glioma has substantially enhanced our understanding of glioma cell biology and molecular pathology. Subtypes of glioma such as astrocytoma and oligodendroglioma are currently grouped together into one pathological class, where they show many differences in histology and molecular etiology. This indicates that it may be beneficial to consider a new and radical subclassification. Thus, we summarize recent developments in glioblastoma multiforme (GBM) subtypes, immunohistochemical analyses useful for diagnoses and the biological evaluation and therapeutic implications of gliomas in this review.	[Ranjit, Melissa; Motomura, Kazuya; Ohka, Fumiharu; Wakabayashi, Toshihiko; Natsume, Atsushi] Nagoya Univ, Sch Med, Dept Neurosurg, Showa Ku, Nagoya, Aichi 4668550, Japan	Natsume, A (reprint author), Nagoya Univ, Sch Med, Dept Neurosurg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	anatsume@med.nagoya-u.ac.jp					Aihara K, 2014, NEURO-ONCOLOGY, V16, P140, DOI 10.1093/neuonc/not144; Jiao YC, 2012, ONCOTARGET, V3, P709; Stamenkovic I, 2009, J INVEST DERMATOL, V129, P1321, DOI 10.1038/jid.2009.13; Wick W, 2014, NAT REV NEUROL, V10, P372, DOI 10.1038/nrneurol.2014.100; NISTER M, 1988, CANCER RES, V48, P3910; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Ruas M, 1998, BBA-REV CANCER, V1378, pF115; Ohka F, 2014, TUMOR BIOL, V35, P5911, DOI 10.1007/s13277-014-1784-5; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Li GH, 2010, INT J ONCOL, V37, P103, DOI 10.3892/ijo_00000658; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Tsujiuchi T, 2014, AM J TRANSL RES, V6, P169; Felsberg J, 2011, INT J CANCER, V129, P659, DOI 10.1002/ijc.26083; Rao RC, 2009, STEM CELLS, V27, P116, DOI 10.1634/stemcells.2007-0205; LOUIS DN, 1994, J NEUROPATH EXP NEUR, V53, P11, DOI 10.1097/00005072-199401000-00002; Ohno M, 2010, CANCER SCI, V101, P2518, DOI 10.1111/j.1349-7006.2010.01734.x; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Frederick L, 2000, CANCER RES, V60, P1383; REIFENBERGER J, 1994, AM J PATHOL, V145, P1175; Weickert CS, 2000, J COMP NEUROL, V423, P359, DOI 10.1002/1096-9861(20000731)423:3<359::AID-CNE1>3.0.CO;2-0; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Kato Y, 2004, ONCOGENE, V23, P8552, DOI 10.1038/sj.onc.1207869; Mikeska T, 2007, J MOL DIAGN, V9, P368, DOI 10.2353/jmoldx.2007.060167; Abedalthagafi M, 2013, MODERN PATHOL, V26, P1425, DOI 10.1038/modpathol.2013.90; Motomura K, 2012, CANCER SCI, V103, P1871, DOI 10.1111/j.1349-7006.2012.02377.x; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Kato T, 2010, GENE THER, V17, P1363, DOI 10.1038/gt.2010.88; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Sampetrean O, 2013, BRAIN TUMOR PATHOL, V30, P209, DOI 10.1007/s10014-013-0141-5; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Kato Y, 2005, TUMOR BIOL, V26, P195, DOI 10.1159/000086952; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Calzolari F, 2010, BRAIN PATHOL, V20, P527, DOI 10.1111/j.1750-3639.2009.00335.x; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Kato Y, 2006, BIOCHEM BIOPH RES CO, V349, P1301, DOI 10.1016/j.bbrc.2006.08.171; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Popova SN, 2014, HISTOPATHOLOGY, V64, P365, DOI 10.1111/his.12252; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sahm F, 2012, ACTA NEUROPATHOL, V123, P853, DOI 10.1007/s00401-012-0993-5; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Kato Y, 2013, BIOCHEM BIOPH RES CO, V432, P564, DOI 10.1016/j.bbrc.2013.02.049; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Lu QR, 2001, P NATL ACAD SCI USA, V98, P10851, DOI 10.1073/pnas.181340798; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Brown KE, 2015, J NEUROCHEM, V133, P730, DOI 10.1111/jnc.13032; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi BD, 2009, BRAIN PATHOL, V19, P713, DOI 10.1111/j.1750-3639.2009.00318.x; Conroy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115687; GERSON SL, 1986, CARCINOGENESIS, V7, P745, DOI 10.1093/carcin/7.5.745; Hantusch B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-20; Komori T, 2013, BRAIN TUMOR PATHOL, V30, P253, DOI 10.1007/s10014-013-0165-x; Le Mercier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045475; Nicoilay DJ, 2007, GLIA, V55, P1287, DOI 10.1002/glia.20540; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.0.CO;2-M; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Reitman ZJ, 2013, ACTA NEUROPATHOL, V126, P789, DOI 10.1007/s00401-013-1207-5; Reuss DE, 2015, ACTA NEUROPATHOL, V129, P133, DOI 10.1007/s00401-014-1370-3; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Schwartzentruber J, 2012, NATURE, V482, P226, DOI 10.1038/nature10833; Suzuki A, 2014, J NEURO-ONCOL, V120, P283, DOI 10.1007/s11060-014-1568-1; Tsankova NM, 2014, J NEURO-ONCOL, V119, P481, DOI 10.1007/s11060-014-1499-x; Wakabayashi T, 2009, NEUROSURGERY, V64, P455, DOI 10.1227/01.NEU.0000340683.19920.E3	80	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JUL	2015	32	3					153	162		10.1007/s10014-015-0224-6		10	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CN0EM	WOS:000358086700001		
J	Takano, S; Kato, Y; Yamamoto, T; Liu, X; Ishikawa, E; Kaneko, MK; Ogasawara, S; Matsuda, M; Noguchi, M; Matsumura, A				Takano, Shingo; Kato, Yukinari; Yamamoto, Tetsuya; Liu, Xing; Ishikawa, Eiichi; Kaneko, Mika K.; Ogasawara, Satoshi; Matsuda, Masahide; Noguchi, Masayuki; Matsumura, Akira			Diagnostic advantage of double immunohistochemistry using two mutation-specific anti-IDH antibodies (HMab-1 and MsMab-1) in gliomas	BRAIN TUMOR PATHOLOGY			English	Article						Glioma; IDH; Immunohistochemistry; Monoclonal antibody; Mutation	OLIGODENDROGLIAL TUMORS; ESTABLISHMENT	Isocitrate dehydrogenase (IDH) mutation is a valuable prognostic marker and a tool for decision-making for glioma treatment. An algorithm for IDH mutation screening was recently proposed-it consists of a two-step process of an initial search for the most common IDH1-R132H mutation using immunohistochemistry (IHC)-based assay, followed by DNA-based analysis of IHC-negative or -equivocal cases. Here, we report that immunohistochemistry using two mutation-specific anti-IDH monoclonal antibodies (mAbs)-an IDH1-R132H-specific mAb (clone HMab-1) and a multi-specific mAb (clone MsMab-1)-is easy and reliable for IDH mutation screening. We investigated the IDH status of 54 grade III gliomas. For the first screening, we used HMab-1 IHC and for the second, (of HMab-1-negative cases) we used MsMab-1 IHC. The double IHC screening results were confirmed using sequence analysis (100 % specificity and 100 % sensitivity). Thirty of 54 cases (55.6 %) had IDH mutations and the remaining 24 were of the IDH wild type; moreover, the screening results predicted grade III glioma prognosis. IDH sequencing procedures are popular but inconsistent across laboratories. By contrast, double IHC screening using HMab-1 and MsMab-1 is very reliable for detecting IDH1/2 mutations and can predict survival in grade III glioma patients.	[Takano, Shingo; Yamamoto, Tetsuya; Ishikawa, Eiichi; Matsuda, Masahide; Matsumura, Akira] Univ Tsukuba, Dept Neurosurg, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Kato, Yukinari; Liu, Xing; Kaneko, Mika K.; Ogasawara, Satoshi] Tohoku Univ, Dept Reg Innovat, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Noguchi, Masayuki] Univ Tsukuba, Dept Pathol, Fac Med, Tsukuba, Ibaraki 3058575, Japan	Takano, S (reprint author), Univ Tsukuba, Dept Neurosurg, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	shingo4@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24390339, 25462242]; Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan; Basic Science and Platform Technology Program for Innovative Biological Medicine from MEXT, Japan; Regional Innovation Strategy Support Program from MEXT, Japan; Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare of Japan; Japan Brain Foundation; Japanese Foundation for Multidisciplinary Treatment of Cancer	We thank Yoshiko Tsukada, Makiko Miyakawa, Takuro Nakamura, Noriko Saidoh, and Kanae Yoshida for their excellent technical assistance. This work was supported in part by Grants-in-Aid for Scientific Research (to S.T., No. 24390339; to Y.K., No. 25462242) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; by the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan (to Y.K.); by the Basic Science and Platform Technology Program for Innovative Biological Medicine from MEXT, Japan (to Y.K.); by the Regional Innovation Strategy Support Program from MEXT, Japan (to Y.K.); by a Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare of Japan (to Y.K.); and by the Japan Brain Foundation (to S.T.) and the Japanese Foundation for Multidisciplinary Treatment of Cancer (to S.T.).	Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Kaneko MK, 2011, BIOCHEM BIOPH RES CO, V406, P608, DOI 10.1016/j.bbrc.2011.02.102; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Takano S, 2012, J NEURO-ONCOL, V108, P361, DOI 10.1007/s11060-012-0837-0; Loussouarn D, 2012, INT J ONCOL, V40, P2058, DOI 10.3892/ijo.2012.1404; [Anonymous], 2014, NCCN CLIN PRACTICE G, V40; Preusser M, 2011, CLIN NEUROPATHOL, V30, P217, DOI 10.5414/NP300422; Agarwal S, 2013, NEURO-ONCOLOGY, V15, P718, DOI 10.1093/neuonc/not015; Liu X, 2013, CANCER MED-US, V2, P803, DOI 10.1002/cam4.149; Cairncross JG, 2014, J CLIN ONCOL, V32, P783, DOI 10.1200/JCO.2013.49.3726; Preusser M, 2011, J NEUROPATH EXP NEUR, V70, P715, DOI 10.1097/NEN.0b013e31822713f0; Takano S, 2011, BRAIN TUMOR PATHOL, V28, P115, DOI 10.1007/s10014-011-0023-7; Kaneko MK, 2013, BIOCHEM BIOPH RES CO, V432, P40, DOI 10.1016/j.bbrc.2013.01.088; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; van den Bent MJ, 2013, J NEURO-ONCOL, V112, P173, DOI 10.1007/s11060-013-1056-z; Arita H, 2014, BRAIN TUMOR PATHOL, V19; Catteau Aurélie, 2014, Acta Neuropathol Commun, V2, P58, DOI 10.1186/2051-5960-2-58; Kaneko MK, 2013, TOHOKU J EXP MED, V230, P103, DOI 10.1620/tjem.230.103; Kato Y, 2014, BRAIN TUMOR IN PRESS; Preusser M, 2013, CLIN NEUROPATHOL, V32, P82, DOI 10.5414/NP300622; von Deimling A, 2009, BRAIN PATHOL, V20, P245	22	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JUL	2015	32	3					169	175		10.1007/s10014-015-0214-8		7	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CN0EM	WOS:000358086700003		
J	Saito, N; Aoki, K; Hirai, N; Fujita, S; Iwama, J; Hiramoto, Y; Ishii, M; Sato, K; Nakayama, H; Harashina, J; Hayashi, M; Izukura, H; Kimura, H; Ito, K; Sakurai, T; Yokouchi, Y; Oharazeki, T; Takahashi, K; Iwabuchi, S				Saito, Norihiko; Aoki, Kazuya; Hirai, Nozomi; Fujita, Satoshi; Iwama, Junya; Hiramoto, Yu; Ishii, Masashi; Sato, Kenichiro; Nakayama, Haruo; Harashina, Junichi; Hayashi, Morito; Izukura, Hideaki; Kimura, Hitoshi; Ito, Keisuke; Sakurai, Takatoshi; Yokouchi, Yuki; Oharazeki, Toshiaki; Takahashi, Kei; Iwabuchi, Satoshi			Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma	BRAIN TUMOR PATHOLOGY			English	Article						Notch; Bevacizumab; Glioma stem cell; Recurrent glioblastoma	NEWLY-DIAGNOSED GLIOBLASTOMA; TUMOR-INITIATING CELLS; SECRETASE INHIBITORS; MALIGNANT GLIOMA; CANCER; PATHWAY; GROWTH; DIFFERENTIATION; TEMOZOLOMIDE; ACTIVATION	Glioma stem cells (GSCs) have the capacity to repopulate tumors and mediate resistance to radiotherapy and chemotherapy. The Notch signaling pathway is important in proliferation, stem cell maintenance, cell differentiation, and tumorigenesis in GSCs. In this study, we compared CD133, Notch, and VEGF expressions in histological sections of primary and recurrent glioblastomas after radiotherapy and chemotherapy. In vitro study, the gamma-secretase inhibitor inhibited NICD, Hes1 and pVEGFR2 expressions in GSCs. GSCs cultured under endothelial conditions undergo endothelial differentiation. Tumor samples were collected from 27 patients at the time of tumor recurrence. We used immunohistochemical techniques to compare expression of CD133, Notch-1 and VEGF. Expressions of CD133-, Notch-1-, and VEGF-positive glioma cells were higher in recurrent glioblastoma after radiotherapy and chemotherapy. To determine the clinical importance of Notch-1 expression in glioblastoma, we analyzed 15 patients who had received bevacizumab therapy followed by a second surgery at recurrence. OS was significantly longer in cases with Notch-1 negativity (8.8 months) than in those with I Notch-1 positivity (6.8 months). We noted that GSCs have the potential for endothelial differentiation with Notch activity. We believe that Notch-1 is a potential target and/or biomarker for antiangiogenic treatments.	[Saito, Norihiko; Aoki, Kazuya; Hirai, Nozomi; Fujita, Satoshi; Iwama, Junya; Hiramoto, Yu; Ishii, Masashi; Sato, Kenichiro; Nakayama, Haruo; Harashina, Junichi; Hayashi, Morito; Izukura, Hideaki; Kimura, Hitoshi; Ito, Keisuke; Sakurai, Takatoshi; Iwabuchi, Satoshi] Toho Univ, Ohashi Med Ctr, Dept Neurosurg, Meguro Ku, Tokyo, Japan; [Yokouchi, Yuki; Oharazeki, Toshiaki; Takahashi, Kei] Toho Univ, Ohashi Med Ctr, Dept Pathol, Tokyo, Japan	Saito, N (reprint author), Toho Univ, Ohashi Med Ctr, Dept Neurosurg, Meguro Ku, 2-17-6 Ohashi, Tokyo, Japan.	bsaitob@med.toho-u.ac.jp					Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Chang SM, 2004, CANCER, V100, P605, DOI 10.1002/cncr.11949; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Gilbert CA, 2010, CANCER RES, V70, P6870, DOI 10.1158/0008-5472.CAN-10-1378; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Hatakeyama J, 2006, DEV NEUROSCI-BASEL, V28, P92, DOI 10.1159/000090756; Saito N, 2014, STEM CELLS, V32, P301, DOI 10.1002/stem.1528; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Phillips TM, 2006, J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Ikushima H, 2010, J BIOL CHEM, V286, P41434; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu SY, 2009, ANN HEMATOL, V88, P613, DOI 10.1007/s00277-008-0646-x; Nandhu MS, 2014, CANCER RES, V74, P5435, DOI 10.1158/0008-5472.CAN-14-0685; Patenaude A, 2014, CANCER RES, V74, P2402, DOI 10.1158/0008-5472.CAN-12-4038; Watters JW, 2009, CANCER RES, V69, P8949, DOI 10.1158/0008-5472.CAN-09-1544	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JUL	2015	32	3					176	183		10.1007/s10014-015-0215-7		8	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CN0EM	WOS:000358086700004		
J	Onishi, M; Ichikawa, T; Kurozumi, K; Inoue, S; Maruo, T; Otani, Y; Fujii, K; Ishida, J; Shimazu, Y; Yoshida, K; Michiue, H; Chiocca, EA; Date, I				Onishi, Manabu; Ichikawa, Tomotsugu; Kurozumi, Kazuhiko; Inoue, Satoshi; Maruo, Tomoko; Otani, Yoshihiro; Fujii, Kentaro; Ishida, Joji; Shimazu, Yosuke; Yoshida, Koichi; Michiue, Hiroyuki; Chiocca, E. Antonio; Date, Isao			Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma	BRAIN TUMOR PATHOLOGY			English	Article						Angiogenesis; Animal model; Annexin A2; Glioma; Invasion	TUMOR INVASION; CELL ADHESION; EXPRESSION; GROWTH; CANCER; GRADE; NEOVASCULARIZATION; GLIOBLASTOMA; PROGRESSION; CARCINOMA	We have established a pair of animal models (J3T-1 and J3T-2) with different invasive and angiogenic phenotypes, and demonstrated that annexin A2 is expressed at higher levels in J3T-1 than J3T-2 cells. The function of annexin A2 in relation to angiogenesis and invasion was investigated using these models. Stable silencing or overexpression of annexin A2 in J3T-1 and J3T-2 cells (J3T-1shA and J3T-2A cells) was established and used. Thirty human glioblastoma samples were evaluated for expression of annexin A2, vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF). Immunohistochemical and quantitative reverse-transcription polymerase chain reaction analyses revealed higher expression of annexin A2, VEGF and PDGF in J3T-1 and J3T-2A cells. Cultured J3T-1 and J3T-2A cells exhibited higher adhesive ability to endothelial cells. Histopathological analysis of animal brain tumors revealed that J3T-1 and J3T-2A tumors displayed marked angiogenesis and invasion along the neovasculature, whereas J3T-2 and J3T-1shA tumors exhibited diffuse, infiltrative invasion without angiogenesis. Positive expression of annexin A2 was observed in tumor cells surrounding dilated vessels in 25/30 human glioblastoma specimens. Our results reveal that the phenotype of glioma invasion is closely related to angiogenesis. We identify annexin A2 as a factor regulating angiogenesis and invasion of malignant gliomas.	[Onishi, Manabu; Ichikawa, Tomotsugu; Kurozumi, Kazuhiko; Inoue, Satoshi; Maruo, Tomoko; Otani, Yoshihiro; Fujii, Kentaro; Ishida, Joji; Shimazu, Yosuke; Yoshida, Koichi; Michiue, Hiroyuki; Date, Isao] Okayama Univ, Dept Neurol Surg, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan; [Chiocca, E. Antonio] Brigham & Womens Faulkner Hosp, Dept Neurosurg, Boston, MA 02116 USA	Ichikawa, T (reprint author), Okayama Univ, Dept Neurol Surg, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	tomoichi@cc.okayama-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [19591675, 22591611, 20890133, 21791364]	We thank M. Arao, A. Ishikawa and N. Uemori for their technical assistance. The following medical students also contributed to the animal experiments: T. Mifune, S. Murai, M. Matsueda, H. Matsumoto and Y. Yoshida. This study was supported by Grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology to T.I. (No. 19591675; No. 22591611) and K.K. (No. 20890133; No. 21791364).	Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Kesavan K, 2010, J BIOL CHEM, V285, P4366, DOI 10.1074/jbc.M109.066092; TRESSLER RJ, 1993, J CELL BIOCHEM, V53, P265, DOI 10.1002/jcb.240530311; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; Zagzag D, 2000, LAB INVEST, V80, P837; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Onishi M, 2011, BRAIN TUMOR PATHOL, V28, P13, DOI 10.1007/s10014-010-0007-z; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Jung YH, 2007, BLOOD, V110, P82, DOI 10.1182/blood-2006-05-021352; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Bao HY, 2009, INT J HEMATOL, V90, P177, DOI 10.1007/s12185-009-0356-8; Emoto K, 2001, ANTICANCER RES, V21, P1339; Godiksen S, 2008, BIOCHEM J, V413, P251, DOI 10.1042/BJ20071496; Ichikawa T, 2000, CANCER GENE THER, V7, P74, DOI 10.1038/sj.cgt.7700086; Inoue S, 2012, WORLD NEUROSURG, V78, P670, DOI 10.1016/j.wneu.2011.09.005; Iwadate Y, 2004, CANCER RES, V64, P2496, DOI 10.1158/0008-5472.CAN-03-1254; Maruo T, 2013, NEUROPATHOLOGY, V33, P264, DOI 10.1111/j.1440-1789.2012.01361.x; Nakamori S, 1997, ANN SURG ONCOL, V4, P361, DOI 10.1007/BF02303588; Onishi M, 2013, NEUROPATHOLOGY, V33, P162, DOI 10.1111/j.1440-1789.2012.01344.x; REEVES SA, 1992, CANCER RES, V52, P6871; ROSEMAN BJ, 1994, ONCOL RES, V6, P561; Sun HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114246; Syed SP, 2007, HUM PATHOL, V38, P508, DOI 10.1016/j.humpath.2006.09.011; Tatenhorst L, 2006, NEUROPATH APPL NEURO, V32, P271, DOI 10.1111/j.1365-2990.2006.00720.x; Zhao SH, 2010, CHINESE MED J-PEKING, V123, P713, DOI 10.3760/cma.j.issn.0366-6999.2010.06.014; Zimmermann U, 2004, VIRCHOWS ARCH, V445, P368, DOI 10.1007/s00428-004-1103-4	29	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JUL	2015	32	3					184	194		10.1007/s10014-015-0216-6		11	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CN0EM	WOS:000358086700005		
J	Takami, H; Mukasa, A; Ikemura, M; Shibahara, J; Takahashi, M; Momose, T; Saito, N				Takami, Hirokazu; Mukasa, Akitake; Ikemura, Masako; Shibahara, Jyunji; Takahashi, Miwako; Momose, Toshimitsu; Saito, Nobuhito			Findings from positron emission tomography and genetic analyses for cerebellar liponeurocytoma	BRAIN TUMOR PATHOLOGY			English	Article						Cerebellar liponeurocytoma; IDH; Immunohistochemistry; PET	PRIMARY BRAIN-TUMORS; DIFFERENTIAL-DIAGNOSIS; CENTRAL NEUROCYTOMA; PET; METHIONINE; MARKER; OLIGODENDROGLIOMAS; MEDULLOBLASTOMA; METABOLISM; EXPRESSION	Cerebellar liponeurocytoma is a rare tumor that usually develops in adult patients, and is categorized as World Health Organization grade II. Because of the small number of reports on its radiological and pathological features, the disease remains poorly characterized. The current case involved a 59-year-old man with tumor in the upper cerebellar vermis. Preoperative positron emission tomography (PET) showed high uptake on C-11-methionine PET, but low uptake on F-18-fluorodeoxyglucose PET. These findings resemble those of central neurocytoma and oligodendroglioma, but are incompatible with other brain tumors. Subtotal tumor removal was performed by suboccipital craniotomy. Histopathological examinations showed sheets of small, isomorphic cells with round nuclei and clear cytoplasm, and focal vacuolated cells resembling adipose cells. On immunohistochemistry, tumor cells were positive for synaptophysin and NeuN. Vacuolated cells were immunoreactive for perilipin. Based on these findings, cerebellar liponeurocytoma was diagnosed. Genetic analyses revealed absences of both chromosome 1p/19q loss and isocitrate dehydrogenase 1 mutation, further ruling out oligodendroglioma. These radiological and genetic aspects of cerebellar liponeurocytoma, which are mostly in common with central neurocytoma, should prove helpful in differentiating this rare tumor from other tumors with similar morphology.	[Takami, Hirokazu; Mukasa, Akitake; Saito, Nobuhito] Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan; [Ikemura, Masako; Shibahara, Jyunji] Tokyo Univ Hosp, Dept Pathol, Tokyo 113, Japan; [Takahashi, Miwako; Momose, Toshimitsu] Tokyo Univ Hosp, Dept Nucl Med, Tokyo 113, Japan	Mukasa, A (reprint author), Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mukasa-nsu@umin.ac.jp					Amina M, 2003, Pathologica, V95, P456; Anghileri E, 2012, J NEURO-ONCOL, V108, P513, DOI 10.1007/s11060-012-0853-0; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Weller M, 2012, NEURO-ONCOLOGY, V14, P100, DOI 10.1093/neuonc/nos206; Capper D, 2011, ACTA NEUROPATHOL, V121, P241, DOI 10.1007/s00401-010-0770-2; Soylemezoglu F, 1996, AM J SURG PATHOL, V20, P413, DOI 10.1097/00000478-199604000-00003; Labussiere M, 2010, NEUROLOGY, V74, P1886, DOI 10.1212/WNL.0b013e3181e1cf3a; Preusser M, 2007, HISTOPATHOLOGY, V50, P365, DOI 10.1111/j.1365-2559.2007.02614.x; Chakraborti S, 2011, J NEURO-ONCOL, V103, P121, DOI 10.1007/s11060-010-0361-z; Reifenberger G, 2003, J NEUROPATH EXP NEUR, V62, P111; Perry A, 2002, J NEUROPATH EXP NEUR, V61, P947; Ueki K, 2002, CLIN CANCER RES, V8, P196; Mukasa A, 2012, CANCER SCI, V103, P587, DOI 10.1111/j.1349-7006.2011.02175.x; Marie Y, 2001, LANCET, V358, P298, DOI 10.1016/S0140-6736(01)05499-X; Borgwardt L, 2000, CLIN POSITRON IMAGIN, V3, P175, DOI 10.1016/S1095-0397(00)00087-X; Cacciola F, 2002, ACTA NEUROCHIR, V144, P829, DOI 10.1007/s007010200082; Giammarile F, 2004, J NEURO-ONCOL, V68, P263, DOI 10.1023/B:NEON.0000033384.43417.82; Gururangan S, 2004, NEUROSURGERY, V55, P1280; Horstmann S, 2004, BRAIN PATHOL, V14, P281; Jackson TR, 2001, J NEUROSURG, V95, P700, DOI 10.3171/jns.2001.95.4.0700; Kleihues P, 2000, PATHOLOGY GENETICS T; Koperek O, 2004, ACTA NEUROPATHOL, V108, P24, DOI 10.1007/s00401-004-0856-9; MINEURA K, 1995, CANCER, V76, P1224, DOI 10.1002/1097-0142(19951001)76:7<1224::AID-CNCR2820760720>3.0.CO;2-R; Mukasa A, 2004, BRAIN PATHOL, V14, P34; Okada M, 2011, BRAIN TUMOR PATHOL, V28, P1; OTUAMA LA, 1990, PEDIATR NEUROL, V6, P163, DOI 10.1016/0887-8994(90)90057-8; Phi JH, 2010, J NUCL MED, V51, P728, DOI 10.2967/jnumed.109.070920; Preusser M, 2006, HISTOPATHOLOGY, V48, P438, DOI 10.1111/j.1365-2559.2006.02359.x; Takao H, 2004, CLIN NUCL MED, V29, P838, DOI 10.1097/00003072-200412000-00023; Tomura N, 2013, AM J NEURORADIOL, V34, P1278, DOI 10.3174/ajnr.A3374	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JUL	2015	32	3					210	215		10.1007/s10014-014-0210-4		6	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CN0EM	WOS:000358086700008		
J	Asai, K; Tani, S; Mineharu, Y; Tsurusaki, Y; Imai, Y; Agawa, Y; Iwaki, K; Matsumoto, N; Sakai, N				Asai, Katsunori; Tani, Shoichi; Mineharu, Yohei; Tsurusaki, Yoshinori; Imai, Yukihiro; Agawa, Yuji; Iwaki, Koichi; Matsumoto, Naomichi; Sakai, Nobuyuki			Familial schwannomatosis with a germline mutation of SMARCB1 in Japan	BRAIN TUMOR PATHOLOGY			English	Article						Schwannomatosis; SMARCB1; NF2; Familial; Germline mutation	SPORADIC SCHWANNOMATOSIS; INI1/SMARCB1; NF2	Schwannomatosis is the third major form of neurofibromatosis (NF) and is distinct from NF1 and NF2. The disease is not well recognized in Asian countries and the role of germline SMARCB1 mutations requires investigation. A 35-year-old Japanese man complaining of headache underwent an MRI examination, which showed a cystic tumor at the left cerebellopontine angle. The tumor was surgically removed and diagnosed as vagus nerve schwannoma. He had a past medical history of multiple schwannomas of the neck, groin and intercostal nerves, which were also treated surgically. He had a family history of multiple schwannomas for his father and sister. Systemic examinations of these family members ruled out a diagnosis of NF1 or NF2, and thus schwannomatosis was suspected. Genetic analysis revealed a germline mutation (c. *82C > T) of SMARCB1, and a somatic mutation of NF2 without loss of heterozygosity at the chromosome 22 locus. This is the first report of familial schwannomatosis associated with a germline mutation of SMARCB1 in an Asian country.	[Asai, Katsunori; Tani, Shoichi; Mineharu, Yohei; Agawa, Yuji; Sakai, Nobuyuki] Kobe City Med Ctr Gen Hosp, Dept Neurosurg, Kobe, Hyogo, Japan; [Asai, Katsunori] Osaka Univ, Sch Med, Dept Neurosurg, Suita, Osaka 5650871, Japan; [Tsurusaki, Yoshinori; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; [Imai, Yukihiro] Kobe City Med Ctr Gen Hosp, Dept Pathol, Kobe, Hyogo, Japan; [Iwaki, Koichi] Kobe City Med Ctr Gen Hosp, Dept Orthoped Surg, Kobe, Hyogo, Japan	Asai, K (reprint author), Osaka Univ, Sch Med, Dept Neurosurg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	asai-osk@umin.ac.jp					Smith MJ, 2012, NEUROGENETICS, V13, P141, DOI 10.1007/s10048-012-0319-8; MacCollin M, 1996, NEUROLOGY, V46, P1072; Patil S, 2008, BRAIN PATHOL, V18, P517, DOI 10.1111/j.1750-3639.2008.00155.x; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; Sestini R, 2008, HUM MUTAT, V29, P227, DOI 10.1002/humu.20679; Piotrowski A, 2014, NAT GENET, V46, P182, DOI 10.1038/ng.2855; Merker VL, 2012, ONCOLOGIST, V17, P1317, DOI 10.1634/theoncologist.2012-0162; Boyd C, 2008, CLIN GENET, V74, P358, DOI 10.1111/j.1399-0004.2008.01060.x; Plotkin SR, 2013, AM J MED GENET A, V161A, P405, DOI 10.1002/ajmg.a.35760; Gonzalvo A, 2011, J NEUROSURG, V114, P756, DOI 10.3171/2010.8.JNS091900; Hadfield KD, 2008, J MED GENET, V45, P332, DOI 10.1136/jmg.2007.056499; Nakajima J, 2014, J HUM GENET, V59, P229, DOI 10.1038/jhg.2013.143; Murakami Y, 2009, J DERMATOL, V36, P508, DOI 10.1111/j.1346-8138.2009.00683.x; SHISHIBA T, 1984, J AM ACAD DERMATOL, V10, P744, DOI 10.1016/S0190-9622(84)70089-2; Yukizane H, 2009, ORTHOP TRAUMATOL, V58, P406	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JUL	2015	32	3					216	220		10.1007/s10014-015-0213-9		5	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CN0EM	WOS:000358086700009		
J	Yoshimoto, T; Takahashi-Fujigasaki, J; Inoshita, N; Fukuhara, N; Nishioka, H; Yamada, S				Yoshimoto, Toyoki; Takahashi-Fujigasaki, Junko; Inoshita, Naoko; Fukuhara, Noriaki; Nishioka, Hiroshi; Yamada, Shozo			TTF-1-positive oncocytic sellar tumor with follicle formation/ependymal differentiation: non-adenomatous tumor capable of two different interpretations as a pituicytoma or a spindle cell oncocytoma	BRAIN TUMOR PATHOLOGY			English	Article						Pituicyte; Folliculostellate cell; Pituicytoma; Spindle cell oncocytoma; Sellar non-adenomatous tumor; TTF-1	FOLLICULOSTELLATE CELLS; STELLATE CELLS; HUMAN PITUITARY; ADENOHYPOPHYSIS; NEUROHYPOPHYSIS; PROTEIN; VARIANT; LUNG	We describe herein the unique case of a 70-year-old male with a TTF-1-positive non-adenomatous sellar tumor that has unusual morphological and immunohistochemical features. MRI examination detected a 2-cm sellar mass that was enhanced heterogeneously. By histology, the tumor was composed of epithelioid and oncocytic cells arranged in a trabecular pattern with occasional luminal structures. The lesion was diffusely immunopositive for thyroid transcription factor-1 (TTF-1) and vimentin but negative for S100 protein and GFAP. Immunoreactivity for epithelial membrane antigen, low molecular weight cytokeratin (CAM 5.2), and neuronal markers was also observed in the tumor cells. By electron microscopy, the tumor cells were filled with abundant mitochondria and extended microvillous projections into small extracellular and intracellular lumens. TTF-1 is considered to be an excellent marker of pituicytes, specialized glia of the neurohypophysis. This case can be regarded as a variant of pituicytoma, showing both ependymal differentiation and oncocytic changes. However, the immunoprofile was not completely consistent with a pituicyte lineage; the epithelial features suggested a possibility of folliculostellate cell origin. TTF-1-positive sellar neoplasms might therefore have variable morphological and immunohistochemical profiles. For suitable classification of TTF-1 positive sellar neoplasms, their histological features should be carefully re-evaluated.	[Yoshimoto, Toyoki; Inoshita, Naoko] Toranomon Gen Hosp, Dept Diagnost Pathol, Minato Ku, Tokyo 1058470, Japan; [Takahashi-Fujigasaki, Junko] Jikei Univ, Sch Med, Div Neuropathol, Minato Ku, Tokyo 1058461, Japan; [Inoshita, Naoko; Nishioka, Hiroshi; Yamada, Shozo] Okinaka Mem Inst Med Res, Minato Ku, Tokyo 1058470, Japan; [Fukuhara, Noriaki; Nishioka, Hiroshi; Yamada, Shozo] Toranomon Gen Hosp, Div Hypothalam & Pituitary Surg, Tokyo 1058470, Japan; [Yoshimoto, Toyoki] Toranomon Gen Hosp, Dept Pathol, Minato Ku, Tokyo 1058470, Japan	Yoshimoto, T (reprint author), Toranomon Gen Hosp, Dept Diagnost Pathol, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	toyokiy@gmail.com					Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Lee EB, 2009, J NEUROPATH EXP NEUR, V68, P482, DOI 10.1097/NEN.0b013e3181a13fca; Coire CI, 2009, CLIN NEUROPATHOL, V28, P303; Brat DJ, 2000, AM J SURG PATHOL, V24, P362, DOI 10.1097/00000478-200003000-00004; Inoue K, 1999, ARCH HISTOL CYTOL, V62, P205, DOI 10.1679/aohc.62.205; Roncaroli F, 2002, AM J SURG PATHOL, V26, P1048, DOI 10.1097/01.PAS.0000020480.56467.9B; COATES PJ, 1988, ACTA ENDOCRINOL-COP, V119, P16; HATTON GI, 1988, J EXP BIOL, V139, P67; Horvath E, 2010, ULTRASTRUCT PATHOL, V34, P133, DOI 10.3109/01913121003662247; Kowalski Robert J, 2004, Ann Diagn Pathol, V8, P290, DOI 10.1016/j.anndiagpath.2004.07.006; Mete O, 2013, AM J SURG PATHOL, V37, P1694, DOI 10.1097/PAS.0b013e31829723e7; NAKAJIMA T, 1980, BRAIN RES, V191, P523, DOI 10.1016/0006-8993(80)91300-1; Kamil ZS, 2014, ENDOCR PATHOL, V25, P436, DOI 10.1007/s12022-013-9279-2; Scheithauer BW, 2009, HUM PATHOL, V40, P435, DOI 10.1016/j.humpath.2008.08.013; Singh G, 2012, CLIN NEUROL NEUROSUR, V114, P267, DOI 10.1016/j.clineuro.2011.10.014; TAKEI Y, 1980, CELL TISSUE RES, V205, P273; Vajtai I, 2011, ACTA NEUROPATHOL, V122, P253, DOI 10.1007/s00401-011-0835-x; Yamashita M, 2005, PATHOL INT, V55, P244, DOI 10.1111/j.1440-1827.2005.01820.x	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JUL	2015	32	3					221	227		10.1007/s10014-015-0219-3		7	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CN0EM	WOS:000358086700010		
J	Miyagishima, K				Miyagishima, Kaname			A CHARACTERIZATION OF THE RAWLSIAN SOCIAL ORDERING OVER INFINITE UTILITY STREAMS	BULLETIN OF ECONOMIC RESEARCH			English	Article						infinite utility streams; Rawlsian social ordering; D63; D71	INTERGENERATIONAL EQUITY; GENERATIONS; SOLIDARITY; PRIORITY	In this paper, we characterize a Rawlsian ordering over infinite utility streams using a fairness principle called Hammond Equity, as well as a weak efficiency principle, Sup Continuity, and a condition that links finite and infinite settings of distributive justice called Preference Continuity.	Waseda Univ, Shinjuku Ku, Tokyo 1698050, Japan	Miyagishima, K (reprint author), Waseda Univ, Shinjuku Ku, 1120 Bldg 3,1-104 Totsukamachi, Tokyo 1698050, Japan.	Kaname1128@gmail.com			Japan Society for the Promotion of Science	Correspondence: Kaname Miyagishima, JSPS Research Fellow, Waseda University, #1120 Building 3, 1-104 Totsukamachi, Shinjuku-ku, Tokyo, 169-8050, Japan. Email: Kaname1128@gmail.com. The author is grateful to Kohei Kamaga, Michele Lombardi, Z. Emel Ozturk, and anonymous referees for helpful comments and suggestions. Financial support from the Japan Society for the Promotion of Science is gratefully acknowledged.	HAMMOND PJ, 1976, ECONOMETRICA, V44, P793, DOI 10.2307/1913445; Basu K, 2003, ECONOMETRICA, V71, P1557, DOI 10.1111/1468-0262.00458; Asheim GB, 2004, ECON THEOR, V24, P221, DOI 10.1007/s00199-003-0412-1; Bossert W, 2007, J ECON THEORY, V135, P579, DOI 10.1016/j.jet.2006.03.005; Chambers CP, 2009, SOC CHOICE WELFARE, V32, P243, DOI 10.1007/s00355-008-0321-0; Chun Y, 2014, SOC CHOICE WELFARE, V43, P577, DOI 10.1007/s00355-014-0796-9; DIAMOND PA, 1965, ECONOMETRICA, V33, P170, DOI 10.2307/1911893; FLEURBAEY M., 2005, REV ECON DES, V9, P145, DOI 10.1007/s10058-005-0124-z; Lauwers L, 1997, ECON THEORY, V9, P143, DOI 10.1007/BF01213448; Lombardi M., 2013, LIBERAL EGALIT UNPUB; Moreno-Ternero JD, 2006, ECONOMETRICA, V74, P1419, DOI 10.1111/j.1468-0262.2006.00710.x; Sakai T, 2003, SOC CHOICE WELFARE, V20, P167, DOI 10.1007/s003550200180; SVENSSON LG, 1980, ECONOMETRICA, V48, P1251, DOI 10.2307/1912181	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-3378	1467-8586		B ECON RES	Bull Econ. Res.	JUL	2015	67	3					303	308		10.1111/boer.12044		6	Economics	Business & Economics	CM7ET	WOS:000357853900007		
J	Miwa, T; Kokuryo, T; Yokoyama, Y; Yamaguchi, J; Nagino, M				Miwa, Tomohiro; Kokuryo, Toshio; Yokoyama, Yukihiro; Yamaguchi, Junpei; Nagino, Masato			Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer	CANCER MEDICINE			English	Article						angiogenesis; IGFBP3; pancreatic cancer; TPX2	ENDOTHELIAL GROWTH-FACTOR; LUNG-CANCER; TPX2; INHIBITION; EXPRESSION; ADENOCARCINOMA; ANGIOGENESIS; SUPPRESSION; PROGRESSION; METASTASIS	The targeting protein for Xklp2 (TPX2) is a microtubule- and, cell cycle-associated protein who's overexpression has been reported in various malignancies. In this study, we verified the overexpression of TPX2 in both surgically resected specimens of pancreatic cancer and multiple pancreatic cancer cell lines. Subsequently, we found that TPX2 siRNA effectively suppressed the proliferation of pancreatic cancer cells in culture, and the direct injection of TPX2 siRNA into subcutaneously implanted pancreatic cancer cells in nude mice revealed antiproliferative effects. These results implied a therapeutic potential of TPX2 siRNA in pancreatic cancer. Among 56 angiogenesis-related factors examined using angiogenesis arrays, the average protein levels of insulin-like growth factor-binding protein-3 (IGFBP-3) were significantly higher in TPX2 siRNA-treated tumors than in the Control siRNA-treated tumors. Moreover, we demonstrated that CD34-positive microvessels were significantly reduced in tumors treated with TPX2 siRNA compared to tumors that treated with Control siRNA. The attenuated expression of CD34 in TPX2 siRNA-treated tumors coincided with the overexpression of IGFBP-3. These results indicated that TPX2 has an impact on tumor angiogenesis in pancreatic cancer. The results also implied that the antiangiogenic effect observed in TPX2 siRNA-treated pancreatic cancer cells may be partly explained by the upregulation of IGFBP-3.	[Miwa, Tomohiro; Kokuryo, Toshio; Yokoyama, Yukihiro; Yamaguchi, Junpei; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, Nagoya, Aichi 4668550, Japan	Kokuryo, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kokuryoh@med.nagoya-u.ac.jp					Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; McCaig C, 2002, J CELL SCI, V115, P4293, DOI 10.1242/jcs.00097; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Yan L, 2013, TUMOR BIOL, V34, P4089, DOI 10.1007/s13277-013-1000-z; Ikeda N, 1999, BRIT J CANCER, V79, P1553, DOI 10.1038/sj.bjc.6690248; Oh SH, 2006, MOL CANCER THER, V5, P2685, DOI 10.1158/1535-7163.MCT-06-0142; Kokuryo T, 2007, CANCER RES, V67, P9637, DOI 10.1158/0008-5472.CAN-07-1489; Chang HP, 2012, ONCOL REP, V27, P1353, DOI 10.3892/or.2012.1668; Kim JH, 2011, BLOOD, V118, P2622, DOI 10.1182/blood-2010-08-299784; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Liu B, 2007, ONCOGENE, V26, P1811, DOI 10.1038/sj.onc.1209977; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Neumayer G, 2012, J BIOL CHEM, V287, P42206, DOI 10.1074/jbc.M112.385674; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jch.200312112; Balaz P, 2001, PANCREATOLOGY, V1, P343, DOI 10.1159/000055833; Hsu PK, 2013, J GASTROENTEROL, V49, P1231; Itakura J, 1997, CLIN CANCER RES, V3, P1309; Korc M, 1998, Surg Oncol Clin N Am, V7, P25; Littlejohn JE, 2008, INT J CANCER, V123, P202, DOI 10.1002/ijc.23452; Ma Y, 2006, CLIN CANCER RES, V12, P1121, DOI 10.1158/1078-0432.CCR-05-1766; Seo Y, 2000, CANCER, V88, P2239, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0.CO;2-V; vansMoorselaar R J., 2002, MOL CELL ENDOCRINOL, V197, P239; Wang S, 2014, BIOMED RES INT, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0089848; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Wei P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-313; Yamori T, 1997, JPN J CANCER RES, V88, P1205	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	JUL	2015	4	7					1091	1100		10.1002/cam4.453		10	Oncology	Oncology	CM7TJ	WOS:000357899100014		
J	Nagasawa, S; Maeda, I; Fukuda, T; Wu, WW; Hayami, R; Kojima, Y; Tsugawa, K; Ohta, T				Nagasawa, Satoi; Maeda, Ichiro; Fukuda, Takayo; Wu, Wenwen; Hayami, Ryosuke; Kojima, Yasuyuki; Tsugawa, Ko-ichiro; Ohta, Tomohiko			MED12 exon 2 mutations in phyllodes tumors of the breast	CANCER MEDICINE			English	Article						Breast; MED12; mutation; phyllodes	SMOOTH-MUSCLE TUMORS; UTERINE LEIOMYOMAS; SOMATIC MUTATIONS; LEIOMYOSARCOMA; COMPLEX; CANCER; GENE	Exon 2 of MED12, a subunit of the transcriptional mediator complex, has been frequently mutated in uterine leiomyomas and breast fibroadenomas; however, it has been rarely mutated in other tumors. Although the mutations were also found in uterine leiomyosarcomas, the frequency was significantly lower than in uterine leiomyomas. Here, we examined the MED12 mutation in phyllodes tumors, another biphasic tumor with epithelial and stromal components related to breast fibroadenomas. Mutations in MED12 exon 2 were analyzed in nine fibroadenomas and eleven phyllodes tumors via Sanger sequencing. A panel of cancer- and sarcoma-related genes was also analyzed using Ion Torrent next-generation sequencing. Six mutations in fibroadenomas, including those previously reported (6/9, 67%), and five mutations in phyllodes tumors (5/11, 45%) were observed. Three mutations in the phyllodes tumors were missense mutations at Gly44, which is common in uterine leiomyomas and breast fibroadenomas. In addition, two deletion mutations (in-frame c.133_144del12 and loss of splice acceptor c.100-68_137del106) were observed in the phyllodes tumors. No other recurrent mutation was observed with next-generation sequencing. Frequent mutations in MED12 exon 2 in the phyllodes tumors suggest that it may share genetic etiology with uterine leiomyoma, a subgroup of uterine leiomyosarcomas and breast fibroadenoma.	[Nagasawa, Satoi; Fukuda, Takayo; Wu, Wenwen; Ohta, Tomohiko] St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa 2168511, Japan; [Nagasawa, Satoi; Hayami, Ryosuke; Kojima, Yasuyuki; Tsugawa, Ko-ichiro] St Marianna Univ, Grad Sch Med, Dept Surg, Div Breast & Endocrine Surg, Kawasaki, Kanagawa 2168511, Japan; [Maeda, Ichiro] St Marianna Univ, Grad Sch Med, Dept Pathol, Kawasaki, Kanagawa 2168511, Japan	Ohta, T (reprint author), St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa 2168511, Japan.	to@marianna-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Science, Sports, Culture and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	We are grateful to Hideyo Yasuda for valuable advice and technical supports. This study was supported by grants from the Japan Society for the Promotion of Science, the Ministry of Education, Science, Sports, Culture and Technology of Japan, the Ministry of Health, Labour and Welfare of Japan.	Ben hassouna J, 2006, AM J SURG, V192, P141, DOI 10.1016/j.amjsurg.2006.04.007; Tan PH, 2005, AM J CLIN PATHOL, V123, P529, DOI 10.1309/U6DVBFM81MLJC1FN; Lim WK, 2014, NAT GENET, V46, P877, DOI 10.1038/ng.3037; Halder SK, 2015, MOL GENET GENOMICS, V290, P505, DOI 10.1007/s00438-014-0938-x; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Markowski DN, 2013, GENE CHROMOSOME CANC, V52, P297, DOI 10.1002/gcc.22029; Ravegnini G, 2013, MODERN PATHOL, V26, P743, DOI 10.1038/modpathol.2012.203; Assie G, 2014, NAT GENET, V46, P607, DOI 10.1038/ng.2953; Mehine M, 2013, NEW ENGL J MED, V369, P43, DOI 10.1056/NEJMoa1302736; Kampjarvi K, 2012, BRIT J CANCER, V107, P1761, DOI 10.1038/bjc.2012.428; Turunen M, 2014, CELL REP, V7, P654, DOI 10.1016/j.celrep.2014.03.047; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bertsch E, 2014, MODERN PATHOL, V27, P1144, DOI 10.1038/modpathol.2013.243; Matsubara A, 2013, HISTOPATHOLOGY, V62, P657, DOI 10.1111/his.12039; desGraaff M. A., 2013, HUM PATHOL, V44, P1597; DisTommaso S., 2014, MOL HUM REPROD, V20, P1009; Guerrero MA, 2003, SURG ONCOL, V12, P27, DOI 10.1016/S0960-7404(03)00005-7; Je EM, 2012, INT J CANCER, V131, pE1044, DOI 10.1002/ijc.27610; McGuire MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033251; Nagasawa S., 2014, ST MARIANNA MED J, V42, P129; Perot G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040015	24	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	JUL	2015	4	7					1117	1121		10.1002/cam4.462		5	Oncology	Oncology	CM7TJ	WOS:000357899100016		
J	Tsuchida, J; Nagahashi, M; Rashid, OM; Takabe, K; Wakai, T				Tsuchida, Junko; Nagahashi, Masayuki; Rashid, Omar M.; Takabe, Kazuaki; Wakai, Toshifumi			At what age should screening mammography be recommended for Asian women?	CANCER MEDICINE			English	Review						Age; Asian women; breast cancer; ethnicity; screening mammography	CANCER-SOCIETY GUIDELINES; SERVICES TASK-FORCE; BREAST-CANCER; FOLLOW-UP; UNITED-STATES; RANDOMIZED-TRIAL; DEATH RATES; MORTALITY; JAPAN; TRENDS	Although regular screening mammography has been suggested to be associated with improvements in the relative survival of breast cancer in recent years, the appropriate age to start screening mammography remains controversial. In November 2009, the United States Preventive Service Task Force published updated guidelines for breast cancer, which no longer support routine screening mammography for women aged 40-49years, but instead, defer the choice of screening in that age group to the patient and physician. The age to begin screening differs between guidelines, including those from the Task Force, the American Cancer Society and the World Health Organization. It remains unclear how this discrepancy impacts patient survival, especially among certain subpopulations. Although the biological characteristics of breast cancer and peak age of incidence differ among different ethnic populations, there have been few reports that evaluate the starting age for screening mammography based on ethnicity. Here, we discuss the benefits and harm of screening mammography in the fifth decade, and re-evaluate the starting age for screening mammography taking ethnicity into account, focusing on the Asian population. Breast cancer incidence peaked in the fifth decade in Asian women, which has been thought to be due to a combination of biological and environmental factors. Previous reports suggest that Asian women in their 40s may receive more benefit and less harm from screening mammography than the age-matched non-Asian US population. Therefore, starting screening mammography at age 40 may be beneficial for women of Asian ethnicity in well-resourced countries, such as Japanese women who reside in Japan.	[Tsuchida, Junko; Nagahashi, Masayuki; Wakai, Toshifumi] Niigata Univ, Grad Sch Med & Dent Sci, Div Digest & Gen Surg, Chuo Ku, Niigata 9518510, Japan; [Nagahashi, Masayuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Med Oncol, Chuo Ku, Niigata 9518510, Japan; [Rashid, Omar M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Takabe, Kazuaki] Virginia Commonwealth Univ, Sch Med, Dept Surg, Div Surg Oncol, Richmond, VA 23219 USA; [Takabe, Kazuaki] Massey Canc Ctr, Richmond, VA 23219 USA	Nagahashi, M (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Digest & Gen Surg, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	mnagahashi@med.niigata-u.ac.jp			Tohoku Cancer Professional Training Promotion Plan; Uehara Memorial Foundation; Nakayama Cancer Research Institute; NIH/NCI [R01CA160688]; Susan G. Komen Investigator Initiated Research Grant [IIR12222224]	J. T. and M. N. are supported by Tohoku Cancer Professional Training Promotion Plan. M. N. is supported by the Uehara Memorial Foundation and Nakayama Cancer Research Institute. K. T. is supported by NIH/NCI grant R01CA160688 and Susan G. Komen Investigator Initiated Research Grant IIR12222224.	Adepoju L, 2014, AM J SURG, V208, P382, DOI 10.1016/j.amjsurg.2014.02.008; Leong SPL, 2010, WORLD J SURG, V34, P2308, DOI 10.1007/s00268-010-0683-1; Servick K, 2014, SCIENCE, V343, P1452, DOI 10.1126/science.343.6178.1452; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Bjurstam N, 2003, CANCER, V97, P2387, DOI 10.1002/cncr.11361; Iwasaki M, 2011, CANCER SCI, V102, P1607, DOI 10.1111/j.1349-7006.2011.01996.x; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Hendrick RE, 2011, AM J ROENTGENOL, V196, pW112, DOI 10.2214/AJR.10.5609; MILLER AB, 1992, CAN MED ASSOC J, V147, P1477; Alexander FE, 1999, LANCET, V353, P1903, DOI 10.1016/S0140-6736(98)07413-3; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; [Anonymous], COMPR SURV LIV COND; Smith RA, 2003, CA-CANCER J CLIN, V53, P141; Saslow D, 2007, CA-CANCER J CLIN, V57, P75; Miller AB, 2002, ANN INTERN MED, V137, P305; ANDERSSON I, 1988, BRIT MED J, V297, P943; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Kasahara Y, 2013, BREAST CANCER-TOKYO, V20, P310, DOI 10.1007/s12282-012-0333-6; MILLER AB, 1992, CAN MED ASSOC J, V147, P1459; Smith RA, 2010, CA-CANCER J CLIN, V60, P99, DOI 10.3322/caac.20063; Helvie MA, 2014, CANCER-AM CANCER SOC, V120, P2649, DOI 10.1002/cncr.28784; Lim SE, 2007, WORLD J SURG, V31, P1387, DOI 10.1007/s00268-007-9086-3; Frisell J, 1997, BREAST CANCER RES TR, V45, P263, DOI 10.1023/A:1005872617944; Miller AB, 2000, J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Berry DA, 2014, CANCER-AM CANCER SOC, V120, P2784, DOI 10.1002/cncr.28795; Bjurstam N., 1997, J NATL CANC I MONOGR, P53; Bleyer A., 2014, CANCER, V121, P320; Centers for Disease Control and Prevention. National Center for Health Statistics National Health Interview Survey, 2010, NAT HLTH INT SURV; HABBEMA JDF, 1986, JNCI-J NATL CANCER I, V77, P317; Habtes I, 2013, CANCER-AM CANCER SOC, V119, P481, DOI 10.1002/cncr.27698; Hellquist BN, 2015, CANCER-AM CANCER SOC, V121, P251, DOI 10.1002/cncr.29011; Howlader N, SEER CANC STAT REV 1; Humphrey LL, 2002, ANN INTERN MED, V137, P347; Js L., 1999, LANCET, V354, P1787; Kopans DB, 2014, CANCER-AM CANCER SOC, V120, P2792, DOI 10.1002/cncr.28791; Miller A B, 1997, J Natl Cancer Inst Monogr, P37; Morimoto T, 2009, BREAST CANCER-TOKYO, V16, P2, DOI 10.1007/s12282-008-0077-5; Nagata C, 1996, MATURITAS, V25, P201, DOI 10.1016/S0378-5122(96)01067-5; National Cancer Center, MON CANC INC JAP SUR; National Cancer Center Research Institute, CANC STAT; Nelson HD, 2009, ANN INTERN MED, V151, pW237, DOI DOI 10.7326/0003-4819-151-10-200911170-00009; Onega T, 2014, CANCER-AM CANCER SOC, V120, P2955, DOI 10.1002/cncr.28771; Printz C, 2014, CANCER-AM CANCER SOC, V120, P1755, DOI 10.1002/cncr.28803; Shin HR, 2010, CANCER SCI, V101, P1241, DOI 10.1111/j.1349-7006.2010.01519.x; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Smith RA, 2012, CA-CANCER J CLIN, V62, P129, DOI 10.3322/caac.20143; Tsunematsu M, 2013, ASIAN PAC J CANCER P, V14, P6041, DOI 10.7314/APJCP.2013.14.10.6041; Uchida K, 2015, BREAST CANCER-TOKYO, V22, P172, DOI 10.1007/s12282-013-0470-6; Calonge N, 2009, ANN INTERN MED, V151, P716; US Preventive Services Task Force, 2009, ANN INTERN MED, V151, pW; U.S. Preventive Services Task Force, 2002, ANN INTERN MED, V137, P344; Webb ML, 2014, CANCER-AM CANCER SOC, V120, P2839, DOI 10.1002/cncr.28199; WHO, GLOBOCAN 2012 EST CA; World Health Organization, WHO POS PAP MAMM SCR; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	JUL	2015	4	7					1136	1144		10.1002/cam4.468		9	Oncology	Oncology	CM7TJ	WOS:000357899100018		
J	Yang, JCH; Ahn, MJ; Nakagawa, K; Tamura, T; Barraclough, H; Enatsu, S; Cheng, R; Orlando, M				Yang, James Chin-Hsin; Ahn, Myung-Ju; Nakagawa, Kazuhiko; Tamura, Tomohide; Barraclough, Helen; Enatsu, Sotaro; Cheng, Rebecca; Orlando, Mauro			Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT	CANCER RESEARCH AND TREATMENT			English	Article						Pemetrexed; Maintenance chemotherapy; Nonsquamous non-small cell lung carcinoma; Far East	PHASE-III TRIAL; SUPPORTIVE CARE; 1ST-LINE TREATMENT; INDUCTION THERAPY; PLUS CISPLATIN; CHEMOTHERAPY; CARBOPLATIN; DOCETAXEL; DURATION; SAFETY	Purpose A recent phase III study (PARAMOUNT) demonstrated that pemetrexed continuation maintenance therapy is a new treatment paradigm for advanced nonsquamous non-small cell lung cancer (NSCLC). The majority of patients enrolled in PARAMOUNT were Caucasian (94%). We reviewed efficacy and safety data from two clinical trials, which enrolled East Asian (EA) patients, to supplement data from PARAMOUNT on pemetrexed continuation maintenance therapy in patients with nonsquamous NSCLC. Materials and Methods Study S110 was a phase II, multicenter, randomized, controlled, open-label trial in never-smoker, chemonaive, EA patients (n=31) with locally advanced or metastatic nonsquamous NSCLC (n=27). Study JMII was a multicenter, open-label, single-arm, post-marketing, clinical trial in Japanese patients (n=109) with advanced nonsquamous NSCLC. PARAMOUNT was a multicenter, randomized, double-blind, placebo-controlled trial in patients with advanced nonsquamous NSCLC. Results In EA patients with nonsquamous NSCLC, the median progression-free survival (PFS) for pemetrexed continuation maintenance therapy was 4.04 months (95% confidence interval [CI], 3.22 to 5.29 months) in study S110 and 3.9 months (95% CI, 3.2 to 5.2 months) in study JMII. The median PFS for pemetrexed continuation maintenance therapy in PARAMOUNT was 4.1 months (95% CI, 3.2 to 4.6 months). Pemetrexed continuation maintenance therapy in EA patients in studies S110 and JMII did not lead to any unexpected safety events, and was consistent with PARAMOUNT's safety profile. Conclusion The efficacy and safety data in the EA trials were similar to those in PARAMOUNT despite differences in patient populations and study designs. These data represent consistent evidence for pemetrexed continuation maintenance therapy in EA patients with advanced nonsquamous NSCLC.	[Yang, James Chin-Hsin] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Ahn, Myung-Ju] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Osaka, Japan; [Tamura, Tomohide] Natl Canc Ctr, Tokyo, Japan; [Barraclough, Helen] Eli Lilly Australia, West Ryde, Australia; [Enatsu, Sotaro] Eli Lilly Japan, Kobe, Hyogo, Japan; [Cheng, Rebecca] Eli Lilly & Co, Taipei, Taiwan; [Cheng, Rebecca] Eli Lilly & Co, Hong Kong, Hong Kong, Peoples R China; [Orlando, Mauro] Eli Lilly Interamer, Buenos Aires, DF, Argentina	Orlando, M (reprint author), Eli Lilly Interamer, Tronador 4890,Piso 12, Buenos Aires, DF, Argentina.	mauro@lilly.com			Eli Lilly and Company	This research was funded by Eli Lilly and Company and/or any of its subsidiaries. We thank Risa Sekiguchi for her critical review of the manuscript and for providing statistical input. We thank Pavan Yenduri, Sharad Wankhade, and Shannon Gardell of inVentiv Health Clinical for writing support, and Noelle Gasco of inVentiv Health Clinical for editorial support.	Gridelli C, 2012, J THORAC ONCOL, V7, P1713, DOI 10.1097/JTO.0b013e318267cf84; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Socinski MA, 2002, J CLIN ONCOL, V20, P1335, DOI 10.1200/JCO.20.5.1335; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Ahn MJ, 2012, LUNG CANCER, V77, P346, DOI 10.1016/j.lungcan.2012.03.011; Paz-Ares LG, 2013, J CLIN ONCOL, V31, P2895, DOI 10.1200/JCO.2012.47.1102; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Shih C, 1997, CANCER RES, V57, P1116; Karayama M, 2013, CANCER CHEMOTH PHARM, V72, P445, DOI 10.1007/s00280-013-2218-6; Azzoli Christopher G, 2012, J Oncol Pract, V8, P63, DOI 10.1200/JOP.2011.000374; Belani CP, 2012, J THORAC ONCOL, V7, P567, DOI 10.1097/JTO.0b013e31823d4f9d; Mubarak N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-423; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Okamoto I, 2013, INVEST NEW DRUG, V31, P1275, DOI 10.1007/s10637-013-9941-z; Smith IE, 2001, J CLIN ONCOL, V19, P1336	16	0	0	KOREAN CANCER ASSOCIATION	SEOUL	RM 1824, GWANGHWAMUN OFFICIA, 92 SAEMUNAN-RO, JONGNO-GU, SEOUL, 110-999, SOUTH KOREA	1598-2998	2005-9256		CANCER RES TREAT	Cancer Res. Treat.	JUL	2015	47	3					424	435		10.4143/crt.2013.266		12	Oncology	Oncology	CM7LR	WOS:000357874900009		
J	Kamiyama, M; Naguro, I; Ichijo, H				Kamiyama, Miki; Naguro, Isao; Ichijo, Hidenori			In vivo gene manipulation reveals the impact of stress-responsive MAPK pathways on tumor progression	CANCER SCIENCE			English	Review						Carcinogenesis; genetic engineering; metastasis; proliferation; differentiation; signal transduction	ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATING KINASE-1; JUN NH2-TERMINAL KINASE-1; INDUCED SKIN-CANCER; GASTRIC-CANCER; INTESTINAL HOMEOSTASIS; TARGETED EXPRESSION; EPIDERMAL NEOPLASIA; CELL PROLIFERATION; MOUSE MODELS	It has been widely accepted that tumor cells and normal stromal cells in the host environment coordinately modulate tumor progression. Mitogen-activated protein kinase pathways are the representative stress-responsive cascades that exert proper cellular responses to divergent environmental stimuli. Genetically engineered mouse models and chemically induced tumorigenesis models have revealed that components of the MAPK pathway not only regulate the behavior of tumor cells themselves but also that of surrounding normal stromal cells in the host environment during cancer pathogenesis. The individual functions of MAPK pathway components in tumor initiation and progression vary depending on the stimuli and the stromal cell types involved in tumor progression, in addition to the molecular isoforms of the components and the origins of the tumor. Recent studies have indicated that MAPK pathway components synergize with environmental factors (e.g. tobacco smoke and diet) to affect tumor initiation and progression. Moreover, some components play distinct roles in the course of tumor progression, such as before and after the establishment of tumors. Hence, a comprehensive understanding of the multifaceted functions of MAPK pathway components in tumor initiation and progression is essential for the improvement of cancer therapy. In this review, we focus on the reports that utilized knockout, conditional knockout, and transgenic mice of MAPK pathway components to investigate the effects of MAPK pathway components on tumor initiation and progression in the host environment.	[Kamiyama, Miki; Naguro, Isao; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan	Ichijo, H (reprint author), 3-1,7 Chome,Bunkyo Ku, Tokyo 1130033, Japan.	ichijo@mol.f.u-tokyo.ac.jp			Japanese Society for the Promotion of Sciences; Japanese Ministry of Education, Culture, Sports, Science and Technology; National Institute of Biomedical Innovation; Ono Medical Research Foundation; Terumo Life Science Foundation; Suzuken Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders	Japanese Society for the Promotion of Sciences; Japanese Ministry of Education, Culture, Sports, Science and Technology; National Institute of Biomedical Innovation; Ono Medical Research Foundation; Terumo Life Science Foundation; Suzuken Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders.	Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; She QB, 2002, CANCER RES, V62, P1343; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; Gay LJ, 2011, CANCER CELL, V20, P553, DOI 10.1016/j.ccr.2011.11.001; Widmann C, 1999, PHYSIOL REV, V79, P143; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Iriyama T, 2009, EMBO J, V28, P843, DOI 10.1038/emboj.2009.32; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Matsuo Y, 2006, J BIOL CHEM, V281, P36767, DOI 10.1074/jbc.M604371200; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; Feith DJ, 2005, CANCER RES, V65, P572; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Nakagawa H, 2011, HEPATOLOGY, V54, P185, DOI 10.1002/hep.24357; Serebrennikova OB, 2012, P NATL ACAD SCI USA, V109, pE1082, DOI 10.1073/pnas.1115098109; Scholl FA, 2009, CANCER RES, V69, P3772, DOI 10.1158/0008-5472.CAN-08-1963; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Das M, 2011, GENE DEV, V25, P634, DOI 10.1101/gad.1989311; Ahn YH, 2011, MOL CELL BIOL, V31, P4270, DOI 10.1128/MCB.05562-11; Cuevas BD, 2006, ONCOGENE, V25, P4998, DOI 10.1038/sj.onc.1209507; Bertheau P, 2013, BREAST, V22, pS27, DOI 10.1016/j.breast.2013.07.005; Chen NY, 2001, CANCER RES, V61, P3908; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Hayakawa Y, 2011, P NATL ACAD SCI USA, V108, P780, DOI 10.1073/pnas.1011418108; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Yang L, 2013, GASTROENTEROLOGY, V144, P1042, DOI 10.1053/j.gastro.2013.01.056; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Gkirtzimanaki K, 2013, P NATL ACAD SCI USA, V110, pE1470, DOI 10.1073/pnas.1215938110; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Schindler EM, 2009, CANCER RES, V69, P4648, DOI 10.1158/0008-5472.CAN-08-4455; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; Mercer K, 2005, CANCER RES, V65, P11493, DOI 10.1158/0008-5472.CAN-05-2211; Gupta J, 2014, CANCER CELL, V25, P484, DOI 10.1016/j.ccr.2014.02.019; Pritchard C, 2007, BIOCHEM SOC T, V35, P1329; Sakurai T, 2013, CANCER RES, V73, P215, DOI 10.1158/0008-5472.CAN-12-1602; Davies CC, 2014, CANCER RES, V74, P3344, DOI 10.1158/0008-5472.CAN-13-2941; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; DeCicco-Skinner KL, 2011, ONCOGENE, V30, P389, DOI 10.1038/onc.2010.447; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Bi XL, 2011, CARCINOGENESIS, V32, P584, DOI 10.1093/carcin/bgq275; Bourcier C, 2006, CANCER RES, V66, P2700, DOI 10.1158/0008-5472.CAN-05-3129; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Cellurale C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012469; Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443; Choi HS, 2009, MOL CELL BIOL, V29, P2168, DOI 10.1128/MCB.01508-08; Dickinson SE, 2011, MOL CARCINOGEN, V50, P469, DOI 10.1002/mc.20734; Ehrenreiter K, 2009, CANCER CELL, V16, P149, DOI 10.1016/j.ccr.2009.06.008; Finegan KG, 2010, CANCER RES, V70, P5797, DOI 10.1158/0008-5472.CAN-09-3669; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Gao YF, 2005, J IMMUNOL, V175, P5783; Hayakawa Y, 2010, GASTROENTEROLOGY, V138, P1055, DOI 10.1053/j.gastro.2009.11.015; Hayakawa Y, 2012, CANCER SCI, V103, P2181, DOI 10.1111/cas.12024; Jeong JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003949; Lamothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051228; Liu KD, 2013, CANCER RES, V73, P2181, DOI 10.1158/0008-5472.CAN-12-3408; Murakami S, 2007, CANCER SCI, V98, P1521, DOI 10.1111/j.1349-7006.2007.00551.x; Nasrazadani Azadeh, 2011, Genes Cancer, V2, P31, DOI 10.1177/1947601911400901; Reino Pd, 2014, CANCER RES, V74, P6150; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; Shibata W, 2008, CANCER RES, V68, P5031, DOI 10.1158/0008-5472.CAN-07-6332; Sobczak I, 2008, ONCOGENE, V27, P4779, DOI 10.1038/onc.2008.128; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Tsatsanis C, 2008, P NATL ACAD SCI USA, V105, P2987, DOI 10.1073/pnas.0708381104; Wakeman D, 2012, SURGERY, V152, P286, DOI 10.1016/j.surg.2012.05.009	80	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					785	796		10.1111/cas.12676		12	Oncology	Oncology	CM7OK	WOS:000357883900001		
J	Hirai, H; Yokota, A; Tamura, A; Sato, A; Maekawa, T				Hirai, Hideyo; Yokota, Asumi; Tamura, Akihiro; Sato, Atsushi; Maekawa, Taira			Non-steady-state hematopoiesis regulated by the C/EBP transcription factor	CANCER SCIENCE			English	Review						Cancer; C/EBP beta; emergency; hematological malignancy; steady-state	SEVERE CONGENITAL NEUTROPENIA; TUMOR-ASSOCIATED MACROPHAGES; PLURIPOTENT STEM-CELLS; BINDING PROTEIN ALPHA; EMERGENCY GRANULOPOIESIS; G-CSF; MYELOID PROGENITOR; INHIBITORY PROTEIN; ACTIVATOR PROTEIN; SUPPRESSOR-CELLS	Steady-state hematopoiesis responds to extracellular stimuli to meet changing demands and also to pathologically altered intracellular signaling. Granulocyte production increases following infection or in response to cytokine stimulation, and activation of the CCAAT/enhancer-binding protein (C/EBP) transcription factor is required for such stress-induced granulopoiesis, whereas C/EBP plays a critical role in maintaining steady-state granulopoiesis. Different roles of these C/EBP transcription factors in different modes of hematopoiesis are evolutionally conserved from zebrafish to humans. In addition to reactions against infections, C/EBP is responsible for cancer-driven myelopoiesis, which promotes cancer progression, at least in part, by abrogating the immune response in the cancer microenvironment. The BCR-ABL fusion protein activates emergency-specific pathway of granulopoiesis by upregulating C/EBP. This in turn causes chronic phase chronic myeloid leukemia, which is characterized by myeloid expansion. The C/EBP transcription factor also plays a role in other hematological malignancies of both myeloid and lymphoid lineage origin. Thus, elucidation of the upstream and downstream networks surrounding C/EBP will lead to the development of novel therapeutic strategies for diseases mediated by non-steady-state hematopoiesis.	[Hirai, Hideyo; Yokota, Asumi; Tamura, Akihiro; Sato, Atsushi; Maekawa, Taira] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 6068507, Japan	Hirai, H (reprint author), Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	hhirai@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; National Cancer Center Research and Development Fund; Takeda Science Foundation; Princess Takamatsu Cancer Research Fund; Kobayashi Foundation for Cancer Research	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; National Cancer Center Research and Development Fund; Takeda Science Foundation; Princess Takamatsu Cancer Research Fund; Kobayashi Foundation for Cancer Research.	Akagi T, 2008, BLOOD, V111, P2999, DOI 10.1182/blood-2007-04-087213; An MR, 1996, MOL CELL BIOL, V16, P2295; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; SCREPANTI I, 1995, EMBO J, V14, P1932; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Hall CJ, 2012, CELL STEM CELL, V10, P198, DOI 10.1016/j.stem.2012.01.007; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Guerzoni C, 2006, BLOOD, V107, P4080, DOI 10.1182/blood-2005-08-3181; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Solinas G, 2010, CANCER METAST REV, V29, P243, DOI 10.1007/s10555-010-9227-2; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Li JM, 2014, INT J HEMATOL, V100, P38, DOI 10.1007/s12185-014-1603-1; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Akasaka T, 2007, BLOOD, V109, P3451, DOI 10.1182/blood-2006-08-041012; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Minami Y, 2008, P NATL ACAD SCI USA, V105, P17967, DOI 10.1073/pnas.0808303105; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Li SR, 2011, BLOOD, V117, P5157, DOI 10.1182/blood-2010-10-314278; Anastasov N, 2010, HAEMATOL-HEMATOL J, V95, P760, DOI 10.3324/haematol.2009.014050; Li Y, 2014, GENE DEV, V28, P2597, DOI 10.1101/gad.253302.114; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/CJI29401; Yoshioka S, 2014, STEM CELLS, V32, P730, DOI 10.1002/stem.1555; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Satake S, 2012, J IMMUNOL, V189, P4546, DOI 10.4049/jimmunol.1103007; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Skokowa J, 2012, NAT MED, V18, P1550, DOI 10.1038/nm.2958; NATSUKA S, 1992, BLOOD, V79, P460; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Ramji DP, 2002, BIOCHEM J, V365, P561; Zhang H, 2013, BLOOD, V122, P1105, DOI 10.1182/blood-2012-08-449413; Haas SC, 2010, BRIT J HAEMATOL, V148, P777, DOI 10.1111/j.1365-2141.2009.08012.x; Radomska HS, 1998, MOL CELL BIOL, V18, P4301; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Fujii W, 2013, J IMMUNOL, V191, P1073, DOI 10.4049/jimmunol.1203535; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Cain DW, 2013, J IMMUNOL, V191, P4665, DOI 10.4049/jimmunol.1300581; Donadieu J, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-26; Bonzheim I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064544; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen XN, 1997, BLOOD, V90, P156; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Friedman AD, 2015, INT J HEMATOL, V111, P33041; Hayashi Y, 2013, LEUKEMIA, V27, P619, DOI 10.1038/leu.2012.258; He QP, 2015, BLOOD, V125, P1098, DOI 10.1182/blood-2014-09-601542; Hirai H, 2014, CLIN EXP METASTAS, V31, P977, DOI 10.1007/s10585-014-9684-z; Hirai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054862; Hiramoto T, 2013, P NATL ACAD SCI USA, V110, P3023, DOI 10.1073/pnas.1217039110; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Lechner MG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-90; Morishima T, 2014, HAEMATOLOGICA, V99, P19, DOI 10.3324/haematol.2013.083873; Pal R, 2009, BLOOD, V114, P3890, DOI 10.1182/blood-2009-01-201111; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Stoilova B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065169; Taketo MM, 2012, J BIOCHEM, V151, P477, DOI 10.1093/jb/mvs035; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; vansDeventer HW, 2013, J IMMUNOL, V190, P4861; Vegesna VA, 2002, LEUKEMIA RES, V26, P451, DOI 10.1016/S0145-2126(01)00150-3; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Watanabe-Okochi N, 2013, BLOOD, V121, P4142, DOI 10.1182/blood-2011-07-368654; Zeidler C, 2009, BRIT J HAEMATOL, V144, P459, DOI 10.1111/j.1365-2141.2008.07425.x	79	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					797	802		10.1111/cas.12690		6	Oncology	Oncology	CM7OK	WOS:000357883900002		
J	Hamashima, C; Ohta, K; Kasahara, Y; Katayama, T; Nakayama, T; Honjo, S; Ohnuki, K				Hamashima, Chisato; Ohta, Koji; Kasahara, Yoshio; Katayama, Takafumi; Nakayama, Tomio; Honjo, Satoshi; Ohnuki, Koji			A meta-analysis of mammographic screening with and without clinical breast examination	CANCER SCIENCE			English	Review						Breast cancer; cancer screening; mammography; meta-analysis; review	RANDOMIZED CONTROLLED-TRIAL; SWEDISH 2-COUNTY TRIAL; FOLLOW-UP; CANCER MORTALITY; DEATH RATES; END-POINT; AGE 40; ULTRASONOGRAPHY; JAPAN; REDUCTION	Mammographic screening with clinical breast examination has been recommended in Japan since 2000. Although mammographic screening without clinical breast examination has not been recommended, its introduction is anticipated. The efficacies of mammographic screening with and without clinical breast examination were evaluated based on the results of randomized controlled trials. PubMed and other databases for studies published between 1985 and 2014 were searched. The study design was limited to randomized controlled trials to evaluate mortality reduction from breast cancer. Five studies were eligible for meta-analysis of mammographic screening without clinical breast examination. The relative risk for women aged 40-74years was 0.75 (95% confidence interval, 0.67-0.83). Three studies evaluated the efficacy of mammographic screening with clinical breast examination. The relative risk for women aged 40-64years was 0.87 (95% confidence interval, 0.77-0.98). The number needed to invite was always lower in mammographic screening without clinical breast examinationthan in mammographic screening with clinical breast examination. In bothscreening methods, the number needed to invite was higher in women aged 40-49years than in women aged 50-70years. These results suggest that mammographic screening without clinical breast examination can afford higher benefits to women aged 50years and over. Although evidence of the efficacy of mammographic screening without clinical breast examination was confirmed based on the results of the randomized controlled trials, a Japanese study is needed to resolve local problems.	[Hamashima, Chisato] Natl Canc Ctr, Canc Screening Assessment & Management Div, Res Ctr Canc Prevent & Screening, Tokyo 1040045, Japan; [Ohta, Koji] Fukui Prefecture Hosp, Dept Surg, Fukui, Japan; [Kasahara, Yoshio] Fukui Ken Saiseikai Hosp, Div Breast Surg, Fukui, Japan; [Katayama, Takafumi] Univ Hyogo, Coll Nursing Art & Sci, Akashi, Hyogo, Japan; [Nakayama, Tomio] Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Osaka, Japan; [Honjo, Satoshi] Natl Hosp Org, Fukuoka Natl Hosp, Dept Pediat, Fukuoka, Japan; [Ohnuki, Koji] Iwate Cent Prefectural Hosp, Div Breast Surg, Morioka, Iwate, Japan	Hamashima, C (reprint author), Natl Canc Ctr, Canc Screening Assessment & Management Div, Res Ctr Canc Prevent & Screening, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	chamashi@ncc.go.jp			National Cancer Center, Japan	National Cancer Center, Japan.	Andersson I., 1997, JNCI MONOGRAPHS, V1997, P63; TABAR L, 1985, LANCET, V1, P829; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Bjurstam N, 2003, CANCER, V97, P2387, DOI 10.1002/cncr.11361; Honjo S, 2007, JPN J CLIN ONCOL, V37, P715, DOI 10.1093/jjco/hym090; MILLER AB, 1992, CAN MED ASSOC J, V147, P1477; Alexander FE, 1999, LANCET, V353, P1903, DOI 10.1016/S0140-6736(98)07413-3; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Boulos S, 2005, BREAST, V14, P340, DOI 10.1016/j.breast.2005.07.002; Miller AB, 2002, ANN INTERN MED, V137, P305; Bjurstam N, 1997, CANCER, V80, P2091, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.0.CO;2-#; Tabar L, 2001, CANCER, V91, P1724, DOI 10.1002/1097-0142(20010501)91:9<1724::AID-CNCR1190>3.0.CO;2-V; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Tabar L, 2002, J MED SCREEN, V9, P159, DOI 10.1136/jms.9.4.159; MILLER AB, 1992, CAN MED ASSOC J, V147, P1459; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Frisell J, 1997, BREAST CANCER RES TR, V45, P263, DOI 10.1023/A:1005872617944; Miller AB, 2000, J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; FRISELL J, 1991, BREAST CANCER RES TR, V18, P49, DOI 10.1007/BF01975443; Lee KC, 1998, ACAD MED, V73, P1013, DOI 10.1097/00001888-199809000-00025; Dickinson J, 2011, CAN MED ASSOC J, V183, P1991, DOI 10.1503/cmaj.110334; Duffy SW, 2003, ANN ONCOL, V14, P1196, DOI 10.1093/annonc/mdg322; HABBEMA JDF, 1986, JNCI-J NATL CANCER I, V77, P317; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P288, DOI 10.1093/jjco/hyn016; Hisamichi S, 2000, GUIDELINES CANC SCRE; International Agency for Research on Cancer, 2008, CANC SCREEN EUR UN R; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV B, P64; Ishida T, 2014, JPN J CLIN ONCOL, V44, P134, DOI 10.1093/jjco/hyt199; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Kanemura S, 1999, JPN J CANCER RES, V90, P607; Kasahara Y, 2012, J JPN ASS BREAST CAN, V21, P48; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Morimoto T, 2000, ANTICANCER RES, V20, P3689; National Cancer Center, EST CANC INC; National Cancer Center. Center for Cancer Control and Information Services, CANC STAT 2012; Oshima A, 1994, Int J Technol Assess Health Care, V10, P346; Paci Eugenio, 2012, J Med Screen, V19 Suppl 1, P5, DOI 10.1258/jms.2012.012077; Sankaranarayanan R, 2011, J NATL CANCER I, V103, P1476, DOI 10.1093/jnci/djr304; Shibata A, 2005, JPN J PUBLIC HLTH, V52, P128; Sloan DA, 1997, SURGERY, V122, P324, DOI 10.1016/S0039-6060(97)90024-6; Tabar L, 1999, Swiss Surg, V5, P199, DOI 10.1024/1023-9332.5.5.199; Uchida K, 2008, BREAST CANCER-TOKYO, V15, P165, DOI 10.1007/s12282-007-0024-x	44	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					812	818		10.1111/cas.12693		7	Oncology	Oncology	CM7OK	WOS:000357883900004		
J	Xu, JG; Alexander, DB; Iigo, M; Hamano, H; Takahashi, S; Yokoyama, T; Kato, M; Usami, I; Tokuyama, T; Tsutsumi, M; Tamura, M; Oguri, T; Niimi, A; Hayashi, Y; Yokoyama, Y; Tonegawa, K; Fukamachi, K; Futakuchi, M; Sakai, Y; Suzui, M; Kamijima, M; Hisanaga, N; Omori, T; Nakae, D; Hirose, A; Kanno, J; Tsuda, H				Xu, Jiegou; Alexander, David B.; Iigo, Masaaki; Hamano, Hirokazu; Takahashi, Satoru; Yokoyama, Takako; Kato, Munehiro; Usami, Ikuji; Tokuyama, Takeshi; Tsutsumi, Masahiro; Tamura, Mouka; Oguri, Tetsuya; Niimi, Akio; Hayashi, Yoshimitsu; Yokoyama, Yoshifumi; Tonegawa, Ken; Fukamachi, Katsumi; Futakuchi, Mitsuru; Sakai, Yuto; Suzui, Masumi; Kamijima, Michihiro; Hisanaga, Naomi; Omori, Toyonori; Nakae, Dai; Hirose, Akihiko; Kanno, Jun; Tsuda, Hiroyuki			Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study	CANCER SCIENCE			English	Article						Asbestos; biological markers; chemokine CCL3; Environmental carcinogens; mesothelioma	MALIGNANT PLEURAL MESOTHELIOMA; MEGAKARYOCYTE POTENTIATING FACTOR; EXHALED BREATH CONDENSATE; LINKED-IMMUNOSORBENT-ASSAY; PLASMA OSTEOPONTIN LEVELS; SOLUBLE MESOTHELIN; TUMOR-MARKER; LUNG-CANCER; OXIDATIVE STRESS; DIAGNOSIS	Exposure to asbestos results in serious risk of developing lung and mesothelial diseases. Currently, there are no biomarkers that can be used to diagnose asbestos exposure. The purpose of the present study was to determine whether the levels or detection rate of chemokine (C-C motif) ligand 3 (CCL3) in the serum are elevated in persons exposed to asbestos. The primary study group consisted of 76 healthy subjects not exposed to asbestos and 172 healthy subjects possibly exposed to asbestos. The secondary study group consisted of 535 subjects possibly exposed to asbestos and diagnosed with pleural plaque (412), benign hydrothorax (10), asbestosis (86), lung cancer (17), and malignant mesothelioma (10). All study subjects who were possibly exposed to asbestos had a certificate of asbestos exposure issued by the Japanese Ministry of Health, Labour and Welfare. For the primary study group, levels of serum CCL3 did not differ between the two groups. However, the detection rate of CCL3 in the serum of healthy subjects possibly exposed to asbestos (30.2%) was significantly higher (P<0.001) than for the control group (6.6%). The pleural plaque, benign hydrothorax, asbestosis, and lung cancer groups had serum CCL3 levels and detection rates similar to that of healthy subjects possibly exposed to asbestos. The CCL3 chemokine was detected in the serum of 9 of the 10 patients diagnosed with malignant mesothelioma. Three of the patients with malignant mesothelioma had exceptionally high CCL3 levels. Malignant mesothelioma cells from four biopsy cases and an autopsy case were positive for CCL3, possibly identifying the source of the CCL3 in the three malignant mesothelioma patients with exceptionally high serum CCL3 levels. In conclusion, a significantly higher percentage of healthy persons possibly exposed to asbestos had detectable levels of serum CCL3 compared to healthy unexposed control subjects.	[Xu, Jiegou; Alexander, David B.; Iigo, Masaaki; Tsuda, Hiroyuki] Nagoya City Univ, Nanotoxicol Project, Nagoya, Aichi 4678603, Japan; [Xu, Jiegou] Anhui Med Univ, Dept Immunol, Coll Basic Med Sci, Hefei, Peoples R China; [Hamano, Hirokazu] Morinaga Milk Ind Co Ltd, Nutr Sci Inst, Zama, Japan; [Takahashi, Satoru] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Nagoya, Aichi 4678603, Japan; [Yokoyama, Takako; Kato, Munehiro; Usami, Ikuji] Asahi Rosai Hosp, Dept Resp Med, Owariasahi, Japan; [Tokuyama, Takeshi] Saiseikai Chuwa Hosp, Dept Internal Med, Sakura, Japan; [Tsutsumi, Masahiro] Saiseikai Chuwa Hosp, Dept Pathol, Sakura, Japan; [Tamura, Mouka] Natl Hosp Org, Nara Med Ctr, Dept Internal Med, Nara, Japan; [Oguri, Tetsuya; Niimi, Akio] Nagoya City Univ Hosp, Diivis Resp Med Allergy & Rheumatol, Nagoya, Aichi, Japan; [Hayashi, Yoshimitsu; Yokoyama, Yoshifumi] Nagoya Shi Koseiin Med Welf Ctr, Dept Med, Nagoya, Aichi, Japan; [Tonegawa, Ken] Nagoya Shi Koseiin Med Welf Ctr, Dept Phys Med & Rehabil, Nagoya, Aichi, Japan; [Fukamachi, Katsumi; Futakuchi, Mitsuru; Sakai, Yuto; Suzui, Masumi] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Toxicol, Nagoya, Aichi 4678603, Japan; [Kamijima, Michihiro] Nagoya City Univ, Grad Sch Med Sci, Dept Occupat & Environm Hlth, Nagoya, Aichi 4678603, Japan; [Hisanaga, Naomi] Aichi Univ Educ, Ctr Campus Hlth & Environm, Kariya, Aichi 448, Japan; [Omori, Toyonori] Nagoya City Univ, Grad Sch Med Sci, Dept Hlth Care Policy & Management, Nagoya, Aichi 4678603, Japan; [Nakae, Dai] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci & Food Safety, Tokyo, Japan; [Hirose, Akihiko] Natl Inst Hlth Sci, Div Risk Assessment, Biol Safety Res Ctr, Tokyo, Japan; [Kanno, Jun] Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Biol Safety Res Ctr, Tokyo, Japan	Tsuda, H (reprint author), Nagoya City Univ, Nanotoxicol Project, Mizuho Ku, 3-1 Tanabedohri, Nagoya, Aichi 4678603, Japan.	htsuda@phar.nagoya-cu.ac.jp			Ministry of Health, Labour and Welfare, Japan; Princess Takamatsu Cancer research Fund	Ministry of Health, Labour and Welfare, Japan. Princess Takamatsu Cancer research Fund.	Scherpereel A, 2006, AM J RESP CRIT CARE, V173, P1155, DOI 10.1164/rccm.200511-1789OC; Pelclova D, 2008, IND HEALTH, V46, P484, DOI 10.2486/indhealth.46.484; Tabata C, 2013, J CLIN GASTROENTEROL, V47, pE7, DOI 10.1097/MCG.0b013e31824e901b; Amati M, 2008, CANCER EPIDEM BIOMAR, V17, P163, DOI 10.1158/1055-9965.EPI-07-0607; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Syslova K, 2009, J CHROMATOGR B, V877, P2477, DOI 10.1016/j.jchromb.2009.06.008; Luo L, 2010, RESP MED, V104, P149, DOI 10.1016/j.rmed.2009.05.017; Pass HI, 2008, ANN THORAC SURG, V85, P265, DOI 10.1016/j.athoracsur.2007.07.042; Creaney J, 2008, J THORAC ONCOL, V3, P851, DOI 10.1097/JTO.0b013e318180477b; Lehtonen H, 2007, THORAX, V62, P602, DOI 10.1136/thx.2006.067868; Comabella M, 2005, J NEUROIMMUNOL, V158, P231, DOI 10.1016/j.jneuroim.2004.09.004; Ray M, 2009, CHEST, V136, P888, DOI 10.1378/chest.08-2665; Grigoriu B, 2009, CLIN BIOCHEM, V42, P1046, DOI 10.1016/j.clinbiochem.2009.03.007; Gube M, 2011, ARCH TOXICOL, V85, P185, DOI 10.1007/s00204-010-0580-2; Amati M, 2008, MUTAT RES-GEN TOX EN, V655, P52, DOI 10.1016/j.mrgentox.2008.06.011; Maeda R, 2011, ANTIOXID REDOX SIGN, V15, P685, DOI 10.1089/ars.2011.3978; Hirayama N, 2011, RESP MED, V105, P137, DOI 10.1016/j.rmed.2010.10.010; Chow S, 2009, RESP MED, V103, P1091, DOI 10.1016/j.rmed.2009.04.009; Yasumitsu A, 2010, J THORAC ONCOL, V5, P479, DOI 10.1097/JTO.0b013e3181d2f008; Grigoriu BD, 2007, CLIN CANCER RES, V13, P2928, DOI 10.1158/1078-0432.CCR-06-2144; Kariuki SN, 2009, GENES IMMUN, V10, P487, DOI 10.1038/gene.2009.15; Portal JAR, 2009, CANCER EPIDEM BIOMAR, V18, P646, DOI 10.1158/1055-9965.EPI-08-0422; Kadota J, 2005, RESP MED, V99, P111, DOI 10.1016/j.rmed.2004.04.018; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Dragonieri S, 2012, LUNG CANCER, V75, P326, DOI 10.1016/j.lungcan.2011.08.009; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Ramazzini C, 2011, AM J IND MED, V54, P168, DOI 10.1002/ajim.20892; Xu JG, 2010, CARCINOGENESIS, V31, P927, DOI 10.1093/carcin/bgq029; Watzka SB, 2011, J THORAC CARDIOV SUR, V142, P384, DOI 10.1016/j.jtcvs.2011.04.034; Hollevoet K, 2010, AM J RESP CRIT CARE, V181, P620, DOI 10.1164/rccm.200907-1020OC; Lehtimaki L, 2010, RESP MED, V104, P1042, DOI 10.1016/j.rmed.2010.01.019; Maeda M, 2006, PATHOL INT, V56, P649, DOI 10.1111/j.1440-1827.2006.02024.x; Creaney J, 2011, LUNG CANCER, V74, P55, DOI 10.1016/j.lungcan.2011.02.007; Cristaudo A, 2011, BIOMARK MED, V5, P261, DOI [10.2217/bmm.11.18, 10.2217/BMM.11.18]; desGennaro G, 2010, ANAL BIOANAL CHEM, V398, P3043; Fujii M, 2012, CANCER SCI, V103, P510, DOI 10.1111/j.1349-7006.2011.02180.x; Grigoriu B D, 2009, Monaldi Arch Chest Dis, V71, P31; Hino Okio, 2008, Environmental Health and Preventive Medicine, V13, P71, DOI 10.1007/s12199-007-0014-9; IARC, 2012, IARC MON EV CARC R C, V100C, P219; Iwahori K, 2008, LUNG CANCER, V62, P45, DOI 10.1016/j.lungcan.2008.02.012; Leivo-Korpela S, 2012, RESP MED, V106, P1435, DOI 10.1016/j.rmed.2012.07.003; Marsili D, 2013, ANN I SUPER SANITA, V49, P249, DOI 10.4415/ANN_13_03_03; Ohmori R, 2003, ATHEROSCLEROSIS, V170, P333, DOI 10.1016/S0021-9150(03)00298-3; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1031, DOI 10.1097/00000478-200308000-00001; Raiko I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-242; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Rostila A, 2012, LUNG CANCER, V77, P450, DOI 10.1016/j.lungcan.2012.03.024; Santarelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018232; Shiomi K, 2008, CLIN CANCER RES, V14, P1431, DOI 10.1158/1078-0432.CCR-07-1613; Tomasetti Marco, 2010, Cancers (Basel), V2, P523, DOI 10.3390/cancers2020523; Yasuda M, 2010, ANTICANCER RES, V30, P2631	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					825	832		10.1111/cas.12687		8	Oncology	Oncology	CM7OK	WOS:000357883900006		
J	Kaneko, Y; Suenaga, Y; Islam, SMR; Matsumoto, D; Nakamura, Y; Ohira, M; Yokoi, S; Nakagawara, A				Kaneko, Yoshiki; Suenaga, Yusuke; Islam, S. M. Rafiqul; Matsumoto, Daisuke; Nakamura, Yohko; Ohira, Miki; Yokoi, Sana; Nakagawara, Akira			Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas	CANCER SCIENCE			English	Article						MYCN; NCYM; neuroblastoma; OCT4; transcriptional regulation	EMBRYONIC STEM-CELLS; N-MYC; EXPRESSION; TRANSPLANTATION; LIN28B; GENES; MICE; KLF4	Neuroblastoma is a pediatric solid tumor that originates from embryonic neural crest cells. The MYCN gene locus is frequently amplified in unfavorable neuroblastomas, and the gene product promotes the progression of neuroblastomas. However, the molecular mechanisms by which MYCN amplification contributes to stem cell-like states of neuroblastoma remain elusive. In this study, we show that MYCN and its cis-antisense gene, NCYM, form a positive feedback loop with OCT4, a core regulatory gene maintaining a multipotent state of neural stem cells. We previously reported that NCYM is co-amplified with the MYCN gene in primary human neuroblastomas and that the gene product promotes aggressiveness of neuroblastoma by stabilization of MYCN. In 36 MYCN-amplified primary human neuroblastomas, OCT4 mRNA expression was associated with unfavorable prognosis and was correlated with that of NCYM. The OCT4 protein induced both NCYM and MYCN in human neuroblastoma cells, whereas NCYM stabilized MYCN to induce OCT4 and stem cell-related genes, including NANOG, SOX2, and LIN28. In sharp contrast to MYCN, enforced expression of c-MYC did not enhance OCT4 expression in human neuroblastoma cells. All-trans retinoic acid treatment reduced MYCN, NCYM, and OCT4 expression, accompanied by the decreased amount of OCT4 recruited onto the intron 1 region of MYCN. Knockdown of NCYM or OCT4 inhibited formation of spheres of neuroblastoma cells and promoted asymmetric cell division in MYCN-amplified human neuroblastoma cells. These results suggest that the functional interplay between MYCN, NCYM, and OCT4 contributes to aggressiveness of MYCN-amplified human neuroblastomas.	[Kaneko, Yoshiki; Suenaga, Yusuke; Islam, S. M. Rafiqul; Matsumoto, Daisuke; Nakamura, Yohko; Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Div Biochem & Innovat Canc Therapeut, Chiba 2608717, Japan; [Kaneko, Yoshiki; Suenaga, Yusuke; Islam, S. M. Rafiqul; Matsumoto, Daisuke; Nakamura, Yohko; Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Childrens Canc Res Ctr, Chiba 2608717, Japan; [Suenaga, Yusuke; Yokoi, Sana] Chiba Canc Ctr, Res Inst, Canc Genome Ctr, Chiba 2608717, Japan; [Ohira, Miki] Chiba Canc Ctr, Res Inst, Lab Canc Genom, Chiba 2608717, Japan	Suenaga, Y (reprint author), Chiba Canc Ctr, Res Inst, Canc Genome Ctr, Chuo Ku, 666-2 Nitona, Chiba 2608717, Japan.	ysuenaga@chiba-cc.jp; nakagawara-a@koseikan.jp			Ministry of Health, Labor and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation; Japan Society for the Promotion of Science	Ministry of Health, Labor and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation; Japan Society for the Promotion of Science.	Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Pezzolo A, 2011, CELL RES, V21, P1470, DOI 10.1038/cr.2011.38; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Izumi H, 2012, P NATL ACAD SCI USA, V109, P18048, DOI 10.1073/pnas.1205525109; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Shum CKY, 2013, ONCOGENE, V32, P4086, DOI 10.1038/onc.2012.437; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; Hammerle B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076761; Kotkamp K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092356; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Ohira M, 2005, CANCER CELL, V7, P337, DOI 10.1016/j.ccr.2005.03.019; Reinhardt JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003860; Suenaga Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003996; Suenaga Y, 2009, BIOCHEM BIOPH RES CO, V390, P21, DOI 10.1016/j.bbrc.2009.09.044; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					840	847		10.1111/cas.12677		8	Oncology	Oncology	CM7OK	WOS:000357883900008		
J	Tatemichi, Y; Shibazaki, M; Yasuhira, S; Kasai, S; Tada, H; Oikawa, H; Suzuki, Y; Takikawa, Y; Masuda, T; Maesawa, C				Tatemichi, Yoshinori; Shibazaki, Masahiko; Yasuhira, Shinji; Kasai, Shuya; Tada, Hiroshi; Oikawa, Hiroki; Suzuki, Yuji; Takikawa, Yasuhiro; Masuda, Tomoyuki; Maesawa, Chihaya			Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification	CANCER SCIENCE			English	Article						Migration; nucleus accumbens associated 1; promyelocytic leukemia nuclear body; SUMO-interacting motif; SUMOylations	OVARIAN-CANCER; TUMOR-SUPPRESSOR; ARSENIC TRIOXIDE; BTB/POZ PROTEIN; CELL-GROWTH; PML; MOTIF; TRANSCRIPTION; SUMOYLATION; REPRESSION	Nucleus accumbens associated 1 (NACC1) is a cancer-associated BTB/POZ (pox virus and zinc finger/bric-a-brac tramtrack broad complex) gene, and is involved in several cellular functions in neurons, cancer and stem cells. Some of the BTB/POZ proteins associated with cancer biology are SUMOylated, which appears to play an important role in transcription regulation. We show that NACC1 is SUMOylated on a phylogenetically conserved lysine (K167) out of three consensus SUMOylation motif sites. Amino acid substitution in the SIM sequence (SIM/M) within the BTB/POZ domain partially reduced K167 SUMOylation activity of NACC1. Overexpression of GFP-NACC1 fusion protein leads to formation of discrete nuclear foci similar to promyelocytic leukemia nuclear bodies (PML-NB), which colocalized with SUMO paralogues (SUMO1/2/3). Both NACC1 nuclear body formation and colocalization with SUMO paralogues were completely suppressed in the GFP-NACC1-SIM/M mutant, whereas they were partially maintained in the NACC1 K167R mutant. Confocal immunofluorescence analysis showed that endogenous and exogenous NACC1 proteins colocalized with endogenous PML protein. A pull-down assay revealed that the consensus motifs of the SUMO acceptor site at K167 and the SIM within the BTB/POZ domain were both necessary for efficient binding to PML protein. Our study demonstrates that NACC1 can be modified by SUMO paralogues, and cooperates with PML protein.	[Tatemichi, Yoshinori; Shibazaki, Masahiko; Yasuhira, Shinji; Kasai, Shuya; Tada, Hiroshi; Maesawa, Chihaya] Iwate Med Univ, Inst Biomed Sci, Dept Tumor Biol, Yahaba, Iwate 0283694, Japan; [Tatemichi, Yoshinori; Suzuki, Yuji; Takikawa, Yasuhiro] Iwate Med Univ, Sch Med, Dept Internal Med, Morioka, Iwate 020, Japan; [Oikawa, Hiroki; Masuda, Tomoyuki] Iwate Med Univ, Sch Med, Dept Pathol, Morioka, Iwate 020, Japan	Maesawa, C (reprint author), Iwate Med Univ, Inst Biomed Sci, Dept Tumor Biol, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	chihaya@iwate-med.ac.jp					Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Nakayama K, 2006, P NATL ACAD SCI USA, V103, P18739, DOI 10.1073/pnas.0604083103; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Jinawath N, 2009, ONCOGENE, V28, P1941, DOI 10.1038/onc.2009.37; Tashiro S, 2004, MOL CELL BIOL, V24, P3473, DOI 10.1128/MCB.24.8.3473-3484.2004; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Muto A, 2002, J BIOL CHEM, V277, P20724, DOI 10.1074/jbc.M112003200; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Zhong S, 2000, BLOOD, V95, P2748; Chao TT, 2007, BIOCHEM BIOPH RES CO, V358, P475, DOI 10.1016/j.bbrc.2007.04.157; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; Gao M, 2014, AM J PATHOL, V184, P133, DOI 10.1016/j.ajpath.2013.09.024; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hong SH, 2001, MOL CELL BIOL, V21, P7172, DOI 10.1128/MCB.21.21.7172-7182.2001; Ishibashi M, 2009, CLIN CANCER RES, V15, P804, DOI 10.1158/1078-0432.CCR-08-2134; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Macauley MS, 2004, J BIOL CHEM, V279, P49131, DOI 10.1074/jbc.M408705200; Motamed-Khorasani A, 2007, ONCOGENE, V26, P198, DOI 10.1038/sj.onc.1209773; Nakayama K, 2007, CANCER RES, V67, P8058, DOI 10.1158/0008-5472.CAN-07-1357; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Sternsdorf T, 1999, MOL CELL BIOL, V19, P5170; Tsunoda K, 2011, J INVEST DERMATOL, V131, P1710, DOI 10.1038/jid.2011.110; Wu PH, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015005; Zhang Y, 2011, ONCOGENE, V31, P1055	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					848	856		10.1111/cas.12680		9	Oncology	Oncology	CM7OK	WOS:000357883900009		
J	Takahashi, K; Nagai, N; Ogura, K; Tsuneyama, K; Saiki, I; Irimura, T; Hayakawa, Y				Takahashi, Kei; Nagai, Nao; Ogura, Keisuke; Tsuneyama, Koichi; Saiki, Ikuo; Irimura, Tatsuro; Hayakawa, Yoshihiro			Mammary tissue microenvironment determines Tcell-dependent breast cancer-associated inflammation	CANCER SCIENCE			English	Article						Breast cancer; imaging; inflammation; T cell; tissue microenvironment	NF-KAPPA-B; TUMOR PROGRESSION; METASTASIS; CELLS; OBESITY; GROWTH; ACTIVATION; MECHANISMS; OVERWEIGHT; CONTRIBUTE	Although the importance of the host tissue microenvironment in cancer progression and metastasis has been established, the spatiotemporal process establishing a cancer metastasis-prone tissue microenvironment remains unknown. In this study, we aim to understand the immunological character of a metastasis-prone microenvironment in a murine 4T1 breast tumor model, by using the activation of nuclear factor-b (NF-B) in cancer cells as a sensor of inflammatory status and by monitoring its activity by bioluminescence imaging. By using a 4T1 breast cancer cell line stably expressing an NF-B/Luc2 reporter gene (4T1 NF-B cells), we observed significantly increased bioluminescence approximately 7days after metastasis-prone orthotopic mammary fat-pad inoculation but not ectopic s.c. inoculation of 4T1 NF-B cells. Such invivo NF-B activation within the fat-pad 4T1 tumor was diminished in immune-deficient SCID or nude mice, or T cell-depleted mice, suggesting the requirement of host T cell-mediated immune responses. Given the fat-pad 4T1 tumor expressed higher inflammatory mediators in a T cell-dependent mechanism compared to the s.c. tumor, our results imply the importance of the surrounding tissue microenvironment for inflaming tumors by collaborating with T cells to instigate metastatic spread of 4T1 breast cancer cells.	[Takahashi, Kei; Nagai, Nao; Irimura, Tatsuro; Hayakawa, Yoshihiro] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo, Japan; [Ogura, Keisuke; Saiki, Ikuo; Hayakawa, Yoshihiro] Toyama Univ, Inst Nat Med, Dept Biosci, Div Pathogen Biochem, Toyama 9300194, Japan; [Tsuneyama, Koichi] Toyama Univ, Fac Med, Dept Diagnost Pathol, Toyama 9300194, Japan; [Irimura, Tatsuro] St Lukes Int Univ, Inst Med Innovat, Tokyo, Japan	Hayakawa, Y (reprint author), Toyama Univ, Inst Nat Med, Dept Biosci, Div Pathogen Biochem, Sugitani 2630, Toyama 9300194, Japan.	haya@inm.u-toyama.ac.jp			Tokyo Biochemical Research Foundation; Cancer Research Institute, Kanazawa University; Japan Society for the Promotion of Science	The Tokyo Biochemical Research Foundation; Cancer Research Institute, Kanazawa University; Japan Society for the Promotion of Science.	Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Park J, 2012, J CLIN INVEST, V122, P4243, DOI 10.1172/JCI63930; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Harmey JH, 2002, INT J CANCER, V101, P415, DOI 10.1002/ijc.10632; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Lou CH, 2014, INT J ONCOL, V45, P2085, DOI 10.3892/ijo.2014.2624; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Nieman KM, 2013, BBA-MOL CELL BIOL L, V1831, P1533, DOI 10.1016/j.bbalip.2013.02.010; Bochet L, 2013, CANCER RES, V73, P5657, DOI 10.1158/0008-5472.CAN-13-0530; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Kim EJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2927; Kushiro Kyoko, 2012, Cancer Microenviron, V5, P73, DOI 10.1007/s12307-011-0087-2; Takahashi K, 2013, CANCER SCI, V104, P558, DOI 10.1111/cas.12112; Ueno S, 2011, CANCER RES, V71, P6419, DOI 10.1158/0008-5472.CAN-11-1773	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					867	874		10.1111/cas.12685		8	Oncology	Oncology	CM7OK	WOS:000357883900011		
J	Yamaguchi, SI; Ueki, A; Sugihara, E; Onishi, N; Yaguchi, T; Kawakami, Y; Horiuchi, K; Morioka, H; Matsumoto, M; Nakamura, M; Muto, A; Toyama, Y; Saya, H; Shimizu, T				Yamaguchi, Sayaka I.; Ueki, Arisa; Sugihara, Eiji; Onishi, Nobuyuki; Yaguchi, Tomonori; Kawakami, Yutaka; Horiuchi, Keisuke; Morioka, Hideo; Matsumoto, Morio; Nakamura, Masaya; Muto, Akihiro; Toyama, Yoshiaki; Saya, Hideyuki; Shimizu, Takatsune			Synergistic antiproliferative effect of imatinib and adriamycin in platelet-derived growth factor receptor-expressing osteosarcoma cells	CANCER SCIENCE			English	Article						Animal model; drug resistance; imatinib; osteosarcoma; platelet-derived growth factor (PDGF) signaling	TYROSINE KINASE INHIBITOR; SERUM DEPRIVATION; PHASE-II; C-KIT; APOPTOSIS; MESYLATE; CANCER; STI571; STATE; PROLIFERATION	Osteosarcoma (OS) is the most frequent primary solid malignant tumor of bone. Its prognosis remains poor in the substantial proportion of patients who do not respond to chemotherapy and novel therapeutic options are therefore needed. We previously established a mouse model that mimics the aggressive behavior of human OS. Enzyme-linked immunosorbent assay-based screening of such mouse tumor lysates identified platelet-derived growth factor-BB (PDGF-BB) as an abundant soluble factor, the gene for which was expressed dominantly in surrounding non-malignant cells of the tumor, whereas that for the cognate receptor (PDGF receptor ) was highly expressed in OS cells. Platelet-derived growth factor-BB induced activation of both MEK-ERK and phosphatidylinositol 3-kinase-protein kinase B signaling pathways and promoted survival in OS cells deprived of serum, and these effects were blocked by the PDGF receptor inhibitor imatinib. However, these actions of PDGF-BB and imatinib were mostly masked in the presence of serum. Whereas imatinib alone did not manifest an antitumor effect in mice harboring OS tumors, combined treatment with imatinib and adriamycin exerted a synergistic antiproliferative effect on OS cells invivo. These results suggest that treatment of OS with imatinib is effective only when cell survival is dependent on PDGF signaling or when imatinib is combined with another therapeutic intervention that renders the tumor cells susceptible to imatinib action, such as by inducing cellular stress.	[Yamaguchi, Sayaka I.; Ueki, Arisa; Sugihara, Eiji; Onishi, Nobuyuki; Saya, Hideyuki; Shimizu, Takatsune] Keio Univ, Sch Med, IAMR, Div Gene Regulat, Tokyo, Japan; [Yamaguchi, Sayaka I.; Horiuchi, Keisuke; Morioka, Hideo; Matsumoto, Morio; Nakamura, Masaya; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Sugihara, Eiji; Saya, Hideyuki; Shimizu, Takatsune] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Yaguchi, Tomonori; Kawakami, Yutaka] Keio Univ, Sch Med, IAMR, Div Cellular Signaling, Tokyo, Japan; [Muto, Akihiro; Shimizu, Takatsune] Hoshi Univ, Dept Pathophysiol, Tokyo 142, Japan	Shimizu, T (reprint author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pathophysiol, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	t-shimizu@hoshi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; National Institute of Biomedical Innovation of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; National Institute of Biomedical Innovation of Japan.	Bond M, 2008, PEDIATR BLOOD CANCER, V50, P254, DOI 10.1002/pbc.21132; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Ostman A, 2007, ADV CANCER RES, V97, P247, DOI 10.1016/S0065-230X(06)97011-0; Cao YH, 2013, TRENDS MOL MED, V19, P460, DOI 10.1016/j.molmed.2013.05.002; Mori T, 2014, ONCOGENE, V33, P4236, DOI 10.1038/onc.2013.545; Allred DC, 1998, MODERN PATHOL, V11, P155; Heinrich MC, 2000, BLOOD, V96, P925; Kubo T, 2008, CANCER, V112, P2119, DOI 10.1002/cncr.23437; Botter SM, 2014, CURR OPIN PHARMACOL, V16, P15, DOI 10.1016/j.coph.2014.02.002; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Sugiura H, 2010, J ORTHOP SCI, V15, P654, DOI 10.1007/s00776-010-1506-9; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Abdeen A, 2009, CANCER, V115, P5243, DOI 10.1002/cncr.24562; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; McGary EC, 2002, CLIN CANCER RES, V8, P3584; Duffaud F, 2009, TARGET ONCOL, V4, P45, DOI 10.1007/s11523-008-0101-x; Fletcher CDM, 2002, OSTEOGENIC TUMOURS W, P259; GambacortiPasserini C, 1997, BLOOD CELL MOL DIS, V23, P380, DOI 10.1006/bcmd.1997.0155; Gobin B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090795; Gorlick R, 2009, CANC TREAT, V152, P467, DOI 10.1007/978-1-4419-0284-9_27; Handolias D, 2008, FUTURE ONCOL, V4, P211, DOI 10.2217/14796694.4.2.211; Ishikawa T, 2013, CANCER SCI, V104, P880, DOI 10.1111/cas.12163; Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje; Kim MY, 2012, CANCER, V118, P740; Kuznetsov AV, 2011, BBA-MOL CELL RES, V1813, P1144, DOI 10.1016/j.bbamcr.2011.03.002; Mukhopadhyay P., 2009, AM J PHYSIOL-HEART C, V296, P1466; Posthuma DJ, 2011, CLIN EXP METASTAS, V28, P493; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/S0006-8993(96)00527-6; Shimizu T, 2014, CANCER RES, V74, P6531, DOI 10.1158/0008-5472.CAN-14-0914; Shimizu T, 2012, MOL CANCER RES, V10, P454, DOI 10.1158/1541-7786.MCR-11-0347; Sjoblom T, 2001, CANCER RES, V61, P5778; Ueki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050621	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					875	882		10.1111/cas.12686		8	Oncology	Oncology	CM7OK	WOS:000357883900012		
J	Yamaue, H; Tsunoda, T; Tani, M; Miyazawa, M; Yamao, K; Mizuno, N; Okusaka, T; Ueno, H; Boku, N; Fukutomi, A; Ishii, H; Ohkawa, S; Furukawa, M; Maguchi, H; Ikeda, M; Togashi, Y; Nishio, K; Ohashi, Y				Yamaue, Hiroki; Tsunoda, Takuya; Tani, Masaji; Miyazawa, Motoki; Yamao, Kenji; Mizuno, Nobumasa; Okusaka, Takuji; Ueno, Hideki; Boku, Narikazu; Fukutomi, Akira; Ishii, Hiroshi; Ohkawa, Shinichi; Furukawa, Masayuki; Maguchi, Hiroyuki; Ikeda, Masafumi; Togashi, Yosuke; Nishio, Kazuto; Ohashi, Yasuo			Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study	CANCER SCIENCE			English	Article						Advanced pancreatic cancer; elpamotide; immunotherapy; peptide vaccine; phase II/III	ENDOTHELIAL-GROWTH-FACTOR; METASTATIC COLORECTAL-CANCER; COOPERATIVE-ONCOLOGY-GROUP; CELL LUNG-CANCER; III TRIAL; PLUS GEMCITABINE; 1ST-LINE TREATMENT; FACTOR RECEPTOR-2; EPITOPE-PEPTIDES; POOR-PROGNOSIS	Gemcitabine is a key drug for the treatment of pancreatic cancer; however, with its limitation in clinical benefits, the development of another potent therapeutic is necessary. Vascular endothelial growth factor receptor 2 is an essential target for tumor angiogenesis, and we have conducted a phase I clinical trial using gemcitabine and vascular endothelial growth factor receptor 2 peptide (elpamotide). Based on the promising results of this phase I trial, a multicenter, randomized, placebo-controlled, double-blind phase II/III clinical trial has been carried out for pancreatic cancer. The eligibility criteria included locally advanced or metastatic pancreatic cancer. Patients were assigned to either the Active group (elpamotide+gemcitabine) or Placebo group (placebo+gemcitabine) in a 2:1 ratio by the dynamic allocation method. The primary endpoint was overall survival. The Harrington-Fleming test was applied to the statistical analysis in this study to evaluate the time-lagged effect of immunotherapy appropriately. A total of 153 patients (Active group, n=100; Placebo group, n=53) were included in the analysis. No statistically significant differences were found between the two groups in the prolongation of overall survival (Harrington-Fleming P-value, 0.918; log-rank P-value, 0.897; hazard ratio, 0.87, 95% confidence interval [CI], 0.486-1.557). Median survival time was 8.36months (95% CI, 7.46-10.18) for the Active group and 8.54months (95% CI, 7.33-10.84) for the Placebo group. The toxicity observed in both groups was manageable. Combination therapy of elpamotide with gemcitabine was well tolerated. Despite the lack of benefit in overall survival, subgroup analysis suggested that the patients who experienced severe injection site reaction, such as ulceration and erosion, might have better survival. Phase II/III trial of elpamotide was performed to evaluate the clinical effect for advanced pancreatic cancer. Despite the lack of benefit in OS, sub-group analysis suggested that the patients with severe ISR might have better survival.	[Yamaue, Hiroki; Tsunoda, Takuya; Tani, Masaji; Miyazawa, Motoki] Wakayama Med Univ, Dept Surg 2, Wakayama 6418509, Japan; [Yamao, Kenji; Mizuno, Nobumasa] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Okusaka, Takuji; Ueno, Hideki] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan; [Boku, Narikazu; Fukutomi, Akira] Shizuoka Canc Ctr, Dept Gastroenterol, Shizuoka, Japan; [Ishii, Hiroshi] Canc Inst Hosp, Hepatobiliary & Pancreat Div, Tokyo, Japan; [Ohkawa, Shinichi] Kanagawa Canc Ctr Hosp, Hepatobiliary & Pancreat Med Oncol Div, Yokohama, Kanagawa, Japan; [Furukawa, Masayuki] Natl Hosp Org, Kyushu Canc Ctr, Dept Gastroenterol, Fukuoka, Japan; [Maguchi, Hiroyuki] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan; [Ikeda, Masafumi] Natl Canc Ctr Hosp East, Div Hepatobiliary & Pancreat Oncol, Chiba, Japan; [Togashi, Yosuke; Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan; [Ohashi, Yasuo] Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan	Yamaue, H (reprint author), Wakayama Med Univ, Dept Surg 2, 811-1 Kimiidera, Wakayama 6418509, Japan.	yamaue-h@wakayama-med.ac.jp			OncoTherapy Science, Inc.; Fuso Pharmaceutical Industries Ltd; Otsuka Pharmaceutical Co., Ltd.	OncoTherapy Science, Inc.; Fuso Pharmaceutical Industries Ltd; Otsuka Pharmaceutical Co., Ltd.	Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Colucci G, 2002, CANCER, V94, P902, DOI 10.1002/cncr.10323; Karayiannakis AJ, 2003, CANCER LETT, V194, P119, DOI 10.1016/S0304-3835(03)00047-8; Itakura J, 2000, INT J CANCER, V85, P27; Van Cutsem E, 2009, ANN ONCOL, V20, P1842, DOI 10.1093/annonc/mdp233; Sobrero A, 2009, ONCOLOGY-BASEL, V77, P113, DOI 10.1159/000229787; Wada S, 2005, CANCER RES, V65, P4939, DOI 10.1158/0008-5472.CAN-04-3759; Colucci G, 2010, J CLIN ONCOL, V28, P1645, DOI 10.1200/JCO.2009.25.4433; Karkkainen MJ, 2000, ONCOGENE, V19, P5598, DOI 10.1038/sj.onc.1203855; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; [Anonymous], 2013, MON CANC INC JAP SUR; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; Berlin JD, 2002, J CLIN ONCOL, V20, P3270, DOI 10.1200/JCO.2002.11.149; Okines A, 2009, BRIT J CANCER, V101, P1033, DOI 10.1038/sj.bjc.6605259; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Fuchs CS, 2007, J CLIN ONCOL, V25, P4779, DOI 10.1200/JCO.2007.11.3357; Miyazawa M, 2010, CANCER SCI, V101, P433, DOI 10.1111/j.1349-7006.2009.01416.x; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Poplin E, 2009, J CLIN ONCOL, V27, P3778, DOI 10.1200/JCO.2008.20.9007; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Heinemann V, 2006, J CLIN ONCOL, V24, P3946, DOI 10.1200/JCO.2005.05.1490; Wolchok JD, 2013, ANN NY ACAD SCI, V1291, P1, DOI 10.1111/nyas.12180; Philip PA, 2010, J CLIN ONCOL, V28, P3605, DOI 10.1200/JCO.2009.25.7550; Risau W, 1997, NATURE, V386, P671; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Clark AJ, 2011, J NEUROSURG, V114, P1609, DOI 10.3171/2010.10.JNS101042; Asahara S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-291; Bruns CJ, 2002, INT J CANCER, V102, P101, DOI 10.1002/ijc.10681; Buchler P, 2003, SURGERY, V134, P772, DOI 10.1016/S0039-6060(03)00296-4; Burris HA, 1997, J CLIN ONCOL, V15, P2403; Hazama S, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-63; Ishigami S, 2004, ANTICANCER RES, V24, P2123; Itakura J, 1997, CLIN CANCER RES, V3, P1309; Klink M, 2012, IMMUNOL INVEST, V41, P382, DOI 10.3109/08820139.2011.640376; Korc M, 2003, Mol Cancer, V2, P8, DOI 10.1186/1476-4598-2-8; Kuwahara K, 2003, PANCREAS, V26, P344, DOI 10.1097/00006676-200305000-00006; Luo JY, 2001, INT J CANCER, V92, P361, DOI 10.1002/ijc.1202; Masood R, 2001, BLOOD, V98, P1904, DOI 10.1182/blood.V98.6.1904; Sakai K, 2012, J THORAC ONCOL, V7, P913, DOI 10.1097/JTO.0b013e31824c7f7a; Seo Y, 2000, CANCER, V88, P2239, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0.CO;2-V; Solorzano CC, 2001, CANCER BIOTHER RADIO, V16, P359, DOI 10.1089/108497801753354267; Von Marschall Z, 2000, GASTROENTEROLOGY, V119, P1358, DOI 10.1053/gast.2000.19578	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					883	890		10.1111/cas.12674		8	Oncology	Oncology	CM7OK	WOS:000357883900013		
J	Komatsu, Y; Okita, K; Yuki, S; Furuhata, T; Fukushima, H; Masuko, H; Kawamoto, Y; Isobe, H; Miyagishima, T; Sasaki, K; Nakamura, M; Ohsaki, Y; Nakajima, J; Tateyama, M; Eto, K; Minami, S; Yokoyama, R; Iwanaga, I; Shibuya, H; Kudo, M; Oba, K; Takahashi, Y				Komatsu, Yoshito; Okita, Kenji; Yuki, Satoshi; Furuhata, Tomohisa; Fukushima, Hiraku; Masuko, Hiroyuki; Kawamoto, Yasuyuki; Isobe, Hiroshi; Miyagishima, Takuto; Sasaki, Kazuaki; Nakamura, Michio; Ohsaki, Yoshinobu; Nakajima, Junta; Tateyama, Miki; Eto, Kazunori; Minami, Shinya; Yokoyama, Ryoji; Iwanaga, Ichiro; Shibuya, Hitoshi; Kudo, Mineo; Oba, Koji; Takahashi, Yasuo			Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron	CANCER SCIENCE			English	Article						Chemotherapy-induced nausea and vomiting; dexamethasone; moderately-emetogenic chemotherapy; palonosetron; phaseIII	MODERATELY EMETOGENIC CHEMOTHERAPY; CONSENSUS CONFERENCE; INDUCED NAUSEA; PREVENTION; DEXAMETHASONE	The purpose of this study is to compare the efficacy of a single administration of dexamethasone (DEX) on day1 against DEX administration on days1-3 in combination with palonosetron (PALO), a second-generation 5-HT3 receptor antagonist, for chemotherapy-induced nausea and vomiting (CINV) in non-anthracycline and cyclophosphamide (AC) moderately-emetogenic chemotherapy (MEC). This phaseIII trial was conducted with a multi-center, randomized, open-label, non-inferiority design. Patients who received non-AC MEC as an initial chemotherapy were randomly assigned to either a group administered PALO (0.75mg, i.v.) and DEX (9.9mg, i.v.) prior to chemotherapy (study treatment group), or a group administered additional DEX (8mg, i.v. or p.o.) on days2-3 (control group). The primary endpoint was complete response (CR) rate. The CR rate difference was estimated by logistic regression with allocation factors as covariates. The non-inferiority margin was set at -15% (study treatment group - control group). From April 2011 to March 2013, 305patients who received non-AC MEC were randomly allocated to one of two study groups. Overall, the CR rate was 66.2% in the study treatment group (N=151) and 63.6% in the control group (N=154). PALO plus DEX day1 was non-inferior to PALO plus DEX days1-3 (difference, 2.5%; 95% confidence interval [CI]: -7.8%-12.8%; P-value for non-inferiority test=0.0004). There were no differences between the two groups in terms of complete control rate (64.9 vs 61.7%) and total control rate (49.7% vs 47.4%). Anti-emetic DEX administration on days2-3 may be eliminated when used in combination with PALO in patients receiving non-AC MEC.	[Komatsu, Yoshito] Hokkaido Univ Hosp, Ctr Canc, Dept Canc Chemotherapy, Sapporo, Hokkaido 0608638, Japan; [Okita, Kenji] Sapporo Med Univ, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan; [Yuki, Satoshi; Fukushima, Hiraku] Hokkaido Univ Hosp, Ctr Canc, Sapporo, Hokkaido 0608638, Japan; [Furuhata, Tomohisa] Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Masuko, Hiroyuki] Sapporo Kosei Gen Hosp, Surg, Sapporo, Hokkaido, Japan; [Kawamoto, Yasuyuki] Hakodate Municipal Hosp, Dept Gastroenterol, Hakodate, Hokkaido, Japan; [Isobe, Hiroshi] KKR Sapporo Med Ctr, Dept Med Oncol, Sapporo, Hokkaido, Japan; [Miyagishima, Takuto] Kushiro Rosai Hosp, Dept Internal Med, Kushiro, Hokkaido, Japan; [Sasaki, Kazuaki] Otaru Ekisaikai Hosp, Surg, Otaru, Hokkaido, Japan; [Nakamura, Michio] Sapporo City Gen Hosp, Gastroenterol, Sapporo, Hokkaido, Japan; [Ohsaki, Yoshinobu] Asahikawa Med Univ, Resp Ctr, Asahikawa, Hokkaido, Japan; [Nakajima, Junta] Obihiro Kousei Gen Hosp, Dept Internal Med 3, Obihiro, Hokkaido, Japan; [Tateyama, Miki] Tomakomai Nisshou Hosp, Internal Med, Tomakomai, Japan; [Eto, Kazunori] Tomakomai City Hosp, Gastroenterol, Tomakomai, Japan; [Minami, Shinya] Oji Gen Hosp, Gastroenterol, Tomakomai, Japan; [Yokoyama, Ryoji] Iwamizawa Municipal Gen Hosp, Surg, Iwamizawa, Japan; [Iwanaga, Ichiro] Japanese Red Cross Kitami Hosp, Gastroenterol, Kitami, Hokkaido, Japan; [Shibuya, Hitoshi] Muroran City Gen Hosp, Surg, Muroran, Hokkaido, Japan; [Kudo, Mineo] Sapporo Hokuyu Hosp, Gastroenterol, Sapporo, Hokkaido, Japan; [Oba, Koji] Univ Tokyo, Grad Sch Med, Dept Biostat, Tokyo, Japan; [Takahashi, Yasuo] Hokkaido Canc Ctr, Dept Gastroenterol, Sapporo, Hokkaido, Japan	Komatsu, Y (reprint author), Hokkaido Univ Hosp, Ctr Canc, Dept Canc Chemotherapy, Kita Ku, North 14,West 5, Sapporo, Hokkaido 0608638, Japan.	ykomatsu@med.hokudai.ac.jp			Hokkaido Gastrointestinal Cancer Study Group(HGCSG)	Hokkaido Gastrointestinal Cancer Study Group(HGCSG)	Aapro Matti S, 2007, Ther Clin Risk Manag, V3, P1009; GAIL M, 1985, BIOMETRICS, V41, P361, DOI 10.2307/2530862; Roila F, 2006, ANN ONCOL, V17, P20, DOI 10.1093/annonc/mdj078; Ioannidis JPA, 2000, J CLIN ONCOL, V18, P3409; Saito M, 2009, LANCET ONCOL, V10, P115, DOI 10.1016/S1470-2045(08)70313-9; Aapro M, 2010, ANN ONCOL, V21, P1083, DOI 10.1093/annonc/mdp584; Roila F, 2010, ANN ONCOL, V21, pv232, DOI 10.1093/annonc/mdq194; Siddiqui MAA, 2004, DRUGS, V64, P1125, DOI 10.2165/00003495-200464100-00006; Segawa Y, 2009, ANN ONCOL, V20, P1874, DOI 10.1093/annonc/mdp243; Morita S, 2003, JPN J CLIN ONCOL, V33, P470, DOI 10.1093/jjco/hyg083; Celio L, 2011, SUPPORT CARE CANCER, V19, P1217, DOI 10.1007/s00520-010-0941-7; Rojas C, 2010, J PHARMACOL EXP THER, V335, P362, DOI 10.1124/jpet.110.166181; Hesketh P J, 1999, Oncologist, V4, P191; Lindley C M, 1992, Qual Life Res, V1, P331, DOI 10.1007/BF00434947; Siddiqui MA, 2004, DRUGS, V64, P1133	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					891	895		10.1111/cas.12675		5	Oncology	Oncology	CM7OK	WOS:000357883900014		
J	Ogura, M; Uchida, T; Terui, Y; Hayakawa, F; Kobayashi, Y; Taniwaki, M; Takamatsu, Y; Naoe, T; Tobinai, K; Munakata, W; Yamauchi, T; Kageyama, A; Yuasa, M; Motoyama, M; Tsunoda, T; Hatake, K				Ogura, Michinori; Uchida, Toshiki; Terui, Yasuhito; Hayakawa, Fumihiko; Kobayashi, Yukio; Taniwaki, Masafumi; Takamatsu, Yasushi; Naoe, Tomoki; Tobinai, Kensei; Munakata, Wataru; Yamauchi, Takeshi; Kageyama, Akiko; Yuasa, Miyuki; Motoyama, Masaaki; Tsunoda, Takeshi; Hatake, Kiyohiko			Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies	CANCER SCIENCE			English	Article						Daily dosing schedule; hematological malignancy; OPB-51602; phase I study; STAT3 inhibitor	RESPONSE CRITERIA; MOLECULAR TARGETS; MYELOID-LEUKEMIA; CANCER; STATS; THERAPY; PATHWAY; RECOMMENDATIONS; TRANSFORMATION; MYELOFIBROSIS	We carried out a multicenter dose-escalation phase I study of oral OPB-51602, a signal transducer and activator of transcription 3 phosphorylation inhibitor, in patients with relapsed or refractory hematological malignancies to evaluate the safety, maximum tolerated dose (MTD), pharmacokinetics, and preliminary antitumor activity. Twenty patients were treated with OPB-51602 at doses of 1, 2, 3, 4, and 6mg in the 3+3 dose escalation design. The most common treatment-related adverse events included nausea (55%), peripheral sensory neuropathy (45%), and diarrhea (40%). The most frequently observed grade 3 or 4 drug-related adverse events were neutropenia (20%), leukopenia (15%), lymphopenia (10%), and thrombocytopenia (10%). The MTD was 6mg, with dose-limiting toxicities of grade 3 lactic acidosis and increased blood lactic acid levels observed in one of three patients and grade 1-2 peripheral neuropathy in three of three patients. The recommended dose was determined to be 4mg. OPB-51602 was rapidly absorbed, and exposure tended to increase in a dose-dependent manner. Accumulation of OPB-51602 was seen with 4weeks of multiple treatments. No clear therapeutic response was observed. Durable stable disease was observed in two patients with acute myeloid leukemia and one with myeloma. In conclusion, the MTD of OPB-51602 was 6mg. OPB-51602 was safe and well tolerated in a dose range of 1-4mg. However, long-term administration at higher doses was difficult with the daily dosing schedule, and no response was seen. Therefore, further clinical development of OPB-51602 for hematological malignancies with a daily dosing schedule was terminated.	[Ogura, Michinori; Uchida, Toshiki] Nagoya Daini Red Cross Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Terui, Yasuhito; Hatake, Kiyohiko] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Hematol & Oncol, Tokyo, Japan; [Hayakawa, Fumihiko] Nagoya Univ Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Kobayashi, Yukio; Tobinai, Kensei; Munakata, Wataru] Natl Canc Ctr, Div Hematol, Tokyo, Japan; [Taniwaki, Masafumi] Kyoto Prefectural Univ Med, Univ Hosp, Div Hematol & Oncol, Kyoto, Japan; [Takamatsu, Yasushi] Fukuoka Univ Hosp, Div Med Oncol Hematol & Infect Dis, Fukuoka, Japan; [Naoe, Tomoki] Nagoya Med Ctr, Nagoya, Aichi, Japan; [Yamauchi, Takeshi] Otsuka Pharmaceut Co Ltd, Fujii Mem Res Inst, Otsu, Shiga, Japan; [Kageyama, Akiko; Yuasa, Miyuki; Motoyama, Masaaki; Tsunoda, Takeshi] Otsuka Pharmaceut Co Ltd, Tokyo, Japan	Ogura, M (reprint author), Natl Hosp Org, Suzuka Natl Hosp, Dept Hematol & Lab Med, Kasado 3-2-1, Suzuka, Mie 5138501, Japan.	mi-ogura@naa.att.ne.jp	Kobayahi, Yukio/F-2901-2015	Kobayahi, Yukio/0000-0003-2378-7865	Otsuka Pharmaceutical Co., Ltd.	Otsuka Pharmaceutical Co., Ltd.	Danial NN, 2000, ONCOGENE, V19, P2523, DOI 10.1038/sj.onc.1203484; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Buettner R, 2002, CLIN CANCER RES, V8, P945; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Germain D, 2007, CLIN CANCER RES, V13, P5665, DOI 10.1158/1078-0432.CCR-06-2491; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-06-1554; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; [Anonymous], 2008, CELL RES; Cheson BD, 1999, J CLIN ONCOL, V17, P1244; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Lin TS, 2000, ONCOGENE, V19, P2496, DOI 10.1038/sj.onc.1203486; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Leong PL, 2003, P NATL ACAD SCI USA, V100, P4138, DOI 10.1073/pnas.0534764100; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Goh BC, 2012, J CLIN ONCOL, V30, p173s; Hayakawa F, 2006, ANN NY ACAD SCI, V1086, P213, DOI 10.1196/annals.1377.002; Rozovski U, 2014, BLOOD, V123, P3797, DOI 10.1182/blood-2013-10-534073; Sternberg DW, 2004, J CLIN ONCOL, V22, P361, DOI 10.1200/JCO.2004.10.124; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					896	901		10.1111/cas.12683		6	Oncology	Oncology	CM7OK	WOS:000357883900015		
J	Mashima, T; Ushijima, M; Matsuura, M; Tsukahara, S; Kunimasa, K; Furuno, A; Saito, S; Kitamura, M; Soma-Nagae, T; Seimiya, H; Dan, S; Yamori, T; Tomida, A				Mashima, Tetsuo; Ushijima, Masaru; Matsuura, Masaaki; Tsukahara, Satomi; Kunimasa, Kazuhiro; Furuno, Aki; Saito, Sakae; Kitamura, Masami; Soma-Nagae, Taeko; Seimiya, Hiroyuki; Dan, Shingo; Yamori, Takao; Tomida, Akihiro			Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation	CANCER SCIENCE			English	Article						Antitumor agents; computational biology; gene expression profiling; molecular targeted therapy; protein kinase inhibitors	ENDOPLASMIC-RETICULUM STRESS; GROWTH-FACTOR RECEPTOR; LARGE GENE LISTS; LUNG-CANCER; THERAPEUTIC TARGET; INDUCED APOPTOSIS; INHIBITOR; EXPRESSION; RESISTANCE; KINASES	Targeted therapy is a rational and promising strategy for the treatment of advanced cancer. For the development of clinical agents targeting oncogenic signaling pathways, it is important to define the specificity of compounds to the target molecular pathway. Genome-wide transcriptomic analysis is an unbiased approach to evaluate the compound mode of action, but it is still unknown whether the analysis could be widely applicable to classify molecularly targeted anticancer agents. We comprehensively obtained and analyzed 129 transcriptomic datasets of cancer cells treated with 83 anticancer drugs or related agents, covering most clinically used, molecularly targeted drugs alongside promising inhibitors of molecular cancer targets. Hierarchical clustering and principal component analysis revealed that compounds targeting similar target molecules or pathways were clustered together. These results confirmed that the gene signatures of these drugs reflected their modes of action. Of note, inhibitors of oncogenic kinase pathways formed a large unique cluster, showing that these agents affect a shared molecular pathway distinct from classical antitumor agents and other classes of agents. The gene signature analysis further classified kinome-targeting agents depending on their target signaling pathways, and we identified target pathway-selective signature gene sets. The gene expression analysis was also valuable in uncovering unexpected target pathways of some anticancer agents. These results indicate that comprehensive transcriptomic analysis with our database () is a powerful strategy to validate and re-evaluate the target pathways of anticancer compounds.	[Mashima, Tetsuo; Tsukahara, Satomi; Kunimasa, Kazuhiro; Furuno, Aki; Saito, Sakae; Kitamura, Masami; Soma-Nagae, Taeko; Seimiya, Hiroyuki; Dan, Shingo; Yamori, Takao; Tomida, Akihiro] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1358550, Japan; [Ushijima, Masaru; Matsuura, Masaaki] Japanese Fdn Canc Res, Genome Ctr, Tokyo 1358550, Japan; [Matsuura, Masaaki] Teikyo Univ, Grad Sch Publ Hlth, Tokyo 1738605, Japan	Tomida, A (reprint author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	mmatsuura@med.teikyo-u.ac.jp; akihiro.tomida@jfcr.or.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan	Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Kurata T, 2009, EXPERT OPIN DRUG MET, V5, P171, DOI [10.1517/17425250802670508 , 10.1517/17425250802670508]; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Chiang CT, 2007, MOL CANCER THER, V6, P2127, DOI 10.1158/1535-7163.MCT-07-0107; Curtin JC, 2010, ONCOTARGET, V1, P563; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Michieli P, 2013, NAT REV CLIN ONCOL, V10, P372, DOI 10.1038/nrclinonc.2013.86; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Yano S, 2012, CANCER SCI, V103, P1189, DOI 10.1111/j.1349-7006.2012.02279.x; Workman P, 2013, CURR OPIN PHARMACOL, V13, P486, DOI 10.1016/j.coph.2013.06.004; Mashima T, 2005, J NATL CANCER I, V97, P765, DOI 10.1093/jnci.dji133; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Sheppard KE, 2013, CLIN CANCER RES, V19, P5320, DOI 10.1158/1078-0432.CCR-13-0259; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Tsai CJ, 2013, SEMIN CANCER BIOL, V23, P235, DOI 10.1016/j.semcancer.2013.04.001; De Smaele E, 2010, CURR OPIN INVEST DR, V11, P707; Mashima T, 2014, CANCER RES, V74, P4888, DOI 10.1158/0008-5472.CAN-13-3718; Arao T, 2004, CANCER RES, V64, P9101, DOI 10.1158/0008-5472.CAN-04-2360; Cepero V, 2010, CURR PHARM DESIGN, V16, P1396; Chen ST, 2010, LEUKEMIA RES, V34, P250, DOI 10.1016/j.leukres.2009.09.028; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Ushijima M, 2013, CANCER SCI, V104, P360, DOI 10.1111/cas.12071	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					909	920		10.1111/cas.12682		12	Oncology	Oncology	CM7OK	WOS:000357883900017		
J	Akita, S; Hattori, N; Masuda, T; Horimasu, Y; Nakashima, T; Iwamoto, H; Fujitaka, K; Miyake, M; Kohno, N				Akita, Shin; Hattori, Noboru; Masuda, Takeshi; Horimasu, Yasushi; Nakashima, Taku; Iwamoto, Hiroshi; Fujitaka, Kazunori; Miyake, Masayuki; Kohno, Nobuoki			MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model	CANCER SCIENCE			English	Article						Aminopeptidase N; angiogenesis; fully humanized monoclonal antibody; invasion; tumor growth	CELL LUNG-CANCER; EXTRACELLULAR-MATRIX DEGRADATION; METASTATIC COLORECTAL-CANCER; CLINICAL-SIGNIFICANCE; ANGIOGENESIS; EXPRESSION; INVASION; N/CD13; CD13; CARCINOMA	Aminopeptidase N (APN/CD13) is involved in tumor cell invasion and tumor angiogenesis and is considered a promising therapeutic target in the treatment of cancer. To develop a novel monoclonal antibody-based cancer therapy targeting APN/CD13, we established a fully humanized anti-APN/CD13 monoclonal antibody, MT95-4. Invitro, MT95-4 inhibited APN/CD13 enzymatic activity on the tumor cell surface and blocked tumor cell invasion. B16 mouse melanoma cells stably expressing human APN/CD13 were also established and were inoculated s.c. or injected i.v. into nude mice. We found that expression of human APN/CD13 in murine melanoma cells increased the size of subcutaneous tumors, extent of lung metastasis and degree of angiogenesis in the subcutaneous tumors; these tumor-promoting and angiogenesis-promoting characteristics were reduced by the i.p. administration of MT95-4. To further verify the specificity of MT95-4 for neutralization of APN/CD13 activity, MT95-4 was administered into NOD/SCID mice inoculated s.c. with H1299 or PC14 cells, which exhibit high expression of APN/CD13, or with A549 cells, which exhibit weak expression of APN/CD13. MT95-4 reduced tumor growth and angiogenesis in mice bearing H1299-derived and PC14-derived tumors, but not in mice bearing A549-derived tumors. These results suggested that the antitumor and anti-angiogenic effects of MT95-4 were dependent on APN/CD13 expression in tumor cells. Given that MT95-4 is the first fully humanized monoclonal antibody against APN/CD13, MT95-4 should be recognized as a promising candidate for monoclonal antibody therapy against tumors expressing APN/CD13.	[Akita, Shin; Hattori, Noboru; Masuda, Takeshi; Horimasu, Yasushi; Nakashima, Taku; Iwamoto, Hiroshi; Fujitaka, Kazunori; Kohno, Nobuoki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol & Internal Med, Hiroshima 7348551, Japan; [Miyake, Masayuki] Koseikai Takeda Hosp, Dept Thorac Surg, Kyoto, Japan	Hattori, N (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol & Internal Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	nhattori@hiroshima-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science.	DIXON J, 1994, J CLIN PATHOL, V47, P43, DOI 10.1136/jcp.47.1.43; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Fukasawa K, 2006, CANCER LETT, V243, P135, DOI 10.1016/j.canlet.2005.11.051; Hashida H, 2002, GASTROENTEROLOGY, V122, P376, DOI 10.1053/gast.2002.31095; Pasqualini R, 2000, CANCER RES, V60, P722; Tokuhara T, 2006, CLIN CANCER RES, V12, P3971, DOI 10.1158/1078-0432.CCR-06-0338; Ikeda N, 2003, CLIN CANCER RES, V9, P1503; Rangel R, 2007, P NATL ACAD SCI USA, V104, P4588, DOI 10.1073/pnas.0611653104; TAYLOR A, 1993, FASEB J, V7, P290; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Murakami H, 2005, CLIN CANCER RES, V11, P8674, DOI 10.1158/1078-0432.CCR-05-1005; LOOK AT, 1989, J CLIN INVEST, V83, P1299, DOI 10.1172/JCI114015; SAIKI I, 1993, INT J CANCER, V54, P137, DOI 10.1002/ijc.2910540122; Bhagwat SV, 2001, BLOOD, V97, P652, DOI 10.1182/blood.V97.3.652; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Guzman-Rojas L, 2012, P NATL ACAD SCI USA, V109, P1637, DOI 10.1073/pnas.1120790109; FUJII H, 1995, CLIN EXP METASTAS, V13, P337; Ichinose Y, 2003, J NATL CANCER I, V95, P605; Inoi K, 1995, Anticancer Res, V15, P2081; Ishida Isao, 2002, Cloning and Stem Cells, V4, P91, DOI 10.1089/153623002753632084; Ito Shinya, 2009, Gen Thorac Cardiovasc Surg, V57, P591, DOI 10.1007/s11748-009-0445-x; Luan YP, 2007, CURR MED CHEM, V14, P639, DOI 10.2174/092986707780059571; Ship A, 1993, BLOOD, V82, P1052; Tsukamoto H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-74; WORZALLA JF, 1990, INVEST NEW DRUG, V8, P241; YONEDA J, 1992, CLIN EXP METASTAS, V10, P49, DOI 10.1007/BF00163576	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					921	928		10.1111/cas.12692		8	Oncology	Oncology	CM7OK	WOS:000357883900018		
J	Yasui, K; Konishi, C; Gen, Y; Endo, M; Dohi, O; Tomie, A; Kitaichi, T; Yamada, N; Iwai, N; Nishikawa, T; Yamaguchi, K; Moriguchi, M; Sumida, Y; Mitsuyoshi, H; Tanaka, S; Arii, S; Itoh, Y				Yasui, Kohichiroh; Konishi, Chika; Gen, Yasuyuki; Endo, Mio; Dohi, Osamu; Tomie, Akira; Kitaichi, Tomoko; Yamada, Nobuhisa; Iwai, Naoto; Nishikawa, Taichiro; Yamaguchi, Kanji; Moriguchi, Michihisa; Sumida, Yoshio; Mitsuyoshi, Hironori; Tanaka, Shinji; Arii, Shigeki; Itoh, Yoshito			EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor--mediated growth inhibition in hepatocellular carcinoma	CANCER SCIENCE			English	Article						Cyclin-dependent kinase inhibitor p15; EVI1; gene amplification; hepatocellular carcinoma; transforming growth factor beta	OVARIAN-CANCER; MYELOID-LEUKEMIA; FACTOR-BETA; CELL-DEATH; EXPRESSION; ONCOGENE; LUNG; SOX2; PROGNOSIS; AMPLICON	EVI1 (ecotropic viral integration site 1) is one of the most aggressive oncogenes associated with myeloid leukemia. We investigated DNA copy number aberrations in human hepatocellular carcinoma (HCC) cell lines using a high-density oligonucleotide microarray. We found that a novel amplification at the chromosomal region 3q26 occurs in the HCC cell line JHH-1, and that MECOM (MDS1 and EVI1 complex locus), which lies within the 3q26 region, was amplified. Quantitative PCR analysis of the three transcripts transcribed from MECOM indicated that only EVI1, but not the fusion transcript MDS1-EVI1 or MDS1, was overexpressed in JHH-1 cells and was significantly upregulated in 22 (61%) of 36 primary HCC tumors when compared with their non-tumorous counterparts. Acopy number gain of EVI1 was observed in 24 (36%) of 66 primary HCC tumors. High EVI1 expression was significantly associated with larger tumor size and higher level of des--carboxy prothrombin, a tumor marker for HCC. Knockdown of EVI1 resulted in increased induction of the cyclin-dependent kinase inhibitor p15(INK4B) by transforming growth factor (TGF)- and decreased expression of c-Myc, cyclin D1, and phosphorylated Rb in TGF--treated cells. Consequently, knockdown of EVI1 led to reduced DNA synthesis and cell viability. Collectively, our results suggest that EVI1 is a probable target gene that acts as a driving force for the amplification at 3q26 in HCC and that the oncoprotein EVI1 antagonizes TGF--mediated growth inhibition of HCC cells.	[Yasui, Kohichiroh; Konishi, Chika; Gen, Yasuyuki; Endo, Mio; Dohi, Osamu; Tomie, Akira; Kitaichi, Tomoko; Yamada, Nobuhisa; Iwai, Naoto; Nishikawa, Taichiro; Yamaguchi, Kanji; Moriguchi, Michihisa; Sumida, Yoshio; Mitsuyoshi, Hironori; Itoh, Yoshito] Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Kyoto 6028566, Japan; [Tanaka, Shinji; Arii, Shigeki] Tokyo Med & Dent Univ, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan; [Tanaka, Shinji] Tokyo Med & Dent Univ, Dept Mol Oncol, Tokyo, Japan; [Arii, Shigeki] Japan Labour Hlth & Welf Org, Hamamatsu Rosai Hosp, Hamamatsu, Shizuoka, Japan	Yasui, K (reprint author), Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	yasuik@koto.kpu-m.ac.jp			Japan Society for the Program of Science	Japan Society for the Program of Science.	Sunde JS, 2006, CANCER RES, V66, P8404, DOI 10.1158/0008-5472.CAN-06-0683; Chen CF, 2010, HEPATOLOGY, V52, P1690, DOI 10.1002/hep.23847; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243; Shirabe K, 2007, J SURG ONCOL, V95, P235, DOI 10.1002/jso.20655; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Kurokawa M, 1998, NATURE, V394, P92; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Gen Y, 2010, CANCER GENET CYTOGEN, V202, P82, DOI 10.1016/j.cancergencyto.2010.01.023; Endo M, 2013, LIVER INT, V33, P105, DOI 10.1111/liv.12005; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Goyama S, 2010, INT J HEMATOL, V91, P753, DOI 10.1007/s12185-010-0618-5; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Barjesteh van Waalwijk van Doorn-Khosrovani S, 2003, BLOOD, V101, P837; Brooks DJ, 1996, BRIT J CANCER, V74, P1518, DOI 10.1038/bjc.1996.583; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Matsuzaki K, 2014, J GASTROENTEROL, V49, P971, DOI 10.1007/s00535-013-0910-2; Tanaka M, 2014, ONCOGENE, V33, P2454, DOI 10.1038/onc.2013.204; Weinberg Robert A, 2014, BIOL CANC, V2nd; Yokoi S, 2003, CLIN CANCER RES, V9, P4705; Zen K, 2009, GENE CHROMOSOME CANC, V48, P109, DOI 10.1002/gcc.20624	30	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					929	937		10.1111/cas.12694		9	Oncology	Oncology	CM7OK	WOS:000357883900019		
J	Kawate, T; Iwaya, K; Koshikawa, K; Moriya, T; Yamasaki, T; Hasegawa, S; Kaise, H; Fujita, T; Matsuo, H; Nakamura, T; Ishikawa, T; Hiroi, S; Iguchi-Ariga, SMM; Ariga, H; Murota, K; Fujimori, M; Yamamoto, J; Matsubara, O; Kohno, N				Kawate, Takahiko; Iwaya, Keiichi; Koshikawa, Kayoko; Moriya, Tomoyuki; Yamasaki, Tamio; Hasegawa, Sho; Kaise, Hiroshi; Fujita, Tomoyuki; Matsuo, Hirotaka; Nakamura, Takahiro; Ishikawa, Takashi; Hiroi, Sadayuki; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi; Murota, Keiichi; Fujimori, Minoru; Yamamoto, Junji; Matsubara, Osamu; Kohno, Norio			High levels of DJ-1 protein and isoelectric point 6.3 isoform in sera of breast cancer patients	CANCER SCIENCE			English	Article						Biomarker; 2-D gel electrophoresis; ELISA; oxidative stress; Parkinson's disease	PARKINSONS-DISEASE; GROWTH	In patients with cancer and Parkinson's disease, the DJ-1 protein may be secreted into the serum during the impaired response of the underlying cell-protective mechanisms. In order to determine the clinical significance of DJ-1 protein in the sera of breast cancer patients, we examined blood samples from a breast cancer group (n=180) and a non-cancerous control group (n=300). Higher levels of DJ-1 were detected in the breast cancer group (mean level, 42.7ng/mL) than the control group (28.3ng/mL) by ELISA (P=0.019). Higher DJ-1 levels were significantly associated with advanced clinical grade, according to the TNM classification, negative hormone receptor status, and high Ki-67 labeling index, of biopsied materials; samples showed low DJ-1 protein expression despite upregulated DJ-1 mRNA. DJ-1 isoforms could be detected clearly in 17 blood samples (from 11 breast cancer patients, and 6 non-cancerous controls) by 2-D gel electrophoresis and immunoblot analysis. The isoform at the pI of 6.3 showed the highest intensity in all 11 cancer cases. Conversely, in the 6 non-cancerous cases, isoforms other than the pI 6.3 isoform were highly expressed, and there was a significant difference in the isoform pattern between breast cancer cases and controls (P=0.00025). These data indicate that high levels of DJ-1, probably of isoform at pI 6.3, is a candidate serum marker of breast cancer.	[Kawate, Takahiko; Iwaya, Keiichi; Hiroi, Sadayuki; Matsubara, Osamu] Natl Def Med Coll, Dept Pathol, Tokorozawa, Saitama 3598513, Japan; [Kawate, Takahiko; Iwaya, Keiichi; Kaise, Hiroshi; Ishikawa, Takashi; Kohno, Norio] Tokyo Med Univ, Dept Breast Oncol, Tokyo 1608402, Japan; [Koshikawa, Kayoko; Fujita, Tomoyuki; Fujimori, Minoru] Tokyo Med Univ, Ibaraki Med Ctr, Dept Breast Surg, Ibaraki, Japan; [Moriya, Tomoyuki; Yamasaki, Tamio; Hasegawa, Sho; Yamamoto, Junji] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 3598513, Japan; [Matsuo, Hirotaka] Natl Def Med Coll, Dept Integrat Physiol & Bionano Med, Tokorozawa, Saitama 3598513, Japan; [Nakamura, Takahiro] Natl Def Med Coll, Math Lab, Tokorozawa, Saitama 3598513, Japan; [Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Fac Agr, Sapporo, Hokkaido 060, Japan; [Ariga, Hiroyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 060, Japan; [Murota, Keiichi] Kasumigaura Inst Hlth Evaluat, Ibaraki, Japan	Iwaya, K (reprint author), Natl Def Med Coll, Dept Basic Pathol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	kiwaya@ndmc.ac.jp			Foundation for Promotion of Cancer Research; Ministry of Defense of Japan; Japan Society for the Promotion of Science	Foundation for Promotion of Cancer Research; Ministry of Defense of Japan; Japan Society for the Promotion of Science.	Lin XM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00954; Devine MJ, 2011, NAT REV CANCER, V11, P812, DOI 10.1038/nrc3150; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Kawate T, 2013, BREAST CANCER RES TR, V139, P51, DOI 10.1007/s10549-013-2523-0; Onodera Y, 2014, J CLIN INVEST, V124, P367, DOI 10.1172/JCI63146; Allred DC, 1998, MODERN PATHOL, V11, P155; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Jain D, 2012, J MOL CELL BIOL, V4, P221, DOI 10.1093/jmcb/mjs025; Le Naour F, 2001, CLIN CANCER RES, V7, P3328; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Tsuchiya B, 2012, HISTOPATHOLOGY, V61, P69, DOI 10.1111/j.1365-2559.2012.04202.x; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Hudson TS, 2007, CANCER RES, V67, P8396, DOI 10.1158/0008-5472.CAN-06-4069; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Ariga H, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/683920; Caputo E, 2011, CELL CYCLE, V10, P2924, DOI 10.4161/cc.10.17.17068; Kim DK, 2013, J ALLERGY CLIN IMMUN, V131, P1653, DOI 10.1016/j.jaci.2012.10.012; Lakhani SR, 2011, WHO CLASSIFICATION T, P39; Natale M, 2010, BIOINFORMATICS, V26, P946, DOI 10.1093/bioinformatics/btq073; Oda M, 2012, CANCER SCI, V103, P1172, DOI 10.1111/j.1349-7006.2012.02267.x; Sobin LH, 2010, TNM CLASSIFICATION M; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Wang T, 2013, NUTRIENTS, V5, P2969; Waragai M, 2006, BIOCHEM BIOPH RES CO, V345, P967, DOI 10.1016/j.bbrc.2006.005.011; Yamaguchi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038144	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	JUL	2015	106	7					938	943		10.1111/cas.12673		6	Oncology	Oncology	CM7OK	WOS:000357883900020		
J	Maruyama, I; Igarashi, G; Nishioka, Y				Maruyama, Ippei; Igarashi, Go; Nishioka, Yukiko			Bimodal behavior of C-S-H interpreted from short-term length change and water vapor sorption isotherms of hardened cement paste	CEMENT AND CONCRETE RESEARCH			English	Article						Drying (A); Calcium-silicate-hydrate (C-S-H) (B); Adsorption (C); Shrinkage (C)	PORE STRUCTURE ANALYSIS; PORTLAND-CEMENT; TRICALCIUM SILICATE; DRYING SHRINKAGE; SURFACE-AREA; PROPOSED MECHANISM; HYDRATED CEMENT; COLLOID MODEL; ADSORPTION; PRESSURE	Short-term length change isotherms (SLCIs) and water vapor sorption isotherms are useful to eliminate the effects of the colloidal features of C-S-H. SLCIs of hardened cement pastes initially conditioned by drying to equilibrium at different relative humidities (RHs) were measured over a complete RH loop between 5% and 98%. Based on the correlation between incremental thickness of adsorption and incremental strain from 40% to 98% RH, the basal spacing of C-S-H above 40% RH appears to increase further with increasing water vapor sorption. However, no correlation of these values was found from 5% to 40% RH and the basal spacing is considered stable in this domain. These properties of C-S-H are directly related to its isothermal volume change as a function of RH. It can be concluded that the dominant shrinkage driver above 40% RH is disjoining or hydration pressure and that below 40% RH is change in surface energy. (C) 2015 Elsevier Ltd. All rights reserved.	[Maruyama, Ippei; Igarashi, Go; Nishioka, Yukiko] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Maruyama, I (reprint author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, ES Bldg,546 Furo Cho, Nagoya, Aichi 4648603, Japan.	ippei@dali.nuac.nagoya-u.ac.jp; go.igarashi@archi.tohoku.ac.jp			Nuclear Regulation Authority of Japan	The work was performed at Nagoya University within the framework of the Japan Ageing Management Program on System Safety project sponsored by the Nuclear Regulation Authority of Japan. The information presented in this paper is the sole opinion of the authors and does not necessarily reflect the views of the sponsoring agencies.	Baroghel-Bouny V, 2007, CEMENT CONCRETE RES, V37, P414, DOI 10.1016/j.cemconres.2006.11.019; BRUNAUER S, 1967, J COLLOID INTERF SCI, V25, P353, DOI 10.1016/0021-9797(67)90041-0; Beltzung F, 2005, CEMENT CONCRETE RES, V35, P2364, DOI 10.1016/j.cemconres.2005.04.004; Jennings HM, 2004, MATER STRUCT, V37, P59, DOI 10.1007/BF02481627; Fonseca PC, 2010, CEMENT CONCRETE RES, V40, P1673, DOI 10.1016/j.cemconres.2010.08.007; Gartner EM, 2000, CEMENT CONCRETE RES, V30, P817, DOI 10.1016/S0008-8846(00)00235-0; Gartner EM, 1997, CEMENT CONCRETE RES, V27, P665, DOI 10.1016/S0008-8846(97)00049-5; Jennings HM, 2008, J ADV CONCR TECHNOL, V6, P5, DOI 10.3151/jact.6.5; Maruyama I, 2010, J ADV CONCR TECHNOL, V8, P187, DOI 10.3151/jact.8.187; MIKHAIL RS, 1968, J COLLOID INTERF SCI, V26, P45, DOI 10.1016/0021-9797(68)90270-1; Jennings HM, 2008, CEMENT CONCRETE RES, V38, P275, DOI 10.1016/j.cemconres.2007.10.006; Maruyama I, 2014, CEMENT CONCRETE RES, V58, P20, DOI 10.1016/j.cemconres.2014.01.007; BADMANN R, 1981, J COLLOID INTERF SCI, V82, P534, DOI 10.1016/0021-9797(81)90395-7; Bangham DN, 1932, P R SOC LOND A-CONTA, V138, P162, DOI 10.1098/rspa.1932.0178; Kirkpatrick RJ, 1997, ADV CEM RES, V9, P31; Nonat A, 2004, CEMENT CONCRETE RES, V34, P1521, DOI 10.1016/j.cemconres.2004.04.035; FELDMAN RF, 1964, J APPL CHEM, V14, P93; Bentz DP, 1998, MODEL SIMUL MATER SC, V6, P211, DOI 10.1088/0965-0393/6/3/002; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; CASES JM, 1992, LANGMUIR, V8, P2730, DOI 10.1021/la00047a025; BRANTON PJ, 1994, J CHEM SOC FARADAY T, V90, P2965, DOI 10.1039/ft9949002965; Bayliss P., 1973, CEMENT CONCRETE RES, V3, P185, DOI 10.1016/0008-8846(73)90046-X; Bazant Z.P., 1972, CEMENT CONCRETE RES, V2, P1, DOI 10.1016/0008-8846(72)90019-1; Beaudoin JJ, 2010, CEMENT CONCRETE COMP, V32, P25, DOI 10.1016/j.cemconcomp.2009.09.004; Churaev N.V., 1990, LIQUID VAPOR FLOWS P, P3; Crank J., 1980, MATH DIFFUSION; Feldman R.F., 1968, 5TH P INT S CHEM CEM, P53; Feldman R.F., 1968, MATER STRUCT, V1, P509, DOI 10.1007/BF02473639; Gutteridge W.A., 1976, CEMENT CONCRETE RES, V6, P357, DOI 10.1016/0008-8846(76)90098-3; Hansen W., 1987, J AM CERAM SOC, V70, P323, DOI 10.1111/j.1151-2916.1987.tb05002.x; HELMUTH RA, 1967, J PCA RES DEV LAB, V9, P8; Houst Y., 1983, AUTOCLAVED AERATED C, P219; HUNT CM, 1960, J RES NBS A PHYS CH, V64, P163, DOI 10.6028/jres.064A.016; Igarashi G., 2011, CEMENT SCI CONCR TEC, V65, P183; Lea F.M., 1962, P FORTH INT S WASH D, P5; LITVAN GG, 1983, CEMENT CONCRETE RES, V13, P49, DOI 10.1016/0008-8846(83)90127-8; Matsui K., 2011, P JPN CONCR I, V33, P605; Matsushita F., 2004, J ADV CONCR TECHNOL, V2, P121, DOI 10.3151/jact.2.121; Mikhail R.S., 1966, P S STRUCT PORTL CEM, V90, P123; Muller A.C.A., 2012, J PHYS CHEM C, V117, P403; PARROTT LJ, 1981, CEMENT CONCRETE RES, V11, P11, DOI 10.1016/0008-8846(81)90004-1; PARROTT LJ, 1980, CEMENT CONCRETE RES, V10, P647, DOI 10.1016/0008-8846(80)90028-9; Powers T.C., 1965, INT C STRUCT CONCR C, P319; RAMACHAN.VS, 1967, J APPL CHEM, V17, P328; Richardson IG, 2004, CEMENT CONCRETE RES, V34, P1733, DOI 10.1016/j.cemconres.2004.05.034; Richardson IG, 2008, CEMENT CONCRETE RES, V38, P137, DOI 10.1016/j.cemconres.2007.11.005; Sato T., 1983, CAJ REV, P52; Setzer M.J., 2007, TRANSPORT CONCRETE N, P3; Tada S., 2000, P JCI, V22, P775; Tada S., 1990, CONCR RES TECHNOL, V1, P155; Thomas JJ, 2008, J AM CERAM SOC, V91, P3362, DOI 10.1111/j.1551-2916.2008.02636.x; TOMES LA, 1957, J RES NAT BUR STAND, V59, P357, DOI 10.6028/jres.059.039; Vidmer A, 2014, CEMENT CONCRETE RES, V60, P11, DOI 10.1016/j.cemconres.2014.03.004; VOLKL JJ, 1987, CEMENT CONCRETE RES, V17, P81, DOI 10.1016/0008-8846(87)90062-7; WITTMANN FH, 1973, J AM CERAM SOC, V56, P409, DOI 10.1111/j.1151-2916.1973.tb12711.x; Wittmann FH, 1968, MATER STRUCT, V1, P547, DOI 10.1007/BF02473643	56	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-8846	1873-3948		CEMENT CONCRETE RES	Cem. Concr. Res.	JUL	2015	73						158	168		10.1016/j.cemconres.2015.03.010		11	Construction & Building Technology; Materials Science, Multidisciplinary	Construction & Building Technology; Materials Science	CM7XI	WOS:000357909400016		
J	Sato, T; Ohno, A; Sarkar, SM; Uozumi, Y; Yamada, YMA				Sato, Takuma; Ohno, Aya; Sarkar, Shaheen M.; Uozumi, Yasuhiro; Yamada, Yoichi M. A.			A Convoluted Polymeric Imidazole Palladium Catalyst: Structural Elucidation and Investigation of the Driving Force for the Efficient Mizoroki-Heck Reaction	CHEMCATCHEM			English	Article						EXAFS spectroscopy; Mizoroki-Heck reaction; nanostructures; palladium; structure elucidation	X-RAY-ABSORPTION; LINKED AMPHIPHILIC POLYMER; CROSS-COUPLING REACTIONS; FINE-STRUCTURE EXAFS; HETEROGENEOUS CATALYSIS; HOMOGENEOUS CATALYSTS; ASSEMBLED CATALYST; PHASE-TRANSITION; HIGHLY EFFICIENT; ARYL HALIDES	MPPI-Pd (7mol ppm Pd), prepared from poly(N-isopropylacrylamide-co-N-vinylimidazole) and (NH4)(2)PdCl4 by our molecular convolution method, promoted the Mizoroki-Heck reaction in water to give the corresponding coupling products with high yield and reusability. To clarify why the catalyst was so active, structural elucidation and temperature-dependent absorption/discharge investigation were performed using X-ray absorption fine structure analysis, Raman and far-IR spectroscopy, elemental analysis, and DFT calculations, which provided the structure of cis-PdCl2L2 (L=imidazole moiety). Moreover, the temperature-dependent absorption and discharge of aryl iodides and water in MPPI-Pd were observed with near-IR spectroscopy and macroscopic observations. The efficient diffusion of organic substrates into the internal nanospaces in MPPI-Pd and the following discharge of the water molecules at 80 degrees C should enhance the catalytic activity dramatically as the driving force of the reaction.	[Sato, Takuma; Ohno, Aya; Sarkar, Shaheen M.; Uozumi, Yasuhiro; Yamada, Yoichi M. A.] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan; [Uozumi, Yasuhiro] Inst Mol Sci, Okazaki, Aichi 4448787, Japan	Uozumi, Y (reprint author), RIKEN Ctr Sustainable Resource Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	ymayamada@riken.jp; uo@ims.ac.jp	Yamada, Yoichi/A-7488-2012		JST ACT-C; JST CREST; JSPS [24550126, 20655035, 2105]; Takeda Science Foundation; Naito Foundation; RIKEN	We thank Dr. Tetsuo Honma, Dr. Masafumi Takagaki (JASRI, SPring-8), and Prof. Hikaru Takaya (Kyoto University) for XAFS measurements (SPring-8, BL14B2, 2012B1868). We are grateful to JASCO Corporation (Tokyo, Japan) for the measurement of Raman spectra (Mr. Takeo Soejima) and to JASCO Engineering (Tokyo, Japan) for the measurement of FIR spectra (Ms. Misa Aoyama). We also thank RIKEN for elemental (Dr. Yoshio Sakaguchi) and ICP-AES (Ms. Chieko Kariya) analyses. We gratefully acknowledge the financial support from JST ACT-C, JST CREST, JSPS (#24550126, #20655035, and #2105), the Takeda Science Foundation, the Naito Foundation, and RIKEN.	Albisson DA, 1998, TETRAHEDRON LETT, V39, P9793, DOI 10.1016/S0040-4039(98)02175-3; Yamada YMA, 2014, ANGEW CHEM INT EDIT, V53, P127, DOI 10.1002/anie.201308541; Buchmeiser MR, 2001, J ORGANOMET CHEM, V634, P39, DOI 10.1016/S0022-328X(01)01083-X; Harada M, 2009, LANGMUIR, V25, P6049, DOI 10.1021/la900550t; Zhang ZH, 2006, J ORG CHEM, V71, P7485, DOI 10.1021/jo061179k; Levina A, 2005, COORDIN CHEM REV, V249, P141, DOI 10.1016/j.ccr.2004.10.008; Lamblin M, 2010, ADV SYNTH CATAL, V352, P33, DOI 10.1002/adsc.200900765; Yamada YMA, 2003, TETRAHEDRON LETT, V44, P2379, DOI 10.1016/S0040-4039(03)00220-X; Alonso DA, 2002, ADV SYNTH CATAL, V344, P172, DOI 10.1002/1615-4169(200202)344:2<172::AID-ADSC172>3.0.CO;2-9; Molenbroek AM, 2009, TOP CATAL, V52, P1303, DOI 10.1007/s11244-009-9314-1; Tromp M, 2002, J AM CHEM SOC, V124, P14814, DOI 10.1021/ja026604f; Aksin O, 2006, J ORGANOMET CHEM, V691, P3027, DOI 10.1016/j.jorganchem.2006.03.012; Farina V, 2004, ADV SYNTH CATAL, V346, P1553, DOI 10.1002/adsc.200404178; Mayr M, 2004, CHEM-EUR J, V10, P1256, DOI 10.1002/chem.200305437; Sun BJ, 2007, APPL SPECTROSC, V61, P765, DOI 10.1366/000370207781393271; Okamoto K, 2005, J AM CHEM SOC, V127, P2125, DOI 10.1021/ja047095f; Baer K, 2009, ANGEW CHEM INT EDIT, V48, P9355, DOI 10.1002/anie.200900582; Parsons JG, 2002, APPL SPECTROSC REV, V37, P187, DOI 10.1081/ASR-120006044; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Alonso F, 2005, TETRAHEDRON, V61, P11771, DOI 10.1016/j.tet.2005.08.054; Ramaker DE, 2010, PHYS CHEM CHEM PHYS, V12, P5514, DOI 10.1039/b927120c; Mitsudome T, 2006, ANGEW CHEM INT EDIT, V45, P481, DOI 10.1002/anie.200502886; HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548; Yamada YMA, 2012, J AM CHEM SOC, V134, P3190, DOI 10.1021/ja210772v; Buchmeiser MR, 1999, J AM CHEM SOC, V121, P11101, DOI 10.1021/ja991501r; Uozumi Y, 2004, TOP CURR CHEM, V242, P77, DOI 10.1007/b96874; Chen LX, 2000, J PHYS CHEM B, V104, P1950, DOI 10.1021/jp993365i; Wang Z, 2009, CHEM REV, V109, P322, DOI 10.1021/cr800406u; Lu J, 2009, CHEM REV, V109, P815, DOI 10.1021/cr8004444; Anpo M, 2009, CATAL TODAY, V142, P114, DOI 10.1016/j.cattod.2008.11.006; FUJISHIGE S, 1989, J PHYS CHEM-US, V93, P3311, DOI 10.1021/j100345a085; Astruc D, 2005, ANGEW CHEM INT EDIT, V44, P7852, DOI 10.1002/anie.200500766; Arisawa M, 2006, ADV SYNTH CATAL, V348, P1063, DOI 10.1002/adsc.200606025; Astruc D., 2005, ANGEW CHEM, V117, P8062, DOI 10.1002/ange.200500766; Backvall J. E., 2010, SCI BACKGROUND NOBEL; Baer K., 2009, ANGEW CHEM, V121, P9519; Bernini R, 2008, ORG LETT, V10, P561, DOI 10.1021/ol7024845; Buback M., 1993, FT NIR ATLAS; Conradson SD, 1998, APPL SPECTROSC, V52, p252A; Crozier ED, 1997, NUCL INSTRUM METH B, V133, P134, DOI 10.1016/S0168-583X(97)00471-0; Dong ZM, 2014, ADV SYNTH CATAL, V356, P3401, DOI 10.1002/adsc.201400520; Dong ZM, 2015, APPL CATAL A-GEN, V489, P61, DOI 10.1016/j.apcata.2014.10.009; DURIG JR, 1965, SPECTROCHIM ACTA, V21, P1367, DOI 10.1016/0371-1951(65)80046-7; Feuerstein M, 2001, J ORG CHEM, V66, P5923, DOI 10.1021/jo015645b; Fiddy SG, 2003, CHEM COMMUN, P2682, DOI 10.1039/b307535d; Franzel T., 2003, POLYM MAT ORGANIC SY; Granovsky A. A., FIREFLY VERSION 8; Guilera G, 2006, CHEM COMMUN, P4306, DOI 10.1039/b606772g; Hagiwara H, 2005, CHEM COMMUN, P2942, DOI 10.1039/b502528a; Hasnain SS, 2003, J SYNCHROTRON RADIAT, V10, P9, DOI 10.1107/S0909049502022446; Hasnain SS, 1999, J SYNCHROTRON RADIAT, V6, P852, DOI 10.1107/S0909049599006792; HIROKAWA Y, 1992, J CHEM PHYS, V96, P8641, DOI 10.1063/1.462912; Uozumi Y, 2002, SYNLETT, P2045, DOI 10.1055/s-2002-35605; Kurisaki T, 2008, ANAL SCI, V24, P1385, DOI 10.2116/analsci.24.1385; Lee JS, 2002, TOP CATAL, V18, P67, DOI 10.1023/A:1013834317787; Mitsudome T., 2006, ANGEW CHEM, V118, P495, DOI 10.1002/ange.200502886; Miyoshi Y, 2012, CHEM-EUR J, V18, P7941, DOI 10.1002/chem.201103489; Molnár Árpád, 2011, Chem Rev, V111, P2251, DOI 10.1021/cr100355b; Morales-Morales D, 2002, INORG CHIM ACTA, V328, P39, DOI 10.1016/S0020-1693(01)00659-4; Nakamoto K., 1997, INFRARED RAMAN SPECT, P1; Purans J, 2005, J PHYS CHEM B, V109, P11074, DOI 10.1021/jp045489n; REED J, 1977, J AM CHEM SOC, V99, P5217, DOI 10.1021/ja00457a072; Sarkar SM, 2011, ANGEW CHEM INT EDIT, V50, P9437, DOI 10.1002/anie.201103799; Sarkar S. M., 2011, ANGEW CHEM, V123, P9609; Schroeder SLM, 1997, J MOL CATAL A-CHEM, V119, P357, DOI 10.1016/S1381-1169(96)00499-2; Shaw WJ, 2005, INORG CHEM COMMUN, V8, P894, DOI 10.1016/j.inoche.2005.07.001; Silberg J, 2001, J ORGANOMET CHEM, V622, P6, DOI 10.1016/S0022-328X(00)00783-X; Strange RW, 2005, COORDIN CHEM REV, V249, P197, DOI 10.1016/j.ccr.2004.03.019; Tada M, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.021013; Thomas JM, 2002, CHEM COMMUN, P2921, DOI 10.1039/b210679p; Thomas J. M., 1999, ANGEW CHEM, V111, P3800, DOI 10.1002/(SICI)1521-3757(19991216)111:24<3800::AID-ANGE3800>3.0.CO;2-1; Thomas J.M., 1999, ANGEW CHEM INT EDIT, V38, P3588, DOI DOI 10.1002/(SICI)1521-3773(19991216)); Uozumi Y, 2009, CHEM REC, V9, P51, DOI 10.1002/tcr.20165; Uozumi Y., 2002, HDB COMBINATORIAL CH; VANKRALINGEN CG, 1979, INORG CHIM ACTA, V36, P69, DOI 10.1016/S0020-1693(00)89373-1; Wennemers H., 2004, HIGHLIGHTS BIOORGANI, P436, DOI 10.1002/3527603727.ch5d; Workman J., 2008, PRACTICAL GUIDE INTE; Yamada YMA, 2011, J SYN ORG CHEM JPN, V69, P542; Yamada YMA, 2004, TETRAHEDRON, V60, P4097, DOI 10.1016/j.tet.2004.02.068; Yamashita H, 2003, CURR OPIN SOLID ST M, V7, P471, DOI 10.1016/j.cossms.2004.02.003; Young JN, 2010, J CATAL, V272, P253, DOI 10.1016/j.jcat.2010.04.005	81	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1867-3880	1867-3899		CHEMCATCHEM	ChemCatChem	JUL	2015	7	14					2141	2148		10.1002/cctc.201500249		8	Chemistry, Physical	Chemistry	CM8OV	WOS:000357962400018		
J	Monguchi, Y; Marumoto, T; Ichikawa, T; Miyake, Y; Nagae, Y; Yoshida, M; Oumi, Y; Sawama, Y; Sajiki, H				Monguchi, Yasunari; Marumoto, Takahisa; Ichikawa, Tomohiro; Miyake, Yutaka; Nagae, Yoshiyuki; Yoshida, Michiyuki; Oumi, Yasunori; Sawama, Yoshinari; Sajiki, Hironao			Unique Chemoselective Hydrogenation using a Palladium Catalyst Immobilized on Ceramic	CHEMCATCHEM			English	Article						ceramic; chemoselectivity; heterogeneous catalysis; hydrogenation; palladium	PD-MONTMORILLONITE CATALYSTS; STEREOSELECTIVE HYDROGENATION; SYNTHETIC ADSORBENT; SELECTIVE HYDROGENATION; MOLECULAR-HYDROGEN; MEMBRANE REACTORS; UNSATURATED BONDS; SMECTITE CLAY; BORON-NITRIDE; SILK-FIBROIN	A heterogeneous palladium catalyst supported on a ceramic (5% Pd/ceramic) was developed. The catalyst exhibited a specific chemoselectivity for hydrogenation that has never been achieved by other palladium-catalyzed methods. Either aliphatic or aromatic N-Cbz groups could be deprotected to the corresponding free-amines, while the hydrogenolysis of benzyl esters and ethers did not proceed. Furthermore, aryl chlorides and epoxides were tolerant under the Pd/ceramic-catalyzed hydrogenation conditions. 5% Pd/ceramic could be reused without any loss of catalyst activity, as no palladium leaching was detected in the reaction media.	[Monguchi, Yasunari; Marumoto, Takahisa; Ichikawa, Tomohiro; Sawama, Yoshinari; Sajiki, Hironao] Gifu Pharmaceut Univ, Organ Chem Lab, Gifu 5011196, Japan; [Miyake, Yutaka] Wako Pure Chem Ind Ltd, Kawagoe, Saitama 3501101, Japan; [Nagae, Yoshiyuki] Brightceram, Gifu 5090204, Japan; [Yoshida, Michiyuki] Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Gifu 5011193, Japan; [Oumi, Yasunori] Gifu Univ, Instrumental Anal, Life Sci Res Ctr, Gifu 5011193, Japan	Monguchi, Y (reprint author), Gifu Pharmaceut Univ, Organ Chem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	monguchi@gifu-pu.ac.jp; sajiki@gifu-pu.ac.jp			Saijiro Endo Memorial Foundation	We thank the N.E. Chemcat Corporation for the ICP-AES measurement of the eluted palladium species from the 5% Pd/ceramic into the reaction mixture. Y.M. thanks the Saijiro Endo Memorial Foundation for the partial financial support of this study.	ABDALLA BK, 1995, J MEMBRANE SCI, V101, P31, DOI 10.1016/0376-7388(94)00271-Y; Molina CB, 2009, J HAZARD MATER, V172, P214, DOI 10.1016/j.jhazmat.2009.06.161; Sajiki H, 2003, TETRAHEDRON LETT, V44, P171, DOI 10.1016/S0040-4039(02)02472-3; Marin-Astorga N, 2005, J MOL CATAL A-CHEM, V226, P81, DOI 10.1016/j.molcata.2004.09.047; Friedrich H, 2009, CHEM REV, V109, P1613, DOI 10.1021/cr800434t; Maegawa T, 2009, ADV SYNTH CATAL, V351, P2091, DOI 10.1002/adsc.200900316; Yabe Y, 2012, ADV SYNTH CATAL, V354, P1264, DOI 10.1002/adsc.201100936; Lv HF, 2014, NANOSCALE, V6, P5063, DOI 10.1039/c4nr00402g; Chambyal OS, 2013, SYNTHETIC COMMUN, V43, P656, DOI 10.1080/00397911.2011.605242; Chen WD, 2010, SEP PURIF TECHNOL, V72, P92, DOI 10.1016/j.seppur.2010.01.010; Monguchi Y, 2012, CHEMCATCHEM, V4, P546, DOI 10.1002/cctc.201100345; Antolini E, 2009, SOLID STATE IONICS, V180, P746, DOI 10.1016/j.ssi.2009.03.007; Choudary BM, 1999, APPL CATAL A-GEN, V181, P139, DOI 10.1016/S0926-860X(98)00390-1; Quicker P, 2000, CATAL TODAY, V56, P21, DOI 10.1016/S0920-5861(99)00259-X; Kawanishi A, 2013, ORG LETT, V15, P1306, DOI 10.1021/ol4002448; Sajiki H, 2003, TETRAHEDRON LETT, V44, P8437, DOI 10.1016/j.tetlet.2003.09.137; Antolini E, 2010, APPL CATAL B-ENVIRON, V100, P413, DOI 10.1016/j.apcatb.2010.08.025; Keane MA, 2003, J MATER SCI, V38, P4661, DOI 10.1023/A:1027406515132; Ikawa T, 2005, TETRAHEDRON, V61, P2217, DOI 10.1016/j.tet.2004.11.080; Monguchi Y, 2009, CHEM-EUR J, V15, P834, DOI 10.1002/chem.200801989; COLLINS JP, 1993, IND ENG CHEM RES, V32, P3006, DOI 10.1021/ie00024a008; Takahashi T, 2012, TETRAHEDRON, V68, P8293, DOI 10.1016/j.tet.2012.07.044; CHOUDARY BM, 1985, J CHEM SOC CHEM COMM, P931, DOI 10.1039/c39850000931; CHOUDARY BM, 1987, J CHEM SOC CHEM COMM, P1505, DOI 10.1039/c39870001505; DENG JF, 1994, APPL CATAL A-GEN, V109, P63, DOI 10.1016/0926-860X(94)85003-8; Divakar D, 2007, J CHEM TECHNOL BIOT, V82, P253, DOI 10.1002/jctb.1661; Divakar D, 2008, CATAL LETT, V125, P277, DOI 10.1007/s10562-008-9532-3; Haag S, 2008, INT J SURF SCI ENG, V2, P202, DOI 10.1504/IJSURFSE.2008.020494; Hara T, 2004, GREEN CHEM, V6, P507, DOI 10.1039/b408185d; Ikawa T, 2004, TETRAHEDRON, V60, P6901, DOI 10.1016/j.tet.2004.05.098; Ikawa T, 2004, TETRAHEDRON, V60, P6189, DOI 10.1016/j.tet.2004.05.040; Ikawa T, 2005, J SYN ORG CHEM JPN, V63, P1218; KIKUCHI E, 1995, CATAL TODAY, V25, P333, DOI 10.1016/0920-5861(95)00085-T; Kiraly Z, 2001, LANGMUIR, V17, P5381, DOI 10.1021/la0102004; Kitamura Y, 2007, SYNTHETIC COMMUN, V37, P4381, DOI 10.1080/00397910701577612; KUMAR KR, 1986, J CHEM SOC CHEM COMM, P130, DOI 10.1039/c39860000130; Mastalir A, 2000, J CATAL, V194, P146, DOI 10.1006/jcat.2000.2929; Mastalir A, 1997, STUD SURF SCI CATAL, V108, P477; Mastalir A, 2004, APPL CATAL A-GEN, V269, P161, DOI 10.1016/j.apcata.2004.04.012; Mastalir A, 2001, REACT KINET CATAL L, V74, P323, DOI 10.1023/A:1017901530788; Mastalir A, 2001, APPL CATAL A-GEN, V213, P133, DOI 10.1016/S0926-860X(00)00889-9; Mondal AM, 2001, SEPAR SCI TECHNOL, V36, P1101, DOI 10.1081/SS-100103639; Monguchi Y, 2012, J SYN ORG CHEM JPN, V70, P711; MUKKANTI K, 1989, TETRAHEDRON LETT, V30, P251, DOI 10.1016/S0040-4039(00)95173-6; Murata M, 2003, TETRAHEDRON LETT, V44, P4981, DOI 10.1016/S0040-4039(03)01181-X; Narayanan S, 1996, APPL CATAL A-GEN, V147, pL253, DOI 10.1016/S0926-860X(96)00298-0; Narayanan S, 1997, CHEM COMMUN, P1991, DOI 10.1039/a704599i; Sajiki H, 2003, CHEM COMMUN, P654, DOI 10.1039/b211313a; SHARMA GVM, 1989, J ORG CHEM, V54, P2997, DOI 10.1021/jo00274a001; SHARMA GVM, 1989, SYNTHETIC COMMUN, V19, P3289, DOI 10.1080/00397918908052731; Singh B, 2006, APPL SURF SCI, V253, P1247, DOI 10.1016/j.apsusc.2006.01.079; Sun X., 2013, HUAXUE FANYING GONGC, V29, P152; Tosti S, 2002, J MEMBRANE SCI, V196, P241, DOI 10.1016/S0376-7388(01)00597-X; Yabe Y, 2013, CHEMCATCHEM, V5, P2360, DOI 10.1002/cctc.201300035; Yabe Y, 2013, CHEM-EUR J, V19, P483, DOI 10.1002/chem.201203337	55	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1867-3880	1867-3899		CHEMCATCHEM	ChemCatChem	JUL	2015	7	14					2155	2160		10.1002/cctc.201500193		6	Chemistry, Physical	Chemistry	CM8OV	WOS:000357962400020		
J	Iwasaki, Y; Saito, Y; Mori, K; Ito, M; Mimuro, M; Aiba, I; Saito, K; Mizuta, I; Yoshida, T; Nakagawa, M; Yoshida, M				Iwasaki, Yasushi; Saito, Yufuko; Mori, Keiko; Ito, Masumi; Mimuro, Maya; Aiba, Ikuko; Saito, Kozo; Mizuta, Ikuko; Yoshida, Tomokatsu; Nakagawa, Masanori; Yoshida, Mari			An autopsied case of adult-onset bulbospinal-form Alexander disease with a novel S393R mutation in the GFAP gene	CLINICAL NEUROPATHOLOGY			English	Article						Alexander disease; Rosenthal fiber; S393R; GFAP; astrocyte	FUNCTIONAL ALTERATION	A 50-year-old Japanese man with no apparent family history noticed diplopia. He gradually showed gait disturbance and dysuria. Abducens disorder of eye movement with nystagmus, tongue atrophy with fasciculation, spastic tetraparesis, and sensory disturbance were also observed. MRI showed severe atrophy of the medulla oblongata to the cervical cord ("tadpole appearance"). Tracheotomy and gastrostomy were performed 7 years after onset due to the development of bulbar palsy. Death occurred following respiratory failure after 11 years total disease duration. The brain weighed 1,380 g. The cerebrum, cerebellum, midbrain, and upper pons were preserved from atrophy, but the medulla oblongata to the cervical cord showed severe atrophy. A few Rosenthal fibers were observed in the cerebral white matter, basal ganglia, and cerebellum, whereas numerous Rosenthal fibers were observed in the medulla oblongata to the cervical cord. Myelin loss with relatively preserved axons was extensively observed from the middle of the pons to the spinal cord. The clinicopathological diagnosis was adult-onset bulbospinal-form Alexander disease. Glial fibrillary acidic protein (GFAP) gene analysis revealed a novel mutation of S393R. Expression patterns of S393R mutant GFAP using adrenal carcinoma-derived cells (SW 13 cells) showed a decreased number of filamentous structures and abnormal aggregates.	[Iwasaki, Yasushi; Mimuro, Maya; Yoshida, Mari] Aichi Med Univ, Inst Med Sci Aging, Dept Neuropathol, Nagakute, Aichi 4801195, Japan; [Saito, Yufuko; Aiba, Ikuko] Natl Hosp Org Higashi Nagoya Natl Hosp, Dept Neurol, Nagoya, Aichi, Japan; [Mori, Keiko; Ito, Masumi] Oyamada Mem Spa Hosp, Dept Neurol, Yokaichi, Japan; [Saito, Kozo; Mizuta, Ikuko; Yoshida, Tomokatsu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurol, Kyoto, Japan; [Nakagawa, Masanori] Kyoto Prefectural Univ Med, Med Ctr N, Div Neurol, Kyoto, Japan	Iwasaki, Y (reprint author), Aichi Med Univ, Inst Med Sci Aging, Dept Neuropathol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	iwasaki@sc4.so-net.ne.jp					Rodriguez D, 2001, AM J HUM GENET, V69, P1134, DOI 10.1086/323799; Yoshida T, 2007, J HUM GENET, V52, P362, DOI 10.1007/s10038-007-0124-7; Yoshida T, 2012, NEUROPATHOLOGY, V32, P440, DOI 10.1111/j.1440-1789.2011.01268.x; TOWFIGHI J, 1983, ACTA NEUROPATHOL, V61, P36; Yoshida T, 2011, J NEUROL, V258, P1998, DOI 10.1007/s00415-011-6056-3; TOMOKANE N, 1991, AM J PATHOL, V138, P875; Prust M, 2011, NEUROLOGY, V77, P1287, DOI 10.1212/WNL.0b013e3182309f72; Salmaggi A, 2007, J NEUROL, V254, P1278, DOI 10.1007/s00415-006-0361-2; Waisman Center. University of Wisconsin-Madison, GFAP MUT ASS AL DIS; Yoshida T, 2009, NEUROSCI LETT, V458, P11, DOI 10.1016/j.neulet.2009.04.032	10	0	0	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0722-5091			CLIN NEUROPATHOL	Clin. Neuropathol.	JUL-AUG	2015	34	4					207	214		10.5414/NP300806		8	Clinical Neurology; Pathology	Neurosciences & Neurology; Pathology	CN0KG	WOS:000358101900006		
J	Dong, RX				Dong, Robert Xin			Boundary asymptotics of the relative Bergman kernel metric for elliptic curves	COMPTES RENDUS MATHEMATIQUE			English	Article							SURFACES; BUNDLES	For a family of compact Riemann surfaces, we study the asymptotic behaviors of the relative Bergman kernel metric near the boundaries of the moduli spaces. We have shown that the relative Bergman kernel metric on a family of elliptic curves has hyperbolic growth at the node. The proof relies largely on the elliptic function theory. (C) 2015 Academie des sciences. Published by Elsevier Masson SAS. All rights reserved.	[Dong, Robert Xin] Tongji Univ, Dept Math, Shanghai 200092, Peoples R China; [Dong, Robert Xin] Nagoya Univ, Grad Sch Math, Nagoya, Aichi 4648602, Japan	Dong, RX (reprint author), Tongji Univ, Dept Math, Shanghai 200092, Peoples R China.	1987xindong@tongji.edu.cn			NSFC [11171255]; Heisei-25 Support Funds for Prominent Graduate School; Gakusei Project of the Nagoya University	This work is supported by the NSFC grant (No. 11171255), the Heisei-25 Support Funds for Prominent Graduate School and the 2013 Gakusei Project of the Nagoya University. The author sincerely thanks Prof. Ohsawa for his guidance to this topic, Professors Adachi, Berndtsson and Hisamoto for the fruitful discussions, Prof. Demailly for his lectures on the Ohsawa-Takegoshi theory at KAWA-NORDAN 2014, and the anonymous referee for the improvement of this paper.	Ahlfors LV, 1979, COMPLEX ANAL INTRO T; Berndtsson B, 2009, ANN MATH, V169, P531; OHSAWA T, 1987, MATH Z, V195, P197, DOI 10.1007/BF01166457; Berndtsson B, 2008, DUKE MATH J, V145, P341, DOI 10.1215/00127094-2008-054; Berndtsson B, 2006, ANN I FOURIER, V56, P1633; Berndtsson B., 2014, ARXIV14074946MATHCV; Donaldson S, 2014, ACTA MATH-DJURSHOLM, V213, P63, DOI 10.1007/s11511-014-0116-3; Dong R.X., 2015, BOUNDARY ASYMP UNPUB; Guan Q, 2015, ANN MATH, V181, P1139, DOI 10.4007/annals.2015.181.3.6; TIAN G, 1990, INVENT MATH, V101, P101, DOI 10.1007/BF01231499; Tsuji H., 2007, ARXIVMATH0703729; Maitani F, 2004, MATH ANN, V330, P477, DOI 10.1007/s00208-004-0556-8	12	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	1631-073X	1778-3569		CR MATH	C. R. Math.	JUL	2015	353	7					611	615		10.1016/j.crma.2015.04.015		5	Mathematics	Mathematics	CM5XG	WOS:000357761700009		
J	Morita, T; Ueno, S; Tokunaga, T; Hosono, E; Oaki, Y; Imai, H; Matsuda, H; Zhou, HS; Hagiwara, M; Fujihara, S				Morita, Takahiro; Ueno, Shintaro; Tokunaga, Takashi; Hosono, Eiji; Oaki, Yuya; Imai, Hiroaki; Matsuda, Hirofumi; Zhou, Haoshen; Hagiwara, Manabu; Fujihara, Shinobu			Fabrication of Transparent ZnO Thick Film with Unusual Orientation by the Chemical Bath Deposition	CRYSTAL GROWTH & DESIGN			English	Article							ZINC-OXIDE FILMS; AQUEOUS-SOLUTIONS; METAL CHALCOGENIDE; DOPED ZNO; GROWTH; NANOPARTICLES; TEMPERATURES; ELECTRODES; NANOWIRES; ROUTE	We report a fabrication of transparent ZnO thick films by a chemical bath deposition using zinc acetate ethanolicaqueous solutions with cetyltrimethylammonium chloride (CTAC). In this system, CTAC plays a particular role in nucleation and crystal growth of ZnO, and the micrometer-thick ZnO films formed on ZnO-buffered glass substrates. The resultant ZnO thick films show a high transmittance of around 80% in the visible region. An orientation of ZnO nuclei formed on the substrates in the early stage is different from a c-axis orientation of the ZnO-buffer layer, and the resultant ZnO thick films also show the unusual orientation. The detailed information on the orientation of these ZnO films was analyzed based on X-ray diffraction (XRD) 2 theta/theta scan measurements at angles between in-plane and out-of-plane geometries. According to the results, the c-axis of ZnO is tilted at around 40-50 degrees with respect to the film normal, and the micrometer-thick ZnO films exhibit the (112)-plane orientation by adjusting the CTAC concentration of reaction solutions.	[Morita, Takahiro; Tokunaga, Takashi; Oaki, Yuya; Imai, Hiroaki; Hagiwara, Manabu; Fujihara, Shinobu] Keio Univ, Dept Appl Chem, Yokohama, Kanagawa 2238522, Japan; [Ueno, Shintaro] Univ Yamanashi, Grad Sch Dept Interdisciplinary Res, Kofu, Yamanashi 4008510, Japan; [Hosono, Eiji; Matsuda, Hirofumi; Zhou, Haoshen] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Hosono, E (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan.	e-hosono@aist.go.jp; shinobu@applc.keio.ac.jp	Hosono, Eiji/M-8402-2013				Mane RS, 2000, MATER CHEM PHYS, V65, P1, DOI 10.1016/S0254-0584(00)00217-0; Bai S, 2011, ADV FUNCT MATER, V21, P4464, DOI 10.1002/adfm.201101319; Ohyama M, 1997, THIN SOLID FILMS, V306, P78, DOI 10.1016/S0040-6090(97)00231-9; Wang LL, 2011, J MATER CHEM, V21, P19331, DOI 10.1039/c1jm13354c; Vanheusden K, 1996, J APPL PHYS, V79, P7983, DOI 10.1063/1.362349; Baxter JB, 2006, J PHYS CHEM B, V110, P25229, DOI 10.1021/jp064399a; Song JM, 2014, CRYSTENGCOMM, V16, P2652, DOI 10.1039/c3ce41943f; Yoshida T, 2009, ADV FUNCT MATER, V19, P17, DOI 10.1002/adfm.200700188; Feng XJ, 2004, J AM CHEM SOC, V126, P62, DOI 10.1021/ja038636o; Vayssieres L, 2003, ADV MATER, V15, P464, DOI 10.1002/adma.200390108; Tahar RBH, 1998, J APPL PHYS, V83, P2631, DOI 10.1063/1.367025; Koumoto K, 2008, B CHEM SOC JPN, V81, P1337, DOI 10.1246/bcsj.81.1337; Xu L, 2009, CHEM MATER, V21, P2875, DOI 10.1021/cm900608d; Pawar SM, 2011, CURR APPL PHYS, V11, P117, DOI 10.1016/j.cap.2010.07.007; TAKATA S, 1986, THIN SOLID FILMS, V135, P183, DOI 10.1016/0040-6090(86)90125-2; Saito M, 2008, ENERG ENVIRON SCI, V1, P280, DOI 10.1039/b806096g; Saliba S, 2010, CHEM MATER, V22, P6301, DOI 10.1021/cm102069w; Yamabi S, 2002, J MATER CHEM, V12, P3773, DOI 10.1039/B205384E; Niesen TP, 2002, SOLID STATE IONICS, V151, P61, DOI 10.1016/S0167-2738(02)00604-5; RAY S, 1983, J APPL PHYS, V54, P3497, DOI 10.1063/1.332415; Hagendorfer H, 2014, ADV MATER, V26, P632, DOI 10.1002/adma.201303186; Chu DW, 2010, J AM CERAM SOC, V93, P887, DOI 10.1111/j.1551-2916.2009.03506.x; Boyle DS, 2002, CHEM COMMUN, P80, DOI 10.1039/b110079n; Wu CT, 2011, J MATER CHEM, V21, P2871, DOI 10.1039/c0jm03481a; Yu HD, 2005, J AM CHEM SOC, V127, P2378, DOI 10.1021/ja043121y; Hosono E, 2012, CRYST GROWTH DES, V12, P2923, DOI 10.1021/cg300116h; Edwards PP, 2004, DALTON T, P2995, DOI 10.1039/b408864f; Gao YF, 2007, LANGMUIR, V23, P4712, DOI 10.1021/la0635404; Hu XL, 2014, THIN SOLID FILMS, V558, P134, DOI 10.1016/j.tsf.2014.03.004; Kawano T., 2010, J CERAM SOC JPN, V11, P969; Lee S, 2011, SEMICOND SCI TECH, V26, DOI 10.1088/0268-1242/26/11/115007; Liu CP, 2014, RSC ADV, V4, P34669, DOI 10.1039/c4ra05107f; Morita T, 2015, J CERAM SOC JPN, V123, P329, DOI 10.2109/jcersj2.123.329; Qian HS, 2005, CRYST GROWTH DES, V5, P935, DOI 10.1021/cg0496661; Ueno S, 2011, ELECTROCHIM ACTA, V56, P2906, DOI 10.1016/j.electacta.2010.12.084; Umar A, 2008, CHEM COMMUN, P166, DOI 10.1039/b711215g; Wu Y, 2013, CHEM MATER, V25, P4619, DOI 10.1021/cm402974j	37	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	JUL	2015	15	7					3150	3156		10.1021/cg501729w		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CM1IY	WOS:000357435800013		
J	Asakawa, H; Sazaki, G; Nagashima, K; Nakatsubo, S; Furukawa, Y				Asakawa, Harutoshi; Sazaki, Gen; Nagashima, Ken; Nakatsubo, Shunichi; Furukawa, Yoshinori			Prism and Other High-Index Faces of Ice Crystals Exhibit Two Types of Quasi-Liquid Layers	CRYSTAL GROWTH & DESIGN			English	Article							FORCE MICROSCOPY; MELTING-POINT; WATER-VAPOR; GROWTH-KINETICS; SPIRAL STEPS; SURFACE; SILICA; FORMS	Surface melting of ice significantly governs a wide variety of phenomena in nature. We recently succeeded in directly observing the surface melting on ice basal faces (Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 1052-1055) by our advanced optical microscopy, which can detect 0.37-nm-thick elementary steps on basal faces. However, the direct observation of surface melting on the other prism and high-index faces remains an experimental challenge. To fully obtain a comprehensive understanding, we need to examine the surface melting on these faces. Here we show the appearance of two types of quasi-liquid layers (QLLs) on prism and high-index faces just below the melting point. We quickly raised the temperature of ice crystals and then observed prism and high-index faces during a roughening process. We found that with increasing temperature, round liquid-like droplets (alpha-QLLs) first appeared at temperatures higher than -1.4 to -0.5 degrees C, and then thin liquid-like layers (beta-QLLs) also appeared at temperatures higher than -0.8 to -0.3 degrees C, as in the case of basal faces. This result demonstrates that the presence of two types of QLL phases with different morphologies plays an intrinsically important role in the surface melting of ice crystals, irrespective of face indexes. We also revealed that the roughening process was caused thermally.	[Asakawa, Harutoshi; Sazaki, Gen; Nagashima, Ken; Nakatsubo, Shunichi; Furukawa, Yoshinori] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan	Sazaki, G (reprint author), Hokkaido Univ, Inst Low Temp Sci, Kita Ku, N19-W8, Sapporo, Hokkaido 0600819, Japan.	sazaki@lowtem.hokudai.ac.jp	Sazaki, Gen/D-8035-2012	Sazaki, Gen/0000-0002-2320-5442	JSPS KAKENHIs [23246001]	The authors thank Y. Saito and S. Kobayashi (Olympus Engineering Co., Ltd.) for their technical support of LCM-DIM, G. Layton (Northern Arizona University) for the provision of AgI crystals, N. Akutsu (Osaka Electro-Communication University), and K. Murata (Hokkaido University) for valuable discussion. G.S. is grateful for the partial support by JSPS KAKENHIs (Grant No. 23246001).	GILPIN RR, 1980, J COLLOID INTERF SCI, V77, P435, DOI 10.1016/0021-9797(80)90314-8; FURUKAWA Y, 1987, J CRYST GROWTH, V82, P665; Furukawa Y, 1997, J PHYS CHEM B, V101, P6167, DOI 10.1021/jp9631700; Bluhm H, 2000, PHYS REV B, V61, P7760, DOI 10.1103/PhysRevB.61.7760; Sazaki G, 2010, P NATL ACAD SCI USA, V107, P19702, DOI 10.1073/pnas.1008866107; Ishizaki T, 1996, J CRYST GROWTH, V163, P455, DOI 10.1016/0022-0248(95)00990-6; DOSCH H, 1995, SURF SCI, V327, P145, DOI 10.1016/0039-6028(94)00801-9; Dash JG, 2006, REV MOD PHYS, V78, P695, DOI 10.1103/RevModPhys.78.695; Sazaki G, 2013, CRYST GROWTH DES, V13, P1761, DOI 10.1021/cg400086j; Wei X, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.085401; Sazaki G, 2012, P NATL ACAD SCI USA, V109, P1052, DOI 10.1073/pnas.1116685109; Doppenschmidt A, 2000, LANGMUIR, V16, P6709, DOI 10.1021/la990799w; Wei X, 2001, PHYS REV LETT, V86, P1554, DOI 10.1103/PhysRevLett.86.1554; Bluhm H, 1999, J CHEM PHYS, V111, P6947, DOI 10.1063/1.479987; Petrenko VF, 1997, J PHYS CHEM B, V101, P6276, DOI 10.1021/jp963217h; ELBAUM M, 1993, J CRYST GROWTH, V129, P491, DOI 10.1016/0022-0248(93)90483-D; GOLECKI I, 1978, J PHYS C SOLID STATE, V11, P4229, DOI 10.1088/0022-3719/11/20/018; Asakawa H, 2014, CRYST GROWTH DES, V14, P3210, DOI 10.1021/cg4014653; DASH JG, 1989, SCIENCE, V246, P1591, DOI 10.1126/science.246.4937.1591; Dosch H, 1996, SURF SCI, V366, P43, DOI 10.1016/0039-6028(96)00805-9; ELBAUM M, 1991, PHYS REV LETT, V67, P2982, DOI 10.1103/PhysRevLett.67.2982; Faraday M., 1859, PHILOS MAG, V17, P162; KURODA T, 1982, J CRYST GROWTH, V56, P189, DOI 10.1016/0022-0248(82)90028-8; MacGorman D.R., 1998, ELECT NATURE STORMS; Mizuno Y., 1987, J PHYS C SOLID STATE, V48, pC1; PLUIS B, 1987, PHYS REV LETT, V59, P2678, DOI 10.1103/PhysRevLett.59.2678; Sazaki G, 2014, CRYST GROWTH DES, V14, P2133, DOI 10.1021/cg4014448; Sazaki G, 2004, J CRYST GROWTH, V262, P536, DOI 10.1016/j.jcrysgro.2003.10.049; Sei T., 1992, PHYS CHAMISTRY ICE, P349; Takehiko G., 1999, POLAR METEOROLOGY GL, V13, P38; VANMILTENBURG JC, 1993, J CRYST GROWTH, V128, P1143, DOI 10.1016/S0022-0248(07)80113-8; Wettlaufer JS, 2000, SCI AM, V282, P50	32	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	JUL	2015	15	7					3339	3344		10.1021/acs.cgd.5b00438		6	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CM1IY	WOS:000357435800033		
J	Fukuda, K; Asaka, T; Hara, S; Berghout, A; Bechade, E; Masson, O; Jouin, J; Thomas, P				Fukuda, Koichiro; Asaka, Toru; Hara, Shinji; Berghout, Abid; Bechade, Emilie; Masson, Olivier; Jouin, Jenny; Thomas, Philippe			Crystal Structure and Oxide-Ion Conductivity of Highly Grain-Aligned Polycrystalline Lanthanum Germanate Oxyapatite Grown by Reactive Diffusion between Solid La2GeO5 and Gases [GeO+1/2O(2)]	CRYSTAL GROWTH & DESIGN			English	Article							BOND-VALENCE PARAMETERS; 3-DIMENSIONAL VISUALIZATION; SILICATE POLYCRYSTAL; INTERSTITIAL OXYGEN; POWDER DIFFRACTION; BISMUTH TITANATE; C-AXIS; APATITE; CERAMICS; ORIENTATION	We prepared the highly c*-axis-aligned polycrystalline lanthanum germanate oxyapatite, La9.68Ge6O26.52, by the reactive diffusion that occurs between a randomly grain-oriented La2GeO5 polycrystal and [GeO + 1/2O(2)] gases at 1723 K in air. The resulting La9.68Ge6O26.52 polycrystal was examined by optical microscopy, X-ray diffractometry, micro-Raman spectroscopy, and impedance spectroscopy. The crystal structure (space group P1) showed the appreciable positional disordering of 9 of the 24 O atoms, bonding to Ge atoms, in the unit cell. We have found an extra O site, with the occupation factor of 0.51, which was located close to one of the six Ge sites with the Ge-O distance of similar to 0.198 nm. The Raman extra band at 649 cm(-1) also suggested the existence of the five coordinate Ge atoms. The conductivity along the c* axis of oxide ions steadily increased from 6.3 x 10(-7) to 1.04 x 10(-2) S/cm as the temperature increased from 573 to 973 K. The activation energy of conduction was 1.2 eV.	[Fukuda, Koichiro; Asaka, Toru; Hara, Shinji] Nagoya Inst Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan; [Berghout, Abid; Bechade, Emilie; Masson, Olivier; Jouin, Jenny; Thomas, Philippe] Univ Limoges, Ctr Europeen Ceram, SPCTS, UMR CNRS 7315, F-87068 Limoges, France	Fukuda, K (reprint author), Nagoya Inst Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan.	fukuda.koichiro@nitech.ac.jp			Japan Society for the Promotion of Science [25630281]	This research was supported by a Grant-in-Aid for Scientific Research (No. 25630281) from the Japan Society for the Promotion of Science. We thank Mr. H. Oka, Nagoya Institute of Technology, for technical assistance.	Fukuda K, 2013, CHEM MATER, V25, P2154, DOI 10.1021/cm400892p; Fukuda K, 2012, CHEM MATER, V24, P2611, DOI 10.1021/cm301484q; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Abram EJ, 2005, SOLID STATE IONICS, V176, P1941, DOI 10.1016/j.ssi.2005.05.016; Fukuda K, 2012, SOLID STATE IONICS, V217, P40, DOI 10.1016/j.ssi.2012.04.018; Hsu CH, 2001, CORROSION, V57, P747; Leon-Reina L, 2003, CHEM MATER, V15, P2099, DOI 10.1021/cm031017u; Leon-Reina L, 2004, J MATER CHEM, V14, P1142, DOI 10.1039/b315257j; Fukuda K, 2011, CHEM MATER, V23, P5474, DOI 10.1021/cm2029905; Pramana SS, 2007, ACTA CRYSTALLOGR B, V63, P597, DOI 10.1107/S0108768107024317; Kaga H, 2007, ACTA MATER, V55, P4753, DOI 10.1016/j.actamat.2007.04.046; LEBAIL A, 1988, MATER RES BULL, V23, P447, DOI 10.1016/0025-5408(88)90019-0; Xiang PH, 2006, J MATER RES, V21, P1830, DOI 10.1557/JMR.2006.0226; Izumi F, 2007, SOL ST PHEN, V130, P15; [Anonymous], 2006, APEX2 W2K NT V1 0; Kendrick E, 2008, MATER RES BULL, V43, P3627, DOI 10.1016/j.materresbull.2008.01.017; Orera A, 2010, J MATER CHEM, V20, P2170, DOI 10.1039/b922834a; LOTGERING FK, 1959, J INORG NUCL CHEM, V9, P113, DOI 10.1016/0022-1902(59)80070-1; Fukuda K, 2012, CHEM MATER, V24, P4623, DOI 10.1021/cm3034643; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Rodriguez-Reyna E, 2006, SOLID STATE SCI, V8, P168, DOI 10.1016/j.solidstatesciences.2005.11.004; Nakayama S, 2013, SOLID STATE IONICS, V253, P47, DOI 10.1016/j.ssi.2013.08.021; KIMURA T, 1982, J AM CERAM SOC, V65, P223, DOI 10.1111/j.1151-2916.1982.tb10410.x; Berastegui P, 2002, J SOLID STATE CHEM, V168, P294, DOI 10.1006/jssc.2002.9724; BRESE NE, 1991, ACTA CRYSTALLOGR B, V47, P192, DOI 10.1107/S0108768190011041; Fukuda K, 2012, J SOLID STATE CHEM, V194, P157, DOI 10.1016/j.jssc.2012.04.043; Higuchi Y, 2010, CERAM INT, V36, P955, DOI 10.1016/j.ceramint.2009.10.022; HOPPE R, 1989, J LESS-COMMON MET, V156, P105, DOI 10.1016/0022-5088(89)90411-6; Irvine J. T. S., 1990, Advanced Materials, V2, DOI 10.1002/adma.19900020304; Johnson D., 1990, ZVIEW PROGRAM VERSIO; KIMURA T, 1989, J AM CERAM SOC, V72, P85, DOI 10.1111/j.1151-2916.1989.tb05958.x; Marrero-Lopez D, 2011, FUEL CELLS, V11, P65, DOI 10.1002/fuce.201000024; Nakayama S, 2004, SOLID STATE IONICS, V170, P219, DOI 10.1016/j.ssi.2004.02.023; Nespolo M, 1999, ACTA CRYSTALLOGR B, V55, P902, DOI 10.1107/S0108768199008708; Orera A, 2011, FUEL CELLS, V11, P10, DOI 10.1002/fuce.201000020; Oszlanyi G, 2004, ACTA CRYSTALLOGR A, V60, P134, DOI 10.1107/S0108767303027569; Petricek V., 2006, JANA2006 CRYSTALLOGR; Pramana SS, 2009, DALTON T, P8280, DOI 10.1039/b907704a; Sansom JEH, 2002, IONICS, V8, P155, DOI 10.1007/BF02377767; Sansom JEH, 2004, SOLID STATE IONICS, V175, P353, DOI 10.1016/j.ssi.2003.12.030; Santacruz I, 2011, J EUR CERAM SOC, V31, P1573, DOI 10.1016/j.jeurceramsoc.2011.03.023; Sheldrick G. M., 1997, SHELXL 97 PROGRAM RE; VETTER G, 1988, J SOLID STATE CHEM, V73, P287, DOI 10.1016/0022-4596(88)90112-0; ZUCKER UH, 1982, ACTA CRYSTALLOGR A, V38, P563, DOI 10.1107/S0567739482001211	44	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	JUL	2015	15	7					3435	3441		10.1021/acs.cgd.5b00509		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CM1IY	WOS:000357435800044		
J	Yousefi, AT; Tanaka, H; Bagheri, S; Elfghi, F; Mahmood, MR; Ikeda, S				Yousefi, Amin T.; Tanaka, Hirofurni; Bagheri, Samira; Elfghi, Fawzi; Mahmood, Mohammad R.; Ikeda, Shoichiro			Vectorial Crystal Growth of Oriented Vertically Aligned Carbon Nanotubes Using Statistical Analysis	CRYSTAL GROWTH & DESIGN			English	Article							RESPONSE-SURFACE METHODOLOGY; CHEMICAL-VAPOR-DEPOSITION; TEMPERATURE; OPTIMIZATION; FERROCENE; UNIFORM	In this present work, crystalline growth conditions of oriented carbon nanotubes based on chemical vapor deposition (CVD) were optimized. The crystallinity and degree of alignment of the grown carbon nanotubes (CNTs) were characterized by field emission scanning electron microscopy, transmission electron microscopy, and Raman spectroscopy. The effects of four variables, namely, deposition time, deposition temperature, annealing process, and concentration of the precursor on the crystallinity of the CNTs, were explored. Furthermore, the correlation of parameters with the growth mechanism was examined using response surface methodology in an attempt to determine the complex interactions between the variables. A total of 30 runs, including predicting and consolidation runs to confirm the results, were required for screening the effect of the parameters on the growth of the CNTs. On the basis of the investigated model, it was found that the crystallinity of the CNTs grown by the CVD method can be controlled via restriction of the effective parameters.	[Yousefi, Amin T.; Elfghi, Fawzi; Ikeda, Shoichiro] Univ Technol Malaysia, MJIIT, Dept Environm & Green Technol EGT, ChECA IKohza, Kuala Lumpur, Malaysia; [Tanaka, Hirofurni] Kyushu Inst Technol Kyutech, Dept Human Intelligence Syst, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan; [Bagheri, Samira] Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, Kuala Lumpur 50603, Malaysia; [Mahmood, Mohammad R.] Univ Teknol MARA UiTM, Inst Sci, NANO SciTech Ctr, Shah Alam, Selangor, Malaysia	Yousefi, AT (reprint author), Univ Technol Malaysia, MJIIT, Dept Environm & Green Technol EGT, ChECA IKohza, Kuala Lumpur, Malaysia.	amin@edu.brain.kyutech.ac.jp			Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan [24510150, 25110002]	This work was supported by Grants-in-Aid for Scientific Research (No. 24510150) and for Scientific Research on Innovative Areas (No. 25110002) from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan.	Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Liu JW, 2005, J PHYS CHEM B, V109, P15769, DOI 10.1021/jp050123b; Kumar M, 2010, J NANOSCI NANOTECHNO, V10, P3739, DOI 10.1166/jnn.2010.2939; Chekin F, 2012, J SOLID STATE ELECTR, V16, P3245, DOI 10.1007/s10008-012-1767-7; Lee CJ, 2001, CHEM PHYS LETT, V343, P33, DOI 10.1016/S0009-2614(01)00680-7; Yadav RM, 2009, NANOSCALE RES LETT, V4, P197, DOI 10.1007/s11671-008-9225-2; Teo KBK, 2003, NANOTECHNOLOGY, V14, P204, DOI 10.1088/0957-4484/14/2/321; Davis JP, 2007, ACAD MANAGE REV, V32, P480; DESS GG, 1993, J MANAGE, V19, P775, DOI 10.1177/014920639301900403; Puretzky AA, 2005, APPL PHYS A-MATER, V81, P223, DOI 10.1007/s00339-005-3256-7; Ko H, 2006, NANO LETT, V6, P1443, DOI 10.1021/nl060608r; Lee YT, 2003, CHEM PHYS LETT, V372, P853, DOI 10.1016/S0009-2614(03)00529-3; Chatterjee S., 2013, REGRESSION ANAL EXAM; Elfghi FM, 2013, REACT KINET MECH CAT, V108, P371, DOI 10.1007/s11144-012-0511-8; Elfghi FM, 2014, REACT KINET MECH CAT, V111, P89, DOI 10.1007/s11144-013-0624-8; Harrell FE, 2001, REGRESSION MODELING; Jorio A., 2007, CARBON NANOTUBES, V111; Jusoh M., 2013, ADV CHEM ENG, P2013; Khan MJH, 2014, MATERIALS, V7, P2440, DOI 10.3390/ma7042440; Kuo CS, 2005, CARBON, V43, P2760, DOI 10.1016/j.carbon.2005.05.022; Myers R. H., 2009, RESPONSE SURFACE MET, V705; Roy R. K., 2001, DESIGN EXPT USING TA; Termeh Yousefi A., 2014, MAT RES INNOV; Termeh Yousefi A., 2015, INT J ELECTROCHEM SC, V10, P4183; Termehyousefi A., 2015, J MAT MANUF PROCESSE, V30, P59; Wang HC, 2006, IND ENG CHEM RES, V45, P8043, DOI 10.1021/ie060299f; Woolson R. F., 2011, STAT METHODS ANAL BI, V371	29	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	JUL	2015	15	7					3457	3463		10.1021/acs.cgd.5b00534		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CM1IY	WOS:000357435800047		
J	Yamamoto, Y; Fujisaki, J; Omae, M; Hirasawa, T; Igarashi, M				Yamamoto, Yorimasa; Fujisaki, Junko; Omae, Masami; Hirasawa, Toshiaki; Igarashi, Masahiro			Helicobacter pylori-negative gastric cancer: Characteristics and endoscopic findings	DIGESTIVE ENDOSCOPY			English	Review						endoscopic finding; gastric adenocarcinoma of the fundic gland type; Helicobacter pylori-negative gastric cancer; signet ring-cell carcinoma; undifferentiated-type gastric cancer	EPSTEIN-BARR-VIRUS; FAMILIAL ADENOMATOUS POLYPOSIS; CELL PREDOMINANT TYPE; E-CADHERIN GENE; SERUM PEPSINOGEN-I; FUNDIC GLAND TYPE; PERNICIOUS-ANEMIA; CLINICOPATHOLOGICAL CHARACTERISTICS; SUBMUCOSAL DISSECTION; MUCOSAL ATROPHY	Helicobacter pylori (H.pylori) leads to chronic gastritis and eventually causes gastric cancer. The prevalence of H.pylori infection is gradually decreasing with improvement of living conditions and eradication therapy. However, some reports have described cases of H.pylori-negative gastric cancers (HpNGC), and the prevalence was 0.42-5.4% of all gastric cancers. Diagnostic criteria of HpNGC vary among the different reports; thus, they have not yet been definitively established. We recommend negative findings in two or more methods that include endoscopic or pathological findings or serum pepsinogen test, and negative urease breath test or serum immunoglobulin G test and no eradication history the minimum criteria for diagnosis of HpNGC. The etiology of gastric cancers, excluding H.pylori infection, is known to be associated with several factors including lifestyle, viral infection, autoimmune disorder and germline mutations, but the main causal factor of HpNGC is still unclear. Regarding the characteristics of HpNGC, the undifferentiated type (UD-type) is more frequent than the differentiated type (D-type). The UD-type is mainly signet ring-cell carcinoma that presents as a discolored lesion in the lower or middle part of the stomach in relatively young patients. The gross type is flat or depressed. The D-type is mainly gastric adenocarcinoma of the fundic gland type that presents as a submucosal tumor-like or flat or depressed lesion in the middle and upper part of the stomach in relatively older patients. Early detection of HpNGC enables minimally invasive treatment which preserves the patient's quality of life. Endoscopists should fully understand the characteristics and endoscopic findings of HpNGC.	[Yamamoto, Yorimasa; Fujisaki, Junko; Omae, Masami; Hirasawa, Toshiaki; Igarashi, Masahiro] Canc Inst Hosp, Div Gastroenterol, Tokyo, Japan	Yamamoto, Y (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Div Gastroenterol, Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	yorimasa.yamamoto@jfcr.or.jp					Matsuo T, 2011, HELICOBACTER, V16, P415, DOI 10.1111/j.1523-5378.2011.00889.x; Ikeda F, 2009, GASTROENTEROLOGY, V136, P1234, DOI 10.1053/j.gastro.2008.12.045; Yamada H, 2011, CANCER SCI, V102, P1782, DOI 10.1111/j.1349-7006.2011.02038.x; Wu MS, 2000, GASTROENTEROLOGY, V118, P1031, DOI 10.1016/S0016-5085(00)70355-6; Fitzgerald RC, 2010, J MED GENET, V47, P436, DOI 10.1136/jmg.2009.074237; Kusano C, 2008, J GASTROEN HEPATOL, V23, P1662, DOI 10.1111/j.1440-1746.2008.05572.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Shinmura K, 1999, CARCINOGENESIS, V20, P1127, DOI 10.1093/carcin/20.6.1127; Kato S, 2007, CANCER SCI, V98, P790, DOI 10.1111/j.1349-7006.2007.00478.x; Norton JA, 2007, ANN SURG, V245, P873, DOI 10.1097/01.sla.0000254370.29893.e4; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Pharoah PDP, 2001, GASTROENTEROLOGY, V121, P1348, DOI 10.1053/gast.2001.29611; Shibata C, 2013, TOHOKU J EXP MED, V229, P143, DOI 10.1620/tjem.229.143; Joossens JV, 1996, INT J EPIDEMIOL, V25, P494, DOI 10.1093/ije/25.3.494; Fujita H, 2012, AM J SURG PATHOL, V36, P1709, DOI 10.1097/PAS.0b013e31826ca204; Yamamoto Y, 2010, DIGEST ENDOSC, V22, P112, DOI 10.1111/j.1443-1661.2010.00945.x; Takao T, 2011, GASTROENT RES PRACT, DOI 10.1155/2011/631461; NAKAMURA S, 1994, CANCER, V73, P2239, DOI 10.1002/1097-0142(19940501)73:9<2239::AID-CNCR2820730902>3.0.CO;2-#; IWAMA T, 1993, ANN SURG, V217, P101, DOI 10.1097/00000658-199302000-00002; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hidaka Y, 2013, HUM PATHOL, V44, P2438, DOI 10.1016/j.humpath.2013.06.002; Yoon H, 2011, HELICOBACTER, V16, P382, DOI 10.1111/j.1523-5378.2011.00859.x; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; Toh BH, 1997, NEW ENGL J MED, V337, P1441; BURKE AP, 1990, MODERN PATHOL, V3, P377; Kitahara F, 1999, GUT, V44, P693; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Anagnostopoulos I, 1996, HISTOPATHOLOGY, V29, P297, DOI 10.1111/j.1365-2559.1996.tb01414.x; La Torre G, 2009, TUMORI, V95, P13; Yanai H, 1999, J CLIN GASTROENTEROL, V29, P39, DOI 10.1097/00004836-199907000-00010; [Anonymous], 1994, IARC MONOGR EVAL CAR, V61, P1; WATANABE H, 1976, CANCER, V38, P232, DOI 10.1002/1097-0142(197607)38:1<232::AID-CNCR2820380135>3.0.CO;2-4; Inoue M, 2005, POSTGRAD MED J, V81, P419, DOI 10.1136/pgmj.2004.029330; Ueyama H, 2010, AM J SURG PATHOL, V34, P609, DOI 10.1097/PAS.0b013e3181d94d53; ODA T, 1994, P NATL ACAD SCI USA, V91, P1858, DOI 10.1073/pnas.91.5.1858; ZAMCHECK N, 1955, NEW ENGL J MED, V252, P1103, DOI 10.1056/NEJM195506302522601; Cisco RM, 2008, CANCER, V113, P1850, DOI 10.1002/cncr.23650; Vannella L, 2013, ALIMENT PHARM THER, V37, P375, DOI 10.1111/apt.12177; Toyokawa T, 2010, J GASTROEN HEPATOL, V25, P544, DOI 10.1111/j.1440-1746.2009.05995.x; Yagi K, 2005, J GASTROENTEROL, V40, P443, DOI 10.1007/s00535-005-1605-0; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Ono S, 2012, DIGESTION, V86, P59, DOI 10.1159/000339176; Wood LD, 2014, AM J SURG PATHOL, V38, P389, DOI 10.1097/PAS.0000000000000146; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Kakinoki R, 2009, DIGEST DIS SCI, V54, P614, DOI 10.1007/s10620-008-0389-5; Asano K, 2008, INT J CANCER, V122, P909, DOI 10.1002/ijc.23191; BOCK OAA, 1963, GUT, V4, P106, DOI 10.1136/gut.4.2.106; Ferlay J., 2013, IARC CANCERBASE; Fujisaki J, 2014, STOMACH INTESTINE, V49, P854; HARUMA K, 1995, AM J GASTROENTEROL, V90, P1107; Iida S, 1999, CLIN CANCER RES, V5, P1445; Kamangar F, 2006, J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393; Kimura K, 1969, ENDOSCOPY, V3, P87, DOI DOI 10.1055/S-0028-1098086; MIKI K, 1993, JPN J CANCER RES, V84, P1086; Nagata N, 2011, GASTROENTEROLOGY RES, V4, P203; Nakashima H, 2010, GASTRIC CANCER, V13, P78, DOI 10.1007/s10120-009-0538-3; Ohkusa T, 2004, ALIMENT PHARM THERAP, V20, P25, DOI 10.1111/j.1365-2036.2004.01970.x; Shiota S, 2013, EXPERT REV GASTROENT, V7, P35, DOI [10.1586/egh.12.67, 10.1586/EGH.12.67]; STEMMERMANN GN, 1987, CLIN CHIM ACTA, V163, P191, DOI 10.1016/0009-8981(87)90022-2; TAKI K, 1981, PATHOL RES PRACT, V172, P176; Ueyama H, 2014, ENDOSCOPY, V46, P153, DOI 10.1055/s-0033-1359042; Vaira D, 2000, ALIMENT PHARM THERAP, V14, P13, DOI 10.1046/j.1365-2036.2000.00096.x; WARREN JR, 1983, LANCET, V1, P1273; Watanabe K, 2013, WORLD J GASTROENTERO, V19, P4374, DOI 10.3748/wjg.v19.i27.4374; Yaita H, 2014, STOMACH INTESTINE, V49, P863; Yao T, 2014, STOMACH INTESTINE, V49, P874	66	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JUL	2015	27	5					551	561		10.1111/den.12471		11	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CM7TM	WOS:000357899400001		
J	Miyabe, K; Hayashi, K; Nakazawa, T; Sano, H; Yamada, T; Takada, H; Naitoh, I; Shimizu, S; Kondo, H; Nishi, Y; Yoshida, M; Umemura, S; Hori, Y; Kato, A; Ohara, H; Joh, T				Miyabe, Katsuyuki; Hayashi, Kazuki; Nakazawa, Takahiro; Sano, Hitoshi; Yamada, Tomonori; Takada, Hiroki; Naitoh, Itaru; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Yoshida, Michihiro; Umemura, Shuichiro; Hori, Yasuki; Kato, Akihisa; Ohara, Hirotaka; Joh, Takashi			Safety and benefits of self-expandable metallic stents with chemotherapy for malignant gastric outlet obstruction	DIGESTIVE ENDOSCOPY			English	Article						drug therapy; malignant gastric outlet obstruction; neoplasm; palliative care; stent	ESOPHAGOGASTRIC CANCER; ESOPHAGEAL CANCER; PRIOR RADIATION; DUODENAL STENT; PALLIATION; MULTICENTER; PLACEMENT; OUTCOMES; PATENCY	Background and AimThe influence of chemotherapy on placement of self-expandable metallic stents (SEMS) for malignant gastric outlet obstruction (MGOO) has not been evaluated extensively. We investigated the influence of chemotherapy on the clinical outcomes of SEMS placement for MGOO. MethodsA total of 152 cancer patients with MGOO from a university hospital and affiliate hospitals were included. The patients were classified according to chemotherapy status and evaluated for palliative efficacy and safety of SEMS placement. ResultsTechnical success rate, time to oral intake, and parameters indicating improvement of physical condition did not differ between the with- and without-chemotherapy groups after stent placement. Re-intervention and stent migration were significantly more frequent in the with-chemotherapy group than in the without-chemotherapy group after stent placement (re-intervention, 32.4% vs 7.8%, P=0.0005; stent migration, 13.5% vs 1.7%, P=0.0097). The frequency of adverse events did not differ between the with- and without-chemotherapy groups. Although chemotherapy after stent placement was an independent predictive factor for shortening the stent patency period (hazard ratio [HR], 3.10; P=0.0264), the use of additional stents facilitated uneventful recovery and further prolonged survival time (HR, 0.60; P=0.0132). ConclusionsVarious cancer patients with MGOO can undergo SEMS placement safely regardless of chemotherapy, and concurrent chemotherapy after stent placement can prolong survival time, although re-intervention and stent migration may be increased.	[Miyabe, Katsuyuki; Hayashi, Kazuki; Nakazawa, Takahiro; Naitoh, Itaru; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Yoshida, Michihiro; Umemura, Shuichiro; Hori, Yasuki; Kato, Akihisa; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi 4678601, Japan; [Ohara, Hirotaka] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi 4678601, Japan; [Yamada, Tomonori] Japanese Red Cross Nagoya Daini Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Sano, Hitoshi] Gifu Prefectural Tajimi Hosp, Dept Gastroenterol, Tajimi, Japan; [Takada, Hiroki] Kasugai Municipal Hosp, Dept Gastroenterol, Kasugai, Aichi, Japan	Hayashi, K (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	khayashi@med.nagoya-cu.ac.jp					Sasaki T, 2013, DIGEST ENDOSC, V25, P1, DOI 10.1111/j.1443-1661.2012.01319.x; Kim JH, 2007, GASTROINTEST ENDOSC, V66, P256, DOI 10.1016/j.gie.2006.12.017; Sharma P, 2010, AM J GASTROENTEROL, V105, P258, DOI 10.1038/ajg.2009.684; Adler DG, 2002, AM J GASTROENTEROL, V97, P72; Kim CG, 2010, GASTROINTEST ENDOSC, V72, P25, DOI 10.1016/j.gie.2010.01.039; Siersema PD, 1998, GASTROINTEST ENDOSC, V47, P113, DOI 10.1016/S0016-5107(98)70342-6; Ly J, 2010, SURG ENDOSC, V24, P290, DOI 10.1007/s00464-009-0577-1; Maetani I, 2007, GASTROINTEST ENDOSC, V66, P355, DOI 10.1016/j.gie.2006.11.060; Cho YK, 2010, DIGEST DIS SCI, V55, P668, DOI 10.1007/s10620-009-0787-3; Kinsman KJ, 1996, GASTROINTEST ENDOSC, V43, P196; van den Berg MW, 2013, ENDOSCOPY, V45, P174, DOI 10.1055/s-0032-1326077; Mittal A, 2004, BRIT J SURG, V91, P205, DOI 10.1002/bjs.4396; Siddiqui AA, 2012, GASTROINTEST ENDOSC, V76, P44, DOI 10.1016/j.gie.2012.02.036; Tringali A, 2014, GASTROINTEST ENDOSC, V79, P66, DOI 10.1016/j.gie.2013.06.032; Siersema PD, 2001, GASTROINTEST ENDOSC, V54, P579, DOI 10.1067/mge.2001.118716; KARNOFSKY DA, 1948, CANCER, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L; Isayama H, 2012, GASTROINTEST ENDOSC, V75, P757, DOI 10.1016/j.gie.2011.11.035; Kim CG, 2012, ENDOSCOPY, V44, P807, DOI 10.1055/s-0032-1309893; Telford JJ, 2004, GASTROINTEST ENDOSC, V60, P916, DOI 10.1016/S0016-5107(04)02228-X; Cha BH, 2013, ASIA-PAC J CLIN ONCO, V9, P162, DOI 10.1111/j.1743-7563.2012.01590.x; Sasaki T, 2012, DIGEST ENDOSC, V24, P226, DOI 10.1111/j.1443-1661.2011.01208.x; Baron TH, 2001, NEW ENGL J MED, V344, P1681, DOI 10.1056/NEJM200105313442206; Hayashi K, 2001, DIGEST ENDOSC, V13, P202, DOI 10.1046/j.1443-1661.2001.00149.x; Hayashi K, 2005, DIGEST ENDOSC, V17, P263, DOI 10.1111/j.1443-1661.2005.00509.x; Levy DM, 2006, CONT EDU ANAESTHESIA, V6, P215, DOI 10.1093/bjaceaccp/mkl048; Maetani I, 2009, GASTROINTEST ENDOSC, V69, P806, DOI 10.1016/j.gie.2008.06.009; Poulsen M, 2009, J GASTROINTEST SURG, V13, P1238, DOI 10.1007/s11605-009-0888-5; Shimura T, 2009, J GASTROEN HEPATOL, V24, P1358, DOI 10.1111/j.1440-1746.2009.05857.x; Soetikno R M, 1999, Gastrointest Endosc Clin N Am, V9, P447; Sumiyoshi T, 2003, GASTROINTEST ENDOSC, V57, P882, DOI 10.1067/mge.2003.234; TRUONG S, 1992, ENDOSCOPY, V24, P433, DOI 10.1055/s-2007-1010515	31	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JUL	2015	27	5					572	581		10.1111/den.12424		10	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CM7TM	WOS:000357899400003		
J	Hatta, W; Iijima, K; Koike, T; Kondo, Y; Ara, N; Asanuma, K; Uno, K; Asano, N; Imatani, A; Shimosegawa, T				Hatta, Waku; Iijima, Katsunori; Koike, Tomoyuki; Kondo, Yutaka; Ara, Nobuyuki; Asanuma, Kiyotaka; Uno, Kaname; Asano, Naoki; Imatani, Akira; Shimosegawa, Tooru			Endoscopic findings for predicting gastric acid secretion status	DIGESTIVE ENDOSCOPY			English	Article						endoscopy; gastric acid; Helicobacter pylori; hyperchlorhydria; hypochlorhydria	HELICOBACTER-PYLORI INFECTION; MUCOSAL EROSIONS; FEATURES; HISTOLOGY; THERAPY	Background and AimGastric acidic abnormalities are related to various types of diseases in Helicobacter pylori (H.pylori) infection status. However, no studies have shown correlations between many tiny endoscopic findings and the acid secretion level simultaneously. In the present study, we investigated predictive tiny endoscopic findings of hyperchlorhydria and hypochlorhydria. MethodsA total of 223 subjects without organic diseases who underwent esophagogastroduodenoscopy and endoscopic gastrin test (EGT) for estimating gastrin-stimulated gastric acid secretory response between 1999 and 2012 at our institution were retrospectively analyzed. Two blinded expert endoscopists reviewed the images independently and recorded the endoscopic findings. ResultsAccording to the EGT values, the enrolled subjects were categorized into hyperchlorhydria, normal acid secretion, and hypochlorhydria groups. In all subjects, hematin (odds ratio [95% confidence interval]=3.32 [1.40-7.84]) and antral erosion(2.88 [1.24-6.70]) were the predictive endoscopic findings for hyperchlorhydria, and swelling of areae gastricae (14.4 [5.74-36.1]) and open-type atrophy (15.1 [7.35-31.1]) were those for hypochlorhydria. In addition, the predictive endoscopic findings for hyperchlorhydria differed according to the H.pylori infection status, hematin in H.pylori-positive subjects and antral erosion in H.pylori-negative subjects, in contrast to those for hypochlorhydria, which were the same irrespective of the H.pylori infection status. ConclusionsWe could predict the acid secretion status based on the endoscopic findings regardless of H.pylori infection status, which would be of some help for evaluating the risk for acid-related diseases.	[Hatta, Waku; Iijima, Katsunori; Koike, Tomoyuki; Kondo, Yutaka; Ara, Nobuyuki; Asanuma, Kiyotaka; Uno, Kaname; Asano, Naoki; Imatani, Akira; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 9808574, Japan	Hatta, W (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	waku-style@festa.ocn.ne.jp					Iijima K, 2004, SCAND J GASTROENTERO, V39, P709, DOI 10.1080/00365520410005911; SAMLOFF IM, 1982, GASTROENTEROLOGY, V83, P204; Iijima K, 2011, J GASTROENTEROL, V46, P612, DOI 10.1007/s00535-011-0385-y; Waldum HL, 2014, ACTA PHYSIOL, V210, P239, DOI 10.1111/apha.12208; Iijima K, 2014, TOHOKU J EXP MED, V232, P293; BAH A, 1995, ENDOSCOPY, V27, P593, DOI 10.1055/s-2007-1005764; Redeen S, 2003, ENDOSCOPY, V35, P946; Iwai W, 2013, J GASTROENTEROL, V48, P214, DOI 10.1007/s00535-012-0634-8; Iijima K, 2000, GUT, V46, P20, DOI 10.1136/gut.46.1.20; Malfertheiner P, 2011, DIGEST DIS, V29, P459, DOI 10.1159/000332213; BORCH K, 1989, SCAND J GASTROENTERO, V24, P870, DOI 10.3109/00365528909089228; KIMURA K, 1972, GASTROENTEROLOGY, V63, P584; Kato T, 2013, DIGEST ENDOSC, V25, P508, DOI 10.1111/den.12031; Calabrese C, 1999, ITAL J GASTROENTEROL, V31, P359; Derakhshan MH, 2006, J CLIN PATHOL, V59, P1293, DOI 10.1136/jcp.2005.036111; Iijima K, 1998, AM J GASTROENTEROL, V93, P2113; Iwamoto J, 2013, WORLD J GASTROENTERO, V19, P1673, DOI 10.3748/wjg.v19.i11.1673; Kaminishi M, 2002, DIGEST ENDOSC, V14, P138, DOI DOI 10.1046/J.1443-1661.2002.00199.X]; KARVONEN AL, 1983, SCAND J GASTROENTERO, V18, P1051; KARVONEN AL, 1987, SCAND J GASTROENTERO, V22, P1095, DOI 10.3109/00365528708991964; KARVONEN AL, 1984, SCAND J GASTROENTERO, V19, P228; Kimura K, 1969, ENDOSCOPY, V3, P87, DOI DOI 10.1055/S-0028-1098086; MIKI K, 1987, Gastroenterologia Japonica, V22, P133; Miyake K, 2005, DIGEST LIVER DIS, V37, P394, DOI 10.1016/j.dld.2004.12.012; Miyake K, 2002, ALIMENT PHARM THERAP, V16, P210, DOI 10.1046/j.1365-2036.16.s2.14.x; Oshima T, 2012, ALIMENT PHARM THER, V35, P175, DOI 10.1111/j.1365-2036.2011.04918.x; Ubukata H, 2011, GASTRIC CANCER, V14, P4, DOI 10.1007/s10120-011-0005-9	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JUL	2015	27	5					582	589		10.1111/den.12427		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CM7TM	WOS:000357899400004		
J	Yoshida, N; Naito, Y; Hirose, R; Ogiso, K; Siah, KTH; Inada, Y; Dohi, O; Kamada, K; Katada, K; Uchiyama, K; Handa, O; Takagi, T; Konishi, H; Yagi, N; Itoh, Y				Yoshida, Naohisa; Naito, Yuji; Hirose, Ryohei; Ogiso, Kiyoshi; Siah, Kewin Tien Ho; Inada, Yutaka; Dohi, Osamu; Kamada, Kazuhiro; Katada, Kazuhiro; Uchiyama, Kazuhiko; Handa, Osamu; Takagi, Tomohisa; Konishi, Hideyuki; Yagi, Nobuaki; Itoh, Yoshito			Risk of lens cloudiness during colorectal endoscopic submucosal dissection and ability of a novel lens cleaner to maintain and restore endoscopic view	DIGESTIVE ENDOSCOPY			English	Article						colorectal cancer; endoscopic gastrointestinal surgery; fatty tissue; lens; surfactant	EN-BLOC RESECTION; CONTAMINATED SOILS; TUMORS; PERFORATION; EFFICACY; REMOVAL	Background and AimGenerally, colorectal endoscopic submucosal dissection (ESD) cannot be carried out with severe lens cloudiness. We examined the occurrence of lens cloudiness during ESD as well as the efficacy of a novel cleaner for it. MethodsThis study was a prospective study compared to historical control. First, we analyzed 103 ESD cases using standard cleaner at the Kyoto Prefectural University of Medicine in 2012. Relationship between lens cloudiness and clinical characteristics of lesions was analyzed. Lens cloudiness was recorded as grade 0 (clear) to grade 2 (very unclear). Then, we recruited 92 consecutive patients who underwent colorectal ESD using the novel cleaner from August 2013 to July 2014. The cleaner was applied on top of the lens before procedure and ability to prevent lens cloudiness was tested. Additionally, the novel cleaner was injected from endoscopic channel into a space created by endoscopic hood and colonic wall in seven cases with grade 1 or 2 of lens cloudiness and the ability to clean lens cloudiness inside the colon was tested. ResultsRate of severe lens cloudiness was 8.7%. Multivariate analysis showed that severe lens cloudiness was related with severe submucosal fatty tissue (P<0.001). The novel cleaner had significantly less cloudiness cases compared to the standard cleaner (14.1% vs 33.0%, P=0.002). Additionally, the novel cleaner enabled us to clean lens cloudiness in all seven cases. ConclusionLens cloudiness during ESD was associated with submucosal fatty tissue. Effective lens cleaner should be used to prevent and clean lens cloudiness.	[Yoshida, Naohisa; Naito, Yuji; Hirose, Ryohei; Ogiso, Kiyoshi; Siah, Kewin Tien Ho; Inada, Yutaka; Dohi, Osamu; Kamada, Kazuhiro; Katada, Kazuhiro; Uchiyama, Kazuhiko; Handa, Osamu; Takagi, Tomohisa; Konishi, Hideyuki; Itoh, Yoshito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto 6028566, Japan; [Yagi, Nobuaki] Asahi Univ Murakami Mem Hosp, Dept Gastroenterol, Gifu, Japan	Yoshida, N (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	naohisa@koto.kpu-m.ac.jp					Kim ES, 2011, ENDOSCOPY, V43, P573, DOI 10.1055/s-0030-1256339; Song SS, 2008, ENVIRON POLLUT, V156, P1368, DOI 10.1016/j.envpol.2008.06.018; Inada Y, 2013, GASTROENT RES PRACT, DOI 10.1155/2013/523084; Tanaka S, 2007, GASTROINTEST ENDOSC, V66, P100, DOI 10.1016/j.gie.2007.02.032; Kawahara Y, 2013, ENDOSCOPY, V45, P869, DOI 10.1055/s-0033-1344229; Saito Y, 2010, GASTROINTEST ENDOSC, V72, P1217, DOI 10.1016/j.gie.2010.08.004; Matsumoto A, 2010, SCAND J GASTROENTERO, V45, P1329, DOI 10.3109/00365521.2010.495416; Yamamoto H, 2003, ENDOSCOPY, V35, P690; Lee EJ, 2012, SURG ENDOSC, V26, P1587, DOI 10.1007/s00464-011-2075-5; Yoshida N, 2009, ENDOSCOPY, V41, P758, DOI 10.1055/s-0029-1215028; Akahoshi K, 2011, DIGEST ENDOSC, V23, P24, DOI 10.1111/j.1443-1661.2010.01037.x; Isomoto H, 2009, ENDOSCOPY, V41, P679, DOI 10.1055/s-0029-1214979; Toyonaga T, 2009, DIGEST ENDOSC, V21, pS31, DOI 10.1111/j.1443-1661.2009.00872.x; Maeda Y, 2013, ENDOSCOPY, V45, P335, DOI 10.1055/s-0032-1326199; [Anonymous], 2009, JAP CLASS COL CARC, V2nd; Urum K, 2006, CHEMOSPHERE, V62, P1403, DOI 10.1016/j.chemosphere.2005.05.016; Fujishiro M, 2007, CLIN GASTROENTEROL H, V5, P674; Hayashi N, 2013, GASTROINTEST ENDOSC, V79, P427; Ito S, 2007, GASTROENTEROL ENDOSC, V49, P3000; Komazawa Y, 2010, ENDOSCOPY, V42, P104, DOI 10.1055/s-0029-1215380; Ono S, 2008, GUT LIVER, V2, P209, DOI 10.5009/gnl.2008.2.3.209; Urum A, 2004, CHEMOSPHERE, V57, P1139; Yoshida N, 2011, J GASTROEN HEPATOL, V26, P286, DOI 10.1111/j.1440-1746.2010.06505.x; Yoshida N, 2010, WORLD J GASTROENTERO, V16, P1688, DOI 10.3748/wjg.v16.i14.1688; Yoshida N, 2013, GASTROENT RES PRACT, DOI 10.1155/2013/287173	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JUL	2015	27	5					609	617		10.1111/den.12442		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CM7TM	WOS:000357899400008		
J	Mori, H; Kobara, H; Rafiq, K; Nishiyama, N; Fujihara, S; Matsunaga, T; Ayaki, M; Yachida, T; Masaki, T				Mori, Hirohito; Kobara, Hideki; Rafiq, Kazi; Nishiyama, Noriko; Fujihara, Shintaro; Matsunaga, Tae; Ayaki, Maki; Yachida, Tatsuo; Masaki, Tsutomu			Novel method for the management of stenosis after gastric endoscopic submucosal dissection: Mucosal incision with steroid injection contralateral to the severely contracted scar	DIGESTIVE ENDOSCOPY			English	Article						contralateral mucosal incision; large antral resection; local steroid injection; stenosis; steroid	ESOPHAGEAL STRICTURE; PREVENTION; RESECTION; CANCER	The aim of the present report was to investigate the efficacy of local steroid injection and oral administration contralateral to a severe contracted scar of large endoscopic submucosal dissection (ESD) for gastric cancer. Among 254 cases that underwent gastric ESD, seven patients underwent resection of more than three-quarters of the circumference of the stomach. Two patients were excluded because they did not meet curative resection criteria of Japan Gastroenterological Endoscopy Society. Therefore, in five patients, circumferentiality, symptom appearance period, and weight loss period were examined. Effect of a contralateral normal mucosa incision for releasing the stenosis followed by local injection and oral steroids were also examined. Abdominal bloating, vomiting, and loss of appetite appeared 42 days on average after gastric ESD, whereas weight loss >5kg was observed an average of 52.6 days after gastric ESD. Average contralateral mucosal incision length was 51mm, whereas the average mucosal incision width was 31mm. All patients underwent a mucosal incision and were given a local injection of 100mg triamcinolone acetonide. Two patients received an additional 20mg oral steroid. In cases combined with oral steroid, there was no re-stenosis after the mucosal incision, but two to three balloon dilatations were necessary in three cases in which oral steroids were not given. This method is considered useful for stenosis after large ESD for gastric cancer.	[Mori, Hirohito; Kobara, Hideki; Nishiyama, Noriko; Fujihara, Shintaro; Matsunaga, Tae; Ayaki, Maki; Yachida, Tatsuo; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Miki, Kagawa 7610793, Japan; [Rafiq, Kazi] Kagawa Univ, Fac Med, Dept Pharmacol, Miki, Kagawa 7610793, Japan	Mori, H (reprint author), Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	hiro4884@med.kagawa-u.ac.jp					Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Yamamoto H, 2003, ENDOSCOPY, V35, P690; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002; Singh R, 2008, ENDOSCOPY, V40, P457, DOI 10.1055/s-2007-995741; Hashimoto S, 2011, GASTROINTEST ENDOSC, V74, P1389, DOI 10.1016/j.gie.2011.07.070; Iizuka H, 2010, DIGEST ENDOSC, V22, P282, DOI 10.1111/j.1443-1661.2010.01008.x; Yamaguchi N, 2011, GASTROINTEST ENDOSC, V73, P1115, DOI 10.1016/j.gie.2011.02.005; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Ohki T, 2006, GUT, V55, P1704, DOI 10.1136/gut.2005.088518; Mori H, 2012, ENDOSCOPY, V44, P641, DOI 10.1055/s-0032-1309815	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JUL	2015	27	5					622	626		10.1111/den.12400		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CM7TM	WOS:000357899400010		
J	Ego, M; Shimamura, Y; Ishii, N				Ego, Mai; Shimamura, Yuto; Ishii, Naoki			Endoscopic band ligation with double-balloon endoscopy for treatment of jejunal Dieulafoy's lesion	DIGESTIVE ENDOSCOPY			English	Letter									[Ego, Mai; Shimamura, Yuto; Ishii, Naoki] St Lukes Int Hosp, Dept Gastroenterol, Tokyo, Japan	Ego, M (reprint author), St Lukes Int Hosp, Dept Gastroenterol, Tokyo, Japan.						Yamamoto H, 2001, GASTROINTEST ENDOSC, V53, P216, DOI 10.1067/mge.2001.112181; Ikeya Takashi, 2014, World J Gastrointest Endosc, V6, P488, DOI 10.4253/wjge.v6.i10.488; Ohmiya N, 2007, GASTROINTEST ENDOSC, V66, P72	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JUL	2015	27	5					627	627		10.1111/den.12473		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CM7TM	WOS:000357899400011		
J	Iwatate, M; Sano, W; Sano, Y				Iwatate, Mineo; Sano, Wataru; Sano, Yasushi			Superficial anal canal squamous cell carcinoma diagnosed using narrow-band imaging and treated by endoscopic submucosal dissection	DIGESTIVE ENDOSCOPY			English	Letter									[Iwatate, Mineo; Sano, Wataru; Sano, Yasushi] Sano Hosp, Gastrointestinal Ctr, Kobe, Hyogo, Japan	Iwatate, M (reprint author), Sano Hosp, Gastrointestinal Ctr, Kobe, Hyogo, Japan.						Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Inoue H, 1997, DIGEST ENDOSC, V9/1, P16, DOI 10.1111/j.1443-1661.1997.tb00453.x; Morisaki T, 2012, DIGEST ENDOSC, V24, P42, DOI 10.1111/j.1443-1661.2011.01153.x	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JUL	2015	27	5					627	629		10.1111/den.12474		3	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CM7TM	WOS:000357899400012		
J	Shiwaku, H; Inoue, H; Yamashita, Y				Shiwaku, Hironari; Inoue, Haruhiro; Yamashita, Yuichi			Mucostomy closure using the endoloop/clips technique in a purse-string manner after an unsuccessful closure during peroral endoscopic myotomy	DIGESTIVE ENDOSCOPY			English	Letter							POEM		[Shiwaku, Hironari; Yamashita, Yuichi] Fukuoka Univ, Fac Med, Dept Surg Gastroenterol, Fukuoka 81401, Japan; [Inoue, Haruhiro] Showa Univ, Koto Toyosu Hosp, Ctr Digest Dis, Tokyo, Japan	Shiwaku, H (reprint author), Fukuoka Univ, Fac Med, Dept Surg Gastroenterol, Fukuoka 81401, Japan.						Saxena P, 2013, ENDOSCOPY, V45, P579, DOI 10.1055/s-0032-1326398; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Shiwaku H, 2013, GASTROINTEST ENDOSC, V77, P149, DOI 10.1016/j.gie.2012.02.008; Li H, 2012, ENDOSCOPY, V44, pE215, DOI 10.1055/s-0032-1309358; Yang D, 2013, ENDOSCOPY, V45, P677, DOI 10.1055/s-0033-1344147	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JUL	2015	27	5					630	631		10.1111/den.12480		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CM7TM	WOS:000357899400014		
J	Kazuhiro, K; Suzuki, S; Shimamura, Y				Kazuhiro, Kosugi; Suzuki, Shoko; Shimamura, Yuto			Fistula formation between perianeurysmal hematoma and sigmoid colon: Rare cause of lower gastrointestinal bleeding	DIGESTIVE ENDOSCOPY			English	Letter							AORTOENTERIC FISTULAS; MANAGEMENT		[Kazuhiro, Kosugi; Shimamura, Yuto] St Lukes Int Hosp, Dept Gastroenterol, Tokyo, Japan; [Suzuki, Shoko] Japanese Red Cross Musashino Hosp, Dept Gastroenterol, Tokyo, Japan	Kazuhiro, K (reprint author), St Lukes Int Hosp, Dept Gastroenterol, Tokyo, Japan.						Song Y, 2008, SURGERY, V143, P43, DOI 10.1016/j.surg.2007.06.036; Antinori CH, 1996, AM SURGEON, V62, P344; Bognár Gábor, 2008, Case Rep Gastroenterol, V2, P138, DOI 10.1159/000121470; Xiromeritis K, 2011, INT SURG, V96, P266	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JUL	2015	27	5					631	632		10.1111/den.12484		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CM7TM	WOS:000357899400015		
J	Nakajima, Y; Kawada, K; Tokairin, Y; Miyawaki, Y; Okada, T; Ryotokuji, T; Fujiwara, N; Saito, K; Fujiwara, H; Ogo, T; Okuda, M; Nagai, K; Miyake, S; Kawano, T				Nakajima, Y.; Kawada, K.; Tokairin, Y.; Miyawaki, Y.; Okada, T.; Ryotokuji, T.; Fujiwara, N.; Saito, K.; Fujiwara, H.; Ogo, T.; Okuda, M.; Nagai, K.; Miyake, S.; Kawano, T.			Salvage chemoradiotherapy for locally advanced esophageal carcinomas	DISEASES OF THE ESOPHAGUS			English	Article						esophageal carcinoma; multimodality treatment; non-curative surgery; salvage therapy; T4	SQUAMOUS-CELL CARCINOMA; DEFINITIVE CHEMORADIOTHERAPY; THORACIC ESOPHAGUS; GASTRIC-CANCER; CHEMOTHERAPY; SURVIVAL; TRIAL; RADIOTHERAPY; METAANALYSIS; CISPLATIN	Salvage chemoradiotherapy (CRT)' was introduced in 2005 to treat thoracic esophageal carcinomas deemed unresectable based on the intraoperative findings. The therapeutic concept is as follows: the surgical plan is changed to an operation that aims to achieve curability by the subsequent definitive CRT. For this purpose, the invading tumor is resected as much as possible, and systematic lymph node dissection is performed except for in the area around the bilateral recurrent nerves. The definitive CRT should be started as soon as possible and should be performed as planned. We hypothesized that this treatment would be feasible and provide good clinical effects. We herein verified this hypothesis. Twenty-seven patients who received salvage CRT were enrolled in the study, and their clinical course, therapeutic response, and prognosis were evaluated. The patients who had poor oral intake because of esophageal stenosis were able to eat solid food soon after the operation. The radiation field could be narrowed after surgery, and this might have contributed to the high rate of finishing the definitive CRT as planned. As a result, the overall response rate was 74.1%, and 48.1% of the patients had a complete response. No patient experienced fistula formation. The 1-, 3-, and 5-year overall survival rates were 66.5%, 35.2%, and 35.2%, respectively. Salvage CRT had clinical benefits, such as the fact that patients became able to have oral intake, that fistula formation could be prevented, that the adverse events associated with the definitive CRT could be reduced, and that prognosis of the patients was satisfactory. Although the rate of recurrent nerve paralysis was relatively high even after the suspension of aggressive bilateral recurrent nerve lymph node dissection, and the rate of the progressive disease after the definitive CRT was high, salvage CRT appears to provide some advantages for the patients who would otherwise not have other treatment options following a non-curative and residual operation.	[Nakajima, Y.; Kawada, K.; Tokairin, Y.; Miyawaki, Y.; Okada, T.; Ryotokuji, T.; Fujiwara, N.; Saito, K.; Fujiwara, H.; Ogo, T.; Okuda, M.; Nagai, K.; Kawano, T.] Tokyo Med & Dent Univ, Grad Sch Med, Dept Esophageal & Gen Surg, Tokyo 1138519, Japan; [Miyake, S.] Tokyo Med & Dent Univ, Grad Sch Med, Dept Clin Oncol, Tokyo 1138519, Japan	Nakajima, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Esophageal & Gen Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	yasu.nakajima.srg1@tmd.ac.jp					Ohtsu A, 1999, J CLIN ONCOL, V17, P2915; Dittmar Y, 2012, LANGENBECK ARCH SURG, V397, P745, DOI 10.1007/s00423-012-0902-3; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Kokkola A, 2012, J SURG ONCOL, V106, P193, DOI 10.1002/jso.23066; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Nakamura K, 2013, JPN J CLIN ONCOL, V43, P752, DOI 10.1093/jjco/hyt061; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; AlSarraf M, 1997, J CLIN ONCOL, V15, P277; Nishimura Y, 2002, INT J RADIAT ONCOL, V53, P134, DOI 10.1016/S0360-3016(01)02813-9; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; Gaspar LE, 1997, INT J RADIAT ONCOL, V37, P593, DOI 10.1016/S0360-3016(96)00591-3; Ishida K, 1996, JPN J CLIN ONCOL, V26, P310; Sobin LH, 2009, TNM CLASSIFICATION M; Taniguchi H, 2011, INT J CLIN ONCOL, V16, P359, DOI 10.1007/s10147-011-0192-8	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1120-8694	1442-2050		DIS ESOPHAGUS	Dis. Esophagus	JUL	2015	28	5					460	467		10.1111/dote.12217		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM8LY	WOS:000357954000010		
J	Fukushima, K; Fukushima, N; Ejima, K; Kato, K; Sato, Y; Uematsu, S; Arai, K; Manaka, T; Takagi, A; Ashihara, K; Shoda, M; Hagiwara, N				Fukushima, Keiko; Fukushima, Noritoshi; Ejima, Koichiro; Kato, Ken; Sato, Yasuto; Uematsu, Shoko; Arai, Kotaro; Manaka, Tetsuyuki; Takagi, Atsushi; Ashihara, Kyomi; Shoda, Morio; Hagiwara, Nobuhisa			Left Atrial Appendage Flow Velocity and Time from P-Wave Onset to Tissue Doppler-Derived A' Predict Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation	ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES			English	Article						left atrial appendage flow velocity; total atrial conduction time; left atrial volume index; paroxysmal atrial fibrillation; atrial remodeling; radiofrequency catheter ablation	PULMONARY VENOUS FLOW; SINUS RHYTHM; CLINICAL-VALUE; CARDIOVERSION; ECHOCARDIOGRAPHY; DETERMINANTS; MAINTENANCE; DYSFUNCTION; MANAGEMENT; IMPACT	BackgroundAtrial fibrillation (AF) is associated with atrial remodeling. We investigate the abilities of preprocedural echocardiographic parameters reflecting atrial remodeling to predict AF recurrence after radiofrequency catheter ablation (RFCA) for paroxysmal AF (PAF). MethodsPreprocedural echocardiographic parameters were measured during sinus rhythm in 105 patients with PAF undergoing RFCA. Electrical remodeling was assessed by the time from the onset of the P-wave to the peak A-wave on the tissue Doppler imaging (PA-TDI), functional remodeling was assessed by the left atrial appendage flow velocity (LAAFV), and structural remodeling was assessed by the left atrial volume index (LAVI). PA-TDI, LAAFV, and LAVI values were divided into tertiles, and their abilities to predict AF recurrence were assessed using Cox regression analysis. ResultsAF recurrence occurred in 39/105 (37.1%) patients. After adjustment for confounders, the rate of AF recurrence was significantly higher in the highest tertile of PA-TDI compared with the lowest tertile (151.3msec vs. <131.0msec; hazard ratio [HR]: 2.477, 95% confidence interval [CI]: 1.031-5.950; P=0.042), and in the lowest tertile of LAAFV compared with the highest tertile (<48.5cm/sec vs. 64.9cm/sec; HR: 2.680, 95% CI: 1.136-6.318; P=0.024). The risk of AF recurrence was also higher in the highest tertile of LAVI (34.2 mL/m(2)) compared with the lowest tertile, but this difference was not significant (HR: 2.146, 95% CI: 0.834-5.523; P=0.113). ConclusionsLAAFV (reflecting functional remodeling) and PA-TDI (reflecting electrical remodeling) are independent predictors of AF recurrence after RFCA for PAF.	[Fukushima, Keiko; Fukushima, Noritoshi; Ejima, Koichiro; Kato, Ken; Uematsu, Shoko; Arai, Kotaro; Manaka, Tetsuyuki; Takagi, Atsushi; Ashihara, Kyomi; Shoda, Morio; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Tokyo 1628666, Japan; [Sato, Yasuto] Tokyo Womens Med Univ, Dept Publ Hlth, Tokyo 1628666, Japan	Fukushima, K (reprint author), Tokyo Womens Med Univ, Dept Cardiol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	waraugocchin@hotmail.com					Akutsu Y, 2011, CIRC-CARDIOVASC IMAG, V4, P524, DOI 10.1161/CIRCIMAGING.110.962761; Kojima T, 2012, EUR HEART J-CARD IMG, V13, P227, DOI 10.1093/ejechocard/jer281; Zabalgoitia M, 1998, J AM COLL CARDIOL, V31, P1622, DOI 10.1016/S0735-1097(98)00146-6; Antonielli E, 2002, J AM COLL CARDIOL, V39, P1443, DOI 10.1016/S0735-1097(02)01800-4; Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893; Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Chao TF, 2011, HEART, V97, P225, DOI 10.1136/hrt.2010.212373; MIYATAKE K, 1984, AM J CARDIOL, V53, P586, DOI 10.1016/0002-9149(84)90035-3; Hara H, 2009, CATHETER CARDIO INTE, V74, P234, DOI 10.1002/ccd.21983; Kamp O, 1999, EUR HEART J, V20, P979, DOI 10.1053/euhj.1998.1453; CHOONG CY, 1987, J AM COLL CARDIOL, V10, P800; Agmon Y, 2002, J AM SOC ECHOCARDIOG, V15, P433, DOI 10.1067/mje.2002.116826; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Hoit BD, 2014, J AM COLL CARDIOL, V63, P493, DOI 10.1016/j.jacc.2013.10.055; Dewire J, 2013, NAT REV CARDIOL, V10, P599, DOI 10.1038/nrcardio.2013.121; Weijs B, 2012, INT J CARDIOL, V156, P121, DOI 10.1016/j.ijcard.2012.01.024; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Ejima K, 2014, CIRC J, V78, P872, DOI 10.1253/circj.CJ-13-1391; Agmon Y, 1999, J AM COLL CARDIOL, V34, P1867, DOI 10.1016/S0735-1097(99)00472-6; Merckx KL, 2005, J AM SOC ECHOCARDIOG, V18, P940, DOI 10.1016/j.echo.2005.03.022; Teh AW, 2012, J CARDIOVASC ELECTR, V23, P232, DOI 10.1111/j.1540-8167.2011.02178.x; Shin SH, 2008, J AM SOC ECHOCARDIOG, V21, P697, DOI 10.1016/j.echo.2007.10.022; Bollmann A, 2007, ECHOCARDIOGR-J CARD, V24, P430, DOI 10.1111/j.1540-8175.2006.00411.x; densUijl DW, 2011, EUROPACE, V13, P1533; DesVos CB, 2009, HEART, V95, P835; Ejima K, 2013, INT J CARDIOL, V164, P88, DOI 10.1016/j.ijcard.2011.06.093; Goldberg YH, 2010, EUR J ECHOCARDIOGR, V11, P290, DOI 10.1093/ejechocard/jep216; Handke M, 2005, J AM SOC ECHOCARDIOG, V18, P1366, DOI 10.1016/j.echo.2005.05.006; Louie EK, 1998, J AM COLL CARDIOL, V32, P2081, DOI 10.1016/S0735-1097(98)00508-7; Maffe S, 2015, ECHOCARDIOGR-J CARD, V32, P420, DOI 10.1111/echo.12702; Nakatani S, 1999, J AM COLL CARDIOL, V34, P795, DOI 10.1016/S0735-1097(99)00263-6; Palinkas A, 2001, EUR HEART J, V22, P2201, DOI 10.1053/euhj.2001.2891; Park MY, 2008, CIRC J, V72, P256, DOI 10.1253/circj.72.256; Wang YC, 2005, CHEST, V128, P2551, DOI 10.1378/chest.128.4.2551; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954; Yao SS, 1998, ECHOCARDIOGR-J CARD, V15, P243, DOI 10.1111/j.1540-8175.1998.tb00603.x; Yoshida N, 2007, J AM SOC ECHOCARDIOG, V20, P521, DOI 10.1016/j.echo.2006.10.010	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-2822	1540-8175		ECHOCARDIOGR-J CARD	Echocardiography-J. Cardiovasc. Ultrasound Allied Tech.	JUL	2015	32	7					1101	1108		10.1111/echo.12823		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CM3TR	WOS:000357607900007		
J	Tanaka, N; Takigiku, K; Takahashi, K; Kuraoka, A; Matsui, K; Iwashima, S; Nii, M; Toyono, M; Takeuchi, M; Kishiro, M; Yasukochi, S; Shimizu, T				Tanaka, Noboru; Takigiku, Kiyohiro; Takahashi, Ken; Kuraoka, Ayako; Matsui, Kotoko; Iwashima, Satoru; Nii, Masaki; Toyono, Manatomo; Takeuchi, Masaaki; Kishiro, Masahiko; Yasukochi, Satoshi; Shimizu, Toshiaki			Assessment of the Developmental Change in the Left Atrial Volume Using Real Time Three-Dimensional Echocardiography	ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES			English	Article						real time 3D echocardiography; LA distensibility; child	VENTRICULAR FILLING PRESSURE; MAGNETIC-RESONANCE; COMPUTED-TOMOGRAPHY; SIZE; QUANTIFICATION; VALIDATION; MASS; DISTENSIBILITY; FIBRILLATION; PARAMETERS	AimsReal time 3D echocardiography (RT3DE) has been applied for the assessment of left atrial (LA) function in patients with adult heart disease; however, LA function is not well known in children. We aimed at determining the normal range of LA volume (LAV) using RT3DE and the feasibility and reproducibility of this method in healthy subjects and at elucidating the developmental changes in the LAV with aging. Methods and ResultsIn this study, 359 healthy people (mean age, 23.921.3; range, 0.1-76.4years) were enrolled. We performed transthoracic RT3DE and measured the maximum and minimum LAV. Simultaneously, we measured the LAV using the 2D biplane Simpson's method. Inter-observer and intra-observer variability and the agreement of LAV measurements between RT3DE and 2DE were assessed in a subset of subjects. The RT3DE feasibility for LAV measurement was 93%. Both maximum and minimum LAVs exponentially increased with age and linearly increased with increasing of body surface area (BSA). The LA distensibility, which demonstrates LA reservoir function, decreased with age and BSA. The LAVs measured by RT3DE were significantly smaller than those measured by the 2D biplane Simpson's method. The 3D volumetric method had favorable intra-observer and inter-observer agreement. ConclusionThe reference values of LAV from early infancy to adulthood were obtained using RT3DE, which could be useful for future studies in children with congenital heart disease. RT3DE is a reproducible method and a feasible tool for evaluating the LAV in children. LA reservoir function is likely to decrease with age and increasing of body size.	[Tanaka, Noboru; Takahashi, Ken; Matsui, Kotoko; Kishiro, Masahiko; Shimizu, Toshiaki] Juntendo Univ, Fac Med, Dept Pediat, Tokyo, Japan; [Tanaka, Noboru; Takigiku, Kiyohiro; Kuraoka, Ayako; Yasukochi, Satoshi] Nagano Childrens Hosp, Dept Pediat Cardiol, Azumino City, Nagano 3998205, Japan; [Kuraoka, Ayako] Kyushu Kosei Nenkin Hosp, Dept Pediat, Kitakyushu, Fukuoka, Japan; [Iwashima, Satoru] Hamamatsu Univ, Fac Med, Dept Pediat, Hamamatsu, Shizuoka, Japan; [Nii, Masaki] Shizuoka Childrens Hosp, Dept Pediat Cardiol, Shizuoka, Japan; [Toyono, Manatomo] Akita Univ, Fac Med, Dept Pediat, Akita 010, Japan; [Takeuchi, Masaaki] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka 807, Japan	Takigiku, K (reprint author), Nagano Childrens Hosp, Dept Pediat Cardiol, 3100 Toyoshina, Azumino City, Nagano 3998205, Japan.	ktaki@naganoch.gr.jp					Corsi C, 2005, CIRCULATION, V112, P1161, DOI 10.1161/CIRCULATIONAHA.104.513689; Miyasaka Y, 2011, J AM SOC ECHOCARDIOG, V24, P680, DOI 10.1016/j.echo.2011.03.009; Mor-Avi V, 2012, JACC-CARDIOVASC IMAG, V5, P769, DOI 10.1016/j.jcmg.2012.05.011; Hsiao SH, 2010, AM J CARDIOL, V105, P709, DOI 10.1016/j.amjcard.2009.10.052; Kaku K, 2011, J AM SOC ECHOCARDIOG, V24, P541, DOI 10.1016/j.echo.2011.01.011; Moller JE, 2003, CIRCULATION, V107, P2207, DOI 10.1161/01.CIR.0000066318.21784.43; Hsiao SH, 2011, CIRC J, V75, P1942, DOI 10.1253/circj.CJ-11-0033; Lin FY, 2008, JACC-CARDIOVASC IMAG, V1, P782, DOI 10.1016/j.jcmg.2008.04.015; Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Murata M, 2008, AM J CARDIOL, V102, P1097, DOI 10.1016/j.amjcard.2008.05.067; Chadaide S, 2013, ECHOCARDIOGR-J CARD, V30, P1078, DOI 10.1111/echo.12218; Mochizuki A, 2013, J AM SOC ECHOCARDIOG, V26, P165, DOI 10.1016/j.echo.2012.10.003; Mor-Avi V, 2009, CIRCULATION, V119, P314, DOI 10.1161/CIRCULATIONAHA.107.751354; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Fukuda S, 2012, CIRC J, V76, P1177, DOI 10.1253/circj.CJ-11-1256; Sugeng L, 2006, CIRCULATION, V114, P654, DOI 10.1161/CIRCULATIONHA.106.626143; Mor-Avi V, 2004, CIRCULATION, V110, P1814, DOI 10.1161/01.CIR.0000142670.65971.5F; Takeuchi M, 2008, J AM SOC ECHOCARDIOG, V21, P1001, DOI 10.1016/j.echo.2008.07.008; Artang R, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-16; Cameli M, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-4; Iwataki M, 2012, J AM SOC ECHOCARDIOG, V25, P1319, DOI 10.1016/j.echo.2012.08.017; Russo C, 2010, J AM SOC ECHOCARDIOG, V23, P954, DOI 10.1016/j.echo.2010.06.010; Yosefy C, 2012, ECHOCARDIOGR-J CARD, V29, P1096, DOI 10.1111/j.1540-8175.2012.01745.x	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-2822	1540-8175		ECHOCARDIOGR-J CARD	Echocardiography-J. Cardiovasc. Ultrasound Allied Tech.	JUL	2015	32	7					1131	1139		10.1111/echo.12829		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CM3TR	WOS:000357607900011		
J	Liu, CC; Yamaguchi, Y; Zhu, XF; Li, ZQ; Ni, Y; Dou, XM				Liu, Chenchen; Yamaguchi, Yoshinori; Zhu, Xifang; Li, Zhenqing; Ni, Yi; Dou, Xiaoming			Analysis of small interfering RNA by capillary electrophoresis in hydroxyethylcellulose solutions	ELECTROPHORESIS			English	Article						Capillary electrophoresis; double-stranded RNA; double-stranded DNA; Hydroxyethylcellulose; small interfering RNA	LINKED POLYMER-SOLUTIONS; SINGLE-STRANDED-DNA; SEPARATION; MECHANISMS; BEHAVIOR; DILUTE; ACIDS	The analysis of small interfering RNA (siRNA) is important for gene function studies and drug developments. We employed CE to study the separation of siRNA ladder marker, which were ten double-stranded RNA (dsRNA) fragments ranged from 20 to 1000 bp, in solutions of hydroxyethylcellulose (HEC) polymer with different concentrations and molecular weights (Mws). Migration mechanism of dsRNA during CE was studied by the mobility and resolution length (RL) plots. We found that the RL depended on not only the concentration of HEC, but also the Mw of HEC. For instance, RL of small dsRNA fragment was more influenced by concentration of high Mw HEC than large dsRNA fragment and RL of large dsRNA fragment was more influenced by concentration of low Mw HEC than small dsRNA fragment. In addition, we found electrophoretic evidence that the structure of dsRNA was more compact than dsDNA with the same length. In practice, we succeeded to separate the glyceraldehyde 3-phosphate dehydrogenase siRNA in the mixture of the siRNA ladder marker within 4 min.	[Liu, Chenchen; Li, Zhenqing] Univ Shanghai Sci & Technol, Engn Res Ctr Opt Instrument & Syst, Shanghai, Peoples R China; [Yamaguchi, Yoshinori; Ni, Yi; Dou, Xiaoming] E China Univ Sci & Technol, Grad Sch Sci, Inst Photon & Biomed IPBM, Shanghai 200237, Peoples R China; [Yamaguchi, Yoshinori] Osaka Univ, Grad Sch Engn, Dept Appl Phys, Suita, Osaka 5650871, Japan; [Zhu, Xifang; Dou, Xiaoming] Changzhou Inst Technol, Sch Optoelect Engn, Changzhou, Jiangsu, Peoples R China	Yamaguchi, Y (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Phys, Suita, Osaka 5650871, Japan.	yoshi.yamaguchi@ap.eng.osaka-u.ac.jp; xiaomingdou@yeah.net			JSPS, Japan [25600049]; Innovation Fund Project for Graduate Student of Shanghai, China [JWCXSL1401]	This project was partly supported by Grand-in-Aid for Scientific Research (Houga) (no. 25600049 [Y. Y.]), JSPS, Japan and The Innovation Fund Project for Graduate Student of Shanghai (no. JWCXSL1401), China.	Albargheuthi MN, 2000, ELECTROPHORESIS, V21, P4096, DOI 10.1002/1522-2683(200012)21:18<4096::AID-ELPS4096>3.0.CO;2-W; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Kitagawa F, 2014, J CHROMATOGR A, V1335, P43, DOI 10.1016/j.chroma.2013.10.066; Anderson GJ, 2011, ANAL CHEM, V83, P1350, DOI 10.1021/ac102671n; Slater GW, 2002, ELECTROPHORESIS, V23, P3791, DOI 10.1002/elps.200290002; Heller C, 2001, ELECTROPHORESIS, V22, P629, DOI 10.1002/1522-2683(200102)22:4<629::AID-ELPS629>3.0.CO;2-S; Guttman A, 1996, NATURE, V380, P461, DOI 10.1038/380461a0; Stellwagen NC, 2009, J CHROMATOGR A, V1216, P1917, DOI 10.1016/j.chroma.2008.11.090; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Schmitz JC, 2004, CANCER RES, V64, P1431, DOI 10.1158/0008-5472.CAN-03-1203; Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; HJERTEN S, 1985, J CHROMATOGR, V347, P191, DOI 10.1016/S0021-9673(01)95485-8; Bannore YC, 2008, J SEP SCI, V31, P2667, DOI 10.1002/jssc.200800196; OGSTON AG, 1958, T FARADAY SOC, V54, P1754, DOI 10.1039/tf9585401754; BARRON AE, 1993, J CHROMATOGR A, V652, P3, DOI 10.1016/0021-9673(93)80639-P; Barron AE, 1996, ELECTROPHORESIS, V17, P744, DOI 10.1002/elps.1150170421; Brinet D, 2014, ELECTROPHORESIS, V35, P3302, DOI 10.1002/elps.201400271; desCarmejane O., 2001, ELECTROPHORESIS, V22, P2433; Fukushima Y, 2014, ANAL CHEM, V86, P5977, DOI 10.1021/ac501039j; Huge BJ, 2014, TALANTA, V130, P288, DOI 10.1016/j.talanta.2014.07.018; Karenga S, 2011, ELECTROPHORESIS, V32, P1044, DOI 10.1002/elps.201000632; KARGER BL, 1989, NATURE, V339, P641, DOI 10.1038/339641a0; Li ZQ, 2014, ANAL METHODS-UK, V6, P2473, DOI 10.1039/c3ay41965g; Li ZQ, 2014, J CHROMATOGR A, V1361, P286, DOI 10.1016/j.chroma.2014.07.100; Li ZQ, 2014, J CHROMATOGR A, V1331, P100, DOI 10.1016/j.chroma.2014.01.021; Liu CC, 2013, ACTA CHIM SINICA, V71, P265, DOI 10.6023/A12110935; Meng ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064708; Nakano S, 2004, J AM CHEM SOC, V126, P1088, DOI 10.1021/ja037314h; Rauch JN, 2013, ANAL CHEM, V85, P9824, DOI 10.1021/ac4023082; Seiffert S, 2011, ANAL BIOCHEM, V414, P47, DOI 10.1016/j.ab.2011.02.040; Shimura K, 2014, ELECTROPHORESIS, V35, P840, DOI 10.1002/elps.201300464; Slater GW, 2003, CURR OPIN BIOTECH, V14, P58, DOI 10.1016/S0958-1669(02)00012-5; Slater GW, 2001, METH MOL B, V162, P27; Todorov TI, 2002, ELECTROPHORESIS, V23, P1033, DOI 10.1002/1522-2683(200204)23:7/8<1033::AID-ELPS1033>3.0.CO;2-7; Todorov TI, 2001, ELECTROPHORESIS, V22, P2442, DOI 10.1002/1522-2683(200107)22:12<2442::AID-ELPS2442>3.0.CO;2-9; Vakonakis Ioannis, 2004, Journal of the American Chemical Society, V126, P5688, DOI 10.1021/ja048981t; Viovy JL, 2000, REV MOD PHYS, V72, P813, DOI 10.1103/RevModPhys.72.813; Yamaguchi Y, 2004, ELECTROPHORESIS, V25, P999, DOI 10.1002/elps.200305783; Zhang XR, 2013, ELECTROPHORESIS, V34, P1778, DOI 10.1002/elps.201200683	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	JUL	2015	36	14					1651	1657		10.1002/elps.201500018		7	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CM9ET	WOS:000358010400015		
J	Kuriyama, K; Shintaku, H; Santiago, JG				Kuriyama, Kentaro; Shintaku, Hirofumi; Santiago, Juan G.			Isotachophoresis for fractionation and recovery of cytoplasmic RNA and nucleus from single cells	ELECTROPHORESIS			English	Article						DNA; Electrophoresis; Microfluidics; RNA; Single cell analysis	HIGH COLUMN UTILIZATION; BIDIRECTIONAL ISOTACHOPHORESIS; COUPLING ISOTACHOPHORESIS; AFFINITY-CHROMATOGRAPHY; SELECTIVE PURIFICATION; DNA HYBRIDIZATION; ACIDS; SENSITIVITY; PROTEINS; QUANTIFICATION	There is a substantial need for simultaneous analyses of RNA and DNA from individual single cells. Such analysis provides unique evidence of cell-to-cell differences and the correlation between gene expression and genomic mutation in highly heterogeneous cell populations. We present a novel microfluidic system that leverages isotachophoresis to fractionate and isolate cytoplasmic RNA and genomic DNA (gDNA) from single cells. The system uniquely enables independent, sequence-specific analyses of these critical markers. Our system uses a microfluidic chip with a simple geometry and four end-channel electrodes, and completes the entire process in <5 min, including lysis, purification, fractionation, and delivery to DNA and RNA output reservoirs, each containing high quality and purity aliquots with no measurable cross-contamination of cytoplasmic RNA versus gDNA. We demonstrate our system with simultaneous, sequence-specific quantitation using off-chip RT-qPCR and qPCR for simultaneous cytoplasmic RNA and gDNA analyses, respectively.	[Kuriyama, Kentaro; Shintaku, Hirofumi; Santiago, Juan G.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Shintaku, Hirofumi] Kyoto Univ, Dept Micro Engn, Nishikyo Ku, Kyoto, Japan	Santiago, JG (reprint author), Stanford Univ, Dept Mech Engn, 440 Escondido, Stanford, CA 94305 USA.	juan.santiago@stanford.edu			National Science Foundation [CBET-1159092]; Japan Society for the Promotion of Science [22686021, 26289035, 26630052]; Kyoto University; Marubun Research Promotion Foundation, Japan	We gratefully thank Hidekazu Nishikii for invaluable discussions, Marc E. Levenston for the use of the real time PCR, and Takuya Waratani for fabricating molds of microfluidic chips. We gratefully acknowledge funding from the National Science Foundation under CBET-1159092. H.S. acknowledges funding from Japan Society for the Promotion of Science under 22686021, 26289035, and 26630052. H.S. was supported by fellowships from the John Mung Program of Kyoto University and Marubun Research Promotion Foundation, Japan.	Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Rogacs A, 2014, J CHROMATOGR A, V1335, P105, DOI 10.1016/j.chroma.2013.12.027; Trouillon R, 2013, ANAL CHEM, V85, P522, DOI 10.1021/ac303290s; Zare RN, 2010, ANNU REV BIOMED ENG, V12, P187, DOI 10.1146/annurev-bioeng-070909-105238; Kalisky T, 2011, ANNU REV GENET, V45, P431, DOI 10.1146/annurev-genet-102209-163607; Pena-Llopis S, 2013, NAT PROTOC, V8, P2240, DOI 10.1038/nprot.2013.141; Persat A, 2011, ANAL CHEM, V83, P2310, DOI 10.1021/ac103225c; Eid C, 2013, ANALYST, V138, P3117, DOI 10.1039/c3an00374d; Bahga SS, 2013, ANALYST, V138, P87, DOI 10.1039/c2an36249j; Shintaku H, 2014, ANAL CHEM, V86, P1953, DOI 10.1021/ac4040218; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; White AK, 2013, ANAL CHEM, V85, P7182, DOI 10.1021/ac400896j; Tischler J, 2013, CURR OPIN BIOTECH, V24, P69, DOI 10.1016/j.copbio.2012.09.013; Qu YT, 2014, ANAL CHEM, V86, P7264, DOI 10.1021/ac501299a; Bercovici M, 2012, P NATL ACAD SCI USA, V109, P11127, DOI 10.1073/pnas.1205004109; Persat A, 2009, ANAL CHEM, V81, P9507, DOI 10.1021/ac901965v; Stahlberg A, 2012, CLIN CHEM, V58, P1682, DOI 10.1373/clinchem.2012.191445; Garcia-Schwarz G, 2012, ANAL CHEM, V84, P6366, DOI 10.1021/ac301586q; Garcia-Schwarz G, 2013, ANGEW CHEM INT EDIT, V52, P11534, DOI 10.1002/anie.201305875; Han CM, 2014, LAB CHIP, V14, P2958, DOI 10.1039/c4lc00374h; Han L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06485; PANNETIER C, 1993, NUCLEIC ACIDS RES, V21, P577, DOI 10.1093/nar/21.3.577; Persat A, 2010, ANAL CHEM, V82, P9631, DOI 10.1021/ac102496m; Rogacs A, 2012, ANAL CHEM, V84, P5858, DOI 10.1021/ac301021d; Schoch RB, 2009, LAB CHIP, V9, P2145, DOI 10.1039/b903542g; Shintaku H, 2014, ANGEW CHEM INT EDIT, V53, P13813, DOI 10.1002/anie.201408403; Shkolnikov V, 2014, ANAL CHEM, V86, P6220, DOI 10.1021/ac5011052; Shkolnikov V, 2014, ANAL CHEM, V86, P6229, DOI 10.1021/ac5011074; Weinstein JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067624; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	JUL	2015	36	14					1658	1662		10.1002/elps.201500040		5	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CM9ET	WOS:000358010400016		
J	Humphries, S; Burns, A				Humphries, Simon; Burns, Anne			'In reality it's almost impossible': CLT-oriented curriculum change	ELT JOURNAL			English	Article								Curriculum innovation is challenging and, as several commentators have reported, moves to introduce communicative language teaching in many contexts internationally have resulted in mixed outcomes, or even failure. In an effort to shed some light on this complex problem, this article focuses on curriculum change through the introduction of new communicative textbooks in an engineering college (kosen) in Japan. First, three key factors that inhibit change are considered and then other factors that specifically hindered change in the kosen environment are identified. A study investigating the attitudes and classroom practices of four Japanese teachers of English highlighted a culture of pedagogical uncertainty and lack of professional support. Suggestions for supporting teachers to implement curriculum change more effectively, both in Japan and elsewhere, are drawn out.	[Humphries, Simon] Kansai Univ, Fac Foreign Language Studies, Suita, Osaka, Japan; [Burns, Anne] Univ New S Wales, TESOL, Sydney, NSW, Australia; [Burns, Anne] Aston Univ, Birmingham B4 7ET, W Midlands, England; [Burns, Anne] Univ Sydney, Sydney, NSW 2006, Australia	Humphries, S (reprint author), Kansai Univ, Fac Foreign Language Studies, Suita, Osaka, Japan.	shumphri@kansai-u.ac.jp; anne.burns@unsw.edu.au			JSPS KAKENHI [26770204]	This work was supported by JSPS KAKENHI grant number 26770204.	King J, 2013, APPL LINGUIST, V34, P325, DOI 10.1093/applin/ams043; Borg S, 2009, CAMBRIDGE GUIDE TO SECOND LANGUAGE TEACHER EDUCATION, P163; Butler YG, 2011, ANNU REV APPL LINGUI, V31, P36, DOI 10.1017/S0267190511000122; Sato K, 2004, TEACH TEACH EDUC, V20, P797, DOI 10.1016/j.tate.2004.09.004; Corbin J., 2008, BASICS QUALITATIVE R; Fullan M., 2011, MORAL IMPERATIVE REA; Humphries S., 2013, DOSHISHA STUDIES ENG, V90, P217; Humphries S., 2012, FUTURE DIRECTIONS AP; Kikuchi K., 2009, RELC J, V40, P172; Littlewood W. T., 2007, LANG TEACHING, V40.3, P243, DOI DOI 10.1017/S0261444807004363; Lortie D. C., 1975, SCHOOLTEACHER SOCIOL; Macaro E., 2013, CODESWITCHING U ENGL; Nishino T., 2008, JALT J, V30, P27; Sato K., 2008, REVITALIZING CURRICU; Waters A., 2008, RELC J, V39, P5, DOI 10.1177/0033688208091138	15	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0951-0893	1477-4526		ELT J	ELT J.	JUL	2015	69	3					239	248		10.1093/elt/ccu081		10	Education & Educational Research; Linguistics; Language & Linguistics	Education & Educational Research; Linguistics	CM7LS	WOS:000357875000003		
J	Siegel, J				Siegel, Joseph			Research involving L2 listening instruction and instructors	ELT JOURNAL			English	Article								'Readers respond' is a forum for individuals to contribute their own reactions, perspectives, or experiences in relation to a specific article or articles published in a recent issue of ELT Journal. These views are not necessarily those of the Editor, the Editorial Panel, or the Publisher.		Siegel, J (reprint author), Meiji Gakuin Univ, Fac Econ, Tokyo, Japan.	siegeljoseph@hotmail.com					Graham S, 2011, LANG TEACH RES, V15, P435, DOI 10.1177/1362168811412026; Chen Y., 2007, ELT J, V61, P20, DOI 10.1093/elt/ccl041; Chen Y., 2005, TESL EJ; Cross J, 2015, ELT J, V69, P86, DOI 10.1093/elt/ccu035; Cross J, 2009, LANG TEACH RES, V13, P151, DOI 10.1177/1362168809103446; Field J, 2012, CAMBRIDGE GUIDE TO PEDAGOGY AND PRACTICE IN SECOND LANGUAGE TEACHING, P207; Galloway N, 2014, ELT J, V68, P386, DOI 10.1093/elt/ccu021; Goh C, 2000, SYSTEM, V28, P55, DOI 10.1016/S0346-251X(99)00060-3; Graham S., 2006, SYSTEM, V34, P165, DOI DOI 10.1016/J.SYSTEM.2005.11.001; Graham S., LANGUAGE TEACHING; Siegel J, 2014, ELT J, V68, P22, DOI 10.1093/elt/cct058; Siegel J., EXPLORING LIST UNPUB	12	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0951-0893	1477-4526		ELT J	ELT J.	JUL	2015	69	3					323	326		10.1093/elt/ccv014		4	Education & Educational Research; Linguistics; Language & Linguistics	Education & Educational Research; Linguistics	CM7LS	WOS:000357875000013		
J	Yatsuzuka, S; Niiyama, Y; Fukuda, K; Muramatsu, K; Shikazono, N				Yatsuzuka, Shinichi; Niiyama, Yasunori; Fukuda, Kentaro; Muramatsu, Kenshiro; Shikazono, Naoki			Experimental and numerical evaluation of liquid-piston steam engine	ENERGY			English	Article						Liquid-piston steam engine; High indicated thermal efficiency; High reliability; Low cost; Optimization of the steam accumulator volume		A liquid-piston steam engine is expected as a low cost and efficient energy conversion system at low operating temperatures (Yatsuzuka et al., 2011). In the present study, a numerical model of the liquid-piston steam engine is developed and a validation experiment is conducted to understand the mechanism of the oscillating steam engine, where a particular attention is paid to the steam accumulator volume. The numerical analysis is able to reproduce qualitatively the characteristics of the liquid-piston steam engine. In the case of the large steam accumulator volume, the indicated work and the indicated thermal efficiency decrease, because the accumulator contributes as a dead volume. On the other hand, indicated work is reduced for small steam accumulator volume cases, because negative work occurs. It is considered that the steam accumulator volume is one of the crucial design parameters for obtaining efficient liquid piston steam engine. (C) 2015 Elsevier Ltd. All rights reserved.	[Yatsuzuka, Shinichi; Niiyama, Yasunori; Fukuda, Kentaro; Muramatsu, Kenshiro] Denso Corp, Kariya, Aichi 4488661, Japan; [Shikazono, Naoki] Univ Tokyo, Meguro Ku, Tokyo 1530041, Japan	Yatsuzuka, S (reprint author), Denso Corp, 1-1 Shouwa Cho, Kariya, Aichi 4488661, Japan.	SHINICHI_YATSUZUKA@denso.co.jp					Backhaus S, 1999, NATURE, V399, P335, DOI 10.1038/20624; KUTATELADZE SS, 1950, ZH TEKH FIZ+, V20, P1389; Han YB, 2010, INT J HEAT FLUID FL, V31, P630, DOI 10.1016/j.ijheatfluidflow.2010.02.002; Klonowicz P, 2014, ENERGY, V72, P322, DOI 10.1016/j.energy.2014.05.040; Enya S., 1966, PROD RES, V18, P198; Kutateladze SS, 1952, AEC TRANSLATION 3770, V2nd; PAYNE PR, 1975, CHEM TECH-LEIPZIG, P47; Saitoho T, 2007, J ENV ENG, V2, P708, DOI 10.1299/jee.2.708; Wagner W, 2002, J PHYS CHEM REF DATA, V31, P427; Yatsuzuka S, 2011, P 16 AS PAC AUT ENG; Yatsuzuka S, 2011, P ASME POW 2011 COL; Yoshida T., 1950, T JSME, V16, P32; Zuber N, 1961, ASME J HEAT TRANSFER, P230	13	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0360-5442	1873-6785		ENERGY	Energy	JUL 1	2015	87						1	9		10.1016/j.energy.2015.03.115		9	Thermodynamics; Energy & Fuels	Thermodynamics; Energy & Fuels	CM1JR	WOS:000357437700001		
J	Kariya, T; Yanagimoto, K; Funakubo, H; Shudo, T				Kariya, Tetsuro; Yanagimoto, Katsu; Funakubo, Hiroshi; Shudo, Toshio			Effects of porous flow field type separators using sintered Ni-based alloy powders on interfacial contact resistances and fuel cell performances	ENERGY			English	Article						Fuel cell; Separator; Bipolar plate; Alloy powder; Porous flow field; Interfacial contact resistance	METALLIC BIPOLAR PLATES; 316L STAINLESS-STEEL; CORROSION-RESISTANCE; COMPOSITE	The novel separators with a porous flow field using sintered corrosion resistant Ni-base alloy C276 (Ni-16Cr-16Mo-5Fe-4W mass%) powders or SUS316L (Fe-17Cr-12Ni-2Mo mass%) powders are investigated for proton exchange membrane fuel cells to enhance power density, which is one of the most important challenges for the widespread use of fuel cells. The developed separator with C276 powders demonstrated low ICRs (interfacial contact resistance) less than 10 m Omega cm(2) between separators and GDLs (gas diffusion layers), and it extensively enhanced power density by 90% higher than a conventional graphite separator. This is due to the superior adherence mechanism between the convex surfaces of the spherical powders and porous GDLs as well as the Ni concentration in passive oxide films in powder surfaces. Furthermore, this developed separator shows potential for using without an expensive conductive coating such as Au coating, which has been usually employed to lower ICRs for metallic separators with passive oxide films. In addition, the amount of eluted Cr, which could deteriorate catalyst and cell performance, from sintered C276 powders in a 1 mass% sulfuric acid aqueous solution is reduced by approximately 82% than SUS316L powders. (C) 2015 Elsevier Ltd. All rights reserved.	[Kariya, Tetsuro; Yanagimoto, Katsu] Sanyo Special Steel Co Ltd, Himeji, Hyogo 6728677, Japan; [Kariya, Tetsuro; Funakubo, Hiroshi] Tokyo Inst Technol, Dept Innovat & Engn Mat, Yokohama, Kanagawa 2268502, Japan; [Shudo, Toshio] Tokyo Metropolitan Univ, Dept Mech Engn, Hachioji, Tokyo 1920397, Japan	Kariya, T (reprint author), 3007 Nakashima,Shikama Ku, Himeji, Hyogo 6728677, Japan.	tkariya@himeji.sanyo-steel.co.jp					Alfredo Iranzo, 2015, ENERGY, V82, P914; Taymaz I, 2010, ENERGY, V35, P2134, DOI 10.1016/j.energy.2010.01.032; Silva RF, 2007, J FUEL CELL SCI TECH, V4, P116, DOI 10.1115/1.2713768; Carton JG, 2012, ENERGY, V39, P63, DOI 10.1016/j.energy.2011.10.023; Tawfik H, 2007, J POWER SOURCES, V163, P755, DOI 10.1016/j.jpowsour.2006.09.088; Turan C, 2011, INT J HYDROGEN ENERG, V36, P12370, DOI 10.1016/j.ijhydene.2011.06.091; Yi PY, 2013, J POWER SOURCES, V230, P25, DOI 10.1016/j.jpowsour.2012.11.063; Wang SH, 2006, J POWER SOURCES, V162, P486, DOI 10.1016/j.jpowsour.2006.06.084; Carton JG, 2010, ENERGY, V35, P2796, DOI 10.1016/j.energy.2010.02.044; Turan C, 2012, INT J HYDROGEN ENERG, V37, P18187, DOI 10.1016/j.ijhydene.2012.09.042; Mehta V, 2003, J POWER SOURCES, V114, P32, DOI 10.1016/S0378-7753(02)00542-6; Netwall CJ, 2013, J POWER SOURCES, V227, P137, DOI 10.1016/j.jpowsour.2012.11.012; Wang JY, 2015, ENERGY, V80, P509, DOI 10.1016/j.energy.2014.12.007; Baroutaji A, 2014, J ENERGY CHALLENGES, V1, P2; Cleghorn SJC, 1997, INT J HYDROGEN ENERG, V22, P1137, DOI 10.1016/S0360-3199(97)00016-5; Huang KK, 2014, ENERGY, V76, P816, DOI 10.1016/j.energy.2014.08.076; Lee SH, 2013, THIN SOLID FILMS, V529, P374, DOI 10.1016/j.tsf.2012.09.027; Shudo T, 2011, 397261 SAE, P1; Suherman H, 2013, CERAM INT, V39, P7159, DOI 10.1016/j.ceramint.2013.02.059; Tian RJ, 2011, INT J HYDROGEN ENERG, V36, P6788, DOI 10.1016/j.ijhydene.2011.03.021; Yang MJ, 2014, ENERGY, V64, P242, DOI 10.1016/j.energy.2013.10.080	21	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0360-5442	1873-6785		ENERGY	Energy	JUL 1	2015	87						134	141		10.1016/j.energy.2015.04.060		8	Thermodynamics; Energy & Fuels	Thermodynamics; Energy & Fuels	CM1JR	WOS:000357437700013		
J	Wu, LJ; Qin, Y; Hojo, T; Li, YY				Wu, Li-Jie; Qin, Yu; Hojo, Toshimasa; Li, Yu-You			Upgrading of anaerobic digestion of waste activated sludge by temperature-phased process with recycle	ENERGY			English	Article						Waste activated sludge; Anaerobic digestion; Temperature-phased anaerobic digestion; Two-stage; Hyper-thermophilic; Recycle	MUNICIPAL SOLID-WASTE; METHANE PRODUCTION; RETENTION TIME; SEWAGE-SLUDGE; ACID-PHASE; PRETREATMENT; SYSTEM; PERFORMANCE; BIOGAS; SILAGE	Thermophilic (55 degrees C)-mesophilic(35 degrees C) and hyper-thermophilic(70 degrees C)-mesophilic TPAD-R (temperature-phased anaerobic digestion with recycle) were conducted to compare and evaluate the operation performance to treat WAS (waste activated sludge) with the MD (conventional mesophilic anaerobic digestion). TPAD-R was based on the TPAD (temperature-phased anaerobic digestion), and introduced a recycle system from the end mesophilic stage to the front stage. Thermophilic-mesophilic TPAD-R produced more biogas 0.99 L/g VS (volatile solids) reduced/d than MD 0.83 L/g VS reduced/d. In thermophilic-mesophilic TPAD-R 35.7% and 18.7% of WAS was converted to methane in the thermophilic stage and in the mesophilic stage, respectively, according to a COD balance. Solids reduction was improved to a similar extent in thermophilic-mesophilic TPAD-R and hyper-thermophilic-mesophilic TPAD-R, which was 10% higher than that in MD (approximately 40% of VS reduction). Hydrolysis, acidogenesis and methanogenesis analysis indicated that thermophilic and hyper-thermophilic stage accelerated the hydrolysis rate of TPAD-R, 0.053 gCOD/gVS/d and 0.040 gCOD/gVS/d, respectively, compared to about 0.025 gCOD/gVS/d in MD. In addition, thermophilic-mesophilic TPAD-R achieved more surplus energy than hyper-thermophilic-mesophilic TPAD-R and MD. (C) 2015 Elsevier Ltd. All rights reserved.	[Wu, Li-Jie; Hojo, Toshimasa; Li, Yu-You] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Qin, Yu; Li, Yu-You] Tohoku Univ, Grad Sch Environm Studies, Dept Environm Studies, Sendai, Miyagi 9808579, Japan	Li, YY (reprint author), Tohoku Univ, Aoba Ku, Aoba 6-6-06, Sendai, Miyagi 9808579, Japan.	yyli@epli.civil.tohoku.ac.jp					van Lier JB, 2001, WATER SCI TECHNOL, V43, P1; Lee DY, 2010, BIORESOURCE TECHNOL, V101, pS42, DOI 10.1016/j.biortech.2009.03.037; Ariunbaatar J, 2014, APPL ENERG, V123, P143, DOI 10.1016/j.apenergy.2014.02.035; Chu CF, 2008, INT J HYDROGEN ENERG, V33, P4739, DOI 10.1016/j.ijhydene.2008.06.060; Orozco AM, 2013, BIORESOURCE TECHNOL, V143, P117, DOI 10.1016/j.biortech.2013.05.118; Bolzonella D, 2002, WATER SCI TECHNOL, V46, P199; Ge HQ, 2011, WATER RES, V45, P1597, DOI 10.1016/j.watres.2010.11.042; Bolzonella D, 2005, PROCESS BIOCHEM, V40, P1453, DOI 10.1016/j.procbio.2004.06.036; Han Y, 1997, WATER SCI TECHNOL, V36, P367, DOI 10.1016/S0273-1223(97)00544-1; Coelho NMG, 2011, WATER RES, V45, P2822, DOI 10.1016/j.watres.2011.02.032; Carrere H, 2010, J HAZARD MATER, V183, P1, DOI 10.1016/j.jhazmat.2010.06.129; Appels L, 2008, PROG ENERG COMBUST, V34, P755, DOI 10.1016/j.pecs.2008.06.002; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Schmit KH, 2001, WATER ENVIRON RES, V73, P314, DOI 10.2175/106143001X139335; Gavala HN, 2003, WATER RES, V37, P4561, DOI 10.1016/S0043-1354(03)00401-9; Bolzonella D, 2007, IND ENG CHEM RES, V46, P6650, DOI 10.1021/ie061627e; ROMLI M, 1994, WATER RES, V28, P475, DOI 10.1016/0043-1354(94)90285-2; Igoni AH, 2008, APPL ENERG, V85, P430, DOI 10.1016/j.apenergy.2007.07.013; Han Y, 1997, WATER ENVIRON RES, V69, P1139; Lay JJ, 1998, WATER ENVIRON RES, V70, P1075, DOI 10.2175/106143098X123426; LOWRY OH, 1951, J BIOL CHEM, V193, P265; EASTMAN JA, 1981, J WATER POLLUT CON F, V53, P352; Riau V, 2012, J CHEM TECHNOL BIOT, V87, P1074, DOI 10.1002/jctb.3709; Zabranska J, 2000, WATER SCI TECHNOL, V42, P49; AOKI N, 1991, WATER SCI TECHNOL, V23, P1147; APHA, 2012, STANDARD METHODS EXA; Coultry J, 2013, ENERGY, V60, P125, DOI 10.1016/j.energy.2013.07.059; Dichtl IN, 1997, WATER ENVIRON J, V11, P98; ELEFSINIOTIS P, 1994, ENVIRON TECHNOL, V15, P741; GHOSH S, 1975, J WATER POLLUT CON F, V47, P30; GHOSH S, 1991, WATER SCI TECHNOL, V23, P1179; GOSSETT JM, 1982, J ENV ENG DIV-ASCE, V108, P1101; Jarvis A, 1995, ANTON LEEUW INT J G, V68, P317, DOI 10.1007/BF00874142; KAISER SK, 1994, WATER SCI TECHNOL, V29, P213; Li Y. Y., 2006, J ENV ENG MANAGE, V16, P297; Lu JQ, 2005, EFFECTS TEMPERATURE; McCarty PL, 1964, PUBLIC WORKS, V95, P91; Metcalf Eddy I., 2002, WASTEWATER ENG TREAT, V4th; MILLS PJ, 1979, AGR WASTES, V1, P57, DOI 10.1016/0141-4607(79)90007-6; Muller JA, 2001, WATER SCI TECHNOL, V44, P121; Oles J, 1997, WATER SCI TECHNOL, V36, P449, DOI 10.1016/S0273-1223(97)00554-4; WECHS F, 1984, WATER SCI TECHNOL, V16, P365; Zack S. I., 1929, SEWAGE WORKS J, V1, P160	44	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0360-5442	1873-6785		ENERGY	Energy	JUL 1	2015	87						381	389		10.1016/j.energy.2015.04.110		9	Thermodynamics; Energy & Fuels	Thermodynamics; Energy & Fuels	CM1JR	WOS:000357437700038		
J	Ohkura, M; Yokoyama, R; Nakamata, T; Wakui, T				Ohkura, Masashi; Yokoyama, Ryohei; Nakamata, Takuya; Wakui, Tetsuya			Numerical analysis on performance enhancement of a CO2 heat pump water heating system by extracting tepid water	ENERGY			English	Article						Heat pump; Water heater; Thermal storage; Natural refrigerant; System performance enhancement; Numerical simulation	CARBON-DIOXIDE; REJECTION PRESSURE; OPTIMIZATION; SIMULATION; CYCLE; REFRIGERANT	Water heating systems each of which is composed of an air-to-water heat pump using CO2 as a natural refrigerant and a hot water storage tank have been developed, and are expected to contribute to energy saving in residential hot water supply. However, the area of tepid water in the storage tank expands because of heat conduction during long time storage, which leads to a degradation of the system performance. One of the ways to reduce the area of tepid water and enhance the system performance is to extract tepid water from the side of the storage tank. In this paper, the performance enhancement of a CO2 heat pump water heating system with such a revised storage tank is analyzed by numerical simulation. The simulation model developed previously for a conventional system is extended by modifying the model for the storage tank and verifying its validity through experiments. Through a performance analysis using a standardized hot water demand, it is clarified how system performance values of the revised system are enhanced, and especially how the trade-off relationship between the system efficiency and the volume of unused hot water is improved, in comparison with those of the conventional system. (C) 2015 Elsevier Ltd. All rights reserved.	[Ohkura, Masashi; Yokoyama, Ryohei; Nakamata, Takuya; Wakui, Tetsuya] Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, Sakai, Osaka 5998531, Japan	Yokoyama, R (reprint author), Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	yokoyama@me.osakafu-u.ac.jp					Sarkar J, 2004, INT J REFRIG, V27, P830, DOI 10.1016/j.ijrefrig.2004.03.006; Neksa P, 1998, INT J REFRIG, V21, P172, DOI 10.1016/S0140-7007(98)00017-6; White SD, 2002, INT J REFRIG, V25, P479, DOI 10.1016/S0140-7007(01)00021-4; Laipradit P, 2008, INT J ENERG RES, V32, P356, DOI 10.1002/er.1357; Ma YT, 2013, ENERGY, V55, P156, DOI 10.1016/j.energy.2013.03.030; Xu XX, 2012, ENERGY, V44, P870, DOI 10.1016/j.energy.2012.04.062; Qi PC, 2013, APPL THERM ENG, V56, P120, DOI 10.1016/j.applthermaleng.2013.03.045; Stene J, 2005, INT J REFRIG, V28, P1259, DOI 10.1016/j.ijrefrig.2005.07.006; Fazelpour F, 2014, INT J REFRIG, V38, P128, DOI 10.1016/j.ijrefrig.2013.09.016; Aprea C, 2009, APPL ENERG, V86, P2373, DOI 10.1016/j.apenergy.2009.03.006; [Anonymous], 2011, C92202011 JIS JAP ST; Cavallini A, 2005, INT J REFRIG, V28, P1274, DOI 10.1016/j.ijrefrig.2005.09.004; Yang JL, 2010, ENERGY, V35, P4812, DOI 10.1016/j.energy.2010.09.007; Neksa P, 2002, INT J REFRIG, V25, P421, DOI 10.1016/S0140-7007(01)00033-0; Sarkar J, 2006, INT J REFRIG, V29, P735, DOI 10.1016/j.ijrefrig.2005.12.006; [Anonymous], 2007, 40502007R JRA; Sarkar J, 2005, ENERG CONVERS MANAGE, V46, P2053, DOI [10.1016/j.enconman.2004.10.022, 10.1016/j.enconm,an.2004.10.022]; Minetto S, 2011, INT J REFRIG, V34, P742, DOI 10.1016/j.ijrefrig.2010.12.018; Lin KH, 2013, INT J REFRIG, V36, P2048, DOI 10.1016/j.ijrefrig.2013.08.008; Cecchinato L, 2005, INT J REFRIG, V28, P1250, DOI 10.1016/j.ijrefrig.2005.05.019; Deng S, 2013, SOL ENERGY, V98, P212, DOI 10.1016/j.solener.2013.10.001; Fernandez N, 2010, INT J REFRIG, V33, P635, DOI 10.1016/j.ijrefrig.2009.12.008; Hashimoto K., 2006, IEA HEAT PUMP CTR NE, V24, P12; Hwang Y, 1998, INT J HEATING VENTIL, V4, P1; Richter MR, 2003, ENERGY, V28, P1005, DOI 10.1016/S0360-5442(03)00065-3; Sarkar J, 2010, ASHRAE TRAN, V116, P534; Skaugen G, 2002, P 5 IIR GUST LOR C N, P82; Yamaguchi S, 2011, INT J HEAT MASS TRAN, V54, P1896, DOI 10.1016/j.ijheatmasstransfer.2011.01.013; Yokoyama R., 2011, P 7 INT S ENV CONSC, P120; Yokoyama R, 2013, INT J THERMODYN, V16, P62; Yokoyama R, 2008, J ENV ENG, V3, P61, DOI 10.1299/jee.3.61; Yokoyama R, 2006, JSME INT J B-FLUID T, V49, P541, DOI 10.1299/jsmeb.49.541; Yokoyama Ryohei, 2010, Transactions of the Japan Society of Refrigerating and Air Conditioning Engineers, V27; Yokoyama R, 2010, ENERGY, V35, P718, DOI 10.1016/j.energy.2009.11.008; Yokoyama R, 2006, ECOS 2006: PROCEEDINGS OF THE 19TH INTERNATIONAL CONFERENCE ON EFFICIENCY, COST, OPTIMIZATION, SIMULATION AND ENVIRONMENTAL IMPACT OF ENERGY SYSTEMS, VOLS 1-3, P1353; Yokoyama R, 2007, ENERGY, V32, P388, DOI 10.1016/j.energy.2006.06.020	36	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0360-5442	1873-6785		ENERGY	Energy	JUL 1	2015	87						435	447		10.1016/j.energy.2015.05.013		13	Thermodynamics; Energy & Fuels	Thermodynamics; Energy & Fuels	CM1JR	WOS:000357437700043		
J	Akiyama, E; Kakutani, H; Nakao, T; Motomura, Y; Takano, Y; Sorakubo, R; Mizuno, A; Aozasa, O; Tachibana, K; Doi, T; Ohta, S				Akiyama, Ema; Kakutani, Hideki; Nakao, Teruyuki; Motomura, Yuka; Takano, Yuki; Sorakubo, Ryota; Mizuno, Ayami; Aozasa, Osamu; Tachibana, Keisuke; Doi, Takefumi; Ohta, Souichi			Facilitation of adipocyte differentiation of 3T3-L1 cells by debrominated tetrabromobisphenol A compounds detected in Japanese breast milk	ENVIRONMENTAL RESEARCH			English	Article						Debrominated tetrabromobisphenol A compounds; Peroxisome proliferator activated receptor gamma; Adipocyte differentiation; Japanese breast milk	BROMINATED FLAME RETARDANTS; BISPHENOL-A; IN-VITRO; TETRACHLOROBISPHENOL-A; EXPOSURE ASSESSMENT; SERUM SAMPLES; TBBPA; MICE; HEXABROMOCYCLODODECANE; BIOTRANSFORMATION	Tetrabromobisphenol A (TeBBPA) is widely used type of brominated flame retardant. In this study, we newly synthesized materials for the debrominated congeners, 2,2',6-tribromobisphenol A (TriBBPA), 2,2'-dibromobisphenol A (2,2'-DiBBPA), 2,6-dibromobisphenol A (2,6-DiBBPA), and 2-monobromobisphenol A (MoBBPA) and evaluated the actual extent of contamination with bisphenol A (BPA), TeBBPA and debrominated congeners in Japanese breast milk samples. TriBBPA was detected at higher levels than that of TeBBPA, while DiBBPA and MoBBPA were detected at lower levels than that of TeBBPA. This observation suggested that humans are exposed to debrominated congeners, which might cause adverse effects. Contamination of the congeners in breast milk was concern about risk infant health, having vulnerable defense system. As pilot study by in vitro experiment, we assessed the toxic potency of debrominated congeners by studying their effect on adipocyte differentiation in 3T3-L1 cells. We observed 2,6-DiBBPA, TriBBPA and TeBBPA elevated the lipid accumulation and adipocyte-specific protein 2 expression in a manner dependent on the number of substituted bromines. Moreover, PPAR gamma transcriptional activities increased in a dose-dependent manner in the presence of 2,6-DiBBPA and TriBBPA as well as TeBBPA. Our study clarified that TeBBPA and its debrominated congeners accumulated in breast milk and the debrominated congeners promoted adipocyte differentiation, showing that a comprehensive evaluation of the influences of these compounds including the debrominated congeners of TeBBPA on health in infants is necessary. (C) 2015 Elsevier Inc. All rights reserved.	[Akiyama, Ema; Kakutani, Hideki; Nakao, Teruyuki; Motomura, Yuka; Takano, Yuki; Sorakubo, Ryota; Mizuno, Ayami; Tachibana, Keisuke; Doi, Takefumi; Ohta, Souichi] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan; [Aozasa, Osamu; Tachibana, Keisuke; Doi, Takefumi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Ohta, S (reprint author), Setsunan Univ, Fac Pharmaceut Sci, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	ohta@pharm.setsunan.ac.jp			Health and Labour Sciences Research Grant of Japan (H23-Food-Young Scientist-017) [11103282]; Japan Society for the Promotion of Science [25281032]	This study was supported by the Health and Labour Sciences Research Grant of Japan (H23-Food-Young Scientist-017, Grant no. 11103282) and by a Grant-in-Aid (Grant no. 25281032) from the Japan Society for the Promotion of Science.	Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Watanabe W, 2010, INT IMMUNOPHARMACOL, V10, P393, DOI 10.1016/j.intimp.2009.12.014; Yeo M, 2013, P NATL ACAD SCI USA, V110, P4315, DOI 10.1073/pnas.1300959110; Gosavi RA, 2013, ENVIRON HEALTH PERSP, V121, P1194, DOI 10.1289/ehp.1306902; Carignan CC, 2012, ENVIRON SCI TECHNOL, V46, P12146, DOI 10.1021/es302638d; Thomsen C, 2002, ENVIRON SCI TECHNOL, V36, P1414, DOI 10.1021/es0102282; Morris S, 2004, ENVIRON SCI TECHNOL, V38, P5497, DOI 10.1021/es049640i; Cariou R, 2008, CHEMOSPHERE, V73, P1036, DOI 10.1016/j.chemosphere.2008.07.084; Meerts IATM, 2000, TOXICOL SCI, V56, P95, DOI 10.1093/toxsci/56.1.95; Kitamura S, 2002, BIOCHEM BIOPH RES CO, V293, P554, DOI 10.1016/S0006-291X(02)00262-0; Johnson-Restrepo B, 2008, CHEMOSPHERE, V70, P1935, DOI 10.1016/j.chemosphere.2007.10.002; Mariussen E, 2003, NEUROCHEM INT, V43, P533, DOI 10.1016/S0197-0186(03)00044-5; Kodavanti PRS, 2010, TOXICOL SCI, V116, P297, DOI 10.1093/toxsci/kfq105; Thomsen C, 2001, J ENVIRON MONITOR, V3, P366, DOI 10.1039/b104304h; Hendriks HS, 2012, TOXICOL SCI, V128, P235, DOI 10.1093/toxsci/kfs136; Cabaton NJ, 2013, ENVIRON HEALTH PERSP, V121, P586, DOI 10.1289/ehp.1205588; Potvin CM, 2012, CHEMOSPHERE, V89, P1183, DOI 10.1016/j.chemosphere.2012.07.011; Riu A, 2011, ENVIRON HEALTH PERSP, V119, P1227, DOI 10.1289/ehp.1003328; Kawashiro Y, 2008, ENDOCR J, V55, P1071; Tada Y, 2006, FOOD CHEM TOXICOL, V44, P1408, DOI 10.1016/j.fct.2006.03.006; Kim UJ, 2014, ENVIRON POLLUT, V184, P193, DOI 10.1016/j.envpol.2013.08.034; Abdallah MA, 2011, ENVIRON INT, V37, P443, DOI 10.1016/j.envint.2010.11.008; Schauer UMD, 2006, TOXICOL SCI, V91, P49, DOI 10.1093/toxsci/kfj132; Olsen CM, 2003, PHARMACOL TOXICOL, V92, P180, DOI 10.1034/j.1600-0773.2003.920408.x; Kim MJ, 2009, MAR BIOTECHNOL, V11, P557, DOI 10.1007/s10126-008-9170-1; Pullen S, 2003, TOXICOLOGY, V184, P11, DOI 10.1016/S0300-483X(02)00442-0; Shi ZX, 2009, ENVIRON SCI TECHNOL, V43, P4314, DOI 10.1021/es8035626; Yang YJ, 2014, J CHROMATOGR A, V1328, P26, DOI 10.1016/j.chroma.2013.12.074; Fini JB, 2012, TOXICOL SCI, V125, P359, DOI 10.1093/toxsci/kfr312; Kibakaya EC, 2009, J IMMUNOTOXICOL, V6, P285, DOI 10.3109/15476910903258260; Arbeli Z, 2006, CHEMOSPHERE, V64, P1472, DOI 10.1016/j.chemosphere.2005.12.069; Cato A, 2014, CELL BIOL TOXICOL, V30, P345, DOI 10.1007/s10565-014-9289-y; Holling H., 2008, EUR CHILD ADOLESC S1, V17, P534; Masuno H, 2002, J LIPID RES, V43, P676; Meerts IATM, 2001, ENVIRON HEALTH PERSP, V109, P399; Ministry of Environment, 2013, ANN REP MIN ENV JAP; Nakagawa Y, 2007, XENOBIOTICA, V37, P693, DOI 10.1080/00498250701397697; Oberg K, 2002, CHEMOSPHERE, V48, P805, DOI 10.1016/S0045-6535(02)00113-3; SALA T, 1979, J CHEM SOC PERK T 1, P2593, DOI 10.1039/p19790002593; Tachibana K, 2009, BIOCHEM BIOPH RES CO, V389, P501, DOI 10.1016/j.bbrc.2009.09.018; Toyama K., 2005, J SAITAMA MED U, V32, P69; WATANABE I, 1983, B ENVIRON CONTAM TOX, V31, P48, DOI 10.1007/BF01608765; Wojtowicz AK, 2014, NEUROTOX RES, V25, P311, DOI 10.1007/s12640-013-9434-z	43	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	JUL	2015	140						157	164		10.1016/j.envres.2015.03.035		8	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CM7VH	WOS:000357904100018		
J	Onozuka, D; Hagihara, A				Onozuka, Daisuke; Hagihara, Akihito			Variation in vulnerability to extreme-temperature-related mortality in Japan: A 40-year time-series analysis	ENVIRONMENTAL RESEARCH			English	Article						Climatic change; Extreme temperatures; Mortality	HEAT-RELATED MORTALITY; CASE-CROSSOVER ANALYSIS; HIGH AMBIENT-TEMPERATURE; ALL-CAUSE MORTALITY; 15 EUROPEAN CITIES; UNITED-STATES; CLIMATE-CHANGE; MINAP DATABASE; US CITIES; IMPACT	Background: Although the impact of extreme heat and cold on mortality has been documented in recent years, few studies have investigated whether variation in susceptibility to extreme temperatures has changed in Japan. Methods: We used data on daily total mortality and mean temperatures in Fukuoka, Japan, for 1973-2012. We used time-series analysis to assess the effects of extreme hot and low temperatures on all-cause mortality, stratified by decade, gender, and age, adjusting for time trends. We used a multivariate meta-analysis with a distributed lag non-linear model to estimate pooled non-linear lag-response relationships associated with extreme temperatures on mortality. Results: The relative risk of mortality increased during heat extremes in all decades, with a declining trend over time. The mortality risk was higher during cold extremes for the entire study period, with a dispersed pattern across decades. Meta-analysis showed that both heat and cold extremes increased the risk of mortality. Cold effects were delayed and lasted for several days, whereas heat effects appeared quickly and did not last long. Conclusions: Our study provides quantitative evidence that extreme heat and low temperatures were significantly and non-linearly associated with the increased risk of mortality with substantial variation. Our results suggest that timely preventative measures are important for extreme high temperatures, whereas several days' protection should be provided for extreme low temperatures. (C) 2015 Elsevier Inc. All rights reserved.	[Onozuka, Daisuke; Hagihara, Akihito] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Commun, Higashi Ku, Fukuoka 8128582, Japan	Hagihara, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Commun, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hagihara@hsmp.med.kyushu-u.ac.jp	Onozuka, Daisuke/F-5067-2014	Onozuka, Daisuke/0000-0001-9596-9188	MEXT KAKENHI [24390130, 15K08714]	The study was supported by MEXT KAKENHI Grant no. 24390130 and 15K08714. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Son JY, 2012, ENVIRON HEALTH PERSP, V120, P566, DOI 10.1289/ehp.1103759; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Huang CR, 2011, ENVIRON HEALTH PERSP, V119, P1681, DOI 10.1289/ehp.1103456; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235; Gasparrini A, 2010, ENVIRON RES, V110, P633, DOI 10.1016/j.envres.2010.06.005; Gasparrini A, 2011, EPIDEMIOLOGY, V22, P68, DOI 10.1097/EDE.0b013e3181fdcd99; Goodman PG, 2004, ENVIRON HEALTH PERSP, V112, P179, DOI 10.1289/ehp.6451; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Murray CJL, 2011, LANCET, V378, P1124, DOI 10.1016/S0140-6736(11)61221-X; Hajat S, 2010, J EPIDEMIOL COMMUN H, V64, P753, DOI 10.1136/jech.2009.087999; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Wilkinson P, 2004, BRIT MED J, V329, P647, DOI 10.1136/bmj.38167.589907.55; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Zanobetti A, 2008, EPIDEMIOLOGY, V19, P563, DOI 10.1097/EDE.0b013e31816d652d; Davis RE, 2003, ENVIRON HEALTH PERSP, V111, P1712, DOI 10.1289/ehp.6336; Barnett AG, 2012, ENVIRON RES, V112, P218, DOI 10.1016/j.envres.2011.12.010; Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Brumback BA, 2000, J AM STAT ASSOC, V95, P16; Medina-Ramon M, 2006, ENVIRON HEALTH PERSP, V114, P1331, DOI 10.1289/ehp.9074; Astrom DO, 2013, EPIDEMIOLOGY, V24, P820, DOI 10.1097/01.ede.0000434530.62353.0b; Le Tertre A, 2006, EPIDEMIOLOGY, V17, P75, DOI 10.1097/01.ede.0000187650.36636.1f; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Bhaskaran K, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8050; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Goldberg MS, 2011, ENVIRON RES, V111, P853, DOI 10.1016/j.envres.2011.05.022; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Carson C, 2006, AM J EPIDEMIOL, V164, P77, DOI 10.1093/aje/kwj147; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Petkov EP, 2014, EPIDEMIOLOGY, V25, P554, DOI 10.1097/EDE.0000000000000123; Rey G, 2007, INT ARCH OCC ENV HEA, V80, P615, DOI 10.1007/s00420-007-0173-4; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170; Rocklov J, 2011, OCCUP ENVIRON MED, V68, P531, DOI 10.1136/oem.2010.058818; Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60935-1; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Donaldson GC, 2003, ENVIRON RES, V91, P1, DOI 10.1016/S0013-9351(02)00002-6; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bhaskaran K, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5531; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Field CB, 2012, MANAGING RISKS EXTRE, P582; Gasparrini A, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-1; Guo YM, 2014, EPIDEMIOLOGY, V25, P781, DOI 10.1097/EDE.0000000000000165; Huang CR, 2013, ENVIRON HEALTH PERSP, V121, P415, DOI 10.1289/ehp.1206025; Lee M, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-89; Lerchl A, 1998, INT J BIOMETEOROL, V42, P84, DOI 10.1007/s004840050089; MACEY SM, 1993, GERONTOLOGIST, V33, P497; Nelder J., 1989, GEN LINEAR MODELS; World Bank, 2014, WORLD DEV IND; Zhou MG, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-60	53	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	JUL	2015	140						177	184		10.1016/j.envres.2015.03.031		8	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CM7VH	WOS:000357904100020		
J	Skroder, H; Hawkesworth, S; Kippler, M; El Arifeen, S; Wagatsuma, Y; Moore, SE; Vahter, M				Skroder, Helena; Hawkesworth, Sophie; Kippler, Maria; El Arifeen, Shams; Wagatsuma, Yukiko; Moore, Sophie E.; Vahter, Marie			Kidney function and blood pressure in preschool-aged children exposed to cadmium and arsenic - potential alleviation by selenium	ENVIRONMENTAL RESEARCH			English	Article						Cadmium; Arsenic; Selenium; blood pressure; children; kidney function	RURAL BANGLADESH; ENVIRONMENTAL EXPOSURE; PROSPECTIVE COHORT; RANDOMIZED-TRIAL; URINARY CADMIUM; RENAL-DISEASE; BIRTH-WEIGHT; HEALTH; ADOLESCENTS; PREGNANCY	Background: Early-life exposure to toxic compounds may cause long-lasting health effects, but few studies have investigated effects of childhood exposure to nephrotoxic metals on kidney and cardiovascular function. Objectives: To assess effects of exposure to arsenic and cadmium on kidney function and blood pressure in pre-school-aged children, and potential protection by selenium. Methods: This cross-sectional study was part of the 4.5 years of age (range: 4.4-5.4 years) follow-up of the children from a supplementation trial in pregnancy (MINIMat) in rural Bangladesh, and nested studies on early-life metal exposures. Exposure to arsenic, cadmium and selenium from food and drinking water was assessed by concentrations in children's urine, measured by ICP-MS. Kidney function was assessed by the estimated glomerular filtration rate (eGFR, n=1106), calculated from serum cystatin C, and by kidney volume, measured by ultrasound (n=375). Systolic and diastolic blood pressure was measured (n=1356) after five minutes rest. Results: Multivariable-adjusted regression analyzes showed that exposure to cadmium, but not arsenic, was inversely associated with eGFR, particularly in girls. A 0.5 mu g/L increase in urinary cadmium among the girls (above spline knot at 0.12) was associated with a decrease in eGFR of 2.6 ml/min/1.73 m(2), corresponding to 0.2SD (p=0.022). A slightly weaker inverse association with cadmium was also indicated for kidney volume, but no significant associations were found with blood pressure. Stratifying on children's urinary selenium (below or above median of 12.6 mu g/L) showed a three times stronger inverse association of U-Cd with eGFR (all children) in the lower selenium stratum (B=-2.8; 95% CI: -5.5, -0.20; p=0.035), compared to those with higher selenium (B=-0.79; 95% CI: -3.0, 1.4; p=0.49). Conclusions: Childhood cadmium exposure seems to adversely affect kidney function, but not blood pressure, in this population of young children in rural Bangladesh. Better selenium status appears to be protective. However, it is important to follow up these children to assess potential long-term consequences of these findings. (C) 2015 Elsevier Inc. All rights reserved.	[Skroder, Helena; Kippler, Maria; Vahter, Marie] Karolinska Inst, Inst Environm Med, Unit Met & Hlth, S-10401 Stockholm, Sweden; [Hawkesworth, Sophie] London Sch Hyg & Trop Med, Int Nutr Grp, MRC, London WC1, England; [El Arifeen, Shams] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Wagatsuma, Yukiko] Univ Tsukuba, Fac Med, Dept Clin Trial & Clin Epidemiol, Tsukuba, Ibaraki, Japan; [Moore, Sophie E.] MRC, Human Nutr Res, Cambridge, England	Vahter, M (reprint author), Karolinska Inst, Inst Environm Med, Unit Met & Hlth, S-10401 Stockholm, Sweden.	marie.vahter@ki.se			UK Medical Research Council [G0501839]; Swedish Research Council [521-2010-3604]; Swedish International Development Cooperation Agency [SWE-2011-170]; Karolinska Institutet; Japan Society for the Promotion of Science [18256005]	We are grateful to all the personnel at icddr, b who helped with measurements of the kidney markers, blood pressure, and collection of urine. Also, Margaretha Grander, Brita Palm and Barbro Nermell at Karolinska Institutet had the responsibility of methodologies for sampling and quality control, as well as the measurements of trace elements. This work was supported by the UK Medical Research Council (G0501839), the Swedish Research Council (521-2010-3604), the Swedish International Development Cooperation Agency (SWE-2011-170), and Karolinska Institutet. Funds were also obtained via a Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (Grant#18256005). The authors declare they have no actual or potential competing financial interests.	Al-Hasan Y, 2012, J PREGNANCY, V2012; Iijima K, 2007, BIOL TRACE ELEM RES, V119, P10, DOI 10.1007/s12011-007-0057-1; Kippler M, 2013, EPIGENETICS-US, V8, P494, DOI 10.4161/epi.24401; Wang Y, 2013, FOOD CHEM TOXICOL, V58, P61, DOI 10.1016/j.fct.2013.04.013; de Burbure C, 2006, ENVIRON HEALTH PERSP, V114, P584, DOI 10.1289/ehp.8202; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Skroder HM, 2015, CLIN NUTR, V34, P923, DOI 10.1016/j.clnu.2014.09.020; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Hamadani JD, 2011, INT J EPIDEMIOL, V40, P1593, DOI 10.1093/ije/dyr176; Grubb A, 2005, CLIN CHEM, V51, P1420, DOI 10.1373/clinchem.2005.051557; Kippler M, 2012, ENVIRON HEALTH PERSP, V120, P1462, DOI 10.1289/ehp.1104431; Saha KK, 2008, AM J CLIN NUTR, V87, P1852; Kippler M, 2010, TOXICOL LETT, V198, P20, DOI 10.1016/j.toxlet.2010.04.029; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Meharg AA, 2013, ENVIRON SCI TECHNOL, V47, P5613, DOI 10.1021/es400521h; Zwolak I, 2012, CELL BIOL TOXICOL, V28, P31, DOI 10.1007/s10565-011-9203-9; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Falkner B, 1996, PEDIATRICS, V98, P649; Berglund M, 2011, ENVIRON RES, V111, P1271, DOI 10.1016/j.envres.2011.09.002; Watanabe T, 2013, INT ARCH OCC ENV HEA, V86, P865, DOI 10.1007/s00420-012-0821-1; Schoeters G, 2006, ACTA PAEDIATR, V95, P50, DOI 10.1080/08035320600886232; Gardner R, 2011, AM J PUBLIC HEALTH, V101, pS333, DOI 10.2105/AJPH.2010.300025; Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g; Hawkesworth S, 2013, J NUTR, V143, P728, DOI 10.3945/jn.112.168518; Schwartz GJ, 2009, CLIN J AM SOC NEPHRO, V4, P1832, DOI 10.2215/CJN.01640309; Kippler M, 2012, ENVIRON HEALTH PERSP, V120, P284, DOI 10.1289/ehp.1103711; Schulz C, 2009, INT J HYG ENVIR HEAL, V212, P637, DOI 10.1016/j.ijheh.2009.05.003; Vahter M, 2002, TOXICOLOGY, V181, P211, DOI 10.1016/S0300-483X(02)00285-8; Gardner RM, 2013, AM J EPIDEMIOL, V177, P1356, DOI 10.1093/aje/kws437; Smith AH, 2012, ENVIRON HEALTH PERSP, V120, P1527, DOI 10.1289/ehp.1104867; Trzcinka-Ochocka M, 2004, ENVIRON RES, V95, P143, DOI 10.1016/j.envres.2003.10.003; Weaver VM, 2014, ENVIRON RES, V132, P226, DOI 10.1016/j.envres.2014.04.013; Ljung K, 2011, FOOD CHEM, V127, P943, DOI 10.1016/j.foodchem.2011.01.062; Flodin M, 2007, SCAND J CLIN LAB INV, V67, P560, DOI 10.1080/00365510601187773; Persson LA, 2012, JAMA-J AM MED ASSOC, V307, P2050, DOI 10.1001/jama.2012.4061; Tofail F, 2008, AM J CLIN NUTR, V87, P704; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; Pirard C, 2014, SCI TOTAL ENVIRON, V472, P730, DOI 10.1016/j.scitotenv.2013.11.028; Madden EF, 2000, DRUG CHEM TOXICOL, V23, P1, DOI 10.1081/DCT-100100098; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; Kippler M, 2007, TOXICOL APPL PHARM, V222, P221, DOI 10.1016/j.taap.2007.04.009; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Davis MA, 2012, ENVIRON HEALTH PERSP, V120, P1418, DOI 10.1289/ehp.1205014; BERGLUND M, 1994, ENVIRON HEALTH PERSP, V102, P1058, DOI 10.2307/3431993; de Burbure C, 2003, J TOXICOL ENV HEAL A, V66, P783, DOI 10.1080/15287390390156182; Engstrom KS, 2010, FREE RADICAL BIO MED, V48, P1211, DOI 10.1016/j.freeradbiomed.2010.02.004; Fransson M.N., 2014, TOXICOL SCI; Gheissari Alaleh, 2014, Saudi J Kidney Dis Transpl, V25, P1004; Hawkesworth S, 2013, INT J EPIDEMIOL, V42, P176, DOI 10.1093/ije/dys215; Iglesias P, 2013, J NEPHROL, V26, P266, DOI 10.5301/jn.5000213; Kippler M., 2011, ENVIRON RES, V112, P164; Maringhini S, 2010, J MATERN-FETAL NEO M, V23, P84, DOI 10.3109/14767058.2010.510245; Muthayya S, 2014, ANN NY ACAD SCI, V1324, P7, DOI 10.1111/nyas.12540; Peters B.A., 2014, PLOS ONE, V1; Riederer AM, 2013, ENVIRON SCI TECHNOL, V47, P1137, DOI 10.1021/es303556n; Suzuki M, 2009, J TOXICOL SCI, V34, pSP267; Szybinski Z, 2010, BIOL TRACE ELEM RES, V138, P28, DOI 10.1007/s12011-009-8601-9; Turgut S, 2005, BIOL TRACE ELEM RES, V108, P197, DOI 10.1385/BTER:108:1-3:197; Vahter ME, 2006, J HEALTH POPUL NUTR, V24, P236; Valent F, 2004, LANCET, V363, P2032, DOI 10.1016/S0140-6736(04)16452-0; Xiao P, 2002, BIOMED ENVIRON SCI, V15, P67; Zachwieja K, 2014, ADV MED SCI, V60, P31; Zheng L, 2014, CURRENT ENV HLTH REP, V1, P192	63	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	JUL	2015	140						205	213		10.1016/j.envres.2015.03.038		9	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CM7VH	WOS:000357904100024		
J	Yoshida, N; Inaoka, T; Sultana, N; Ahmad, SA; Mabuchi, A; Shimizu, H; Watanabe, C				Yoshida, Nao; Inaoka, Tsukasa; Sultana, Nayar; Ahmad, Sk. Akhtar; Mabuchi, Akihiko; Shimizu, Hana; Watanabe, Chiho			Non-monotonic relationships between arsenic and selenium excretion and its implication on arsenic methylation pattern in a Bangladeshi population	ENVIRONMENTAL RESEARCH			English	Article						Arsenic; Urinary arsenic speciation; Selenium; Genetic polymorphism; Non-monotonic relationship	SKIN-LESIONS; GENETIC POLYMORPHISMS; NUTRITIONAL-STATUS; CONTAMINATED AREA; GST POLYMORPHISMS; URINARY SELENIUM; DRINKING-WATER; METABOLISM; EXPOSURE; RESIDENTS	The toxicity of arsenic differs markedly between individuals and populations, which might be related to the metabolism (methylation) of inorganic arsenic (As), as well as the selenium (Se) nutritional status. Urinary excretion of As (u-As) and Se (u-Se) was examined in an adult population (n=128) living in an As-contaminated area in Bangladesh. Although there was a significant negative correlation between u-Se and u-As (median 137; range 49-927 mu g/g creatinine), closer examination revealed a non-monotonous relationship between them. A quadratic curve with an axis of As at 155 mu g/g Cre gave a better fit, and u-As and u-Se were positively or negatively correlated depending on whether the As concentration was lower or higher than 155 mu g As/g Cre, respectively. Likewise, the relationships between the As methylation pattern and glutathione-S-transferase (GST) polymorphism, body mass index (BMI), and u-Se differed depending on the u-As range; i.e., higher or lower than 155 mu g/g Cre. Although we did not determine the causal mechanism for these observations, the non-monotonic relationship between As exposure and the variables examined suggested the existence of a threshold at which the handling of As by human body is qualitatively changed. The possible importance of Se nutrition for As toxicity is also discussed. (C) 2015 Elsevier Inc. All rights reserved.	[Yoshida, Nao; Sultana, Nayar; Shimizu, Hana; Watanabe, Chiho] Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Human Ecol,Bunkyo Ku, Tokyo 1130033, Japan; [Inaoka, Tsukasa] Saga Univ, Fac Agr, Dept Human Ecol, Saga 8408502, Japan; [Ahmad, Sk. Akhtar] Bangladesh Univ Hlth Sci, Dept Occupat & Environm Med, Dhaka 1216, Bangladesh; [Mabuchi, Akihiko] Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Human Genet,Bunkyo Ku, Tokyo 1130033, Japan	Watanabe, C (reprint author), Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Human Ecol,Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	chiho@humeco.m.u-tokyo.ac.jp			Ministry of Environment, Japan (Global environment Research Fund) [H-063]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [23310045]	This work has been financially supported by Ministry of Environment, Japan (Global environment Research Fund, H-063) and Ministry of Education, Culture, Sports, Science, and Technology, Japan (Grant-in-aid for Scientific Research, 23310045).	Christian WJ, 2006, ENVIRON RES, V100, P115, DOI 10.1016/j.envres.2005.03.009; Watanabe C, 2001, ENVIRON HEALTH PERSP, V109, P1265, DOI 10.2307/3454749; Pilsner JR, 2011, ENVIRON HEALTH PERSP, V119, P113, DOI 10.1289/ehp.1001937; Agusa T, 2010, TOXICOL APPL PHARM, V242, P352, DOI 10.1016/j.taap.2009.11.007; Watanabe C, 2004, TOXICOL APPL PHARM, V198, P272, DOI 10.1016/j.taap.2003.10.024; Steinmaus C, 2007, J TOXICOL ENV HEAL A, V70, P159, DOI 10.1080/15287390600755240; Lin GF, 2007, ARCH TOXICOL, V81, P545, DOI 10.1007/s00204-007-0187-4; Hsueh YM, 2003, TOXICOL LETT, V137, P49, DOI 10.1016/S0378-4274(02)00380-6; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Chiou HY, 1997, MUTAT RES-REV MUTAT, V386, P197, DOI 10.1016/S1383-5742(97)00005-7; PEMBLE S, 1994, BIOCHEM J, V300, P271; Chen YC, 2003, CANCER CAUSE CONTROL, V14, P303, DOI 10.1023/A:1023905900171; Zakharyan RA, 2001, CHEM RES TOXICOL, V14, P1051, DOI 10.1021/tx010052h; Franca R, 2012, PHARMACOGENOMICS, V13, P1905, DOI [10.2217/pgs.12.169, 10.2217/PGS.12.169]; Rahman M, 2006, ENVIRON HEALTH PERSP, V114, P1847, DOI 10.1289/ehp.9207; Xu SJ, 1998, J BIOL CHEM, V273, P3517, DOI 10.1074/jbc.273.6.3517; Li L, 2008, ENVIRON HEALTH PERSP, V116, P315, DOI 10.1289/ehp.10639; Parvez F, 2011, ENVIRON HEALTH PERSP, V119, P1665, DOI 10.1289/ehp.1103548; ZHONG S, 1993, CARCINOGENESIS, V14, P1821, DOI 10.1093/carcin/14.9.1821; Concha G, 1998, TOXICOL SCI, V44, P185, DOI 10.1093/toxsci/44.2.185; Lindberg AL, 2008, TOXICOL APPL PHARM, V230, P9, DOI 10.1016/j.taap.2008.02.001; Bae M.-J., 2003, THESIS U TOKYO; Engstrom KS, 2007, ENVIRON HEALTH PERSP, V115, P599, DOI 10.1289/ehp.9734; Ghosh P, 2006, INT J CANCER, V118, P2470, DOI 10.1002/ijc.21640; Guifan Sun Y.X., 2007, ENV HLTH PERSPECT, V115, P648; Hogberg J., 2007, SELENIUM HDB TOXICOL, P784; Liu CJ, 2005, J ORAL PATHOL MED, V34, P473, DOI 10.1111/j.1600-0714.2005.00345.x; Maharjan M, 2007, J EPIDEMIOL COMMUN H, V61, P389, DOI 10.1136/jech.2005.045062; Marcos R, 2006, J OCCUP ENVIRON MED, V48, P334, DOI 10.1097/01.jom.0000194149.17574.3c; McCarty KM, 2007, ENVIRON HEALTH PERSP, V115, P341, DOI 10.1289/ehp.9152; McCarty KM, 2007, ENVIRON HEALTH-UK, V6, DOI 10.1186/1476-069X-6-5; Mead M.N., 2005, ENV HLTH PERSPECT, V113, P379; Miyazaki K, 2003, J HEALTH SCI, V49, P239; NRC, 2001, ARS DRINK WAT 2001 U; Spallholz JE, 2005, BIOL TRACE ELEM RES, V106, P133, DOI 10.1385/BTER:106:2:133; Stamatelos SK, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-16; Watanabe C., 2012, HDB SUSTAINABLE ENG; Wu Y., 2001, CURR SCI, V81, P1215	38	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	JUL	2015	140						300	307		10.1016/j.envres.2015.03.019		8	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CM7VH	WOS:000357904100033		
J	Igata, S; Tahara, N; Tahara, A; Honda, A; Nitta, Y; Kusaba, K; Niiyama, H; Kaida, H; Abe, T; Yoshiyama, H; Fukumoto, Y				Igata, Sachiyo; Tahara, Nobuhiro; Tahara, Atsuko; Honda, Akihiro; Nitta, Yoshikazu; Kusaba, Ken; Niiyama, Hiroshi; Kaida, Hayato; Abe, Toshi; Yoshiyama, Hideki; Fukumoto, Yoshihiro			Demonstration of the disease activity by serial carotid artery ultrasonography, magnetic resonance imaging and 18-fluoro-deoxyglucose positron emission tomography in a Beh double dagger et's disease patient with carotid artery stenosis	EUROPEAN HEART JOURNAL			English	Editorial Material									[Igata, Sachiyo; Tahara, Nobuhiro; Tahara, Atsuko; Honda, Akihiro; Nitta, Yoshikazu; Niiyama, Hiroshi; Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Med, Div Cardiovasc Med, Kurume, Fukuoka 8300011, Japan; [Kusaba, Ken; Yoshiyama, Hideki] Yame Gen Hosp, Dept Med, Div Cardiovasc Med, Yame, Japan; [Kaida, Hayato; Abe, Toshi] Kurume Univ, Sch Med, Dept Radiol, Kurume, Fukuoka 830, Japan	Tahara, N (reprint author), Kurume Univ, Sch Med, Dept Med, Div Cardiovasc Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	ntahara@med.kurume-u.ac.jp						0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0195-668X	1522-9645		EUR HEART J	Eur. Heart J.	JUL 1	2015	36	25					1629	1629		10.1093/eurheartj/ehv031		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN1KD	WOS:000358177800016		
J	Ota, H; Sugimura, K; Miura, M; Shimokawa, H				Ota, Hideki; Sugimura, Koichiro; Miura, Masanobu; Shimokawa, Hiroaki			Four-dimensional flow magnetic resonance imaging visualizes drastic change in vortex flow in the main pulmonary artery after percutaneous transluminal pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension	EUROPEAN HEART JOURNAL			English	Editorial Material									[Ota, Hideki; Sugimura, Koichiro; Miura, Masanobu; Shimokawa, Hiroaki] Tohoku Univ Hosp, Diagnost Radiol, Aoba Ku, Sendai, Miyagi, Japan	Ota, H (reprint author), Tohoku Univ Hosp, Diagnost Radiol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi, Japan.	h-ota@rad.med.tohoku.ac.jp	Ota, Hideki/A-3717-2012	Ota, Hideki/0000-0002-7239-3152				0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0195-668X	1522-9645		EUR HEART J	Eur. Heart J.	JUL 1	2015	36	25					1630	1630		10.1093/eurheartj/ehv054		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN1KD	WOS:000358177800017		
J	Nomura, Y; Sugimoto, K; Gotake, Y; Yamanaka, K; Sakamoto, T; Muradi, A; Okada, T; Yamaguchi, M; Okita, Y				Nomura, Y.; Sugimoto, K.; Gotake, Y.; Yamanaka, K.; Sakamoto, T.; Muradi, A.; Okada, T.; Yamaguchi, M.; Okita, Y.			Comparison of Volumetric and Diametric Analysis in Endovascular Repair of Descending Thoracic Aortic Aneurysm	EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY			English	Article						Volumetric analysis; Descending thoracic aortic aneurysm; Thoracic endovascular aneurysm repair	ENDOLUMINAL EXCLUSION; STENT-GRAFTS; II ENDOLEAK; ZENITH TX2; SAC; COMPLICATIONS; REGRESSION; OUTCOMES; TRIAL	Objectives: The aim was to evaluate computed tomography angiography (CIA) volumetric and diametric analysis after endovascular repair of descending thoracic aortic aneurysms (DTAAs) and its correlation with and applicability for clinical follow up. Methods: Fifty-four consecutive endovascular repairs for DTAA were retrospectively evaluated from 2008 to 2014. All patients underwent pre-operative CIA and at least one post-operative CIA at 6 months. Fifty-four preoperative and 137 post-operative CTAs were evaluated (using the Ziosoft 2 software) to analyze the aneurysm and thrombus volume, the maximum aneurysm diameter, and their changes at the last follow up CIA (mean 30.5 months; range 6.5-66.4 months). A statistical analysis was performed to assess the correlation between diameter and volume changes, as well as association with endoleaks. The cut off point to predict endoleaks was determined using a receiver operating characteristic (ROC) curve. The predictive accuracy of volume change versus diameter change for Type I endoleak was analyzed. Results: The mean pre-operative aneurysm diameter, aneurysm volume, and thrombus volume were 56.7 +/- 11.7 mm, 145.8 +/- 120.0 mL, and 48.8 +/- 54.8 mL, respectively. Within the observational period, a mean decrease of -27.9 +/- 30.5% in the aortic volume and -15.9 +/- 15.4% in diameter was observed. Correlation between aneurysm diameter and volume changes was good (r = 0.854). Volume and diameter changes were significantly different between groups with and without endoleaks (volume change 16.9 +/- 38.8% vs. -35.6 +/- 23.1%, p < .001; diameter change 8.0 +/- 12.1% vs. -18.8 +/- 14.3%, p < .001). A pre-operative thrombus volume percentage of <11.3% and increase in aneurysm volume +11.6% were predictive factors for Type II and Type I endoleak, respectively. The accuracy of a >10% volume increase in predicting a Type I endoleak was higher (accuracy 96.3%, sensitivity 75%, and specificity 98%) than a >5 mm diameter increase (accuracy 92.6%, sensitivity 25%, and specificity 98%). Conclusions: CT volumetric analysis is a more reliable modality for predicting endoleaks after endovascular repair for DTAA than diameter analysis. (C) 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.	[Nomura, Y.; Gotake, Y.; Yamanaka, K.; Sakamoto, T.; Okita, Y.] Kobe Univ, Div Cardiovasc Surg, Dept Surg, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Sugimoto, K.; Muradi, A.; Okada, T.; Yamaguchi, M.] Kobe Univ, Dept Radiol, Grad Sch Med, Kobe, Hyogo 6500017, Japan	Nomura, Y (reprint author), Kobe Univ, Div Cardiovasc Surg, Dept Surg, Grad Sch Med,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	y_katsu1027@yahoo.co.jp					Lee JT, 2003, J VASC SURG, V38, P1254, DOI 10.1016/S0741-5214(03)00924-8; Preventza O, 2008, J VASC SURG, V48, P69, DOI 10.1016/j.jvs.2008.02.032; Matsumura JS, 2008, J VASC SURG, V47, P247, DOI 10.1016/j.jvs.2007.10.032; Morales JP, 2008, J ENDOVASC THER, V15, P631, DOI 10.1583/08-2551.1; Buth J, 2007, J VASC SURG, V46, P1103, DOI 10.1016/j.jvs.2007.08.020; Sadek M, 2013, ANN VASC SURG, V27, P1036, DOI 10.1016/j.avsg.2013.04.006; Kim KM, 2011, J VASC SURG, V54, P316, DOI 10.1016/j.jvs.2010.11.134; Matsumura JS, 2014, J VASC SURG, V60, P1, DOI 10.1016/j.jvs.2014.01.043; Makaroun MS, 2005, J VASC SURG, V41, P1, DOI 10.1016/j.jvs.2004.10.046; Rai D, 2014, EUR RADIOL, V24, P1768, DOI 10.1007/s00330-014-3185-y; DAKE MD, 1994, NEW ENGL J MED, V331, P1729, DOI 10.1056/NEJM199412293312601; AbuRahma AF, 2011, J VASC SURG, V53, P1534, DOI 10.1016/j.jvs.2011.02.016; Piazza M, 2013, J VASC SURG, V57, P934, DOI 10.1016/j.jvs.2012.10.078; Arsicot M, 2014, ANN VASC SURG, V28, P1618, DOI 10.1016/j.avsg.2014.03.034; Bley TA, 2009, RADIOLOGY, V253, P253, DOI 10.1148/radiol.2531082093; Chemelli-Steingruber IE, 2009, J VASC SURG, V49, P20, DOI 10.1016/j.jvs.2008.08.062; Ghatwary TMH, 2013, CARDIOVASC INTER RAD, V36, P14, DOI 10.1007/s00270-011-0296-6; Kim KM, 2011, J VASC SURG, V54, P316; Leurs U, 2007, J VASC INTERV RADIOL, V18, P491; Ricotta JJ, 2010, J VASC SURG, V52, p91S; Timaran GH, 2004, J VASC SURG, V39, P1157; Weyer JJ, 2000, EUR J VASC ENDOVASC, V20, P177; Wolf YG, 2002, J VASC SURG, V36, P305, DOI 10.1067/mva.2002.126085	23	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1078-5884	1532-2165		EUR J VASC ENDOVASC	Eur. J. Vasc. Endovasc. Surg.	JUL	2015	50	1					53	59		10.1016/j.ejvs.2015.02.021		7	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CM5DB	WOS:000357705900009		
J	Toshino, S; Miyake, H; Ohtsuka, S; Adachi, A; Kondo, Y; Okada, S; Hirabayashi, T; Hiratsuka, T				Toshino, Sho; Miyake, Hiroshi; Ohtsuka, Susumu; Adachi, Aya; Kondo, Yusuke; Okada, Shoma; Hirabayashi, Takeshi; Hiratsuka, Tatsuya			Monodisc strobilation in Japanese giant box jellyfish Morbakka virulenta (Kishinouye, 1910): a strong implication of phylogenetic similarity between Cubozoa and Scyphozoa	EVOLUTION & DEVELOPMENT			English	Article							CNIDARIA CUBOZOA; LIFE-HISTORY; EVOLUTION; CYCLE; POLYP; CUBOMEDUSAE; CARYBDEIDAE; MEDUSOZOA	Both sexes of the Japanese giant box jellyfish Morbakka virulenta were collected from the Seto Inland Sea, western Japan in December 2011, in order to observe the developmental processes from polyps to medusae. The medusa production in M. virulenta is up to now a unique process in cubozoans in that it exhibits a form of monodisc strobilation where the polyp is regenerated before the medusa detaches. This mode of medusa production was previously thought to be exclusive to scyphozoans. The general shape of young medusae resembles that of other cubozoans such as Alatina moseri and Copula sivickisi, but is differentiated from these by the short capitate tentacles and the lack of gastric filaments in the stomach. The unique medusa production of M. virulenta highly implies a phylogenetic similarity between cubozoans and scyphozoans.	[Toshino, Sho; Miyake, Hiroshi] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan; [Toshino, Sho] Kuroshio Biol Res Fdn, Kochi 7880333, Japan; [Ohtsuka, Susumu; Kondo, Yusuke; Okada, Shoma; Hirabayashi, Takeshi] Hiroshima Univ, Grad Sch Biosphere Sci, Setouchi Field Sci Ctr, Hiroshima 7250024, Japan; [Adachi, Aya] Enoshima Aquarium, Fujisawa, Kanagawa 2510035, Japan; [Hiratsuka, Tatsuya] Kamogawa Seaworld, Chiba 2960041, Japan	Toshino, S (reprint author), Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan.	mf09008y@st.kitasato-u.ac.jp			Japan Society of the Promotion of Science [25304031]; Sasakawa Scientific Research Grant from The Japan Science Society; Research Institute of Marine Invertebrates Foundation; Kuroshio Biological Research Foundation	We would like to express our sincere thanks to Sadaharu Iwasaki, Takehara Marine Science Station Setouchi Field Science Center, for corporation culturing specimens. The manuscript was greatly improved by the constructive comments of Ilka Straehler-Pohl and Kisei Tanaka. This research was financially supported by a grant-in-aid of the Japan Society of the Promotion of Science (No. 25304031) (awarded to SO), and grants from Sasakawa Scientific Research Grant from The Japan Science Society (awarded to ST), the Research Institute of Marine Invertebrates Foundation (awarded to ST) and from the Kuroshio Biological Research Foundation (awarded to ST).	Adler L, 2009, MAR BIOL, V156, P1411, DOI 10.1007/s00227-009-1181-6; LOTAN A, 1992, MAR BIOL, V112, P237, DOI 10.1007/BF00702467; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; CALDER DR, 1982, BIOL BULL, V162, P149, DOI 10.2307/1540810; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Bentlage B, 2010, P ROY SOC B-BIOL SCI, V277, P493, DOI 10.1098/rspb.2009.1707; Arneson AC, 1976, COELENTERATE ECOLOGY, P227; Bentlage B, 2012, J NAT HIST, V46, P2595, DOI 10.1080/00222933.2012.717645; Bigelow R. P., 1900, MEM BOST SOC NAT HIS, V5, P193; CALDER DR, 1973, MAR BIOL, V21, P109, DOI 10.1007/BF00354606; Carrette T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084377; CHAPMAN DM, 1978, HELGOLAND WISS MEER, V31, P128, DOI 10.1007/BF02296994; Collins AG, 2011, ZOOTAXA, P53; Cutress C. E., 1973, P ASS ISLAND MARINE, V9, P25; Gershwin LA, 2006, ZOOTAXA, P1; Gohar H. A. F., 1960, PUBL MAR BIOL STA GH, V11, P147; KAKINUMA Y, 1975, Bulletin of the Marine Biological Station of Asamushi, V15, P101; Kayal Ehsan, 2013, BMC Evolutionary Biology, V13, P1; Kishinouye K., 1910, COLL SCI IMPERIAL U, V27, P1; Kramp P.L., 1961, J MAR BIOL ASSOC UK, V40, P1, DOI DOI 10.1017/S0025315400007347; Kubota S., 2012, B BIOGEOGR SOC JPN, V67, P197; Linnaeus C., 1758, SYSTEMA NATURAE REGN, VI, P1, DOI DOI 10.5962/BHL.TITLE.542; Mehnert G., 1984, THESIS RHEINISCHEN F, P161; Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504; Okada S., 2014, B HIROSHIMA U MUSEUM, V6, P1; Straehler-Pohl I., 2009, THESIS U HAMBURG, P1; Straehler-Pohl I, 2011, ZOOTAXA, P1; Straehler-Pohl I, 2011, ZOOTAXA, P36; Straehler-Pohl I., 2001, THESIS U HAMBURG, P108; SUGIURA Y, 1966, EMBRYOLOGIA, V9, P105, DOI 10.1111/j.1440-169X.1966.tb00219.x; Sugiura Y., 1963, Annotationes Zoologicae Japonenses, V36, P194; Toshino Sho, 2014, Plankton & Benthos Research, V9, P32; Toshino Sho, 2013, Plankton & Benthos Research, V8, P1; UCHIDA T, 1978, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V21, P279; WERNER B, 1973, MAR BIOL, V18, P212, DOI 10.1007/BF00367987; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0; Werner B., 1973, Publications Seto Mar Biol Lab, V20, P35; Werner B., 1984, LEHRB SPEZIELLE, VI, P11; Werner B., 1976, VERH DTSCH ZOOL GES, P230; WERNER B, 1975, HELGOLAND WISS MEER, V27, P461, DOI 10.1007/BF01611150; WIDERSTEN B, 1968, Zoologiska Bidrag fran Uppsala, V37, P139; Yamada T., 2010, KUROSHIO BIOSPHERE, V6, P27	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-541X	1525-142X		EVOL DEV	Evol. Dev.	JUL-AUG	2015	17	4					231	239		10.1111/ede.12127		9	Evolutionary Biology; Developmental Biology; Genetics & Heredity	Evolutionary Biology; Developmental Biology; Genetics & Heredity	CM8OZ	WOS:000357962800003		
J	Namera, A; Kawamura, M; Nakamoto, A; Saito, T; Nagao, M				Namera, Akira; Kawamura, Maho; Nakamoto, Akihiro; Saito, Takeshi; Nagao, Masataka			Comprehensive review of the detection methods for synthetic cannabinoids and cathinones	FORENSIC TOXICOLOGY			English	Review						Synthetic cannabinoids; Cannabimimetics; Cathinones; GC-MS-MS; LC-MS-MS; Analytical methods	TANDEM MASS-SPECTROMETRY; DRUG ALPHA-PYRROLIDINOVALEROPHENONE; IN-VITRO METABOLISM; DESIGNER DRUG; HUMAN URINE; LC-MS/MS; ILLEGAL PRODUCTS; LEGAL HIGHS; WHOLE-BLOOD; BATH SALTS	A number of N-alkyl indole or indazole-3-carbonyl analogs, with modified chemical structures, are distributed throughout the world as synthetic cannabinoids. Like synthetic cannabinoids, cathinone analogs are also abused and cause serious problems worldwide. Acute deaths caused by overdoses of these drugs have been reported. Various analytical methods that can cope with the rapid changes in chemical structures are required for routine analysis and screening of these drugs in seized and biological materials for forensic and clinical purposes. Although many chromatographic methods to analyze each drug have been published, there are only a few articles summarizing these analytical methods. This review presents the various colorimetric detections, immunochemical assays, gas chromatographic-mass spectrometric methods, and liquid chromatographic-mass spectrometric methods proposed for the analysis of synthetic cannabinoids and cathinones.	[Namera, Akira; Nagao, Masataka] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Forens Med, Minami Ku, Hiroshima 7348553, Japan; [Kawamura, Maho; Nakamoto, Akihiro] Hiroshima Prefectural Police Headquarters, Forens Sci Lab, Hiroshima, Japan; [Saito, Takeshi] Tokai Univ, Sch Med, Dept Emergency & Crit Care Med, Isehara, Kanagawa 25911, Japan	Namera, A (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Forens Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	namera@hiroshima-u.ac.jp					Adamowicz P, 2013, J ANAL TOXICOL, V37, P308, DOI 10.1093/jat/bkt025; Lusthof KJ, 2011, FORENSIC SCI INT, V206, pE93, DOI 10.1016/j.forsciint.2010.12.014; Chimalakonda KC, 2011, ANAL CHEM, V83, P6381, DOI 10.1021/ac201377m; Logan BK, 2012, J FORENSIC SCI, V57, P1168, DOI 10.1111/j.1556-4029.2012.02207.x; Rust KY, 2012, DRUG TEST ANAL, V4, P402, DOI 10.1002/dta.1338; Namera A, 2013, FORENSIC TOXICOL, V31, P338, DOI 10.1007/s11419-013-0192-7; Seely KA, 2013, FORENSIC SCI INT, V233, P416, DOI 10.1016/j.forsciint.2013.10.002; Hermanns-Clausen M, 2013, ADDICTION, V108, P534, DOI 10.1111/j.1360-0443.2012.04078.x; Bertol E, 2014, FORENSIC SCI INT, V243, P149, DOI 10.1016/j.forsciint.2014.08.002; Wright TH, 2013, J FORENSIC SCI, V58, P1558, DOI 10.1111/1556-4029.12260; ElSohly MA, 2014, LIFE SCI, V97, P78, DOI 10.1016/j.lfs.2013.12.212; Shanks KG, 2012, J ANAL TOXICOL, V36, P145, DOI 10.1093/jat/bks013; Harris DN, 2014, INT J MASS SPECTROM, V368, P23, DOI 10.1016/j.ijms.2014.05.005; Hutter M, 2012, J MASS SPECTROM, V47, P54, DOI 10.1002/jms.2026; Musshoff F, 2014, INT J LEGAL MED, V128, P59, DOI 10.1007/s00414-013-0864-1; Teske J, 2010, J CHROMATOGR B, V878, P2659, DOI 10.1016/j.jchromb.2010.03.016; Favretto D, 2013, J CHROMATOGR A, V1287, P84, DOI 10.1016/j.chroma.2012.12.049; Dresen S, 2011, J MASS SPECTROM, V46, P163, DOI 10.1002/jms.1877; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P243, DOI 10.1007/s11419-014-0230-0; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P93, DOI 10.1007/s11419-012-0171-4; Kesha K, 2013, J FORENSIC SCI, V58, P1654, DOI 10.1111/1556-4029.12202; Ibanez M, 2013, J MASS SPECTROM, V48, P685, DOI 10.1002/jms.3217; Kneisel S, 2012, J MASS SPECTROM, V47, P825, DOI 10.1002/jms.3020; Meyer MR, 2010, J MASS SPECTROM, V45, P1426, DOI 10.1002/jms.1859; Concheiro M, 2013, ANAL BIOANAL CHEM, V405, P9437, DOI 10.1007/s00216-013-7386-z; Hutter M, 2012, J CHROMATOGR B, V903, P95, DOI 10.1016/j.jchromb.2012.07.002; Uralets V, 2014, J ANAL TOXICOL, V38, P233, DOI 10.1093/jat/bku021; Wohlfarth A, 2013, ANAL CHEM, V85, P3730, DOI 10.1021/ac3037365; Yeakel JK, 2013, J ANAL TOXICOL, V37, P547, DOI 10.1093/jat/bkt065; Yanes EG, 2012, J CHROMATOGR B, V909, P42, DOI 10.1016/j.jchromb.2012.10.013; Adamowicz P, 2013, FORENSIC SCI INT, V233, P320, DOI 10.1016/j.forsciint.2013.10.005; Sauer C, 2009, J MASS SPECTROM, V44, P952, DOI 10.1002/jms.1571; Torrance H, 2010, FORENSIC SCI INT, V202, pE62, DOI 10.1016/j.forsciint.2010.07.014; Swortwood MJ, 2013, ANAL BIOANAL CHEM, V405, P1383, DOI 10.1007/s00216-012-6548-8; Maxwell JC, 2014, DRUG ALCOHOL DEPEN, V134, P71, DOI 10.1016/j.drugalcdep.2013.09.011; Moran CL, 2011, ANAL CHEM, V83, P4228, DOI 10.1021/ac2005636; Maskell PD, 2011, J ANAL TOXICOL, V35, P188; Kikura-Hanajiri R, 2013, FORENSIC TOXICOL, V31, P44, DOI 10.1007/s11419-012-0165-2; Uchiyama N, 2012, FORENSIC TOXICOL, V30, P114, DOI 10.1007/s11419-012-0136-7; Fornal E, 2013, J PHARMACEUT BIOMED, V81-82, P13, DOI 10.1016/j.jpba.2013.03.016; Patton AL, 2013, J FORENSIC SCI, V58, P1676, DOI 10.1111/1556-4029.12216; Saito T, 2013, FORENSIC TOXICOL, V31, P328, DOI 10.1007/s11419-013-0183-8; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; Wyman JF, 2013, J ANAL TOXICOL, V37, P182, DOI 10.1093/jat/bkt001; Springer D, 2003, J CHROMATOGR B, V796, P253, DOI 10.1016/j.jchromb.2003.07.008; Sorensen LK, 2011, J CHROMATOGR B, V879, P727, DOI 10.1016/j.jchromb.2011.02.010; Pearson JM, 2012, J ANAL TOXICOL, V36, P444, DOI 10.1093/jat/bks043; Zuba D, 2012, TRAC-TREND ANAL CHEM, V32, P15, DOI 10.1016/j.trac.2011.09.009; Cosbey SH, 2013, J ANAL TOXICOL, V37, P74, DOI 10.1093/jat/bks094; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P225, DOI 10.1007/s11419-014-0227-8; Westphal F, 2012, FORENSIC SCI INT, V223, P97, DOI 10.1016/j.forsciint.2012.08.011; Hudson S, 2011, DRUG TEST ANAL, V3, P466, DOI 10.1002/dta.268; de Jager AD, 2012, J CHROMATOGR B, V897, P22, DOI 10.1016/j.jchromb.2012.04.002; Bijlsma L, 2011, J MASS SPECTROM, V46, P865, DOI 10.1002/jms.1963; Spiller HA, 2011, CLIN TOXICOL, V49, P499, DOI 10.3109/15563650.2011.590812; Marinetti LJ, 2013, J ANAL TOXICOL, V37, P135, DOI 10.1093/jat/bks136; Auwarter V, 2009, J MASS SPECTROM, V44, P832, DOI 10.1002/jms.1558; Hermanns-Clausen M, 2013, DRUG TEST ANAL, V5, P790, DOI 10.1002/dta.1483; Kriikku P, 2011, FORENSIC SCI INT, V210, P195, DOI 10.1016/j.forsciint.2011.03.015; Brandt SD, 2010, DRUG TEST ANAL, V2, P377, DOI 10.1002/dta.155; Barratt MJ, 2013, DRUG ALCOHOL REV, V32, P141, DOI 10.1111/j.1465-3362.2012.00519.x; Brandt SD, 2011, DRUG TEST ANAL, V3, P569, DOI 10.1002/dta.204; Kneisel S, 2013, DRUG TEST ANAL, V5, P657, DOI 10.1002/dta.1429; Scheidweiler KB, 2014, J CHROMATOGR A, V1327, P105, DOI 10.1016/j.chroma.2013.12.067; Saito T, 2013, FORENSIC TOXICOL, V31, P333, DOI 10.1007/s11419-013-0190-9; Grigoryev A, 2013, J ANAL TOXICOL, V37, P265, DOI 10.1093/jat/bkt028; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P223, DOI 10.1007/s11419-013-0182-9; Anizan S, 2014, ANAL CHIM ACTA, V827, P54, DOI 10.1016/j.aca.2014.04.015; Arntson A, 2013, J ANAL TOXICOL, V37, P284, DOI 10.1093/jat/bkt024; Adamowicz P, 2013, J ANAL TOXICOL, V37, P37, DOI 10.1093/jat/bks085; DeRuiter J, 2014, ANAL CHEM, V86, P3801, DOI 10.1021/ac500316x; Tyrkko E, 2013, ANAL BIOANAL CHEM, V405, P6697, DOI 10.1007/s00216-013-7137-1; Behonick G, 2014, J ANAL TOXICOL, V38, P559, DOI 10.1093/jat/bku048; Caudevilla-Galligo F, 2013, HUM PSYCHOPHARM CLIN, V28, P341, DOI 10.1002/hup.2296; Cawrse BM, 2012, J ANAL TOXICOL, V36, P434, DOI 10.1093/jat/bks046; Choi H, 2013, ANAL BIOANAL CHEM, V405, P3937, DOI 10.1007/s00216-012-6560-z; Chung H, 2014, FORENSIC TOXICOL, V32, P82, DOI 10.1007/s11419-013-0213-6; Cox AO, 2012, J ANAL TOXICOL, V36, P293, DOI 10.1093/jat/bks025; DalCason TA, 1997, FORENSIC SCI INT, V87, P9, DOI 10.1016/S0379-0738(97)02133-6; Ellefsen KN, 2014, DRUG TEST ANAL, V6, P728, DOI 10.1002/dta.1633; Ernst L, 2012, FORENSIC SCI INT, V222, P216, DOI 10.1016/j.forsciint.2012.05.027; Gil D, 2013, FORENSIC SCI INT, V228, pE11, DOI 10.1016/j.forsciint.2013.03.011; Isaacs RCA, 2014, FORENSIC SCI INT, V242, P135, DOI 10.1016/j.forsciint.2014.06.027; Jankovics P, 2011, FORENSIC SCI INT, V210, P213, DOI 10.1016/j.forsciint.2011.03.019; Johnson RD, 2013, J ANAL TOXICOL, V37, P51, DOI 10.1093/jat/bks138; Kacinko SL, 2011, J ANAL TOXICOL, V35, P386; Kneisel S, 2013, ANAL BIOANAL CHEM, V405, P4691, DOI 10.1007/s00216-013-6887-0; Kneisel S, 2012, J MASS SPECTROM, V47, P195, DOI 10.1002/jms.2059; Kovacs Katalin, 2012, Orvosi Hetilap, V153, P271, DOI 10.1556/OH.2012.29310; Matsuta S, 2014, JPN J FORENSIC SCI T, V19, P77; Mazzarino M, 2014, ANAL CHIM ACTA, V837, P70, DOI 10.1016/j.aca.2014.06.003; Murray Brittany L, 2012, J Med Toxicol, V8, P69, DOI 10.1007/s13181-011-0196-9; Namera A, 2014, FORENSIC TOXICOL, V32, P68, DOI 10.1007/s11419-013-0203-8; Ojanpera IA, 2011, THER DRUG MONIT, V33, P257, DOI 10.1097/FTD.0b013e318208b693; Penders TM, 2012, AM J DRUG ALCOHOL AB, V38, P616, DOI 10.3109/00952990.2012.694535; Presley B C, 2013, Forensic Sci Rev, V25, P27; Rojek S, 2012, FORENSIC SCI INT, V222, pE1, DOI 10.1016/j.forsciint.2012.04.034; Sekula K, 2012, J MASS SPECTROM, V47, P632, DOI 10.1002/jms.3004; Shevyrin V, 2014, FORENSIC SCI INT, V242, P72, DOI 10.1016/j.forsciint.2014.06.022; Shima N, 2013, FORENSIC TOXICOL, V31, P101, DOI 10.1007/s11419-012-0172-3; Shima N, 2014, FORENSIC TOXICOL, V32, P59, DOI 10.1007/s11419-013-0202-9; Strano-Rossi S, 2010, RAPID COMMUN MASS SP, V24, P2706, DOI 10.1002/rcm.4692; Swortwood MJ, 2014, DRUG TEST ANAL, V6, P716, DOI 10.1002/dta.1489; Tsujikawa K, 2014, FORENSIC TOXICOL, V32, P201, DOI 10.1007/s11419-013-0221-6; Uchiyama N, 2008, YAKUGAKU ZASSHI, V128, P981, DOI 10.1248/yakushi.128.981; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P105, DOI 10.1007/s11419-013-0217-2; Usui K, 2014, LEGAL MED-TOKYO, V16, P222, DOI 10.1016/j.legalmed.2014.03.008; Wood DM, 2012, PROG NEURO-PSYCHOPH, V39, P227, DOI 10.1016/j.pnpbp.2012.04.020; Wurita A, 2014, LEGAL MED-TOKYO, V16, P241, DOI 10.1016/j.legalmed.2014.05.001; Zaitsu K, 2011, JPN J FORENSIC SCI T, V16, P73; Zuba D, 2013, FORENSIC SCI INT, V227, P15, DOI 10.1016/j.forsciint.2012.08.034	111	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					175	194		10.1007/s11419-015-0270-0		20	Toxicology	Toxicology	CM9UU	WOS:000358055400001		
J	Wurita, A; Hasegawa, K; Minakata, K; Gonmori, K; Nozawa, H; Yamagishi, I; Watanabe, K; Suzuki, O				Wurita, Amin; Hasegawa, Koutaro; Minakata, Kayoko; Gonmori, Kunio; Nozawa, Hideki; Yamagishi, Itaru; Watanabe, Kanako; Suzuki, Osamu			Identification and quantitation of 5-fluoro-ADB-PINACA and MAB-CHMINACA in dubious herbal products	FORENSIC TOXICOLOGY			English	Article						5-Fluoro-ADB-PINACA; 5-Fluoro-AB-PINACA; MAB-CHMINACA; AB-CHMINACA; Herbal products; Synthetic cannabinoid; LC-MS-MS	CHROMATOGRAPHY-MASS SPECTROMETRY; SYNTHETIC CANNABINOIDS; PROPYLENE-GLYCOL; ILLEGAL PRODUCTS; ETHYLENE-GLYCOL; SOLID TISSUES; POSTMORTEM DISTRIBUTION; APPRECIABLE AMOUNTS; DIETHYLENE GLYCOL; HEALTHY-SUBJECTS	Police officials brought three different packages of herbal blends, with brand names "AL 37", "AP 31", and "GM sapphire", to our laboratory for drug testing. Using our in-house high-resolution mass spectrometric analysis, we were able to estimate the presence of 5-fluoro-ADB-PINACA and MAB-CHMINACA in them without their reference standards. After obtaining the reference standards, we compared the mass spectra of the extracts of the herbal blends with those of the reference standards using both gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry. The mass spectra of the herbal blend extracts coincided with those of the reference standards, disclosing the presence of 5-fluoro-ADB-PINACA in "AL 37" and "AP 31", and MAB-CHMINACA in "GM sapphire". We then quantitated the concentrations of both compounds in the herbal blends using the standard addition method. The concentrations of 5-fluoro-ADB-PINACA were 19.4 +/- A 0.55 and 19.0 +/- A 0.47 mg/g (mean +/- A standard deviation of triplicate determinations) for herbal product brands "AL 37" and "AP 31", respectively, and that of MAB-CHMINACA was 133 +/- A 4.5 mg/g for the "GM sapphire" herbal product. To our knowledge, this is the first study to demonstrate the identification and quantitation of the newest synthetic cannabinoids 5-fluoro-ADB-PINACA and MAB-CHMINACA in herbal blend products.	[Wurita, Amin; Hasegawa, Koutaro; Minakata, Kayoko; Gonmori, Kunio; Nozawa, Hideki; Yamagishi, Itaru; Watanabe, Kanako; Suzuki, Osamu] Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hasegawa, K (reprint author), Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	07484771@hama-med.ac.jp					Hasegawa K, 2014, FORENSIC TOXICOL, V32, P243, DOI 10.1007/s11419-014-0230-0; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P93, DOI 10.1007/s11419-012-0171-4; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; Wurita A, 2013, FORENSIC TOXICOL, V31, P272, DOI 10.1007/s11419-013-0188-3; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P225, DOI 10.1007/s11419-014-0227-8; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P223, DOI 10.1007/s11419-013-0182-9; BONILLA E, 1978, CLIN CHEM, V24, P471; Hasegawa K, 2015, FORENSIC TOXICOL, V33, P112, DOI 10.1007/s11419-014-0259-0; Minakata K, 2014, FORENSIC TOXICOL, V32, P169, DOI 10.1007/s11419-013-0212-7; Tsujikawa K, 2014, FORENSIC TOXICOL, V32, P201, DOI 10.1007/s11419-013-0221-6; Wurita A, 2014, FORENSIC TOXICOL, V32, P331, DOI 10.1007/s11419-014-0240-y; Wurita A, 2014, LEGAL MED-TOKYO, V16, P241, DOI 10.1016/j.legalmed.2014.05.001; Wurita A, 2014, FORENSIC TOXICOL, V32, P39, DOI 10.1007/s11419-013-0206-5; Wurita A, 2014, FORENSIC TOXICOL, V32, P162, DOI 10.1007/s11419-013-0210-9	14	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					213	220		10.1007/s11419-015-0264-y		8	Toxicology	Toxicology	CM9UU	WOS:000358055400004		
J	Uchiyama, N; Shimokawa, Y; Kikura-Hanajiri, R; Demizu, Y; Goda, Y; Hakamatsuka, T				Uchiyama, Nahoko; Shimokawa, Yoshihiko; Kikura-Hanajiri, Ruri; Demizu, Yosuke; Goda, Yukihiro; Hakamatsuka, Takashi			A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N-OH-EDMA, and a cathinone derivative dimethoxy-alpha-PHP, newly identified in illegal products	FORENSIC TOXICOLOGY			English	Article						2H-indazole isomer; Synthetic cannabinoid; FDU-NNEI; N-OH-EDMA; Dimethoxy-alpha-PHP; Cathinone derivative	DESIGNER DRUGS; 3,4-METHYLENEDIOXYAMPHETAMINE; PREVALENCE	Six new psychoactive substances were identified together with two other substances (compounds 1-8) in illegal products by our ongoing survey in Japan between January and July 2014. A new synthetic cannabinoid, FDU-NNEI [1-(4-fluorobenzyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide, 2], was detected with the newly distributed synthetic cannabinoid FDU-PB-22 (1). Two 2H-indazole isomers of synthetic cannabinoids, AB-CHMINACA 2H-indazole analog (3) and NNEI 2H-indazole analog (4), were newly identified with 1H-indazoles [AB-CHMINACA and NNEI indazole analog (MN-18)]. In addition, 2-methylpropyl N-(naphthalen-1-yl) carbamate (5) and isobutyl 1-pentyl-1H-indazole-3-carboxylate (6) were detected in illegal products. Compound 6 is considered to be a by-product of the preparation of NNEI indazole analog from compound 5 and 1-pentyl-1H-indazole. A phenethylamine derivative, N-OH-EDMA [N-hydroxy-3,4-ethylenedioxy-N-methylamphetamine, 7], and a cathinone derivative, dimethoxy-alpha-PHP (dimethoxy-alpha-pyrrolidinohexanophenone, 8), were newly identified in illegal products. Among them, compounds 1 and 8 have been controlled as designated substances (Shitei-Yakubutsu) under the Pharmaceutical Affairs Law in Japan since August and November 2014, respectively.	[Uchiyama, Nahoko; Shimokawa, Yoshihiko; Kikura-Hanajiri, Ruri; Demizu, Yosuke; Goda, Yukihiro; Hakamatsuka, Takashi] Natl Inst Hlth Sci, Div Pharmacognosy Phytochem & Narcot, Setagaya Ku, Tokyo 1588501, Japan	Uchiyama, N (reprint author), Natl Inst Hlth Sci, Div Pharmacognosy Phytochem & Narcot, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	nuchiyama@nihs.go.jp			Ministry of Health, Labour, and Welfare, Japan	A portion of this work was supported by a Health and Labor Sciences Research Grant from the Ministry of Health, Labour, and Welfare, Japan.	Zuba D, 2013, FORENSIC TOXICOL, V31, P21, DOI 10.1007/s11419-012-0159-0; Uchiyama N, 2013, FORENSIC SCI INT, V227, P21, DOI 10.1016/j.forsciint.2012.08.047; Kikura-Hanajiri R, 2013, FORENSIC TOXICOL, V31, P44, DOI 10.1007/s11419-012-0165-2; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P223, DOI 10.1007/s11419-013-0182-9; Chung H, 2014, FORENSIC TOXICOL, V32, P82, DOI 10.1007/s11419-013-0213-6; Elguero J., 2011, MODERN HETEROCYCLIC, V2, P635; EMCDDA-European Monitoring Centre for Drugs and Drug Addiction, 2014, EUR DRUG REP 2014 TR; Kikura-Hanajiri R, 2014, DRUG TEST ANAL, V6, P832, DOI 10.1002/dta.1584; MCKENNA DJ, 1991, PHARMACOL BIOCHEM BE, V38, P505, DOI 10.1016/0091-3057(91)90005-M; NOGGLE FT, 1988, J CHROMATOGR SCI, V26, P410; Uchiyama N, 2014, FORENSIC SCI INT, V243, P1, DOI 10.1016/j.forsciint.2014.03.013; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P9, DOI 10.1007/s11419-013-0194-5; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P105, DOI 10.1007/s11419-013-0217-2; UNODC, 2014, 2014 GLOB SYNTH DRUG	15	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					244	259		10.1007/s11419-015-0268-7		16	Toxicology	Toxicology	CM9UU	WOS:000358055400007		
J	Shima, N; Kakehashi, H; Matsuta, S; Kamata, H; Nakano, S; Sasaki, K; Kamata, T; Nishioka, H; Zaitsu, K; Sato, T; Miki, A; Katagi, M; Tsuchihashi, H				Shima, Noriaki; Kakehashi, Hidenao; Matsuta, Shuntaro; Kamata, Hiroe; Nakano, Shihoko; Sasaki, Keiko; Kamata, Tooru; Nishioka, Hiroshi; Zaitsu, Kei; Sato, Takako; Miki, Akihiro; Katagi, Munehiro; Tsuchihashi, Hitoshi			Urinary excretion and metabolism of the alpha-pyrrolidinophenone designer drug 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one (PV9) in humans	FORENSIC TOXICOLOGY			English	Article						PV9; Cathinone derivative; Metabolism; Urine; alpha-POP; LC-MS-MS	IN-VITRO METABOLISM; FLIGHT MASS-SPECTROMETRY; BATH SALTS; 3,4-METHYLENEDIOXYPYROVALERONE MDPV; POSTMORTEM DISTRIBUTION; SYNTHETIC CANNABINOIDS; CATHINONE DERIVATIVES; SOLID TISSUES; GC-MS; IDENTIFICATION	1-Phenyl-2-(pyrrolidin-1-yl)octan-1-one (PV9) and 16 metabolites, including diastereomers and conjugates, were identified or tentatively detected in human urine by gas chromatography-mass spectrometry and liquid chromatography-high-resolution tandem mass spectrometry. These urinary metabolites indicated that the metabolic pathways of PV9 include: (1) the reduction of ketone groups to their corresponding alcohols; (2) oxidation of the pyrrolidine ring to the corresponding pyrrolidone; (3) aliphatic oxidation of the terminal carbon atom to the corresponding carboxylate form, possibly through an alcohol intermediate (not detected); and (4) hydroxylation at the penultimate carbon atom to the corresponding alcohols followed by further oxidation to ketones, and combinations of these steps. In addition, results from the quantitative analyses of five phase-I metabolites using newly synthesized authentic standards suggested that the main metabolic pathway includes the aliphatic oxidation of terminal and/or penultimate carbons. Human metabolism of PV9 differed significantly from those of alpha-pyrrolidinovalerophenone and alpha-pyrrolidinobutiophenone, suggesting that the main metabolic pathways of alpha-pyrrolidinophenones significantly change depending on the alkyl chain length of the parent molecule.	[Shima, Noriaki; Kakehashi, Hidenao; Matsuta, Shuntaro; Kamata, Hiroe; Nakano, Shihoko; Sasaki, Keiko; Kamata, Tooru; Nishioka, Hiroshi; Miki, Akihiro; Katagi, Munehiro] Osaka Prefectural Police Headquarters, Forens Sci Lab, Chuo Ku, Osaka 5410053, Japan; [Zaitsu, Kei] Nagoya Univ, Grad Sch Med, Dept Legal Med & Bioeth, Nagoya, Aichi 4648601, Japan; [Sato, Takako; Tsuchihashi, Hitoshi] Osaka Med Coll, Dept Legal Med, Div Prevent & Social Med, Takatsuki, Osaka 569, Japan	Shima, N (reprint author), Osaka Prefectural Police Headquarters, Forens Sci Lab, Chuo Ku, 1-3-18 Hommachi, Osaka 5410053, Japan.	shima6499@hotmail.co.jp					Kaizaki A, 2014, J TOXICOL SCI, V39, P1; Namera A, 2013, FORENSIC TOXICOL, V31, P338, DOI 10.1007/s11419-013-0192-7; Matsuta S, 2015, FORENSIC SCI INT, V249, P181, DOI 10.1016/j.forsciint.2015.02.004; Meyer MR, 2010, ANAL BIOANAL CHEM, V397, P1225, DOI 10.1007/s00216-010-3636-5; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P243, DOI 10.1007/s11419-014-0230-0; Meyer MR, 2010, J MASS SPECTROM, V45, P1426, DOI 10.1002/jms.1859; Valente MJ, 2014, ARCH TOXICOL, V88, P15, DOI 10.1007/s00204-013-1163-9; Zaitsu K, 2009, FORENSIC SCI INT, V188, P131, DOI 10.1016/j.forsciint.2009.04.001; Saito T, 2013, FORENSIC TOXICOL, V31, P328, DOI 10.1007/s11419-013-0183-8; Baumann MH, 2013, NEUROPSYCHOPHARMACOL, V38, P552, DOI 10.1038/npp.2012.204; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; Shin HS, 1996, J ANAL TOXICOL, V20, P568; Wyman JF, 2013, J ANAL TOXICOL, V37, P182, DOI 10.1093/jat/bkt001; Springer D, 2003, J CHROMATOGR B, V796, P253, DOI 10.1016/j.jchromb.2003.07.008; Simmler LD, 2013, BRIT J PHARMACOL, V168, P458, DOI 10.1111/j.1476-5381.2012.02145.x; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P225, DOI 10.1007/s11419-014-0227-8; Tyrkko E, 2013, ANAL BIOANAL CHEM, V405, P6697, DOI 10.1007/s00216-013-7137-1; Cottencin O, 2014, CURR PHARM DESIGN, V20, P4106; Hasegawa K, 2015, FORENSIC TOXICOL, V33, P141, DOI 10.1007/s11419-014-0262-5; Iversen L, 2014, NEUROPHARMACOLOGY, V87, P59, DOI 10.1016/j.neuropharm.2014.01.015; Jane MP, 2012, J MED TOXICOL, V8, P33; Kamata HT, 2006, XENOBIOTICA, V36, P709, DOI 10.1080/00498250600780191; Marusich JA, 2014, NEUROPHARMACOLOGY, V87, P206, DOI 10.1016/j.neuropharm.2014.02.016; Meyer MR, 2014, DRUG TEST ANAL, V6, P746, DOI 10.1002/dta.1559; Minakata K, 2015, FORENSIC TOXICOL, V33, P148, DOI 10.1007/s11419-014-0248-3; Namera A, 2014, FORENSIC TOXICOL, V32, P68, DOI 10.1007/s11419-013-0203-8; Paillet-Loilier Magalie, 2014, Subst Abuse Rehabil, V5, P37, DOI 10.2147/SAR.S37257; Sauer C, 2011, FORENSIC SCI INT, V208, P20; Sauer S, 2009, J MASS SPECTROM, V44, P952; Shima N, 2013, FORENSIC TOXICOL, V31, P101, DOI 10.1007/s11419-012-0172-3; Shima N, 2014, FORENSIC TOXICOL, V32, P59, DOI 10.1007/s11419-013-0202-9; Strano-Rossi S, 2010, RAPID COMMUN MASS SP, V24, P2706, DOI 10.1002/rcm.4692; Westphal F, 2007, FORENSIC SCI INT, V169, P32, DOI 10.1016/j.forsciint.2006.07.024; Zaitsu K, 2014, FORENSIC TOXICOL, V32, P1, DOI 10.1007/s11419-013-0218-1	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					279	294		10.1007/s11419-015-0274-9		16	Toxicology	Toxicology	CM9UU	WOS:000358055400009		
J	Asada, A; Doi, T; Takeda, A; Tagami, T; Kawaguchi, M; Satsuki, Y; Sawabe, Y				Asada, Akiko; Doi, Takahiro; Takeda, Akihiro; Tagami, Takaomi; Kawaguchi, Masami; Satsuki, Yuka; Sawabe, Yoshiyuki			Identification of analogs of LY2183240 and the LY2183240 2'-isomer in herbal products	FORENSIC TOXICOLOGY			English	Article						LY2183240; LY2183240 2 '-isomer; New analogs; Herbal product; Decomposition product; Designer drug	ILLEGAL PRODUCTS; SYNTHETIC CANNABINOIDS; DESIGNER DRUGS; DERIVATIVES; INHIBITORS	LY2183240 and the LY2183240 2'-isomer inhibit cellular reuptake and enzymatic hydrolysis of endocannabinoids. These compounds were detected in herbal blend products as designer drugs. Simultaneously, two analogs of LY2183240 and LY2183240 2'-isomer were also detected; (A) 5-[(biphenyl-4-yl)methyl]-1H-tetrazole and (B) 2-(N,N-dimethylamino)-5-[(biphenyl-4-yl)methyl]-1,3,4-oxadiazole. The structure of compound B was identified by nuclear magnetic resonance spectroscopy and X-ray crystallography. To reveal the mechanism of production of these compounds in herbal products, we analyzed the reference standard solution of LY2183240 or the LY2183240 2'-isomer after treatment under various conditions. Compound A was easily formed as a decomposition product of both LY2183240 and the LY2183240 2'-isomer under hydrolysis conditions. Compound B was only detected from the solution of the LY2183240 2'-isomer. These findings suggest that compound B was produced by elimination of N-2 from the tetrazole structure; LY2183240 and the LY2183240 2'-isomer may be decomposed at the step of producing herbal blend products, extraction procedure, and/or instrumental analysis. This is the first report to reveal the presence of two analogs of LY2183240 or the LY2183240 2'-isomer in herbal blend products.	[Asada, Akiko; Doi, Takahiro; Takeda, Akihiro; Tagami, Takaomi; Kawaguchi, Masami; Satsuki, Yuka; Sawabe, Yoshiyuki] Osaka Prefectural Inst Publ Hlth, Higashinari Ku, Osaka 5370025, Japan	Asada, A (reprint author), Osaka Prefectural Inst Publ Hlth, Higashinari Ku, 1-3-69 Nakamichi, Osaka 5370025, Japan.	asada@iph.pref.osaka.jp			JSPS KAKENHI [25860475]	The present study received the support and encouragement of Dr. Takashi Sato (Agilent Technologies Japan, Ltd.). This study was partly supported by JSPS KAKENHI Grant No. 25860475.	Holtfrerich A, 2013, EUR J MED CHEM, V63, P64, DOI 10.1016/j.ejmech.2013.01.050; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Ortar G, 2008, EUR J MED CHEM, V43, P62, DOI 10.1016/j.ejmech.2007.02.023; Moore SA, 2005, P NATL ACAD SCI USA, V102, P17852, DOI 10.1073/pnas.0507470102; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P223, DOI 10.1007/s11419-013-0182-9; BROWN HC, 1967, J ORG CHEM, V32, P1871, DOI 10.1021/jo01281a038; Furmeier S, 2003, EUR J ORG CHEM, P885; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Uchiyama N, 2014, FORENSIC SCI INT, V243, P1, DOI 10.1016/j.forsciint.2014.03.013; Uemura N, 2014, FORENSIC TOXICOL, V32, P45, DOI 10.1007/s11419-013-0201-x	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					311	320		10.1007/s11419-015-0278-5		10	Toxicology	Toxicology	CM9UU	WOS:000358055400011		
J	Negishi, S; Nakazono, Y; Iwata, YT; Kanamori, T; Tsujikawa, K; Kuwayama, K; Yamamuro, T; Miyamoto, K; Yamashita, T; Kasuya, F; Inoue, H				Negishi, Shoko; Nakazono, Yukiko; Iwata, Yuko T.; Kanamori, Tatsuyuki; Tsujikawa, Kenji; Kuwayama, Kenji; Yamamuro, Tadashi; Miyamoto, Kazuna; Yamashita, Takuya; Kasuya, Fumiyo; Inoue, Hiroyuki			Differentiation of regioisomeric chloroamphetamine analogs using gas chromatography-chemical ionization-tandem mass spectrometry	FORENSIC TOXICOLOGY			English	Article						Chloroamphetamine analogs; Regioisomeric differentiation; GC-MS-MS; Chemical ionization	GC-MS; P-CHLOROAMPHETAMINE; DESIGNER DRUGS; SEROTONIN; DISCRIMINATION; DERIVATIVES; BRAIN; 1-(CHLOROPHENYL)-2-AMINOPROPANES; IDENTIFICATION; BEHAVIOR	In recent years, a large number of clandestinely synthesized new psychoactive substances with high structural variety have been detected in forensic samples. Analytical differentiation of regioisomers is a significant issue in forensic drug analysis, because, in most cases, legal controls are placed on only one or two of the conceivable isomers. In this study, gas chromatography-tandem mass spectrometry (GC-MS-MS) was used to differentiate the regioisomers of chloroamphetamine analogs (chloroamphetamines and chloromethamphetamines) synthesized in the authors' laboratories. Free bases, trifluoroacetyl derivatives, and trimethylsilyl derivatives were subjected to GC-MS-MS using DB-1ms, DB-5ms, and DB-17ms capillary columns, respectively. The regioisomers of chloroamphetamine analogs in all forms were well separated on the DB-5ms column. The electron ionization mass spectra of the chloroamphetamine analogs gave very little structural information for differentiation among these analogs, even after trifluoroacetyl and trimethylsilyl derivatization of the analytes. Characteristic product ions of the 2-positional isomers were observed by electron ionization-MS-MS. In contrast, chemical ionization-MS-MS of the free bases provided more structural information about chloride position on the aromatic ring when [M+H-HCl](+) was selected as a precursor ion. The results suggest that a combination of chromatographic analysis and MS-MS supports differentiation for regioisomers of chloroamphetamine analogs.	[Negishi, Shoko; Nakazono, Yukiko; Iwata, Yuko T.; Kanamori, Tatsuyuki; Tsujikawa, Kenji; Kuwayama, Kenji; Yamamuro, Tadashi; Inoue, Hiroyuki] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan; [Negishi, Shoko; Nakazono, Yukiko; Miyamoto, Kazuna] Technopro R&D Co, Chuo Ku, Chiba 2600045, Japan; [Miyamoto, Kazuna; Yamashita, Takuya; Kasuya, Fumiyo] Kobegakuin Univ, Fac Pharmaceut Sci, Biochem Toxicol Lab, Chuo Ku, Kobe, Hyogo 6508586, Japan	Inoue, H (reprint author), Natl Res Inst Police Sci, 6-3-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	inoue@nrips.go.jp			R&D Program for Implementation of Anti-Crime and Anti-Terrorism Technologies for a Safe and Secure Society; Funds for Integrated Promotion of Social System Reform and Research and Development by Japan's Ministry of Education, Culture, Sports, Science and Technology	This work was supported in part by the R&D Program for Implementation of Anti-Crime and Anti-Terrorism Technologies for a Safe and Secure Society and by Funds for Integrated Promotion of Social System Reform and Research and Development (provided by Japan's Ministry of Education, Culture, Sports, Science and Technology).	HARVEY JA, 1975, SCIENCE, V187, P841, DOI 10.1126/science.47181; Zaitsu K, 2008, FORENSIC TOXICOL, V26, P45, DOI 10.1007/s11419-008-0050-1; Zaitsu K, 2013, FORENSIC TOXICOL, V31, P292, DOI 10.1007/s11419-013-0193-6; Kusano M, 2015, J MASS SPECTROM, V50, P586, DOI 10.1002/jms.3565; Nakazono Y, 2013, FORENSIC TOXICOL, V31, P241, DOI 10.1007/s11419-013-0184-7; KOTIAHO T, 1993, J AM CHEM SOC, V115, P1004, DOI 10.1021/ja00056a027; Belal T, 2008, FORENSIC SCI INT, V178, P61, DOI 10.1016/j.forsciint.2008.02.002; Borth S, 2000, FORENSIC SCI INT, V114, P139, DOI 10.1016/S0379-0738(00)00296-6; Clark CR, 1996, J CHROMATOGR SCI, V34, P34; FULLER RW, 1992, NEUROCHEM RES, V17, P449, DOI 10.1007/BF00969891; FULLER RW, 1975, NEUROPHARMACOLOGY, V14, P739, DOI 10.1016/0028-3908(75)90099-4; INCB, 2013, INCB ANN REP; Lee SF, 2013, J FOOD DRUG ANAL, V21, P390, DOI 10.1016/j.jfda.2013.09.003; Lin TC, 2011, J ANAL TOXICOL, V35, P205; MILLER F P, 1970, Biochemical Pharmacology, V19, P435, DOI 10.1016/0006-2952(70)90199-1; Nakazono Y, 2014, FORENSIC TOXICOL, V32, P154, DOI 10.1007/s11419-013-0208-3; Negishi S, 2014, JPN J FORENSIC SCI T, V19, P111; OGREN SO, 1977, ACTA PHARMACOL TOX, V41, P353; OWEN JE, 1963, J PHARM SCI, V52, P679, DOI 10.1002/jps.2600520716; OWEN JE, 1963, J PHARM SCI, V52, P684, DOI 10.1002/jps.2600520717; Pirisi MA, 2013, FORENSIC TOXICOL, V31, P197, DOI 10.1007/s11419-012-0177-y; PLETSCHER A., 1963, LIFE SCI, V11, P828; SANDERSB.E, 1970, J PHARMACOL EXP THER, V175, P419; TRULSON ME, 1976, EUR J PHARMACOL, V36, P149, DOI 10.1016/0014-2999(76)90266-1; Westphal F, 2010, FORENSIC SCI INT, V194, P53, DOI 10.1016/j.forsciint.2009.10.007; Zaitsu K, 2008, J MASS SPECTROM, V43, P528, DOI 10.1002/jms.1347	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					338	347		10.1007/s11419-015-0280-y		10	Toxicology	Toxicology	CM9UU	WOS:000358055400013		
J	Shintani-Ishida, K; Nakamura, M; Tojo, M; Idota, N; Ikegaya, H				Shintani-Ishida, Kaori; Nakamura, Mami; Tojo, Misa; Idota, Nozomi; Ikegaya, Hiroshi			Identification and quantification of 4'-methoxy-alpha-pyrrolidinobutiophenone (4-MeOPBP) in human plasma and urine using LC-TOF-MS in an autopsy case	FORENSIC TOXICOLOGY			English	Article						4 '-Methoxy-alpha-pyrrolidinobutiophenone; 4-MeOPBP; Synthetic cathinone derivative; Liquid chromatography-time-of-flight mass spectrometry; LC-TOF-MS; Human plasma	ALPHA-PYRROLIDINOVALEROPHENONE; MASS-SPECTROMETRY; BLOOD; PYRROLIDINOBUTIOPHENONE; CATHINONES; TOXICOLOGY; SPECIMENS; DRUGS	We encountered an autopsy case of a 35-year-old man who drowned in a bathtub. Nine opened packages of designer drugs containing herbal blends, powders, or liquid were found at the scene, implying abuse. The plasma and urine samples of the deceased were analyzed using liquid chromatography-time-of-flight-mass spectrometry (LC-TOF-MS) with MSE. A new synthetic cathinone, 4'-methoxy-alpha-pyrrolidinobutiophenone (4-MeOPBP), emerged as a suspected component via elemental composition and molecular structure analyses with acquisition of full spectra of the precursor and product ions by MSE mode. The component was finally identified by comparing the mass spectra obtained from the deceased's samples with those of the reference standard 4-MeOPBP using LC-TOF-MS and gas chromatography-mass spectrometry. Furthermore, 4-MeOPBP was the main component of an opened package labeled "Silver Snow". The concentrations of 4-MeOPBP in plasma and urine samples were as high as 9.5 and 12 mu g/ml, respectively. To our knowledge, this is the first report disclosing 4-MeOPBP in human specimens.	[Shintani-Ishida, Kaori; Nakamura, Mami; Tojo, Misa; Idota, Nozomi; Ikegaya, Hiroshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Forens Med, Kamigyo Ku, Kyoto 6028566, Japan	Shintani-Ishida, K (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Forens Med, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	kaori@koto.kpu-m.ac.jp			JSPS KAKENHI [25293162]	We thank Dr. Kanju Saka of the Department of Forensic Medicine, Graduate School of Medicine, at the University of Tokyo for advice on data analysis. This study was supported by JSPS KAKENHI Grant Number 25293162.	Namera A, 2013, FORENSIC TOXICOL, V31, P338, DOI 10.1007/s11419-013-0192-7; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P243, DOI 10.1007/s11419-014-0230-0; Coppola M, 2012, TOXICOL LETT, V211, P144, DOI 10.1016/j.toxlet.2012.03.009; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Saito T, 2013, FORENSIC TOXICOL, V31, P328, DOI 10.1007/s11419-013-0183-8; Rosano TG, 2013, J ANAL TOXICOL, V37, P580, DOI 10.1093/jat/bkt071; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P225, DOI 10.1007/s11419-014-0227-8; Guale F, 2013, J ANAL TOXICOL, V37, P17, DOI 10.1093/jat/bks084; Eiden C, 2013, CLIN TOXICOL, V51, P899, DOI 10.3109/15563650.2013.847187; Borek HA, 2012, ANN EMERG MED, V60, P103, DOI 10.1016/j.annemergmed.2012.01.005; Galloway FR, 1999, J ANAL TOXICOL, V23, P615; Minakata K, 2014, FORENSIC TOXICOL, V32, P169, DOI 10.1007/s11419-013-0212-7; Murray Brittany L, 2012, J Med Toxicol, V8, P69, DOI 10.1007/s13181-011-0196-9; Namera A, 2014, FORENSIC TOXICOL, V32, P68, DOI 10.1007/s11419-013-0203-8; Sauer C, 2011, FORENSIC SCI INT, V208, pE20, DOI 10.1016/j.forsciint.2011.02.026; Yonamine M, 2002, J CHROMATOGR B, V773, P83, DOI 10.1016/S0378-4347(01)00516-3; Zaitsu K, 2014, FORENSIC TOXICOL, V32, P1, DOI 10.1007/s11419-013-0218-1	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					348	354		10.1007/s11419-015-0281-x		7	Toxicology	Toxicology	CM9UU	WOS:000358055400014		
J	Uchiyama, N; Asakawa, K; Kikura-Hanajiri, R; Tsutsumi, T; Hakamatsuka, T				Uchiyama, Nahoko; Asakawa, Kazuhiro; Kikura-Hanajiri, Ruri; Tsutsumi, Taizo; Hakamatsuka, Takashi			A new pyrazole-carboxamide type synthetic cannabinoid AB-CHFUPYCA [N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide] identified in illegal products	FORENSIC TOXICOLOGY			English	Article						AB-CHFUPYCA [N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide]; Pyrazole-carboxamide	SOLID TISSUES; DERIVATIVES; RECEPTOR; ANTAGONIST; SR141716A; FUBINACA; POTENT; ANALOG; DRUGS	A new pyrazole-carboxamide type synthetic cannabinoid, AB-CHFUPYCA (1), was detected in illegal herbal products by our ongoing survey in Japan. The structure of 1 was identified by gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), liquid chromatography-high-resolution-mass spectrometry (LC-HR-MS) and nuclear magnetic resonance (NMR) analyses. Compound 1 showed a molecular weight of 400, and accurate mass measurement using LC-HR-MS revealed its molecular formula to be C22H29N4O2F. The MS and NMR spectrometric data revealed that the structure of 1 was N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide. Compound 1, which is a new type of synthetic cannabinoid, has a 3-(4-fluorophenyl)-1H-pyrazole group in place of a 1H-indazole group of AB-CHMINACA. To our knowledge, data on the chemistry and pharmacology of compound 1 have never been reported, and we therefore named compound 1 "AB-CHFUPYCA.".	[Uchiyama, Nahoko; Kikura-Hanajiri, Ruri; Hakamatsuka, Takashi] Natl Inst Hlth Sci, Div Pharmacognosy Phytochem & Narcot, Setagaya Ku, Tokyo 1588501, Japan; [Asakawa, Kazuhiro; Tsutsumi, Taizo] Tokushima Prefectural Publ Hlth Pharmaceut & Envi, Tokushima, Japan	Uchiyama, N (reprint author), Natl Inst Hlth Sci, Div Pharmacognosy Phytochem & Narcot, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	nuchiyama@nihs.go.jp			Ministry of Health, Labour, and Welfare, Japan	A portion of this work was supported by a Health and Labor Sciences Research Grant from the Ministry of Health, Labour, and Welfare, Japan.	Uchiyama N, 2013, FORENSIC TOXICOL, V31, P93, DOI 10.1007/s11419-012-0171-4; Uchiyama N, 2009, CHEM PHARM BULL, V57, P439, DOI 10.1248/cpb.57.439; Uchiyama N, 2013, FORENSIC SCI INT, V227, P21, DOI 10.1016/j.forsciint.2012.08.047; Kikura-Hanajiri R, 2013, FORENSIC TOXICOL, V31, P44, DOI 10.1007/s11419-012-0165-2; Uchiyama N, 2012, FORENSIC TOXICOL, V30, P114, DOI 10.1007/s11419-012-0136-7; RINALDICARMONA M, 1995, LIFE SCI, V56, P1941, DOI 10.1016/0024-3205(95)00174-5; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Uchiyama N, 2009, FORENSIC TOXICOL, V27, P61, DOI 10.1007/s11419-009-0069-y; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P223, DOI 10.1007/s11419-013-0182-9; EMCDDA, 2015, NEW PSYCH SUBST EUR; Ernst L, 2012, FORENSIC SCI INT, V222, P216, DOI 10.1016/j.forsciint.2012.05.027; Hasegawa K, 2015, FORENSIC TOXICOL, V33, P45, DOI 10.1007/s11419-014-0245-6; Hasegawa K, 2015, FORENSIC TOXICOL, V33, P380, DOI 10.1007/s11419-015-0272-y; Hasegawa K, 2015, FORENSIC TOXICOL, V33, P112, DOI 10.1007/s11419-014-0259-0; Huffman John W., 2009, P49, DOI 10.1007/978-1-59745-503-9_3; Katritzky AR, 2010, HDB HETEROCYCLIC CHE, P139, DOI 10.1016/B978-0-08-095843-9.00005-7; Kikura-Hanajiri R, 2014, DRUG TEST ANAL, V6, P832, DOI 10.1002/dta.1584; Lan R, 1999, AAPS PharmSci, V1, pE4; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Pinto DGA, 2007, RECENT RES DEV HETER, P397; Uchiyama N, 2015, FORENSIC TOXICOL, V33, P244, DOI 10.1007/s11419-015-0268-7; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P105, DOI 10.1007/s11419-013-0217-2	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					367	373		10.1007/s11419-015-0283-8		7	Toxicology	Toxicology	CM9UU	WOS:000358055400016		
J	Fuchigami, Y; Fu, XS; Ikeda, R; Kawakami, S; Wada, M; Kikura-Hanajiri, R; Kuroda, N; Nakashima, K				Fuchigami, Yuki; Fu, Xunsing; Ikeda, Rie; Kawakami, Shigeru; Wada, Mitsuhiro; Kikura-Hanajiri, Ruri; Kuroda, Naotaka; Nakashima, Kenichiro			Evaluation of the neurochemical effects of methoxetamine using brain microdialysis in mice	FORENSIC TOXICOLOGY			English	Article						Methoxetamine; Ketamine; Dopamine; Serotonin; Prefrontal cortex; NMDA receptor antagonist	KETAMINE DERIVATIVE METHOXETAMINE; RECREATIONAL USE; RAT-BRAIN; DOPAMINE; DRUGS; MDMA; SEROTONIN	The ketamine analogue, 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) has emerged as a drug of abuse. Both methoxetamine and ketamine are antagonists of glutamate N-methyl-d-asparate receptors, and several case reports show that methoxetamine produces similar schizophrenia-like symptoms and hallucinations to ketamine. Although methoxetamine is believed to change levels of dopamine, glutamate, and serotonin in the brain, few studies thus far have examined these effects. We investigated the influence of methoxetamine on dopamine and serotonin concentrations using microdialysis and high performance liquid chromatography with electrochemical detection. To reveal the effects of methoxetamine, we monitored dopamine and serotonin concentrations in several brain areas [striatum, nucleus accumbens, and prefrontal cortex (mPFC)] after an administration of 20 mg/kg of methoxetamine. We compared the effects of methoxetamine with those of ketamine using two ketamine doses. Methoxetamine increased dopamine and serotonin concentrations most robustly in the mPFC. In addition, its effects were stronger than those of ketamine at the same molar dose, suggesting that methoxetamine causes schizophrenia-like symptoms and hallucinations by increasing the dopamine and serotonin concentrations. We conclude that consumption of methoxetamine may be more dangerous than consumption of ketamine.	[Fuchigami, Yuki; Fu, Xunsing; Ikeda, Rie; Kawakami, Shigeru; Kuroda, Naotaka] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Wada, Mitsuhiro] Kyusyu Univ Hlth & Welf, Sch Pharmaceut Sci, Nobeoka, Miyazaki 8828508, Japan; [Kikura-Hanajiri, Ruri] Natl Inst Hlth Sci, Tokyo 1588501, Japan; [Nakashima, Kenichiro] Nagasaki Int Univ, Fac Pharmaceut Sci, Sasebo, Nagasaki 8593298, Japan	Wada, M (reprint author), Kyusyu Univ Hlth & Welf, Sch Pharmaceut Sci, 1714-1 Yoshino Cho, Nobeoka, Miyazaki 8828508, Japan.	m-wada@phoenix.ac.jp			Ministry of Health, Labour, and Welfare of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research	This study was supported in part by a research grant from the Ministry of Health, Labour, and Welfare of Japan, and the Mochida Memorial Foundation for Medical and Pharmaceutical Research.	YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P547, DOI 10.1007/BF01062109; Baumann MH, 2008, PHARMACOL BIOCHEM BE, V90, P208, DOI 10.1016/j.pbb.2008.02.018; Kamiyama H, 2011, NEUROSCIENCE, V177, P159, DOI 10.1016/j.neuroscience.2010.12.012; Lyles J, 2003, BRAIN RES REV, V42, P155, DOI 10.1016/S0165-0173(03)00173-5; Hofer KE, 2012, ANN EMERG MED, V60, P97, DOI 10.1016/j.annemergmed.2011.11.018; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; BENVENISTE H, 1989, J NEUROCHEM, V52, P1667, DOI 10.1111/j.1471-4159.1989.tb07243.x; Brady JE, 2014, AM J EPIDEMIOL, V179, P692, DOI 10.1093/aje/kwt327; Corazza O, 2012, HUM PSYCHOPHARM CLIN, V27, P145, DOI 10.1002/hup.1242; Corazza O, 2013, CNS NEUROSCI THER, V19, P454, DOI 10.1111/cns.12063; Curran HV, 2000, ADDICTION, V95, P575, DOI 10.1046/j.1360-0443.2000.9545759.x; Franklin K. B. J., 2007, MOUSE BRAIN STEREOTA; Fuchigami Y, 2013, EUR J PHARM SCI, V49, P57; Ikeda R, 2011, EUR J PHARMACOL, V660, P318, DOI 10.1016/j.ejphar.2011.03.050; KOSHIKAWA N, 1988, BRAIN RES, V444, P394, DOI 10.1016/0006-8993(88)90954-7; Kudo K, 2010, FORENSIC TOXICOL, V28, P25, DOI 10.1007/s11419-009-0088-8; Masuzawa M, 2003, ANESTH ANALG, V96, P148, DOI 10.1213/01.ANE.0000041458.58089.E8; Rosenbaum Christopher D, 2012, J Med Toxicol, V8, P15, DOI 10.1007/s13181-011-0202-2; SADZOT B, 1989, PSYCHOPHARMACOLOGY, V98, P495, DOI 10.1007/BF00441948; van Aerde KI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002725; Wood DM, 2012, EUR J CLIN PHARMACOL, V68, P853, DOI 10.1007/s00228-011-1199-9; Wurita A, 2014, FORENSIC TOXICOL, V32, P331, DOI 10.1007/s11419-014-0240-y	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					374	379		10.1007/s11419-015-0267-8		6	Toxicology	Toxicology	CM9UU	WOS:000358055400017		
J	Hasegawa, K; Wurita, A; Minakata, K; Gonmori, K; Nozawa, H; Yamagishi, I; Watanabe, K; Suzuki, O				Hasegawa, Koutaro; Wurita, Amin; Minakata, Kayoko; Gonmori, Kunio; Nozawa, Hideki; Yamagishi, Itaru; Watanabe, Kanako; Suzuki, Osamu			Postmortem distribution of MAB-CHMINACA in body fluids and solid tissues of a human cadaver	FORENSIC TOXICOLOGY			English	Article						MAB-CHMINACA; Synthetic cannabinoid; Postmortem distribution; Solid tissue; LC-MS-MS; 5-Fluoro-ADB	SYNTHETIC CANNABINOIDS; ALPHA-PYRROLIDINOVALEROPHENONE; PROPYLENE-GLYCOL; ETHYLENE-GLYCOL; CATHINONE DERIVATIVES; APPRECIABLE AMOUNTS; DIETHYLENE GLYCOL; URINARY-EXCRETION; HEALTHY-SUBJECTS; WHOLE-BLOOD	During the latter part of 2014, we experienced an autopsy case in which 5-fluoro-ADB, one of the most dangerous synthetic cannabinoids, was identified and quantitated in solid tissues and in three herbal blend products [Forensic Toxicol (2015) 33:112-121]. At that time, although we suspected that there may be some drug(s) other than 5-fluoro-ADB in the herbal products, all trials to find it/them were unsuccessful. Subsequently, we carefully re-examined the presence of other synthetic cannabinoid(s) in the above herbal blend products using accurate mass spectrometry and found two new compounds, 5-fluoro-ADB-PINACA and MAB-CHMINACA (Forensic Toxicol. doi: 10.1007/s 11419-015-0264-y). In the present communication, we report the distribution of MAB-CHMINACA in body fluids and solid tissue specimens collected from the same deceased individual (kept frozen at -80 A degrees C) as described above for demonstration of 5-fluoro-ADB. Unexpectedly, unchanged MAB-CHMINACA could be identified and quantitated in whole blood and in pericardial fluid specimens, but it was below the detection limit (0.1 ng/ml) in the urine specimen. A higher concentration of MAB-CHMINACA could be found in all of the nine solid tissues; the highest concentration of MAB-CHMINACA was found in the liver (156 ng/g), followed by the kidney, pancreas and so on. The compounds were detected in all nine solid tissues; their levels were generally higher than those in the whole blood and pericardial fluid. Contrary to expectations, the concentration of MAB-CHMINACA in the adipose tissue was relatively low. Our results show that the victim smoked one of the three herbal blend products containing both MAB-CHMINACA and 5-fluoro-ADB, resulting in the coexistence of both compounds. It should be concluded that 5-fluoro-ADB and MAB-CHMINACA synergically exerted their toxicities, leading to death after a short interval. The differences in the distribution of 5-fluoro-ADB and MAB-CHMINACA among the cadaver specimens were also discussed in view of the structures of both compounds. To our knowledge, this is the first report to demonstrate MAB-CHMINACA in biological/human specimens.	[Hasegawa, Koutaro; Wurita, Amin; Minakata, Kayoko; Gonmori, Kunio; Nozawa, Hideki; Yamagishi, Itaru; Watanabe, Kanako; Suzuki, Osamu] Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hasegawa, K (reprint author), Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	07484771@hama-med.ac.jp					Zuba D, 2013, FORENSIC TOXICOL, V31, P21, DOI 10.1007/s11419-012-0159-0; Namera A, 2013, FORENSIC TOXICOL, V31, P338, DOI 10.1007/s11419-013-0192-7; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P243, DOI 10.1007/s11419-014-0230-0; Kikura-Hanajiri R, 2013, FORENSIC TOXICOL, V31, P44, DOI 10.1007/s11419-012-0165-2; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; Wurita A, 2013, FORENSIC TOXICOL, V31, P272, DOI 10.1007/s11419-013-0188-3; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P225, DOI 10.1007/s11419-014-0227-8; Saito T, 2013, FORENSIC TOXICOL, V31, P333, DOI 10.1007/s11419-013-0190-9; BONILLA E, 1978, CLIN CHEM, V24, P471; Cayman Chemical, 2014, CAYM SPECTR LIB; Chung H, 2014, FORENSIC TOXICOL, V32, P82, DOI 10.1007/s11419-013-0213-6; Hasegawa K, 2015, FORENSIC TOXICOL, V33, P45, DOI 10.1007/s11419-014-0245-6; Hasegawa K, 2015, FORENSIC TOXICOL, V33, P112, DOI 10.1007/s11419-014-0259-0; Miserez B, 2014, FORENSIC TOXICOL, V32, P305, DOI 10.1007/s11419-014-0232-y; Namera A, 2014, FORENSIC TOXICOL, V32, P68, DOI 10.1007/s11419-013-0203-8; Shima N, 2013, FORENSIC TOXICOL, V31, P101, DOI 10.1007/s11419-012-0172-3; Wurita A, 2014, FORENSIC TOXICOL, V32, P331, DOI 10.1007/s11419-014-0240-y; Wurita A, 2014, LEGAL MED-TOKYO, V16, P241, DOI 10.1016/j.legalmed.2014.05.001; Wurita A, 2015, FORENSIC TOXICOL, V33, P213, DOI 10.1007/s11419-015-0264-y; Wurita A, 2014, FORENSIC TOXICOL, V32, P39, DOI 10.1007/s11419-013-0206-5; Wurita A, 2014, FORENSIC TOXICOL, V32, P162, DOI 10.1007/s11419-013-0210-9; Zaitsu K, 2014, FORENSIC TOXICOL, V32, P1, DOI 10.1007/s11419-013-0218-1	22	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					380	387		10.1007/s11419-015-0272-y		8	Toxicology	Toxicology	CM9UU	WOS:000358055400018		
J	Yoshida, K; Saka, K; Shintani-Ishida, K; Maeda, H; Nakajima, M; Hara, S; Ueno, M; Sasaki, K; Iwase, H; Sakamoto, T				Yoshida, Ken-ichi; Saka, Kanju; Shintani-Ishida, Kaori; Maeda, Hideyuki; Nakajima, Makoto; Hara, Shu-ichi; Ueno, Masahide; Sasaki, Katsunori; Iwase, Hirotaro; Sakamoto, Tetsuya			A case of fatal intoxication due to the new designer drug 25B-NBOMe	FORENSIC TOXICOLOGY			English	Article						25B-NBOMe; 2-(4-Bromo-25-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine; 25C-NBOMe; New designer drug; Serotonin syndrome; Rhabdomyolysis	25I-NBOME; BLOOD; POSTMORTEM; TOXICITY; TISSUES; SERIES	N-Benzyl-substituted phenethylamines (NBOMes) have emerged as novel hallucinogenic designer drugs with potent serotonin-receptor activation. We present the first scientific case report of fatal intoxication with 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe). The plasma concentration of 25B-NBOMe upon admission was low, 3.15 ng/ml, but it exceeded concentrations reported previously in NBOMe intoxications cases. Our case documents complete clinical and pathophysiological findings that developed shortly after drug ingestion and highlights the danger of 25B-NBOMe use at small doses, based on autopsy and toxicological analyses. The patient presented symptoms consistent with serotonin syndrome.	[Yoshida, Ken-ichi; Hara, Shu-ichi] Tokyo Med Univ, Dept Forens Med, Shinjuku Ku, Tokyo 1608402, Japan; [Saka, Kanju; Maeda, Hideyuki; Nakajima, Makoto; Iwase, Hirotaro] Univ Tokyo, Grad Sch Med, Dept Forens Med, Tokyo, Japan; [Shintani-Ishida, Kaori] Kyoto Prefectural Univ Med, Dept Forens Med, Kyoto, Japan; [Ueno, Masahide; Sasaki, Katsunori; Sakamoto, Tetsuya] Teikyo Univ, Sch Med, Dept Emergency Med, Tokyo 173, Japan	Yoshida, K (reprint author), Tokyo Med Univ, Dept Forens Med, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	kenyoshi@tokyo-med.ac.jp					Lawn W, 2014, J PSYCHOPHARMACOL, V28, P780, DOI 10.1177/0269881114523866; Walterscheid JP, 2014, AM J FOREN MED PATH, V35, P20, DOI 10.1097/PAF.0000000000000082; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Poklis JL, 2014, FORENSIC SCI INT, V234, pE14, DOI 10.1016/j.forsciint.2013.10.015; Tang MHY, 2014, CLIN TOXICOL, V52, P561, DOI 10.3109/15563650.2014.909932; Braden MR, 2006, MOL PHARMACOL, V70, P1956, DOI 10.1124/mol.106.028720; Bersani FS, 2014, BIOMED RES INT, DOI 10.1155/2014/734749; Hill SL, 2013, CLIN TOXICOL, V51, P487, DOI 10.3109/15563650.2013.802795; Moriya F, 1999, J FORENSIC SCI, V44, P10; Juncosa JI, 2013, ACS CHEM NEUROSCI, V4, P96, DOI 10.1021/cn3000668; De Letter EA, 2004, FORENSIC SCI INT, V141, P85, DOI 10.1016/j.forsciint.2003.12.015; Papoutsis I, 2015, FORENSIC TOXICOL, V33, P1, DOI 10.1007/s11419-014-0242-9; Poklis JL, 2005, DRUG TEST ANAL, V6, P764; Schulz M, 2012, CRIT CARE, V16, DOI 10.1186/cc11441; Shioda K, 2010, NEUROSCI LETT, V482, P216, DOI 10.1016/j.neulet.2010.07.039; Sporkert F, 2013, 51 ANN M INT ASS FOR; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P105, DOI 10.1007/s11419-013-0217-2	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					396	401		10.1007/s11419-015-0276-7		6	Toxicology	Toxicology	CM9UU	WOS:000358055400020		
J	Minakata, K; Yamagishi, I; Nozawa, H; Hasegawa, K; Wurita, A; Gonmori, K; Suzuki, M; Watanabe, K; Suzuki, O				Minakata, Kayoko; Yamagishi, Itaru; Nozawa, Hideki; Hasegawa, Koutaro; Wurita, Amin; Gonmori, Kunio; Suzuki, Masako; Watanabe, Kanako; Suzuki, Osamu			Diphenidine and its metabolites in blood and urine analyzed by MALDI-Q-TOF mass spectrometry	FORENSIC TOXICOLOGY			English	Letter							ALPHA-PYRROLIDINOVALEROPHENONE; CATHINONE DERIVATIVES; DESIGNER; DRUGS		[Minakata, Kayoko; Yamagishi, Itaru; Nozawa, Hideki; Hasegawa, Koutaro; Wurita, Amin; Gonmori, Kunio; Watanabe, Kanako; Suzuki, Osamu] Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Suzuki, Masako] Hamamatsu Univ Sch Med, Res Equipment Ctr, Hamamatsu, Shizuoka 4313192, Japan	Minakata, K (reprint author), Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kminakat@hama-med.ac.jp					Berger ML, 2009, BIOORGAN MED CHEM, V17, P3456, DOI 10.1016/j.bmc.2009.03.025; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; Springer D, 2003, J CHROMATOGR B, V796, P253, DOI 10.1016/j.jchromb.2003.07.008; Hasegawa K, 2015, FORENSIC TOXICOL, V33, P45, DOI 10.1007/s11419-014-0245-6; Minakata K, 2015, FORENSIC TOXICOL, V33, P148, DOI 10.1007/s11419-014-0248-3; Namera A, 2014, FORENSIC TOXICOL, V32, P68, DOI 10.1007/s11419-013-0203-8; PsychonautWiki, 2014, DIPH; Shima N, 2014, FORENSIC TOXICOL, V32, P59, DOI 10.1007/s11419-013-0202-9; Wurita A, 2014, FORENSIC TOXICOL, V32, P331, DOI 10.1007/s11419-014-0240-y	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					402	408		10.1007/s11419-015-0273-x		7	Toxicology	Toxicology	CM9UU	WOS:000358055400021		
J	Ishii, A; Zaitsu, K; Kusano, M; Asano, T; Ogawa, T; Hattori, H; Seno, H				Ishii, Akira; Zaitsu, Kei; Kusano, Maiko; Asano, Tomomi; Ogawa, Tadashi; Hattori, Hideki; Seno, Hiroshi			Identification and quantitation of mifepristone and its N-demethyl metabolite in the plasma of an aborted fetus by liquid chromatography-quadrupole-time-of-flight-mass spectrometry (LC-Q-TOFMS) and ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS-MS)	FORENSIC TOXICOLOGY			English	Letter							INTERNAL STANDARD; PHARMACOKINETICS; RU-486; WOMEN; BLOOD		[Ishii, Akira; Zaitsu, Kei; Kusano, Maiko] Nagoya Univ, Dept Legal Med & Bioeth, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Ogawa, Tadashi; Hattori, Hideki; Seno, Hiroshi] Aichi Med Univ, Dept Legal Med, Nagakute, Aichi 4801195, Japan; [Asano, Tomomi] Kinjo Gakuin Univ, Dept Food & Nutr Environm, Nagoya, Aichi 4638521, Japan	Ishii, A (reprint author), Nagoya Univ, Dept Legal Med & Bioeth, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	akishii@med.nagoya-u.ac.jp					Tang C, 2009, BIOMED CHROMATOGR, V23, P71, DOI 10.1002/bmc.1086; Guo ZY, 2006, J CHROMATOGR B, V832, P181, DOI 10.1016/j.jchromb.2005.12.019; Nomura M, 2012, FORENSIC TOXICOL, V30, P185, DOI 10.1007/s11419-012-0146-5; Heikinheimo O, 2003, CONTRACEPTION, V68, P421, DOI 10.1016/S0010-7824(03)00077-5; Foldesi I, 1996, CONTRACEPTION, V54, P27, DOI 10.1016/0010-7824(96)00116-3; WANG JD, 1994, CONTRACEPTION, V49, P245, DOI 10.1016/0010-7824(94)90042-6; Guo ZY, 2007, CONTRACEPTION, V76, P228, DOI 10.1016/j.contraception.2007.04.004; Gu K, 2000, FRESEN J ANAL CHEM, V368, P832, DOI 10.1007/s002160000569; Guo ZY, 2007, J CHROMATOGR B, V856, P312, DOI 10.1016/j.jchromb.2007.06.016; HE CH, 1989, CONTRACEPTION, V40, P449, DOI 10.1016/0010-7824(89)90052-8; HEIKINHEIMO O, 1989, J STEROID BIOCHEM, V32, P21, DOI 10.1016/0022-4731(89)90008-3; Heikinheimo O, 1997, CLIN PHARMACOKINET, V33, P7; Homer NZM, 2009, J CHROMATOGR B, V877, P497, DOI 10.1016/j.jchromb.2008.12.051; Ishii A, 2014, FORENSIC TOXICOL, V32, P342, DOI 10.1007/s11419-014-0241-x; KAWAI S, 1987, J PHARMACOL EXP THER, V241, P401; Kekkonen R, 1996, CONTRACEPTION, V54, P229, DOI 10.1016/S0010-7824(96)00193-X; Leminen R, 2003, CONTRACEPTION, V68, P427, DOI 10.1016/S0010-7824(03)00181-1; Minakata K, 2013, FORENSIC TOXICOL, V31, P138, DOI 10.1007/s11419-012-0157-2; Minakata K, 2014, FORENSIC TOXICOL, V32, P299, DOI 10.1007/s11419-014-0229-6; Ministry of Health Labour and Welfare, 2004, WARN PUBL MIF OR AB; Ogawa T, 2014, FORENSIC TOXICOL, V32, P126, DOI 10.1007/s11419-013-0195-4; Sarkar NN, 2002, EUR J OBSTET GYN R B, V101, P113, DOI 10.1016/S0301-2115(01)00522-X; SHI YE, 1993, CONTRACEPTION, V48, P133, DOI 10.1016/0010-7824(93)90004-Q; Stith C, 2003, J CHROMATOGR B, V794, P9, DOI 10.1016/S1570-0232(03)00392-1; Yoshioka N, 2014, FORENSIC TOXICOL, V32, P89, DOI 10.1007/s11419-013-0214-5	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JUL	2015	33	2					409	412		10.1007/s11419-015-0284-7		4	Toxicology	Toxicology	CM9UU	WOS:000358055400022		
J	Nakashima, Y; Sakamoto, M; Takeda, H; Ichimura, K; Hosoda, Y; Iwamoto, M; Shimizu, K; Hosoi, K; Oki, K; Yoshikawa, M; Hirata, M; Ikezoe, R; Imai, T; Kariya, T; Katanuma, I; Kohagura, J; Minami, R; Numakura, T; Wang, X; Ichimura, M				Nakashima, Y.; Sakamoto, M.; Takeda, H.; Ichimura, K.; Hosoda, Y.; Iwamoto, M.; Shimizu, K.; Hosoi, K.; Oki, K.; Yoshikawa, M.; Hirata, M.; Ikezoe, R.; Imai, T.; Kariya, T.; Katanuma, I.; Kohagura, J.; Minami, R.; Numakura, T.; Wang, X.; Ichimura, M.			RECENT RESULTS OF DIVERTOR SIMULATION EXPERIMENTS USING D-MODULE IN THE GAMMA 10/PDX TANDEM MIRROR	FUSION SCIENCE AND TECHNOLOGY			English	Article						divertor simulation; plasma detachment; GAMMA 10/PDX	END-CELL; RESEARCH PLAN; PLASMA; MODEL	This paper describes the recent results of divertor simulation research toward the realization of the detached plasma using the end-mirror of a large tandem mirror device. The additional ion cyclotron range of frequency heating in the anchor-cells for higher particle flux generation significantly increases the density, which attained the highest particle flux up to 1.7 x 10(23) particlesl s.m(2) at the end-mirror exit. Massive gas injection (H-2 and noble gases) into the divertor simulation experimental module (D-module) was performed, and a remarkable reduction of the electron temperature on the target plate was successfully achieved associated with the strong reduction of particle and heat fluxes in D-module. Two-dimensional images of Ha emission in D-module observed with a high-speed camera showed strong emission in the upstream region and significant reduction near the target plate. These results clarified the effect of radiation cooling and formation of detached plasma due to gas injection. It is also found that Xe gas is much more effective in achieving detached plasma than Ar gas. Numerical simulation studies also have been performed toward the understanding of the cooling mechanism of divertor plasma. The above results will contribute to establishment of detached plasma control and clarification of the radiation cooling mechanism toward the development of future divertor systems.	[Nakashima, Y.; Sakamoto, M.; Takeda, H.; Ichimura, K.; Hosoda, Y.; Iwamoto, M.; Shimizu, K.; Hosoi, K.; Oki, K.; Yoshikawa, M.; Hirata, M.; Ikezoe, R.; Imai, T.; Kariya, T.; Katanuma, I.; Kohagura, J.; Minami, R.; Numakura, T.; Wang, X.; Ichimura, M.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan	Nakashima, Y (reprint author), Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan.	nakashma@prc.tsukuba.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [24360378];  [NIFS12KUGM066];  [NIFS13KUGM076];  [NIFS14KUGM089]	The authors would like to acknowledge the members of the GAMMA 10 group, University of Tsukuba, for their collaboration in the experiments. This work was performed with the support by the bi-directional collaboration research programs (NIFS12KUGM066, NIFS13KUGM076 and NIFS14KUGM089) and grant-in-aid for scientific research from Ministry of Education, Science, Sports and Culture of Japan (24360378).	Pitts RA, 2011, J NUCL MATER, V415, pS957, DOI 10.1016/j.jnucmat.2011.01.114; TAMANO T, 1995, PHYS PLASMAS, V2, P2321, DOI 10.1063/1.871256; Roth J, 2009, J NUCL MATER, V390-91, P1, DOI 10.1016/j.jnucmat.2009.01.037; INUTAKE M, 1985, PHYS REV LETT, V55, P939, DOI 10.1103/PhysRevLett.55.939; BRAMMS B. J., 1987, 68 NET CEC; HEIFETZ D, 1982, J COMPUT PHYS, V46, P309, DOI 10.1016/0021-9991(82)90017-1; Ichimura K., 2012, PLASMA FUSION RES, V7; Ichimura M, 2013, FUSION SCI TECHNOL, V63, P115; IMAI T., 2013, FUSION SCI TECHNOL, V59, P8; MATTHEWS GF, 1995, J NUCL MATER, V220, P104, DOI 10.1016/0022-3115(94)00450-1; Minami R, 2013, FUSION SCI TECHNOL, V63, P298; NAKASHIMA Y., 2008, CONTRIB PLASM PHYS, V1-3, P141; Nakashima Y, 2013, J NUCL MATER, V438, pS738, DOI 10.1016/j.jnucmat.2013.01.157; Nakashima Y, 2011, FUSION SCI TECHNOL, V59, P61; NAKASHIMA Y, 1992, J NUCL MATER, V196, P493, DOI 10.1016/S0022-3115(06)80086-3; Nakashima Y, 2010, FUSION ENG DES, V85, P956, DOI 10.1016/j.fusengdes.2010.09.015; Nakashima Y, 2013, FUSION SCI TECHNOL, V63, P100; Nakashima Y, 2011, J NUCL MATER, V415, pS996, DOI 10.1016/j.jnucmat.2010.11.081; Stotler DP, 1996, PHYS PLASMAS, V3, P4084, DOI 10.1063/1.871540; Takeda H, 2014, CONTRIB PLASM PHYS, V54, P605, DOI 10.1002/ctpp.201410036; Pigarov AY, 1996, PHYS LETT A, V222, P251, DOI 10.1016/0375-9601(96)00629-9	21	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					28	35				8	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600006		
J	Ikezoe, R; Ichimura, M; Hirata, M; Yokoyama, T; Iwamoto, Y; Okada, T; Sumida, S; Takeyama, K; Jang, S; Oi, T; Ichimura, K; Nakashima, Y				Ikezoe, R.; Ichimura, M.; Hirata, M.; Yokoyama, T.; Iwamoto, Y.; Okada, T.; Sumida, S.; Takeyama, K.; Jang, S.; Oi, T.; Ichimura, K.; Nakashima, Y.			EXTENSION OF OPERATIONAL REGIMES WITH ICRF HEATING ON GAMMA 10/PDX	FUSION SCIENCE AND TECHNOLOGY			English	Article						ICRF heating; tandem mirror; operational regime	DIVERTOR SIMULATION EXPERIMENTS; TANDEM MIRROR GAMMA-10; ANTENNAS; WAVES; CELL	Recent ICRF heating experiments performed in GAMMA 10/PDX are reported. Owing to antenna-phasing technique and four ICRF antennas installed in the mirror cells other than the central cell, the operational regime of GAMMA 10/PDX is significantly extended. Several ICRF heating schemes to increase the parameters (plasma density in the central cell, particle flux flowing to the machine end and its ion temperature parallel to the field lines) are demonstrated. These results present positive progress in the ongoing divertor simulation experiments on GAMMA 10/PDX.	[Ikezoe, R.; Ichimura, M.; Hirata, M.; Yokoyama, T.; Iwamoto, Y.; Okada, T.; Sumida, S.; Takeyama, K.; Jang, S.; Oi, T.; Ichimura, K.; Nakashima, Y.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 305, Japan	Ikezoe, R (reprint author), Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 305, Japan.	ikezoe@prc.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25400531]; National Institute for Fusion Science, Japan [NIFS14KUGM086, NIFS14KUGM097]	The authors thank the GAMMA 10 group at the University of Tsukuba for their collaboration. This study is partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 25400531) and by the bidirectional collaborative research programme of the National Institute for Fusion Science, Japan (NIFS14KUGM086 and NIFS14KUGM097).	Ikezoe R, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073040; ICHIMURA M, 1988, NUCL FUSION, V28, P799, DOI 10.1088/0029-5515/28/5/005; INUTAKE M, 1990, PHYS REV LETT, V65, P3397, DOI 10.1103/PhysRevLett.65.3397; INUTAKE M, 1985, PHYS REV LETT, V55, P939, DOI 10.1103/PhysRevLett.55.939; Ichimura K., 2012, PLASMA FUSION RES, V7; Ikezoe Ryuya, 2011, Plasma and Fusion Research, V6, DOI 10.1585/pfr.6.2402047; Ikezoe R, 2013, FUSION SCI TECHNOL, V63, P58; Minami R, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063003; Nakashima Y, 2015, FUSION SCI TECHNOL, V68, P28; Nakashima Y, 2013, FUSION SCI TECHNOL, V63, P100; Oki K, 2015, FUSION SCI TECHNOL, V68, P81; Sakamoto M, 2013, FUSION SCI TECHNOL, V63, P188; Sumida S, 2015, FUSION SCI TECHNOL, V68, P136; Ugajin Y, 2013, FUSION SCI TECHNOL, V63, P268; WATARI T, 1982, NUCL FUSION, V22, P1359, DOI 10.1088/0029-5515/22/10/011; Yokoyama T, 2015, FUSION SCI TECHNOL, V68, P185	16	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					63	69				7	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600011		
J	Matsuura, H; Kobayashi, H; Tanaka, S; Iijima, T; Tonegawa, A				Matsuura, Hiroto; Kobayashi, Hiroaki; Tanaka, Suguru; Iijima, Takaaki; Tonegawa, Akira			EFFECT OF THE DIVERTOR LEG LENGTH ON THE POPULATION OF MOLECULAR IONS IN THE DIVERTOR SIMULATOR TPD-SheetIV	FUSION SCIENCE AND TECHNOLOGY			English	Article						TPD-SheetIV; DEGAS 2; molecular assisted recombination		In TPD-SheetIV, a simulation experiment on a long leg divertor configuration has been conducted and hydrogen molecular ion formation in detached plasma was observed. Improvements to the simulation geometry used in DEGAS 2 allowed us to study the effect of leg length on neutral transport. This paper also describes a simple ion balance equation and the ion density ratios obtained with it. From these data, it is shown that a long leg divertor enhances molecular ion density in the divertor, which might enhance molecular assisted recombination.	[Matsuura, Hiroto] Osaka Prefecture Univ, Sakai Naka Ku, Osaka 5998570, Japan; [Kobayashi, Hiroaki; Tanaka, Suguru; Iijima, Takaaki; Tonegawa, Akira] Tokai Univ, Hiratsuka, Kanagawa 2591292, Japan	Matsuura, H (reprint author), Osaka Prefecture Univ, Sakai Naka Ku, Gakuen Cho 1-2, Osaka 5998570, Japan.	matsu@me.osakafu-u.ac.jp			National Institute for Fusion Science (NIFS) [NIFS12KOBF024]	The authors would like to thank E. M. Hollmann (University of California, San Diego) for the permission to use his rate coefficient data. One of the authors (H. M.) acknowledges D. Stotler (Princeton Plasma Physics Laboratory) for his advice on DEGAS 2 simulation. This work was partially performed with the support and under the auspices of the National Institute for Fusion Science (NIFS) Collaborative Research Program (NIFS12KOBF024).	STOTLER D, 1994, CONTRIB PLASM PHYS, V34, P392, DOI 10.1002/ctpp.2150340246; Hollmann EM, 2002, PHYS PLASMAS, V9, P4330, DOI 10.1063/1.1503070; Matsuura Hiroto, 2011, Plasma and Fusion Research, V6, DOI 10.1585/pfr.6.2401104; Tanaka S, 2013, FUSION SCI TECHNOL, V63, P420; TONEGAWA A., 2007, PLASMA FUSION RES, V2, pS1079, DOI 10.1585/pfr.2.S1079; Yazawa H, 2006, JPN J APPL PHYS 1, V45, P8208, DOI 10.1143/JJAP.45.8208	6	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					76	80				5	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600013		
J	Oki, K; Sakamoto, M; Nakashima, Y; Yoshikawa, M; Nohara, R; Nojiri, K; Terakado, A; Mizuguchi, M; Ichimura, K; Takeda, H; Iwamoto, M; Hosoda, Y; Shimizu, K; Yoshikawa, M; Kohagura, J; Imai, T; Ichimura, M				Oki, K.; Sakamoto, M.; Nakashima, Y.; Yoshikawa, M.; Nohara, R.; Nojiri, K.; Terakado, A.; Mizuguchi, M.; Ichimura, K.; Takeda, H.; Iwamoto, M.; Hosoda, Y.; Shimizu, K.; Yoshikawa, M.; Kohagura, J.; Imai, T.; Ichimura, M.			ELECTRON TEMPERATURE AND DENSITY DISTRIBUTIONS IN A DIVERTOR SIMULATION EXPERIMENTAL MODULE WITH GAS INJECTION IN GAMMA 10/PDX	FUSION SCIENCE AND TECHNOLOGY			English	Article						divertor simulation; gas injection; electron temperature and density distribution	TANDEM MIRROR; END-CELL; PLASMA	In tandem mirror GAMMA 10/PDX, H-2 gas has been injected to a divertor simulation experimental module (D-module) for radiation cooling and detachment study. Electron temperature (T-e) and density (n(e)) distributions have been measured by Langmuir probes in the D-module. With increase of H-2 gas amount, T-e has decreased especially at the V-shaped target plate from 30-40 eV to 3-5 eV. Moreover, n(e) and ion saturation current I-is have increased at the inlet but decreased at the target and had a steeper distribution toward the corner. These results suggest detachment. The movement of the ionization front to the upstream side with increase of the gas is suggested from the change in the plasma parameters' profiles along the magnetic field line.	[Oki, K.; Sakamoto, M.; Nakashima, Y.; Yoshikawa, M.; Nohara, R.; Nojiri, K.; Terakado, A.; Mizuguchi, M.; Ichimura, K.; Takeda, H.; Iwamoto, M.; Hosoda, Y.; Shimizu, K.; Yoshikawa, M.; Kohagura, J.; Imai, T.; Ichimura, M.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan	Oki, K (reprint author), Univ Tsukuba, Plasma Res Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	oki@prc.tsukuba.ac.jp			National Institute for Fusion Science (NIFS) [NEFS12KUGM066, NIFS13KUGM083, NIFS14KUGM086]	This work is performed with the support and under the auspices of the National Institute for Fusion Science (NIFS) Collaboration Research Program (NIFS12KUGM066, NIFS13KUGM083, NIFS14KUGM086).	Kallenbach A, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/12/124041; Takamura S, 2002, PLASMA SOURCES SCI T, V11, pA42, DOI 10.1088/0963-0252/11/3A/306; Wischmeier M, 2009, J NUCL MATER, V390-91, P250, DOI 10.1016/j.jnucmat.2009.01.081; Fantz U, 2001, J NUCL MATER, V290, P367, DOI 10.1016/S0022-3115(00)00638-3; MATTHEWS GF, 1995, J NUCL MATER, V220, P104, DOI 10.1016/0022-3115(94)00450-1; Nakashima Y, 2013, J NUCL MATER, V438, pS738, DOI 10.1016/j.jnucmat.2013.01.157; Nakashima Y, 2010, FUSION ENG DES, V85, P956, DOI 10.1016/j.fusengdes.2010.09.015; Nakashima Y, 2013, FUSION SCI TECHNOL, V63, P100; Nakashima Y, 2011, J NUCL MATER, V415, pS996, DOI 10.1016/j.jnucmat.2010.11.081; Sakamoto M, 2013, FUSION SCI TECHNOL, V63, P188; Pigarov AY, 1996, PHYS LETT A, V222, P251, DOI 10.1016/0375-9601(96)00629-9	11	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					81	86				6	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600014		
J	Yoshikawa, M; Wang, XL; Morishita, M; Shima, Y; Chikatsu, M; Kohagura, J; Sakamoto, M; Minami, R; Iso, M; Nakashima, Y; Imai, T; Ichimura, M; Yasuhara, R; Yamada, I; Funaba, H; Minami, T				Yoshikawa, Masayuki; Wang, Xiaolong; Morishita, Masahiro; Shima, Yoriko; Chikatsu, Masayuki; Kohagura, Junko; Sakamoto, Mizuki; Minami, Ryutaro; Iso, Masaki; Nakashima, Yousuke; Imai, Tsuyoshi; Ichimura, Makoto; Yasuhara, Ryo; Yamada, Ichihiro; Funaba, Hisamichi; Minami, Takashi			DEVELOPMENT OF THOMSON SCATTERING SYSTEM IN GAMMA 10	FUSION SCIENCE AND TECHNOLOGY			English	Article						GAMMA 10; multipass Thomson scattering system; electron temperature and density		Thomson scattering (TS) is one of the most reliable diagnostics to measure the electron temperature and electron density radial profiles in fusion plasmas. In GAMMA 10, a yttrium-aluminum-garnet (YAG)-TS system was constructed with the large solid angle of TS collection optics. We carried out Rayleigh and Raman scattering experiments for system settings and density calibration. We applied the YAG-TS system to the GAMMA 10 plasma. We can successfully measure the radial profiles of electron temperature and density in the central cell of GAMMA 10 by using the YAG-TS system in a single plasma shot. Moreover, in order to increase the TS signal intensities, we have constructed a multipass TS system of the polarization-based system with image relaying optics. Clear TS signals from first to fourth passing lasers through the GAMMA 10 plasma were obtained. The obtained TS signal intensity was about three times larger by first to fourth passing lasers through the plasma than that of the first pass.	[Yoshikawa, Masayuki; Wang, Xiaolong; Morishita, Masahiro; Shima, Yoriko; Chikatsu, Masayuki; Kohagura, Junko; Sakamoto, Mizuki; Minami, Ryutaro; Iso, Masaki; Nakashima, Yousuke; Imai, Tsuyoshi; Ichimura, Makoto] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan; [Yasuhara, Ryo; Yamada, Ichihiro; Funaba, Hisamichi] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Minami, Takashi] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan	Yoshikawa, M (reprint author), Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan.	yosikawa@prc.tsukuba.ac.jp			NIFS Collaborative Research Program [NIFS10KUGM045, NIFS14KUGM086]	The authors thank the members of the GAMMA 10 group of the University of Tsukuba for their collaboration. This study was conducted with the support and under the auspices of the NIFS Collaborative Research Program, NIFS10KUGM045 and NIFS14KUGM086.	Narihara K, 1997, FUSION ENG DES, V34-35, P67, DOI 10.1016/S0920-3796(96)00689-8; Hatae T, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2228347; Kainaga S., 2008, PLASMA FUSION RES, V3; Mase A., 1983, P KYUSH INT S LAS AI, P319; MINAMI R., 2014, REV SCI INSTRUM, V85; Yasuhara R, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4734495; Yoshikawa M., 2014, PLASMA FUSION RES, V9; Yoshikawa Masayuki, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S2010; Yoshikawa M., 2013, PLASMA FUSION RES, V8; Yoshikawa M, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4734490; YOSHIKAWA M., 2007, PLASMA FUSION RES, P2, DOI 10.1585/pfr.2.S1036; Yoshikawa Masayuki, 2011, Plasma and Fusion Research, V6, DOI 10.1585/pfr.6.1202095; Yoshikawa M, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/03/C03003; Yoshikawa M, 2013, FUSION SCI TECHNOL, V63, P127; Yoshikawa M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073031; Yoshikawa M, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/10/C10016; Yoshikawa M, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4885542	17	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					99	104				6	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600017		
J	Nojiri, K; Sakamoto, M; Oki, K; Yoshikawa, M; Nakashima, Y; Yoshikawa, M; Terakado, A; Nohara, R; Mizuguchi, M; Imai, T; Ichimura, M				Nojiri, K.; Sakamoto, M.; Oki, K.; Yoshikawa, M.; Nakashima, Y.; Yoshikawa, M.; Terakado, A.; Nohara, R.; Mizuguchi, M.; Imai, T.; Ichimura, M.			RELATION BETWEEN ELECTRON DENSITY AND TEMPERATURE OF DIVERTOR SIMULATION PLASMA AND UPSTREAM PLASMA IN GAMMA 10/PDX	FUSION SCIENCE AND TECHNOLOGY			English	Article						divertor simulation; gas injection; plasma detachment	TANDEM MIRROR; END-CELL; EXHAUST	In GAMMA 10/PDX, the relationship between electron density and temperature of the divertor simulation plasma in the divertor simulation experimental module (D-module) and the density of the upstream plasma has been studied. As the amount of gas (H-2 and Ar) injected into the D-module increases, the line-averaged electron density (n(e)_wp) of the west plug plasma (i.e., upstream plasma) increases due to gas flow from the D-module to the upstream. The electron temperature of the divertor simulation plasma monotonically decreases with increase in n(e)_wp. The electron density of the divertor simulation plasma becomes saturated against increase in n(e)_wp when the plasma is sustained only by the ion cyclotron heating. This may suggest a sign of the beginning of the density roll-over. Additional electron cyclotron heating to the upstream plasma increases the density of both the upstream plasma and the divertor simulation plasma, and the saturated density of the divertor simulation plasma recovers to a linear dependence on n(e)_wp, suggesting an enhanced ionization of neutral gases in the upstream and the D-module.	[Nojiri, K.; Sakamoto, M.; Oki, K.; Yoshikawa, M.; Nakashima, Y.; Yoshikawa, M.; Terakado, A.; Nohara, R.; Mizuguchi, M.; Imai, T.; Ichimura, M.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan	Nojiri, K (reprint author), Univ Tsukuba, Plasma Res Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	sakamoto@prc.tsukuba.ac.jp			National Institute for Fusion Science (NIFS) [NIFS13KUGM083, NIFS14KUGM086]	This study has been carried out under collaboration with the National Institute for Fusion Science (NIFS) (NIFS13KUGM083 and NIFS14KUGM086).	Asakura N, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/11/115010; Giroud C, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113025; Loarte A, 2007, NUCL FUSION, V47, pS203, DOI 10.1088/0029-5515/47/6/S04; Takamura S, 2002, PLASMA SOURCES SCI T, V11, pA42, DOI 10.1088/0963-0252/11/3A/306; Schweinzer J, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/11/113003; Kallenbach A, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/5/055002; Kallenbach A, 2011, J NUCL MATER, V415, pS19, DOI 10.1016/j.jnucmat.2010.11.105; Hoshino K, 2014, CONTRIB PLASM PHYS, V54, P404, DOI 10.1002/ctpp.201410032; IWAMOTO M., 2014, PLASMA FUSION RES, V9; Kallenbach A, 2005, J NUCL MATER, V337, P732, DOI 10.1016/j.jnucmat.2004.10.027; Loarte A, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3567547; Monier-Garbet P, 2005, NUCL FUSION, V45, P1404, DOI 10.1088/0029-5515/45/11/022; Nakashima Y, 2013, J NUCL MATER, V438, pS738, DOI 10.1016/j.jnucmat.2013.01.157; Nakashima Y, 2010, FUSION ENG DES, V85, P956, DOI 10.1016/j.fusengdes.2010.09.015; Nakashima Y, 2013, FUSION SCI TECHNOL, V63, P100; Nakashima Y, 2011, J NUCL MATER, V415, pS996, DOI 10.1016/j.jnucmat.2010.11.081; Sakamoto M, 2013, FUSION SCI TECHNOL, V63, P188; Tobita K, 2007, NUCL FUSION, V47, P892, DOI 10.1088/0029-5515/47/8/022	18	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					120	124				5	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600020		
J	Tanaka, H; Sakamoto, M; Furutachi, K; Oki, K; Mizuguchi, M; Nagatsuka, Y; Yoshikawa, M; Nohara, R; Yoshikawa, M; Kohagura, J; Ohno, N; Tsuji, Y				Tanaka, H.; Sakamoto, M.; Furutachi, K.; Oki, K.; Mizuguchi, M.; Nagatsuka, Y.; Yoshikawa, M.; Nohara, R.; Yoshikawa, M.; Kohagura, J.; Ohno, N.; Tsuji, Y.			CORRELATION ANALYSIS OF 3-4 KILOHERTZ CORE AND EDGE DENSITY FLUCTUATIONS IN THE GAMMA 10 TANDEM MIRROR DEVICE	FUSION SCIENCE AND TECHNOLOGY			English	Article						GAMMA 10; correlation analysis; gold neutral beam probe		Propagation behavior of 3-4 kHz electron density fluctuation in the core and edge regions was investigated in the GAMMA 10 tandem mirror device. Frequency analysis was employed for high spatiotemporal-resolution fluctuations measured by gold neutral beam probe (GNBP) in the central cell and Langmuir probes in the end region. We found same-frequency periodic fluctuations in both signals and applied the correlation analysis technique. By considering the geometry of the measurement system, propagation speeds of the periodic fluctuation along and across the magnetic field lines were estimated.	[Tanaka, H.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Sakamoto, M.; Furutachi, K.; Oki, K.; Mizuguchi, M.; Nagatsuka, Y.; Yoshikawa, M.; Nohara, R.; Yoshikawa, M.; Kohagura, J.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan; [Ohno, N.; Tsuji, Y.] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan	Tanaka, H (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Orochi Cho, Toki, Gifu 5095292, Japan.	tanaka.hirohiko@lhd.nifs.ac.jp			National Institute for Fusion Science (NIFS) [NIFS12KUGM074, NIFS13KUGM083, NIFS14KUGM087]	This work was performed with the support and under the auspices of the National Institute for Fusion Science (NIFS) Collaboration Research Program (NIFS12KUGM074, NIFS13KUGM083, and NIFS14KUGM087).	Vershkov VA, 2005, NUCL FUSION, V45, pS203, DOI 10.1088/0029-5515/45/10/S17; Fedorczak N, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4769849; KRUPNIK L., 2006, P 33 EPS C PLASM P I, V301; Miyata Yoshiaki, 2011, Plasma and Fusion Research, V6, DOI 10.1585/pfr.6.1202090; Mizuguchi M, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2964227; Nakashima Y, 2011, J NUCL MATER, V415, pS996, DOI 10.1016/j.jnucmat.2010.11.081; Sakamoto M, 2013, FUSION SCI TECHNOL, V63, P188; Tanaka H, 2010, CONTRIB PLASM PHYS, V50, P256, DOI 10.1002/ctpp.201010043	8	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					125	129				5	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600021		
J	Shimizu, K; Nakashima, Y; Hosoda, Y; Ichimura, K; Takeda, H; Iwamoto, M; Oki, K; Sakamoto, M; Imai, T; Ichimura, M				Shimizu, K.; Nakashima, Y.; Hosoda, Y.; Ichimura, K.; Takeda, H.; Iwamoto, M.; Oki, K.; Sakamoto, M.; Imai, T.; Ichimura, M.			SPECTROSCOPIC MEASUREMENTS IN THE EXPERIMENTS OF GAS INJECTION TO THE DIVERTOR SIMULATION EXPERIMENTAL MODULE OF GAMMA 10/PDX	FUSION SCIENCE AND TECHNOLOGY			English	Article						detached plasma; impurity transport; GAMMA 10/PDX	TANDEM MIRROR	In this paper, detailed results on spectral measurement are reported and the argument on impurity transport is presented from the comparison of the spectral measurements in the end-cell and the plug/barrier-cell. Spectroscopic measurement in the plug/barrier-cell was carried out for the first time. Ionization behavior in the plug/barrier-cell showed a significant difference from that in the end-cell. Discussion of detached plasma generation from the change of the electron temperature, density and emission spectrum by the gas injection conditions is also presented. In the case that the plenum pressure of noble gas was increased, the radiation of hydrogen neutrals decreased by 20 similar to 90% and the ion saturation current decreased by 90 similar to 95%, which indicated that electron density is reduced by recombination. It is suggested that the effect of molecular activated recombination may have appeared.	[Shimizu, K.; Nakashima, Y.; Hosoda, Y.; Ichimura, K.; Takeda, H.; Iwamoto, M.; Oki, K.; Sakamoto, M.; Imai, T.; Ichimura, M.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan	Shimizu, K (reprint author), Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan.	shimizu_keita@prc.tsukuba.ac.jp			University of Tsukuba; National Institute for Fusion Science [NlFS12KUGM066]	This study was supported by the bi-directional collaboration research program from the University of Tsukuba and the National Institute for Fusion Science (NlFS12KUGM066). The authors thank the members of the GAMMA 10 groups for their collaboration in the experiments and their helpful discussions.	EZUMI N., 1999, J NUCL MATER, V266-269, P377; HOSODA Y., 2014, PLASMA FUSION RES, V9; Nakashima Y, 2013, J NUCL MATER, V438, pS738, DOI 10.1016/j.jnucmat.2013.01.157; Nakashima Y, 2011, FUSION SCI TECHNOL, V59, P61; Nakashima Y, 2010, FUSION ENG DES, V85, P956, DOI 10.1016/j.fusengdes.2010.09.015	5	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					130	135				6	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600022		
J	Sumida, S; Ichimura, M; Yokoyama, T; Hirata, M; Ikezoe, R; Iwamoto, Y; Okada, T; Takeyama, K; Jang, S; Sakamoto, M; Nakashima, Y; Yoshikawa, M; Minami, R; Oki, K; Mizuguchi, M; Ichimura, K				Sumida, S.; Ichimura, M.; Yokoyama, T.; Hirata, M.; Ikezoe, R.; Iwamoto, Y.; Okada, T.; Takeyama, K.; Jang, S.; Sakamoto, M.; Nakashima, Y.; Yoshikawa, M.; Minami, R.; Oki, K.; Mizuguchi, M.; Ichimura, K.			HIGH-DENSITY PLASMA PRODUCTION IN THE GAMMA 10 CENTRAL CELL WITH ICRF HEATING ON BOTH ANCHOR CELLS	FUSION SCIENCE AND TECHNOLOGY			English	Article						ICRF heating; GAMMA 10; minimum B	TANDEM MIRROR GAMMA-10; ALFVEN WAVES; ANTENNAS	In the GAMMA 10 tandem mirror, divertor simulation experiments that utilize particle flux toward the west end region (called end-loss flux) have been implemented. Since a positive correlation has been reported between the end-loss flux and the central-cell density, an increase of the central-cell density is important for obtaining a higher end-loss flux on the divertor simulation experiments. By arranging the ion cyclotron range of frequency (ICRF) systems so as to excite strong ICRF waves in both anchor cells simultaneously, we have succeeded in producing high-density plasmas (line density of 1.2 x 10(14) cm(-2)) in both anchor cells. As a result, a higher central-cell density of 4.4 x 10(12) cm(-3) and a higher end-loss flux of more than 10(23) m(-2)s(-1) have been obtained. One of the possible mechanisms of the high density production is a formation of positive potentials on both anchor cells. Plasmas in the central cell are confined due to those potentials.	[Sumida, S.; Ichimura, M.; Yokoyama, T.; Hirata, M.; Ikezoe, R.; Iwamoto, Y.; Okada, T.; Takeyama, K.; Jang, S.; Sakamoto, M.; Nakashima, Y.; Yoshikawa, M.; Minami, R.; Oki, K.; Mizuguchi, M.; Ichimura, K.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 305, Japan	Sumida, S (reprint author), Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 305, Japan.	sumida_shuhei@prc.tsukuba.ac.jp			National Institute for Fusion Science, Japan [NIFS14KUGM086, NIFS13KUGM077]	The authors acknowledge the GAMMA 10 group of the University of Tsukuba for their collaboration. This work was partly supported by the bidirectional collaborative research program of the National Institute for Fusion Science, Japan (NIFS14KUGM086 and NIFS13KUGM077).	ICHIMURA M, 1988, NUCL FUSION, V28, P799, DOI 10.1088/0029-5515/28/5/005; INUTAKE M, 1990, PHYS REV LETT, V65, P3397, DOI 10.1103/PhysRevLett.65.3397; INUTAKE M, 1985, PHYS REV LETT, V55, P939, DOI 10.1103/PhysRevLett.55.939; HOJO H, 1991, PHYS REV LETT, V66, P1866, DOI 10.1103/PhysRevLett.66.1866; INUTAKE M., 1994, P INT C OPEN PLASMA, P51; ISHII K, 1985, REV SCI INSTRUM, V56, P1053, DOI 10.1063/1.1138266; NAKASHIMA Y., 2012, P 24 INT C FUS EN SA; TAMANO T., 1995, P 15 INT C PLASM PHY, V2, P399; Ugajin Y, 2013, FUSION SCI TECHNOL, V63, P268; WATARI T, 1982, NUCL FUSION, V22, P1359, DOI 10.1088/0029-5515/22/10/011; YOKOYAMA T., 2012, PLASMA FUSION RES, V7	11	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					136	141				6	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600023		
J	Minami, R; Imai, T; Kariya, T; Numakura, T; Kato, T; Uehara, M; Goto, R; Tsumura, K; Endo, Y; Ichimura, M				Minami, R.; Imai, T.; Kariya, T.; Numakura, T.; Kato, T.; Uehara, M.; Goto, R.; Tsumura, K.; Endo, Y.; Ichimura, M.			EXPERIMENTAL RESULTS AND DESIGN OF MIRROR ANTENNA AND MW GYROTRON FOR CONTROL OF HIGH INTERMITTENT HEAT FLUX IN GAMMA 10 TANDEM MIRROR	FUSION SCIENCE AND TECHNOLOGY			English	Article						ECH; gyrotron; tandem mirror	ITER	Development of an electron cyclotron heating (ECH) mirror antenna and MW gyrotrons for power modulation experiments in GAMMA 10 has been started in order to generate and control the high heat flux and to make the edge-localized mode (ELM)-like intermittent heat load pattern for divertor simulation studies. A peak heat flux of more than 10 MW/m(2) on the GAMMA 10 axis has been obtained during ECH injection within the available power of ECH. This value almost corresponds to the steady-state heat load of the divertor plate of ITER. However, we need a substantial upgrade of the heating power to approach the ITER level ELM energy density. We carry out a design study for a mirror antenna and higher power gyrotrons in order to generate higher intermittent heat flux in GAMMA 10 tandem mirror for future divertor simulation studies.	[Minami, R.; Imai, T.; Kariya, T.; Numakura, T.; Kato, T.; Uehara, M.; Goto, R.; Tsumura, K.; Endo, Y.; Ichimura, M.] Univ Tsukuba, Plasma Res Ctr, Ibaraki, Japan	Minami, R (reprint author), Univ Tsukuba, Plasma Res Ctr, Ibaraki, Japan.	minami@prc.tsukuba.ac.jp			National Institute for Fusion Science (NIFS) [NIFS11KUGM050]; Ministry of Education, Science, Sports and Culture of Japan [23560997]	The authors thank the members of the GAMMA 10 group of the University of Tsukuba for their collaboration and valuable discussion during this study. This work was partially supported by National Institute for Fusion Science (NIFS) Collaborative Program (NIFS11KUGM050) and the grant-in-aid for Scientific Research from Ministry of Education, Science, Sports and Culture of Japan (23560997).	Janeschitz G, 2001, J NUCL MATER, V290, P1, DOI 10.1016/S0022-3115(00)00623-1; Federici G, 2001, J NUCL MATER, V290, P260, DOI 10.1016/S0022-3115(00)00627-9; Imai T, 2011, FUSION SCI TECHNOL, V59, P1; Kariya T, 2011, J INFRARED MILLIM TE, V32, P295, DOI 10.1007/s10762-010-9727-8; Kariya T, 2007, FUSION SCI TECHNOL, V51, P397; Minami R, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063003; NAKASHIMA Y., 2010, P 23 IAEA FUS EN C D; Nakashima Y, 2011, J NUCL MATER, V415, pS996, DOI 10.1016/j.jnucmat.2010.11.081; SAITO T, 1995, FUSION ENG DES, V26, P241, DOI 10.1016/0920-3796(94)00191-9; Tatematsu Y, 2005, JPN J APPL PHYS 1, V44, P6791, DOI 10.1143/JJAP.44.6791	10	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					142	146				5	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600024		
J	Kariya, T; Minami, R; Imai, T; Kato, T; Idei, H; Hanada, K; Zushi, H; Numakura, T; Endo, Y; Ichimura, M				Kariya, T.; Minami, R.; Imai, T.; Kato, T.; Idei, H.; Hanada, K.; Zushi, H.; Numakura, T.; Endo, Y.; Ichimura, M.			DEVELOPMENT OF 28 GHz GYROTRON FOR COOPERATIVE ECH STUDY	FUSION SCIENCE AND TECHNOLOGY			English	Article						gyrotron; ECH; electron cyclotron current drive	1 MW GYROTRON; FUSION-RESEARCH; ECRH	At the Plasma Research Center at University of Tsukuba, development of megawatt gyrotrons is being performed as a collaborative electron cyclotron heating (ECH) study with some research organizations. A 28 GHz 1 MW 1 s gyrotron has been developed to upgrade the GAMMA 10/PDX ECH systems. To improve the oscillation efficiency in high current regions, the magnetron injection gun (MIG) of the 28 GHz gyrotron has been modified. Output power of 1.25 MW has been achieved with this gyrotron. For the first step of the collaborative research between Tsukuba University and Kyushu University, the Tsukuba 28 GHz gyrotron was adapted to the Q-shu University Experiment with Steady-State Spherical Tokamak (QUEST) ECH system, and the plasma heating and current drive effect were demonstrated. We obtained successful results, including an electron cyclotron-driven plasma current of 66 kA in the QUEST plasma experiment. For the next step of the collaborative research, the design targets of a 2 MW 3 s and 0.4 MW continuous wave have been achieved in a design study of a new 28 GHz gyrotron.	[Kariya, T.; Minami, R.; Imai, T.; Kato, T.; Numakura, T.; Endo, Y.; Ichimura, M.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan; [Idei, H.; Hanada, K.; Zushi, H.] Kyushu Univ, Appl Mech Res Inst, Fukuoka 8168580, Japan	Kariya, T (reprint author), Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan.	kariya@prc.tsukuba.ac.jp	Kyushu, RIAM/F-4018-2015		NIFS [NIFS13KUGM080, NIFS11KUGM050]; Ministry of Education, Science, Sports and Culture of Japan [26249141]	The authors thank the members of the GAMMA 10 group of the University of Tsukuba for their collaboration and valuable discussion during this study. This work is partially supported by NIFS Collaborative Program (NIFS13KUGM080, NIFS11KUGM050) and the grant-in-aid for scientific research from Ministry of Education, Science, Sports and Culture of Japan (26249141).	Takahashi H, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4884365; Eguchi T, 2013, FUSION SCI TECHNOL, V63, P280; IDEI H., 2012, J PLASMA FUSION RES, V7; IDEI H., 2014, P 25 IAEA FUS EN C S; Kariya T, 2011, J INFRARED MILLIM TE, V32, P295, DOI 10.1007/s10762-010-9727-8; Kariya T, 2013, FUSION SCI TECHNOL, V63, P265; Kariya T, 2009, FUSION SCI TECHNOL, V55, P91; Kariya T, 2011, FUSION SCI TECHNOL, V59, P241; KARIYA T., 2013, J PLASMA FUSION RES, V8; Minami R, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063003; Nakabayashi H, 2013, FUSION SCI TECHNOL, V63, P283; Neilson J., 2002, IEEE T PLASMA SCI, V30, P755; Ota M, 2011, FUSION SCI TECHNOL, V59, P238	13	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					147	151				5	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600025		
J	Okada, T; Ikezoe, R; Ichimura, M; Hirata, M; Yokoyama, T; Iwamoto, Y; Sumida, S; Takeyama, K; Jang, S; Yoshikawa, M; Kohagura, J; Shima, Y				Okada, T.; Ikezoe, R.; Ichimura, M.; Hirata, M.; Yokoyama, T.; Iwamoto, Y.; Sumida, S.; Takeyama, K.; Jang, S.; Yoshikawa, M.; Kohagura, J.; Shima, Y.			INTERNAL MEASUREMENT OF PROPAGATION OF ICRF WAVES BY USING REFLECTOMETERS ON GAMMA 10	FUSION SCIENCE AND TECHNOLOGY			English	Article						ICRF wave; antenna phasing; reflectometer	DIVERTOR SIMULATION EXPERIMENTS; TANDEM MIRROR; ANTENNAS; CELL	In GAMMA 10 IPDX, the divertor simulation experiment has been performed recently. Ion cyclotron range of frequency (ICRF) waves are used for plasma production and ion heating. It is necessary for obtaining better controllability and extending the operational regime to understand the excitation, propagation, and absorption of the waves. The density fluctuations accompanied by the ICRF waves propagating in the inner region of plasma has been measured by using a microwave reflectometer on the antenna-phasing experiments, where the propagation of the ICRF waves is actively controlled. The phase difference between two axially separated ICRF antennas remarkably affects the global plasma parameters. The density fluctuation caused by the interfered ICRF waves is shown to depend clearly on the phase difference between the waves excited from two antennas. The availability of a reflectometer for the evaluation of the internal wave propagation is shown.	[Okada, T.; Ikezoe, R.; Ichimura, M.; Hirata, M.; Yokoyama, T.; Iwamoto, Y.; Sumida, S.; Takeyama, K.; Jang, S.; Yoshikawa, M.; Kohagura, J.; Shima, Y.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 305, Japan	Okada, T (reprint author), Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 305, Japan.	okada_takuya@prc.tsukuba.ac.jp			Japan Society for Promotion of Science [25400531]; National Institute for Fusion Science, Japan [NIFS14KUGM097]	This work was partly supported by a Grant-in-Aid for Scientific Research from the Japan Society for Promotion of Science (No. 25400531) and by the bidirectional collaborative research program of the National Institute for Fusion Science, Japan (NIFS14KUGM097).	Ikezoe R, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073040; ICHIMURA M, 1988, NUCL FUSION, V28, P799, DOI 10.1088/0029-5515/28/5/005; HOJO H, 1993, JPN J APPL PHYS 1, V32, P3287, DOI 10.1143/JJAP.32.3287; INUTAKE M, 1990, PHYS REV LETT, V65, P3397, DOI 10.1103/PhysRevLett.65.3397; Nakashima Y, 2013, FUSION SCI TECHNOL, V63, P100; Sakamoto M, 2013, FUSION SCI TECHNOL, V63, P188; Ugajin Y, 2013, FUSION SCI TECHNOL, V63, P268; YOKOYAMA T., 2012, PLASMA FUSION RES, V7	8	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					161	165				5	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600028		
J	Nakamoto, S; Takeshita, Y; Hagihara, S; Wada, T; Takeno, H; Yasaka, Y; Furuyama, Y; Taniike, A				Nakamoto, Satoshi; Takeshita, Yousuke; Hagihara, Shota; Wada, Takayuki; Takeno, Hiromasa; Yasaka, Yasuyoshi; Furuyama, Yuichi; Taniike, Akira			ENHANCED ENERGY RECOVERY IN A SECONDARY ELECTRON DIRECT ENERGY CONVERTER THROUGH REDUCTION OF THE MAGNETIC MIRROR EFFECT	FUSION SCIENCE AND TECHNOLOGY			English	Article						advanced fusion; direct energy conversion; secondary electron	FUSION; IONS	With an aim to improve the total efficiency of a D-(3) He nuclear fusion direct energy conversion system, a secondary electron direct energy converter (SEDEC) is proposed. The incident high-energy protons in an SEDEC penetrate a large number of foil electrodes aligned in the direction of the proton beam, and emitted secondary electrons are recovered. The results of the initial experiments showed that most of the secondary electrons flowed into anteroposterior electrodes and did not arrive at the electron collector located alongside and perpendicular to the direction of the proton beam. A magnetic field was introduced to push the electrons toward the electron collector, but it was not effective for energy recovery. This technical note analyzes the trajectories of electrons in the presence of the magnetic field and proposes and examines a revised arrangement of permanent magnets. The arrangement of the magnets along one side of the proton beam greatly improved the energy recovery; however, the recovery level was lower than that without magnets.	[Nakamoto, Satoshi; Takeshita, Yousuke; Hagihara, Shota; Wada, Takayuki; Takeno, Hiromasa; Yasaka, Yasuyoshi] Kobe Univ, Dept Elect & Elect Engn, Kobe, Hyogo 657, Japan; [Furuyama, Yuichi; Taniike, Akira] Kobe Univ, Grad Sch Maritime Sci, Kobe, Hyogo 657, Japan	Nakamoto, S (reprint author), Kobe Univ, Dept Elect & Elect Engn, Kobe, Hyogo 657, Japan.	nakamoto@kobe-u.ac.jp					Akashi D, 2013, FUSION SCI TECHNOL, V63, P301; MOIR RW, 1973, NUCL FUSION, V13, P35, DOI 10.1088/0029-5515/13/1/005; MOMOTA H., 1990, LA11808C, P8; Ogawa H, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.012902; TAKESHITA Y., 2013, 9 GEN SCI ASS AS PLA; Yasaka Y, 2009, FUSION SCI TECHNOL, V55, P1	6	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					166	170				5	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600029		
J	Wang, X; Kanno, S; Kohagura, J; Yoshikawa, M; Shima, Y; Nakashima, Y; Sakamoto, M; Oki, K; Imai, T; Ichimura, M; Nagayama, Y; Kuwahara, D; Mase, A				Wang, X.; Kanno, S.; Kohagura, J.; Yoshikawa, M.; Shima, Y.; Nakashima, Y.; Sakamoto, M.; Oki, K.; Imai, T.; Ichimura, M.; Nagayama, Y.; Kuwahara, D.; Mase, A.			A NOVEL FREQUENCY-MULTIPLIED INTERFEROMETER SYSTEM WITH 1-D HORN-ANTENNA MIXER ARRAY IN THE GAMMA 10/PDX END DIVERTOR MODULE	FUSION SCIENCE AND TECHNOLOGY			English	Article						frequency-multiplied interferometer system; 1-D horn-antenna mixer array; GAMMA 10/PDX		In GAMMA 10/PDX, divertor simulation studies have been started as a new research plan by using end-loss plasma flux at the end-mirror region. A divertor simulation experimental module (D-module) was installed in the west end-cell. Here we introduce a novel microwave interferometer system with a phase imaging method, and all the crucial components are designed and tested. Finally, we tested the interferometer system using a Teflon plate in substitution for plasma. In order to improve the system accuracy, the phase detection circuit was modified and the phase difference of each channel was verified.	[Wang, X.; Kanno, S.; Kohagura, J.; Yoshikawa, M.; Shima, Y.; Nakashima, Y.; Sakamoto, M.; Oki, K.; Imai, T.; Ichimura, M.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 305, Japan; [Nagayama, Y.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kuwahara, D.] Tokyo Univ Agr & Technol, Koganei, Tokyo, Japan; [Mase, A.] Kyushu Univ, KASTEC, Kasuga, Fukuoka 816, Japan	Wang, X (reprint author), Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 305, Japan.	wang_xl@prc.tsukuba.ac.jp			NIFS [NIFS14KUGM086, NIFS13KUGM078]	The authors would like to acknowledge the members of the GAMMA 10 group, University of Tsukuba, for their collaboration in the experiments. This work is partially supported by the NIFS Collaborative Program (NIFS14KUGM086 and NIFS13KUGM078).	Akiyama T, 2010, FUSION SCI TECHNOL, V58, P352; Esteban L, 2010, FUSION SCI TECHNOL, V58, P771; Kogi Y, 2013, FUSION SCI TECHNOL, V63, P172; Kohagura J, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4731006; KUWAHARA D., 2010, J PLASMA FUSION RES, V9, P125; KUWAHARA D., 2009, J PLASMA FUSION RES, V8, P649; Kuwahara D, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3491223; Nagayama Y, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4729259; Yoshikawa M, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3464577	9	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					178	184				7	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600031		
J	Yokoyama, T; Ichimura, M; Fukuyama, A; Sumida, S; Hirata, M; Ikezoe, R; Iwamoto, Y; Okada, T; Takeyama, K; Jang, S				Yokoyama, T.; Ichimura, M.; Fukuyama, A.; Sumida, S.; Hirata, M.; Ikezoe, R.; Iwamoto, Y.; Okada, T.; Takeyama, K.; Jang, S.			ANALYSIS OF WAVE EXCITATION OF THE PHASE-CONTROL ICRF ANTENNAS WITH THREE-DIMENSIONAL FULL WAVE CODE ON GAMMA 10	FUSION SCIENCE AND TECHNOLOGY			English	Article						GAMMA 10; ICRF heating; minimum-B configuration	TANDEM MIRROR; ALFVEN WAVES	On the GAMMA 10 tandem mirror, divertor simulation experiments progress with high-temperature plasmas produced by waves in ion-cyclotron range of frequency (ICRF) and open magnetic fields. In these experiments, high-temperature and high-density plasmas are required to be produced and controlled. In order to enhance the ion heating in the anchor cell, phase-control experiments, which use two ICRF antennas installed in the central cell and the anchor cell, are introduced. In these experiments, ICRF waves in the same frequency (10 MHz) are excited. Ion heating in the anchor cell is performed more effectively with phase control. In order to analyze wave propagation in the phase-control experiments, a three-dimensional full wave code (TASK/WF), in which parallel processing has been implemented recently, is introduced. In this technical note, we discuss ICRF wave excitation and propagation in the phase-control experiments. It is clearly observed by the experiments and wave analysis that the enhancement of ion heating in the anchor cell is performed by phase-control experiments.	[Yokoyama, T.; Ichimura, M.; Sumida, S.; Hirata, M.; Ikezoe, R.; Iwamoto, Y.; Okada, T.; Takeyama, K.; Jang, S.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 305, Japan; [Fukuyama, A.] Kyoto Univ, Dept Nucl Engn, Grad Sch Engn, Kyoto 606, Japan	Yokoyama, T (reprint author), Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 305, Japan.	yokoyama_takuro@prc.tsukuba.ac.jp			National Institute for Fusion Science, Japan [NIFS14KUGM086, NIFS13KUGM077]	The authors appreciate all members of GAMMA 10 and related efforts. This work is partially supported by the bidirectional collaborative research program of National Institute for Fusion Science, Japan (NIFS14KUGM086 and NIFS13KUGM077).	ICHIMURA M, 1988, NUCL FUSION, V28, P799, DOI 10.1088/0029-5515/28/5/005; INUTAKE M, 1990, PHYS REV LETT, V65, P3397, DOI 10.1103/PhysRevLett.65.3397; FUKUYAMA A., 2004, P 20 INT C FUS EN VI; HOJO H, 1991, PHYS REV LETT, V66, P1866, DOI 10.1103/PhysRevLett.66.1866; Ichimura M, 2013, FUSION SCI TECHNOL, V63, P115; TIMAI T., 2011, J PLASMA FUSION RES, V87, P752; WATARI T, 1982, NUCL FUSION, V22, P1359, DOI 10.1088/0029-5515/22/10/011; YOKOYAMA T., 2012, PLASMA FUSION RES, V7	8	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					185	189				5	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600032		
J	Takahashi, H; Okamoto, A; Takahashi, T; Kitajima, S				Takahashi, H.; Okamoto, A.; Takahashi, T.; Kitajima, S.			ENERGETIC HELIUM ION INJECTION INTO HELIUM RECOMBINING PLASMA IN RADIO-FREQUENCY PLASMA SOURCE	FUSION SCIENCE AND TECHNOLOGY			English	Article						helium; volumetric recombination; ion beam injection	COLLISIONAL-RADIATIVE MODEL; SIMULATOR	This technical note reports the first experimental investigation aiming for divertor plasma dynamics study using helium recombining plasma and energetic helium ion beam. A divertor plasma relevant experiment was performed using a linear plasma device, DT-ALPHA, and a multicusp ion source. The radial profiles of the line emission intensities from helium Rydberg atoms were investigated, and the reaction rate of volumetric recombination was confirmed to increase in the central region of the cylindrical plasma. Then an energetic helium ion beam was superimposed onto the helium recombining plasma. The optical emission intensities from the helium recombining plasma with and without energetic ions were obtained and compared. The temporal evolution of the optical emission indicated that charge-exchange momentum transfer between energetic helium ions and ground state helium atoms can affect population density even in recombining plasma where population density is dominated by recombining processes rather than ionizing processes.	[Takahashi, H.; Okamoto, A.; Takahashi, T.; Kitajima, S.] Tohoku Univ, Dept Quantum Sci & Energy Engn, Sendai, Miyagi 9808579, Japan	Takahashi, H (reprint author), Tohoku Univ, Dept Quantum Sci & Energy Engn, 6-6-01-2 Aobayama, Sendai, Miyagi 9808579, Japan.	hiroyuki.takahashi@pp12.qse.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) [22740357, 26420848];  [264331]	The work is partly supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) grant numbers 22740357 and 26420848 and by Grant-in-Aid for JSPS Fellows grant number 264331.	FUJIMOTO T, 1979, J QUANT SPECTROSC RA, V21, P439, DOI 10.1016/0022-4073(79)90004-9; Daibo A, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4826099; EZUMI N., 1998, CONTRIB PLASM PHYS, V38, P31, DOI 10.1002/ctpp.19980380110; Goto M, 2003, J QUANT SPECTROSC RA, V76, P331, DOI 10.1016/S0022-4073(02)00060-2; Nakashima Y, 2011, J NUCL MATER, V415, pS996, DOI 10.1016/j.jnucmat.2010.11.081; Ohno N, 1999, PHYS PLASMAS, V6, P2486, DOI 10.1063/1.873520; OKAMOTO A., 2008, PLASMA FUSION RES, V3; Okamoto Atsushi, 2011, Plasma and Fusion Research, V6, DOI 10.1585/pfr.6.1201153; Shinto K, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2165775; Takahashi H, 2013, FUSION SCI TECHNOL, V63, P404; Uesugi Y, 2001, J NUCL MATER, V290, P1134, DOI 10.1016/S0022-3115(00)00477-3	11	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	JUL	2015	68	1					190	195				6	Nuclear Science & Technology	Nuclear Science & Technology	CN0LH	WOS:000358104600033		
J	Leal-Bertioli, SCM; Cavalcante, U; Gouvea, EG; Ballen-Taborda, C; Shirasawa, K; Guimaraes, PM; Jackson, SA; Bertioli, DJ; Moretzsohn, MC				Leal-Bertioli, Soraya C. M.; Cavalcante, Uiara; Gouvea, Ediene G.; Ballen-Taborda, Carolina; Shirasawa, Kenta; Guimaraes, Patricia M.; Jackson, Scott A.; Bertioli, David J.; Moretzsohn, Marcio C.			Identification of QTLs for Rust Resistance in the Peanut Wild Species Arachis magna and the Development of KASP Markers for Marker-Assisted Selection	G3-GENES GENOMES GENETICS			English	Article						Arachis; peanut; marker-assisted selection; rust; molecular breeding	LATE LEAF-SPOT; QUANTITATIVE TRAIT LOCI; CULTIVATED PEANUT; HYPOGAEA L.; PUCCINIA-ARACHIDIS; GERMPLASM LINES; LINKAGE MAPS; A-GENOME; REGISTRATION; GROUNDNUT	Rust is a major pathogen of the peanut crop. Development and adoption of rust-resistant cultivars is the most cost efficient and effective way to control the spread of the disease and reduce yield losses. Some cultivated peanut germplasm accessions have a degree of resistance, but the secondary gene pool is a source of much stronger resistance alleles. Wild species, however, have undesirable agronomic traits that are a disincentive to their use in breeding. The identification of genomic regions that harbor disease resistance in wild species is the first step in the implementation of marker-assisted selection that can speed the introgression of wild disease resistances and the elimination of linkage drag. In this work, we identify genome regions that control different components of rust resistance in a recombinant inbred line population developed from a cross between two Arachis species, the susceptible most probable B genome ancestor of cultivated peanut, Arachis ipaensis, and an accession of its closest relative, Arachis magna, which is resistant to rust. Quantitative trait loci for several components of resistance were placed in the same position on linkage group B08. Single-nucleotide polymorphism Kompetitive allele-specific polymerase chain reaction markers for rust resistance region were designed and validated for marker function in both diploid and tetraploid contexts.	[Leal-Bertioli, Soraya C. M.; Cavalcante, Uiara; Gouvea, Ediene G.; Guimaraes, Patricia M.; Moretzsohn, Marcio C.] Embrapa Genet Resources & Biotechnol, BR-70770917 Brasilia, DF, Brazil; [Leal-Bertioli, Soraya C. M.; Ballen-Taborda, Carolina; Jackson, Scott A.; Bertioli, David J.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Cavalcante, Uiara; Gouvea, Ediene G.; Bertioli, David J.] Univ Brasilia, Inst Biol Sci, BR-70910900 Brasilia, DF, Brazil; [Shirasawa, Kenta] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan	Leal-Bertioli, SCM (reprint author), Embrapa Genet Resources & Biotechnol, PqEB W5 Norte Final, BR-70770917 Brasilia, DF, Brazil.	soraya.bertioli@embrapa.br			Fundacao de Apoio a Pesquisa do DF (FAP-DF); Generation Challenge Program Tropical Legumes 1; National Council for Scientific and Technological Development of Brazil (CNPq); MARS Inc.; Peanut Foundation	We acknowledge the greenhouse assistance of Leandro F. Mesquita; undergraduate students Aline Santana Pereira, Karinne Dantas, Iugo Galhardo, and Silvio Santos for assistance with phenotyping; Drs. Marcos Gimenes and Andrea Barbosa for providing F<INF>2</INF> plants of the mapping population; and Drs. Alessandra P. Favero and Ignacio Godoy for providing MagSten DNAs for marker analysis. This work was supported by the Fundacao de Apoio a Pesquisa do DF (FAP-DF); the Generation Challenge Program Tropical Legumes 1; National Council for Scientific and Technological Development of Brazil (CNPq); MARS Inc.; The Peanut Foundation; and host institutions.	SUBRAHMANYAM P, 1989, ECON BOT, V43, P444, DOI 10.1007/BF02935917; Burow MD, 2009, GENOME, V52, P107, DOI [10.1139/g08-094, 10.1139/G08-094]; Moretzsohn MC, 2013, ANN BOT-LONDON, V111, P113, DOI 10.1093/aob/mcs237; CHURCHILL GA, 1994, GENETICS, V138, P963; Varshney RK, 2014, THEOR APPL GENET, V127, P1771, DOI 10.1007/s00122-014-2338-3; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Leal-Bertioli SCD, 2010, J PHYTOPATHOL, V158, P792, DOI 10.1111/j.1439-0434.2010.01704.x; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Chu Y, 2011, PLANT GENOME-US, V4, P110, DOI 10.3835/plantgenome2011.01.0001; Pande S, 2001, PLANT DIS, V85, P851, DOI 10.1094/PDIS.2001.85.8.851; SAVARY S, 1989, J PHYTOPATHOL, V124, P259; ZENG ZB, 1994, GENETICS, V136, P1457; Simpson CE, 2003, CROP SCI, V43, P1561; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; Milla SR, 2005, GENOME, V48, P1, DOI 10.1139/G04-089; Robledo G, 2009, THEOR APPL GENET, V118, P1295, DOI 10.1007/s00122-009-0981-x; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Seijo G, 2007, AM J BOT, V94, P1963, DOI 10.3732/ajb.94.12.1963; Shirasawa K, 2013, DNA RES, V20, P173, DOI 10.1093/dnares/dss042; Doerge RW, 1996, GENETICS, V142, P285; Favero AP, 2009, SCI AGR, V66, P110, DOI 10.1590/S0103-90162009000100015; Holbrook CC, 2008, J PLANT REGIST, V2, P92, DOI 10.3198/jpr2007.12.0662crc; Bertioli DJ, 2014, G3-GENES GENOM GENET, V4, P89, DOI 10.1534/g3.113.007617; Bechara MD, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-255; Burow MD, 2014, MOL BREEDING, V34, P393, DOI 10.1007/s11032-014-0042-2; Duitama J., 2014, NUCLEIC ACIDS RES, V42, pe44; Fonceka D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-26; Fonceka D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048642; Gautami B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041213; Gibbons RW, 1980, P INT S DEV TRANSF T, P27; Gowda M. V. C., 2002, INT ARACHIS NEWSLETT, V22, P29; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hammons R. O., 1973, PEANUTS CULTURE USES, P17; Krapovickas A., 2007, BONPLANDIA S, V16, P1; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Leal-Bertioli S, 2015, GENETICS, V199, P1093, DOI 10.1534/genetics.115.174607; Leal-Bertioli S. C. M., 2014, ANN BOT-LONDON, V115, P237; Leal-Bertioli S. C. M., 2014, 7 INT C ADV AR GEN B; Leal-Bertioli SCM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-112; Lincoln S. E., 1992, TECHNICAL REPORT, V3, pXXX; MORAES S A, 1982, Summa Phytopathologica, V8, P39; Moretzsohn MC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-40; Simpson CE, 2001, CROP SCI, V41, P918; Stalker HT, 2002, CROP SCI, V42, P312; Stalker HT, 2002, CROP SCI, V42, P313; SUBRAHMANYAM P, 1993, CURR PLANT SCI BIOT, V18, P147; Subrahmanyam P., 1982, Peanut Science, V9, P6, DOI 10.3146/i0095-3679-9-1-2; Vale F. X. R., 2001, QUANT QUANTIFICACAO, P101; VAN DER PLANK J. E., 1963, PLANT DIS EPIDEMICS; Wang S, 2006, WINDOWS QTL CARTOGRA	52	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	JUL 1	2015	5	7					1403	1413		10.1534/g3.115.018796		11	Genetics & Heredity	Genetics & Heredity	CM8LD	WOS:000357951500009		
J	Winkelstroter, LK; Dolan, SK; dos Reis, TF; Bom, VLP; de Castro, PA; Hagiwara, D; Alowni, R; Jones, GW; Doyle, S; Brown, NA; Goldman, GH				Winkelstroeter, Lizziane K.; Dolan, Stephen K.; dos Reis, Thaila Fernanda; Pedro Bom, Vinicius Leite; de Castro, Patricia Alves; Hagiwara, Daisuke; Alowni, Raneem; Jones, Gary W.; Doyle, Sean; Brown, Neil Andrew; Goldman, Gustavo H.			Systematic Global Analysis of Genes Encoding Protein Phosphatases in Aspergillus fumigatus	G3-GENES GENOMES GENETICS			English	Article						Aspergillus fumigatus; HOG phosphatases; gliotoxin; iron metabolism; protein phosphatases	OXIDATIVE STRESS-RESPONSE; CELL-WALL INTEGRITY; TYROSINE PHOSPHATASES; INVASIVE ASPERGILLOSIS; ASEXUAL DEVELOPMENT; PHOSPHORYL TRANSFER; BIOFILM FORMATION; CANDIDA-ALBICANS; FUNCTIONAL ROLES; KINASE PATHWAY	Aspergillus fumigatus is a fungal pathogen that causes several invasive and noninvasive diseases named aspergillosis. This disease is generally regarded as multifactorial, considering that several pathogenicity determinants are present during the establishment of this illness. It is necessary to obtain an increased knowledge of how, and which, A. fumigatus signal transduction pathways are engaged in the regulation of these processes. Protein phosphatases are essential to several signal transduction pathways. We identified 32 phosphatase catalytic subunit-encoding genes in A. fumigatus, of which we were able to construct 24 viable deletion mutants. The role of nine phosphatase mutants in the HOG (high osmolarity glycerol response) pathway was evaluated by measuring phosphorylation of the p38 MAPK (SakA) and expression of osmo-dependent genes. We were also able to identify 11 phosphatases involved in iron assimilation, six that are related to gliotoxin resistance, and three implicated in gliotoxin production. These results present the creation of a fundamental resource for the study of signaling in A. fumigatus and its implications in the regulation of pathogenicity determinants and virulence in this important pathogen.	[Winkelstroeter, Lizziane K.; dos Reis, Thaila Fernanda; Pedro Bom, Vinicius Leite; de Castro, Patricia Alves; Brown, Neil Andrew; Goldman, Gustavo H.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-13083970 Ribeirao Preto, Brazil; [Dolan, Stephen K.; Alowni, Raneem; Jones, Gary W.; Doyle, Sean] Maynooth Univ, Dept Biol, Maynooth, Kildare, Ireland; [Hagiwara, Daisuke] Chiba Univ, Med Mycol Res Ctr, Chiba 2608673, Japan; [Goldman, Gustavo H.] Natl Lab Sci & Technol Bioethanol CTBE, BR-13083970 Campinas, SP, Brazil	Goldman, GH (reprint author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao, Dept Ciencias Farmaceut, Av Cafe S-N, BR-14040903 Sao Paulo, Brazil.	ggoldman@usp.br			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Irish Research Council Embark PhD Fellowship; Science Foundation Ireland [PI/11/1188, 12/IP/1695]; Irish Higher Education Authority; Government of the Kingdom of Saudi Arabia;  [SFI/12/ISCA/2494]	We thank Drs. Axel Brakhage and Vito Valiante for providing us the A. fumigatus Delta mpkA mutant, the two anonymous reviewers and the editor for their comments and suggestions, and Dr. Elodie Bovier for help with the phylogenetic analysis. We also thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) for providing financial support. S.K.D. is a recipient of an Irish Research Council Embark PhD Fellowship. Fungal research in the laboratory of S.D. is funded by Science Foundation Ireland Awards (PI/11/1188 & 12/IP/1695). HPLC and LC-MS facilities were funded by a competitive award from the Irish Higher Education Authority. Research exchanges between the laboratories of G.H.G., G.W.J., and S.D. were funded in part by SFI/12/ISCA/2494. R.A. is supported by a PhD scholarship from the Government of the Kingdom of Saudi Arabia.	Adam C, 2012, MICROBIOL-SGM, V158, P1258, DOI 10.1099/mic.0.057075-0; Erental A, 2007, MOL PLANT MICROBE IN, V20, P944, DOI 10.1094/MPMI-20-8-0944; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Gorska M, 2012, FRONT BIOSCI-LANDMRK, V17, P2269, DOI 10.2741/4050; Hawle P, 2007, EUKARYOT CELL, V6, P521, DOI 10.1128/EC.00343-06; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Schrettl M, 2011, CURR OPIN MICROBIOL, V14, P400, DOI 10.1016/j.mib.2011.06.002; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Greenberger PA, 2002, J ALLERGY CLIN IMMUN, V110, P685, DOI 10.1067/mai.2002.130179; Carberry S, 2012, FUNGAL GENET BIOL, V49, P302, DOI 10.1016/j.fgb.2012.02.003; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Cuellar-Cruz M, 2012, FUTURE MICROBIOL, V7, P755, DOI [10.2217/fmb.12.48, 10.2217/FMB.12.48]; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; ten Cate JM, 2009, J DENT RES, V88, P105, DOI 10.1177/0022034508329273; Son S, 2009, EUKARYOT CELL, V8, P573, DOI 10.1128/EC.00346-08; Zhang MM, 2010, PROTEIN SCI, V19, P974, DOI 10.1002/pro.375; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Haas H, 2014, NAT PROD REP, V31, P1266, DOI 10.1039/c4np00071d; Mattison CP, 1999, MOL CELL BIOL, V19, P7651; Dolan SK, 2014, CHEM BIOL, V21, P999, DOI 10.1016/j.chembiol.2014.07.006; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Wezensky SJ, 2011, MED MYCOL, V49, pS120, DOI 10.3109/13693786.2010.495139; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Käfer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Scharf DH, 2012, APPL MICROBIOL BIOT, V93, P467, DOI 10.1007/s00253-011-3689-1; Reyes G, 2006, EUKARYOT CELL, V5, P1934, DOI 10.1128/EC.00178-06; Yu FW, 2014, NEW PHYTOL, V203, P219, DOI 10.1111/nph.12776; Leach MD, 2012, NAT REV MICROBIOL, V10, P693, DOI 10.1038/nrmicro2875; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Grahl N, 2012, EUKARYOT CELL, V11, P560, DOI 10.1128/EC.00031-12; Xue T, 2004, EUKARYOT CELL, V3, P557, DOI 10.1128/EC.3.2.557-560.2004; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Arino J, 2011, EUKARYOT CELL, V10, P21, DOI 10.1128/EC.00249-10; Assis L. J. A., 2015, G3 BETHESDA, pG3; Brewster JL, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005458; Brown NA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-91; Chotirmall SH, 2014, MYCOPATHOLOGIA, V178, P363, DOI 10.1007/s11046-014-9768-y; da Silva FME, 2007, FUNGAL GENET BIOL, V44, P219; Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562; Ding C, 2014, MOL MICROBIOL, V93, P10, DOI 10.1111/mmi.12653; Di Stasio M, 2009, MOL MICROBIOL, V73, P73, DOI 10.1111/j.1365-2958.2009.06747.x; Du YX, 2013, CURR GENET, V59, P33, DOI 10.1007/s00294-012-0385-3; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Feng J., 2010, YEAST, V27, P753; Ghosh A., 2014, G3-GENES GENOM GENET, V4, P349; Gonzalez A, 2006, J BIOL CHEM, V281, P35057, DOI 10.1074/jbc.M607919200; Hagiwara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080881; Hagiwara D, 2014, FUNGAL GENET BIOL, V73, P138, DOI 10.1016/j.fgb.2014.10.011; Hartmann T, 2011, INT J MED MICROBIOL, V301, P408, DOI 10.1016/j.ijmm.2011.04.008; Hoi JWS, 2011, MOL BIOL CELL, V22, P1896, DOI 10.1091/mbc.E10-11-0914; Jiang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025311; Kosti I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-133; Lee K. T., 2014, EUKARYOT CELL, V13, P796; Leiter E, 2012, FUNGAL GENET BIOL, V49, P708, DOI 10.1016/j.fgb.2012.06.010; MAY GS, 2008, MYCOLOGY S, V26, P121; Moore MM, 2013, CURR OPIN MICROBIOL, V16, P692, DOI [10.1016/j.mib.2013.07.012, 10.1016/j.mib.2013:07.012]; Muszkieta L, 2014, FUNGAL GENET BIOL, V66, P79, DOI 10.1016/j.fgb.2014.02.009; POSAS F, 1993, J BIOL CHEM, V268, P1349; PUNT PJ, 1991, GENE, V104, P119, DOI 10.1016/0378-1119(91)90476-R; RUSSELL P, 1989, CELL, V57, P295, DOI 10.1016/0092-8674(89)90967-7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sambrook J., 1989, MOL CLONING LAB MANU; Sanvoisin J, 2001, BIOORG MED CHEM LETT, V11, P471, DOI 10.1016/S0960-894X(00)00694-6; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000952; Shin JH, 2013, MOL PLANT PATHOL, V14, P518, DOI 10.1111/mpp.12023; Szigeti ZM, 2014, ACTA MICROBIOL IMM H, V61, P107, DOI 10.1556/AMicr.61.2014.2.2; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Williams NH, 2004, BBA-PROTEINS PROTEOM, V1697, P279, DOI 10.1016/j.bbapap.2003.11.031; Winkelstroter L. K., 2015, MOL MICROBI IN PRESS; Yang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061307; Yang QQ, 2013, ENVIRON MICROBIOL, V15, P2696, DOI 10.1111/1462-2920.12126; Yang X. X., 2007, FEMS YEAST RES, V7, P796; ZUCKERKANDL EMILE, 1965, P97	85	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	JUL 1	2015	5	7					1525	1539		10.1534/g3.115.016766		15	Genetics & Heredity	Genetics & Heredity	CM8LD	WOS:000357951500021		
J	Matsumoto, T; Akashi, H; Yang, ZH				Matsumoto, Tomotaka; Akashi, Hiroshi; Yang, Ziheng			Evaluation of Ancestral Sequence Reconstruction Methods to Infer Nonstationary Patterns of Nucleotide Substitution	GENETICS			English	Article						ancestral reconstruction; codon usage; GC content; nonstationary models; nucleotide substitution; stochastic mapping	CODON USAGE BIAS; EPISODIC ADAPTIVE EVOLUTION; MAXIMUM-LIKELIHOOD APPROACH; BASE COMPOSITION EVOLUTION; AMINO-ACID-SEQUENCES; DROSOPHILA-MELANOGASTER; PROTEIN EVOLUTION; PHYLOGENETIC ANALYSIS; NATURAL-SELECTION; GENE CONVERSION	Inference of gene sequences in ancestral species has been widely used to test hypotheses concerning the process of molecular sequence evolution. However, the approach may produce spurious results, mainly because using the single best reconstruction while ignoring the suboptimal ones creates systematic biases. Here we implement methods to correct for such biases and use computer simulation to evaluate their performance when the substitution process is nonstationary. The methods we evaluated include parsimony and likelihood using the single best reconstruction (SBR), averaging over reconstructions weighted by the posterior probabilities (AWP), and a new method called expected Markov counting (EMC) that produces maximum-likelihood estimates of substitution counts for any branch under a nonstationary Markov model. We simulated base composition evolution on a phylogeny for six species, with different selective pressures on G+C content among lineages, and compared the counts of nucleotide substitutions recorded during simulation with the inference by different methods. We found that large systematic biases resulted from (i) the use of parsimony or likelihood with SBR, (ii) the use of a stationary model when the substitution process is nonstationary, and (iii) the use of the Hasegawa-Kishino-Yano (HKY) model, which is too simple to adequately describe the substitution process. The nonstationary general time reversible (GTR) model, used with AWP or EMC, accurately recovered the substitution counts, even in cases of complex parameter fluctuations. We discuss model complexity and the compromise between bias and variance and suggest that the new methods may be useful for studying complex patterns of nucleotide substitution in large genomic data sets.	[Matsumoto, Tomotaka; Akashi, Hiroshi] Natl Inst Genet, Div Evolutionary Genet, Mishima, Shizuoka 4118540, Japan; [Akashi, Hiroshi] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Yang, Ziheng] Chinese Acad Sci, Beijing Inst Genom, Beijing 100101, Peoples R China; [Yang, Ziheng] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England	Akashi, H (reprint author), Natl Inst Genet, Div Evolutionary Genet, Mishima, Shizuoka 4118540, Japan.	hiakashi@lab.nig.ac.jp; z.yang@ucl.ac.uk			Biotechnological and Biological Sciences Research Council; National Institute of Genetics Collaborative Research Program [2012-A16, 2013-A18, 2014-A16]	We are grateful to D. Pollock, R. Goldstein, T. Ohta, N. Osada, N. Mishra and K Kawashima, and two anonymous reviewers for their comments that helped to improve this manuscript. This study is supported by a grant from the Biotechnological and Biological Sciences Research Council (to Z.Y.) and by an award from the National Institute of Genetics Collaborative Research Program (2012-A16, 2013-A18, 2014-A16).	AKASHI H, 1994, GENETICS, V136, P927; Akashi H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001065; Akashi H, 1996, GENETICS, V144, P1297; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Jayaswal V, 2011, SYST BIOL, V60, P74, DOI 10.1093/sysbio/syq076; Moriyama EN, 1997, J MOL EVOL, V45, P514, DOI 10.1007/PL00006256; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315; Huelsenbeck JP, 2002, SYST BIOL, V51, P32, DOI 10.1080/106351502753475862; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Goldstein RA, 2006, MOL BIOL EVOL, V23, P1444, DOI 10.1093/molbev/msl010; Zou LW, 2012, SYST BIOL, V61, P927, DOI 10.1093/sysbio/sys046; KLIMAN RM, 1993, MOL BIOL EVOL, V10, P1239; Nielsen R, 2007, MOL BIOL EVOL, V24, P228, DOI 10.1093/molbev/msl146; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Pupko T, 2000, MOL BIOL EVOL, V17, P890; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8; Whelan S, 2001, MOL BIOL EVOL, V18, P691; Comeron JM, 2005, MOL BIOL EVOL, V22, P2519, DOI 10.1093/molbev/msi246; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Terekhanova NV, 2013, MOL BIOL EVOL, V30, P1315, DOI 10.1093/molbev/mst036; Eyre-Walker A, 1998, J MOL EVOL, V47, P686, DOI 10.1007/PL00006427; Hernandez RD, 2007, MOL BIOL EVOL, V24, P1792, DOI 10.1093/molbev/msm108; McVean GAT, 2001, GENETICS, V157, P245; Vicario S, 2008, MOL BIOL EVOL, V25, P2269, DOI 10.1093/molbev/msn189; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Galtier N, 1998, MOL BIOL EVOL, V15, P871; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335; Ko WY, 2003, J MOL EVOL, V57, P562, DOI 10.1007/s00239-003-2510-x; Dutheil J, 2005, MOL BIOL EVOL, V22, P1919, DOI 10.1093/molbev/msi183; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; YANG ZB, 1994, J MOL EVOL, V39, P105; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275; Lohse K, 2011, GENETICS, V189, P977, DOI 10.1534/genetics.111.129569; NAGYLAKI T, 1983, P NATL ACAD SCI-BIOL, V80, P6278, DOI 10.1073/pnas.80.20.6278; O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003; Blanquart S, 2006, MOL BIOL EVOL, V23, P2058, DOI 10.1093/molbev/msl091; AKASHI H, 1995, GENETICS, V139, P1067; YANG ZH, 1995, MOL BIOL EVOL, V12, P451; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; Ababneh F, 2006, BIOINFORMATICS, V22, P1225, DOI 10.1093/bioinformatics/btl064; Koshi JM, 1996, J MOL EVOL, V42, P313, DOI 10.1007/BF02198858; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Hobolth A, 2005, STAT APPL GENET MO B, V4; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155; Singh ND, 2009, MOL BIOL EVOL, V26, P1591, DOI 10.1093/molbev/msp071; Groussin M, 2013, SYST BIOL, V62, P523, DOI 10.1093/sysbio/syt016; Groussin M, 2011, MOL BIOL EVOL, V28, P2661, DOI 10.1093/molbev/msr098; Osada N, 2012, MOL BIOL EVOL, V29, P337, DOI 10.1093/molbev/msr211; Aoki S, 2013, MOL BIOL EVOL, V30, P2494, DOI 10.1093/molbev/mst153; Arndt PF, 2003, MOL BIOL EVOL, V20, P1887, DOI 10.1093/molbev/msg204; Barry D., 1987, STAT SCI, V2, P191, DOI DOI 10.1214/SS/1177013353; Begun DJ, 2001, MOL BIOL EVOL, V18, P1343; BULMER M, 1991, GENETICS, V129, P897; Campos JL, 2013, MOL BIOL EVOL, V30, P811, DOI 10.1093/molbev/mss222; Chang BSW, 2002, METHOD ENZYMOL, V343, P274; COLLINS TM, 1994, SYST BIOL, V43, P482, DOI 10.2307/2413547; Dayhoff M. O., 1965, ATLAS PROTEIN SEQUEN; DuMont VB, 2004, GENETICS, V167, P171, DOI 10.1534/genetics.167.1.171; DuMont VLB, 2009, GENOME BIOL EVOL, V1, P67, DOI 10.1093/gbe/evp008; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Duret L, 2002, GENETICS, V162, P1837; Dutheil J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-255; Eanes WF, 1996, GENETICS, V144, P1027; Edwards A. W. F., 1972, LIKELIHOOD; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fisher R. A., 1930, P R SOC EDINBURGH, V50, P205; FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Gardiner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001513; GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904; Goldstein R. A., 2015, MOL BIOL EV IN PRESS; Gu X, 1996, P NATL ACAD SCI USA, V93, P4671, DOI 10.1073/pnas.93.10.4671; Gueguen L, 2013, MOL BIOL EVOL, V30, P1745, DOI 10.1093/molbev/mst097; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; HARTIGAN JA, 1973, BIOMETRICS, V29, P53, DOI 10.2307/2529676; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Jayaswal V, 2014, SYST BIOL, V63, P726, DOI 10.1093/sysbio/syu036; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; JUKES T H, 1969, P21; Khelifi A, 2006, J MOL EVOL, V62, P745, DOI 10.1007/s00239-005-0186-0; Kilman R. M., 1999, J MOL BIOL, V49, P343; Krishnan NM, 2004, MOL BIOL EVOL, V21, P1871, DOI 10.1093/molbev/msh198; LI WH, 1987, J MOL EVOL, V24, P337, DOI 10.1007/BF02134132; Liao HX, 2013, NATURE, V496, P469; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176; PERNA NT, 1995, MOL BIOL EVOL, V12, P359; Poh YP, 2012, GENOME BIOL EVOL, V4, P1245, DOI 10.1093/gbe/evs097; Takano-Shimizu T, 2001, MOL BIOL EVOL, V18, P606; Tataru P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-465; Tavare S., 1986, LECTURES MATH LIFE S, V17, P57; Tuffery P, 2000, MOL BIOL EVOL, V17, P1753; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Yang Z., 2006, COMPUTATIONAL MOL EV; YANG ZH, 1995, J MOL EVOL, V41, P254; Yang ZH, 1996, MOL BIOL EVOL, V13, P650; YANG ZH, 1995, GENETICS, V141, P1641	105	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JUL	2015	200	3					873	+		10.1534/genetics.115.177386		25	Genetics & Heredity	Genetics & Heredity	CM7OJ	WOS:000357883800019		
J	Matsunaga, M				Matsunaga, Masaki			Development and Validation of an Employee Voice Strategy Scale through Four Studies in Japan	HUMAN RESOURCE MANAGEMENT			English	Article						employee voice; exploratory and confirmatory factor analysis; Japan; measurement validation; process-centered perspectives; "Western" bias	EXPLORATORY FACTOR-ANALYSIS; COVARIANCE STRUCTURE-ANALYSIS; PROACTIVE PERSONALITY; UNITED-STATES; WORKFORCE DIVERSITY; INFLUENCE TACTICS; NATIONAL CULTURE; CAREER SUCCESS; MEDIA RICHNESS; FIT INDEXES	Employee voice is an important organizational behavior that affects work group performance, and many studies have explored its mechanism; nonetheless, the existing literature narrowly defines the construct and overlooks a variety of strategic approaches employees take as they engage in voice. Based on this problematization, the current research has developed and validated a scale of employee voice strategy through four studies in Japan (total N = 1,156). Employee voice strategy is defined as a set of direct and indirect communicative approaches that organizational members utilize to share ideas with intentions to exert constructive influence to their work group. Studies 1 and 2 analyzed interview narratives to develop an initial typology, which was refined in Study 3 into a six-factor scale. Study 4 replicated it through confirmatory factor analyses. Construct validity of the scale was also examined by testing the strategy factors' nomological networkas expected, proactive personality was positively associated with assertive strategies, while relationship maintenance goal orientation was linked to conciliatory, nonconfrontational strategies; negative emotion display showed negative associations with voice strategy use in general. These findings were discussed vis-a-vis culturally inclusive human resource management practices, as well as theoretical exploration of the employee voice phenomena from process-centered perspectives. (c) 2014 Wiley Periodicals, Inc.	[Matsunaga, Masaki] Rikkyo Univ, Coll Business, Commun, Tokyo 1718501, Japan	Matsunaga, M (reprint author), Rikkyo Univ, Coll Business, Toshima Ku, McKim Hall,M716,3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	matsunaga@rikkyo.ac.jp					BATEMAN TS, 1993, J ORGAN BEHAV, V14, P103, DOI 10.1002/job.4030140202; Ralston DA, 2008, J INT BUS STUD, V39, P8, DOI 10.1057/palgrave.jibs.8400330; Ashkanasy NM, 2002, ACAD MANAGE EXEC, V16, P76; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Ohbuchi K, 1999, J CROSS CULT PSYCHOL, V30, P51, DOI 10.1177/0022022199030001003; Crant JM, 2000, J MANAGE, V26, P435, DOI 10.1177/014920630002600303; Kopelman S, 2008, GROUP DECIS NEGOT, V17, P65, DOI 10.1007/s10726-007-9087-5; Seibert SE, 2001, PERS PSYCHOL, V54, P845, DOI 10.1111/j.1744-6570.2001.tb00234.x; Morrison EW, 2011, J APPL PSYCHOL, V96, P183, DOI 10.1037/a0020744; Morrison EW, 2000, ACAD MANAGE REV, V25, P706, DOI 10.2307/259200; Van Dyne L, 2003, J MANAGE STUD, V40, P1359; Ohbuchi KI, 1997, J APPL SOC PSYCHOL, V27, P2177, DOI 10.1111/j.1559-1816.1997.tb01647.x; Detert JR, 2007, ACAD MANAGE J, V50, P869; Alcazar FM, 2013, CROSS CULT MANAG, V20, P39, DOI 10.1108/13527601311296247; Liang J, 2012, ACAD MANAGE J, V55, P71, DOI 10.5465/amj.2010.0176; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037//1082-989X.4.3.272; Fuller JB, 2006, J ORGAN BEHAV, V27, P1089, DOI 10.1002/job.408; DAFT RL, 1986, MANAGE SCI, V32, P554, DOI 10.1287/mnsc.32.5.554; Rahim MF, 2002, INT J CONFL MANAGE, V13, P206, DOI 10.1108/eb022874; Venkataramani V, 2010, J APPL PSYCHOL, V95, P582, DOI 10.1037/a0018315; Zhang XM, 2010, ACAD MANAGE J, V53, P107; YUKL G, 1990, J APPL PSYCHOL, V75, P132, DOI 10.1037//0021-9010.75.2.132; Roberge ME, 2010, HUM RESOUR MANAGE R, V20, P295, DOI 10.1016/j.hrmr.2009.09.002; Tangirala S, 2008, ACAD MANAGE J, V51, P1189; Milliken FJ, 2003, J MANAGE STUD, V40, P1453, DOI 10.1111/1467-6486.00387; Oetzel J, 2001, COMMUN MONOGR, V68, P235, DOI 10.1080/03637750128061; Brinsfield CT, 2009, VOICE AND SILENCE IN ORGANIZATIONS, P3; Burris ER, 2008, J APPL PSYCHOL, V93, P912, DOI 10.1037/0021-9010.93.4.912; Detert JR, 2011, ACAD MANAGE J, V54, P461, DOI 10.5465/AMJ.2011.61967925; RICE RE, 1992, ORGAN SCI, V3, P475, DOI 10.1287/orsc.3.4.475; Batt R, 2002, IND LABOR RELAT REV, V55, P573, DOI 10.2307/3270623; Fan XT, 1999, STRUCT EQU MODELING, V6, P56, DOI 10.1080/10705519909540119; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Botero IC, 2009, MANAGE COMMUN Q, V23, P84, DOI 10.1177/089331890335415; Burris ER, 2012, ACAD MANAGE J, V55, P851, DOI 10.5465/amj.2010.0562; Parker SK, 2006, J APPL PSYCHOL, V91, P636, DOI 10.1037/0021-9010.91.3.636; Holland P, 2012, HUM RESOUR MANAG J, V22, P377, DOI 10.1111/1748-8583.12002; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P393, DOI 10.1177/0013164405282485; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879; Kanagawa C, 2001, PERS SOC PSYCHOL B, V27, P90, DOI 10.1177/0146167201271008; Ng TWH, 2012, J ORGAN BEHAV, V33, P216, DOI 10.1002/job.754; O'Boyle EH, 2011, J APPL PSYCHOL, V96, P1, DOI 10.1037/a0020539; Bowler WM, 2006, J APPL PSYCHOL, V91, P70, DOI 10.1037/0021-9010.91.1.70; Claes R, 1998, J VOCAT BEHAV, V52, P357, DOI 10.1006/jvbe.1997.1626; Seibert SE, 1999, J APPL PSYCHOL, V84, P416, DOI 10.1037//0021-9010.84.3.416; Tangirala S, 2012, PERS PSYCHOL, V65, P251, DOI 10.1111/j.1744-6570.2012.01248.x; Van Dyne L, 1998, ACAD MANAGE J, V41, P108; Black S., 2004, ECON J, V114, P97; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Bryson A, 2006, IND RELATIONS J, V37, P438, DOI 10.1111/j.1468-2338.2006.00414.x; Chan D, 2006, J APPL PSYCHOL, V91, P475, DOI 10.1037/0021-9010.91.2.475; Childs JTT, 2005, HUM RESOURCE MANAGE, V44, P73, DOI 10.1002/hrm.20042; Claes R, 2005, APPL PSYCHOL-INT REV, V54, P476, DOI 10.1111/j.1464-0597.2005.00221.x; Collins LM, 2010, LATENT CLASS LATENT; Crant JM, 2000, J ORGAN BEHAV, V21, P63, DOI 10.1002/(SICI)1099-1379(200002)21:1<63::AID-JOB8>3.3.CO;2-A; Frese M, 1997, J OCCUP ORGAN PSYCH, V70, P139; Fuller J. B., 2007, J MANAGERIAL ISSUES, V29, P134; Gomez R., 2009, 924 CTR EC PERF; Greenberg J, 2009, VOICE AND SILENCE IN ORGANIZATIONS, P1; Harlos KP, 2001, J APPL BEHAV SCI, V37, P324, DOI 10.1177/0021886301373005; Hofstede G., 2010, CULTURES ORG SOFTWAR; Hofstede G., 2001, CULTURES CONSEQUENCE; Kim M. S., 2002, NONWESTERN PERSPECTI; Kitayama S, 1999, COHERENCE OF PERSONALITY, P242; Knapp M. L., 2011, HDB INTERPERSONAL CO; Muthen L. K., 2007, M PLUS USERS GUIDE; NONAKA I, 1988, SLOAN MANAGE REV, V29, P9; Pizer M. K., 2005, EMOTIONS ORG BEHAV; SATORRA A, 1985, PSYCHOMETRIKA, V50, P83, DOI 10.1007/BF02294150; Spitzberg B. H., 1984, INTERPERSONAL COMMUN; Strauss Anselm, 1998, BASICS QUALITATIVE R; Yukl G, 2005, J ORGAN BEHAV, V26, P705, DOI 10.1002/job.335	72	0	0	WILEY PERIODICALS, INC	SAN FRANCISCO	ONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA	0090-4848	1099-050X		HUM RESOUR MANAGE-US	Hum. Resour. Manage.	JUL-AUG	2015	54	4					653	671		10.1002/hrm.21636		19	Psychology, Applied; Management	Psychology; Business & Economics	CM8NJ	WOS:000357958300007		
J	Kim, S; Katsumata, KI; Okada, K; Matsushita, N				Kim, Sangmo; Katsumata, Ken-Ichi; Okada, Kiyoshi; Matsushita, Nobuhiro			Highly Dispersed Iron Oxide Nanoparticles Synthesized by Solvothermal Method Adding Electrostatic Stabilizers	IEEE TRANSACTIONS ON MAGNETICS			English	Article						Clusters; electrostatic stabilizers; Fe3O4; nanoparticles; solvothermal method	FE3O4 NANOPARTICLES; MONODISPERSE; MICROSPHERES; PARTICLES	Magnetite nanoparticles (Fe3O4) in the range of submicrometer in diameters were prepared by modified solvothermal process adding electrostatic stabilizers to be applied for biomedical applications. Added electrostatic stabilizers could prevent the magnetic particles from agglomerating and slow down the reaction rate so that the size of Fe3O4 nanoparticles could be controlled. The average diameter of magnetic nanoparticles synthesized in the presence of different electrostatic stabilizers (citrate, didodecyldimethylammonium bromide, and polyethylene glycol) was in the range of 150-350 nm. All of the prepared samples exhibited sufficiently high saturation magnetization M-s value of 60-73 emu/g showing superparamagnetic behavior. They could also be easily redispersed in water after magnetic collection.	[Kim, Sangmo; Katsumata, Ken-Ichi; Okada, Kiyoshi; Matsushita, Nobuhiro] Tokyo Inst Technol, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan	Matsushita, N (reprint author), Tokyo Inst Technol, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan.	matsushita.n.ab@m.titech.ac.jp					Deng H, 2005, ANGEW CHEM INT EDIT, V44, P2782, DOI 10.1002/anie.200462551; Liu J, 2009, ANGEW CHEM INT EDIT, V48, P5875, DOI 10.1002/anie.200901566; Zhu LJ, 2013, J CONTROL RELEASE, V169, P228, DOI 10.1016/j.jconrel.2013.02.015; Cheng CM, 2011, NEW J CHEM, V35, P1072, DOI 10.1039/c0nj00986e; Mahdavi M, 2013, MOLECULES, V18, P7533, DOI 10.3390/molecules18077533; Ge JP, 2007, ANGEW CHEM INT EDIT, V46, P4342, DOI 10.1002/anie.200700197; Horak D, 2007, J SEP SCI, V30, P1751, DOI 10.1002/jssc.200700088; Chen FH, 2008, J MAGN MAGN MATER, V320, P1775, DOI 10.1016/j.jmmm.2008.02.117; Fan T, 2011, IND ENG CHEM RES, V50, P9009, DOI 10.1021/ie200970j; Zhu LP, 2008, CRYST GROWTH DES, V8, P957, DOI 10.1021/cg700861a; Cheng W, 2010, J MATER CHEM, V20, P1799, DOI 10.1039/b919164j; Cheng CM, 2009, J MATER CHEM, V19, P8782, DOI 10.1039/b910832g; Yu DB, 2006, J PHYS CHEM B, V110, P21667, DOI 10.1021/jp0646933; Chen H., 2010, NANOSCALE RES LETT, V6, DOI DOI 10.1007/S11671-010-9741-8; Hasany S. F., 2012, NANOSCI NANOTECHNOL, V2, P148; Xi GC, 2008, EUR J INORG CHEM, P425, DOI 10.1002/ejic.200700863; Yan A., 2007, J ALLOY COMPD, V458, P487	17	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	JUL	2015	51	7							5200304	10.1109/TMAG.2015.2394445		4	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CM3OO	WOS:000357592000014		
J	Shimokoshi, M; Hsiao, WC; Kaya, A; Luo, YS; Cheng, N; Ramamoorthy, L; Jen, D; Schouterden, K				Shimokoshi, Masayoshi; Hsiao, Wen-Chien; Kaya, Ahmet; Luo, Yansheng; Cheng, Nelson; Ramamoorthy, Lakshmi; Jen, David; Schouterden, Kris			Investigation for Mechanism of Far Track Interference in Hard Disk Drives	IEEE TRANSACTIONS ON MAGNETICS			English	Article						Adjacent track interference (ATI); far track interference (FTI); hard disk drive (HDD); magnetic domain and wall; perpendicular magnetic recording; wrap around shield (WAS)	ERASURE; DENSITY; CHALLENGES; DESIGN; HEADS	In hard disk drives (HDDs) using perpendicular magnetic recording, an adjacent track interference (ATI) is a major barrier to increasing areal density because both strong writing and narrow track pitch are required. Recent head/disk combinations have exhibited not only ATI, but also a phenomenon we call far track interference (FTI). FTI is a gradual magnetic damage to written data on nearby but non-adjacent tracks that accumulate with increasing number of writes. We developed HDD level measurement ways to detect FTI and investigate the FTI mechanism considering skew angle and external field effects. We also confirmed that the minor shape change of wrap around shield (WAS) causes difference of magnetic domain structures on WAS and FTI incidence. The results support the hypothesis that the FTI is created by structures of magnetic domains and walls on a WAS of a single-pole head on the HDD.	[Shimokoshi, Masayoshi] Hitachi Global Storage Technol Japan Ltd, Fujisawa, Kanagawa 2528588, Japan; [Hsiao, Wen-Chien; Kaya, Ahmet; Luo, Yansheng; Cheng, Nelson; Ramamoorthy, Lakshmi; Jen, David; Schouterden, Kris] HGST, San Jose, CA 95135 USA	Shimokoshi, M (reprint author), Hitachi Global Storage Technol Japan Ltd, Fujisawa, Kanagawa 2528588, Japan.	masayoshi.shimokoshi@hgst.com					WIESEN K, 1995, IEEE T MAGN, V31, P3066, DOI 10.1109/20.490271; Bai DZ, 2010, IEEE T MAGN, V46, P722, DOI 10.1109/TMAG.2009.2034753; Guarisco D, 2006, IEEE T MAGN, V42, P3868, DOI 10.1109/TMAG.2006.884786; Jiang W, 2003, IEEE T MAGN, V39, P1891, DOI 10.1109/TMAG.2003.813784; Jiang W, 2003, J APPL PHYS, V93, P6754, DOI 10.1063/1.1557716; Li SP, 2006, IEEE T MAGN, V42, P3874, DOI 10.1109/TMAG.2006.883836; Cain W, 1996, IEEE T MAGN, V32, P97, DOI 10.1109/20.477557; Cheng N., 2011, U.S. Patent, Patent No. [20 110 149 427, 20110149427]; Feng J, 2004, IEEE T MAGN, V40, P2588, DOI 10.1109/TMAG.2004.830189; Hamaguchi T, 2007, IEEE T MAGN, V43, P704, DOI 10.1109/TMAG.2006.888361; Hsu YM, 2007, IEEE T MAGN, V43, P605, DOI 10.1109/TMAG.2006.888199; Liu Y, 2009, IEEE T MAGN, V45, P3660, DOI 10.1109/TMAG.2009.2022052; Miura K, 2011, PHYSCS PROC, V16, DOI 10.1016/j.phpro.2011.06.098; Ohtsu T., 1996, J MAGN SOC JPN, V20, P101, DOI 10.3379/jmsjmag.20.101; Song SP, 2009, IEEE T MAGN, V45, P3730, DOI 10.1109/TMAG.2009.2024545; Tang YH, 2013, IEEE T MAGN, V49, P744, DOI 10.1109/TMAG.2012.2222361; Xing XZ, 2011, IEEE T MAGN, V47, P3312, DOI 10.1109/TMAG.2011.2153835	17	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	JUL	2015	51	7							3100908	10.1109/TMAG.2015.2402271		8	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CM3OO	WOS:000357592000009		
J	Farsad, N; Eckford, AW; Hiyama, S				Farsad, Nariman; Eckford, Andrew W.; Hiyama, Satoshi			Design and Optimizing of On-Chip Kinesin Substrates for Molecular Communication	IEEE TRANSACTIONS ON NANOTECHNOLOGY			English	Article						Microfluidic channels; molecular communication; optimal channel design; channel capacity; kinesin substrate; microtubule motility; active transport	ELECTRIC-FIELDS; CHANNELS; CAPACITY; SYSTEM; MODEL; NANONETWORKS; MICROTUBULES; NOISE	Lab-on-chip devices and point-of-care diagnostic chip devices are composed of many different components, such as nanosensors that must be able to communicate with other components within the device. Molecular communication is a promising solution for on-chip communication. In particular, kinesin driven microtubule motility is an effective means of transferring information particles from one component to another. However, finding an optimal shape for these channels can be challenging. In this paper, we derive a mathematical optimization model that can be used to find the optimal channel shape and dimensions for any transmission period. We derive three specific models for the rectangular channels, regular polygonal channels, and regular polygonal ring channels. We show that the optimal channel shapes are the square-shaped channel for the rectangular channel, and circular-shaped channel for the other classes of shapes. Finally, we show that among all 2-D shapes the optimal design choice that maximizes information rate is the circular-shaped channel.	[Farsad, Nariman; Eckford, Andrew W.] York Univ, Dept Elect Engn & Comp Sci, Toronto, ON M3J 1P3, Canada; [Hiyama, Satoshi] NTTDOCOMO Inc, Res Labs, Yokosuka, Kanagawa 2898536, Japan	Farsad, N (reprint author), York Univ, Dept Elect Engn & Comp Sci, Toronto, ON M3J 1P3, Canada.	nariman@cse.yorku.ca; aeckford@yorku.ca; hiyamas@nttdocomo.com					Alla SK, 2011, IEEE T BIO-MED ENG, V58, P777, DOI 10.1109/TBME.2010.2093132; Pierobon M, 2013, IEEE T INFORM THEORY, V59, P942, DOI 10.1109/TIT.2012.2219496; Gregori M, 2010, IEEE J SEL AREA COMM, V28, P612, DOI 10.1109/JSAC.2010.100510; BLAHUT RE, 1972, IEEE T INFORM THEORY, V18, P460, DOI 10.1109/TIT.1972.1054855; Farsad N, 2012, IEEE T NANOBIOSCI, V11, P304, DOI 10.1109/TNB.2012.2186460; Dujovne I, 2008, NANO LETT, V8, P4217, DOI 10.1021/nl801837j; Hiyama S, 2010, LAB CHIP, V10, P2741, DOI 10.1039/c004615a; Chahibi Y, 2013, IEEE T BIO-MED ENG, V60, P3468, DOI 10.1109/TBME.2013.2271503; Moore MJ, 2009, IEEE T NANOBIOSCI, V8, P169, DOI 10.1109/TNB.2009.2025039; Briani M, 2013, IEEE T BIO-MED ENG, V60, P2161, DOI 10.1109/TBME.2013.2250503; Teh SY, 2008, LAB CHIP, V8, P198, DOI 10.1039/b715524g; Nakano T, 2008, LECT NOTES COMPUT SC, V5410, P81; Daw R, 2006, NATURE, V442, P367, DOI 10.1038/442367a; Nakano T, 2012, IEEE T NANOBIOSCI, V11, P135, DOI 10.1109/TNB.2012.2191570; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Akyildiz IF, 2008, COMPUT NETW, V52, P2260, DOI 10.1016/j.comnet.2008.04.001; Pierobon M, 2010, IEEE J SEL AREA COMM, V28, P602, DOI 10.1109/JSAC.2010.100509; ARIMOTO S, 1972, IEEE T INFORM THEORY, V18, P14, DOI 10.1109/TIT.1972.1054753; Eckford AW, 2009, L N INST COMP SCI SO, V20, P24; Srinivas KV, 2012, IEEE T INFORM THEORY, V58, P4678, DOI 10.1109/TIT.2012.2193554; Bush S. F., 2010, NANOSCALE COMMUNICAT; Clemmens J, 2003, LANGMUIR, V19, P1738, DOI 10.1021/la026155x; Cobo L. C., 2010, NANOCOMMUN NETW, V1, P244, DOI 10.1016/j.nancom.2010.12.002; Cover T. M., 2006, ELEMENTS INFORM THEO; Enomoto A., 2011, NANOCOMMUN NETW, V2, P16; Farsad N., 2011, NANOCOMMUN NETW, V2, P175; Farsad N., 2012, IEEE INT C COMM WORK; Farsad N., 2012, P 12 IEEE C NAN IEEE, P1, DOI [DOI 10.1109/NAN0.2012.6322018, 10.1109/NANO.2012.6322018]; Farsad N., 2011, P IEEE INFOCOM WORKS, P473; Farsad N, 2014, IEEE T SIGNAL PROCES, V62, P2424, DOI 10.1109/TSP.2014.2311970; Hiyama S., 2005, P NSTI NAN C TRAD SH, V3, P391; Hiyama S, 2009, NANO LETT, V9, P2407, DOI 10.1021/nl901013k; Hiyama S, 2010, NANOCOMMUN NETW, V1, P20, DOI DOI 10.1016/J.NANCOM.2010.04.003; Kim E., 2013, NANOTECHNOLOGY, V24; Kim T, 2007, NANO LETT, V7, P211, DOI 10.1021/nl061474k; Lio P., 2012, NANOCOMMUN NETW, V3, P36; Mahfuz M. U., 2010, NANO COMMUNICATION N, V1, P289, DOI [10.1016/j.nancom.2011.01.001, DOI 10.1016/J.NANCOM.2011.01.001]; Nitta T, 2006, LAB CHIP, V6, P881, DOI 10.1039/b601754a; Nitta T, 2010, LAB CHIP, V10, P1447, DOI 10.1039/b926210e; Steuerwald D, 2014, LAB CHIP, V14, P3729, DOI 10.1039/c4lc00385c	40	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-125X	1941-0085		IEEE T NANOTECHNOL	IEEE Trans. Nanotechnol.	JUL	2015	14	4					699	708		10.1109/TNANO.2015.2431995		10	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	CM6SZ	WOS:000357821500018		
J	Imai, S; Kumagai, H; Iwata, M; Onodera, M; Suzuki, M				Imai, Shin-ichi; Kumagai, Hironori; Iwata, Motoyoshi; Onodera, Mari; Suzuki, Masa-aki			In-Water Plasma Generation on a Liquid Wall Using a Compact Device and Dedicated Power Supply	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Device; electron spin resonance (ESR); fine bubble; hydroxyl (OH); lifetime; plasma generation; radical; water	COEFFICIENTS; POTENTIALS; DISCHARGE	Plasmas that are generated on and in liquids are generally the subject of pure research at universities; however, they have considerable practical potential for use in material processing, water purification, and sterilization. Their chief drawback is that they require a large device to generate in-water plasmas and a bulky power supply. If the device size and the volume of the power supply could be reduced, it might be possible to realize water sterilization in home electric appliances, such as washing machines. We have developed a compact device with a unique structure and a dedicated power supply that provides high voltage at high frequencies for generating in-water plasmas. Our dedicated power supply occupies one-sixth of the volume of comparable types. The device can generate in-water plasmas in an air stream using ambient air introduced from outside using a pump. Hydroxyl (OH) radicals in in-water plasmas were detected by optical emission spectroscopy, and their spatial distribution was observed in the air steam using an intensified charge-coupled device camera and a bandpass filter of 309 nm. Hydroxyl radicals in water were detected as 5, 5-dimethyl-1-pyrroline-N-oxide (DMPO)-OH signals using electron spin resonance spin trapping, both before adding DMPO to water and after doping the plasma-treated water with DMPO. It was found that OH radicals were generated in in-water plasmas and persisted in plasma-treated water. Using the detection of DMPO-OH signals employing the postdoped method, OH radicals were measured at 0.86 nmol/cc; they remained in the water for a long time after turning OFF the power supply. Finally, we demonstrated the decomposition rate of indigo carmine using our device and power supply to be about 13-fold that of the comparable device, despite its consuming about one-seventh of the input power. Hydroxyl radicals have high oxidation potential, so in-water plasmas as a source of radicals may be applicable to water sterilization in home electric appliances.	[Imai, Shin-ichi; Onodera, Mari; Suzuki, Masa-aki] Panasonic Corp, Adv Res Div, Osaka 5708501, Japan; [Kumagai, Hironori; Iwata, Motoyoshi] Panasonic Corp, Automot & Ind Syst Co, Osaka 5718506, Japan	Imai, S (reprint author), Panasonic Corp, Adv Res Div, Osaka 5708501, Japan.	imai.shinichi001@jp.panasonic.com					Akolkar R., 2013, J VAC SCI TECHNOL A, V31; Machala Z, 2007, J MOL SPECTROSC, V243, P194, DOI 10.1016/j.jms.2007.03.001; [Anonymous], 2011, REACTION PROCESSES A, V1224, P1; Takeda T, 2008, IEEE T PLASMA SCI, V36, P1158, DOI 10.1109/TPS.2008.925713; Wu HY, 2012, PLASMA PROCESS POLYM, V9, P417, DOI 10.1002/ppap.201100065; Liao WB, 2012, SCI HORTIC-AMSTERDAM, V139, P32, DOI 10.1016/j.scienta.2012.02.040; Locke BR, 2012, PLASMA CHEM PLASMA P, V32, P875, DOI 10.1007/s11090-012-9403-y; WARDMAN P, 1989, J PHYS CHEM REF DATA, V18, P1637; Takahashi M, 2007, J PHYS CHEM B, V111, P1343, DOI 10.1021/jp0669254; Hagelaar GJM, 2005, PLASMA SOURCES SCI T, V14, P722, DOI 10.1088/0963-0252/14/4/011; Schutze A, 1998, IEEE T PLASMA SCI, V26, P1685, DOI 10.1109/27.747887; Bai N, 2011, PLASMA PROCESS POLYM, V8, P424, DOI 10.1002/ppap.201000078; BRATSCH SG, 1989, J PHYS CHEM REF DATA, V18, P1; De Smedt F, 2002, OZONE-SCI ENG, V24, P379, DOI 10.1080/01919510208901628; Kieft IE, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/149; Luiz S. E., 2000, ECLER ENDOD, V2; Lukes P., 2014, PLASMA SOUR SCI TECH, V23; Morooka S., 1978, KAGAKU KOGAKU RONBUN, V4, P377; PANDIS SN, 1989, J GEOPHYS RES-ATMOS, V94, P1105, DOI 10.1029/JD094iD01p01105; Parvulescu V. I., 2012, PLASMA CHEM CATALYSI, P1; Rodgers M. A. J., J AM CHEM SOC; Sugai T., 2008, J I ELECTROSTATICS J, V32, P19; Takai O, 2008, PURE APPL CHEM, V80, P2003, DOI 10.1351/pac200880092003; Tresp H., 2013, J PHYS D, V46; van Gils C. A. J., 2013, J PHYS D, V46	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	JUL	2015	43	7					2166	2173		10.1109/TPS.2015.2429571		8	Physics, Fluids & Plasmas	Physics	CM3XG	WOS:000357618100008		
J	Zhou, H; Ji, YS; Wang, XY; Zhao, BH				Zhou, Hao; Ji, Yusheng; Wang, Xiaoyan; Zhao, Baohua			Joint Resource Allocation and User Association for SVC Multicast Over Heterogeneous Cellular Networks	IEEE TRANSACTIONS ON WIRELESS COMMUNICATIONS			English	Article						Heterogeneous cellular networks; SVC multicast; resource allocation; user association; multi-issue negotiation problem	SCALABLE VIDEO MULTICAST; INTERFERENCE COORDINATION; WIRELESS NETWORKS; RELAY NETWORKS; NEGOTIATION	Scalable video coding (SVC) is attractive technology for multicasting video to users with different available transmission capacities. In this paper, we investigate the joint optimization of resource allocation and user association problems for SVC multicast over heterogeous cellular networks (HetNet) employing the schemes of cell range expansion (RE) and almost blank subframe (ABS). We solve the joint optimization problem by decoupling it into two problems, namely, resource allocation (RA) subproblem and user association (UA) master problem. For the RA subproblem, we propose a dynamic programming based algorithm to optimally set the transmission profile. For the UA master problem, we propose a similarity-based negotiation protocol (SBNP) based algorithm to obtain the Pareto-optimal range expansion bias. The simulation results demonstrate the efficiency of these algorithms.	[Zhou, Hao; Zhao, Baohua] Univ Sci & Technol China, Sch Comp Sci & Technol, Hefei 230027, Peoples R China; [Zhou, Hao; Zhao, Baohua] Beijing Univ Posts & Telecommun, State Key Lab Networking & Switching Technol, Beijing 100876, Peoples R China; [Ji, Yusheng; Wang, Xiaoyan] Natl Inst Informat, Tokyo 1018430, Japan	Zhou, H (reprint author), Univ Sci & Technol China, Sch Comp Sci & Technol, Hefei 230027, Peoples R China.	kitewind@ustc.edu.cn; kei@nii.ac.jp; wangxy@nii.ac.jp; bhzhao@ustc.edu.cn			National Natural Science Foundation of China [61371118]; Fundamental Research Funds for the Central Universities of China [WK0110000029]; State Scholarship Fund of China; JSPS [23240011]; Open Foundation of State Key Laboratory of Networking and Switching Technology in Beijing University of Posts and Telecommunications [SKLNST-2013-1-10]	This research was supported in part by the National Natural Science Foundation of China (61371118), the Fundamental Research Funds for the Central Universities of China (WK0110000029), the State Scholarship Fund of China, a JSPS Grant-in-Aid for Scientific Research A (23240011), and the Open Foundation of State Key Laboratory of Networking and Switching Technology in Beijing University of Posts and Telecommunications (SKLNST-2013-1-10). The associate editor coordinating the review of this paper and approving it for publication was A. A. Abouzeid.	Alay O, 2010, IEEE T CIRC SYST VID, V20, P1095, DOI 10.1109/TCSVT.2010.2056951; Seeling P, 2012, IEEE COMMUN SURV TUT, V14, P1142, DOI 10.1109/SURV.2011.082911.00067; Lai G, 2009, GROUP DECIS NEGOT, V18, P169, DOI 10.1007/s10726-008-9119-9; Singh S, 2014, IEEE T WIREL COMMUN, V13, P888, DOI 10.1109/TWC.2013.120713.130548; Ghimire J, 2013, IEEE T WIREL COMMUN, V12, P1340, DOI 10.1109/TWC.2013.013013.120940; Oh J, 2012, UEEE INT SYM PERS IN, P653; Corroy S, 2012, IEEE ICC, P2457, DOI 10.1109/ICC.2012.6364568; Fooladivanda D, 2013, IEEE T WIREL COMMUN, V12, P248, DOI 10.1109/TWC.2012.121112.120018; Peng MG, 2011, IEEE WIREL COMMUN, V18, P48; Deb S, 2014, IEEE ACM T NETWORK, V22, P137, DOI 10.1109/TNET.2013.2246820; Schwarz H, 2007, IEEE T CIRC SYST VID, V17, P1103, DOI 10.1109/TCSVT.2007.905532; Damnjanovic A, 2011, IEEE WIREL COMMUN, V18, P10, DOI 10.1109/MWC.2011.5876496; Jin YH, 2013, IEEE COMMUN LETT, V17, P2296, DOI 10.1109/LCOMM.2013.102113.131836; Ye QY, 2013, IEEE T WIREL COMMUN, V12, P2706, DOI 10.1109/TWC.2013.040413.120676; Guvenc I, 2011, IEEE COMMUN LETT, V15, P1084, DOI 10.1109/LCOMM.2011.082611.111387; Li PL, 2009, I C NETWORK PROTOCOL, P141, DOI 10.1109/ICNP.2009.5339688; Kraus S, 1998, ARTIF INTELL, V104, P1, DOI 10.1016/S0004-3702(98)00078-2; Chi HY, 2008, IEEE INT SYMP CIRC S, P1838; Cierny M., 2013, ARXIV13042269; Deb S., 2008, P IEEE INFOCOM 08 PH, P1579; Ghimire J., 2012, P 10 INT S MOD WIOPT, P254; Gong P., 2012, P ICACT, P502; Guttman A, 1984, ACM SIGMOD REC, V14, P47, DOI DOI 10.1145/971697.602266; Kuo WH, 2007, IEEE ICC, P1754, DOI 10.1109/ICC.2007.293; Lee CN, 2012, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2012-187; Li CL, 2014, IEEE CONF COMPUT, P275; Li Q, 2012, GLOB TELECOMM CONF, P5457; Lopez-Carmona MA, 2011, COMPUT INTELL-US, V27, P166, DOI 10.1111/j.1467-8640.2011.00377.x; Lopez-Perez D, 2012, IEEE J-STSP, V6, P281, DOI 10.1109/JSTSP.2012.2190381; Rosenschein J. S., 1994, RULES ENCOUNTER DESI; Sheu JP, 2013, IEEE T MOBILE COMPUT, V12, P90, DOI 10.1109/TMC.2011.250; Sun S. Q., 2011, P IEEE ICC, P1; Tall A, 2014, 2014 12TH INTERNATIONAL SYMPOSIUM ON MODELING AND OPTIMIZATION IN MOBILE, AD HOC, AND WIRELESS NETWORKS (WIOPT), P318, DOI 10.1109/WIOPT.2014.6850315; Xiao Y, 2013, 2013 IEEE MILITARY COMMUNICATIONS CONFERENCE (MILCOM 2013), P1353, DOI 10.1109/MILCOM.2013.230; Xie X, 2011, IEEE WIREL COMMUN, V18, P58; Yu Y., 2009, P IEEE 8 INT C DEV L, P1; Zhou H., 2012, P IEEE GLOBECOM, P5903; Zhou H, 2013, IEICE T FUND ELECTR, VE96A, P2089, DOI 10.1587/transfun.E96.A.2089	38	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1276	1558-2248		IEEE T WIREL COMMUN	IEEE Trans. Wirel. Commun.	JUL	2015	14	7					3673	3684		10.1109/TWC.2015.2409834		12	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CM6NJ	WOS:000357805200013		
J	Kitamura, Y; Nakagawa, H; Fujii, T; Sakoda, T; Enomoto, T; Mizuguchi, H; Fukui, H; Takeda, N				Kitamura, Y.; Nakagawa, H.; Fujii, T.; Sakoda, T.; Enomoto, T.; Mizuguchi, H.; Fukui, H.; Takeda, N.			EFFECT OF H1-ANTIHISTAMINES ON HISTAMINE H-1 RECEPTOR GENE EXPRESSION IN THE NASAL MUCOSA OF PATIENTS WITH POLLINOSIS INDUCED BYARTIFICIAL EXPOSURE TO CEDAR POLLEN	INFLAMMATION RESEARCH			English	Meeting Abstract	44th Annual Meeting of the European-Histamine-Research-Society (EHRS)	MAY 06-09, 2015	Malaga, SPAIN	European Histamine Res Soc					Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Otolaryngol, Tokushima 7708503, Japan; Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol Pharmacol, Tokushima 7708503, Japan; Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol Studies Incurable Dis, Tokushima 7708503, Japan		hfukui@tokushima-u.ac.jp						0	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	JUL	2015	64			1			S11	S11				1	Cell Biology; Immunology	Cell Biology; Immunology	CN0ZJ	WOS:000358144300011		
J	Naganuma, F; Yoshikawa, T; Nakamura, T; Miura, Y; Horigome, A; Matsuzawa, T; Yanai, K				Naganuma, F.; Yoshikawa, T.; Nakamura, T.; Miura, Y.; Horigome, A.; Matsuzawa, T.; Yanai, K.			ANALYSIS OF HISTAMINE N-METHYLTRANSFERASE DEFICIENT MICE	INFLAMMATION RESEARCH			English	Meeting Abstract	44th Annual Meeting of the European-Histamine-Research-Society (EHRS)	MAY 06-09, 2015	Malaga, SPAIN	European Histamine Res Soc					[Naganuma, F.; Yoshikawa, T.; Nakamura, T.; Miura, Y.; Horigome, A.; Matsuzawa, T.; Yanai, K.] Tohoku Univ, Grad Sch Med, Dept Pharmacol, Aoba Ku, Sendai, Miyagi 9808575, Japan		f.naganuma@med.tohoku.ac.jp						0	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	JUL	2015	64			1			S19	S19				1	Cell Biology; Immunology	Cell Biology; Immunology	CN0ZJ	WOS:000358144300021		
J	Nakamura, T; Yoshikawa, T; Naganuma, F; Iida, T; Miura, Y; Yanai, K				Nakamura, T.; Yoshikawa, T.; Naganuma, F.; Iida, T.; Miura, Y.; Yanai, K.			H-1-KNOCKED OUT MOUSE HAS HIGH SENSITIVITY TO ISOFLURANE-INDUCED ANESTHESIA	INFLAMMATION RESEARCH			English	Meeting Abstract	44th Annual Meeting of the European-Histamine-Research-Society (EHRS)	MAY 06-09, 2015	Malaga, SPAIN	European Histamine Res Soc					[Nakamura, T.; Yoshikawa, T.; Naganuma, F.; Iida, T.; Miura, Y.; Yanai, K.] Tohoku Univ, Grad Sch Med, Dept Pharmacol, Sendai, Miyagi 9808575, Japan		tadaho@med.tohoku.ac.jp						0	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	JUL	2015	64			1			S22	S23				2	Cell Biology; Immunology	Cell Biology; Immunology	CN0ZJ	WOS:000358144300030		
J	Khung, R; Shiba, H; Kajiya, M; Kittaka, M; Ouhara, K; Takeda, K; Mizuno, N; Fujita, T; Komatsuzawa, H; Kurihara, H				Khung, R.; Shiba, H.; Kajiya, M.; Kittaka, M.; Ouhara, K.; Takeda, K.; Mizuno, N.; Fujita, T.; Komatsuzawa, H.; Kurihara, H.			LL37 induces VEGF expression in dental pulp cells through ERK signalling	INTERNATIONAL ENDODONTIC JOURNAL			English	Article						ERK; LL37; pulp cells; vascular endothelial growth factor	ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; PEPTIDE ANTIBIOTIC LL-37/HCAP-18; EPITHELIAL-CELLS; GENE-EXPRESSION; BETA-DEFENSINS; MESSENGER-RNA; ANGIOGENESIS; PROTEIN; LL-37	Aim To examine the in vitro effects of LL37 on the expression of vascular endothelial growth factor (VEGF) in human pulp cells and to identify the intracellular signalling pathway involved. Methodology Pulp cells at passage 6 were treated with 10 mu g mL(-1) synthesized LL37, and an inhibition assay was performed with MAPK or NF-kappa B inhibitors to determine the possible signalling pathway. VEGF mRNA, VEGF protein and phosphorylated ERK1/2 levels were determined by real-time PCR, ELISA and Western blot, respectively. Data were analysed using t-tests. Results LL37 significantly increased both the mRNA and protein levels of VEGF in pulp cells (P < 0.01). However, pre-treatment with an ERK kinase inhibitor suppressed these increases. Furthermore, the inhibitor blocked LL37-induced ERK1/2 phosphorylation. Conclusions LL37 activated the ERK pathway to boost VEGF secretion from human pulp cells. Because of this angiogenic effect and its reported induction of pulp cell migration and antimicrobial activity against cariogenic bacteria, LL37 may be applicable as a pulp capping material.	[Khung, R.; Shiba, H.; Kajiya, M.; Kittaka, M.; Ouhara, K.; Takeda, K.; Mizuno, N.; Fujita, T.; Kurihara, H.] Hiroshima Univ, Dept Periodontal Med, Appl Life Sci, Inst Biomed & Hlth Sci, Hiroshima 7348553, Japan; [Komatsuzawa, H.] Kagoshima Univ, Dept Oral Microbiol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Shiba, H (reprint author), Hiroshima Univ, Dept Periodontal Med, Appl Life Sci, Inst Biomed & Hlth Sci,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	bashihi@hiroshima-u.ac.jp			Japan Society for the Promotion of Science, Japan [24593122]	The authors deny any conflict of interests. This study was supported in part by a Grant-in-Aid for Scientific Research (C) (No. 24593122) from the Japan Society for the Promotion of Science, Japan.	Kajiya M, 2010, J ENDODONT, V36, P1009, DOI 10.1016/j.joen.2010.02.028; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Artese L, 2002, J ENDODONT, V28, P20, DOI 10.1097/00004770-200201000-00005; VLODAVSKY I, 1991, J CELL BIOCHEM, V45, P167, DOI 10.1002/jcb.240450208; Elssner A, 2004, J IMMUNOL, V172, P4987; Midorikawa K, 2003, INFECT IMMUN, V71, P3730, DOI 10.1128/IAI.71.7.3730-3739.2003; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ouhara K, 2005, J ANTIMICROB CHEMOTH, V55, P888, DOI 10.1093/jac/dki103; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Agerberth B, 2000, BLOOD, V96, P3086; Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; LARRICK JW, 1995, INFECT IMMUN, V63, P1291; Matsushita K, 2000, J DENT RES, V79, P1596; PERTOVAARA L, 1994, J BIOL CHEM, V269, P6271; Shiba H, 2003, BIOCHEM BIOPH RES CO, V306, P867, DOI 10.1016/S0006-291X(03)01075-1; Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834; Tran-Hung L, 2006, J DENT RES, V85, P819; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; BROWN LF, 1992, KIDNEY INT, V42, P1457, DOI 10.1038/ki.1992.441; FAVARD C, 1991, BIOL CELL, V73, P1, DOI 10.1016/0248-4900(91)90002-5; Frohm Nilsson M, 1999, INFECT IMMUN, V67, P2561; Girnita A, 2012, ONCOGENE, V31, P352, DOI 10.1038/onc.2011.239; Kajiya M, 2008, J BIOL CHEM, V283, P16259, DOI 10.1074/jbc.M800668200; Kittaka M, 2013, J PERIODONTAL RES, V48, P228, DOI 10.1111/j.1600-0765.2012.01524.x; SHARKEY AM, 1993, J REPROD FERTIL, V99, P609; Tjäderhane Leo, 2002, Aust Endod J, V28, P68; Tran-Hung L, 2008, ARCH ORAL BIOL, V53, P9, DOI 10.1016/j.archoralbio.2007.07.001	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0143-2885	1365-2591		INT ENDOD J	Int. Endod. J.	JUL	2015	48	7					673	679		10.1111/iej.12365		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM7KK	WOS:000357870700007		
J	Okiyama, N; Hasegawa, H; Oida, T; Hirata, S; Yokozeki, H; Fujimoto, M; Miyasaka, N; Kohsaka, H				Okiyama, Naoko; Hasegawa, Hisanori; Oida, Takatoku; Hirata, Shinya; Yokozeki, Hiroo; Fujimoto, Manabu; Miyasaka, Nobuyuki; Kohsaka, Hitoshi			Experimental myositis inducible with transfer of dendritic cells presenting a skeletal muscle C protein-derived CD8 epitope peptide	INTERNATIONAL IMMUNOLOGY			English	Article						bone marrow-derived dendritic cell; CD4 T cell; RMA-S cell	MHC CLASS-I; MONOCLONAL-ANTIBODY ANALYSIS; T-CELLS; MURINE MODEL; AUTOIMMUNE ENCEPHALOMYELITIS; MONONUCLEAR-CELLS; PYRUVATE-KINASE; BALB/C MICE; MOUSE MODEL; POLYMYOSITIS	It is suggested that polymyositis, an autoimmune inflammatory myopathy, is mediated by autoaggressive CD8 T cells. Skeletal muscle C protein is a self-antigen that induces C protein-induced myositis, a murine model of polymyositis. To establish a new murine model of myositis inducible with a single CD8 T-cell epitope peptide that derives from the C protein, three internet-based prediction systems were employed to identify 24 candidate peptides of the immunogenic fragment of the C protein and bind theoretically to major histocompatibility complex class I molecules of C57BL/6 ( B6) mice. RMA-S cell assay revealed that a HILIYSDV peptide, amino acid position 399-406 of the C protein, had the highest affinity to the H2-K-b molecules. Transfer of mature bone marrow-derived dendritic cells pulsed with HILIYSDV induced myositis in naive B6 mice. This myositis was suppressed by anti-CD8-depleting antibodies but not by anti-CD4-depleting antibodies. Because this myositis model is mediated by CD8 T cells independently of CD4 T cells, it should be a useful tool to investigate pathology of polymyositis and develop therapies targeting CD8 T cells.	[Okiyama, Naoko; Hasegawa, Hisanori; Hirata, Shinya; Miyasaka, Nobuyuki; Kohsaka, Hitoshi] Tokyo Med & Dent Univ, Dept Rheumatol, Bunkyo Ku, Tokyo 1138519, Japan; [Okiyama, Naoko; Yokozeki, Hiroo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Bunkyo Ku, Tokyo 1138519, Japan; [Okiyama, Naoko; Oida, Takatoku] Japan Soc Promot Sci, Tokyo 1020083, Japan; [Okiyama, Naoko; Kohsaka, Hitoshi] RIKEN, Res Ctr Allergy & Immunol, Yokohama Inst, Yokohama, Kanagawa 2300045, Japan; [Okiyama, Naoko; Fujimoto, Manabu] Univ Tsukuba, Fac Med, Dept Dermatol, Tsukuba, Ibaraki 3058575, Japan; [Miyasaka, Nobuyuki; Kohsaka, Hitoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program,Bunkyo Ku, Tokyo 1138519, Japan	Kohsaka, H (reprint author), Tokyo Med & Dent Univ, Dept Rheumatol, Bunkyo Ku, Tokyo 1138519, Japan.	kohsaka.rheu@tmd.ac.jp			Ministry of Health, Labour and Welfare; Global Center of Excellence (GCOE) Program, 'International Research Center for Molecular Science in Tooth and Bone Diseases'; Japan Society for the Promotion of Science; Shiseido Co.; Japan Rheumatism Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Global Center of Excellence (GCOE) Program, 'International Research Center for Molecular Science in Tooth and Bone Diseases'; Japan Society for the Promotion of Science (to N.O.); Shiseido Co.; Japan Rheumatism Foundation.	AICHELE P, 1994, P NATL ACAD SCI USA, V91, P444, DOI 10.1073/pnas.91.2.444; Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Mogi S, 2000, IMMUNOLOGY, V101, P541, DOI 10.1046/j.1365-2567.2000.00138.x; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Bennett SRM, 1998, NATURE, V393, P478; Sugihara T, 2007, ARTHRITIS RHEUM, V56, P1304, DOI 10.1002/art.22521; Goebels N, 1996, J CLIN INVEST, V97, P2905, DOI 10.1172/JCI118749; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; Tisch R, 1999, J IMMUNOL, V163, P1178; Sugihara T, 2010, ARTHRITIS RHEUM-US, V62, P3088, DOI 10.1002/art.27625; ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; ENGEL AG, 1984, ANN NEUROL, V16, P209, DOI 10.1002/ana.410160207; Tsutsumi H, 1988, GENOMICS, V2, P86, DOI 10.1016/0888-7543(88)90112-7; Kojima T, 1997, J NEUROL SCI, V151, P141, DOI 10.1016/S0022-510X(97)00148-2; Behrens G, 2004, IMMUNOL CELL BIOL, V82, P84, DOI 10.1111/j.1440-1711.2004.01211.x; Bercovici N, 2000, J IMMUNOL, V165, P202; ENGEL AG, 1990, RES P ARNMD, V68, P141; Galea I, 2012, EUR J IMMUNOL, V42, P256, DOI 10.1002/eji.201142010; GAUR A, 1992, SCIENCE, V258, P1491, DOI 10.1126/science.1279812; Gutermuth J, 2009, J IMMUNOL, V183, P3130, DOI 10.4049/jimmunol.0900793; Kawachi I, 2001, J NEUROIMMUNOL, V117, P108, DOI 10.1016/S0165-5728(01)00327-7; Kohyama K, 1999, J NEUROIMMUNOL, V98, P130, DOI 10.1016/S0165-5728(99)00087-9; Llopiz D, 2008, CANCER IMMUNOL IMMUN, V57, P19, DOI 10.1007/s00262-007-0346-8; Okiyama N, 2009, ARTHRITIS RHEUM, V60, P2505, DOI 10.1002/art.24689; Okiyama N, 2012, ARTHRITIS RHEUM-US, V64, P3741, DOI 10.1002/art.34629; Paek SY, 2012, J INVEST DERMATOL, V132, P677, DOI 10.1038/jid.2011.347; PARKER KC, 1995, IMMUNOL RES, V14, P34, DOI 10.1007/BF02918496; Sugihara T, 2012, ARTHRITIS RHEUM-US, V64, P2655, DOI 10.1002/art.34465; TITUS RG, 1985, J IMMUNOL, V135, P2108; Townsend A, 2007, J IMMUNOL, V179, P4301; von Herrath MG, 1998, J IMMUNOL, V161, P5087	39	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	JUL	2015	27	7					327	332		10.1093/intimm/dxv001		6	Immunology	Immunology	CM7NW	WOS:000357882100002		
J	Kobayashi, K; Tomiki, H; Inaba, Y; Ichikawa, M; Kim, BS; Koh, CS				Kobayashi, Kunitoshi; Tomiki, Hiroki; Inaba, Yuji; Ichikawa, Motoki; Kim, Byung S.; Koh, Chang-Sung			Dimethyl fumarate suppresses Theiler's murine encephalomyelitis virus-induced demyelinating disease by modifying the Nrf2-Keap1 pathway	INTERNATIONAL IMMUNOLOGY			English	Article						dimethyl fumarate (DMF); multiple sclerosis (MS); Nrf2-Keap1 pathway; Theiler's murine encephalomyelitis virus (TMEV); TMEV-induced demyelinating disease (TMEV-IDD)	ANTIOXIDANT RESPONSE ELEMENT; CENTRAL-NERVOUS-SYSTEM; HUMAN NEUROBLASTOMA-CELLS; NITRIC-OXIDE SYNTHASE; CD8(+) T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SIGNAL-REGULATED KINASE; SUSCEPTIBLE SJL/J MICE; MULTIPLE-SCLEROSIS; OXIDATIVE STRESS	Dimethyl fumarate (DMF) is a modifier of the nuclear factor (erythroid-derived 2)-2 (Nrf2)-kelch-like ECH-associated protein 1 (Keap1) pathway. DMF treatment in the effector phase significantly suppressed the development of Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) both clinically and histologically. DMF treatment leads to an enhanced Nrf2 antioxidant response in TMEV-IDD mice. DMF treatment in the effector phase significantly suppressed the level of IL-17A mRNA. DMF is known to inhibit differentiation of T helper 17 (T(h)17) cells via suppressing NF-kappa B. Taken together, our data suggest that DMF treatment in the effector phase may suppress TMEV-IDD not only via enhancing the antioxidant response but also via suppressing IL-17A.	[Kobayashi, Kunitoshi; Tomiki, Hiroki; Ichikawa, Motoki; Koh, Chang-Sung] Grad Sch Med, Dept Biomed Lab Sci, Matsumoto, Nagano 3908621, Japan; [Inaba, Yuji] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 3908621, Japan; [Kim, Byung S.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Koh, CS (reprint author), Grad Sch Med, Dept Biomed Lab Sci, Matsumoto, Nagano 3908621, Japan.	kshosei@shinshu-u.ac.jp			Ministry of Health, Labour and Welfare of Japan; Terumo Lifescience Foundation	This work was supported in part by Health and Labour Sciences Research Grants for research on intractable disease from the Ministry of Health, Labour and Welfare of Japan and grants from Terumo Lifescience Foundation.	Alexoudi A., 2014, INT J NEUROSCI, V125, P32; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445; Kim YC, 2001, J BIOL CHEM, V276, P18399, DOI 10.1074/jbc.M100103200; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; van Meeteren ME, 2004, BIOCHEM PHARMACOL, V67, P967, DOI 10.1016/j.bcp.2003.10.018; Peng HY, 2012, J BIOL CHEM, V287, P28017, DOI 10.1074/jbc.M112.383380; Lee DH, 2012, INT J MOL SCI, V13, P11783, DOI 10.3390/ijms130911783; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Vandermeeren M, 1997, BIOCHEM BIOPH RES CO, V234, P19, DOI 10.1006/bbrc.1997.6570; Phillips JT, 2013, SEMIN NEUROL, V33, P56, DOI 10.1055/s-0033-1343796; Reick C, 2014, EXP NEUROL, V257, P50, DOI 10.1016/j.expneurol.2014.04.003; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Witte ME, 2009, J PATHOL, V219, P193, DOI 10.1002/path.2582; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Murray PD, 1998, J VIROL, V72, P7320; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Hidaka Y, 2014, J NEUROL SCI, V340, P117, DOI 10.1016/j.jns.2014.02.039; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; Myoung J, 2012, J VIROL, V86, P13717, DOI 10.1128/JVI.01733-12; Schilling S, 2006, CLIN EXP IMMUNOL, V145, P101, DOI 10.1111/j.1365-2249.2006.03094.x; OKUDA Y, 1995, J NEUROIMMUNOL, V62, P103, DOI 10.1016/0165-5728(95)00114-H; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Alam J, 2000, J BIOL CHEM, V275, P27694; Moehlenkamp JD, 1999, ARCH BIOCHEM BIOPHYS, V363, P98, DOI 10.1006/abbi.1998.1046; Lee JM, 2001, BIOCHEM BIOPH RES CO, V280, P286, DOI 10.1006/bbrc.2000.4106; CLATCH RJ, 1990, VIROLOGY, V176, P244, DOI 10.1016/0042-6822(90)90249-Q; Kang KW, 2002, MOL PHARMACOL, V62, P1001, DOI 10.1124/mol.62.5.1001; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Bista P, 2012, MULT SCLER J, V18, P357; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; DALCANTO MC, 1977, AM J PATHOL, V88, P497; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Ellrichmann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016172; GERETY SJ, 1994, J IMMUNOL, V152, P908; Gill AJ, 2013, CRIT REV IMMUNOL, V33, P307; Gold R., 2014, MULT SCLER, V21, P57; Inoue A, 1996, INT IMMUNOL, V8, P1001, DOI 10.1093/intimm/8.7.1001; Iwahashi T, 1999, CELL IMMUNOL, V194, P186, DOI 10.1006/cimm.1999.1482; Jin YH, 2009, J VIROL, V83, P10981, DOI 10.1128/JVI.01398-09; Johnson R T, 1975, Adv Neurol, V13, P1; De Jong Rolien, 1996, European Journal of Immunology, V26, P2067, DOI 10.1002/eji.1830260916; Kaneyama T, 2010, PATHOLOGY, V42, P564, DOI 10.3109/00313025.2010.508784; Kang BS, 2002, J VIROL, V76, P11780, DOI 10.1128/JVI.76.22.11780-11784.2002; Kim BS, 2001, IMMUNOL RES, V24, P121, DOI 10.1385/IR:24:2:121; Dal Canto Mauro C., 1996, Methods (Orlando), V10, P453, DOI 10.1006/meth.1996.0123; Kolamunne RT, 2013, REDOX BIOL, V1, P418, DOI 10.1016/j.redox.2013.08.002; Lin SX, 2011, ASN NEURO, V3, DOI 10.1042/AN20100033; LIPTON HL, 1984, NEUROLOGY, V34, P1117; Lyman MA, 2004, EUR J IMMUNOL, V34, P2730, DOI 10.1002/eji.200324811; Martinez N. E., 2014, BRAIN BEHAV IMMUN, V43, P86; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1183, DOI 10.1056/NEJM198211043071905; Myoung JJ, 2008, J VIROL, V82, P5606, DOI 10.1128/JVI.02442-07; NGUYEN T, 1992, J BIOL CHEM, V267, P13535; Nicholas J, 2012, J Cent Nerv Syst Dis, V4, P81, DOI 10.4137/JCNSD.S6692; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; PEVEAR DC, 1987, J VIROL, V61, P1507; PULLEN LC, 1994, J NEUROIMMUNOL, V55, P143, DOI 10.1016/0165-5728(94)90004-3; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Schulze-Topphoff U, 2013, MULT SCLER J, V19, P236; Thiessen A, 2010, NEUROSCI LETT, V475, P56, DOI 10.1016/j.neulet.2010.03.048; Tomiki H, 2014, J NEUROIMMUNOL, V268, P25, DOI 10.1016/j.jneuroim.2013.12.013; Tsunoda I, 2006, J NEUROIMMUNOL, V172, P85, DOI 10.1016/j.jneuroim.2005.11.004; Van Ly D., 2011, J ALLERGY CAIRO, V2011; Wilms H, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-30; Yauch RL, 1998, J VIROL, V72, P6169	78	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	JUL	2015	27	7					333	344		10.1093/intimm/dxv006		12	Immunology	Immunology	CM7NW	WOS:000357882100003		
J	Inui, M; Hirota, S; Hirano, K; Fujii, H; Sugahara-Tobinai, A; Ishii, T; Harigae, H; Takai, T				Inui, Masanori; Hirota, Saeko; Hirano, Kumiko; Fujii, Hiroshi; Sugahara-Tobinai, Akiko; Ishii, Tomonori; Harigae, Hideo; Takai, Toshiyuki			Human CD43(+) B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals	INTERNATIONAL IMMUNOLOGY			English	Article						auto-antibody; ILT3/LILRB4; natural antibody; plasmablast/plasma cell	SYSTEMIC-LUPUS-ERYTHEMATOSUS; CLASS-I MOLECULES; COMMON VARIABLE IMMUNODEFICIENCY; HUMAN B-1 CELLS; INHIBITORY RECEPTORS; SORTING ARTIFACTS; DENDRITIC CELLS; MICROARRAY DATA; MYELOID CELLS; RESPONSES	CD20(+)CD27(+)CD43(+) B (CD43(+) B) cells have been newly defined among PBMCs and proposed to be human B1 cells. However, it is controversial as to whether they are orthologs of murine B1 cells and how they are related to other B-cell populations, particularly CD20(+)CD27(+)CD43(-) memory B cells and CD20(low)CD27(high)CD43(high) plasmablasts. Our objective is to identify phenotypically the position of CD43(+) B cells among peripheral B-lineage cell compartments in healthy donors, with reference to B-cell subsets from patients with systemic lupus erythematosus (SLE). We found that CD43(+) B cells among PBMCs from healthy subjects were indistinguishable phenotypically from memory B cells in terms of surface markers, and spontaneous in vitro Ig and IL-10 secretion capability, but quite different from plasmablasts. However, a moderate correlation was found in the frequency of CD43(+) B cells with that of plasmablasts in healthy donors but not in SLE patients. An in vitro differentiation experiment indicated that CD43(+) B cells give rise to plasmablasts more efficiently than do memory B cells, suggesting that they are more closely related to plasmablasts developmentally than are memory B cells, which is also supported by quantitative PCR analysis of mRNA expression of B-cell and plasma cell signature genes. Thus, we conclude that, in healthy individuals, CD43(+) B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally, although the developmental origin of CD43(+) B cells is not necessarily the same as that of plasmablasts.	[Inui, Masanori; Hirota, Saeko; Hirano, Kumiko; Sugahara-Tobinai, Akiko; Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan; [Fujii, Hiroshi; Ishii, Tomonori; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808574, Japan	Takai, T (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan.	tostakai@idac.tohoku.ac.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [24249016, 24590572]; Global Center of Excellence Program for Innovative Therapeutic Development Towards the Conquest of Signal Transduction Diseases with Network Medicine	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency (to T.T.); Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24249016 to T.T. and 24590572 to M.I.); grant from the Global Center of Excellence Program for Innovative Therapeutic Development Towards the Conquest of Signal Transduction Diseases with Network Medicine (to T.T.).	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Suchanek O, 2012, CLIN EXP IMMUNOL, V170, P333, DOI 10.1111/j.1365-2249.2012.04656.x; Kubo T, 2009, J EXP MED, V206, P1971, DOI 10.1084/jem.20082392; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.1399-0039.2004.00290.x; Carroll MC, 2005, ADV IMMUNOL, V86, P137, DOI 10.1016/S0065-2776(04)86004-8; Dorner T, 2011, J IMMUNOL METHODS, V363, P187, DOI 10.1016/j.jim.2010.06.009; Griffin DO, 2011, J EXP MED, V208, P2591, DOI 10.1084/jem.20110978; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Jellusova J, 2010, J IMMUNOL, V184, P3618, DOI 10.4049/jimmunol.0902711; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Kuroki K, 2005, HUM MOL GENET, V14, P2469, DOI 10.1093/hmg/ddi247; Jackson SM, 2008, ADV IMMUNOL, V98, P151, DOI 10.1016/S0065-2776(08)00405-7; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Kraljevic K, 2013, CLIN EXP IMMUNOL, V171, P278, DOI 10.1111/cei.12008; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095; Nitschke L, 2009, IMMUNOL REV, V230, P128, DOI 10.1111/j.1600-065X.2009.00801.x; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Jourdan M, 2009, BLOOD, V114, P5173, DOI 10.1182/blood-2009-07-235960; Vital EM, 2011, ARTHRITIS RHEUM-US, V63, P3038, DOI 10.1002/art.30466; Furtado J, 2013, CLIN IMMUNOL, V146, P90, DOI 10.1016/j.clim.2012.11.006; Li WT, 2013, BLOOD, V122, P3691, DOI 10.1182/blood-2013-08-520031; Griffin DO, 2012, MOL MED, V18, P1003, DOI 10.2119/molmed.2012.00203; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Reynaud CA, 2012, J EXP MED, V209, P433, DOI 10.1084/jem.20120402; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Descatoire M, 2011, J EXP MED, V208, P2563, DOI 10.1084/jem.20112232; Covens K, 2013, BLOOD, V121, P5176, DOI [10.1182/blood-2012-12-471953, 10.1182/blood-2012-12471953]; Griffin DO, 2012, J EXP MED, V209, P434, DOI 10.1084/jem.20120403; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Avrameas S, 2007, J AUTOIMMUN, V29, P213, DOI 10.1016/j.jaut.2007.07.010; Borges L, 1997, J IMMUNOL, V159, P5192; Odendahl M, 2000, J IMMUNOL, V165, P5970; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Perez-Andres M, 2011, J EXP MED, V208, P2565, DOI 10.1084/jem.20112203; Tarte K, 2003, BLOOD, V102, P592, DOI 10.1128/blood-2002-10-3161; Brown DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-56; Cella M, 2000, CURR TOP MICROBIOL, V251, P161; Covens K, 2013, BLOOD, V122, P3693, DOI 10.1182/blood-2013-09-528091; Dorner T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3433; Griffin DO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00122; Hayami K, 1997, J BIOL CHEM, V272, P7320; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Mabbott NA, 2014, IMMUNOLOGY, V141, P79, DOI 10.1111/imm.12171	49	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	JUL	2015	27	7					345	355		10.1093/intimm/dxv009		11	Immunology	Immunology	CM7NW	WOS:000357882100004		
J	Kozaki, T; Takahama, M; Misawa, T; Matsuura, Y; Akira, S; Saitoh, T				Kozaki, Tatsuya; Takahama, Michihiro; Misawa, Takuma; Matsuura, Yoshiharu; Akira, Shizuo; Saitoh, Tatsuya			Role of zinc-finger anti-viral protein in host defense against Sindbis virus	INTERNATIONAL IMMUNOLOGY			English	Article						host defense; IFN; innate immunity; pattern-recognition receptor; RNA degradation	VIRAL MESSENGER-RNAS; INDUCIBLE GENE-I; HELICASE RIG-I; CYCLIC GMP-AMP; IMMUNE-RESPONSES; CYTOSOLIC DNA; INFECTION; RECOGNITION; ZAP; REPLICATION	Accumulating evidence indicates that type I interferon (IFN) mediates the host protective response to RNA viruses. However, the anti-viral effector molecules involved in this response have not been fully identified. Here, we show that zinc-finger anti-viral protein (ZAP), an IFN-inducible gene, plays a critical role in the elimination of Sindbis virus (SINV) in vitro and in vivo. The loss of ZAP greatly enhances the replication of SINV but does not inhibit type I IFN production in primary mouse embryonic fibroblasts (MEFs). ZAP binds and destabilizes SINV RNA, thereby suppressing the replication of SINV. Type I IFN fails to suppress SINV replication in ZAP-deficient MEFs, whereas the ectopic expression of ZAP is sufficient to suppress the replication of SINV in MEFs lacking the expression of type I IFN and the IFN-inducible genes. ZAP-deficient mice are highly susceptible to SINV infection, although they produce sufficient amounts of type I IFN. Therefore, ZAP is an RNA-sensing anti-viral effector molecule that mediates the type-I-IFN-dependent host defense against SINV.	[Kozaki, Tatsuya; Takahama, Michihiro; Misawa, Takuma; Akira, Shizuo; Saitoh, Tatsuya] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Lab Host Def, Suita, Osaka 5650871, Japan; [Kozaki, Tatsuya; Misawa, Takuma; Akira, Shizuo; Saitoh, Tatsuya] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Suita, Osaka 5650871, Japan	Saitoh, T (reprint author), Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Lab Host Def, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	tatsuya@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009		National Institutes of Health [PO1-AI070167]; Japan Society for the Promotion of Science (JSPS) Funding Program for World-Leading Innovative R&D on Science and Technology 'FIRST Program'; JSPS KAKENHI [26713005, 25117717, 23659231]; Research Grant of the Naito Foundation; Visionary Research Grant of the Takeda Science Foundation	National Institutes of Health (grant PO1-AI070167), the Japan Society for the Promotion of Science (JSPS) Funding Program for World-Leading Innovative R&D on Science and Technology 'FIRST Program', JSPS KAKENHI (grant nos. 26713005, 25117717, 23659231), the Research Grant of the Naito Foundation and the Visionary Research Grant of the Takeda Science Foundation. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Klimstra WB, 1999, J VIROL, V73, P10387; Lee H, 2013, P NATL ACAD SCI USA, V110, P12379, DOI 10.1073/pnas.1310604110; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Zhu YP, 2008, RNA BIOL, V5, P65; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Ryman KD, 2000, J VIROL, V74, P3366, DOI 10.1128/JVI.74.7.3366-3378.2000; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Glasker S, 2014, J GEN VIROL, V95, P816, DOI 10.1099/vir.0.060988-0; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Hemmi H, 2003, J IMMUNOL, V170, P3059; Zhu YP, 2012, EMBO J, V31, P4236, DOI 10.1038/emboj.2012.271; Moriishi K, 2002, VIROLOGY, V292, P258, DOI 10.1006/viro.2001.1206; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Lin RJ, 2013, NUCLEIC ACIDS RES, V41, P3314, DOI 10.1093/nar/gkt019; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Hurt JA, 2009, J CELL BIOL, V185, P265, DOI 10.1083/jcb.200811072; Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Liang XH, 1999, J VIROL, V73, P2563; Lin RJ, 2014, J IMMUNOL, V193, P4159, DOI 10.4049/jimmunol.1400337; Lin Y, 2014, P NATL ACAD SCI USA, V111, pE4504, DOI 10.1073/pnas.1408759111; Maeda M, 2006, MICROBES INFECT, V8, P2647, DOI 10.1016/j.micinf.2006.07.010; Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494	41	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	JUL	2015	27	7					357	364		10.1093/intimm/dxv010		8	Immunology	Immunology	CM7NW	WOS:000357882100005		
J	Yamashima, R; Matsumoto, J; Takata, K; Takahashi, HG				Yamashima, Ryoji; Matsumoto, Jun; Takata, Kumiko; Takahashi, Hiroshi G.			Impact of historical land-use changes on the Indian summer monsoon onset	INTERNATIONAL JOURNAL OF CLIMATOLOGY			English	Article						land-use change; Indian summer monsoon; land-atmosphere interaction; rainy season onset; monsoon onset	INTERANNUAL VARIABILITY; OBJECTIVE DEFINITION; RAINY-SEASON; WITHDRAWAL; CIRCULATION; EVOLUTION; INDEXES; ASIA	We investigate the impact of historical land-use changes (HLUCs) from 1700 to 1850 on the onset of the Indian summer monsoon (ISM), focusing on the onsets of broad-scale ISM circulation and the local rainy season and their relationships, by conducting three equilibrium experiments under 1700, 1850, and 1992 conditions. During that time period, land use changed from primarily forest to cropland in India, eastern China, and Europe. This study used an atmospheric general circulation model, Model for Interdisciplinary Research on Climate version 3.2, coupled with a land surface scheme, Minimal Advanced Treatments of Surface Interaction and Runoff. The results showed that HLUC decreased rainfall amounts by more than 2mmday(-1) during the onset phase and delayed the onset date of the local rainy season by approximately four pentads over the Indian subcontinent. The onset date over southeastern China was also delayed by four pentads. The changes in precipitation and the onset of the local rainy season result from the change in the surface water budget induced by HLUC, as discussed in previous work. Although ISM circulation activity, defined by a large-scale land-sea thermal contrast, was slightly decreased from late May to early June, its onset date did not change. Thus, in the onset phase, HLUC affected the local rainy season onset over the same region, although the ISM circulation was weakened only marginally, showing no change in its onset timing. Hence, unlike the broad-scale ISM circulation onset, the beginning of the local rainy season is dominantly influenced by local surface conditions.	[Yamashima, Ryoji; Matsumoto, Jun; Takahashi, Hiroshi G.] Tokyo Metropolitan Univ, Dept Geog, Hachioji, Tokyo, Japan; [Matsumoto, Jun; Takahashi, Hiroshi G.] Japan Agcy Marine Earth Sci & Technol, Kanagawa, Japan; [Takata, Kumiko] Natl Inst Polar Res, Tokyo, Japan; [Takata, Kumiko] Natl Inst Environm Res, Ibaraki, Japan	Yamashima, R (reprint author), Tokyo Metropolitan Univ, Dept Geog, 1-1 Minami Osawa, Hachioji, Tokyo, Japan.	r.yamashima@gmail.com	Takahashi, Hiroshi G./F-1380-2010	Takahashi, Hiroshi G./0000-0002-1991-422X	Ministry of the Environment, Japan [A-0902]; Green Network of Excellence (GRENE) project of the Ministry of Education, Culture, Sports, Science and Technology, Japan; KAKENHI from the Japan Society for the Promotion of Science (JSPS) [26220202]	This work was partly supported by the Global Environment Research Fund (A-0902) of the Ministry of the Environment, Japan, the Green Network of Excellence (GRENE) project of the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the KAKENHI No. 26220202 from the Japan Society for the Promotion of Science (JSPS). The authors are deeply grateful to Prof. Tetsuzo Yasunari for support on this study.	Hirabayashi Y, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005492; Guimberteau M, 2012, CLIM DYNAM, V39, P1329, DOI 10.1007/s00382-011-1252-5; Takata K, 2009, P NATL ACAD SCI USA, V106, P9586, DOI 10.1073/pnas.0807346106; Wang B, 1999, B AM METEOROL SOC, V80, P629, DOI 10.1175/1520-0477(1999)080<0629:COSASM>2.0.CO;2; Fu CB, 2003, GLOBAL PLANET CHANGE, V37, P219, DOI 10.1016/S0921-8181(02)00207-2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Takata K, 2003, GLOBAL PLANET CHANGE, V38, P209, DOI 10.1016/S0921-8181(03)00030-4; Wang B, 2009, J CLIMATE, V22, P3303, DOI 10.1175/2008JCLI2675.1; Zeng XB, 2004, J CLIMATE, V17, P2241, DOI 10.1175/1520-0442(2004)017<2241:GUMOAR>2.0.CO;2; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1256/smsqj.44904; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; Li CF, 1996, J CLIMATE, V9, P358, DOI 10.1175/1520-0442(1996)009<0358:TOAIVO>2.0.CO;2; Ji ZM, 2011, CLIM DYNAM, V36, P1633, DOI 10.1007/s00382-010-0982-0; Xavier PK, 2007, Q J ROY METEOR SOC, V133, P749, DOI 10.1002/qj.45; Fasullo J, 2003, J CLIMATE, V16, P3200, DOI 10.1175/1520-0442(2003)016<3200a:AHDOIM>2.0.CO;2; Hasumi H, 2004, 1 AORI U TOK; Hsu HH, 1999, J CLIMATE, V12, P793, DOI 10.1175/1520-0442(1999)012<0793:EOLSCA>2.0.CO;2; Inoue T, 2009, J METEOROL SOC JPN, V87, P539, DOI 10.2151/jmsj.87.539; Intergovernmental Panel on Climate Change-IPCC, 2000, SPECIAL REPORT EMISS; Kajikawa Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050540; Kanae S, 2001, J HYDROMETEOROL, V2, P51, DOI 10.1175/1525-7541(2001)002<0051:IODORP>2.0.CO;2; Kitoh A, 2006, J METEOROL SOC JPN, V84, P247, DOI 10.2151/jmsj.84.247; Li JP, 2009, CLIM DYNAM, V32, P935, DOI 10.1007/s00382-008-0465-8; Matsumoto J, 1997, ADV ATMOS SCI, V14, P231, DOI 10.1007/s00376-997-0022-0; Shen XH, 1998, J METEOROL SOC JPN, V76, P217; Wang B, 2001, J CLIMATE, V14, P4073, DOI 10.1175/1520-0442(2001)014<4073:IVOTAS>2.0.CO;2; Yamashima R, 2011, J METEOROL SOC JPN, V89A, P291, DOI 10.2151/jmsj.2011-A19	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-8418	1097-0088		INT J CLIMATOL	Int. J. Climatol.	JUL	2015	35	9					2419	2430		10.1002/joc.4132		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CM7RO	WOS:000357894100016		
J	Grossman, MJ; Zaiki, M; Nagata, R				Grossman, Michael J.; Zaiki, Masumi; Nagata, Rena			Interannual and interdecadal variations in typhoon tracks around Japan	INTERNATIONAL JOURNAL OF CLIMATOLOGY			English	Article						Japan; North Pacific subtropical high; tropical cyclones; typhoon tracks; western North Pacific	WESTERN NORTH PACIFIC; TROPICAL CYCLONE ACTIVITY; SOUTH CHINA SEA; EAST-ASIA; DECADAL VARIATIONS; KOREAN PENINSULA; EL-NINO; SUMMER; VARIABILITY; CIRCULATION	This study employs Geographical Information Systems software to develop a classification system for typhoons (TYs) affecting Japan (1951-2011) and uses that system to investigate the spatial and temporal variations of storm tracks and their connection to the location and strength of the North Pacific subtropical high (NPSH). TYs coming within a 300-km buffer zone around the four main islands of Japan (JZOI) are grouped into two main types: those that remain on the Pacific Coast (PC) and those that enter the Japan Sea (JS). Results indicate that fewer TYs enter the JZOI when the NPSH extends strongly to the west and more reach Japan when it extends to the northwest. The winds around the periphery of the NPSH affect the recurvature of TYs directing them either west towards the China Mainland or around the western edge of the high towards Japan. More importantly, during periods when greater numbers of TYs affect the PC side of Japan (PC+), the NPSH extends to the southwest. However, during periods when greater numbers of TYs affect JS side of Japan (JS+), the NPSH extends to the northwest closer to Japan. The southwest extension of the NPSH enables TYs to recurve and pass to the eastern side (PC) of Japan while the northwest extension forces TYs around or across Japan into the JS. An important finding is that the moderately different positions of the NPSH change the atmospheric circulation around Japan dramatically and affect whether TYs pass over the PC side or the JS coast side of Japan. At the interannual time scale, increased JS+ years were observed since 1980 because of the frequent occurrence of the Pacific-Japan pattern. We also found that at the interdecadal time scale, PC+ years have increased due to the southwestward extension of the NPSH since 1980.	[Grossman, Michael J.] So Illinois Univ, Dept Geog, Edwardsville, IL 62026 USA; [Zaiki, Masumi] Seikei Univ, Dept Econ, Tokyo, Japan	Grossman, MJ (reprint author), So Illinois Univ, Dept Geog, Edwardsville, IL 62026 USA.	mgrossm@siue.edu			U.S. Department of Energy, Office of Science Innovative and Novel Computational Impact on Theory and Experiment (DOE INCITE) program; Office of Biological and Environmental Research (BER); National Oceanic and Atmospheric Administration Climate Program Office; Japan Society for the Promotion of Science [24501297]	Support for the 20th Century Reanalysis Project dataset is provided by the U.S. Department of Energy, Office of Science Innovative and Novel Computational Impact on Theory and Experiment (DOE INCITE) program, and Office of Biological and Environmental Research (BER), and by the National Oceanic and Atmospheric Administration Climate Program Office. The Generic Mapping Tools (GMT) from the University of Hawaii Manoa was used to create some of the figures in this study. This research was supported by a Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research(C) 24501297. We would also like to thank the International Journal of Climatology reviewers for their many helpful comments.	Liu KS, 2008, J CLIMATE, V21, P4464, DOI 10.1175/2008JCLI2207.1; Wang B, 2002, J CLIMATE, V15, P1643, DOI 10.1175/1520-0442(2002)015<1643:HSEEAT>2.0.CO;2; Lee CS, 2006, MON WEATHER REV, V134, P2670, DOI 10.1175/MWR3221.1; Chan JCL, 2009, INT J CLIMATOL, V29, P1285, DOI 10.1002/joc.1782; Ho CH, 2004, J CLIMATE, V17, P1767, DOI 10.1175/1520-0442(2004)017<1767:ICISTT>2.0.CO;2; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; Stowasser M, 2007, J CLIMATE, V20, P2378, DOI 10.1175/JCLI4126.1; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Chu PS, 2002, J CLIMATE, V15, P2678, DOI 10.1175/1520-0442(2002)015<2678:LSCFAW>2.0.CO;2; Gong DY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014523; CHAN JCL, 1982, MON WEATHER REV, V110, P1354, DOI 10.1175/1520-0493(1982)110<1354:TCMASF>2.0.CO;2; NITTA T, 1987, J METEOROL SOC JPN, V65, P373; Song JJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013058; Zhang RH, 1999, ADV ATMOS SCI, V16, P229, DOI 10.1007/BF02973084; Chan JCL, 2005, METEOROL ATMOS PHYS, V89, P143, DOI 10.1007/s00703-005-0126-y; Chan JCL, 1996, GEOPHYS RES LETT, V23, P2765, DOI 10.1029/96GL02637; Choi KS, 2012, NAT HAZARDS, V64, P1, DOI 10.1007/s11069-012-0192-7; Choi KS, 2007, J KOREAN METEOR SOC, V43, P97; Choi KS, 2010, INT J CLIMATOL, V30, P1472, DOI 10.1002/joc.1986; Ding YH, 2001, J METEOROL SOC JPN, V79, P1119, DOI 10.2151/jmsj.79.1119; Environmental Systems Research Institute, 2009, ARCGIS 9 3 1 DESKT S; Goh AZC, 2010, INT J CLIMATOL, V30, P827, DOI 10.1002/joc.1943; Goh AZC, 2012, INT J CLIMATOL, V32, P178, DOI 10.1002/joc.2258; He Xuezhao, 2002, Journal of Geographical Sciences, V12, P202; Japan Meteorological Agency (JMA), 2012, CLIM TYPH; Japan Meteorological Agency (JMA), 2012, NUMB TYPH MAK LANDF; Kataoka K., 2003, TENKI, V50, P705; Kawamura R, 1998, J METEOROL SOC JPN, V76, P597; Kawamura R, 2006, SOLA, V2, P37, DOI 10.2151/sola.2006-010; Kim JH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027430; Kim JH, 2005, J CLIMATE, V18, P5344, DOI 10.1175/JCLI3601.1; Lee T.-C., 2012, TROP CYCLONE RES REV, V1, P213, DOI [10.6057/2012TCRR02.08, DOI 10.6057/2012TCRR02.08]; Lyons SW, 2004, WEATHER FORECAST, V19, P473, DOI 10.1175/1520-0434(2004)019<0473:UTCLV>2.0.CO;2; Nagata R, 2010, INT J CLIMATOL, V30, P813, DOI 10.1002/joc.1909; Nakazawa T, 2007, J METEOROL SOC JPN, V85, P101, DOI 10.2151/jmsj.85.101; Park Jae Yun, 2006, [Journal of the Korean Magneitcs Society, 한국자기학회지], V16, P1; Wu LG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022937; Yeung KH, 2005, SCI ASS INT ASS MET; Ying M., 2012, TROP CYCLONE RES REV, V1, P231, DOI [10.6057/2012TCRR02.09, DOI 10.6057/2012TCRR02.09]; Zhang W, 2012, J CLIMATE, V25, P6510, DOI 10.1175/JCLI-D-11-00488.1	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-8418	1097-0088		INT J CLIMATOL	Int. J. Climatol.	JUL	2015	35	9					2514	2527		10.1002/joc.4156		14	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CM7RO	WOS:000357894100023		
J	Yanada, M; Okamoto, A; Inaguma, Y; Tokuda, M; Morishima, S; Kanie, T; Yamamoto, Y; Mizuta, S; Akatsuka, Y; Okamoto, M; Emi, N				Yanada, Masamitsu; Okamoto, Akinao; Inaguma, Yoko; Tokuda, Masutaka; Morishima, Satoko; Kanie, Tadaharu; Yamamoto, Yukiya; Mizuta, Shuichi; Akatsuka, Yoshiki; Okamoto, Masataka; Emi, Nobuhiko			The fate of patients with acute myeloid leukemia not undergoing induction chemotherapy	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Acute myeloid leukemia; Induction; Unfit; Survival	ORGANIZATION	Advances in chemotherapy for acute myeloid leukemia (AML) have resulted in the exclusion of patients not undergoing induction chemotherapy from research studies. To examine in detail the clinical experience of such patients, we retrospectively analyzed the outcomes of consecutive patients diagnosed with AML at our hospital from 2004 to 2012. Of 158 AML patients, 43 (27 %) did not undergo induction chemotherapy. Their median survival duration was 1.5 months, with 11, six, and four patients surviving more than 3, 6, and 12 months, respectively. As expected, their survival was worse than that of those treated with intensive or less-intensive induction therapy (14, 74, and 47 % at 1 year, and 0, 40, and 10 % at 4 years, respectively). Low white blood cell count at AML diagnosis and prior history of myelodysplastic syndrome were significantly associated with longer survival. Our findings suggest that modern supportive care measures do not prolong survival for AML patients not undergoing induction chemotherapy, although certain patients show relatively long survival. These data should prove helpful in discussing treatment pathways with patients for cases in which palliative or supportive therapy alone may be a viable treatment option.	[Yanada, Masamitsu; Okamoto, Akinao; Inaguma, Yoko; Tokuda, Masutaka; Morishima, Satoko; Kanie, Tadaharu; Yamamoto, Yukiya; Mizuta, Shuichi; Akatsuka, Yoshiki; Okamoto, Masataka; Emi, Nobuhiko] Fujita Hlth Univ, Sch Med, Dept Hematol, Toyoake, Aichi 4701192, Japan	Yanada, M (reprint author), Fujita Hlth Univ, Sch Med, Dept Hematol, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	myanada@fujita-hu.ac.jp					Burnett AK, 2007, CANCER, V109, P1114, DOI 10.1002/cncr.22496; LOWENBERG B, 1989, J CLIN ONCOL, V7, P1268; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Oran B, 2012, HAEMATOL-HEMATOL J, V97, P1916, DOI 10.3324/haematol.2012.066100; Freireich EJ, 2014, J CLIN ONCOL, V32, P3463, DOI 10.1200/JCO.2014.57.1034; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Juliusson G, 2009, BLOOD, V113, P4179, DOI 10.1182/blood-2008-07-172007; YATES JW, 1973, CANCER CHEMOTH REP 1, V57, P485; Appelbaum FR, 2007, BLOOD, V109, P1810, DOI 10.1182/blood-2006-08-041152; FREIREICH E, 1961, J CHRON DIS, V14, P593, DOI 10.1016/0021-9681(61)90118-7; Kim SJ, 2014, INT J HEMATOL, V100, P141, DOI 10.1007/s12185-014-1617-8; Matsunaga T, 2012, INT J HEMATOL, V96, P342, DOI 10.1007/s12185-012-1146-2; TIVEY HAROLD, 1954, ANN NEW YORK ACAD SCI, V60, P322	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JUL	2015	102	1					35	40		10.1007/s12185-015-1786-0		6	Hematology	Hematology	CN1AE	WOS:000358146600005		
J	Nishikori, M; Kitano, T; Kobayashi, M; Hishizawa, M; Kitawaki, T; Kondo, T; Yamashita, K; Kawabata, H; Kadowaki, N; Takei, Y; Haga, H; Takaori-Kondo, A				Nishikori, Momoko; Kitano, Toshiyuki; Kobayashi, Masayuki; Hishizawa, Masakatsu; Kitawaki, Toshio; Kondo, Tadakazu; Yamashita, Kouhei; Kawabata, Hiroshi; Kadowaki, Norimitsu; Takei, Yusuke; Haga, Hironori; Takaori-Kondo, Akifumi			Increased number of peripheral CD8(+) T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustine	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Bendamustine; Skin reactions; CD8(+) T cells; Cytomegalovirus	MULTICENTER PHASE-II; CHRONIC LYMPHOCYTIC-LEUKEMIA; 1ST-LINE TREATMENT; HODGKIN-LYMPHOMA; PLUS RITUXIMAB; OPEN-LABEL; TRIAL; INDOLENT; THERAPY; REACTIVATION	Bendamustine is a chemotherapeutic drug that has recently come to be used frequently in the treatment of indolent B cell lymphomas. Skin toxicity is recognized as one of its characteristic side effects, but detailed information on such reactions has not yet been obtained. To clarify the clinical features of skin toxicity associated with bendamustine, we retrospectively analyzed skin reactions that developed in patients treated with bendamustine and rituximab (BR). Of 34 patients treated with 3-6 cycles of BR, 11 developed late-onset, persistent skin eruptions. These patients demonstrated increases in CD8(+) T cell number and CD8(+):CD4(+) cell ratio at the end of chemotherapy. In contrast, peripheral eosinophil count was not associated with such adverse events, whereas eosinophil infiltration was frequently observed in the skin. Patients with skin reactions tended to have higher seropositivity of hepatitis B core antibody, and multiplex viral screening PCR of the frozen sera demonstrated cytomegalovirus-DNA in some of the eruption-positive patients. It is speculated that inappropriate activation of CD8(+) T cells by latently infected pathogens may be one of the triggers of late-onset skin reactions caused by bendamustine.	[Nishikori, Momoko; Kitano, Toshiyuki; Kobayashi, Masayuki; Hishizawa, Masakatsu; Kitawaki, Toshio; Kondo, Tadakazu; Yamashita, Kouhei; Kawabata, Hiroshi; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol Oncol, Sakyo Ku, Kyoto 6068507, Japan; [Takei, Yusuke; Haga, Hironori] Kyoto Univ Hosp, Dept Pathol, Sakyo Ku, Kyoto 6068507, Japan	Nishikori, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Hematol Oncol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	nishikor@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24591391]	We are grateful to Dr. Norio Shimizu, Department of Virology, Medical Research Institute, Tokyo Medical and Dental University, and Dr. Naoko Hashimoto and Ms. Rieko Kobayashi, Cell Management Center, Institute of Biomedical Research and Innovation, for comprehensive viral screening test. We also thank Dr. Naoshi Sugimoto, Department of Hematology/Oncology, Kyoto University, for giving us valuable comments. This work was supported partly by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (24591391), Japan.	Afonso JPJM, 2012, J AM ACAD DERMATOL, V67, P269, DOI 10.1016/j.jaad.2011.11.923; Alamdari Habibollah S, 2010, Dermatol Online J, V16, P1; Ohmachi K, 2013, J CLIN ONCOL, V31, P2103, DOI 10.1200/JCO.2012.46.5203; Moskowitz AJ, 2013, J CLIN ONCOL, V31, P456, DOI 10.1200/JCO.2012.45.3308; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; Fischer K, 2011, J CLIN ONCOL, V29, P3559, DOI 10.1200/JCO.2010.33.8061; Evens AM, 2011, ANN ONCOL, V22, P1170, DOI 10.1093/annonc/mdq583; Damaj G, 2013, J CLIN ONCOL, V31, P104, DOI 10.1200/JCO.2012.43.7285; Flinn IW, 2014, BLOOD, V123, P2944, DOI 10.1182/blood-2013-11-531327; Cheson BD, 2010, CL LYMPH MYELOM LEUK, V10, P21, DOI 10.3816/CLML.2010.n.002; Lan JL, 2011, ANN RHEUM DIS, V70, P1719, DOI 10.1136/ard.2010.148783; Fischer K, 2012, J CLIN ONCOL, V30, P3209, DOI 10.1200/JCO.2011.39.2688; Shiohara Tetsuo, 2010, Allergology International, V59, P333, DOI 10.2332/allergolint.10-RAI-0260; Gavini A, 2012, INT J HEMATOL, V95, P311, DOI 10.1007/s12185-012-1012-2; Intlekofer AM, 2014, INT J HEMATOL, V99, P249, DOI 10.1007/s12185-014-1521-2; Ito K, 2013, INTERNAL MED, V52, P201, DOI 10.2169/internalmedicine.52.8206; Lambertini M, 2012, LEUKEMIA RES, V36, pE153, DOI 10.1016/j.leukres.2012.03.006; LIAUTAUD B, 1989, ARCH DERMATOL, V125, P629, DOI 10.1001/archderm.125.5.629; Malipatil B, 2011, Hematol Oncol Stem Cell Ther, V4, P157, DOI 10.5144/1658-3876.2011.157; Matthews SN, 1998, INT J DERMATOL, V37, P401, DOI 10.1046/j.1365-4362.1998.00507.x; Ohmachi K, 2010, CANCER SCI, V101, P2059, DOI 10.1111/j.1349-7006.2010.01635.x; WAKEEL RAP, 1994, BRIT J DERMATOL, V131, P371	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JUL	2015	102	1					53	58		10.1007/s12185-015-1791-3		6	Hematology	Hematology	CN1AE	WOS:000358146600008		
J	Muto, T; Takeuchi, M; Yamazaki, A; Sugita, Y; Tsukamoto, S; Sakai, S; Takeda, Y; Mimura, N; Ohwada, C; Sakaida, E; Aotsuka, N; Iseki, T; Nakaseko, C				Muto, Tomoya; Takeuchi, Masahiro; Yamazaki, Atsuko; Sugita, Yasumasa; Tsukamoto, Shokichi; Sakai, Shio; Takeda, Yusuke; Mimura, Naoya; Ohwada, Chikako; Sakaida, Emiko; Aotsuka, Nobuyuki; Iseki, Tohru; Nakaseko, Chiaki			Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						MLL-ELL; Acute myeloid leukemia; Allogeneic stem cell transplantation; Minimal residual disease	11Q23 ABNORMALITIES; FUSION TRANSCRIPT; IDENTIFICATION; PROTEIN; FORM	Acute myeloid leukemia (AML) with mixed lineage leukemia-eleven-nineteen lysine-rich leukemia (MLL-ELL) is a rare subtype of MLL-rearranged AML. The outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for patients with this disease remains unknown. In the present study, we retrospectively investigated the efficacy of allo-HSCT in eight adult MLL-ELL-positive AML patients. Although all eight patients achieved first complete remission (CR1), three (37.5 %) patients experienced relapse after induction therapy. Five (62.5 %) patients underwent allo-HSCT during CR1, whereas two (25.0 %) underwent allo-HSCT during disease relapse, and one (12.5 %) during CR2. All three patients who received allo-HSCT beyond CR1 died due to AML progression after allo-HSCT. Of the five patients who received allo-HSCT during CR1, three (60.0 %) remained alive at study conclusion. The overall survival rate at five years was 50.0 %. Intriguingly, clonally expanded non-leukemic cells expressing MLL-ELL during consolidation therapy were found to be eradicated after allo-HSCT during the monitoring of minimal residual disease in one patient; this indicates that allo-HSCT is efficacious for eliminating pre-leukemic cells resistant to chemotherapy. In conclusion, allo-HSCT soon after CR1 represents a promising therapeutic option for adult AML patients with MLL-ELL, although the outcome of allo-HSCT for patients beyond CR1 was dismal.	[Muto, Tomoya; Takeuchi, Masahiro; Yamazaki, Atsuko; Sugita, Yasumasa; Tsukamoto, Shokichi; Sakai, Shio; Takeda, Yusuke; Mimura, Naoya; Ohwada, Chikako; Sakaida, Emiko; Iseki, Tohru; Nakaseko, Chiaki] Chiba Univ Hosp, Dept Hematol, Chuo Ku, Chiba 2608670, Japan; [Sakai, Shio; Mimura, Naoya; Iseki, Tohru] Chiba Univ Hosp, Div Transfus Med & Cell Therapy, Chiba 2608670, Japan; [Aotsuka, Nobuyuki] Japanese Red Cross Soc Narita Hosp, Div Hematol Oncol, Narita, Japan	Nakaseko, C (reprint author), Chiba Univ Hosp, Dept Hematol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	chiaki-nakaseko@faculty.chiba-u.jp					Chen Y, 2013, LEUKEMIA, V27, P836, DOI 10.1038/leu.2012.319; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Garrido SM, 2000, LEUKEMIA RES, V24, P481, DOI 10.1016/S0145-2126(00)00011-4; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Suzukawa K, 2005, INT J HEMATOL, V82, P38, DOI 10.1532/IJH97.05025; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Chen J, 2008, CANCER RES, V68, P6199, DOI 10.1158/0008-5472.CAN-07-6514; Krauter J, 2009, J CLIN ONCOL, V27, P3000, DOI 10.1200/JCO.2008.16.7981; Schoch C, 2003, BLOOD, V102, P2395, DOI 10.1182/blood-2003-02-0434; Chan SM, 2013, INT J HEMATOL, V98, P648, DOI 10.1007/s12185-013-1407-8; Kakihana K, 2008, CANCER GENET CYTOGEN, V184, P109, DOI 10.1016/j.cancergencyto.2008.04.001; Muntean AG, 2008, BLOOD, V112, P4690, DOI 10.1182/blood-2008-01-134056; Takeuchi M, 2008, LEUKEMIA, V22, P861, DOI 10.1038/sj.leu.2404954; Tamai Hayato, 2010, J Clin Exp Hematop, V50, P91, DOI 10.3960/jslrt.50.91; Tamai H, 2008, INT J HEMATOL, V87, P195, DOI 10.1007/s12185-008-0034-2; Yamamoto K, 2002, INT J HEMATOL, V75, P503, DOI 10.1007/BF02982114; Yu W, 2014, AM J HEMATOL, V89, P130; Zhang Y, 2012, INT J HEMATOL, V96, P428, DOI 10.1007/s12185-012-1180-0	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JUL	2015	102	1					86	92		10.1007/s12185-015-1779-z		7	Hematology	Hematology	CN1AE	WOS:000358146600012		
J	Matsuyama, N; Yasui, K; Amakishi, E; Hayashi, T; Kuroishi, A; Ishii, H; Matsukura, H; Tani, Y; Furuta, RA; Hirayama, F				Matsuyama, Nobuki; Yasui, Kazuta; Amakishi, Etsuko; Hayashi, Tomoya; Kuroishi, Ayumu; Ishii, Hiroyuki; Matsukura, Harumichi; Tani, Yoshihiko; Furuta, Rika A.; Hirayama, Fumiya			The IgE-dependent pathway in allergic transfusion reactions: involvement of donor blood allergens other than plasma proteins	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Allergic transfusion reactions; Basophil activation test; IgE-dependent pathway; Fish (mackerel) antigen	FC-EPSILON-RI; HUMAN BASOPHILS; TYROSINE KINASES; ACTIVATION; RECEPTOR; ANAPHYLAXIS; INHIBITOR; PLATELETS; ANTIBODY; MECHANISMS	On transfusion, several plasma proteins can cause anaphylaxis in patients deficient in the corresponding plasma proteins. However, little is known about other allergens, which are encountered much more infrequently. Although it has been speculated that an allergen-independent pathway underlying allergic transfusion reactions (ATRs) is elicited by biological response modifiers accumulated in blood components during storage, the exact mechanisms remain unresolved. Furthermore, it is difficult even to determine whether ATRs are induced via allergen-dependent or allergen-independent pathways. To distinguish these two pathways in ATR cases, we established a basophil activation test, in which the basophil-activating ability of supernatants of residual transfused blood of ATR cases to whole blood basophils was assessed in the presence or absence of dasatinib, an inhibitor of IgE-mediated basophil activation. Three of 37 supernatants from the platelet concentrates with ATRs activated panel blood basophils in the absence, but not in the presence, of dasatinib. The basophil activation was inhibited by treatment of anti-fish collagen I MoAb in one case, suggesting that the involvement of fish allergens may have been present in donor plasma. We concluded that unknown non-plasma proteins, some of which had epitopes similar to fish antigens, in blood component may be involved in ATRs via an allergen/IgE-dependent pathway.	[Matsuyama, Nobuki; Yasui, Kazuta; Amakishi, Etsuko; Hayashi, Tomoya; Kuroishi, Ayumu; Ishii, Hiroyuki; Matsukura, Harumichi; Tani, Yoshihiko; Furuta, Rika A.; Hirayama, Fumiya] Japanese Red Cross Kinki Block Blood Ctr, Osaka 5670085, Japan	Yasui, K (reprint author), Japanese Red Cross Kinki Block Blood Ctr, 7-5-17 Saitoasagi, Osaka 5670085, Japan.	kazuta-yasui@kk.bbc.jrc.or.jp					Aihara Y, 2001, J ALLERGY CLIN IMMUN, V107, P1100, DOI 10.1067/mai.2001.115627; EISEMAN E, 1992, NATURE, V355, P78; Metcalfe DD, 2009, J ALLERGY CLIN IMMUN, V124, P639, DOI 10.1016/j.jaci.2009.08.035; Kneidinger M, 2008, BLOOD, V111, P3097, DOI 10.1182/blood-2007-08-104372; Savage WJ, 2013, TRANSFUSION, V53, P1361, DOI 10.1111/j.1537-2995.2012.03892.x; Burks AW, 2008, J ALLERGY CLIN IMMUN, V121, P1344, DOI 10.1016/j.jaci.2008.02.037; Domen RE, 2003, ARCH PATHOL LAB MED, V127, P316; Sakaguchi M, 2000, J ALLERGY CLIN IMMUN, V106, P579, DOI 10.1067/mai.2000.108499; Turner H, 1999, NATURE, V402, pB24; Jacobs JFM, 2011, NEW ENGL J MED, V364, P1981, DOI 10.1056/NEJMc1101692; Hirayama F, 2013, BRIT J HAEMATOL, V160, P434, DOI 10.1111/bjh.12150; Gilfillan AM, 2009, IMMUNOL RES, V43, P15, DOI 10.1007/s12026-008-8046-9; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Phipps RP, 2001, LANCET, V357, P2023, DOI 10.1016/S0140-6736(00)05108-4; Shimada E, 2002, TRANSFUSION, V42, P766, DOI 10.1046/j.1537-2995.2002.00117.x; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; HEDDLE NM, 1994, NEW ENGL J MED, V331, P625, DOI 10.1056/NEJM199409083311001; Arnold P, 1969, NEW ENGL J MED, V280, P188; Benhamou M, 1996, J LEUKOCYTE BIOL, V59, P461; Costello PS, 1996, ONCOGENE, V13, P2595; Doggrell SA, 2005, EXPERT OPIN INV DRUG, V14, P89, DOI 10.1517/13543784.14.1.89; Edvardsen L, 1998, BRIT J HAEMATOL, V103, P445, DOI 10.1046/j.1365-2141.1998.00990.x; Gambacorti-Passerini C, 2005, LEUKEMIA, V19, P1267, DOI 10.1038/sj.leu.2403775; Gao LB, 2014, TRANSFUS APHER SCI, V50, P68, DOI 10.1016/j.transci.2013.09.016; Garraud O, 2012, TRANSFUS CLIN BIOL, V19, P104, DOI 10.1016/j.tracli.2012.02.004; Geiger TL, 2007, TRANSFUS MED REV, V21, P1, DOI 10.1016/j.tmrv.2006.09.001; Hirayama F, 2010, TRANSFUSION, V50, P252, DOI 10.1111/j.1537-2995.2009.02388.x; Kepley CL, 1998, J ALLERGY CLIN IMMUN, V102, P304, DOI 10.1016/S0091-6749(98)70100-9; Koda Y, 2000, BLOOD, V95, P1138; LAMBIN P, 1984, VOX SANG, V47, P242; Matsuyama N, 2009, TRANSFUSION MED, V19, P274, DOI 10.1111/j.1365-3148.2009.00939.x; Miura K, 2000, BLOOD, V96, P2199; Sander SG, 1995, TRANSFUS MED REV, V1, P1; Sandler SG, 2015, TRANSFUSION, V55, P199, DOI 10.1111/trf.12796; Sandler SG, 2006, TRANSFUSION, V46, P10, DOI 10.1111/j.1537-2995.2006.00686.x; Savage WJ, 2011, TRANSFUSION, V51, P2337, DOI 10.1111/j.1537-2995.2011.03160.x; Wadhwa M, 1996, BRIT J HAEMATOL, V93, P225, DOI 10.1046/j.1365-2141.1996.4611002.x; Wakamoto S, 2003, TRANSFUSION, V43, P1038, DOI 10.1046/j.1537-2995.2003.00458.x; WESTHOFF CM, 1992, TRANSFUSION, V32, P576, DOI 10.1046/j.1537-2995.1992.32692367205.x	39	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JUL	2015	102	1					93	100		10.1007/s12185-015-1794-0		8	Hematology	Hematology	CN1AE	WOS:000358146600013		
J	Hashimoto, H; Kitano, S; Ueda, R; Ito, A; Tada, K; Fuji, S; Yamashita, T; Tomura, D; Nukaya, I; Mineno, J; Fukuda, T; Mori, S; Takaue, Y; Heike, Y				Hashimoto, Hisayoshi; Kitano, Shigehisa; Ueda, Ryosuke; Ito, Ayumu; Tada, Kohei; Fuji, Shigeo; Yamashita, Takuya; Tomura, Daisuke; Nukaya, Ikuei; Mineno, Junichi; Fukuda, Takahiro; Mori, Shinichiro; Takaue, Yoichi; Heike, Yuji			Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Donor lymphocyte infusion; Herpes simplex virus thymidine kinase suicide gene; Hematologic malignancy; Allogeneic hematopoietic stem cell transplantation	GRAFT-VERSUS-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; HUMAN T-CELLS; RESPONSE CRITERIA; TRANSFUSIONS; GANCICLOVIR; RELAPSE; DISEASE; CANCER	The infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene (TK-cells) is a promising strategy for the treatment of hematologic malignancies relapsing after allogeneic hematopoietic stem cell transplantation. Here we report the results of a phase I clinical trial designed to examine the feasibility, safety, and efficacy of donor lymphocyte infusion (DLI) of TK-cells. Three patients (two with malignant lymphomas, one with acute myeloid leukemia) were enrolled in the trial and received a single DLI of 1 x 10(7) or 5 x 10(7) TK-cells/kg. No local or systemic toxicity related to the gene-transfer procedure was observed. Two patients achieved stable disease. No patient had severe graft-versus-host disease requiring systemic steroid and/or ganciclovir administration. TK-cells were detected in the peripheral blood of all three patients by PCR, but did not persist longer than 28 days. Analysis of cytotoxic T lymphocyte activity detected no immune response against TK-cells by the recipient's own T cells. Flow cytometric analysis showed low proliferative activity and cytotoxic function of TK-cells. In conclusion, DLI of TK-cells was safely performed in all three patients. Our analysis suggests the probable cause of rapid disappearance of TK-cells to be insufficient in vivo expansion of TK-cells in these patients.	[Hashimoto, Hisayoshi; Ueda, Ryosuke] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, Tokyo 1040045, Japan; [Kitano, Shigehisa] Natl Canc Ctr, Div Expt Therapeut, Chuo Ku, Tokyo 1040045, Japan; [Kitano, Shigehisa; Tada, Kohei] Natl Canc Ctr, Div Canc Immunotherapy, Exploratory Oncol Res & Clin Trial Ctr, Chuo Ku, Tokyo 1040045, Japan; [Ito, Ayumu; Tada, Kohei; Fuji, Shigeo; Yamashita, Takuya; Fukuda, Takahiro] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Chuo Ku, Tokyo 1040045, Japan; [Tomura, Daisuke; Nukaya, Ikuei; Mineno, Junichi] Takara Bio Inc, Ctr Cell & Gene Therapy, Otsu, Shiga 5202193, Japan; [Mori, Shinichiro] St Lukes Int Hosp, Div Hematol & Oncol, Chou Ku, Tokyo 1048560, Japan; [Takaue, Yoichi] St Lukes Int Hosp, Res Planning & Management Dept, Chou Ku, Tokyo 1048560, Japan; [Heike, Yuji] St Lukes Int Univ & Hosp, Immunotherapy & Cell Therapy Serv, Chou Ku, Tokyo 1048560, Japan	Heike, Y (reprint author), St Lukes Int Univ & Hosp, Immunotherapy & Cell Therapy Serv, Chou Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	heiyuji@luke.ac.jp			Japanese Ministry of Health, Labour and Welfare; National Cancer Research and Development Fund	This work was supported by grants from the Japanese Ministry of Health, Labour and Welfare and the National Cancer Research and Development Fund. We further thank our strategic partner and the developer of TK, MolMed S.p.A., for all of the support, advice, and technical information provided to us that has allowed progress in this work.	Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Ciceri F, 2007, BLOOD, V109, P4698, DOI 10.1182/blood-2006-05-023416; STCLAIR MH, 1987, ANTIMICROB AGENTS CH, V31, P844; Cornelissen JJ, 2007, BLOOD, V109, P3658, DOI 10.1182/blood-2006-06-025627; MOOLTEN FL, 1986, CANCER RES, V46, P5276; Depil S, 2004, BONE MARROW TRANSPL, V33, P531, DOI 10.1038/sj.bmt.1704381; Onodera M, 2008, FRONT BIOSCI, V13, P3408; Borchers S, 2011, HUM GENE THER, V22, P829, DOI 10.1089/hum.2010.162; MAVILIO F, 1994, BLOOD, V83, P1988; Deol A, 2010, CANCER TREAT REV, V36, P528, DOI 10.1016/j.ctrv.2010.03.004; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; Verzeletti S, 1998, HUM GENE THER, V9, P2243, DOI 10.1089/hum.1998.9.15-2243; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Ciceri F, 2005, CYTOTHERAPY, V7, P144, DOI 10.1080/14653240510018136; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Kolb HJ, 2008, BLOOD, V112, P4371, DOI 10.1182/blood-2008-03-077974; Tiberghien P, 2001, BLOOD, V97, P63, DOI 10.1182/blood.V97.1.63; Burt RK, 2003, EXP HEMATOL, V31, P903, DOI 10.1016/S0301-472X(03)00226-1; Traversari C, 2007, BLOOD, V109, P4708, DOI 10.1182/blood-2006-04-015230; Collins RH, 1997, J CLIN ONCOL, V15, P433; Bonini C, 2003, NAT MED, V9, P367, DOI 10.1038/nm0403-367; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; KOLB HJ, 1990, BLOOD, V76, P2462; KOLB HJ, 1995, BLOOD, V86, P2041; Marktel S, 2003, BLOOD, V101, P1290, DOI 10.1182/blood-2002-08-2351; Barrett AJ, 2008, BRIT J HAEMATOL, V142, P877, DOI 10.1111/j.1365-2141.2008.07260.x; Carlens S, 2001, BIOL BLOOD MARROW TR, V7, P31, DOI 10.1053/bbmt.2001.v7.pm11215696; LABRECQUE N, 1993, J EXP MED, V177, P1735, DOI 10.1084/jem.177.6.1735; Mailly L, 2010, CURR OPIN INVEST DR, V11, P559; Mercier-Letondal P, 2008, HUM GENE THER, V19, P937, DOI 10.1089/hum.2007.156; Nicholson E, 2012, ADV HEMATOL, V2012; Zeng WH, 1999, BLOOD, V93, P3008	34	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JUL	2015	102	1					101	110		10.1007/s12185-015-1801-5		10	Hematology	Hematology	CN1AE	WOS:000358146600014		
J	Takeuchi, Y; Takeuchi, E; Ishida, T; Onodera, M; Nakauchi, H; Otsu, M				Takeuchi, Yasuo; Takeuchi, Emiko; Ishida, Takashi; Onodera, Masafumi; Nakauchi, Hiromitsu; Otsu, Makoto			Curative haploidentical BMT in a murine model of X-linked chronic granulomatous disease	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Chronic granulomatous disease; Haploidentical hematopoietic cell transplantation; Non-myeloablative conditioning; Anti-CD40 ligand therapy; Tolerance	BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; MONOCLONAL-ANTIBODY; ANTI-CD40 LIGAND; HEMATOPOIETIC ALLOGRAFT; MIXED CHIMERISM; UNRELATED DONOR; HOST-DEFENSE; TOLERANCE; DELETION	Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder characterized by defective microbial killing in phagocytes. Long-term prognosis for CGD patients is generally poor, highlighting the need to develop minimally toxic, curative therapeutic approaches. We here describe the establishment of a mouse model in which X-linked CGD can be cured by allogeneic bone marrow transplantation. Using a combination of non-myeloablative-dose total body irradiation and a single injection of anti-CD40 ligand monoclonal antibody, transplantation of whole bone marrow cells achieved long-lasting mixed chimerism in X-linked CGD mice in a haploidentical transplantation setting. Stable mixed chimerism was maintained for up to 1 year even at a low range (< 20 % donor cells), indicating induction of donor-specific tolerance. The regimen induced mild myelosuppression without severe acute complications. Stable chimerism was therapeutic, as it suppressed cutaneous granuloma formation in an in vivo test suited for evaluation of treatment efficacy in murine CGD models. These results warrant future development of a simplified allogeneic hematopoietic cell transplantation regimen that would benefit CGD patients by allowing the use of haploidentical donor grafts without serious concerns of severe treatment-related toxicity.	[Takeuchi, Yasuo] Kitasato Univ, Sch Med, Dept Internal Med, Div Nephrol, Sagamihara, Kanagawa 228, Japan; [Takeuchi, Yasuo; Takeuchi, Emiko] Kitasato Univ, Sch Med, Dept Immunol, Sagamihara, Kanagawa 228, Japan; [Ishida, Takashi] Kitasato Univ, Sch Med, Dept Hematol, Sagamihara, Kanagawa 228, Japan; [Onodera, Masafumi] Natl Ctr Child Hlth & Dev, Dept Human Genet, Tokyo, Japan; [Ishida, Takashi; Nakauchi, Hiromitsu; Otsu, Makoto] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Tokyo 1088639, Japan; [Otsu, Makoto] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Stem Cell Bank,Minato Ku, Tokyo 1088639, Japan; [Otsu, Makoto] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Proc,Minato Ku, Tokyo 1088639, Japan	Otsu, M (reprint author), Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Tokyo 1088639, Japan.	motsu@ims.u-tokyo.ac.jp			JSPS KAKENHI; Ministry of Health, Labor and Welfare; National Center for Child Health and Development	We thank Dr. A. S. Knisely for critical reading of the manuscript, Dr. Michiko Abe for the Aspergillus fumigatus debris suspension, Dr. Yasuteru Urano for fluorescent probes and his technical advice, Dr. Yasunori Ota for histopathological analysis, and Dr. Masanori Nojima for statistical analysis. This work was supported in part of by a JSPS KAKENHI Grant-in-Aid for Yasuo Takeuchi and Makoto Otsu, and by grants from the Ministry of Health, Labor and Welfare and National Center for Child Health and Development (M. Onodera).	Ahlin A, 2013, ACTA PAEDIATR, V102, P1087, DOI 10.1111/apa.12384; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Grez M, 2011, MOL THER, V19, P28, DOI 10.1038/mt.2010.232; Seger RA, 2002, BLOOD, V100, P4344, DOI 10.1182/blood-2002-02-0583; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Dinauer MC, 2001, BLOOD, V97, P3738, DOI 10.1182/blood.V97.12.3738; Martinez CA, 2012, J ALLERGY CLIN IMMUN, V129, P176, DOI 10.1016/j.jaci.2011.10.005; Boumpas DT, 2003, ARTHRITIS RHEUM, V48, P719, DOI 10.1002/art.10856; Maeda Y, 2013, INT J HEMATOL, V98, P293, DOI 10.1007/s12185-013-1421-x; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Sykes M, 2001, IMMUNITY, V14, P417, DOI 10.1016/S1074-7613(01)00122-4; Kurtz J, 2004, BLOOD, V103, P4336, DOI 10.1182/blood-2003-08-2642; Wekerle T, 1998, J EXP MED, V187, P2037, DOI 10.1084/jem.187.12.2037; Paczesny S, 2013, INT J HEMATOL, V98, P275, DOI 10.1007/s12185-013-1406-9; Durham MM, 2000, J IMMUNOL, V165, P1; Tomita Y, 1996, TRANSPLANTATION, V61, P469, DOI 10.1097/00007890-199602150-00027; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Seger RA, 2011, CURR OPIN HEMATOL, V18, P36, DOI 10.1097/MOH.0b013e32834115e7; Kang EM, 2011, J ALLERGY CLIN IMMUN, V127, P1319, DOI 10.1016/j.jaci.2011.03.028; Robles-Carrillo L, 2010, J IMMUNOL, V185, P1577, DOI 10.4049/jimmunol.0903888; Xie JH, 2014, J IMMUNOL, V192, P4083, DOI 10.4049/jimmunol.1303239; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Nikolic B, 2004, DIABETES, V53, P376, DOI 10.2337/diabetes.53.2.376; Kuijpers T, 2012, CELL MOL LIFE SCI, V69, P7, DOI 10.1007/s00018-011-0834-z; Fehr T, 2005, EUR J IMMUNOL, V35, P2679, DOI 10.1002/eji.200526190; Gozdzik J, 2011, J CLIN IMMUNOL, V31, P332, DOI 10.1007/s10875-011-9513-y; Gungor T, 2005, TRANSPLANTATION, V79, P1596, DOI 10.1097/01.TP.0000163466.73485.5E; Hasegawa D, 2008, INT J HEMATOL, V87, P88, DOI 10.1007/s12185-007-0017-8; Hoenig M, 2014, BONE MARROW TRANSPL, V49, P1337, DOI 10.1038/bmt.2014.125; Horwitz ME, 2001, NEW ENGL J MED, V344, P881, DOI 10.1056/NEJM200103223441203; Kang EM, 2011, J ALLERGY CLIN IMMUN, V127, P27; Kikuta A, 2006, BONE MARROW TRANSPL, V38, P665, DOI 10.1038/sj.bmt.1705511; LINDAHL JA, 1984, J PEDIATR GASTR NUTR, V3, P637, DOI 10.1097/00005176-198409000-00028; Patel VL, 2008, BRIT J HAEMATOL, V141, P545, DOI 10.1111/j.1365-2141.2008.07039.x; Petersen JE, 2002, J INVEST DERMATOL, V118, P424, DOI 10.1046/j.0022-202x.2001.01691.x; Schuetz C, 2007, EUR J PEDIATR, V166, P785, DOI 10.1007/s00431-006-0317-7; Soncini E, 2009, BRIT J HAEMATOL, V145, P73, DOI 10.1111/j.1365-2141.2009.07614.x; Takeuchi E, 2011, AUTOIMMUNITY, V44, P363, DOI 10.3109/08916934.2010.541172; Takeuchi Y, 2004, AM J TRANSPLANT, V4, P31, DOI 10.1046/j.1600-6135.2003.00272.x; Wekerle Thomas, 2000, Nature Medicine, V6, P464	42	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JUL	2015	102	1					111	120		10.1007/s12185-015-1799-8		10	Hematology	Hematology	CN1AE	WOS:000358146600015		
J	Ueda, R; Fuji, S; Mori, S; Hiramoto, N; Hashimoto, H; Tanaka, T; Tada, K; Kobayashi, Y; Morikawa, N; Shinohara, A; Okinaka, K; Maeshima, AM; Kurosawa, S; Kim, SW; Yamashita, T; Fukuda, T				Ueda, Ryosuke; Fuji, Shigeo; Mori, Shin-ichiro; Hiramoto, Nobuhiro; Hashimoto, Hisayoshi; Tanaka, Takashi; Tada, Kohei; Kobayashi, Yujin; Morikawa, Noriyuki; Shinohara, Akihito; Okinaka, Keiji; Maeshima, Akiko M.; Kurosawa, Saiko; Kim, Sung-Won; Yamashita, Takuya; Fukuda, Takahiro			Characteristics and outcomes of patients diagnosed with norovirus gastroenteritis after allogeneic hematopoietic stem cell transplantation based on immunochromatography	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Norovirus gastroenteritis; Allogeneic hematopoietic stem cell transplantation; Immunochromatgraphy	FECAL SPECIMENS; NOSOCOMIAL TRANSMISSION; INFECTION; RECIPIENTS; EXCRETION; INPATIENTS; OUTBREAK; DIARRHEA; ASSAY; KIT	Norovirus gastroenteritis (NV-GE) is a highly transmittable disease that can lead to fatal outcomes in vulnerable populations including patients after hematopoietic stem cell transplantation (HSCT). Prompt detection of NV is therefore important for HSCT recipients. Immunochromatography (IC) can be used to easily and rapidly diagnose NV-GE by detecting NV antigens. In this study, we examined 642 stool specimens in patients who developed diarrhea after allogeneic HSCT between January 2007 and June 2011. NV was detected in 10 of 350 (2.9 %) HSCT recipients. The median onset of symptoms was 36 days (range 3-93) after HSCT. The median duration of symptoms was 42 days (3-135). A second or subsequent allogeneic HSCT was associated with a higher incidence of NV-GE (P = 0.034). Of four patients who underwent colonoscopy, two showed intestinal graft-versus-host disease (GVHD) histopathology, whereas the other two showed no evidence of GVHD, and thus no need for intensified immunosuppression. None of the patients died of NV-GE. In conclusion, IC may be useful in the differential diagnosis of diarrhea after allogeneic HSCT, and could enable the appropriate adjustment of immunosuppressive drugs and prompt preventive measures.	[Ueda, Ryosuke; Fuji, Shigeo; Hiramoto, Nobuhiro; Hashimoto, Hisayoshi; Tanaka, Takashi; Tada, Kohei; Kobayashi, Yujin; Morikawa, Noriyuki; Shinohara, Akihito; Okinaka, Keiji; Kurosawa, Saiko; Kim, Sung-Won; Yamashita, Takuya; Fukuda, Takahiro] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Div, Chuo Ku, Tokyo 1040045, Japan; [Mori, Shin-ichiro] St Lukes Int Hosp, Dept Hematooncol, Tokyo, Japan; [Maeshima, Akiko M.] Natl Canc Ctr, Pathol & Clin Lab Div, Tokyo 1040045, Japan	Fuji, S (reprint author), Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	sfuji@ncc.go.jp			Japanese Ministry of Health, Labour and Welfare; Advanced Clinical Research Organization	The authors thank Ms. Mariko Ohnishi for immunochromatographic analysis and clinical research assistance. This work was supported by grants from the Japanese Ministry of Health, Labour and Welfare and the Advanced Clinical Research Organization. Some of these results were presented at the 38th Annual Meeting of the European Group for Blood and Marrow Transplantation in Geneva, Switzerland, April 2, 2012.	Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Kim MJ, 2011, J PEDIATR GASTR NUTR, V52, P314, DOI 10.1097/MPG.0b013e3181ebfa01; Morotti RA, 2004, HUM PATHOL, V35, P1236, DOI 10.1016/j.humpath.2004.06.013; Doshi M, 2013, AM J INFECT CONTROL, V41, P820, DOI 10.1016/j.ajic.2012.10.025; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Shefer Abigail, 2011, Morbidity and Mortality Weekly Report, V60, P1; Roddie C, 2009, CLIN INFECT DIS, V49, P1061, DOI 10.1086/605557; Atmar RL, 2001, CLIN MICROBIOL REV, V14, P15, DOI 10.1128/CMR.14.1.15-37.2001; Gallimore CI, 2004, J CLIN MICROBIOL, V42, P2271, DOI 10.1128/JCM.42.5.2271-2274.2004; Kirby A, 2010, J CLIN VIROL, V49, P254, DOI 10.1016/j.jcv.2010.08.004; Saif MA, 2011, PEDIATR TRANSPLANT, V15, P505, DOI 10.1111/j.1399-3046.2011.01500.x; Ambert-Balay K, 2013, J CLIN VIROL, V56, P194, DOI 10.1016/j.jcv.2012.11.001; Schwartz S, 2011, BLOOD, V117, P5850, DOI 10.1182/blood-2010-12-325886; Sukhrie FHA, 2012, CLIN INFECT DIS, V54, P931, DOI 10.1093/cid/cir971; Sukhrie FHA, 2010, J CLIN MICROBIOL, V48, P4303, DOI 10.1128/JCM.01308-10; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Geginat G, 2012, EUR J CLIN MICROBIOL, V31, P733, DOI 10.1007/s10096-011-1366-z; Tomov VT, 2013, J VIROL, V87, P7015, DOI 10.1128/JVI.03389-12; Battaglioli G, 2012, J CLIN VIROL, V53, P262, DOI 10.1016/j.jcv.2011.12.007; Blanco NB, 2011, TRANSPL INFECT DIS, V13, P213, DOI 10.1111/j.1399-3062.2010.00565.x; Bruggink LD, 2011, J VIROL METHODS, V173, P121, DOI 10.1016/j.jviromet.2011.01.017; Bruins MJ, 2010, EUR J CLIN MICROBIOL, V29, P741, DOI 10.1007/s10096-010-0911-5; Capizzi T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-131; Ebdrup L, 2011, J CLIN VIROL, V50, P263, DOI 10.1016/j.jcv.2010.11.007; Furuya D, 2011, JPN J INFECT DIS, V64, P104; Greig JD, 2012, EPIDEMIOL INFECT, V140, P1151, DOI 10.1017/S0950268811002731; Kaltsas A, 2012, CURR OPIN INFECT DIS, V25, P423, DOI 10.1097/QCO.0b013e328355660b; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim HS, 2012, J VIROL METHODS, V186, P94, DOI 10.1016/j.jviromet.2012.08.014; Ljungman P, 2010, INT J HEMATOL, V91, P596, DOI 10.1007/s12185-010-0570-4; Park KS, 2012, ANN LAB MED, V32, P79, DOI 10.3343/alm.2012.32.1.79; Pombubpa K, 2012, EUR J CLIN MICROBIOL, V31, P2379, DOI 10.1007/s10096-012-1579-9; Robles JDF, 2012, BIOL BLOOD MARROW TR, V18, P1883, DOI 10.1016/j.bbmt.2012.07.005; Roos-Weil D, 2011, TRANSPLANTATION, V92, P61, DOI 10.1097/TP.0b013e31821c9392; Takanashi S, 2008, J VIROL METHODS, V148, P1, DOI 10.1016/j.jviromet.2007.10.010	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JUL	2015	102	1					121	128		10.1007/s12185-015-1804-2		8	Hematology	Hematology	CN1AE	WOS:000358146600016		
J	Nakamura, Y; Murata, M; Takagi, Y; Kozuka, T; Nakata, Y; Hasebe, R; Takagi, A; Kitazawa, J; Shima, M; Kojima, T				Nakamura, Yuki; Murata, Moe; Takagi, Yuki; Kozuka, Toshihiro; Nakata, Yukiko; Hasebe, Ryo; Takagi, Akira; Kitazawa, Jun-ichi; Shima, Midori; Kojima, Tetsuhito			SVA retrotransposition in exon 6 of the coagulation factor IX gene causing severe hemophilia B	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Hemophilia B; F9; SVA retrotransposon; Exontrap analysis; mRNA splicing	HUMAN-DISEASE	Hemophilia B is an X-linked recessive bleeding disorder caused by abnormalities of the coagulation factor IX gene (F9). Insertion mutations in F9 ranging from a few to more than 100 base pairs account for only a few percent of all hemophilia B cases. We investigated F9 to elucidate genetic abnormalities causing severe hemophilia B in a Japanese subject. We performed PCR-mediated analysis of F9 and identified a large insertion in exon 6. Next, we carried out direct sequencing of a PCR clone of the whole insert using nested deletion by exonuclease III and S1 nuclease. We identified an approximately 2.5-kb SINE-VNTR-Alu (SVA)-F element flanked by 15-bp duplications in the antisense orientation in exon 6. Additionally, we carried out exontrap analysis to assess the effect of this retrotransposition on mRNA splicing. We observed that regular splicing at exons 5 and 6 of F9 was disturbed by the SVA retrotransposition, suggesting that abnormal FIX mRNA may be reduced by nonsense-mediated mRNA decay. In conclusion, this is the first report of SVA retrotransposition causing severe hemophilia B; only five cases of LINE-1 or Alu retrotranspositions in F9 have been reported previously.	[Nakamura, Yuki; Murata, Moe; Takagi, Yuki; Kozuka, Toshihiro; Nakata, Yukiko; Hasebe, Ryo; Takagi, Akira; Kojima, Tetsuhito] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Murata, Moe] Japan Soc Promot Sci, Tokyo, Japan; [Kitazawa, Jun-ichi] Kuroishi Gen Hosp, Kuroishi, Aomori, Japan; [Shima, Midori] Nara Med Univ, Dept Paediat, Nara, Japan	Kojima, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Higashi Ku, 1-1-20 Daiko Minami, Nagoya, Aichi 4618673, Japan.	kojima@met.nagoya-u.ac.jp	Kojima, Tetsuhito/I-6271-2014	Kojima, Tetsuhito/0000-0002-1905-1065	Japanese Ministry of Education, Culture, Sports, Science, and Technology Subsidy Program [25293129]; Japanese Ministry of Health, Labour and Welfare Research Subsidy Program	The authors thank Ms. C. Wakamatsu for her expert technical assistance and Ms. M. Goto for data collection. This study was financially supported in part by the Japanese Ministry of Education, Culture, Sports, Science, and Technology Subsidy Program (25293129: T. Kojima) and the Japanese Ministry of Health, Labour and Welfare Research Subsidy Program (T. Kojima and M. S.). The authors would like to thank Enago (www.enago.jp) for the English language review.	Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Taniguchi-Ikeda M, 2011, NATURE, V478, P127, DOI 10.1038/nature10456; Kaer K, 2013, GENE, V518, P231, DOI 10.1016/j.gene.2013.01.008; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Callinan P, 2006, GENOME DYN, V1, P104, DOI 10.1159/000092503; Makino S, 2007, AM J HUM GENET, V80, P393, DOI 10.1086/512129; Conley Mary Ellen, 2005, Hum Mutat, V25, P324, DOI 10.1002/humu.9321; Hancks DC, 2009, GENOME RES, V19, P1983, DOI 10.1101/gr.093153.109; Kato I, 2014, INT J HEMATOL, V100, P200, DOI 10.1007/s12185-014-1596-9; KOJIMA T, 1987, BLOOD, V69, P349; Li Tengguo, 2013, Mol Genet Genomic Med, V1, P238, DOI 10.1002/mgg3.30; Okumura K, 2008, HAEMOPHILIA, V14, P1088, DOI 10.1111/j.1365-2516.2008.01786.x; Raiz J, 2012, NUCLEIC ACIDS RES, V40, P1666, DOI 10.1093/nar/gkr863; Takagi A, 1996, J BIOCHEM-TOKYO, V119, P979; Wilund KR, 2002, HUM MOL GENET, V11, P3019, DOI 10.1093/hmg/11.24.3019; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JUL	2015	102	1					134	139		10.1007/s12185-015-1765-5		6	Hematology	Hematology	CN1AE	WOS:000358146600018		
J	Izawa, G; Kobayashi, W; Haraguchi, M; Sudo, A; Ozawa, M				Izawa, Genya; Kobayashi, Wakako; Haraguchi, Misako; Sudo, Akiharu; Ozawa, Masayuki			The ectopic expression of Snail in MDBK cells does not induce epithelial-mesenchymal transition	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						epithelial-mesenchymal transition; Snail; Slug; zinc finger E-box-binding homeobox 1; Madin-Darby bovine kidney cells	TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; TUMOR PROGRESSION; ADHESION MOLECULES; DNA METHYLATION; TGF-BETA; METASTASIS; CANCER; PHOSPHORYLATION; P53	Epithelial-mesenchymal transition (EMT), a key process in the tumor metastatic cascade, is characterized by the loss of cell-cell junctions and cell polarity, as well as by the acquisition of migratory and invasive properties. However, the precise molecular events that initiate this complex EMT process are poorly understood. Snail expression induces EMT in Madin-Darby canine kidney (MDCK) cells and the human epidermoid carcinoma cell line, A431. Snail is a zinc finger transcription factor and triggers EMT by suppressing E-cadherin expression. In the present study, to broaden our knowledge of Snail-induced EMT, we generated stable Snail transfectants using Madin-Darby bovine kidney (MDBK) cells. Contrary to the MDCK or A431 cells examined in our previous studies, the MDBK cells transfected with the Snail construct maintained an epithelial morphology and showed no sign of reduced cell-cell adhesiveness compared to the control cells. Consistent with these observations, the down-regulation of epithelial marker proteins, e.g. E-cadherin and desmoglein, and the upregulation of mesenchymal marker proteins, e.g., N-cadherin and fibronectin, were not detected. Furthermore, the E-cadherin promoter was not methylated. Therefore, in the MDBK cells, the ectopic expression of Snail failed to induce EMT. As previously demonstrated, in MDCK cells, Snail expression is accompanied by the increased expression of other EMT-inducing transcription factors, e.g., Slug and zinc finger E-box-binding homeobox 1 (ZEB1). However, the MDBK cells transfected with the Snail construct did not exhibit an increased expression of these factors. Thus, it is possible that the failure to upregulate other EMT-related transcription factors may explain the lack of Snail-mediated induction of EMT in MDBK cells.	[Izawa, Genya; Kobayashi, Wakako; Haraguchi, Misako; Ozawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, Kagoshima 8908544, Japan; [Sudo, Akiharu] Kokushikan Univ, Fac Phys Educ, Dept Sport & Phys Educ, Tama, Tokyo 2068515, Japan	Ozawa, M (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	mozawa@m.kufm.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	We would like thank Dr M. Sato (Kagoshima University) for his helpful discussion. This study was supported by the following grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We would also like to thank the Joint Research Laboratory at Kagoshima University Graduate School of Medical and Dental Sciences for the use of their facilities.	Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Shimokawa M, 2013, BIOCHEM BIOPH RES CO, V430, P1078, DOI 10.1016/j.bbrc.2012.12.035; Duband JL, 1995, ACTA ANAT, V154, P63; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Zheng HQ, 2014, CANCER CELL, V26, P358, DOI 10.1016/j.ccr.2014.07.022; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Kume K, 2013, BIOCHEM BIOPH RES CO, V430, P889, DOI 10.1016/j.bbrc.2012.12.060; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Hay ED, 1995, ACTA ANAT, V154, P8; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Zhang P, 2014, NAT CELL BIOL, V16, P864, DOI 10.1038/ncb3013; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Haraguchi M, 2008, J BIOL CHEM, V283, P23514, DOI 10.1074/jbc.M801125200; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Yang XF, 2009, J CELL SCI, V122, P2473, DOI 10.1242/jcs.049148; Kobayashi W, 2013, BIOCHEM BIOPH RES CO, V442, P133, DOI 10.1016/j.bbrc.2013.11.031; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Ozawa M, 2015, BIOCHEM BIOPH RES CO, V458, P608, DOI 10.1016/j.bbrc.2015.02.012; Romano LA, 2000, DEV BIOL, V223, P91, DOI 10.1006/dbio.2000.9750; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; Devireddy LR, 1999, J VIROL, V73, P3778; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; KOCH PJ, 1990, EUR J CELL BIOL, V53, P1; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Zhang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085624	44	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JUL	2015	36	1					166	172		10.3892/ijmm.2015.2215		7	Medicine, Research & Experimental	Research & Experimental Medicine	CN0WO	WOS:000358134900018		
J	Hiramoto, M; Udagawa, H; Watanabe, A; Miyazawa, K; Ishibashi, N; Kawaguchi, M; Uebanso, T; Nishimura, W; Nammo, T; Yasuda, K				Hiramoto, Masaki; Udagawa, Haruhide; Watanabe, Atsushi; Miyazawa, Keisuke; Ishibashi, Naoko; Kawaguchi, Miho; Uebanso, Takashi; Nishimura, Wataru; Nammo, Takao; Yasuda, Kazuki			Comparative analysis of type 2 diabetes-associated SNP alleles identifies allele-specific DNA-binding proteins for the KCNQ1 locus	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						type 2 diabetes; KCNQ1; single nucleotide polymorphism; DNA-binding proteins; affinity purification	BECKWITH-WIEDEMANN-SYNDROME; AFFINITY LATEX-PARTICLES; INSULIN-SECRETION; BETA-CELLS; SUSCEPTIBILITY; PURIFICATION; VARIANTS; CHANNEL; CHROMATOGRAPHY; ATF/E4TF3	Although recent genome-wide association studies (GWAS) have been extremely successful, it remains a big challenge to functionally annotate disease-associated single nucleotide polymorphisms (SNPs), as the majority of these SNPs are located in non-coding regions of the genome. In this study, we described a novel strategy for identifying the proteins that bind to the SNP-containing locus in an allele-specific manner and successfully applied this method to SNPs in the type 2 diabetes mellitus susceptibility gene, potassium voltage-gated channel, KQT-like subfamily Q, member 1 (KCNQ1). DNA fragments encompassing SNPs, and risk or non-risk alleles were immobilized onto the novel nanobeads and DNA-binding proteins were purified from the nuclear extracts of pancreatic cells using these DNA-immobilized nanobeads. Comparative analysis of the allele-specific DNA-binding proteins indicated that the affinities of several proteins for the examined SNPs differed between the alleles. Nuclear transcription factor Y (NF-Y) specifically bound the non-risk allele of the SNP rs2074196 region and stimulated the transcriptional activity of an artificial promoter containing SNP rs2074196 in an allele-specific manner. These results suggest that SNP rs2074196 modulates the affinity of the locus for NF-Y and possibly induces subsequent changes in gene expression. The findings of this study indicate that our comparative method using novel nanobeads is effective for the identification of allele-specific DNA-binding proteins, which may provide important clues for the functional impact of disease-associated non-coding SNPs.	[Hiramoto, Masaki; Udagawa, Haruhide; Ishibashi, Naoko; Kawaguchi, Miho; Uebanso, Takashi; Nishimura, Wataru; Nammo, Takao; Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Dept Metab Disorder, Diabet Res Ctr, Res Inst, Tokyo 1628655, Japan; [Watanabe, Atsushi] Natl Ctr Geriatr & Gerontol, Res Inst, Lab Res Adv, Obu, Aichi 4748511, Japan; [Hiramoto, Masaki; Miyazawa, Keisuke] Tokyo Med Univ, Dept Biochem, Tokyo 1608402, Japan	Yasuda, K (reprint author), Natl Ctr Global Hlth & Med, Dept Metab Disorder, Diabet Res Ctr, Res Inst,Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	hiramoto@tokyo-med.ac.jp; kyasuda@ri.ncgm.go.jp		Nishimura, Wataru/0000-0002-8068-1277	Japan Society for the Promotion of Science (JSPS) [22510216]; Japan Diabetes Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institute of Biomedical Innovation; National Center for Global Health and Medicine	We would like to thank Mr. Dai Suzuki and Ms. Kazuko Nagase for providing technical assistance. This study was supported by grants from the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI), grant no. 22510216 (to M.H.), the Japan Diabetes Foundation (to M.H.), the Leading Research Project of Ministry of Education, Culture, Sports, Science and Technology, Japan (to K.Y.), National Institute of Biomedical Innovation (to K.Y.) and National Center for Global Health and Medicine (to K.Y.).	Yamagata K, 2011, BIOCHEM BIOPH RES CO, V407, P620, DOI 10.1016/j.bbrc.2011.03.083; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Imamura M, 2011, ENDOCR J, V58, P723; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Nishio K, 2008, COLLOID SURFACE B, V64, P162, DOI 10.1016/j.colsurfb.2008.01.013; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Avrahami D, 2014, J CLIN INVEST, V124, P670, DOI 10.1172/JCI69519; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Arima T, 2005, NUCLEIC ACIDS RES, V33, P2650, DOI 10.1093/nar/gki555; Hiramoto M, 2010, BIOMED CHROMATOGR, V24, P606, DOI 10.1002/bmc.1334; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; Kyriazis GA, 2012, P NATL ACAD SCI USA, V109, pE524, DOI 10.1073/pnas.1115183109; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Bungartz G, 2012, BLOOD, V119, P1380, DOI 10.1182/blood-2011-06-359406; Brixel LR, 2010, PFLUG ARCH EUR J PHY, V460, P69, DOI 10.1007/s00424-010-0835-z; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; INOMATA Y, 1992, ANAL BIOCHEM, V206, P109, DOI 10.1016/S0003-2697(05)80018-1; Kassem SA, 2001, DIABETES, V50, P2763, DOI 10.2337/diabetes.50.12.2763; KAWAGUCHI H, 1989, NUCLEIC ACIDS RES, V17, P6229, DOI 10.1093/nar/17.15.6229; Krishnan K, 2014, PANCREAS, V43, P597, DOI 10.1097/MPA.0000000000000027; Luo R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00136; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Wada T, 1996, NUCLEIC ACIDS RES, V24, P876, DOI 10.1093/nar/24.5.876; WADA T, 1995, METHOD ENZYMOL, V254, P595	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JUL	2015	36	1					222	230		10.3892/ijmm.2015.2203		9	Medicine, Research & Experimental	Research & Experimental Medicine	CN0WO	WOS:000358134900024		
J	Yamamoto, Y; Hisataka, F; Harada, S				Yamamoto, Yasufumi; Hisataka, Fumiya; Harada, Shusaku			Numerical simulation of concentration interface in stratified suspension: Continuum-particle transition	INTERNATIONAL JOURNAL OF MULTIPHASE FLOW			English	Article						Stratified suspension; Concentration interface; Numerical simulation; Fingering instability	RAYLEIGH-TAYLOR INSTABILITY; LINEAR-STABILITY ANALYSIS; MULTIPHASE FLOW; SEDIMENTATION; CONVECTION; GRAVITY; FLUIDS; DROPS	Behavior of concentration interfaces, which are apparent interfaces between a suspension and pure liquid, was studied using numerical techniques. Two types of numerical simulations were used to classify whether collective or individual behavior occurred in the ratio of the average particle separation to the wavelength of the fastest growing perturbation. The first is Lagrangian tracking of individual particles in fluid, and the second type is interface tracking of two immiscible continuum phases. These two extremely different approaches represent the dual nature of the concentration interface: immiscible with no interfacial tension and miscible with no diffusion. These results reflect the experimentally-observed behavior of particles, which is both collective and individual. Sealing of the concentration interface by particle-induced flow is crucial to collective motion of suspended particles. A proposed dimensionless parameter describes quantitatively the transition from collective to individual settling of suspended particles. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamamoto, Yasufumi] Kansai Univ, Dept Mech Engn, Suita, Osaka 5648680, Japan; [Hisataka, Fumiya] Kansai Univ, Grad Sch Sci & Engn, Suita, Osaka 5648680, Japan; [Harada, Shusaku] Hokkaido Univ, Div Sustainable Resources Engn, Sapporo, Hokkaido 0608628, Japan	Yamamoto, Y (reprint author), Kansai Univ, Dept Mech Engn, 3-35 Yamate Cho 3 Chome, Suita, Osaka 5648680, Japan.	yamayasu@kansai-u.ac.jp			JSPS [23560178, 26420095]	This study was supported by JSPS KAKENHI Grants Nos. 23560178 and 26420095. The authors would like to thank Enago (www.enago.jp) for the English language review.	Amsden A. A., 1970, Journal of Computational Physics, V6, DOI 10.1016/0021-9991(70)90029-X; Warrick JA, 2008, CONT SHELF RES, V28, P991, DOI 10.1016/j.csr.2007.11.002; Hoyal DCJD, 1999, J GEOPHYS RES-OCEANS, V104, P7953, DOI 10.1029/1998JC900065; Blanchette F, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1947987; Machu G, 2001, J FLUID MECH, V447, P299, DOI 10.1017/S0022112001005882; Peskin CS, 2002, ACT NUMERIC, V11, P479; PEDLEY TJ, 1992, ANNU REV FLUID MECH, V24, P313, DOI 10.1146/annurev.fluid.24.1.313; Parsons JD, 2001, SEDIMENTOLOGY, V48, P465, DOI 10.1046/j.1365-3091.2001.00384.x; Yu X, 2013, J GEOPHYS RES-OCEANS, V118, P256, DOI 10.1029/2012JC008255; McCool WW, 2004, CONT SHELF RES, V24, P1129, DOI 10.1016/j.csr.2004.03.009; Nitsche JM, 1997, J FLUID MECH, V340, P161, DOI 10.1017/S0022112097005223; Bergougnoux L, 2003, PHYS FLUIDS, V15, P1875, DOI 10.1063/1.1578486; Balachandar S, 2010, ANNU REV FLUID MECH, V42, P111, DOI 10.1146/annurev.fluid.010908.165243; Carey S, 1997, GEOLOGY, V25, P839, DOI 10.1130/0091-7613(1997)025<0839:IOCSOT>2.3.CO;2; Shin S, 2002, J COMPUT PHYS, V180, P427, DOI 10.1006/jcph.2002.7086; Burns P, 2012, J FLUID MECH, V691, P279, DOI 10.1017/jfm.2011.474; KYNCH GJ, 1952, T FARADAY SOC, V48, P166, DOI 10.1039/tf9524800166; Metzger B, 2007, J FLUID MECH, V580, P283, DOI 10.1017/S0022112007005381; Bosse T, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1851428; Chou YJ, 2014, INT J MULTIPHAS FLOW, V64, P44, DOI 10.1016/j.ijmultiphaseflow.2013.12.009; Fernandez J, 2001, PHYS FLUIDS, V13, P3120, DOI 10.1063/1.1410120; Ferziger J. H., 1996, COMPUTATIONAL METHOD; Ferziger JH, 2003, INT J NUMER METH FL, V41, P551, DOI 10.1002/fld.455; Pan TW, 2001, J FLUID MECH, V434, P23; Harada S, 2013, CHEM ENG SCI, V93, P307, DOI 10.1016/j.ces.2013.01.054; Harada S, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12001-6; KUENEN PH, 1968, J SEDIMENT PETROL, V38, P817; Mucha PJ, 2003, PHYS FLUIDS, V15, P1305, DOI 10.1063/1.1564824; Sumita I., 2005, GEOPHYS RES LETT, V32; Uemura T., 2011, T JPN SOC MECH ENG, V77, P237; Voltz C, 2001, PHYS REV E, V65, P1, DOI 10.1103/PhysRevE.65.011404; Voltz C., 2003, PHYS REV E, V68	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-9322	1879-3533		INT J MULTIPHAS FLOW	Int. J. Multiph. Flow	JUL	2015	73						71	79		10.1016/j.ijmultiphaseflow.2015.03.007		9	Mechanics	Mechanics	CN0HL	WOS:000358094600008		
J	Youn, YJ; Muramatsu, K; Han, Y; Shikazono, N				Youn, Young Jik; Muramatsu, Kenshiro; Han, Youngbae; Shikazono, Naoki			The effect of initial flow velocity on the liquid film thickness in micro tube accelerated slug flow	INTERNATIONAL JOURNAL OF MULTIPHASE FLOW			English	Article						Liquid film thickness; Two-phase flow; Micro tube; Acceleration; Initial flow velocity	FOCUS DISPLACEMENT METER; HEAT-TRANSFER; MICROCHANNELS; BUBBLE; WALL; PREDICTION; DEPOSITION; FLUID	Liquid film thickness is an important parameter for predicting boiling and condensation heat transfer in micro tubes. In the present study, the effect of initial flow velocity on the liquid film thickness in accelerated flows under adiabatic condition is experimentally investigated. The laser focus displacement meter is used to measure the initial liquid film thickness. Circular tube with inner diameter of 1 mm was used for the test tube, and water, ethanol and FC-40 are used as working fluids. When the flow is accelerated from small initial velocities under small Bond number condition, initial liquid film thickness is identical to that of steady flow at small capillary numbers, and then deviates from the steady condition and eventually follows that of accelerated flow from zero initial velocity as capillary number is increased. When the flow is accelerated from large initial velocities, initial liquid film thickness deviates from the steady condition earlier and starts to follow that of accelerated flow from zero initial velocity as capillary number is increased. It is found that the initial flow velocity cannot be neglected in accelerated flows especially at large initial flow velocities and at large Bond numbers. Finally, an empirical correlation is proposed for the initial liquid film thickness of accelerated flows that accounts for the initial flow velocities. (C) 2015 Elsevier Ltd. All rights reserved.	[Youn, Young Jik; Muramatsu, Kenshiro; Shikazono, Naoki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1510041, Japan; [Muramatsu, Kenshiro] DENSO CORP, Kariya, Aichi 4488661, Japan; [Han, Youngbae] Hongik Univ, Jochiwon Eup 339701, Sejong, South Korea	Youn, YJ (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1510041, Japan.	yjyoun@iis.u-tokyo.ac.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) program, JST	This work is partly supported by the Advanced Low Carbon Technology Research and Development Program (ALCA) program, JST.	Thome JR, 2004, INT J HEAT MASS TRAN, V47, P3375, DOI 10.1016/j.ijheatmasstransfer.2004.01.006; Saitoh S, 2007, INT J HEAT MASS TRAN, V50, P5215, DOI 10.1016/j.ijheatmasstransfer.2007.06.019; Moriyama K, 1996, J HEAT TRANS-T ASME, V118, P132, DOI 10.1115/1.2824026; Han Y, 2009, INT J MULTIPHAS FLOW, V35, P896, DOI 10.1016/j.ijmultiphaseflow.2009.06.006; Han Y, 2009, INT J HEAT FLUID FL, V30, P842, DOI 10.1016/j.ijheatfluidflow.2009.02.019; Qu WL, 2003, INT J HEAT MASS TRAN, V46, P2737, DOI 10.1016/S0017-9310(03)00044-9; Han YB, 2010, INT J HEAT FLUID FL, V31, P630, DOI 10.1016/j.ijheatfluidflow.2010.02.002; Takamasa T, 2000, INT J MULTIPHAS FLOW, V26, P1493, DOI 10.1016/S0301-9322(99)00099-3; Chen YP, 2014, AICHE J, V60, P1182; Aussillous P, 2000, PHYS FLUIDS, V12, P2367, DOI 10.1063/1.1289396; Hazuku T, 2005, EXP FLUIDS, V38, P780, DOI 10.1007/s00348-005-0973-9; Howard JA, 2013, INT J MULTIPHAS FLOW, V55, P32, DOI 10.1016/j.ijmultiphaseflow.2013.04.005; Kenning DBR, 2006, INT J HEAT MASS TRAN, V49, P4653, DOI 10.1016/j.ijheatmasstransfer.2006.04.010; Qu W., 2004, INT J HEAT MASS TRAN, V46, P3387; TAYLOR GI, 1961, J FLUID MECH, V10, P161, DOI 10.1017/S0022112061000159	15	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-9322	1879-3533		INT J MULTIPHAS FLOW	Int. J. Multiph. Flow	JUL	2015	73						108	117		10.1016/j.ijmultiphaseflow.2015.03.006		10	Mechanics	Mechanics	CN0HL	WOS:000358094600012		
J	Han, Y; Kanno, H; Ahn, YJ; Shikazono, N				Han, Youngbae; Kanno, Hiroshi; Ahn, Young-Ju; Shikazono, Naoki			Measurement of liquid film thickness in micro tube annular flow	INTERNATIONAL JOURNAL OF MULTIPHASE FLOW			English	Article						Micro tube; Annular flow; Liquid film thickness; Laser confocal displacement meter	2-PHASE FLOW; MICROCHANNELS	Heat transfer in micro scale two-phase flow attracts large attention since it can achieve large heat transfer area per unit volume. At large flow rate and high quality, annular flow becomes one of the major flow regimes in micro two-phase flow. Heat is transferred by evaporation or condensation of the liquid film, which are the dominant mechanisms of micro scale heat transfer. Therefore, liquid film thickness is one of the most important parameters in modeling the heat transfer phenomena. In the present study, time averaged annular liquid film thickness is measured by laser confocal displacement meter (LCDM), and the gas-liquid interface profile is observed by a high-speed camera. Glass tubes with inner diameters of D = 0.3, 0.5 and 1.0 mm are used. Degassed water and air are used for working fluids, and the total mass flux is varied from G = 100 to 500 kg/m(2) s. Flow patterns are observed and flow pattern map based on Reynolds numbers of gas and liquid flows is suggested. Pressure drop is measured and compared with the prediction using Lockhart and Martinelli parameter. Pressure drop is well predicted with Lockhart-Martinelli correlation. Dimensionless mean film thickness is then plotted against quality, and compared with the annular film model assuming flat gas-liquid interface. Flat interface model overestimated the experimental data. It is considered that the shear stress on the gas-liquid interface in the real annular flow is larger than that estimated in the ideal flat interface model. Prediction using new empirical correlation considering the effect of the non-flat gas-liquid interface showed good agreement with the experiment data. (C) 2015 Elsevier Ltd. All rights reserved.	[Han, Youngbae; Ahn, Young-Ju] Hongik Univ, Sejong City 339701, South Korea; [Kanno, Hiroshi; Shikazono, Naoki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1510041, Japan	Han, Y (reprint author), Hongik Univ, Sejong Campus,Sejong Ro 2639, Sejong City 339701, South Korea.	ybhan@hongik.ac.kr			Hongik University Research Fund; JST ALCA program	This work was partly supported by 2013 Hongik University Research Fund and by JST ALCA program "Development of Trilateral steam cycle for waste heat recovery.	Wang X, 2012, CHEM ENG SCI, V69, P578, DOI 10.1016/j.ces.2011.11.012; Revellin R, 2006, INT J MULTIPHAS FLOW, V32, P755, DOI 10.1016/j.ijmultiphaseflow.2006.02.016; Han Y, 2009, INT J MULTIPHAS FLOW, V35, P896, DOI 10.1016/j.ijmultiphaseflow.2009.06.006; Han Y, 2009, INT J HEAT FLUID FL, V30, P842, DOI 10.1016/j.ijheatfluidflow.2009.02.019; Serizawa A, 2002, EXP THERM FLUID SCI, V26, P703, DOI 10.1016/S0894-1777(02)00175-9; Schubring D, 2008, INT J MULTIPHAS FLOW, V34, P636, DOI 10.1016/j.ijmultiphaseflow.2008.01.004; Kawahara A, 2002, INT J MULTIPHAS FLOW, V28, P1411, DOI 10.1016/S0301-9322(02)00037-X; LOCKHART RW, 1949, CHEM ENG PROG, V45, P39; Okawa T, 2010, INT J HEAT MASS TRAN, V53, P962, DOI 10.1016/j.ijheatmasstransfer.2009.11.024; Hazuku T, 2005, EXP FLUIDS, V38, P780, DOI 10.1007/s00348-005-0973-9; Hazuku T, 2008, INT J MULTIPHAS FLOW, V34, P111, DOI 10.1016/j.ijmultiphaseflow.2007.10.008; Tibri&ccedil;a C.B., 2010, EXP THERM FLUID SCI, V34, P463	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-9322	1879-3533		INT J MULTIPHAS FLOW	Int. J. Multiph. Flow	JUL	2015	73						264	274		10.1016/j.ijmultiphaseflow.2015.03.016		11	Mechanics	Mechanics	CN0HL	WOS:000358094600023		
J	Charalambides, M; Zinner, T; Saito, H; Calyam, P; Latre, S				Charalambides, Marinos; Zinner, Thomas; Saito, Hiroshi; Calyam, Prasad; Latre, Steven			Advances in management of multimedia services	INTERNATIONAL JOURNAL OF NETWORK MANAGEMENT			English	Editorial Material									[Charalambides, Marinos] UCL, London, England; [Zinner, Thomas] Univ Wurzburg, D-97070 Wurzburg, Germany; [Saito, Hiroshi] Nippon Telegraph & Tel Corp, Tokyo, Japan; [Calyam, Prasad] Univ Missouri, Columbia, MO USA; [Latre, Steven] Antwerp Univ IMinds, Antwerp, Belgium	Charalambides, M (reprint author), UCL, London, England.	marinos.charalambides@ucl.ac.uk						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1055-7148	1099-1190		INT J NETW MANAG	Int. J. Netw. Manag.	JUL-AUG	2015	25	4			SI		203	204		10.1002/nem.1896		2	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CM7FD	WOS:000357854900001		
J	Kageyama, S; Isono, T; Iwaki, H; Hanada, E; Tomita, K; Yoshida, T; Yoshiki, T; Kawauchi, A				Kageyama, Susumu; Isono, Takahiro; Iwaki, Hideaki; Hanada, Eiki; Tomita, Keiji; Yoshida, Tetsuya; Yoshiki, Tatsuhiro; Kawauchi, Akihiro			Proteome research in urothelial carcinoma	INTERNATIONAL JOURNAL OF UROLOGY			English	Review						proteome; proteomics; urothelial carcinoma	TRANSITIONAL-CELL CARCINOMAS; HUMAN BLADDER-CANCER; GAMMA-GLUTAMYL CYCLOTRANSFERASE; DIFFERENCE GEL-ELECTROPHORESIS; MULTIVARIATE INDEX ASSAY; IN-SITU HYBRIDIZATION; EML4-ALK FUSION GENE; ACID-BINDING PROTEIN; HUMAN C7ORF24 GENE; LUNG-CANCER	In all creatures including humans, the molecules that function in accordance with the genetic code are mainly proteins. After completing the sequencing of the human genome, rapid progress has been made in proteome analysis. The primary structures of almost all proteins were determined by the human genome sequence. However, the whole picture of proteins cannot be elucidated because of alternative splicing and post-translational modifications. Therefore, genomic as well as systematic and comprehensive information of proteins is required. Modern methods of proteomics have dramatically improved the quality and speed of protein analysis. Developments in both bioinformatics and mass spectrometry have contributed to the technical improvement, making it possible to identify proteins in a short time with high accuracy even from a very small sample. In the field of cancer research, many studies of useful diagnostic and prognostic biomarkers using these proteomic technologies have been reported, and target molecules for treatment have been explored. The aim of the present review was to summarize the basic technologies of proteomics and recent research in the field of urothelial cancer obtained using proteomic methods.	[Kageyama, Susumu; Iwaki, Hideaki; Hanada, Eiki; Tomita, Keiji; Yoshida, Tetsuya; Kawauchi, Akihiro] Shiga Univ Med Sci, Dept Urol, Otsu, Shiga 5202192, Japan; [Isono, Takahiro] Shiga Univ Med Sci, Cent Res Lab, Otsu, Shiga 5202192, Japan; [Yoshiki, Tatsuhiro] Kyoto Pharmaceut Univ, Dept Clin Oncol, Kyoto 607, Japan	Kageyama, S (reprint author), Shiga Univ Med Sci, Dept Urol, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	kageyama@belle.shiga-med.ac.jp		Kageyama, Susumu/0000-0001-7150-647X	JSPS KAKENHI [24592384]; Promotion Plan for the Platform of Human Resource Development for Cancer	This work was supported in part by a JSPS KAKENHI (grant number 24592384) and a grant from the Promotion Plan for the Platform of Human Resource Development for Cancer.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Saito M, 2005, EUR UROL, V48, P865, DOI 10.1016/j.eururo.2005.04.028; Takemura K, 2014, HUM PATHOL, V45, P331, DOI 10.1016/j.humpath.2013.09.009; Miura N, 2012, MOL ONCOL, V6, P311, DOI 10.1016/j.molonc.2011.12.002; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Zhao LL, 2009, CANCER RES, V69, P7696, DOI 10.1158/0008-5472.CAN-08-4901; Kageyama S, 2009, INT J UROL, V16, P481, DOI 10.1111/j.1442-2042.2009.02287.x; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Fung ET, 2010, CLIN CHEM, V56, P327, DOI 10.1373/clinchem.2009.140855; Chen YT, 2010, J PROTEOME RES, V9, P5803, DOI 10.1021/pr100576x; Gromov P, 2010, J PROTEOME RES, V9, P3941, DOI 10.1021/pr100160u; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Sarosdy MF, 2006, J UROLOGY, V176, P44, DOI 10.1016/S0022-5347(06)00576-3; Kageyama S, 2007, PROTEOM CLIN APPL, V1, P192, DOI 10.1002/prca.200600468; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; Chen CL, 2013, J PROTEOMICS, V85, P28, DOI 10.1016/j.jprot.2013.04.024; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273; Konety BR, 2000, CLIN CANCER RES, V6, P2618; Yang MH, 2011, BIOCHEM BIOPH RES CO, V411, P714, DOI 10.1016/j.bbrc.2011.07.010; Uejima D, 2011, ANTICANCER RES, V31, P1297; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; McShane LM, 2012, J CLIN ONCOL, V30, P4223, DOI 10.1200/JCO.2012.42.6858; Konety BR, 2000, J UROLOGY, V164, P634, DOI 10.1016/S0022-5347(05)67269-2; Bristow RE, 2013, GYNECOL ONCOL, V128, P252, DOI 10.1016/j.ygyno.2012.11.022; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Celis JE, 1996, CANCER RES, V56, P4782; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Thongboonkerd V, 2007, J PROTEOME RES, V6, P3881, DOI 10.1021/pr070328s; Iwaki H, 2004, CANCER SCI, V95, P955, DOI 10.1111/j.1349-7006.2004.tb03183.x; Link AJ, 1999, NAT BIOTECHNOL, V17, P676; Grossman HB, 2005, JAMA-J AM MED ASSOC, V293, P810, DOI 10.1001/jama.293.7.810; Chen CL, 2012, J PROTEOME RES, V11, P5611, DOI 10.1021/pr3008732; Cabezon T, 2013, MOL CELL PROTEOMICS, V12, P381, DOI 10.1074/mcp.M112.019786; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Meng Q, 2013, J CANCER RES CLIN, V139, P509, DOI 10.1007/s00432-012-1350-8; Tsui KH, 2010, J UROLOGY, V183, P339, DOI 10.1016/j.juro.2009.08.109; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Ostergaard M, 1997, CANCER RES, V57, P4111; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Getzenberg RH, 1996, CANCER RES, V56, P1690; Ohno Y, 2011, FEBS J, V278, P4088, DOI 10.1111/j.1742-4658.2011.08314.x; Kawanishi H, 2008, CLIN CANCER RES, V14, P2579, DOI 10.1158/1078-0432.CCR-07-1922; WASINGER VC, 1995, ELECTROPHORESIS, V16, P1090, DOI 10.1002/elps.11501601185; Zhang Z, 2010, CANCER EPIDEM BIOMAR, V19, P2995, DOI 10.1158/1055-9965.EPI-10-0580; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Grossman HB, 2006, JAMA-J AM MED ASSOC, V295, P299, DOI 10.1001/jama.295.3.299; Banks RE, 2000, LANCET, V356, P1749, DOI 10.1016/S0140-6736(00)03214-1; Kato M, 2012, CANCER SCI, V103, P1363, DOI 10.1111/j.1349-7006.2012.02298.x; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Babjuk M., 2002, European Urology, V41, P34, DOI 10.1016/S0302-2838(01)00015-X; Beckham CJ, 2014, J UROLOGY, V192, P583, DOI 10.1016/j.juro.2014.02.035; Boman H, 2002, J UROLOGY, V167, P80, DOI 10.1016/S0022-5347(05)65387-6; Celis JE, 2014, J PROTEOMICS, V107, P31, DOI 10.1016/j.jprot.2014.01.021; Celis JE, 1999, ELECTROPHORESIS, V20, P300; Celis JE, 1999, CANCER RES, V59, P3003; Celis JE, 1996, J UROLOGY, V155, P2105, DOI 10.1016/S0022-5347(01)66118-4; Chung H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-45; Goodison S, 2009, EXPERT REV PROTEOMIC, V6, P507, DOI [10.1586/epr.09.70, 10.1586/EPR.09.70]; Graus L, 2013, PLOS ONE, V8; Gromov P, 2008, PROTEOM CLIN APPL, V2, P974, DOI 10.1002/prca.200780163; Guos S, 2013, DRUG DES DEV THER, V7, P1259; Halling KC, 2000, J UROLOGY, V164, P1768, DOI 10.1016/S0022-5347(05)67104-2; Hama S, 2012, CANCER GENE THER, V19, P553, DOI 10.1038/cgt.2012.31; Kageyama S, 2004, CLIN CHEM, V50, P857, DOI 10.1373/clinchem.2003.027425; Kondo T, 2006, NAT PROTOC, V1, P2940, DOI 10.1038/nprot.2006.421; Konety BR, 2006, UROL ONCOL-SEMIN ORI, V24, P326, DOI 10.1016/j.urolonc.2005.11.023; Kreunin P, 2007, J PROTEOME RES, V6, P2631, DOI 10.1021/pr0700807; Lis C, 2014, BIOCHEM BIOPH RES CO, V446, P1047; Lis F, 2012, J PROTEOMICS, V77, P225; Majewski T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042452; Minami Sho, 2010, Cancer Genomics & Proteomics, V7, P181; Miyanaga N, 1997, Int J Urol, V4, P557, DOI 10.1111/j.1442-2042.1997.tb00308.x; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Oakley AJ, 2008, J BIOL CHEM, V283, P22031, DOI 10.1074/jbc.M803623200; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ohlsson G, 2005, MOL CELL PROTEOMICS, V4, P570, DOI 10.1074/mcp.M500017-MCP200; Ohno Y, 2013, J BIOCHEM, V154, P355, DOI 10.1093/jb/mvt063; Ongs SE, 2002, MOL CELL PROTEOMICS, V1, P376; Peng XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027309; Rans R, 2015, J PHARM SCI, V104, P476; Rens F, 2010, MOL CANCER, V9, P81; Schiffer E, 2009, CLIN CANCER RES, V15, P4935, DOI 10.1158/1078-0432.CCR-09-0226; Schultz IJ, 2007, ANTICANCER RES, V27, P1051; Schwamborn K, 2009, EUR UROL, V56, P989, DOI 10.1016/j.eururo.2009.02.031; Shimwell NJ, 2013, BRIT J CANCER, V108, P1854, DOI 10.1038/bjc.2013.157; Simpson RJ, 2008, CURR OPIN CHEM BIOL, V12, P72, DOI 10.1016/j.cbpa.2008.02.010; Smalley David M, 2008, J Proteome Res, V7, P2088, DOI 10.1021/pr700775x; Tans LB, 2010, WORLD J UROL, V28, P117; Tyan YC, 2011, RAPID COMMUN MASS SP, V25, P2851, DOI 10.1002/rcm.5169; Ummanni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016833; Van Houdts WJ, 2011, MOL CELL PROTEOMICS, V10; Wilkins MR, 1996, BIO-TECHNOL, V14, P61, DOI 10.1038/nbt0196-61; Zoidakiss J, 2012, MOL CELL PROTEOMICS, V11	97	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					621	628		10.1111/iju.12793		8	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000003		
J	Sakamoto, S				Sakamoto, Shinichi			Editorial Comment to Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stents	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							EXPERIENCE		Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan	Sakamoto, S (reprint author), Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan.	rbatbat1@yahoo.co.jp					FINNEY RP, 1978, J UROLOGY, V120, P678; GIBBONS RP, 1976, J UROLOGY, V115, P22; Elsamra SE, 2015, INT J UROL, V22, P629, DOI 10.1111/iju.12795; Yachia D, 2008, CURR OPIN UROL, V18, P241, DOI 10.1097/MOU.0b013e3282f46d81; Yachia Daniel, 2011, Indian J Urol, V27, P307, DOI 10.4103/0970-1591.85421	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					637	637		10.1111/iju.12835		1	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000005		
J	Taguchi, S; Nakagawa, T; Matsumoto, A; Nagase, Y; Kawai, T; Tanaka, Y; Yoshida, K; Yamamoto, S; Enomoto, Y; Nose, Y; Sato, T; Ishikawa, A; Uemura, Y; Fujimura, T; Fukuhara, H; Kume, H; Homma, Y				Taguchi, Satoru; Nakagawa, Tohru; Matsumoto, Akihiko; Nagase, Yasushi; Kawai, Taketo; Tanaka, Yoshinori; Yoshida, Kanae; Yamamoto, Sachi; Enomoto, Yutaka; Nose, Yorito; Sato, Toshikazu; Ishikawa, Akira; Uemura, Yukari; Fujimura, Tetsuya; Fukuhara, Hiroshi; Kume, Haruki; Homma, Yukio			Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						bladder cancer; chemotherapy; metastatic; neutrophil-to-lymphocyte ratio; urothelial carcinoma	CISPLATIN-BASED CHEMOTHERAPY; RADICAL CYSTECTOMY; PROGNOSTIC VALUE; BLADDER-CANCER; RISK STRATIFICATION; EUROPEAN COHORT; VALIDATION; MODEL; METHOTREXATE; GEMCITABINE	ObjectivesTo evaluate the prognostic significance of the pretreatment neutrophil-to-lymphocyte ratio in patients with metastatic urothelial carcinoma who underwent salvage chemotherapy. MethodsWe reviewed 200 metastatic urothelial carcinoma patients who received salvage chemotherapy at our five affiliate institutions between 2003 and 2011. The associations of pretreatment clinicopathological factors, including neutrophil-to-lymphocyte ratio, with cancer-specific survival and overall survival from the start of chemotherapy were assessed. Cox proportional hazards model was used for multivariate analysis. ResultsA total of 15 cases with missing data were excluded. Among the remaining 185 patients, 157 died during follow up, with a median survival of 13.0months. Multivariate analysis showed that the pretreatment neutrophil-to-lymphocyte ratio 3, Eastern Cooperative Oncology Group performance status 2 and liver metastasis were independent poor prognostic factors, both for cancer-specific survival and overall survival. A prognostic model predicting overall survival was constructed based on the number of these three variables (0, 1 and 2). The classified patients showed significantly different overall survival (each P<0.0001, log-rank test), with Harrell's concordance index as high as 0.81. ConclusionsPretreatment neutrophil-to-lymphocyte ratio elevation was an independent poor prognostic factor for metastatic urothelial carcinoma undergoing salvage chemotherapy. Our newly constructed prognostic model including the pretreatment neutrophil-to-lymphocyte ratio proved to be an excellent discriminator of overall survival.	[Taguchi, Satoru; Nakagawa, Tohru; Fujimura, Tetsuya; Fukuhara, Hiroshi; Kume, Haruki; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138655, Japan; [Matsumoto, Akihiko; Nagase, Yasushi] Tokyo Metropolitan Tama Med Ctr, Dept Urol, Tokyo, Japan; [Kawai, Taketo; Tanaka, Yoshinori] Musashino Red Cross Hosp, Dept Urol, Tokyo, Japan; [Yoshida, Kanae; Yamamoto, Sachi; Enomoto, Yutaka] Mitsui Mem Hosp, Dept Urol, Tokyo 101, Japan; [Nose, Yorito; Sato, Toshikazu; Ishikawa, Akira] Tokyo Teishin Hosp, Dept Urol, Tokyo, Japan; [Uemura, Yukari] Tokyo Univ Hosp, Cent Coordinating Unit, Clin Res Support Ctr, Div Biostat, Tokyo 113, Japan	Nakagawa, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Urol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tohru-tky@umin.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Fogar P, 2006, PANCREAS, V32, P22, DOI 10.1097/01.mpa.0000188305.90290.50; Okamoto M, 1997, INT J CANCER, V72, P149, DOI 10.1002/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D; Galsky MD, 2013, CANCER-AM CANCER SOC, V119, P3012, DOI 10.1002/cncr.28146; Saroha S, 2013, J UROLOGY, V189, P454, DOI 10.1016/j.juro.2012.09.166; Gondo T, 2012, UROLOGY, V79, P1085, DOI 10.1016/j.urology.2011.11.070; von der Maase H, 2000, J CLIN ONCOL, V18, P3068; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Dalpiaz O, 2014, BRIT J CANCER, V110, P2531, DOI 10.1038/bjc.2014.180; Nakagawa T, 2013, J UROLOGY, V189, P1275, DOI 10.1016/j.juro.2012.10.065; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Takahashi S, 2005, JPN J CLIN ONCOL, V35, P79, DOI 10.1093/jjco/hyi023; Kinoshita T, 1999, CANCER, V85, P2526, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2526::AID-CNCR6>3.0.CO;2-3; Apolo AB, 2013, JNCI-J NATL CANCER I, V105, P499, DOI 10.1093/jnci/djt015; Azuma T, 2013, CLIN GENITOURIN CANC, V11, P337, DOI 10.1016/j.clgc.2013.04.003; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5; Dalpiaz O, 2014, BJU INT, V114, P334, DOI 10.1111/bju.12441; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Kims R, 2007, IMMUNOLOGY, V121, P1; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI [10.2217/fon.09.136, 10.2217/FON.09.136]; Lins CC, 2007, UROLOGY, V69, P479; Luos HL, 2014, BJU INT, V113, pE144; Taguchi S, 2013, JPN J CLIN ONCOL, V43, P923, DOI 10.1093/jjco/hyt096; Tanaka N, 2014, ANN SURG ONCOL, V21, P4041, DOI 10.1245/s10434-014-3830-3; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Viers BR, 2014, EUR UROL, V66, P1157, DOI 10.1016/j.eururo.2014.02.042; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					638	643		10.1111/iju.12766		6	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000006		
J	Mitsui, Y				Mitsui, Yozo			Editorial Comment to Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							BLADDER		Shimane Univ, Fac Med, Dept Urol, Izumo, Shimane, Japan	Mitsui, Y (reprint author), Shimane Univ, Fac Med, Dept Urol, Izumo, Shimane, Japan.	mitsui@med.shimane-u.ac.jp					Hermanns T, 2014, BRIT J CANCER, V111, P444, DOI 10.1038/bjc.2014.305; Dalpiaz O, 2014, BRIT J CANCER, V110, P2531, DOI 10.1038/bjc.2014.180; Feng L, 2012, CHINESE MED J-PEKING, V125, P1254, DOI 10.3760/cma.j.issn.0366-6999.2012.07.012; Grabrilovichs D., 2004, NAT REV IMMUNOL, V4, P941; Mitsui Y, 2012, INT UROL NEPHROL, V44, P431, DOI 10.1007/s11255-011-0009-8; Taguchi S, 2015, INT J UROL, V22, P638, DOI 10.1111/iju.12766	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					643	644		10.1111/iju.12772		2	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000007		
J	Satake, N; Ohno, Y; Nakashima, J; Ohori, M; Tachibana, M				Satake, Naoya; Ohno, Yoshio; Nakashima, Jun; Ohori, Makoto; Tachibana, Masaaki			Prognostic value of preoperative pyuria in patients with non-muscle-invasive bladder cancer	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						bladder cancer; non-muscle-invasive bladder cancer; pyuria; prognosis; bacillus; Calmette-Guerin	BACILLUS-CALMETTE-GUERIN; CARCINOMA IN-SITU; TRANSITIONAL-CELL CARCINOMA; MAINTENANCE THERAPY; STAGE TA; T1; BCG; IMMUNOTHERAPY; NEUTROPHILS; INDEX	ObjectivesTo investigate the prognostic value of preoperative pyuria in patients with non-muscle-invasive bladder cancer. MethodsWe retrospectively reviewed data from 237 patients diagnosed with non-muscle-invasive bladder cancer. Pyuria was defined as urine containing 5 white blood cells per high power field. The association between clinicopathological factors and recurrence was assessed by Cox univariate and multivariate analyses. ResultsPreoperative pyuria was found in 116 (49.0%) patients. Pyuria was significantly associated with advanced age, positive cytology, multiple tumors, large tumor size, non-papillary tumors, T1 tumors and high-grade tumors. In univariate analysis of the entire patient population, pyuria, positive urine cytology, multiple tumors, pT1 tumors and no bacillus Calmette-Guerin were significantly associated with recurrence. Multivariate analysis showed that pyuria was an independent predictor of recurrence (hazard ratio 3.332, 95% confidence interval 2.052-5.410; P<0.001), along with positive urine cytology, multiple tumors and no bacillus Calmette-Guerin therapy. Subanalysis of the patients who underwent bacillus Calmette-Guerin therapy also showed that pyuria was an independent predictor of recurrence (hazard ratio 2.062, 95% confidence interval 1.085-3.918, P=0.027). The 2-year recurrence-free survival rate for patients with pyuria was significantly lower than for patients without pyuria (65.5% vs 80.7%; P=0.027). ConclusionsPreoperative pyuria seems to be significantly associated with recurrence in patients with non-muscle-invasive bladder cancer, and it might be a useful predictor for recurrence after bacillus Calmette-Guerin therapy.	[Satake, Naoya; Ohno, Yoshio; Nakashima, Jun; Ohori, Makoto; Tachibana, Masaaki] Tokyo Med Univ, Dept Urol, Tokyo 1600023, Japan	Ohno, Y (reprint author), Tokyo Med Univ, Dept Urol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	satake@tokyo-med.ac.jp			MEXT	This study was partially supported by MEXT-Supported Program for the Strategic Foundation at Private Universities, 2013-2017.	Andius P, 2004, SCAND J UROL NEPHROL, V38, P285, DOI 10.1080/00365590410028692; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Liang SL, 2007, CANCER RES, V67, P5814, DOI 10.1158/0008-5472.CAN-06-4233; Fernandez-Gomez J, 2009, J UROLOGY, V182, P2195, DOI 10.1016/j.juro.2009.07.016; van der Meijden APM, 2001, J UROLOGY, V166, P476, DOI 10.1016/S0022-5347(05)65966-6; Allard P, 1998, BRIT J UROL, V81, P692; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Lamm DL, 2000, J UROLOGY, V163, P1124, DOI 10.1016/S0022-5347(05)67707-5; Jablonska J, 2010, J CLIN INVEST, V120, P1151, DOI 10.1172/JCI37223; Tazzyman S, 2009, INT J EXP PATHOL, V90, P222, DOI 10.1111/j.1365-2613.2009.00641.x; Videira PA, 2009, UROLOGY, V74, P944, DOI 10.1016/j.urology.2009.02.053; Eruslanov E, 2012, INT J CANCER, V130, P1109, DOI 10.1002/ijc.26123; Boorjian SA, 2010, BJU INT, V106, P357, DOI 10.1111/j.1464-410X.2009.09137.x; Saint F, 2002, J UROLOGY, V167, P364, DOI 10.1016/S0022-5347(05)65469-9; Sylvester RJ, 2011, INT J UROL, V18, P113, DOI 10.1111/j.1442-2042.2010.02678.x; Hinotsu S, 2011, BJU INT, V108, P187, DOI 10.1111/j.1464-410X.2010.09891.x; Lopez-Beltran A, 2004, AM J CLIN PATHOL, V122, P444, DOI 10.1309/LTFU3UUMBY095HUM; Azuma T, 2013, CLIN GENITOURIN CANC, V11, P331, DOI 10.1016/j.clgc.2013.04.002; des Reijkes TM, 1996, J UROLOGY, V155, P477; Hooker JB, 2014, J AM BOARD FAM MED, V27, P97, DOI 10.3122/jabfm.2014.01.130084; Jallad S, 2014, BJU INT, V113, pE22, DOI 10.1111/bju.12334; Saint F, 2001, UROLOGY, V57, P617, DOI 10.1016/S0090-4295(01)00921-9; Saint F, 2001, UROLOGY, V57, P883, DOI 10.1016/S0090-4295(00)01117-1; TACHIBANA M, 1995, CANCER RES, V55, P3438; Takashi M., 2002, International Urology and Nephrology, V33, P41, DOI 10.1023/A:1014444601158; VANDERMEIJDEN APM, 1995, EUR UROL, V27, P23; Watanabe E, 2003, CANCER IMMUNOL IMMUN, V52, P481, DOI 10.1007/s00262-003-0384-9	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					645	649		10.1111/iju.12788		5	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000008		
J	Shindo, T				Shindo, Tetsuya			Editorial Comment to Prognostic value of preoperative pyuria in patients with non-muscle-invasive bladder cancer	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							RADICAL CYSTECTOMY; RISK		Sapporo Med Univ, Dept Urol, Sch Med, Sapporo, Hokkaido, Japan	Shindo, T (reprint author), Sapporo Med Univ, Dept Urol, Sch Med, Sapporo, Hokkaido, Japan.	shindo1013@yahoo.co.jp					Solsona E, 2004, BJU INT, V94, P1258, DOI 10.1111/j.1464-410X.2004.05228.x; Gondo T, 2012, UROLOGY, V79, P1085, DOI 10.1016/j.urology.2011.11.070; Sylvester RJ, 2002, J UROLOGY, V168, P1964, DOI 10.1097/01.ju.0000034450.80198.1c; Azuma T, 2013, CLIN GENITOURIN CANC, V11, P331, DOI 10.1016/j.clgc.2013.04.002; Satake N, 2015, INT J UROL, V22, P645, DOI 10.1111/iju.12788; TACHIBANA M, 1995, CANCER RES, V55, P3438	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					650	650		10.1111/iju.12802		1	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000009		
J	Abe, T				Abe, Takashige			Editorial Comment from Dr Abe to Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							FUNCTION OUTCOMES		Hokkaido Univ, Grad Sch Med, Dept Urol, Sapporo, Hokkaido, Japan	Abe, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Urol, Sapporo, Hokkaido, Japan.	takataka@rf6.so-net.ne.jp					Eisenberg MS, 2014, J UROLOGY, V191, P619, DOI 10.1016/j.juro.2013.09.011; Osawa T, 2013, UROL J, V10, P784; Gershman B, 2015, INT J UROL, V22, P651, DOI 10.1111/iju.12770; Jins XD, 2012, EUR UROL, V61, P491	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					656	656		10.1111/iju.12778		1	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000011		
J	Nakamura, T; Oishi, M; Ueda, T; Fujihara, A; Nakanishi, H; Kamoi, K; Naya, Y; Hongo, F; Okihara, K; Miki, T				Nakamura, Terukazu; Oishi, Masakatsu; Ueda, Takashi; Fujihara, Atsuko; Nakanishi, Hiroyuki; Kamoi, Kazumi; Naya, Yoshio; Hongo, Fumiya; Okihara, Koji; Miki, Tsuneharu			Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						advanced testicular cancer; extraretroperitoneal mass resection; histological discordance; post-chemotherapy; retroperitoneal lymph node dissection	TESTICULAR CANCER; DISSECTION; CHEMOTHERAPY	ObjectivesTo assess clinical outcomes of patients with advanced germ cell tumor undergoing post-chemotherapy retroperitoneal lymph node dissection with or without extraretroperitoneal mass resection. MethodsBetween 1998 and 2013, 175 retroperitoneal lymph node dissections for advanced metastatic germ cell tumors were carried out at Kyoto Prefectural University of Medicine, Kyoto, Japan. Of patients receiving retroperitoneal lymph node dissections, 156 underwent post-chemotherapy retroperitoneal lymph node dissection with or without extraretroperitoneal mass resection as first surgery after completion of chemotherapy. Of these 156 patients, 47 underwent both post-chemotherapy retroperitoneal lymph node dissection and extraretroperitoneal mass resection. ResultsThe histological findings were necrosis in 59.6%, teratoma in 31.4% and viable cancer in 9.0% at retroperitoneal lymph node. At extraretroperitoneal mass resection, necrosis was present in 59.6%, teratoma in 31.9% and viable cancer in 8.5%. Overall histological discordance between retroperitoneal lymph node and extraretroperitoneal mass was found in 31.9%. Five-year disease-free survival stratified by retroperitoneal lymph node histology in 156 patients was 91.3% for necrosis, 78.7% for teratoma and 63.5% for viable cancer (log-rank, P=0.009). Antegrade ejaculation was preserved in 80.9%. In the worst histology of post-chemotherapy retroperitoneal lymph node dissection or extraretroperitoneal mass resection in 156 patients, 5-year disease-free survival was 93.2% for necrosis, 79.0% for teratoma and 63.4% for viable cancer (log-rank, P<0.001). Independent prognostic factors for disease-free survival were presence of viable cancer in retroperitoneal lymph node histology and salvage chemotherapy. ConclusionThe presence of viable cancer at the retroperitoneal lymph node is an independent predictor of disease recurrence. In approximately one-third of cases, there is a histological discordance between retroperitoneal lymph node and extraretroperitoneal mass. Resection of residual retroperitoneal lymph node and extraretroperitoneal masses remains an important procedure in the management of advanced germ cell tumors.	[Nakamura, Terukazu; Oishi, Masakatsu; Ueda, Takashi; Fujihara, Atsuko; Nakanishi, Hiroyuki; Kamoi, Kazumi; Naya, Yoshio; Hongo, Fumiya; Okihara, Koji; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kyoto 6028566, Japan	Nakamura, T (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	teru@koto.kpu-m.ac.jp					Brenner PC, 1996, J CLIN ONCOL, V14, P1765; [Anonymous], 2012, CLIN PRACT GUID ONC; Spiess PE, 2006, CANCER, V107, P1483, DOI 10.1002/cncr.22182; Hartmann JT, 1997, EUR J CANCER, V33, P843, DOI 10.1016/S0959-8049(96)00517-5; Besse B, 2009, J THORAC CARDIOV SUR, V137, P448, DOI 10.1016/j.jtcvs.2008.09.032; Eggener SE, 2007, CANCER, V109, P528, DOI 10.1002/cncr.22440; Carver BS, 2007, J CLIN ONCOL, V25, P5603, DOI 10.1200/JCO.2007.13.6283; Carver BS, 2009, WORLD J UROL, V27, P489, DOI 10.1007/s00345-009-0412-2; European Association of Urology, 2012, GUID TEST CANC; Foxs EP, 1993, J CLIN ONCOL, V11, P1294; Gupta A, 2011, UROLOGY, V77, P655, DOI 10.1016/j.urology.2010.10.002; Hejase MJ, 1996, J UROLOGY, V156, P1345, DOI 10.1016/S0022-5347(01)65583-6; Jacobsen NEB, 2010, J UROLOGY, V184, P949, DOI 10.1016/j.juro.2010.05.039; Masterson TA, 2012, UROLOGY, V79, P156, DOI 10.1016/j.urology.2011.09.038; Masterson TA, 2012, UROLOGY, V79, P1079, DOI 10.1016/j.urology.2011.11.090; McGuire MS, 2003, BJU INT, V91, P469, DOI 10.1046/j.1464-4096.2003.04128.x; Miki T, 2009, INT J UROL, V16, P379, DOI 10.1111/j.1442-2042.2009.02251.x; Pettus JA, 2009, UROLOGY, V73, P328, DOI 10.1016/j.urology.2008.08.501; Shayegans B, 2006, J UROLOGY, V175, p449A; Vallier C, 2014, WORLD J UROL, V32, P1573, DOI 10.1007/s00345-014-1240-6; Vledders MG, 2010, ANN SURG ONCOL, V17, P1682	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					663	668		10.1111/iju.12760		6	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000014		
J	Yokoyama, O; Yamaguchi, A; Yoshida, M; Yamanishi, T; Ishizuka, O; Seki, N; Takahashi, S; Yamaguchi, O; Higo, N; Minami, H; Masegi, Y				Yokoyama, Osamu; Yamaguchi, Akito; Yoshida, Masaki; Yamanishi, Tomonori; Ishizuka, Osamu; Seki, Narihito; Takahashi, Satoru; Yamaguchi, Osamu; Higo, Naruhito; Minami, Hidenao; Masegi, Yu			Once-daily oxybutynin patch improves nocturia and sleep quality in Japanese patients with overactive bladder: Post-hoc analysis of a phaseIII randomized clinical trial	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						antimuscarinic agent; nocturia; oxybutynin patch; overactive bladder; sleep quality	URINARY-TRACT SYMPTOMS; OF-LIFE; IMPACT; PREVALENCE; COMMUNITY; EFFICACY; INCONTINENCE; POPULATION; LUTS/BPH	ObjectivesTo investigate the efficacy of a once-daily oxybutynin patch for nocturia, and its influence on sleep quality in patients with overactive bladder. MethodsWe carried out post-hoc analysis of a phaseIII, randomized, double-blind, comparative study in which an oxybutynin patch was administered once daily for 12weeks to Japanese patients with overactive bladder. Patients with a baseline mean of one or more episodes of nocturia per night (data from voiding diaries) were analyzed. The mean number of micturitions, mean voided volume per micturition, mean first voided volume at night, mean sleep duration, and hours of undisturbed sleep were compared between the once-daily oxybutynin patch group and the placebo group. All parameters were expressed as the least squares mean values. ResultsThe analysis included 576 patients. The number of nocturia episodes decreased by 0.66 in the oxybutynin patch group versus 0.51 in the placebo group (P=0.0249). Also, the voided volume per nocturnal micturition and the first voided volume at night showed a significant increase in the oxybutynin patch group compared with the placebo group (P=0.0073 and P=0.0005, respectively). The hours of undisturbed sleep showed significant prolongation by 76.14min in the oxybutynin patch group versus 56.07min in the placebo group (P=0.0257). ConclusionsOxybutynin patch treatment reduces the number of nocturia episodes and prolongs the hours of undisturbed sleep, thus improving sleep quality and sleep-related quality of life in patients with overactive bladder.	[Yokoyama, Osamu] Univ Fukui, Dept Urol, Fac Med Sci, Eiheiji, Fukui 9101193, Japan; [Yamaguchi, Akito] Harasanshin Hosp, Div Urol, Fukuoka, Japan; [Yoshida, Masaki] Natl Ctr Geriatr & Gerontol, Dept Urol, Obu, Obu, Japan; [Yamanishi, Tomonori] Dokkyo Med Univ, Continence Ctr, Dept Urol, Shimotsuga, Tochigi, Japan; [Ishizuka, Osamu] Shinshu Univ, Sch Med, Dept Urol, Matsumoto, Nagano 390, Japan; [Seki, Narihito] Kyushu Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Dept Urol, Fukuoka, Japan; [Takahashi, Satoru] Nihon Univ, Sch Med, Dept Urol, Tokyo, Japan; [Yamaguchi, Osamu] Nihon Univ, Sch Engn, Div Bioengn Lower Urinary Tract Dysfunct Res, Koriyama, Fukushima, Japan; [Higo, Naruhito; Minami, Hidenao; Masegi, Yu] Hisamitsu Pharmaceut, Tokyo, Japan	Yokoyama, O (reprint author), Univ Fukui, Dept Urol, Fac Med Sci, 23-3 Matsuokashimoaizuki, Eiheiji, Fukui 9101193, Japan.	oyoko@u-fukui.ac.jp			Hisamitsu Pharmaceutical (Saga, Japan)	This study was sponsored by Hisamitsu Pharmaceutical (Saga, Japan). The authors thank all of the investigators who contributed to the phase III study on which this analysis was based.	STEWART RB, 1992, J AM GERIATR SOC, V40, P1217; Nakagawa H, 2010, J UROLOGY, V184, P1413, DOI 10.1016/j.juro.2010.05.093; Davila GW, 2001, J UROLOGY, V166, P140, DOI 10.1016/S0022-5347(05)66095-8; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Homma Y, 2006, UROLOGY, V68, P560, DOI 10.1016/j.urology.2006.03.035; Asplund R, 1999, BJU INT, V84, P297; Bing MH, 2006, BJU INT, V98, P599, DOI 10.1111/j.1464-410X.2006.06390.x; Chartier-Kastler E, 2006, EUR UROL SUPPL, V5, P3, DOI 10.1016/j.eursup.2005.10.003; Coyne KS, 2003, BJU INT, V92, P948, DOI 10.1046/j.1464-410X.2003.04527.x; Appell RA, 2003, MAYO CLIN PROC, V78, P696; Christophers R, 2006, EUR UROL SUPPL, V5, P12; Djavan B, 2005, EUR UROL SUPPL, V4, P61, DOI 10.1016/j.eursup.2004.12.001; Doos SW, 2012, WORLD J MENS HLTH, V30, P123; Ganpule AP, 2004, BJU INT, V94, P332, DOI 10.1111/j.1464-410X.2004.04931.x; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Keenan S A, 1999, Respir Care Clin N Am, V5, P319; Kobelt G, 2003, BJU INT, V91, P190, DOI 10.1046/j.1464-4096.2003.04062.x; Pinnock CB, 1997, MED J AUSTRALIA, V167, P72; Schulmans CC, 2005, EUR UROL S, V4, P1; Shvartzman P, 2001, FAM PRACT, V18, P610, DOI 10.1093/fampra/18.6.610; Stanley N, 2005, EUR UROL SUPPL, V4, P17, DOI 10.1016/j.eursup.2005.07.002; Yamaguchi O, 2014, INT J UROL, V21, P586, DOI 10.1111/iju.12372; Yokoyama O, 2011, J UROLOGY, V186, P170, DOI 10.1016/j.juro.2011.02.2700; Yokoyama O, 2014, UROLOGY, V83, P750, DOI 10.1016/j.urology.2013.12.008; Yokoyama O, 2013, UROLOGY, V82, P515, DOI 10.1016/j.urology.2013.05.017	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					684	688		10.1111/iju.12755		5	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000018		
J	Matsumoto, S; Matsumoto, S; Homma, Y				Matsumoto, Shinya; Matsumoto, Shinichi; Homma, Yukio			Measurement of oxyhemoglobin concentration changes in interstitial cystitis female patients: A near-infrared spectroscopy study	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						bladder; brain; cerebral blood flow; interstitial cystitis; near-infrared spectroscopy	BLADDER SYNDROME; WOMEN; MICTURITION; TOMOGRAPHY; PREVALENCE; FNIRS	ObjectivesTo investigate brain activity related to bladder sensation in interstitial cystitis patients. MethodsA total of 10 interstitial cystitis patients (all women; mean age 68years) and 10 healthy controls (all women; mean age 64years) participated in the present study. Frontal lobe blood flow was measured non-invasively by using multichannel near-infrared spectroscopy with large and small bladder volumes (created by infusing water) up to the first desire to void. ResultsThe frontal cortex of the right and left hemisphere was activated, and the activation was detected as an increase in oxyhemoglobin concentration. The increase during the first desire to void in the interstitial cystitis group was greater than that in the control group. In addition, this difference was particularly observed in Brodmann's areas 9, 44, 45 and 46, reportedly associated with micturition and sensory modulation. ConclusionsThe present study shows that the frontal area is largely activated during bladder filling in interstitial cystitis patients. Our findings suggest that the major change in cerebral blood flow is related to the characteristic urinary symptoms of interstitial cystitis patients.	[Matsumoto, Shinya; Matsumoto, Shinichi] Shinmatsudo Cent Gen Hosp, Dept Urol, Matsudo, Chiba 2700034, Japan; [Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan	Matsumoto, S (reprint author), Shinmatsudo Cent Gen Hosp, Dept Urol, 1-380 Shinmatsudo, Matsudo, Chiba 2700034, Japan.	shinyamatsumoto-jua@umin.ac.jp					Rorden C, 2000, BEHAV NEUROL, V12, P191; Griffiths DJ, 2013, ACTA PHYSIOL, V207, P93, DOI 10.1111/apha.12019; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Homma Y, 2009, INT J UROL, V16, P4, DOI 10.1111/j.1442-2042.2008.02208.x; OLeary MP, 1997, UROLOGY, V49, P58, DOI 10.1016/S0090-4295(99)80333-1; Griffiths D, 2007, NEUROIMAGE, V37, P1, DOI 10.1016/j.neuroimage.2007.04.061; Kilpatrick LA, 2014, J UROLOGY, V192, P947, DOI 10.1016/j.juro.2014.03.093; Fukuyama H, 1996, NEUROREPORT, V7, P3009, DOI 10.1097/00001756-199611250-00042; Tadic SD, 2012, NEUROUROL URODYNAM, V31, P652, DOI 10.1002/nau.21240; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Matsumoto S, 2009, INT J UROL, V16, P760, DOI 10.1111/j.1442-2042.2009.02358.x; Matsumoto S, 2011, NEUROUROL URODYNAM, V30, P529, DOI 10.1002/nau.21016; DasGupta R, 2007, BJU INT, V99, P731, DOI 10.1111/j.1464-410X.2007.06749.x; Itos T, 2007, INT J UROL, V14, P1068; Kairys AE, 2015, J UROLOGY, V193, P131, DOI 10.1016/j.juro.2014.08.042; Leppilahti M, 2005, J UROLOGY, V174, P581, DOI 10.1097/01.ju.0000165452.39125.98; Sakakibara R, 2010, NEUROUROL URODYNAM, V29, P757, DOI 10.1002/nau.20815; Takao T, 2008, INT J UROL, V15, P724, DOI 10.1111/j.1442-2042.2008.02076.x; Temml C, 2007, EUR UROL, V51, P803, DOI 10.1016/j.eururo.2006.08.028	19	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					689	693		10.1111/iju.12785		5	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000019		
J	Furuta, A				Furuta, Akira			Editorial Comment from Dr Furuta to Measurement of oxyhemoglobin concentration changes in interstitial cystitis female patients: A near-infrared spectroscopy study	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							PAIN		Jikei Univ, Dept Urol, Sch Med, Tokyo, Japan	Furuta, A (reprint author), Jikei Univ, Dept Urol, Sch Med, Tokyo, Japan.	a-furuta@rf7.so-net.ne.jp					Kairys AE, 2015, J UROLOGY, V193, P131, DOI 10.1016/j.juro.2014.08.042; Matsumoto S, 2015, INT J UROL, V22, P689, DOI 10.1111/iju.12785; Nordling J, 2012, WORLD J UROL, V30, P457, DOI 10.1007/s00345-011-0785-x	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					694	694		10.1111/iju.12832		1	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000021		
J	Sakakibara, R				Sakakibara, Ryuji			Editorial Comment from Dr Sakakibara to Measurement of oxyhemoglobin concentration changes in interstitial cystitis female patients: A near-infrared spectroscopy study	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Toho Univ, Div Neurol, Dept Internal Med, Sakura Med Ctr, Sakura, Japan	Sakakibara, R (reprint author), Toho Univ, Div Neurol, Dept Internal Med, Sakura Med Ctr, Sakura, Japan.	sakakibara@sakura.med.toho-u.ac.jp					Griffiths DJ, 2013, ACTA PHYSIOL, V207, P93, DOI 10.1111/apha.12019; Tsunoyama K, 2011, NEUROUROL URODYNAM, V30, P339, DOI 10.1002/nau.20953; Tadic SD, 2012, NEUROUROL URODYNAM, V31, P652, DOI 10.1002/nau.21240; Matsumoto S, 2015, INT J UROL, V22, P689, DOI 10.1111/iju.12785	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					694	694		10.1111/iju.12831		1	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000020		
J	Horiguchi, A				Horiguchi, Akio			Editorial Comment from Dr Horiguchi to Risk of urethral stricture recurrence increases over time after urethroplasty	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Natl Def Med Coll, Dept Urol, Tokorozawa, Saitama 359, Japan	Horiguchi, A (reprint author), Natl Def Med Coll, Dept Urol, Tokorozawa, Saitama 359, Japan.	impreza@cb3.so-net.ne.jp					Meeks JJ, 2009, J UROLOGY, V182, P1266, DOI 10.1016/j.juro.2009.06.027; Barbagli G, 2014, J UROLOGY, V192, P808, DOI 10.1016/j.juro.2014.02.038; Andrich DE, 2003, J UROLOGY, V170, P90, DOI 10.1097/01.ju.0000069820.81726.00; Santucci RA, 2002, J UROLOGY, V167, P1715, DOI 10.1016/S0022-5347(05)65184-1; Hans JS, 2015, INT J UROL, V22, P695; Kinnaird Adam S, 2014, Can Urol Assoc J, V8, pE296, DOI 10.5489/cuaj.1661	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					700	700		10.1111/iju.12790		1	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000023		
J	Myoen, S; Mitsuzuka, K; Saito, H; Ota, H; Takase, K; Arai, Y				Myoen, Shingo; Mitsuzuka, Koji; Saito, Hideo; Ota, Hideki; Takase, Kei; Arai, Yoichi			Spontaneous rupture of a renal angiomyolipoma at 25 weeks of pregnancy treated with transarterial embolization: A case report and review of the literature	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						angiomyolipoma; indication; pregnancy; radiation exposure; transcatheter arterial embolization	MANAGEMENT	Treatment for ruptured renal angiomyolipoma in pregnancy requires immediate and appropriate decision-making based on the condition of the mother and fetus, and gestational age. A 37-year-old woman at 25weeks of pregnancy presented with severe right flank pain. Computed tomography showed a ruptured right renal angiomyolipoma (8cm in diameter). The maternal and fetal conditions were stable. Transcatheter arterial embolization was carried out electively 4days after the rupture. Minimization of radiation exposure to the fetus was achieved by X-ray shielding for the fetus, low-dose-rate fluoroscopy, minimal angiography imaging and a color Doppler ultrasonography-guided procedure. Although threatened premature labor occurred because of post-embolization syndrome, the pregnancy was continued until cesarean section at 37weeks of pregnancy.	[Myoen, Shingo; Mitsuzuka, Koji; Saito, Hideo; Arai, Yoichi] Tohoku Univ, Sch Med, Dept Urol, Sendai, Miyagi 9808574, Japan; [Ota, Hideki; Takase, Kei] Tohoku Univ, Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 9808574, Japan	Mitsuzuka, K (reprint author), Tohoku Univ, Sch Med, Dept Urol, Aoba Ku, Seiryo Machi, Sendai, Miyagi 9808574, Japan.	mitsuzuka@uro.med.tohoku.ac.jp	Ota, Hideki/A-3717-2012	Ota, Hideki/0000-0002-7239-3152			Eble JN, 1998, SEMIN DIAGN PATHOL, V15, P21; Ewalt DH, 2005, J UROLOGY, V174, P1764, DOI 10.1097/01.ju.0000177497.31986.64; STEINER MS, 1993, J UROLOGY, V150, P1782; Ramon J, 2009, EUR UROL, V55, P1155, DOI 10.1016/j.eururo.2008.04.025; Japan Society of Obstetrics and Gynecology Japan Association of Obstetricians and Gynecologists, 2011, J OBSTET GYNECOL RES, V37, P1174; Komeya Mitsuru, 2010, Hinyokika Kiyo, V56, P261; OESTERLING JE, 1986, J UROLOGY, V135, P1121; Storm DW, 2006, OBSTET GYNECOL, V107, P490, DOI 10.1097/01.AOG.0000167392.59472.c3; Yanai H, 1996, UROL INT, V56, P188; Zapardiel I, 2011, GYNECOL OBSTET INVES, V72, P217, DOI 10.1159/000329328	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					710	712		10.1111/iju.12775		3	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000027		
J	Yoshida, S; Kihara, K; Fukuyo, T; Ishioka, J; Saito, K; Fujii, Y				Yoshida, Soichiro; Kihara, Kazunori; Fukuyo, Tsuneo; Ishioka, Junichiro; Saito, Kazutaka; Fujii, Yasuhisa			Novel three-dimensional image system for transurethral surgery	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									[Yoshida, Soichiro; Kihara, Kazunori; Ishioka, Junichiro; Saito, Kazutaka; Fujii, Yasuhisa] Tokyo Med & Dent Univ Grad Sch, Dept Urol, Tokyo, Japan; [Fukuyo, Tsuneo] Shinko Opt Co Ltd, Tokyo, Japan	Yoshida, S (reprint author), Tokyo Med & Dent Univ Grad Sch, Dept Urol, Tokyo, Japan.	k-kihara.uro@tmd.ac.jp					Binder J, 2004, BJU INT, V94, P1183, DOI 10.1111/j.1464-410X.2004.05130.x; Fujii Y, 2014, VIDEOSURGERY MINIINV, V9, P638, DOI 10.5114/wiitm.2014.44407; Igarashi T, 2009, INT J UROL, V16, P533, DOI 10.1111/j.1442-2042.2009.02258.x; Kihara K, 2014, VIDEOSURGERY MINIINV, V9, P634, DOI 10.5114/wiitm.2014.44155; Kihara K, 2012, INT J UROL, V19, P886, DOI 10.1111/j.1442-2042.2012.03044.x; Matsuoka Y, 2014, VIDEOSURGERY MINIINV, V9, P613, DOI 10.5114/wiitm.2014.44135	6	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					714	715		10.1111/iju.12768		2	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000029		
J	Nagai, T				Nagai, Tatsuya			Editorial Comment to Novel three-dimensional image system for transurethral surgery	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Toyohashi Municipal Hosp, Dept Urol, Toyohashi, Aichi, Japan	Nagai, T (reprint author), Toyohashi Municipal Hosp, Dept Urol, Toyohashi, Aichi, Japan.	nagai-tatsuya@toyohashi-mh.jp					Aykan S, 2014, J ENDOUROL, V28, P539, DOI 10.1089/end.2013.0630; Harwerths RS, 2011, ADLERS PHYSL EYE, P677; Krols JD, 1980, RECEPTION, V9, P651; Yoshida S, 2015, INT J UROL, V22, P714, DOI 10.1111/iju.12768	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUL	2015	22	7					716	716		10.1111/iju.12787		1	Urology & Nephrology	Urology & Nephrology	CM8KB	WOS:000357948000030		
J	Ozaki, K; Doi, H; Mitsui, J; Sato, N; Iikuni, Y; Majima, T; Yamane, K; Irioka, T; Ishiura, H; Doi, K; Morishita, S; Higashi, M; Sekiguchi, T; Koyama, K; Ueda, N; Miura, Y; Miyatake, S; Matsumoto, N; Yokota, T; Tanaka, F; Tsuji, S; Mizusawa, H; Ishikawa, K				Ozaki, Kokoro; Doi, Hiroshi; Mitsui, Jun; Sato, Nozomu; Iikuni, Yoichiro; Majima, Takamasa; Yamane, Kiyomi; Irioka, Takashi; Ishiura, Hiroyuki; Doi, Koichiro; Morishita, Shinichi; Higashi, Miwa; Sekiguchi, Teruhiko; Koyama, Kazuo; Ueda, Naohisa; Miura, Yoshiharu; Miyatake, Satoko; Matsumoto, Naomichi; Yokota, Takanori; Tanaka, Fumiaki; Tsuji, Shoji; Mizusawa, Hidehiro; Ishikawa, Kinya			A Novel Mutation in ELOVL4 Leading to Spinocerebellar Ataxia (SCA) With the Hot Cross Bun Sign but Lacking Erythrokeratodermia A Broadened Spectrum of SCA34	JAMA NEUROLOGY			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; MULTIPLE SYSTEM ATROPHY; HIDDEN MARKOV MODEL; MACULAR DYSTROPHY; GENE; MECHANISM; IDENTIFICATION; GENOMES	IMPORTANCE Although mutations in 26 causative genes have been identified in the spinocerebellar ataxias (SCAs), the causative genes in a substantial number of families with SCA remain unidentified. OBJECTIVE To identify the causative gene of SCA in 2 Japanese families with distinct neurological symptoms and radiological presentations. DESIGN, SETTING, AND PARTICIPANTS Clinical genetic study at a referral center of 11 members from 2 Japanese families, which started in 1997. MAIN OUTCOMES AND MEASURES Results of neurological examinations and radiological evaluations. The causative mutation was identified using genome-wide linkage analysis and next-generation sequencing. RESULTS Affected members (9 of 11 members [81.8%]) showed slowly progressive cerebellar ataxia (all 9 members [100%]), ocular movement disturbance (all 9 members [100%]), and pyramidal tract signs (8 of 9 members [88.9%]) with an age at onset between the second and sixth decades of life. Besides cerebellar and pontine atrophy, magnetic resonance imaging of the brain revealed the hot cross bun sign (4 of 6 members [66.7%]), pontine midline linear hyperintensity (2 of 6 members [33.3%]), or high intensity in the middle cerebellar peduncle (1 of 6 members [16.7%]), which are all reminiscent of multiple system atrophy in tested patients. Using linkage analysis combined with exome and whole-genome sequencing, we identified a novel heterozygous mutation in the ELOVL fatty acid elongase 4 (ELOVL4) gene (c.736T>G, p.W246G) in both families. Haplotype analysis indicated that it was unlikely that these 2 Japanese families shared a common ancestor. Although a missense mutation in ELOVL4 (c.504G>C, p.L168F) was recently reported to be associated with SCA with erythrokeratodermia variabilis (SCA34) in a French-Canadian family, signs of erythrokeratodermia variabilis were absent in our families. CONCLUSIONS AND RELEVANCE Combined with the results of the family with SCA34 reported previously, this report confirms that mutations in ELOVL4 can cause dominantly inherited neurodegeneration severely affecting the cerebellum and brainstem. We should be aware that the presence of multiple system atrophy-like features on magnetic resonance imaging scans, together with cerebellar and brainstem atrophy, suggests SCA34, even when erythrokeratodermia variabilis is absent. The present study further broadened the spectrum of the clinical presentations of SCA34 associated with mutations in ELOVL4, which is involved in the biosynthesis of very long-chain fatty acids.	[Ozaki, Kokoro; Sato, Nozomu; Higashi, Miwa; Yokota, Takanori; Mizusawa, Hidehiro; Ishikawa, Kinya] Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Doi, Hiroshi; Ueda, Naohisa; Tanaka, Fumiaki] Yokohama City Univ, Dept Neurol & Stroke Med, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Mitsui, Jun; Ishiura, Hiroyuki; Tsuji, Shoji] Univ Tokyo, Dept Neurol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Iikuni, Yoichiro; Yamane, Kiyomi] Ohta Atami Hosp, Neurol Inst, Dept Neurol, Koriyama, Fukushima, Japan; [Majima, Takamasa; Irioka, Takashi] Yokosuka Kyosai Hosp, Dept Neurol, Yokosuka, Kanagawa, Japan; [Doi, Koichiro; Morishita, Shinichi] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Sekiguchi, Teruhiko] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo, Japan; [Koyama, Kazuo] Fujisawa City Hosp, Dept Neurol, Fujisawa, Kanagawa, Japan; [Miura, Yoshiharu] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Neurol, Bunkyo Ku, Tokyo, Japan; [Miyatake, Satoko; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Mizusawa, Hidehiro] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan	Ishikawa, K (reprint author), Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	pico.nuro@tmd.ac.jp			Health and Labour Sciences Research Grants on Ataxic Diseases from the Ministry of Health, Labour, and Welfare, Japan; Japan Society for the Promotion of Science; Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency, Saitama, Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan	This study was funded by the Health and Labour Sciences Research Grants on Ataxic Diseases from the Ministry of Health, Labour, and Welfare, Japan (Drs Mizusawa, Tsuji, and Ishikawa), Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Drs Matsumoto, Mizusawa, and Ishikawa), the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Drs Matsumoto and Mizusawa), a grant for Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency, Saitama, Japan (Dr Mizusawa), and Grants-in-Aid for Scientific Research on Innovative Areas, "Exploring molecular basis for brain diseases based on personal genomics," from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Drs Morishita, Tanaka, Tsuji, and Ishikawa).	Lee YC, 2009, EUR J NEUROL, V16, P513, DOI 10.1111/j.1468-1331.2008.02524.x; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Zhang K, 2001, NAT GENET, V27, P89; Horimoto Y, 2002, J NEUROL, V249, P847, DOI 10.1007/s00415-002-0734-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; McMahon A, 2007, FEBS LETT, V581, P5459, DOI 10.1016/j.febslet.2007.10.050; Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Di Gregorio E, 2014, AM J HUM GENET, V95, P209, DOI 10.1016/j.ajhg.2014.07.001; Cadieux-Dion M, 2014, JAMA NEUROL, V71, P470, DOI 10.1001/jamaneurol.2013.6337; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Caramins M, 2013, HUM MOL GENET, V22, P4329, DOI 10.1093/hmg/ddt282; Lee YC, 2012, ANN NEUROL, V72, P859, DOI 10.1002/ana.23701; Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Delplanque J, 2014, BRAIN, V137, P2657, DOI 10.1093/brain/awu202; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Fukuda Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-121; GIROUX JM, 1972, ARCH DERMATOL, V106, P183, DOI 10.1001/archderm.106.2.183; Grayson C, 2005, J BIOL CHEM, V280, P32521, DOI 10.1074/jbc.M503411200; Karan G, 2005, MOL VIS, V11, P657; Lagali PS, 2003, INVEST OPHTH VIS SCI, V44, P2841, DOI 10.1167/iovs.02-0991; Logan S, 2014, J LIPID RES, V55, P698, DOI 10.1194/jlr.M045443; Magrane M, 2011, DATABASE-OXFORD, V2011, DOI [DOI 10.1093/DATABASE/BAR009, 10.1093/database/bar009]; Martelli PL, 2003, BIOINFORMATICS S1, V19, pi205; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Okuda A, 2010, MOL VIS, V16, P2438; SAVOIARDO M, 1990, RADIOLOGY, V174, P693; Takao M, 2007, INTERNAL MED, V46, P1883, DOI 10.2169/internalmedicine.46.0514; Vasireddy V, 2005, MOL VIS, V11, P665; Vasireddy V, 2010, PROG RETIN EYE RES, V29, P191, DOI 10.1016/j.preteyeres.2010.01.001; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	43	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	JUL	2015	72	7					797	805		10.1001/jamaneurol.2015.0610		9	Clinical Neurology	Neurosciences & Neurology	CM8EP	WOS:000357931000013		
J	Kremer, S; Renard, F; Achard, S; Lana-Peixoto, MA; Palace, J; Asgari, N; Klawiter, EC; Tenembaum, SN; Banwell, B; Greenberg, BM; Bennett, JL; Levy, M; Villoslada, P; Saiz, A; Fujihara, K; Chan, KH; Schippling, S; Paul, F; Kim, HJ; de Seze, J; Wuerfel, JT				Kremer, Stephane; Renard, Felix; Achard, Sophie; Lana-Peixoto, Marco A.; Palace, Jacqueline; Asgari, Nasrin; Klawiter, Eric C.; Tenembaum, Silvia N.; Banwell, Brenda; Greenberg, Benjamin M.; Bennett, Jeffrey L.; Levy, Michael; Villoslada, Pablo; Saiz, Albert; Fujihara, Kazuo; Chan, Koon Ho; Schippling, Sven; Paul, Friedemann; Kim, Ho Jin; de Seze, Jerome; Wuerfel, Jens T.		Guthy-Jackson Charitable Fdn GJCF	Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder	JAMA NEUROLOGY			English	Review							BRAIN-LESION DISTRIBUTION; VOXEL-BASED MORPHOMETRY; APPEARING WHITE-MATTER; MULTIPLE-SCLEROSIS; COGNITIVE IMPAIRMENT; MRI ABNORMALITIES; FUNCTIONAL MRI; DIFFUSION; DAMAGE; MS	Brain parenchymal lesions are frequently observed on conventional magnetic resonance imaging (MRI) scans of patients with neuromyelitis optica (NMO) spectrum disorder but the specific morphological and temporal patterns distinguishing them uneqtaivcally from lesions caused by other disorders have not been identified. This literature review summarizes the literature on advanced quantitative imaging measures reported for patients with NMO spectrum disorder, including proton MR spectroscopy, diffusion tensor imaging, magnetization transfer imaging, quantitative MR voltametry, and ultrahigh-field strength MRI. It was undertaken to consider the advanced MRI techniques used for patients with NMO different specialists in the field. Although quantitative measures such as proton MR spectroscopy or magnetization transfer imaging have not reproducibly revealed diffuse brain injury, preliminary data from diffusion-weighted imaging and brain tissue volumetry indicate greater white matter than gray matter degradation. These findings could be confirmed by ultrahigh-field MRI. The use of nonconventional MR I techniques may further our understanding of the pathogenic processes hi NMO spectrum disorders and may help us identify the distinct radiographic features corresponding to specific phenotypic manifestations of this disease.	[Kremer, Stephane] Univ Strasbourg, CNRS, ICube UMR 7357, Federat Med Translat Strasbourg,UdS, Strasbourg, France; [Kremer, Stephane] Hop Univ Strasbourg, Dept Radiol, Strasbourg, France; [Renard, Felix; Achard, Sophie] Grenoble Image Parole Signal Automat, CNRS, Grenoble, France; [Lana-Peixoto, Marco A.] Univ Fed Minas Gerais, CIEM MS Res Ctr, Belo Horizonte, MG, Brazil; [Palace, Jacqueline] Oxford Univ Hosp Trust, Dept Neurol, Oxford, England; [Asgari, Nasrin] Univ Southern Denmark, Inst Mol Med, Dept Neurobiol, Odense, Denmark; [Asgari, Nasrin] Vejle Hosp, Dept Neurol, Vejle, Denmark; [Klawiter, Eric C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA USA; [Tenembaum, Silvia N.] Natl Pediat Hosp Dr Juan P Garrahan, Dept Neurol & Neurophysiol, Buenos Aires, DF, Argentina; [Banwell, Brenda] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Banwell, Brenda] Childrens Hosp Philadelphia, Dept Pediat, Div Child Neurol, Philadelphia, PA 19104 USA; [Greenberg, Benjamin M.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Greenberg, Benjamin M.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO USA; [Levy, Michael] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Villoslada, Pablo; Saiz, Albert] Hosp Clin Barcelona, Inst Biomed Res August Pi Sunyer, Barcelona, Spain; [Fujihara, Kazuo] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Sendai, Miyagi 980, Japan; [Chan, Koon Ho] Univ Hong Kong, Univ Dept Med, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Schippling, Sven] Univ Zurich Hosp, Neuroimmunol & Multiple Sclerosis Res Sect, CH-8091 Zurich, Switzerland; [Schippling, Sven] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Schippling, Sven] Fed Tech High Sch Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Schippling, Sven] Univ Zurich, Zurich, Switzerland; [Paul, Friedemann; Wuerfel, Jens T.] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Paul, Friedemann; Wuerfel, Jens T.] Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany; [Paul, Friedemann; Wuerfel, Jens T.] Charite, Dept Neurol, D-13353 Berlin, Germany; [Kim, Ho Jin] Res Inst, Dept Neurol, Goyang, South Korea; [Kim, Ho Jin] Natl Canc Ctr Hosp, Goyang, South Korea; [de Seze, Jerome] Hop Univ Strasbourg, Dept Neurol, Strasbourg, France; [de Seze, Jerome] Hop Univ Strasbourg, Clin Invest Ctr INSERM 1434, Strasbourg, France; [de Seze, Jerome] UMR INSERM 1119, Strasbourg, France; [de Seze, Jerome] Federat Med Translat, Strasbourg, France; [Wuerfel, Jens T.] Univ Med Gottingen, Inst Neuroradiol, Gottingen, Germany	Wuerfel, JT (reprint author), Univ Med Gottingen, Inst Neuroradiol, Robert Koch Str 40, D-37075 Gottingen, Germany.	jens.wuerfel@charite.de	Sato, Douglas/F-2508-2013	paul, friedemann/0000-0002-6378-0070; Sato, Douglas/0000-0002-7695-6020	Bayer Schering Pharma; Biogen Idec; Genzyme; Kael-GemVax; Merck Serono; Novartis; Teva-Handok; UCB; German Research Council; German Ministry of Education and Research (Competence Network Multiple Sclerosis [KKNMS]); GJCF; Bayer; Teva; Merck; Sanofi; Chugai Pharma; Bayer Schering; National MS Society; Roche; Bayer Healthcare; Genzyme Corp; Teva Neuroscience; Ministry of Education, Culture, Sports, Science and Technology in Japan; Ichiro Kanehara Foundation; German Ministry of Science (BMBF/KKNMS); Canadian MS Research Foundation; Canadian MS Society; Canadian Institutes of Health Research; Multiple Sclerosis Association of America; DioGenix; Amplimmune; Biogen; National Institutes of Health; Patient-Centered Outcomes Research Institute; Acorda Therapeutics; Viropharma; Acorda; NeuralStem; Genentech; European Commission; Instituto Salud Carlos III; Marato TV3; Eisai; Mitsubishi Tanabe Pharma Corp; Novartis Pharma; Astellas Pharma; Takeda Pharmaceutical Company Limited; Asahi Kasei Medical; Daiichi Sankyo; Nihon Pharmaceutical; Biogen Idec Japan; Chemo-Sero-Therapeutic Research Institute; Teva Pharmaceutical; Mitsubishi Tanabe Pharma; Teijin Pharma; Chugai Pharmaceutical; Ono Pharmaceutical; Genzyme Japan; Ministry of Education, Science and Technology in Japan [22229008]; Ministry of Health, Welfare and Labour of Japan; Teva Pharmaceuticals; Opexa Therapeutics; US Department of Veterans Affairs; German Research Council (DFG); German Ministry of Education and Research (BMBF-EDEN); Alexion; Terumo BCT	Dr Kim has given talks, consulted, and received honoraria and/or research support from Bayer Schering Pharma, Biogen Idec, Genzyme, Kael-GemVax, Merck Serono, Novartis, Teva-Handok, and UCB. He serves on a steering committee for MedImmune. Dr Paul has received funding from the German Research Council, the German Ministry of Education and Research (Competence Network Multiple Sclerosis [KKNMS]), and the GJCF. He has received travel compensation, speaker honoraria, and research support from Biogen Idec, Bayer, Teva, Merck, Novartis, and Sanofi and has served as a steering committee member of the OCTIMS study sponsored by Novartis. Dr Tenembaum has provided consulting services to Genzyme Corp and Biogen Idec and has received lecture fees from Merck Serono. Dr Palace is partly funded by highly specialized services to run a national congenital myasthenia service and a neuromyelitis service. She has received support for scientific meetings and honoraria for advisory work from Merck Serono, Biogen Idec, Novartis, Teva, Chugai Pharma, and Bayer Schering and unrestricted grants from Merck Serono, Novartis, Biogen Idec, and Bayer Schering. Her hospital trust receives funds for her role as clinical leader for the RSS, and she has received grants from the National MS Society and the GJCF for unrelated research studies. Dr Klawiter has received research funding from Roche. He has received consulting fees and/or speaking honoraria from Biogen Idec, Bayer Healthcare, Genzyme Corp, and Teva Neuroscience. Dr Sato receives a scholarship from the Ministry of Education, Culture, Sports, Science and Technology in Japan and has received research support from the Ichiro Kanehara Foundation. Dr de Seze has received honoraria from Bayer Schering, Biogen Idec, LFB, Merck Serono, Novartis, Sanofi, and Teva. He serves as a consultant for Alexion and Chugai. DrWuerfel serves on advisory boards for Novartis and Biogen Idec. He received a research grant from Novartis and speaker honoraria from Bayer, Novartis, and Biogen Idec. He is supported by the German Ministry of Science (BMBF/KKNMS). Dr Banwell serves as a senior editor for Multiple Sclerosis and Related Disorders and on the editorial board of Neurology. She serves as a consultant for Biogen Idec, Novartis, Teva Neuroscience, and Merck Serono. She has been funded by the Canadian MS Research Foundation, the Canadian MS Society, and the Canadian Institutes of Health Research. Dr Greenberg serves as a section editor for JAMA Neurology. He has received consulting fees or honoraria from the Multiple Sclerosis Association of America, DioGenix, Amplimmune, Novartis, and Biogen. He has received grant funding from the National Institutes of Health, the Patient-Centered Outcomes Research Institute, the GJCF, Acorda Therapeutics, and Biogen Idec. Dr Bennett serves as a consultant for Novartis Pharmaceuticals, Alnaylam Pharmaceuticals, MedImmune, Chugai Pharmaceuticals, EMD Serono, AbbVie, Genentech, Genzyme, Apsara Therapeutics, and Questcor Pharmaceuticals; receives license royalties for a patent regarding "Compositions and Methods for the Treatment of Neuromyelitis Optica"; and serves on the editorial boards of the Multiple Sclerosis Journal and the Journal of Neuro-Ophthalmology. Dr Levy receives research support from the National Institutes of Health, the GJCF, Viropharma, Acorda, Sanofi, NeuralStem, and Genentech and serves as a consultant for Chugai Pharmaceuticals, GlaxoSmithKline, and MedImmune.; Dr Villoslada serves as a board member for Roche, Novartis, Neurotec Pharma, and Bionure Farma and as a consultant for Novartis, Roche, TFS, Heidelberg Engineering, MedImmune, Digna Biotec, and Neurotec Pharma. He has received research support from the European Commission, the Instituto Salud Carlos III, Marato TV3, Novartis, and Roche and travel expenses from Novartis. He holds patents with Digna Biotec and Bionure Farma and stock/stock options of Bionure Farma. Dr Saiz has received compensation for consulting services and speaking from Bayer Schering, Merck Serono, Biogen Idec, Sanofi, Teva Pharmaceutical Industries, and Novartis. Dr Fujihara serves on scientific advisory boards for Bayer Schering Pharma, Biogen Idec, Mitsubishi Tanabe Pharma Corp, Novartis Pharma, Chugai Pharmaceutical, Ono Pharmaceutical, Nihon Pharmaceutical, Merck Serono, Alexion Pharmaceuticals, MedImmune, and Medical Review; has received funding for travel and speaker honoraria from Bayer Schering Pharma, Biogen Idec, Eisai, Mitsubishi Tanabe Pharma Corp, Novartis Pharma, Astellas Pharma, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical, Daiichi Sankyo, and Nihon Pharmaceutical; serves as an editorial board member of Clinical and Experimental Neuroimmunology (2009 to the present) and an advisory board member of the Sri Lanka Journal of Neurology; has received research support from Bayer Schering Pharma, Biogen Idec Japan, Asahi Kasei Medical, The Chemo-Sero-Therapeutic Research Institute, Teva Pharmaceutical, Mitsubishi Tanabe Pharma, Teijin Pharma, Chugai Pharmaceutical, Ono Pharmaceutical, Nihon Pharmaceutical, and Genzyme Japan; and is funded as the secondary investigator (grant 22229008, 2010-2015) by the Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Technology in Japan and as the secondary investigator by the Grants-in-Aid for Scientific Research from the Ministry of Health, Welfare and Labour of Japan (2010 to the present). Dr Stuve serves on the editorial boards of JAMA Neurology, the Multiple Sclerosis Journal, and Therapeutic Advances in Neurological Disorders. He has received grant support from Teva Pharmaceuticals and Opexa Therapeutics. Dr. Steve has served on data monitoring committees for Pfizer and Sanofi without monetary compensation. He is funded by a Merit grant from the US Department of Veterans Affairs. Dr Aktas receives research support from the German Research Council (DFG), the German Ministry of Education and Research (BMBF-EDEN), Bayer, Biogen Idec, Merck Serono, Novartis, and Teva and serves on an advisory board for MedImmune. He is an academic editor for PLOS ONE. Dr Wingerchuk has received research support from Alexion, Terumo BCT, and the GJCF; receives financial compensation for participation in a relapse adjudication panel for MedImmune; and has served as a consultant to Alexion, MedImmune, and Chugai Pharmaceuticals. No other disclosures are reported.	Aboul-Enein F, 2010, AM J NEURORADIOL, V31, P76, DOI 10.3174/ajnr.A1791; Rocca MA, 2004, NEUROLOGY, V62, P476; Absinta M, 2013, ANN NEUROL, V74, P669, DOI 10.1002/ana.23959; Ito S, 2009, ANN NEUROL, V66, P425, DOI 10.1002/ana.21753; Zhao DD, 2012, NEUROIMAGE, V59, P3173, DOI 10.1016/j.neuroimage.2011.11.022; Yu CS, 2006, AM J NEURORADIOL, V27, P1009; Chanson JB, 2013, EUR J NEUROL, V20, P361, DOI 10.1111/j.1468-1331.2012.03867.x; Barnett Y, 2014, AM J NEURORADIOL, V35, P1458, DOI 10.3174/ajnr.A3592; Yonezu T, 2014, MULT SCLER J, V20, P331, DOI 10.1177/1352458513495581; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Pichiecchio A, 2012, MULT SCLER J, V18, P817, DOI 10.1177/1352458511431072; Grassiot B, 2009, J NEUROL, V256, P1397, DOI 10.1007/s00415-009-5108-4; de Seze J, 2010, J NEUROL NEUROSUR PS, V81, P409, DOI 10.1136/jnnp.2008.168070; Matthews L, 2013, NEUROLOGY, V80, P1330, DOI 10.1212/WNL.0b013e3182887957; Tallantyre EC, 2011, NEUROLOGY, V76, P534, DOI 10.1212/WNL.0b013e31820b7630; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Yu CS, 2008, RADIOLOGY, V246, P222; Filippi M, 1999, NEUROLOGY, V53, P1705; Saji E, 2013, ANN NEUROL, V73, P65, DOI 10.1002/ana.23721; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/aw1371; Popescu BFG, 2010, NEUROLOGY, V75, P2103, DOI 10.1212/WNL.0b013e318200d80c; Sinnecker T, 2012, NEUROLOGY, V79, P708, DOI 10.1212/WNL.0b013e3182648bc8; Makino T, 2013, MULT SCLER J, V19, P308, DOI 10.1177/1352458512454772; Jarius S, 2014, CLIN EXP IMMUNOL, V176, P149, DOI 10.1111/cei.12271; Liang PP, 2011, CLIN NEUROPHYSIOL, V122, P121, DOI 10.1016/j.clinph.2010.05.026; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Duan YY, 2014, ACTA RADIOL, V55, P589, DOI 10.1177/0284185113501815; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964; Liu Y, 2011, EUR J RADIOL, V80, P407, DOI 10.1016/j.ejrad.2010.05.002; Lopes FCR, 2012, RADIOLOGY, V263, P235, DOI 10.1148/radiol.12111241; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390; Kuchling J, 2014, NERVENARZT, V85, P445, DOI 10.1007/s00115-013-3967-5; Bichuetti DB, 2008, J NEUROL, V255, P1895, DOI 10.1007/s00415-009-0940-0; Blanc F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033878; Cabrera-Gomez J, 2008, MULT SCLER, V14, P248, DOI 10.1177/1352458507082617; Cabrera-Gomez JA, 2012, EUR J NEUROL, V19, P812, DOI 10.1111/j.1468-1331.2011.03565.x; Ciccarelli O, 2013, ANN NEUROL, V74, P301, DOI 10.1002/ana.23909; Duan YY, 2012, EUR J RADIOL, V81, pE110, DOI 10.1016/j.ejrad.2011.01.065; Hemmert C, 2013, 29 C EUR COMM TREATM; Jeantroux J, 2012, J NEURORADIOLOGY, V39, P295, DOI 10.1016/j.neurad.2011.10.003; Kim JE, 2011, J NEUROL SCI, V302, P43, DOI 10.1016/j.jns.2010.12.001; Kim W, 2012, MULT SCLER INT, V2012; Kister I., 2013, MULT SCLER INT, V2013; Kister I, 2013, NEUROLOGY, V81, P1966, DOI 10.1212/01.wnl.0000436079.95856.1f; Klawiter EC, 2012, MULT SCLER J, V18, P1259, DOI 10.1177/1352458512436593; Kremer S, 2010, J NEURORADIOLOGY, V37, P301, DOI 10.1016/j.neurad.2009.12.008; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048846; Liu Y, 2012, MULT SCLER J, V18, P1013, DOI 10.1177/1352458511431731; Pires CE, 2012, J CLIN NEUROSCI, V19, P969, DOI 10.1016/j.jocn.2011.10.009; Qian WS, 2011, J MAGN RESON IMAGING, V33, P1312, DOI 10.1002/jmri.22575; Quinn Matthew P, 2013, Front Neurol, V4, P98, DOI 10.3389/fneur.2013.00098; Rocca MA, 2004, NEUROIMAGE, V21, P1061, DOI 10.1016/j.neuroimage.2003.10.013; Sahraian MA, 2013, NEUROL CLIN, V31, P139, DOI 10.1016/j.ncl.2012.09.010; Sinnecker T, 2013, MULT SCLER J, V19, P316, DOI 10.1177/1352458512451941; Wang F, 2011, EUR J RADIOL, V80, P445, DOI 10.1016/j.ejrad.2010.06.024	57	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	JUL	2015	72	7					815	822		10.1001/jamaneurol.2015.0248		8	Clinical Neurology	Neurosciences & Neurology	CM8EP	WOS:000357931000016		
J	Tanihara, H; Inoue, T; Yamamoto, T; Kuwayama, Y; Abe, H; Suganami, H; Araie, M				Tanihara, Hidenobu; Inoue, Toshihiro; Yamamoto, Tetsuya; Kuwayama, Yasuaki; Abe, Haruki; Suganami, Hideki; Araie, Makoto		K-115 Clinical Study Grp	Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost A Report of 2 Randomized Clinical Trials	JAMA OPHTHALMOLOGY			English	Article							OPEN-ANGLE GLAUCOMA; PROTEIN-KINASE; OCULAR HYPERTENSION; OUTFLOW; RABBITS; Y-27632; CELLS	IMPORTANCE Ripasudil hydrochloride hydrate (K-115), a novel rho kinase inhibitor, provides statistically significant intraocular pressure (IOP)-lowering effects and has a tolerable safety profile. However, no studies have evaluated ripasudil combined with beta-blockers and prostaglandin analogues. OBJECTIVE To evaluate the additive IOP-lowering effects and the safety of ripasudil, 0.4%, combined with timolol, 0.5%, or latanoprost, 0.005%, in patients with primary open-angle glaucoma or ocular hypertension. DESIGN, SETTING, AND PARTICIPANTS We conducted 2, multicenter, randomized, double-masked, parallel group comparison studies of ripasudil-timolol and ripasudil-latanoprost in 29 and 36 Japanese clinical centers, respectively. Analyses were performed on an intention-treat-treat basis. After appropriate run-in periods with timolol or latanoprost, 208 and 205 patients whose IOP levels were 18 mm Hg or higher were enrolled in the ripasudil-timolol and ripasudil-latanoprost groups, respectively. Enrollment began December 1, 2011, and follow-up was completed on September 7, 2012, in the ripasudil-timolol study. Enrollment began December 1, 2011, and follow-up was completed on September 27, 2012, in the ripasudil-latanoprost study. INTERVENTIONS Patients were subdivided into 2 groups in each study and were treated with ripasudil or placebo twice daily for 8 weeks. MAIN OUTCOMES AND MEASURES The IOP reductions in the ripasudil and placebo groups were analyzed with a repeated-measures analysis of variance model at weeks 4, 6, and 8, at trough (before instillation [9 AM]) and peak (2 hours after instillation [11 AM]) levels. RESULTS In the ripasudil-timolol study, the mean IOP reductions from baseline in the ripasudil and placebo groups were -2.4 and -1.5 mm Hg at 9 AM for a difference of 0.9 mm Hg (95% CI, 0.4-1.3 mm Hg; P < .001) and -2.9 and -1.3 mm Hg at 11 AM for a difference of 1.6 mm Hg (95% CI, 1.1-2.1 mm Hg; P < .001), respectively. In the ripasudil-latanoprost study, those IOP reductions were -2.2 and -1.8 mm Hg at 9 AM for a difference of 0.4 mm Hg (95% CI, -0.0 to 0.9 mm Hg; P = .06) and -3.2 and -1.8 mm Hg at 11 AM for a difference of 1.4 mm Hg (95% CI, 0.9-1.9 mm Hg; P < .001), respectively. The most frequently reported adverse event was conjunctival hyperemia, which was mild and in most cases resolved without treatment before the next instillation. CONCLUSIONS AND RELEVANCE These clinical trials found additive IOP-lowering effects of ripasudil from placebo at trough and peak levels in combination with timolol and at peak level in combination with latanoprost. However, a definitive difference in the addition of placebo to latanoprost was not identified in the trough level.	[Tanihara, Hidenobu; Inoue, Toshihiro] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Kumamoto 8608556, Japan; [Yamamoto, Tetsuya] Gifu Univ, Grad Sch Med, Dept Ophthalmol, Gifu, Japan; [Kuwayama, Yasuaki] Fukushima Eye Clin, Osaka, Japan; [Abe, Haruki] Niigata Univ Hlth & Welf, Dept Orthopt & Visual Sci, Niigata, Japan; [Suganami, Hideki] Kowa Co Ltd, Nagoya, Aichi, Japan; [Araie, Makoto] Mutual Aid Assoc Publ Sch Teachers, Kanto Cent Hosp, Tokyo, Japan	Tanihara, H (reprint author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Chuo Ku, 1-1-1 Honjo, Kumamoto, Kumamoto 8608556, Japan.	tanihara@pearl.ocn.ne.jp			Kowa Company Ltd, Nagoya, Japan	This study was sponsored by Kowa Company Ltd, Nagoya, Japan.	American Academy of Ophthalmology Preferred Practice Patterns Committee Glaucoma Panel, 2010, PREF PRACT PATT PRIM; Tokushige H, 2007, INVEST OPHTH VIS SCI, V48, P3216, DOI 10.1167/iovs.05-1617; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Tanihara H, 2013, JAMA OPHTHALMOL, V131, P1288, DOI 10.1001/jamaophthalmol.2013.323; Isobe T, 2014, CURR EYE RES, V39, P813, DOI 10.3109/02713683.2013.874444; Kameda T, 2012, INVEST OPHTH VIS SCI, V53, P3092, DOI 10.1167/iovs.11-8018; Tanihara H, 2013, AM J OPHTHALMOL, V156, P731, DOI 10.1016/j.ajo.2013.05.016; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Fujimoto T, 2012, INVEST OPHTH VIS SCI, V53, P7097, DOI 10.1167/iovs.12-9989; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Koga T, 2006, EXP EYE RES, V82, P362, DOI 10.1016/j.exer.2005.07.006; Kitazawa Yoshiaki, 2011, Nippon Ganka Gakkai Zasshi, V115, P495; Tanna AP, 2010, ARCH OPHTHALMOL-CHIC, V128, P825, DOI 10.1001/archophthalmol.2010.131	14	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6165	2168-6173		JAMA OPHTHALMOL	JAMA Ophthalmol.	JUL	2015	133	7					755	761		10.1001/jamaophthalmol.2015.0525		7	Ophthalmology	Ophthalmology	CM6TO	WOS:000357823100007		
J	Aburano, H; Ueda, F; Yoshie, Y; Matsui, O; Nakada, M; Hayashi, Y; Gabata, T				Aburano, Hiroyuki; Ueda, Fumiaki; Yoshie, Yuichi; Matsui, Osamu; Nakada, Mitsutoshi; Hayashi, Yutaka; Gabata, Toshifumi			Differences between glioblastomas and primary central nervous system lymphomas in H-1-magnetic resonance spectroscopy	JAPANESE JOURNAL OF RADIOLOGY			English	Article						H-1-magnetic resonance spectroscopy; Glioblastoma; Primary central nervous system lymphoma; Glutamate; Glutamine	PROTON MR SPECTROSCOPY; GLUTAMATE TRANSPORTERS; CHOLINE PEAK; GD-CONTRAST; SPECTRA; GLIOMA; MULTIFORME; LCMODEL	The present study aimed to distinguish between glioblastomas and primary central nervous system lymphomas (PCNSLs) using H-1-magnetic resonance spectroscopy (MRS), especially glutamate (Glu)/creatine (Cr) and Glu/Glu+glutamine (Gln) ratios. A total of 46 patients (31 cases diagnosed with glioblastoma, 15 with PCNSL) were examined by in vivo single-voxel proton H-1-MRS with a 3-T MR imaging system. Differences in absolute concentration of Cr, choline/Cr, lipid (1.3 ppm)/Cr, Glu+Gln/Cr, Glu/Cr, and Glu/Glu+Gln ratios among groups were evaluated with Mann-Whitney U tests. PCNSLs [3.408 +/- A 1.194 (standard deviation)] showed significantly higher Glu/Cr ratios as compared to glioblastomas (2.220 +/- A 0.942; P = 0.003) [Glu/Cr cutoff ratio of 2.509 showed a sensitivity of 88 % (7/8) and a specificity of 92 % (22/24)], while glioblastomas (0.539 +/- A 0.098) showed significantly lower Glu/Glu+Gln ratios as compared to PCNSLs (0.728 +/- A 0.147; P < 0.001) [Glu/Glu+Gln cutoff ratio of 0.558 showed a sensitivity of 69 % (18/26) and a specificity of 100 % (13/13)]. And PCNSLs (1.101 +/- A 0.387) showed significantly higher Cho/Cr ratios as compared to glioblastomas (0.850 +/- A 0.465; P = 0.026). Glu/Cr, Glu/Glu+Gln, and Cho/Cr ratios may be useful in distinguishing between glioblastomas and PCNSLs.	[Aburano, Hiroyuki; Ueda, Fumiaki; Matsui, Osamu; Gabata, Toshifumi] Kanazawa Univ, Dept Radiol, Grad Sch Med, Kanazawa, Ishikawa 9208641, Japan; [Yoshie, Yuichi] Toyama City Hosp, Dept Radiol, Toyama, Toyama 9398511, Japan; [Nakada, Mitsutoshi; Hayashi, Yutaka] Kanazawa Univ, Dept Neurosurg, Grad Sch Med, Kanazawa, Ishikawa 9208641, Japan	Aburano, H (reprint author), Kanazawa Univ, Dept Radiol, Grad Sch Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	aburano@arrow.ocn.ne.jp					Agarwal N, 2012, AM J NEURORADIOL, V33, P595, DOI 10.3174/ajnr.A2587; Shigeri Y, 2004, BRAIN RES REV, V45, P250, DOI 10.1016/j.brainsrev.2004.04.004; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Sijens PE, 1997, MAGNET RESON MED, V37, P222, DOI 10.1002/mrm.1910370214; Ye ZC, 1999, J NEUROSCI, V19, P10767; Pfund Z, 2000, J CEREBR BLOOD F MET, V20, P871; Toh CH, 2008, AM J NEURORADIOL, V29, P471, DOI 10.3174/ajnr.A0872; Sijens PE, 1998, MAGN RESON IMAGING, V16, P1273, DOI 10.1016/S0730-725X(98)00143-X; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; Chawla S, 2010, J COMPUT ASSIST TOMO, V34, P836, DOI 10.1097/RCT.0b013e3181ec554e; Kinoshita Y, 1997, NMR BIOMED, V10, P2, DOI 10.1002/(SICI)1099-1492(199701)10:1<2::AID-NBM442>3.0.CO;2-N; POW DV, 1994, NEUROSCIENCE, V60, P355, DOI 10.1016/0306-4522(94)90249-6; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; POPTANI H, 1995, AM J NEURORADIOL, V16, P1593; Helms G, 1999, MAGN RESON IMAGING, V17, P1211, DOI 10.1016/S0730-725X(99)00058-2; Braitenberg V., 1998, CORTEX STAT GEOMETRY; Evan N, 2009, CANCER BIOL THER, V8, P1791; Harting I, 2003, NEUROSCI LETT, V342, P163, DOI 10.1016/S0304-3940(03)00272-6; Kosaka N, 2008, AM J ROENTGENOL, V190, P365; Lehmann C, 2009, BRAIN RES, V1297, P1, DOI 10.1016/j.brainres.2009.08.070; Lima EC, 2013, AM J NEURORADIOL, V34, P80, DOI 10.3174/ajnr.A3181; Murphy PS, 2002, PHYS MED BIOL, V47, P53; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUL	2015	33	7					392	403		10.1007/s11604-015-0430-5		12	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM9RY	WOS:000358047900002		
J	Tanaka, F; Kawai, N; Sato, M; Minamiguchi, H; Nakai, M; Nakata, K; Sanda, H; Sonomura, T; Matuzaki, I; Murata, S				Tanaka, Fumihiro; Kawai, Nobuyuki; Sato, Morio; Minamiguchi, Hiroki; Nakai, Motoki; Nakata, Kohei; Sanda, Hiroki; Sonomura, Tetsuo; Matuzaki, Ibu; Murata, Shinichi			Effect of transcatheter arterial embolization with a mixture of n-butyl cyanoacrylate, lipiodol, and ethanol on the vascular wall: macroscopic and microscopic studies	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Transcatheter arterial embolization; n-Butyl cyanoacrylate; Lipiodol; Ethanol; Pathological effect	POLYMERIZATION TIME; 2-CYANOACRYLATE	To compare the pathologic effect of a mixture of n-butyl cyanoacrylate (NBCA), lipiodol, and ethanol (NLE) with a mixture of NBCA and lipiodol (NL) on the embolized vascular wall. Embolization was performed using four swine with NBCA and lipiodol in a volume ratio of 1:1 (NL11group) in the common hepatic artery (n = 1) and the internal iliac artery (n = 2); and with NBCA, lipiodol, and ethanol in a volume ratio of 1:1:2 (NLE112 group) in the common hepatic artery (n = 3) and the internal iliac artery (n = 6). NL11 casts had an intricate appearance in reticular configuration with red thrombus, while NLE112 casts presented in a single round configuration with surrounding ring-like red thrombus. Desquamation of endothelial cells and infiltration of neutrophils into the adventitial layer were found in all embolized vessels in both groups. Infiltration of neutrophils into the intermediate layer was found in the NL11 group but not in the NLE112 group. The damage to the vascular wall caused by NLE112 was milder than that by NL11, implying the adverse effects of NLE112 are within tolerable limits.	[Tanaka, Fumihiro; Kawai, Nobuyuki; Sato, Morio; Minamiguchi, Hiroki; Nakai, Motoki; Nakata, Kohei; Sanda, Hiroki; Sonomura, Tetsuo] Wakayama Med Univ, Dept Radiol, Wakayama, Wakayama 6418510, Japan; [Matuzaki, Ibu; Murata, Shinichi] Wakayama Med Univ, Dept Pathol 2, Wakayama, Wakayama 6418510, Japan	Sato, M (reprint author), Wakayama Med Univ, Dept Radiol, 811-1 Kimiidera, Wakayama, Wakayama 6418510, Japan.	arida_fumi_mikan@yahoo.co.jp; nobkawai@wakayama-med.ac.jp; morisato@mail.wakayama-med.ac.jp; hiromina4@hotmail.com; momonga@wakayama-med.ac.jp; kohei0120@yahoo.co.jp; sandabird88@ybb.ne.jp; sonomura@wakayama-med.ac.jp; m_ibu@wakayama-med.ac.jp; smurata@wakayama-med.ac.jp					BROTHERS MF, 1989, AM J NEURORADIOL, V10, P777; SPIEGEL SM, 1986, AM J NEURORADIOL, V7, P109; Petersen B, 2004, GASTROINTEST ENDOSC, V60, P327, DOI 10.1016/S0016-5107(04)01564-0; Scotland RS, 2000, CARDIOVASC RES, V46, P403, DOI 10.1016/S0008-6363(00)00023-7; ONEILL JF, 1947, ANN SURG, V126, P270; CYLWIK B, 1985, International Urology and Nephrology, V17, P303, DOI 10.1007/BF02083498; Debrun G M, 1997, Interv Neuroradiol, V3, P13; Gad SC., 2008, PHARM MANUFACTURING, P364; Gounis MJ, 2002, AM J NEURORADIOL, V23, P938; IVANICK MJ, 1983, AM J ROENTGENOL, V141, P535; Kawai N, 2012, J VASC INTERV RADIOL, V23, P1516, DOI 10.1016/j.jvir.2012.08.017; KAWANO M, 1989, Gastroenterologia Japonica, V24, P663; Matsuo T, 2008, JPN J OPHTHALMOL, V52, P308, DOI 10.1007/s10384-008-0563-5; Purdy P, 2002, AM J NEURORADIOL, V23, P748; Petkewich R., 2008, CHEM ENG NEWS, V86, P81; Qureshi A, 1997, ANN ROY COLL SURG, V79, P414; SHIINA S, 1987, AM J ROENTGENOL, V149, P949; STOESSLEIN F, 1982, CARDIOVASC INTER RAD, V5, P264, DOI 10.1007/BF02565409; Tanaka T, 2012, WORLD J RADIOL, V28, P455; Woerner CA, 1959, THE ARTERIAL WALL, P1	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUL	2015	33	7					404	409		10.1007/s11604-015-0432-3		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM9RY	WOS:000358047900003		
J	Sugimoto, K; Moriyasu, F; Kobayashi, Y; Saito, K; Takeuchi, H; Ogawa, S; Ando, M; Sano, T; Mori, T; Furuichi, Y; Nakamura, I				Sugimoto, Katsutoshi; Moriyasu, Fuminori; Kobayashi, Yoshiyuki; Saito, Kazuhiro; Takeuchi, Hirohito; Ogawa, Saori; Ando, Mayumi; Sano, Takatomo; Mori, Toshifumi; Furuichi, Yoshihiro; Nakamura, Ikuo			Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Hepatocellular carcinoma; Ablation; Irreversible electroporation (IRE)	RADIOFREQUENCY ABLATION; ENHANCED ULTRASOUND; US; SONOGRAPHY; EFFICACY; SOCIETY; SAFETY; TRIAL	This clinical study was conducted to evaluate the safety and short-term outcomes of irreversible electroporation (IRE) for the treatment of patients with hepatocellular carcinoma (HCC) in Japan. The study was designed in a prospective setting. Five patients (3 men and 2 women; mean age, 66.6 +/- A 5.8 years) with 6 HCCs were enrolled and treated using percutaneous ultrasound (US)-guided IRE. Safety was assessed based on adverse events and laboratory values. Local control was assessed using contrast-enhanced US with a perflubutane microbubble contrast agent, contrast-enhanced multiphase CT, and gadoxetic acid-enhanced MRI (EOB-MRI) at designated points. The tumors ranged in diameter from 11 to 28 mm (mean diameter, 17.5 +/- A 6.3 mm). Five of the 6 tumors (83 %) were successfully treated, with no local recurrence to date (mean follow-up 244 +/- A 55 days). In 1 lesion located in liver segment 1, residual tumor was diagnosed at 7 days after intervention by follow-up EOB-MRI. No serious complications related to the IRE procedure were observed. The results of this study suggest that image-guided percutaneous IRE can achieve satisfactory local disease control, particularly for small HCCs, and is well tolerated by patients.	[Sugimoto, Katsutoshi; Moriyasu, Fuminori; Kobayashi, Yoshiyuki; Takeuchi, Hirohito; Ogawa, Saori; Ando, Mayumi; Sano, Takatomo; Mori, Toshifumi; Furuichi, Yoshihiro; Nakamura, Ikuo] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1600023, Japan; [Saito, Kazuhiro] Tokyo Med Univ, Dept Radiol, Tokyo 1600023, Japan	Sugimoto, K (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	sugimoto@tokyo-med.ac.jp			MEXT KAKENHI [26865030]	This work was supported by MEXT KAKENHI Grant Number 26865030.	Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Guo Y, 2011, RADIOLOGY, V258, P461, DOI 10.1148/radiol.10100645; Lee EW, 2007, TECHNOL CANCER RES T, V6, P287; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Moriyasu F, 2009, AM J ROENTGENOL, V193, P86, DOI 10.2214/AJR.08.1618; Cheung W, 2013, TECHNOL CANCER RES T, V12, P233, DOI 10.7785/tcrt.2012.500317; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Rhim H, 2008, AM J ROENTGENOL, V190, P1324, DOI 10.2214/AJR.07.2970; Kingham TP, 2012, J AM COLL SURGEONS, V215, P379, DOI 10.1016/j.jamcollsurg.2012.04.029; Wilson SR, 2010, RADIOLOGY, V257, P24, DOI 10.1148/radiol.10091210; Kunishi Y, 2012, AM J ROENTGENOL, V198, P106, DOI 10.2214/AJR.10.6039; Qin ZP, 2013, ANN BIOMED ENG, V41, P619, DOI 10.1007/s10439-012-0686-1; Cardella JF, 2009, J VASC INTERV RADIOL, V20, pS189, DOI 10.1016/j.jvir.2009.04.035; Martin RCG, 2013, ANN SURG ONCOL, V20, pS443, DOI 10.1245/s10434-012-2736-1; Martin RCG, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-540; Party IW, 1995, HEPATOLOGY, V22, P983; Sugimoto K, 2015, J VASC INTERV RADIOL, V26, P279, DOI 10.1016/j.jvir.2014.11.007; Sugimoto K, 2012, EUR RADIOL, V22, P1205, DOI 10.1007/s00330-011-2372-3; Sugimoto K, 2014, J MED ULTRASON, V41, P531, DOI 10.1007/s10396-014-0547-7; Valerio M, 2014, CONTEMP CLIN TRIALS, V39, P57, DOI 10.1016/j.cct.2014.07.006	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUL	2015	33	7					424	432		10.1007/s11604-015-0442-1		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM9RY	WOS:000358047900006		
J	Takashima, Y; Kamitani, T; Kawanami, S; Nagao, M; Yonezawa, M; Yamasaki, Y; Baba, S; Yabuuchi, H; Hida, T; Kohashi, K; Nakamura, K; Sonoda, H; Oda, Y; Honda, H				Takashima, Yoko; Kamitani, Takeshi; Kawanami, Satoshi; Nagao, Michinobu; Yonezawa, Masato; Yamasaki, Yuzo; Baba, Shingo; Yabuuchi, Hidetake; Hida, Tomoyuki; Kohashi, Kenichi; Nakamura, Katsuya; Sonoda, Hiromichi; Oda, Yoshinao; Honda, Hiroshi			Mediastinal paraganglioma	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Mediastinum; Paraganglioma; MRI; FDG-PET	BODY; DISEASE	We present a case of mediastinal paraganglioma with radiologic-pathologic correlation. A 48-year-old woman was found incidentally to have a middle mediastinal mass on CT. The mass showed iso-signal intensity compared to that of muscle on T1-weighted images and high signal intensity on T2-weighted images. The lesion showed intermediate intensity on diffusion-weighted imaging, and its apparent diffusion coefficient was 1.72 x 10(-3) mm(2)/s. A contrast-enhanced dynamic study revealed a rapid peak and washout enhancement pattern. F-18-FDG-PET revealed abnormal uptake in the mediastinal tumor with a maximal standardized uptake value of 7.88. I-123-meta-iodobenzylguanidine scintigraphy also showed abnormal uptake in the tumor. These findings corresponded to the hypervascularity, rich stroma, low nuclear/cytoplasmic ratio, and nest-forming proliferation of tumor cells with positive neuroendocrine markers.	[Takashima, Yoko; Kamitani, Takeshi; Yonezawa, Masato; Yamasaki, Yuzo; Baba, Shingo; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Kawanami, Satoshi; Nagao, Michinobu] Kyushu Univ, Dept Mol Imaging & Diag, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Yabuuchi, Hidetake] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Fukuoka 8128582, Japan; [Hida, Tomoyuki; Kohashi, Kenichi; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan; [Nakamura, Katsuya] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan; [Sonoda, Hiromichi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Surg, Fukuoka 8128582, Japan	Kamitani, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kamitani@radiol.med.kyushu-u.ac.jp					Aschenbach R, 2009, CLIN NEURORADIOL, V19, P215, DOI 10.1007/s00062-009-9004-1; Taieb D, 2012, J NUCL MED, V53, P264, DOI 10.2967/jnumed.111.098152; Wang HY, 2011, EUR J RADIOL, V80, pE217, DOI 10.1016/j.ejrad.2010.09.020; Madan R, 2012, EUR J RADIOL, V81, P123, DOI 10.1016/j.ejrad.2010.06.018; Whitten CR, 2007, RADIOGRAPHICS, V27, P657, DOI 10.1148/rg.273065136; Balcombe J, 2007, AM J ROENTGENOL, V188, P1054, DOI 10.2214/AJR.05.1497; BLANDINO A, 1992, EUR J RADIOL, V15, P1, DOI 10.1016/0720-048X(92)90191-B; FLICKINGER FW, 1988, CHEST, V94, P652, DOI 10.1378/chest.94.3.652; Hatakenaka Masamitsu, 2008, Magn Reson Med Sci, V7, P23, DOI 10.2463/mrms.7.23; Khalil G, 2013, CLIN IMAG, V37, P185, DOI 10.1016/j.clinimag.2012.02.015; Lee KY, 2006, AM J ROENTGENOL, V187, P492, DOI 10.2214/AJR.05.0370; Matsumoto Jun, 2013, Asian Cardiovasc Thorac Ann, V21, P476, DOI 10.1177/0218492312459641; Paul S, 2007, ANN THORAC SURG, V83, pE14, DOI 10.1016/j.athoracsur.2007.02.090; Uhl M, 2002, EUR RADIOL, V12, P2335, DOI 10.1007/s00330-002-1310-9; Yamamoto J, 2010, JJSRE, V32, P285	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUL	2015	33	7					433	436		10.1007/s11604-015-0436-z		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM9RY	WOS:000358047900007		
J	Yamamoto, J; Kurokawa, T; Miyaoka, R; Soejima, Y; Nishizawa, S				Yamamoto, Junkoh; Kurokawa, Toru; Miyaoka, Ryo; Soejima, Yoshiteru; Nishizawa, Shigeru			Primary intraosseous meningioma in the calvaria: morphological feature changes on magnetic resonance images over several years	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Meningioma; Extradural; Ectopic; Calvaria; Cranioplasty	PRIMARY EXTRADURAL MENINGIOMAS	Primary intraosseous meningiomas (PIMs) are rare, and their pathogenesis remains unclear. We report the case of a sizable PIM in the calvaria that progressively enlarged over several years and presented temporal changes in the morphological features on magnetic resonance images. Along with discussing the case, we further emphasize the potential pitfalls of diagnosing a PIM in the calvaria.	[Yamamoto, Junkoh; Kurokawa, Toru; Miyaoka, Ryo; Soejima, Yoshiteru; Nishizawa, Shigeru] Univ Occupat & Environm Hlth, Dept Neurosurg, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Yamamoto, J (reprint author), Univ Occupat & Environm Hlth, Dept Neurosurg, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	yama9218@med.uoeh-u.ac.jp					Johnson DR, 2011, NEURO-ONCOLOGY, V13, P1011, DOI 10.1093/neuonc/nor081; WHICKER JH, 1973, AM J SURG, V126, P452, DOI 10.1016/S0002-9610(73)80029-7; Mattox A, 2011, CANCER-AM CANCER SOC, V117, P24, DOI 10.1002/cncr.25384; Muzumdar D P, 2001, J Postgrad Med, V47, P116; Lang FF, 2000, J NEUROSURG, V93, P940, DOI 10.3171/jns.2000.93.6.0940; Elder James B, 2007, Neurosurg Focus, V23, pE13, DOI 10.3171/FOC-07/10/E13; Ilica AT, 2014, CLIN IMAG, V38, P599, DOI 10.1016/j.clinimag.2014.05.013; Talacchi A, 2011, ACTA NEUROCHIR, V153, P53, DOI 10.1007/s00701-010-0838-8; Tokgoz N, 2005, AM J NEURORADIOL, V26, P2053; Tsutsumi S, 2013, NEUROL MED-CHIR, V53, P727, DOI 10.2176/nmc.cr2012-0324; Yamamoto J, 2011, NEURORADIOLOGY, V53, P413, DOI 10.1007/s00234-010-0751-0	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUL	2015	33	7					437	440		10.1007/s11604-015-0437-y		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM9RY	WOS:000358047900008		
J	Nishii, T; Kono, AK; Nishio, M; Kyotani, K; Nishiyama, K; Sugimura, K				Nishii, Tatsuya; Kono, Atsushi K.; Nishio, Mizuho; Kyotani, Katsusuke; Nishiyama, Kouya; Sugimura, Kazuro			Evaluation of blood volume by use of blood oxygen level-dependent magnetic resonance imaging in a cuff-compression model: usefulness of calculated echo time image	JAPANESE JOURNAL OF RADIOLOGY			English	Article						MRI; BOLD; Skeletal muscle; Blood volume	HUMAN SKELETAL-MUSCLE; BOLD MRI; REACTIVE HYPEREMIA; CONTRACTIONS; PERFUSION; ISCHEMIA; CONTRAST; DISEASE; LEG	Separate assessment of changes in blood oxygenation and blood volume is required in blood oxygen level-dependent (BOLD) imaging. We developed a calculated echo time (TE) imaging technique designed to minimize effects of blood oxygenation and to evaluate blood volume specifically. Dynamic 3T multi-echo BOLD images of calf muscle were acquired from six healthy volunteers by use of a cuff-compression model. Calculated TE images at TE = 0 ms (cTE(0)) and map () were calculated from acquired multi-echo images. The time courses of the mean value for the entire calf muscles in cTE(0), in acquired BOLD images at TE = 45.2 ms (aTE(45)), and in were obtained. The Euclidean distances between the two pairs of time courses were calculated: distance between aTE(45) and (D (at)), and that between cTE(0) and (D (ct)). The difference between D (at) and D (ct) was tested by use of the Wilcoxon signed rank test. D (at) was significantly different from D (ct) (P = 0.031), indicating that the time course of cTE(0) was significantly different from that of blood oxygenation-weighted images ( and aTE(45)). The effect of blood oxygenation could be minimized using cTE(0). Thus, signal intensity changes of cTE(0) reflected changes in blood volume more specifically.	[Nishii, Tatsuya; Kono, Atsushi K.; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 6500017, Japan; [Nishio, Mizuho] Kobe Univ, Div Funct & Diagnost Imaging Res, Dept Radiol, Grad Sch Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Kyotani, Katsusuke; Nishiyama, Kouya] Kobe Univ Hosp, Div Radiol, Kobe, Hyogo, Japan	Nishio, M (reprint author), Kobe Univ, Div Funct & Diagnost Imaging Res, Dept Radiol, Grad Sch Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	nmizuho@med.kobe-u.ac.jp			JSPS KAKENHI [25861102]	This research was supported by JSPS KAKENHI grant number 25861102.	Haque M, 2010, J MAGN RESON IMAGING, V32, P988, DOI 10.1002/jmri.22329; Partovi S, 2012, J MAGN RESON IMAGING, V35, P1227, DOI 10.1002/jmri.23583; Jahnke C, 2010, JACC-CARDIOVASC IMAG, V3, P375, DOI 10.1016/j.jcmg.2009.12.008; Pedersen M, 2005, KIDNEY INT, V67, P2305, DOI 10.1111/j.1523-1755.2005.00334.x; Versluis B, 2011, INVEST RADIOL, V46, P11, DOI 10.1097/RLI.0b013e3181f2bfb8; Meyer RA, 2004, NMR BIOMED, V17, P392, DOI 10.1002/nbm.893; Ledermann HP, 2006, RADIOLOGY, V241, P477, DOI 10.1148/radiol.2412050701; Towse TF, 2011, J APPL PHYSIOL, V111, P27, DOI 10.1152/japplphysiol.01054.2009; Robson MD, 2003, J COMPUT ASSIST TOMO, V27, P825, DOI 10.1097/00004728-200311000-00001; Ledermann HP, 2006, CIRCULATION, V113, P2929, DOI 10.1161/CIRCULATIONAHA.105.605717; Damon BM, 2007, MAGN RESON MED, V57, P670, DOI 10.1002/mrm.21191; Jacobi B, 2012, J MAGN RESON IMAGING, V35, P1253, DOI 10.1002/jmri.23536; Kido A, 2007, J MAGN RESON IMAGING, V26, P695, DOI 10.1002/jmri.21061; Duteil S, 2006, MAGN RESON MED, V55, P450, DOI 10.1002/mrm.20760; Towse TF, 2005, J APPL PHYSIOL, V99, P715, DOI 10.1152/japplphysiol.00272.2005; Ding H., 2008, P VLDB ENDOWMENT, V1, P1542, DOI DOI 10.1145/1454159.1454226; Englund EK, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-70; Faloutsos C., 1994, ACM SIGMOD RECORD, V23, P419, DOI 10.1145/191843.191925; Lebon V, 1998, MAGNET RESON MED, V40, P551, DOI 10.1002/mrm.1910400408; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUL	2015	33	7					441	447		10.1007/s11604-015-0435-0		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM9RY	WOS:000358047900009		
J	Murakami, M; Yokoo, K; Ozawa, M; Fujimoto, S; Funaba, Y; Hattori, M				Murakami, Mari; Yokoo, Kyoko; Ozawa, Mio; Fujimoto, Saori; Funaba, Yuki; Hattori, Minoru			Development of a Neonatal End-of-Life Care Education Program for NICU Nurses in Japan	JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING			English	Article						neonatal; end-of-life care; NICU nurse; education; program development	PALLIATIVE CARE	We developed the first end-of-life care education program for neonatal intensive care unit (NICU) nurses in Japan. It focused on ethical decision making, care of dying neonates, bereavement, and cultural communication. The program improved nurses' knowledge, F(2.16, 62.5)=260.6, p<.001, and understanding, F(2.05, 59.4)=29.1, p<.001, and significantly reduced weaknesses in neonatal end-of-life care. It was considered well designed and may provide further mentoring support for NICU nurses.	[Murakami, Mari; Yokoo, Kyoko; Ozawa, Mio; Fujimoto, Saori; Funaba, Yuki; Hattori, Minoru] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima, Hiroshima 7348553, Japan	Murakami, M (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348553, Japan.	Japan.muromari@hiroshima-u.ac.jp					American Association of Colleges of Nursing, 2012, END OF LIF NURS ED C; McHaffie HE, 2001, J MED ETHICS, V27, P104, DOI 10.1136/jme.27.2.104; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Paice JA, 2010, CLIN J ONCOL NURS, V14, P161, DOI 10.1188/10.CJON.161-166; Custers EJFM, 2011, MED EDUC, V45, P422, DOI 10.1111/j.1365-2923.2010.03889.x; Care for Life-Threatening Illnesses in Childhood, 2012, ED PALL CAR; Cohen J., 1988, STAT POWER ANAL BEHA; DesLisle-Porter M., 2009, NEONATAL NETWORK, V28, P75; End-of-Life Nursing Education Consortium, 2012, ED PALL CAR; Jacobs Hollye Harrington, 2009, J Pediatr Nurs, V24, P216, DOI 10.1016/j.pedn.2008.03.001; Kang J, 2010, J PALLIAT MED, V13, P703, DOI 10.1089/jpm.2009.0345; Mayring P., 2012, FORUM QUALITATIVE SO, V1; Murakami M., 2012, J JAPAN ACAD NEONATA, V18, P19; Naomi R. C., 2014, J OBSTET GYNECOLOGIC, V43, pS6, DOI [10.1111/1552-6909.12352, DOI 10.1111/1552-6909.12352]; National Health Service West Midlands, 2012, PED PALL CAR; National Hospice and Palliative Care Organization, 2012, PED PALL CAR COURS; Quinn K, 2008, J PALLIAT MED, V11, P1122, DOI 10.1089/jpm.2008.0044; Rogers Susan, 2008, Adv Neonatal Care, V8, P56, DOI 10.1097/01.ANC.0000311017.02005.20; Romesberg Tricia L, 2007, Neonatal Netw, V26, P111; Stutts Amy, 2002, Neonatal Netw, V21, P23; Tamura M., 2013, GUIDELINES HEALTHCAR; Together for short lives, 2012, TRAIN TO CAR; Vlach HA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00046	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-2175	1552-6909		JOGNN-J OBST GYN NEO	JOGNN	JUL-AUG	2015	44	4					481	491		10.1111/1552-6909.12569		11	Nursing; Obstetrics & Gynecology	Nursing; Obstetrics & Gynecology	CM7TE	WOS:000357898600005		
J	Magistro, D; Candela, F; Brustio, PR; Liubicich, ME; Rabaglietti, E				Magistro, Daniele; Candela, Filippo; Brustio, Paolo Riccardo; Liubicich, Monica Emma; Rabaglietti, Emanuela			A Longitudinal Study on the Relationship Between Aerobic Endurance and Lower Body Strength in Italian Sedentary Older Adults	JOURNAL OF AGING AND PHYSICAL ACTIVITY			English	Article						older adults; longitudinal study; cross lag	AGE-RELATED DIFFERENCES; MUSCLE STRENGTH; ELDERLY-PEOPLE; PHYSICAL PERFORMANCE; GAIT SPEED; STAND TEST; POWER; FITNESS; MEN; DISABILITY	Functional aging processes are characterized by a loss of performance capabilities for most physiological systems, such as aerobic endurance and lower body strength, which are important for independent living and active aging. The present study examines the direction of influence between aerobic endurance and lower body strength over time in Italian sedentary older adults. A three-wave longitudinal model was tested using cross-lagged analysis for 202 individuals aged over 65 years (mean = 73.92, SD = 5.84; 140 females). Analysis revealed that aerobic endurance and lower body strength decline over time. In addition, greater aerobic endurance positively affected lower body strength over time; however, the converse was true only during the first period (first 6 months). These findings emphasize the importance of these relationships for the design and implementation of effective physical intervention for older adults.	[Magistro, Daniele] Tohoku Univ, Dept Funct Brain Imaging, IDAC, Sendai, Miyagi 980, Japan; [Magistro, Daniele; Candela, Filippo; Brustio, Paolo Riccardo; Rabaglietti, Emanuela] Univ Turin, Dept Psychol, I-10124 Turin, Italy; [Liubicich, Monica Emma] Univ Turin, Univ Sch Motor & Sport Sci, Motor Sci Res Ctr, I-10124 Turin, Italy	Magistro, D (reprint author), Tohoku Univ, Dept Funct Brain Imaging, IDAC, Sendai, Miyagi 980, Japan.	daniele.magistro@unito.it		Magistro, Daniele/0000-0002-2554-3701; , Emanuela/0000-0002-5286-3743	Regione Piemonte, Direzione e Innovazione Ricerca e Universita, Bando Scienze Umane e Sociali [59]	Research presented in this article has been supported by Regione Piemonte, Direzione e Innovazione Ricerca e Universita, Bando Scienze Umane e Sociali 2008 (ID 59), for their contribution to ACT ON AGEING study. The authors would like to express their thanks to the JSPS Postdoctoral Fellowship Programme for Foreigner Researchers FY2012.	Hollman JH, 2007, GAIT POSTURE, V26, P113, DOI 10.1016/j.gaitpost.2006.08.005; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037//1082-989X.3.4.424; Voelcker-Rehage C, 2005, EXP BRAIN RES, V166, P61, DOI 10.1007/s00221-005-2342-6; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cadore EL, 2011, J STRENGTH COND RES, V25, P997, DOI 10.1519/JSC.0b013e3181d650ba; Olsson UH, 2000, STRUCT EQU MODELING, V7, P557, DOI 10.1207/S15328007SEM0704_3; Judge JO, 2003, AM J PREV MED, V25, P150, DOI 10.1016/S0749-3797(03)00178-8; Macaluso A, 2004, EUR J APPL PHYSIOL, V91, P450, DOI 10.1007/s00421-003-0991-3; HAYS RD, 1994, J CONSULT CLIN PSYCH, V62, P441, DOI 10.1037//0022-006X.62.3.441; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; McLaren L, 2005, J EPIDEMIOL COMMUN H, V59, P6, DOI 10.1136/jech.2003.018044; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Shea CH, 2006, PHYS THER, V86, P478; Burkholder GJ, 2003, STRUCT EQU MODELING, V10, P465, DOI 10.1207/S15328007SEM1003_8; Nader GA, 2006, MED SCI SPORT EXER, V38, P1965, DOI 10.1249/01.mss.0000233795.39282.33; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Magistro D, 2014, GERONTOLOGIST, V54, P611, DOI 10.1093/geront/gnt039; Daley MJ, 2000, SPORTS MED, V29, P1, DOI 10.2165/00007256-200029010-00001; Hunter GR, 2004, SPORTS MED, V34, P329, DOI 10.2165/00007256-200434050-00005; Hicks GE, 2012, J GERONTOL A-BIOL, V67, P66, DOI 10.1093/gerona/glr055; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Sayers SP, 2007, J STRENGTH COND RES, V21, P518; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Katzel LI, 2001, J AM GERIATR SOC, V49, P1657, DOI 10.1046/j.1532-5415.2001.t01-1-49276.x; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Jackson AS, 2009, ARCH INTERN MED, V169, P1781, DOI 10.1001/archinternmed.2009.312; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Hollenberg M, 2006, J GERONTOL A-BIOL, V61, P851; Leon DA, 2011, INT J EPIDEMIOL, V40, P271, DOI 10.1093/ije/dyr061; Hakkinen K, 2000, EUR J APPL PHYSIOL, V83, P51, DOI 10.1007/s004210000248; Latham NK, 2004, J GERONTOL A-BIOL, V59, P48; Hawkins SA, 2003, SPORTS MED, V33, P877, DOI 10.2165/00007256-200333120-00002; Onatsu-Arvilommi T, 2000, J EDUC PSYCHOL, V92, P478, DOI 10.1037/0022-0663.92.3.478; Rantanen T, 2003, SCAND J MED SCI SPOR, V13, P3, DOI 10.1034/j.1600-0838.2003.00298.x; Hayward MD, 2004, DEMOGRAPHY, V41, P87, DOI 10.1353/dem.2004.0005; Olshansky SJ, 2002, J GERONTOL A-BIOL, V57, pB292; Nilsson LG, 2004, AGING NEUROPSYCHOL C, V11, P134, DOI 10.1080/13825580490511026; Fleg JL, 2012, HEART FAIL REV, V17, P545, DOI 10.1007/s10741-011-9270-2; Fiser WM, 2010, J GERONTOL A-BIOL, V65, P1332, DOI 10.1093/gerona/glq137; Bohannon RW, 2007, ISOKINET EXERC SCI, V15, P77; AOYAGI Y, 1992, SPORTS MED, V14, P376, DOI 10.2165/00007256-199214060-00005; Baltes P.B., 1979, LONGITUDINAL RES STU, V1, P59; Binder EF, 1999, J GERONTOL A-BIOL, V54, pM353, DOI 10.1093/gerona/54.7.M353; Brown M. W., 1993, TESTING STRUCTURAL E; Candela F., 2015, ACTIVITIES ADAPTATIO, V39, P77, DOI [10.1080/01924788.2014.977191, DOI 10.1080/01924788.2014.977191]; Carvalho M. J., 2004, J AGING PHYS ACTIV, V55, P41; Caserotti P, 2008, EUR J APPL PHYSIOL, V103, P151, DOI 10.1007/s00421-008-0678-x; DEARY IJ, 1995, DEV PSYCHOL, V31, P237, DOI 10.1037/0012-1649.31.2.237; Fleck S, 2004, DESIGNING RESISTANCE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hughes VA, 2001, J GERONTOL A-BIOL, V56, pB209; Lovell DI, 2010, J AGING PHYS ACTIV, V18, P14; Menard S., 2002, LONGITUDINAL RES, V76; National Institute of Statistics, 2010, ANN STAT IT 2010; Orlando M, 2001, J CONSULT CLIN PSYCH, V69, P959, DOI 10.1037//0022-006X.69.6.959; Protas EJ, 2009, J AGING PHYS ACTIV, V17, P257; Rikli RE, 2013, GERONTOLOGIST, V53, P255, DOI 10.1093/geront/gns071; Rikli RE, 2013, SENIOR FITNESS TEST; Rutter M.E., 1988, STUDIES PSYCHOSOCIAL; Thomas J, 2011, RES METHODS PHYS ACT; TOTH MJ, 1994, J APPL PHYSIOL, V77, P647; Wallerstein LF, 2012, J AGING PHYS ACTIV, V20, P171; Weineck J., 2007, OPTIMAL TRAINING; World Health Organization, 2002, ACT AG POL FRAM; World Health Organization, 2010, GLOB REC PHYS ACT HL; Zatsiorsky V.M., 2008, STRENGTH POWER SPORT, V2nd	70	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1063-8652	1543-267X		J AGING PHYS ACTIV	J. Aging Phys. Act.	JUL	2015	23	3					444	451		10.1123/japa.2013-0215		8	Geriatrics & Gerontology; Gerontology; Sport Sciences	Geriatrics & Gerontology; Sport Sciences	CM9GB	WOS:000358014300017		
J	Takeshima, N; Shimada, K; Islam, MM; Kanehisa, H; Ishida, Y; Brechue, WF				Takeshima, Nobuo; Shimada, Keizo; Islam, Mohammod M.; Kanehisa, Hiroaki; Ishida, Yoshie; Brechue, William F.			Progressive, Site-Specific Loss of Muscle Mass in Older, Frail Nursing Home Residents	JOURNAL OF AGING AND PHYSICAL ACTIVITY			English	Article						longitudinal study; B-mode ultrasonography; muscle thickness; sarcopenia; subcutaneous fat thickness; nursing home residents	DAILY PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; NUTRITIONAL-STATUS; ELDERLY-PEOPLE; WEIGHT-LOSS; SARCOPENIA; EXERCISE; WOMEN; ADULTS; PREVALENCE	To clarify the progression of muscle loss in nursing home residents, frail women (n = 16; age: 85 +/- 9 years; residence time: 764 days) were assessed for physical activity, caloric intake, and site-specific muscle thickness (MTH) and subcutaneous fat thickness (SFT) using B-mode ultrasound at nine anatomical sites at four intervals over one year. Height, body weight, and BMI did not change. Physical activity (246 steps/day) and nutritional intake (1,441 kcal, 60.3 g protein/day) were unaltered throughout the study. Subjects experienced a significant, progressive loss of muscle indicated by decrements in anterior upper arm (20%), posterior upper arm (25%), abdomen (20%), subscapular (33%), anterior thigh (15%), posterior thigh (22%), anterior lower leg (11%), posterior lower leg (13%), and forearm (15%) MTH. At study inception, prevalence of sarcopenia was related to muscle loss in the upper leg, while upper body muscle wasting contributed to sarcopenia later and was unrelated to physical activity, nutritional input, or duration of residence.	[Takeshima, Nobuo; Kanehisa, Hiroaki] Natl Inst Fitness & Sports Kanoya, Kanoya, Japan; [Shimada, Keizo] Suzuka Holy Crosss Welf Grp, Suzuka, Japan; [Islam, Mohammod M.] Yonaha Gen Hosp, Dept Rehabil, Kuwana, Mie, Japan; [Ishida, Yoshie] Nihon Wellness Sports Univ, Tone, Ibaragi, Japan; [Brechue, William F.] AT Still Univ Hlth Sci, Kirksville Coll Osteopath Med, Dept Physiol, Kirksville, MO USA	Takeshima, N (reprint author), Natl Inst Fitness & Sports Kanoya, Kanoya, Japan.	takeshima@nifs-k.ac.jp					Abe T, 1995, DISTRIBUTION SUBCUTA; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Sullivan DH, 2004, J GERONTOL A-BIOL, V59, P633; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Koizumi D, 2009, J PHYS ACT HEALTH, V6, P467; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755; KAWAKAMI Y, 1993, J APPL PHYSIOL, V74, P2740; Welk GJ, 2000, MED SCI SPORT EXER, V32, pS481, DOI 10.1097/00005768-200009001-00007; Reimers CD, 1998, J NEUROL SCI, V159, P60, DOI 10.1016/S0022-510X(98)00134-8; Biolo G, 2002, J CLIN ENDOCR METAB, V87, P3378, DOI 10.1210/jc.87.7.3378; Bahat G, 2010, AGING MALE, V13, P211, DOI 10.3109/13685538.2010.489130; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Cosqueric G, 2006, BRIT J NUTR, V96, P895, DOI 10.1017/BJN20061943; Landi F, 2012, J GERONTOL A-BIOL, V67, P48, DOI 10.1093/gerona/glr035; Bauer JM, 2008, J AM MED DIR ASSOC, V9, P545, DOI 10.1016/j.jamda.2008.04.010; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Abe T, 2011, J GERIATR PHYS THER, V34, P168, DOI 10.1519/JPT.0b013e31821c9294; Miyatani M, 2004, EUR J APPL PHYSIOL, V91, P264, DOI 10.1007/s00421-003-0974-4; Sanada K, 2006, EUR J APPL PHYSIOL, V96, P24, DOI 10.1007/s00421-005-0061-0; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; RYAN C, 1995, SOUTHERN MED J, V88, P721; Balagopal P, 2001, AM J PHYSIOL-ENDOC M, V280, pE203; Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI [10.1016/S1470-2045(08)70153-0, 10.1016/51470-2045(08)70153-0]; Thomas DR, 2007, CLIN NUTR, V26, P389, DOI 10.1016/j.clnu.2007.03.008; Song MY, 2004, AM J CLIN NUTR, V79, P874; Bloomfield SA, 1997, MED SCI SPORT EXER, V29, P197, DOI 10.1097/00005768-199702000-00006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; ISHIDA Y, 1995, MED SCI SPORT EXER, V27, P270; Japanese Ministry of Health Labor and Welfare, 2010, STAND FOOD INT; Japanese Ministry of Health Labor and Welfare, 2000, PHYS ACT EX REP HLTH; Meuleman JR, 2000, ARCH PHYS MED REHAB, V81, P312, DOI 10.1053/apmr.2000.0810312; Miyatani M, 2003, INT J SPORTS HLTH SC, V1, P34, DOI 10.5432/ijshs.1.34; MURDEN RA, 1994, J GEN INTERN MED, V9, P648, DOI 10.1007/BF02600311; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; SHAVER HJ, 1980, JPEN-PARENTER ENTER, V4, P367, DOI 10.1177/0148607180004004367; Tajima O., 2004, GERIATR GERONTOL INT, V4, P93, DOI [10.1111/j.1447-0594.2004.00128.x, DOI 10.1111/J.1447-0594.2004.00128.X]; Tudor-Locke C, 2002, RES Q EXERCISE SPORT, V73, P350; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-79; Y atano, 1993, INT COUNCIL HLTH PHY, V29, P4	43	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1063-8652	1543-267X		J AGING PHYS ACTIV	J. Aging Phys. Act.	JUL	2015	23	3					452	459		10.1123/japa.2014-0055		8	Geriatrics & Gerontology; Gerontology; Sport Sciences	Geriatrics & Gerontology; Sport Sciences	CM9GB	WOS:000358014300018		
J	Zhao, HK; Yoshida, R; Raga, GB				Zhao, Haikun; Yoshida, Ryuji; Raga, G. B.			Impact of the Madden-Julian Oscillation on Western North Pacific Tropical Cyclogenesis Associated with Large-Scale Patterns	JOURNAL OF APPLIED METEOROLOGY AND CLIMATOLOGY			English	Article							SUMMER INTRASEASONAL OSCILLATIONS; WAVE ENERGY DISPERSION; ROSSBY-GRAVITY WAVES; GULF-OF-MEXICO; CYCLONE ACTIVITY; BOREAL SUMMER; PART I; VERTICAL SHEAR; INTERDECADAL VARIABILITY; RAPID INTENSIFICATION	The intraseasonal variability of tropical cyclogenesis in the western North Pacific (WNP) basin is explored in this study. The relation of cyclogenesis in each of the five large-scale patterns identified in recent work by Yoshida and Ishikawa is associated with the Madden-Julian oscillation (MJO). Confirming previous results, more events of cyclogenesis are found during the active MJO phase in the WNP. Furthermore, results indicate that most of the tropical cyclogenesis is associated with the monsoon shear line large-scale pattern during the active phase. The genesis potential index (GPI) and its individual components are used to evaluate the environmental factors that most contribute toward cyclogenesis under the different phases of the MJO. GPI exhibits a large positive anomaly during the active phase of the MJO, and such an anomaly is spatially correlated with the events of cyclogenesis. The analysis of each factor indicates that low-level relative vorticity and midlevel relative humidity are the two dominant contributors to the MJO-composited GPI anomalies. The positive GPI anomalies during the active phase are partially offset by the negative contributions from vertical wind shear and potential intensity. This is valid for all five large-scale patterns. It is noteworthy that the easterly wave (EW) large-scale pattern, while exhibiting the same influence of relative vorticity and midlevel humidity contributing toward positive GPI anomalies, presents slightly more cyclogenesis events under the inactive phase of the MJO. This unexpected result suggests that other factors not included in the definition of the GPI and/or changes in environmental flows on other time scales contribute to the tropical cyclogenesis associated with the EW large-scale pattern.	[Zhao, Haikun] Nanjing Univ Informat Sci & Technol, Pacific Typhoon Res Ctr, Key Lab Meteorol Disaster, Minist Educ, Nanjing 210044, Peoples R China; [Yoshida, Ryuji] RIKEN Adv Inst Computat Sci, Kobe, Hyogo, Japan; [Raga, G. B.] Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Mexico City, DF, Mexico	Zhao, HK (reprint author), Nanjing Univ Informat Sci & Technol, Pacific Typhoon Res Ctr, Key Lab Meteorol Disaster, Minist Educ, Nanjing 210044, Peoples R China.	zhk2004y@gmail.com			National Natural Science Foundation of China [41305050, 41275093, 41475091]; National Basic Research Program of China [2013CB430103, 2015CB452803]; project of the specially appointed professorship of Jiangsu Province; foundation of the Jiangsu Government Scholarship for overseas studies; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Inter-American Institute for Global Change Research (IAI) - U.S. National Science Foundation [CRNII-048, GEO-0452325]	The authors are grateful to Dr. David A. R. Kristovich and two anonymous reviewers for their helpful and critical comments. This study was jointly supported by the National Natural Science Foundation of China (41305050, 41275093, and 41475091), the National Basic Research Program of China (2013CB430103 and 2015CB452803), the project of the specially appointed professorship of Jiangsu Province, the foundation of the Jiangsu Government Scholarship for overseas studies, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). GBR acknowledges the support of the Inter-American Institute for Global Change Research (IAI; Grant CRNII-048), which is supported by the U.S. National Science Foundation (Grant GEO-0452325). This study is Earth System Modeling Center Contribution Number 044.	Liu KS, 2008, J CLIMATE, V21, P4464, DOI 10.1175/2008JCLI2207.1; Hsu PC, 2014, J CLIMATE, V27, P4296, DOI 10.1175/JCLI-D-13-00417.1; Ritchie EA, 1999, MON WEATHER REV, V127, P2027, DOI 10.1175/1520-0493(1999)127<2027:LSPAWT>2.0.CO;2; Wang B, 2002, J CLIMATE, V15, P1643, DOI 10.1175/1520-0442(2002)015<1643:HSEEAT>2.0.CO;2; Li RCY, 2013, J CLIMATE, V26, P2919, DOI 10.1175/JCLI-D-12-00211.1; Aiyyer A, 2008, J ATMOS SCI, V65, P2691, DOI 10.1175/2007JAS2348.1; Kaplan J, 2010, WEATHER FORECAST, V25, P220, DOI 10.1175/2009WAF2222280.1; LIEBMANN B, 1994, J METEOROL SOC JPN, V72, P401; Yoshida R, 2013, MON WEATHER REV, V141, P451, DOI 10.1175/MWR-D-11-00309.1; MCBRIDE JL, 1981, J ATMOS SCI, V38, P1132, DOI 10.1175/1520-0469(1981)038<1132:OAOTCF>2.0.CO;2; Hall JD, 2001, MON WEATHER REV, V129, P2970, DOI 10.1175/1520-0493(2001)129<2970:TMOTCA>2.0.CO;2; Li T, 2006, J ATMOS SCI, V63, P1377, DOI 10.1175/JAS3692.1; Goldenberg SB, 1996, J CLIMATE, V9, P1169, DOI 10.1175/1520-0442(1996)009<1169:PMFTAO>2.0.CO;2; RAYMOND DJ, 1990, J ATMOS SCI, V47, P3067, DOI 10.1175/1520-0469(1990)047<3067:ATFLLM>2.0.CO;2; Ho CH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007289; Frank WM, 2006, MON WEATHER REV, V134, P2397, DOI 10.1175/MWR3204.1; Wang B, 2008, METEOROL ATMOS PHYS, V99, P1, DOI 10.1007/s00703-006-0238-z; Zhao HK, 2014, ADV ATMOS SCI, V31, P57, DOI 10.1007/s00376-013-3011-5; McDonald NR, 1998, J FLUID MECH, V361, P237, DOI 10.1017/S0022112098008696; GUINN TA, 1993, J ATMOS SCI, V50, P3380, DOI 10.1175/1520-0469(1993)050<3380:HSB>2.0.CO;2; Hsu PC, 2011, J CLIMATE, V24, P942, DOI 10.1175/2010JCLI3834.1; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Jones SC, 2000, Q J ROY METEOR SOC, V126, P3161, DOI 10.1002/qj.49712657009; Li T, 2006, J ATMOS SCI, V63, P1390, DOI 10.1175/JAS3693.1; Liu KS, 2013, J CLIMATE, V26, P2614, DOI 10.1175/JCLI-D-12-00053.1; Chen SS, 1996, J ATMOS SCI, V53, P1380, DOI 10.1175/1520-0469(1996)053<1380:MVODCI>2.0.CO;2; Chen TC, 2008, MON WEATHER REV, V136, P4527, DOI 10.1175/2008MWR2149.1; Lee JY, 2013, CLIM DYNAM, V40, P493, DOI 10.1007/s00382-012-1544-4; Huang P, 2011, J CLIMATE, V24, P6339, DOI 10.1175/2011JCLI4200.1; Li RCY, 2013, J CLIMATE, V26, P2904, DOI 10.1175/JCLI-D-12-00210.1; HOLLAND GJ, 1995, METEOROL ATMOS PHYS, V56, P57, DOI 10.1007/BF01022521; Camargo SJ, 2009, J ATMOS SCI, V66, P3061, DOI 10.1175/2009JAS3101.1; Maloney ED, 2000, SCIENCE, V287, P2002, DOI 10.1126/science.287.5460.2002; WEARE BC, 1982, MON WEATHER REV, V110, P481, DOI 10.1175/1520-0493(1982)110<0481:EOEEOF>2.0.CO;2; Jiang XA, 2012, J CLIMATE, V25, P6524, DOI 10.1175/JCLI-D-11-00531.1; Kim JH, 2008, J CLIMATE, V21, P1171, DOI 10.1175/2007JCLI1493.1; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Maloney ED, 2000, J CLIMATE, V13, P1451, DOI 10.1175/1520-0442(2000)013<1451:MOENPH>2.0.CO;2; Zhou CH, 2010, J CLIMATE, V23, P5738, DOI 10.1175/2010JCLI3468.1; Dickinson M, 2002, J ATMOS SCI, V59, P2183, DOI 10.1175/1520-0469(2002)059<2183:MRGWAW>2.0.CO;2; Klotzbach PJ, 2010, J CLIMATE, V23, P282, DOI 10.1175/2009JCLI2978.1; Chan JCL, 2008, P ROY SOC A-MATH PHY, V464, P249, DOI 10.1098/rspa.2007.0183; HETA Y, 1991, J METEOROL SOC JPN, V69, P337; DeMaria M, 1996, J ATMOS SCI, V53, P2076, DOI 10.1175/1520-0469(1996)053<2076:TEOVSO>2.0.CO;2; Bessafi M, 2006, MON WEATHER REV, V134, P638, DOI 10.1175/MWR3087.1; HETA Y, 1990, J METEOROL SOC JPN, V68, P65; Wheeler MC, 2004, MON WEATHER REV, V132, P1917, DOI 10.1175/1520-0493(2004)132<1917:AARMMI>2.0.CO;2; Maloney ED, 2008, J CLIMATE, V21, P2898, DOI 10.1175/2007JCLI1999.1; MADDEN RA, 1971, J ATMOS SCI, V28, P702, DOI 10.1175/1520-0469(1971)028<0702:DOADOI>2.0.CO;2; Aiyyer AR, 2003, J ATMOS SCI, V60, P2837, DOI 10.1175/1520-0469(2003)060<2837:EOMRWI>2.0.CO;2; Hsu PC, 2011, J CLIMATE, V24, P927, DOI 10.1175/2010JCLI3833.1; Chen GTJ, 2006, MON WEATHER REV, V134, P874, DOI 10.1175/MWR3099.1; Bister M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000776; Emanuel K. A., 2004, 26 C HURR TROP MET M, V10A, P2; Ferreira RN, 1999, J ATMOS SCI, V56, P2891, DOI 10.1175/1520-0469(1999)056<2891:TROTCI>2.0.CO;2; GRAY WM, 1968, MON WEATHER REV, V96, P669, DOI 10.1175/1520-0493(1968)096<0669:GVOTOO>2.0.CO;2; Gray WM, 1979, METEOROLOGY TROPICAL, P155; Hsu HH, 2004, J CLIMATE, V17, P727, DOI 10.1175/1520-0442(2004)017<0727:CCBTNA>2.0.CO;2; Jiang XN, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036820; Jones SC, 2000, Q J ROY METEOR SOC, V126, P3137, DOI 10.1256/smsqj.57007; Kikuchi K, 2010, J METEOROL SOC JPN, V88, P475, DOI 10.2151/jmsj.2010-313; LANDER MA, 1994, WEATHER FORECAST, V9, P640, DOI 10.1175/1520-0434(1994)009<0640:DOAMGA>2.0.CO;2; LAU KH, 1990, MON WEATHER REV, V118, P1888, DOI 10.1175/1520-0493(1990)118<1888:OSAPCO>2.0.CO;2; Maue RN, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047711; SHAPIRO LJ, 1977, J ATMOS SCI, V34, P1007, DOI 10.1175/1520-0469(1977)034<1007:TSFFEW>2.0.CO;2; Sprent P., 1989, APPL NONPARAMETRIC S; [王磊 WANG Lei], 2009, [大气科学, Chinese Journal of Atmospheric Sciences], V33, P416; Yanai M., 1968, J METEOR SOC JAPAN, V46, P85; Yanai M., 1961, J METEOR SOC JAPAN, V39, P187; Yasunari T., 1979, J METEOR SOC JAPAN, V57, P227; Yoshida R, 2014, SOLA, V10, P15, DOI 10.2151/sola.2014-004; Zehr R., 1992, 61 NOAA NESDIS, V61; Zhao HK, 2015, J METEOROL SOC JPN, V93, P81, DOI 10.2151/jmsj.2015-006	73	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	1558-8424	1558-8432		J APPL METEOROL CLIM	J. Appl. Meteorol. Climatol.	JUL	2015	54	7					1413	1429		10.1175/JAMC-D-14-0254.1		17	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CM9AT	WOS:000357998100003		
J	Yoshida, R; Onodera, Y; Tojo, T; Yamazaki, T; Kanno, H; Takayabu, I; Suzuki-Parker, A				Yoshida, Ryuhei; Onodera, Yumi; Tojo, Takamasa; Yamazaki, Takeshi; Kanno, Hiromitsu; Takayabu, Izuru; Suzuki-Parker, Asuka			An Application of a Physical Vegetation Model to Estimate Climate Change Impacts on Rice Leaf Wetness	JOURNAL OF APPLIED METEOROLOGY AND CLIMATOLOGY			English	Article							ESTIMATING DEW DURATION; LAND-SURFACE MODEL; EASTERN SIBERIA; PLANT-DISEASES; BLAST DISEASE; TEMPERATURE; SIMULATION; WATER; INTERCEPTION; RESISTANCE	A physical vegetation model [the Two-Layer Model (2LM)] was applied to estimate the climate change impacts on rice leaf wetness (LW) as a potential indicator of rice blast occurrence. Japan was used as an example. Dynamically downscaled data at 20-km-mesh resolution from three global climate models (CCSM4, MIROC5, and MRI-CGCM3) were utilized for present (1981-2000) and future (2081-2100) climates under the representative concentration pathway 4.5 scenario. To evaluate the performance of the 2LM, the LW and other meteorological variables were observed for 108 days during the summer of 2013 at three sites on the Pacific Ocean side of Japan. The derived correct estimation rate was 77.4%, which is similar to that observed in previous studies. Using the downscaled dataset, the changes in several precipitation indices were calculated. The regionally averaged ensemble mean precipitation increased by 6%, although large intermodel differences were found. By defining a wet day as any day in which the daily precipitation was >= 1 mm day(-1), it was found that the precipitation frequency decreased by 6% and the precipitation intensity increased by 11% for the entire area. The leaf surface environment was estimated to be dry; leaf wetness, wet frequency, and wet times all decreased. It was found that a decrease in water trap opportunities due to reduced precipitation frequency was the primary contributor to the LW decrease. For blast fungus, an increased precipitation intensity was expected to enhance the washout effect on the leaf surface. In the present case, the infection risk was estimated to decrease for Japan.	[Yoshida, Ryuhei; Onodera, Yumi; Tojo, Takamasa; Yamazaki, Takeshi] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi 980, Japan; [Kanno, Hiromitsu] Natl Agr & Food Res Org, Tsukuba, Ibaraki, Japan; [Takayabu, Izuru] Meteorol Res Inst, Tsukuba, Ibaraki 305, Japan; [Suzuki-Parker, Asuka] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan	Yoshida, R (reprint author), Fukushima Univ, Fac Symbiot Syst Sci, 1 Kanayagawa, Fukushima 9601296, Japan.	yoshida@sss.fukushima-u.ac.jp			JSPS KAKENHI [24540467, 25892004, 26350412]; Asahi Group Foundation; Research Program on Climate Change Adaptation (RECCA); Program for Risk Information on Climate Change (SOUSEI) - Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Risk Information on Climate Change (SOUSEI) - Cross-ministerial Strategic Innovation Promotion Program of the Cabinet Office, Government of Japan	This study was supported by JSPS KAKENHI (Grants 24540467, 25892004, and 26350412), Asahi Group Foundation, the Research Program on Climate Change Adaptation (RECCA) and the Program for Risk Information on Climate Change (SOUSEI) funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Cross-ministerial Strategic Innovation Promotion Program of the Cabinet Office, Government of Japan. We thank Mr. Hiroei Kanno, Dr. Sayuri Okubo, Dr. Shota Ishii, Mr. Sho Ikeda, and the staffs of the Kashimadai Experimental Farm Station of the Institute of Genetic Ecology and Tohoku University Kawatabi Field Center for their operational support; Dr. Toshinori Aoyagi supported the data operation for the climate change scenario. Some of the experimentally obtained data in this research were obtained using the supercomputing resources of the Cyberscience Center at Tohoku University. Our thanks are extended to the editor and three anonymous reviewers for their many informative and invaluable comments.	Valente F, 1997, J HYDROL, V190, P141, DOI 10.1016/S0022-1694(96)03066-1; Kobayashi T, 2006, PHYTOPATHOLOGY, V96, P425, DOI 10.1094/PHYTO-96-0425; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; BONMAN JM, 1992, EUPHYTICA, V63, P115, DOI 10.1007/BF00023917; Nakanishi M, 2004, BOUND-LAY METEOROL, V112, P1, DOI 10.1023/B:BOUN.0000020164.04146.98; Yukimoto S, 2012, J METEOROL SOC JPN, V90A, P23, DOI 10.2151/jmsj.2012-A02; GARRATT JR, 1988, BOUND-LAY METEOROL, V45, P209, DOI 10.1007/BF01066671; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; Kim KS, 2002, PLANT DIS, V86, P179, DOI 10.1094/PDIS.2002.86.2.179; Luo Y, 1998, AGR ECOSYST ENVIRON, V68, P187, DOI 10.1016/S0167-8809(97)00082-0; MONTEITH JL, 1981, Q J ROY METEOR SOC, V107, P1, DOI 10.1256/smsqj.45101; PEDRO MJ, 1982, AGR METEOROL, V25, P297; Buser CM, 2009, CLIM DYNAM, V33, P849, DOI 10.1007/s00382-009-0588-6; Lee JY, 2014, CLIM DYNAM, V42, P101, DOI 10.1007/s00382-012-1564-0; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Ghini R, 2012, TROP PLANT PATHOL, V37, P5, DOI 10.1590/S1982-56762012000100002; Zhu YY, 2005, PHYTOPATHOLOGY, V95, P433, DOI 10.1094/PHYTO-95-0433; Kain JS, 2004, J APPL METEOROL, V43, P170, DOI 10.1175/1520-0450(2004)043<0170:TKCPAU>2.0.CO;2; Bregaglio S, 2013, AGRON SUSTAIN DEV, V33, P767, DOI 10.1007/s13593-013-0149-6; Yoshida R, 2012, J METEOROL SOC JPN, V90B, P75, DOI 10.2151/jmsj.2012-B06; Bregaglio S, 2011, AGR FOREST METEOROL, V151, P1163, DOI 10.1016/j.agrformet.2011.04.003; Chen C, 2014, J INTEGR AGR, V13, P1555, DOI 10.1016/S2095-3119(14)60816-9; Ogata T, 2014, J METEOROL SOC JPN, V92, P207, DOI 10.2151/jmsj.2014-302; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; PEDRO MJ, 1982, AGR METEOROL, V25, P283; Kawase H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011803; Greer CA, 2001, PLANT DIS, V85, P1096, DOI 10.1094/PDIS.2001.85.10.1096; Challinor AJ, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034012; Dunne T., 1978, WATER ENV PLANNING; Earth System Grid Federation, 2014, ESGF PORT PROGR CLIM; GASH JHC, 1995, J HYDROL, V170, P79, DOI 10.1016/0022-1694(95)02697-N; Gautam HR, 2013, CURR SCI INDIA, V105, P1685; Hayashi T., 1988, B TOHOKU NAT AGR EXP, V78, P123; Iizumi Toshichika, 2010, Journal of Agricultural Meteorology, V66, P131, DOI 10.2480/agrmet.66.2.5; Iizumi T, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017197; Ishizaki NN, 2012, J METEOROL SOC JPN, V90, P235, DOI 10.2151/jmsj.2012-206; Kerkhoff C, 2014, J CLIMATE, V27, P6799, DOI 10.1175/JCLI-D-13-00716.1; Kim KS, 2006, PLANT DIS, V90, P650, DOI 10.1094/PD-90-0650; Kondo J., 1992, TENKI, V39, P159; Koshimizu Y., 1988, B TOHOKU NATL AGR EX, V78, P67; Launay M, 2014, AGR ECOSYST ENVIRON, V197, P147, DOI 10.1016/j.agee.2014.07.020; Luo WH, 1999, AGR FOREST METEOROL, V97, P33, DOI 10.1016/S0168-1923(99)00046-5; Magarey RD, 2006, AGR FOREST METEOROL, V139, P373, DOI 10.1016/j.agrformet.2006.08.016; Mashonjowa E, 2013, COMPUT ELECTRON AGR, V95, P70, DOI 10.1016/j.compag.2013.04.007; Ministry of Agriculture Forestry and Fisheries, 2014, CROP STAT; Mizuta R, 2014, SOLA, V10, P167, DOI 10.2151/sola.2014-035; Oh'izumi M., 2013, Journal of the Meteorological Society of Japan, V91, P229, DOI 10.2151/jmsj.2013-209; Solomon S., 2007, CLIMATE CHANGE, P235, DOI DOI 10.1038/NCLIMATE1258; Suzuki-Parker A., 2014, P 21 CENT CHALL REG, P374; Kruit RJW, 2008, ATMOS ENVIRON, V42, P5304, DOI 10.1016/j.atmosenv.2008.02.061; Yamazaki T, 2004, J HYDROMETEOROL, V5, P504, DOI 10.1175/1525-7541(2004)005<0504:WAEEAF>2.0.CO;2; Yamazaki T, 2007, HYDROL PROCESS, V21, P2009, DOI 10.1002/hyp.6708; YAMAZAKI T, 1992, J APPL METEOROL, V31, P86, DOI 10.1175/1520-0450(1992)031<0086:AHBMWA>2.0.CO;2; Yamazaki T, 2001, J METEOROL SOC JPN, V79, P1107, DOI 10.2151/jmsj.79.1107; YOSHIDA R, 2011, TENKI, V58, P599	55	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	1558-8424	1558-8432		J APPL METEOROL CLIM	J. Appl. Meteorol. Climatol.	JUL	2015	54	7					1482	1495		10.1175/JAMC-D-14-0219.1		14	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CM9AT	WOS:000357998100007		
J	Kikuchi, DM; Watanuki, Y; Sato, N; Hoshina, K; Takahashi, A; Watanabe, YY				Kikuchi, Dale M.; Watanuki, Yutaka; Sato, Nobuhiko; Hoshina, Kenji; Takahashi, Akinori; Watanabe, Yuuki Y.			Strouhal number for flying and swimming in rhinoceros auklets Cerorhinca monocerata	JOURNAL OF AVIAN BIOLOGY			English	Article							HIGH PROPULSIVE EFFICIENCY; WING-PROPELLED DIVERS; OSCILLATING FOILS; STROKE PATTERNS; FLIGHT; FREQUENCY; BIRDS; SPEED; ADAPTATIONS; GUILLEMOTS	Alcids propel themselves by flapping wings in air and water that have vastly different densities. We hypothesized that alcids change wing kinematics and maintain Strouhal numbers (St = fA/U, where f is wingbeat frequency, A is the wingbeat amplitude, and U is forward speed) within a certain range, to achieve efficient locomotion during both flying and swimming. We used acceleration and GPS loggers to measure the wingbeat frequency and forward speed of free-ranging rhinoceros auklets Cerorhinca monocerata during both flying and swimming. We also measured wingbeat amplitude from video footage taken in the wild. On average, wingbeat frequency, forward speed, and wingbeat amplitude were 8.9 Hz, 15.3 m s(-1), and 0.39 m, respectively, during flying, and 2.6 Hz, 1.3 m s(-1), and 0.18 m, respectively, during swimming. The smaller wingbeat amplitude during swimming was achieved by partially folding the wings, while maintaining the dorso-ventral wingbeat angle. Mean St was 0.23 during flying and 0.36 during swimming. The higher St value for swimming might be related to the higher thrust force required for propulsion in water. Our results suggest that rhinoceros auklets maintain St for both flying and swimming within the range (0.2-0.4) that propulsive efficiency is known to be high and St in both flying specialists and swimming specialists are known to converge.	[Kikuchi, Dale M.; Sato, Nobuhiko; Takahashi, Akinori; Watanabe, Yuuki Y.] SOKENDAI Grad Univ Adv Studies, Dept Polar Sci, JP-1908518 Tokyo, Japan; [Takahashi, Akinori; Watanabe, Yuuki Y.] Natl Inst Polar Res, JP-1908518 Tokyo, Japan; [Watanuki, Yutaka; Hoshina, Kenji] Hokkaido Univ, Grad Sch Fisheries Sci, JP-0418611 Sapporo, Hokkaido, Japan	Kikuchi, DM (reprint author), SOKENDAI Grad Univ Adv Studies, Dept Polar Sci, JP-1908518 Tokyo, Japan.	dale.kikuchi@nipr.ac.jp			JSPS [20241001, 26-5363]	We would like to thank Yuuya Suzuki and Kenta Uchida for their support during field work. We are grateful to Kozue Shiomi, Jean-Baptiste Thiebot, Nicholas Payne, Motohiro Ito and Taiki Adachi for helpful comments and discussion on the draft. We are also grateful to Kyle Elliott his constructive comments that improved the manuscript. This study was supported partly by a JSPS Grant-in-Aid for Scientific Research (20241001) and a JSPS Research Fellowship for Young Scientists (26-5363).	Alexander R M, 2003, PRINCIPLES ANIMAL LO; Rohr JJ, 2004, J EXP BIOL, V207, P1633, DOI 10.1242/jeb.00948; Triantafyllou MS, 2000, ANNU REV FLUID MECH, V32, P33, DOI 10.1146/annurev.fluid.32.1.33; Watanuki Y, 2006, J EXP BIOL, V209, P1217, DOI 10.1242/jeb.02128; Taylor GK, 2003, NATURE, V425, P707, DOI 10.1038/nature02000; LOVVORN JR, 1994, ESTUARIES, V17, P62, DOI 10.2307/1352335; Watanabe YY, 2011, J EXP BIOL, V214, P412, DOI 10.1242/jeb.050161; Sato K, 2007, P R SOC B, V274, P471, DOI 10.1098/rspb.2006.0005; Aoki K, 2011, J EXP BIOL, V214, P2973, DOI 10.1242/jeb.055137; Wang ZJ, 2000, J FLUID MECH, V410, P323, DOI 10.1017/S0022112099008071; BANNASCH R, 1994, J EXP BIOL, V194, P83; Anderson JM, 1998, J FLUID MECH, V360, P41, DOI 10.1017/S0022112097008392; Elliott KH, 2013, P NATL ACAD SCI USA, V110, P9380, DOI 10.1073/pnas.1304838110; Zavalaga CB, 2010, MAR ECOL PROG SER, V404, P259, DOI 10.3354/meps08490; Watanuki Y, 2003, P ROY SOC B-BIOL SCI, V270, P483, DOI 10.1098/rspb.2002.2252; Norberg Ulla M., 1996, P199; Gaston AJ, 2004, SEABIRDS NATURAL HIS; Hedenstrom A, 2004, TRENDS ECOL EVOL, V19, P217, DOI 10.1016/j.tree.2004.02.005; Johansson LC, 2002, J EXP BIOL, V205, P371; Kodansha, 2011, PICTORIAL ENCY BIRDS; Lieber RL, 1997, ACTA ANAT, V159, P84; Lovvorn JR, 2004, J EXP BIOL, V207, P4679, DOI 10.1242/jeb.01331; Nudds RL, 2004, P ROY SOC B-BIOL SCI, V271, P2071, DOI 10.1098/rspb.2004.2838; Osa Y., 1994, THESIS TOKYO FISHERI; Pennycuick CJ, 2012, J ORNITHOL, V153, P633, DOI 10.1007/s10336-011-0781-3; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Rassier DE, 1999, J APPL PHYSIOL, V86, P1445; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Shiomi K, 2012, ANIM BEHAV, V83, P355, DOI 10.1016/j.anbehav.2011.11.010; SPRING L, 1971, CONDOR, V73, P1, DOI 10.2307/1366120; Taylor GK, 2014, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780198566373.001.0001; Thaxter CB, 2010, J EXP BIOL, V213, P1018, DOI 10.1242/jeb.037390; TRIANTAFYLLOU MS, 1991, PHYS FLUIDS A-FLUID, V3, P2835, DOI 10.1063/1.858173; Vogel S., 1994, LIFE MOVING FLUIDS P; Watanuki Y, 2005, J EXP BIOL, V208, P2207, DOI 10.1242/jeb.01639	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0908-8857	1600-048X		J AVIAN BIOL	J. Avian Biol.	JUL	2015	46	4					406	411		10.1111/jav.00642		6	Ornithology	Zoology	CM8KL	WOS:000357949300011		
J	Mori, S; Fukuzawa, K; Takaya, T; Takamine, S; Ito, T; Fujiwara, S; Nishii, T; Kono, AK; Yoshida, A; Hirata, KI				Mori, Shumpei; Fukuzawa, Koji; Takaya, Tomofumi; Takamine, Sachiko; Ito, Tatsuro; Fujiwara, Sei; Nishii, Tatsuya; Kono, Atsushi K.; Yoshida, Akihiro; Hirata, Ken-Ichi			Clinical Structural Anatomy of the Inferior Pyramidal Space Reconstructed Within the Cardiac Contour Using Multidetector-Row Computed Tomography	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						atrioventricular node; inferior pyramidal space; membranous septum; multidetector-row computed tomography; muscular atrioventricular sandwich	ATRIOVENTRICULAR JUNCTIONS; CATHETER ABLATION; ACCESSORY PATHWAYS; CONDUCTION SYSTEM; FREE-WALL; HEART; IMPLANTATION; NOMENCLATURE; DEFECT	Clinical Anatomy of the Inferior Pyramidal Space Although many studies have described the detailed anatomy of the inferior pyramidal space, it may not be easy for cardiologists who have few chances to study cadaveric hearts to understand the correct morphology of the structure. The inferior pyramidal space is the part of extracardiac fibro-adipose tissue wedging between the 4 cardiac chambers from the diaphragmatic surface of the heart. Many cardiologists have interests in pericardial adipose tissue, but the inferior pyramidal space seems to have been neglected. A number of important structures, including the coronary sinus, atrioventricular node, atrioventricular nodal artery, membranous septum, muscular atrioventricular sandwich (previously called the muscular atrioventricular septum), atrial septum, ventricular septum, aortic valvar complex, mitral valvar attachment, and tricuspid valvar attachment are associated with the inferior pyramidal space. We previously revealed its 3-dimensional live anatomy using multidetector-row computed tomography. Moreover, the 3-dimensional understanding of the anatomy in association with the cardiac contour is important from the viewpoints of clinical cardiac electrophysiology. The purpose of this article is to demonstrate extended findings regarding the clinical structural anatomy of the inferior pyramidal space, which was reconstructed in combination with the cardiac contour using multidetector-row computed tomography, and discuss the clinical implications of the findings.	[Mori, Shumpei; Fukuzawa, Koji; Takaya, Tomofumi; Takamine, Sachiko; Ito, Tatsuro; Fujiwara, Sei; Yoshida, Akihiro; Hirata, Ken-Ichi] Kobe Univ, Div Cardiovasc Med, Dept Internal Med, Grad Sch Med, Kobe, Hyogo 657, Japan	Mori, S (reprint author), Kobe Univ, Div Cardiovasc Med, Dept Internal Med, Grad Sch Med, Kobe, Hyogo 657, Japan.	shumpei_8@hotmail.com		Takaya, Tomofumi/0000-0001-5775-8072			Adachi M, 2009, PACE, V32, pS182, DOI 10.1111/j.1540-8159.2008.02290.x; Anderson RH, 2013, WILCOXS SURG ANATOMY, V4th, P111; Anderson RH, 2000, ANAT REC, V260, P81, DOI 10.1002/1097-0185(20000901)260:1<81::AID-AR90>3.0.CO;2-3; Sanchez-Quintana D, 2001, J CARDIOVASC ELECTR, V12, P210, DOI 10.1046/j.1540-8167.2001.00210.x; TITUS JL, 1973, CIRCULATION, V47, P170; GERBODE F, 1958, ANN SURG, V148, P433, DOI 10.1097/00000658-195809000-00012; Anderson RH, 2013, J CARDIOVASC TRANSL, V6, P118, DOI 10.1007/s12265-012-9434-z; Asirvatham SJ, 2009, J CARDIOVASC ELECTR, V20, P955, DOI 10.1111/j.1540-8167.2009.01472.x; Piazza N, 2008, CIRC-CARDIOVASC INTE, V1, P74, DOI 10.1161/CIRCINTERVENTIONS.108.780858; Anderson RH, 2003, HEART, V89, P949, DOI 10.1136/heart.89.8.949; Can I, 2009, CIRCULATION, V119, pE553, DOI 10.1161/CIRCULATIONAHA.108.838086; Kim JS, 2001, CIRC RES, V88, P395; Mazgalev TN, 2001, CIRCULATION, V103, P2660; Marshall HJ, 1999, EUROPACE, V1, P26, DOI 10.1053/eupc.1998.0004; Anderson RH, 2004, J ANAT, V205, P159, DOI 10.1111/j.0021-8782.2004.00330.x; Cosio FG, 1999, CIRCULATION, V100, pE31; DEAN JW, 1994, J AM COLL CARDIOL, V24, P1725; Ergun K, 2005, J AM SOC ECHOCARDIOG, V18, P71, DOI 10.1016/j.echo.2004.08.017; Farre J, 2010, PACE, V33, P497, DOI 10.1111/j.1540-8159.2009.02644.x; JACKMAN WM, 1989, PACE, V12, P204, DOI 10.1111/j.1540-8159.1989.tb02648.x; KUCK KH, 1992, CIRCULATION, V86, P1743; Mori S, 2014, CLIN ANAT, DOI [10.1002/ca.22483, DOI 10.1002/CA.22483]; Saremi F, 2007, RADIOGRAPHICS, V27, P1539, DOI 10.1148/rg.276075003; SCHEINMAN MM, 1992, J AM COLL CARDIOL, V20, P1220; SEALY WC, 1980, J THORAC CARDIOV SUR, V79, P542; WIDRAN J, 1951, CIRCULATION, V4, P863	26	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	JUL	2015	26	7					705	712		10.1111/jce.12687		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CM8NW	WOS:000357959900003		
J	Takigawa, M; Takahashi, A; Kuwahara, T; Okubo, K; Takahashi, Y; Nakashima, E; Watari, Y; Yamao, K; Nakajima, J; Takagi, K; Kimura, S; Hikita, H; Hirao, K; Isobe, M				Takigawa, Masateru; Takahashi, Atsushi; Kuwahara, Taishi; Okubo, Kenji; Takahashi, Yoshihide; Nakashima, Emiko; Watari, Yuji; Yamao, Kazuya; Nakajima, Jun; Takagi, Katsumasa; Kimura, Shigeki; Hikita, Hiroyuki; Hirao, Kenzo; Isobe, Mitsuaki			Impact of Non-Pulmonary Vein Foci on the Outcome of the Second Session of Catheter Ablation for Paroxysmal Atrial Fibrillation	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						atrial fibrillation; catheter ablation; focal ablation; non-pulmonary vein foci; predictor; outcome; pulmonary vein isolation; recurrence	TERM-FOLLOW-UP; SUPERIOR VENA; CAVA	Impact of Non-PV AF Foci on the Second Catheter Ablation for PAF BackgroundParoxysmal atrial fibrillation (AF) is primarily triggered by pulmonary veins (PVs). However, non-PV AF foci may also trigger AF. MethodsWe examined 207 patients (mean age, 62 11 years; 166 men) who underwent a second catheter ablation (CA) and evaluated the clinical significance of non-PV AF foci on the outcomes. ResultsElectrical reconnections between the PVs and left atrium (LA) were observed in 162 patients (78.3%). Non-PV AF foci were identified in 95 patients (45.9%, 60 patients with successfully ablated non-PV AF foci and 35 with unmappable non-PV AF foci). During a median follow-up period of 22.7 months, 61 patients (29.5%; 18/112 [16.1%] without non-PV AF foci vs. 20/60 [33.3%] with successfully ablated non-PV AF foci vs. 23/35 [65.7%] with unmappable non-PV AF foci, P < 0.0001) developed AF recurrence; 52 (85.2%) developed recurrence within 1 year. The presence of non-PV AF foci was a significant clinical predictor of AF recurrence after the second CA; successfully ablated non-PV AF foci increased the AF recurrence risk by 2.24 times (95% confidence interval [CI], 1.12-4.54; P = 0.02), and unmappable AF foci increased this risk by 5.58 times (95% CI, 2.73-11.63; P < 0.0001). ConclusionNearly half of the patients had non-PV AF foci at the second CA session. AF recurred after the second CA session in approximately 30%, with most recurrences happening within 1 year. The presence of non-PV AF foci significantly increased the AF recurrence risk after a second CA. When non-PV AF foci were unmappable, the AF recurrence rate was extremely high.	[Takigawa, Masateru; Takahashi, Atsushi; Kuwahara, Taishi; Okubo, Kenji; Takahashi, Yoshihide; Nakashima, Emiko; Watari, Yuji; Yamao, Kazuya; Nakajima, Jun; Takagi, Katsumasa; Kimura, Shigeki; Hikita, Hiroyuki] Yokosuka Kyosai Hosp, Cardiovasc Ctr, Yokosuka, Kanagawa, Japan; [Takigawa, Masateru; Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo, Japan; [Takigawa, Masateru; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan	Takigawa, M (reprint author), Kyosai Hosp, Cardiovasc Ctr, 1-16 Yonegahama St, Yokosuka, Kanagawa 2388558, Japan.	teru.takigawa@gmail.com					Shah D, 2003, PACE, V26, P1631, DOI 10.1046/j.1460-9592.2003.t01-1-00243.x; Haissaguerre M, 2000, CIRCULATION, V101, P1409; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Katritsis DG, 2011, HEART RHYTHM, V8, P672, DOI 10.1016/j.hrthm.2010.12.047; Katritsis D, 2008, EUROPACE, V10, P419, DOI 10.1093/europace/eun018; Medi C, 2011, J CARDIOVASC ELECTR, V22, P137, DOI 10.1111/j.1540-8167.2010.01885.x; Gerstenfeld ER, 2003, J CARDIOVASC ELECTR, V14, P685; Sauer WH, 2006, HEART RHYTHM, V3, P1024, DOI 10.1016/j.hrthm.2006.05.007; Jais P, 2004, CIRCULATION, V110, P2996, DOI 10.1161/01.CIR.0000146917.75041.58; Nademanee K, 2010, J CARDIOL, V55, P1, DOI 10.1016/j.jjcc.2009.11.002; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Hachiya H, 2007, J CARDIOVASC ELECTR, V18, P392, DOI 10.1111/j.1540-8167.2006.00753.x; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D; Hocini M, 2005, CIRCULATION, V112, P3688, DOI 10.1161/CIRCULATIONAHA.105.541052; Ganesan AN, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004549; Goya M, 2002, CIRCULATION, V106, P1317, DOI 10.1161/01.CIR.0000033115.92612.F4; Higuchi K, 2010, HEART RHYTHM, V7, P1186, DOI 10.1016/j.hrthm.2010.05.017; Mehall JR, 2007, ANN THORAC SURG, V83, P538, DOI 10.1016/j.athoracsur.2006.09.022; Takigawa M, 2014, CIRC-ARRHYTHMIA ELEC, V7, P267, DOI 10.1161/CIRCEP.113.000471; Winkle RA, 2011, AM HEART J, V162, P193, DOI 10.1016/j.ahj.2011.04.013	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	JUL	2015	26	7					739	746		10.1111/jce.12681		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CM8NW	WOS:000357959900009		
J	Yamashita, S; Yoshida, A; Fukuzawa, K; Nakanishi, T; Matsumoto, A; Konishi, H; Ichibori, H; Hyogo, K; Imada, H; Hirata, KI				Yamashita, Soichiro; Yoshida, Akihiro; Fukuzawa, Koji; Nakanishi, Tomoyuki; Matsumoto, Akinori; Konishi, Hiroki; Ichibori, Hirotoshi; Hyogo, Kiyohiro; Imada, Hiroshi; Hirata, Ken-Ichi			The Relationship Between Cardiac Vulnerability and Restitution Properties of the Ventricular Activation Recovery Interval	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						activation recovery interval; defibrillation; fibrillation; implantable cardioverter defibrillator; restitution; upper limit of vulnerability	ACTION-POTENTIAL DURATION; T-WAVE ALTERNANS; DEFIBRILLATION THRESHOLD; UPPER LIMIT; IMPLANTABLE DEFIBRILLATORS; FIBRILLATION INDUCTION; THERAPY; SHOCKS; ARRHYTHMIAS; MECHANISMS	Upper Limit of Vulnerability and the APD Dynamics IntroductionThe restitution of the action potential duration (APD) is an important contributor to ventricular fibrillation (VF) initiation by a single critically timed ectopic beat. We hypothesized that a steep slope of the activation recovery interval restitution curve was related to the upper limit of vulnerability (ULV). Methods and ResultsFifty-four consecutive patients with implantable cardioverter defibrillators (ICDs) implanted between April 2012 and July 2013 were included. At the implantation, pacing from the right ventricular (RV) coil to an indifferent electrode inserted in the ICD pocket was performed, and the unipolar electrograms from the RV coil were simultaneously recorded. We assessed the standard restitution by introducing extra-stimuli, while measuring the activation recovery interval (ARI). Our protocol for the vulnerability test consisted of delivering three 15 J shocks on the T-peak and within 20 milliseconds of it. If VF was not induced by that procedure, a ULV of 15 J was defined. The relationship between the ULV and maximum slope of the restitution curve was analyzed. A restitution curve could finally be obtained in a total of 40 patients. The background characteristics were similar between the two groups. The maximum slope of the restitution curve was steeper in the ULV > 15 J group than ULV 15 J group (1.55 +/- 0.45 vs. 0.91 +/- 0.64, P < 0.05). A maximum slope exceeding 1.0 was the optimal point for discriminating patients with a ULV > 15 J from a ULV 15 J (sensitivity 61.5% and specificity 96.3%). ConclusionThe maximum slope of the restitution curve was significantly related to the ULV. High defibrillation threshold patients could be detected by the ARI dynamics.	[Yamashita, Soichiro; Yoshida, Akihiro; Fukuzawa, Koji; Nakanishi, Tomoyuki; Matsumoto, Akinori; Konishi, Hiroki; Ichibori, Hirotoshi; Hyogo, Kiyohiro; Imada, Hiroshi; Hirata, Ken-Ichi] Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Dept Internal Med, Kobe, Hyogo 657, Japan	Yamashita, S (reprint author), Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Dept Internal Med, Kobe, Hyogo 657, Japan.	ayoshida@med.kobe-u.ac.jp					Bloomfield DM, 2004, CIRCULATION, V110, P1885, DOI 10.1161/01.CIR.0000143160.14610.53; Yue AM, 2005, J AM COLL CARDIOL, V46, P1067, DOI 10.1016/j.jacc.2005.05.074; Lee DS, 2003, J AM COLL CARDIOL, V41, P1573, DOI 10.1016/S0735-1097(03)00253-5; Tracy CM, 2012, CIRCULATION, V126, P1784, DOI 10.1161/CIR.0b013e3182618569; CHEN PS, 1986, CIRCULATION, V73, P1022; Narayan SM, 2007, J AM COLL CARDIOL, V50, P2385, DOI 10.1016/j.jacc.2007.10.011; Birnie D, 2008, HEART RHYTHM, V5, P387, DOI 10.1016/j.hrthm.2007.11.018; Wang NC, 2001, CIRCULATION, V104, P227; Taggart P, 2003, CIRCULATION, V107, P285, DOI 10.1161/01.CIR.0000044941.13346.74; Hohnloser SH, 2003, LANCET, V362, P125, DOI 10.1016/S0140-6736(03)13865-2; Ashihara T, 2008, CIRC RES, V102, P737, DOI 10.1161/CIRCRESAHA.107.168112; Birgersdotter-Green U, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1073, DOI 10.1161/CIRCEP.112.971275; Cohen TJ, 2000, J INVASIVE CARDIOL, V12, P121; Day JD, 2007, CIRCULATION, V115, P2382, DOI 10.1161/CIRCULATIONAHA.106.663112; Efimov IR, 2000, J CARDIOVASC ELECTR, V11, P861, DOI 10.1111/j.1540-8167.2000.tb00065.x; HWANG C, 1994, CIRCULATION, V90, P2308; Lemke B, 2008, EUROPACE, V10, P907, DOI 10.1093/europace/eun136; Lerman BB, 1995, J ELECTROCARDIOL, V28, P21, DOI 10.1016/S0022-0736(95)80004-2; Maharaj T, 2008, PROG BIOPHYS MOL BIO, V96, P321, DOI 10.1016/j.pbiomolbio.2007.07.017; Mazeh N, 2009, HEART RHYTHM, V6, P361, DOI 10.1016/j.hrthm.2008.11.010; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Qi XQ, 2001, CIRCULATION, V104, P1544, DOI 10.1161/hc3801.095587; Selvaraj RJ, 2007, AM J PHYSIOL-HEART C, V292, pH1262, DOI 10.1152/ajpheart.00913.2006; Takami K, 2013, CIRC J, V77, P2490, DOI 10.1253/circj.CJ-13-0149; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Trayanova NA, 2003, J CARDIOVASC ELECTR, V14, P756; Ujhelyi MR, 1996, J AM COLL CARDIOL, V27, P1534, DOI 10.1016/0735-1097(96)00027-7; Yamashita S, 2014, CIRC J, V78, P1606, DOI 10.1253/circj.CJ-14-0136; Yue AM, 2004, CIRCULATION, V110, P1343, DOI 10.1161/01.CIR.0000141734.43393.BE	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	JUL	2015	26	7					768	773		10.1111/jce.12672		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CM8NW	WOS:000357959900013		
J	Shirai, Y; Goya, M; Isobe, M; Hirao, K				Shirai, Yasuhiro; Goya, Masahiko; Isobe, Mitsuaki; Hirao, Kenzo			Preferential Pathway Pacing within the Aortic Sinus of Valsalva: Strong Evidence for the Existence of Preferential Conduction with Different Exit Sites Traversing the Ventricular Septum	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						aortic sinus of Valsalva; catheter ablation; outflow tract; premature ventricular complexes; right ventricular outflow tract	RADIOFREQUENCY CATHETER ABLATION; ARRHYTHMIAS; TACHYCARDIA; CUSP	Preferential Pathway Pacing within the Aortic Sinus of Valsalva A 57-year-old male who presented with frequent ventricular premature contraction (VPC) was referred for catheter ablation. Two different QRS morphologies (VPC1 and VPC2) were recorded. Pace mapping at the right ventricular outflow (RVOT) was identical to VPC1 without latency. During the mapping within the right sinus of Valsalva where the RF applications were successful for elimination of VPC, discrete prepotential was recorded and the pace mapping produced both VPC1 and VPC2 morphology with different latency. These electrophysiological findings were thought to prove the existence of preferential pathway traversing the ventricular outflow septum with different exit sites.	[Shirai, Yasuhiro; Goya, Masahiko; Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo, Japan; [Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan	Shirai, Y (reprint author), Tokyo Med & Dent Univ Hosp, Heart Rhythm Ctr, Bunkyo Ku, 1-5-45 Yushima, Tokyo, Japan.	whity_yasuo@yahoo.co.jp					Tanaka Y, 2011, CIRC J, V75, P1585, DOI 10.1253/circj.CJ-10-0941; Hachiya H, 2013, CIRC-ARRHYTHMIA ELEC, V6, P898, DOI 10.1161/CIRCEP.113.000157; KLEIN LS, 1992, CIRCULATION, V85, P1666; Yamada T, 2007, J AM COLL CARDIOL, V50, P884, DOI 10.1016/j.jacc.2007.05.021; Hai JJ, 2015, J CARDIOVASC ELECTR, V26, P158, DOI 10.1111/jce.12587; Yamada T, 2008, CIRC-ARRHYTHMIA ELEC, V1, P140, DOI 10.1161/CIRCEP.108.778563	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	JUL	2015	26	7					805	808		10.1111/jce.12669		4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CM8NW	WOS:000357959900019		
J	Mager, LF; Riether, C; Schurch, CM; Banz, Y; Wasmer, MH; Stuber, R; Theocharides, AP; Li, XH; Xia, Y; Saito, H; Nakae, S; Baerlochers, GM; Manz, MG; McCoy, KD; Macphersons, AJ; Ochsenbein, AF; Beutler, B; Krebs, P				Mager, Lukas F.; Riether, Carsten; Schuerch, Christian M.; Banz, Yara; Wasmer, Marie-Helene; Stuber, Regula; Theocharides, Alexandre P.; Li, Xiaohong; Xia, Yu; Saito, Hirohisa; Nakae, Susumu; Baerlochers, Gabriela M.; Manz, Markus G.; McCoy, Kathy D.; Macphersons, Andrew J.; Ochsenbein, Adrian F.; Beutler, Bruce; Krebs, Philippe			IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms	JOURNAL OF CLINICAL INVESTIGATION			English	Article							CHRONIC MYELOID-LEUKEMIA; COLONY-STIMULATING FACTOR; POLYCYTHEMIA-VERA; STEM-CELLS; MICE; SHIP; ALPHA; JAK2-V617F; CYTOKINES; GROWTH	Myeloproliferative neoplasms (MPNs) are characterized by the clonal expansion of one or more myeloid cell lineage. In most cases, proliferation of the malignant clone is ascribed to defined genetic alterations. MPNs are also associated with aberrant expression and activity of multiple cytokines; however, the mechanisms by which these cytokines contribute to disease pathogenesis are poorly understood. Here, we reveal a non-redundant role for steady-state IL-33 in supporting dysregulated myelopoiesis in a murine model of MPN. Genetic ablation of the IL-33 signaling pathway was sufficient and necessary to restore normal hematopoiesis and abrogate MPN-like disease in animals lacking the inositol phosphatase SHIP. Stromal cell derived IL-33 stimulated the secretion of cytokines and growth factors by myeloid and non-hematopoietic cells of the BM, resulting in myeloproliferation in SHIP-deficient animals. Additionally, in the transgenic JAK2(V617F) model, the onset of MPN was delayed in animals lacking IL-33 in radio-resistant cells. In human BM, we detected increased numbers of IL-33 expressing cells, specifically in biopsies from MPN patients. Exogenous IL-33 promoted cytokine production and colony formation by primary CD34(+) MPN stem/progenitor cells from patients. Moreover, IL-33 improved the survival of JAK2(V617F)-positive cell lines. Together, these data indicate a central role for IL-33 signaling in the pathogenesis of MPNs.	[Mager, Lukas F.; Schuerch, Christian M.; Banz, Yara; Wasmer, Marie-Helene; Stuber, Regula; Krebs, Philippe] Univ Bern, Inst Pathol, CH-3010 Bern, Switzerland; [Mager, Lukas F.] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3010 Bern, Switzerland; [Riether, Carsten; Schuerch, Christian M.; Baerlochers, Gabriela M.; McCoy, Kathy D.; Macphersons, Andrew J.; Ochsenbein, Adrian F.] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Theocharides, Alexandre P.; Manz, Markus G.] Univ Zurich Hosp, Div Hematol, CH-8091 Zurich, Switzerland; [Theocharides, Alexandre P.; Manz, Markus G.] Univ Zurich, Zurich, Switzerland; [Li, Xiaohong; Beutler, Bruce] Univ Texas SW Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA; [Xia, Yu] Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA; [Saito, Hirohisa; Nakae, Susumu] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Baerlochers, Gabriela M.] Univ Bern, Dept Hematol, CH-3010 Bern, Switzerland; [Macphersons, Andrew J.] Univ Bern, Dept Gastroenterol, CH-3010 Bern, Switzerland; [Ochsenbein, Adrian F.] Univ Hosp Bern, Inselspital, Dept Med Oncol, CH-3010 Bern, Switzerland; [Ochsenbein, Adrian F.] Univ Bern, CH-3010 Bern, Switzerland	Krebs, P (reprint author), Univ Bern, Inst Pathol, Div Expt Pathol, Murtenstr 31, CH-3010 Bern, Switzerland.	philippe.krebs@pathology.unibe.ch	Krebs, Philippe/A-3449-2012	Krebs, Philippe/0000-0003-4918-6654			Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Fleischman AG, 2011, BLOOD, V118, P6392, DOI 10.1182/blood-2011-04-348144; Bhagwat N, 2013, INT J HEMATOL, V97, P695, DOI 10.1007/s12185-013-1353-5; Jiang XY, 1999, P NATL ACAD SCI USA, V96, P12804, DOI 10.1073/pnas.96.22.12804; Kristinsson SY, 2011, J CLIN ONCOL, V29, P2897, DOI 10.1200/JCO.2011.34.8540; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Skov V, 2012, LEUKEMIA RES, V36, P1387, DOI 10.1016/j.leukres.2012.07.009; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Manshouri T, 2011, CANCER RES, V71, P3831, DOI 10.1158/0008-5472.CAN-10-4002; Hazen AL, 2009, BLOOD, V113, P2924, DOI 10.1182/blood-2008-02-138008; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Xiao WB, 2008, J CLIN INVEST, V118, P924, DOI 10.1172/JCI34013; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Gallipoli P, 2013, BLOOD, V122, P3335, DOI 10.1182/blood-2013-02-485607; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Paster EV, 2009, COMPARATIVE MED, V59, P234; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Kubovcakova L, 2013, BLOOD, V121, P1188, DOI 10.1182/blood-2012-03-415646; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Anderson LA, 2009, BRIT J CANCER, V100, P822, DOI 10.1038/sj.bjc.6604935; Wadleigh M, 2010, INT J HEMATOL, V91, P174, DOI 10.1007/s12185-010-0529-5; Medinger M, 2009, BRIT J HAEMATOL, V146, P150, DOI 10.1111/j.1365-2141.2009.07726.x; Cheng CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036085; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; Fleischman AG, 2013, BLOOD, V122, P4097; Gangemi S, 2013, CANCER INVEST, V31, P212, DOI 10.3109/07357907.2013.764566; Ha CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109249; Hasselbalch HC, 2013, CYTOKINE GROWTH F R, V24, P133, DOI 10.1016/j.cytogfr.2013.01.004; Jedidi A, 2009, BLOOD, V114, P1842, DOI 10.1182/blood-2008-09-176875; Jiang XY, 2002, BLOOD, V100, P3731, DOI 10.1182/blood-2002-05-1324; Levescot A, 2014, CANCER RES, V74, P2669, DOI 10.1158/0008-5472.CAN-13-2797; Maeda K, 2005, BLOOD, V106, P879, DOI 10.1182/blood-2005-02-0456; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Rivas MN, 2012, J CLIN INVEST, V122, P1933, DOI 10.1172/JCI40591; Singh VK, 2012, CYTOKINE, V58, P406, DOI 10.1016/j.cyto.2012.03.011; Titmarsh GJ, 2014, CANCER EPIDEMIOL, V38, P56, DOI 10.1016/j.canep.2013.10.009	49	2	2	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	JUL	2015	125	7					2579	2591		10.1172/JCI77347		13	Medicine, Research & Experimental	Research & Experimental Medicine	CM3AK	WOS:000357553300009		
J	Li, H; Fu, YX; Wu, Q; Zhou, Y; Crossman, DK; Yang, PA; Li, J; Luo, B; Morel, LM; Kabarowski, JH; Yagita, H; Ware, CF; Hsu, HC; Mountz, JD				Li, Hao; Fu, Yang-Xin; Wu, Qi; Zhou, Yong; Crossman, David K.; Yang, PingAr; Li, Jun; Luo, Bao; Morel, Laurence M.; Kabarowski, Janusz H.; Yagita, Hideo; Ware, Carl F.; Hsu, Hui-Chen; Mountz, John D.			Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus	JOURNAL OF CLINICAL INVESTIGATION			English	Article							SPLENIC MARGINAL ZONE; AUTOIMMUNE BXD2 MICE; PRECURSOR B-CELLS; DENDRITIC CELLS; I INTERFERON; T-CELL; PATHOGENIC AUTOANTIBODIES; ADAPTIVE IMMUNITY; LYMPHOID-TISSUES; ACTIN DYNAMICS	Systemic lupus erythematosus (SLE) is a severe autoimmune disease that is associated with increased circulating apoptotic cell autoantigens (AC-Ags) as well as increased type I IFN signaling. Here, we describe a pathogenic mechanism in which follicular translocation of marginal zone (MZ) B cells in the spleens of BXD2 lupus mice disrupts marginal zone macrophages (MZMs), which normally clear AC debris and prevent follicular entry of AC-Ags. Phagocytosis of ACs by splenic MZMs required the megakaryoblastic leukemia 1 (MKL1) transcriptional coactivator-mediated mechanosensing pathway, which was maintained by MZ B cells through expression of membrane lymphotoxin-alpha 1 beta 2 (mLT). Specifically, type I IFN-induced follicular shuttling of mLT-expressing MZ B cells disengaged interactions between these MZ B cells and up receptor-expressing MZMs, thereby downregulating MKL1 in MZMs. Loss of MKL1 expression in MZMs led to defective F-actin polymerization, inability to clear ACs, and, eventually, MZM dissipation. Aggregation of plasmacytoid DCs in the splenic perifollicular region, follicular translocation of MZ B cells, and loss of MKL1 and MZMs were also observed in an additional murine lupus model and in the spleens of patients with SLE. Collectively, the results suggest that lupus might be interrupted by strategies that maintain or enhance mechanosensing signaling in the MZM barrier to prevent follicular entry of AC-Ags.	[Li, Hao; Wu, Qi; Yang, PingAr; Li, Jun; Luo, Bao; Hsu, Hui-Chen; Mountz, John D.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Zhou, Yong] UAB, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA; [Crossman, David K.] UAB, Heflin Ctr Genom Sci, Birmingham, AL USA; [Crossman, David K.] UAB, Dept Genet, Div Genet Res, Birmingham, AL USA; [Morel, Laurence M.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Kabarowski, Janusz H.; Mountz, John D.] UAB, Dept Microbiol, Birmingham, AL USA; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Ware, Carl F.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Mountz, John D.] Birmingham VA Med Ctr, Birmingham, AL USA	Hsu, HC (reprint author), Shelby Rm 311,1825 Univ Blvd, Birmingham, AL 35294 USA.	rheu078@uab.edu; jdmountz@uab.edu			NIH [R01-AI-071110, R01-AI-083705, R01-A1058150, R01-HL-124076, 5 R01-AI048073, P30-AR-048311, P30-AI-027767]; Department of Veterans Affairs [1I01BX000600-01]; Lupus Research Institute; Rheumatology Research Foundation; American Heart Association [14GRNT20180023]; American Thoracic Society Recognition Award; UAB RDCC [P30-AR-048311]; Cancer Center [CA-013148]; Center for AIDS Research grant [AI-027767]	This worked was supported by grants from the NIH (R01-AI-071110, to J.D. Mountz; R01-AI-083705, to H.C. Hsu; R01-A1058150, to L.M. Morel; R01-HL-124076, to Y. Zhou; 5 R01-AI048073, to C.F. Ware; P30-AR-048311, to the UAB Rheumatic Diseases Core Centers [RDCC], including the Comprehensive Flow Cytometry Core and the Analytic Imaging and Immunore-agent Core; and P30-AI-027767, to the UAB Center for AIDS Research Comprehensive Flow Cytometry Core). Support was also provided by a Merit Review grant from the Department of Veterans Affairs (1I01BX000600-01, to J.D. Mountz); Novel Research grants from the Lupus Research Institute (to J.H. Kabarowski and H.C. Hsu); the Rheumatology Research Foundation (to J.D. Mountz); the American Heart Association (14GRNT20180023, to Y. Zhou); an American Thoracic Society Recognition Award (to Y. Zhou); and the UAB RDCC P30 Pilot and Feasibility Project (P30-AR-048311, to J. Li). We thank Michael Crowley and Bing Xue, supported by a Cancer Center grant (CA-013148) and a Center for AIDS Research grant (AI-027767), for performing the GeneChip analysis. We thank UAB Tissue Procurement for providing normal and SLE splenic tissue sections. We also thank Fiona Hunter for careful review of the manuscript.	Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Smith EC, 2012, BLOOD, V120, P2317, DOI 10.1182/blood-2012-04-420828; Ding YN, 2013, J IMMUNOL, V191, P1614, DOI 10.4049/jimmunol.1300479; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Kiefer K, 2012, IMMUNOL CELL BIOL, V90, P498, DOI 10.1038/icb.2012.10; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Aichele P, 2003, J IMMUNOL, V171, P1148; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Ravishankar B, 2014, P NATL ACAD SCI USA, V111, P4215, DOI 10.1073/pnas.1320924111; McGaha TL, 2011, BLOOD, V117, P5403, DOI 10.1182/blood-2010-11-320028; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Johnson LA, 2014, INFLAMM BOWEL DIS, V20, P154, DOI 10.1097/01.MIB.0000437615.98881.31; Fransen JH, 2009, ARTHRITIS RHEUM, V60, P2304, DOI 10.1002/art.24719; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; May RC, 2001, J CELL SCI, V114, P1061; Fleige A, 2007, J BIOL CHEM, V282, P24320, DOI 10.1074/jbc.M703119200; Mountz JD, 2005, SCAND J IMMUNOL, V61, P128, DOI 10.1111/j.0300-9475.2005.01548.x; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Tumanov AV, 2002, IMMUNITY, V17, P239, DOI 10.1016/S1074-7613(02)00397-7; Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017; Li H, 2013, J IMMUNOL, V190, P4465, DOI 10.4049/jimmunol.1300041; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Nolte MA, 2004, J IMMUNOL, V172, P3620; Elkon KB, 2012, ADV EXP MED BIOL, V750, P14, DOI 10.1007/978-1-4614-3461-0_2; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Moriyama Y, 2008, INT IMMUNOL, V20, P763, DOI 10.1093/intimm/dxn034; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Chen XW, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3230; Ding YN, 2014, ARTHRITIS RHEUMATOL, V66, P2601, DOI 10.1002/art.38735; Fan HL, 2006, J LEUKOCYTE BIOL, V79, P155, DOI 10.1189/jlb.0705408; Gommerman JL, 2014, CYTOKINE GROWTH F R, V25, P139, DOI 10.1016/j.cytogfr.2014.02.002; Hsu HC, 2007, J IMMUNOL, V178, P5357; Hsu HC, 2011, ARTHRITIS RHEUM-US, V63, P2038, DOI 10.1002/art.30257; Hsu HC, 2006, ARTHRITIS RHEUM, V54, P343, DOI 10.1002/art.21550; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Mountz JD, 2011, DISCOV MED, V56, P76; Myers RC, 2013, EUR J IMMUNOL, V43, P348, DOI 10.1002/eji.201242471; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Sang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102151; Sullivan AL, 2011, MOL CELL BIOL, V31, P861, DOI 10.1128/MCB.00836-10; Wang JH, 2013, ARTHRITIS RHEUM-US, V65, P2703, DOI 10.1002/art.38059; Wang JH, 2011, ARTHRITIS RHEUM-US, V63, P1054, DOI 10.1002/art.30231; Wang JH, 2010, J IMMUNOL, V184, P442, DOI 10.4049/jimmunol.0900870; Wu Q, 1999, J EXP MED, V190, P629, DOI 10.1084/jem.190.5.629; Xie ST, 2010, J IMMUNOL, V184, P2289, DOI 10.4049/jimmunol.0903133; Zhou ZH, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-7	62	2	2	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	JUL	2015	125	7					2877	2890		10.1172/JCI81059		14	Medicine, Research & Experimental	Research & Experimental Medicine	CM3AK	WOS:000357553300032		
J	Matsumoto, H; Koo, SL; Dent, R; Tan, PH; Iqbal, J				Matsumoto, Hirofumi; Koo, Si-lin; Dent, Rebecca; Tan, Puay Hoon; Iqbal, Jabed			Role of inflammatory infiltrates in triple negative breast cancer	JOURNAL OF CLINICAL PATHOLOGY			English	Review							REGULATORY T-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-ASSOCIATED MACROPHAGES; PATHOLOGICAL COMPLETE RESPONSE; LYMPHOCYTES PREDICT RESPONSE; IMMUNE-RESPONSE; DENDRITIC CELLS; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-SIGNIFICANCE; ANTIGEN-EXPRESSION	Triple negative breast cancer (TNBC) is a heterogenous disease often characterised by aggressive biology and poor prognosis. Efforts to precisely treat TNBC have been compounded by the lack of specific therapeutic molecular targets. Recent transcriptomic studies have revealed, among others, an immunomodulatory subtype of TNBC, whereby activated immune response genes are associated with good prognosis. Since then, a great deal of effort has been made to understand the immune microenvironment of some TNBC subtype, which comprises several immune cell populations including lymphocytes and macrophages. There is increasing evidence that the basal subtype may be significantly regulated by tumour-infiltrating T-cells and that high levels of tumour-infiltrating CD8+ T-cells may be a reflection of improved prognosis with chemotherapy sensitivity in TNBC. On the other hand, tumour-associated macrophages have been associated with a relatively poor outcome in TNBC. Comparison of the immune signatures in TNBC with non-TNBC may furthermore help us to understand these immune mechanisms potentially leading to new therapeutic approaches. Within this short review, we discuss the current scientific evidence regarding (a) the role of tumour-infiltrating lymphocytes in the clinical outcome in TNBC and (b) the newly discovered immunomodulatory genotype that may provide for a therapeutic target in TNBC.	[Matsumoto, Hirofumi; Tan, Puay Hoon; Iqbal, Jabed] Singapore Gen Hosp, Dept Pathol, Singapore 169608, Singapore; [Matsumoto, Hirofumi] Ryukyu Univ Hosp, Dept Pathol, Okinawa, Japan; [Koo, Si-lin; Dent, Rebecca] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore	Iqbal, J (reprint author), Singapore Gen Hosp, Dept Pathol, 20 Coll Rd,Acad,Diagnost Tower,Level 10, Singapore 169608, Singapore.	jabed.iqbal@sgh.com.sg		Koo, Si-Lin/0000-0002-8217-3321	 [SMPO201302]	This study was funded by the grant SMPO201302.	Ademuyiwa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038783; Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Lee HJ, 2013, J BREAST CANCER, V16, P32, DOI 10.4048/jbc.2013.16.1.32; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Stewart DA, 2012, MOL CANCER RES, V10, P727, DOI 10.1158/1541-7786.MCR-11-0604; Ladoire S, 2008, CLIN CANCER RES, V14, P2413, DOI 10.1158/1078-0432.CCR-07-4491; Yang D, 2009, TRENDS IMMUNOL, V30, P531, DOI 10.1016/j.it.2009.07.004; Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Ha NH, 2011, CANCER RES, V71, P7259, DOI 10.1158/0008-5472.CAN-11-1143; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Naito Y, 1998, CANCER RES, V58, P3491; Yu P, 2006, LAB INVEST, V86, P231, DOI 10.1038/labinvest.3700389; Leek RD, 1996, CANCER RES, V56, P4625; Iwamoto M, 2003, INT J CANCER, V104, P92, DOI 10.1002/ijc.10915; Demaria S, 2001, CLIN CANCER RES, V7, P3025; Karn T, 2012, EUR J CANCER, V48, P12, DOI 10.1016/j.ejca.2011.06.025; Hanker LC, 2013, BREAST CANCER RES TR, V137, P407, DOI 10.1007/s10549-012-2356-2; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lee S, 2013, ACTA ONCOL, V52, P73, DOI 10.3109/0284186X.2012.731520; Curigliano G, 2011, ANN ONCOL, V22, P98, DOI 10.1093/annonc/mdq325; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Yamaguchi R, 2012, HUM PATHOL, V43, P1688, DOI 10.1016/j.humpath.2011.12.013; Schulz DM, 2009, J PROTEOME RES, V8, P3430, DOI 10.1021/pr900071h; Sisirak V, 2012, CANCER RES, V72, P5188, DOI 10.1158/0008-5472.CAN-11-3468; Roxanis I, 2013, J CLIN PATHOL, V66, P517, DOI 10.1136/jclinpath-2012-201348; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Mahmoud SMA, 2011, BREAST CANCER RES TR, V127, P99, DOI 10.1007/s10549-010-0987-8; Bohling SD, 2008, MODERN PATHOL, V21, P1527, DOI 10.1038/modpathol.2008.160; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524; Mittendorf EA, 2014, CANCER IMMUNOL RES, V2, P361, DOI 10.1158/2326-6066.CIR-13-0127; Ghebeh H, 2007, INT J CANCER, V121, P751, DOI 10.1002/ijc.22703; Stagg J, 2013, THER ADV MED ONCOL, V5, P169, DOI 10.1177/1758834012475152; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Schumacher K, 2001, CANCER RES, V61, P3932; Mahmoud SMA, 2012, J CLIN PATHOL, V65, P159, DOI 10.1136/jclinpath-2011-200355; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Wolf JS, 2007, CLIN CANCER RES, V13, P1601, DOI 10.1158/1078-0432.CCR-06-2008; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Ono M, 2012, BREAST CANCER RES TR, V132, P793, DOI 10.1007/s10549-011-1554-7; Baker K, 2011, HISTOPATHOLOGY, V58, P1107, DOI 10.1111/j.1365-2559.2011.03846.x; Palazon A, 2012, CLIN CANCER RES, V18, P1207, DOI 10.1158/1078-0432.CCR-11-1591; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Hartman ZC, 2013, CANCER RES, V73, P3470, DOI 10.1158/0008-5472.CAN-12-4524-T; Winerdal ME, 2011, BJU INT, V108, P1672, DOI 10.1111/j.1464-410X.2010.10020.x; Arranz EE, 2012, TRANSL ONCOL, V5, P398, DOI 10.1593/tlo.12244; Bron L, 2013, INT J CANCER, V132, pE85, DOI 10.1002/ijc.27728; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Chen YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017844; Coventry BJ, 2003, BRIT J CANCER, V89, P533, DOI 10.1038/sj.bjc.6601114; Criscitiello C, 2012, ANN ONCOL S, V23, pvi13; Deng XS, 2012, CELL CYCLE, V11, P367, DOI [10.4161/cc.11.2.18813, 10.4161/cc/11.2.18813]; Droeser R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-134; IOACHIM HL, 1976, CANCER, V38, P2296, DOI 10.1002/1097-0142(197612)38:6<2296::AID-CNCR2820380617>3.0.CO;2-1; Lespagnard L, 1999, INT J CANCER, V84, P309; Liu SZ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3148; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; MOORE OS, 1949, CANCER, V2, P635, DOI 10.1002/1097-0142(194907)2:4<635::AID-CNCR2820020411>3.0.CO;2-Q; van der Most RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006982; Reiman JM, 2010, CANCER RES, V70, P3005, DOI 10.1158/0008-5472.CAN-09-4041; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Scandiuzzi L, 2011, DISCOV MED, V63, P119; Seo AN, 2013, BRIT J CANCER, V109, P2705, DOI 10.1038/bjc.2013.634; Soliman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088557; Tanchot C, 2013, Cancer Microenviron, V6, P147, DOI 10.1007/s12307-012-0122-y; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Teschendorff AE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-604; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West NR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3072; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753	78	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0021-9746	1472-4146		J CLIN PATHOL	J. Clin. Pathol.	JUL	2015	68	7					506	510		10.1136/jclinpath-2015-202944		5	Pathology	Pathology	CM7JK	WOS:000357867700014		
J	Morita, K; Nakamine, H; Nakai, T; Takano, M; Takeda, M; Enomoto, Y; Yoshii, Y; Kanno, M; Ohbayashi, C				Morita, Kohei; Nakamine, Hirokazu; Nakai, Tokiko; Takano, Masato; Takeda, Maiko; Enomoto, Yasunori; Yoshii, Yumi; Kanno, Masatoshi; Ohbayashi, Chiho			A retrospective study of patients with follicular lymphoma (FL): identification of in situ FL or FL-like B cells of uncertain significance in lymph nodes resected at the time of previous surgery for carcinomas	JOURNAL OF CLINICAL PATHOLOGY			English	Article								Background and aims In situ follicular lymphoma (iFL)/intrafollicular neoplasia and follicular lymphoma (FL)-like B cells of uncertain significance represent proliferation of Bcl-2/t(14; 18)-positive B cells solely in the germinal centres. The condition is interpreted as an early event in the multi-step lymphomagenesis of FL. The aim of this study is to examine the issue more specifically. Methods We reviewed medical history of FL patients in whom thoracoabdominal surgery with lymphadenectomy had been performed for management of carcinomas. These previously resected lymph nodes as well as the current FL nodes were analysed by immunohistochemistry, fluorescent in situ hybridisation, and PCR amplification with direct sequencing. Results We studied four such FL patients from a total of 150 patients with FL; all had iFL in the previously resected lymph nodes. Clonal relation was verified and suggested in one case each. The time from lymphadenectomy to the diagnosis of FL was 23-120 months. There appeared to be a reverse correlation between the rate of Bcl-2-positive follicle proliferation and the time from surgery to diagnosis of FL. Conclusions Although the rate for development of FL in individuals having iFL has been reported to be low from prospective studies, the present data indicate that follow-up studies for a longer period is necessary; the rate of Bcl-2-positive follicle proliferation could be a factor to predict development of FL in prospective studies. Such a retrospective study may contribute to elucidate mechanism(s) involved in lymphomagenesis of FL.	[Morita, Kohei; Nakai, Tokiko; Takano, Masato; Takeda, Maiko; Ohbayashi, Chiho] Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara 6348521, Japan; [Nakamine, Hirokazu] Japan Baptist Hosp, Div Pathol & Lab Med, Kyoto, Japan; [Enomoto, Yasunori] Toho Univ, Ohashi Med Ctr, Dept Surg Pathol, Tokyo, Japan; [Yoshii, Yumi; Kanno, Masatoshi] Nara Med Univ Hosp, Oncol Ctr, Kashihara, Nara, Japan	Morita, K (reprint author), Nara Med Univ, Dept Diagnost Pathol, Shijo Cho 840, Kashihara, Nara 6348521, Japan.	moritak@naramed-u.ac.jp					Jegalian AG, 2011, BLOOD, V118, P2976, DOI 10.1182/blood-2011-05-355255; Ghia P, 2012, BLOOD, V119, P4358, DOI 10.1182/blood-2012-01-404681; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467; Pillai RK, 2013, HAEMATOLOGICA, V98, P1571, DOI 10.3324/haematol.2013.085506; LIU YF, 1994, P NATL ACAD SCI USA, V91, P8910, DOI 10.1073/pnas.91.19.8910; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Henopp T, 2011, HISTOPATHOLOGY, V59, P139, DOI 10.1111/j.1365-2559.2011.03897.x; Carbone A, 2014, LEUKEMIA LYMPHOMA, V55, P482, DOI 10.3109/10428194.2013.807926; Carbone A, 2011, BLOOD, V117, P3954, DOI 10.1182/blood-2010-10-299628; Carbone A, 2012, LEUKEMIA LYMPHOMA, V53, P603, DOI 10.3109/10428194.2011.624229; Carbone A, 2012, J CLIN PATHOL, V65, P955, DOI 10.1136/jclinpath-2012-200879; Cong R, 2002, BLOOD, V99, P3376; Harris NL, 2008, WHO CLASSIFICATION T, P220; Mamessier E, 2014, HAEMATOLOGICA, V99, P802, DOI 10.3324/haematol.2013.085548; Montes-Moreno S, 2010, HISTOPATHOLOGY, V56, P652; Ruiz M, 2000, NUCLEIC ACIDS RES, V28, P219, DOI 10.1093/nar/28.1.219; Sakhadeo U, 2012, INDIAN J PATHOL MICR, V55, P218, DOI 10.4103/0377-4929.97878	19	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0021-9746	1472-4146		J CLIN PATHOL	J. Clin. Pathol.	JUL	2015	68	7					541	546		10.1136/jclinpath-2015-202933		6	Pathology	Pathology	CM7JK	WOS:000357867700020		
J	Miyazaki, Y; Murase, A; Shiina, M; Masui, R; Senou, H				Miyazaki, Yusuke; Murase, Atsunobu; Shiina, Masato; Masui, Ryuta; Senou, Hiroshi			Integrating and Utilizing Citizen Biodiversity Data on the Web for Science: An Example of a Rare Triggerfish Hybrid Image Provided by a Sport Fisherman	JOURNAL OF COASTAL RESEARCH			English	Article						Citizen science; FishPix; GBIF; parataxonomist; verifiability; voucher	SPECIMEN COLLECTION; SOUTHERN JAPAN; WATER FISHES; PERCIFORMES; DIVERSITY	We report a photograph of the rare triggerfish hybrid, Rhinecanthus aculeatus x R. rectangulus (order Tetraodontiformes; family Balistidae), from Miyako-jima Island, Ryukyu Islands, southern Japan, that was provided by a sport fisherman via WEB sakana-zukan (an online photographic database of fish in Japan). The image was registered in the Fish Image Database of the Kanagawa Prefectural Museum of Natural History to make it available for scientific scrutiny. Here we emphasize the importance of communication between citizens, such as fishermen, scuba divers, and others, and experts via the Internet, to make possible the processing of biodiversity information provided by citizens into museum collections. This communication contributes Global Biodiversity Information Facility data for various biological studies, such as those on taxonomy, morphology, fauna/flora, community ecology, and biogeography.	[Miyazaki, Yusuke; Senou, Hiroshi] Kanagawa Prefectural Museum Nat Hist, Odawara, Kanagawa 2500031, Japan; [Murase, Atsunobu] Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Lab Ichthyol, Tokyo 1088477, Japan; [Shiina, Masato] Uwajima Fisheries High Sch, Ehime 7980068, Japan	Miyazaki, Y (reprint author), Kanagawa Prefectural Museum Nat Hist, Odawara, Kanagawa 2500031, Japan.	yukke-bibimba@10.alumni.u-tokyo.ac.jp			Japan Society for the Promotion of Science [25 . 11038]; Ministry of Education, Culture, Sports, Science and Technology in Japan [24501278]	We thank all participants in the KPM-NR database and WEB sakana-zukan. We are grateful to Dr. K. Matsuura and anonymous reviewers for comments on the manuscript. This work was supported by the Japan Society for the Promotion of Science (Research Fellowship for Young Scientists No. 25 . 11038 to Y. Miyazaki) and by the Ministry of Education, Culture, Sports, Science and Technology in Japan (Grants-in-Aid No. 24501278 to H. Senou).	Adams J., 2012, HYBRID TRIGGERFISH S; Krell FT, 2014, SCIENCE, V344, P815, DOI 10.1126/science.344.6186.815; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003; Miyazaki Y, 2014, BIODIVERS CONSERV, V23, P2383, DOI 10.1007/s10531-014-0724-4; Bariche Michel, 2012, Marine Biodiversity Records, V5, pe1, DOI 10.1017/S1755267211000509; Dickinson JL, 2012, CITIZEN SCI PUBLIC P; Doiuchi R, 2005, ICHTHYOL RES, V52, P132, DOI 10.1007/s10228-004-0263-1; Doiuchi R, 2011, ICHTHYOL RES, V58, P99, DOI 10.1007/s10228-010-0180-4; GBIF (Global Biodiversity Information Facility) Staff, 2012, GBIF ANN REP 2012; GBIF Staff, 2013, GBIF SCI REV; Hackett S., 2004, P 6 INT ACM SIGACCES, P32, DOI 10.1145/1028630.1028638; Hayashi M., 2013, FISHES JAPAN PICTORI, V3rd, p[1703, 2235]; Hayashi M., 2002, FISHES JAPAN PICTORI, P1396; Internet Archive, 2014, THE WAYB MACH; Kai Yoshiaki, 2009, Aquatic Invasions, V4, P417, DOI 10.3391/ai.2009.4.2.23; Kano Yuichi, 2014, Japanese Journal of Ichthyology, V61, P123; Kano Y, 2013, ICHTHYOL RES, V60, P293, DOI 10.1007/s10228-013-0349-8; Mabuchi Kohji, 2003, Japanese Journal of Ichthyology, V50, P103; Matsuura Keiichi, 2002, Research Report from the National Institute for Environmental Studies Japan, V171, P220; Matsuura K., 1980, Bulletin of the National Science Museum Series A (Zoology), V6, P27; Miyazaki Y., 2015, MANAGEMENT IN PRESS, V6; Motomura H., 2012, B BIOGEOGRAPHICAL SO, V67, P75; Murase A., 2013, BIOGEOGRAPHY, V15, P79; Murase A, 2007, ICHTHYOL RES, V54, P287, DOI 10.1007/s10228-007-0403-5; Murphy J., 2007, J COMPUT-MEDIAT COMM, V13, P60, DOI 10.1111/j.1083-6101.2007.00386.x; Parr C.S., 2014, BIODIVERS DATA J, V2, pe1079, DOI DOI 10.3897/BDJ.2.E1079; Randall John E., 2002, Aqua (Miradolo Terme), V5, P77; Robertson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102623; Rocha LA, 2014, SCIENCE, V344, P814, DOI 10.1126/science.344.6186.814; SENOU H, 2008, B KANAGAWA PREFECT M, V36, P39; Senou Hiroshi, 2006, Memoirs of the National Science Museum (Tokyo), P389; Smith VS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S6; Wiggins A., 2011, Proceedings of the 2011 IEEE Seventh International Conference on e-Science Workshops (eScienceW 2011), DOI 10.1109/eScienceW.2011.27; Yahara T., 2012, BIODIVERSITY OBSERVA, P3, DOI [10.1007/978-4-431-54032-81, DOI 10.1007/978-4-431-54032-8_1]; Yamaide J., 2014, WEB SAKANA ZUKAN	35	0	0	COASTAL EDUCATION & RESEARCH FOUNDATION	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	0749-0208	1551-5036		J COASTAL RES	J. Coast. Res.	JUL	2015	31	4					1035	1039		10.2112/JCOASTRES-D-14-00170.1		5	Environmental Sciences; Geography, Physical; Geosciences, Multidisciplinary	Environmental Sciences & Ecology; Physical Geography; Geology	CM9KS	WOS:000358027900024		
J	Aucouturier, JJ; Fujita, M; Sumikura, H				Aucouturier, Jean-Julien; Fujita, Marketa; Sumikura, Hiroko			Experiential response and intention to purchase in the cocreative consumption of music: The Nine Inch Nails experiment	JOURNAL OF CONSUMER BEHAVIOUR			English	Article							VALUE CREATION; CONSUMERS; CUSTOMIZATION; INNOVATION; PRODUCTS	Customers allowed to cocreate products are more willing to purchase them eventually because of not only their utilitarian but also their hedonic and experiential value. Experiential responses seem especially relevant in the cocreative consumption of cultural and intangible goods, such as music. To examine how such intangible aspects of cocreation can influence a consumer's intention to purchase, we let two groups of participants rate their experience consuming music in either a traditional or cocreative way, in an experimental situation inspired by the work of American rock band Nine Inch Nails. Participants in the traditional group had to passively watch a series of music videos; participants in the cocreative group were tasked to produce a video montage using the same material. In the traditional group, purchase intention was predicted by music quality, mediated by willingness to reexperience; in the cocreative group, however, purchase intention was only predicted by the consumers' experiential response, with no mediation of either music quality or willingness to reexperience. Additionally, the overall experiential response to music was lower in the cocreative group than in the traditional group, leading to lower intention to purchase. These results suggest that cocreated value for intangible goods is predicted at least as much by the consumers' experiential response as by their evaluation of product quality. It also suggests that there is nothing systematically positive in having consumers participate in the coproduction of intangible goods and that research is needed to identify the factors predicting the perceived quality of a cocreative experience. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Aucouturier, Jean-Julien] UPMC, CNRS, IRCAM, UMR9912, Paris, France; [Fujita, Marketa] Temple Univ, Tokyo, Japan	Aucouturier, JJ (reprint author), CNRS, Cognit Sci, Paris, France.	aucouturier@gmail.com					Fuller J, 2010, CALIF MANAGE REV, V52, P98, DOI 10.1525/cmr.2010.52.2.98; Franke N, 2010, MANAGE SCI, V56, P125, DOI 10.1287/mnsc.1090.1077; Fuchs C, 2010, J MARKETING, V74, P65; Franke N, 2009, J MARKETING, V73, P103; Fuller J, 2012, CREAT INNOV MANAG, V21, P247, DOI 10.1111/j.1467-8691.2012.00650.x; Chan KW, 2010, J MARKETING, V74, P48; Franke N, 2004, J PROD INNOVAT MANAG, V21, P401, DOI 10.1111/j.0737-6782.2004.00094.x; Dahl DW, 2007, J MARKETING RES, V44, P357, DOI 10.1509/jmkr.44.3.357; Jarvenpaa SL, 2011, LONG RANGE PLANN, V44, P440, DOI 10.1016/j.lrp.2011.09.002; Jackson SA, 1996, J SPORT EXERCISE PSY, V18, P17; Asmuss EP, 1985, PSYCHOL MUSIC, V13, P19, DOI 10.1177/0305735685131002; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Csikszentmihalyi Mihalyi, 1991, FLOW PSYCHOL OPTIMAL, V41; Durgees J., 2003, COCREATION MEANING M; Fuchs C, 2013, J MARKETING, V77, P75; HARGREAVES DJ, 1984, J RES MUSIC EDUC, V32, P35, DOI 10.2307/3345279; HUBER J, 1979, J MARKETING RES, V16, P507, DOI 10.2307/3150811; Humphreyss S, 2005, MEDIA INT AUST, P16; LACHER KT, 1994, J CONSUM RES, V21, P366, DOI 10.1086/209404; North AC, 2006, J APPL SOC PSYCHOL, V36, P3043, DOI 10.1111/j.0021-9029.2006.00142.x; Pages W, 2008, EC INSIGHT, V10; Prahalads R., 2004, FUTURE COMPETITION C; Purcells K, 2010, UNDERSTANDING PARTIC; Schreiers M, 2006, J CONSUM BEHAV, V5, P317, DOI DOI 10.1002/CB.183; SLOBODA J. A., 2001, MUSIC SCI, V5, P9	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1472-0817	1479-1838		J CONSUM BEHAV	J. Consum. Behav.	JUL-AUG	2015	14	4					219	227		10.1002/cb.1510		9	Business	Business & Economics	CM9IX	WOS:000358023200001		
J	Goto, K				Goto, Keisuke			Immunohistochemistry for CD117 (KIT) is effective in distinguishing cutaneous adnexal tumors with apocrine/eccrine or sebaceous differentiation from other epithelial tumors of the skin	JOURNAL OF CUTANEOUS PATHOLOGY			English	Article						c-KIT protein; immunohistochemistry; skin neoplasms	STEM-CELL FACTOR; ADENOID CYSTIC CARCINOMA; GASTROINTESTINAL STROMAL TUMORS; C-KIT; RECEPTOR EXPRESSION; MALIGNANT-MELANOMA; GENE-MUTATIONS; LUNG-CANCER; TISSUES; COEXPRESSION	BackgroundThe aim of this study was to evaluate the effectiveness of CD117 immunostaining for diagnosing cutaneous adnexal tumors, which has not been previously established. MethodsCD117 immunostaining was performed on representative sections of 87 clinicopathologically confirmed cutaneous apocrine/eccrine tumors, 13 sebaceous tumors, 52 follicular tumors, 55 keratinocytic tumors, 24 metastatic tumors of the skin of known origin and 1 mammary Paget disease. Staining of 5-50% of cells was considered focally positive, and staining of 51-100% of cells was considered diffusely positive. Staining intensity was semi-quantitatively graded as weak, moderate or strong. ResultsA total of 82 (94.3%) tumors with apocrine/eccrine differentiation were CD117-positive, whereas one mucinous carcinoma, one apocrine carcinoma, and three primary cutaneous extramammary Paget diseases were CD117-negative. For most positive cases, staining was diffuse (64/82 cases) and moderate to strong in intensity (74/82). Twelve (92.3%) sebaceous tumors were CD117-positive, showing mainly focal (9/12) and weak (7/12) positivity. Of the 52 follicular tumors, all 4 cases of pilomatricoma and other 5 tumors were positive for CD117. Of the 55 keratinocytic tumors, only 2 cases were CD117-positive. The 24 metastatic tumors and mammary Paget disease were CD117-negative. ConclusionsCD117 may be useful for the differential diagnosis of cutaneous adnexal tumors.	Kainan Hosp, Dept Diagnost Pathol, Yatomi City, Aichi 4988502, Japan	Goto, K (reprint author), Kainan Hosp, Dept Diagnost Pathol, 396 Minamihonden,Maegasu Cho, Yatomi City, Aichi 4988502, Japan.	vapour-trail@nifty.com					Ahmed A, 2004, PEDIATR DEVEL PATHOL, V7, P342, DOI 10.1007/s10024-002-0077-y; Espinosa I, 2008, AM J SURG PATHOL, V32, P210, DOI 10.1097/PAS.0b013e3181238cec; Holst VA, 1999, MODERN PATHOL, V12, P956; Gonzalez I, 2004, CLIN CANCER RES, V10, P751, DOI 10.1158/1078-0432.CCR-0778-03; Swick BL, 2013, J CUTAN PATHOL, V40, P623, DOI 10.1111/cup.12160; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Jordan JH, 2001, HUM PATHOL, V32, P545, DOI 10.1053/hupa.2001.24319; Arber DA, 1998, HUM PATHOL, V29, P498, DOI 10.1016/S0046-8177(98)90066-1; Montone KT, 1997, MODERN PATHOL, V10, P939; HIBI K, 1991, ONCOGENE, V6, P2291; Kim HJ, 2006, ARCH PATHOL LAB MED, V130, P707; Perrotto J, 2010, AM J DERMATOPATH, V32, P137, DOI 10.1097/DAD.0b013e3181b71481; Krystal GW, 1996, CANCER RES, V56, P370; Willman JH, 2005, AM J DERMATOPATH, V27, P185, DOI 10.1097/01.dad.0000158291.20440.13; Penner CR, 2002, MODERN PATHOL, V15, P687, DOI 10.1097/01.MP.0000018973.17736.F8; Pan CC, 2004, J PATHOL, V202, P375, DOI 10.1002/path.1514; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Ohashi A, 1996, MELANOMA RES, V6, P25, DOI 10.1097/00008390-199602000-00004; Kitamura Y, 2004, CELL MOL LIFE SCI, V61, P2924, DOI 10.1007/s00018-004-4273-y; Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; Feinmesser M, 2004, AM J DERMATOPATH, V26, P458, DOI 10.1097/00000372-200412000-00003; van Roggen JFG, 2001, J CLIN PATHOL, V54, P96, DOI 10.1136/jcp.54.2.96; HINES SJ, 1995, CELL GROWTH DIFFER, V6, P769; Inoue M, 2003, CANCER, V98, P758; Isabel ZY, 2006, J CUTAN PATHOL, V33, P33; Ito Y, 2008, J EUR ACAD DERMATOL, V22, P353, DOI 10.1111/j.1468-3083.2007.02440.x; Kandemir NO, 2010, CLIN EXP DERMATOL, V35, P525, DOI 10.1111/j.1365-2230.2009.03661.x; Levy G, 2010, J CUTAN PATHOL, V37, P411, DOI 10.1111/j.1600-0560.2009.01436.x; Marucci G, 2002, VIRCHOWS ARCH, V441, P117, DOI 10.1007/s00428-001-0581-x; MATSUDA R, 1993, AM J PATHOL, V142, P339; Miliaras D, 2004, J CLIN PATHOL, V57, P463, DOI 10.1136/jcp.2003.013532; Misago N, 2014, J CUTAN PATHOL, V41, P437, DOI 10.1111/cup.12317; NATALI PG, 1992, INT J CANCER, V52, P197, DOI 10.1002/ijc.2910520207; Pan CX, 2005, MODERN PATHOL, V18, P320, DOI 10.1038/modpathol.3800318; Ramakrishnan R, 2013, AM J SURG PATHOL, V37, P1603, DOI 10.1097/PAS.0b013e318299fcac; Requena L, 2006, PATHOLOGY GENETICS S, P125; Scotlandi K, 2003, J CLIN ONCOL, V21, P1952, DOI 10.1002/JCO.2003.11.111; Su LD, 2002, AM J DERMATOPATH, V24, P289, DOI 10.1097/01.DAD.0000019962.96609.00; TAKAHASHI H, 1995, VIRCHOWS ARCH, V427, P283; Terada T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0444-0; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Vita M, 2014, JAMA DERMATOL, V150, P1345, DOI 10.1001/jamadermatol.2014.1437; Volmar Keith E, 2005, Arch Pathol Lab Med, V129, pe113; Wang HY, 2005, AM J SURG PATHOL, V29, P640, DOI 10.1097/01.pas.0000157943.33903.92; Wells SJ, 1996, AM J CLIN PATHOL, V106, P192; Yang DT, 2004, J CUTAN PATHOL, V31, P254, DOI 10.1111/j.0303-6987.2003.00175.x	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-6987	1600-0560		J CUTAN PATHOL	J. Cutan. Pathol.	JUL	2015	42	7					480	488		10.1111/cup.12492		9	Dermatology; Pathology	Dermatology; Pathology	CN0RS	WOS:000358121700007		
J	Kosaki, Y; Pearce, JM				Kosaki, Yutaka; Pearce, John M.			Asymmetrical Generalization of Length in the Rat	JOURNAL OF EXPERIMENTAL PSYCHOLOGY-ANIMAL LEARNING AND COGNITION			English	Article						generalization of magnitude; spatial learning; discrimination of length	STIMULUS-INTENSITY DYNAMISM; DISCRIMINATION; DIMENSION	Two groups of rats in Experiment 1 were required to escape from a square pool by swimming to 1 of 2 submerged platforms that were situated beside the centers of 2 opposite walls. To help rats find a platform, black panels of equal width were pasted to the middle of the walls that were adjacent to the platforms. The width of the 2 panels was 50 cm for Group 50, and 100 cm for Group 100. Test trials were then conducted in the same pool, but with the platforms removed and with a 50-cm panel on 1 wall and a 100-cm panel on the opposite wall. Group 50 expressed a stronger preference for the 100-cm than the 50-cm panel during the test, whereas Group 100 expressed a similar preference for both panels. Thus the degree of generalization from the short to the long panel was greater than from the long to the short panel. Experiments 2 and 3 pointed to the same conclusion. They were of a similar design to Experiment 1, except that the lengths of the panels for the 2 groups were 25 and 50 cm in Experiment 2, and 25 and 100 cm in Experiment 3. The results are explained by assuming the original training results in the walls without black panels entering into inhibitory associations. This inhibition is then assumed to generalize more to the short than the long test panels and thereby result in an asymmetry in the gradients of generalization between the different lengths.	[Kosaki, Yutaka; Pearce, John M.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	Kosaki, Y (reprint author), Keio Univ, Adv Res Ctr, Minato Ku, 2-15-45 Mita, Tokyo, Japan.	y.kosaki@cantab.net			United Kingdom Biotechnology and Biological Sciences Research Council [BB/H006176]; Wellcome Trust [WT 087855]	This research was supported in part by grants from the United Kingdom Biotechnology and Biological Sciences Research Council (BB/H006176) and the Wellcome Trust (WT 087855). We thank Alex Roberts and Amelia Stanton for assistance with data collection in a preliminary experiment for the present study.	Spence KW, 1937, PSYCHOL REV, V44, P430, DOI 10.1037/h0062885; Steiger JH, 2004, PSYCHOL METHODS, V9, P164, DOI 10.1037/1082-989X.9.2.164; Kosaki Y, 2013, J EXP PSYCHOL ANIM B, V39, P342, DOI 10.1037/a0032570; PEARCE JM, 1994, PSYCHOL REV, V101, P587, DOI 10.1037//0033-295X.101.4.587; HULL CL, 1949, PSYCHOL REV, V56, P67, DOI 10.1037/h0058051; Bouton ME, 2011, J EXP PSYCHOL ANIM B, V37, P79, DOI 10.1037/a0021214; Blough D. S., 1975, J EXPT PSYCHOLOGY AN, V1, P3, DOI [DOI 10.1037/0097-7403.1.1.3, 10.1037/0097-7403.1.1.3]; GRICE GR, 1950, J EXP PSYCHOL, V40, P702, DOI 10.1037/h0054435; Hovland C. I., 1937, J GENET PSYCHOL, V1937, P261; LOGAN FA, 1954, PSYCHOL REV, V61, P77, DOI 10.1037/h0057534; Mackintosh N.J., 1974, PSYCHOL ANIMAL LEARN; PERKINS CC, 1953, J EXP PSYCHOL, V46, P225, DOI 10.1037/h0063567; PURTLE RB, 1973, PSYCHOL BULL, V80, P408, DOI 10.1037/h0035233; RAZRAN G, 1949, PSYCHOL BULL, V46, P337, DOI 10.1037/h0060507; Rescorla R. A., 1972, CLASSICAL CONDITION, V2, P64, DOI DOI 10.1016/J.COGPSYCH.2004.11.001; SCAVIO MJ, 1974, PAVLOVIAN J BIOL SCI, V9, P25; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243	17	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0097-7403	1939-2184		J EXP PSYCHOL-ANIM L	J. Exp. Psychol.-Anim. Learn. Cogn.	JUL	2015	41	3					266	276		10.1037/xan0000056		11	Psychology, Biological; Behavioral Sciences; Psychology; Psychology, Experimental; Zoology	Psychology; Behavioral Sciences; Zoology	CM6RJ	WOS:000357816900005		
J	Nakano, M				Nakano, Miyo			Detection and Quantification of Thermophilic Spore-Forming Moorella thermoacetica in Canned Beverages Using Real-Time PCR	JOURNAL OF FOOD PROTECTION			English	Article							BACTERIA; SPOILAGE; FOOD; RISK	A quantitative real-time PCR assay was developed to specifically detect and quantify Moorella thermoacetica and/or Moorella thermoautotrophica from canned coffee beverages. Six different combinations of newly designed primers were examined, and primer pair v1-1F/v4R was found to specifically amplify M. thermoacetica and M. thermoautotrophica. The minimum detection sensitivity was 15 fg of pure culture DNA from M. thermoacetica. Twenty commercial canned coffee beverages were then screened for the presence of M. thermoacetica, and two were shown to contain >1.3 and >1.0 CFU/ml, respectively. Therefore, the assay developed in this study may be useful for accurately tracking and quantifying M. thermoacetica and M. thermoautotrophica in beverage samples.	Toyo Inst Food Technol, Div Food Sci, Kawanishi, Hyogo 6660026, Japan	Nakano, M (reprint author), Toyo Inst Food Technol, Div Food Sci, 23-2,4 Chome, Kawanishi, Hyogo 6660026, Japan.	miyo_nakano@shokuken.or.jp					Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Postollec F, 2011, FOOD MICROBIOL, V28, P848, DOI 10.1016/j.fm.2011.02.008; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Ruckert A, 2004, INT J FOOD MICROBIOL, V96, P263, DOI 10.1016/j.ijfoodmicro.2004.03.020; Oomes SJCM, 2007, INT J FOOD MICROBIOL, V120, P85, DOI 10.1016/j.ijfoodmicro.2007.06.013; Andre S, 2013, INT J FOOD MICROBIOL, V165, P134, DOI 10.1016/j.ijfoodmicro.2013.04.019; Prevost S, 2010, CURR MICROBIOL, V61, P525, DOI 10.1007/s00284-010-9648-8; Le Drean G, 2010, INT J FOOD MICROBIOL, V138, P100, DOI 10.1016/j.ijfoodmicro.2009.12.013; Asaka M., 2009, TOYO I FOOD TECHNOL, V27, P71; Byrer DE, 2000, ARCH MICROBIOL, V174, P334, DOI 10.1007/s002030000211; Carrlier J. P., 2006, SYST APPL MICROBIOL, V29, P581; Cooper RM, 2006, J BASIC MICROB, V46, P358, DOI 10.1002/jobm.200510132; Malorny B, 2008, APPL ENVIRON MICROB, V74, P1299, DOI 10.1128/AEM.02489-07; Matsuda N., 1982, Journal of the Food Hygienic Society of Japan, V23, P480; Moriyama R., 1996, Journal of Antibacterial and Antifungal Agents, Japan, V24, P3; Nakayama A., 1980, J FOOD HYG SOC JPN, V22, P30; NAKAYAMA A, 1982, Journal of the Food Hygienic Society of Japan, V23, P25; Rigaux C, 2014, INT J FOOD MICROBIOL, V171, P119, DOI 10.1016/j.ijfoodmicro.2013.11.014; Rose HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022668; SUWA N, 1986, J JPN SOC FOOD SCI, V33, P44; Yamamoto K., 1987, J FOOD HYG SOC JPN, V29, P256; YAMAMOTO K, 1984, J FOOD HYG SOC JPN, V25, P233	22	0	0	INT ASSOC FOOD PROTECTION	DES MOINES	6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA	0362-028X	1944-9097		J FOOD PROTECT	J. Food Prot.	JUL	2015	78	7					1392	1396		10.4315/0362-028X.JFP-14-547		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CM5YS	WOS:000357765500022		
J	Honda, M; Kawana, T; Takehara, M; Inoue, Y				Honda, Masaki; Kawana, Takahiro; Takehara, Munenori; Inoue, Yoshinori			Enhanced E/Z Isomerization of (All-E)-lycopene by Employing Iron(III) Chloride as a Catalyst	JOURNAL OF FOOD SCIENCE			English	Article						carotenoids; catalyst; iron; isomerization; tomato	DIFFERENT GEOMETRICAL-ISOMERS; BETA-CAROTENE; CIS-ISOMERS; ALL-TRANS; THERMAL-ISOMERIZATION; LYCOPENE ISOMERS; IN-VITRO; ALPHA-CAROTENE; HEAT-TREATMENT; CHLOROPHYLL-A	Catalytic isomerization of (all-E)-lycopene to Z-isomers using iron(III) chloride was investigated and optimized under various conditions of solvents, concentrations of iron(III) chloride, and reaction temperatures. The total contents of Z-isomers converted were higher in the order of CH2Cl2 (78.4%) > benzene (61.4%) > acetone (51.5%) > ethyl acetate (50.8%) at 20 degrees C for 3 h using 1.0 x 10(-3) mg/mL iron(III) chloride for 0.1 mg/mL (all-E)-lycopene. However, the decomposition of lycopene was markedly accelerated in CH2Cl2: the remaining lycopene after the reaction for 3 h and 12 h was only 79.4% and 47.5%, respectively. As the concentration of catalyst increased in acetone, the Z-isomerization ratio of lycopene increased to more than 80%, followed by rapid degradation of lycopene to undetectable levels using >4.0 x 10(-3) mg/mL iron(III) chloride with the above concentration of (all-E)-lycopene. Finally, greater isomerization (79.9%) was attained at 60 degrees C in acetone for 3 h in the presence of 1.0 x 10(-3) mg/mL iron(III) chloride, largely without decomposition of lycopene (remaining ratio of total amount of lycopene isomers after the reaction, 96.5%). As iron(III) chloride has found general use as a food additive for iron fortification and acetone is also widely used in the food field, this method can be applied to the food and beverage processing industry. Practical Application The dietary intake of lycopene, a natural red pigment found in brightly colored vegetables and fruits such as tomatoes and watermelons, has been reported to lower the risk of some diseases, including cancer. Lycopene molecules occur naturally in a long and straight shape, but on the other hand lycopene molecules with bent forms are highly absorbed by living cells, and showed good antioxidant activity. This study has demonstrated the efficient production of the bent lycopene using ionic iron as an accelerator, which is often contained in nutritional supplements.	[Honda, Masaki; Kawana, Takahiro] Kagome Co Ltd, Div Res & Dev, Nishitomiyama, Nasushiobara 3292762, Japan; [Takehara, Munenori; Inoue, Yoshinori] Univ Shiga Prefecture, Dept Mat Sci, Hassaka, Hikone 5228533, Japan	Honda, M (reprint author), Kagome Co Ltd, Div Res & Dev, Nishitomiyama, Nasushiobara 3292762, Japan.	Masaki_Honda2@kagome.co.jp					Heymann T, 2013, J AGR FOOD CHEM, V61, P11133, DOI 10.1021/jf403694q; Schierle J, 1997, FOOD CHEM, V59, P459, DOI 10.1016/S0308-8146(96)00177-X; Palozza P, 2010, ARCH BIOCHEM BIOPHYS, V504, P26, DOI 10.1016/j.abb.2010.06.031; Yuan JP, 1999, J AGR FOOD CHEM, V47, P3656, DOI 10.1021/jf981319u; Boileau AC, 1999, J NUTR, V129, P1176; Schieber A, 2005, TRENDS FOOD SCI TECH, V16, P416, DOI 10.1016/j.tifs.2005.03.018; Clinton SK, 1998, NUTR REV, V56, P35; Clinton SK, 1996, CANCER EPIDEM BIOMAR, V5, P823; STAHL W, 1993, CLIN CHEM, V39, P810; Richelle M, 2010, BRIT J NUTR, V103, P1800, DOI 10.1017/S0007114510000103; Lee MT, 2002, FOOD CHEM, V78, P425, DOI 10.1016/S0308-8146(02)00146-2; Lee MT, 2001, CHROMATOGRAPHIA, V54, P613, DOI 10.1007/BF02492187; Bohm V, 2002, J AGR FOOD CHEM, V50, P221, DOI 10.1021/jf010888q; Frohlich K, 2007, INT J VITAM NUTR RES, V77, P369, DOI 10.1024/0300-9831.77.6.369; Chasse GA, 2001, J MOL STRUC-THEOCHEM, V571, P27, DOI 10.1016/S0166-1280(01)00424-9; Alwis DDDH, 2015, J LUMIN, V158, P60, DOI 10.1016/j.jlumin.2014.08.036; Caris-Veyrat C, 2003, J AGR FOOD CHEM, V51, P7318, DOI 10.1021/jf034735+; Knockaert G, 2012, J AGR FOOD CHEM, V60, P10312, DOI 10.1021/jf3025776; Omoni AO, 2005, TRENDS FOOD SCI TECH, V16, P344, DOI 10.1016/j.tifs.2005.02.002; Unlu NZ, 2007, BRIT J NUTR, V98, P140, DOI 10.1017/S0007114507685201; Updike AA, 2003, J AGR FOOD CHEM, V51, P6184, DOI 10.1021/jf030350f; Muller L, 2011, J AGR FOOD CHEM, V59, P4504, DOI 10.1021/jf1045969; Honda M, 2014, J AGR FOOD CHEM, V62, P11353, DOI 10.1021/jf504502t; Ouchi A, 2010, J AGR FOOD CHEM, V58, P9967, DOI 10.1021/jf101947a; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; STAHL W, 1992, ARCH BIOCHEM BIOPHYS, V294, P173, DOI 10.1016/0003-9861(92)90153-N; Aman R, 2005, J AGR FOOD CHEM, V53, P9512, DOI 10.1021/jf050926w; Khoo HE, 2011, MOLECULES, V16, P1710, DOI 10.3390/molecules16021710; Failla ML, 2008, J NUTR, V138, P482; HENGARTNER U, 1992, HELV CHIM ACTA, V75, P1848, DOI 10.1002/hlca.19920750611; Hwang ES, 2012, J FOOD SCI, V77, pC1109, DOI 10.1111/j.1750-3841.2012.02909.x; Guo WH, 2008, J PHYS CHEM B, V112, P12158, DOI 10.1021/jp8019705; Kispert LD, 2010, CHEM LETT, V39, P148, DOI 10.1246/cl.2010.148; Aoki H, 2002, BIOSCI BIOTECH BIOCH, V66, P2479, DOI 10.1271/bbb.66.2479; Bhuvaneswari V., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P627, DOI 10.2174/156801105774574667; Britton G., 1995, CAROTENOIDS, V1B, P13; CHEN BH, 1994, J AGR FOOD CHEM, V42, P2391, DOI 10.1021/jf00047a006; Chen BH, 1998, FOOD CHEM, V62, P299, DOI 10.1016/S0308-8146(97)00201-X; Colle I, 2010, J FOOD SCI, V75, pC753, DOI 10.1111/j.1750-3841.2010.01862.x; Gao Y, 2004, J PHYS CHEM B, V108, P9456, DOI 10.1021/jp036091e; Gao YL, 2003, J PHYS CHEM B, V107, P5333, DOI 10.1021/jp034063q; Glaser T., 2002, On-line LC-NMR and related techniques, P129, DOI 10.1002/0470854820.ch5b; Hackett MM, 2004, J FOOD SCI, V69, P536; Holden Joanne M., 1999, Journal of Food Composition and Analysis, V12, P169, DOI 10.1006/jfca.1999.0827; Honda M, 2015, FOOD CHEM, V171, P323, DOI 10.1016/j.foodchem.2014.09.004; JENSEN NH, 1982, J AM CHEM SOC, V104, P6117, DOI 10.1021/ja00386a048; KUKI M, 1991, J PHYS CHEM-US, V95, P7171, DOI 10.1021/j100172a016; ONEIL CA, 1995, J AGR FOOD CHEM, V43, P631, DOI 10.1021/jf00051a014; Qiu D, 2012, J FOOD SCI, V77, pC934, DOI 10.1111/j.1750-3841.2012.02842.x; Rajendran V, 2007, J CHEM SCI, V119, P253, DOI 10.1007/s12039-007-0033-5; RIBAYAMERCADO JD, 1995, J NUTR, V125, P1854; Richelle M, 2012, BRIT J NUTR, V107, P1482, DOI 10.1017/S0007114511004569; Story EN, 2010, ANNU REV FOOD SCI T, V1, P189, DOI 10.1146/annurev.food.102308.124120; Subagio A, 1998, BIOSCI BIOTECH BIOCH, V62, P2453, DOI 10.1271/bbb.62.2453; Takehara M, 2014, J AGR FOOD CHEM, V62, P264, DOI 10.1021/jf404497k; Wei C-C, 1997, J CHEM SOC PERK T, V2, P783, DOI 10.1039/A605027A; Yuan JP, 2001, FOOD CHEM, V73, P131, DOI 10.1016/S0308-8146(01)00107-8	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	JUL	2015	80	7					C1453	C1459		10.1111/1750-3841.12916		7	Food Science & Technology	Food Science & Technology	CM8JX	WOS:000357947600005		
J	Itoh, K; Mizuno, S; Hama, S; Oshima, W; Kawamata, M; Hossain, A; Ishihara, Y; Tokuda, M				Itoh, Kouichi; Mizuno, Shodo; Hama, Sayuri; Oshima, Wataru; Kawamata, Miku; Hossain, Akram; Ishihara, Yasuhiro; Tokuda, Masaaki			Beneficial Effects of Supplementation of the Rare Sugar "D-allulose" Against Hepatic Steatosis and Severe Obesity in Lep(ob)/Lep(ob) Mice	JOURNAL OF FOOD SCIENCE			English	Article						D-allulose; dietary supplements; hepatic steatosis; obesity; sugar	FATTY LIVER-DISEASE; DIETARY D-PSICOSE; D-FRUCTOSE; ADIPOSE CONVERSION; CELL-LINE; RATS; DIFFERENTIATION; STEATOHEPATITIS; WEIGHT; PERSPECTIVES	A rare sugar, D-allulose (also called D-psicose), has recently been applied as a food supplement in view of controlling diabetes and obesity in Japan. D-allulose has been proven to have unique effects against hyperglycemia and hyperlipidemia in a number of studies using several species of rats and mice. However, the antiobesity effects of D-allulose have not yet been assessed in Lep(ob)/Lep(ob) (ob/ob) mice. Therefore, this study explored the dietary supplemental effects of this sugar in leptin-deficient ob/ob mice. Consequently, the subchronic ingestion of D-allulose in ob/ob mice for 15 wk significantly decreased the body and liver weights, and the loss of body weight was involved in the reduction of the total fat mass, including abdominal visceral fat, and not fat-free body mass, including muscle. Furthermore, D-allulose improved hepatic steatosis, as evaluated using hepatic histological studies and MRI. In the normal mice, none of these parameters were influenced by the single or long-term ingestion of D-allulose. These results indicate that dietary supplementation of D-allulose especially influences postprandial hyperglycemia and obesity-related hepatic steatosis, without exercise therapy or dietary restriction. Therefore, D-allulose may be useful as a supplement for preventing and improving obesity and obesity-related disorders.	[Itoh, Kouichi; Mizuno, Shodo; Hama, Sayuri; Oshima, Wataru; Kawamata, Miku] Tokushima Bunri Univ, Lab Pharmacotherapy & Expt Neurol, Kagawa Sch Pharmaceut Sci, Kagawa 7692193, Japan; [Hossain, Akram; Tokuda, Masaaki] Kagawa Univ, Fac Med, Dept Cell Physiol, Kagawa 7610793, Japan; [Ishihara, Yasuhiro] Hiroshima Univ, Lab Mol Brain Sci, Grad Sch Integrated Arts & Sci, Hiroshima 7398521, Japan; [Tokuda, Masaaki] Kagawa Univ, Rare Sugar Res Ctr, Kagawa 7610793, Japan; [Hossain, Akram] Matsutani Chem Ind Co Ltd, Res Lab, Kobe, Hyogo, Japan; [Mizuno, Shodo] Shikoku Med Ctr Children & Adults, Dept Pharm, Kagawa 7658507, Japan; [Hama, Sayuri] Otsuka Pharmaceut Co Ltd, Tokushima Factory 2, Bulk Pharmaceut Chem Dept, Tokushima Factory Prod Headquarters 2, Tokushima 7710192, Japan	Itoh, K (reprint author), Tokushima Bunri Univ, Lab Pharmacotherapy & Expt Neurol, Kagawa Sch Pharmaceut Sci, Kagawa 7692193, Japan.	itoh@kph.bunri-u.ac.jp			"The Regional Innovation Cluster Program" in Japan; Tokushima Bunri Univ.	This work was supported by a grant from "The Regional Innovation Cluster Program" in Japan and, in part, by Tokushima Bunri Univ. We thank Ms. H. Fukuoka for her outstanding technical expertise.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Takeshita K, 2000, J BIOSCI BIOENG, V90, P453, DOI 10.1263/jbb.90.453; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Granstrom TB, 2004, J BIOSCI BIOENG, V97, P89, DOI 10.1016/S1389-1723(04)70173-5; Sass DA, 2005, DIGEST DIS SCI, V50, P171, DOI 10.1007/s10620-005-1267-7; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Hayashi N, 2010, BIOSCI BIOTECH BIOCH, V74, P510, DOI 10.1271/bbb.90707; Hossain MA, 2011, BIOCHEM BIOPH RES CO, V405, P7, DOI 10.1016/j.bbrc.2010.12.091; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Matsuo T, 2006, BIOSCI BIOTECH BIOCH, V70, P2081, DOI 10.1271/bbb.60036; Montague CT, 1997, NATURE, V387, P903; van Baak MA, 2009, OBES REV, V10, P9, DOI 10.1111/j.1467-789X.2008.00561.x; Fishbein MH, 1997, MAGN RESON IMAGING, V15, P287, DOI 10.1016/S0730-725X(96)00224-X; Matsuo T, 2002, J NUTR SCI VITAMINOL, V48, P77; Matsuo T, 2009, J CLIN BIOCHEM NUTR, V45, P202, DOI 10.3164/jcbn.09-36; Matsuo T, 2001, ASIA PAC J CLIN NUTR, V10, P233, DOI 10.1046/j.1440-6047.2001.00246.x; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; BRAY GA, 1979, PHYSIOL REV, V59, P719; WISE LS, 1979, J BIOL CHEM, V254, P273; Wang YF, 2005, AM J CLIN NUTR, V81, P555; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; INGALLS AM, 1950, J HERED, V41, P317; Valls C, 2006, EUR RADIOL, V16, P2292, DOI 10.1007/s00330-006-0146-0; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; CREE GM, 1968, CAN J BIOCHEM CELL B, V46, P765; [Anonymous], 2012, OECD HLTH STAT; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Oshima H, 2006, FOOD SCI TECHNOL RES, V12, P137, DOI 10.3136/fstr.12.137; FOWLER SD, 1985, J HISTOCHEM CYTOCHEM, V33, P833; Mu WM, 2012, APPL MICROBIOL BIOT, V94, P1461, DOI 10.1007/s00253-012-4093-1; Gardner C, 2012, CIRCULATION, V126, P509, DOI 10.1161/CIR.0b013e31825c42ee; Nagata Y, 2015, J AGR FOOD CHEM, V63, P3168, DOI 10.1021/jf502535p; Hishiike T, 2013, J AGR FOOD CHEM, V61, P7381, DOI 10.1021/jf401449m; Baek SH, 2010, J FOOD SCI, V75, P49; BRISTOL JB, 1985, BRIT MED J, V291, P1467; Burt B A, 2001, J Dent Educ, V65, P1017; HERBERG L, 1977, METABOLISM, V26, P59, DOI 10.1016/0026-0495(77)90128-7; Hossain A, 2015, DRUG DES DEV THER, V9, P525, DOI 10.2147/DDDT.S71289; Hossain MA, 2012, BIOCHEM BIOPH RES CO, V425, P717; Iida T, 2008, J NUTR SCI VITAMINOL, V54, P511, DOI 10.3177/jnsv.54.511; Lillie R.D., 1943, ARCH PATHOL, V36, P432; MAYER J, 1951, SCIENCE, V113, P746, DOI 10.1126/science.113.2948.746; MILICH R, 1986, CLIN PSYCHOL REV, V6, P493, DOI 10.1016/0272-7358(86)90034-6; PHILLIPS M, 1995, J CELL SCI, V108, P395; Rinella ME, 2003, LIVER TRANSPLANT, V9, P851, DOI 10.1053/jlts.2003.50153; Sanyal A. J., 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Smith D.J., 2009, INT J BODY COMPOS RE, V7, P21; Te Morenga L, 2012, BMJ-BRIT MED J, V346, pe7492, DOI DOI 10.1136/BMJ.E7492	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	JUL	2015	80	7					H1619	H1626		10.1111/1750-3841.12908		8	Food Science & Technology	Food Science & Technology	CM8JX	WOS:000357947600028		
J	Darwish, WS; Nakayama, SMM; Itotani, Y; Ohno, M; Ikenaka, Y; Ishizuka, M				Darwish, Wageh S.; Nakayama, Shouta M. M.; Itotani, Yuumi; Ohno, Marumi; Ikenaka, Yoshinori; Ishizuka, Mayumi			Metabolic Activation of Heterocyclic Amines and Expression of Xenobiotic-Metabolizing Enzymes in the Gastrointestinal Tract of Rats	JOURNAL OF FOOD SCIENCE			English	Article						gastrointestinal tract; heterocyclic amines; xenobiotic-metabolizing enzymes	AROMATIC-AMINES; IN-VITRO; GENETIC SUSCEPTIBILITY; SMALL-INTESTINE; HUMAN CANCER; RISK; INDUCTION; EXPOSURE; 2-AMINO-1-METHYL-6-PHENYLIMIDAZO<4,5-B>PYRIDINE; DETOXIFICATION	Heterocyclic amines get entry into human body mainly through ingestion of pan-fried meats cooked at high temperatures. Exposure of the gastrointestinal tract (GIT) to ingested xenobiotics prior to delivery to the liver may lead to metabolic activation, which may explain the high incidence of GIT carcinogenesis. Therefore, this study investigated the mutagenic activation of 2 heterocyclic amines, 2-aminoanthracene (2-AA) and 3-amino-1-methyl-5H-prydo[4,3-b]indole (Trp-P-2), in the GIT of rats. In addition, the constitutive mRNA expression profiles of xenobiotic-metabolizing enzymes (XMEs) in the GIT of rats were examined. Metabolic activation of 2-AA was detected in all GIT tissues except the duodenum and rectum, and it was detected at high levels in the ileum and cecum. Furthermore, we revealed high metabolic activation of 2-AA and Trp-P-2 in the jejunum. The mRNA expression of phase I and II enzymes in rat GIT corresponded with their mutagenic activation ability. In conclusion, our results suggest that different expression levels of XME among GIT tissues may contribute to the tissue-specific differences in metabolic activation of xenobiotics such as heterocyclic amines in rats. Practical Application This study declares mutagenic activation of 2 heterocyclic amines namely 2-aminoanthracene (2-AA) and 3-amino-1-methyl-5H-prydo[4,3-b]indole (Trp-P-2), in the gastrointestinal tract (GIT) of rats. In addition, results obtained in this study suggest that GIT tissue-specific expression of xenobiotic metabolizing enzymes may contribute to the tissue-specific mutagenesis/carcinogenesis.	[Darwish, Wageh S.; Nakayama, Shouta M. M.; Itotani, Yuumi; Ohno, Marumi; Ikenaka, Yoshinori; Ishizuka, Mayumi] Hokkaido Univ, Lab Toxicol, Dept Environm Vet Sci, Grad Sch Vet Med,Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Darwish, Wageh S.] Zagazig Univ, Food Control Dept, Fac Vet Med, Zagazig 44510, Egypt	Ishizuka, M (reprint author), Hokkaido Univ, Lab Toxicol, Dept Environm Vet Sci, Grad Sch Vet Med,Kita Ku, Kita 18,Nishi 9, Sapporo, Hokkaido 0600818, Japan.	ishizum@vetmed.hokudai.ac.jp		Darwish, Wageh/0000-0002-4399-1401	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24248056, 24405004, 23710038]; Japan Society for the Promotion of Science [23001097]; Mitsui & Co., Ltd. Environment Fund	This study was supported in part by the Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan awarded to M. Ishizuka (Nos. 24248056 and 24405004) and Y. Ikenaka (No. 23710038); as well as Research Fellowships from the Japan Society for the Promotion of Science Grant-in-Aid awarded to W.S. Darwish (No. 23001097). We also acknowledge the financial support by The Mitsui & Co., Ltd. Environment Fund.	Alaejos MS, 2008, FOOD RES INT, V41, P327, DOI 10.1016/j.foodres.2008.02.001; Ames N., 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; KAISERMAN MJ, 1992, AM J PUBLIC HEALTH, V82, P1023, DOI 10.2105/AJPH.82.7.1023; Turesky RJ, 1996, CHEM RES TOXICOL, V9, P397, DOI 10.1021/tx950131r; Jemnitz K, 2004, MUTAGENESIS, V19, P245, DOI 10.1093/mutage/geh026; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; Ma Q, 2007, DRUG METAB DISPOS, V35, P1009, DOI 10.1124/dmd.107.015826; Darwish W, 2010, FOOD CHEM TOXICOL, V48, P2526, DOI 10.1016/j.fct.2010.06.026; Zheng Z, 2002, DRUG METAB DISPOS, V30, P397, DOI 10.1124/dmd.30.4.397; MURRAY GI, 1994, GUT, V35, P599, DOI 10.1136/gut.35.5.599; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; Hagiwara A, 2001, CANCER LETT, V171, P17, DOI 10.1016/S0304-3835(01)00510-9; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; Berger I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026794; Blanchard DK, 2000, WORLD J SURG, V24, P421; Dingley KH, 1999, CANCER EPIDEM BIOMAR, V8, P507; Ghosh MC, 2001, ENVIRON RES, V86, P167, DOI 10.1006/enrs.2001.4249; Hein DW, 2006, MOL CARCINOGEN, V45, P230, DOI 10.1002/mc.20164; Hernandez-Martinez N, 2007, ENVIRON TOXICOL PHAR, V24, P297, DOI 10.1016/j.etap.2007.07.004; Ho V, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0430-6; Mate L, 2010, J VET PHARMACOL THER, V33, P537, DOI 10.1111/j.1365-2885.2010.01177.x; NEBERT DW, 1991, MUTAT RES, V247, P267, DOI 10.1016/0027-5107(91)90022-G; ODA Y, 1995, MUTAT RES-ENVIR MUTA, V334, P145, DOI 10.1016/0165-1161(95)90005-5; Paulsen JE, 1999, CARCINOGENESIS, V20, P1277, DOI 10.1093/carcin/20.7.1277; Sugimura T, 1996, ENVIRON HEALTH PERSP, V104, P429, DOI 10.2307/3432798; TAKAYAMA K, 1989, JPN J CANCER RES, V80, P1145; Takiguchi M, 2010, TOXICOL SCI, V116, P79, DOI 10.1093/toxsci/kfq087; Turesky RJ, 2007, TOXICOL LETT, V168, P219, DOI 10.1016/j.toxlet.2006.10.018	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	JUL	2015	80	7					T1627	T1632		10.1111/1750-3841.12931		6	Food Science & Technology	Food Science & Technology	CM8JX	WOS:000357947600029		
J	Kato, Y; Islam, MM; Young, KC; Rogers, ME; Takeshima, N				Kato, Yoshiji; Islam, Mohammod M.; Young, Kaelin C.; Rogers, Michael E.; Takeshima, Nobuo			Threshold of Chair Stand Power Necessary to Perform Activities of Daily Living Independently in Community-Dwelling Older Women	JOURNAL OF GERIATRIC PHYSICAL THERAPY			English	Article							MUSCLE POWER; NEUROMUSCULAR ACTIVATION; FUNCTIONAL PERFORMANCE; LONGITUDINAL DECLINE; ELDERLY-MEN; ADULTS; STRENGTH; ASSOCIATION; HEALTHY; SPEED	Purpose: To determine (1) the reproducibility of measurements of chair stand mean power (CSMP), (2) the relationships of CSMP with age, height, body mass, and body mass index, and (3) to identify the threshold of CSMP below which performing activities of daily living (ADL) is limited in older women. Methods: Eighty-seven older women (70-88 years) were divided into an independent group (n = 48) who needed no assistance and a dependent group (n = 39) who needed assistance to perform ADL. The CSMP expressed in watts (velocity x load) for each repetition was assessed by a device that measures mean velocity. Results: The intraclass correlation coefficient for CSMP suggested a high level of reproducibility (intra-class correlation coefficient = 0.88-0.92, P < .05). Relationships existed between CSMP and age (r = -0.37; P < .001), CSMP and height (r = 0.31; P < .001), CSMP and body mass (r = 0.43; P < .001), and CSMP and body mass index (r = 0.30; P < .001). A receiver operator characteristic curve analysis revealed the optimal threshold criteria; a CSMP of 214 watts resulted in the highest combination of sensitivity (82.1%) and specificity (81.2%). Conclusion: The threshold of CSMP below which assistance is required to perform ADL in community-dwelling older women was identified.	[Kato, Yoshiji] Nagoya City Univ, Grad Sch Nat Sci, Lab Exercise Gerontol, Nagoya, Aichi, Japan; [Islam, Mohammod M.] Yonaha Gen Hosp, Dept Rehabil, Kuwana, Mie, Japan; [Young, Kaelin C.; Rogers, Michael E.] Wichita State Univ, Ctr Phys Act & Aging, Dept Human Performance Studies, Wichita, KS USA; [Takeshima, Nobuo] Natl Inst Fitness & Sports Kanoya, Kanoya 8912393, Japan	Takeshima, N (reprint author), Natl Inst Fitness & Sports Kanoya, Sports & Life Sci, 1 Shiromizu Cho, Kanoya 8912393, Japan.	takeshima@nifs-k.ac.jp					American College of Sports Medicine, 2009, POSITION STAND MED S, V41, P1519; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113; Bohannon RW, 2006, PERCEPT MOTOR SKILL, V103, P215, DOI 10.2466/PMS.103.1.215-222; Cuoco A, 2004, J GERONTOL A-BIOL, V59, P1200; Foldvari M, 2000, J GERONTOL A-BIOL, V55, pM192; Bottaro M, 2007, EUR J APPL PHYSIOL, V99, P257, DOI 10.1007/s00421-006-0343-1; Clark DJ, 2013, J GERONTOL A-BIOL, V68, P1419, DOI 10.1093/gerona/glt036; Evans WJ, 2000, J GERONTOL A-BIOL, V55, pM309; Porter M. M., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P129; Hazell T, 2007, J AGING PHYS ACTIV, V15, P349; Hunter GR, 2004, SPORTS MED, V34, P329, DOI 10.2165/00007256-200434050-00005; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Jennings CL, 2005, J STRENGTH COND RES, V19, P859; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; MARGARIA R, 1966, J APPL PHYSIOL, V21, P1662; Bean JF, 2007, ARCH PHYS MED REHAB, V88, P604, DOI 10.1016/j.apmr.2007.02.004; Whitney SL, 2005, PHYS THER, V85, P1034; Takai Yohei, 2009, Journal of Physiological Anthropology, V28, P123, DOI 10.2114/jpa2.28.123; Latham NK, 2004, J GERONTOL A-BIOL, V59, P48; Miszko TA, 2003, J GERONTOL A-BIOL, V58, P171; Coelho CW, 2003, J STRENGTH COND RES, V17, P334; den Ouden MEM, 2013, GERIATR GERONTOL INT, V13, P274, DOI 10.1111/j.1447-0594.2012.00890.x; Lindemann U, 2003, EUR J APPL PHYSIOL, V89, P466, DOI 10.1007/s00421-003-0837-z; BASSEY EJ, 1992, CLIN SCI, V82, P321; Coelho CW, 2002, MED SCI SPORT EXER, V34, P1577, DOI 10.1249/01.MSS.0000031095.32154.D0; Earles D. R., 1997, Medicine and Science in Sports and Exercise, V29, pS11; Hakkinen K, 1996, J GERONTOL A-BIOL, V51, pB21; Izquierdo M, 1999, ACTA PHYSIOL SCAND, V167, P57; Reid KF, 2014, EUR J APPL PHYSIOL, V114, P29, DOI 10.1007/s00421-013-2728-2; SimAo R, 2001, REV BRAS MED ESPORTE, V7, P118	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1539-8412	2152-0895		J GERIATR PHYS THER	J. Geriatr. Phys. Ther.	JUL-SEP	2015	38	3					122	126		10.1519/JPT.0000000000000036		5	Geriatrics & Gerontology; Rehabilitation	Geriatrics & Gerontology; Rehabilitation	CM8HT	WOS:000357940800003		
J	Kitazawa, K; Showa, S; Hiraoka, A; Fushiki, Y; Sakauchi, H; Mori, M				Kitazawa, Kazutoshi; Showa, Satoko; Hiraoka, Akira; Fushiki, Yasuhiro; Sakauchi, Humio; Mori, Mitsuru			Effect of a Dual-Task Net-Step Exercise on Cognitive and Gait Function in Older Adults	JOURNAL OF GERIATRIC PHYSICAL THERAPY			English	Article							PHYSICAL-ACTIVITY; EXECUTIVE FUNCTIONS; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; LINKING THINKING; RANDOMIZED-TRIAL; ASSESSMENT SCALE; RATING-SCALE; PERFORMANCE; BALANCE	Background and Purpose: Participation in generally recommended aerobics or strength exercises may be challenging for older adults. Therefore, it is necessary to consider the types and levels of physical activities suited for them to improve their cognitive and gait function and adherence to exercise programs. This has prompted efforts to identify exercises that require less physical strength and frequency of performance, while still offering cognitive and health benefits. Here, we aimed to assess the effect of a novel dual-task net-step exercise (NSE) performed once a week for 8 consecutive weeks on improvements in cognitive performance and gait function in an older population. Methods: In this pretest/posttest experimental case control study, 60 healthy older adults (mean age 76.4 years) were recruited from community-dwelling people and separated randomly into 2 groups: a dual-task NSE group and a control group. The NSE group was asked to walk across a net without stepping on the ropes or being caught in the net. Two computer panel-type cognitive functional assessments, the Touch-M and Touch Panel-Type Dementia Assessment Scale, were administered at baseline and after 8 weeks of intervention to determine the effects of NSE. Improvements in gait function were also evaluated using Timed Up and Go test scores. Mixed-effect models with repeated measures (group x time) (analysis of variance, F test) were used to test the effects of NSE. Adjustments were made for covariates including age and sex (analysis of covariance). Results: The NSE group showed significant improvement in cognitive performance (6.8% change; total Touch-M score 5.4 points; P = .04) and gait performance (11.5% change; Timed Up and Go time -0.98 second; P < .001) over the 8-week period. In the control group, there was no significant improvement. Conclusions: This study shows that dual-task NSE is capable of improving cognitive and gait performance in healthy older adults. Our results indicate that NSE offers an option for a large segment of the older population who need an easier way to maintain their cognitive health and gait function.	[Kitazawa, Kazutoshi; Showa, Satoko; Fushiki, Yasuhiro; Sakauchi, Humio; Mori, Mitsuru] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido 0608556, Japan; [Kitazawa, Kazutoshi; Hiraoka, Akira] Hokkaido Univ, Asahikawa, Hokkaido, Japan	Kitazawa, K (reprint author), Sapporo Med Univ, Sch Med, Dept Publ Hlth, Chuo Ku, Minami 1,Nishi 17, Sapporo, Hokkaido 0608556, Japan.	kkitazawa@sapmed.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 22530598]; Hokkaido Kenko-zukuri Zaidan	This work was supported by a Grant-in-Aid for Scientific Research(C) from the Ministry of Education, Culture, Sports, Science and Technology (KAKENHI 22530598) and a grant from Hokkaido Kenko-zukuri Zaidan in 2009-2010.	Alexander NB, 2008, J GERONTOL A-BIOL, V63, P1325; Yang YR, 2007, ARCH PHYS MED REHAB, V88, P1236, DOI 10.1016/j.apmr.2007.06.762; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Nordin E, 2006, PHYS THER, V86, P646; van Iersel MB, 2008, J GERONTOL A-BIOL, V63, P1344; Williamson JD, 2009, J GERONTOL A-BIOL, V64, P688, DOI 10.1093/gerona/glp014; Rozzini L, 2008, J GERIATR PSYCH NEUR, V21, P261, DOI 10.1177/0891988708324940; Low KA, 2009, PSYCHOPHYSIOLOGY, V46, P1069, DOI 10.1111/j.1469-8986.2009.00854.x; Verghese J, 2010, J GERONTOL A-BIOL, V65, P1338, DOI 10.1093/gerona/glq127; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Hausdorff JM, 2008, J GERONTOL A-BIOL, V63, P1335; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1249/mss.0b013e3180616aa2; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Dux PE, 2009, NEURON, V63, P127, DOI 10.1016/j.neuron.2009.06.005; Li KZH, 2010, J GERONTOL A-BIOL, V65, P1344, DOI 10.1093/gerona/glq151; Larson EB, 2006, ANN INTERN MED, V144, P73; Erickson KI, 2007, CEREB CORTEX, V17, P192, DOI 10.1093/cercor/bhj137; Bherer L, 2008, EXP AGING RES, V34, P188, DOI 10.1080/03610730802070068; Elsawy B, 2010, AM FAM PHYSICIAN, V81, P55; Evans JJ, 2009, J INT NEUROPSYCH SOC, V15, P112, DOI 10.1017/S1355617708090152; Evans W., 2010, AM J CLIN NUTR, V91, P1123, DOI DOI 10.3945/AJCN.2010.28608A.PMID:20164314; Fukuhara S, 2004, MANUAL SF 8 JAPANESE; Hatakeyama Y, 2006, PSYCHOGERIATRICS, V17, P655; Herning Margaret M, 2005, J Geriatr Phys Ther, V28, P34; Inoue M, 2011, PSYCHOGERIATRICS, V11, P28, DOI 10.1111/j.1479-8301.2010.00345.x; Kruger J, 2009, GERONTOLOGIST, V49, DOI 10.1093/geront/gnp075; Liu-Ambrose T, 2009, J GERONTOL A-BIOL, V64, P975, DOI 10.1093/gerona/glp063; Logsdon RG, 2009, GERONTOLOGIST, V49, DOI 10.1093/geront/gnp082; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; Pondal Margarita, 2008, J Geriatr Phys Ther, V31, P57; Shubert TE, 2010, J GERIATR PHYS THER, V33, P157, DOI 10.1097/JPT.0b013e3181ff22f5; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P472	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1539-8412	2152-0895		J GERIATR PHYS THER	J. Geriatr. Phys. Ther.	JUL-SEP	2015	38	3					133	140		10.1519/JPT.0000000000000029		8	Geriatrics & Gerontology; Rehabilitation	Geriatrics & Gerontology; Rehabilitation	CM8HT	WOS:000357940800005		
J	Umehara, T; Matsuno, H; Toyoda, C; Oka, H				Umehara, Tadashi; Matsuno, Hiromasa; Toyoda, Chizuko; Oka, Hisayoshi			Thyroid hormone level is associated with motor symptoms in de novo Parkinson's disease	JOURNAL OF NEUROLOGY			English	Article						Thyroid hormone; Free triiodothyronine; Cardiac I-123-meta-iodobenzylguanidine uptake; Parkinson's disease; Motor symptoms	ORTHOSTATIC HYPOTENSION; SYMPATHETIC DENERVATION; MIBG UPTAKE; SECRETION; DOPAMINE; METAIODOBENZYLGUANIDINE; HYPOTHYROIDISM; NEUROENDOCRINE; FAILURE; SYSTEM	Sympathetic denervation has been observed not only in the myocardium but also in the thyroid of patients with Parkinson's disease (PD). We investigated whether sympathetic denervation as indicated by decreased cardiac I-123-meta-iodobenzylguanidine uptake is associated with the levels of thyroid hormones and whether the levels of thyroid hormones affect clinical manifestations in patients with PD. The subjects were 75 patients with de novo PD and 20 age-matched healthy controls. We examined the levels of thyroid-stimulating hormone, free triiodothyronine, and free thyroxine, and evaluated the associations of these levels with cardiac I-123-meta-iodobenzylguanidine uptake and motor symptoms. The results showed that the free triiodothyronine level was below the normal range in 29 patients (approximately 40 %) and was significantly lower in the patients with PD than in the controls. The decreased free triiodothyronine level was associated with akinetic-rigid motor subtype and washout ratio of cardiac I-123-meta-iodobenzylguanidine scintigraphy. The free triiodothyronine level negatively correlated with disease severity. Thyroid-stimulating hormone level was within normal range. However, its level was lower in patients with tremor-dominant type or mixed type than in those with akinetic-rigid type. All correlations of these variables with the levels of thyroid hormones remained statistically significant on multiple regression analysis. Our results suggest that the thyroid hormone level, especially the free triiodothyronine level, is closely related to motor symptoms in patients with de novo PD. Further studies are needed to clarify whether the decreased hormone levels have functional roles in motor and non-motor symptoms.	[Umehara, Tadashi; Matsuno, Hiromasa; Oka, Hisayoshi] Jikei Univ, Sch Med, Daisan Hosp, Dept Neurol, Komae, Tokyo 2018601, Japan; [Toyoda, Chizuko] Jikei Univ, Sch Med, Dept Neurol, Komae, Tokyo 2018601, Japan	Umehara, T (reprint author), Jikei Univ, Sch Med, Daisan Hosp, Dept Neurol, 4-11-1 Izumihoncho, Komae, Tokyo 2018601, Japan.	tumety@jikei.ac.jp					Orimo S, 2008, BRAIN, V131, P642, DOI 10.1093/brain/awm302; SISSON JC, 1987, J NUCL MED, V28, P1625; Spiegel J, 2007, J NEURAL TRANSM, V114, P331, DOI 10.1007/s00702-006-0518-2; Rossi C, 2010, EUR J NEUROL, V17, P626, DOI 10.1111/j.1468-1331.2009.02898.x; Goldstein DS, 2002, NEUROLOGY, V58, P1247; Del Tredici K, 2010, ACTA NEUROPATHOL, V119, P703, DOI 10.1007/s00401-010-0665-2; Flotats A, 2010, EUR J NUCL MED MOL I, V37, P1802, DOI 10.1007/s00259-010-1491-4; BERGER JR, 1981, NEUROLOGY, V31, P93; Bonuccelli U, 1999, PARKINSONISM RELAT D, V5, P49, DOI 10.1016/S1353-8020(99)00010-3; CARADOCDAVIES TH, 1986, BRIT MED J, V293, P38; CARDINALI DP, 1981, J NEURAL TRANSM, V52, P1, DOI 10.1007/BF01253092; Falaschi P, 2004, NEUROENDOCRINOL LETT, V25, P292; Garcia-Moreno JM, 2003, MOVEMENT DISORD, V18, P1058, DOI 10.1002/mds.10475; Garcia-Moreno JM, 2002, REV NEUROLOGIA, V35, P741; GUERIN V, 1990, ANN ENDOCRINOL-PARIS, V51, P43; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Imamura Y, 1996, J AM COLL CARDIOL, V28, P371, DOI 10.1016/0735-1097(96)00165-9; Jang W, 2013, CLIN AUTON RES, V23, P221, DOI 10.1007/s10286-013-0204-z; Kim HT, 2005, PARKINSONISM RELAT D, V11, P331, DOI 10.1016/j.parkreldis.2005.01.009; MANNISTO P, 1981, EUR J PHARMACOL, V76, P403, DOI 10.1016/0014-2999(81)90111-4; Matsui H, 2005, ANN NUCL MED, V19, P225, DOI 10.1007/BF02984609; MELANDER A, 1974, ENDOCRINOLOGY, V94, P959; Munhoz RP, 2004, PARKINSONISM RELAT D, V10, P381, DOI 10.1016/j.parkreldis.2004.03.008; Oka H, 2011, EUR J NEUROL, V18, P286, DOI 10.1111/j.1468-1331.2010.03135.x; Orimo S, 1999, J NEUROL NEUROSUR PS, V67, P189, DOI 10.1136/jnnp.67.2.189; Prakash KM, 2010, PARKINSONISM RELAT D, V16, P691, DOI 10.1016/j.parkreldis.2010.07.009; SAMUELS MH, 1992, J CLIN ENDOCR METAB, V74, P217, DOI 10.1210/jc.74.1.217; Sapin R, 2003, ANN BIOL CLIN-PARIS, V61, P411; SCHILLING JC, 1992, CLIN PHARMACOL THER, V51, P541; Silva JE, 2008, THYROID, V18, P157, DOI 10.1089/thy.2007.0252; Tandeter H, 2001, ARCH GERONTOL GERIAT, V33, P295, DOI 10.1016/S0167-4943(01)00196-0; TANDETER HB, 1993, POSTGRAD MED, V94, P187; Tipre DN, 2005, J NUCL MED, V46, P1775; Wingert TD, 1997, NEUROLOGY, V29, P1073	34	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	JUL	2015	262	7					1762	1768		10.1007/s00415-015-7780-x		7	Clinical Neurology	Neurosciences & Neurology	CM9PG	WOS:000358040600020		
J	Kano, T; Inaba, Y; D'Antuono, M; Biagini, G; Levesque, M; Avoli, M				Kano, Toshiyuki; Inaba, Yuji; D'Antuono, Margherita; Biagini, Giuseppe; Levesque, Maxime; Avoli, Massimo			Blockade of in vitro ictogenesis by low-frequency stimulation coincides with increased epileptiform response latency	JOURNAL OF NEUROPHYSIOLOGY			English	Article						amygdala; ictogenesis; perirhinal cortex; repetitive stimulation	LONG-TERM DEPRESSION; PERIRHINAL CORTEX; PYRAMIDAL NEURONS; GABA(B) RECEPTORS; CELLULAR MECHANISMS; POTASSIUM CURRENTS; LIMBIC SEIZURES; RAT; EPILEPSY; SYNCHRONIZATION	Low-frequency stimulation, delivered through transcranial magnetic or deep-brain electrical procedures, reduces seizures in patients with pharmacoresistant epilepsy. A similar control of ictallike discharges is exerted by low-frequency electrical stimulation in rodent brain slices maintained in vitro during convulsant treatment. By employing field and "sharp" intracellular recordings, we analyzed here the effects of stimuli delivered at 0.1 or 1 Hz in the lateral nucleus of the amygdala on ictallike epileptiform discharges induced by the K+ channel blocker 4-aminopyridine in the perirhinal cortex, in a rat brain slice preparation. We found that 1) ictal events were nominally abolished when the stimulus rate was brought from 0.1 to 1 Hz; 2) this effect was associated with an increased latency of the epileptiform responses recorded in perirhinal cortex following each stimulus; and 3) both changes recovered to control values following arrest of the 1-Hz stimulation protocol. The control of ictal activity by 1-Hz stimulation and the concomitant latency increase were significantly reduced by GABA(B) receptor antagonism. We propose that this frequency-dependent increase in latency represents a short-lasting, GABA(B) receptor-dependent adaptive mechanism that contributes to decrease epileptiform synchronization, thus blocking seizures in epileptic patients and animal models.	[Kano, Toshiyuki; Inaba, Yuji; D'Antuono, Margherita; Biagini, Giuseppe; Levesque, Maxime; Avoli, Massimo] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Kano, Toshiyuki; Inaba, Yuji; D'Antuono, Margherita; Biagini, Giuseppe; Levesque, Maxime; Avoli, Massimo] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Kano, Toshiyuki; Inaba, Yuji; D'Antuono, Margherita; Biagini, Giuseppe; Levesque, Maxime; Avoli, Massimo] McGill Univ, Dept Physiol, Montreal, PQ H3A 2B4, Canada; [Inaba, Yuji] Shinshu Univ, Sch Med, Matsumoto, Nagano 390, Japan; [Biagini, Giuseppe] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Metab & Neurosci, Modena, Italy	Avoli, M (reprint author), McGill Univ, Montreal Neurol Inst, 3801 Rue Univ, Montreal, PQ H3A 2B4, Canada.	massimo.avoli@mcgill.ca	Biagini, Giuseppe/I-3227-2013	Biagini, Giuseppe/0000-0002-7130-2511	Canadian Institutes of Health Research [8109, 130328]; Savoy Foundation	This study was supported by the Canadian Institutes of Health Research (Grants 8109 and 130328) and the Savoy Foundation.	De Guzman P, 2004, NEUROSCIENCE, V123, P875, DOI 10.1016/j.neuroscience.2003.11.013; Tergau F, 1999, LANCET, V353, P2209, DOI 10.1016/S0140-6736(99)01301-X; Viitanen T, 2010, J PHYSIOL-LONDON, V588, P1527, DOI 10.1113/jphysiol.2009.181826; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233; Avoli M, 2011, PROG NEUROBIOL, V95, P104, DOI 10.1016/j.pneurobio.2011.07.003; Abolafia JM, 2011, CEREB CORTEX, V21, P977, DOI 10.1093/cercor/bhq163; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Cho K, 2000, NAT NEUROSCI, V3, P150; Vonck K, 2002, ANN NEUROL, V52, P556, DOI 10.1002/ana.10323; Avoli M, 2013, NEUROPHARMACOLOGY, V69, P37, DOI 10.1016/j.neuropharm.2012.06.044; Traub RD, 1996, EPILEPSIA, V37, P879, DOI 10.1111/j.1528-1157.1996.tb00042.x; Brenowitz S, 1998, NEURON, V20, P135, DOI 10.1016/S0896-6273(00)80441-9; Barbarosie M, 1997, J NEUROSCI, V17, P9308; de Curtis M, 1998, J NEUROSCI, V18, P7543; Kano T, 2005, NEUROSCIENCE, V130, P1041, DOI 10.1016/j.neuroscience.2004.10.012; Craig MT, 2014, CURR OPIN NEUROBIOL, V26, P15, DOI 10.1016/j.conb.2013.10.002; Haas HL, 2000, N-S ARCH PHARMACOL, V362, P375, DOI 10.1007/s002100000314; Kohl MM, 2010, ADV PHARMACOL, V58, P205, DOI 10.1016/S1054-3589(10)58009-8; Shi CJ, 1999, J COMP NEUROL, V406, P299, DOI 10.1002/(SICI)1096-9861(19990412)406:3<299::AID-CNE2>3.0.CO;2-9; Kaila K, 1997, J NEUROSCI, V17, P7662; Gulledge AT, 2013, J NEUROSCI, V33, P13025, DOI 10.1523/JNEUROSCI.0220-13.2013; Paz R, 2013, CURR OPIN NEUROBIOL, V23, P381, DOI [10.1016/j.conb.2013.01.008, 10.1016/j.conb.2013.1.008]; Sudbury JR, 2007, EUR J NEUROSCI, V26, P3571, DOI 10.1111/j.1460-9568.2007.05962.x; CHURCH J, 1991, J NEUROSCI, V11, P3289; de Curtis M, 2004, PROG NEUROBIOL, V74, P101, DOI 10.1016/j.pneurobio.2004.08.005; Theodore WH, 2004, LANCET NEUROL, V3, P111, DOI 10.1016/S1474-4422(03)00664-1; Swiader MJ, 2014, PHARMACOL REP, V66, P335, DOI 10.1016/j.pharep.2013.10.005; Barbarosie M, 2002, EPILEPSIA, V43, P1469, DOI 10.1046/j.1528-1157.2002.17402.x; Benini R, 2003, NEUROSCIENCE, V120, P75, DOI 10.1016/S0306-4522(03)00262-8; Biagini G, 2015, PFLUG ARCH EUR J PHY, V467, P805, DOI 10.1007/s00424-014-1545-8; Biagini G, 2013, FRONT CELL NEUROSCI, V7, P1, DOI DOI 10.3389/FNCEL.2013.00001; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; D'Antuono M, 2001, HIPPOCAMPUS, V11, P662, DOI 10.1002/hipo.1081; Durand DM, 2010, PHILOS T R SOC B, V365, P2347, DOI 10.1098/rstb.2010.0050; Gloor P, 1997, TEMPORAL LOBE LIMBIC; Heinemann U, 1986, Adv Neurol, V44, P641; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schiller Y, 2007, J NEUROPHYSIOL, V97, P1887, DOI 10.1152/jn.00514.2006; SPAIN WJ, 1991, J PHYSIOL-LONDON, V434, P591; Squire LR., 1993, BRAIN MECH PERCEPTIO; VALIANTE TA, 1995, J NEUROSCI, V15, P6946; von Bohlen und Halbach O, 2002, NEUROSCI RES, V44, P91, DOI 10.1016/S0168-0102(02)00092-5; Yamamoto J, 2006, SEIZURE-EUR J EPILEP, V15, P520, DOI 10.1016/j.seizure.2006.06.004	44	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	JUL 1	2015	114	1					21	28		10.1152/jn.00248.2015		8	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CM9EV	WOS:000358010600003		
J	Genovesio, A; Cirillo, R; Tsujimoto, S; Abdellatif, SM; Wise, SP				Genovesio, Aldo; Cirillo, Rossella; Tsujimoto, Satoshi; Abdellatif, Sara Mohammad; Wise, Steven P.			Automatic comparison of stimulus durations in the primate prefrontal cortex: the neural basis of across-task interference	JOURNAL OF NEUROPHYSIOLOGY			English	Article						prefrontal; decision; monkey; interference; timing	DORSOMEDIAL FRONTAL-CORTEX; VENTRAL PREMOTOR CORTEX; NEURONAL-ACTIVITY; WORKING-MEMORY; TEMPORAL-ORDER; REPRESENTATION; SELECTION; DECISION; OBJECTS; GOALS	Rhesus monkeys performed two tasks, both requiring a choice between a red square and a blue circle. In the duration task, the two stimuli appeared sequentially on each trial, for varying durations, and, later, during the choice phase of the task, the monkeys needed to choose the one that had lasted longer. In the matching-to-sample task, one of the two stimuli appeared twice as a sample, with durations matching those in the duration task, and the monkey needed to choose that stimulus during the choice phase. Although stimulus duration was irrelevant in the matching-to-sample task, the monkeys made twice as many errors when the second stimulus was shorter. This across-task interference supports an order-dependent model of the monkeys' choice and reveals something about their strategy in the duration task. The monkeys tended to choose the second stimulus when its duration exceeded the first and to choose the alternative stimulus otherwise. For the duration task, this strategy obviated the need to store stimulus-duration conjunctions for both stimuli, but it generated errors on the matching-to-sample task. We examined duration coding in prefrontal neurons and confirmed that a population of cells encoded relative duration during the matching-to-sample task, as expected from the order-dependent errors.	[Genovesio, Aldo; Cirillo, Rossella; Abdellatif, Sara Mohammad] Univ Roma La Sapienza, Dept Physiol & Pharmacol, I-00185 Rome, Italy; [Tsujimoto, Satoshi] Kyoto Univ, Grad Sch Informat, Dept Intelligence Sci & Technol, Kyoto, Japan; [Tsujimoto, Satoshi] Nielsen Neuro, Tokyo, Japan; [Wise, Steven P.] Olschefskie Inst Neurobiol Knowledge, Potomac, MD USA; [Wise, Steven P.] Maryland & Edmond & Lily Safra Int Inst Neurosci, Natal, RN, Brazil	Genovesio, A (reprint author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	aldo.genovesio@uniroma1.it			Division of Intramural Research of National Institute of Mental Health Grant [Z01MH-01092]	This work was supported by Division of Intramural Research of the National Institute of Mental Health Grant Z01MH-01092.	Acuna C, 2011, EUR J NEUROSCI, V33, P2338, DOI 10.1111/j.1460-9568.2011.07708.x; Funahashi S, 1997, BEHAV BRAIN RES, V84, P203, DOI 10.1016/S0166-4328(96)00151-9; Genovesio A, 2006, J NEUROSCI, V26, P7305, DOI 10.1523/JNEUROSCI.0699-06.2006; Genovesio A, 2012, NEURON, V74, P656, DOI 10.1016/j.neuron.2012.02.023; Genovesio A, 2014, TRENDS COGN SCI, V18, P72, DOI 10.1016/j.tics.2013.11.007; Tsujimoto S, 2012, J COGNITIVE NEUROSCI, V24, P627, DOI 10.1162/jocn_a_00171; Ninokura Y, 2004, J NEUROPHYSIOL, V91, P555, DOI 10.1152/jn.00694.2003; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Genovesio A, 2011, J NEUROSCI, V31, P3968, DOI 10.1523/JNEUROSCI.5373-10.2011; MILNER B, 1985, HUM NEUROBIOL, V4, P137; Kusunoki M, 2010, J COGNITIVE NEUROSCI, V22, P751, DOI 10.1162/jocn.2009.21216; Tsujimoto S, 2012, J NEUROSCI, V32, P11017, DOI 10.1523/JNEUROSCI.1230-12.2012; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Genovesio A, 2009, NEURON, V63, P254, DOI 10.1016/j.neuron.2009.06.018; Genovesio A, 2014, J NEUROSCI, V34, P1970, DOI 10.1523/JNEUROSCI.3228-13.2014; Genovesio A, 2006, J NEUROPHYSIOL, V95, P3281, DOI 10.1152/jn.01011.2005; Ninokura Y, 2003, J NEUROPHYSIOL, V89, P2868, DOI 10.1152/jn.00647.2002; Woodman GF, 2007, J EXP PSYCHOL HUMAN, V33, P363, DOI 10.1037/0096-1523.33.2.363; Lauwereyns J, 2001, J NEUROPHYSIOL, V86, P2001; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Kim JN, 1999, NAT NEUROSCI, V2, P176; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; PETRIDES M, 1991, P ROY SOC B-BIOL SCI, V246, P299, DOI 10.1098/rspb.1991.0158; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/j.neuron.2009.01.002; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; DIAMOND A, 1989, EXP BRAIN RES, V74, P24; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Hasegawa RP, 2004, NEURON, V43, P415, DOI 10.1016/j.neuron.2004.07.013; Tudusciuc O, 2009, J NEUROPHYSIOL, V101, P2984, DOI 10.1152/jn.90713.2008; Averbeck BB, 2006, NAT NEUROSCI, V9, P276, DOI 10.1038/nn1634; Chen NH, 2001, EXP BRAIN RES, V139, P116, DOI 10.1007/s002210100760; Genovesio A, 2014, ADV EXP MED BIOL, V829, P167, DOI 10.1007/978-1-4939-1782-2_10; Genovesio A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0477; Genovesio A, 2007, J NEUROSCI METH, V165, P38, DOI 10.1016/j.jneumeth.2007.05.026; Genovesio A, 2008, NEUROSCIENCE RULE GU, P81; Hussar CR, 2012, J NEUROSCI, V32, P2747, DOI 10.1523/JNEUROSCI.5135-11.2012; Hussar CR, 2009, NEURON, V64, P730, DOI 10.1016/j.neuron.2009.11.018; Lennert T, 2011, NEURON, V70, P141, DOI 10.1016/j.neuron.2011.02.041; MANN SE, 1988, EXP BRAIN RES, V69, P460; Matsushima A, 2012, J COGNITIVE NEUROSCI, V24, P2043, DOI 10.1162/jocn_a_00265; Peters JC, 2012, J NEUROSCI, V32, P17003, DOI 10.1523/JNEUROSCI.0591-12.2012; Qi XL, 2012, J NEUROSCI, V32, P6161, DOI 10.1523/JNEUROSCI.6365-11.2012; Warden MR, 2007, CEREB CORTEX, V17, pI41, DOI 10.1093/cercor/bhm070	45	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	JUL 1	2015	114	1					48	56		10.1152/jn.00057.2015		9	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CM9EV	WOS:000358010600006		
J	Tanaka, T; Nishida, S; Ogawa, T				Tanaka, Tomohiro; Nishida, Satoshi; Ogawa, Tadashi			Different target-discrimination times can be followed by the same saccade-initiation timing in different stimulus conditions during visual searches	JOURNAL OF NEUROPHYSIOLOGY			English	Article						discrimination time; reaction time; stimulus luminance; visual search; LIP; monkey	FRONTAL EYE FIELD; LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; PRIMATE SUPERIOR COLLICULUS; PERCEPTUAL DECISION-MAKING; NEURAL MECHANISMS; BOTTOM-UP; TOP-DOWN; SURROUND SUPPRESSION; ACCUMULATOR MODEL	The neuronal processes that underlie visual searches can be divided into two stages: target discrimination and saccade preparation/generation. This predicts that the length of time of the prediscrimination stage varies according to the search difficulty across different stimulus conditions, whereas the length of the latter postdiscrimination stage is stimulus invariant. However, recent studies have suggested that the length of the postdiscrimination interval changes with different stimulus conditions. To address whether and how the visual stimulus affects determination of the postdiscrimination interval, we recorded single-neuron activity in the lateral intraparietal area (LIP) when monkeys (Macaca fuscata) performed a color-singleton search involving four stimulus conditions that differed regarding luminance (Bright vs. Dim) and target-distractor color similarity (Easy vs. Difficult). We specifically focused on comparing activities between the Bright-Difficult and Dim-Easy conditions, in which the visual stimuli were considerably different, but the mean reaction times were indistinguishable. This allowed us to examine the neuronal activity when the difference in the degree of search speed between different stimulus conditions was minimal. We found that not only prediscrimination but also postdiscrimination intervals varied across stimulus conditions: the postdiscrimination interval was longer in the Dim-Easy condition than in the Bright-Difficult condition. Further analysis revealed that the postdiscrimination interval might vary with stimulus luminance. A computer simulation using an accumulation-to-threshold model suggested that the luminance-related difference in visual response strength at discrimination time could be the cause of different postdiscrimination intervals.	[Tanaka, Tomohiro; Nishida, Satoshi; Ogawa, Tadashi] Kyoto Univ, Dept Integrat Brain Sci, Grad Sch Med, Kyoto 6068302, Japan; [Ogawa, Tadashi] Kyoto Univ, Ctr Enhancing Next Generat Res, Kyoto 6068302, Japan	Ogawa, T (reprint author), Kyoto Univ, Ctr Enhancing Next Generat Res, Sakyo Ku, Kyoto 6068302, Japan.	ogawa.tadashi.7a@kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [20033010, 20500283, 23500391, 26290004]	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) to T. Ogawa (20033010, 20500283, 23500391, and 26290004).	MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871; Thompson KG, 2005, J NEUROPHYSIOL, V93, P337, DOI 10.1152/jn.00330.2004; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040; Peng XM, 2008, J NEUROPHYSIOL, V100, P796, DOI 10.1152/jn.01188.2007; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.00181.2002; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; SCHALL JD, 1995, J NEUROSCI, V15, P6905; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; BOCH R, 1984, EXP BRAIN RES, V55, P223; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; Everling S, 1999, J NEUROSCI, V19, P2740; Bichot NP, 1999, NAT NEUROSCI, V2, P549; Pare M, 2003, J NEUROSCI, V23, P6480; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Thomas NWD, 2007, J NEUROPHYSIOL, V97, P942, DOI 10.1152/jn.00413.2006; Schall JD, 2004, J NEUROPHYSIOL, V91, P2765, DOI 10.1152/jn.00780.2003; Roitman JD, 2002, J NEUROSCI, V22, P9475; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Lehky SR, 2007, J NEUROPHYSIOL, V97, P307, DOI 10.1152/jn.00168.2006; Cohen JY, 2009, J NEUROPHYSIOL, V101, P1699, DOI 10.1152/jn.00035.2009; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Heitz RP, 2012, NEURON, V76, P616, DOI 10.1016/j.neuron.2012.08.030; Everling S, 2000, J NEUROSCI, V20, P387; Falkner AL, 2010, J NEUROSCI, V30, P12787, DOI 10.1523/JNEUROSCI.2327-10.2010; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Schall JD, 2011, EUR J NEUROSCI, V33, P1991, DOI 10.1111/j.1460-9568.2011.07715.x; Wardak C, 2002, J NEUROSCI, V22, P9877; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; Jantz JJ, 2013, J NEUROPHYSIOL, V109, P2767, DOI 10.1152/jn.00611.2012; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Marino RA, 2012, EUR J NEUROSCI, V35, P1738, DOI 10.1111/j.1460-9568.2012.08079.x; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Nishida S, 2014, CEREB CORTEX, V24, P1671, DOI 10.1093/cercor/bht031; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P147; Balan PF, 2008, PLOS BIOL, V6, P1443, DOI 10.1371/journal.pbio.0060158; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109; Bell AH, 2000, J NEUROPHYSIOL, V84, P2595; Bichot NP, 2001, J NEUROSCI, V21, P713; Costello MG, 2013, J NEUROSCI, V33, P16394, DOI 10.1523/JNEUROSCI.1899-13.2013; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Gee AL, 2010, J NEUROPHYSIOL, V104, P2187, DOI 10.1152/jn.00898.2009; Gifford GW, 2004, J NEUROPHYSIOL, V91, P2929, DOI 10.1152/jn.01117.2003; Gottlieb J, 2010, CURR OPIN NEUROBIOL, V20, P731, DOI 10.1016/j.conb.2010.09.015; Gruber N, 2014, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00101; Ipata AE, 2006, J NEUROSCI, V26, P3656, DOI 10.1523/JNEUROSCI.5074-05.2006; Jaskowski P, 2004, PERCEPT PSYCHOPHYS, V66, P535, DOI 10.3758/BF03194899; Liu YQ, 2010, NAT NEUROSCI, V13, P495, DOI 10.1038/nn.2496; Marino RA, 2009, EXP BRAIN RES, V197, P321, DOI 10.1007/s00221-009-1919-x; MILLER J, 1982, J EXP PSYCHOL HUMAN, V8, P273, DOI 10.1037/0096-1523.8.2.273; Nishida S, 2013, J NEUROPHYSIOL, V110, P2773, DOI 10.1152/jn.00360.2013; Ogawa T, 2009, J NEUROPHYSIOL, V101, P721, DOI 10.1152/jn.90817.2008; Ogawa T, 2006, EXP BRAIN RES, V173, P1, DOI 10.1007/s00221-006-0362-5; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Sato T, 2001, NEURON, V30, P583, DOI 10.1016/S0896-6273(01)00304-X; Schall Jeffrey D, 2007, Science, V318, P44; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916; Shen K, 2011, EUR J NEUROSCI, V33, P2003, DOI 10.1111/j.1460-9568.2011.07722.x; Shive J, 2013, HUM FACTORS, V55, P373, DOI 10.1177/0018720812459341; SMID HGOM, 1991, J EXP PSYCHOL HUMAN, V17, P696, DOI 10.1037/0096-1523.17.3.696; Tanaka T, 2013, EUR J NEUROSCI, V37, P942, DOI 10.1111/ejn.12100; White BJ, 2011, J NEUROSCI, V31, P1570, DOI 10.1523/JNEUROSCI.5349-10.2011; Woodman GF, 2008, PSYCHOL SCI, V19, P128, DOI 10.1111/j.1467-9280.2008.02058.x	79	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	JUL 1	2015	114	1					366	380		10.1152/jn.00043.2015		15	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CM9EV	WOS:000358010600033		
J	Yorifuji, T; Bae, S; Kashima, S; Tsuda, T; Doi, H; Honda, Y; Kim, H; Hong, YC				Yorifuji, Takashi; Bae, Sanghyuk; Kashima, Saori; Tsuda, Toshihide; Doi, Hiroyuki; Honda, Yasushi; Kim, Ho; Hong, Yun-Chul			Health Impact Assessment of PM10 and PM2.5 in 27 Southeast and East Asian Cities	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							PARTICULATE AIR-POLLUTION; LONG-TERM EXPOSURE; EUROPEAN CITIES; LUNG-CANCER; MORTALITY; ASSOCIATION; APHEIS; MATTER; JAPAN	Objective: We aimed to evaluate the annual health impacts of particulate matter (PM) less than 10 mu m diameter (PM10) and less than 2.5-mu m diameter (PM2.5) in 27 cities in Southeast and East Asian countries (Japan, the Philippines, the Republic of Korea, Singapore, and Vietnam) for the year 2009 (n = 50,756,699). Methods: We estimated the number of cases attributable to long-term exposure. We used a scenario that reduced the annual mean values for PM10 and PM2.5 to 20 and 10 mu g/m(3), respectively. Results: A reduction in long-term exposure to PM10 and PM2.5 would have postponed 8% to 9% of all-cause mortality or about 37,000 deaths. One third of them were associated with cardiopulmonary mortality and one ninth of them were associated with lung cancer mortality. Conclusions: Current air pollution levels in Southeast and East Asian countries have a nonnegligible public health impact.	[Yorifuji, Takashi; Tsuda, Toshihide] Okayama Univ, Grad Sch Environm Sci, Dept Human Ecol, Okayama 7008530, Japan; [Bae, Sanghyuk] Seoul Natl Univ Hosp, Publ Hlth Med Serv, Seoul, South Korea; [Kashima, Saori] Hiroshima Univ, Dept Publ Hlth & Hlth Policy, Inst Biomed & Hlth Sci, Hiroshima 730, Japan; [Doi, Hiroyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama 7008530, Japan; [Honda, Yasushi] Univ Tsukuba, Dept Hlth Care Policy & Hlth Econ, Fac Med, Tsukuba, Ibaraki 305, Japan; [Kim, Ho] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Epidemiol & Biostat, Seoul 151, South Korea; [Hong, Yun-Chul] Seoul Natl Univ, Inst Environm Med, Med Res Ctr, Seoul 151, South Korea	Yorifuji, T (reprint author), Okayama Univ, Grad Sch Environm Sci, Dept Human Ecol, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	yorichan@md.okayama-u.ac.jp			Graduate School of Environmental and Life Science, Okayama University [20802C4302];  [24510033]	This work was partly supported by a Grant-in-Aid for Scientific Research (C) No. 24510033 and by a grant from the discretionary research fund of the Dean of the Graduate School of Environmental and Life Science, Okayama University (No 20802C4302).	Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Kunzli N, 2000, LANCET, V356, P795, DOI 10.1016/S0140-6736(00)02653-2; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709; Cao J, 2011, J HAZARD MATER, V186, P1594, DOI 10.1016/j.jhazmat.2010.12.036; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Yorifuji T, 2013, SCI TOTAL ENVIRON, V443, P397, DOI 10.1016/j.scitotenv.2012.10.088; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669; Ballester F, 2008, J EPIDEMIOL COMMUN H, V62, P98, DOI 10.1136/jech.2007.059857; Boldo E, 2006, EUR J EPIDEMIOL, V21, P449, DOI 10.1007/s10654-006-9014-0; Pascal M, 2013, SCI TOTAL ENVIRON, V449, P390, DOI 10.1016/j.scitotenv.2013.01.077; Bae HJ, 2009, SCI TOTAL ENVIRON, V407, P5971, DOI 10.1016/j.scitotenv.2009.08.022; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Jamrozik E, 2011, RESPIROLOGY, V16, P3, DOI 10.1111/j.1440-1843.2010.01844.x; Kan HD, 2004, ATMOS ENVIRON, V38, P95, DOI 10.1016/j.atmosenv.2003.09.038; Krewski D.B.R., 2000, REANALYSIS HARVARD 6; Krzyzanowski M, 1997, OCCUP ENVIRON MED, V54, P145; Medina S, 2004, J EPIDEMIOL COMMUN H, V58, P831, DOI 10.1136/jech.2003.016386; WHO (World Health Organization), 2006, AIR QUAL GUID GLOB U; World Health Organization, 2014, WHO EXP M METH TOOLS; World Health Organization, 2014, AIR POLL EST; Yorifuji T, 2005, ARCH ENVIRON OCCUP H, V60, P179, DOI 10.3200/AEOH.60.4.179-185	25	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-2752	1536-5948		J OCCUP ENVIRON MED	J. Occup. Environ. Med.	JUL	2015	57	7					751	756		10.1097/JOM.0000000000000485		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CM8IV	WOS:000357944000007		
J	Miyashita, M; Morita, T; Sato, K; Tsuneto, S; Shima, Y				Miyashita, Mitsunori; Morita, Tatsuya; Sato, Kazuki; Tsuneto, Satoru; Shima, Yasuo			A Nationwide Survey of Quality of End-of-Life Cancer Care in Designated Cancer Centers, Inpatient Palliative Care Units, and Home Hospices in Japan: The J-HOPE Study	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT			English	Article						Palliative care; satisfaction; quality of care; good death; neoplasms; bereaved family members	BEREAVED FAMILY-MEMBERS; LAST 3 MONTHS; GOOD-DEATH; SAMPLE CHARACTERISTICS; ILL PATIENTS; PERSPECTIVE; PLACE; QUESTIONNAIRE; EXPERIENCE	Context. End-of-life (EOL) cancer care in general hospitals and home care has not previously been evaluated in Japan. Objectives. This study aimed to evaluate EOL cancer care from the perspective of bereaved family members in nationwide designated cancer centers, inpatient palliative care units (PCUs), and home hospices in Japan. Methods. We conducted a cross-sectional, anonymous, self-report questionnaire survey for bereaved family members of cancer patients in March 2008 for 56 designated cancer centers and in June 2007 for 100 PCUs and 14 home hospices. Outcomes were overall care satisfaction, structure and process of care (Care Evaluation Scale), and achievement of a good death (Good Death Inventory). Results. In designated cancer centers, PCUs, and home hospices, 2794 (response rate 59%), 5312 (response rate 69%), and 292 (response rate 67%) bereaved family members participated, respectively. Mean scores for overall care satisfaction were high for all places of death, at 4.3 +/- 1.2 for designated cancer centers, 5.0 +/- 1.2 for PCUs, and 5.0 +/- 1.0 for home hospices. Designated cancer centers showed significantly lower ratings than PCUs and home hospices for structure and process of care and achievement of a good death (P = 0.0001 each). Home hospices were rated significantly higher than PCUs for achievement of a good death (P = 0.0001). Conclusion. The main findings of this study were: 1) overall, bereaved family members were satisfied with end-of-life care in all three places of death; 2) designated cancer centers were inferior to PCUs and home hospices and had more room for improvement; and 3) home hospices were rated higher than PCUs for achieving a good death, although home hospices remain uncommon in Japan. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.	[Miyashita, Mitsunori; Sato, Kazuki] Univ Tokyo, Grad Sch Med, Sch Hlth Sci & Nursing Sci, Dept Adult Nursing Palliat Care Nursing,Bunkyo Ku, Sendai, Miyagi, Japan; [Miyashita, Mitsunori; Sato, Kazuki] Univ Tokyo, Grad Sch Med, Div Palliat Nursing, Hlth Sci, Sendai, Miyagi, Japan; [Morita, Tatsuya] Seirei Mikatahara Hosp, Palliat Care Team, Dept Palliat & Support Care, Hamamatsu, Shizuoka, Japan; [Morita, Tatsuya] Seirei Mikatahara Hosp, Seirei Hosp, Hamamatsu, Shizuoka, Japan; [Tsuneto, Satoru] Osaka Univ, Grad Sch Med, Dept Palliat Med, Osaka, Japan; [Shima, Yasuo] Tsukuba Med Ctr Hosp, Dept Palliat Med, Tsukuba, Ibaraki, Japan	Miyashita, M (reprint author), Tohoku Univ, Grad Sch Med, Div Palliat Nursing, Hlth Sci,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	miyasita-tky@umin.net			Japan Hospice Palliative Care Foundation; Health and Labor Sciences Research Grant for a third term for comprehensive control research for cancer [H19-ganrinsho-ip-pan-004]	This work was supported by the Japan Hospice Palliative Care Foundation and a Health and Labor Sciences Research Grant for a third term for comprehensive control research for cancer (H19-ganrinsho-ip-pan-004). The authors declare no conflicts of interest.	Addington-hall J, 2001, RES PALLIATIVE CARE; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Lynn J, 1997, ANN INTERN MED, V126, P97; Addington-Hall J, 1998, SOC SCI MED, V46, P1011, DOI 10.1016/S0277-9536(97)10021-1; Fukui S, 2004, CANCER, V101, P421, DOI 10.1002/cncr.20383; Weitzen S, 2003, MED CARE, V41, P323, DOI 10.1097/00005650-200302000-00013; McPherson CJ, 2003, SOC SCI MED, V56, P95, DOI 10.1016/S0277-9536(02)00011-4; Hirai K, 2006, J PAIN SYMPTOM MANAG, V31, P140, DOI 10.1016/j.jpainsymman.2005.06.012; Sanjo M, 2007, ANN ONCOL, V18, P1539, DOI 10.1093/annonc/mdm199; Gomes B, 2006, BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Morita T, 2004, J PAIN SYMPTOM MANAG, V27, P492, DOI 10.1016/j.jpainsymman.2003.10.014; Addington-Hall JM, 2009, PALLIATIVE MED, V23, P190, DOI 10.1177/0269216309102525; Costantini M, 2005, PALLIATIVE MED, V19, P628, DOI 10.1191/0269216305pm1086oa; ADDINGTONHALL J, 1995, PALLIATIVE MED, V9, P27, DOI 10.1177/026921639500900105; Miyashita M, 2008, J CLIN ONCOL, V26, P3845, DOI 10.1200/JCO.2007.15.8287; ADDINGTONHALL JM, 1992, BRIT MED J, V305, P1317; Fukui S, 2011, J PAIN SYMPTOM MANAG, V42, P882, DOI 10.1016/j.jpainsymman.2011.02.024; Miyashita M, 2007, ANN ONCOL, V18, P1090, DOI 10.1093/annonc/mom068; Casarett D, 2011, ARCH INTERN MED, V171, P649, DOI 10.1001/archinternmed.2011.87; Kizawa Y, 2013, AM J HOSP PALLIAT ME, V30, P552, DOI 10.1177/1049909112457874; Miyashita M, 2008, J PAIN SYMPTOM MANAG, V35, P486, DOI [10.1016/j.jpainsymman.2007.07.009, 10.1016/j.jpainsmman.2007.07.009]; Miyashita M, 2008, AM J HOSP PALLIAT ME, V25, P223, DOI 10.1177/1049909108315517; Morita T, 2002, PALLIATIVE MED, V16, P185, DOI 10.1191/0269216302pm524oa; Nakazawa Y, 2012, JPN J CLIN ONCOL, V42, P432, DOI 10.1093/jjco/hys022; Teno Joan M, 2005, J Palliat Med, V8 Suppl 1, pS42; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; Tsuneto S, 2013, JPN J CLIN ONCOL, V43, P17, DOI 10.1093/jjco/hys188	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0885-3924	1873-6513		J PAIN SYMPTOM MANAG	J. Pain Symptom Manage.	JUL	2015	50	1					38	+		10.1016/j.jpainsymman.2015.01.007		13	Health Care Sciences & Services; Medicine, General & Internal; Clinical Neurology	Health Care Sciences & Services; General & Internal Medicine; Neurosciences & Neurology	CM3GM	WOS:000357570100007		
J	Ishibashi, N; Maebayashi, T; Aizawa, T; Sakaguchi, M; Abe, O; Saito, T; Tanaka, Y; Chin, M; Mugishima, H				Ishibashi, Naoya; Maebayashi, Toshiya; Aizawa, Takuya; Sakaguchi, Masakuni; Abe, Osamu; Saito, Tsutomu; Tanaka, Yoshiaki; Chin, Motoaki; Mugishima, Hideo			Successful Pregnancy and Delivery After Radiation With Ovarian Shielding for Acute Lymphocytic Leukemia Before Menarche	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						acute lymphocytic leukemia (ALL); ovarian function preservation; ovarian shielding; pregnancy; total body irradiation (TBI)	TOTAL-BODY IRRADIATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; MARROW-TRANSPLANTATION; CHILDHOOD; CANCER; STRATEGY	Total body irradiation is performed as a preconditioning regimen to inhibit graft-versus-host disease after bone marrow transplantation and to eradicate remaining tumor cells. However, these regimens result in delayed secondary sex characteristics and failure of ovarian function recovery, leading to amenorrhea and infertility. Herein, we report a case of an 11-year-old girl diagnosed with acute lymphocytic leukemia who received induction chemotherapy and prophylactic cranial irradiation. For bone marrow transplantation, she received total body irradiation of 12 Gy with uterine and ovarian shielding at 13 years of age. The patient remained in remission and menarche began at 14 years of age. At 23, she became pregnant and delivered a baby naturally with no abnormalities.	[Ishibashi, Naoya; Maebayashi, Toshiya; Aizawa, Takuya; Sakaguchi, Masakuni; Abe, Osamu] Nihon Univ, Sch Med, Dept Radiol, Tokyo, Japan; [Chin, Motoaki; Mugishima, Hideo] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan; [Saito, Tsutomu] Saonoda Med Corp, Radiol Clin, Tokyo, Japan; [Tanaka, Yoshiaki] Kawasaki Saiwai Hosp, Dept Radiat Oncol, Kawasaki, Kanagawa, Japan	Ishibashi, N (reprint author), Nihon Univ, Sch Med, Dept Radiol, Itabashi Ku, 30-1 Oyaguchi Kami Cho, Tokyo 1738610, Japan.	ishibashi.naoya@nihon-u.ac.jp					Green DN, 2002, AM J OBSTET GYNECOL, V187, P1070, DOI 10.1067/mob.2002.126643; CRITCHLEY HOD, 1992, BRIT J OBSTET GYNAEC, V99, P392, DOI 10.1111/j.1471-0528.1992.tb13755.x; Socie G, 2003, BLOOD, V101, P3373, DOI 10.1182/blood-2002-07-2231; SPINELLI S, 1994, BONE MARROW TRANSPL, V14, P373; Wong JYC, 2009, INT J RADIAT ONCOL, V73, P273, DOI 10.1016/j.ijrobp.2008.04.071; Wallace WHB, 2005, INT J RADIAT ONCOL, V62, P738, DOI 10.1016/j.ijrobp.2004.11.038; Nakagawa K, 2006, BONE MARROW TRANSPL, V37, P583, DOI 10.1038/sj.bmt.1705279; Newton H, 1998, HUM REPROD UPDATE, V4, P237, DOI 10.1093/humupd/4.3.237; SAMUELSSON A, 1993, BONE MARROW TRANSPL, V12, P659; SANDERS JE, 1983, TRANSPLANTATION, V36, P252, DOI 10.1097/00007890-198309000-00005; Sasano N, 2009, BIOMED THER, V43, P793; Shank B, 2003, RADIOTHERAPEUTIC PRI, P178; Watanabe A, 2003, BLOOD, V102, p223A	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	JUL	2015	37	5					e292	e294		10.1097/MPH.0000000000000309		3	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CM4MM	WOS:000357658800004		
J	Kobayashi, C; Hanadate, T; Niwa, T; Yoshiyasu, T; So, M; Matsui, K				Kobayashi, Chie; Hanadate, Tomoko; Niwa, Toshiro; Yoshiyasu, Takashi; So, Masahiro; Matsui, Keita			Safety and Effectiveness of Micafungin in Japanese Pediatric Patients: Results of a Postmarketing Surveillance Study	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						effectiveness; micafungin; postmarketing surveillance study; safety	INVASIVE FUNGAL-INFECTIONS; LIPOSOMAL AMPHOTERICIN-B; DOUBLE-BLIND TRIAL; BREAKTHROUGH TRICHOSPORONOSIS; RECEIVING MICAFUNGIN; CHILDREN; PHARMACOKINETICS; ECHINOCANDIN; MYCOSIS	Limited data are available about the safety and efficacy of micafungin in children. A postmarketing surveillance study was conducted to assess the safety and effectiveness of micafungin, an echinocandin antifungal, in pediatric patients. A prospective multicenter postmarketing observational study was carried out between October 2006 and September 2008 in Japan. Pediatric patients under 16 years received an intravenous infusion of micafungin at a dose of 1 mg/kg for candidiasis and 1 to 3 mg/kg for aspergillosis, with the option of increasing the dose if required to 6 mg/kg once daily. All adverse events were recorded. A total of 201 pediatric patients were enrolled. There were 55 adverse drug reactions reported among 42 of 190 patients evaluated for safety (22.1%); the most frequently reported adverse drug reaction was hepatobiliary disorders. No adverse drug reactions were reported in 18 neonates (aged below 4 wk). The overall clinical response rate in 91 patients evaluated for efficacy was 86.8%. The response rate in neonates was 90.0%, and there were no differences in the response rate by age. Micafungin was found to have sufficient safety and effectiveness for the treatment of fungal infections in pediatric patients with various backgrounds.	[Kobayashi, Chie; Yoshiyasu, Takashi; So, Masahiro; Matsui, Keita] Astellas Pharma Inc, Dept Med Affairs, Tokyo 1038411, Japan; [Hanadate, Tomoko] Astellas Pharma Inc, Dept Pharmacovigilance, Tokyo 1038411, Japan; [Niwa, Toshiro] Shujitsu Univ, Sch Pharm, Okayama, Japan	Kobayashi, C (reprint author), Astellas Pharma Inc, Dept Med Affairs, Chuo Ku, 2-5-11 Nihonbashi, Tokyo 1038411, Japan.	chie.kobayashi@astellas.com			Astellas Pharma Inc., Tokyo, Japan	Supported by Astellas Pharma Inc., Tokyo, Japan.	Akagi T, 2006, LEUKEMIA LYMPHOMA, V47, P1182, DOI 10.1080/10428190500272499; Heresi GP, 2006, PEDIATR INFECT DIS J, V25, P1110, DOI 10.1097/01.inf.0000245103.07614.e1; Chandrasekar PH, 2006, CLIN INFECT DIS, V42, P1171, DOI 10.1086/501020; Smith PB, 2009, PEDIATR INFECT DIS J, V28, P412, DOI 10.1097/INF.0b013e3181910e2d; Kohno S, 2004, SCAND J INFECT DIS, V36, P372, DOI 10.1080/00365540410020406; Benjamin DK, 2010, CLIN PHARMACOL THER, V87, P93, DOI 10.1038/clpt.2009.200; Blyth CC, 2007, PEDIATRICS, V119, P772, DOI 10.1542/peds.2006-2931; Matsue K, 2006, CLIN INFECT DIS, V42, P753, DOI 10.1086/500323; Hanadate T, 2011, J INFECT CHEMOTHER, V17, P622, DOI 10.1007/s10156-011-0219-0; Kuse ER, 2007, LANCET, V369, P1519, DOI 10.1016/S0140-6736(07)60605-9; Arrieta AC, 2011, PEDIATR INFECT DIS J, V30, pE97, DOI 10.1097/INF.0b013e3182127eaf; Cornely OA, 2011, EXPERT OPIN DRUG SAF, V10, P171, DOI 10.1517/14740338.2011.557062; Emiroglu M, 2011, EXPERT REV ANTI-INFE, V9, P821, DOI [10.1586/eri.11.91, 10.1586/ERI.11.91]; Ikeda F, 2007, CURR MED CHEM, V14, P1263, DOI 10.2174/092986707780597970; Jarvis B, 2004, DRUGS, V64, P969, DOI 10.2165/00003495-200464090-00004; Jarvis B, 2004, DRUGS, V64, P983; Queiroz-Telles F, 2008, PEDIATR INFECT DIS J, V27, P820, DOI 10.1097/INF.0b013e31817275e6; Steinbach WJ, 2010, CLIN MICROBIOL INFEC, V16, P1321, DOI 10.1111/j.1469-0691.2010.03288.x	18	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	JUL	2015	37	5					e285	e291		10.1097/MPH.0000000000000343		7	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CM4MM	WOS:000357658800003		
J	Kimura, T; Satoh, T				Kimura, Tsutomu; Satoh, Tsuyoshi			Mechanism of magnesium carbenoid 1,3-C-H insertion: a DFT study	JOURNAL OF PHYSICAL ORGANIC CHEMISTRY			English	Article						1,3-C-H insertion; cyclopropane; DFT calculation; magnesium carbenoid; S(N)2 reaction; three-center two-electron bond	ALPHA-CHLOROCYCLOPROPYLLITHIUM COMPOUNDS; NEIGHBORING HETEROATOMS; ELECTROPHILIC REACTIONS; SYNTHETIC METHODS; 1ST EXAMPLE; CHEMISTRY; CYCLOPROPYL; SULFOXIDES; HYDROGEN	The 1,3-C-H insertion of magnesium carbenoid and related species was investigated via density functional theory (DFT) calculations. The 1,3-C-H insertion occurred according to an S(N)2-like mechanism wherein the nucleophilic C-H bond attacked the electrophilic carbenoid carbon atom. The activation energies for the 1,3-C-H insertion of (1-chloropropyl) magnesium chloride, (1-methoxypropyl) magnesium chloride, and [1-(methylthio) propyl] magnesium chloride were 20.0, 33.8, and 47.1 kcal/mol, respectively. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Kimura, Tsutomu; Satoh, Tsuyoshi] Tokyo Univ Sci, Fac Sci, Dept Chem, Div 2,Shinjuku Ku, Tokyo 1620826, Japan	Kimura, T (reprint author), Tokyo Univ Sci, Fac Sci, Dept Chem, Div 2,Shinjuku Ku, Ichigayafunagawaramachi 12, Tokyo 1620826, Japan.	kimtwo@rs.tus.ac.jp			JSPS KAKENHI [25810030]; MEXT KAKENHI [22590021]; TUS Grant for Research Promotion from the Tokyo University of Science	This work was supported by JSPS KAKENHI grant number 25810030 (T.K.), MEXT KAKENHI grant number 22590021 (T.S.), and a TUS Grant for Research Promotion from the Tokyo University of Science, which are gratefully acknowledged. High-performance computing resources were provided by the Tokyo University of Science.	Kimura T, 2013, TETRAHEDRON, V69, P6371, DOI 10.1016/j.tet.2013.05.108; Satoh T, 2005, TETRAHEDRON LETT, V46, P599, DOI 10.1016/j.tetlet.2004.11.146; Kimura T, 2012, J ORGANOMET CHEM, V715, P1, DOI 10.1016/j.jorganchem.2012.04.028; Sulzbach HM, 1997, J AM CHEM SOC, V119, P5682, DOI 10.1021/ja970181d; SIEGEL H, 1982, TOP CURR CHEM, V106, P55; Satoh T, 2007, CHEM SOC REV, V36, P1561, DOI 10.1039/b615630b; BACH RD, 1993, J AM CHEM SOC, V115, P10237, DOI 10.1021/ja00075a045; Ogata S, 2008, TETRAHEDRON, V64, P5711, DOI 10.1016/j.tet.2008.04.024; Capriati V, 2010, CHEM-EUR J, V16, P4152, DOI 10.1002/chem.200902870; Satoh T, 2012, HETEROCYCLES, V85, P1, DOI 10.3987/REV-11-718; Boche G, 2001, CHEM REV, V101, P697, DOI 10.1021/cr940260x; ARMSTRONG BM, 1995, J AM CHEM SOC, V117, P3685, DOI 10.1021/ja00118a004; Frisch M. J., 2004, GAUSSIAN 03 REVISION; GOLDSTEI.MJ, 1965, J AM CHEM SOC, V87, P2293, DOI 10.1021/ja01088a041; GORDON MS, 1984, J AM CHEM SOC, V106, P5421, DOI 10.1021/ja00331a007; Kimura T., 2013, DENSITY FUNCTIONAL T; Kimura T, 2013, TETRAHEDRON, V69, P3961, DOI 10.1016/j.tet.2013.03.019; Kimura T, 2013, TETRAHEDRON LETT, V54, P5072, DOI 10.1016/j.tetlet.2013.07.030; KIRMSE W, 1966, TETRAHEDRON, V22, P73, DOI 10.1016/0040-4020(66)80103-5; KOBRICH G, 1967, ANGEW CHEM INT EDIT, V6, P41, DOI 10.1002/anie.196700411; KOBRICH G, 1972, ANGEW CHEM INT EDIT, V11, P473, DOI 10.1002/anie.197204731; Nozaki H., 1966, J SYNTH ORG CHEM JPN, V24, P519; Satoh T, 2012, TETRAHEDRON, V68, P1071, DOI 10.1016/j.tet.2011.11.085; Satoh T, 2004, CHEM REC, V3, P329, DOI 10.1002/tcr.10075; Satoh T, 2010, TETRAHEDRON-ASYMMETR, V21, P1, DOI 10.1016/j.tetasy.2009.12.027; Satoh T, 2003, CHEM PHARM BULL, V51, P181, DOI 10.1248/cpb.51.181; Satoh T, 2013, J SYN ORG CHEM JPN, V71, P1033; Satoh T, 2012, TETRAHEDRON LETT, V53, P2074, DOI 10.1016/j.tetlet.2012.02.034; TAYLOR KG, 1982, TETRAHEDRON, V38, P2751, DOI 10.1016/0040-4020(82)85001-1; TAYLOR KG, 1976, J AM CHEM SOC, V98, P4163, DOI 10.1021/ja00430a026; TAYLOR KG, 1972, J AM CHEM SOC, V94, P8924, DOI 10.1021/ja00780a056; Watanabe H, 2010, TETRAHEDRON, V66, P5675, DOI 10.1016/j.tet.2010.05.061	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-3230	1099-1395		J PHYS ORG CHEM	J. Phys. Org. Chem.	JUL	2015	28	7					509	512		10.1002/poc.3440		4	Chemistry, Organic; Chemistry, Physical	Chemistry	CM6RV	WOS:000357818400010		
J	Nakagawa, K; Saita, M; Ikeda, T; Hirota, M; Park, W; Lee, MCI; Ogawa, T				Nakagawa, Kaori; Saita, Makiko; Ikeda, Takayuki; Hirota, Makoto; Park, Wonhee; Lee, Masaichi Chang-Il; Ogawa, Takahiro			Biocompatibility of 4-META/MMA-TBB resin used as a dental luting agent	JOURNAL OF PROSTHETIC DENTISTRY			English	Article							GLASS-IONOMER CEMENTS; IN-VITRO CYTOTOXICITY; OSTEOBLAST-LIKE CELLS; NORMAL-BUTYL BORANE; PULP CELLS; BONE-CEMENT; OPAQUE RESIN; ADHESIVE; 4-META; DURABILITY	Statement of problem. The bonding and biological properties of currently used luting/cementing materials need to be improved. 4-Acryloyloxyethyl trimellitate anhydride/methyl methacrylate-tri-n-butylborane (4-META/MMA-TBB) resin is primarily used for splinting mobile teeth or treating fractured teeth. It undergoes moisture-resistant polymerization and bonds strongly to dentin and metals. Purpose. The purpose of this in vitro study was to compare the biological and biochemical properties META/MMA-TBB resin with those of conventional polymethyl methacrylate (PMMA)-MMA resin and other currently used luting materials in order to determine whether it may be a viable dental luting agent. Material and methods. The degree of polymerization of 4-META/MMA-TBB resin, PMMA-MMA autopolymerizing resin, 10-methacryloyloxydecyl dihydrogen phosphate-dimethacrylate (MDP-DMA) adhesive resin, and a glass ionomer cement was measured by Fourier-transformed infrared spectroscopy. Free radical production during setting was evaluated by electron spin resonance (ESR) spectroscopy. Rat dental pulp cells cultured on these materials were examined for cell viability, attachment, proliferation, and functional phenotype. Results. The degree of polymerization of 4-META/MMA-TBB resin was 82% thirty minutes after preparation, compared to 66% for PMMA-MMA autopolymerizing resin. ESR spectroscopy revealed free radical production from 4-META/MMA-TBB resin and glass ionomer cement was equivalent 24 hours after preparation, with no spike in radical generation observed. In contrast, free radical production from PMMA-MMA and MDP-DMA adhesive resins was rapid and sustained and 10 to 20 times greater than that from 4-META/MMA-TBB. The percentage of viable dental pulp cells 24 hours after seeding was considerably higher on MDP-DMA and 4-META/MMA-TBB resin than on glass ionomer cement. Cell number, proliferation, and alkaline phosphatase activity were highest on 4-META/MMA-TBB resin and lowest on the glass ionomer cement. Conclusions. 4-META/MMA-TBB resin is at least as biocompatible, and perhaps even more biocompatible, than other current luting materials, with fast, favorable, and nontoxic polymerization properties. Further in vivo and human studies of 4-META/MMA-TBB resin as a dental luting agent are warranted.	[Saita, Makiko; Lee, Masaichi Chang-Il] Kanagawa Dent Coll, Dept Clin Care Med, Yokosuka, Kanagawa 238, Japan; [Ogawa, Takahiro] Univ Calif Los Angeles, Sch Dent, Div Adv Prosthodont, Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA 90095 USA	Ogawa, T (reprint author), Univ Calif Los Angeles, Sch Dent, 10833 Le Conte Ave,33-081 CHS,Box 951668, Los Angeles, CA 90095 USA.	togawa@dentistry.ucla.edu					Ahmed Hany Mohamed Aly, 2011, J Conserv Dent, V14, P406, DOI 10.4103/0972-0707.87212; Hume WR, 1996, CRIT REV ORAL BIOL M, V7, P172; Yamada M, 2008, J DENT RES, V87, P372; Kojima N, 2008, DENT MATER, V24, P1686, DOI 10.1016/j.dental.2008.04.008; NAKABAYASHI N, 1992, DENT MATER, V8, P259, DOI 10.1016/0109-5641(92)90096-U; Uctasli S, 2005, DENT MATER, V21, P469, DOI 10.1016/j.dental.2004.08.001; Chang JC, 2002, J PROSTHET DENT, V87, P216, DOI 10.1067/mpr.2002.121584; Schweikl H, 2006, J DENT RES, V85, P870; Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2; NAKABAYASHI N, 1982, J BIOMED MATER RES, V16, P265, DOI 10.1002/jbm.820160307; Nakamura H, 2005, J DENT RES, V84, P515; Costa CAD, 2003, BIOMATERIALS, V24, P3853, DOI 10.1016/S0142-9612(03)00253-9; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; TANAKA T, 1981, J DENT RES, V60, P1697, DOI 10.1177/00220345810600091101; Kong NH, 2009, DENT MATER, V25, P1371, DOI 10.1016/j.dental.2009.06.008; Schmid-Schwap M, 2009, DENT MATER, V25, P360, DOI 10.1016/j.dental.2008.08.002; Ciapetti G, 2002, BIOMATERIALS, V23, P617, DOI 10.1016/S0142-9612(01)00149-1; Spagnuolo G, 2004, J DENT RES, V83, P703; Lee MC, 2005, J DENT RES, V84, P178; Aoki K, 2011, DENT MATER J, V30, P438, DOI 10.4012/dmj.2011-003; Bouillaguet S, 1996, J ENDODONT, V22, P244, DOI 10.1016/S0099-2399(06)80141-X; GOODMAN SB, 1985, ARCH ORTHOP TRAUM SU, V104, P150, DOI 10.1007/BF00454691; GRANCHI D, 1995, BIOMATERIALS, V16, P1187, DOI 10.1016/0142-9612(95)93585-2; ISHIHARA K, 1989, J BIOMED MATER RES, V23, P1475, DOI 10.1002/jbm.820231209; JOHANSON NA, 1987, CLIN ORTHOP RELAT R, P123; Lan WH, 2003, OPER DENT, V28, P251; Lee C, 2000, J BIOL CHEM, V275-38965-72; Mahasti Sahabi, 2011, Cell J, V13, P163; MATSUMURA H, 1990, J DENT RES, V69, P1614, DOI 10.1177/00220345900690091601; Minamikawa H, 2010, BIOMATERIALS, V31, P7213, DOI 10.1016/j.biomaterials.2010.06.018; Minamikawa H, 2011, J ENDODONT, V37, P637, DOI 10.1016/j.joen.2011.02.012; NAKABAYASHI N, 1978, J BIOMED MATER RES, V12, P149, DOI 10.1002/jbm.820120203; Nakabayashi N, 1992, Oper Dent, VSuppl 5, P125; Sakai T, 2000, J BIOMED MATER RES, V52, P128, DOI 10.1002/1097-4636(200010)52:1<128::AID-JBM16>3.0.CO;2-L; Selimovic-Dragas M, 2012, BOSNIAN J BASIC MED, V12, P273; Spagnuolo G, 2004, J DENT RES, V83, P837; Tanaka S, 2007, J BIOMED MATER RES B, V80B, P140, DOI 10.1002/jbm.b.30578; Tanaka Y, 2004, DENT MATER J, V23, P453; Tanaka Y, 2004, DENT MATER J, V23, P265; Tomita S, 2010, DENT MATER J, V29, P690, DOI 10.4012/dmj.2010-021; Tsuchiya Y, 2009, J PERIODONTAL RES, V44, P496, DOI 10.1111/j.1600-0765.2008.01146.x; Tsukimura N, 2009, BIOMATERIALS, V30, P3378, DOI 10.1016/j.biomaterials.2009.02.043; Yamada M, 2009, REDOX REP, V14, P13, DOI 10.1179/135100009X392430; Yoshino F, 2002, REDOX REP, V7, P266, DOI 10.1179/135100002125000767	44	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3913	1097-6841		J PROSTHET DENT	J. Prosthet. Dent.	JUL	2015	114	1					114	121				8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM3ZM	WOS:000357624000021		
J	Sekinishi, T; Inukai, S; Murakami, N; Wakabayashi, N				Sekinishi, Takashi; Inukai, Shusuke; Murakami, Natsuko; Wakabayashi, Noriyuki			Influence of denture tooth thickness on fracture mode of thin acrylic resin bases: An experimental and finite element analysis	JOURNAL OF PROSTHETIC DENTISTRY			English	Article							SUPPORTING TISSUES; BITE FORCE; PRESSURE TRANSMISSION; MECHANICAL-PROPERTIES; BOND STRENGTH; TEETH; ANGULATIONS; PROSTHESES; POLYMER; MONOMER	Statement of problem. The optimum selection of denture teeth for patients with a reduced interarch distance has not been established. Purpose. The purpose of this in vitro study was to investigate the influence of denture tooth material and thickness on the fracture resistance of thin acrylic resin denture bases. Material and methods. Acrylic resin (AC), composite resin (CO), or ceramic (CE) molar denture teeth were embedded in denture base blocks (2.0 mm thick). The distance from the central fossa to the tooth base was 0.5, 1.0, 2.0, or 2.5 mm for AC and CO, and 1.0 mm for CE (n=7), with a total thickness of 2.5 mm for all specimens. Each specimen was placed on a 3-point flexural setup with a shorter (8 mm) or longer (12 mm) support span than the tooth width and vertically loaded. A finite element analysis was performed to assess the stress distributions. The effects of tooth thickness and support span were statistically tested with ANOVA, followed by the Tukey honestly significant difference post hoc test (alpha=.05). Results. With the shorter support, the mean fracture load was higher in CO than AC, regardless of the tooth thickness. Under the longer support, the mean fracture load with the CO decreased significantly as the tooth thickness increased, with increased maximum stress. Some CO tooth specimens of 2.0 mm or 2.5 mm thickness failed at the tooth-denture base interface at significantly lower loads than those exhibited by tooth fractures. CE showed minor cracks before bulk fracture. Conclusions. Higher fracture resistance was indicated with CO; however, the resistance decreased as the thickness of the CO tooth increased.	[Sekinishi, Takashi] Tokyo Med & Dent Univ TMDU, Div Oral Hlth Sci, Removable Partial Prosthodont, Tokyo 1138549, Japan; [Inukai, Shusuke; Murakami, Natsuko; Wakabayashi, Noriyuki] Tokyo Med & Dent Univ TMDU, Div Oral Hlth Sci, Removable Partial Prosthodont, Grad Sch, Tokyo 1138549, Japan	Inukai, S (reprint author), Tokyo Med & Dent Univ TMDU, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	shu.inukai.rpro@tmd.ac.jp			Japan Society for Promotion of Science/MEXT [24592902, 24792064]	Supported by a Grant-in-Aid (24592902 to N.W. and 24792064 to S.I.) from the Japan Society for Promotion of Science/MEXT. Presented at the 122nd Annual Meeting of the Japan Prosthodontic Society, the 80th Anniversary, Fukuoka, Japan, May 2013.	Alkurt M, 2014, J PROSTHET DENT, V111, P71, DOI 10.1016/j.prosdent.2013.09.007; HELKIMO E, 1977, ACTA ODONTOL SCAND, V35, P297, DOI 10.3109/00016357709064128; Wang HY, 2011, J PROSTHET DENT, V105, P338, DOI 10.1016/S0022-3913(11)60066-8; Fontijn-Tekamp FA, 1998, J DENT RES, V77, P1832; Baca E, 2013, ACTA ODONTOL SCAND, V71, P1181, DOI 10.3109/00016357.2012.757360; Al-Sukhun J, 2007, INT J ORAL MAX IMPL, V22, P455; DARBAR UR, 1994, BRIT DENT J, V176, P342, DOI 10.1038/sj.bdj.4808449; Cho E, 2011, DENT MATER, V27, P1070, DOI 10.1016/j.dental.2011.07.008; Arksornnukit M, 2011, J PROSTHET DENT, V105, P127, DOI 10.1016/S0022-3913(11)60013-9; Bural C, 2010, GERODONTOLOGY, V27, P217, DOI 10.1111/j.1741-2358.2009.00321.x; Carlsson G E, 1976, J Oral Rehabil, V3, P267, DOI 10.1111/j.1365-2842.1976.tb00951.x; Choi M, 2012, INT J PROSTHODONT, V25, P53; Chowdhary R, 2008, GERODONTOLOGY, V25, P155, DOI 10.1111/j.1741-2358.2007.00210.x; Davies SJ, 2002, BRIT DENT J, V192, P11, DOI 10.1038/sj.bdj.4801278a; Davies SJ, 2002, BR DENT J, V192, P9; Ikebe K, 2005, J DENT, V33, P131, DOI 10.1016/j.jdent.2004.09.002; Inoue S, 1996, INT J PROSTHODONT, V9, P179; Kawano F, 1996, J ORAL REHABIL, V23, P456, DOI 10.1111/j.1365-2842.1996.tb00879.x; Koroglu A, 2009, J APPL POLYM SCI, V113, P716, DOI 10.1002/app.30123; Lu YL, 2010, CHINESE MED J-PEKING, V123, P917, DOI 10.3760/cma.j.issn.0366-6999.2010.07.028; Memon MS, 2001, INT J PROSTHODONT, V14, P214; Narva KK, 2005, DENT MATER, V21, P421, DOI 10.1016/j.dental.2004.07.007; Perea L, 2014, J PROSTHET DENT, V112, P257, DOI 10.1016/j.prosdent.2014.02.019; Phunthikaphadr T, 2009, J PROSTHET DENT, V102, P319, DOI 10.1016/S0022-3913(09)60183-9; Powers JM, 2006, CRAIGS RESTORATIVE D, P544; Shimizu H, 2004, J ORAL REHABIL, V31, P879, DOI 10.1111/j.1365-2842.2004.01307.x; Takahashi Y, 2000, INT J PROSTHODONT, V13, P59; VALLITTU PK, 1993, ACTA ODONTOL SCAND, V51, P363, DOI 10.3109/00016359309040587; Zarb GA, 2013, PROSTHODONTIC TREATM, P139; ZARB GA, 1980, AUST DENT J, V25, P63	30	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3913	1097-6841		J PROSTHET DENT	J. Prosthet. Dent.	JUL	2015	114	1					122	129				8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM3ZM	WOS:000357624000022		
J	Chakraborty, S; Salekdeh, GH; Yang, PF; Woo, SH; Chin, CF; Gehring, C; Haynes, PA; Mirzaei, M; Komatsu, S				Chakraborty, Subhra; Salekdeh, Ghasem Hosseini; Yang, Pingfang; Woo, Sun Hee; Chin, Chiew Foan; Gehring, Chris; Haynes, Paul A.; Mirzaei, Mehdi; Komatsu, Setsuko			Proteomics of Important Food Crops in the Asia Oceania Region: Current Status and Future Perspectives	JOURNAL OF PROTEOME RESEARCH			English	Review						food crop; proteomics; review	CICER-ARIETINUM L.; VANILLA-PLANIFOLIA ANDREWS; TRITICUM-AESTIVUM L.; ORYZA-SATIVA L.; 2-DIMENSIONAL GEL-ELECTROPHORESIS; DIFFERENTIALLY EXPRESSED PROTEINS; PLANTHOPPER NILAPARVATA-LUGENS; GENETICALLY-MODIFIED CROPS; REVEALS PATHWAY ABUNDANCE; PALM PHOENIX-DACTYLIFERA	In the rapidly growing economies of Asia and Oceania, food security has become a primary concern. With the rising population, growing more food at affordable prices is becoming even more important. In addition, the predicted climate change will lead to drastic changes in global surface temperature and changes in rainfall patterns that in turn will pose a serious threat to plant vegetation worldwide. As a result, understanding how plants will survive in a changing climate will be increasingly important. Such challenges require integrated approaches to increase agricultural production and cope with environmental threats. Proteomics can play a role in unraveling the underlying mechanisms for food production to address the growing demand for food. In this review, the current status of food crop proteomics is discussed, especially in regard to the Asia and Oceania regions. Furthermore, the future perspective in relation to proteomic techniques for the important food crops is highlighted.	[Chakraborty, Subhra] Natl Inst Plant Genome Res, New Delhi 110067, India; [Salekdeh, Ghasem Hosseini] Agr Biotechnol Res Inst Iran, Karaj, Iran; [Yang, Pingfang] Chinese Acad Sci, Wuhan Bot Garden, Wuhan 430074, Peoples R China; [Woo, Sun Hee] Chungbuk Natl Univ, Cheongju 362763, South Korea; [Chin, Chiew Foan] Univ Nottingham Malaysia Campus, Semenyih 43500, Selangor, Malaysia; [Gehring, Chris] King Abdullah Univ Sci & Technol, Thuwal 239556900, Saudi Arabia; [Haynes, Paul A.; Mirzaei, Mehdi] Macquarie Univ, Sydney, NSW 2109, Australia; [Komatsu, Setsuko] Natl Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan	Haynes, PA (reprint author), Macquarie Univ, Sydney, NSW 2109, Australia.	paul.haynes@mq.edu.au; skomatsu@affrc.go.jp		Gehring, Christoph A/0000-0003-4355-4591			Abiko M., 2013, PLOS ONE, V8; Alam I, 2011, PLANT SOIL, V346, P45, DOI 10.1007/s11104-011-0792-0; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Sobhanian H, 2011, J PROTEOMICS, V74, P1323, DOI 10.1016/j.jprot.2011.03.018; Al-Farsi M, 2005, J AGR FOOD CHEM, V53, P7586, DOI 10.1021/jf050578y; Vanderschuren H, 2013, J PROTEOMICS, V93, P5, DOI 10.1016/j.jprot.2013.05.036; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Guo BJ, 2014, PROTEOMICS, V14, P1071, DOI 10.1002/pmic.201300147; Nevo E, 2012, P NATL ACAD SCI USA, V109, P3412, DOI 10.1073/pnas.1121411109; Jin Z, 2013, J PROTEOMICS, V93, P93, DOI 10.1016/j.jprot.2013.05.038; Caruso G, 2008, ANAL BIOANAL CHEM, V391, P381, DOI 10.1007/s00216-008-2008-x; Fercha A, 2013, J PROTEOMICS, V91, P486, DOI 10.1016/j.jprot.2013.08.010; Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Neilson KA, 2011, PROTEOMICS, V11, P1696, DOI 10.1002/pmic.201000727; Vayalil PK, 2012, CRIT REV FOOD SCI, V52, P249, DOI 10.1080/10408398.2010.499824; Swigonska S, 2013, J PLANT PHYSIOL, V170, P470, DOI 10.1016/j.jplph.2012.11.020; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Zhu JM, 2007, PLANT PHYSIOL, V145, P1533, DOI 10.1104/pp.107.107250; Nadaud I, 2010, PROTEOMICS, V10, P2901, DOI 10.1002/pmic.200900792; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Zolla L, 2008, J PROTEOME RES, V7, P1850, DOI 10.1021/pr0705082; Peng ZY, 2009, MOL CELL PROTEOMICS, V8, P2676, DOI 10.1074/mcp.M900052-MCP200; Subba P, 2013, J PROTEOME RES, V12, P5025, DOI 10.1021/pr400628j; Agrawal GK, 2013, MASS SPECTROM REV, V32, P335, DOI 10.1002/mas.21365; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Xu XY, 2011, J ZHEJIANG UNIV-SC B, V12, P507, DOI 10.1631/jzus.B1100061; Kalimuthu K, 2006, CURR SCI INDIA, V91, P1401; Sule A, 2004, PHYTOCHEMISTRY, V65, P1853, DOI 10.1016/j.phytochem.2004.03.030; Han QX, 2013, PLANT PHYSIOL BIOCH, V63, P236, DOI 10.1016/j.plaphy.2012.12.002; Pandey A, 2008, MOL CELL PROTEOMICS, V7, P88, DOI 10.1074/mcp.M700314-MCP200; Alam I, 2010, PLANT SOIL, V333, P491, DOI 10.1007/s11104-010-0365-7; Toorchi M, 2009, PEPTIDES, V30, P2108, DOI 10.1016/j.peptides.2009.09.006; Sasaki T, 2000, CURR OPIN PLANT BIOL, V3, P138, DOI 10.1016/S1369-5266(99)00047-3; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Facette MR, 2013, PLANT CELL, V25, P2798, DOI 10.1105/tpc.113.112227; Peltier JB, 2000, PLANT CELL, V12, P319, DOI 10.1105/tpc.12.3.319; Demirevska K, 2009, ACTA PHYSIOL PLANT, V31, P1129, DOI 10.1007/s11738-009-0331-2; Sghaier-Hammami B, 2009, J PROTEOMICS, V73, P161, DOI 10.1016/j.jprot.2009.07.003; Witzel K, 2009, J EXP BOT, V60, P3545, DOI 10.1093/jxb/erp198; Kim ST, 2008, PROTEOMICS, V8, P3577, DOI 10.1002/pmic.200800183; Collins HM, 2010, CEREAL CHEM, V87, P272, DOI 10.1094/CCHEM-87-4-0272; Pompa M, 2013, J AGR FOOD CHEM, V61, P2606, DOI 10.1021/jf304566d; Vitamvas P, 2012, PROTEOMICS, V12, P68, DOI 10.1002/pmic.201000779; Singh R, 2013, J PROTEOME RES, V12, P4652, DOI 10.1021/pr400689j; Vensel WH, 2005, PROTEOMICS, V5, P1594, DOI 10.1002/pmic.200401034; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Dihazi A, 2012, PLANT PHYSIOL BIOCH, V55, P7, DOI 10.1016/j.plaphy.2012.03.003; Giridhar P, 2001, CURR SCI INDIA, V81, P1166; Bai XG, 2011, J PROTEOME RES, V10, P4349, DOI 10.1021/pr200333f; Kausar R, 2013, AMINO ACIDS, V44, P345, DOI 10.1007/s00726-012-1338-3; Groisman PY, 2005, J CLIMATE, V18, P1326, DOI 10.1175/JCLI3339.1; Zorb C, 2009, PROTEOMICS, V9, P4209, DOI 10.1002/pmic.200800791; Agrawal GK, 2008, PLANT PHYSIOL, V148, P504, DOI 10.1104/pp.108.119222; Zivy M, 2000, PLANT MOL BIOL, V44, P575, DOI 10.1023/A:1026525406953; Ge P, 2012, ANAL BIOANAL CHEM, V402, P1297, DOI 10.1007/s00216-011-5532-z; Sun QP, 2009, PROTEIN J, V28, P341, DOI 10.1007/s10930-009-9199-7; Wang YM, 2013, PROTEOMICS, V13, P1901, DOI 10.1002/pmic.201200454; Huang H, 2012, J PROTEOMICS, V75, P1247, DOI 10.1016/j.jprot.2011.10.036; Jacoby RP, 2010, J PROTEOME RES, V9, P6595, DOI 10.1021/pr1007834; Ahsan N, 2010, PROTEOMICS, V10, P2605, DOI 10.1002/pmic.201000180; Budak H, 2013, PLANT MOL BIOL, V83, P89, DOI 10.1007/s11103-013-0024-5; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; Yu HT, 2012, J PROTEOME RES, V11, P359, DOI 10.1021/pr200779p; Yang PF, 2006, PROTEOMICS, V6, P3330, DOI 10.1002/pmic.200500260; Sallon S, 2008, SCIENCE, V320, P1464, DOI 10.1126/science.1153600; Bhushan D, 2011, J PROTEOME RES, V10, P2027, DOI 10.1021/pr200010f; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Han C, 2014, J PROTEOME RES, V13, P1766, DOI 10.1021/pr401295c; Hajduch M, 2005, PLANT PHYSIOL, V137, P1397, DOI 10.1104/pp.104.056614; Rasoulnia A, 2011, MOL BIOL REP, V38, P5055, DOI 10.1007/s11033-010-0651-8; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Xu CP, 2008, PHYTOCHEMISTRY, V69, P38, DOI 10.1016/j.phytochem.2007.06.010; Komatsu S, 2010, AMINO ACIDS, V38, P729, DOI 10.1007/s00726-009-0277-0; Salekdeh GH, 2007, PROTEOMICS, V7, P2976, DOI 10.1002/pmic.200700181; Oh MW, 2014, MOL BIOL REP, V41, P671, DOI 10.1007/s11033-013-2905-8; Li GZ, 2013, J PROTEOME RES, V12, P4846, DOI 10.1021/pr4008283; Bazargani MM, 2011, J PROTEOMICS, V74, P1959, DOI 10.1016/j.jprot.2011.05.015; Tan BC, 2011, PLANT CELL TISS ORG, V105, P457, DOI 10.1007/s11240-010-9866-6; Marques J, 2011, PLANT PHYSIOL BIOCH, V49, P388, DOI 10.1016/j.plaphy.2011.02.008; Majeran W, 2010, PLANT CELL, V22, P3509, DOI 10.1105/tpc.110.079764; Ferro M, 2003, MOL CELL PROTEOMICS, V2, P325, DOI 10.1074/mcp.M300030-MCP200; Schulte D, 2009, PLANT PHYSIOL, V149, P142, DOI 10.1104/pp.108.128967; Gao LY, 2009, J PROTEOMICS, V73, P279, DOI 10.1016/j.jprot.2009.09.014; Laino P, 2010, PROTEOMICS, V10, P2359, DOI 10.1002/pmic.200900803; Castellana N, 2010, J PROTEOMICS, V73, P2124, DOI 10.1016/j.jprot.2010.06.007; He DL, 2011, J INTEGR PLANT BIOL, V53, P835, DOI 10.1111/j.1744-7909.2011.01074.x; Guo GF, 2012, J PROTEOMICS, V75, P1867, DOI 10.1016/j.jprot.2011.12.032; Kosova K, 2012, J PLANT PHYSIOL, V169, P567, DOI 10.1016/j.jplph.2011.12.013; Majoul T, 2004, PROTEOMICS, V4, P505, DOI 10.1002/pmic.200300570; Tan BC, 2013, PLANT MOL BIOL REP, V31, P1220, DOI 10.1007/s11105-013-0590-3; Komatsu S, 2009, J PROTEOME RES, V8, P4766, DOI 10.1021/pr900460x; Wu LJ, 2013, PLANT MOL BIOL REP, V31, P507, DOI 10.1007/s11105-012-0522-7; Aghaei K, 2009, Amino Acids, V36, P91, DOI 10.1007/s00726-008-0036-7; Moller ALB, 2011, PLANT CELL ENVIRON, V34, P2024, DOI 10.1111/j.1365-3040.2011.02396.x; Majeran W, 2012, PLANT PHYSIOL, V158, P156, DOI 10.1104/pp.111.188474; Kong FJ, 2010, BBA-PROTEINS PROTEOM, V1804, P124, DOI 10.1016/j.bbapap.2009.09.023; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Yang F, 2011, PROTEOMICS, V11, P1684, DOI 10.1002/pmic.201000654; Geetha S, 2000, CURR SCI INDIA, V79, P886; Kumar R, 2014, J PROTEOMICS, V105, P58, DOI 10.1016/j.jprot.2014.04.002; Friso G, 2010, PLANT PHYSIOL, V152, P1219, DOI 10.1104/pp.109.152694; Khatoon A, 2012, J PROTEOMICS, V75, P5706, DOI 10.1016/j.jprot.2012.07.031; Ashoub A, 2013, PLANTA, V237, P771, DOI 10.1007/s00425-012-1798-4; Nozu Y, 2006, PROTEOMICS, V6, P3665, DOI 10.1002/pmic.200600043; Thiellement H, 1999, ELECTROPHORESIS, V20, P2013, DOI 10.1002/(SICI)1522-2683(19990701)20:10<2013::AID-ELPS2013>3.0.CO;2-#; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gao L, 2011, PHYTOCHEMISTRY, V72, P1180, DOI 10.1016/j.phytochem.2010.12.008; Bory S, 2008, GENET RESOUR CROP EV, V55, P551, DOI 10.1007/s10722-007-9260-3; Jung YH, 2012, PROTEOMICS, V12, P878, DOI 10.1002/pmic.201100142; Bhushan D, 2006, J PROTEOME RES, V5, P1711, DOI 10.1021/pr060116f; Kang GZ, 2012, J PROTEOME RES, V11, P6066, DOI 10.1021/pr300728y; Alvarez S, 2014, J PROTEOME RES, V13, P1688, DOI 10.1021/pr401165b; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Nestler J, 2011, J PROTEOME RES, V10, P2525, DOI 10.1021/pr200003k; Nelson CJ, 2014, PLANT PHYSIOL, V166, P91, DOI 10.1104/pp.114.243014; Ghabooli M, 2013, J PROTEOMICS, V94, P289, DOI 10.1016/j.jprot.2013.09.017; Hossain Z, 2012, J PROTEOME RES, V11, P37, DOI 10.1021/pr200863r; Heidarvand L, 2010, ACTA PHYSIOL PLANT, V32, P419, DOI 10.1007/s11738-009-0451-8; D'Hooghe P, 2014, MOL CELL PROTEOMICS, V13, P1165, DOI 10.1074/mcp.M113.034215; Liu YL, 2013, J INTEGR PLANT BIOL, V55, P965, DOI 10.1111/jipb.12058; Kim SG, 2013, J PROTEOMICS, V78, P58, DOI 10.1016/j.jprot.2012.10.029; Minoo D, 2008, GENET RESOUR CROP EV, V55, P459, DOI 10.1007/s10722-007-9252-3; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Pechanova O, 2013, PROTEOMICS, V13, P637, DOI 10.1002/pmic.201200275; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Caruso G, 2009, PLANT SCI, V177, P570, DOI 10.1016/j.plantsci.2009.08.007; Hashiguchi A, 2009, J PROTEOME RES, V8, P2058, DOI 10.1021/pr801051m; Jiang SS, 2012, INT J MOL SCI, V13, P16065, DOI 10.3390/ijms131216065; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Ruebelt MC, 2006, J AGR FOOD CHEM, V54, P2169, DOI 10.1021/jf052358q; Alikhani M, 2013, MOL BIOSYST, V9, P1498, DOI 10.1039/c3mb70069k; Chandran S, 2009, ACTA PHYSIOL PLANT, V31, P1023, DOI 10.1007/s11738-009-0321-4; Rinalducci S, 2011, ELECTROPHORESIS, V32, P1807, DOI 10.1002/elps.201000663; Mohammadi PP, 2012, J PROTEOMICS, V75, P1906, DOI 10.1016/j.jprot.2011.12.041; Bhushan D, 2007, MOL CELL PROTEOMICS, V6, P1868, DOI 10.1074/mcp.M700015-MCP200; Coram TE, 2006, PLANT BIOTECHNOL J, V4, P647, DOI 10.1111/j.1467-7652.2006.00208.x; Janarthanam B, 2008, IN VITRO CELL DEV-PL, V44, P84, DOI 10.1007/s11627-008-9123-4; Zorb C, 2010, PROTEOMICS, V10, P4441, DOI 10.1002/pmic.201000231; Shiferaw B, 2011, FOOD SECUR, V3, P307, DOI 10.1007/s12571-011-0140-5; Galant A, 2012, NEW PHYTOL, V194, P220, DOI 10.1111/j.1469-8137.2011.04037.x; Young ND, 2012, ANNU REV PLANT BIOL, V63, P283, DOI 10.1146/annurev-arplant-042110-103754; Wei Z, 2009, PROTEOMICS, V9, P2798, DOI 10.1002/pmic.200800840; Wardhan V, 2012, PLANT MOL BIOL, V79, P479, DOI 10.1007/s11103-012-9925-y; Nwugo CC, 2011, J PROTEOME RES, V10, P518, DOI 10.1021/pr100716h; Majoul T, 2003, PROTEOMICS, V3, P175, DOI 10.1002/pmic.200390026; Bourgeois M, 2011, PROTEOMICS, V11, P1581, DOI 10.1002/pmic.201000687; Gupta S, 2011, J PROTEOME RES, V10, P5006, DOI 10.1021/pr200493d; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Finnie C, 2009, J PROTEOMICS, V72, P315, DOI 10.1016/j.jprot.2008.12.001; Li KP, 2007, PROTEOMICS, V7, P1501, DOI 10.1002/pmic.200600960; Hwang H, 2011, BBA-PROTEINS PROTEOM, V1814, P470, DOI 10.1016/j.bbapap.2011.01.010; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Mamone G, 2009, J MASS SPECTROM, V44, P1709, DOI 10.1002/jms.1680; KONONOWICZ H, 1984, HORTSCIENCE, V19, P58; Pandey A, 2006, J PROTEOME RES, V5, P3301, DOI 10.1021/pr060147a; Alam I, 2010, J BIOSCIENCES, V35, P49, DOI 10.1007/s12038-010-0007-5; Sarhadi E, 2010, J PROTEOME RES, V9, P5658, DOI 10.1021/pr100475r; Patterson J, 2007, PLANT PHYSIOL, V144, P1612, DOI 10.1104/pp.107.096388; Zhai YF, 2013, J PROTEOME RES, V12, P5199, DOI 10.1021/pr400561c; Ruebelt MC, 2006, J AGR FOOD CHEM, V54, P2162, DOI 10.1021/jf052357y; Walley JW, 2013, P NATL ACAD SCI USA, V110, pE4808, DOI 10.1073/pnas.1319113110; Lee-Espinosa HE, 2008, HORTSCIENCE, V43, P454; Tasleem-Tahir A, 2011, PROTEOMICS, V11, P371, DOI 10.1002/pmic.201000333; Irar S, 2010, J PROTEOMICS, V73, P1707, DOI 10.1016/j.jprot.2010.05.003; Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; Walton NJ, 2003, PHYTOCHEMISTRY, V63, P505, DOI 10.1016/S0031-9422(03)00149-3; Subba P, 2013, PROTEOMICS, V13, P1973, DOI 10.1002/pmic.201200380; Asensio Leticia, 2007, Revista Iberoamericana de Micologia, V24, P299; Ashraf N., 2009, BMC GENOMICS, V10; Banos E., 2010, PLANT BIOTECHNOL J, V8, P436; Bernardo L., 2012, BMC GENOMICS, V13; Bonsager BC, 2007, PROTEOMICS, V7, P4528, DOI 10.1002/pmic.200700766; Buhariwalla H. K., 2005, BMC PLANT BIOL, V5; BURSTIN J, 1994, THEOR APPL GENET, V89, P943, DOI 10.1007/BF00224522; Capriotti AL, 2014, ANAL BIOANAL CHEM, V406, P1423, DOI 10.1007/s00216-013-7549-y; Castellana NE, 2014, MOL CELL PROTEOMICS, V13, P157, DOI 10.1074/mcp.M113.031260; Chakraborty S., 2008, PLANT PROTEOMICS TEC, P327, DOI 10.1002/9780470369630.ch22; Chen Y., 2014, PROTEOME SCI, V12; Duan JiangYan, 2013, American Journal of Plant Sciences, V4, P1227, DOI 10.4236/ajps.2013.46150; DunIdey T. P. J., 2006, P NATL ACAD SCI USA, V103, P6518; El-Rayes D. A., 2009, ENV ARID AGR SCI, V20, P3; Ford KL, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00044; Gallage N. J., 2004, NAT COMMUN, V5; Gonzalez JF, 2012, J PROTEOMICS, V75, P5911, DOI 10.1016/j.jprot.2012.07.019; Gu Z., 1987, Lindleyana, V2, P48; Guo BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065867; Guo G., 2012, BMC PLANT BIOL, V12; Han C, 2014, PLANT CELL PHYSIOL, V55, P1376, DOI 10.1093/pcp/pcu060; Han C, 2014, PLANT CELL PHYSIOL, V55, P1826, DOI 10.1093/pcp/pcu114; He D., 2013, FRONT PLANT SCI, V4; Hossain Z, 2012, AMINO ACIDS, V43, P2393, DOI 10.1007/s00726-012-1319-6; Hossain Z, 2014, PROTEOMES, V2, P107; Hossain Z., 2013, FRONT PLANT SCI, V3; IWGSC, 2014, SCIENCE, V345, DOI DOI 10.1126/SCIENCE.1251788; Jaiswal D. K., 2012, PROTEOME SCI, V10; Jaiswal D. K., 2014, SCI REP, V4; Jin XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059353; Kamal A. H. M., 2009, PLANT OMICS J, V2, P110; Kang GZ, 2013, J PROTEOMICS, V83, P130, DOI 10.1016/j.jprot.2013.03.020; Kaspar S, 2010, J PROTEOME RES, V9, P2402, DOI 10.1021/pr901113z; Kawano Y, 2013, CURR OPIN PLANT BIOL, V16, P496, DOI 10.1016/j.pbi.2013.07.004; Kerim T, 2003, PROTEOMICS, V3, P738, DOI 10.1002/pmic.200300424; Khatoon A, 2012, CURR PROTEOMICS, V9, P217; Khatoon A, 2012, MOL BIOL REP, V39, P10581, DOI 10.1007/s11033-012-1946-8; KIKUCHI N, 1978, MIKROCHIM ACTA, V1, P89; Kim KH, 2010, ACTA BIOCH BIOPH SIN, V42, P709, DOI 10.1093/abbs/gmq079; Kim ST, 2014, PROTEOMICS, V14, P593, DOI 10.1002/pmic.201300388; Komatsu S, 2012, J PROTEOME RES, V11, P68, DOI 10.1021/pr2008863; Komatsu S, 2014, PROTEIN PEPTIDE LETT, V21, P1308; Komatsu S, 2012, J PROTEOME RES, V11, P1461, DOI 10.1021/pr300063z; Komatsu S, 2013, J PROTEOME RES, V12, P4651, DOI 10.1021/pr4010426; Komatsu S., 2010, PROTEOMICS, V10, P1930; Lin Z., 2014, BMC PLANT BIOL, V14; Liu W, 2012, J SCI FOOD AGR, V92, P106, DOI 10.1002/jsfa.4548; MAIER VP, 1965, J FOOD SCI, V30, P80, DOI 10.1111/j.1365-2621.1965.tb00267.x; Maleki M., 2014, Annual Research & Review in Biology, V4, P1784, DOI 10.9734/ARRB/2014/7795; Mantri NL, 2007, BMC GENOMICS, V8; March TJ, 2012, PROTEOMICS, V12, P2843, DOI 10.1002/pmic.201200117; Marondedze C, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-1; Marondedze C., 2014, HORTIC RES, V1; Meekijjaroenroj A, 2003, NATURWISSENSCHAFTEN, V90, P452, DOI 10.1007/s00114-003-0454-z; Meng LB, 2014, MOL BIOL REP, V41, P3431, DOI 10.1007/s11033-014-3205-7; Milan T. H. J., 2006, EUPHYTICA, V147, P81; Mohammadi PP, 2012, CURR PROTEOMICS, V9, P232; Morton J., 1987, FRUITS WARM CLIMATES, P5; Narula K., 2013, FRONT PLANT SCI, V4; Narula K., 2012, CROP PLANTS, P145; Neilson KA, 2014, METHODS MOL BIOL, V1072, P289, DOI 10.1007/978-1-62703-631-3_21; Neilson KA, 2013, PROTEOMICS, V13, P1922, DOI 10.1002/pmic.201200475; Newman K, 2014, REPROD HEALTH MATTER, V22, P53, DOI 10.1016/S0968-8080(14)43770-4; Palama T. L., 2010, BMC PLANT BIOL, V10; Pascovici D, 2013, J PROTEOME RES, V12, P4870, DOI 10.1021/pr400531y; Peremarti A., 2014, BMC GENOMICS, V15; Petrovska B, 2014, CYTOGENET GENOME RES, V143, P78, DOI 10.1159/000365311; Pinheiro C, 2013, J PROTEOME RES, V12, P3152, DOI 10.1021/pr400012t; Rao SR, 2000, J SCI FOOD AGR, V80, P289, DOI 10.1002/1097-0010(200002)80:3<289::AID-JSFA543>3.0.CO;2-2; Rugman-Jones PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078379; Saker M. M., 1999, ARAB J BIOTECHNOL, V2, P71; Sarhadi E, 2012, PLANT PHYSIOL BIOCH, V58, P280, DOI 10.1016/j.plaphy.2012.07.013; Sheychenko A., 2014, J PROTEOMICS, V105, P363; Sobhanian H, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-19; Sun HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079158; Uvackova L, 2012, J PROTEOMICS, V75, P1886, DOI 10.1016/j.jprot.2011.12.033; Vensel W. H., 2014, PROTEOME SCI, V12; Vessal S, 2012, J PROTEOME RES, V11, P4289, DOI 10.1021/pr300415w; Wang K, 2014, PROTEOMICS, V14, P2319, DOI 10.1002/pmic.201400004; Wang Y, 2011, ACTA PHYSIOL PLANT, V33, P349, DOI 10.1007/s11738-010-0554-2; Wang Y, 2011, J PROTEOME RES, V10, P3136, DOI 10.1021/pr200202m; Wang ZZ, 2011, PROTEOMICS, V11, P225, DOI 10.1002/pmic.201000065; Witzel K, 2010, PLANT CELL ENVIRON, V33, P211, DOI 10.1111/j.1365-3040.2009.02071.x; Wu LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070295; Wu XT, 2014, PROCEEDINGS OF 2014 3RD ASIA-PACIFIC CONFERENCE ON ANTENNAS AND PROPAGATION (APCAP 2014), P1; Xu H, 2012, PLANTA, V235, P687, DOI 10.1007/s00425-011-1535-4; Yan JJ, 2014, J PROTEOMICS, V108, P110, DOI 10.1016/j.jprot.2014.05.014; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Yang PF, 2007, PROTEOMICS, V7, P2459, DOI 10.1002/pmic.200600215; Guo HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022255; Yu J., 2014, PROTEOMES, V2, P258; Zhang S., 2014, FRONT AGR SCI ENG, V1, P37; Zheng YS, 2013, PROTEOMICS, V13, P2622, DOI 10.1002/pmic.201300026; Zi J, 2012, ELECTROPHORESIS, V33, P1129, DOI 10.1002/elps.201100398; Zuber H, 2013, PLANT J, V76, P982, DOI 10.1111/tpj.12350	263	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	JUL	2015	14	7					2723	2744		10.1021/acs.jproteome.5b00211		22	Biochemical Research Methods	Biochemistry & Molecular Biology	CM3ZQ	WOS:000357624400001		
J	Li, M; Yin, XJ; Sakata, K; Yang, PF; Komatsu, S				Li, Ming; Yin, Xiaojian; Sakata, Katsumi; Yang, Pingfang; Komatsu, Setsuko			Proteomic Analysis of Phosphoproteins in the Rice Nucleus During the Early Stage of Seed Germination	JOURNAL OF PROTEOME RESEARCH			English	Article						rice; nucleus; phosphoproteomics; germination; phosphonetwork	DISEASE RESISTANCE GENES; ZINC-FINGER PROTEINS; DNA-BINDING DOMAIN; ORYZA-SATIVA; ARABIDOPSIS; LOCALIZATION; IDENTIFICATION; PROTEASES; RESPONSES; OXYGEN	The early stage of seed germination is the first step in the plant life cycle without visible morphological change, To investigate the mechanism controlling the early stage of rice seed germination, we performed gel-and label free nuclear phosphoproteomics. A total of 3467 phosphopeptides belonging to 102 nuclear phosphoproteins from rice embryos were identified. Protein-synthesisrelated proteins were mainly phosphorylated. During the first 24 h following imbibition, 115 nuclear phosphoproteins were identified, and significant changes in the phosphorylation level over time were observed in 29 phOsphoproteins. Cluster analysis indicated that nucleotide-binding proteins and zinc finger CCCH- and BED-type proteins increased in abundance during the first 12 h of imbibition and then decreased. The in silk protein-protein interactions for 29 nuclear phosphoproteins indicated that the Sas10/Utp3 protein, which functions in snoRNA binding and gene silencing, was the center of the phosphoprotein network in nuclei. The germination rate of seeds was significantly slowed with phosphatase inhibitor treatment. The mRNA expression of the zinc finger CCCH-type protein did not change, and the zinc finger BED-type protein was upregulated in rice embryos during the early stage of germination with phosphatase inhibitor treatthent. These results suggest that the phosphorylation and dephosphorylation of nuclear proteins are involved in rice seed germination. Furthermore, transcription factors such as zinc finger CCCH- and BED-type proteins might play a key role through nuclear phosphoproteins, and Sas10/Utp3 protein might interact with nuclear phosphoproteins in rice embryos to mediate the early stage of seed germination.	[Li, Ming; Yang, Pingfang] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan 430074, Peoples R China; [Li, Ming; Yin, Xiaojian; Komatsu, Setsuko] Natl Inst Crop Sci, Natl Agr & Food Res Org, Tsukuba, Ibaraki 3058518, Japan; [Sakata, Katsumi] Maebashi Inst Technol, Dept Life Sci & Informat, Maebashi, Gumma 3710816, Japan	Komatsu, S (reprint author), Natl Inst Crop Sci, Natl Agr & Food Res Org, Tsukuba, Ibaraki 3058518, Japan.	skomatsu@affrc.go.jp			National Natural Science Foundation of China [31271805]; National Agriculture and Food Research Organization	The authors thank Dr. K. Sugimoto at the National Institute of Agrobiological Sciences for providing rice seeds and Drs. Y. Nanjo and K. Nishizawa at the National Institute of Crop Science for useful suggestions and comments. The authors also thank Ms. C. Kawashima and Ms. A. Sato at the National Institute of Crop Science for experimental support during this research. This work was supported by the National Natural Science Foundation of China (31271805) and by the National Agriculture and Food Research Organization.	MILLER J, 1985, EMBO J, V4, P1609; Schuhmann H, 2012, PHYSIOL PLANTARUM, V145, P224, DOI 10.1111/j.1399-3054.2011.01533.x; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Shingaki-Wells RN, 2011, PLANT PHYSIOL, V156, P1706, DOI 10.1104/pp.111.175570; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Bendahmane A, 2000, PLANT J, V21, P73, DOI 10.1046/j.1365-313x.2000.00654.x; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Kim ST, 2008, PROTEOMICS, V8, P3577, DOI 10.1002/pmic.200800183; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Cho JN, 2012, DEV CELL, V22, P736, DOI 10.1016/j.devcel.2012.01.024; Sihn CR, 2008, GENES CELLS, V13, P787, DOI 10.1111/j.1365-2443.2008.01205.x; Han C, 2014, J PROTEOME RES, V13, P1766, DOI 10.1021/pr401295c; Rajjou L, 2012, ANNU REV PLANT BIOL, V63, P507, DOI 10.1146/annurev-arplant-042811-105550; PERATA P, 1992, PLANTA, V188, P611, DOI 10.1007/BF00197056; He DL, 2011, PROTEOMICS, V11, P2693, DOI 10.1002/pmic.201000598; Tanaka N, 2005, MOL CELL PROTEOMICS, V4, P796, DOI 10.1074/mcp.M400211-MCP200; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Adam Z, 2001, PLANT PHYSIOL, V125, P1912, DOI 10.1104/pp.125.4.1912; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Howell KA, 2007, J BIOL CHEM, V282, P15619, DOI 10.1074/jbc.M609866200; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Pendle AF, 2005, MOL BIOL CELL, V16, P260; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Jones AME, 2009, J PROTEOMICS, V72, P439, DOI 10.1016/j.jprot.2009.02.004; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Howell KA, 2006, PLANT MOL BIOL, V60, P201, DOI 10.1007/s11103-005-3688-7; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Narsai R, 2009, PLANT PHYSIOL, V151, P306, DOI 10.1104/pp.109.142026; Bogamuwa S, 2013, PLANT CELL ENVIRON, V36, P1507, DOI 10.1111/pce.12084; Matsushita A, 2007, PLANT PHYSIOL, V143, P1152, DOI 10.1104/pp.106.093542; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Bazzaz F. A., 2000, Seeds: the ecology of regeneration in plant communities, P1, DOI 10.1079/9780851994321.0001; Black M., 1994, SEEDS PHYSL DEV GERM, P377; CHIATANTE D, 1995, J EXP BOT, V46, P815, DOI 10.1093/jxb/46.7.815; Ferrari F, 2009, ELECTROPHORESIS, V30, P4083, DOI 10.1002/elps.200900469; Fujimoto S, 2004, PLANT MOL BIOL, V56, P225, DOI 10.1007/s11103-004-3249-5; Garcia-Lorenzo M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-30; Han C, 2014, PLANT CELL PHYSIOL, V55, P1376, DOI 10.1093/pcp/pcu060; Han C, 2014, PLANT CELL PHYSIOL, V55, P1826, DOI 10.1093/pcp/pcu114; Henfrey R. D., 1988, NEW NUCL ACID TECHNI, P447; Huesgen P. F., 2007, THESIS U KONSTANZ GE; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kamakaka RT, 1998, GENETICS, V149, P903; Liu SJ, 2015, PHYSIOL PLANTARUM, V154, P142, DOI 10.1111/ppl.12292; Magneschi L, 2009, ANN BOT-LONDON, V103, P181, DOI 10.1093/aob/mcn121; RAYMOND P, 1985, PLANT PHYSIOL, V79, P879, DOI 10.1104/pp.79.3.879; REEVES R, 1990, J BIOL CHEM, V265, P8573; Sadiq I, 2011, J PLANT PHYSIOL, V168, P2234, DOI 10.1016/j.jplph.2011.07.009; Schuhmann H., 2008, THESIS U KONSTANZ GE; Schuhmann H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-52; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Voit E. O., 2000, COMPUTATIONAL ANAL B, P37; Wu JH, 2014, PLANT J, V80, P1118, DOI 10.1111/tpj.12714; Yamauchi M, 2000, AGRON J, V92, P275, DOI 10.1007/s100870050033; Yang P. F., 2013, PROTEOMICS IN FOODS, P383; Yano H, 2006, PROTEOMICS, V6, P294, DOI 10.1002/pmic.200402033; Yano H, 2001, P NATL ACAD SCI USA, V98, P4794, DOI 10.1073/pnas.071041998	66	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	JUL	2015	14	7					2884	2896				13	Biochemical Research Methods	Biochemistry & Molecular Biology	CM3ZQ	WOS:000357624400014		
J	Motono, T; Nagai, T; Kitagawa, S; Ohtani, H				Motono, Tomohiro; Nagai, Takashi; Kitagawa, Shinya; Ohtani, Hajime			Chromatographic behavior of small organic compounds in low-temperature high-performance liquid chromatography using liquid carbon dioxide as the mobile phase	JOURNAL OF SEPARATION SCIENCE			English	Article						Column efficiency; Liquid carbon dioxide; Low-temperature high-performance liquid chromatography; van't Hoff plots	SUPERCRITICAL-FLUID CHROMATOGRAPHY; CHIRAL STATIONARY-PHASE; SUPERHEATED WATER; THERMALLY LABILE; SEPARATIONS; HPLC; ENANTIOMERS; RETENTION; ELUENT; COLUMN	Low-temperature high-performance liquid chromatography, in which a loop injector, column, and detection cell were refrigerated at -35 degrees C, using liquid carbon dioxide as the mobile phase was developed. Small organic compounds (polyaromatic hydrocarbons, alkyl-benzenes, and quinones) were separated by low-temperature high-performance liquid chromatography at temperatures from -35 to -5 degrees C. The combination of liquid carbon dioxide mobile phase with an octadecyl-silica (C-18) column provided reversed phase mode separation, and a bare silica-gel column resulted in normal phase mode separation. In both the cases, nonlinear behavior at approximately -15 degrees C was found in the relationship between the temperature and the retention factors of the analytes (van't Hoff plots). In contrast to general trends in high-performance liquid chromatography, the decrease in temperature enhanced the separation efficiency of both the columns.	[Motono, Tomohiro; Nagai, Takashi; Kitagawa, Shinya; Ohtani, Hajime] Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Kitagawa, S (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.	kitagawa.shinya@nitech.ac.jp			JSPS KAKENHI [23655065]	This work was supported by JSPS KAKENHI Grant Number 23655065.	Abbott E, 2008, J SEP SCI, V31, P1223, DOI 10.1002/jssc.200700579; Biba M, 2014, J CHROMATOGR A, V1363, P250, DOI 10.1016/j.chroma.2014.07.010; Mangelings D, 2008, J SEP SCI, V31, P1252, DOI 10.1002/jssc.200700564; Tasaki Y, 2006, ANAL CHEM, V78, P4155, DOI 10.1021/ac0602470; Pirkle WH, 1996, J CHROMATOGR A, V753, P109, DOI 10.1016/S0021-9673(96)00460-8; Lesellier E, 2008, J SEP SCI, V31, P1238, DOI 10.1002/jssc.200800057; Bamba T, 2008, J SEP SCI, V31, P1274, DOI 10.1002/jssc.200700499; COLE LA, 1992, ANAL CHEM, V64, P1317, DOI 10.1021/ac00037a004; Sabia R, 2014, J CHROMATOGR A, V1363, P144, DOI 10.1016/j.chroma.2014.07.097; Li FB, 2008, J SEP SCI, V31, P1231, DOI 10.1002/jssc.200700581; Smith RM, 1997, J CHROMATOGR A, V785, P49, DOI 10.1016/S0021-9673(97)00570-0; Xiang YQ, 2013, J CHROMATOGR A, V1293, P150, DOI 10.1016/j.chroma.2013.03.048; Fields SM, 2001, J CHROMATOGR A, V913, P197, DOI 10.1016/S0021-9673(00)01246-2; BEYER J, 1986, J LIQ CHROMATOGR, V9, P2433, DOI 10.1080/01483918608076876; Chennuru N. L., 2013, J SEP SCI, V36, P3004; Droux S, 2011, CHIRALITY, V23, pE105, DOI 10.1002/chir.21019; FIELDS SM, 1985, J CHROMATOGR, V349, P305, DOI 10.1016/S0021-9673(01)83787-0; HANSEN SJ, 1983, J CHROMATOGR SCI, V21, P560; HENDERSON DE, 1984, ADV CHROMATOGR, V23, P65; HENDERSON DE, 1985, J CHROMATOGR SCI, V23, P477; Kaufmann M. J., 1997, CHROMATOGR B, V699, P347; Kimura T, 2013, CHROMATOGRAPHIA, V76, P921, DOI 10.1007/s10337-013-2491-x; Layton C, 2013, J SEP SCI, V36, P3941, DOI 10.1002/jssc.201300800; Ohmori T., EOS SCS VER 0 2W; Ooms B, 1996, LC GC-MAG SEP SCI, V14, P306; PIRKLE WH, 1991, J CHROMATOGR, V557, P173, DOI 10.1016/S0021-9673(01)87131-4; Sajewicz M, 2010, J LIQ CHROMATOGR R T, V33, P936, DOI 10.1080/10826071003765890; Wolf C, 1997, J CHROMATOGR A, V785, P173, DOI 10.1016/S0021-9673(97)00681-X	28	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	JUL	2015	38	14					2381	2386		10.1002/jssc.201500151		6	Chemistry, Analytical	Chemistry	CM9BR	WOS:000358001000002		
J	Shahruzzaman, M; Takafuji, M; Ihara, H				Shahruzzaman, Md; Takafuji, Makoto; Ihara, Hirotaka			Porous silica particles grafted with an amphiphilic side-chain polymer as a stationary phase in reversed-phase high-performance liquid chromatography	JOURNAL OF SEPARATION SCIENCE			English	Article						Amphiphilic polymer; Aggregation structure; High-performance liquid chromatography; Polycyclic aromatic hydrocarbons; Quaternization	POLYCYCLIC AROMATIC-HYDROCARBONS; MOLECULAR-SHAPE SELECTIVITY; RETENTION BEHAVIOR; HPLC; CRYSTALLINE; POLY(4-VINYLPYRIDINE); INDEXES; GELS	The amphiphilic polymer-grafted silica was newly prepared as a stationary phase in high-performance liquid chromatography. Poly(4-vinylpyridine) with a trimethoxysilyl group at one end was grafted onto porous silica particles and the pyridyl side chains were quaternized with 1-bromooctadecane. The obtained poly(octadecylpyridinium)-grafted silica was characterized by elemental analysis, diffuse reflectance infrared Fourier transform spectroscopy and Brunauer-Emmett-Teller analysis. The degree of quaternization of the pyridyl groups on the obtained stationary phase was estimated to be 70%. The selective retention behaviors of polycyclic aromatic hydrocarbons including some positional isomers were investigated using poly(octadecylpyridinium)-grafted silica as an amphiphilic polymer stationary phase in high-performance liquid chromatography and results were compared with commercially available polymeric octadecylated silica and phenyl-bonded silica columns. The results indicate that the selectivity toward polycyclic aromatic hydrocarbons exhibited by the amphiphilic polymer stationary phase is higher than the corresponding selectivity exhibited by a conventional phenyl-bonded silica column. However, compared with the polymeric octadecylated silica phase, the new stationary phase presents similar retention behavior for polycyclic aromatic hydrocarbons but different retention behavior particularly for positional isomers of disubstituted benzenes as the aggregation structure of amphiphilic polymers on the surface of silica substrate has been altered during mobile phase variation.	[Shahruzzaman, Md; Takafuji, Makoto; Ihara, Hirotaka] Kumamoto Univ, Dept Appl Chem & Biochem, Kumamoto 8608555, Japan; [Takafuji, Makoto; Ihara, Hirotaka] Kumamoto Inst Photoelectro Organ PHOENICS, Higashi Ku, Kumamoto, Japan; [Shahruzzaman, Md] Daffodil Int Univ, Dept Nat Sci, Dhaka, Bangladesh	Ihara, H (reprint author), Kumamoto Univ, Dept Appl Chem & Biochem, Kumamoto 8608555, Japan.	ihara@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This research was supported in part by a grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Claessens HA, 1998, J CHROMATOGR A, V826, P135, DOI 10.1016/S0021-9673(98)00749-3; Rahman MM, 2005, ANAL CHEM, V77, P6671, DOI 10.1021/ac050851v; Gu L, 2014, ACCOUNTS CHEM RES, V47, P2867, DOI 10.1021/ar4003009; Qiu HD, 2013, CHEM COMMUN, V49, P2454, DOI 10.1039/c3cc00138e; Deng ZF, 2014, J SEP SCI, V37, P3268, DOI 10.1002/jssc.201400366; SANDER LC, 1984, ANAL CHEM, V56, P504, DOI 10.1021/ac00267a047; Chester TL, 2013, ANAL CHEM, V85, P579, DOI 10.1021/ac303180y; Ihara H, 2005, ANAL CHIM ACTA, V548, P51, DOI 10.1016/j.aca.2005.05.056; Sun M, 2014, J SEP SCI, V37, P2153, DOI 10.1002/jssc.201400176; Horak J, 2004, J CHROMATOGR A, V1045, P43, DOI 10.1016/j.chroma.2004.05.096; KIMATA K, 1989, J CHROMATOGR SCI, V27, P721; Sander LC, 1999, ANAL CHEM, V71, P4821, DOI 10.1021/ac9908187; Dong J, 2011, ANAL BIOANAL CHEM, V399, P3415, DOI 10.1007/s00216-010-4462-5; Gritti F, 2007, J CHROMATOGR A, V1169, P111, DOI 10.1016/j.chroma.2007.08.071; Pino V, 2012, ANAL CHIM ACTA, V714, P20, DOI 10.1016/j.aca.2011.11.045; Qiu HD, 2013, CHEM-EUR J, V19, P18004, DOI 10.1002/chem.201302746; Bell CM, 1997, J CHROMATOGR A, V757, P29, DOI 10.1016/S0021-9673(96)00664-4; Bocian S, 2014, J SEP SCI, V37, P3435, DOI 10.1002/jssc.201400764; Buszewski B, 2003, J SEP SCI, V26, P313, DOI 10.1002/jssc.200390037; Chan F, 2005, J CHROMATOGR A, V1069, P217, DOI 10.1016/j.chroma.2005.02.022; Chowdhury MAJ, 2000, J CHROMATOGR A, V877, P71, DOI 10.1016/S0021-9673(00)00187-4; Gadzala-Kopciuch R. M., 1999, POL J ENVIRON STUD, V8, P383; Hayrapetyan SS, 2006, J SEP SCI, V29, P810, DOI 10.1002/jssc.200500403; Heron S, 1996, J CHROMATOGR A, V725, P205, DOI 10.1016/0021-9673(95)00990-6; HIRAYAMA C, 1992, MACROMOLECULES, V25, P6375, DOI 10.1021/ma00049a041; Hu K, 2015, J SEP SCI, V38, P60, DOI 10.1002/jssc.201400836; Ihara H, 1996, J LIQ CHROMATOGR R T, V19, P2967, DOI 10.1080/10826079608015120; Ihara H, 1999, POLYMER, V40, P2555, DOI 10.1016/S0032-3861(98)00485-6; Ihara H, 2001, CHEM LETT, P1252; JINNO K, 1987, J CHROMATOGR, V392, P75, DOI 10.1016/S0021-9673(01)94255-4; JINNO K, 1989, J CHROMATOGR, V461, P209, DOI 10.1016/S0021-9673(00)94288-2; Jinno K., 1996, CHROMATOGRAPHIC SEPA, P1; JINNO K, 1984, CHROMATOGRAPHIA, V18, P499, DOI 10.1007/BF02267235; KALISZAN R, 1978, J CHROMATOGR SCI, V16, P246; LAMPARCZYK H, 1985, CHROMATOGRAPHIA, V20, P283, DOI 10.1007/BF02310384; Mallik AK, 2008, J CHROMATOGR A, V1187, P119, DOI 10.1016/j.chroma.2008.02.011; Miyabe K, 2003, ANALYST, V128, P1425, DOI 10.1039/b308293h; Ohyama K, 2015, J SEP SCI, V38, P720, DOI 10.1002/jssc.201401243; Saito Y, 2003, J SEP SCI, V26, P225, DOI 10.1002/jssc.200390029; Schborn J. F., 1977, ANAL CHEM, V49, P2253; Shi W, 2001, J CHROMATOGR A, V924, P123, DOI 10.1016/S0021-9673(01)00760-9; Takafuji M, 2005, J NANOSCI NANOTECHNO, V5, P390, DOI 10.1166/jnn.2005.069; WISE SA, 1981, J CHROMATOGR SCI, V19, P457; Yang DZ, 2015, J SEP SCI, V38, P381, DOI 10.1002/jssc.201400981	44	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	JUL	2015	38	14					2403	2413		10.1002/jssc.201500189		11	Chemistry, Analytical	Chemistry	CM9BR	WOS:000358001000005		
J	Amasaki, S; Lokan, C				Amasaki, S.; Lokan, C.			On the effectiveness of weighted moving windows: Experiment on linear regression based software effort estimation	JOURNAL OF SOFTWARE-EVOLUTION AND PROCESS			English	Article						effort estimation; moving window; gradual weighting	COST ESTIMATION	In construction of an effort estimation model, it seems effective to use a window of training data so that the model is trained with only recent projects. Considering the chronological order of projects within the window, and weighting projects according to their order within the window, may also affect estimation accuracy. In this study, we examined the effects of weighted moving windows on effort estimation accuracy. We compared weighted and non-weighted moving windows under the same experimental settings. We confirmed that weighting methods significantly improved estimation accuracy in larger windows, although the methods also significantly worsened accuracy in smaller windows. This result contributes to understanding properties of moving windows. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Amasaki, S.] Okayama Prefectural Univ, Dept Syst Engn, Okayama 7191197, Japan; [Lokan, C.] UNSW Canberra, Sch Engn & Informat Technol, Canberra, ACT 2600, Australia	Amasaki, S (reprint author), Okayama Prefectural Univ, Dept Syst Engn, 111 Kuboki, Okayama 7191197, Japan.	amasaki@cse.oka-pu.ac.jp			Japan Society for the Promotion of Science [25330083]; Wesco Scientific Promotion Foundation	A part of this work is supported by Grant-in-Aid for Scientific Research (C) 25330083, Japan Society for the Promotion of Science, and Wesco Scientific Promotion Foundation.	Amasaki S, 2013, LECT NOTES COMPUT SC, V7983, P214, DOI 10.1007/978-3-642-39259-7_18; Amasaki S., 2012, 2012 Joint Conference of the 22nd International Workshop on Software Measurement and the 2012 7th International Conference on Software Process and Product Measurement (IWSM-MENSURA), DOI 10.1109/IWSM-MENSURA.2012.13; Mendes E, 2008, EMPIR SOFTW ENG, V13, P3, DOI 10.1007/s10664-007-9045-5; Jorgensen M, 2007, IEEE T SOFTWARE ENG, V33, P33, DOI 10.1109/TSE.2007.256943; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Keung JW, 2008, IEEE T SOFTWARE ENG, V34, P471, DOI 10.1109/TSE.2008.34; Auers M, 2004, P INT S EMP SOFTW EN, P147, DOI 10.1109/ISESE.2004.1334902; Kitchenham B, 2002, J SYST SOFTWARE, V64, P57, DOI 10.1016/S0164-1212(02)00021-3; Lis J, 2007, EMPIR SOFTW ENG, V13, P63; Loaders C., 1999, LOCAL REGRESSION LIK; Lokans C, 2009, P 2009 3 INT S EMP S, P111; Lokans C, 2012, SOFTW ENG C APSEC 20, P818; MacDonells SG, 2010, P 2010 ACM IEEE INT; Maxwells KD., 2002, APPL STAT SOFTWARE M; Mendess E, 2009, P 13 C EV ASS SOFTW; Ports D, 2008, P 2 ACM IEEE INT S E; Tabachnicks BG, 1996, USING MULTIVARIATE S	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2047-7473	2047-7481		J SOFTW-EVOL PROC	J. Softw.-Evol. Proc.	JUL	2015	27	7			SI		488	507		10.1002/smr.1672		20	Computer Science, Software Engineering	Computer Science	CM8UG	WOS:000357977000003		
J	Kato, M; Taneichi, H; Suda, K				Kato, Minori; Taneichi, Hiroshi; Suda, Kota			Advantage of Pedicle Screw Placement Into the Sacral Promontory (Tricortical Purchase) on Lumbosacral Fixation	JOURNAL OF SPINAL DISORDERS & TECHNIQUES			English	Article						lumbosacral spine; fixation; pedicle screw; pseudoarthrosis	PULL-OUT STRENGTH; SPINAL DEFORMITY; MINERAL DENSITY; SAGITTAL PLANE; FUSION; LUMBAR; COMPLICATIONS; ANATOMY; PAIN; S1	Study Design:Retrospective clinical study.Objective:To evaluate the clinical outcome of the tricortical method for lumbosacral fixation.Summary of Background Data:Despite advances in surgical techniques, failure to achieve solid arthrodesis of the lumbosacral junction continues to be significant clinical problems. To overcome these problems, tricortical purchase fixation has recently been advocated and studied. In this method, a trajectory directly into the medial sacral promontory is used to gain purchase in the dorsal, anterior, and superior cortices. This fixation method has been shown to double the insertional torque of the classic bicortical technique.Methods:Patients who had undergone lumbosacral fixation were included in this study. The average area of fusion was 1.7 segments. The patients were divided into a tricortical fixation group (TF, n=98) and a nontricortical fixation group (non-TF, n=33). We examined clinical outcome [Japanese Orthopaedic Association scoring system (JOA score)], fusion status, and the characteristics and safety of pedicle screwing in both groups. To identify risk factors for postoperative loss of lordosis (postoperative loss of >5 degrees in L5/S1 disk angle), risk factor analysis was performed by multivariate logistic regression.Results:In TF and non-TF, the JOA score changed from 13.4 and 13.8 points at surgery to 24.9 and 23.8 points, respectively, at final follow-up, and the recovery rate was 73.7% and 64.2%, respectively. Pseudoarthrosis of the fused L5/S1 occurred in 3 patients in whom the lumbosacral spine had not been fixed by tricortical purchase. The screw angle was 22.0 and 16.1 degrees in TF and non-TF, respectively, that is, a significant difference was shown. Significantly fewer TF cases encountered the risk of injured vascular tissue compared with non-TF. Non-TF (OR, 3.37) and correction of the L5/S1 disk angle (OR, 1.11) were significant risk factors for postoperative loss of lordosis.Conclusions:In patients who underwent short-segment lumbosacral fusion, TF enhanced postoperative stability at the lumbosacral junction. Pseudoarthrosis did not occur in patients who underwent TF, and the risk of vascular injury was less. TF is regarded as a successful technique in short-segment lumbosacral fixation.	[Kato, Minori; Taneichi, Hiroshi; Suda, Kota] Hokkaido Chuo Rosai Hosp, Spinal Cord Injury Ctr, Bibai, Hokkaido, Japan; [Taneichi, Hiroshi] Dokkyo Med Univ, Sch Med, Dept Orthopaed Surg, Mibu, Tochigi 3210293, Japan	Taneichi, H (reprint author), Dokkyo Med Univ, Sch Med, Dept Orthopaed Surg, Kitakobayashi 880, Mibu, Tochigi 3210293, Japan.	htane@sea.plala.or.jp					LICHT NJ, 1992, SPINE, V17, P892, DOI 10.1097/00007632-199208000-00006; Rechtine GR, 1996, J SPINAL DISORD, V9, P382; Pihlajamaki H, 1997, J BONE JOINT SURG BR, V79B, P183, DOI 10.1302/0301-620X.79B2.7224; Kumar MN, 2001, EUR SPINE J, V10, P314, DOI 10.1007/s005860000239; Zheng YG, 2000, SPINE, V25, P353, DOI 10.1097/00007632-200002010-00016; Zhu QG, 2000, SPINE, V25, P1065, DOI 10.1097/00007632-200005010-00005; MIRKOVIC S, 1991, SPINE, V16, pS289; Myers BS, 1996, SPINE, V21, P1962, DOI 10.1097/00007632-199609010-00004; Emami A, 2002, SPINE, V27, P776, DOI 10.1097/00007632-200204010-00017; Kaptanoglu E, 2003, J NEUROSURG, V99, P229, DOI 10.3171/spi.2003.99.2.0229; Ota M, 2010, SPINE, V35, pE452, DOI 10.1097/BRS.0b013e3181ce0696; Lazennec JY, 2000, EUR SPINE J, V9, P47, DOI 10.1007/s005860050008; Lehman RA, 2002, SPINE, V27, P806, DOI 10.1097/00007632-200204150-00006; Tsuchiya K, 2006, SPINE, V31, P303, DOI 10.1097/01.brs.0000197193.81296.f1; SMITH SA, 1993, SPINE, V18, P1006, DOI 10.1097/00007632-199306150-00009; BRANTIGAN JW, 1993, SPINE, V18, P2106, DOI 10.1097/00007632-199310001-00030; CARLSON GD, 1992, SPINE, V17, pS196, DOI 10.1097/00007632-199206001-00023; DEVLIN VJ, 1991, J SPINAL DISORD, V4, P1; ESSES SI, 1991, SPINE, V16, pS283, DOI 10.1097/00007632-199106001-00021; Hadjipavlou AG, 1997, J SPINAL DISORD, V10, P12; JACKSON RP, 1993, SPINE, V18, P1318, DOI 10.1097/00007632-199308000-00011; Korovessis P, 1999, J SPINAL DISORD, V12, P131; KRAG MH, 1986, CLIN ORTHOP RELAT R, P75; Linville DA, 2005, CURR OPIN ORTHOP, V16, P137, DOI 10.1097/01.bco.0000160041.16762.41; Molinari Robert W., 1999, Spine, V24, P1701; Pihlajamaki H, 1996, ACTA ORTHOP SCAND, V67, P63, DOI 10.3109/17453679608995612; Polly DW, 2004, SEMIN SPINE SURG, P101; SABATIER J P, 1989, Clinical Rheumatology, V8, P41, DOI 10.1007/BF02207232; Wood KB, 1996, SPINE, V21, P1357, DOI 10.1097/00007632-199606010-00016; XU RM, 1995, SPINE, V20, P936, DOI 10.1097/00007632-199504150-00010	30	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1536-0652	1539-2465		J SPINAL DISORD TECH	J. Spinal Disord. Tech.	JUL	2015	28	6					E336	E342		10.1097/BSD.0b013e31828ffc70		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CL9ST	WOS:000357319100003		
J	Yagi, M; Patel, R; Boachie-Adjei, O				Yagi, Mitsuru; Patel, Ravi; Boachie-Adjei, Oheneba			Complications and Unfavorable Clinical Outcomes in Obese and Overweight Patients Treated for Adult Lumbar or Thoracolumbar Scoliosis With Combined Anterior/Posterior Surgery	JOURNAL OF SPINAL DISORDERS & TECHNIQUES			English	Article						anterior; posterior spinal fusion; lumbar scoliosis; thoracolumbar scoliosis; adult scoliosis; scoliosis	ADOLESCENT IDIOPATHIC SCOLIOSIS; ANTERIOR SPINAL-FUSION; PERIOPERATIVE COMPLICATIONS; THORACOABDOMINAL APPROACH; RADIOGRAPHIC OUTCOMES; SURGICAL-TREATMENT; INSTRUMENTATION; THORACOTOMY; MORBIDITY; DEFORMITY	Background Context:Combined anterior/posterior (A/P) spinal fusion with instrumentation has been used for many years in the treatment of adult thoracolumbar and lumbar (TL/L) scoliosis. However, the risk factors for complications and poor clinical outcomes with this procedure are not well known.Purpose:To assess the risk factors for poor clinical outcomes in a series of adult lumbar or scoliosis patients undergoing combined A/P-instrumented spinal fusion.Study Design:This study was a retrospective case series of surgically treated adult lumbar or thoracolumbar scoliosis patients.Patient Sample:From 1998 to 2006, 57 patients with diagnoses of adult idiopathic scoliosis or degenerative TL/L scoliosis underwent combined A/P spinal instrumentation and fusion at 1 institution, performed by 1 senior author.Outcome Measurements:The preoperative and postoperative outcome measurements included self-report measurements, physiological measurements, and functional measurements.Materials and Methods:A retrospective review of this patient group was performed to evaluate patient satisfaction, functional outcomes, pain, curve progression, and complications. Radiographic measurements included coronal balance, sagittal vertical axis, Cobb angle, thoracic kyphosis, lumbar lordosis, and pelvic incidence preoperatively, immediately postoperatively, and during follow-up. In terms of risk factors, bone mineral density, body mass index, age, kyphosis, and fusion to the sacrum were reviewed. Postoperative Scoliosis Research Society Patient Questionnaire outcome scores, Oswestry Disability Index (ODI), and anterior surgical site pain (ASSP) were also evaluated. Means were compared with the Student t test and the (2) test. Logistic regression analyses were used to predict the probabilities and the odds ratios (ORs) of the risk factors for poor clinical outcomes. A P-value of <0.05 with a confidence interval of 95% was considered significant.Results:Fifty patients had adult idiopathic scoliosis, and 7 patients had degenerative scoliosis. The average age at surgery was 53.8 years (34-74 y), and the average follow-up was 4.8 years (2-11 y). Coronal correction for thoracic, thoracolumbar, and lumbosacral curves improved significantly. The degree of sagittal curve and coronal and sagittal balance were not significantly changed after surgery or at the final follow-up. ODI, the pain intensity domain of the ODI, and ASSP were significantly worse in obese and overweight patients, whereas OR time, estimated blood loss, and number of fused vertebrae were not different in the entire group (P=0.03 for ODI, P=0.002 for pain domain of ODI, and P=0.003 for ASSP). Logistic regression analyses for the risk factors of poor clinical outcomes indicated obesity and overweight as risk factors for poor clinical outcomes (OR=6.25 for ODI and 5.88 for ODI pain intensity score). A significantly higher rate of major complications occurred in this group compared to the entire group (30.4%, P=0.04). Low bone mineral density, old age, kyphosis, and fusion to the sacrum were not risk factors for poor clinical outcomes.Conclusions:Despite the good function scores and acceptable pain levels in most patients, the ODI scores of obese and overweight patients were worse compared to the rest of the patients in this study. Significantly worse scores on the pain intensity domain of the ODI and ASSP differences were likely caused by extensive dissection of the abdominal wall and psoas muscles and the technical difficulty of achieving an anterior approach to the thoracolumbar spine. Radiographs revealed no progression of the TL/L curves. This study indicates that obesity and overweight are potential risk factors for combined A/P-instrumented spinal fusion in patients with adult TL/L scoliosis, perhaps due to the technical difficulty of achieving an anterior approach to the thoracolumbar spine.	[Yagi, Mitsuru; Patel, Ravi; Boachie-Adjei, Oheneba] Hosp Special Surg, Adult & Pediat Spine & Scoliosis Surg, New York, NY 10021 USA; [Yagi, Mitsuru] Natl Hosp Org, Murayama Med Ctr, Dept Orthoped Surg, Tokyo, Japan	Yagi, M (reprint author), 2-37-1 Gakuen Musasahi Murayama, Tokyo 2080011, Japan.	yagiman@gmail.com			DePuy Spine; K2M; Osteotech; Trans 1	O.B.-A. received Grants/Research Support and is a Consultant of DePuy Spine; received Grants/Research Support and is a Consultant, Stock/Shareholder of K2M; received Grants/Research Support and is a Consultant of Osteotech; and is a Consultant, Speakers' Bureau and received Other Financial Support from Trans 1. The remaining authors declare no conflict of interest.	Ali RM, 2003, SPINE, V28, P1163, DOI 10.1097/00007632-200306010-00015; Ali RM, 2003, SPINE, V28, P1169; Kelly DM, 2010, SPINE, V35, P194, DOI 10.1097/BRS.0b013e3181bc948e; ALLEN BL, 1984, SPINE, V9, P388, DOI 10.1097/00007632-198405000-00011; Borm W, 2004, ZBL NEUROCHIR, V65, P1, DOI 10.1055/s-2004-44889; Peng CWB, 2009, SPINE J, V9, P715, DOI 10.1016/j.spinee.2009.04.023; Lonner BS, 2009, J SPINAL DISORD TECH, V22, P551, DOI 10.1097/BSD.0b013e318192d8ad; Kim YB, 2009, SPINE, V34, P822, DOI 10.1097/BRS.0b013e31818e3157; Kim YJ, 2008, SPINE, V33, P1055, DOI 10.1097/BRS.0b013e31816fc3a5; GAU YL, 1991, J SPINAL DISORD, V4, P399; SAER EH, 1990, SPINE, V15, P650, DOI 10.1097/00007632-199007000-00007; Coe JD, 2006, SPINE, V31, P345, DOI 10.1097/01.brs.0000197188.76369.13; Kim YB, 2008, SPINE, V33, P1125, DOI 10.1097/BRS.0b013e31816f5f57; McDonnell MF, 1996, J BONE JOINT SURG AM, V78A, P839; FACISZEWSKI T, 1995, SPINE, V20, P1592, DOI 10.1097/00007632-199507150-00007; LAGRONE MO, 1988, ORTHOP CLIN N AM, V19, P383; ter Gunne AFP, 2009, SPINE, V34, P1422, DOI 10.1097/BRS.0b013e3181a03013; Asher MA, 1999, CLIN ORTHOP RELAT R, P11; Berven SH, 2007, NEUROSURG CLIN N AM, V18, P261, DOI 10.1016/j.nec.2007.03.003; Boachie-Adjei Oheneba, 2007, HSS J, V3, P93, DOI 10.1007/s11420-006-9038-8; White SF, 1999, SPINE, V24, P1693, DOI 10.1097/00007632-199908150-00011; Ferguson RL, 1983, CONT ORTHOP, V7, P51; FLOMAN Y, 1982, CLIN ORTHOP RELAT R, P110; GARDNER GP, 1994, ARCH SURG-CHICAGO, V129, P753; Geck MJ, 2009, SPINE, V34, P1942, DOI 10.1097/BRS.0b013e3181a3c777; Geervliet PC, 2007, SPINE, V32, pE730; Heyworth BE, 2008, CLIN ORTHOP RELAT R, V466, P2271, DOI 10.1007/s11999-008-0318-0; Horton W C, 1990, J Bone Joint Surg Am, V72, P1268; Lonner Baron S, 2005, Spine J, V5, P104, DOI 10.1016/j.spinee.2004.04.008; Newton PO, 1997, SPINE, V22, P1398, DOI 10.1097/00007632-199706150-00020; WESTFELT JN, 1991, SPINE, V16, P1124, DOI 10.1097/00007632-199109000-00019	31	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1536-0652	1539-2465		J SPINAL DISORD TECH	J. Spinal Disord. Tech.	JUL	2015	28	6					E368	E376		10.1097/BSD.0b013e3182999526		9	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CL9ST	WOS:000357319100009		
J	Tanaka, A; Tanaka, R; Kasai, N; Tsukada, S; Okajima, T; Sumitomo, K				Tanaka, Aya; Tanaka, Ryosuke; Kasai, Nahoko; Tsukada, Shingo; Okajima, Takaharu; Sumitomo, Koji			Time-lapse imaging of morphological changes in a single neuron during the early stages of apoptosis using scanning ion conductance microscopy	JOURNAL OF STRUCTURAL BIOLOGY			English	Article						Scanning ion conductance microscopy (SICM); Apoptosis; Time-lapse imaging; Apoptotic volume decrease (AVD); Membrane blebbing; Phosphatidylserine translocation (PS translocation)	ATOMIC-FORCE MICROSCOPY; LIVING CELLS; RESOLUTION; SHRINKAGE; MEMBRANES; SURFACE; BLEBS; DEATH	Apoptosis plays an important role in many physiologic and pathologic conditions. The biochemical and morphological characteristics of apoptosis including cellular volume decrease, cell membrane blebbing, and phosphatidylserine translocation from the inner to the outer leaflet of the cell membrane are considered important events for phagocyte detection. Despite its importance, the relationship between the biological and morphological changes in a living cell has remained controversial. Scanning ion conductance microscopy is a suitable technique for investigating a series of these changes, because it allows us to observe the morphology of living cells without any mechanical interactions between the probe and the sample surface with a high resolution. Here, we investigated the biochemical and morphological changes in single neurons during the early stages of apoptosis, including apoptotic volume decrease, membrane blebbing and phosphatidylserine translocation, by using scanning ion conductance microscopy. Time-course imaging of apoptotic neurons showed there was a reduction in apoptotic volume after exposure to staurosporine and subsequent membrane bleb formation, which has a similar onset time to phosphatidylserine translocation. Our results show that a reduction in cellular volume is one of the earliest morphological changes in apoptosis, and membrane blebbing and phosphatidylserine translocation occur as subsequent biological and morphological changes. This is the first report to describe this series of morphological and biochemical changes ranging from an apoptotic volume decrease to membrane blebbing and PS translocation by scanning ion conductance microscopy (SICM). This new and direct imaging technique will provide new insight into the relationship between biochemical events inside a cell and cellular morphological changes. (C) 2015 Elsevier Inc. All rights reserved.	[Tanaka, Aya; Kasai, Nahoko; Tsukada, Shingo; Sumitomo, Koji] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; [Tanaka, Ryosuke; Okajima, Takaharu] Hokkaido Univ, Grad Sch Informat Sci & Technol, Kita Ku, Sapporo, Hokkaido 0600814, Japan	Tanaka, A (reprint author), NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	tanaka.aya@lab.ntt.co.jp					Korchev YE, 1997, BIOPHYS J, V73, P653; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; HANSMA PK, 1989, SCIENCE, V243, P641, DOI 10.1126/science.2464851; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004; Shevchuk AI, 2006, ANGEW CHEM INT EDIT, V45, P2212, DOI 10.1002/anie.200503915; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Hessler JA, 2005, LANGMUIR, V21, P9280, DOI 10.1021/la051837g; Lane JD, 2005, J CELL SCI, V118, P4059, DOI 10.1242/jcs.02529; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; MULLER DJ, 1995, BIOPHYS J, V68, P1681; Rheinlaender J, 2009, J APPL PHYS, V105, DOI 10.1063/1.3122007; Mills JC, 1999, J CELL BIOL, V146, P703, DOI 10.1083/jcb.146.4.703; Rotsch C, 2000, BIOPHYS J, V78, P520; Ushiki T, 2012, MICRON, V43, P1390, DOI 10.1016/j.micron.2012.01.012; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/nmeth.1306, 10.1038/NMETH.1306]; BEAUVAIS F, 1995, J LEUKOCYTE BIOL, V57, P851; Borner C.D., 2007, METHOD ENZYMOL, p[428, 161]; Brat F., 2001, J ELECTRON MICROSC, V50, P283; Burattini S, 2013, Methods Mol Biol, V1004, P77, DOI 10.1007/978-1-62703-383-1_7; Chalut K.J., 2009, CANCER RES, V3, P791; CORNET M, 1994, J MORPHOL, V222, P269, DOI 10.1002/jmor.1052220305; D'Amelio M, 2008, METHOD ENZYMOL, V446, P259, DOI 10.1016/S0076-6879(08)01615-7; Elliott JI, 2006, BLOOD, V108, P1611, DOI 10.1182/blood-2005-11-012328; Kasai N, 2010, BBA-GEN SUBJECTS, V1800, P655, DOI 10.1016/j.bbagen.2010.03.002; Khmaladze A, 2012, J STRUCT BIOL, V178, P270, DOI 10.1016/j.jsb.2012.03.008; Klenerman D, 2011, CURR OPIN CHEM BIOL, V15, P696, DOI 10.1016/j.cbpa.2011.04.001; Kuznetsov YG, 1997, J STRUCT BIOL, V120, P180, DOI 10.1006/jsbi.1997.3936; Mizutani Y, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803469; Rasband WS, 1997, IMAGEJ; Sanchez D, 2008, BIOPHYS J, V95, P3017, DOI 10.1529/biophysj.108.129551; Shinozaki Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000103; Sumitomo K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.08JB18; Ushiki T, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384022; Yingge Zhang, 2003, Journal of Structural Biology, V144, P327, DOI 10.1016/j.jsb.2003.09.022; Zhang Y, 2011, MICROSC RES TECHNIQ, V74, P614, DOI 10.1002/jemt.20925	38	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1047-8477	1095-8657		J STRUCT BIOL	J. Struct. Biol.	JUL	2015	191	1					32	38		10.1016/j.jsb.2015.06.002		7	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CM7WR	WOS:000357907700004		
J	Hirose, S; Haruki, K; Ando, A; Kimura, T				Hirose, Sakyo; Haruki, Kohei; Ando, Akira; Kimura, Tsuyoshi			Effect of High-Pressure Oxygen Annealing on Electrical and Magnetoelectric Properties of BaSrCo2Fe11AlO22 Ceramics	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							HEXAGONAL FERRITES; GRAIN-BOUNDARY; MAGNETIZATION; HELIMAGNET; SRTIO3	The effect of high-pressure oxygen (HPO) annealing on the electrical, magnetic, and magnetoelectric (ME) properties of room-temperature multiferroic BaSrCo2Fe11AlO22 ceramics was investigated. The electrical resistivity of the ceramics was found to strongly depend on the partial oxygen pressure during annealing at 1040 degrees C. Samples annealed under 10atm of oxygen exhibited a resistivity of up to 1.6x10(9)cm at room temperature, more than two orders of magnitude higher than that of samples without oxygen annealing. Thermally stimulated current and complex impedance measurements suggested that the enhancement of the resistivity by the HPO annealing originated from a decrease in the amount of defects related to oxygen vacancies and an increase in the resistance of grains and interfaces. HPO annealing also affects the magnetic-field response of spiral magnetic ordering, which is ascribed to the ME properties. Furthermore, samples subjected to HPO annealing exhibited a lower contribution of the space charges trapped at the grain boundaries and/or defects to the magnitude of the measured magnetoelectrically induced electric polarization P. The present results indicate that HPO annealing is an effective method to evaluate authentic ME effects in multiferroic BaSrCo2Fe11AlO22 ceramics.	[Hirose, Sakyo; Ando, Akira] Murata Mfg Co Ltd, Kyoto 6178555, Japan; [Haruki, Kohei; Kimura, Tsuyoshi] Osaka Univ, Grad Sch Engn Sci, Div Mat Phys, Toyonaka, Osaka 5608531, Japan	Hirose, S (reprint author), Murata Mfg Co Ltd, 1-10-1 Higashikotari, Kyoto 6178555, Japan.	h_sakyo@murata.com					ALBERSSCHOENBERG E, 1958, J AM CERAM SOC, V41, P484, DOI 10.1111/j.1151-2916.1958.tb12901.x; ALIM MA, 1988, J APPL PHYS, V63, P2337, DOI 10.1063/1.341176; Harris VG, 2009, J MAGN MAGN MATER, V321, P2035, DOI 10.1016/j.jmmm.2009.01.004; Bai Y, 2004, J MAGN MAGN MATER, V278, P208, DOI 10.1016/j.jmmm.2003.12.1389; Elahi A, 2013, CERAM INT, V39, P983, DOI 10.1016/j.ceramint.2012.07.016; Pullar RC, 2012, PROG MATER SCI, V57, P1191, DOI 10.1016/j.pmatsci.2012.04.001; ALBANESE G, 1975, APPL PHYS, V7, P227, DOI 10.1007/BF00936028; Chun SH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.177201; Kitagawa Y, 2010, NAT MATER, V9, P797, DOI 10.1038/nmat2826; Batoo KM, 2011, PHYSICA B, V406, P382, DOI 10.1016/j.physb.2010.10.075; Ishiwata S, 2008, SCIENCE, V319, P1643, DOI 10.1126/science.1154507; Chai YS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5208; Wu YJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2780116; BAHADUR D, 1992, B MATER SCI, V15, P431, DOI 10.1007/BF02745292; Batoo KM, 2009, CURR APPL PHYS, V9, P1397, DOI 10.1016/j.cap.2009.03.012; Bube R. H., 1992, PHOTOELECTRONIC PROP, P149; Devan RS, 2006, J PHYS-CONDENS MAT, V18, P9809, DOI 10.1088/0953-8984/18/43/004; Hiraoka Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3622332; Hirose S, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862432; KASAMI A, 1966, J PHYS SOC JPN, V21, P552, DOI 10.1143/JPSJ.21.552; Kim SH, 1999, MATER RES BULL, V34, P415, DOI 10.1016/S0025-5408(99)00019-7; Kimura T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.137201; Kohara Y., 2010, PHYS REV B, V82; Loyau V, 2012, J APPL PHYS, V111, DOI 10.1063/1.3693544; Mityata N., 1960, J PHYS SOC JPN, V16, P206; Okumura K, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816268; Okumura K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3593371; RAVINDER D, 1994, J APPL PHYS, V75, P6118, DOI 10.1063/1.355479; Rodewald S, 2001, J EUR CERAM SOC, V21, P1749, DOI 10.1016/S0955-2219(01)00108-X; SMITH A, 1989, J APPL PHYS, V65, P5119, DOI 10.1063/1.343190; Sugimoto M, 1999, J AM CERAM SOC, V82, P269; Takada Y, 2006, J APPL PHYS, V100, DOI 10.1063/1.2204334; Tokunaga Y., 2010, PHYS REV LETT, V105, P25201; Wang F, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3697636; Yadav S, 2010, CHALCOGENIDE LETT, V7, P241	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JUL	2015	98	7					2104	2111		10.1111/jace.13573		8	Materials Science, Ceramics	Materials Science	CM7RT	WOS:000357894800019		
J	Wang, RP; Wang, K; Yao, FZ; Li, JF; Schader, FH; Webber, KG; Jo, W; Rodel, J				Wang, Ruiping; Wang, Ke; Yao, Fangzhou; Li, Jing-Feng; Schader, Florian H.; Webber, Kyle G.; Jo, Wook; Roedel, Juergen			Temperature Stability of Lead-Free Niobate Piezoceramics with Engineered Morphotropic Phase Boundary	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							FREE PIEZOELECTRIC CERAMICS; POLARIZATION ROTATION; CURIE-TEMPERATURE; TERNARY-SYSTEM; TITANATE; ZIRCONATE; DIAGRAM; PBTIO3; ORIGIN; D(33)	The temperature dependence of piezoelectric properties (direct piezoelectric coefficient d(33), converse piezoelectric coefficient d(33)(E=0), strain S and electromechanical coupling coefficient k(p)) for two niobate-based lead-free piezoceramics have been contrasted. 0.92(Na0.5K0.5)NbO3-0.02(Bi1/2Li1/2)TiO3-0.06BaZrO(3) (6BZ/2BLT/92NKN) has a morphotropic phase boundary (MPB) between rhombohedral and tetragonal at room temperature and 0.92(Na0.5K0.5)NbO3-0.03(Bi1/2Li1/2)TiO3-0.05BaZrO(3) (5BZ/3BLT/92NKN) features an MPB engineered to be located below room temperature. At 30 degrees C, d(33),d(33)(E=0), S (at 2kV/mm), and k(p) are 252pC/N, 230pm/V, 0.069%, 0.51 for 5BZ/3BLT/92NKN; and 348pC/N, 380pm/V, 0.106%, 0.57 for 6BZ/2BLT/92NKN, respectively. With increasing temperature, the piezoelectric properties decrease. At 200 degrees C, d(33), d(33)(E=0), S (at 2kV/mm), and k(p) are 170pC/N, 160pm/V, 0.059%, 0.36 for 5BZ/3BLT/92NKN; and 181pC/N, 190pm/V, 0.061%, 0.39 for 6BZ/2BLT/92NKN. It is found that the electromechanical coupling coefficient has a better temperature stability than the piezoelectric coefficient in the studied system due to a large temperature-dependent compliance change. The results demonstrate that engineering an MPB is highly effective in tailoring temperature stability of piezoceramics.	[Wang, Ruiping] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Wang, Ke; Yao, Fangzhou; Li, Jing-Feng] Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China; [Schader, Florian H.; Webber, Kyle G.; Roedel, Juergen] Tech Univ Darmstadt, Inst Mat Sci, D-64287 Darmstadt, Germany; [Jo, Wook] Ulsan Natl Inst Sci & Engn, Sch Mat Sci & Engn, Ulsan 689798, South Korea	Wang, RP (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan.	rp-wang@aist.go.jp	Li, Jing-Feng/D-2770-2014; Wang, Ke/J-8050-2012; Jo, Wook/G-7025-2011; Webber, Kyle/B-1453-2013	Li, Jing-Feng/0000-0002-0185-0512; Wang, Ke/0000-0001-9840-2427; Jo, Wook/0000-0002-7158-5654; Webber, Kyle/0000-0002-1283-7874	Deutsche Forschungsgemeinschaft [WE4972/1-1, WE4972/2-1]; National Nature Science Foundation of China [51332002, 51302144]; UNIST (Ulsan National Institute of Science and Technology) [1.140040]	F.H.S. and K.G.W. gratefully acknowledge financial support from the Deutsche Forschungsgemeinschaft under WE4972/1-1 and WE4972/2-1. JR is thankful for travel support for RW through SFB 595. K.W. and J.-F. Li acknowledge the support from National Nature Science Foundation of China (grants no. 51332002 and 51302144). WJ acknowledges the financial support from the 2014 Research Fund (1.140040) of UNIST (Ulsan National Institute of Science and Technology).	Guo YP, 2004, APPL PHYS LETT, V85, P4121, DOI 10.1063/1.1813636; Liu WF, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257602; Acosta M, 2014, ACTA MATER, V80, P48, DOI 10.1016/j.actamat.2014.07.058; Wang K, 2013, ADV FUNCT MATER, V23, P4079, DOI 10.1002/adfm.201203754; Damjanovic D, 1998, REP PROG PHYS, V61, P1267, DOI 10.1088/0034-4885/61/9/002; Wang XP, 2014, J AM CHEM SOC, V136, P2905, DOI 10.1021/ja500076h; Wang RP, 2005, PHYS STATUS SOLIDI A, V202, pR57, DOI 10.1002/pssa.200510014; Leontsev SO, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/4/044302; Fu HX, 2000, NATURE, V403, P281; Dittmer R, 2011, J AM CERAM SOC, V94, P4283, DOI 10.1111/j.1551-2916.2011.04631.x; Noheda B, 2001, PHYS REV LETT, V86, P3891, DOI 10.1103/PhysRevLett.86.3891; TAKENAKA T, 1991, JPN J APPL PHYS 1, V30, P2236, DOI 10.1143/JJAP.30.2236; Han HX, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802757; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Nagata H, 2003, JPN J APPL PHYS 1, V42, P7401, DOI 10.1143/JJAP.42.7401; Rodel J, 2009, J AM CERAM SOC, V92, P1153, DOI 10.1111/j.1551-2916.2009.03061.x; Wang RP, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3224196; Bennett J, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824652; Bellaiche L, 2000, PHYS REV LETT, V84, P5427, DOI 10.1103/PhysRevLett.84.5427; Guo R, 2000, PHYS REV LETT, V84, P5423, DOI 10.1103/PhysRevLett.84.5423; Zhang SJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2794400; Wang RP, 2009, PHYS STATUS SOLIDI-R, V3, P142, DOI 10.1002/pssr.200903090; Schaab S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3493191; Li F, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4861260; Cheng XJ, 2014, ACS APPL MATER INTER, V6, P750, DOI 10.1021/am404793e; Shrout TR, 2007, J ELECTROCERAM, V19, P113, DOI 10.1007/s10832-007-9047-0; Wang XP, 2014, J MATER CHEM A, V2, P4122, DOI 10.1039/c3ta15075e; Yao FZ, 2014, RSC ADV, V4, P20062, DOI 10.1039/c4ra01697a; Anton EM, 2011, J APPL PHYS, V110, DOI 10.1063/1.3660253; Berlincourt D. A., 1964, PHYS ACOUSTICS, V1; CROSS LE, 1991, J APPL PHYS, V69, P896, DOI 10.1063/1.347330; Higashide K, 2007, J EUR CERAM SOC, V27, P4107, DOI [10.1016/j.jeurceramsoc.2007.02.103, 10.1016/j.jeurceramsoc.2007.02.013]; Hollenstein E, 2007, J EUR CERAM SOC, V27, P4093, DOI 10.1016/j.jeurceramsoc.2007.02.100; Jaffe B, 1971, PIEZOELECTRIC CERAMI; Karaki T., 2013, JPN J APPL PHYS, V52; PAN W, 1988, J AM CERAM SOC, V71, pC302; Saghi-Szabo G, 1999, PHYS REV B, V59, P12771, DOI 10.1103/PhysRevB.59.12771; UCHIDA N, 1965, JPN J APPL PHYS, V4, P867, DOI 10.1143/JJAP.4.867; Wang R., 2009, 2009 JOINT M 12 INT; Wang R., 2011, MAT INTEGR, V24, P11; Zhang S.J., 2006, J APPL PHYS, V100; Zhang Y, 2005, ACTA MATER, V53, P2203, DOI 10.1016/j.actamat.2005.01.048	42	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JUL	2015	98	7					2177	2182		10.1111/jace.13604		6	Materials Science, Ceramics	Materials Science	CM7RT	WOS:000357894800030		
J	Zhang, JH; Huang, M; Yanagisawa, K; Yao, SS; Qiu, YS; Zheng, HJ				Zhang, Junhao; Huang, Man; Yanagisawa, Kazumichi; Yao, Shanshan; Qiu, Yushi; Zheng, Hongjuan			Large Scale Preparation of -CaSiO3 Nanostructures by Solid-State Reaction in NaCl-H2O(v) System at Lower Temperature	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							ENVIRONMENTALLY FRIENDLY GROWTH; NACL FLUX; WHISKERS	An environmentally friendly NaCl-H2O(v) system was developed to prepare -CaSiO3 nanostructures from commercially available raw materials, CaCO3 and amorphous SiO2 (-SiO2), by a one-step solid-state reaction at 575 degrees C for 2h. The formation of -CaSiO3 was accelerated by NaCl-H2O(v) system. The results demonstrated that both NaCl and H2O(v) played vital roles in the formation of -CaSiO3 nanostructures at a lower temperature. NaCl is considered to enhance the diffusivity of starting materials and the rate of solid-state reactions, and promote the crystallization at lower temperature. Water vapor can accelerate the decomposition of CaCO3, and absorbed water on the surface of solid materials can dissolve NaCl to form an aqueous ionic liquid composed of Na and Cl ions, which is similar to a hydrothermal process, and will further increase the diffusivity of components and reduce the reaction temperature.	[Zhang, Junhao; Huang, Man] Jiangsu Univ Sci & Technol, Sch Environm & Chem Engn, Zhenjiang 212018, Jiangsu, Peoples R China; [Zhang, Junhao; Yanagisawa, Kazumichi; Yao, Shanshan; Qiu, Yushi; Zheng, Hongjuan] Kochi Univ, Fac Sci, Res Lab Hydrothermal Chem, Kochi 7808520, Japan	Yanagisawa, K (reprint author), Kochi Univ, Fac Sci, Res Lab Hydrothermal Chem, 2-5-1 Akebono Cho, Kochi 7808520, Japan.	yanagi@kochi-u.ac.jp			Natural Science Foundation of Jiangsu Province [BK20141293]; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province [13KJB430012]; Opening Project of CAS Key Laboratory of Materials for Energy Conversion [KF 2014006]; Natural Science Foundation of China [51203069]; Qing Lan Project [1614101401];  [24655195]	This work was supported by Grant-in-Aid for Challenging Exploratory Research (24655195), Natural Science Foundation of Jiangsu Province (no. BK20141293), Natural Science Foundation of the Higher Education Institutions of Jiangsu Province (no. 13KJB430012), the Opening Project of CAS Key Laboratory of Materials for Energy Conversion (no. KF 2014006), Natural Science Foundation of China (no. 51203069) and Qing Lan Project (No. 1614101401).	Teshima K, 2010, CRYST GROWTH DES, V10, P4471, DOI 10.1021/cg100705d; Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f; Teshima K, 2010, CRYST GROWTH DES, V10, P2533, DOI 10.1021/cg901229d; Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052; Wang HP, 2008, CERAM INT, V34, P1405, DOI 10.1016/j.ceramint.2007.05.001; Teshima K, 2008, CRYST GROWTH DES, V8, P465, DOI 10.1021/cg070341p; WANG Y, 1995, CHEM ENG SCI, V50, P1373, DOI 10.1016/0009-2509(95)00002-M; Yu QY, 2011, LANGMUIR, V27, P7185, DOI 10.1021/la200719g; Chen S, 2010, J ALLOY COMPD, V505, P613, DOI 10.1016/j.jallcom.2010.06.090; Kozawa T, 2013, J CERAM SOC JPN, V121, P103, DOI 10.2109/jcersj2.121.103; Ru XH, 2012, J AM CERAM SOC, V95, P3478, DOI 10.1111/j.1551-2916.2012.05429.x; Saravanapavan P, 2003, J NON-CRYST SOLIDS, V318, P1, DOI 10.1016/S0022-3093(02)01864-1; Tsutsui S. P., 2012, J NONCRYST SOLIDS, V3358, P885; Wang WZ, 2013, MAT SCI ENG C-MATER, V33, P2288, DOI 10.1016/j.msec.2013.01.060; Wu J, 2010, MATER RES BULL, V45, P509, DOI 10.1016/j.materresbull.2009.10.006; Zhang NL, 2013, BIOMATER SCI-UK, V1, P1101, DOI 10.1039/c3bm60034c; Zhang ZL, 2012, CRYST GROWTH DES, V12, P5635, DOI 10.1021/cg301143r; Zimmerman H., 2012, J CHEM ENG DATA, V57, P2415	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JUL	2015	98	7					2264	2268		10.1111/jace.13524		5	Materials Science, Ceramics	Materials Science	CM7RT	WOS:000357894800041		
J	Onishi, R; Matsuda, K; Takahashi, K				Onishi, Ryo; Matsuda, Keigo; Takahashi, Keiko			Lagrangian Tracking Simulation of Droplet Growth in Turbulence-Turbulence Enhancement of Autoconversion Rate	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							HOMOGENEOUS ISOTROPIC TURBULENCE; INERTIAL PARTICLES; CLOUD DROPLETS; CUMULUS CLOUDS; STOCHASTIC COALESCENCE; COLLISION STATISTICS; MICROPHYSICAL MODEL; COLLECTION EQUATION; SIZE DISTRIBUTION; COAGULATION	The authors describe the Lagrangian cloud simulator (LCS), which simulates droplet growth in air turbulence. The LCS adopts the Euler-Lagrangian framework and can provide reference data for cloud microphysical models by tracking the growth of particles individually. The collisional growth in a stagnant flow is calculated by the LCS and also by solving the stochastic collision-coalescence equation (SCE). Good agreement is obtained between the LCS and SCE simulations. Comparisons between the results for stagnant and turbulent flows confirm that in-cloud turbulence enhances collisional growth. The enhancement is well predicted by the SCE method if a proper collision model is employed. To quantify the enhancement, the paper defines the time scale of the autoconversion process, in which cloud droplets grow into raindrops through collisions, as the time taken for 10% of the cloud to become rain (t(10%)). The authors then define the turbulence enhancement factor E-turb as [GRAPHICS] , where the overbar denotes the mean value of the LCS runs and the subscripts NoT and T indicate stagnant (nonturbulent) flow and turbulent flow simulations, respectively. It was found that the enhancement factor increases linearly with the energy dissipation rate, while it does not show a consistent dependence on the Reynolds number. The levels of statistical fluctuations in the autoconversion time scales were directly obtained for the first time. It is shown that the relative standard deviation of t(10%) simply follows the power law that the binomial distribution theory predicts, independently of the flow conditions.	[Onishi, Ryo; Matsuda, Keigo; Takahashi, Keiko] Japan Agcy Marine Earth Sci & Technol, Ctr Earth Informat Sci & Technol, Yokohama, Kanagawa 2360001, Japan	Onishi, R (reprint author), Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	onishi.ryo@jamstec.go.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24760152]	This research was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan for Young Scientists (B) 24760152. The numerical simulations presented were carried out on the supercomputers, including the Earth Simulator, of the Japan Agency for Marine-Earth Science and Technology. The authors are grateful to Dr. Orlando Ayala for providing the collision kernel values obtained from the Ayala model.	Alfonso L, 2008, ATMOS CHEM PHYS, V8, P969; SAFFMAN PG, 1956, J FLUID MECH, V1, P16, DOI 10.1017/S0022112056000020; Morinishi Y, 1998, J COMPUT PHYS, V143, P90, DOI 10.1006/jcph.1998.5962; Wang LP, 2005, J ATMOS SCI, V62, P1255, DOI 10.1175/JAS3397.1; Pinsky M, 2001, J ATMOS SCI, V58, P742, DOI 10.1175/1520-0469(2001)058<0742:CEODIA>2.0.CO;2; Van Den Heever SC, 2007, J APPL METEOROL CLIM, V46, P828, DOI 10.1175/JAM2492.1; Pinsky MB, 2002, Q J ROY METEOR SOC, V128, P501, DOI 10.1256/003590002321042072; Franklin CN, 2008, J ATMOS SCI, V65, P1795, DOI 10.1175/2007JAS2556.1; HALL WD, 1980, J ATMOS SCI, V37, P2486, DOI 10.1175/1520-0469(1980)037<2486:ADMMWA>2.0.CO;2; LONG AB, 1974, J ATMOS SCI, V31, P1040, DOI 10.1175/1520-0469(1974)031<1040:STTDCE>2.0.CO;2; Onishi R, 2013, J COMPUT PHYS, V242, P809, DOI 10.1016/j.jcp.2013.02.027; Wang LP, 2000, J FLUID MECH, V415, P117, DOI 10.1017/S0022112000008661; Zhou Y, 2001, J FLUID MECH, V433, P77; Sundaram S, 1996, J COMPUT PHYS, V124, P337, DOI 10.1006/jcph.1996.0064; HIRT CW, 1972, J COMPUT PHYS, V10, P324, DOI 10.1016/0021-9991(72)90070-8; Sundaram S, 1997, J FLUID MECH, V335, P75, DOI 10.1017/S0022112096004454; Wang LP, 2006, ATMOS RES, V82, P416, DOI 10.1016/j.atmosres.2005.12.011; Kostinski AB, 2005, B AM METEOROL SOC, V86, P235, DOI 10.1175/BAMS-86-2-235; Reisner J, 1998, Q J ROY METEOR SOC, V124, P1071, DOI 10.1002/qj.49712454804; Falkovich G, 2007, J ATMOS SCI, V64, P4497, DOI 10.1175/2007JAS2371.1; Seifert A, 2010, Q J ROY METEOR SOC, V136, P1753, DOI 10.1002/qj.684; Jonas PR, 1996, ATMOS RES, V40, P283, DOI 10.1016/0169-8095(95)00035-6; Woittiez EJP, 2009, J ATMOS SCI, V66, P1926, DOI 10.1175/2005JAS2669.1; Thompson G, 2004, MON WEATHER REV, V132, P519, DOI 10.1175/1520-0493(2004)132<0519:EFOWPU>2.0.CO;2; Pinsky M, 2008, J ATMOS SCI, V65, P357, DOI 10.1175/2007JAS2358.1; Khairoutdinov M, 2000, MON WEATHER REV, V128, P229, DOI 10.1175/1520-0493(2000)128<0229:ANCPPI>2.0.CO;2; Grabowski WW, 2009, ATMOS CHEM PHYS, V9, P2335; Zaichik LI, 2003, PHYS FLUIDS, V15, P2995, DOI 10.1063/1.1608014; Yin Y, 2000, ATMOS RES, V53, P91, DOI 10.1016/S0169-8095(99)00046-0; Wang LP, 1998, PHYS FLUIDS, V10, P2647, DOI 10.1063/1.869777; GILLESPIE DT, 1975, J ATMOS SCI, V32, P1977, DOI 10.1175/1520-0469(1975)032<1977:AEMFNS>2.0.CO;2; Krueger SK, 1997, J ATMOS SCI, V54, P2697, DOI 10.1175/1520-0469(1997)054<2697:MEAFMI>2.0.CO;2; Ayala O, 2007, J COMPUT PHYS, V225, P51, DOI 10.1016/j.jcp.2006.11.016; Ayala O, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/075015; Ayala O, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/075016; BLYTH AM, 1993, J APPL METEOROL, V32, P626, DOI 10.1175/1520-0450(1993)032<0626:EICC>2.0.CO;2; Dallas V, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046315; Derevyanko S, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/075019; Grabowski WW, 1999, J ATMOS SCI, V56, P1433, DOI 10.1175/1520-0469(1999)056<1433:COPCOC>2.0.CO;2; Kessler E., 1969, METEOR MONOGR, V32; Onishi R, 2012, J ATMOS SCI, V69, P1474, DOI 10.1175/JAS-D-11-0166.1; Onishi R, 2014, J FLUID MECH, V745, P279, DOI 10.1017/jfm.2014.97; Onishi R, 2005, THESIS; Onishi R, 2011, INT J MULTIPHAS FLOW, V37, P125, DOI 10.1016/j.ijmultiphaseflow.2010.10.004; Onishi R, 2011, J COMPUT PHYS, V230, P4088, DOI 10.1016/j.jcp.2011.02.034; Onishi R, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3276906; Pruppacher H. R., 1998, MICROPHYSICS OF CLOU; Reade WC, 2000, J FLUID MECH, V415, P45, DOI 10.1017/S0022112000008521; ROBERTSO.D, 1974, J ATMOS SCI, V31, P1344, DOI 10.1175/1520-0469(1974)031<1344:MCSODG>2.0.CO;2; Rogers R. R., 1989, SHORT COURSE CLOUD P; Rosa B, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/4/045032; Rowe P. N., 1961, I TRANS INST CHEM EN, V39, P43; Saw EW, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.214501; Sidin RSR, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3244646; SOONG ST, 1974, J ATMOS SCI, V31, P1262, DOI 10.1175/1520-0469(1974)031<1262:NSOWRD>2.0.CO;2; Uchida E., 1969, J METEOR SOC JAPAN, V47, P279; VALIOULIS IA, 1984, J ATMOS SCI, V41, P2516, DOI 10.1175/1520-0469(1984)041<2516:ANEOTS>2.0.CO;2; Wang LP, 2006, J ATMOS SCI, V63, P2397, DOI 10.1175/JAS3750.1; Wang LP, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/075013; Xue Y, 2008, J ATMOS SCI, V65, P331, DOI 10.1175/2007JAS2406.1	60	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	JUL	2015	72	7					2591	2607		10.1175/JAS-D-14-0292.1		17	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CM3OY	WOS:000357593300002		
J	Miyamoto, Y; Takemi, T				Miyamoto, Yoshiaki; Takemi, Tetsuya			A Triggering Mechanism for Rapid Intensification of Tropical Cyclones	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							INDUCED SECONDARY FLOWS; HURRICANE-LIKE VORTICES; SEA INTERACTION THEORY; BOUNDARY-LAYER JETS; PART II; CONVECTIVE PARAMETERIZATION; NUMERICAL SIMULATION; WARM-CORE; MODEL; DYNAMICS	Triggering processes for the rapidly intensifying phase of a tropical cyclone (TC) were investigated on the basis of numerical experiments using a three-dimensional nonhydrostatic model. The results revealed that the rapid intensification of the simulated TC commenced following the formation of a circular cloud, which occurred about 12 h after the TC became essentially axisymmetric. The circular cloud (eyewall) evolved from a cloudy convective cell that was originally generated near the radius of maximum wind speed (RMW). The development of the convective cell in the eyewall was closely related to the radial location of the strong boundary layer convergence of axisymmetric flow. The radius of maximum convergence (RMC) was small relative to the RMW when the TC vortex was weak, which is consistent with the boundary layer theory for a rotating fluid system on a frictional surface. As the TC intensified, the RMC approached the RMW. An eyewall was very likely to form in the simulated TC when the RMC approached the RMW. Because the RMC is theoretically determined by a Rossby number defined by the maximum tangential velocity, RMW, and Coriolis parameter, a series of numerical experiments was conducted by changing the three parameters. The results were consistent with the hypothesis that intensification occurs earlier for larger Rossby numbers. This finding indicates that initial TC vortices with larger Rossby numbers are more likely to experience rapid intensification and, hence, to evolve into strong hurricanes.	[Miyamoto, Yoshiaki] RIKEN Adv Inst Computat Sci, Kobe, Hyogo 6510084, Japan; [Takemi, Tetsuya] Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto, Japan	Miyamoto, Y (reprint author), RIKEN Adv Inst Computat Sci, Chuo Ku, 7-1-26 Minamimachi, Kobe, Hyogo 6510084, Japan.	ymiyamoto@riken.jp			JSPS [20-776]; Disaster Prevention Research Institute, Kyoto University [24G-04]	This study was partly supported by JSPS Scientific Research 20-776 for JSPS Research Fellows and General Collaborative Research #24G-04 provided by the Disaster Prevention Research Institute, Kyoto University. We would like to express our gratitude to Prof. Dave Nolan, who kindly provided the nature run data of N13. We would also like to acknowledge the three anonymous reviewers for their helpful comments and fruitful discussion. We also thank Prof. Hirohiko Ishikawa and Dr. Junshi Ito for providing helpful comments.	Zhang DL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050578; OOYAMA K, 1969, J ATMOS SCI, V26, P3, DOI 10.1175/1520-0469(1969)026<0003:NSOTLC>2.0.CO;2; Davis C, 2008, MON WEATHER REV, V136, P1990, DOI 10.1175/2007MWR2085.1; Kepert J, 2001, J ATMOS SCI, V58, P2469, DOI 10.1175/1520-0469(2001)058<2469:TDOBLJ>2.0.CO;2; Emanuel KA, 1997, J ATMOS SCI, V54, P1014, DOI 10.1175/1520-0469(1997)054<1014:SAOHIC>2.0.CO;2; SHAPIRO LJ, 1982, J ATMOS SCI, V39, P378, DOI 10.1175/1520-0469(1982)039<0378:TROBHT>2.0.CO;2; Guimond SR, 2010, J ATMOS SCI, V67, P633, DOI 10.1175/2009JAS3119.1; Donelan MA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019460; EMANUEL KA, 1995, J ATMOS SCI, V52, P3960, DOI 10.1175/1520-0469(1995)052<3960:TBOASH>2.0.CO;2; Rogers RF, 2015, MON WEATHER REV, V143, P536, DOI 10.1175/MWR-D-14-00175.1; Miyamoto Y, 2013, GEOPHYS RES LETT, V40, P4922, DOI 10.1002/grl.50944; CHARNEY JG, 1964, J ATMOS SCI, V21, P68, DOI 10.1175/1520-0469(1964)021<0068:OTGOTH>2.0.CO;2; Noh Y, 2003, BOUND-LAY METEOROL, V107, P401, DOI 10.1023/A:1022146015946; Jiang HY, 2012, MON WEATHER REV, V140, P1164, DOI 10.1175/MWR-D-11-00134.1; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; Reasor PD, 2012, MON WEATHER REV, V140, P425, DOI 10.1175/MWR-D-11-00080.1; Chen H, 2013, J ATMOS SCI, V70, P146, DOI 10.1175/JAS-D-12-062.1; Harnos DS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047010; Vigh JL, 2009, J ATMOS SCI, V66, P3335, DOI 10.1175/2009JAS3092.1; LILLY DK, 1962, TELLUS, V14, P148; Kieper ME, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052115; EMANUEL KA, 1986, J ATMOS SCI, V43, P585, DOI 10.1175/1520-0469(1986)043<0585:AASITF>2.0.CO;2; Kepert J, 2001, J ATMOS SCI, V58, P2485, DOI 10.1175/1520-0469(2001)058<2485:TDOBLJ>2.0.CO;2; Molinari J, 2010, MON WEATHER REV, V138, P3869, DOI 10.1175/2010MWR3378.1; Chen H, 2011, WEATHER FORECAST, V26, P885, DOI 10.1175/WAF-D-11-00001.1; Nolan DS, 2013, J ADV MODEL EARTH SY, V5, P382, DOI 10.1002/jame.20031; ROTUNNO R, 1987, J ATMOS SCI, V44, P542, DOI 10.1175/1520-0469(1987)044<0542:AAITFT>2.0.CO;2; Willoughby HE, 2009, MON WEATHER REV, V137, P822, DOI 10.1175/2008MWR2658.1; KAIN JS, 1990, J ATMOS SCI, V47, P2784, DOI 10.1175/1520-0469(1990)047<2784:AODEPM>2.0.CO;2; Nolan DS, 2007, J ATMOS SCI, V64, P3377, DOI 10.1175/JAS3988.1; SCHUBERT WH, 1982, J ATMOS SCI, V39, P1687, DOI 10.1175/1520-0469(1982)039<1687:ISATCD>2.0.CO;2; Rogers R, 2013, MON WEATHER REV, V141, P2970, DOI 10.1175/MWR-D-12-00357.1; Kaplan J, 2003, WEATHER FORECAST, V18, P1093, DOI 10.1175/1520-0434(2003)018<1093:LCORIT>2.0.CO;2; Persing J, 2013, ATMOS CHEM PHYS, V13, P12299, DOI 10.5194/acp-13-12299-2013; Kain JS, 2004, J APPL METEOROL, V43, P170, DOI 10.1175/1520-0450(2004)043<0170:TKCPAU>2.0.CO;2; Van Sang N, 2008, Q J ROY METEOR SOC, V134, P563, DOI 10.1002/qj.235; Miyamoto Y, 2015, ATMOS SCI LETT, V16, P305, DOI 10.1002/asl2.558; Nolan DS, 2003, J ATMOS SCI, V60, P2717, DOI 10.1175/1520-0469(2003)060<2717:NTPTBH>2.0.CO;2; Hong SY, 2006, MON WEATHER REV, V134, P2318, DOI 10.1175/MWR3199.1; Sitkowski M, 2009, MON WEATHER REV, V137, P645, DOI 10.1175/2008MWR2531.1; Pendergrass AG, 2009, MON WEATHER REV, V137, P805, DOI 10.1175/2008MWR2657.1; Smith RK, 2009, Q J ROY METEOR SOC, V135, P1321, DOI 10.1002/qj.428; Iacono MJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009944; Reasor PD, 2009, MON WEATHER REV, V137, P603, DOI 10.1175/2008MWR2487.1; Rogers R, 2010, J ATMOS SCI, V67, P44, DOI 10.1175/2009JAS3122.1; Barnes GM, 2010, MON WEATHER REV, V138, P1446, DOI 10.1175/2009MWR3145.1; Dudhia J., 2008, 28TH CONF ON HURRICA, V18A, P2; Eliassen A., 1977, Geophysica Norvegica, V31; Eliassen A., 1971, J METEOR SOC JAPAN, V49, P784; JORDAN CL, 1958, J METEOROL, V15, P91, DOI 10.1175/1520-0469(1958)015<0091:MSFTWI>2.0.CO;2; Kessler E., 1969, METEOR MONOGR, V32; Li T., 2012, TROP CYCLONE RES REV, V1, P242, DOI DOI 10.6057/2012TCRR02.04; Lim J. -O., 2010, MON WEA REV, V138, P1587, DOI [10.1175/2009MWR2968.1., DOI 10.1175/2009MWR2968.1]; Miyamoto Y, 2013, J ATMOS SCI, V70, P112, DOI 10.1175/JAS-D-11-0285.1; Montgomery MT, 2014, AUST METEOROL OCEAN, V64, P37; Montgomery MT, 2001, J ATMOS SCI, V58, P421, DOI 10.1175/1520-0469(2001)058<0421:ASDOHL>2.0.CO;2; OGURA Y, 1964, J ATMOS SCI, V21, P610, DOI 10.1175/1520-0469(1964)021<0610:FCTDCI>2.0.CO;2; Skamarock W. C., 2008, NOTE NCAR TN 475 STR; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Smith RK, 2008, Q J ROY METEOR SOC, V134, P551, DOI 10.1002/qj.241; Stevenson SN, 2014, MON WEATHER REV, V142, P4364, DOI 10.1175/MWR-D-14-00078.1	61	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	JUL	2015	72	7					2666	2681		10.1175/JAS-D-14-0193.1		16	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CM3OY	WOS:000357593300008		
J	Aiki, H; Takaya, K; Greatbatch, RJ				Aiki, Hidenori; Takaya, Koutarou; Greatbatch, Richard J.			A Divergence-Form Wave-Induced Pressure Inherent in the Extension of the Eliassen-Palm Theory to a Three-Dimensional Framework for All Waves at All Latitudes	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							MEAN-FLOW INTERACTION; QUASI-GEOSTROPHIC EDDIES; VARYING BASIC FLOW; GRAVITY-WAVES; ACTIVITY FLUX; POTENTIAL VORTICITY; OCEAN CIRCULATION; MOMENTUM-TRANSFER; EQUATORIAL WAVES; BAROCLINIC FLOWS	Classical theory concerning the Eliassen-Palm relation is extended in this study to allow for a unified treatment of midlatitude inertia-gravity waves (MIGWs), midlatitude Rossby waves (MRWs), and equatorial waves (EQWs). A conservation equation for what the authors call the impulse-bolus (IB) pseudomomentum is useful, because it is applicable to ageostrophic waves, and the associated three-dimensional flux is parallel to the direction of the group velocity of MRWs. The equation has previously been derived in an isentropic coordinate system or a shallow-water model. The authors make an explicit comparison of prognostic equations for the IB pseudomomentum vector and the classical energy-based (CE) pseudomomentum vector, assuming inviscid linear waves in a sufficiently weak mean flow, to provide a basis for the former quantity to be used in an Eulerian time-mean (EM) framework. The authors investigate what makes the three-dimensional fluxes in the IB and CE pseudomomentum equations look in different directions. It is found that the two fluxes are linked by a gauge transformation, previously unmentioned, associated with a divergence-form wave-induced pressure [GRAPHICS] . The quantity [GRAPHICS] vanishes for MIGWs and becomes nonzero for MRWs and EQWs, and it may be estimated using the virial theorem. Concerning the effect of waves on the mean flow, [GRAPHICS] represents an additional effect in the pressure gradient term of both (the three-dimensional versions of) the transformed EM momentum equations and the merged form of the EM momentum equations, the latter of which is associated with the nonacceleration theorem.	[Aiki, Hidenori] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan; [Takaya, Koutarou] Kyoto Sangyo Univ, Fac Sci, Dept Phys, Kyoto 603, Japan; [Greatbatch, Richard J.] GEOMAR Helmholtz Zentrum Ozeanforsch Kiel, Kiel, Germany	Aiki, H (reprint author), JAMSTEC, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	aiki@jamstec.go.jp					Aiki H, 2006, OCEAN SCI, V2, P161; Plumb R. A., 1985, Journal of the Atmospheric Sciences, V42, DOI 10.1175/1520-0469(1985)042<0217:OTTDPO>2.0.CO;2; ECKART C, 1963, PHYS FLUIDS, V6, P1042, DOI 10.1063/1.1706860; Noda A, 2010, SOLA, V6, P85, DOI 10.2151/sola.2010-022; Buhler O, 2014, EUR J MECH B-FLUID, V47, P12, DOI 10.1016/j.euromechflu.2014.01.010; Horinouchi T, 1998, J ATMOS SCI, V55, P502, DOI 10.1175/1520-0469(1998)055<0502:WMFIAW>2.0.CO;2; ANDREWS DG, 1984, GEOPHYS ASTRO FLUID, V28, P243, DOI 10.1080/03091928408230366; Ardhuin F, 2008, OCEAN MODEL, V20, P35, DOI 10.1016/j.ocemod.2007.07.001; HAYASHI YY, 1987, J FLUID MECH, V184, P477, DOI 10.1017/S0022112087002982; HAYNES PH, 1988, J ATMOS SCI, V45, P2352, DOI 10.1175/1520-0469(1988)045<2352:FDGOFA>2.0.CO;2; Greatbatch RJ, 1998, J PHYS OCEANOGR, V28, P422, DOI 10.1175/1520-0485(1998)028<0422:ETRBEI>2.0.CO;2; Aiki H, 2008, J PHYS OCEANOGR, V38, P1845, DOI 10.1175/2008JPO3820.1; Aiki H, 2013, J PHYS OCEANOGR, V43, P149, DOI 10.1175/JPO-D-12-059.1; ANDREWS DG, 1983, J ATMOS SCI, V40, P1877, DOI 10.1175/1520-0469(1983)040<1877:AFAEPT>2.0.CO;2; MCPHADEN MJ, 1990, ANNU REV FLUID MECH, V22, P167; Ishioka K, 1996, J METEOROL SOC JPN, V74, P167; Jacobson T, 2006, J PHYS OCEANOGR, V36, P558, DOI 10.1175/JPO2872.1; ANDREWS DG, 1978, J FLUID MECH, V89, P647, DOI 10.1017/S0022112078002785; ANDREWS DG, 1983, J ATMOS SCI, V40, P85, DOI 10.1175/1520-0469(1983)040<0085:ACLFSA>2.0.CO;2; CRAIK ADD, 1976, J FLUID MECH, V73, P401, DOI 10.1017/S0022112076001420; Eden C, 2007, J PHYS OCEANOGR, V37, P727, DOI 10.1175/JPO2987.1; CHU VH, 1970, J FLUID MECH, V41, P873, DOI 10.1017/S0022112070000988; CHARNEY JG, 1961, J GEOPHYS RES, V66, P83, DOI 10.1029/JZ066i001p00083; Constantin A, 2013, J PHYS OCEANOGR, V43, P165, DOI 10.1175/JPO-D-12-062.1; TAKEHIRO SI, 1992, J FLUID MECH, V236, P259, DOI 10.1017/S0022112092001411; McDougall TJ, 2001, J PHYS OCEANOGR, V31, P1222, DOI 10.1175/1520-0485(2001)031<1222:TTRMVP>2.0.CO;2; TUNG KK, 1986, J ATMOS SCI, V43, P2600, DOI 10.1175/1520-0469(1986)043<2600:NTOZAC>2.0.CO;2; Sassi F, 1997, J ATMOS SCI, V54, P1925, DOI 10.1175/1520-0469(1997)054<1925:TROEWF>2.0.CO;2; RIPA P, 1982, J PHYS OCEANOGR, V12, P97, DOI 10.1175/1520-0485(1982)012<0097:NWIIAO>2.0.CO;2; Nakamura N, 2011, J ATMOS SCI, V68, P2783, DOI 10.1175/2011JAS3685.1; Solomon A, 2012, J FLUID MECH, V693, P69, DOI 10.1017/jfm.2011.460; TRENBERTH KE, 1986, J ATMOS SCI, V43, P2070, DOI 10.1175/1520-0469(1986)043<2070:AAOTIO>2.0.CO;2; Aiki H, 2014, J PHYS OCEANOGR, V44, P3, DOI 10.1175/JPO-D-12-0228.1; SCINOCCA JF, 1992, J ATMOS SCI, V49, P5, DOI 10.1175/1520-0469(1992)049<0005:NWACLA>2.0.CO;2; Takaya K, 2001, J ATMOS SCI, V58, P608, DOI 10.1175/1520-0469(2001)058<0608:AFOAPI>2.0.CO;2; HOLLIDAY D, 1981, J FLUID MECH, V107, P221, DOI 10.1017/S0022112081001742; Kinoshita T, 2014, J ATMOS SCI, V71, P3427, DOI 10.1175/JAS-D-13-0161.1; GENT PR, 1995, J PHYS OCEANOGR, V25, P463, DOI 10.1175/1520-0485(1995)025<0463:PEITTI>2.0.CO;2; ANDREWS DG, 1976, J ATMOS SCI, V33, P2031, DOI 10.1175/1520-0469(1976)033<2031:PWIHAV>2.0.CO;2; Iwasaki T, 2001, J ATMOS SCI, V58, P3036, DOI 10.1175/1520-0469(2001)058<3036:AECVFW>2.0.CO;2; IWASAKI T, 1989, J METEOROL SOC JPN, V67, P293; Miyahara S, 2006, SOLA, V2, P108, DOI 10.2151/sola.2006-028; CHANG EKM, 1994, J ATMOS SCI, V51, P3823, DOI 10.1175/1520-0469(1994)051<3823:OEFAGV>2.0.CO;2; Greatbatch RJ, 2003, J PHYS OCEANOGR, V33, P1231, DOI 10.1175/1520-0485(2003)033<1231:TNTRM>2.0.CO;2; LONGUETHIGGINS MS, 1964, DEEP-SEA RES, V11, P35, DOI 10.1016/0011-7471(64)91080-0; PLUMB RA, 1986, J ATMOS SCI, V43, P1657, DOI 10.1175/1520-0469(1986)043<1657:TDPOTQ>2.0.CO;2; DURRAN DR, 1988, J ATMOS SCI, V45, P4020, DOI 10.1175/1520-0469(1988)045<4020:OAPMFR>2.0.CO;2; ANDREWS DG, 1978, J FLUID MECH, V89, P609, DOI 10.1017/S0022112078002773; Dritschel DG, 2008, J ATMOS SCI, V65, P855, DOI 10.1175/2007JAS2227.1; Takaya K, 1997, GEOPHYS RES LETT, V24, P2985, DOI 10.1029/97GL03094; Cai M, 2013, J ATMOS SCI, V70, P2179, DOI 10.1175/JAS-D-12-0249.1; BLECK R, 1985, DYNAM ATMOS OCEANS, V9, P17, DOI 10.1016/0377-0265(85)90014-4; BRETHERT.FP, 1966, Q J ROY METEOR SOC, V92, P325, DOI 10.1002/qj.49709239302; Bretherton F.P., 1969, P ROY SOC          A, V302, P529, DOI DOI 10.1098/RSPA.1968.0034; Brunet G, 1996, J ATMOS SCI, V53, P482, DOI 10.1175/1520-0469(1996)053<0482:LLRORW>2.0.CO;2; Buhler O., 2009, WAVES AND MEAN FLOWS; ELIASSEN A, 1960, GEOFYS PUBL, V22, P1; Gill AE, 1982, INT GEOPHYS SERIES, V30; Greatbatch RJ, 2001, J PHYS OCEANOGR, V31, P2797, DOI 10.1175/1520-0485(2001)031<2797:AFFMEP>2.0.CO;2; HASSELMA.K, 1971, J FLUID MECH, V50, P189, DOI 10.1017/S0022112071002520; HELD IM, 1985, J ATMOS SCI, V42, P2280, DOI 10.1175/1520-0469(1985)042<2280:PATOOM>2.0.CO;2; Holton J. R., 1992, INTRO DYNAMIC METEOR; HOSKINS BJ, 1983, J ATMOS SCI, V40, P1595, DOI 10.1175/1520-0469(1983)040<1595:TSPAMF>2.0.CO;2; Kinoshita T, 2013, J ATMOS SCI, V70, P1577, DOI 10.1175/JAS-D-12-0137.1; Lagrange J.-L., 1788, MECH ANALITIQUE; LONGUETHIGGINS MS, 1953, PHILOS TR R SOC S-A, V245, P535, DOI 10.1098/rsta.1953.0006; LONGUETH.MS, 1969, DEEP-SEA RES, V16, P431, DOI 10.1016/0011-7471(69)90031-X; Maddison JR, 2013, J FLUID MECH, V729, P69, DOI 10.1017/jfm.2013.259; Masuda A., 1978, J OCEANOGR SOC JAPAN, V34, P1, DOI DOI 10.1007/BF02109610; Matsuno T., 1966, J METEOR SOC JAPAN, V44, P25; Methven J, 2013, J ATMOS SCI, V70, P1616, DOI 10.1175/JAS-D-12-0228.1; MULLER P, 1995, REV GEOPHYS, V33, P67, DOI 10.1029/94RG03215; Rhines P., 1982, WHOI8245, P1, DOI [10.1575/1912/2895, DOI 10.1575/1912/2895]; Sato K, 1997, J GEOPHYS RES-ATMOS, V102, P26247, DOI 10.1029/96JD02514; Taylor G.I., 1915, Philosophical Transactions of the Royal Society of London, V215, DOI 10.1098/rsta.1915.0001; Uryu M, 1974, J METEOR SOC JAPAN, V52, P481; Whitham G.B., 1974, LINEAR NONLINEAR WAV; Yanai M., 1966, J METEOR SOC JAPAN, V44, P291; Young WR, 2012, J PHYS OCEANOGR, V42, P692, DOI 10.1175/JPO-D-11-0102.1	79	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	JUL	2015	72	7					2822	2849		10.1175/JAS-D-14-0172.1		28	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CM3OY	WOS:000357593300017		
J	Banerjee, R; Ray, D; Ishii, T				Banerjee, Ranadip; Ray, Dwijesh; Ishii, Teruaki			Mineral Chemistry and Alteration Characteristics of Spinel in Serpentinised Peridotites from the Northern Central Indian Ridge	JOURNAL OF THE GEOLOGICAL SOCIETY OF INDIA			English	Article						Mineral chemistry; Spinel; Serpentinites; Alteration characteristics; Central Indian Ridge	MID-ATLANTIC RIDGE; ABYSSAL PERIDOTITES; CHROMIAN SPINEL; OCEAN; OLIVINE; MANTLE; ROCKS; SLOW	Serpentinites (frequently cross cut by gabbroic dikelet), collected from Northern Central Indian Ridge (NCIR), Indian Ocean, contain both Cr-rich (Group I) and Cr-poor (Group II) variety of spinel. Based on mineralogy they can be classified as non-residual and residual spinel, respectively. While, non residual spinel (TiO2 up to 0.5 wt %; Group I) display the evidences of peridotite-gabbro interaction, residual spinel (TiO2 < 0.1 wt%; Cr# similar to 24; Group II), suggests intermediate degree of partial melting (similar to 10%) of mantle peridotite, which falls between most depleted mantle peridotite (similar to 15%) and most fertile peridotite (similar to 5%). Alteration of spinel porphyroclast is conceded by the presence of relict fresh interior, intermediate ferritchromit zone and secondary magnetite at the margins. Due to the effect of serpentinisation, marginal areas of spinel porphyroclasts display increasing Fe, but decreasing Al and Mg, while their Cr content remains unaffected throughout the spinel.	[Banerjee, Ranadip] Natl Inst Oceanog, Panaji 403004, Goa, India; [Ray, Dwijesh] Phys Res Lab, PLANEX, Ahmadabad 380009, Gujarat, India; [Ishii, Teruaki] Fukada Geol Inst, Tokyo 1130021, Japan	Banerjee, R (reprint author), Natl Inst Oceanog, Panaji 403004, Goa, India.	ocean1@rediffmail.com; dwijesh@rediffmail.com			ONR [0014-97-1-0925]; CSIR Network Programme [COR 0006]; INSA, New Delhi; JSPS, Tokyo; CSIR, New Delhi	We thank the Director, NIO, for permission to publish this manuscript. Ship time was provided by the Ministry of Earth Sciences, New Delhi. This research is partly funded by ONR grant no. 0014-97-1-0925 and partly by CSIR Network Programme (COR 0006). RB acknowledges INSA, New Delhi and JSPS, Tokyo for a fellowship to visit ORI, the University of Tokyo. We appreciate the help extended by the Captain, crew members and other colleagues, onboard ORV Sagar Kanya (cruise SK#195), during the sampling operations. DR is grateful to CSIR, New Delhi, for financial support in the form of a Senior Research Fellowship during the course of this research. Critical reviews by an anonynomous reviewer are greatly appreciated. This is NIO's contribution no. 5598.	KIMBALL KL, 1990, CONTRIB MINERAL PETR, V105, P337, DOI 10.1007/BF00306543; ARAI S, 1994, CHEM GEOL, V113, P191, DOI 10.1016/0009-2541(94)90066-3; Bach W, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025681; Seyler M, 1997, EARTH PLANET SC LETT, V146, P273, DOI 10.1016/S0012-821X(96)00220-8; Mellini M, 2005, CONTRIB MINERAL PETR, V149, P266, DOI 10.1007/s00410-005-0654-y; DROOP GTR, 1987, MINERAL MAG, V51, P431, DOI 10.1180/minmag.1987.051.361.10; Bach W, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000744; DICK HJB, 1984, CONTRIB MINERAL PETR, V86, P54, DOI 10.1007/BF00373711; MAHONEY JJ, 1989, J GEOPHYS RES-SOLID, V94, P4033, DOI 10.1029/JB094iB04p04033; Hellebrand E, 2002, J PETROL, V43, P2305, DOI 10.1093/petrology/43.12.2305; Deer W. A., 1992, ROCK FORMING MINERAL; Dick H.J.B., 1989, GEOL SOC LOND SPEC P, V42, P71, DOI DOI 10.1144/GSL.SP.1989.042.01.06; Dick H.J.B., 1996, SCI RESULTS, V147, P103; Drolia RK, 2003, CURR SCI INDIA, V85, P290; Drolia R.K., 2006, GEOCHEM GEOPHY GEOSY, V6, DOI [10.1029/2005GC00950, DOI 10.1029/2005GC00950]; Engel C.G., 1975, GEOL SOC AM BULL, V82, P553; Gahlan HA, 2007, J MINER PETROL SCI, V102, P69, DOI 10.2465/jmps.060212; Ghose I, 1996, GEOLOGY, V24, P1139, DOI 10.1130/0091-7613(1996)024<1139:TFEOMM>2.3.CO;2; Kamenetsky VS, 2001, J PETROL, V42, P655, DOI 10.1093/petrology/42.4.655; Raju KAK, 2012, TECTONOPHYSICS, V554, P114, DOI 10.1016/j.tecto.2012.06.001; Morishita T, 2009, J PETROL, V50, P1299, DOI 10.1093/petrology/egp025; Natland J.H., 1991, OCEANIC BASALTS, P289; Ray D, 2011, GEOL MAG, V148, P404, DOI 10.1017/S001675681000083X; Ray D, 2013, J ASIAN EARTH SCI, V70-71, P125, DOI 10.1016/j.jseaes.2013.03.008; Ray D, 2007, ACTA GEOL SIN-ENGL, V81, P99; Ray D, 2008, ACTA GEOL SIN-ENGL, V82, P1213; Rehkamper M., 1997, EARTH PLANET SC LETT, V78, P379; Da Costa IR, 2008, EUR J MINERAL, V20, P173, DOI 10.1127/0935-1221/2008/0020-1803; Ross K., 1997, P OCEAN DRILLING PRO, V153, P277; Seyler M, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000305; Spangenberg K., 1943, Z PRAKTISCHE GEOLOGI, V5, P13	31	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0016-7622	0974-6889		J GEOL SOC INDIA	J. Geol. Soc. India	JUL	2015	86	1					41	51				11	Geosciences, Multidisciplinary	Geology	CN0VX	WOS:000358133200005		
J	Li, WH; Nakayama, A				Li, Wenhao; Nakayama, Akira			Temperature Dependency of Thermophysical Properties in Convective Heat Transfer Enhancement in Nanofluids	JOURNAL OF THERMOPHYSICS AND HEAT TRANSFER			English	Article							THERMAL-CONDUCTIVITY; SYSTEMS; FLUIDS	The temperature dependency of the thermophysical properties of an alumina-water nanofluid and their effects on laminar forced-convective heat transfer enhancement in nanofluids have been investigated analytically in this study. Exact solutions have been obtained for hydrodynamically and thermally fully developed nanofluid flows in a tube subject to constant heat flux, with and without accounting for the temperature dependency of thermophysical properties. The solutions reveal that the anomalous heat transfer enhancement is possible, irrespective of the account of the temperature dependency of nanofluid thermophysical properties, such that the heat transfer rate exceeds the rate expected from the increase in the nanofluid thermal conductivity. A comparison between the solutions, with and without accounting for the temperature dependency of nanofluid thermophysical properties, indicates that the temperature dependency of thermophysical properties only reflects on the relative magnitude of the Nusselt number and its asymptotic value, and that it does not have any significant influence on the occurrence of anomalous heat transfer enhancement.	[Li, Wenhao; Nakayama, Akira] Shizuoka Univ, Dept Mech Engn, Grad Sch Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan; [Nakayama, Akira] Wuhan Polytech Univ, Sch Civil Engn & Architecture, Wuhan 430023, Hubei, Peoples R China	Li, WH (reprint author), Shizuoka Univ, Dept Mech Engn, Grad Sch Engn, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.						Akbari Mahmood, 2011, Heat Transfer-Asian Research, V40, DOI 10.1002/htj.20350; Das SK, 2003, J HEAT TRANS-T ASME, V125, P567, DOI 10.1115/1.1561080; BRINKMAN HC, 1952, J CHEM PHYS, V20, P571, DOI 10.1063/1.1700493; Lee S, 1999, J HEAT TRANS-T ASME, V121, P280, DOI 10.1115/1.2825978; Heris SZ, 2007, INT J HEAT FLUID FL, V28, P203, DOI 10.1016/j.ijheatfluidflow.2006.05.001; Pak BC, 1998, EXP HEAT TRANSFER, V11, P151, DOI 10.1080/08916159808946559; Williams W, 2008, J HEAT TRANS-T ASME, V130, DOI 10.1115/1.2818775; HAMILTON RL, 1962, IND ENG CHEM FUND, V1, P187, DOI 10.1021/i160003a005; Corcione M, 2011, ENERG CONVERS MANAGE, V52, P789, DOI 10.1016/j.enconman.2010.06.072; Ding YL, 2010, PHYS SCRIPTA, VT139, DOI 10.1088/0031-8949/2010/T139/014078; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Maiga SE, 2005, INT J HEAT FLUID FL, V26, P530, DOI 10.1016/j.ijheatfluidflow.2005.02.004; Lee J, 2007, INT J HEAT MASS TRAN, V50, P452, DOI 10.1016/j.ijheatmasstransfer.2006.08.001; Khanafer K, 2011, INT J HEAT MASS TRAN, V54, P4410, DOI 10.1016/j.ijheatmasstransfer.2011.04.048; Jang SP, 2006, APPL THERM ENG, V26, P2457, DOI 10.1016/j.applthermaleng.2006.02.036; Palm SJ, 2006, APPL THERM ENG, V26, P2209, DOI 10.1016/j.applthermaleng.2006.03.014; Avramenko AA, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3623432; Chien R., 2007, INT J THERM SCI, V46, P57; Choi S. U. S., 1996, INT MECH ENG C EXH A, P1; Fuerth R., 1956, INVESTIGATIONS THEOR, P1; Kakac S, 2009, INT J HEAT MASS TRAN, V52, P3187, DOI 10.1016/j.ijheatmasstransfer.2009.02.006; Masuda H., 1993, NETSU BUSSEI, V4, P227; Maxwell J. C., 1881, TREATISE ELECT MAGNE, P360; Nakayama A., 1995, PC AIDED NUMERICAL H, p[49, 103]; Prabhat N, 2012, J NANOFLUIDS, V1, P55, DOI DOI 10.1166/JON.2012.1003; Venerus D. C., 2010, J APPL RHEOLOGY, V20, DOI [10.3933/ApplRheol-20-44582, DOI 10.3933/APPLRHEOL-20-44582]; Xuan YM, 2000, INT J HEAT MASS TRAN, V43, P3701, DOI 10.1016/S0017-9310(99)00369-5; Yang C, 2013, J HEAT TRANS-T ASME, V135, DOI 10.1115/1.4023539	28	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0887-8722	1533-6808		J THERMOPHYS HEAT TR	J. Thermophys. Heat Transf.	JUL	2015	29	3					504	512		10.2514/1.T4460		9	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CM8HR	WOS:000357940400008		
J	Daimaru, T; Nagai, H				Daimaru, Takurou; Nagai, Hiroki			Operational Characteristics of the Oscillating Heat Pipe with Noncondensable Gas	JOURNAL OF THERMOPHYSICS AND HEAT TRANSFER			English	Article							PART	In this study, the effects of noncondensable gas on the behavior of oscillating heat pipes were investigated. The oscillating heat pipe was made of capillary copper tube, and its turn number was 16. The working fluid used was ethanol, and argon gas was used as noncondensable gas. Experiments were conducted using four different noncondensable gas volume ratios. The temperature and inner pressure of the oscillating heat pipe were measured over a heat input range from 40 to 180 W. The results of this study suggest that the operating characteristics of the oscillating heat pipe were affected by noncondensable gas. In particular, the thermal resistance of the oscillating heat pipe increased with lower heat input as the amount of noncondensable gas increased. In addition, the thermal performance rapidly deteriorated with a large amount of noncondensable gas after local dryout. With higher heat input, the thermal resistance increased even with small noncondensable gas amounts.	[Daimaru, Takurou; Nagai, Hiroki] Tohoku Univ, Dept Aerosp Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Daimaru, T (reprint author), Tohoku Univ, Dept Aerosp Engn, Aoba Ku, 6-6-01 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	daimaru.takurou@aero.mech.tohoku.ac.jp; nagai.hiroki@aero.mech.tohoku.ac.jp					Akachi H., 1996, P 5 INT HEAT PIP S M, P208; Akachi H., 1993, US Patent, Patent No. 5219020; Akachi H., 1990, US Patent, Patent No. [4921041, 4,921,041]; Khandekar S, 2004, INT J THERM SCI, V43, P13, DOI 10.1016/S1290-0729(03)00100-5; Lin LC, 2001, J THERMOPHYS HEAT TR, V15, P395, DOI 10.2514/2.6641; KROGER DG, 1968, INT J HEAT MASS TRAN, V11, P15, DOI 10.1016/0017-9310(68)90060-4; Khandekar S, 2003, APPL THERM ENG, V23, P707, DOI 10.1016/S1359-4311(02)00237-5; Yang HH, 2008, APPL THERM ENG, V28, P49, DOI 10.1016/j.applthermaleng.2007.01.033; Charoensawan P, 2003, APPL THERM ENG, V23, P2009, DOI 10.1016/S1359-4311(03)00159-5; Khandekar S, 2003, APPL THERM ENG, V23, P2021, DOI 10.1016/S1359-4311(03)00168-6; Borgmeyer B, 2007, J THERMOPHYS HEAT TR, V21, P405, DOI 10.2514/1.23263; Cai QJ, 2007, J SPACECRAFT ROCKETS, V44, P439, DOI 10.2514/1.16051; Charoensawan P, 2008, APPL THERM ENG, V28, P460, DOI 10.1016/j.applthermaleng.2007.05.007; Hosoda M., 1999, P 5 ASKE JSME JOINT; Iwata N, 2011, J THERMOPHYS HEAT TR, V25, P386, DOI 10.2514/1.51128; Maeda M., 2011, 41 INT C ENV SYST JU; Matsushita T., 1975, P 11 INT S SPAC TECH, P385; Miyazaki Y., 2000, P 6 INT HEAT PIP S C, P389; Miyazaki Y., 1999, P 11 INT HEAT PIP C, P131; Nikitkin M. N., 1998, 981584 SAE; OConnor JP, 1996, J HEAT TRANS-T ASME, V118, P662, DOI 10.1115/1.2822683; Okamoto A., 2013, P 17 INT HEAT PIP C; Okazaki S., 2014, J ASTRONOMICAL INSTR, V3, DOI [10.1142/S2251171714400042, DOI 10.1142/S2251171714400042]; Taft S. B, 2013, FRONTIERS HEAT PIPES, V4, DOI [10.5098/fhp.v4.1.3003, DOI 10.5098/FHP.V4.1.3003]	24	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0887-8722	1533-6808		J THERMOPHYS HEAT TR	J. Thermophys. Heat Transf.	JUL	2015	29	3					563	571		10.2514/1.T4461		9	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CM8HR	WOS:000357940400014		
J	Furukawa, S; Nogami, K; Ogiwara, K; Yada, K; Minami, H; Shima, M				Furukawa, S.; Nogami, K.; Ogiwara, K.; Yada, K.; Minami, H.; Shima, M.			Systematic monitoring of hemostatic management in hemophilia A patients with inhibitor in the perioperative period using rotational thromboelastometry	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						blood coagulation tests; factor VIIa; feiba; hemophilia A; hemostasis; surgical; thromboelastography	THERAPY	BackgroundThe management of hemophilia A (HA) patients with inhibitors on bypassing therapy remains challenging. In particular, the monitoring of treatment is restricted by the limited reliability and lack of standardization of currently available methods to evaluate the physiological effects of various hemostatic agents. Accurate monitoring of these patients is particularly important in surgical situations. The recently developed comprehensive coagulation assays, including rotational thromboelastometry (ROTEM), may be useful in these circumstances. ObjectiveWe have attempted to establish a systematic monitoring protocol using ROTEM (NATEM triggered by CaCl2) to evaluate the choice and effectiveness of different bypassing agents in the perioperative period. Methods and ResultsThe hemostatic effects of recombinant factor VIIa (rFVIIa) and activated prothrombin complex concentrates (aPCC) were determined using a three-step procedure (spike, preoperative and perioperative) in eight patients with HA inhibitor admitted for elective surgery and assessed for individually tailored therapy. The ROTEM parameters demonstrated similar improvement to approximately normal levels at each stage after treatment with rFVIIa. Results in the presence of aPCC showed a marked improvement in the spike data, although this appeared to be different from those in the preoperative and perioperative assessments. The information derived from the spike and preoperative findings provided a useful guide for establishing an effective dose of therapeutic material, and facilitated good hemostatic control during and after surgery in all cases. ConclusionThe findings suggest that this systematic analysis using ROTEM could provide a promising strategy for the use of bypassing therapy in HA patients with inhibitor.	[Furukawa, S.; Nogami, K.; Ogiwara, K.; Yada, K.; Minami, H.; Shima, M.] Nara Med Univ, Dept Pediat, Kashihara, Nara 6348522, Japan	Nogami, K (reprint author), Nara Med Univ, Dept Pediat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	roc-noga@naramed-u.ac.jp					Hoffman M, 2012, J THROMB HAEMOST, V10, P1478, DOI 10.1111/j.1538-7836.2012.04793.x; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958; Dargaud Y, 2010, BLOOD, V116, P5734, DOI 10.1182/blood-2010-06-291906; Matsumoto T, 2009, INT J HEMATOL, V90, P576, DOI 10.1007/s12185-009-0450-y; Young G, 2008, BLOOD COAGUL FIBRIN, V19, P276, DOI 10.1097/MBC.0b013e3283001cdc; Chitlur M, 2014, J THROMB HAEMOST, V12, P103, DOI 10.1111/jth.12458; Dargaud Y, 2008, HAEMOPHILIA, V14, P20, DOI 10.1111/j.1365-2516.2008.01735.x; Ogiwara K, 2014, INT J HEMATOL, V99, P577, DOI 10.1007/s12185-014-1572-4; Sakai M, 2013, JPN J THROMB HEMOST, V24, P640; Young G, 2006, HAEMOPHILIA, V12, P598, DOI 10.1111/j.1365-2516.2006.01319	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	JUL	2015	13	7					1279	1284		10.1111/jth.12987		6	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CM2DB	WOS:000357488900014		
J	Chou, J; Hao, J; Hatoyama, H; Ben-Nissan, B; Milthorpe, B; Otsuka, M				Chou, Joshua; Hao, Jia; Hatoyama, Hirokazu; Ben-Nissan, Besim; Milthorpe, Bruce; Otsuka, Makoto			Effect of biomimetic zinc-containing tricalcium phosphate (Zn-TCP) on the growth and osteogenic differentiation of mesenchymal stem cells	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						biomimetic; zinc tricalcium phosphate; bone tissue engineering; bone marrow stem cell; osteoblasts	LUMBAR SPINAL-FUSION; CALCIUM-PHOSPHATE; BONE-FORMATION; MINERAL DENSITY; STROMAL CELLS; IN-VITRO; HYDROXYAPATITE; MARROW; SUBSTITUTE; CERAMICS	Several studies have shown the effectiveness of zinc-tricalcium phosphate (Zn-TCP) for bone tissue engineering. In this study, marine calcareous foraminifera possessing uniform pore size distribution were hydrothermally converted to Zn-TCP. The ability of a scaffold to combine effectively with mesenchymal stem cells (MSCs) is a key tissue-engineering aim. In order to demonstrate the osteogenic ability of MSCs with Zn-TCP, the scaffolds were cultured in an osteogenic induction medium to elicit an osteoblastic response. The physicochemical properties of Zn-TCP were characterized by XRD, FT-IR and ICP-MS. MSCs were aspirated from rat femurs and cultured for 3 days before indirectly placing four samples into each respective well. After culture for 7, 10 and 14 days, osteoblastic differentiation was evaluated using alizarin red S stain, measurement of alkaline phosphatase (ALP) levels, cell numbers and cell viability. XRD and FT-IR patterns both showed the replacement of CO32- with PO43-. Chemical analysis showed zinc incorporation of 5 mol%. Significant increases in cell numbers were observed at 10 and 14 days in the Zn-TCP group, while maintaining high levels of cell viability (> 90%). ALP activity in the Zn-TCP group was statistically higher at 10 days. Alizarin red S staining also showed significantly higher levels of calcium mineralization in Zn-TCP compared with the control groups. This study showed that MSCs in the presence of biomimetically derived Zn-TCP can accelerate their differentiation to osteoblasts and could potentially be useful as a scaffold for bone tissue engineering. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Chou, Joshua; Hatoyama, Hirokazu; Otsuka, Makoto] Musashino Univ, Pharmaceut Sci Res Inst, Fac Pharm, Tokyo 2028585, Japan; [Hao, Jia] Tokyo Med & Dent Univ, Oral Implantal & Regenerat Dent Med, Tokyo, Japan; [Chou, Joshua; Ben-Nissan, Besim; Milthorpe, Bruce] Univ Technol Sydney, Fac Sci, Adv Tissue Regenerat & Drug Delivery Grp, Sydney, NSW 2007, Australia	Chou, J (reprint author), Musashino Univ, Pharmaceut Sci Res Inst, Fac Pharm, 1-1-20 Shin Machi, Tokyo 2028585, Japan.	Joshua.chou@uts.edu.au			Japanese Society for the Promotion of Science; Musashino University; University of Technology Sydney; Tokyo Medical and Dental University	The authors acknowledge the support of this research by the Japanese Society for the Promotion of Science, Musashino University, University of Technology Sydney and Tokyo Medical and Dental University.	Lu HX, 2010, J BIOMATER APPL, V25, P39, DOI 10.1177/0885328209342469; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109; Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1; Hench LL, 1998, J AM CERAM SOC, V81, P1705; Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028; Ito A, 2005, CURR APPL PHYS, V5, P402, DOI 10.1016/j.cap.2004.10.006; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g; Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23; Otsuka M, 2004, J BIOMED MATER RES A, V69A, P552, DOI 10.1002/jbm.a.30040; Daculsi G, 2010, J MATER SCI-MATER M, V21, P855, DOI 10.1007/s10856-009-3914-y; JARCHO M, 1986, DENT CLIN N AM, V30, P25; Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; [Anonymous], 2002, CLIN ORFHOP REL RES, DOI DOI 10.1097/00003086-200202000-00009; Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2; Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; Pina S, 2010, EUR CELLS MATER, V20, P162; Aoki H., 1994, MED APPL HYDROXYAPAT, P13; ARNAUD E, 1994, CALCIFIED TISSUE INT, V54, P493, DOI 10.1007/BF00334331; Boden SD, 1997, J SPINAL DISORD, V10, P1; Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004; Chou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071821; Chou J, 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1576/, DOI 10.1002/TERM.1576/]; Chou J., 2007, J AUST CERAM SOC, V43, P44; DUCHEYNE P, 1981, J BIOMED MATER RES, V15, P441, DOI 10.1002/jbm.820150315; Gao T, 1996, INT ORTHOP, V20, P321, DOI 10.1007/s002640050086; Hayakawa S, 2007, J AM CERAM SOC, V90, P565, DOI 10.1111/j.1551-2916.2006.01396.x; JARCHO M, 1981, CLIN ORTHOP RELAT R, P259; Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3; KISHI S, 1994, BIOCHEM PHARMACOL, V48, P1225, DOI 10.1016/0006-2952(94)90160-0; KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z; Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018; Spence G, 2008, J BONE JOINT SURG BR, V90B, P1635, DOI 10.1302/0301-620X.90B12.20931; Ta AC, 1997, J MATER SCI-MATER M, V8, P91; Tman M, 2013, MAT SCI ENG C, V33, P2569; Tokudome Y, 2011, BIOL PHARM BULL, V34, P1215; VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	JUL	2015	9	7					852	858		10.1002/term.1901		7	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CM7NV	WOS:000357881900012		
J	Cheong, HW; Lee, W; Kim, JW; Whang, KW; Kim, H; Park, W				Cheong, Hee-Woon; Lee, Woohyun; Kim, Ji-Won; Whang, Ki-Woong; Kim, Hyuk; Park, Wanjae			Study on spatial distribution of plasma parameters in a magnetized inductively coupled plasma	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A			English	Article							ION ETCHING LAG; CYCLOTRON-RESONANCE PLASMA; DENSITY; SIO2; DEPENDENCE; PROBE	Spatial distributions of various plasma parameters such as plasma density, electron temperature, and radical density in an inductively coupled plasma (ICP) and a magnetized inductively coupled plasma (M-ICP) were investigated and compared. Electron temperature in between the rf window and the substrate holder of M-ICP was higher than that of ICP, whereas the one just above the substrate holder of M-ICP was similar to that of ICP when a weak (<8 G) magnetic field was employed. As a result, radical densities in M-ICP were higher than those in ICP and the etch rate of oxide in M-ICP was faster than that in ICP without severe electron charging in 90 nm high aspect ratio contact hole etch. (C) 2015 American Vacuum Society.	[Cheong, Hee-Woon; Lee, Woohyun; Kim, Ji-Won; Whang, Ki-Woong] Seoul Natl Univ, Dept Elect & Comp Engn, Interuniv Semicond Res Ctr, Plasma Lab, Seoul 151742, South Korea; [Kim, Hyuk] Samsung Elect Co, Banwol Dong 445701, Hwaseong, South Korea; [Park, Wanjae] Tokyo Electron Miyagi Ltd, Taiwa, Miyagi 9813629, Japan	Cheong, HW (reprint author), Seoul Natl Univ, Dept Elect & Comp Engn, Interuniv Semicond Res Ctr, Plasma Lab, Seoul 151742, South Korea.	kwhang@snu.ac.kr			Inter-University Semiconductor Research Center (ISRC) in Seoul National University, Seoul, Korea; Semiconductor R&D Center of Samsung Electronics Co., Ltd., Gyeonggi-do, Korea	This work has been supported by the Inter-University Semiconductor Research Center (ISRC) in Seoul National University, Seoul, Korea, and Semiconductor R&D Center of Samsung Electronics Co., Ltd., Gyeonggi-do, Korea.	Akimoto T, 1995, J VAC SCI TECHNOL B, V13, P2390, DOI 10.1116/1.588006; Wu BQ, 2010, J APPL PHYS, V108, DOI 10.1063/1.3474652; Kokkoris G, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195211; Imai S, 2008, J VAC SCI TECHNOL B, V26, P2008, DOI 10.1116/1.3021031; COBURN JW, 1980, J APPL PHYS, V51, P3134, DOI 10.1063/1.328060; Cheng D.K., 1989, FIELD WAVE ELECTROMA; Cheong HW, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/6/065051; DING J, 1993, J VAC SCI TECHNOL A, V11, P1283, DOI 10.1116/1.578540; Franck CM, 2002, REV SCI INSTRUM, V73, P3768, DOI 10.1063/1.1512341; Godyak V. A., 1994, Plasma Sources, Science and Technology, V3, DOI 10.1088/0963-0252/3/2/007; Hosomi S, 1997, J VAC SCI TECHNOL A, V15, P585, DOI 10.1116/1.580688; Hwang GS, 1997, PHYS REV LETT, V79, P845, DOI 10.1103/PhysRevLett.79.845; Jenq J. S., 1994, PLASMA SOURCES SCI T, V3, P154, DOI 10.1088/0963-0252/3/2/005; JOUBERT O, 1994, J VAC SCI TECHNOL A, V12, P1957, DOI 10.1116/1.578989; Karouta F, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/23/233501; Kim H, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4804136; Kim SS, 1999, PHYS PLASMAS, V6, P2926, DOI 10.1063/1.873250; Lee H. J., 1996, THESIS SEOUL NATL U; Lee HJ, 1996, PLASMA SOURCES SCI T, V5, P383, DOI 10.1088/0963-0252/5/3/005; Lee HJ, 1996, J VAC SCI TECHNOL A, V14, P1007, DOI 10.1116/1.580122; LEE YH, 1991, J ELECTROCHEM SOC, V138, P2439, DOI 10.1149/1.2085991; Lieberman MA, 2005, PRINCIPLES OF PLASMA DISCHARGES AND MATERIALS PROCESSING, 2ND EDITION, P1; NOJIRI K, 1995, J VAC SCI TECHNOL B, V13, P1451, DOI 10.1116/1.588170; Sung YI, 2002, J ANAL ATOM SPECTROM, V17, P565, DOI 10.1039/b110219m; WESTERHEIM AC, 1995, J VAC SCI TECHNOL A, V13, P853, DOI 10.1116/1.579841	25	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0734-2101	1520-8559		J VAC SCI TECHNOL A	J. Vac. Sci. Technol. A	JUL	2015	33	4							041304	10.1116/1.4923027		7	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	CM6UQ	WOS:000357826400009		
J	de Sousa, RRM; Sato, PS; Viana, BC; Alves, C; Nishimoto, A; Nascente, PAP				de Sousa, Romulo R. M.; Sato, Patricia S.; Viana, Bartolomeu C.; Alves, Clodomiro, Jr.; Nishimoto, Akio; Nascente, Pedro A. P.			Cathodic cage plasma deposition of TiN and TiO2 thin films on silicon substrates	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A			English	Article							CHEMICAL-VAPOR-DEPOSITION; TITANIUM NITRIDE FILMS; AISI 316 INFLUENCE; STAINLESS-STEEL; VACUUM-ARC; COATINGS; MICROSTRUCTURE; GROWTH; ALLOY; CH4	Cathodic cage plasma deposition (CCPD) was used for growing titanium nitride (TiN) and titanium dioxide (TiO2) thin films on silicon substrates. The main advantages of the CCPD technique are the uniformity, tridimensionality, and high rate of the film deposition that occurs at higher pressures, lower temperatures, and lower treatment times than those used in conventional nitriding treatments. In this work, the influence of the temperature and gas atmosphere upon the characteristics of the deposited films was investigated. The TiN and TiO2 thin films were characterized by x-ray diffraction, scanning electron microscopy, and Raman spectroscopy to analyze their chemical, structural, and morphological characteristics, and the combination of these results indicates that the low-cost CCPD technique can be used to produce even and highly crystalline TiN and TiO2 films. (C) 2015 American Vacuum Society.	[de Sousa, Romulo R. M.] Fed Inst Educ Sci & Technol Piaui, Dept Mech, BR-64000040 Teresina, Piaui, Brazil; [de Sousa, Romulo R. M.] Univ Fed Piaui, Dept Mech Engn, BR-64049550 Teresina, Piaui, Brazil; [Sato, Patricia S.; Nascente, Pedro A. P.] Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Paulo, Brazil; [Viana, Bartolomeu C.] Univ Fed Piaui, Dept Phys, BR-64049550 Teresina, Piaui, Brazil; [Alves, Clodomiro, Jr.] Fed Rural Univ Semi Arido, Dept Exact & Nat Sci, BR-59625900 Mossoro, RN, Brazil; [Nishimoto, Akio] Kansai Univ, Fac Chem Mat & Bioengn, Dept Chem & Mat Engn, Suita, Osaka 5648680, Japan	de Sousa, RRM (reprint author), Fed Inst Educ Sci & Technol Piaui, Dept Mech, Praca Liberdade 1597, BR-64000040 Teresina, Piaui, Brazil.	nascente@ufscar.br			ProAGRUPAR of the Federal Institute of Piaui (IFPI); National Council for Scientific and Technological Development (CNPq) of Brazil	This work was partially supported by ProAGRUPAR of the Federal Institute of Piaui (IFPI) and the National Council for Scientific and Technological Development (CNPq) of Brazil.	Alves C, 2006, SURF COAT TECH, V201, P2450, DOI 10.1016/j.surfcoat.2006.04.014; Aarik J, 2000, APPL SURF SCI, V161, P385, DOI 10.1016/S0169-4332(00)00274-9; Wang HR, 2011, APPL SURF SCI, V257, P5576, DOI 10.1016/j.apsusc.2011.01.047; Yang WL, 2006, THIN SOLID FILMS, V515, P1708, DOI 10.1016/j.tsf.2006.06.010; Kadoshima M, 2003, THIN SOLID FILMS, V424, P224, DOI 10.1016/S0040-6090(02)01105-7; Vaz F, 2004, THIN SOLID FILMS, V447, P449, DOI 10.1016/S0040-6090(03)01123-4; VALVODA V, 1995, J ALLOY COMPD, V219, P83, DOI 10.1016/0925-8388(94)05012-0; Muratore C, 2006, J VAC SCI TECHNOL A, V24, P25, DOI 10.1116/1.2134706; Liu JX, 2003, THIN SOLID FILMS, V429, P225, DOI 10.1016/S0040-6090(03)00146-9; Agnarsson B, 2013, THIN SOLID FILMS, V545, P445, DOI 10.1016/j.tsf.2013.07.058; Hultman L, 2000, VACUUM, V57, P1, DOI 10.1016/S0042-207X(00)00143-3; Chen L, 2006, THIN SOLID FILMS, V515, P1176, DOI 10.1016/j.tsf.2006.07.094; Chawla V, 2008, MATER CHARACT, V59, P1015, DOI 10.1016/j.matchar.2007.08.017; Mazali IO, 2006, J NANOPART RES, V8, P141, DOI 10.1007/s11051-005-9003-3; SPROUL WD, 1985, THIN SOLID FILMS, V126, P257, DOI 10.1016/0040-6090(85)90319-0; de Sousa RRM, 2012, VACUUM, V86, P2048, DOI 10.1016/j.vacuum.2012.05.008; Droulers G, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3553209; LOBL P, 1994, THIN SOLID FILMS, V251, P72, DOI 10.1016/0040-6090(94)90843-5; CHATTERJEE S, 1992, J MATER SCI, V27, P3409, DOI 10.1007/BF01151815; Chaukulkar RP, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4798385; Cheng YH, 2002, J VAC SCI TECHNOL B, V20, P2000, DOI 10.1116/1.1505957; Cheng YH, 2002, J APPL PHYS, V92, P1845, DOI 10.1063/1.1491588; Cleveland ER, 2012, J VAC SCI TECHNOL A, V30, DOI 10.1116/1.3669522; de Sousa RRM, 2007, MAT SCI ENG A-STRUCT, V465, P223, DOI [10.1016/j.msea.2007.03.007, 10.1016/j.mesa.2007.03.007]; de Sousa RRM, 2008, MAT SCI ENG A-STRUCT, V487, P124, DOI 10.1016/j.msea.2007.10.001; de Araujo FO, 2006, SURF COAT TECH, V201, P2990, DOI 10.1016/j.surfcoat.2006.06.015; de Sousa RRM, 2012, MATER RES-IBERO-AM J, V15, P260, DOI 10.1590/S1516-14392012005000016; de Sousa RRM, 2009, VACUUM, V83, P1402, DOI 10.1016/j.vacuum.2009.04.054; de Sousa RRM, 2008, SURF ENG, V24, P52, DOI 10.1179/174329408X271589; HILTON MR, 1987, THIN SOLID FILMS, V154, P377, DOI 10.1016/0040-6090(87)90380-4; Hossain MF, 2008, THIN SOLID FILMS, V516, P7149, DOI 10.1016/j.tsf.2007.12.022; Jouanny I, 2010, THIN SOLID FILMS, V518, P3212, DOI 10.1016/j.tsf.2009.09.046; Lilja M, 2011, J MATER SCI-MATER M, V22, P2727, DOI 10.1007/s10856-011-4465-6; Lou HQ, 1997, SURF COAT TECH, V90, P123, DOI 10.1016/S0257-8972(96)03104-0; MENG LJ, 1995, VACUUM, V46, P233, DOI 10.1016/0042-207X(94)00052-2; Negishi N, 2001, THIN SOLID FILMS, V392, P249, DOI 10.1016/S0040-6090(01)01036-7; Nishimoto A, 2013, SURF COAT TECH, V228, pS558, DOI 10.1016/j.surfcoat.2012.04.021; Nishimoto A, 2010, SURF ENG, V26, P74, DOI 10.1179/026708409X12454193831760; REBENNE HE, 1994, SURF COAT TECH, V63, P1, DOI 10.1016/S0257-8972(05)80002-7; RICHTER F, 1992, SURF COAT TECH, V54, P338; Rigato V, 2001, SURF COAT TECH, V142, P943, DOI 10.1016/S0257-8972(01)01258-0; Samal N, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4769204; SPENGLER W, 1976, SOLID STATE COMMUN, V18, P881, DOI 10.1016/0038-1098(76)90228-3; Wisitsmat A, 2009, THIN SOLID FILMS, V517, P2775, DOI 10.1016/j.tsf.2008.10.090; Yasuda Y, 2012, J VAC SCI TECHNOL A, V30, DOI 10.1116/1.4748803; Zhang M, 2007, SURF COAT TECH, V201, P7252, DOI 10.1016/j.surfcoat.2007.01.043; Zhang YJ, 2004, J VAC SCI TECHNOL A, V22, P2419, DOI 10.1116/1.1807836	47	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0734-2101	1520-8559		J VAC SCI TECHNOL A	J. Vac. Sci. Technol. A	JUL	2015	33	4							041502	10.1116/1.4919770		5	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	CM6UQ	WOS:000357826400014		
J	Kotake, H; Jia, J; Nakamura, S; Okajima, T; Shigesato, Y				Kotake, Haruka; Jia, Junjun; Nakamura, Shin-ichi; Okajima, Toshihiro; Shigesato, Yuzo			Tailoring the crystal structure of TiO2 thin films from the anatase to rutile phase	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A			English	Article							TITANIUM-DIOXIDE; SN; TEMPERATURE; IONS	TiO2 films with various Sn concentrations were deposited on quartz substrates using rf reactive magnetron sputtering. The crystal structure was investigated by using x-ray diffraction, Raman spectroscopy, and transmission electron microscopy, and the chemical states of Ti and Sn were analyzed by x-ray absorption near edge structure (XANES) spectroscopy. Without Sn doping, TiO2 films change the crystal structure from rutile to anatase as the total gas pressure increases in the sputtering deposition. On the other hand, Sn doping induces the transformation of TiO2 crystalline structure from anatase to rutile phase, where the XANES spectra implied that Sn substitutes into Ti site of rutile TiO2. Atomic force microscope analyses revealed that the Sn-doped TiO2 films exhibited a flat surface with the roughness of approximately 2 nm. (C) 2015 American Vacuum Society.	[Kotake, Haruka; Jia, Junjun; Nakamura, Shin-ichi; Shigesato, Yuzo] Aoyama Gakuin Univ, Grad Sch Sci & Engn, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan; [Okajima, Toshihiro] Kyushu Synchrotron Light Res Ctr, Tosu, Saga 8410005, Japan	Shigesato, Y (reprint author), Aoyama Gakuin Univ, Grad Sch Sci & Engn, Chuo Ku, 5-10-1 Fuchinobe, Sagamihara, Kanagawa 2525258, Japan.	yuzo@chem.aoyama.ac.jp					Alves AK, 2013, CATAL TODAY, V208, P7, DOI 10.1016/j.cattod.2012.10.020; Ito N, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.041105; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Zeuner M, 1998, J APPL PHYS, V83, P5083, DOI 10.1063/1.367325; MEYER K, 1981, J APPL PHYS, V52, P5803, DOI 10.1063/1.329473; Yamagishi M, 2003, THIN SOLID FILMS, V442, P227, DOI 10.1016/S0040-6090(03)00987-8; BURDETT JK, 1987, J AM CHEM SOC, V109, P3639, DOI 10.1021/ja00246a021; [Anonymous], 1969, NBS US MON, V25, P83; BENNETT JM, 1989, APPL OPTICS, V28, P3303, DOI 10.1364/AO.28.003303; Kaleji BK, 2011, J SOL-GEL SCI TECHN, V60, P99, DOI 10.1007/s10971-011-2560-2; Tominaga K, 2001, J VAC SCI TECHNOL A, V19, P1582, DOI 10.1116/1.1368664; CHENG HM, 1995, CHEM MATER, V7, P663, DOI 10.1021/cm00052a010; Mardare D, 2000, APPL SURF SCI, V156, P200, DOI 10.1016/S0169-4332(99)00508-5; Okada K, 2001, J AM CERAM SOC, V84, P1591; Jia JJ, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4812668; Kawamoto M, 2010, AIP CONF PROC, V1234, P355, DOI 10.1063/1.3463211; Li S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.201204; Liu ZL, 2004, J ELECTRON SPECTROSC, V135, P155, DOI 10.1016/j.elspec.2004.03.002; Lutzenkirchen-Hecht D, 2001, J SYNCHROTRON RADIAT, V8, P698, DOI 10.1107/S0909049500015119; Mahanty S, 2004, J CRYST GROWTH, V261, P77, DOI 10.1016/j.jcrysgro.2003.09.023; McCarthy G. J., 1989, POWDER DIFFR, V4, P156; Okimura K, 2001, SURF COAT TECH, V135, P286, DOI 10.1016/S0257-8972(00)00999-3; Pearson W.B., 1972, CRYSTAL CHEM PHYSICS, P135; Song PK, 2004, JPN J APPL PHYS 2, V43, pL358, DOI 10.1143/JJAP.43.L358; Song PK, 1999, JPN J APPL PHYS 1, V38, P2921, DOI 10.1143/JJAP.38.2921; Yoshioka S., 2011, DIAMOND LIGHT SOURCE, V1, pe129, DOI 10.1017/S2044820110000857	26	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0734-2101	1520-8559		J VAC SCI TECHNOL A	J. Vac. Sci. Technol. A	JUL	2015	33	4							041505	10.1116/1.4921302		6	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	CM6UQ	WOS:000357826400017		
J	Li, H; Muraki, Y; Karahashi, K; Hamaguchi, S				Li, Hu; Muraki, Yu; Karahashi, Kazuhiro; Hamaguchi, Satoshi			Suboxide/subnitride formation on Ta masks during magnetic material etching by reactive plasmas	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A			English	Article							CFX+ X=1,2,3 ION; FILM DEPOSITION; THIN-FILMS; ENERGY; BEAM; MRAM; XPS	Etching characteristics of tantalum (Ta) masks used in magnetoresistive random-access memory etching processes by carbon monoxide and ammonium (CO/NH3) or methanol (CH3OH) plasmas have been examined by mass-selected ion beam experiments with in-situ surface analyses. It has been suggested in earlier studies that etching of magnetic materials, i.e., Fe, Ni, Co, and their alloys, by such plasmas is mostly due to physical sputtering and etch selectivity of the process arises from etch resistance (i.e., low-sputtering yield) of the hard mask materials such as Ta. In this study, it is shown that, during Ta etching by energetic CO+ or N+ ions, suboxides or subnitrides are formed on the Ta surface, which reduces the apparent sputtering yield of Ta. It is also shown that the sputtering yield of Ta by energetic CO+ or N+ ions has a strong dependence on the angle of ion incidence, which suggests a correlation between the sputtering yield and the oxidation states of Ta in the suboxide or subnitride; the higher the oxidation state of Ta, the lower is the sputtering yield. These data account for the observed etch selectivity by CO/NH3 and CH3OH plasmas. (C) 2015 American Vacuum Society.	[Li, Hu; Muraki, Yu; Karahashi, Kazuhiro; Hamaguchi, Satoshi] Osaka Univ, Ctr Atom & Mol Technol, Suita, Osaka 5650871, Japan	Li, H (reprint author), Osaka Univ, Ctr Atom & Mol Technol, Yamadaoka 2-1, Suita, Osaka 5650871, Japan.	hamaguch@ppl.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	The authors would like to thank Makoto Satake of Hitachi, Ltd. for his helpful discussion. This work was partially supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Tehrani S, 2000, IEEE T MAGN, V36, P2752, DOI 10.1109/20.908581; Karahashi K, 2004, J VAC SCI TECHNOL A, V22, P1166, DOI 10.1116/1.1761119; Kim EH, 2012, J ELECTROCHEM SOC, V159, pH230, DOI 10.1149/2.012203jes; STEINBRUCHEL C, 1989, APPL PHYS LETT, V55, P1960; Gallagher WJ, 1997, J APPL PHYS, V81, P3741, DOI 10.1063/1.364744; Yanai K, 2005, J APPL PHYS, V97, DOI 10.1063/1.1854726; ATANASSOVA E, 1995, APPL SURF SCI, V84, P193, DOI 10.1016/0169-4332(94)00538-9; Kong X, 2008, MICROELECTRON ENG, V85, P988, DOI 10.1016/j.mee.2007.12.006; Ivanov MV, 2011, J APPL PHYS, V110, DOI 10.1063/1.3606416; Kubota H, 2004, J MAGN MAGN MATER, V272, pE1421, DOI 10.1016/j.jmmm.2003.12.724; Ito T, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4793426; Ishikawa K, 2003, J VAC SCI TECHNOL A, V21, pL1, DOI 10.1116/1.1578653; Karahashi K, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/22/224008; Nakatani I, 1996, IEEE T MAGN, V32, P4448, DOI 10.1109/20.538896; Tehrani S, 1999, IEEE T MAGN, V35, P2814, DOI 10.1109/20.800991; Ito T, 2011, J VAC SCI TECHNOL A, V29, DOI 10.1116/1.3610981; Park JY, 2011, J ELECTROCHEM SOC, V158, pH1, DOI 10.1149/1.3505295; Arranz A, 2005, APPL PHYS A-MATER, V81, P1405, DOI 10.1007/s00339-004-3182-0; Haynes W.M., 2010, CRC HDB CHEM PHYS; HEIJMAN MGJ, 1988, PLASMA CHEM PLASMA P, V8, P383, DOI 10.1007/BF01016056; Ito T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.08HB01; Ito T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08KD02; Jeon MH, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.05EB03; Jung KB, 1999, J APPL PHYS, V85, P4788, DOI 10.1063/1.370482; Kim T, 2015, J VAC SCI TECHNOL A, V33, DOI 10.1116/1.4904215; Kim T, 2014, J VAC SCI TECHNOL A, V32, DOI 10.1116/1.4885061; Kinoshita K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.08JB02; Lee R. E., 1979, J VAC SCI TECHNOL, V61, P164; Matsui N., 2002, VACUUM, V66, P472; Miyazaki T, 1997, J APPL PHYS, V81, P3753, DOI 10.1063/1.364957; Osada T., 2004, P 26 INT S DRY PROC, P127; Satake M., J VAC SOC TE B UNPUB; Tu VJ, 2000, J VAC SCI TECHNOL A, V18, P2799, DOI 10.1116/1.1310652	33	2	2	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0734-2101	1520-8559		J VAC SCI TECHNOL A	J. Vac. Sci. Technol. A	JUL	2015	33	4							040602	10.1116/1.4919925		5	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	CM6UQ	WOS:000357826400002		
J	Nakano, Y; Ogawa, D; Nakamura, K; Kawakami, R; Niibe, M				Nakano, Yoshitaka; Ogawa, Daisuke; Nakamura, Keiji; Kawakami, Retsuo; Niibe, Masahito			Ar+-irradiation-induced damage in hydride vapor-phase epitaxy GaN films	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A			English	Article							GALLIUM VACANCIES; DEFECTS; HYDROGEN	The authors have investigated the electrical characteristics of hydride vapor-phase epitaxy GaN films exposed to Ar+ irradiation, employing Schottky barrier diodes. The Ar+ irradiation tends to largely increase the effective carrier concentration in the near surface region of GaN up to similar to 25 nm, due to the generation of donor-type N vacancy defects, compared to the original value before the irradiation. More interestingly, acceptor-type deep-level defects are found to be formed at similar to 2.1, similar to 2.9, and similar to 3.2 eV below the conduction band in the subsequently deeper region, in which Ga vacancies introduced by the Ar+ irradiation are considered to be in-diffused and immediately combined with hydrogen. These N vacancies and hydrogenated Ga vacancies formed are dominantly responsible for changing the depth profiles of the effective carrier concentration via the carrier generation, the carrier trapping, and/or carrier compensation. (C) 2015 American Vacuum Society.	[Nakano, Yoshitaka; Ogawa, Daisuke; Nakamura, Keiji] Chubu Univ, Dept Elect, Kasugai, Aichi 4878501, Japan; [Nakano, Yoshitaka; Ogawa, Daisuke; Nakamura, Keiji] Chubu Univ, Dept Elect Engn, Kasugai, Aichi 4878501, Japan; [Kawakami, Retsuo] Univ Tokushima, Inst Sociotechno Sci Technol, Tokushima 7708506, Japan; [Niibe, Masahito] Univ Hyogo, Lab Adv Sci & Technol Ind, Kamigori, Hyogo 6781205, Japan	Nakano, Y (reprint author), Chubu Univ, Dept Elect, Kasugai, Aichi 4878501, Japan.	nakano@isc.chubu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25420300]	A part of this work was partly supported by the Grant-in-Aid for Scientific Research (C) 25420300 of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Demchenko DO, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.087404; Pearton SJ, 1999, J APPL PHYS, V86, P1, DOI 10.1063/1.371145; Neugebauer J, 1996, APPL PHYS LETT, V69, P503, DOI 10.1063/1.117767; Lyons JL, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3492841; Wright AF, 2001, J APPL PHYS, V90, P1164, DOI 10.1063/1.1383980; Usui A, 1997, JPN J APPL PHYS 2, V36, pL899, DOI 10.1143/JJAP.36.L899; Look DC, 1997, PHYS REV LETT, V79, P2273, DOI 10.1103/PhysRevLett.79.2273; Look DC, 2003, APPL PHYS LETT, V83, P3525, DOI 10.1063/1.1623009; Chen MG, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.111003; Cheung R, 1999, J VAC SCI TECHNOL B, V17, P2759, DOI 10.1116/1.591059; Cheung R, 2000, J APPL PHYS, V88, P7110, DOI 10.1063/1.1328780; Duc TT, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4895390; Fang ZQ, 2001, APPL PHYS LETT, V78, P332, DOI 10.1063/1.1338970; Kawakami R, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.08HF01; Lee C, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.076503; Lo CF, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3454279; Nakamura S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.088001; Nakamura S, 2007, PHYS STATUS SOLIDI C, V4, P2581, DOI 10.1002/pssc.200674792; Nakano Y, 2010, PHYS STATUS SOLIDI-R, V4, P374, DOI 10.1002/pssr.201004421; Nakano Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4767367; Niibe M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.01AB02; Rong B, 2001, J VAC SCI TECHNOL B, V19, P2917, DOI 10.1116/1.1421543; Saarinen A. K., 1998, APPL PHYS LETT, V73, P3253; Van de Walle CG, 1997, PHYS REV B, V56, P10020	24	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0734-2101	1520-8559		J VAC SCI TECHNOL A	J. Vac. Sci. Technol. A	JUL	2015	33	4							043002	10.1116/1.4922593		5	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	CM6UQ	WOS:000357826400030		
J	Tamura, M; Eguchi, T				Tamura, Motonori; Eguchi, Takashi			Nanostructured thin films for hydrogen-permeation barrier	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A			English	Article							FUSION-REACTOR APPLICATIONS; HIGH-PRESSURE HYDROGEN; 316L STAINLESS-STEEL; HIGH-STRENGTH STEELS; GRAIN-SIZE; DIFFUSION; ALLOY; EMBRITTLEMENT; TEMPERATURE; MECHANISMS	The authors confirmed that applying a coating of Al2O3, TiC, or TiN on a substrate reduced the hydrogen permeation by a factor of at least one order of magnitude compared with uncoated substrates. Al2O3 films consisting of fine crystal grains, with diameters of about 40 nm or less, provided superior hydrogen-permeation barriers on the test specimens. The test specimens coated with TiN or TiC films, with columnar crystals grown vertically on the substrate, tended to exhibit higher hydrogen permeability. The microcrystalline structures with many grain boundaries are expected to provide effective hydrogen-barrier performance. (C) 2015 American Vacuum Society.	[Tamura, Motonori] Univ Electrocommun, Ctr Ind & Govt Relat, Chofu, Tokyo 1828585, Japan; [Eguchi, Takashi] Toho Kaken Co Ltd, Koshigaya, Saitama 3430822, Japan	Tamura, M (reprint author), Univ Electrocommun, Ctr Ind & Govt Relat, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	mtamura@sangaku.uec.ac.jp					Ando M., 2007, Journal of Japan Institute of Light Metals, V57, DOI 10.2464/jilm.57.19; ANDREW PL, 1992, J APPL PHYS, V72, P2749, DOI 10.1063/1.351526; Evans JW, 2006, SURF SCI REP, V61, P1, DOI 10.1016/j.surfrep.2005.08.004; Nagumo M, 2001, METALL MATER TRANS A, V32, P339, DOI 10.1007/s11661-001-0265-9; Yamabe J, 2013, INT J HYDROGEN ENERG, V38, P10141, DOI 10.1016/j.ijhydene.2013.05.152; Oudriss A, 2012, ACTA MATER, V60, P6814, DOI 10.1016/j.actamat.2012.09.004; Oyama ST, 2011, J JPN PETROL INST, V54, P298; Szost BA, 2013, METALL MATER TRANS A, V44A, P4542, DOI 10.1007/s11661-013-1795-7; Takai K, 1996, J JPN I MET, V60, P1155; HIRTH JP, 1980, METALL TRANS A, V11, P861, DOI 10.1007/BF02654700; [Anonymous], ISO1510512007; Huang PY, 2011, NATURE, V469, P389, DOI 10.1038/nature09718; THORNTON JA, 1974, J VAC SCI TECHNOL, V11, P666, DOI 10.1116/1.1312732; WHITEMAN MB, 1965, CORROSION, V21, P53; HURLBERT RC, 1961, J CHEM PHYS, V34, P655, DOI 10.1063/1.1701003; FUKUYAMA S, 1985, T JPN I MET, V26, P325; BEACHEM CD, 1972, METALL TRANS, V3, P437; Caravella A, 2008, CHEM ENG SCI, V63, P2149, DOI 10.1016/j.ces.2008.01.009; [Anonymous], K712622006 JIS; Han G, 1998, ACTA MATER, V46, P4559, DOI 10.1016/S1359-6454(98)00136-0; Ariza M. P., 2014, Advances in Science and Technology, V93, DOI 10.4028/www.scientific.net/AST.93.118; Checchetto R, 1996, SURF COAT TECH, V83, P40, DOI 10.1016/0257-8972(96)02851-4; Chikada T, 2009, FUSION ENG DES, V84, P590, DOI 10.1016/j.fusengdes.2008.12.030; Choi S, 2004, THIN SOLID FILMS, V464, P277, DOI 10.1016/j.tsf.2004.06.081; Gaude-Fugarolas D., 2013, P METAL; HOLLENBERG GW, 1995, FUSION ENG DES, V28, P190, DOI 10.1016/0920-3796(95)90039-X; Horikawa K, 2010, J JPN I MET, V74, P199, DOI 10.2320/jinstmet.74.199; Kiselev DA, 2007, J PHYS D APPL PHYS, V40, P7109, DOI 10.1088/0022-3727/40/22/037; Koyama R, 2014, T NONFERR METAL SOC, V24, P2102, DOI 10.1016/S1003-6326(14)63318-5; Lamsal B. S., 2014, J MAT, V11, P3965; Lee NR, 2013, INT J HYDROGEN ENERG, V38, P7654, DOI 10.1016/j.ijhydene.2012.08.080; Lee S. K., 2011, J KOREAN PHYS SOC, V5, P3019; Lee SK, 2011, J KOREAN PHYS SOC, V59, P3019, DOI 10.3938/jkps.59.3019; MacGuiness P. J., 2011, SURF COAT TECH, V205, P2709; Osaki S., 2001, Journal of Japan Institute of Light Metals, V51, DOI 10.2464/jilm.51.222; Pisarev A, 2003, J NUCL MATER, V320, P214, DOI 10.1016/S0022-3115(03)00110-7; Plawsky JL, 2014, NANOSC MICROSC THERM, V18, P251, DOI 10.1080/15567265.2013.878419; San Marchi C., 2007, INT J HYDROGEN ENERG, V32, P100; Sarkar S, 2009, SURF COAT TECH, V204, P391, DOI 10.1016/j.surfcoat.2009.08.001; Serra E, 1998, J NUCL MATER, V258, P1028, DOI 10.1016/S0022-3115(98)00276-1; SHAN CQ, 1992, J NUCL MATER, V191, P221; Song R. G., 2003, SURF COAT TECHNOL, V168, P191; STERN SA, 1968, J POLYM SCI A2, V6, P1933, DOI 10.1002/pol.1968.160061108; Tamura M, 2014, SURF COAT TECH, V260, P148, DOI 10.1016/j.surfcoat.2014.09.041; Tamura M, 2005, J JPN I MET, V69, P1039, DOI 10.2320/jinstmet.69.1039; THORNTON JA, 1977, ANNU REV MATER SCI, V7, P239, DOI 10.1146/annurev.ms.07.080177.001323; Troiano A, 1960, T AM SOC MET, V52, P54; Yazdipour N, 2012, MATER SCI FORUM, V706-709, P1568, DOI 10.4028/www.scientific.net/MSF.706-709.1568; Young GA, 2002, METALL MATER TRANS A, V33, P101, DOI 10.1007/s11661-002-0009-5; Zhang GK, 2014, INT J HYDROGEN ENERG, V39, P610, DOI 10.1016/j.ijhydene.2013.10.063	50	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0734-2101	1520-8559		J VAC SCI TECHNOL A	J. Vac. Sci. Technol. A	JUL	2015	33	4							041503	10.1116/1.4919736		6	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	CM6UQ	WOS:000357826400015		
J	Pakozdy, A; Patzl, M; Zimmermann, L; Jokinen, TS; Glantschnigg, U; Kelemen, A; Hasegawa, D				Pakozdy, A.; Patzl, M.; Zimmermann, L.; Jokinen, T. S.; Glantschnigg, U.; Kelemen, A.; Hasegawa, D.			LGI Proteins and Epilepsy in Human and Animals	JOURNAL OF VETERINARY INTERNAL MEDICINE			English	Review						Autoimmune; Epilepsy; Genetic; LGI	TEMPORAL-LOBE EPILEPSY; DOMINANT PARTIAL EPILEPSY; GLIOMA INACTIVATED 3; POTASSIUM CHANNEL ANTIBODIES; LAGOTTO-ROMAGNOLO DOGS; LIMBIC ENCEPHALITIS; AUTOSOMAL-DOMINANT; LEUCINE-RICH; SYNAPTIC-TRANSMISSION; AUDITORY FEATURES	Leucine-rich glioma-inactivated (LGI) protein was first thought to have a suppressor effect in the formation of some cancers. Developments in physiology and medicine made it possible to characterize the function of the LGI protein family and its crucial role in different conditions more precisely. These proteins play an important role in synaptic transmission, and dysfunction may cause hyperexcitability. Genetic mutation of LGI1 was confirmed to be the cause of autosomal dominant lateral temporal lobe epilepsy in humans. The LGI2 mutation was identified in benign familial juvenile epilepsy in Lagotto Romagnolo (LR) dogs. Cats with familial spontaneous temporal lobe epilepsy have been reported, and the etiology might be associated with LGI protein family dysfunction. In addition, an autoimmune reaction against LGI1 was detected in humans and cats with limbic encephalitis. These advances prompted a review of LGI protein function and its role in different seizure disorders.	[Pakozdy, A.; Glantschnigg, U.] Univ Vet Med, Univ Clin Small Anim, Vienna, Austria; [Patzl, M.] Univ Vet Med, Inst Immunol, Vienna, Austria; [Zimmermann, L.] Univ Vet Med, Unit Physiol & Biophys, Vienna, Austria; [Jokinen, T. S.] Univ Helsinki, Dept Equine & Small Anim Med, Helsinki, Finland; [Kelemen, A.] Natl Inst Clin Neurosci, Epilepsy Ctr, Budapest, Hungary; [Hasegawa, D.] Nippon Vet & Life Sci Univ, Dept Clin Vet Med, Tokyo, Japan	Pakozdy, A (reprint author), Clin Small Anim Internal Med, Veterinaerpl 1, A-1210 Vienna, Austria.	akos.pakozdy@vetmeduni.ac.at			Vicerectorate for Research and International Relations of the University of Veterinary Medicine Vienna [Pp13011230]	This study received financial support from the Vicerectorate for Research and International Relations of the University of Veterinary Medicine Vienna ( grant number: Pp13011230).	Irani SR, 2008, NEUROLOGY, V71, P1647, DOI 10.1212/01.wnl.0000326572.93762.51; BRIERLEY JB, 1960, BRAIN, V83, P357, DOI 10.1093/brain/83.3.357; Malter MP, 2010, ANN NEUROL, V67, P470, DOI 10.1002/ana.21917; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Pakozdy A, 2011, J FELINE MED SURG, V13, P687, DOI 10.1016/j.jfms.2011.05.014; Claes L, 2004, J MED GENET, V41, P710, DOI 10.1136/jmg.2004.019257; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Irani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213; Lai MZ, 2009, ANN NEUROL, V65, P424, DOI 10.1002/ana.21589; Klang A, 2014, J NEUROPATH EXP NEUR, V73, P403, DOI 10.1097/NEN.0000000000000063; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.192511199; Dalmau J, 2008, LANCET NEUROL, V7, P327, DOI 10.1016/S1474-4422(08)70060-7; Thomas R, 2010, J NEUROSCI, V30, P6607, DOI 10.1523/JNEUROSCI.5147-09.2010; Fukata Y, 2010, P NATL ACAD SCI USA, V107, P3799, DOI 10.1073/pnas.0914537107; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Baulac S, 2001, ANN NEUROL, V49, P786, DOI 10.1002/ana.1014; Ozkaynak E, 2010, J NEUROSCI, V30, P3857, DOI 10.1523/JNEUROSCI.6287-09.2010; Nishino J, 2010, J NEUROSCI, V30, P15228, DOI 10.1523/JNEUROSCI.2286-10.2010; Thieben MJ, 2004, NEUROLOGY, V62, P1177; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Lalic T, 2011, EPILEPSIA, V52, P121, DOI 10.1111/j.1528-1167.2010.02756.x; Irani SR, 2011, ANN NEUROL, V69, P892, DOI 10.1002/ana.22307; Owuor K, 2009, MOL CELL NEUROSCI, V42, P448, DOI 10.1016/j.mcn.2009.09.008; Berkovic SF, 1996, ANN NEUROL, V40, P227, DOI 10.1002/ana.410400214; Bermingham JR, 2006, NAT NEUROSCI, V9, P76, DOI 10.1038/nn1598; Buckley C, 2001, ANN NEUROL, V50, P73, DOI 10.1002/ana.1097; TANAKA T, 1992, PROG NEUROBIOL, V38, P317, DOI 10.1016/0301-0082(92)90023-8; Bien CG, 2007, NEUROLOGY, V69, P1236, DOI 10.1212/01.wnl.0000276946.08412.ef; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; Berendt M, 2009, J SMALL ANIM PRACT, V50, P655, DOI 10.1111/j.1748-5827.2009.00849.x; Graus F, 2008, NEUROLOGY, V71, P930, DOI 10.1212/01.wnl.0000325917.48466.55; Lai MZ, 2010, LANCET NEUROL, V9, P776, DOI 10.1016/S1474-4422(10)70137-X; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Vincent A, 2004, BRAIN, V127, P701, DOI 10.1093/brain/awh077; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Fanciulli M, 2014, EPILEPSY RES, V108, P232, DOI 10.1016/j.eplepsyres.2013.11.002; Berendt M, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-51; Berkovic SF, 2004, NEUROLOGY, V62, P1115; Chabrol E, 2010, BRAIN, V133, P2749, DOI 10.1093/brain/awq171; Cowell JK, 2010, EXP MOL PATHOL, V88, P77, DOI 10.1016/j.yexmp.2009.09.008; D'Adamo MC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00134; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Gambardella A, 2000, EPILEPSY RES, V38, P127, DOI 10.1016/S0920-1211(99)00080-7; Gambardella A, 2009, EPILEPSIA, V50, P55, DOI 10.1111/j.1528-1167.2009.02123.x; Gelberg HB, 2013, VET PATHOL, V50, P1156, DOI 10.1177/0300985813480215; Gullov CH, 2012, J VET INTERN MED, V26, P1115, DOI 10.1111/j.1939-1676.2012.00977.x; Hasegawa D, 2014, EPILEPSY RES, V108, P1018, DOI 10.1016/j.eplepsyres.2014.05.007; Head K, 2007, MAMM GENOME, V18, P328, DOI 10.1007/s00335-007-9024-6; Herranz-Perez V, 2010, BRAIN RES, V1307, P177, DOI 10.1016/j.brainres.2009.10.013; Ho YY, 2012, NEUROLOGY, V78, P563, DOI 10.1212/WNL.0b013e318247ccbf; Jeong HS, 2014, EXP DERMATOL, V23, P600, DOI 10.1111/exd.12462; Jeong YM, 2013, WOUND REPAIR REGEN, V21, P634, DOI 10.1111/wrr.12066; Jokinen TS, 2014, VET RADIOL ULTRASOUN, V55, P331, DOI 10.1111/vru.12129; Jokinen TS, 2007, J VET INTERN MED, V21, P464, DOI 10.1892/0891-6640(2007)21[464:BFJEIL]2.0.CO;2; Kegel L, 2013, ASN NEURO, V5, DOI 10.1042/AN20120095; Kim HA, 2012, BBA-MOL CELL BIOL L, V1821, P914, DOI 10.1016/j.bbalip.2012.02.010; KING JT, 1989, EPILEPSIA, V30, P257, DOI 10.1111/j.1528-1157.1989.tb05296.x; Kobayashi E, 2003, ARCH NEUROL-CHICAGO, V60, P1546, DOI 10.1001/archneur.60.11.1546; Kuwabara T, 2010, EPILEPSY RES, V92, P85, DOI 10.1016/j.eplepsyres.2010.08.010; Lee SH, 2012, EXP DERMATOL, V21, P716, DOI 10.1111/j.1600-0625.2012.01550.x; Limviphuvadh V, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-39; Marioni-Henry K, 2012, VET REC, V170, DOI 10.1136/vr.e3140; Maurer-Morelli CV, 2007, ARQ NEURO-PSIQUIAT, V65, P20, DOI 10.1590/S0004-282X2007000100006; Maurer-Morelli CV, 2006, EPILEPSY RES, V71, P233, DOI 10.1016/j.eplepsyres.2006.06.016; Michelucci R, 2009, EPILEPSIA, V50, P52, DOI 10.1111/j.1528-1167.2009.02122.x; Mizoguchi S, 2014, EPILEPSY RES, V108, P1940, DOI 10.1016/j.eplepsyres.2014.09.009; Nobile C, 2009, HUM MUTAT, V30, P530, DOI 10.1002/humu.20925; Oberbauer AM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-35; Ottman R, 2004, NEUROLOGY, V62, P1120; Pakozdy A, 2013, J VET INTERN MED, V27, P212, DOI 10.1111/jvim.12026; Pakozdy A, 2014, EPILEPTIC DISORD, V16, P116, DOI 10.1684/epd.2014.0635; Pakozdy A, 2014, J VET INTERN MED, V28, P255, DOI 10.1111/jvim.12297; Park WJ, 2010, NEUROCHEM RES, V35, P789, DOI 10.1007/s11064-010-0136-0; Piepoli T, 2006, NEURO-ONCOLOGY, V8, P96, DOI 10.1215/15228517-2005-006; Poza JJ, 1999, ANN NEUROL, V45, P182, DOI 10.1002/1531-8249(199902)45:2<182::AID-ANA8>3.0.CO;2-G; Rossi MR, 2005, GENE, V356, P85, DOI 10.1016/j.gene.2005.04.018; Sagane K, 2008, INT J BIOL SCI, V4, P387; Sagane K, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-33; Sato M, 1975, Folia Psychiatr Neurol Jpn, V29, P239; Scheel H, 2002, HUM MOL GENET, V11, P1757, DOI 10.1093/hmg/11.15.1757; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Seppala EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033549; Seppala EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002194; Smith BK, 2009, J FELINE MED SURG, V11, P385; Staub E, 2002, TRENDS BIOCHEM SCI, V27, P441, DOI 10.1016/S0968-0004(02)02163-1; Tamura M, 2013, J FELINE MED SURG, V15, P1137, DOI 10.1177/1098612X13488383; Tessa C, 2007, NEUROLOGY, V69, P1298, DOI 10.1212/01.wnl.0000277045.16688.b6; Vanhaesebrouck AE, 2012, J FELINE MED SURG, V14, P932, DOI 10.1177/1098612X12454419; Vincent A, 1999, J NEUROIMMUNOL, V100, P169, DOI 10.1016/S0165-5728(99)00210-6; Vincent A, 2006, NEURON, V52, P123, DOI 10.1016/j.neuron.2006.09.024; WADA JA, 1974, NEUROLOGY, V24, P565; Wagner E, 2014, BRAIN PATHOL, V24, P607, DOI 10.1111/bpa.12147; Wahle AM, 2014, J VET INTERN MED, V28, P182, DOI 10.1111/jvim.12250; Wieser S, 2005, EPILEPTIC DISORD, V7, P205; Winawer MR, 2000, NEUROLOGY, V54, P2173; Zandi MS, 2009, NEUROLOGY, V73, P2039, DOI 10.1212/WNL.0b013e3181c55e9b; Zhou YD, 2009, NAT MED, V15, P1208, DOI 10.1038/nm.2019; Zhu YH, 2014, CARCINOGENESIS, V35, P1154, DOI 10.1093/carcin/bgu040	99	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0891-6640	1939-1676		J VET INTERN MED	J. Vet. Intern. Med.	JUL-AUG	2015	29	4					997	1005		10.1111/jvim.12610		9	Veterinary Sciences	Veterinary Sciences	CM9QW	WOS:000358045000001		
J	Sawatari, H; Chishaki, A; Miyazono, M; Hashiguchi, N; Maeno, Y; Chishaki, H; Tochihara, Y				Sawatari, Hiroyuki; Chishaki, Akiko; Miyazono, Mami; Hashiguchi, Nobuko; Maeno, Yukari; Chishaki, Hiroaki; Tochihara, Yutaka			Different Physiological and Subjective Responses to the Hyperthermia Between Young and Older Adults: Basic Study for Thermal Therapy in Cardiovascular Diseases	JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES			English	Article						Sauna; Thermal therapy; Heart failure; Hemodynamics; Thermal sensation	PASSIVE HEAT EXPOSURE; REGIONAL DIFFERENCES; BLOOD-PRESSURE; SAUNA; AGE	Background. Thermal therapy has been used as adjuvant therapy in patients with cardiovascular disease. However, little is known about responses to thermal stress in older adults. We examined the effects of thermal stress in younger and older healthy Japanese individuals. Methods: The study included 12 young (mean age, 22 years) and 12 older (mean age, 68 years) healthy adults and was performed under strict temperature and humidity control to minimize confounding. Participants lay supine throughout three consecutive 30-minute phases: Phase I (heating at 70 degrees C in a dome-shaped sauna), Phase II (insulation in the sauna), and Phase III (cool down). Physiological parameters and subjective thermal sensations were compared within and between two age groups. Results: Mean skin temperature increased significantly in both age groups (Phase I) and after the first 10 minutes was higher among older adults (by 6.8 degrees C vs 6.0 degrees C among younger; p<.01). Mean rectal temperature increased by 0.6 degrees C in both groups (Phase II). Mean heart rate increased significantly in both age groups (Phase II) and was higher among younger adults (by 21.4 vs 11.3 beats/min among older adults; p<.05). Both systolic (by 15.1 mmHg) and diastolic (by 10.5 mmHg) blood pressure dropped significantly among older adults (Phase I), returning to baseline in Phase III; no changes were noted among those younger. There was no between-group difference in fluid loss or thermal sensations. Conclusions: Compared with younger adults, older adults are more likely to drop blood pressure in response to thermal stress but had similar fluid loss and subjective responses.	[Sawatari, Hiroyuki; Chishaki, Akiko; Miyazono, Mami; Hashiguchi, Nobuko; Maeno, Yukari] Kyushu Univ, Fac Med, Dept Hlth Sci, Fukuoka, Fukuoka 8128582, Japan; [Chishaki, Hiroaki] Coll Healthcare Management, Dept Healthcare Management, Miyama, Japan; [Tochihara, Yutaka] Kyushu Univ, Fac Design, Dept Human Sci, Fukuoka, Fukuoka 8128582, Japan	Chishaki, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	chishaki@hs.med.kyushu-u.ac.jp			JSPS KAKENHI [18390586, 22390423]; Pfizer Health Research Foundation	This study was supported by JSPS KAKENHI Grand-in-Aid for Scientific Research B (18390586 and 22390423) and Pfizer Health Research Foundation.	Imamura M, 2001, J AM COLL CARDIOL, V38, P1083, DOI 10.1016/S0735-1097(01)01467-X; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Masuda A, 2005, J PSYCHOSOM RES, V58, P383, DOI 10.1016/j.jpsychores.2004.11.005; KENNEY WL, 1988, EUR J APPL PHYSIOL O, V57, P120, DOI 10.1007/BF00691250; Du Bois D, 1916, ARCH INTERN MED, V17, P863; Hardy JD, 1938, J NUTR, V15, P461; Kenney WL, 2003, J APPL PHYSIOL, V95, P2598, DOI 10.1152/japplphysiol.00202.2003; Kihara T, 2002, J AM COLL CARDIOL, V39, P754, DOI 10.1016/S0735-1097(01)01824-1; Hannuksela ML, 2001, AM J MED, V110, P118, DOI 10.1016/S0002-9343(00)00671-9; Minson CT, 1998, J APPL PHYSIOL, V84, P1323; Dufour A, 2007, EUR J APPL PHYSIOL, V100, P19, DOI 10.1007/s00421-007-0396-9; Hansen A, 2011, INT J ENV RES PUB HE, V8, P4714, DOI 10.3390/ijerph8124714; Inoue Y, 1998, EUR J APPL PHYSIOL O, V79, P17, DOI 10.1007/s004210050467; Inoue Y, 1996, EUR J APPL PHYSIOL O, V74, P78, DOI 10.1007/BF00376498; Kawamura H, 2000, HYPERTENS RES, V23, P177, DOI 10.1291/hypres.23.177; Keast M L, 2000, J Cardiopulm Rehabil, V20, P225, DOI 10.1097/00008483-200007000-00002; Kenttamies A, 2008, J FORENSIC SCI, V53, P724, DOI 10.1111/j.1556-4029.2008.00703.x; KONIETZNY F, 1975, PFLUG ARCH EUR J PHY, V359, P265, DOI 10.1007/BF00587384; KUKKONENHARJULA K, 1989, EUR J APPL PHYSIOL O, V58, P543, DOI 10.1007/BF02330710; LEPPALUOTO J, 1991, J APPL PHYSIOL, V71, P716; LEPPALUOTO J, 1987, J CLIN ENDOCR METAB, V65, P1035; Nakamura Yasuto, 1998, Applied Human Science, V17, P167, DOI 10.2114/jpa.17.167; Staessen JA, 1997, HYPERTENSION, V29, P30; SUDAKOV KV, 1988, PAVLOVIAN J BIOL SCI, V23, P89; Tochihara Y, 2011, J THERM BIOL, V36, P105, DOI 10.1016/j.jtherbio.2010.11.007; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Weber Adrianna A, 2007, Congest Heart Fail, V13, P81, DOI 10.1111/j.1527-5299.2007.06348.x	27	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5006	1758-535X		J GERONTOL A-BIOL	J. Gerontol. Ser. A-Biol. Sci. Med. Sci.	JUL	2015	70	7					912	916		10.1093/gerona/glu224		5	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CM7MW	WOS:000357878900017		
J	Sugahara, S; Kamiya, H; Suyama, Y; Senga, Y; Ayukawa, K; Okumura, M; Seike, Y				Sugahara, Shogo; Kamiya, Hiroshi; Suyama, Yusuke; Senga, Yukiko; Ayukawa, Kazuhiro; Okumura, Minoru; Seike, Yasushi			Influence of hypersaturated dissolved oxygenated water on the elution of hydrogen sulfide and methane from sediment in the dredged area in polyhaline Lake Nakaumi	LANDSCAPE AND ECOLOGICAL ENGINEERING			English	Article						Hypolimnetic oxygenation; Anoxia; High concentration of DO water; Hydrogen sulfide; Methane Lake Nakaumi; Dredged area	HYPOLIMNETIC OXYGENATION; SPECTROPHOTOMETRIC DETERMINATION; SOUTHWEST JAPAN; ORGANIC-CARBON; BUBBLE PLUME; HYPOXIA; FISH; BAY; LAGOON; CONSEQUENCES	Equipment for supplying hypersaturated dissolved oxygen (DO) into water without vertical mixing was installed at a depth of 13.8 m (1 m above the bottom) in the dredged area of polyhaline Lake Nakaumi. The vertical profile of dissolved sulfides, including H2S and HS- (I H2S) pound, and the CH4 concentrations in the water column and interstitial water of bottom sediment were investigated monthly during a period when hypersaturated DO water was delivered at a depth of 13.8 m. The area near the bottom was identified as oxic. H2S is easily and rapidly oxidized in an oxic environment through a chemical reaction with DO. Although the concentration of CH4 in the experimental area was 95 % lower than that in the control area, CH4 was detected, even though 20-220 % DO was observed near the bottom, where no H2S was detected. We can therefore confirm that supplying hypersaturated DO can improve the water quality, as well as the ecosystem, by preventing the evolution of H2S.	[Sugahara, Shogo; Ayukawa, Kazuhiro; Okumura, Minoru; Seike, Yasushi] Shimane Univ, Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan; [Kamiya, Hiroshi] Shimane Prefectural Inst Publ Hlth & Environm Sci, Matsue, Shimane 6900823, Japan; [Suyama, Yusuke] Un Nan City Off, Un Nan, Shimane 6991392, Japan; [Senga, Yukiko] Toho Univ, Fac Sci, Chiba 2748510, Japan	Sugahara, S (reprint author), Shimane Univ, Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan.	suga@riko.shimane-u.ac.jp			 [19201016]	This study was partly supported by a Grant-in-Aid for Scientific Research (A) (project no: 19201016).	Aku PMK, 1999, T AM FISH SOC, V128, P17, DOI 10.1577/1548-8659(1999)128<0017:EOHOOT>2.0.CO;2; American Public Health Association, 1936, STANDARD METHOD EXAM, V18, P4; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Bryant LD, 2011, WATER RES, V45, P3692, DOI 10.1016/j.watres.2011.04.018; Sampei Y, 1997, GEOCHEM J, V31, P245; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Breitburg DL, 2001, COAST EST S, V58, P241; Beutel MW, 2006, ECOL ENG, V28, P271, DOI 10.1016/j.ecoleng.2006.05.009; WUEST A, 1992, WATER RESOUR RES, V28, P3235, DOI 10.1029/92WR01681; Sampei Y, 2001, GEOCHEM J, V35, P189; Okumura M, 1999, ANAL SCI, V15, P427, DOI 10.2116/analsci.15.427; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454; Gantzer PA, 2009, WATER RES, V43, P1700, DOI 10.1016/j.watres.2008.12.053; Breitburg DL, 1997, ECOL MONOGR, V67, P489, DOI 10.1890/0012-9615(1997)067[0489:VEOLDO]2.0.CO;2; Thomas P, 2007, P R SOC B, V274, P2693, DOI 10.1098/rspb.2007.0921; Weeks SJ, 2002, NATURE, V415, P493, DOI 10.1038/415493b; Vaquer-Sunyer R, 2010, LIMNOL OCEANOGR, V55, P1075, DOI 10.4319/lo.2010.55.3.1075; McGinnis DF, 2004, WATER RESOUR RES, V40, DOI 10.1029/2004WR003038; BAKER SM, 1992, BIOL BULL, V182, P265, DOI 10.2307/1542120; PIHL L, 1991, MAR BIOL, V108, P349, DOI 10.1007/BF01313644; VISMANN B, 1991, OPHELIA, V34, P1; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Bertolacini RJ, 1957, ANAL CHEM, V29, P281, DOI 10.1021/ac60122a031; Bryant LD, 2011, WATER RES, V45, P6381, DOI 10.1016/j.watres.2011.09.030; Cong HB, 2009, RENEW ENERG, V34, P2054, DOI 10.1016/j.renene.2009.02.007; Culkin F, 1965, CHEM OCEANOGR, P121; Fujii T, 2001, CIV ENG OCEAN, V17, P111; Gantzer PA, 2009, WATER RES, V43, P1285, DOI 10.1016/j.watres.2008.12.019; Ichikawa T, 2007, LIMNOLOGY, V8, P281, DOI 10.1007/s10201-007-0222-4; Imai T, 2006, J JPN SOC WATER ENV, V29, P737; Ishitobi Y, 2000, J MARINE SYST, V26, P171, DOI 10.1016/S0924-7963(00)00052-X; James JR, 2009, J EXP MAR BIOL ECOL, V281, pS132; Jorgensen B.B., 2006, MARINE GEOCHEMISTRY, P271, DOI DOI 10.1007/3-540-32144-6_; Kato Kenji, 2004, Japanese Journal of Limnology, V65, P69; Kirsten SH, 2002, SCIENCE, V298, P2372; Koizumi Y, 2003, FEMS MICROBIOL ECOL, V44, P101, DOI 10.1016/S0168-6496(02)00463-4; KONDO K, 1990, Japanese Journal of Limnology, V51, P173; KONDO K, 1990, Bulletin of Plankton Society of Japan, V36, P103; Liboriussen L, 2009, HYDROBIOLOGIA, V625, P157, DOI 10.1007/s10750-009-9705-0; Luther GW, 2004, ESTUARIES, V27, P551, DOI 10.1007/BF02803546; MaGinnis DF, 2002, WATER RES, V36, P4627; Marcus NH, 2001, COAST EST S, V58, P49; Masuki S, 2012, J JPN SOC CIVIL E B1, V67, P1525; Mitamura Osamu, 2000, Limnology, V1, P75, DOI 10.1007/s102010070013; Mitterer RM, 2010, EARTH PLANET SC LETT, V295, P358, DOI 10.1016/j.epsl.2010.04.009; Nakamura M., 2010, Journal of Water and Environment Technology, V8, P393, DOI 10.2965/jwet.2010.393; OHTAKE H, 1984, ARCH HYDROBIOL, V99, P443; Pimenov NV, 2012, MICROBIOLOGY+, V81, P79, DOI 10.1134/S0026261712010122; Powers SP, 2001, COAST EST S, V58, P185; Qureshi NA, 2001, COAST EST S, V58, P61; Sakai S, 2004, LAGUNA, V11, P65; Sakai S, 2013, ENVIRON EARTH SCI, V68, P1999, DOI 10.1007/s12665-012-1887-5; SCRANTON MI, 1977, J GEOPHYS RES-OC ATM, V82, P4947, DOI 10.1029/JC082i031p04947; Sugahara S, 2012, JPN J LIMNOL, V73, P23; Sugahara S, 2010, BUNSEKI KAGAKU, V59, P1155, DOI 10.2116/bunsekikagaku.59.1155; Takii S, 2001, J JPN SOC WATER ENV, V24, P35, DOI 10.2965/jswe.24.35; Thomas P, 2006, MAR ENVIRON RES, V62, P249; Thomas P, 2009, ENVIRON SCI TECHNOL, V43, P4175, DOI 10.1021/es9000399; Tokuoka T, 2001, LAGUNA, V8, P57; Tsurushima Nobuo, 1996, Journal of Oceanography, V52, P221, DOI 10.1007/BF02235671; Ueda Shinji, 2002, Japanese Journal of Limnology, V63, P125; Vismann B, 1996, J EXP MAR BIOL ECOL, V204, P141, DOI 10.1016/0022-0981(96)02577-4; Wetzel MA, 2001, COAST ESTUAR STUD, V58, P49; Yajima H, 2009, ANNU J HYDRAUL ENG, V53, P1339	65	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1871	1860-188X		LANDSC ECOL ENG	Landsc. Ecol. Eng.	JUL	2015	11	2					269	282		10.1007/s11355-014-0270-y		14	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CM9XF	WOS:000358062500004		
J	Oishi, Y; Doei, H				Oishi, Yoshitaka; Doei, Hiroshi			Changes in epiphyte diversity in declining forests: implications for conservation and restoration	LANDSCAPE AND ECOLOGICAL ENGINEERING			English	Article						Bryophyte; Drought stress; Fern; Metal pollution	DEER; BIODIVERSITY; REGENERATION; VEGETATION; SCALE	Biodiversity degradation is a serious global problem, and conservation or restoration has been conducted in various ecosystems. The objective of this study was to examine effective conservation measures and restoration goals for epiphytes on the basis of changes in epiphyte flora during the past 30 years on Mt. Odaigahara, Japan. Comparison of epiphyte diversity between 1983 and 2008 indicated that species richness and cover in plots surveyed in 1983 had declined significantly by 2008. The results of nonmetric multidimensional scaling showed that the dominance of hygrophilous species decreased on trees surveyed in 2008 accompanied with forest decline. In addition, total species richness decreased with increasing coverage of wire mesh installed for protection against debarking by deer. We conclude that severe drought stress caused by forest decline after the 1980s and the toxic effects of wire mesh on epiphytes have led to a dramatic decrease in epiphyte diversity during the past 30 years. To conserve epiphyte diversity, first, tree protection without wire mesh should be adopted. In addition, intensive conservation of undamaged forest patches may be necessary to prevent loss of remaining hygrophilous species from this region. The results also indicate that epiphyte diversity can be strongly affected by slight changes in forest structure, and by site-specific environmental factors. Considering that these changes or environmental factors are often not easy to evaluate, comparison of epiphyte diversity before and after disturbance can be an important means of determining appropriate restoration objectives.	[Oishi, Yoshitaka] Hokkaido Univ, Tomakomai Expt Forest Field Sci Ctr Northern Bios, Tomakomai, Hokkaido 0530035, Japan; [Doei, Hiroshi] Wakayama Prefectural Kashima Senior High Sch, Wakayama 6460023, Japan	Oishi, Y (reprint author), Hokkaido Univ, Tomakomai Expt Forest Field Sci Ctr Northern Bios, Tomakomai, Hokkaido 0530035, Japan.	oishiy@fsc.hokudai.ac.jp			Japan Society for the Promotion of Science [18201008]	The author thanks Tomoko Doei for providing her studies on vegetation at the study sites, Kaori Kuriyama for the bryophyte survey and photos, and Dr. Kosaku Yamada for assistance with bryophyte identification. This research was supported by a Grant-in-Aid for Scientific Research (A) (no. 18201008) from the Japan Society for the Promotion of Science.	Ando M, 2009, ECOLOGY SIKA DEER FO, P46; Ando M, 2009, ECOLOGY SIKA DEER FO, P128; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Takatsuki S, 2009, BIOL CONSERV, V142, P1922, DOI 10.1016/j.biocon.2009.02.011; NADKARNI NM, 1984, BIOTROPICA, V16, P249, DOI 10.2307/2387932; Pellerin S, 2006, BIOL CONSERV, V128, P316, DOI 10.1016/j.biocon.2005.09.039; Bates JW, 1998, OIKOS, V82, P223, DOI 10.2307/3546962; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Miller JR, 2007, RESTOR ECOL, V15, P382, DOI 10.1111/j.1526-100X.2007.00234.x; Pypker TG, 2006, CAN J FOREST RES, V36, P819, DOI 10.1139/X05-286; Vieira C, 2012, ECOL INDIC, V18, P98, DOI 10.1016/j.ecolind.2011.10.012; Fuller RJ, 2001, FORESTRY, V74, P193, DOI 10.1093/forestry/74.3.193; Development Core Team R., 2012, R LANG ENV STAT COMP; Doei H, 1984, B FAC ED KOBE U, V73, P61; Doei H, 1988, I NANKI BIOL, V30, P14; Doei T, 1987, NARA BOT, V10, P31; Doei T, 1994, NANKI BIOL, V36, P87; Ellenberg H., 1974, AIMS METHODS VEGETAT; FASHAM MJR, 1977, ECOLOGY, V58, P551, DOI 10.2307/1939004; Grace J.B., 2002, ANAL ECOLOGICAL COMM, P125; Iwatsuki K, 1992, FERNS FERN ALLIES JA; Iwatsuki Z., 2001, MOSSES LIVERWORTS JA; Kurata S, 1998, ILLUSTRATIONS PTERID, V2; Legendre P., 1998, NUMERICAL ECOLOGY; Mefford M. J., 2006, PC ORD MULTIVARIATE; Ministry of the Environment-Kinki Regional Environment Office, 2009, NAT RESTORATION PLAN; Nakajima N, 2007, REBELLION WILDLIFE C, P57; Oishi Y, 2013, J ENVIRON INF SCI, V41, P47; Oishi Y, 2012, BIODIVERSITY ENRICHM, P153; Oishi Y, 2014, MOSS CLASSIFICATION, P199; Oishi Y, 2011, BIODIVERS CONSERV, V20, P2527, DOI 10.1007/s10531-011-0090-4; Pardow A, 2012, BIODIVERS CONSERV, V21, P3637, DOI 10.1007/s10531-012-0386-z; Shibata E, 2008, J FOREST RES-JPN, V13, P89, DOI 10.1007/s10310-007-0056-2; STEWART GH, 1989, BIOL CONSERV, V49, P275, DOI 10.1016/0006-3207(89)90048-7; VerCauteren KC, 2006, WILDLIFE SOC B, V34, P191, DOI 10.2193/0091-7648(2006)34[191:FADMAR]2.0.CO;2; Yokoyama Shotaro, 2001, Forest Ecology and Management, V140, P93, DOI 10.1016/S0378-1127(00)00279-6; Zots G, 2009, PROG BOT, V70, P147	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1871	1860-188X		LANDSC ECOL ENG	Landsc. Ecol. Eng.	JUL	2015	11	2					283	291		10.1007/s11355-015-0273-3		9	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CM9XF	WOS:000358062500005		
J	Takagi, M				Takagi, Masahiro			Water chemistry of headwater streams under stormflow conditions in catchments covered by evergreen broadleaved forest and by coniferous plantation	LANDSCAPE AND ECOLOGICAL ENGINEERING			English	Article						Evergreen broadleaved forest; Nitrate; Stormflow; Stream water chemistry	NORTHEASTERN UNITED-STATES; TREE SPECIES COMPOSITION; NITRATE CONCENTRATIONS; NITROGEN SATURATION; ORGANIC-CARBON; JAPAN; DYNAMICS; FLOW; SOIL; THROUGHFALL	It is important to determine the effects of vegetation on the water chemistry of headwater streams to ensure appropriate water resource management and landscape planning, particularly because vegetation is known to be one of the primary determinants of the chemistry in such streams and is easily altered by silvicultural operations. Previous studies of headwater stream water chemistry have investigated primarily the effects on baseflow. However, the sources and processes involved vary considerably between baseflow and stormflow due to rainfall. Stormflow water is supplied primarily through soil; accordingly, its chemistry is influenced by vegetation. The present study investigates the water chemistry of streams of headwater catchments, six with coniferous plantations and six with evergreen broadleaved forests, under four stormflow events and three times under baseflow conditions. The studied catchments were located in a hilly region in southwestern Japan and covered relatively small areas (0.7-3.6 ha). Inorganic ions, pH, and dissolved organic carbon were analyzed. A higher concentration of dissolved organic carbon and a lower concentration of Cl- were found in the broadleaved catchments compared to the coniferous catchments under stormflow conditions, but no differences were detected under baseflow conditions. For catchments with older forests, the NO3 (-) concentration was higher in the coniferous catchments than the broadleaved catchments under stormflow conditions. These results indicate that these three constituents were not diluted during stormflow and that their presence in soil water may be affected by the type of vegetation. The observed increased NO3 (-) concentration under stormflow conditions may result in higher loading downstream.	Miyazaki Univ, Fac Agr, Miyazaki 88921, Japan	Takagi, M (reprint author), Miyazaki Univ, Fac Agr, Tano Cho Otsu 11300, Miyazaki 88921, Japan.	mtakagi@cc.miyazaki-u.ac.jp			Sumitomo Foundation; JSPS [25252029]	I would like to express my gratitude to Dr. Sadatoshi Meguro for the analysis of DOC and two anonymous reviewers for their valuable comments. This study was supported by the Sumitomo Foundation and Grants-in-Aid for Scientific Research from the JSPS (no. 25252029). The vegetation survey was conducted as part of the Monitoring Sites 1000 Project of the Ministry of Environment, Japan.	MULHOLLAND PJ, 1990, WATER RESOUR RES, V26, P3021, DOI 10.1029/WR026i012p03021; Knops JMH, 2002, ECOL LETT, V5, P454, DOI 10.1046/j.1461-0248.2002.00332.x; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Williard KWJ, 2005, WATER AIR SOIL POLL, V160, P55, DOI 10.1007/s11270-005-3649-4; Chiwa M, 2010, HYDROL PROCESS, V24, P631, DOI 10.1002/hyp.7557; De Schrijver A, 2007, OECOLOGIA, V153, P663, DOI 10.1007/s00442-007-0776-1; Lovett GM, 2002, ECOSYSTEMS, V5, P712, DOI 10.1007/s10021-002-0153-1; Tobari Y, 2010, RAPID COMMUN MASS SP, V24, P1281, DOI 10.1002/rcm.4498; Rusjan S, 2008, J HYDROL, V354, P187, DOI 10.1016/j.jhydrol.2008.03.009; Staelens J, 2012, BIOGEOCHEMISTRY, V108, P259, DOI 10.1007/s10533-011-9598-7; van Verseveld WJ, 2009, J HYDROL, V367, P177, DOI 10.1016/j.jhydrol.2008.11.002; Sidle RC, 2000, HYDROL PROCESS, V14, P369, DOI 10.1002/(SICI)1099-1085(20000228)14:3<369::AID-HYP943>3.3.CO;2-G; Inagaki Y, 2004, FOREST ECOL MANAG, V202, P107, DOI 10.1016/j.foreco.2004.07.029; Rothe A, 2004, WATER AIR SOIL POLL, V156, P337, DOI 10.1023/B:WATE.0000036826.17273.b3; Chiwa M, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000944; Creed IF, 1998, WATER RESOUR RES, V34, P3079, DOI 10.1029/98WR02102; Goodale CL, 2003, ECOSYSTEMS, V6, P75, DOI 10.1007/s10021-002-0219-0; Ishihara M, 2011, ECOL RES, V26, P1007, DOI 10.1007/s11284-011-0847-y; Japan Environmental Laboratories Association, 2010, J ENVIRON LAB ASSOC, V35, P179; Katsuyama M, 2000, J JPN SOC HYDROL WAT, V13, P227; Konohira E, 2005, ECOL RES, V20, P359, DOI 10.1007/s11284-005-0051-z; Konohira E, 2006, J JPN ASS HYDROL SCI, V36, P145; Koshikawa MK, 2011, JPN J LIMNOL, V72, P71; Mitchell MJ, 1997, FOREST ECOL MANAG, V97, P39, DOI 10.1016/S0378-1127(97)00047-9; Oda T, 2011, FOREST ECOL MANAG, V262, P1305, DOI 10.1016/j.foreco.2011.06.032; Ogawa A, 2006, HYDROL PROCESS, V20, P251, DOI 10.1002/hyp.5901; Ohrui K, 1998, WATER RESOUR RES, V34, P1553, DOI 10.1029/98WR00918; Ohrui K, 1997, ECOL APPL, V7, P391; Ohrui K, 1999, HYDROL PROCESS, V13, P877, DOI 10.1002/(SICI)1099-1085(19990430)13:6<877::AID-HYP762>3.3.CO;2-5; Ohte N, 2001, WATER AIR SOIL POLL, V130, P649, DOI 10.1023/A:1013804728336; Ohte N, 2001, HYDROL PROCESS, V15, P1771, DOI 10.1002/hyp.239; Peters NE, 1998, IAHS PUBL, V248, P483; Piatek KB, 2009, HYDROL EARTH SYST SC, V13, P423; Piatek KB, 2005, WATER AIR SOIL POLL, V165, P13, DOI 10.1007/s11270-005-4641-8; REYNOLDS B, 1994, ENVIRON POLLUT, V84, P27, DOI 10.1016/0269-7491(94)90067-1; STEVENS PA, 1994, WATER AIR SOIL POLL, V73, P297, DOI 10.1007/BF00477994; Tabayashi Y, 2011, WATER AIR SOIL POLL, V216, P105, DOI 10.1007/s11270-010-0519-5; Takagi M., 2004, Journal of the Japanese Forestry Society, V86, P279; Tanaka M, 2005, J JPN ASSOC HYDROL S, V36, P3; VITOUSEK PM, 1977, ECOL MONOGR, V47, P65, DOI 10.2307/1942224; Welsch DL, 2001, HYDROL PROCESS, V15, P1925, DOI 10.1002/hyp.247; Yoh M, 2001, WATER AIR SOIL POLL, V130, P655, DOI 10.1023/A:1013856729245; Zhang Z, 2008, CATENA, V76, P63, DOI 10.1016/j.catena.2008.09.007; Zhang Z, 2008, SCI TOTAL ENVIRON, V402, P113, DOI 10.1016/j.scitotenv.2008.04.045	44	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1871	1860-188X		LANDSC ECOL ENG	Landsc. Ecol. Eng.	JUL	2015	11	2					293	302		10.1007/s11355-014-0269-4		10	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CM9XF	WOS:000358062500006		
J	Yoon, TK; Noh, NJ; Han, S; Kwak, H; Lee, WK; Son, Y				Yoon, Tae Kyung; Noh, Nam Jin; Han, Saerom; Kwak, Hanbin; Lee, Woo-Kyun; Son, Yowhan			Small-scale spatial variability of soil properties in a Korean swamp	LANDSCAPE AND ECOLOGICAL ENGINEERING			English	Article						Factor analysis; Geostatistics; Reference wetland; Semivariogram; Soil quality indicator; Soil survey	REFERENCE WETLANDS; FOREST SOILS; CENTRAL IOWA; QUALITY; GEOSTATISTICS; OPPORTUNITIES; INDICATORS; PREDICTION; MOISTURE; FIELD	Wetland soils have distinctive biogeochemical processes and ecosystem functions. Therefore, knowledge of wetland soils is important for conserving and rehabilitating wetland ecosystems. We investigated soil properties and their spatial variability in a temperate swamp and compared them with those of an adjacent upland within a small-scale watershed in Korea. Soil water content and carbon and nitrogen concentrations were two- to four-times higher in wetland than in upland soils. Soil water content and organic matter, which represented a large proportion of the variability of wetland soil properties, could be considered primary soil quality indicators for wetland soils. Wetland soils were characterized as having high spatial variability and moderate to strong spatial autocorrelation within a 30- to 50-m range. Nutrient availability was mainly regulated by soil water content and organic matter, not by pH, which had low variability and showed an independent pattern. These findings imply that wetland soils should be surveyed using an appropriate sampling design to determine characteristics of spatial variability in soil quality indicators in wetlands. Reference values of wetland soil properties reported from this study are expected to contribute to wetland conservation and rehabilitation.	[Yoon, Tae Kyung; Han, Saerom; Kwak, Hanbin; Lee, Woo-Kyun; Son, Yowhan] Korea Univ, Dept Environm Sci & Ecol Engn, Grad Sch, Seoul 136713, South Korea; [Noh, Nam Jin; Son, Yowhan] Gifu Univ, Inst Basin Ecosyst Studies, Gifu 5011193, Japan	Son, Y (reprint author), Korea Univ, Dept Environm Sci & Ecol Engn, Grad Sch, Seoul 136713, South Korea.	yson@korea.ac.kr			Seoul Metropolitan Government [2008-221]; National Research Foundation of Korea [2010-0020227]; Korea University	This study was supported by the Seoul Metropolitan Government (No. 2008-221), National Research Foundation of Korea (2010-0020227), and the Korea University Grant (2013). We appreciate the cooperation of Heolleung Office, Culture Heritage Administration of Korea for conserving this precious ecosystem and allowing us to access HELCA. We also appreciate Ah Reum Lee, Sue Kyoung Lee, and Joomi Kim for their assistance in the laboratory and field. This study complies with the current laws of Republic of Korea.	Anctil F, 2002, J HYDROL, V260, P30, DOI 10.1016/S0022-1694(01)00600-X; Fujita Hiroko, 2008, P225; ZAK DR, 1991, OECOLOGIA, V88, P189, DOI 10.1007/BF00320810; Gallardo A, 2003, ECOSYSTEMS, V6, P564, DOI 10.1007/s10021-003-0198-9; Sparling GP, 2002, J ENVIRON QUAL, V31, P1848; Henderson BL, 2005, GEODERMA, V124, P383, DOI 10.1016/j.geoderma.2004.06.007; Western AW, 1998, J HYDROL, V205, P20, DOI 10.1016/S0022-1694(97)00142-X; Zhao SQ, 2006, ECOL RES, V21, P890, DOI 10.1007/s11284-006-0048-2; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; Karlen DL, 1997, SOIL SCI SOC AM J, V61, P4; Shukla MK, 2006, SOIL TILL RES, V87, P194, DOI 10.1016/j.still.2005.03.011; Stoddard JL, 2006, ECOL APPL, V16, P1267, DOI 10.1890/1051-0761(2006)016[1267:SEFTEC]2.0.CO;2; Ross DS, 2008, EUR J SOIL SCI, V59, P1141, DOI 10.1111/j.1365-2389.2008.01069.x; Karlen DL, 2008, SOIL TILL RES, V99, P291, DOI 10.1016/j.still.2008.03.002; Bruland GL, 2005, SOIL SCI SOC AM J, V69, P273; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Scull P, 2003, PROG PHYS GEOG, V27, P171, DOI 10.1191/0309133303pp366ra; Verhoeven JTA, 2010, ANN BOT-LONDON, V105, P155, DOI 10.1093/aob/mcp172; Heuvelink GBM, 2001, GEODERMA, V100, P269, DOI 10.1016/S0016-7061(01)00025-8; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Castrignano A, 2000, GEODERMA, V97, P39, DOI 10.1016/S0016-7061(00)00025-2; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; BishelMachung L, 1996, WETLANDS, V16, P532; Boyd CE, 2011, N AM J AQUACULT, V73, P403, DOI 10.1080/15222055.2011.620861; Brown IC, 1943, SOIL SCI, V56, P353, DOI 10.1097/00010694-194311000-00004; Burrough PA, 1997, GEODERMA, V77, P115, DOI 10.1016/S0016-7061(97)00018-9; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501; Camberato JJ, 2000, HDB SOIL SCI, pA321; Cha E-J, 2010, J ENVIRON SCI, V19, P1363, DOI 10.5322/JES.2010.19.11.1363; Finlayson C.M., 1999, GLOBAL REV WETLAND R; Government-General of Korea, 1931, PICTORIAL ALBUM ANCI, V11; 정진현, 2002, [Journal of Korean Forest Society, 한국임학회지], V91, P694; Kim J-W, 2005, KOR J ECOL, V28, P99; Kim K, 2010, THESIS; Koo HK, 2001, THESIS; Larson W. E., 1994, SSSA SPECIAL PUBLICA, V35, P37; MEA, 2005, ECOSYSTEM HUMAN WELL; Mitsch WJ, 2007, WETLANDS; Mulla DJ, 2000, HDB SOIL SCI, pA321; Raymond JE, 2013, SOIL SCI SOC AM J, V77, P307, DOI 10.2136/sssaj2012.0129; Ryan PJ, 2000, FOREST ECOL MANAG, V138, P139, DOI 10.1016/S0378-1127(00)00393-5; SAS Institute Inc, 2009, SAS STAT 9 2 USERS G, V2nd; Song H-K, 2006, KOR J ENVIRON ECOL, V20, P407; Stolt MH, 2000, WETLANDS, V20, P671, DOI 10.1672/0277-5212(2000)020[0671:COSAOE]2.0.CO;2; Stolt MH, 2001, SOIL SCI SOC AM J, V65, P527; Vepraskas MJ, 2001, WETLAND SOILS GENESI, P85; Whang B, 2006, LANDSCAPE ECOLOGY EN, V2, P147, DOI 10.1007/s11355-006-0014-8	48	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1871	1860-188X		LANDSC ECOL ENG	Landsc. Ecol. Eng.	JUL	2015	11	2					303	312		10.1007/s11355-013-0236-5		10	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CM9XF	WOS:000358062500007		
J	Hyodoh, H; Shimizu, J; Watanabe, S; Okazaki, S; Mizuo, K; Inoue, H				Hyodoh, Hideki; Shimizu, Jyunya; Watanabe, Satoshi; Okazaki, Shunichiro; Mizuo, Keisuke; Inoue, Hiromasa			Time-related course of pleural space fluid collection and pulmonary aeration on postmortem computed tomography (PMCT)	LEGAL MEDICINE			English	Article						Postmortem CT; Hypostasis; Pleural effusion; Postmortem change; Forensic radiology	QUANTITATIVE-ANALYSIS; EDEMA; DEATH; AUTOPSY; WATER; LUNG; MRI; CT; RADIOLOGY; EFFUSION	Postmortem CT (PMCT) is increasingly used in forensic practice, and knowledge and classification of typical postmortem imaging findings would facilitate the interpretation of PMCT. The goal of this study was to define the time-related course of postmortem chest findings. Twelve cadavers (eight male, four female, 27-81 [mean, 60.0] years) were examined twice by PMCT within an interval of time (4-164 h [mean, 30.8; median, 17.5]). The pleural-space-fluid volume, pulmonary parenchyma volume, decreased aerated lung volume (DLV), %DLV (=DLV/pulmonary parenchyma volume) and chest cavity volume were compared between the first and second PMCT examinations. To evaluate the volume change rate, the rate of increase in pleural space fluid volume (mL/h) and the DLV rate (mL/h) were plotted according to the postmortem period. On the second PMCT, the volume of pleural space fluid (p = 0.0469) and %DLV (p = 0.0161) were significantly increased. The increase rate of the pleural space fluid increased at approximately 30 h and the volume continued to increase until approximately 40 h after death. The rate of DLV constantly decreased in the early postmortem period. In conclusion, the pleural-space-fluid collection and the DLV increased over different time-related courses in the postmortem period. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.	[Hyodoh, Hideki; Shimizu, Jyunya; Watanabe, Satoshi; Okazaki, Shunichiro; Mizuo, Keisuke; Inoue, Hiromasa] Sapporo Med Univ, Dept Legal Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	Hyodoh, H (reprint author), Sapporo Med Univ, Dept Legal Med, Chuo Ku, S1 W17, Sapporo, Hokkaido 0608556, Japan.	hyodoh@sapmed.ac.jp			JSPS KAKENHI, Japan [25461836]	This study was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research(C), Japan (Grant No. 25461836).	Aghayev E, 2006, AM J ROENTGENOL, V187, P209, DOI 10.2214/AJR.05.0222; Jackowski C, 2006, INT J LEGAL MED, V120, P233, DOI 10.1007/s00414-005-0023-4; Yen K, 2007, FORENSIC SCI INT, V173, P21, DOI 10.1016/j.forsciint.2007.01.027; Takahashi N, 2010, JPN J RADIOL, V28, P349, DOI 10.1007/s11604-010-0430-4; Christe A, 2008, EUR RADIOL, V18, P283, DOI 10.1007/s00330-007-0745-4; Kanazawa A, 2014, LEGAL MED-TOKYO, V16, P297, DOI 10.1016/j.legalmed.2014.05.004; Shiotani S, 2002, J COMPUT ASSIST TOMO, V26, P892, DOI 10.1097/00004728-200211000-00006; BROOKS RA, 1981, PHYS MED BIOL, V26, P141, DOI 10.1088/0031-9155/26/1/014; Chen Jian-Hua, 2009, Leg Med (Tokyo), V11 Suppl 1, pS238, DOI 10.1016/j.legalmed.2009.03.004; DURLACHER SH, 1950, YALE J BIOL MED, V22, P565; Gordon I, 1988, FORENSIC MED, P80; Guyton AC, 1996, CARDIAC FAILURE; HEDLUND LW, 1984, INVEST RADIOL, V19, P254, DOI 10.1097/00004424-198407000-00004; Hyodoh H, 2012, JPN J RADIOL, V30, P840, DOI 10.1007/s11604-012-0134-z; Hyodoh H, 2013, FORENSIC SCI INT, V231, P190, DOI 10.1016/j.forsciint.2013.05.011; Inoue Hiromasa, 2005, Legal Medicine, V7, P96, DOI 10.1016/j.legalmed.2004.09.002; Lunetta P, 2004, AM J FOREN MED PATH, V25, P291, DOI 10.1097/01.paf.0000146240.92905.7e; Michaud K, 2014, INT J LEGAL MED, V128, P127, DOI 10.1007/s00414-013-0819-6; Michiue T, 2012, FORENSIC SCI INT, V220, P232, DOI 10.1016/j.forsciint.2012.03.007; Murken DR, 2012, AM J ROENTGENOL, V199, P394, DOI 10.2214/AJR.11.8386; Okuma H, 2013, INT J LEGAL MED; Saukko P, 2004, PATHOPHYSIOLOGY DEAT; Scillia P, 1999, RADIOLOGY, V211, P161; Shiotani S, 2011, LEGAL MED-TOKYO, V13, P151, DOI 10.1016/j.legalmed.2010.12.008; Shiotani S, 2004, FORENSIC SCI INT, V139, P39, DOI 10.1016/j.forsciint.2003.09.016; Sogawa N, 2014, FORENSIC SCI INT, V241, P112, DOI 10.1016/j.forsciint.2014.05.012; Takahashi N, 2013, FORENSIC SCI INT, V225, P27, DOI 10.1016/j.forsciint.2012.04.037; Yajima D, 2013, FORENSIC SCI INT, V233, P167, DOI 10.1016/j.forsciint.2013.08.027; Yorulmaz C, 2003, FORENSIC SCI INT, V136, P16, DOI 10.1016/S0379-0738(03)00226-3; Zhu Bao-Li, 2003, Leg Med (Tokyo), V5, P20, DOI 10.1016/S1344-6223(02)00172-4	30	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	JUL	2015	17	4					221	225		10.1016/j.legalmed.2015.01.002		5	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CM7UM	WOS:000357902000001		
J	Torimitsu, S; Makino, Y; Saitoh, H; Sakuma, A; Ishii, N; Inokuchi, G; Motomura, A; Chiba, F; Hoshioka, Y; Iwase, H				Torimitsu, Suguru; Makino, Yohsuke; Saitoh, Hisako; Sakuma, Ayaka; Ishii, Namiko; Inokuchi, Go; Motomura, Ayumi; Chiba, Fumiko; Hoshioka, Yumi; Iwase, Hirotaro			Estimation of sex in Japanese cadavers based on sternal measurements using multidetector computed tomography	LEGAL MEDICINE			English	Article						Forensic anthropology; Multidetector computed tomography; Sternum; Japanese; Sex discrimination	MORPHOMETRIC-ANALYSIS; FORAMEN MAGNUM; POPULATION; IDENTIFICATION; RECONSTRUCTION; ANTHROPOMETRY; ANTHROPOLOGY; RADIOGRAPHS	This study assessed the sex-discrimination potential of the sternum in a Japanese population using three-dimensional (3D) computed tomographic (CT) images. A total of 200 cadavers (100 males, 100 females) who underwent postmortem CT and subsequent forensic autopsy between December 2011 and June 2014 were used. Five measurements of each sternum were performed on 3D CT reconstructed images that extracted only bone data, and two sternal dimensions and three indices were calculated. Univariate discriminant function analyses using these linear measurements and calculated sternal dimensions and indices yielded sex classification accuracy rates of 62.5-84.0%, and 63.0-90.5%, respectively. The results of this study indicate that sternal measurements may be useful for the forensic assessment of sex in Japanese individuals, particularly in cases where better predictors, such as the pelvis or skull, are unavailable. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Torimitsu, Suguru; Makino, Yohsuke; Saitoh, Hisako; Sakuma, Ayaka; Ishii, Namiko; Inokuchi, Go; Motomura, Ayumi; Chiba, Fumiko; Hoshioka, Yumi; Iwase, Hirotaro] Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, Chiba 2608670, Japan; [Makino, Yohsuke; Chiba, Fumiko; Iwase, Hirotaro] Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, Tokyo 1130033, Japan	Torimitsu, S (reprint author), Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	number60188@chiba-u.jp; ymakino-tky@umin.ac.jp; hms1466@faculty.chiba-u.jp; a.sakuma@chiba-u.jp; acua2807@chiba-u.jp; goinokuchi@chiba-u.jp; aama01718@chiba-u.jp; chibafumico@chiba-u.jp; yhoshio-ka@chiba-u.jp; iwase@faculty.chiba-u.jp					Adhvaryu AV, 2013, INT J MED RES HLTH S, V2, P577; Selthofer R, 2006, COLLEGIUM ANTROPOL, V30, P43; Dedouit F, 2007, FORENSIC SCI INT, V173, P182, DOI 10.1016/j.forsciint.2007.01.002; Menezes RG, 2009, J FORENSIC LEG MED, V16, P441, DOI 10.1016/j.jflm.2009.05.001; JIT I, 1980, AM J PHYS ANTHROPOL, V53, P217, DOI 10.1002/ajpa.1330530206; Spradley MK, 2011, J FORENSIC SCI, V56, P289, DOI 10.1111/j.1556-4029.2010.01635.x; Gapert R, 2009, INT J LEGAL MED, V123, P25, DOI 10.1007/s00414-008-0256-0; Walker PL, 2005, AM J PHYS ANTHROPOL, V127, P385, DOI 10.1002/ajpa.10422; Karakas HM, 2011, SKELETAL RADIOL, V40, P623, DOI 10.1007/s00256-010-0937-x; Slaus M, 2005, FORENSIC SCI INT, V147, P147, DOI 10.1016/j.forsciint.2004.09.073; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; Ashley GT, 1956, J FORENSIC MED, V3, P27; Atal DK, 2008, INT J MED TOXICOL LE, V11, P53; Atal OK, 2009, J IND ACAD FORENSIC, V30, P198; Barrio PA, 2006, J FORENSIC SCI, V51, P990, DOI 10.1111/j.1556-4029.2006.00237.x; Benazzi S, 2009, J FORENSIC SCI, V54, P249, DOI 10.1111/j.1556-4029.2008.00947.x; Bongiovanni R, 2012, FORENSIC SCI INT, V219, pe1; Changani MV, 2014, J RES MED DEN SCI, V2, P59; Cunha E, 2007, SKELETAL SERIES THEI, P23; Dahiphale VP, 2002, J ANAT SOC INDIA, V51, P162; Fernandez ED, 2007, REV ESCUELA MED LEGA, P27; Franklin D, 2012, FORENSIC SCI INT, V217, pe1; Garcia-Parra P, 2014, FORENSIC SCI INT, V244, pe1; Giurazza F, 2013, LEGAL MED-TOKYO, V15, P202, DOI 10.1016/j.legalmed.2013.01.002; Hunnargi Shahm A., 2008, Legal Medicine, V10, P6, DOI 10.1016/j.legaimed.2007.05.011; Macaluso PJ, 2014, INT J LEGAL MED, V128, P389, DOI 10.1007/s00414-013-0910-z; Macaluso Jr PJ, 2010, FORENSIC SCI INT, V202, pe1; Mahajan A, 2009, J PUNJAB ACAD FORENS, V9, P12; MCCORMICK WF, 1985, AM J PHYS ANTHROPOL, V68, P173, DOI 10.1002/ajpa.1330680205; Ramadan SU, 2010, FORENSIC SCI INT, V197, pe1; Sakuma A, 2010, J FORENSIC SCI, V55, P1624, DOI 10.1111/j.1556-4029.2010.01526.x; Singh J, 2012, EGYPT J FORENSIC SCI, V2, P18, DOI DOI 10.1016/J.EJFS.2011.12.002; Singh J, 2013, FORENSIC SCI INT, V228, pe1; SUTHERLAND LD, 1991, J FORENSIC SCI, V36, P501; TEIXEIRA WRG, 1982, AM J FOREN MED PATH, V3, P203, DOI 10.1097/00000433-198209000-00003; Thali MJ, 2005, J FORENSIC SCI, V50, P428; Torwalt CRMM, 2005, J FORENSIC SCI, V50, P785; WARD RE, 1991, J CRAN GENET DEV BIO, V11, P156; Weinberg SM, 2005, AM J HUM BIOL, V17, P368, DOI 10.1002/ajhb.20129	39	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	JUL	2015	17	4					226	231		10.1016/j.legalmed.2015.01.003		6	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CM7UM	WOS:000357902000002		
J	Ma, SH; You, SZ; Hao, L; Zhang, DC; Quan, L				Ma, Suhua; You, Shengzhong; Hao, Li; Zhang, Dongchuan; Quan, Li			Fatal mechanical asphyxia induces changes in energy utilization in the rat brain: An F-18-FDG-PET study	LEGAL MEDICINE			English	Article						Positron emission tomography (PET); 2-Deoxy-2-[F-18]fluoro-D-glucose (F-18-FDG); Global cerebral ischemia; Mechanical asphyxia	INDUCED CEREBRAL-ISCHEMIA; C-FOS; PET; VULNERABILITY; METABOLISM; ACTIVATION; EXPRESSION; NEURONS; SCANNER; MRI	Purpose: This study was designed to evaluate changes in brain glucose metabolism in rats following ligature strangulation. Materials and methods: Thirteen male Wistar rats were used in the present study, divided into control (n = 7) and asphyxia groups (n = 6, ligature strangulation). Positron emission tomography (PET) with 2-deoxy-2-[F-18]fluoro-D-glucose (F-18-FDG) was used to evaluate brain glucose metabolism. Rats were scanned for PET-CT, and image data co-registered with a T2WI MRI template using SPM8 software. Image J was employed to draw regions of interest (ROls) from the MRI template and acquire ROI activity information from the PET images. Results: In the asphyxia group vs. controls, F-18-FDG uptake (FU) was decreased in the substantia nigra (25.26%, p < 0.001), rhombencephalon (pons/medulla oblongata, 13.92%, p < 0.01), hypothalamus (22.06%, p < 0.01), ventral tegmentum (10.12%, p < 0.05) and amygdala (12.74%, p < 0.05); however, FU was increased in motor (18.21%, p < 0.05) and visual cortices (19.2%, p < 0.05). Conclusions: The glucose metabolism distribution map in the asphyxiated rat brains were substantially changed versus controls. PET with F-18-FDG can demonstrate excitement and inhibition of different brain areas even in cases of ligature strangulation. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ma, Suhua; You, Shengzhong; Hao, Li; Zhang, Dongchuan; Quan, Li] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Forens Pathol, Guangzhou 510080, Guangdong, Peoples R China; [Quan, Li] Osaka City Univ, Sch Med, Dept Legal Med, Osaka 5458585, Japan	Quan, L (reprint author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Forens Pathol, 74 Zhongshan 2 Rd, Guangzhou 510080, Guangdong, Peoples R China.	quanli2@mail.sysu.edu.cn		Ma, Suhua/0000-0002-2704-3540	Provincial Natural Science Fund Project of Guangdong [S2013010016749]	We thank Tu Qing-Qiang for his guidance on the experimental procedure, and Zhong Xia for her invaluable help in pre-experimental work. This work is financially supported by the Provincial Natural Science Fund Project of Guangdong (Grant No. S2013010016749).	Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Stark JA, 2006, NEUROIMAGE, V31, P1228, DOI 10.1016/j.neuroimage.2006.01.046; Neumann JT, 2013, CURR DRUG TARGETS, V14, P20; Quan L, 2001, INT J LEGAL MED, V115, P6, DOI 10.1007/s004140000200; Young GB, 2009, NEW ENGL J MED, V361, P605, DOI 10.1056/NEJMcp0903466; Centonze D, 2001, PROG NEUROBIOL, V63, P687, DOI 10.1016/S0301-0082(00)00037-X; Traystman RJ, 2003, ILAR J, V44, P85; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Azmak D, 2006, AM J FOREN MED PATH, V27, P134, DOI 10.1097/01.paf.0000221082.72186.2e; Dodd GT, 2010, J NEUROCHEM, V113, P1123, DOI 10.1111/j.1471-4159.2010.06671.x; Catana C, 2006, J NUCL MED, V47, P1968; Lang PJ, 2011, PSYCHOPHYSIOLOGY, V48, P393, DOI 10.1111/j.1469-8986.2010.01076.x; Constantinescu CC, 2009, PHYS MED BIOL, V54, P2885, DOI 10.1088/0031-9155/54/9/020; Demirci S, 2009, J FORENSIC LEG MED, V16, P248, DOI 10.1016/j.jflm.2008.12.013; Bonab AA, 2012, NEUROSCIENCE, V223, P457, DOI 10.1016/j.neuroscience.2012.07.032; Nasrallah I, 2013, SEMIN NUCL MED, V43, P449, DOI 10.1053/j.semnuclmed.2013.06.003; Brisson CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096585; Brisson CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079589; Cizkova D, 2000, CELL MOL NEUROBIOL, V20, P367, DOI 10.1023/A:1007018327133; DiMaio V.J., 2001, FORENSIC PATHOLOGY; DiMaio VJM, 2000, AM J FOREN MED PATH, V21, P1, DOI 10.1097/00000433-200003000-00001; Garcia JH, 1988, CRIT CARE MED, V16; Ikematsu K, 2008, FORENSIC SCI INT, V179, P152, DOI 10.1016/j.forsciint.2008.05.007; Islekel H, 1999, BRAIN RES, V843, P18, DOI 10.1016/S0006-8993(99)01845-4; Lancelot S, 2010, TRENDS PHARMACOL SCI, V31, P411, DOI 10.1016/j.tips.2010.06.002; Lijowska AS, 1997, J APPL PHYSIOL, V83, P219; Luigetti M, 2012, ACTA NEUROL BELG, V112, P105, DOI 10.1007/s13760-012-0007-3; MINK JW, 1981, AM J PHYSIOL, V241, pR203; Nogami M, 1999, INT J LEGAL MED, V112, P351, DOI 10.1007/PL00007703; Quan Li, 2005, Legal Medicine, V7, P81, DOI 10.1016/j.legalmed.2004.08.007; Quan Li, 2005, Legal Medicine, V7, P151, DOI 10.1016/j.legalmed.2004.11.003; Sauvageau A, 2010, J FORENSIC SCI, V55, P1259, DOI 10.1111/j.1556-4029.2010.01459.x; Soto-Montenegro M, 2009, MOL IMAGING BIOL, V11, P94, DOI 10.1007/s11307-008-0179-7; Torbey MT, 2002, AM J NEURORADIOL, V23, P738; Vanicky I, 1997, BRAIN RES, V766, P262, DOI 10.1016/S0006-8993(97)00730-0; Verma Satish K., 2006, Legal Medicine, V8, P1, DOI 10.1016/j.legalmed.2005.06.004; Wang Qi, 2009, Leg Med (Tokyo), V11 Suppl 1, pS161, DOI 10.1016/j.legalmed.2009.01.039; Watson C, 2007, RAT BRAIN STEREOTAXI; WYTRZES LM, 1989, ARCH NEUROL-CHICAGO, V46, P93	39	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	JUL	2015	17	4					239	244		10.1016/j.legalmed.2015.02.002		6	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CM7UM	WOS:000357902000004		
J	Abe, S; Hasegawa, I; Vogel, H; Heinemann, A; Suzuki, K; Puschel, K				Abe, Shuntaro; Hasegawa, Iwao; Vogel, Hermann; Heinemann, Axel; Suzuki, Koichi; Pueschel, Klaus			Evaluation of thymic volume by postmortem computed tomography	LEGAL MEDICINE			English	Article						Thymic involution; Child abuse; Postmortem computed tomography; Forensic autopsy	STRESS; INVOLUTION; DISEASE; ATROPHY	The thymus is exceedingly sensitive to stress and undergoes abrupt involution as a result of exposure to strong stress in early childhood. Therefore, thymic involution is often utilized to assess the presence of a stressful environment, such as an environment involving child abuse, in forensic medicine. In recent years, computed tomography (CT) has been commonly used in the daily practice of forensic medicine. We have focused on the thymic volume in postmortem CT images to evaluate the presence of a stressful antemortem environment. We calculated the thymus volume from postmortem CT images of children under six years old and demonstrated that the volume showed a positive correlation with the real weight obtained from an autopsy. The evaluation of thymic volume by CT may make it possible for us to identify child maltreatment. The most useful feature of this application of CT is to be able to demonstrate thymic involution less invasively in a surviving victim. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Abe, Shuntaro; Hasegawa, Iwao; Vogel, Hermann; Heinemann, Axel; Pueschel, Klaus] Univ Med Ctr Hamburg Eppendorf, Dept Legal Med, D-22529 Hamburg, Germany; [Abe, Shuntaro; Suzuki, Koichi] Osaka Med Coll, Fac Med, Dept Legal Med, Div Prevent & Social Med, Takatsuki, Osaka 5698686, Japan; [Abe, Shuntaro; Hasegawa, Iwao] Tokyo Metropolitan Govt, Tokyo Med Examiners Off, Bunkyo Ku, Tokyo, Japan	Abe, S (reprint author), Osaka Med Coll, Fac Med, Dept Legal Med, Div Prevent & Social Med, 2-7 Daigaku machi, Takatsuki, Osaka 5698686, Japan.	zelkova@art.osaka-med.ac.jp			Institutional Program for Young Researcher Overseas Visits (Japan Society for the Promotion of Science)	This research is supported by the Institutional Program for Young Researcher Overseas Visits (Japan Society for the Promotion of Science).	Inaoka T, 2007, RADIOLOGY, V243, P869, DOI 10.1148/radiol.2433060797; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Ye P, 2004, CURR HIV RES, V2, P177, DOI 10.2174/1570162043484898; Nishino M, 2006, RADIOGRAPHICS, V26, P335, DOI 10.1148/rg.262045213; SELYE H, 1955, SCIENCE, V122, P625, DOI 10.1126/science.122.3171.625; BREIMAN RS, 1982, AM J ROENTGENOL, V138, P329; Tarcic N, 1998, J NEUROIMMUNOL, V82, P40, DOI 10.1016/S0165-5728(97)00186-0; Bogot Naama R, 2005, Cancer Imaging, V5, P139, DOI 10.1102/1470-7330.2005.0107; Chandra R, 1997, AM J CLIN NUTR, V122, P460; CHOYKE PL, 1987, AM J ROENTGENOL, V149, P269; FUKUNAGA T, 1992, FORENSIC SCI INT, V53, P69, DOI 10.1016/0379-0738(92)90134-I; Prodhomme O, 2012, ARCH DIS CHILD-FETAL, P434; Raica M., 2007, J MORPHOL EMBRIOL, V48, P101; Senati M, 2013, LEGAL MED-TOKYO, V15, P28, DOI 10.1016/j.legalmed.2012.08.001; Tanegashima A, 1999, FORENSIC SCI INT, V101, P55, DOI 10.1016/S0379-0738(99)00003-1	15	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	JUL	2015	17	4					251	254		10.1016/j.legalmed.2015.02.006		4	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CM7UM	WOS:000357902000006		
J	Kameyama, H; Udagawa, O; Hoshi, T; Toukairin, Y; Arai, T; Nogami, M				Kameyama, Hiroshi; Udagawa, One; Hoshi, Tomoaki; Toukairin, Yoko; Arai, Tomomi; Nogami, Makoto			The mRNA expressions and immunohistochemistry of factors involved in angiogenesis and lymphangiogenesis in the early stage of rat skin incision wounds	LEGAL MEDICINE			English	Article						Angiogenesis; Lymphangiogenesis; Wound; Real time RT-PCR; Immunohistochemistry	ENDOTHELIAL GROWTH-FACTOR; PLASMINOGEN-ACTIVATOR INHIBITOR-1; COLONY-STIMULATING FACTOR; IN-VIVO; PROMOTES ANGIOGENESIS; EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; TISSUE REGENERATION; TROPONIN-I; TGF-BETA	Wound healing evaluation is important in forensic pathology, in which angiogenesis plays an important role. We have already shown that vascular endothelial growth factor A (VEGF) is produced in the rat skin incision wounds by neutrophils, endothelial cells, and fibroblasts. In this study, we assessed the changes in the mRNA expressions of various factors possibly involved in angiogenesis including angiopoietin (ANGPT) 1 and 2, cadherin 5 (CDH5), granulocyte-macrophage colony stimulating factor (CSF2/GM-CSF), granulocyte colony stimulating factor (CSF3/G-CSF), chemokine (C-X-C motif) ligand 2 (CXCL2), chemokine (C-X-C motif) ligand12 (CXCL12/SDF1), endothelin 1 (ET1), fibroblast growth factor 1 (FGF 1), hepatocyte growth factor (HGF), hypoxia inducible factor 1 alpha (HIFI a), leptin, matrix metallopepitidase 9 (MMP9), serpine/plasminogen activator inhibitorl (PAI1), platelet-derived growth factor-A (PDGF-A), transforming growth factor alpha and beta 1 (TGFa and bl), tenomodulin (TNMD), and troponin I type 2 (TNNI2) in the early stage of the rat skin incision wounds by real time RT-PCR. Factors reported to be involved in lymphangiogenesis such as fibroblast growth factor 2 (FGF 2), c-fos induced growth factor (FIGF/VEGF-D), forkhead box C2 (FOXC2), and prospero homeobox 1 (PROX1) were also studied. One and 3 days after the dorsal skin incisions, wounds on male Sprague-Dawley rats showed the statistically significant increases in the mRNA expressions for CXCL2, CSF3, MMP9, PAIL and CSF2, whereas TGFa, TNNI2, FGF1, TNMD, leptin, and CXCL12 showed the statistically significant decreases. Interestingly, lymphgangiogenic factors FOXC2, PROX1, and FGF2 also showed the statistically significant decreases. In situ hybridization and immunohistochemistry showed the mRNA and protein positivity in endothelial cells, fibroblasts, and some leukocytes at the bottom of the wound tissue for PAIL CSF3, and MMP9, 1 day after the skin incisions. Our novel findings show the possible involvement of several factors involved in angiogenesis and lymphangiogenesis in the early stage of wound healing process, which may be useful for forensic wound evaluations. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kameyama, Hiroshi] Saitama Prefectural Police Headquarters, Criminal Invest Lab, Urawa Ku, Saitama 3308533, Japan; [Kameyama, Hiroshi; Udagawa, One; Hoshi, Tomoaki; Toukairin, Yoko; Arai, Tomomi; Nogami, Makoto] Teikyo Univ, Sch Med, Dept Legal Med, Tokyo 1738605, Japan	Nogami, M (reprint author), Saitama Prefectural Police Headquarters, Criminal Invest Lab, Urawa Ku, 3-15-1 Takasago, Saitama 3308533, Japan.	mnogami@med.teikyo-u.ac.jp					Lin Q, 2011, J IMMUNOL, V186, P3710, DOI 10.4049/jimmunol.1003007; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Tan YH, 2007, CARDIOVASC RES, V73, P823, DOI 10.1016/j.cardiores.2006.12.015; Tammela T, 2005, TRENDS CELL BIOL, V15, P434, DOI 10.1016/j.tcb.2005.06.004; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; BUSSOLINO F, 1991, J CLIN INVEST, V87, P986, DOI 10.1172/JCI115107; Tuan TL, 2003, AM J PATHOL, V162, P1579, DOI 10.1016/S0002-9440(10)64292-7; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Nogami Makoto, 2009, Legal Medicine, V11, P213, DOI 10.1016/j.legalmed.2009.05.001; Ji Rui-Cheng, 2006, Lymphatic Research and Biology, V4, P83, DOI 10.1089/lrb.2006.4.83; Cao RH, 2012, P NATL ACAD SCI USA, V109, P15894, DOI 10.1073/pnas.1208324109; Ferrari G, 2009, J CELL PHYSIOL, V219, P449, DOI 10.1002/jcp.21706; Hose D, 2009, BLOOD, V114, P128, DOI 10.1182/blood-2008-10-184226; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marconcini L, 1999, P NATL ACAD SCI USA, V96, P9671, DOI 10.1073/pnas.96.17.9671; Tashiro Y, 2012, BLOOD, V119, P6382, DOI 10.1182/blood-2011-12-399659; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Xie XY, 2012, J AM PODIAT MED ASSN, V102, P299; Ebrahimian TG, 2012, STEM CELLS, V30, P1436, DOI 10.1002/stem.1126; Chen X, 2003, CLIN CANCER RES, V9, P3115; Yoneda J, 1998, J NATL CANCER I, V90, P447, DOI 10.1093/jnci/90.6.447; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jace.2006.09.053; Shaw JP, 2003, J SURG RES, V109, P37, DOI 10.1006/jsre.2002.6559; Stuelten CH, 2005, J CELL SCI, V118, P2143, DOI 10.1242/jcs.02334; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Gu Y, 2008, CLIN EXP METASTAS, V25, P717, DOI 10.1007/s10585-008-9180-4; Romanic AM, 1998, STROKE, V29, P1020; WISEMAN DM, 1988, BIOCHEM BIOPH RES CO, V157, P793, DOI 10.1016/S0006-291X(88)80319-X; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Belo AV, 2005, MICROCIRCULATION, V12, P597, DOI 10.1080/10739680500253535; Moses MA, 1999, P NATL ACAD SCI USA, V96, P2645, DOI 10.1073/pnas.96.6.2645; SALLERFORS B, 1992, EUR J HAEMATOL, V49, P199; Platonova N, 2013, BLOOD, V121, P1229, DOI 10.1182/blood-2012-08-450502; Aizawa K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253325; Larsen M, 2014, MICROSURG, V34, P301, DOI 10.1002/micr.22221; Morishita R, 2004, CURR GENE THER, V4, P199; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Isogai C, 2001, CANCER RES, V61, P5587; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Ding I, 2003, ADV EXP MED BIOL, V530, P603; Feldman L, 2002, MICROVASC RES, V63, P41, DOI 10.1006/mvre.2001.2364; HAMILTON JA, 1992, BLOOD, V79, P1413; Hayashi H, 2008, J BIOL CHEM, V283, P23791, DOI 10.1074/jbc.M800190200; Heissig B, 2010, HISTOL HISTOPATHOL, V25, P765; Kasama Tsuyoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P273, DOI 10.2174/1568010054022114; Leker RR, 2009, NEUROSCIENCE, V163, P233, DOI 10.1016/j.neuroscience.2009.05.050; Li BY, 2015, J INTERF CYTOK RES, V35, P23, DOI 10.1089/jir.2014.0004; Liapaki I, 2008, ACTA CIR BRAS, V23, P118, DOI 10.1590/S0102-86502008000200002; Mishima K, 2007, MOL BIOL CELL, V18, P1421, DOI 10.1091/mbc.E06-09-0780; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; Nogami M, 2007, MED MOL MORPHOL, V40, P82, DOI 10.1007/s00795-007-0357-8; Nogami M, 2010, LEGAL MED, V12, P128, DOI 10.1016/j.legalmed.2010.01.005; Palomero J, 2014, BLOOD, V124, P2235, DOI 10.1182/blood-2014-04-569566; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I; Providence KM, 2002, J CELL SCI, V115, P3767, DOI 10.1242/jcs.00051; Rahimi N, 1999, MOL BIOL CELL, V10, P3401; Rohrl J, 2012, J IMMUNOL, V188, P4931, DOI 10.4049/jimmunol.1102442; Sakai T, 2011, THROMB RES, V127, P443, DOI 10.1016/j.thromres.2011.02.001; SALO T, 1994, LAB INVEST, V70, P176; Sasahira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092534; Shukunami C, 2007, CURR PHARM DESIGN, V13, P2101; Song QH, 2002, J CLIN PATHOL-MOL PA, V55, P164; Staton CA, 2010, BRIT J DERMATOL, V163, P920, DOI 10.1111/j.1365-2133.2010.09940.x; SUNDERKOTTER C, 1991, PHARMACOL THERAPEUT, V51, P195, DOI 10.1016/0163-7258(91)90077-Y; Tsui JCS, 2002, BRIT J SURG, V89, P741, DOI 10.1046/j.1365-2168.2002.02100.x; Ullah M, 2014, J ORAL PATHOL MED; Wong V., 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/190486; Zgheib A, 2013, CYTOKINE, V63, P187, DOI 10.1016/j.cyto.2013.04.027; Zhao JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092691	74	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	JUL	2015	17	4					255	260		10.1016/j.legalmed.2015.02.007		6	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CM7UM	WOS:000357902000007		
J	Bunai, Y; Ishii, A; Akaza, K; Nagai, A; Nishida, N; Yamaguchi, S				Bunai, Yasuo; Ishii, Akira; Akaza, Kayoko; Nagai, Atsushi; Nishida, Naoki; Yamaguchi, Seiji			A case of sudden death after Japanese encephalitis vaccination	LEGAL MEDICINE			English	Article						Sudden death; Japanese encephalitis vaccine; Psychotropic drugs; Adverse effects; Vasovagal syncope; Fatal arrhythmia	TORSADE-DE-POINTES; MYOCARDIAL-CONTRACTION BANDS; LA-TOURETTES SYNDROME; IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; CONDUCTION SYSTEM; UNITED-STATES; OPEN-LABEL; PIMOZIDE; DISORDER	Japanese encephalitis (JE) virus is estimated to result in 3500-50,000 clinical cases every year, with mortality rates of up to 20-50% and a high percentage of neurological sequelae in survivors. Vaccination is the single most important measure in preventing. this disease. Inactivated Vero cell culture-derived JE vaccines have not been linked to any fatalities, and few serious adverse events after vaccination have been reported. Here, we report a case of sudden death in which a 10-year-old boy experienced cardiopulmonary arrest 5 min after receiving a Japanese encephalitis vaccination. He had been receiving psychotropic drugs for the treatment of pervasive developmental disorders. Postmortem examinations were nonspecific, and no signs of dermatologic or mucosal lesions or an elevation of the serum tryptase level, which are characteristic of anaphylaxis, were observed. A toxicological examination revealed that the blood concentrations of the orally administered psychotropic drugs were within the therapeutic ranges. The patient was considered to have died of an arrhythmia that was not directly associated with the vaccination. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Bunai, Yasuo; Akaza, Kayoko; Nagai, Atsushi] Gifu Univ, Grad Sch Med, Dept Legal Med, Gifu 5011194, Japan; [Ishii, Akira] Nagoya Univ, Grad Sch Med, Dept Legal Med & Bioeth, Nagoya, Aichi 4668550, Japan; [Nishida, Naoki] Toyama Univ, Sch Med, Dept Legal Med, Toyama 9300194, Japan; [Yamaguchi, Seiji] Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane 6938501, Japan	Bunai, Y (reprint author), Gifu Univ, Grad Sch Med, Dept Legal Med, Gifu 5011194, Japan.	bunaiy@gifu-u.ac.jp		Nishida, Naoki/0000-0002-6921-1768			Cairney J, 2005, INT J OBESITY, V29, P369, DOI 10.1038/sj.ijo.0802893; McCallum AD, 2013, J TRAVEL MED, V20, P60, DOI 10.1111/jtm.12001; Glassman AH, 2001, AM J PSYCHIAT, V158, P1774, DOI 10.1176/appi.ajp.158.11.1774; Pumphrey RSH, 2000, J CLIN PATHOL, V53, P273, DOI 10.1136/jcp.53.4.273; Lyon GJ, 2009, J CHILD ADOL PSYCHOP, V19, P623, DOI 10.1089/cap.2009.0035; Rickards H, 2012, EUR J PAEDIATR NEURO, V16, P361, DOI 10.1016/j.ejpn.2011.12.001; Ruggeberg JU, 2007, VACCINE, V25, P5675, DOI 10.1016/j.vaccine.2007.02.064; Alderman J, 2005, CLIN THER, V27, P1050, DOI 10.1016/j.clinthera.2005.07.013; Slade BA, 2009, JAMA-J AM MED ASSOC, V302, P750, DOI 10.1001/jama.2009.1201; Madaan A, 2003, IMMUNOL ALLERGY CLIN, V23, P555, DOI 10.1016/S0889-8561(03)00099-7; Haddad PM, 2002, DRUGS, V62, P1649, DOI 10.2165/00003495-200262110-00006; Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fineschi V, 2006, INT J LEGAL MED, V120, P79, DOI 10.1007/s00414-005-0011-8; Pacher P, 2004, CURR PHARM DESIGN, V10, P2463, DOI 10.2174/1381612043383872; Antzelevitch C, 2007, EUROPACE, V9, P4, DOI 10.1093/europace/eum166; Baroldi G, 2005, INT J CARDIOL, V100, P435, DOI 10.1016/j.ijard.2004.10.007; Baroldi G, 2001, INT J LEGAL MED, V115, P142, DOI 10.1007/s004140100229; Bocchini JA, 2013, MMWR-MORBID MORTAL W, V62, P898; Bunai Yasuo, 2003, Leg Med (Tokyo), V5 Suppl 1, pS302, DOI 10.1016/S1344-6223(02)00156-6; Sutherland A., 2008, Morbidity and Mortality Weekly Report, V57, P457; Cohle SD, 2002, AM J FOREN MED PATH, V23, P83, DOI 10.1097/00000433-200203000-00018; Committee on Safety of Medicines-Medicines Control Agency, 1995, CURR PROBL PHARMACOV, V21, P2; Cubeddu Luigi X, 2009, Curr Cardiol Rev, V5, P166, DOI 10.2174/157340309788970397; Erlewyn-Lajeunesse M, 2012, ARCH DIS CHILD, V97, P487, DOI 10.1136/archdischild-2011-301163; Ewan PW, 1998, BRIT MED J, V316, P1442; FRANKENBURG FR, 1994, J CLIN PSYCHOPHARM, V14, P359, DOI 10.1097/00004714-199410000-00015; FULOP G, 1987, AM J PSYCHIAT, V144, P673; Gulisano M, 2011, NEUROL SCI, V32, P1213, DOI 10.1007/s10072-011-0678-1; Hubscher SG, 2006, HISTOPATHOLOGY, V49, P450, DOI 10.1111/j.1365-2559.2006.02416.x; KARCH SB, 1986, HUM PATHOL, V17, P9, DOI 10.1016/S0046-8177(86)80150-2; Kim JJ, 2013, AM J PHYSIOL-HEART C, V304, P848; Nishida N, 2000, Leg Med (Tokyo), V2, P216, DOI 10.1016/S1344-6223(00)80044-9; Nishida N, 2002, INT J LEGAL MED, V116, P344, DOI 10.1007/s00414-002-0334-7; Okada K, 2012, VACCINE, V30, P5967, DOI 10.1016/j.vaccine.2012.07.034; Okada Kenji, 2011, Nihon Rinsho, V69, P1639; REGEUR L, 1986, J NEUROL NEUROSUR PS, V49, P791, DOI 10.1136/jnnp.49.7.791; ROSS MS, 1978, AM J PSYCHIAT, V135, P585; Takahashi H, 2000, VACCINE, V18, P2963, DOI 10.1016/S0264-410X(00)00111-0; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298	39	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	JUL	2015	17	4					279	282		10.1016/j.legalmed.2015.03.003		4	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CM7UM	WOS:000357902000010		
J	Fujihara, J; Yasuda, T; Iida, R; Ueki, M; Sano, R; Kominato, Y; Inoue, K; Kimura-Kataoka, K; Takeshita, H				Fujihara, Junko; Yasuda, Toshihiro; Iida, Reiko; Ueki, Misuzu; Sano, Rie; Kominato, Yoshihiko; Inoue, Ken; Kimura-Kataoka, Kaori; Takeshita, Haruo			Global analysis of genetic variations in a 56-bp variable number of tandem repeat polymorphisms within the human deoxyribonuclease I gene	LEGAL MEDICINE			English	Article						DNase I; DNASE1; HumDN1; VNTR polymorphism; Ethnic variation	SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMDN1 VNTR POLYMORPHISM; MYOCARDIAL-INFARCTION; HAN CHINESE; RISK-FACTOR; ASSOCIATION; POPULATIONS; EXPRESSION; CARCINOMA; FREQUENCY	A 56-bp variable number of tandem repeat polymorphism is confirmed in intron 4 of the human deoxyribonuclease I (DNase I) gene (HumDN1). The purpose of the present study was to document global ethnic variations of allelic frequencies in HumDN1 VNTR polymorphisms. In this study, HumDN1 VNTR polymorphisms in 11 worldwide populations were examined by polymerase chain reaction and compared with those reported previously. Fifteen genotypes were identified in these 11 populations. Novel genotypes were found: 1/2 was observed in Ghanaians and mestizos, 3/6 was in Tamangs, 4/6 was in Tibetans and Nahuas, 6/6 was in Sinhalese. The African population showed the highest frequency for the HumDN1*3 allele. Among Asian populations, the different genotype distribution was observed. The predominant allele in Mongolian, Korean, Japanese, and Chinese populations was HumDN1*3, followed by HumDN1*4, and then HumDN1*5. In Chinese from South China, Tamangs, and Sinhalese, HumDN1*4 and HumDN1*5 were predominant. The allele frequency for HumDN1*4 was high in three Mexican populations, but a significant difference was observed between Nahuas and Huicoles. Germans and Turks showed a similar distribution. This study is the first to show the existence of a certain genetic heterogeneity in the worldwide distribution of HumDN1 VNTR polymorphism. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Fujihara, Junko; Kimura-Kataoka, Kaori; Takeshita, Haruo] Shimane Univ, Dept Legal Med, Fac Med, Izumo, Shimane 6938501, Japan; [Yasuda, Toshihiro; Ueki, Misuzu] Univ Fukui, Fac Med Sci, Div Med Genet & Biochem, Eiheiji Cho, Japan; [Iida, Reiko] Univ Fukui, Fac Med Sci, Div Life Sci, Eiheiji Cho, Japan; [Sano, Rie; Kominato, Yoshihiko] Gunma Univ, Grad Sch Med, Dept Legal Med, Maebashi, Gumma 371, Japan; [Inoue, Ken] Shimane Univ, Fac Med, Dept Publ Hlth, Izumo, Shimane, Japan	Fujihara, J (reprint author), Shimane Univ, Dept Legal Med, Fac Med, 89-1 Enya, Izumo, Shimane 6938501, Japan.	jfujihar@med.shimane-u.ac.jp			Japan Society for the Promotion of Science [26713025]	DNA samples were kindly provided by Dr. Y. Koda. This work was supported in part by Grants-in-Aid from the Japan Society for the Promotion of Science (26713025 to JF).	AlFadhli S, 2010, INT J IMMUNOGENET, V37, P5, DOI 10.1111/j.1744-313X.2009.00881.x; AlFadhli S, 2014, IMMUNOL INVEST, V43, P411, DOI 10.3109/08820139.2013.864666; Dittmar M, 2009, J AUTOIMMUN, V32, P7, DOI 10.1016/j.jaut.2008.09.005; Shin HD, 2004, HUM MOL GENET, V13, P2343, DOI 10.1093/hmg/ddh275; Wiley KL, 2013, J CLIN IMMUNOL, V33, P342, DOI 10.1007/s10875-012-9803-z; Napirei M, 2000, NAT GENET, V25, P177; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Panneer D, 2013, LUPUS, V22, P996, DOI 10.1177/0961203313498801; Takeshita H, 2009, CLIN CHEM LAB MED, V47, P51, DOI 10.1515/CCLM.2009.002; KISHI K, 1990, AM J HUM GENET, V47, P121; Fujihara Junko, 2007, Legal Medicine, V9, P233, DOI 10.1016/j.legalmed.2007.01.006; YASUDA T, 1990, J BIOCHEM-TOKYO, V108, P393; CHITRABAMRUNG S, 1981, RHEUMATOL INT, V1, P55, DOI 10.1007/BF00541153; Bodano A, 2006, RHEUMATOLOGY, V45, P819, DOI 10.1093/rheumatology/ke1019; Fujihara J, 2006, CLIN CHEM LAB MED, V44, P1188, DOI 10.1515/CCLM.2006.225; Kumamoto T, 2006, EUR HEART J, V27, P2081, DOI 10.1093/eurheartj/ehl177; lida R, 1996, HUM GENET, V98, P415; Ni YH, 2009, MOL BIOL REP, V36, P595, DOI 10.1007/s11033-008-9218-3; Ni YH, 2008, MOL BIOL REP, V35, P479, DOI 10.1007/s11033-007-9110-6; Peitsch M C, 1994, Cell Death Differ, V1, P1; Takeshita H, 2008, CELL BIOCHEM FUNCT, V26, P151, DOI 10.1002/cbf.1414; Tsutsumi S, 1998, CANCER, V82, P1621, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1621::AID-CNCR4>3.0.CO;2-D; Tsutsumi S, 2000, CANCER LETT, V159, P109, DOI 10.1016/S0304-3835(00)00540-1; Yasuda Toshihiro, 2004, Leg Med (Tokyo), V6, P242, DOI 10.1016/j.legalmed.2004.07.001; Yasuda T, 1999, BIOCHEM BIOPH RES CO, V260, P280, DOI 10.1006/bbrc.1999.0900	25	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	JUL	2015	17	4					283	286		10.1016/j.legalmed.2015.01.005		4	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	CM7UM	WOS:000357902000011		
J	Della Porta, MG; Tuechler, H; Malcovati, L; Schanz, J; Sanz, G; Garcia-Manero, G; Sole, F; Bennett, JM; Bowen, D; Fenaux, P; Dreyfus, F; Kantarjian, H; Kuendgen, A; Levis, A; Cermak, J; Fonatsch, C; Le Beau, MM; Slovak, ML; Krieger, O; Luebbert, M; Maciejewski, J; Magalhaes, SMM; Miyazaki, Y; Pfeilstocker, M; Sekeres, MA; Sperr, WR; Stauder, R; Tauro, S; Valent, P; Vallespi, T; van de Loosdrecht, AAV; Germing, U; Haase, D; Greenberg, PL; Cazzola, M				Della Porta, M. G.; Tuechler, H.; Malcovati, L.; Schanz, J.; Sanz, G.; Garcia-Manero, G.; Sole, F.; Bennett, J. M.; Bowen, D.; Fenaux, P.; Dreyfus, F.; Kantarjian, H.; Kuendgen, A.; Levis, A.; Cermak, J.; Fonatsch, C.; Le Beau, M. M.; Slovak, M. L.; Krieger, O.; Luebbert, M.; Maciejewski, J.; Magalhaes, S. M. M.; Miyazaki, Y.; Pfeilstoecker, M.; Sekeres, M. A.; Sperr, W. R.; Stauder, R.; Tauro, S.; Valent, P.; Vallespi, T.; van de Loosdrecht, A. A.; Germing, U.; Haase, D.; Greenberg, P. L.; Cazzola, M.			Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)	LEUKEMIA			English	Article							WORLD-HEALTH-ORGANIZATION; EUROPEAN LEUKEMIANET; CLINICAL-RELEVANCE; MYELOID NEOPLASMS; FLOW-CYTOMETRY; CORE DATASET; IPSS-R; MDS; MUTATIONS; SURVIVAL	A risk-adapted treatment strategy is mandatory for myelodysplastic syndromes (MDS). We refined the World Health Organization (WHO)-classification-based Prognostic Scoring System (WPSS) by determining the impact of the newer clinical and cytogenetic features, and we compared its prognostic power to that of the revised International Prognostic Scoring System (IPSS-R). A population of 5326 untreated MDS was considered. We analyzed single WPSS parameters and confirmed that the WHO classification and severe anemia provide important prognostic information in MDS. A strong correlation was found between the WPSS including the new cytogenetic risk stratification and WPSS adopting original criteria. We then compared WPSS with the IPSS-R prognostic system. A highly significant correlation was found between the WPSS and IPSS-R risk classifications. Discrepancies did occur among lower-risk patients in whom the number of dysplastic hematopoietic lineages as assessed by morphology did not reflect the severity of peripheral blood cytopenias and/or increased marrow blast count. Moreover, severe anemia has higher prognostic weight in the WPSS versus IPSS-R model. Overall, both systems well represent the prognostic risk of MDS patients defined by WHO morphologic criteria. This study provides relevant in formation for the implementation of risk-adapted strategies in MDS.	[Della Porta, M. G.; Pfeilstoecker, M.] Fdn Ist Ricovero & Cura Carattere Sci Policlin Sa, Dept Hematol Oncol, Pavia, Italy; [Della Porta, M. G.] Univ Pavia, Dept Internal Med, I-27100 Pavia, Italy; [Tuechler, H.] Boltzmann Inst Leukemia Res, Hanusch Hosp, Vienna, Austria; [Malcovati, L.] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Schanz, J.; Haase, D.] Univ Gottingen, D-37073 Gottingen, Germany; [Sanz, G.] Hosp Univ La Fe, Valencia, Spain; [Garcia-Manero, G.; Kantarjian, H.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Sole, F.] Inst Recerca Leucemia Josep Carreras, Barcelona, Spain; [Bennett, J. M.] Univ Rochester, Med Ctr, James P Wilmot Canc Inst, Rochester, NY 14642 USA; [Bowen, D.] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Fenaux, P.] Univ Paris 13, Hop Avicenne, AP HP, Bobigny, France; [Dreyfus, F.] Univ Paris 05, Hop Cochin, AP HP, Paris, France; [Kuendgen, A.] Univ Dusseldorf, Dusseldorf, Germany; [Levis, A.] Fdn Italiana Sindromi Mielodisplast SS Antonio &, Alessandria, Italy; [Cermak, J.] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic; [Fonatsch, C.; Sperr, W. R.; Valent, P.] Med Univ Vienna, Vienna, Austria; [Le Beau, M. M.] Univ Chicago, Comprehens Canc Res Ctr, Chicago, IL 60637 USA; [Slovak, M. L.] Quest Diagnost Nichols Inst, Chantilly, VA USA; [Krieger, O.] Elisabethinen Hosp, Linz, Austria; [Luebbert, M.] Univ Freiburg, Med Ctr, D-79106 Freiburg, Germany; [Maciejewski, J.; Sekeres, M. A.] Cleveland Clin, Cleveland, OH 44106 USA; [Magalhaes, S. M. M.] Univ Fed Ceara, Fortaleza, Ceara, Brazil; [Miyazaki, Y.] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Pfeilstoecker, M.; Stauder, R.] Hanusch Hosp & L Boltzmann Cluster Oncol, Vienna, Austria; [Tauro, S.] Univ Dundee, Dundee, Scotland; [Vallespi, T.] Hosp Univ Vall dHebron, Barcelona, Spain; [van de Loosdrecht, A. A.] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands; [Greenberg, P. L.] Stanford Univ, Ctr Canc, Div Hematol, Stanford, CA 94305 USA	Greenberg, PL (reprint author), Stanford Univ, Ctr Canc, Div Hematol, 875 Blake Wilbur Dr,Room 2335, Stanford, CA 94305 USA.	peterg@stanford.edu; mario.cazzola@unipv.it	Schanz, Julie/L-1856-2015		Fondazione Berlucchi, Brescia; Fondazione Veronesi, Milan; Fondazione IRCCS Policlinico San Matteo, Pavia; Fondazione Cariplo/Regione Lombardia, Milan, Italy; Associazione Italiana per la Ricerca sul Cancro, Milan, Italy	We thank the MDS Foundation Inc., for statistical support (HT), Ms Tracey Iraca and MDS Foundation staff for helpful logistical assistance for the IWG-PM project. The study was supported by Fondazione Berlucchi, Brescia, Fondazione Veronesi, Milan, Fondazione IRCCS Policlinico San Matteo, Pavia, and Fondazione Cariplo/Regione Lombardia, Milan, Italy (MGDP and MC), and by Associazione Italiana per la Ricerca sul Cancro, Milan, Italy (LM and MC).	Alhan C, 2014, BRIT J HAEMATOL, V167, P100, DOI 10.1111/bjh.12994; Schanz J, 2011, J CLIN ONCOL, V29, P1963, DOI 10.1200/JCO.2010.28.3978; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Malcovati L, 2013, BLOOD, V122, P2943, DOI 10.1182/blood-2013-03-492884; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Naqvi K, 2011, J CLIN ONCOL, V29, P2240, DOI 10.1200/JCO.2010.31.3353; Kao JM, 2008, AM J HEMATOL, V83, P765, DOI 10.1002/ajh.21249; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Neukirchen J, 2014, LEUKEMIA RES, V38, P57, DOI 10.1016/j.leukres.2013.10.013; Deeg HJ, 2012, BLOOD, V120, P1398, DOI 10.1182/blood-2012-04-423046; Malcovati L, 2007, J CLIN ONCOL, V25, P3503, DOI 10.1200/JCO.2006.08.5696; Porwit A, 2014, LEUKEMIA, V28, P1793, DOI 10.1038/leu.2014.191; Della Porta MG, 2009, J CLIN ONCOL, V27, P754, DOI 10.1200/JCO.2008.18.2246; Voso MT, 2013, J CLIN ONCOL, V31, P2671, DOI 10.1200/JCO.2012.48.0764; Germing U, 2006, HAEMATOL-HEMATOL J, V91, P1596; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Cazzola M, 2011, SEMIN ONCOL, V38, P627, DOI 10.1053/j.seminoncol.2011.04.007; Malcovati L, 2011, HAEMATOL-HEMATOL J, V96, P1433, DOI 10.3324/haematol.2011.044602; Killick SB, 2014, BRIT J HAEMATOL, V164, P503, DOI 10.1111/bjh.12694; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Cazzola M, 2005, NEW ENGL J MED, V352, P536, DOI 10.1056/NEJMp048266; Greenberg P, 1997, BLOOD, V89, P2079; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Westers TM, 2012, LEUKEMIA, V26, P1730, DOI 10.1038/leu.2012.30; Schanz J, 2012, J CLIN ONCOL, V30, P820, DOI 10.1200/JCO.2011.35.6394; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Ades L, 2014, LANCET, V383, P2239, DOI 10.1016/S0140-6736(13)61901-7; Kuendgen A, 2006, J CLIN ONCOL, V24, P5358, DOI 10.1200/JCO.2006.07.5598; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Della Porta MG, 2014, BLOOD, V123, P2333, DOI 10.1182/blood-2013-12-542720; Greenberg PL, 2013, J NATL COMPR CANC NE, V11, P838; Cazzola Mario, 2008, Hematology Am Soc Hematol Educ Program, P166, DOI 10.1182/asheducation-2008.1.166; Cazzola M, 2013, BLOOD, V122, P4021, DOI 10.1182/blood-2013-09-381665; Della Porta MG, 2014, LEUKEMIA, V29, P66; Della Porta MG, 2011, HAEMATOL-HEMATOL J, V96, P441, DOI 10.3324/haematol.2010.033506; Gerstung M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6901; Malcovati L, 2014, BLOOD, V124, P1513, DOI 10.1182/blood-2014-03-560227; R Development Core Team, 2015, R LANG ENV STAT COMP; Senent L, 2013, HAEMATOLOGICA, V98, P568, DOI 10.3324/haematol.2012.071449; Shaffer LG, 2009, INT SYSTEM HUMAN CYT; Sperr WR, 2010, ANN ONCOL, V21, P114, DOI 10.1093/annonc/mdp258; Stauder Reinhard, 2008, J Natl Compr Canc Netw, V6, P927; Therneau TM, 2015, PACKAGE SURVIVAL ANA; van Spronsen MF, 2014, EUR J CANCER, V18, P3198	45	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	JUL	2015	29	7					1502	1513		10.1038/leu.2015.55		12	Oncology; Hematology	Oncology; Hematology	CM3ZE	WOS:000357623100010		
J	So, M; Ohtsuki, H; Makino, W; Ishida, S; Kumagai, H; Yamaki, KG; Urabe, J				So, Mika; Ohtsuki, Hajime; Makino, Wataru; Ishida, Seiji; Kumagai, Hitoshi; Yamaki, Kenyu G.; Urabe, Jotaro			Invasion and molecular evolution of Daphnia pulex in Japan	LIMNOLOGY AND OCEANOGRAPHY			English	Article							MITOCHONDRIAL-DNA VARIATION; POLYPHYLETIC ORIGINS; CLONAL DIVERSITY; ZOOPLANKTON; ASEXUALITY; CLADOCERA; COMPLEX; DISPERSAL; PATTERNS; SPREAD	We examined Daphnia pulex in Japan to clarify if they were representative of indigenous populations or colonized recently. Phylogenetic analysis of mtDNA suggests that Japanese lineages of D. pulex are immigrants from North America, and are hybrids formed with Daphnia pulicaria prior to this immigration. Based on the mtDNA sequences, the D. pulex individuals aggregated into four distinct genetic groups (JPN 1-4) comprising a total of 21 haplotypes. Surprisingly, microsatellite analysis with 12 loci revealed only a single multilocus genotype per genetic group, suggesting that D. pulex populations in Japan are comprised of asexual individuals, derived from only four clones. According to the reported mutation rate of mtDNA, JPN 1 and 2, now widely distributed across Japan, were estimated to have invaded between 680 yr and 3400 yr ago, while JPN 3 and 4 colonized much more recently. Results also indicated that the invasion of some clones could not be attributed to recent human activities and most likely occurred by rare natural events. Since the evolutional longevity of asexual clones is thought to be limited, genetic diversity of D. pulex in Japan has the possibility of decreasing in the near future without addition of novel gene flow.	[So, Mika; Ohtsuki, Hajime; Makino, Wataru; Ishida, Seiji; Kumagai, Hitoshi; Yamaki, Kenyu G.; Urabe, Jotaro] Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Sendai, Miyagi 9808578, Japan	Urabe, J (reprint author), Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Sendai, Miyagi 9808578, Japan.	urabe@m.tohoku.ac.jp			MEXT Japan [22370007, 16770011, 19770010]	We thank Marcia Kyle and two anonymous reviewers for their helpful comments and Larry Weider who provided a Daphnia pulex clone collected from a pond in Manitoba. This study was supported by Grants-in-Aid for Scientific Research from MEXT Japan to JU (22370007 and 22370007) and Grants-in-Aid for Young Scientists to MW (16770011 and 19770010).	Hebert PDN, 2001, HEREDITY, V87, P153, DOI 10.1046/j.1365-2540.2001.00885.x; Cristescu ME, 2012, MOL ECOL, V21, P1411, DOI 10.1111/j.1365-294X.2011.05465.x; Xu S, 2013, MOL ECOL, V22, P4549, DOI 10.1111/mec.12407; Kotov AA, 2006, J PLANKTON RES, V28, P1067, DOI 10.1093/plankt/fbl041; LaMontagne JM, 2001, ECOL LETT, V4, P64, DOI 10.1046/j.1461-0248.2001.00197.x; Mergeay J, 2006, P R SOC B, V273, P2839, DOI 10.1098/rspb.2006.3661; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Cristescu MEA, 2006, GENOMICS, V88, P415, DOI 10.1016/j.ygeno.2006.03.007; Paland S, 2005, EVOLUTION, V59, P800; Lynch M, 2008, GENETICS, V180, P317, DOI 10.1534/genetics.107.084657; Havel JE, 2006, BIOL INVASIONS, V8, P459, DOI 10.1007/s10530-005-6410-4; Eads BD, 2012, P NATL ACAD SCI USA, V109, P858, DOI 10.1073/pnas.1119667109; HEBERT PDN, 1983, HEREDITY, V51, P353, DOI 10.1038/hdy.1983.40; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1111/j.1095-8312.1998.tb01146.x; Tucker AE, 2013, P NATL ACAD SCI USA, V110, P15740, DOI 10.1073/pnas.1313388110; HEBERT PDN, 1989, EVOLUTION, V43, P1004, DOI 10.2307/2409581; CREASE TJ, 1989, EVOLUTION, V43, P1016, DOI 10.2307/2409582; Crease TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046620; DesMeester L., 2002, ACTA OECOL, V23, P121, DOI [10.1016/S1146-609X(02)01145-1, DOI 10.1016/S1146-609X(02)01145-1]; Duggan IC, 2012, AQUAT INVASIONS, V7, P585, DOI 10.3391/ai.2012.7.4.015; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Felsenstein J., 2005, PHYLIP PHYLOGENY INF; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; HANAZATO T, 1989, OECOLOGIA, V81, P450, DOI 10.1007/BF00378951; Hebert P. D. N., 1993, METHODOLOGIES ALLOZY, P32; Innes DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0564; Innes DJ, 2000, P ROY SOC B-BIOL SCI, V267, P991; Ishida S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-209; Ishida S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-52; Ishida S, 2007, MOL ECOL, V16, P569, DOI 10.1111/j.1365-294X.2006.03160.x; Kotov AA, 2010, J PLANKTON RES, V32, P937, DOI 10.1093/plankt/fbq018; TANAKA S, 1987, Japanese Journal of Limnology, V48, P111; Tatarazako N, 2007, ECOTOXICOLOGY, V16, P197, DOI 10.1007/s10646-006-0120-2; Ueno M., 1934, Memoirs of the College of Science Kyoto, V9, P289; Ueno M., 1926, Memoirs of the College of Science Kyoto Imperial University, VB2, P259; Urabe J., 1986, Bulletin of the Japanese Society of Scientific Fisheries, V52, P2045; Urabe J, 2003, LIMNOLOGY, V4, P35, DOI 10.1007/s10201-002-0087-5; Ventura M, 2014, MOL ECOL, V23, P1014, DOI 10.1111/mec.12656; Walworth A., 1946, BLACK SHIPS JAPAN ST, P277; Weider LJ, 1999, EVOLUTION, V53, P777, DOI 10.2307/2640718; Xu S, 2012, MOL BIOL EVOL, V29, P763, DOI 10.1093/molbev/msr243	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-3590	1939-5590		LIMNOL OCEANOGR	Limnol. Oceanogr.	JUL	2015	60	4					1129	1138		10.1002/lno.10087		10	Limnology; Oceanography	Marine & Freshwater Biology; Oceanography	CM7RR	WOS:000357894500004		
J	Shikata, T; Matsunaga, S; Nishide, H; Sakamoto, S; Onistuka, G; Yamaguchi, M				Shikata, Tomoyuki; Matsunaga, Shigeru; Nishide, Hiroyo; Sakamoto, Setsuko; Onistuka, Goh; Yamaguchi, Mineo			Diurnal vertical migration rhythms and their photoresponse in four phytoflagellates causing harmful algal blooms	LIMNOLOGY AND OCEANOGRAPHY			English	Article							HETEROSIGMA-AKASHIWO RAPHIDOPHYCEAE; RED-TIDE; CHATTONELLA-ANTIQUA; GYMNODINIUM-MIKIMOTOI; HETEROCAPSA-CIRCULARISQUAMA; YATSUSHIRO SEA; LIGHT; DINOFLAGELLATE; GROWTH; BAY	We observed diurnal vertical migrations (DVMs) of four noxious phytoflagellates: Chattonella antiqua, Heterosigma akashiwo (raphidophyte), Karenia mikimotoi, and Heterocapsa circularisquama (dinoflagellate) under various light conditions such as fluence rate, day length, light regime, and wavelength in the laboratory. For all flagellates cyclic DVMs were observed at an irradiance of 30 mol quanta m(-2) s(-1) on a 12 h : 12 h light : dark (L : D) cycle. Start times of upward and downward migrations under the light condition differed among species, indicating that each flagellate has its own original DVM cycle. The ascent period of C. antiqua during the photoperiod was much longer than the other flagellates, whereas K. mikimotoi remained submerged longer. No flagellate displayed cyclic DVM in the dark, and only K. mikimotoi did even under weak light of 1 mol quanta m(-2) s(-1). C. antiqua and K. mikimotoi extended their surface-accumulation periods at longer photoperiods, but the other species scarcely changed theirs. For all the flagellates, a DVM rhythm was entrained by shifting the L : D cycle; this occurred under white or blue light, but not under red light. These results indicate that all flagellates require (blue) light for maintenance and adjustment of DVM cycle but responses to change in light intensity and day length differ among species. The present study suggests that the species-specific DVM cycle and its photoresponse property can change time staying in surface or bottom layers in the natural environment, and therefore, may affect photosynthesis and nutrient uptake for survival and growth in four phytoflagellates.	[Shikata, Tomoyuki; Sakamoto, Setsuko; Onistuka, Goh; Yamaguchi, Mineo] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Res Ctr Environm Coservat, Hiroshima, Japan; [Matsunaga, Shigeru] Hamamatsu Photon KK, Cent Res Labs, Lab 9, Hamamatsu, Shizuoka, Japan; [Nishide, Hiroyo] Natl Inst Nat Sci, Natl Inst Basic Biol, Data Integrat & Anal Facil, Okazaki, Aichi 4448585, Japan	Shikata, T (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Res Ctr Environm Coservat, Hiroshima, Japan.	shikatat@affrc.go.jp			Japanese Fisheries Agency	We thank Drs. Tsuneo Honjo and Kiyohito Nagai for thoughtful comments and valuable information in the present study. We are grateful to Dr. Yukihiko Matsuyama for providing the culture strain of H. cirularisquama and Drs. Yuji Oshima and Yohei Shimasaki for use of the optical apparatus. This work was partially supported by the Japanese Fisheries Agency-aided project for addressing red tides and oxygen-depleted water masses.	Uchida T, 1999, J EXP MAR BIOL ECOL, V241, P285, DOI 10.1016/S0022-0981(99)00088-X; Shikata T, 2008, LIMNOL OCEANOGR, V53, P2503, DOI 10.4319/lo.2008.53.6.2503; Watanabe M, 1995, LIMNOL OCEANOGR, V40, P1447; Bearon RN, 2006, MAR ECOL PROG SER, V306, P153, DOI 10.3354/meps306153; Itakura S, 1996, J PLANKTON RES, V18, P1975, DOI 10.1093/plankt/18.10.1975; Shikata T, 2011, NIPPON SUISAN GAKK, V77, P40, DOI 10.2331/suisan.77.40; Kamykowski D, 1999, J PHYCOL, V35, P1397, DOI 10.1046/j.1529-8817.1999.3561397.x; YAMAGUCHI M, 1989, NIPPON SUISAN GAKK, V55, P2029; WATANABE M, 1988, J PHYCOL, V24, P22; Katano T, 2014, MAR BIOL RES, V10, P1007, DOI 10.1080/17451000.2013.879987; Katano T, 2012, J OCEANOGR, V68, P497, DOI 10.1007/s10872-012-0112-1; Shikata T, 2010, NIPPON SUISAN GAKK, V76, P34; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Berdalet E, 2014, DEEP-SEA RES PT II, V101, P4, DOI 10.1016/j.dsr2.2013.09.042; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1132; Park JG, 2001, PHYCOLOGIA, V40, P292, DOI 10.2216/i0031-8884-40-3-292.1; Koizumi Y, 1996, J PLANKTON RES, V18, P289, DOI 10.1093/plankt/18.2.289; YAMOCHI S, 1984, MAR BIOL, V83, P255, DOI 10.1007/BF00397457; Jephson T, 2009, J PLANKTON RES, V31, P1353, DOI 10.1093/plankt/fbp078; Imai I, 2012, HARMFUL ALGAE, V14, P46, DOI 10.1016/j.hal.2011.10.014; OLSSON P, 1991, J PLANKTON RES, V13, P1313, DOI 10.1093/plankt/13.6.1313; EGGERSDORFER B, 1991, FEMS MICROBIOL ECOL, V85, P319, DOI 10.1111/j.1574-6968.1991.tb04758.x; Brunelle SA, 2007, J PHYCOL, V43, P509, DOI 10.1111/j.1529-8817.2007.00339.x; Hall NS, 2011, MAR ECOL PROG SER, V425, P1, DOI 10.3354/meps09031; HEANEY S I, 1981, Journal of Plankton Research, V3, P331, DOI 10.1093/plankt/3.2.331; Hegemann P, 2001, J PHYCOL, V37, P668, DOI 10.1046/j.1529-8817.2001.01095.x; Honjo Tsuneo, 2004, P345; HONJO T, 1990, TOXIC MARINE PHYTOPLANKTON, P165; Ichimi Kazuhiko, 2003, Plankton Biology and Ecology, V50, P22; Iizuka S., 1966, B FAC FISH NAGASAKI, V21, P67; Kimura T, 1999, J APPL PHYCOL, V11, P301, DOI 10.1023/A:1008196308564; Kingston MB, 1999, J PHYCOL, V35, P245, DOI 10.1046/j.1529-8817.1999.3520245.x; Kirk J. T. O., 1994, LIGHT PHOTOSYNTHESIS; Kononen K, 2003, LIMNOL OCEANOGR, V48, P594; Nagai K., 2008, RES MEANS ALLEVIATIN; NAKAMURA Y, 1989, Journal of the Oceanographical Society of Japan, V45, P116, DOI 10.1007/BF02108885; Olli K, 1999, J MARINE SYST, V23, P145, DOI 10.1016/S0924-7963(99)00055-X; Qiu XC, 2011, HARMFUL ALGAE, V11, P81, DOI 10.1016/j.hal.2011.08.001; Richter PR, 2002, ACTA PROTOZOOL, V41, P343; Roenneberg T., 1989, J BIOL RHYTHM, V4, P89, DOI [10.1177/074873048900400208, DOI 10.1177/074873048900400208]; Shikata T, 2013, J PLANKTON RES, V35, P542, DOI 10.1093/plankt/fbt006; Shikata Tomoyuki, 2014, Plankton & Benthos Research, V9, P42; Shikata T, 2009, MAR BIOL, V156, P875, DOI 10.1007/s00227-009-1131-3; Shikata T, 2007, HARMFUL ALGAE, V6, P700, DOI 10.1016/j.hal.2007.02.008; Shiraishi Tomotaka, 2007, Plankton & Benthos Research, V2, P49, DOI 10.3800/pbr.2.49; Steinbuck JV, 2009, LIMNOL OCEANOGR, V54, P1353, DOI 10.4319/lo.2009.54.4.1353; Takeuchi T, 1997, NIPPON SUISAN GAKK, V63, P184; TOMAS CR, 1980, J PHYCOL, V16, P157; WATANABE M, 1991, LIMNOL OCEANOGR, V36, P593; Yamaguchi Mineo, 1994, Bulletin of Nansei National Fisheries Research Institute, V27, P251; Yamasaki Y, 2007, MAR BIOL, V152, P157, DOI 10.1007/s00227-007-0671-7; Yamatogi T, 2005, NIPPON SUISAN GAKK, V71, P746, DOI 10.2331/suisan.71.746	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-3590	1939-5590		LIMNOL OCEANOGR	Limnol. Oceanogr.	JUL	2015	60	4					1251	1264		10.1002/lno.10095		14	Limnology; Oceanography	Marine & Freshwater Biology; Oceanography	CM7RR	WOS:000357894500012		
J	Terauchi, M; Ikeda, G; Nishida, K; Tamura, A; Yamaguchi, S; Harada, K; Yui, N				Terauchi, Masahiko; Ikeda, Go; Nishida, Kei; Tamura, Atsushi; Yamaguchi, Satoshi; Harada, Kiyoshi; Yui, Nobuhiko			Supramolecular Polyelectrolyte Complexes of Bone Morphogenetic Protein-2 with Sulfonated Polyrotaxanes to Induce Enhanced Osteogenic Differentiation	MACROMOLECULAR BIOSCIENCE			English	Article						blood coagulation; BMP-2; bone regeneration; heparin; polyrotaxane	GROWTH-FACTORS; IN-VIVO; CARBOXYETHYLESTER-POLYROTAXANES; HYDROLYZABLE POLYROTAXANE; CLINICAL-APPLICATIONS; CONTROLLED-RELEASE; SCAFFOLD DESIGN; HEPARIN; REGENERATION; BMP-2	Although bone morphogenetic protein-2 (BMP-2) has received considerable attention because of its strong osteoinductivity, the clinical application of BMP-2 is limited due to its degradation and deactivation under physiological conditions. Negatively charged heparin is known to form polyelectrolyte complexes with BMP-2 to prevent deactivation and enhance the osteoinduction capability of BMP-2. Herein, we report the sulfonated polyrotaxanes (S-PRX) composed of a-cyclodextrin threaded onto a linear polymer for the protection of BMP-2 through the polyelectrolyte complex formation. When MC3T3-E1 osteoprogenitor cells were treated with the S-PRX/BMP-2 complexes, significantly high alkaline phosphatase production and mineralized matrix deposition were observed compared with that of free BMP-2 and heparin/BMP-2 complexes. Note that the S-PRXs showed negligible anticoagulant activity and cytotoxicity, whereas heparin showed strong anticoagulant activity. Accordingly, the S-PRXs are promising candidates for enhanced osteoinduction ability of BMP-2 without toxicity and anticoagulant activity and could contribute to clinical bone regeneration.	[Terauchi, Masahiko; Yamaguchi, Satoshi; Harada, Kiyoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Surg, Tokyo 1138549, Japan; [Terauchi, Masahiko; Ikeda, Go; Nishida, Kei; Tamura, Atsushi; Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Tokyo 1010062, Japan	Harada, K (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Surg, 1-5-45 Yushima, Tokyo 1138549, Japan.	haradak.mfs@tmd.ac.jp; yui.org@tmd.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24592954, 23107004, 26750155]	This work was financially supported by a Grant-in-Aid for Scientific Research (C) (No. 24592954) (to K.H.), a Grant-in-Aid for Scientific Research in Innovative Areas "Nano-medicine Molecular Science" (No. 23107004) (to N.Y.), and a Grant-in-Aid for Young Scientists (B) (No. 26750155) (to A.T.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565; Yui N, 2002, BIOCONJUGATE CHEM, V13, P582, DOI 10.1021/bc015567z; Tamura A, 2013, BIOMATERIALS, V34, P2480, DOI 10.1016/j.biomaterials.2012.12.006; Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Tamura A, 2014, CHEM COMMUN, V50, P13433, DOI 10.1039/c4cc03709j; KANATANI M, 1995, J BONE MINER RES, V10, P1681; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; Wenz G, 2006, CHEM REV, V106, P782, DOI 10.1021/cr970027+; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716; URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005; Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2; Zhou HJ, 2009, BIOMATERIALS, V30, P1715, DOI 10.1016/j.biomaterials.2008.12.016; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544; Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200; Peschel D, 2012, ACTA BIOMATER, V8, P183, DOI 10.1016/j.actbio.2011.08.012; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Harada A, 2009, CHEM REV, V109, P5974, DOI 10.1021/cr9000622; Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023; Huang FH, 2005, PROG POLYM SCI, V30, P982, DOI 10.1016/j.progpolymsci.2005.07.003; Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5; Ooya T, 2003, J AM CHEM SOC, V125, P13016, DOI 10.1021/ja034583z; Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Block MS, 1997, J ORAL MAXIL SURG, V55, P1281, DOI 10.1016/S0278-2391(97)90185-3; Bramono DS, 2012, BONE, V50, P954, DOI 10.1016/j.bone.2011.12.013; Fujimoto M, 2005, J BIOMAT SCI-POLYM E, V16, P1611, DOI 10.1163/156856205774576664; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1; DAMUS PS, 1973, NATURE, V246, P355, DOI 10.1038/246355a0; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; GLOWACKI J, 1981, LANCET, V1, P959; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]; Miyazaki T, 2008, J CELL PHYSIOL, V217, P769, DOI 10.1002/jcp.21557; Feldman GJ, 2007, AM J MED GENET A, V143A, P699, DOI 10.1002/ajmg.a.31649; HIRSH J, 1995, CHEST, V108, pS258, DOI 10.1378/chest.108.4_Supplement.258S; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; Hyun H, 2011, MACROMOL BIOSCI, V11, P765, DOI 10.1002/mabi.201000507; Joung YK, 2005, SCI TECHNOL ADV MAT, V6, P484, DOI 10.1016/j.stam.2005.03.013; Kanzaki S., 2011, PHARM REP, V63, P1221; LeGeros R. Z., 2002, CLIN ORTHOP RELAT RE, V81; Ooya T, 2007, REACT FUNCT POLYM, V67, P1408, DOI 10.1016/j.reactfunctpolym.2007.07.055; Ooya T, 2002, INT J PHARM, V242, P47, DOI 10.1016/S0378-5173(02)00139-4; ROSENBER.RD, 1973, J BIOL CHEM, V248, P6490; Tamura A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02252; Tamura A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04356; Zhang DH, 2002, J BONE MINER RES, V17, P293, DOI 10.1359/jbmr.2002.17.2.293	59	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1616-5187	1616-5195		MACROMOL BIOSCI	Macromol. Biosci.	JUL	2015	15	7					953	964		10.1002/mabi.201500032		12	Biochemistry & Molecular Biology; Materials Science, Biomaterials; Polymer Science	Biochemistry & Molecular Biology; Materials Science; Polymer Science	CM9GN	WOS:000358015600007		
J	Ageitos, JM; Chuah, JA; Numata, K				Ageitos, Jose Manuel; Chuah, Jo-Ann; Numata, Keiji			Chemo-Enzymatic Synthesis of Linear and Branched Cationic Peptides: Evaluation as Gene Carriers	MACROMOLECULAR BIOSCIENCE			English	Article						chemo-enzymatic synthesis; gene delivery; oligo(L-arginine); oligo(L-lysine); proteinase K	PROTEASE-CATALYZED OLIGOMERIZATION; POLY-L-LYSINE; TRITIRACHIUM-ALBUM LIMBER; IN-VITRO CYTOTOXICITY; DNA CONDENSATION; PROTEINASE-K; ETHYL-ESTER; AQUEOUS-SOLUTION; CELLULAR UPTAKE; DELIVERY	Cationic peptides such as poly(L-lysine) and poly(L-arginine) are important tools for gene delivery since they can efficiently condense DNA. It is difficult to produce cationic peptides by recombinant bacterial expression, and its chemical synthesis requires several steps of protection/deprotection and toxic agents. Chemo-enzymatic synthesis of peptides is a clean chemistry technique that allows fast production under mild conditions. With the aim to simplify the production of cationic peptides, the present work develops an enzymatic reaction which enables the synthesis of linear cationic peptides and, through terminal functionalization with tris(2-aminoethyl) amine, of branched cationic peptide conjugates, which show improved DNA complex formation. Cytotoxicity and transfection efficiency of all the chemo-enzymatically synthesized cationic peptides are evaluated for their novel use as gene delivery agents. Synthesized peptides exhibit transfection efficiencies comparable to previously reported monodisperse peptides. Chemo-enzymatic synthesis opens the door for efficient production of cationic peptides for their use as gene delivery carriers.	[Ageitos, Jose Manuel; Chuah, Jo-Ann; Numata, Keiji] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Program, Cooperat Div, Enzyme Res Team, Wako, Saitama 3510198, Japan	Numata, K (reprint author), RIKEN Ctr Sustainable Resource Sci, Biomass Engn Program, Cooperat Div, Enzyme Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	keiji.numata@riken.jp	Ageitos, Jose Manuel/A-1384-2012	Ageitos, Jose Manuel/0000-0002-2195-7499	RIKEN Biomass Engineering Program	This study was financially supported by the RIKEN Biomass Engineering Program.	Ageitos JM, 2013, BIOMACROMOLECULES, V14, P3635, DOI 10.1021/bm4009974; Kadlecova Z, 2012, BIOMACROMOLECULES, V13, P3127, DOI 10.1021/bm300930j; DeRouchey J, 2013, BIOCHEMISTRY-US, V52, P3000, DOI 10.1021/bi4001408; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Chandrudu S, 2013, MOLECULES, V18, P4373, DOI 10.3390/molecules18044373; Kim TH, 2007, PROG POLYM SCI, V32, P726, DOI 10.1016/j.progpolymsci.2007.05.001; Luo K, 2011, J CONTROL RELEASE, V155, P77, DOI 10.1016/j.jconrel.2010.10.006; Zhang PC, 2001, NATURE, V413, P428, DOI 10.1038/35096578; Qin X, 2011, ACS CATAL, V1, P1022, DOI 10.1021/cs2002884; Alhakamy NA, 2013, MOL PHARMACEUT, V10, P1940, DOI 10.1021/mp3007117; DeRouchey J, 2005, EUR PHYS J E, V16, P17, DOI 10.1140/epje/e2005-00003-4; Xie WC, 2013, ANAL BIOANAL CHEM, V405, P9739, DOI 10.1007/s00216-013-7397-9; Wibowo SH, 2014, CHEM COMMUN, V50, P4971, DOI 10.1039/c4cc00293h; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; WU GY, 1987, J BIOL CHEM, V262, P4429; Viswanathan K, 2010, BIOMACROMOLECULES, V11, P2152, DOI 10.1021/bm100516x; Lai JJ, 2013, BIOMACROMOLECULES, V14, P4515, DOI 10.1021/bm4013259; Whitesides GM, 2005, SMALL, V1, P172, DOI 10.1002/smll.200400130; Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Schmidt FR, 2004, APPL MICROBIOL BIOT, V65, P363, DOI 10.1007/s00253-004-1656-9; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; van Asbeck AH, 2013, ACS NANO, V7, P3797, DOI 10.1021/nn305754c; Li G, 2008, MACROMOLECULES, V41, P7003, DOI 10.1021/ma800946d; Baoum A, 2012, INT J PHARMACEUT, V427, P134, DOI 10.1016/j.ijpharm.2011.08.012; Shek PYI, 2006, J PHYS CHEM A, V110, P8282, DOI 10.1021/jp055426k; Bordusa F, 2002, CHEM REV, V102, P4817, DOI 10.1021/cr010164d; Folin O, 1927, J BIOL CHEM, V73, P627; Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7; Mann A, 2008, J CONTROL RELEASE, V125, P252, DOI 10.1016/j.jconrel.2007.10.019; Wolfert MA, 1999, BIOCONJUGATE CHEM, V10, P993, DOI 10.1021/bc990025r; Guzman F, 2007, ELECTRON J BIOTECHN, V10, P279, DOI 10.2225/vol10-issue2-fulltext-13; EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x; Guo X, 2012, ACCOUNTS CHEM RES, V45, P971, DOI 10.1021/ar200151m; DEMORENO MR, 1986, J PHARM SCI, V75, P907, DOI 10.1002/jps.2600750919; Zhou T, 2013, NANOSCALE, V5, P8288, DOI 10.1039/c3nr01630g; ARDELT W, 1985, BIOCHEMISTRY-US, V24, P5313, DOI 10.1021/bi00341a007; ASO K, 1992, BIOSCI BIOTECH BIOCH, V56, P755; Ayoub M, 2006, CHIM OGGI, V24, P46; Baker PJ, 2012, BIOMACROMOLECULES, V13, P947, DOI 10.1021/bm201862z; Beck-Piotraschke K, 1998, TETRAHEDRON-ASYMMETR, V9, P1505, DOI 10.1016/S0957-4166(98)00134-7; Chen FF, 2010, AFR J PHARM PHARMACO, V4, P721; Fagerland J, 2014, BIOMACROMOLECULES, V15, P735, DOI 10.1021/bm4015254; GLAZER AN, 1966, J BIOL CHEM, V241, P3811; Guzman F, 2013, J PEPT SCI, V19, P792, DOI 10.1002/psc.2578; HUD NV, 1994, BIOCHEMISTRY-US, V33, P7528, DOI 10.1021/bi00190a005; KAWASHIMA S, 1978, J BIOCHEM-TOKYO, V84, P343; Kim TI, 2007, BIOCONJUGATE CHEM, V18, P309, DOI 10.1021/bc0601525; Lochmann D, 2004, EUR J PHARM BIOPHARM, V58, P237, DOI 10.1016/j.ejpb.2004.03.031; Mann A, 2011, MOL PHARMACEUT, V8, P1729, DOI 10.1021/mp2000814; MAUERSBERGER B, 1977, EXP PATHOL-JENA, V13, P268; Metlitskaia L, 2004, BIOTECHNOL APPL BIOC, V39, P339; MORIHARA K, 1975, AGR BIOL CHEM TOKYO, V39, P1489; Murachi T, 1976, Methods Enzymol, V45, P475; Numata K, 2010, BIOMACROMOLECULES, V11, P3189, DOI 10.1021/bm101055m; Numata K, 2014, BIOMACROMOLECULES, V15, P3206, DOI 10.1021/bm5009052; Qin X, 2013, CHEM COMMUN, V49, P385, DOI 10.1039/c2cc36381j; Qin X, 2014, ACS CATAL, V4, P1783, DOI 10.1021/cs500268d; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Tunnemann G., 2010, MEMBRANE ACTIVE PEPT, P329; Viswanathan K, 2012, GREEN CHEM, V14, P1020, DOI 10.1039/c2gc16063c; WATSON J, 1956, T FARADAY SOC, V52, P592, DOI 10.1039/tf9565200592; Yalcin T, 1996, J MASS SPECTROM, V31, P1237, DOI 10.1002/(SICI)1096-9888(199611)31:11<1237::AID-JMS416>3.3.CO;2-G; Yazawa K, 2014, MOLECULES, V19, P13755, DOI 10.3390/molecules190913755; YOSHIOKA S, 1991, PHARMACEUT RES, V8, P480, DOI 10.1023/A:1015899011324	65	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1616-5187	1616-5195		MACROMOL BIOSCI	Macromol. Biosci.	JUL	2015	15	7					990	1003		10.1002/mabi.201400487		14	Biochemistry & Molecular Biology; Materials Science, Biomaterials; Polymer Science	Biochemistry & Molecular Biology; Materials Science; Polymer Science	CM9GN	WOS:000358015600010		
J	Ito, S; Goseki, R; Manners, I; Ishizone, T; Hirao, A				Ito, Shotaro; Goseki, Raita; Manners, Ian; Ishizone, Takashi; Hirao, Akira			Successive Synthesis of Multiarmed and Multicomponent Star-Branched Polymers by New Iterative Methodology Based on Linking Reaction between Block Copolymer In-Chain Anion and alpha-Phenylacrylate-Functionalized Polymer	MACROMOLECULAR CHEMISTRY AND PHYSICS			English	Article						anionic polymerization; block copolymers; living polymerization; star polymers; synthesis	SPECIALLY DESIGNED 1,1-DIPHENYLETHYLENE; BENZYL BROMIDE MOIETIES; PRECISE SYNTHESIS; MULTICOMPARTMENT MICELLES; LIVING POLYMERIZATION; SHAPED TERPOLYMERS; DIBLOCK COPOLYMERS; COUPLING REACTION; DERIVATIVES; POLYSTYRENES	A series of multiarmed and multicomponent miktoarm (mu-) star polymers have been successfully synthesized by developing a new iterative methodology based on a specially designed linking reaction of the block copolymer in-chain anions, whose anions are positioned between the blocks, with alpha-phenylacrylate (PA)-functionalized polymers. The iterative methodology involves the following two reaction steps: a) introduction of two different polymer segments by the linking reaction of a block copolymer in-chain anion with a PA-functionalized polymer and b) regeneration of the PA reaction site. By repeating this reaction sequence, two different polymer segments are advantageously and successively introduced into the mu- star polymer. In practice, repetition of the reaction sequence affords well-defined 3-arm ABC, 5-arm ABCDE, 7-arm ABCDEFG, and even 9-arm ABCDEFGHI mu-star polymers, composed of polystyrene, polystyrenes substituted with functional groups, polyisoprene, and poly(alkyl methacrylate) arms, respectively.	[Ito, Shotaro; Goseki, Raita; Ishizone, Takashi; Hirao, Akira] Tokyo Inst Technol, Polymer & Organ Mat Dept, Grad Sch Sci & Engn, Meguro Ku, Tokyo 1528552, Japan; [Manners, Ian] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	Ito, S (reprint author), Tokyo Inst Technol, Polymer & Organ Mat Dept, Grad Sch Sci & Engn, Meguro Ku, 2-12-S1-13 Ohokayama, Tokyo 1528552, Japan.	sito@polymer.titech.ac.jp; hirao@ntu.edu.tw			DIC Co. Ltd. in Japan; Japan Society for the Promotion of Science (JSPS)	A.H. acknowledges the financial support from DIC Co. Ltd. in Japan. S.I. appreciates the support by Grant-in-Aid for JSPS fellows from Japan Society for the Promotion of Science (JSPS). S.I. also thanks Dr. Adam Nunns and Dr. Van An Du for experimental support to synthesize poly(ferrocenylsilane)s.	Aissou K, 2013, NANO LETT, V13, P835, DOI 10.1021/nl400006c; Li ZB, 2006, LANGMUIR, V22, P9409, DOI 10.1021/la0620051; Zhao YL, 2005, J AM CHEM SOC, V127, P14158, DOI 10.1021/ja054821l; Higashihara T, 2005, MACROMOLECULES, V38, P4577, DOI 10.1021/ma0502248e; Hirao A, 2011, POLYM CHEM-UK, V2, P1219, DOI 10.1039/c0py00344a; Ito S, 2013, MACROMOLECULES, V46, P819, DOI 10.1021/ma3024975; Moughton AO, 2012, MACROMOLECULES, V45, P2, DOI 10.1021/ma201865s; Li ZB, 2006, NANO LETT, V6, P1245, DOI 10.1021/nl0608700; Li ZB, 2006, MACROMOLECULES, V39, P765, DOI 10.1021/ma052199b; Gadt T, 2009, NAT MATER, V8, P144, DOI [10.1038/nmat2356, 10.1038/NMAT2356]; Hadjichristidis N, 2005, PROG POLYM SCI, V30, P725, DOI 10.1016/j.progpolymsci.2005.04.001; Hirao A, 2005, PROG POLYM SCI, V30, P111, DOI 10.1016/j.progpolymsci.2004.12.002; Matsushita Y, 2008, POLYM J, V40, P177, DOI 10.1295/polymj.PJ2007132; Hanisch A, 2012, MACROMOLECULES, V45, P8300, DOI 10.1021/ma3017579; Hirao A, 2001, MACROMOL CHEM PHYSIC, V202, P1606, DOI 10.1002/1521-3935(20010601)202:9<1606::AID-MACP1606>3.0.CO;2-M; Huckstadt H, 2000, MACROMOL CHEM PHYSIC, V201, P296; IATROU H, 1993, MACROMOLECULES, V26, P2479, DOI 10.1021/ma00062a013; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Ito S, 2012, MACROMOLECULES, V45, P4997, DOI 10.1021/ma300699m; IATROU H, 1992, MACROMOLECULES, V25, P4649, DOI 10.1021/ma00044a028; Hadjichristidis N, 2006, PROG POLYM SCI, V31, P1068, DOI 10.1016/j.progpolymsci.2006.07.002; Wang X, 2007, J POLYM SCI POL CHEM, V45, P4818, DOI 10.1002/pola.22229; Hirao A, 2008, MACROMOLECULES, V41, P3579, DOI 10.1021/ma800146p; Fragouli P, 2006, J POLYM SCI POL CHEM, V44, P6587, DOI 10.1002/pola.21707; Takano A, 2004, MACROMOLECULES, V37, P9941, DOI 10.1021/ma048893t; Hirao A, 2004, MACROMOLECULES, V37, P5179, DOI 10.1021/ma049320j; Hirao A, 2008, POLYM J, V40, P923, DOI 10.1295/polymj.PJ2008064; Sioula S, 1998, MACROMOLECULES, V31, P5272, DOI 10.1021/ma971848j; FUJIMOTO T, 1992, POLYMER, V33, P2208, DOI 10.1016/0032-3861(92)90890-9; Goseki R, 2013, POLYMER, V54, P2049, DOI 10.1016/j.polymer.2013.01.026; Nunns A, 2013, MACROMOLECULES, V46, P2628, DOI 10.1021/ma302602u; Hadjichristidis N, 2000, J POLYM SCI POL CHEM, V38, P3211, DOI 10.1002/1099-0518(20000915)38:18<3211::AID-POLA10>3.0.CO;2-L; Gilroy JB, 2010, NAT CHEM, V2, P566, DOI [10.1038/nchem.664, 10.1038/NCHEM.664]; Hirao A, 2002, MACROMOLECULES, V35, P7238, DOI 10.1021/ma0203400; Higashihara T, 2004, J POLYM SCI POL CHEM, V42, P4535, DOI 10.1002/pola.20362; Birshtein TM, 2004, MACROMOL THEOR SIMUL, V13, P512, DOI 10.1002/mats.200400024; El-Magd A. A., 2011, MACROMOLECULES, V44, P826; Gitsas A, 2010, MACROMOLECULES, V43, P1874, DOI 10.1021/ma902631e; Goseki R, 2013, ACS MACRO LETT, V2, P625, DOI 10.1021/mz400125t; Hayashida K, 2006, MACROMOLECULES, V39, P9402, DOI 10.1021/ma0618474; Higashihara T, 2009, MACROMOLECULES, V42, P6006, DOI 10.1021/ma900750n; Higashihara T, 2002, MACROMOL CHEM PHYSIC, V203, P166, DOI 10.1002/1521-3935(20020101)203:1<166::AID-MACP166>3.0.CO;2-8; Higashihara T, 2010, MACROMOL RAPID COMM, V31, P1031, DOI 10.1002/marc.200900773; Higashihara T, 2006, MACROMOL RES, V14, P287; Higashihara T, 2010, MACROMOL SY, V296, P53, DOI 10.1002/masy.201051009; Hirano T, 2010, J INORG ORGANOMET P, V20, P445, DOI 10.1007/s10904-010-9377-2; HIRAI A, 1982, MAKROMOL CHEM-RAPID, V3, P941; HIRAO A, 1993, MACROMOLECULES, V26, P4995, DOI 10.1021/ma00071a002; Hirao A, 2011, COMPLEX MACROMOLECULAR ARCHITECTURES: SYNTHESIS, CHARACTERIZATION, AND SELF-ASSEMBLY, P97; Hirao A, 2006, MACROMOL SYMP, V240, P31, DOI 10.1002/masy.200650805; Hirao A, 2006, MACROMOLECULES, V39, P6081, DOI 10.1021/ma061078b; Hirao A, 2001, MACROMOL CHEM PHYSIC, V202, P3165, DOI 10.1002/1521-3935(20011101)202:16<3165::AID-MACP3165>3.0.CO;2-5; Hirao A, 2003, MACROMOLECULES, V36, P6081, DOI 10.1021/ma030118a; HOCKER H, 1972, MAKROMOLEKUL CHEM, V158, P191; Junnila S, 2010, MACROMOLECULES, V43, P9071, DOI 10.1021/ma101990e; Karatzas A, 2008, BIOMACROMOLECULES, V9, P2072, DOI 10.1021/bm800316w; Lambert O, 1997, MACROMOL RAPID COMM, V18, P343, DOI 10.1002/marc.1997.030180411; Lohse DJ, 1997, CURR OPIN COLLOID IN, V2, P171; Mavroudis A, 2006, MACROMOLECULES, V39, P535, DOI 10.1021/ma052040z; Nunns A, 2014, MACROMOLECULES, V47, P8420, DOI 10.1021/ma501725h; Rho Y, 2013, ACS MACRO LETT, V2, P849, DOI 10.1021/mz400363k; Walther A, 2009, CHEM COMMUN, P1127, DOI 10.1039/b820507h; Xie D, 2001, J POLYM SCI POL CHEM, V39, P1403, DOI 10.1002/pola.1117; Yamauchi K, 2003, MACROMOLECULES, V36, P6962, DOI 10.1021/ma034840k; Ye CN, 2012, MACROMOLECULES, V45, P7429, DOI 10.1021/ma3015118; Zhao YL, 2007, MACROMOLECULES, V40, P228, DOI 10.1021/ma061261h	66	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1352	1521-3935		MACROMOL CHEM PHYS	Macromol. Chem. Phys.	JUL	2015	216	14					1523	1533		10.1002/macp.201500148		11	Polymer Science	Polymer Science	CN0RJ	WOS:000358120700004		
J	Kohsaka, Y; Ishihara, S; Kitayama, T				Kohsaka, Yasuhiro; Ishihara, Shoya; Kitayama, Tatsuki			Termination of Living Anionic Polymerization of Butyl Acrylate with alpha-(Chloromethyl) acrylate for End-Functionalization and Application to the Evaluation of Monomer Reactivity	MACROMOLECULAR CHEMISTRY AND PHYSICS			English	Article						alpha-substituted acrylate; anionic polymerization; end-functional polymer; relative reactivity; terminator	POLY(METHYL METHACRYLATE); VINYL MONOMERS; CATIONIC-POLYMERIZATION; RADICAL POLYMERIZATION; METHYL-METHACRYLATE; CLICK-CHEMISTRY; POLYMERS; COPOLYMERIZATION; DERIVATIVES; SPECTRA	Anionic polymerization of n-butyl acrylate (nBA) in toluene initiated with a binary initiator, isopropyl alpha-lithioisobutyrate/ethylaluminum bis(2,6-di-tert-butylphenoxide) at -60 degrees C, is terminated with ethyl alpha-(chloromethyl) acrylate (ECMA) to afford a poly(nBA) possessing an acryloyl group at the terminal with 80% of termination efficiency. The reactivity of nBA against a polymer anion of methyl methacrylate formed under identical conditions is estimated relative to the termination with ECMA by reacting a mixture of nBA and ECMA followed by H-1 NMR spectroscopic chain-end analysis; the relative reactivity of nBA is found 80 times or more higher than ECMA.	[Kohsaka, Yasuhiro] Shinshu Univ, Fac Text Sci & Technol, Udeda, Nagano 3868567, Japan; [Ishihara, Shoya; Kitayama, Tatsuki] Osaka Univ, Grad Sch Engn Sci, Dept Chem, Toyonaka, Osaka 5608531, Japan	Kitayama, T (reprint author), Osaka Univ, Grad Sch Engn Sci, Dept Chem, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	kitayama@chem.es.osaka-u.ac.jp			JSPS KAKENHI [26620105]; Shorai Foundation for Science and Technology	This work was supported by JSPS KAKENHI Grant Number 26620105. The authors appreciate Shorai Foundation for Science and Technology for the financial support (for Y.K.).	Hall DJ, 2011, POLYM INT, V60, P1149, DOI 10.1002/pi.3121; Hirao A, 2011, POLYM CHEM-UK, V2, P1219, DOI 10.1039/c0py00344a; Quirk RP, 2000, ADV POLYM SCI, V153, P67; Yang WJ, 2013, POLYM CHEM-UK, V4, P3105, DOI 10.1039/c3py00009e; Wang CG, 2014, ACS MACRO LETT, V3, P286, DOI 10.1021/mz500069f; Moad G, 2011, POLYM INT, V60, P9, DOI 10.1002/pi.2988; Geng J, 2008, ANGEW CHEM INT EDIT, V47, P4180, DOI 10.1002/anie.200800179; Kitaura T, 2007, MACROMOL RAPID COMM, V28, P1889, DOI 10.1002/marc.200700259; Satoh K, 2009, CHEM REV, V109, P5120, DOI 10.1021/cr900115u; Gadwal I, 2013, POLYM CHEM-UK, V4, P2440, DOI 10.1039/c3py00136a; Kade MJ, 2010, J POLYM SCI POL CHEM, V48, P743, DOI 10.1002/pola.23824; Gody G, 2012, J AM CHEM SOC, V134, P12596, DOI 10.1021/ja3030643; Hirao A, 2002, PROG POLYM SCI, V27, P1399, DOI 10.1016/S0079-6700(02)00016-3; Iha RK, 2009, CHEM REV, V109, P5620, DOI 10.1021/cr900138t; Stanford MJ, 2010, CHEM SOC REV, V39, P486, DOI 10.1039/b815104k; Childers MI, 2014, CHEM REV, V114, P8129, DOI 10.1021/cr400725x; Dag A, 2008, J POLYM SCI POL CHEM, V46, P302, DOI 10.1002/pola.22381; Roth PJ, 2009, J POLYM SCI POL CHEM, V47, P3118, DOI 10.1002/pola.23392; Tasdelen MA, 2011, PROG POLYM SCI, V36, P455, DOI 10.1016/j.progpolymsci.2010.10.002; Puskas JE, 2004, BIOMACROMOLECULES, V5, P1141, DOI 10.1021/bm034513k; Coessens V, 2001, PROG POLYM SCI, V26, P337, DOI 10.1016/S0079-6700(01)00003-X; Barner-Kowollik C, 2011, ANGEW CHEM INT EDIT, V50, P60, DOI 10.1002/anie.201003707; Chen GJ, 2007, SOFT MATTER, V3, P732, DOI 10.1039/b618325e; Grover GN, 2009, MACROMOLECULES, V42, P7657, DOI 10.1021/ma901036x; Grrenley R. Z., 1999, POLYM HDB, V4th, pII/310; Hatada K, 2002, CURR ORG CHEM, V6, P121, DOI 10.2174/1385272023374454; Hatada K, 1996, POLYM BULL, V36, P399, DOI 10.1007/BF00315055; Hatada K, 2002, J MACROMOL SCI PURE, VA39, P801, DOI 10.1081/MA-120005801; Hatada K, 2002, J POLYM SCI POL CHEM, V40, P2134, DOI 10.1002/pola.10296; Hatada K, 1996, POLYM J, V28, P185, DOI 10.1295/polymj.28.185; HATADA K, 1988, PROG POLYM SCI, V13, P189, DOI 10.1016/0079-6700(88)90004-4; Inglis AJ, 2010, MACROMOLECULES, V43, P33, DOI 10.1021/ma902464a; Kanazawa A, 2010, CHEM LETT, V39, P1232, DOI 10.1246/cl.2010.1232; Kitayama T, 1997, TETRAHEDRON, V53, P15263, DOI 10.1016/S0040-4020(97)00962-9; Kitayama T, 2002, POLYM J, V34, P370, DOI 10.1295/polymj.34.370; Kitayama T, 2000, POLYM J, V32, P796, DOI 10.1295/polymj.32.796; Tabuchi M, 2002, POLYMER, V43, P7185, DOI 10.1016/S0032-3861(02)00461-5; Kohsaka Y., MACROMOL S; Kohsaka Y, 2013, POLYM CHEM-UK, V4, P5043, DOI 10.1039/c3py00799e; Kohsaka Y, 2015, POLYM CHEM-UK, V6, P1078, DOI 10.1039/c4py01285b; Kohsaka Y, 2011, ANGEW CHEM INT EDIT, V50, P10417, DOI 10.1002/anie.201103869; Kohsaka Y, 2015, POLYM CHEM-UK, V6, P3601, DOI 10.1039/c5py00357a; Kohsaka Y., 2014, J POLYM SCI A, V52, P2804; Liras M, 2011, MACROMOLECULES, V44, P1335, DOI 10.1021/ma102829s; Lowe AB, 2014, POLYM CHEM-UK, V5, P4820, DOI 10.1039/c4py00339j; Lowe AB, 2010, POLYM CHEM-UK, V1, P17, DOI 10.1039/b9py00216b; Nishiura T, 2010, POLYM J, V42, P868, DOI 10.1038/pj.2010.91; Opsteen J. A., 2005, CHEM COMMUN, V57; SAWAMOTO M, 1990, MAKROMOL CHEM-M SYMP, V32, P131, DOI 10.1002/masy.19900320112; Tao L, 2009, MACROMOLECULES, V42, P8028, DOI 10.1021/ma901540p; WARREN SC, 1990, J POLYM SCI POL CHEM, V28, P1637, DOI 10.1002/pola.1990.080280627; YAMADA B, 1991, MAKROMOL CHEM, V192, P333	52	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1352	1521-3935		MACROMOL CHEM PHYS	Macromol. Chem. Phys.	JUL	2015	216	14					1534	1539		10.1002/macp.201500100		6	Polymer Science	Polymer Science	CN0RJ	WOS:000358120700005		
J	McDaniel, L				McDaniel, Lauralyn			3D Printing Adds the Fourth Dimension (Time)	MANUFACTURING ENGINEERING			English	Editorial Material									Med Mfg Innovat, SME Technol Interchange, Innovat Watch, Tokyo, Japan	McDaniel, L (reprint author), Med Mfg Innovat, SME Technol Interchange, Innovat Watch, Tokyo, Japan.	LMcDaniel@sme.org						0	0	0	SOC MANUFACTURING ENGINEERS	DEARBORN	ONE SME DRIVE, PO BOX 930, DEARBORN, MI 48121-0930 USA	0361-0853			MANUF ENG	Manuf. Eng.	JUL	2015	155	1					14	14				1	Engineering, Manufacturing	Engineering	CM9KY	WOS:000358028500003		
J	Matsumura, M				Matsumura, M.			Wall thinning in carbon steel pipeline carrying pure water at high temperature	MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION			English	Article								In the boilers of thermal and nuclear power plants, neutral pure water with low electric conductivity is generally used after de-oxygenation, which is utilized to suppress the corrosiveness of the water. Nevertheless, a relatively high rate of wall thinning occurs on the inside surface of carbon steel pipes, in particular the downstream orifice meters and T-junctions, sometimes leading to the rupture of the pipe. The generation of wall thinning has been attributed to FAC (flow accelerated corrosion), implying that the water flow must raise the corrosiveness of the boiler water. Contrary to this explanation, the macro-cell corrosion theory, which was proposed by this author, regards this occurrence as merely localized corrosion. Under such circumstances, a case study was conducted on a burst carbon steel pipe from a high pressure steam line, and the cause was substantially proven to be water-line corrosion. Because water-line corrosion is a localized corrosion that can occur without water flow, the wall thinning damage that occurred in the carbon steel pipes must have been brought about by localized corrosion and not FAC.		Matsumura, M (reprint author), 237-101 Fukumoto, Higashihiroshima 7390031, Japan.	mmatsu@rapid.ocn.ne.jp					Fontana M. G., 1967, CORROSION ENG, P35; Matsumura M., 2012, INTRO FLOW INDUCED M, P126; Nuclear and Industrial Safety Agency and Ministry of Economy, 2002, INV REP PIP RUPT INC; Uhlig H. H., 1971, CORROSION CORROSION, V2nd, P12	4	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-5117	1521-4176		MATER CORROS	Mater. Corros.	JUL	2015	66	7					688	694		10.1002/maco.201407650		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CL9XR	WOS:000357332900010		
J	Cecchinato, F; Karlsson, J; Ferroni, L; Gardin, C; Galli, S; Wennerberg, A; Zavan, B; Andersson, M; Jimbo, R				Cecchinato, Francesca; Karlsson, Johan; Ferroni, Letizia; Gardin, Chiara; Galli, Silvia; Wennerberg, Ann; Zavan, Barbara; Andersson, Martin; Jimbo, Ryo			Osteogenic potential of human adipose-derived stromal cells on 3-dimensional mesoporous TiO2 coating with magnesium impregnation	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						3-D nanostructure; Magnesium; Osteogenesis; Osteogenic markers; Osteopontin	MESENCHYMAL STEM-CELLS; UMBILICAL-CORD BLOOD; IUPAC RECOMMENDATIONS 2001; OSTEOBLAST-LIKE CELLS; HUMAN BONE-MARROW; GENE-EXPRESSION; COMPOSITIONAL CHARACTERISTICS; INORGANIC HOSTS; TITANIUM-ALLOY; IN-VITRO	The aim of this study was to evaluate the osteogenic response of human adipose-derived stromal cells (ADScs) to mesoporous titania (TiO2) coatings produced with evaporation-induced self-assembly method (EISA) and loaded with magnesium. Our emphasis with the magnesium release functionality was to modulate progenitor cell osteogenic differentiation under standard culture conditions. Osteogenic properties of the coatings were assessed for stromal cells by means of scanning electron microscopy (SEM) imaging, colorimetric mitochondrial viability assay (MTT), colorimetric alkaline phosphates activity (ALP) assay and real time RT-polymerase chain reaction (PCR). Using atomic force microscopy (AFM) it was shown that the surface expansion area (S-dr) was strongly enhanced by the presence of magnesium. From MTT results it was shown that ADSc viability was significantly increased on mesoporous surfaces compared to the non-porous one at a longer cell culture time. However, no differences were observed between the magnesium impregnated and non-impregnated surfaces. The alkaline phosphatase activity confirmed that ADSc started to differentiate into the osteogenic phenotype after 2 weeks of culturing. The gene expression profile at 2 weeks of cell growth showed that such coatings were capable to incorporate specific osteogenic markers inside their interconnected nano-pores and, at 3 weeks, ADSc differentiated into osteoblasts. Interestingly, magnesium significantly promoted the osteopontin gene expression, which is an essential gene for the early biomaterial-cell osteogenic interaction. (C) 2015 Elsevier B.V. All rights reserved.	[Cecchinato, Francesca; Galli, Silvia; Wennerberg, Ann; Jimbo, Ryo] Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden; [Karlsson, Johan; Andersson, Martin] Chalmers, Dept Chem & Biol Engn Appl Surface Chem, S-41296 Gothenburg, Sweden; [Ferroni, Letizia; Gardin, Chiara; Zavan, Barbara] Univ Padua, Dept Histol Microbiol & Med Biotechnol, Padua, Italy; [Jimbo, Ryo] Nagasaki Univ, Dept Appl Prosthodont, Grad Sch Biomed Sci, Nagasaki 852, Japan	Cecchinato, F (reprint author), Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden.	francesca.cecchinato@mah.se		Gardin, Chiara/0000-0003-3817-0032	People Programme (Marie Curie Actions) of the European Union's under REA [n289163]	The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/under REA grant agreement no. n289163.	Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986; Grosso D, 2004, ADV FUNCT MATER, V14, P309, DOI 10.1002/adfm.200305036; Katagiri YU, 1999, CANCER RES, V59, P219; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Gabbay JS, 2006, ANN PLAS SURG, V57, P89, DOI 10.1097/01.sap.0000205378.89052.d3; de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Ryu HH, 2012, J VET MED SCI, V74, P1617, DOI 10.1292/jvms.12-0065; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Wu CW, 2006, J AM CHEM SOC, V128, P4544, DOI 10.1021/ja060453p; Hu Y, 2012, BIOMATERIALS, V33, P3515, DOI 10.1016/j.biomaterials.2012.01.040; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196; [Anonymous], 2009, J DENT IMPLANTOL, P250; Gastaldi G, 2010, J BIOMED MATER RES A, V94A, P790, DOI 10.1002/jbm.a.32721; Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020; Owen M, 1988, J Cell Sci Suppl, V10, P63; Lin Z, 2011, J PERIODONTOL, V82, P1007, DOI 10.1902/jop.2010.100577; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Karlsson J, 2012, ACTA BIOMATER, V8, P4438, DOI 10.1016/j.actbio.2012.07.035; Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; MERRY K, 1993, J CELL SCI, V104, P1013; OWEN M, 1988, CIBA F SYMP, V136, P42; McCusker LB, 2001, PURE APPL CHEM, V73, P381, DOI 10.1351/pac200173020381; Montezano AC, 2010, HYPERTENSION, V56, P453, DOI 10.1161/HYPERTENSIONAHA.110.152058; Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024; CARPENTER TO, 1992, AM J PHYSIOL, V263, pE107; Cecchinato F., 2013, J BLAMED MAT RES A, V102, P3862; Dalby Matthew J, 2012, Nanomedicine (Lond), V7, P20; Flammang BE, 2011, INTEGR COMP BIOL, V51, P128, DOI 10.1093/icb/icr014; Galli S., 2013, CLIN IMPLANT DENT RE; McCusker LB, 2003, MICROPOR MESOPOR MAT, V58, P3; Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010; SODEK J, 1977, ARCH ORAL BIOL, V22, P647, DOI 10.1016/0003-9969(77)90094-2; Bressan E, 2013, INT J MOL SCI, V14, P1918, DOI 10.3390/ijms14011918; Xia W, 2012, J BIOMED MATER RES B, V100B, P82, DOI 10.1002/jbm.b.31925; Zhang Y., 2012, SCI WORLD J, V2012, P14; Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825	45	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	JUL 1	2015	52						225	234		10.1016/j.msec.2015.03.026		10	Materials Science, Biomaterials	Materials Science	CM5TH	WOS:000357751100030		
J	Chatzistavrou, X; Velamakanni, S; DiRenzo, K; Lefkelidou, A; Fenno, JC; Kasuga, T; Boccaccini, AR; Papagerakis, P				Chatzistavrou, Xanthippi; Velamakanni, Saalini; DiRenzo, Kyle; Lefkelidou, Anna; Fenno, J. Christopher; Kasuga, Toshihiro; Boccaccini, Aldo R.; Papagerakis, Petros			Designing dental composites with bioactive and bactericidal properties	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Ag-doped bioactive glass; Dental composite; Antibacterial properties; Bioactivity; Total bond strength	AMORPHOUS CALCIUM-PHOSPHATE; GLASS-IONOMER CEMENT; MATRIX COMPONENTS; BOND STRENGTH; IN-VIVO; RESIN; MINERALIZATION; CYTOTOXICITY; RESTORATIONS; DEGRADATION	Objectives: The aim of this work was to fabricate and evaluate new antibacterial and bioactive composites capable of strictly controlling oral bacteria, enhancing apatite layer formation and retaining their mechanical properties. Methods: A new Ag-doped bioactive glass (Ag-BG) was incorporated into flowable dental composite (COMP) in different concentrations (1, 5, and 15 wt.%) in order to fabricate new combined bioactive and antibacterial composite materials (Ag-BGCOMPs). The antibacterial properties, bioactivity, and total bond strength of the Ag-BGCOMPs were evaluated. Results: The bioactivity of the Ag-BG was confirmed after its immersion in simulated body fluid (SBF). The total bond strength between the surrounding tooth tissue and the new composites or the control (dental composite alone) has not shown any statistically significant difference in the performed pilot study. Antibacterial activity was observed against Escherichia coli (E. coli) and Streptococcus mutans (S. mutans) for the Ag-BGCOMP 5 wt.% and 15 wt.% but not for the Ag-BGCOMP 1 wt.% or the control. Conclusions: This work contributes to our long term aim which is the fabrication of dental materials capable of reducing bacteria invasion and enhancing remineralization of the surrounding dental tissues. Significance: We anticipate that these new composites could ultimately prevent restoration failure by inhibiting the formation of secondary caries and by remineralizing the hard tissues surrounding tooth lesions. (C) 2015 Elsevier B.V. All rights reserved.	[Chatzistavrou, Xanthippi; Velamakanni, Saalini; Papagerakis, Petros] Univ Michigan, Sch Dent, Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA; [DiRenzo, Kyle] Univ Michigan, Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Lefkelidou, Anna] Aristotle Univ Thessaloniki, Sch Dent, Thessaloniki, Greece; [Fenno, J. Christopher] Univ Michigan, Sch Dent, Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Kasuga, Toshihiro] Nagoya Inst Technol, Dept Frontier Mat, Nagoya, Aichi, Japan; [Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91054 Erlangen, Germany	Chatzistavrou, X (reprint author), Univ Michigan, Sch Dent, Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA.	xchatzis@umich.edu; perrosp@umich.edu			University of Michigan, School of Dentistry, Department of Orthodontics & Pediatric Dentistry	This work was supported by the University of Michigan, School of Dentistry, Department of Orthodontics & Pediatric Dentistry start-up Funds of Dr. Papagerakis. Authors wish to thank Ivoclar Vivadent for providing materials.	Moreau JL, 2011, J BIOMED MATER RES B, V98B, P80, DOI 10.1002/jbm.b.31834; Moshaverinia A, 2011, J MATER SCI-MATER M, V22, P2029, DOI 10.1007/s10856-011-4391-7; Chatzistavrou X, 2014, ACTA BIOMATER, V10, P3723, DOI 10.1016/j.actbio.2014.04.030; Tomson PL, 2007, J DENT, V35, P636, DOI 10.1016/j.jdent.2007.04.008; IMAZATO S, 1994, J DENT RES, V73, P1437; Melo MAS, 2013, DENT MATER, V29, P199, DOI 10.1016/j.dental.2012.10.005; Yli-Urpo H, 2005, BIOMATERIALS, V26, P5934, DOI 10.1016/j.biomaterials.2005.03.008; Drummond JL, 2008, J DENT RES, V87, P710; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Sarrett DC, 2005, DENT MATER, V21, P9, DOI 10.1016/j.dental.2004.10.001; KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306; Miguez PA, 2004, DENT MATER, V20, P839, DOI 10.1016/j.dental.2003.10.015; Takahashi Y, 2004, J DENT RES, V83, P302; Sauro S, 2012, J MATER SCI-MATER M, V23, P1521, DOI 10.1007/s10856-012-4606-6; Li F, 2013, DENT MATER, V29, P450, DOI 10.1016/j.dental.2013.01.012; Graham L, 2006, BIOMATERIALS, V27, P2865, DOI 10.1016/j.biomaterials.2005.12.020; Barounian M, 2012, J MATER SCI-MATER M, V23, P1569, DOI 10.1007/s10856-012-4637-z; Burke F J, 1999, Prim Dent Care, V6, P17; Chatzistavrou X., 2012, MRS ONLINE P LIB, V1417, DOI org/10.1557/opl.2012.743; Forsback AP, 2004, ACTA ODONTOL SCAND, V62, P14, DOI 10.1080/00016350310008012; Gillam DG, 2002, J ORAL REHABIL, V29, P305, DOI 10.1046/j.1365-2842.2002.00824.x; Kim J, 2010, J DENT RES, V89, P575, DOI 10.1177/0022034510363380; Kremer EA, 1998, J BONE MINER RES, V13, P1890, DOI 10.1359/jbmr.1998.13.12.1890; Lenzi Tathiane Larissa, 2013, J Dent Child (Chic), V80, P20; Maupome G, 1998, J ORAL REHABIL, V25, P896; Zollner A, 2000, J ORAL REHABIL, V27, P93, DOI 10.1046/j.1365-2842.2000.00503.x; Qi Y-p, 2012, ACTA BIOMATER, V8, P836; Research NIoDaC, 2002, BIOMIMETICS TISSUE E; Sakaguchi Ronald L, 2005, Dent Mater, V21, P3, DOI 10.1016/j.dental.2004.10.008; Saravanapavan P, 2004, KEY ENG MATER, V254-2, P1087; Sauro S., 2012, J BIOMAT SCI-POLYM E, V24, P940; Sauro S, 2012, EUR J ORAL SCI, V120, P168, DOI 10.1111/j.1600-0722.2012.00939.x; Smith Anthony J, 2003, J Dent Educ, V67, P678; Xie H, 2008, AUST DENT J, V53, P325, DOI 10.1111/j.1834-7819.2008.00074.x	34	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	JUL 1	2015	52						267	272		10.1016/j.msec.2015.03.062		6	Materials Science, Biomaterials	Materials Science	CM5TH	WOS:000357751100035		
J	Moreno-Cortez, IE; Romero-Garcia, J; Gonzalez-Gonzalez, V; Garcia-Gutierrez, DI; Garza-Navarro, MA; Cruz-Silva, R				Moreno-Cortez, Ivan E.; Romero-Garcia, Jorge; Gonzalez-Gonzalez, Virginia; Garcia-Gutierrez, Domingo I.; Garza-Navarro, Marco A.; Cruz-Silva, Rodolfo			Encapsulation and immobilization of papain in electrospun nanofibrous membranes of PVA cross-linked with glutaraldehyde vapor	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Nanofibers; Papain; Enzyme immobilization; Electrospinning	PROTEASE-CATALYZED OLIGOMERIZATION; ALPHA-AMINO-ACIDS; PROTEINS; ENZYME; ESTER; HYDROLYSIS; BIOSENSOR; CELLULASE; RELEASE; LIPASE	In this paper, papain enzyme (E.C. 3.4.22.2, 1.6 U/mg) was successfully immobilized in poly(vinyl alcohol) (PVA) nanofibers prepared by electrospinning. The morphology of the electrospun nanofibers was characterized by scanning electron microscopy (SEM) and the diameter distribution was in the range of 80 to 170 nm. The presence of the enzyme within the PVA nanofibers was confirmed by infrared spectroscopy (FTIR), X-ray photoelectron spectroscopy (XPS) and energy dispersive X-ray spectroscopy (EDXS) analyses. The maximum catalytic activity was reached when the enzyme loading was 13%. The immobilization of papain in the nanofiber membrane was achieved by chemical crosslinking with a glutaraldehyde vapor treatment (GAvt). The catalytic activity of the immobilized papain was 88% with respect to the free enzyme. The crosslinking time by GAvt to immobilize the enzyme onto the nanofiber mat was 24 h, and the enzyme retained its catalytic activity after six cycles. The crosslinked samples maintained 40% of their initial activity after being stored for 14 days. PVA electrospun nanofibers are excellent matrices for the immobilization of enzymes due to their high surface area and their nanoporous structure. (C) 2015 Published by Elsevier B.V.	[Moreno-Cortez, Ivan E.; Romero-Garcia, Jorge] CIQA, Sakillo 25100, Coahuila, Mexico; [Moreno-Cortez, Ivan E.; Gonzalez-Gonzalez, Virginia; Garcia-Gutierrez, Domingo I.; Garza-Navarro, Marco A.] UANL, FIME, San Nicolas De Lo Garza 66450, Nuevo Lean, Mexico; [Gonzalez-Gonzalez, Virginia; Garcia-Gutierrez, Domingo I.; Garza-Navarro, Marco A.] UANL, CIIDIT, Apodaca, Nuevo Leon, Mexico; [Cruz-Silva, Rodolfo] Shinshu Univ, Res Ctr Exot Nanocarbons, Nagano 3808553, Japan	Romero-Garcia, J (reprint author), CIQA, Blvd Enrique Reyna 140, Sakillo 25100, Coahuila, Mexico.	jromero@ciqa.mx	Cruz-Silva, Rodolfo/A-2149-2012	Cruz-Silva, Rodolfo/0000-0002-6120-9524	CONACYT-Mexico (Convocatoria conjunta CONACYT-CNPq Mexico-Brasil en nanotecnologias) [174806]; CONACYT (Convocatoria CienciaBasica) [176671]; PROMEP-SEP-Mexico [103.5/12/4296]	The funding support from CONACYT-Mexico (Project 174806, Convocatoria conjunta CONACYT-CNPq Mexico-Brasil en nanotecnologias 2011) and CONACYT (Project 176671, Convocatoria CienciaBasica 2012) as well as PROMEP-SEP-Mexico (103.5/12/4296) are greatly appreciated. The authors also want to thank Ms. Gabriela Padron and M.C. Monica Ceniceros for their technical assistance.	ANDERSON G, 1979, HELV CHIM ACTA, V62, P488, DOI 10.1002/hlca.19790620214; Lee SM, 2010, BIOPROC BIOSYST ENG, V33, P141, DOI 10.1007/s00449-009-0386-x; Yao L, 2003, CHEM MATER, V15, P1860, DOI 10.1021/cm0210795; Wu LL, 2005, J MEMBRANE SCI, V250, P167, DOI 10.1016/j.memsci.2004.10.024; Wang W, 2011, TALANTA, V84, P71, DOI 10.1016/j.talanta.2010.12.015; Wang Y, 2008, J MEMBRANE SCI, V309, P73, DOI 10.1016/j.memsci.2007.10.008; Li G, 2006, MACROMOLECULES, V39, P7915, DOI 10.1021/ma061419y; Kim IB, 2006, J AM CHEM SOC, V128, P2818, DOI 10.1021/ja058431a; Salalha W, 2006, NANOTECHNOLOGY, V17, P4675, DOI 10.1088/0957-4484/17/18/025; Hung TC, 2011, ENZYME MICROB TECH, V49, P30, DOI 10.1016/j.enzmictec.2011.04.012; Qin X, 2011, ACS CATAL, V1, P1022, DOI 10.1021/cs2002884; Ma ZW, 2006, J MEMBRANE SCI, V272, P179, DOI 10.1016/j.memsci.2005.07.038; Schwab LW, 2012, POLYMERS-BASEL, V4, P710, DOI 10.3390/polym4010710; Vasconcellos FC, 2011, POWDER TECHNOL, V205, P65, DOI 10.1016/j.powtec.2010.08.066; Sawicka K, 2005, SENSOR ACTUAT B-CHEM, V108, P585, DOI 10.1016/j.snb.2004.12.013; Park JM, 2013, INT J BIOL MACROMOL, V54, P37, DOI 10.1016/j.ijbiomac.2012.11.025; Viswanathan K, 2010, BIOMACROMOLECULES, V11, P2152, DOI 10.1021/bm100516x; Marx S, 2011, BIOSENS BIOELECTRON, V26, P2981, DOI 10.1016/j.bios.2010.11.050; Xin BJ, 2010, CHEM-ASIAN J, V5, P1389, DOI 10.1002/asia.200900696; Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481; Ghosh S, 2012, J MOL CATAL B-ENZYM, V74, P132, DOI 10.1016/j.molcatb.2011.09.009; Wang MF, 2011, BIORESOURCE TECHNOL, V102, P3541, DOI 10.1016/j.biortech.2010.08.120; Shaikh RP, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025002; Arecchi A, 2010, ANAL CHIM ACTA, V659, P133, DOI 10.1016/j.aca.2009.11.039; Rao RS, 2006, ENZYME MICROB TECH, V39, P958, DOI 10.1016/j.enzmictec.2006.03.020; Ha M, 2012, FOOD CHEM, V134, P95, DOI 10.1016/j.foodchem.2012.02.071; Toksoz S, 2011, J COLLOID INTERF SCI, V356, P131, DOI 10.1016/j.jcis.2010.12.076; Chen PC, 2011, CELLULOSE, V18, P1563, DOI 10.1007/s10570-011-9593-0; Dai YR, 2011, ENVIRON SCI TECHNOL, V45, P10611, DOI 10.1021/es203286e; Moreno I, 2011, EUR POLYM J, V47, P1264, DOI 10.1016/j.eurpolymj.2011.03.005; Chen JP, 2011, ACTA BIOMATER, V7, P234, DOI 10.1016/j.actbio.2010.08.015; McKee MG, 2006, MACROMOLECULES, V39, P575, DOI 10.1021/ma051786u; Ren GL, 2006, REACT FUNCT POLYM, V66, P1559, DOI 10.1016/j.reactfunctpolym.2006.05.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Anuradha S., 2011, BIOMED MATER, V6; Bian WY, 2012, MAT SCI ENG C-MATER, V32, P364, DOI 10.1016/j.msec.2011.11.006; Chankhampan C., 2012, J EXP NANOSCI, P1; Colowick S. P., 1971, METHOD ENZYMOL, VXIX, P226; Das V., 2011, COMPUTER NETWORKS IN, V142, P553; Fran D. N., 2011, J MOL CATAL B-ENZYM, V72, P1; Gyorgy E, 2009, J APPL PHYS, V106, DOI 10.1063/1.3266670; He H. Z.-L., 2009, CHIN J BIOCH MOL BIO, V25, P25; JOST R, 1980, HELV CHIM ACTA, V63, P375, DOI 10.1002/hlca.19800630207; KENNEDY JF, 1981, ENZYME MICROB TECH, V3, P59, DOI 10.1016/0141-0229(81)90037-5; Kim H., BIOSENS BIOELECTRON, V26, P3908; Li ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015168; SLUYTERM.LA, 1972, BIOCHIM BIOPHYS ACTA, V289, P194, DOI 10.1016/0005-2744(72)90122-2; Wang Q, 2011, ENZYME MICROB TECH, V49, P11, DOI 10.1016/j.enzmictec.2011.04.007; Xue Y, 2010, APPL BIOCHEM BIOTECH, V160, P109, DOI 10.1007/s12010-009-8588-x	49	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	JUL 1	2015	52						306	314		10.1016/j.msec.2015.03.049		9	Materials Science, Biomaterials	Materials Science	CM5TH	WOS:000357751100040		
J	Sugama, Y; Nishio, T; Onishi, H				Sugama, Yuya; Nishio, Teiji; Onishi, Hiroshi			Technical Note: Experimental determination of the effective point of measurement of two cylindrical ionization chambers in a clinical proton beam	MEDICAL PHYSICS			English	Article						proton therapy; effective point of measurement; radiation therapy; radiation dosimetry; ionization chamber	DOSIMETRY; WATER; DEPTH; CODE	Purpose: IAEA TRS-398 notes that cylindrical ionization chambers are preferred for reference proton dosimetry. If a cylindrical ionization chamber is used in a phantom to measure the dose as a function of depth, the effective point of measurement (EPOM) must be taken into account. IAEA TRS-398 recommends a displacement of 0.75 times the inner cavity radius (0.75R) for heavy ion beams. Theoretical models by Palmans and by Bhullar and Watchman confirmed this value. However, the experimental results vary from author to author. The purpose of this study is to accurately measure the displacement and explain the past experimental discrepancies. Methods: In this work, we measured the EPOM of cylindrical ionization chambers with high accuracy by comparing the Bragg-peak position obtained with cylindrical ionization chambers (PTW 30013, PTW 31016) to that obtained using a plane-parallel ionization chamber (PTW 34045). Results: The EPOMs of PTW 30013 and 31016 were shifted by 0.92+/-0.07R with R = 3.05 mm and 0.90+/-0.14R with R = 1.45 mm, respectively, from the reference point toward the source. Conclusions: The EPOMs obtained were greater than the value of 0.75R proposed by the IAEA TRS-398 and the analytical results. (C) 2015 American Association of Physicists in Medicine.	[Sugama, Yuya] Aizawa Hosp, Proton Therapy Ctr, Nagano 3900821, Japan; [Sugama, Yuya; Onishi, Hiroshi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Yamanashi 4093898, Japan; [Nishio, Teiji] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima 7348551, Japan	Sugama, Y (reprint author), Aizawa Hosp, Proton Therapy Ctr, Nagano 3900821, Japan.	yuya.sugama@gmail.com					American Association of Physicists in Medicine (AAPM), 1986, 16 AAPM AM I PHYS; Bhullar AS, 2012, PHYS MED BIOL, V57, P273, DOI 10.1088/0031-9155/57/1/273; Hartmann GH, 1999, PHYS MED BIOL, V44, P1193, DOI 10.1088/0031-9155/44/5/008; International Atomic Energy Agency: IAEA Vienna, 2000, IAEA TECHN REP SER, V398; International Commission on Radiation Units and Measurements (ICRU), 1998, 59 ICRU; Jakel O, 2000, PHYS MED BIOL, V45, P599, DOI 10.1088/0031-9155/45/3/303; Kanai T, 2004, PHYS MED BIOL, V49, P771, DOI 10.1088/0031-9155/49/5/008; Mobit PN, 2000, MED PHYS, V27, P2780, DOI 10.1118/1.1323985; Nishio T., 1999, J AT ENERGY SOC, V41, P1134; Palmans H, 2006, PHYS MED BIOL, V51, P3483, DOI 10.1088/0031-9155/51/14/014; Palmans H., 2000, DQLRD002; Palmans H, 2000, PHYS MED BIOL, V45, pL20, DOI 10.1088/0031-9155/45/8/103; Tachikawa T., 1999, RAD IND, V84, P48; VYNCKIER S, 1991, RADIOTHER ONCOL, V20, P53, DOI 10.1016/0167-8140(91)90112-T; VYNCKIER S, 1994, RADIOTHER ONCOL, V32, P174, DOI 10.1016/0167-8140(94)90104-X	15	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	JUL	2015	42	7					3892	3895		10.1118/1.4921617		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM4WN	WOS:000357686400011		
J	Saito, M				Saito, Masatoshi			Technical Note: Relation between dual-energy subtraction of CT images for electron density calibration and virtual monochromatic imaging	MEDICAL PHYSICS			English	Article						dual-energy CT; electron density; virtual monochromatic imaging; material decomposition	SINGLE LINEAR RELATIONSHIP; EXPERIMENTAL-VERIFICATION; CONVERSION; QUALITY; PHANTOM; NUMBERS	Purpose: For accurate tissue inhomogeneity correction in radiotherapy treatment planning, the author previously proposed a simple conversion of the energy-subtracted computed tomography (CT) number to an electron density (Delta HU-rho(e) conversion), which provides a single linear relationship between Delta HU and rho(e) over a wide rho(e) range. The purpose of the present study was to reveal the relation between the Delta HU image for rho(e) calibration and a virtually monochromatic CT image by performing numerical analyses based on the basis material decomposition in dual-energy CT. Methods: The author determined the weighting factor, alpha(0), of the Delta HU-rho(e) conversion through numerical analyses of the International Commission on Radiation Units and Measurements Report-46 human body tissues using their attenuation coefficients and given rho(e) values. Another weighting factor, alpha(E), for synthesizing a virtual monochromatic CT image from high-and low-kV CT images, was also calculated in the energy range of 0.03 < E < 5 MeV, assuming that cortical bone and water were the basis materials. The mass attenuation coefficients for these materials were obtained using the XCOM photon cross sections database. The effective x-ray energies used to calculate the attenuation were chosen to imitate a dual-source CT scanner operated at 80-140 and 100-140 kV/Sn. Results: The determined alpha(0) values were 0.455 for 80-140 kV/Sn and 0.743 for 100-140 kV/Sn. These values coincided almost perfectly with the respective maximal points of the calculated a(E) curves located at approximately 1 MeV, in which the photon-matter interaction in human body tissues is exclusively the incoherent (Compton) scattering. Conclusions: The Delta HU image could be regarded substantially as a CT image acquired with monoenergetic 1-MeV photons, which provides a linear relationship between CT numbers and electron densities. (C) 2015 American Association of Physicists in Medicine.	Niigata Univ, Dept Radiol Technol, Sch Hlth Sci, Fac Med, Niigata 9518518, Japan	Saito, M (reprint author), Niigata Univ, Dept Radiol Technol, Sch Hlth Sci, Fac Med, Niigata 9518518, Japan.	masaito@clg.niigata-u.ac.jp					Hunemohr N, 2014, PHYS MED BIOL, V59, P83, DOI 10.1088/0031-9155/59/1/83; Schneider U, 1996, PHYS MED BIOL, V41, P111, DOI 10.1088/0031-9155/41/1/009; LEHMANN LA, 1981, MED PHYS, V8, P659, DOI 10.1118/1.595025; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Saito M, 2012, MED PHYS, V39, P2021, DOI 10.1118/1.3694111; CONSTANTINOU C, 1992, MED PHYS, V19, P325, DOI 10.1118/1.596862; Yu LF, 2011, MED PHYS, V38, P6371, DOI 10.1118/1.3658568; PARKER RP, 1979, PHYS MED BIOL, V24, P802, DOI 10.1088/0031-9155/24/4/011; Yu LF, 2009, MED PHYS, V36, P1019, DOI 10.1118/1.3077921; ASTM, 2013, E1935 ASTM; Berger M. J., 1999, E1935 ASTM; Evans JD, 2013, MED PHYS, V40, DOI 10.1118/1.4828787; ICRU, 1992, 46 ICRU; Landry G, 2013, PHYS MED BIOL, V58, DOI 10.1088/0031-9155/58/15/5029; Saito M, 2014, MED PHYS, V41, DOI 10.1118/1.4881327; Tsukihara M, 2013, PHYS MED BIOL, V58, pN135, DOI 10.1088/0031-9155/58/9/N135; Tsukihara M, 2015, MED PHYS, V42, P1378, DOI 10.1118/1.4908207	17	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	JUL	2015	42	7					4088	4093		10.1118/1.4921999		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM4WN	WOS:000357686400030		
J	Ida, S; Ozaki, N; Araki, K; Hirashima, K; Zaitsu, Y; Taki, K; Sakamoto, Y; Miyamoto, Y; Oki, E; Morita, M; Watanabe, M; Maehara, Y; Yamamura, K; Baba, H; Ohmuraya, M				Ida, Satoshi; Ozaki, Nobuyuki; Araki, Kimi; Hirashima, Kotaro; Zaitsu, Yoko; Taki, Katsunobu; Sakamoto, Yasuo; Miyamoto, Yuji; Oki, Eiji; Morita, Masaru; Watanabe, Masayuki; Maehara, Yoshihiko; Yamamura, Ken-ichi; Baba, Hideo; Ohmuraya, Masaki			SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer	MOLECULAR CANCER RESEARCH			English	Article							SECRETORY-TRYPSIN-INHIBITOR; EPIDERMAL-GROWTH-FACTOR; PANCREATIC ACINAR-CELLS; DEXTRAN SODIUM-SULFATE; HEPATOCELLULAR-CARCINOMA; EARLY RECURRENCE; OVARIAN-CANCER; PSTI GENE; EXPRESSION; TUMOR	Colorectal cancer is a major cause of deaths due to cancer; therefore, research into its etiology is urgently needed. Although it is clear that chronic inflammation is a risk factor for colorectal cancer, the details remain uncertain. Serine protease inhibitor, Kazal type 1 (SPINK1) is mainly produced in pancreatic acinar cells. However, SPINK1 is expressed in various cancers and in inflammatory states, such as colon cancer and inflammatory bowel disease. There are structural similarities between SPINK1 and epidermal growth factor (EGF). Hence, it was hypothesized that SPINK1 functions as a growth factor for tissue repair in inflammatory states, and if prolonged, acts as a promoter for cell proliferation in cancerous tissues. Here, immunohistochemical staining for SPINK1 was observed in a high percentage of colorectal cancer patient specimens and SPINK1 induced proliferation of human colon cancer cell lines. To clarify its role in colon cancer in vivo, a mouse model exposed to the colon carcinogen azoxymethane and nongenotoxic carcinogen dextran sodium sulfate revealed that Spink3 (mouse homolog of SPINK1) is overexpressed in cancerous tissues. In Spink3 heterozygous mice, tumor multiplicity and tumor volume were significantly decreased compared with wild-type mice. These results suggest that SPINK1/Spink3 stimulates the proliferation of colon cancer cells and is involved in colorectal cancer progression. (C)2015 AACR.	[Ida, Satoshi; Araki, Kimi; Taki, Katsunobu; Yamamura, Ken-ichi; Ohmuraya, Masaki] Kumamoto Univ, Inst Resource Dev & Anal, Kumamoto 8600811, Japan; [Ida, Satoshi; Ozaki, Nobuyuki; Taki, Katsunobu; Sakamoto, Yasuo; Miyamoto, Yuji; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8600811, Japan; [Hirashima, Kotaro] Niigata Univ, Grad Sch Med & Dent Sci, Dept Digest & Gen Surg, Niigata, Japan; [Zaitsu, Yoko; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Watanabe, Masayuki] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan	Ohmuraya, M (reprint author), Kumamoto Univ, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	ohmuraya@kumamoto-u.ac.jp			KAKENHI from Japanese Society for the Promotion of Science [25861196]	This work was supported by a grant-in-aid for Young Scientists (B) (KAKENHI) (25861196) from the Japanese Society for the Promotion of Science.	HUNT LT, 1974, BIOCHEM BIOPH RES CO, V60, P1020, DOI 10.1016/0006-291X(74)90415-X; Gouyer V, 2008, ONCOGENE, V27, P4024, DOI 10.1038/onc.2008.42; Chambers WM, 2005, BRIT J SURG, V92, P928, DOI 10.1002/bjs.5106; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; Suzuki R, 2006, CARCINOGENESIS, V27, P162, DOI 10.1093/carcin/bgi205; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; SCHEVING LA, 1983, ARCH BIOCHEM BIOPHYS, V226, P411, DOI 10.1016/0003-9861(83)90309-0; Soreide K, 2006, J PATHOL, V209, P147, DOI 10.1002/path.1999; Ozaki N, 2009, MOL CANCER RES, V7, P1572, DOI 10.1158/1541-7786.MCR-08-0567; COOPER HS, 1993, LAB INVEST, V69, P238; HUHTALA ML, 1982, J BIOL CHEM, V257, P13713; Ateeq B, 2011, SCI TRANSL MED, V3, P1, DOI DOI 10.1126/SCITRANSLMED.3001498; FUKUOKA S, 1987, BIOCHEM BIOPH RES CO, V145, P646, DOI 10.1016/0006-291X(87)91013-8; Gaber A, 2009, BRIT J CANCER, V100, P1540, DOI 10.1038/sj.bjc.6605047; HIGASHIYAMA M, 1992, TUMOR BIOL, V13, P299; HIGASHIYAMA M, 1990, BRIT J CANCER, V62, P954, DOI 10.1038/bjc.1990.416; Hirashima K, 2012, BRIT J CANCER, V106, P876, DOI 10.1038/bjc.2012.36; HORII A, 1987, BIOCHEM BIOPH RES CO, V149, P635, DOI 10.1016/0006-291X(87)90415-3; Ida S, 2010, EXP ANIM TOKYO, V59, P421; KAZAL LA, 1948, J AM CHEM SOC, V70, P3034, DOI 10.1021/ja01189a060; KITAHARA T, 1980, CLIN CHIM ACTA, V103, P135, DOI 10.1016/0009-8981(80)90205-3; Koskensalo S, 2012, ONCOLOGY-BASEL, V82, P234, DOI 10.1159/000336080; Koskensalo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076906; Lee YC, 2007, EUR J CANCER, V43, P736, DOI 10.1016/j.ejca.2006.11.020; Marchbank T, 1996, AM J PATHOL, V148, P715; Marchbank T, 1998, DIGESTION, V59, P167, DOI 10.1159/000007485; MATSUDA K, 1985, AM J GASTROENTEROL, V80, P694; Neuschwander-Tetri BA, 2004, PANCREAS, V28, pE104, DOI 10.1097/00006676-200405000-00022; NIINOBU T, 1990, J EXP MED, V172, P1133, DOI 10.1084/jem.172.4.1133; OGAWA M, 1987, RES COMMUN CHEM PATH, V55, P137; OHMACHI Y, 1993, INT J CANCER, V55, P728, DOI 10.1002/ijc.2910550505; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; Ohmuraya M, 2006, PANCREAS, V33, P104, DOI 10.1097/01.mpa.0000226889.86322.9b; Paju A, 2006, CRIT REV CL LAB SCI, V43, P103, DOI 10.1080/10408360500523852; PLAYFORD RJ, 1995, AM J PATHOL, V146, P310; Sakata K, 2014, EXP ANIM TOKYO, V63, P45; Solakidi S, 2003, HISTOL HISTOPATHOL, V18, P1181; STENMAN UH, 1982, INT J CANCER, V30, P53, DOI 10.1002/ijc.2910300110; Stenman UH, 2002, CLIN CHEM, V48, P1206; Suzuki R, 2004, CANCER SCI, V95, P721, DOI 10.1111/j.1349-7006.2004.tb03252.x; TOMITA N, 1987, FEBS LETT, V225, P113, DOI 10.1016/0014-5793(87)81141-9; TOMITA N, 1990, CANCER, V66, P2144, DOI 10.1002/1097-0142(19901115)66:10<2144::AID-CNCR2820661017>3.0.CO;2-#; Tonouchi A, 2006, AM J GASTROENTEROL, V101, P1601, DOI 10.1111/j.1572-0241.2006.00612.x; Wang J, 2010, LAB INVEST, V90, P654, DOI 10.1038/labinvest.2010.44; Wang J, 2008, HISTOCHEM CELL BIOL, V130, P387, DOI 10.1007/s00418-008-0425-8; Wiksten JP, 2005, HISTOPATHOLOGY, V46, P380, DOI 10.1111/j.1365-2559.2005.02073.x; YAMAMOTO T, 1985, BIOCHEM BIOPH RES CO, V132, P605, DOI 10.1016/0006-291X(85)91176-3; YASUDA T, 1993, GENE, V131, P275	48	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1541-7786	1557-3125		MOL CANCER RES	Mol. Cancer Res.	JUL	2015	13	7					1130	1138		10.1158/1541-7786.MCR-14-0581		9	Oncology; Cell Biology	Oncology; Cell Biology	CM9WF	WOS:000358059500007		
J	Ibuki, N; Ghaffari, M; Reuveni, H; Pandey, M; Fazli, L; Azuma, H; Gleave, ME; Levitzki, A; Cox, ME				Ibuki, Naokazu; Ghaffari, Mazyar; Reuveni, Hadas; Pandey, Mitali; Fazli, Ladan; Azuma, Haruhito; Gleave, Martin E.; Levitzki, Alexander; Cox, Michael E.			The tyrphostin, NT157, suppresses insulin receptor substrates and augments therapeutic response of prostate cancer	MOLECULAR CANCER THERAPEUTICS			English	Meeting Abstract									[Ibuki, Naokazu; Ghaffari, Mazyar; Pandey, Mitali; Fazli, Ladan; Gleave, Martin E.; Cox, Michael E.] Vancouver Gen Hosp, Vancouver, BC, Canada; [Ibuki, Naokazu; Azuma, Haruhito] Osaka Med Coll, Osaka, Japan; [Reuveni, Hadas] TyrNovo Ltd, Herzliyya, Israel; [Reuveni, Hadas; Levitzki, Alexander] Hebrew Univ Jerusalem, Jerusalem, Israel; [Ghaffari, Mazyar; Gleave, Martin E.; Cox, Michael E.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada								0	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	JUL	2015	14	7		S		B51				10.1158/1538-8514.PI3K14-B51		1	Oncology	Oncology	CN1EF	WOS:000358159200083		
J	Isoyama, S; Kajiwara, G; Tamaki, N; Mutsumi, O; Yoshimi, H; Nakamura, N; Nishimura, Y; Yamori, T; Dan, S				Isoyama, Sho; Kajiwara, Gensei; Tamaki, Naomi; Mutsumi, Okamura; Yoshimi, Hisashi; Nakamura, Naoki; Nishimura, Yumiko; Yamori, Takao; Dan, Shingo			Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a PI3K inhibitor ZSTK474	MOLECULAR CANCER THERAPEUTICS			English	Meeting Abstract									[Isoyama, Sho; Yoshimi, Hisashi] Zenyaku Kogyo Co Ltd, Tokyo, Japan; [Kajiwara, Gensei; Tamaki, Naomi; Mutsumi, Okamura; Nakamura, Naoki; Nishimura, Yumiko; Yamori, Takao; Dan, Shingo] Japanese Fdn Canc Res, Tokyo, Japan								0	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	JUL	2015	14	7		S		A43				10.1158/1538-8514.PI3K14-A43		2	Oncology	Oncology	CN1EF	WOS:000358159200036		
J	Iwao, C; Shidoji, Y				Iwao, Chieko; Shidoji, Yoshihiro			Geranylgeranoic acid (GGA) induced autophagic cell death through induction of unfolded protein response (UPR) and suppression of mTOR signaling pathway	MOLECULAR CANCER THERAPEUTICS			English	Meeting Abstract									[Iwao, Chieko; Shidoji, Yoshihiro] Nagasaki Univ, Grad Sch Human Hlth Sci, Nagasaki 852, Japan								0	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	JUL	2015	14	7		S		A18				10.1158/1538-8514.PI3K14-A18		2	Oncology	Oncology	CN1EF	WOS:000358159200016		
J	Noguchi, M; Suizu, F; Lennikov-Matsuda, M; Jyoti, B; Ohba, Y; Hirata, N				Noguchi, Masayuki; Suizu, Futoshi; Lennikov-Matsuda, Mami; Jyoti, Bala; Ohba, Yusuke; Hirata, Noriyuki			Lysosomal interaction of Akt with Phafin2: A critical step in the induction of autophagy	MOLECULAR CANCER THERAPEUTICS			English	Meeting Abstract									[Noguchi, Masayuki; Suizu, Futoshi; Lennikov-Matsuda, Mami; Jyoti, Bala; Hirata, Noriyuki] Hokkaido Univ, Div Canc Biol, Inst Med Genet, Sapporo, Hokkaido, Japan; [Ohba, Yusuke] Hokkaido Univ, Lab Pathophysiol & Signal Transduct, Sapporo, Hokkaido, Japan								0	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	JUL	2015	14	7		S		B20				10.1158/1538-8514.PI3K14-B20		1	Oncology	Oncology	CN1EF	WOS:000358159200061		
J	Takahashi, H; Nishimura, J; Kagawa, Y; Kano, Y; Takahashi, Y; Wu, X; Hiraki, M; Hamabe, A; Konno, M; Haraguchi, N; Takemasa, I; Mizushima, T; Ishii, M; Mimori, K; Ishii, H; Doki, Y; Mori, M; Yamamoto, H				Takahashi, Hidekazu; Nishimura, Junichi; Kagawa, Yoshinori; Kano, Yoshihiro; Takahashi, Yusuke; Wu, Xin; Hiraki, Masayuki; Hamabe, Atsushi; Konno, Masamitsu; Haraguchi, Naotsugu; Takemasa, Ichiro; Mizushima, Tsunekazu; Ishii, Masaru; Mimori, Koshi; Ishii, Hideshi; Doki, Yuichiro; Mori, Masaki; Yamamoto, Hirofumi			Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer	MOLECULAR CANCER THERAPEUTICS			English	Article							LYMPH-NODE METASTASIS; RIBOSOMAL ENTRY SITE; MESSENGER-RNA; PYRUVATE-KINASE; STEM-CELLS; DEPENDENT TRANSLATION; SPLICING REGULATION; EXON DEFINITION; CARCINOMA-CELLS; CD44 VARIANT	Polypyrimidine tract-binding protein (PTBP1) is an RNA-binding protein with various molecular functions related to RNA metabolism and a major repressive regulator of alternative splicing, causing exon skipping in numerous alternatively spliced pre-mRNAs. Here, we have investigated the role of PTBP1 in colorectal cancer. PTBP1 expression levels were significantly overexpressed in cancerous tissues compared with corresponding normal mucosal tissues. We also observed that PTBP1 expression levels, c-MYC expression levels, and PKM2: PKM1 ratio were positively correlated in colorectal cancer specimens. Moreover, PTBP1 expression levels were positively correlated to poor prognosis and lymph node metastasis. In analyses of colorectal cancer cells using siRNA for PTBP1, we observed that PTBP1 affects cell invasion, which was partially correlated to CD44 splicing, and this correlation was also confirmed in clinical samples. PTBP1 expression also affected anchorage-independent growth in colorectal cancer cell lines. PTBP1 expression also affected cell proliferation. Using time-lapse imaging analysis, PTBP1 was implicated in prolonged G(2)-M phase in HCT116 cells. As for the mechanism of prolonged G(2)-M phase in HCT116 siPTBP1 cells, Western blotting revealed that PTBP1 expression level was correlated to CDK11(p58) expression level, which was reported to play an important role on progression to complete mitosis. These findings indicated that PTBP1 is a potential therapeutic target for colorectal cancer. (C) 2015 AACR.	[Takahashi, Hidekazu; Nishimura, Junichi; Kagawa, Yoshinori; Takahashi, Yusuke; Wu, Xin; Hiraki, Masayuki; Hamabe, Atsushi; Haraguchi, Naotsugu; Takemasa, Ichiro; Mizushima, Tsunekazu; Doki, Yuichiro; Mori, Masaki; Yamamoto, Hirofumi] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Suita, Osaka 5650871, Japan; [Kagawa, Yoshinori; Ishii, Masaru] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Cellular Dynam, Suita, Osaka 5650871, Japan; [Kano, Yoshihiro; Konno, Masamitsu; Ishii, Hideshi] Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Osaka, Japan; [Takahashi, Yusuke; Mimori, Koshi] Kyushu Univ, Med Inst Bioregulat, Div Mol & Surg Oncol, Dept Mol & Cellular Biol, Ohita, Japan	Yamamoto, H (reprint author), Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	hyamamoto@gesurg.med.osaka-u.ac.jp	Nishimura, Junichi/K-8390-2015	Nishimura, Junichi/0000-0001-8220-3423	Taiho Co.	H. Ishii reports receiving commercial research support from Taiho Co. No potential conflicts of interest were disclosed by the other authors.	Zeilstra J, 2014, ONCOGENE, V33, P665, DOI 10.1038/onc.2012.611; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Cheung HC, 2009, BRAIN, V132, P2277, DOI 10.1093/brain/awp153; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Rofstad EK, 2002, CANCER RES, V62, P1847; PATTON JG, 1991, GENE DEV, V5, P1237, DOI 10.1101/gad.5.7.1237; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Takahashi H, 2011, ANN SURG ONCOL, V18, P1166, DOI 10.1245/s10434-010-1373-9; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Koukourakis MI, 2001, CLIN CANCER RES, V7, P3399; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Zhou ZJ, 2013, INT J CANCER, V132, P1080, DOI 10.1002/ijc.27742; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Cheung HC, 2006, MODERN PATHOL, V19, P1034, DOI 10.1038/modpathol.3800635; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Lou H, 1996, GENE DEV, V10, P208, DOI 10.1101/gad.10.2.208; TAKEUCHI K, 1995, JPN J CANCER RES, V86, P292; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Miyoshi H, 1998, J VIROL, V72, P8150; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Lou H, 1999, MOL CELL BIOL, V19, P78; Cairns RA, 2004, CANCER RES, V64, P2054, DOI 10.1158/0008-5472.CAN-03-3196; Perez I, 1997, RNA, V3, P764; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Ueno H, 2002, HISTOPATHOLOGY, V40, P127, DOI 10.1046/j.1365-2559.2002.01324.x; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Cho SC, 2005, MOL CELL BIOL, V25, P1283, DOI 10.1128/MCB.25.4.1283-1297.2005; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Shibayama M, 2009, FEBS J, V276, P6658, DOI 10.1111/j.1742-4658.2009.07380.x; Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Zhou CF, 2012, IUBMB LIFE, V64, P775, DOI 10.1002/iub.1066; Yamamoto H, 1999, ONCOGENE, V18, P103, DOI 10.1038/sj.onc.1202269; Chi YY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-577; HELLEN CUT, 1994, J VIROL, V68, P941; Kaminski A, 1995, RNA, V1, P924; Kim Y, 2015, ONCOGENE, V34, P226, DOI 10.1038/onc.2013.538; NCI, 2013, COL CANC 2013; Ohno S, 2011, CELL CYCLE, V10, P3706, DOI 10.4161/cc.10.21.17903; Pickering BM, 2003, NUCLEIC ACIDS RES, V31, P639, DOI 10.1093/nar/gkg146; Pino MS, 2010, GASTROENTEROLOGY, V138, P1406, DOI 10.1053/j.gastro.2009.12.010; Robinson F, 2006, J BIOL CHEM, V281, P800, DOI 10.1074/jbc.M510578200; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Witherell GW, 1995, VIROLOGY, V214, P660, DOI 10.1006/viro.1995.0081; Yamaguchi A, 1996, J CLIN ONCOL, V14, P1122; Yang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000363	54	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	JUL	2015	14	7					1705	1716		10.1158/1535-7163.MCT-14-0142		12	Oncology	Oncology	CM9UZ	WOS:000358055900018		
J	Shinoda, K; Uehara, T; Suzuki, SO; Iwaki, T; Kira, J				Shinoda, Koji; Uehara, Taira; Suzuki, Satoshi O.; Iwaki, Toru; Kira, Jun-ichi			Multiphasic acute disseminated encephalomyelitis associated with atypical rubella virus infection - response to the letter from Wu et al	MULTIPLE SCLEROSIS JOURNAL			English	Letter									[Shinoda, Koji; Uehara, Taira; Suzuki, Satoshi O.; Iwaki, Toru; Kira, Jun-ichi] Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Neurol, Fukuoka 8128582, Japan; [Shinoda, Koji; Uehara, Taira; Suzuki, Satoshi O.; Iwaki, Toru; Kira, Jun-ichi] Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Neuropathol, Fukuoka 8128582, Japan	Kira, J (reprint author), Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Neurol,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kira@neuro.med.kyushu-u.ac.jp					Tenembaum S, 2002, NEUROLOGY, V59, P1224; Shinoda K, 2014, MULT SCLER; Wu X, 2014, MULT SCLER IN PRESS	3	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	JUL	2015	21	8					1089	1089		10.1177/1352458514567730		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CM5OX	WOS:000357738700020		
J	Arimoto-Kobayashi, S; Ohta, K; Yuhara, Y; Ayabe, Y; Negishi, T; Okamoto, K; Nakajima, Y; Ishikawa, T; Oguma, K; Otsuka, T				Arimoto-Kobayashi, Sakae; Ohta, Kaori; Yuhara, Yuta; Ayabe, Yuka; Negishi, Tomoe; Okamoto, Keinosuke; Nakajima, Yoshihiro; Ishikawa, Takeshi; Oguma, Keiji; Otsuka, Takanao			Mutagenicity and clastogenicity of extracts of Helicobacter pylori detected by the Ames test and in the micronucleus test using human lymphoblastoid cells	MUTAGENESIS			English	Article							ABERRANT DNA METHYLATION; GASTRIC EPITHELIAL-CELLS; STOMACH CARCINOGENESIS; MONGOLIAN GERBILS; INCREASED RISK; WATER EXTRACT; N-NITROSOUREA; IN-VITRO; INFECTION; CANCER	Epidemiological studies have demonstrated a close association between infection with Helicobacter pylori (H.pylori) and the development of gastric carcinoma. Chronic H.pylori infection increases the frequency of mutation in gastric epithelial cells. However, the mechanism by which infection of H.pylori leads to mutation in gastric epithelial cells is unclear. We suspected that components in H.pylori may be related to the mutagenic response associated with DNA alkylation, and could be detected with the Ames test using a more sensitive strain for alkylating agents. Our investigation revealed that an extract of H.pylori was mutagenic in the Ames test with Salmonella typhimurium YG7108, which is deficient in the DNA repair of O-6-methylguanine. The extract of H.pylori may contain methylating or alkylating agents, which might induce O-6-alkylguanine in DNA. Mutagenicity of the alkylating agents N-methyl-N-nitrosourea (MNU) and N-methyl-N'-nitro-N-nitrosoguanidine in the Ames test with S.typhimurium TA1535 was enhanced significantly in the presence of the extract of H.pylori. The tested extracts of H.pylori resulted in a significant induction of micronuclei in human-derived lymphoblastoid cells. Heat instability and dialysis resistance of the extracts of H.pylori suggest that the mutagenic component in the extracts of H.pylori is a heat-unstable large molecule or a heat-labile small molecule strongly attached or adsorbed to a large molecule. Proteins in the extracts of H.pylori were subsequently fractionated using ammonium sulphate precipitation. However, all fractions expressed enhancing effects toward MNU mutagenicity. These results suggest the mutagenic component is a small molecule that is absorbed into proteins in the extract of H.pylori, which resist dialysis. Continuous and chronic exposure of gastric epithelial cells to the alkylative mutagenic component from H.pylori chronically infected in the stomach might be a causal factor in the gastric carcinogenesis associated with H.pylori.	[Arimoto-Kobayashi, Sakae; Yuhara, Yuta; Negishi, Tomoe; Okamoto, Keinosuke; Oguma, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med Genotoxicol, Kita Ku, Okayama 7008530, Japan; [Arimoto-Kobayashi, Sakae; Ohta, Kaori; Ayabe, Yuka] Okayama Univ, Dept Genet Toxicol, Fac Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan; [Nakajima, Yoshihiro] Matsushita Mem Hosp, Dept Med Technol, Moriguchi, Osaka 5708540, Japan; [Ishikawa, Takeshi] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto 6028566, Japan; [Otsuka, Takanao] Okayama Univ Sci, Fac Engn, Dept Appl Chem & Biotechnol, Okayama 7000005, Japan	Arimoto-Kobayashi, S (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med Genotoxicol, Kita Ku, Okayama 7008530, Japan.	arimoto@cc.okayama-u.ac.jp			Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), The Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), The Ministry of Education, Culture, Sports, Science and Technology, Japan.	Izzotti A, 2007, CARCINOGENESIS, V28, P892, DOI 10.1093/carcin/bgl208; Matsusaka K, 2014, WORLD J GASTROENTERO, V20, P3916, DOI 10.3748/wjg.v20.i14.3916; Toller IM, 2011, P NATL ACAD SCI USA, V108, P14944, DOI 10.1073/pnas.1100959108; Touati E, 2003, GASTROENTEROLOGY, V124, P1408, DOI 10.1016/S0016-5085(03)00266-X; Sugiyama A, 1998, CANCER RES, V58, P2067; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; Wang F, 2014, CANCER LETT, V345, P196, DOI 10.1016/j.canlet.2013.08.016; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Liu ZF, 2012, J CELL BIOCHEM, V113, P1080, DOI 10.1002/jcb.23440; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; LEE YW, 1995, MOL CELL BIOL, V15, P2547; Shimizu N, 2000, CANCER RES, V60, P1512; Chitcholtan K, 2008, CARCINOGENESIS, V29, P2400, DOI 10.1093/carcin/bgn218; YAHAGI T, 1975, CANCER LETT, V1, P91, DOI 10.1016/S0304-3835(75)95563-9; Chung HW, 2014, WORLD J GASTROENTERO, V20, P1667, DOI 10.3748/wjg.v20.i7.1667; BLASER MJ, 1995, CANCER RES, V55, P2111; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Nishibayashi H, 2003, J GASTROEN HEPATOL, V18, P1384, DOI 10.1046/j.1440-1746.2003.03192.x; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Hur K, 2011, CARCINOGENESIS, V32, P35, DOI 10.1093/carcin/bgq219; Belair Cédric, 2011, Silence, V2, P7, DOI 10.1186/1758-907X-2-7; Bhandari Abhishek, 2012, Curr Gastroenterol Rep, V14, P489, DOI 10.1007/s11894-012-0296-y; BOFFA LC, 1994, EXP CELL RES, V211, P420, DOI 10.1006/excr.1994.1107; Friedberg E. C., 1995, DNA REPAIR MUTAGENES, P110; Honma M, 1997, MUTAT RES-FUND MOL M, V374, P89, DOI 10.1016/S0027-5107(96)00223-0; Hudson T. J., 2014, WORLD CANC REPORT 20, P184; Ishikawa T, 2003, CANCER LETT, V191, P41, DOI 10.1016/S0304-3835(02)00628-6; Kaneko T, 2000, J INT MED RES, V28, P222; Kassai K, 1999, DIGEST DIS SCI, V44, P237, DOI 10.1023/A:1026629812245; MATSUOKA A, 1992, MUTAT RES, V272, P223, DOI 10.1016/0165-1161(92)91535-Y; Osman MA, 2013, CYTOSKELETON, V70, P349, DOI 10.1002/cm.21114; Papa A, 2002, SCAND J GASTROENTERO, V37, P409, DOI 10.1080/003655202317316033; Piazuelo MB, 2010, INFECT DIS CLIN N AM, V24, P853, DOI 10.1016/j.idc.2010.07.010; Pulling LC, 2004, CANCER RES, V64, P3844, DOI 10.1158/0008-5472.CAN-03-2119; Schmausser B, 2000, CANCER LETT, V152, P145, DOI 10.1016/S0304-3835(99)00442-5; Siomek A, 2006, CARCINOGENESIS, V27, P405, DOI 10.1093/carcin/bgi238; Stopper H, 2002, MUTAGENESIS, V17, P177, DOI 10.1093/mutage/17.2.177; Suarez S, 2007, MUTAT RES-GEN TOX EN, V626, P162, DOI 10.1016/j.mrgentox.2006.09.012; Tatematsu M, 1998, JPN J CANCER RES, V89, P97; Ushijima T, 2005, CANCER SCI, V96, P206, DOI 10.1111/j.1349-7006.2005.00035.x; YAMADA M, 1995, J BACTERIOL, V177, P1511; Yamada M, 1997, MUTAT RES-FUND MOL M, V381, P15, DOI 10.1016/S0027-5107(97)00139-5	44	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0267-8357	1464-3804		MUTAGENESIS	Mutagenesis	JUL	2015	30	4					537	544		10.1093/mutage/gev016		8	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CM7PB	WOS:000357885900009		
J	Hattori, AN; Fujiwara, Y; Fujiwara, K; Nguyen, TVA; Nakamura, T; Ichimiya, M; Ashida, M; Tanaka, H				Hattori, Azusa N.; Fujiwara, Yasushi; Fujiwara, Kohei; Thi Van Anh Nguyen; Nakamura, Takuro; Ichimiya, Masayoshi; Ashida, Masaaki; Tanaka, Hidekazu			Identification of Giant Mott Phase Transition of Single Electric Nanodomain in Manganite Nanowall Wire	NANO LETTERS			English	Article						Electric nanodomain; phase separation; manganite nanowall wire; insulator-metal transition; first-order transition	COLOSSAL MAGNETORESISTANCE; METAL; TEMPERATURES; SEPARATION; FILMS	In the scaling down of electronic devices, functional oxides with strongly correlated electron system provide advantages to conventional semiconductors, namely, huge switching owing to their phase transition and high carrier density, which guarantee their rich functionalities even at the 10 nm scale. However, understanding how their functionalities behave at a scale of 10 nm order is still a challenging issue. Here, we report the construction of the well-defined (La,Pr,Ca)MnO3 epitaxial oxide nanowall wire by combination of nanolithography and subsequent thin-film growth, which allows the direct investigation of its insulator-metal transition (IMT) at the single domain scale. We show that the width of a (La,Pr,Ca)MnO3 nanowall sample can be reduced to 50 nm, which is smaller than the observed 70-200 nm-size electronic domains, and that a single electronic nanodomain in (La,Pr,Ca)MnO3 exhibited an intrinsic first-order IMT with an unusually steep single-step change in its magnetoresistance and temperature-induced resistance due to the domains arrangement in series. A simple model of the first-order transition for single electric domains satisfactorily illustrates the IMT behavior from macroscale down to the nanoscale.	[Hattori, Azusa N.; Fujiwara, Yasushi; Fujiwara, Kohei; Thi Van Anh Nguyen; Nakamura, Takuro; Tanaka, Hidekazu] Osaka Univ, Nanoscie & Nanotechnol Ctr, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Ichimiya, Masayoshi; Ashida, Masaaki] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Ichimiya, Masayoshi] Univ Shiga Prefecture, Sch Engn, Hikone, Shiga 5228533, Japan	Hattori, AN (reprint author), Osaka Univ, Nanoscie & Nanotechnol Ctr, Inst Sci & Ind Res, 8-1 Mihoga Oka, Ibaraki, Osaka 5670047, Japan.	a-hattori@sanken.osaka-u.ac.jp; h-tanaka@sanken.osaka-u.ac.jp	Fujiwara, Kohei/O-2412-2013	Fujiwara, Kohei/0000-0002-2164-2462	Network Joint Research Center for Materials and Devices from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; "Nanotechnology Platform Project (Nanotechnology Open Facilities in Osaka University)" of MEXT, Japan [S-12-OS-0002, F-12-OS-0005]; Shiseido Female Research Science Grant;  [21676001];  [25800178]	The authors are grateful to M. Sakuma, A. Iwald, and the staff in the Comprehensive Analysis Center (CAC) in ISIR, Osaka University, for their helpful assistance. The authors gratefully acknowledge Ken Hattori for his helpful suggestion and useful advices for SEM-CL measurements. This study was partially supported by Grants-in-Aid for Young Scientists S (No. 21676001), Young Scientists B (No. 25800178), and Network Joint Research Center for Materials and Devices from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. Part of this work was also supported by "Nanotechnology Platform Project (Nanotechnology Open Facilities in Osaka University)" of MEXT, Japan [Nos. S-12-OS-0002 and F-12-OS-0005]. One of the authors (ANH) was supported in part by Shiseido Female Research Science Grant.	Abramovich AI, 2004, J EXP THEOR PHYS+, V99, P820, DOI 10.1134/1.1826175; Mori S, 1998, NATURE, V392, P473; Uehara M, 1999, NATURE, V399, P560; Takagi H, 2010, SCIENCE, V327, P1601, DOI 10.1126/science.1182541; Zhao GM, 2000, PHYS REV LETT, V84, P6086, DOI 10.1103/PhysRevLett.84.6086; Zhang LW, 2002, SCIENCE, V298, P805, DOI 10.1126/science.1077346; Kiryukhin V, 1997, NATURE, V386, P813, DOI 10.1038/386813a0; Becker H, 1997, PHYS REV B, V56, P1893, DOI 10.1103/PhysRevB.56.1893; Burkhardt MH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.237202; Dagotto E, 2001, PHYS REP, V344, P1, DOI 10.1016/S0370-1573(00)00121-6; Joshi L, 2010, PHASE TRANSIT, V83, P263, DOI 10.1080/01411591003665758; Chen CH, 1996, PHYS REV LETT, V76, P4042, DOI 10.1103/PhysRevLett.76.4042; Li G, 2002, J APPL PHYS, V92, P1406, DOI 10.1063/1.1490153; Asamitsu A, 1997, NATURE, V388, P50, DOI 10.1038/40363; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Cao GX, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.174414; CHANCE RR, 1975, J CHEM PHYS, V62, P2245, DOI 10.1063/1.430748; Egilmez M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2908931; Fujiwara Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.015001; Hattori AN, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.045201; Hattori AN, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.125203; Hervieu M, 1996, PHYS REV B, V53, P14274, DOI 10.1103/PhysRevB.53.14274; Ichimiya M, 2006, PHYS STATUS SOLIDI C, V3, P1189, DOI 10.1002/pssc.200564702; Ichimiya M, 2006, J PHYS-CONDENS MAT, V18, P1967, DOI 10.1088/0953-8984/18/6/012; Kanki T, 2003, APPL PHYS LETT, V83, P1184, DOI 10.1063/1.1599971; Kim TH, 2010, P NATL ACAD SCI USA, V107, P5272, DOI 10.1073/pnas.1000655107; Kushizaki T, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/48/485308; Mayr M, 2001, PHYS REV LETT, V86, P135, DOI 10.1103/PhysRevLett.86.135; Nguyen TVA, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4834876; Pasupathy AN, 2008, SCIENCE, V320, P196, DOI 10.1126/science.1154700; Rao GH, 1996, J PHYS-CONDENS MAT, V8, P5393, DOI 10.1088/0953-8984/8/29/014; Tomioka Y, 1996, PHYS REV B, V53, pR1689; Ward TZ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.247204; Yanagisawa Y, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2423235; ZHANG B, 1985, APPL OPTICS, V24, P2779	35	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	JUL	2015	15	7					4322	4328		10.1021/acs.nanolett.5b00264		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CM8PM	WOS:000357964100013		
J	Kim, D; Tomita, S; Ohshiro, K; Watanabe, T; Sakai, T; Chang, IY; Hyeon-Deuk, K				Kim, DaeGwi; Tomita, Shougo; Ohshiro, Kazuma; Watanabe, Taichi; Sakai, Takenobu; Chang, I-Ya; Hyeon-Deuk, Kim			Evidence of Quantum Resonance in Periodically-Ordered Three-Dimensional Super lattice of CdTe Quantum Dots	NANO LETTERS			English	Article						Quantum dot; three-dimensional superlattice; quantum resonance; HOMO/LUMO delocalization; density functional theory	BAND-LIKE TRANSPORT; SOLIDS	Semiconductor quantum dot (QD) superlattices, which are periodically ordered three-dimensional (3D) array structures of QDs, are expected to exhibit novel photo-optical properties arising from the resonant interactions between adjacent QDs. Since the resonant interactions such as long-range dipole-dipole Coulomb coupling and short-range quantum resonance strongly depend on inter-QD nano space, precise control of the nano space is essential for physical understanding of the superlattice, which includes both of nano and bulk scales. Here, we study the pure quantum resonance in the 3D CdTe QD superlattice deposited by a layer-by-layer assembly of positively charged polyelectrolytes and negatively charged CdTe QDs. From XRD measurements, existence of the periodical ordering of QPs both in the lamination and in-plane directions, that is, the formation of the 3D periodic QD superlattice, was confirmed. The lowest excitation energy decreases exponentially with decreasing the nano space between the CdTe QD layers and also with decreasing the QD size, which is apparently indicative of the quantum resonance between the QDs rather than a dipole dipole Coulomb coupling. The quantum resonance was also computationally demonstrated and rationalized by the orbital delocalization to neighboring CdTe QDs in the superlattice.	[Kim, DaeGwi; Tomita, Shougo; Ohshiro, Kazuma; Watanabe, Taichi] Osaka City Univ, Dept Appl Phys, Osaka 5588585, Japan; [Sakai, Takenobu] Nagoya Univ, Green Mobil Collaborat Res Ctr, Nagoya, Aichi 4648603, Japan; [Chang, I-Ya; Hyeon-Deuk, Kim] Kyoto Univ, Dept Chem, Kyoto 6068502, Japan; [Chang, I-Ya; Hyeon-Deuk, Kim] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kim, D (reprint author), Osaka City Univ, Dept Appl Phys, Osaka 5588585, Japan.	tegi@a-phys.eng.osaka-cu.ac.jp; kim@kuchem.kyoto-u.ac.jp			JST (PRESTO); Japan Society for the Promotion of Science (KAKENHI) [15K05386]; JSPS KAKENHI [24560015]	K.H.-D. acknowledges financial support from JST (PRESTO) and Grant-in-Aids for Scientific Research from Japan Society for the Promotion of Science (KAKENHI), Grant No. 15K05386. D.K. acknowledges the financial support by JSPS KAKENHI Grant Number 24560015.	Dollefeld H, 2002, J PHYS CHEM B, V106, P5604, DOI 10.1021/jp013234t; EKIMOV AI, 1982, SOV PHYS SEMICOND+, V16, P775; Artemyev MV, 2000, J PHYS CHEM B, V104, P11617, DOI 10.1021/jp002085w; Geiregat P, 2013, ACS NANO, V7, P987, DOI 10.1021/nn305524a; Lee JS, 2011, NAT NANOTECHNOL, V6, P348, DOI 10.1038/nnano.2011.46; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Choi JH, 2012, NANO LETT, V12, P2631, DOI 10.1021/nl301104z; HENGLEIN A, 1982, BER BUNSEN PHYS CHEM, V86, P301; Talgorn E, 2011, NAT NANOTECHNOL, V6, P733, DOI [10.1038/nnano.2011.159, 10.1038/NNANO.2011.159]; Decher G., 2003, MULTILAYER THIN FILM; Hanrath T, 2012, J VAC SCI TECHNOL A, V30, DOI 10.1116/1.4705402; Hodes G, 2005, J ELECTROCHEM SOC, V152, pG917, DOI 10.1149/1.2098447; Kim D, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.153301; Kotov N. A., 2005, NANOPARTICLE ASSEMBL; Micic O. I., 2001, J APPL PHYS LETT, V78, P4022; Yang Y, 2013, NANO LETT, V13, P3678, DOI 10.1021/nl401573x	16	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	JUL	2015	15	7					4343	4347		10.1021/acs.nanolett.5b00335		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CM8PM	WOS:000357964100016		
J	Yamazaki, S; Maeda, K; Sugimoto, Y; Abe, M; Zobac, V; Pou, P; Rodrigo, L; Mutombo, P; Perez, R; Jelinek, P; Morita, S				Yamazaki, Shiro; Maeda, Keisuke; Sugimoto, Yoshiaki; Abe, Masayuki; Zobac, Vladimir; Pou, Pablo; Rodrigo, Lucia; Mutombo, Pingo; Perez, Ruben; Jelinek, Pavel; Morita, Seizo			Interplay between Switching Driven by the Tunneling Current and Atomic Force of a Bistable Four-Atom Si Quantum Dot	NANO LETTERS			English	Article						Atomic manipulation; atomic switch; Si quantum dot; scanning tunneling microscopy; noncontact atomic force microscopy; density functional theory	SURFACE; MICROSCOPY; MOLECULES; ENERGY; SPECTROSCOPY; MANIPULATION; DYNAMICS; DIMERS; MOTION	We assemble bistable silicon quantum dots consisting of four buckled atoms (Si-4-QD) using atom manipulation. We demonstrate two competing atom Switching mechanisms, downward switching induced by tunneling current of scanning tunneling microscopy (STM) and opposite upward switching induced by atomic force of atomic force microscopy (AFM). Simultaneous application of competing current and force allows us to tune switching direction continuously. Assembly of the few-atom Si-QDs and controlling their states using versatile combined AFM/STM will contribute to further miniaturization of nanodevices.	[Yamazaki, Shiro; Morita, Seizo] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Maeda, Keisuke; Sugimoto, Yoshiaki; Jelinek, Pavel] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Abe, Masayuki] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5600043, Japan; [Zobac, Vladimir; Mutombo, Pingo; Jelinek, Pavel] Acad Sci Czech Republic, Inst Phys, CR-16200 Prague, Czech Republic; [Pou, Pablo; Rodrigo, Lucia; Perez, Ruben] Univ Autonoma Madrid, Dept Fis Teor Mat Condensada, E-28049 Madrid, Spain; [Pou, Pablo; Rodrigo, Lucia; Perez, Ruben] Univ Autonoma Madrid, Condensed Matter Phys Ctr IFIMAC, E-28049 Madrid, Spain	Yamazaki, S (reprint author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	yamazaki@afm.eei.eng.osaka-u.ac.jp; pablo.pou@uam.es; jelinekp@fzu.cz	Pou, Pablo/C-3888-2012; Perez, Ruben/F-1849-2010; Jelinek, Pavel/G-1542-2010	Pou, Pablo/0000-0002-5854-8218; Perez, Ruben/0000-0001-5896-541X; Jelinek, Pavel/0000-0002-5645-8542	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [22221006, 25106002, 24360016, 26600099, 26600015, 26110516, 25790057]; Funding Program for Next-Generation World-Leading Researchers; GACR [14-02079S]; MINECO, Spain [MAT2011-23627, CSD2010-00024]; Ramon y Cajal program	We thank A. Sweetman, R. Takatani, and D. Sawada for technical support and E. Inami, Y. Kim, T. Shimizu, T. Komeda, and H. Okuyama for valuable discussions. This work was supported by Grants-in-Aid for Scientific Research (22221006, 25106002, 24360016, 26600099, 26600015, 26110516, and 25790057) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), the Funding Program for Next-Generation World-Leading Researchers, the GACR Project 14-02079S, and the projects MAT2011-23627 and CSD2010-00024 of MINECO, Spain. P.P. was supported by the Ramon y Cajal program. Computer time provided by the Spanish Supercomputing Network (PBS) in the Barcelona Supercomputer Center (MareNostrum III) and Czech National Grid Infrastructure MetaCentrum LM2010005 is gratefully acknowledged.	Sweetman A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.136101; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Moresco F, 2001, PHYS REV LETT, V86, P672, DOI 10.1103/PhysRevLett.86.672; Auwarter W, 2012, NAT NANOTECHNOL, V7, P41, DOI [10.1038/nnano.2011.211, 10.1038/NNANO.2011.211]; Majzik Z, 2012, BEILSTEIN J NANOTECH, V3, P249, DOI 10.3762/bjnano.3.28; Kumagai T, 2014, NAT CHEM, V6, P41, DOI [10.1038/nchem.1804, 10.1038/NCHEM.1804]; Henkelman G, 2000, J CHEM PHYS, V113, P9978, DOI 10.1063/1.1323224; Pawlak R, 2012, ACS NANO, V6, P6318, DOI 10.1021/nn301774d; Sato T, 2000, SURF SCI, V445, P130, DOI 10.1016/S0039-6028(99)01059-6; Stipe BC, 1998, SCIENCE, V279, P1907, DOI 10.1126/science.279.5358.1907; ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Lewis JP, 2011, PHYS STATUS SOLIDI B, V248, P1989, DOI 10.1002/pssb.201147259; Stroscio JA, 2004, SCIENCE, V306, P242, DOI 10.1126/science.1102370; Blanco JM, 2006, PROG SURF SCI, V81, P403, DOI 10.1016/j.progsurf.2006.07.004; EIGLER DM, 1991, NATURE, V352, P600, DOI 10.1038/352600a0; Schaffert J, 2013, NAT MATER, V12, P223, DOI [10.1038/nmat3527, 10.1038/NMAT3527]; Liljeroth P, 2007, SCIENCE, V317, P1203, DOI 10.1126/science.1144366; Giessibl FJ, 1998, APPL PHYS LETT, V73, P3956, DOI 10.1063/1.122948; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288; Betz G., 1990, DES IND EL TRANS DIE; Hata K, 2001, PHYS REV LETT, V86, P3084, DOI 10.1103/PhysRevLett.86.3084; Inami E., 2015, NAT COMMUN IN PRESS, P62015; Loppacher C, 2000, PHYS REV B, V62, P16944, DOI 10.1103/PhysRevB.62.16944; Loppacher C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.066107; Perera U. G. E., 2012, NAT NANOTECHNOL, V8, P46; Sagisaka K, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.146103; Sugimoto Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5360; TANAKA H, 1994, JPN J APPL PHYS 1, V33, P3696, DOI 10.1143/JJAP.33.3696; Tomatsu K, 2007, SCIENCE, V315, P1696, DOI 10.1126/science.1137848	31	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	JUL	2015	15	7					4356	4363		10.1021/acs.nanolett.5b00448		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CM8PM	WOS:000357964100018		
J	Ezzat, K; Aoki, Y; Koo, T; McClorey, G; Benner, L; Coenen-Stass, A; O'Donovan, L; Lehto, T; Garcia-Guerra, A; Nordin, J; Saleh, AF; Behlke, M; Morris, J; Goyenvalle, A; Dugovic, B; Leumann, C; Gordon, S; Gait, MJ; El-Andaloussi, S; Wood, MJA				Ezzat, Kariem; Aoki, Yoshitsugu; Koo, Taeyoung; McClorey, Graham; Benner, Leif; Coenen-Stass, Anna; O'Donovan, Liz; Lehto, Taavi; Garcia-Guerra, Antonio; Nordin, Joel; Saleh, Amer F.; Behlke, Mark; Morris, John; Goyenvalle, Aurelie; Dugovic, Branislav; Leumann, Christian; Gordon, Siamon; Gait, Michael J.; El-Andaloussi, Samir; Wood, Matthew J. A.			Self-Assembly into Nanoparticles Is Essential for Receptor Mediated Uptake of Therapeutic Antisense Oligonucleotides	NANO LETTERS			English	Article						Antisense oligonucleotides; self-assembly; nanoparticles; scavenger receptors; uptake mechanism; delivery	MACROPHAGE SCAVENGER RECEPTORS; CELL-PENETRATING-PEPTIDES; EXON SKIPPING ACTIVITY; NEUROMUSCULAR DISEASE; MUSCULAR-DYSTROPHY; DELIVERY; RNA; ENDOCYTOSIS; BINDING; OLIGODEOXYNUCLEOTIDES	Antisense oligonucleotides (ASOs) have the potential to revolutionize medicine due to their ability to manipulate gene function for therapeutic purposes. ASOs are chemically modified and/or incorporated within nanoparticles to enhance their stability and cellular uptake, however, a major challenge is the poor understanding of their uptake mechanisms, which would facilitate improved ASO designs with enhanced activity and reduced toxicity. Here, we study the uptake mechanism of three therapeutically relevant ASOs (peptide-conjugated phosphorodiamidate morpholino (PPMO), 2'Omethyl phosphorothioate (2'OMe), and phosphorothioated tricyclo DNA (tcDNA) that have been optimized to induce exon skipping in models of Duchenne muscular dystrophy (DMD). We show that PPMO and tcDNA have high propensity to spontaneously self-assemble into nanoparticles. PPMO forms micelles of defined size and their net charge (zeta potential) is dependent on the medium and concentration. In biomimetic conditions and at low concentrations, PPMO obtains net negative charge and its uptake is mediated by class A scavenger receptor subtypes (SCARAs) as shown by competitive inhibition and RNAi silencing experiments in vitro. In vivo, the activity of PPMO was significantly decreased in SCARA1 knockout mice compared to wild-type animals. Additionally, we show that SCARA1 is involved in the uptake of tcDNA and 2'OMe as shown by competitive inhibition and colocalization experiments. Surface plasmon resonance binding analysis to SCARA1 demonstrated that PPMO and tcDNA have higher binding profiles to the receptor compared to 2'OMe. These results demonstrate receptor-mediated uptake for a range of therapeutic ASO chemistries, a mechanism that is dependent on their self-assembly into nanoparticles.	[Ezzat, Kariem; Aoki, Yoshitsugu; Koo, Taeyoung; McClorey, Graham; Benner, Leif; Coenen-Stass, Anna; Morris, John; El-Andaloussi, Samir; Wood, Matthew J. A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Koo, Taeyoung] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul 151747, South Korea; [Koo, Taeyoung] Univ Sci & Technol, Funct Genom, Taejon 305338, South Korea; [O'Donovan, Liz; Saleh, Amer F.; Gait, Michael J.] Med Res Council Lab Mol Biol, Cambridge CB2 0QH, England; [Lehto, Taavi; Nordin, Joel; El-Andaloussi, Samir] Karolinska Inst, Dept Lab Med, SE-17177 Stockholm, Sweden; [Garcia-Guerra, Antonio] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Behlke, Mark] IDT, Coralville, IA 52241 USA; [Goyenvalle, Aurelie] Univ Versailles St Quentin, F-78180 Montigny Le Bretonneux, France; [Dugovic, Branislav; Leumann, Christian] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Gordon, Siamon] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Aoki, Yoshitsugu] NCNP, Dept Mol Therapy, Tokyo 1878551, Japan	Wood, MJA (reprint author), Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England.	matthew.wood@dpag.ox.ac.uk	Lehto, Taavi/B-7798-2010		Medical Research Council (MRC) [U105178803]; Swedish Medical Research Council (VR-Med); Swedish Medical Research Council (EuroNanoMED2); Swedish Society of Medical Research (SSMF); European Commission under the Seventh Framework Programme (FP7), as part of the Marie Curie Initial Training Network, EScoDNA (GA) [317110]	Work in the laboratory of M.J.G. was supported by the Medical Research Council (MRC programme number U105178803). S.EL.A. is supported by Swedish Medical Research Council (VR-Med and EuroNanoMED2) and the Swedish Society of Medical Research (SSMF). A.G.C. was supported by the European Commission under the Seventh Framework Programme (FP7), as part of the Marie Curie Initial Training Network, EScoDNA (GA no. 317110). We would like to thank Dr. David Staunton at the Biophysical Instrumentation Facility, Department of Biochemistry and Mr. Marcus Bridge at the Dunn School of Pathology for help with physicochemical characterization and SPR.	Pujals S, 2006, BBA-BIOMEMBRANES, V1758, P264, DOI 10.1016/j.bbamem.2006.01.006; Bijsterbosch MK, 1997, NUCLEIC ACIDS RES, V25, P3290, DOI 10.1093/nar/25.16.3290; Peiser L, 2001, MICROBES INFECT, V3, P149, DOI 10.1016/S1286-4579(00)01362-9; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Cheng CJ, 2013, CURR MED CHEM, V20, P3582; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Yin H, 2008, HUM MOL GENET, V17, P3909, DOI 10.1093/hmg/ddn293; Deleavey GF, 2012, CHEM BIOL, V19, P937, DOI 10.1016/j.chembiol.2012.07.011; Ge W, 2008, J NON-NEWTON FLUID, V154, P1, DOI 10.1016/j.jnnfm.2008.01.011; Zhou H, 2013, J IMMUNOL, V190, P115, DOI 10.4049/jimmunol.1202136; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Wood MJA, 2010, BRAIN, V133, P957, DOI 10.1093/brain/awq002; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Koo T, 2013, HUM GENE THER, V24, P479, DOI 10.1089/hum.2012.234; Platt N, 1998, CHEM BIOL, V5, pR193, DOI 10.1016/S1074-5521(98)90156-9; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]; Bishop JS, 1996, J BIOL CHEM, V271, P5698; Patist A, 2000, J SURFACTANTS DETERG, V3, P53, DOI 10.1007/s11743-000-0113-4; Soifer HS, 2012, METHODS MOL BIOL, V815, P333, DOI 10.1007/978-1-61779-424-7_25; Yin HF, 2010, MOL THER, V18, P1822, DOI 10.1038/mt.2010.151; Aoki Y, 2013, HUM MOL GENET, V22, P4914, DOI 10.1093/hmg/ddt341; Lehto T, 2014, NUCLEIC ACIDS RES, V42, P3207, DOI 10.1093/nar/gkt1220; Arnida, 2011, EUR J PHARM BIOPHARM, V77, P417, DOI 10.1016/j.ejpb.2010.11.010; de Diesbach P, 2002, NUCLEIC ACIDS RES, V30, P1512; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; PEARSON AM, 1993, J BIOL CHEM, V268, P3546; Mastrobattista E, 2006, NAT REV DRUG DISCOV, V5, P115, DOI 10.1038/nrd1960; Zaias J, 2009, J AM ASSOC LAB ANIM, V48, P387; Douglas AGL, 2013, MOL CELL NEUROSCI, V56, P169, DOI 10.1016/j.mcn.2013.04.005; Murray S, 2012, NUCLEIC ACIDS RES, V40, P6135, DOI 10.1093/nar/gks273; Bowdish DME, 2009, IMMUNOL REV, V227, P19, DOI 10.1111/j.1600-065X.2008.00728.x; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Benimetskaya L, 1997, NUCLEIC ACIDS RES, V25, P2648, DOI 10.1093/nar/25.13.2648; Betts C, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.30; Biessen EAL, 1998, MOL PHARMACOL, V53, P262; DeWitte-Orr SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000829; El Andaloussi SA, 2012, CURR GENE THER, V12, P161; Ezzat K., 2012, FASEB J, V3, P1172; Goyenvalle A., 2015, NAT MED; Kohno M, 2014, CHEM BIOL, V21, P1522, DOI 10.1016/j.chembiol.2014.09.008; Kondo E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1952; Leumann Christian J, 2006, Nucleic Acids Symp Ser (Oxf), P55; Sawai K, 1996, J PHARMACOL EXP THER, V279, P284; Shabanpoor F, 2013, CHEM COMMUN, V49, P10260, DOI 10.1039/c3cc46067c; Ski W., 2008, PHYS REV E, V78; Suzuki K, 1999, EUR J BIOCHEM, V260, P855, DOI 10.1046/j.1432-1327.1999.00233.x; Wu CCN, 2003, HUM GENE THER, V14, P849, DOI 10.1089/104303403765701141; Wu RP, 2007, NUCLEIC ACIDS RES, V35, P5182, DOI 10.1093/nar/gkm478	51	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	JUL	2015	15	7					4364	4373		10.1021/acs.nanolett.5b00490		10	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CM8PM	WOS:000357964100019		
J	Nozawa, T; Takagi, H; Watanabe, K; Arakawa, Y				Nozawa, Tomohiro; Takagi, Hiroyuki; Watanabe, Katsuyuki; Arakawa, Yasuhiko			Direct Observation of Two-Step Photon Absorption in an InAs/GaAs Single Quantum Dot for the Operation of Intermediate-Band Solar Cells	NANO LETTERS			English	Article						Single quantum dot; two-step photon absorption; intermediate-band solar cell; two-color photoexcitation spectroscopy	ELECTRIC-FIELD; MU-M; PHOTOLUMINESCENCE; PHOTOCURRENT; EFFICIENCY; EMISSION	We present the first direct observation of two-step photon absorption in an InAs/GaAs single quantum dot (QD) using photocurrent spectroscopy with two lasers. The sharp peaks of the photocurrent are shifted due to the quantum confined Stark effect, indicating that the photocurrent from a single QD is obtained. In addition, the intensity of the peaks depends on the power of the secondary laser. These results reveal the direct demonstration of the two-step photon absorption in a single QD. This is an essential result for both the fundamental operation and the realization of ultrahigh solar-electricity energy conversion in quantum dot intermediate-band solar cells.	[Nozawa, Tomohiro; Takagi, Hiroyuki; Watanabe, Katsuyuki; Arakawa, Yasuhiko] Univ Tokyo, Inst Nanoquantum Informat Elect, Meguro Ku, Tokyo 1538505, Japan; [Nozawa, Tomohiro; Takagi, Hiroyuki; Watanabe, Katsuyuki; Arakawa, Yasuhiko] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Nozawa, Tomohiro] Sharp Co Ltd, Adv Technol Res Labs, Tenri, Nara 6328567, Japan	Nozawa, T (reprint author), Univ Tokyo, Inst Nanoquantum Informat Elect, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	tnozawa@iis.u-tokyo.ac.jp; arakawa@iis.u-tokyo.ac.jp			Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	We thank S. Iwamoto, T. Miyazawa, Y. Ota, S. Takahashi, and T. Kotani for useful comments and discussions, S. Ishida for a lot of advice about device fabrication, and M. Holmes and S. Sergent for invaluable comments on our manuscript as well as fruitful discussions. We also show sincere gratitude to A. Takahashi, Y. Tomomura, S. Ito, S. Aomori, and M. Izumi for their encouragement and support to our research. This work was supported by Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Yoshikawa H, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4889805; Nozawa T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3583587; VINCENT G, 1979, J APPL PHYS, V50, P5484, DOI 10.1063/1.326601; Aivaliotis P, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2816128; Tatebayashi J, 2001, APPL PHYS LETT, V78, P3469, DOI 10.1063/1.1375842; FOX AM, 1991, IEEE J QUANTUM ELECT, V27, P2281, DOI 10.1109/3.97272; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Luque A, 2010, SOL ENERG MAT SOL C, V94, P2032, DOI 10.1016/j.solmat.2010.06.008; Fry PW, 2000, APPL PHYS LETT, V77, P4344, DOI 10.1063/1.1334363; ARAKAWA Y, 1982, APPL PHYS LETT, V40, P939, DOI 10.1063/1.92959; Elborg M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FF15; Findeis F, 2001, APPL PHYS LETT, V78, P2958, DOI 10.1063/1.1369148; Kita T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035301; Krishna S, 2003, APPL PHYS LETT, V83, P2745, DOI 10.1063/1.1615838; Kuo DMT, 2000, PHYS REV B, V61, P11051, DOI 10.1103/PhysRevB.61.11051; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Marti A., 2000, 28 IEEE PHOT SPEC C, P940; Marti A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247701; Nevou L, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462960; Nozawa T, 2013, J APPL PHYS, V113, DOI 10.1063/1.4811681; Nozawa T, 2014, SEMICOND SCI TECH, V29, DOI 10.1088/0268-1242/29/4/045014; Okada Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3533423; Raisky OY, 1997, J APPL PHYS, V81, P394, DOI 10.1063/1.364070; Scaccabarozzi A, 2013, PHYS STATUS SOLIDI-R, V7, P173, DOI 10.1002/pssr.201206518; Sellers DG, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4881181; Takagi H, 2008, OPT EXPRESS, V16, P13949, DOI 10.1364/OE.16.013949; Tamaki R, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893879; Tex DM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04125	28	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	JUL	2015	15	7					4483	4487		10.1021/acs.nanolett.5b00947		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CM8PM	WOS:000357964100038		
J	Ren, Y; Yuan, HT; Wu, XY; Chen, ZY; Iwasa, Y; Cui, Y; Hwang, HY; Lai, KJ				Ren, Yuan; Yuan, Hongtao; Wu, Xiaoyu; Chen, Zhuoyu; Iwasa, Yoshihiro; Cui, Yi; Hwang, Harold Y.; Lai, Keji			Direct Imaging of Nanoscale Conductance Evolution in Ion-Gel-Gated Oxide Transistors	NANO LETTERS			English	Article						Electric double-layer transistors; microwave impedance microscope; electrical imaging; metal-insulator transition; spatial inhomogeneity	FIELD-EFFECT TRANSISTORS; THIN-FILM TRANSISTORS; ELECTRIC-FIELD; INSULATOR-TRANSITION; SURFACE; SUPERCONDUCTIVITY; DIELECTRICS; FERROMAGNETISM; ACCUMULATION; TEMPERATURE	Electrostatic modification of functional materials by electrolytic gating has demonstrated a remarkably wide range of density modulation, a condition Crucial for developing novel electronic phases in systems ranging from complex oxides to layered chalcogenides. Yet little is known microscopically when carriers are modulated in electrolyte-gated electric double-layer transistors (EDLTs) due to the technical challenge of imaging the buried electrolyte-semiconductor interface. Here, we demonstrate the real-space mapping of the channel conductance, in ZnO EDLTs using a cryogenic microwave impedance microscope. A spin-coated ionic gel layer with typical thicknesses below 50 nm allows us to perform high resolution (on the Order of 100 nm) subsurface imaging, while maintaining the capability of inducing the metal-insulator transition under a gate bias, The microwave images vividly show the spatial evolution of channel conductance and its local fluctuations through the transition as well as the uneven conductance distribution established by a large source-drain bias. The unique combination of ultrathin ion-gel gating and microwave imaging offers a new opportunity to study the local transport and mesoscopic electronic properties in EDLTs.	[Ren, Yuan; Wu, Xiaoyu; Lai, Keji] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Yuan, Hongtao; Chen, Zhuoyu; Cui, Yi; Hwang, Harold Y.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Yuan, Hongtao; Cui, Yi; Hwang, Harold Y.] Stanford Inst Mat & Energy Sci, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Iwasa, Yoshihiro] Univ Tokyo, Quantum Phase Elect Ctr, Tokyo 1138656, Japan; [Iwasa, Yoshihiro] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Iwasa, Yoshihiro] RIKEN Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	Lai, KJ (reprint author), Univ Texas Austin, Dept Phys, Austin, TX 78712 USA.	kejilai@physics.utexas.edu	Yuan, Hongtao/C-9807-2012		US Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0010308]; Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-76SF00515]; JSPS [25000003]	We thank Chih-Kang Shih for valuable discussions. The MIM work at UT-Austin (Y.R., X.W., and K.L.) was supported by the US Department of Energy, Office of Science, Basic Energy Sciences, under Early Career Award DE-SC0010308. The work at Stanford (H-T.Y., Z.C., Y.C., and H.Y.H.) was supported by the Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, under Contract DE-AC02-76SF00515. Y.I. was supported by JSPS Grant-in-Aid for Specially Promoted Research (No. 25000003).	Ahn CH, 2006, REV MOD PHYS, V78, P1185, DOI 10.1103/RevModPhys.78.1185; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Yuan HT, 2010, J AM CHEM SOC, V132, P6672, DOI 10.1021/ja909110s; Yuan HT, 2010, J AM CHEM SOC, V132, P18402, DOI 10.1021/ja108912x; Zhang YJ, 2014, SCIENCE, V344, P725, DOI 10.1126/science.1251329; Ahn CH, 2003, NATURE, V424, P1015, DOI 10.1038/nature01878; Checkelsky JG, 2012, NAT PHYS, V8, P729, DOI [10.1038/nphys2388, 10.1038/NPHYS2388]; Shimotani H, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2772781; Kundhikanjana W, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3554438; Kim D, 2012, NAT PHYS, V8, P459, DOI 10.1038/NPHYS2286; Yang YL, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/11/115040; Yomogida Y, 2012, ADV MATER, V24, P4392, DOI 10.1002/adma.201200655; Lee Y, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.136809; Yuan HT, 2013, NAT PHYS, V9, P563, DOI 10.1038/NPHYS2691; Beidenkopf H, 2011, NAT PHYS, V7, P939, DOI [10.1038/nphys2108, 10.1038/NPHYS2108]; Misra R, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2437663; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Lai K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.176809; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Martin J, 2008, NAT PHYS, V4, P144, DOI 10.1038/nphys781; Nakano M, 2012, NATURE, V487, P459, DOI 10.1038/nature11296; Sciascia C, 2011, ADV MATER, V23, P5086, DOI 10.1002/adma.201102410; Lai K, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2949109; Yuan HT, 2009, ADV FUNCT MATER, V19, P1046, DOI 10.1002/adfm.200801633; Lee KH, 2012, ADV MATER, V24, P4457, DOI 10.1002/adma.201200950; Dhoot AS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.136402; Yamada Y, 2011, SCIENCE, V332, P1065, DOI 10.1126/science.1202152; Cho JH, 2008, NAT MATER, V7, P900, DOI 10.1038/nmat2291; TAN IH, 1990, J APPL PHYS, V68, P4071, DOI 10.1063/1.346245; Yin CM, 2013, NANO LETT, V13, P2024, DOI 10.1021/nl400153p; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Jeong J, 2013, SCIENCE, V339, P1402, DOI 10.1126/science.1230512; Burgi L, 2002, APPL PHYS LETT, V80, P2913, DOI 10.1063/1.1470702; Zhang YJ, 2013, NANO LETT, V13, P3023, DOI 10.1021/nl400902v; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Salamon MB, 2001, REV MOD PHYS, V73, P583, DOI 10.1103/RevModPhys.73.583; Muller EM, 2005, ADV MATER, V17, P1410, DOI 10.1002/adma.200401174; Zaumseil J, 2013, J PHYS CHEM C, V117, P26361, DOI 10.1021/jp409849w; Lai KJ, 2010, SCIENCE, V329, P190, DOI 10.1126/science.1189925; Ye JT, 2010, NAT MATER, V9, P125, DOI [10.1038/nmat2587, 10.1038/NMAT2587]; Cho JH, 2008, ADV MATER, V20, P686, DOI 10.1002/adma.200701069; Ueno K, 2011, NAT NANOTECHNOL, V6, P408, DOI [10.1038/nnano.2011.78, 10.1038/NNANO.2011.78]; Bonnell DA, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.1343; Dagotto E., 2002, NANOSCALE PHASE SEPA; Lai K., 2011, APPL NANOSCI, V1, P13, DOI [DOI 10.1007/S13204-011-0002-7, 10.1007/s13204-011-0002-7]; Mann C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3277; Sze S. M., 2007, PHYS SEMICONDUCTOR D; Ueno K, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.032001; Yuan HT, 2014, NAT NANOTECHNOL, V9, P851, DOI [10.1038/nnano.2014.183, 10.1038/NNANO.2014.183]	49	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	JUL	2015	15	7					4730	4736		10.1021/acs.nanolett.5b01631		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CM8PM	WOS:000357964100073		
J	Mishra, P; Hill, JP; Vijayaraghavan, S; Van Rossom, W; Yoshizawa, S; Grisolia, M; Echeverria, J; Ono, T; Ariga, K; Nakayama, T; Joachim, C; Uchihashi, T				Mishra, Puneet; Hill, Jonathan P.; Vijayaraghavan, Saranyan; Van Rossom, Wim; Yoshizawa, Shunsuke; Grisolia, Maricarmen; Echeverria, Jorge; Ono, Teruo; Ariga, Katsuhiko; Nakayama, Tomonobu; Joachim, Christian; Uchihashi, Takashi			Current-Driven Supramolecular Motor with In Situ Surface Chiral Directionality Switching	NANO LETTERS			English	Article						Molecular motor; chirality; supramolecule; switching; scanning tunneling microscope; surface	SCANNING TUNNELING MICROSCOPE; ROTARY MOLECULAR MOTOR; SINGLE-MOLECULE; ADSORBED MOLECULES; ROTATION; MANIPULATION; MOTION; ASSEMBLIES; DYNAMICS; CHAINS	Surface-supported molecular motors are nanomechanical devices of particular interest in terms of future nanoscale applications. However, the molecular motors realized so far consist of covalently bonded groups that cannot be reconfigured without undergoing a chemical reaction. Here we demonstrate that a platinum-porphyrin-based supramolecularly assembled dimer supported on a Au(111) surface can be rotated with high directionality using the tunneling current of a scanning tunneling microscope (STM). Rotational direction of this molecular motor is determined solely by the surface chirality of the dimer, and most importantly, the chirality can be inverted in situ through a process involving an intradimer rearrangement. Our result opens the way for the construction of complex molecular machines on a surface to mimic at a smaller scale versatile biological supramolecular motors.	[Mishra, Puneet; Hill, Jonathan P.; Vijayaraghavan, Saranyan; Van Rossom, Wim; Yoshizawa, Shunsuke; Ariga, Katsuhiko; Nakayama, Tomonobu; Joachim, Christian; Uchihashi, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan; [Grisolia, Maricarmen; Echeverria, Jorge; Joachim, Christian] CNRS, CEMES, F-31055 Toulouse, France; [Grisolia, Maricarmen; Echeverria, Jorge; Joachim, Christian] CNRS, MANA Satellite, F-31055 Toulouse, France; [Ono, Teruo] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Hill, JP (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	jonathan.hill@nims.go.jp; joachim@cemes.fr; uchihashi.takashi@nims.go.jp	ARIGA, Katsuhiko/H-2695-2011; Yoshizawa, Shunsuke/M-5889-2014; Mishra, Puneet/D-2441-2010	Yoshizawa, Shunsuke/0000-0003-3380-5473; Mishra, Puneet/0000-0003-2890-432X	JSPS under Kakenhi Grant [24651125]; World Premier International Research Center (WPI) Initiative on Materials Nanoarchitechtonics; Generalitat de Catalunya; European Union	The authors thank Y. Nakajima and F. Ozawa for their contributions in the early stage of the research and W. H. Soe for fruitful discussions. T.U. and P.M. acknowledge financial support from JSPS under Kakenhi Grant 24651125 and from World Premier International Research Center (WPI) Initiative on Materials Nanoarchitechtonics. J.E. thanks the Generalitat de Catalunya and the European Union for a Beatriu de Pinos scholarship. The authors also thank CALMIP-Toulouse for computing time at Hyperion supercomputer.	Ample F, 2006, SURF SCI, V600, P3243, DOI 10.1016/j.susc.2006.06.015; Jung TA, 1996, SCIENCE, V271, P181, DOI 10.1126/science.271.5246.181; Jung TA, 1997, NATURE, V386, P696, DOI 10.1038/386696a0; Moresco F, 2001, PHYS REV LETT, V86, P672, DOI 10.1103/PhysRevLett.86.672; Reimann P, 2002, APPL PHYS A-MATER, V75, P169, DOI 10.1007/s003390201331; Stipe BC, 1998, SCIENCE, V279, P1907, DOI 10.1126/science.279.5358.1907; STROSCIO JA, 1991, SCIENCE, V254, P1319, DOI 10.1126/science.254.5036.1319; Ernst KH, 2012, PHYS STATUS SOLIDI B, V249, P2057, DOI 10.1002/pssb.201248188; Shirai Y, 2005, NANO LETT, V5, P2330, DOI 10.1021/nl051915k; Kim HW, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.146101; Perera UGE, 2013, NAT NANOTECHNOL, V8, P46, DOI [10.1038/nnano.2012.218, 10.1038/NNANO.2012.218]; Gimzewski JK, 1998, SCIENCE, V281, P531, DOI 10.1126/science.281.5376.531; Hernandez JV, 2004, SCIENCE, V306, P1532, DOI 10.1126/science.1103949; Iancu V, 2006, P NATL ACAD SCI USA, V103, P13718, DOI 10.1073/pnas.0603643103; Ruangsupapichat N, 2011, NAT CHEM, V3, P53, DOI [10.1038/nchem.872, 10.1038/NCHEM.872]; Iacovita C, 2012, CHEM-EUR J, V18, P14610, DOI 10.1002/chem.201201037; Gao L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197209; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Komeda T, 2002, SCIENCE, V295, P2055, DOI 10.1126/science.1069016; Kottas GS, 2005, CHEM REV, V105, P1281, DOI 10.1021/cr0300993; Schaffert J, 2013, NAT MATER, V12, P223, DOI [10.1038/nmat3527, 10.1038/NMAT3527]; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; Ait-Haddou R, 2003, CELL BIOCHEM BIOPHYS, V38, P191, DOI 10.1385/CBB:38:2:191; Koumura N, 1999, NATURE, V401, P152; Kudernac T, 2011, NATURE, V479, P208, DOI 10.1038/nature10587; Tierney HL, 2011, NAT NANOTECHNOL, V6, P625, DOI [10.1038/nnano.2011.142, 10.1038/NNANO.2011.142]; Seideman T, 2003, J PHYS-CONDENS MAT, V15, pR521, DOI 10.1088/0953-8984/15/14/201; van Delden RA, 2005, NATURE, V437, P1337, DOI 10.1038/nature04127; Yokoyama T, 2001, NATURE, V413, P619; Bohringer M, 1999, PHYS REV LETT, V83, P324, DOI 10.1103/PhysRevLett.83.324; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Echeverria J, 2014, NANOSCALE, V6, P2793, DOI 10.1039/c3nr05814j; Manzano C, 2009, NAT MATER, V8, P576, DOI [10.1038/nmat2467, 10.1038/NMAT2467]; Nickel A, 2013, ACS NANO, V7, P191, DOI 10.1021/nn303708h; SAUTET P, 1992, SURF SCI, V271, P387, DOI 10.1016/0039-6028(92)90902-I	36	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	JUL	2015	15	7					4793	4798		10.1021/acs.nanolett.5b01908		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CM8PM	WOS:000357964100082		
J	Kurokawa, R; Kim, P				Kurokawa, Ryu; Kim, Phyo			Cervical Laminoplasty: The History and the Future	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						cervical spine; spinal cord; myelopathy; radiculopathy; laminectomy	OPEN-DOOR LAMINOPLASTY; POSTERIOR LONGITUDINAL LIGAMENT; DEFORMITY FOLLOWING LAMINOPLASTY; OF-THE-LITERATURE; SPONDYLOTIC MYELOPATHY; EXTENSOR MUSCULATURE; STENOTIC MYELOPATHY; COMPRESSIVE MYELOPATHY; EXPANSIVE LAMINOPLASTY; NUCHAL LIGAMENT	Cervical laminoplasty was developed as an alternative to cervical laminectomy for treatment of cervical myelopathy, in which hinges are created to lift the lamina. Various techniques of laminoplasty have since been developed after two prototype techniques: Hirabayashi's open-door laminoplasty and Kurokawa's spinous process splitting (double-door) laminoplasty. Several in vitro studies report superior biomechanical stability of the cervical spine after laminoplasty compared with laminectomy. In clinical situation, randomized control studies are scarce and superiority of one procedure over another is not uniformly shown. Lack of hard evidence supporting the purported advantages of laminoplasty over laminectomy, that is, reduced rate of postoperative instability and kyphosis development, while preserving range of motion (ROM), has been a weak selling point. Currently, laminoplasty is performed by majority of spine surgeons in Japan, but is rarely performed in the United States and Europe. Recent development in laminoplasty is preservation of muscle attachment, which enabled dynamic stabilization of the cervical spine by neck extensor muscles. After treatment with new laminoplasty techniques with active postoperative neck ROM exercises, postoperative instability, kyphosis, axial neck pain, and loss of ROM seems minimal. Well-designed clinical trials to show the effectiveness and long-term outcome of this surgical procedure are warranted.	[Kurokawa, Ryu; Kim, Phyo] Dokkyo Med Univ Hosp, Dept Neurol Surg, Mibu, Tochigi 3210293, Japan	Kurokawa, R (reprint author), Dokkyo Med Univ Hosp, Dept Neurol Surg, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	ryukurokaw@aol.com					NOLAN JP, 1988, SPINE, V13, P9, DOI 10.1097/00007632-198801000-00003; Liu JY, 2007, SPINE J, V7, P159, DOI 10.1016/j.spinee.2006.07.007; McGirt MJ, 2010, NEUROSURGERY, V66, P1005, DOI 10.1227/01.NEU.0000367721.73220.C9; Manzano GR, 2012, NEUROSURGERY, V70, P264, DOI 10.1227/NEU.0b013e3182305669; Kode S, 2012, SPINE, V37, pE1165, DOI 10.1097/BRS.0b013e31825e6251; Suda K, 2003, SPINE, V28, P1258, DOI 10.1097/00007632-200306150-00008; Matz PG, 2009, J NEUROSURG-SPINE, V11, P157, DOI 10.3171/2009.1.SPINE08726; NURICK S, 1972, BRAIN, V95, P87; Cunningham MRA, 2010, SPINE, V35, P537, DOI 10.1097/BRS.0b013e3181b204cc; Machino M, 2013, J SPINAL DISORD TECH, V26, P135, DOI 10.1097/BSD.0b013e31823d848b; Hosono N, 2006, EUR SPINE J, V15, P1375, DOI 10.1007/s00586-006-0089-9; Okada M, 2009, SPINE, V34, P1119, DOI 10.1097/BRS.0b013e31819c3b61; Hosono N, 2007, SPINE, V32, P2985; Iizuka H, 2001, SPINE, V26, P2220, DOI 10.1097/00007632-200110150-00013; Maeda T, 2002, CLIN ORTHOP RELAT R, P132; Nurboja B, 2012, NEUROSURGERY, V70, P965, DOI 10.1227/NEU.0b013e31823cf16b; ITOH T, 1985, SPINE, V10, P729, DOI 10.1097/00007632-198510000-00007; Machino M, 2012, SPINE, V37, pE1243, DOI 10.1097/BRS.0b013e3182659d3e; Kim P, 2007, J NEUROSURG-SPINE, V7, P293, DOI 10.3171/SPI-07/09/293; Roselli R, 2000, J NEUROSURG, V92, P38, DOI 10.3171/spi.2000.92.1.0038; Takeuchi K, 2005, SPINE, V30, P2544, DOI 10.1097/01.brs.0000186332.66490.ba; HIRABAYASHI K, 1988, SPINE, V13, P870, DOI 10.1097/00007632-198807000-00032; HASE H, 1991, SPINE, V16, P1269, DOI 10.1097/00007632-199111000-00005; Tomita K, 1998, SPINE, V23, P32, DOI 10.1097/00007632-199801010-00007; OBrien MF, 1996, SPINE, V21, P474, DOI 10.1097/00007632-199602150-00012; Takeuchi K, 2005, CLIN ORTHOP RELAT R, P126, DOI 10.1097/01.blo.0000160710.11991.33; [Anonymous], 1999, CLIN ORTHOPAEDICS, DOI 10.1097/00003086-199902000-00005; Mummaneni PV, 2009, J NEUROSURG-SPINE, V11, P130, DOI 10.3171/2009.3.SPINE08728; Bydon M, 2014, NEUROSURGERY, V74, P595, DOI 10.1227/NEU.0000000000000322; Subramaniam V, 2009, SPINE, V34, pE573, DOI 10.1097/BRS.0b013e3181aa0214; RAIMONDI AJ, 1976, J NEUROSURG, V45, P555, DOI 10.3171/jns.1976.45.5.0555; Edwards CC, 2002, SPINE, V27, P1168, DOI 10.1097/00007632-200206010-00007; Ratliff JK, 2003, J NEUROSURG, V98, P230, DOI 10.3171/spi.2003.98.3.0230; Hyun SJ, 2009, SPINE, V34, P1134, DOI 10.1097/BRS.0b013e31819c389b; YONENOBU K, 1992, SPINE, V17, P1281, DOI 10.1097/00007632-199211000-00004; Yoshida M, 2002, SPINE, V27, P1414, DOI 10.1097/00007632-200207010-00008; Chiba K, 2006, SPINE, V31, P2998, DOI 10.1097/01.brs.0000250307.78987.6b; HIRABAYASHI K, 1983, SPINE, V8, P693, DOI 10.1097/00007632-198310000-00003; NOWINSKI GP, 1993, SPINE, V18, P1995, DOI 10.1097/00007632-199310001-00012; Halvorsen CM, 2011, ACTA NEUROL SCAND, V123, P358, DOI 10.1111/j.1600-0404.2010.01405.x; Baisden J, 1999, SPINE, V24, P1283, DOI 10.1097/00007632-199907010-00003; Bartels RH, 2013, EUR SPINE J; COBB MA, 1994, PEDIATR NEUROSURG, V21, P237, DOI 10.1159/000120842; Fields MJ, 2000, SPINE, V25, P2925, DOI 10.1097/00007632-200011150-00015; Fujiyoshi T, 2008, SPINE, V33, pE990, DOI 10.1097/BRS.0b013e318188b300; Hardman J, 2010, NEUROL RES, V32, P416, DOI 10.1179/174313209X459084; Heller John G, 2013, Evid Based Spine Care J, V4, P105, DOI 10.1055/s-0033-1357361; Herkowitz H N, 1988, J Spinal Disord, V1, P179; Holmes A, 1996, SPINE, V21, P1313, DOI 10.1097/00007632-199606010-00006; Hosono N, 2005, J NEUROSURG-SPINE, V3, P29, DOI 10.3171/spi.2005.3.1.0029; HUKUDA S, 1988, J BONE JOINT SURG BR, V70, P325; Iizuka H, 2007, J NEUROSURG-SPINE, V7, P610, DOI 10.3171/SPI-07/12/610; Japanese Orthopedic Association, 1994, NIPPON SEIKEIGEKA GA, V68, P490; KADOYA S, 1992, Neurologia Medico-Chirurgica, V32, P40, DOI 10.2176/nmc.32.40; Kaminsky S B, 2004, Iowa Orthop J, V24, P95; Kato M, 2008, SPINE, V33, pE455, DOI 10.1097/BRS.0b013e318178e607; Kawaguchi Y, 2014, SPINE J, V14, P955, DOI 10.1016/j.spinee.2013.07.457; Kim SW, 2013, SPINE J, V13, P914, DOI 10.1016/j.spinee.2013.02.032; Kimura A, 2011, EUR SPINE J, V20, P1560, DOI 10.1007/s00586-011-1724-7; Kirita Y, 1975, RINSHO SEIKEIGEKA, V10, P1077; Kubo S, 2002, J SPINAL DISORD TECH, V15, P477; Kurokawa T, 1982, BESSATSU SEIKEI GEKA, V2, P234; Lao LF, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-45; MATSUZAKI H, 1989, SPINE, V14, P1198, DOI 10.1097/00007632-198911000-00011; Naderi S, 1996, Neurosurg Focus, V1, pe1; Nakama Sueo, 2003, J Orthop Sci, V8, P36, DOI 10.1007/s007760300006; NAKANO N, 1988, SPINE, V13, P792, DOI 10.1097/00007632-198807000-00014; Oyama M, 1973, CENT JPN J ORTHOP TR, V16, P792; Sasai K, 2000, J SPINAL DISORD, V13, P26, DOI 10.1097/00002517-200002000-00005; Satomi K, 2001, Spine J, V1, P26, DOI 10.1016/S1529-9430(01)00008-0; SATOMI K, 1994, SPINE, V19, P507, DOI 10.1097/00007632-199403000-00003; Seichi A, 2001, SPINE, V26, P479, DOI 10.1097/00007632-200103010-00010; Shaffrey CI, 1999, J NEUROSURG, V90, P170, DOI 10.3171/spi.1999.90.2.0170; Shiraishi T, 2002, J NEUROSURG, V96, P122, DOI 10.3171/spi.2002.96.1.0122; Tadepalli Srinivas C, 2011, Iowa Orthop J, V31, P207; Takayasu M, 2002, J NEUROSURG, V96, P22, DOI 10.3171/spi.2002.96.1.0022; Takeshita K, 2004, SPINE, V29, pE388, DOI 10.1097/01.brs.0000138309.11926.72; Takeuchi T, 2007, EUR SPINE J, V16, P1417, DOI 10.1007/s00586-007-0352-8; Tani S, 2010, NEUROL MED-CHIR, V50, P1132, DOI 10.2176/nmc.50.1132; Tani S, 2002, NEUROSURGERY, V50, P97, DOI 10.1097/00006123-200201000-00017; TSUJI H, 1982, SPINE, V7, P28, DOI 10.1097/00007632-198200710-00002; Yoon ST, 2013, SPINE, V38, pS183, DOI 10.1097/BRS.0b013e3182a7eb7c; Yucesoy K, 2000, J NEUROSURG, V92, P371	83	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JUL	2015	55	7					529	539		10.2176/nmc.ra.2014-0387		11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CN0ML	WOS:000358107600001		
J	Sugawara, T				Sugawara, Taku			Anterior Cervical Spine Surgery for Degenerative Disease: A Review	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						anterior cervical spine surgery; degenerative disease; indication; outcome; complication	ADJACENT SEGMENT DISEASE; LARYNGEAL NERVE INJURY; VOCAL FOLD PARALYSIS; VERTEBRAL ARTERY; CAROTID-ARTERY; ESOPHAGEAL PERFORATIONS; FUSION; DISKECTOMY; RADICULOPATHY; DECOMPRESSION	Anterior cervical spine surgery is an established surgical intervention for cervical degenerative disease and high success rate with excellent long-term outcomes have been reported. However, indications of surgical procedures for certain conditions are still controversial and severe complications to cause neurological dysfunction or deaths may occur. This review is focused mainly on five widely performed procedures by anterior approach for cervical degenerative disease; anterior cervical discectomy, anterior cervical discectomy and fusion, anterior cervical corpectomy and fusion, anterior cervical foraminotomy, and arthroplasty. Indications, procedures, outcomes, and complications of these surgeries are discussed.	Res Inst Brain & Blood Vessels, Dept Spinal Surg, Akita 0100874, Japan	Sugawara, T (reprint author), Res Inst Brain & Blood Vessels, Dept Spinal Surg, 6-10 Senshu Kubota Machi, Akita 0100874, Japan.	sugawara-taku@akita-noken.jp					Matz PG, 2009, J NEUROSURG-SPINE, V11, P183, DOI 10.3171/2009.2.SPINE08721; Pollard ME, 2002, SPINE, V27, P152, DOI 10.1097/00007632-200201150-00006; Sagi HC, 2002, SPINE, V27, P949, DOI 10.1097/00007632-200205010-00013; Hashimoto M, 2010, EUR SPINE J, V19, P1702, DOI 10.1007/s00586-010-1427-5; Bazaz R, 2002, SPINE, V27, P2453, DOI 10.1097/01.BRS.0000031407.52778.4B; Pait TG, 1996, NEUROSURGERY, V39, P769, DOI 10.1097/00006123-199610000-00026; Yanagisawa T, 2004, J NEUROSURG, V100, P146, DOI 10.3171/jns.2004.100.1.0146; Dakwar E, 2009, J NEUROSURG-SPINE, V11, P320, DOI 10.3171/2009.3.SPINE08522; SHINTANI A, 1972, J NEUROSURG, V36, P447, DOI 10.3171/jns.1972.36.4.0447; Gaudinez RF, 2000, J SPINAL DISORD, V13, P77, DOI 10.1097/00002517-200002000-00015; VACCARO AR, 1994, SPINE, V19, P2637, DOI 10.1097/00007632-199412010-00007; Carrier CS, 2013, SPINE J, V13, P1370, DOI 10.1016/j.spinee.2013.05.050; Curylo LJ, 2000, SPINE, V25, P2860, DOI 10.1097/00007632-200011150-00004; Malhotra NR, 2010, SPINE, V35, P2167, DOI 10.1097/BRS.0b013e3181f6f0d0; Lee MJ, 2007, SPINE J, V7, P141, DOI 10.1016/j.spinee.2006.02.024; Orlando ER, 2003, SPINE, V28, pE290, DOI 10.1097/00007632-200308010-00023; Sakaura H, 2003, SPINE, V28, P2447, DOI 10.1097/01.BRS.0000090833.96168.3F; Inamasu J, 2005, NEUROSURG REV, V28, P239, DOI 10.1007/s10143-005-0412-7; Neo M, 2008, SPINE, V33, P779, DOI 10.1097/BRS.0b013e31816957a7; Sugawara T, 2009, ACTA NEUROCHIR, V151, P303, DOI 10.1007/s00701-009-0217-5; Oh SH, 1996, NEUROSURGERY, V38, P1139, DOI 10.1097/00006123-199606000-00016; Matz PG, 2009, J NEUROSURG-SPINE, V11, P170, DOI 10.3171/2009.3.SPINE08724; Mummaneni PV, 2009, J NEUROSURG-SPINE, V11, P130, DOI 10.3171/2009.3.SPINE08728; Bono CM, 2011, SPINE J, V11, P64, DOI 10.1016/j.spinee.2010.10.023; BERTALANFFY H, 1989, ACTA NEUROCHIR, V99, P41, DOI 10.1007/BF01407775; Hida K, 2008, NEUROL MED-CHIR, V48, P440, DOI 10.2176/nmc.48.440; Lee SH, 2011, SPINE, V36, P2286, DOI 10.1097/BRS.0b013e318237e5d0; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519; Fehlings MG, 2010, SPINE, V35, pS37, DOI 10.1097/BRS.0b013e3181d8338e; Joaquim AF, 2014, SPINE J, V14, P2246, DOI 10.1016/j.spinee.2014.03.030; Boselie TF, 2012, COCHRANE DB SYST REV, V9; Fogel Guy R, 2005, Spine J, V5, P140, DOI 10.1016/j.spinee.2004.06.022; Gandhoke G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11156; Higashiyama N, 2014, SPINAL SURG JPN, V28, P40; Hwang SL, 2004, J NEUROSURG-SPINE, V1, P160, DOI 10.3171/spi.2004.1.2.0160; Inamasu J, 2006, ACTA NEUROCHIR, V148, P375, DOI 10.1007/s00701-005-0669-1; Jacobs W, 2011, COCHRANE DB SYST REV, V1; Burke James P, 2005, Spine J, V5, P508, DOI 10.1016/j.spinee.2004.11.015; Jung A, 2005, J NEUROSURG-SPINE, V2, P123, DOI 10.3171/spi.2005.2.2.0123; Kilburg C, 2006, J NEUROSURG-SPINE, V4, P273, DOI 10.3171/spi.2006.4.4.273; Kriskovich MD, 2000, LARYNGOSCOPE, V110, P1467, DOI 10.1097/00005537-200009000-00011; Manski TJ, 1998, J NEUROSURG, V89, P839, DOI 10.3171/jns.1998.89.5.0839; Matz PG, 2009, J NEUROSURG-SPINE, V11, P174, DOI 10.3171/2009.3.SPINE08720; Netterville JL, 1996, ANN OTO RHINOL LARYN, V105, P85; Nikolaidis I, 2010, COCHRANE DB SYST REV, V1; Pichler W, 2006, SPINE, V31, pE268, DOI 10.1097/01.brs.0000215012.84443.c2; Resnick DK, 2005, J NEUROSURG-SPINE, V2, P637, DOI 10.3171/spi.2005.2.6.0637; Schaberg MR, 2007, LARYNGOSCOPE, V117, P1899, DOI 10.1097/MLG.0b013e31812eee01; Smith JS, 2010, SPINE, V35, P2140, DOI 10.1097/BRS.0b013e3181cbc8e7; Sugawara Taku, 2013, No Shinkei Geka, V41, P1023; Sugawara T, 2005, NEUROSURGERY, V57, P290, DOI 10.1227/01.NEU.0000176410.65750.C0; van Eck CF, 2014, SPINE, V39, P2143, DOI 10.1097/BRS.0000000000000636; Verma K, 2013, SPINE, V38, P2253, DOI 10.1097/BRS.0000000000000052; Beutler WJ, 2001, SPINE, V26, P1337, DOI 10.1097/00007632-200106150-00014; Yeh YC, 2004, SPINE, V29, pE431, DOI 10.1097/01.brs.0000141177.95850.b1; Yoshihara H, 2015, J SPINAL DISORD TECH, V28, P19, DOI 10.1097/BSD.0000000000000071	56	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JUL	2015	55	7					540	546		10.2176/nmc.ra.2014-0403		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CN0ML	WOS:000358107600002		
J	Hara, M; Nishimura, Y; Nakajima, Y; Umebayashi, D; Takemoto, M; Yamamoto, Y; Haimoto, S				Hara, Masahito; Nishimura, Yusuke; Nakajima, Yasuhiro; Umebayashi, Daisuke; Takemoto, Masaya; Yamamoto, Yuu; Haimoto, Shoichi			Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Disorders: Mini-open TLIF and Corrective TLIF	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						corrective transforaminal lumbar interbody fusion; lumbar lordosis; minimally invasive transforaminal lumbar interbody fusion; pelvic incidence	SPINAL DEFORMITY; POSTMENOPAUSAL OSTEOPOROSIS; VERTEBRAL FRACTURES; PEDICLE SCREWS; SURGERY; REDUCTION; ALIGNMENT; RISK	Minimally invasive transforaminal lumbar interbody fusion (TLIF) as a short fusion is widely accepted among the spine surgeons. However in the long fusion for degenerative kyphoscoliosis, corrective spinal fixation by an open method is thought to be frequently selected. Our objective is to study whether the mini-open TLIF and corrective TLIF contribute to the improvement of the spinal segmental and global alignment. We divided the patients who performed lumbar fixation surgery into three groups. Group 1 (G1) consisted of mini-open TLIF procedures without complication. Group 2 (G2) consisted of corrective TLIF without complication. Group 3 (G3) consisted of corrective TLIF with instrumentation-related complication postoperatively. In all groups, the lumbar lordosis (LL) highly correlated with developing surgical complications. LL significantly changed postoperatively in all groups, but was not corrected in the normal range in G3. There were statistically significant differences in preoperative and postoperative LL and mean difference between the pelvic incidence (PI) and LL between G3 and other groups. The most important thing not to cause the instrumentation-related failure is proper correction of the sagittal balance. In the cases with minimal sagiffal imbalance with or without coronal imbalance, short fusion by mini-open TLIF or long fusion by corrective TLIF contributes to good clinical results if the lesion is short or easily correctable. However, if the patients have apparent sagittal imbalance with or without coronal imbalance, we should perform proper correction of the sagittal spinal alignment introducing various technologies.	[Hara, Masahito; Nakajima, Yasuhiro; Yamamoto, Yuu] Inazawa Municipal Hosp, Dept Neurosurg, Inazawa, Aichi 4928510, Japan; [Nishimura, Yusuke; Umebayashi, Daisuke; Yamamoto, Yuu; Haimoto, Shoichi] Nagoya Univ, Dept Neurosurg, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Takemoto, Masaya] Chukyo Hosp, Dept Neurosurg, Nagoya, Aichi, Japan	Hara, M (reprint author), Inazawa Municipal Hosp, Dept Neurosurg, 100 Numa,Nazuka Cho, Inazawa, Aichi 4928510, Japan.	masahara219@hotmail.co.jp					Ames CP, 2005, SPINE, V30, pE562, DOI 10.1097/01.brs.0000180505.80347.b1; Oliveira L, 2010, SPINE, V35, pS331, DOI 10.1097/BRS.0b013e3182022db0; Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96; Jang JS, 2009, NEUROSURGERY, V64, P115, DOI 10.1227/01.NEU.0000335642.14527.26; Lewis SJ, 2012, SPINE, V37, P1407, DOI 10.1097/BRS.0b013e31824fffb9; Mayer HM, 1997, SPINE, V22, P691, DOI 10.1097/00007632-199703150-00023; Ames CP, 2012, J NEUROSURG-SPINE, V16, P547, DOI 10.3171/2012.2.SPINE11320; Youssef JA, 2010, SPINE, V35, pS302, DOI 10.1097/BRS.0b013e3182023438; LOGUIDICE VA, 1988, SPINE, V13, P366, DOI 10.1097/00007632-198803000-00027; Nakamura T, 2012, J CLIN ENDOCR METAB, V97, P3097, DOI 10.1210/jc.2011-3479; Santoni BG, 2009, SPINE J, V9, P366, DOI 10.1016/j.spinee.2008.07.008; BERNHARDT M, 1989, SPINE, V14, P717, DOI 10.1097/00007632-198907000-00012; Acosta FL, 2011, J NEUROSURG-SPINE, V15, P92, DOI 10.3171/2011.3.SPINE10425; Schwab F, 2010, SPINE, V35, P2224, DOI 10.1097/BRS.0b013e3181ee6bd4; Wu RH, 2010, SPINE, V35, P2273, DOI 10.1097/BRS.0b013e3181cd42cc; Brau Salvador A, 2002, Spine J, V2, P216, DOI 10.1016/S1529-9430(02)00184-5; Costanzo G, 2014, EUR SPINE J, V23, pS699, DOI 10.1007/s00586-014-3561-y; Harms J G, 1998, Oper Orthop Traumatol, V10, P90, DOI 10.1007/s00064-006-0112-7; Hasegawa K, 2003, J NEUROSURG, V99, P125, DOI 10.3171/spi.2003.99.1.0125; Hirsch BP, 2013, SPINE J, V13, P190, DOI 10.1016/j.spinee.2012.03.035; Inoue G, 2014, J NEUROSURG-SPINE, V21, P425, DOI 10.3171/2014.5.SPINE13656; Lee JS, 2011, J SPINAL DISORD TECH, V24, pE11, DOI 10.1097/BSD.0b013e3181dd812f; Li FC, 2011, J SPINAL DISORD TECH, V24, P308, DOI 10.1097/BSD.0b013e3181f9a7d5; Nishimura Y, 2014, NEUROL MED-CHIR, V54, P707, DOI 10.2176/nmc.oa.2014-0026; Ohtori S, 2012, SPINE, V37, pE1464, DOI 10.1097/BRS.0b013e31826ca2a8; Ozgur Burak M, 2006, Spine J, V6, P435, DOI 10.1016/j.spinee.2005.08.012; Schwab F, 2012, SPINE, V37, P1077, DOI 10.1097/BRS.0b013e31823e15e2; Schwender JD, 2005, J SPINAL DISORD TECH, V18, pS1, DOI 10.1097/01.bsd.0000132291.50455.d0; Silvestre Clément, 2012, Asian Spine J, V6, P89, DOI 10.4184/asj.2012.6.2.89; Steffee A D, 1988, Clin Orthop Relat Res, V227, P99; Takahashi T, 2005, OSTEOPOROSIS INT, V16, P273, DOI 10.1007/s00198-004-1669-3; THIRANONT N, 1993, SPINE, V18, P2517, DOI 10.1097/00007632-199312000-00023	32	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JUL	2015	55	7					547	556		10.2176/nmc.oa.2014-0402		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CN0ML	WOS:000358107600003		
J	Ito, K; Aoyama, T; Miyaoka, Y; Horiuchi, T; Hongo, K				Ito, Kiyoshi; Aoyama, Tatsuro; Miyaoka, Yoshinari; Horiuchi, Tetsuyoshi; Hongo, Kazuhiro			Surgical Strategies for Cervical Spinal Neurinomas	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						dumbbell type; nerve root resection; neurofibromatosis; spinal neurinoma; surgical strategy	NERVE SHEATH TUMORS; OPEN-DOOR LAMINOPLASTY; DUMBBELL TUMORS; CLASSIFICATION; SCHWANNOMA; SERIES; ROOTS; MANAGEMENT; MYELOPATHY; RESECTION	Cervical spinal neurinomas are benign tumors that arise from nerve roots. Based on their location, these tumors can also take the form of a dumbbell-shaped mass. Treatment strategies for these tumors have raised several controversial issues such as appropriate surgical indications and selection of surgical approaches for cervical dumbbell-shaped spinal neurinomas. In this report, we review previous literature and retrospectively analyze cervical spinal neurinoma cases that have been treated at our hospital. Surgical indications and approaches based on tumor location and severity are discussed in detail. Thus, with advances in neuroimaging and neurophysiological monitoring, we conclude that appropriate surgical approaches and intraoperative surgical manipulations should be chosen on a case-by-case basis.	[Ito, Kiyoshi; Aoyama, Tatsuro; Miyaoka, Yoshinari; Horiuchi, Tetsuyoshi; Hongo, Kazuhiro] Shinshu Univ, Sch Med, Dept Neurosurg, Matsumoto, Nagano 3908621, Japan	Ito, K (reprint author), Shinshu Univ, Sch Med, Dept Neurosurg, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	kitoh@shinshu-u.ac.jp					Conti P, 2004, SURG NEUROL, V61, P34, DOI 10.1016/S0090-3019(03)00537-8; Jinnai T, 2005, NEUROSURGERY, V56, P510, DOI 10.1227/01.NEU.0000153752.59565.BB; Pilavaki M, 2004, EUR J RADIOL, V52, P229, DOI 10.1016/j.ejrad.2003.12.001; Jiang L, 2009, SPINE, V34, P1307, DOI 10.1097/BRS.0b013e3181a27a32; Ito K, 2009, SURG NEUROL, V72, P470, DOI 10.1016/j.surneu.2009.01.012; SEPPALA MT, 1995, J NEUROSURG, V83, P621, DOI 10.3171/jns.1995.83.4.0621; Celli P, 2002, NEUROSURGERY, V51, P684, DOI 10.1227/01.NEU.0000024155.40431.CD; ITOH T, 1985, SPINE, V10, P729, DOI 10.1097/00007632-198510000-00007; HIRABAYASHI K, 1988, SPINE, V13, P870, DOI 10.1097/00007632-198807000-00032; Tanaka N, 2000, SPINE, V25, P286, DOI 10.1097/00007632-200002010-00005; Nakamura M, 2013, J ORTHOP SCI, V18, P8, DOI 10.1007/s00776-012-0300-2; YASUOKA S, 1982, J NEUROSURG, V57, P441, DOI 10.3171/jns.1982.57.4.0441; Medin PM, 2011, INT J RADIAT ONCOL, V79, P1302, DOI 10.1016/j.ijrobp.2010.10.052; Asazuma T, 2004, SPINE, V29, pE10, DOI 10.1097/01.BRS.0000103662.13689.76; McCormick PC, 1996, NEUROSURGERY, V38, P294, DOI 10.1097/00006123-199602000-00012; Klekamp J, 1998, NEUROSURGERY, V42, P279, DOI 10.1097/00006123-199802000-00042; HIRABAYASHI K, 1983, SPINE, V8, P693, DOI 10.1097/00007632-198310000-00003; Ozawa H, 2007, J NEUROSURG-SPINE, V7, P587, DOI 10.3171/SPI-07/12/587; Asazuma T, 2007, SPINE SPINAL CORD, V21, P231; KIM P, 1989, J NEUROSURG, V71, P810, DOI 10.3171/jns.1989.71.6.0810; Lot G, 1997, NEUROSURGERY, V41, P813, DOI 10.1097/00006123-199710000-00010; GEORGE B, 1995, J NEUROSURG, V82, P917, DOI 10.3171/jns.1995.82.6.0917; Hasegawa M, 2005, CLIN NEUROPATHOL, V24, P19; HERMAN JM, 1994, J NEUROSURG, V80, P963, DOI 10.3171/jns.1994.80.6.0963; Ito K, 2014, BRIT J NEUROSURG, V28, P324, DOI 10.3109/02688697.2013.835372; Kim P, 2007, GUIDEBOOK FUTURE EXP, P230; Klekamp J, 1993, Acta Neurochir (Wien), V123, P221; Lot G, 1997, NEUROSURGERY, V41, P820; Mizuno J, 1994, SURG ANATOMY MICRONE, P3; OCONNOR M, 1990, CLIN J PAIN, V6, P240; Skovronsky DM, 2004, NEUROSURG CLIN N AM, V15, P157, DOI 10.1016/j.nec.2004.02.005; Sohn S, 2013, J NEURO-ONCOL, V114, P345, DOI 10.1007/s11060-013-1190-7; Steinmetz Michael P, 2006, Spine J, V6, p274S, DOI 10.1016/j.spinee.2006.04.023; Toyama Y, 1992, J JAP MED SOC PARAPL, V5, P86; Uchikado H, 2010, GUIDEBOOK DIAGNOSIS, P182	35	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JUL	2015	55	7					557	563		10.2176/nmc.ra.2014-0421		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CN0ML	WOS:000358107600004		
J	Asahi, T; Sato, M; Kajimoto, H; Koh, M; Kashiwazaki, D; Kuroda, S				Asahi, Takashi; Sato, Michi; Kajimoto, Hiroyuki; Koh, Masaki; Kashiwazaki, Daina; Kuroda, Satoshi			Rate of Hanger Reflex Occurrence: Unexpected Head Rotation on Fronto-temporal Head Compression	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						hanger reflex; cervical dystonia; neuromodulation	DEEP BRAIN-STIMULATION; PRIMARY CERVICAL DYSTONIA; SPASMODIC TORTICOLLIS	When the head is encircled with a wire clothes hanger and the unilateral fronto-temporal region is compressed, the head rotates unexpectedly. As the mechanism is unclear, however, we have temporarily named this phenomenon as the "hanger reflex." We previously reported a case wherein this phenomenon was applied to treat cervical dystonia. Because little is known about this phenomenon, we determined how often this phenomenon is observed in healthy subjects. Study participants were 120 healthy Japanese adults (60 men and 60 women) aged 19-65 years. A wire clothes hanger was applied to each subject's head. The longer side of the hanger was attached over the volunteer's fronto-temporal regions on both sides of the head in succession (i.e., two applications per volunteer). We evaluated whether the subjects felt the sensation of head rotation by using a questionnaire. The sensation of head rotation was observed in 95.8% of subjects. There were five non-responders (4.2%). In 85.4% of the trials, head rotation was observed in the direction that coincided with the side compressed by the hanger. There were no differences in responses between genders. The incident rate of the hanger reflex was remarkably high and most likely represents a prevalent phenomenon in humans. The mechanism underlying the reflex remains unknown. Further research should be performed to elucidate the underlying causes of the hanger reflex, which represents a potential treatment for cervical dystonia.	[Asahi, Takashi; Koh, Masaki; Kashiwazaki, Daina; Kuroda, Satoshi] Toyama Univ, Sch Med & Pharmaceut Sci, Dept Neurosurg, Toyama 9300194, Japan; [Sato, Michi; Kajimoto, Hiroyuki] Univ Electrocommun, Dept Informat, Chofu, Tokyo 182, Japan	Asahi, T (reprint author), Toyama Univ, Sch Med & Pharmaceut Sci, Dept Neurosurg, Sugitani 2630, Toyama 9300194, Japan.	takashi-tym@umin.ac.jp			JSPS KAKENHI [23791587]	This study was supported by JSPS KAKENHI (23791587) and a Hokugin grant for young scientists. The JSPS KAKENHI and Hokugin grant for young scientists provided unrestricted support and had no role in the oversight or review of the research data or reporting. The authors have no conflicts of interest to declare.	Aiba A, 2014, J MOV DISORD DISABIL, V24, P13; LEIS AA, 1992, J NEUROL SCI, V110, P79; JAHANSHAHI M, 1991, BIOFEEDBACK SELF-REG, V16, P413, DOI 10.1007/BF00999994; Poewe W, 1998, J NEUROL NEUROSUR PS, V64, P13, DOI 10.1136/jnnp.64.1.13; Albanese A, 2011, EUR J NEUROL, V18, P5, DOI 10.1111/j.1468-1331.2010.03042.x; Hung SW, 2007, NEUROLOGY, V68, P457, DOI 10.1212/01.wnl.0000252932.71306.89; Kiss ZHT, 2007, BRAIN, V130, P2879, DOI 10.1093/brain/awm229; Ostrem JL, 2011, NEUROLOGY, V76, P870, DOI 10.1212/WNL.0b013e31820f2e4f; Asahi T, 2014, Japanese patent, Patent No. 5552844; Asahi T, 2010, FUNCT NEUROSURG, V49, P173; CHRISTENSEN JEJ, 1991, LANCET, V338, P573, DOI 10.1016/0140-6736(91)91138-K; Matsue Rika, 2008, SICE 2008 - 47th Annual Conference of the Society of Instrument and Control Engineers of Japan, DOI 10.1109/SICE.2008.4654889; Nakamura T, 2014, 2014 IEEE VIRTUAL REALITY (VR), P181, DOI 10.1109/VR.2014.6802111; Sato M, 2009, 18 IEEE INT S ROB HU, P534; Smania N, 2003, FUNCT NEUROL, V18, P219; Snaith A, 2011, BMJ CLIN EVID, V2011; Taira T, 2003, STEREOT FUNCT NEUROS, V80, P92, DOI 10.1159/000075166; WALTZ JM, 1985, APPL NEUROPHYSIOL, V48, P324; Zetterberg Lena, 2008, Physiotherapy Theory and Practice, V24, P275, DOI 10.1080/09593980701884816	19	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JUL	2015	55	7					587	591		10.2176/nmc.oa.2014-0324		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CN0ML	WOS:000358107600008		
J	Kondo, K; Nemoto, M; Masuda, H; Okonogi, S; Nomoto, J; Harada, N; Sugo, N; Miyazaki, C				Kondo, Kosuke; Nemoto, Masaaki; Masuda, Hiroyuki; Okonogi, Shinichi; Nomoto, Jun; Harada, Naoyuki; Sugo, Nobuo; Miyazaki, Chikao			Anatomical Reproducibility of a Head Model Molded by a Three-dimensional Printer	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						three-dimensional printer; rapid prototyping; cerebral aneurysm; computed tomography angiography; microsurgical anatomy	MICROSURGICAL ANATOMY; NECK RECONSTRUCTION; CEREBRAL-ARTERY	We prepared rapid prototyping models of heads with unruptured cerebral aneurysm based on image data of computed tomography angiography (CTA) using a three-dimensional (3D) printer. The objective of this study was to evaluate the anatomical reproducibility and accuracy of these models by comparison with the CTA images on a monitor. The subjects were 22 patients with unruptured cerebral aneurysm who underwent preoperative CTA. Reproducibility of the microsurgical anatomy of skull bone and arteries, the length and thickness of the main arteries, and the size of cerebral aneurysm were compared between the CTA image and rapid prototyping model. The microsurgical anatomy and arteries were favorably reproduced, apart from a few minute regions, in the rapid prototyping models. No significant difference was noted in the measured lengths of the main arteries between the CTA image and rapid prototyping model, but errors were noted in their thickness (p < 0.001). A significant difference was also noted in the longitudinal diameter of the cerebral aneurysm (p < 0.01). Regarding the CTA image as the gold standard, reproducibility of the microsurgical anatomy of skull bone and main arteries was favorable in the rapid prototyping models prepared using a 3D printer. It was concluded that these models are useful tools for neurosurgical simulation. The thickness of the main arteries and size of cerebral aneurysm should be comprehensively judged including other neuroimaging in consideration of errors.	[Kondo, Kosuke; Nemoto, Masaaki; Masuda, Hiroyuki; Okonogi, Shinichi; Nomoto, Jun; Harada, Naoyuki; Sugo, Nobuo] Toho Univ, Sch Med, Dept Neurosurg Omori, Tokyo 1438541, Japan; [Miyazaki, Chikao] Toho Univ, Sch Med, Dept Neurosurg Sakura, Sakura, Japan	Sugo, N (reprint author), Toho Univ, Fac Med, Dept Neurosurg Omori,Sch Med, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	nsugo@med.toho-u.ac.jp					Hakansson A, 2011, VASA, V40, P453, DOI 10.1024/0301-1526/a000148; GIBO H, 1981, J NEUROSURG, V54, P151, DOI 10.3171/jns.1981.54.2.0151; Chae MP, 2014, BREAST CANCER RES TR, V146, P457, DOI 10.1007/s10549-014-3028-1; Silva DN, 2008, J CRANIO MAXILL SURG, V36, P443, DOI 10.1016/j.jcms.2008.04.003; Ebert LC, 2011, FORENSIC SCI INT, V211, pE1, DOI 10.1016/j.forsciint.2011.04.022; Kim BJ, 2012, J KOREAN NEUROSURG S, V52, P541, DOI 10.3340/jkns.2012.52.6.541; Li JH, 2011, AESTHET PLAST SURG, V35, P636, DOI 10.1007/s00266-010-9602-y; Ibrahim D, 2009, J CRANIO MAXILL SURG, V37, P167, DOI 10.1016/j.jcms.2008.10.008; Hirsch DL, 2009, J ORAL MAXIL SURG, V67, P2115, DOI 10.1016/j.joms.2009.02.007; Kunz M, 2012, KNEE SURG SPORT TR A, V20, P857, DOI 10.1007/s00167-011-1638-2; Taft RM, 2011, J PROSTHET DENT, V106, P399, DOI 10.1016/S0022-3913(11)60154-6; Choi JY, 2002, INT J ORAL MAX SURG, V31, P23, DOI 10.1054/ijom.2000.0135; Rankin TM, 2014, J SURG RES, V189, P193, DOI 10.1016/j.jss.2014.02.020; [Anonymous], U.S. Patent, Patent No. [4,575,330, 4575330]; Oishi M, 2013, J NEUROSURG, V119, P94, DOI 10.3171/2013.3.JNS121109; Harada N, 2011, NEUROL MED-CHIR, V51, P567; Huotilainen E, 2014, J CRANIO MAXILL SURG, V42, pE259, DOI 10.1016/j.jcms.2013.10.001; KODAMA H, 1981, REV SCI INSTRUM, V52, P1770, DOI 10.1063/1.1136492; Lueders C, 2014, EUR J CARDIO-THORAC, V46, P593, DOI 10.1093/ejcts/ezt510; Mankovich N J, 1990, J Digit Imaging, V3, P200; Mori Kentaro, 2010, Neurosurgery, V66, P339; Morita A, 2012, NEW ENGL J MED, V366, P2474; Niikura Takahiro, 2014, Orthopedics, V37, P237, DOI 10.3928/01477447-20140401-05; PERLMUTTER D, 1978, J NEUROSURG, V49, P204, DOI 10.3171/jns.1978.49.2.0204; Saijo H, 2011, INT J ORAL MAX SURG, V40, P955, DOI 10.1016/j.ijom.2011.03.018; Waran V, 2014, J SURG EDUC, V71, P193, DOI 10.1016/j.jsurg.2013.08.010; Yasargil MG, 1984, MICRONEUROSURGERY, V2, P260	27	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JUL	2015	55	7					592	598		10.2176/nmc.oa.2014-0436		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CN0ML	WOS:000358107600009		
J	Ogihara, S; Kunogi, J				Ogihara, Satoshi; Kunogi, Junichi			Single-stage Anterior and Posterior Fusion Surgery for Correction of Cervical Kyphotic Deformity Using Intervertebral Cages and Cervical Lateral Mass Screws: Postoperative Changes in Total Spine Sagittal Alignment in Three Cases with a Minimum Follow-up of Five Years	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						cervical spine; kyphosis; alignment; correction	KYPHOSIS; FIXATION; RECONSTRUCTION; DECOMPRESSION; CORPECTOMY; GRAFTS	The surgical treatment of cervical kyphotic deformity remains challenging. As a surgical method that is safer and avoids major complications, the authors present a procedure of single-stage anterior and posterior fusion to correct cervical kyphosis using anterior interbody fusion cages without plating, as illustrated by three consecutive cases. Case 1 was a 78-year-old woman who presented with a dropped head caused by degeneration of her cervical spine. Case 2 was a 54-year-old woman with athetoid cerebral palsy. She presented with cervical myelopathy and cervical kyphosis. Case 3 was a 71-year-old woman with cervical kyphotic deformity following a laminectomy. All three patients underwent anterior release and interbody fusion with cages and posterior fusion with cervical lateral mass screw (LMS) fixation. Postoperative radiographs showed that correction of kyphosis was 39 degrees in case 1, 43 degrees in case 2, and 39 degrees in case 3. In all three cases, improvement of symptoms was established without major perioperative complications, solid fusion was achieved, and no loss of correction was observed at a minimum follow-up of 61 months. We also report that preoperative total spine sagittal malalignment was improved after corrective surgery for cervical kyphosis and was maintained at the latest follow-up in all three cases. The combination of anterior fusion cages and LMS is considered a safe and effective procedure in cases of severe cervical kyphotic deformity. Preoperative total spine sagittal malalignment improved, accompanied by correction of cervical kyphosis, and was maintained at last follow-up in all three cases.	[Ogihara, Satoshi] Sagamihara Natl Hosp, Dept Spine & Orthoped Surg, Spine Ctr, Sagamihara, Kanagawa 2520392, Japan; [Kunogi, Junichi] Japanese Red Cross Med Ctr, Spine Ctr, Dept Spine & Orthoped Surg, Tokyo, Japan	Ogihara, S (reprint author), Sagamihara Natl Hosp, Dept Spine & Orthoped Surg, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa 2520392, Japan.	s-ogihara@sagamihara-hosp.gr.jp					Abumi K, 1999, SPINE, V24, P2389, DOI 10.1097/00007632-199911150-00017; O'Shaughnessy BA, 2008, SPINE, V33, P771, DOI 10.1097/BRS.0b013e3181695082; Schultz KD, 2000, J NEUROSURG, V93, P214, DOI 10.3171/spi.2000.93.2.0214; Han K, 2011, EUR SPINE J, V20, P523, DOI 10.1007/s00586-010-1602-8; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Hart RA, 2008, SPINE, V33, P2887, DOI 10.1097/BRS.0b013e318190affe; Sawin PD, 1998, J NEUROSURG, V88, P255, DOI 10.3171/jns.1998.88.2.0255; Sekhon LHS, 2005, J SPINAL DISORD TECH, V18, P297, DOI 10.1097/01.bsd.0000166640.23448.09; Sasso RC, 2003, SPINE, V28, P140, DOI 10.1097/00007632-200301150-00009; Potter BK, 2004, J BONE JOINT SURG AM, V86A, P1793; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Mummaneni PV, 2008, J NEUROSURG-SPINE, V9, P515, DOI 10.3171/SPI.2008.10.08226; Dahdaleh NS, 2009, J NEUROSURG-SPINE, V10, P133, DOI 10.3171/2008.11.SPI08416; DiAngelo DJ, 2000, SPINE, V25, P783, DOI 10.1097/00007632-200004010-00005; Hacker RJ, 2000, SPINE, V25, P2646, DOI 10.1097/00007632-200010150-00017; HERMAN JM, 1994, J NEUROSURG, V80, P963, DOI 10.3171/jns.1994.80.6.0963; Nottmeier EW, 2009, J SPINAL DISORD TECH, V22, P385, DOI 10.1097/BSD.0b013e318180e672; Song KJ, 2010, J BONE JOINT SURG BR, V92B, P1548, DOI 10.1302/0301-620X.92B11.24995; Takeshita K, 2013, J ORTHOP SCI, V18, P14, DOI 10.1007/s00776-012-0304-y	19	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JUL	2015	55	7					599	604		10.2176/nmc.cr.2014-0263		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CN0ML	WOS:000358107600010		
J	Horie, N; Hayashi, K; Morikawa, M; Izumo, T; Nagata, I				Horie, Nobutaka; Hayashi, Kentaro; Morikawa, Minoru; Izumo, Tsuyoshi; Nagata, Izumi			A Novel Method for Super-selective Coil Embolization Using an Extremely Soft Bare Coil through a Liquid Embolic Delivery Microcatheter	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						coil; super-selective embolization; microcatheter	INTRACRANIAL ARTERIOVENOUS-MALFORMATIONS; N-BUTYL CYANOACRYLATE; PREOPERATIVE EMBOLIZATION; MULTIMODALITY TREATMENT; ONYX; EXPERIENCE; ANEURYSMS	Endovascular coil embolization for intracranial aneurysms, arteriovenous malformations (AVMs), dural arteriovenous fistulas (AVFs), and hypervascular tumors are recognized as an effective adjunctive or curative treatment. In this setting, it is sometimes difficult to navigate a coil delivery microcatheter to the target point of a tiny, tortuous vessel. We herein present a case series of a novel method that enabled super-selective coil embolization using an extremely soft bare, electrodetachable coil (ED extrasoft (R) coil) through a liquid embolic delivery microcatheter (Marathon (R)). The Marathon (R) catheter was successfully placed at the target point of the tiny, tortuous vessel, and coil embolization was achieved in all 16 patients with 9 AVMs, 2 distal aneurysms, 2 AVFs, and 3 meningiomas. The primary ED extrasoft (R) coil and delivery wire have a very small radius, and the coil is rapidly detachable with an alarm notice from the generator even under Marathon (R) with one marker. We believe that this technique can provide safe and efficient embolization for selected patients.	[Horie, Nobutaka; Hayashi, Kentaro; Izumo, Tsuyoshi; Nagata, Izumi] Nagasaki Univ, Sch Med, Dept Neurosurg, Nagasaki, Nagasaki 8528501, Japan; [Morikawa, Minoru] Nagasaki Univ, Sch Med, Dept Radiol, Nagasaki, Nagasaki 8528501, Japan	Horie, N (reprint author), Nagasaki Univ, Sch Med, Dept Neurosurg, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528501, Japan.	nobstanford@gmail.com			Nagasaki University President's Fund	This work was supported in part by a Nagasaki University President's Fund Grant.	DEMERITT JS, 1995, AM J NEURORADIOL, V16, P1801; Yuki I, 2010, J NEUROSURG, V113, P715, DOI 10.3171/2009.9.JNS081588; Weber W, 2007, NEUROSURGERY, V61, P244, DOI 10.1227/01.NEU.0000255473.60505.84; Panagiotopoulos V, 2009, AM J NEURORADIOL, V30, P99, DOI 10.3174/ajnr.A1314; JAFAR JJ, 1993, J NEUROSURG, V78, P60, DOI 10.3171/jns.1993.78.1.0060; Fiorella D, 2006, NEUROSURGERY, V59, pS163; Fiorella D, 2006, NEUROSURGERY, V59, pS3; Gupta R, 2008, NEUROSURGERY, V59, pS3, DOI DOI 10.1227/01.NEU.0000239249.65742.1C; Gupta R, 2006, NEUROSURGERY, V59, pS251; Harada K, 2013, J NEUROINTERV SURG, V5, P577, DOI 10.1136/neurintsurg-2012-010498; Horie N, 2012, ACTA NEUROCHIR, V154, P989, DOI 10.1007/s00701-012-1287-3; Miyachi S, 2010, INTERV NEURORADIOL, V16, P353; Murugesan C, 2008, NEURORADIOLOGY, V50, P439, DOI 10.1007/s00234-007-0348-4; Natarajan SK, 2008, NEUROSURGERY, V62, P1213, DOI 10.1227/01.neu.0000333293.74986.e5; Velat GJ, 2008, NEUROSURGERY, V63, pONS73; Velat GJ, 2008, NEUROSURGERY, V63, pONS78	16	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JUL	2015	55	7					605	609		10.2176/nmc.tn.2013-0335		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CN0ML	WOS:000358107600011		
J	Higuchi, H; Takagi, S; Zhang, K; Furui, I; Ozaki, M				Higuchi, Hideyuki; Takagi, Shunichi; Zhang, Kan; Furui, Ikue; Ozaki, Makoto			Effect of Lateral Tilt Angle on the Volume of the Abdominal Aorta and Inferior Vena Cava in Pregnant and Nonpregnant Women Determined by Magnetic Resonance Imaging	OBSTETRICAL & GYNECOLOGICAL SURVEY			English	Editorial Material								Assumed aortocaval compression (inferior vena cava [IVC] compression and compression of the abdominal aorta) by the gravid uterus in parturients in the supine position can cause hemodynamic disturbances and uteroplacental hypoperfusion. The left-lateral tilt position is used to reduce aortocaval compression, although this assumption has not been morphologically validated. Reported recommended angles, although controversial, are 15 degrees after spinal anesthesia for cesarean delivery, and 30 degrees is recommended during resuscitation in pregnant women. This study, using magnetic resonance imaging (MRI), aims to investigate whether the left-lateral tilt angle reduces aortocaval compression. Two groups of women, 10 healthy women at full term with cephalic singleton pregnancies and 10 nonpregnant healthy women, volunteered and gave written consent for the study. Magnetic resonance imaging scans were taken to measure the volume of the abdominal aorta and IVC from the L1-L2 disk level to the L3-L4 disk level at supine and 15-, 30-, and 45-degree positions. These angles were achieved by using a 1.5-long hard V block, running the length of the woman's body. Mean arterial pressure, heart rate, and cardiac output were recorded in each position for each subject. Statistical significance was achieved when P < 0.05. The fetus was in the right occiput position in 7 of the group of 10 and in the left occiput position in 3. While the shape of the aorta in pregnant women was different in some MRI slices, there was no significance in the difference in aortic volume between groups in any position, nor was there significant difference in either group in any of the left-lateral tilt positions. In the supine position, IVC volume in pregnant women was significantly smaller than that in nonpregnant women (3.2 +/- 3.4 vs 17.5 +/- 7.8 mL; mean difference, 14.3 mL; P < 0.001). In pregnant women, IVC volume between the supine position and 15-degree left-tilt position was not significantly different (3.0 +/- 2.1 mL; mean difference, -0.2 mL; P > 0.99), but IVC volume was significantly different between the supine position and 30-degree left-tilt position (11.5 +/- 8.6 mL; mean difference, 8.3 mL; P = 0.009) and was also significantly between the supine position and 45 degrees (10.9 +/- 6.8 mL; mean difference, 7.7 mL; P = 0.015). While tilt positions of 30 and 45 degrees partially relieved IVC compression compared with the supine position, a tilt position of 15 degrees did not. However, there are limitations of this study; for example, the pregnant and nonpregnant women did not receive anesthesia, and the parturients were not in labor. Future research should attempt to examine physiologic measures as well.	[Higuchi, Hideyuki; Takagi, Shunichi; Zhang, Kan; Furui, Ikue; Ozaki, Makoto] Tokyo Womens Med Univ, Dept Anesthesiol, Tokyo, Japan	Higuchi, H (reprint author), Tokyo Womens Med Univ, Dept Anesthesiol, Tokyo, Japan.							0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7828	1533-9866		OBSTET GYNECOL SURV	Obstet. Gynecol. Surv.	JUL	2015	70	7					425	426		10.1097/OGX.0000000000000221		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CM5OO	WOS:000357737800001		
J	Nagasawa, M; Mitsui, S; En, S; Ohtani, N; Ohta, M; Sakuma, Y; Onaka, T; Mogi, K; Kikusui, T				Nagasawa, Miho; Mitsui, Shouhei; En, Shiori; Ohtani, Nobuyo; Ohta, Mitsuaki; Sakuma, Yasuo; Onaka, Tatsushi; Mogi, Kazutaka; Kikusui, Takefumi			Oxytocin-Gaze Positive Loop and the Coevolution of Human-Dog Bonds	OBSTETRICAL & GYNECOLOGICAL SURVEY			English	Editorial Material									[Nagasawa, Miho; Mitsui, Shouhei; En, Shiori; Ohtani, Nobuyo; Ohta, Mitsuaki; Mogi, Kazutaka; Kikusui, Takefumi] Azabu Univ, Dept Anim Sci & Biotechnol, Sagamihara, Kanagawa, Japan; [Nagasawa, Miho; Onaka, Tatsushi] Jichi Med Univ, Dept Physiol, Shimotsuke, Tochigi, Japan; [Sakuma, Yasuo] Univ Tokyo Hlth Sci, Tokyo, Japan	Nagasawa, M (reprint author), Azabu Univ, Dept Anim Sci & Biotechnol, Sagamihara, Kanagawa, Japan.							0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7828	1533-9866		OBSTET GYNECOL SURV	Obstet. Gynecol. Surv.	JUL	2015	70	7					450	451				2	Obstetrics & Gynecology	Obstetrics & Gynecology	CM5OO	WOS:000357737800014		
J	Sterner, RW; Hood, JM; Kearney, MR; Urabe, J; Raubenheimer, D				Sterner, Robert W.; Hood, James M.; Kearney, Michael R.; Urabe, Jotaro; Raubenheimer, David			Couples that have chemistry: when ecological theories meet	OIKOS			English	Editorial Material							EVOLUTION		[Sterner, Robert W.] Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA; [Hood, James M.] Montana State Univ, Dept Ecol, Bozeman, MT 59715 USA; [Kearney, Michael R.] Univ Melbourne, Sch BioSci, Melbourne, Vic 2010, Australia; [Raubenheimer, David] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Fac Vet Sci & Sch Biol Sci, Sydney, NSW 2006, Australia; [Urabe, Jotaro] Tohoku Univ, Grad Sch Life Sci, JP-9808578 Sendai, Miyagi, Japan	Sterner, RW (reprint author), Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA.	stern007@d.umn.edu					Urabe J, 2010, OIKOS, V119, P737, DOI 10.1111/j.1600-0706.2009.18596.x; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Sitters J, 2015, OIKOS, V124, P920, DOI 10.1111/oik.02392; Cease A., 2015, OIKOS, V124, P917; Hessen DO, 2005, OIKOS, V109, P3, DOI 10.1111/j.0030-1299.2005.14055.x; Pickett S.T.A., 1994, ECOLOGICAL UNDERSTAN; Scheiner S.M., 2011, THEORY ECOLOGY; Sistla SA, 2015, OIKOS, V124, P949, DOI 10.1111/oik.02385; Sterner R. W., 2002, ECOLOGICAL STOICHIOM; Yamamichi M, 2015, OIKOS, V124, P960, DOI 10.1111/oik.02388	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0030-1299	1600-0706		OIKOS	Oikos	JUL	2015	124	7					917	919		10.1111/oik.02672		3	Ecology	Environmental Sciences & Ecology	CM6UD	WOS:000357824900012		
J	Yamamichi, M; Meunier, CL; Peace, A; Prater, C; Rua, MA				Yamamichi, Masato; Meunier, Cedric L.; Peace, Angela; Prater, Clay; Rua, Megan A.			Rapid evolution of a consumer stoichiometric trait destabilizes consumer-producer dynamics	OIKOS			English	Article							PREDATOR-PREY INTERACTIONS; ECOLOGICAL STOICHIOMETRY; POPULATION-DYNAMICS; BIOLOGICAL STOICHIOMETRY; TROPHIC INTERACTIONS; NUTRIENT ENRICHMENT; ECOSYSTEM ECOLOGY; COMMUNITIES; DAPHNIA; SYSTEM	Recent studies have shown that adaptive evolution can be rapid enough to affect contemporary ecological dynamics in nature (i.e. 'rapid evolution'). These studies tend to focus on trait functions relating to interspecific interactions; however, the importance of rapid evolution of stoichiometric traits has been relatively overlooked. Various traits can affect the balance of elements (carbon, nitrogen, and phosphorus) of organisms, and rapid evolution of such stoichiometric traits will not only alter population and community dynamics but also influence ecosystem functions such as nutrient cycling. Multiple environmental changes may exert a selection pressure leading to adaptation of stoichiometrically important traits, such as an organism's growth rate. In this paper, we use theoretical approaches to explore the connections between rapid evolution and ecological stoichiometry at both the population and ecosystem level. First, we incorporate rapid evolution into an ecological stoichiometry model to investigate the effects of rapid evolution of a consumer's stoichiometric phosphorus: carbon ratio on consumer-producer population dynamics. We took two complementary approaches, an asexual clonal genotype model and a quantitative genetic model. Next, we extended these models to explicitly track nutrients in order to evaluate the effect of rapid evolution at the ecosystem level. Our model results indicate rapid evolution of the consumer stoichiometric trait can cause complex dynamics where rapid evolution destabilizes population dynamics and rescues the consumer population from extinction (evolutionary rescue). The model results also show that rapid evolution may influence the level of nutrients available in the environment and the flux of nutrients across trophic levels. Our study represents an important step for theoretical integration of rapid evolution and ecological stoichiometry.	[Yamamichi, Masato] Kyoto Univ, Hakubi Ctr Adv Research, Ctr Ecol Res, JP-6068501 Kyoto, Japan; [Meunier, Cedric L.] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden; [Peace, Angela] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA; [Prater, Clay] Trent Univ, Environm & Life Sci, Peterborough, ON K9J 7B8, Canada; [Rua, Megan A.] Univ Mississippi, Dept Biol, University, MS 38677 USA	Yamamichi, M (reprint author), Kyoto Univ, Hakubi Ctr Adv Research, Ctr Ecol Res, JP-6068501 Kyoto, Japan.	yamamichi@ecology.kyoto-u.ac.jp	Meunier, Cedric/K-2792-2015	Meunier, Cedric/0000-0002-4070-4286	Charles Perkins Center at the University of Sydney; U.S. National Science Foundation [DEB-1347502]; NIMBioS; NSF [DBI-1300426, DBI-12-02676]; Univ. of Tennessee, Knoxville	We thank Woodstoich III organizers for the groovy time. We are grateful to J. Elser, R. Sterner and J. Sitters for their helpful comments. Financial support was provided by the Charles Perkins Center at the University of Sydney and the U.S. National Science Foundation (award DEB-1347502). AP was supported by a postdoctoral fellowship at NIMBioS, sponsored by NSF grant no. DBI-1300426 and the Univ. of Tennessee, Knoxville. MAR was supported by a NSF Postdoctoral Research Fellowship in Biology under grant no. DBI-12-02676.	ABRAMS P, 1987, THEOR POPUL BIOL, V32, P262, DOI 10.1016/0040-5809(87)90050-5; ABRAMS PA, 1992, EVOL ECOL, V6, P56, DOI 10.1007/BF02285334; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Chowdhury PR, 2014, J EXP ZOOL PART A, V321, P387, DOI 10.1002/jez.1869; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Cross WF, 2006, ECOLOGY, V87, P1556, DOI 10.1890/0012-9658(2006)87[1556:WNEISP]2.0.CO;2; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Loladze I, 2004, THEOR POPUL BIOL, V65, P1, DOI 10.1016/S0040-5809(03)00105-9; Yoshida T, 2007, PLOS BIOL, V5, P1868, DOI 10.1371/journal.pbio.0050235; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Elser JJ, 2011, TRENDS ECOL EVOL, V26, P38, DOI 10.1016/j.tree.2010.10.006; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Elser J, 2006, AM NAT, V168, pS25, DOI 10.1086/509048; Moe SJ, 2005, OIKOS, V109, P29, DOI 10.1111/j.0030-1299.2005.14056.x; Cross WF, 2003, ECOL LETT, V6, P721, DOI 10.1046/j.1461-0248.2003.00481.x; Hall SR, 2009, ANNU REV ECOL EVOL S, V40, P503, DOI 10.1146/annurev.ecolsys.39.110707.173518; Matthews B, 2011, ECOL LETT, V14, P690, DOI 10.1111/j.1461-0248.2011.01627.x; Dickman EM, 2008, P NATL ACAD SCI USA, V105, P18408, DOI 10.1073/pnas.0805566105; Gonzalez A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0404; Jeyasingh PD, 2014, ECOL EVOL, V4, P528, DOI 10.1002/ece3.950; Elser JJ, 2012, ECOL MODEL, V245, P3, DOI 10.1016/j.ecolmodel.2012.02.006; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Cortez MH, 2010, AM NAT, V176, pE109, DOI 10.1086/656485; Loladze I, 2000, B MATH BIOL, V62, P1137, DOI 10.1006/bulm.2000.0201; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; Post DM, 2009, PHILOS T R SOC B, V364, P1629, DOI 10.1098/rstb.2009.0012; Branco P, 2010, AM NAT, V176, pE162, DOI 10.1086/657036; Darwin Charles, 1859, ORIGIN SPECIES MEANS; Deng B, 2007, CHAOS, V17, DOI 10.1063/1.2752491; Ellner SP, 2013, FUNCT ECOL, V27, P1087, DOI 10.1111/1365-2435.12174; Fox JW, 2008, AM NAT, V172, P667, DOI 10.1086/591689; Gorokhova E, 2002, P ROY SOC B-BIOL SCI, V269, P2373, DOI 10.1098/rspb.2002.2145; Hao LN, 2014, MATH BIOSCI ENG, V11, P841, DOI 10.3934/mbe.2014.11.841; Jeyasingh PD, 2005, ECOL LETT, V8, P1021, DOI 10.1111/j.1461-0248.2005.00803.x; Kay AD, 2005, OIKOS, V109, P6, DOI 10.1111/j.0030-1299.2005.14048.x; Miner BE, 2012, P ROY SOC B-BIOL SCI, V279, P1873, DOI 10.1098/rspb.2011.2404; Mizuno AN, 2009, J THEOR BIOL, V259, P209, DOI 10.1016/j.jtbi.2009.02.025; Mougi A, 2010, P ROY SOC B-BIOL SCI, V277, P3163, DOI 10.1098/rspb.2010.0691; Sterner R. W., 2002, ECOLOGICAL STOICHIOM; Wang Hao, 2008, Journal of Biological Dynamics, V2, P286, DOI 10.1080/17513750701769881; Weider LJ, 2005, OECOLOGIA, V143, P537, DOI 10.1007/s00442-005-0003-x; Yamamichi M, 2011, AM NAT, V178, P287, DOI 10.1086/661241	50	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0030-1299	1600-0706		OIKOS	Oikos	JUL	2015	124	7					960	969		10.1111/oik.02388		10	Ecology	Environmental Sciences & Ecology	CM6UD	WOS:000357824900016		
J	Takamizawa, T; Barkmeier, WW; Tsujimoto, A; Scheidel, DD; Erickson, RL; Latta, MA; Miyazaki, M				Takamizawa, T.; Barkmeier, W. W.; Tsujimoto, A.; Scheidel, D. D.; Erickson, R. L.; Latta, M. A.; Miyazaki, M.			Effect of Phosphoric Acid Pre-etching on Fatigue Limits of Self-etching Adhesives	OPERATIVE DENTISTRY			English	Article							NONCARIOUS CERVICAL LESIONS; IN-ONE ADHESIVE; MICROTENSILE BOND STRENGTH; SINGLE-STEP ADHESIVES; BUR-CUT ENAMEL; RESTORATIVE MATERIALS; CLINICAL-PERFORMANCE; HEMA-FREE; DENTIN; DURABILITY	The purpose of this study was to use shear bond strength (SBS) and shear fatigue limit (SFL) testing to determine the effect of phosphoric acid pre-etching of enamel and dentin prior to application of self-etch adhesives for bonding resin composite to these substrates. Three selfetch adhesives-1) G-aenial Bond (GC Corporation, Tokyo, Japan); 2) OptiBond XTR (Kerr Corp, Orange, CA, USA); and 3) Scotchbond Universal (3M ESPE Dental Products, St Paul, MN, USA)-were used to bond Z100 Restorative resin composite to enamel and dentin surfaces. A stainless-steel metal ring with an inner diameter of 2.4 mm was used to bond the resin composite to flat-ground (4000 grit) tooth surfaces for determination of both SBS and SFL. Fifteen specimens each were used to determine initial SBS to human enamel/dentin, with and without pre-etching with a 35% phosphoric acid (Ultra-Etch, Ultradent Products Inc, South Jordan, UT, USA) for 15 seconds prior to the application of the adhesives. A staircase method of fatigue testing (25 specimens for each test) was then used to determine the SFL of resin composite bonded to enamel/dentin using a frequency of 10 Hz for 50,000 cycles or until failure occurred. A two-way analysis of variance and Tukey post hoc test were used for analysis of SBS data, and a modified t-test with Bonferroni correction was used for the SFL data. Scanning electron microscopy was used to examine the area of the bonded restorative/tooth interface. For all three adhesive systems, phosphoric acid pre-etching of enamel demonstrated significantly higher (p<0.05) SBS and SFL with pre-etching than it did without pre-etching. The SBS and SFL of dentin bonds decreased with phosphoric acid pre-etching. The SBS and SFL of bonds using phosphoric acid prior to application of self-etching adhesives clearly demonstrated different tendencies between enamel and dentin. The effect of using phosphoric acid, prior to the application of the self-etching adhesives, on SBS and SFL was dependent on the adhesive material and tooth substrate and should be carefully considered in clinical situations.	[Takamizawa, T.; Tsujimoto, A.; Miyazaki, M.] Nihon Univ, Sch Dent, Operat Dent, Tokyo 101, Japan; [Barkmeier, W. W.; Erickson, R. L.; Latta, M. A.] Creighton Univ, Sch Dent, Gen Dent, Omaha, NE 68178 USA; [Barkmeier, W. W.; Latta, M. A.] Creighton Univ, Sch Dent, Omaha, NE 68178 USA; [Scheidel, D. D.] Creighton Univ, Sch Dent, Diagnost Sci, Omaha, NE 68178 USA	Barkmeier, WW (reprint author), 2500 Calif Plaza, Omaha, NE 68178 USA.	wbark@creighton.edu					Abo T, 2004, EUR J ORAL SCI, V112, P286, DOI 10.1111/j.1600-0722.2004.00126.x; Erickson RL, 2009, DENT MATER, V25, P716, DOI [10.1016/j.dental.2008.12.001, 10.1016/j.denta1.2008.12.001]; Baran G, 2001, CRIT REV ORAL BIOL M, V12, P350; Frankenberger R, 2003, J BIOMED MATER RES B, V67B, P712, DOI 10.1002/jbm.b.10052; Frankenberger R, 2008, J ADHES DENT, V10, P339; Pashley EL, 2002, J DENT, V30, P83, DOI 10.1016/S0300-5712(02)00002-7; Frankenberger R, 2005, DENT MATER, V21, P397, DOI 10.1016/j.dental.2004.07.005; Kimmes NS, 2010, OPER DENT, V35, P112, DOI 10.2341/09-081-L; De Munck J, 2003, AM J DENT, V16, P414; Ritter AV, 2008, OPER DENT, V33, P370, DOI 10.2341/07-128; Van Landuyt KL, 2006, DENT MATER, V22, P533, DOI 10.1016/j.dental.2005.05.010; Spencer P, 1999, QUINTESSENCE INT, V30, P501; Van Landuyt KL, 2007, J DENT RES, V86, P739; Yoshioka M, 2002, J BIOMED MATER RES, V59, P56, DOI 10.1002/jbm.1216; Moszner N, 2005, DENT MATER, V21, P895, DOI 10.1016/j.dental.2005.05.001; Takahashi M, 2011, J DENT, V39, P506, DOI 10.1016/j.jdent.2011.04.008; De Munck J, 2005, J DENT RES, V84, P118; Adebayo OA, 2008, ACTA ODONTOL SCAND, V66, P159, DOI 10.1080/00016350802123118; Sandberg E, 2002, J DENT RES, V81, P633; Erickson RL, 2009, DENT MATER, V25, P1187, DOI 10.1016/j.dental.2009.04.004; Tsujimoto A, 2010, J DENT, V38, P123, DOI 10.1016/j.jdent.2009.09.011; Nakaoki Y, 2000, DENT MATER, V16, P441, DOI 10.1016/S0109-5641(00)00042-7; Barkmeier WW, 2009, OPER DENT, V34, P217, DOI 10.2341/08-72; Sato M, 2005, J DENT, V33, P475, DOI 10.1016/j.jdent.2004.10.024; Van Landuyt KL, 2008, DENT MATER, V24, P1412, DOI 10.1016/j.dental.2008.02.018; Watanabe T, 2008, OPER DENT, V33, P426, DOI 10.2341/07-110; Ikeda M, 2008, OPER DENT, V33, P702, DOI 10.2341/08-26; Erickson RL, 2009, DENT MATER, V25, P1459, DOI 10.1016/j.dental.2009.07.002; Peumans M, 2010, DENT MATER, V26, P1176, DOI 10.1016/j.dental.2010.08.190; Perdigao J, 2007, AM J DENT, V20, P125; Sano H, 1999, J DENT RES, V78, P906; Van Landuyt KL, 2006, J DENT, V34, P77, DOI 10.1016/j.jdent.2005.04.001; De Munck J, 2005, BIOMATERIALS, V26, P1145, DOI 10.1016/j.biomaterials.2004.04.013; DRAUGHN RA, 1979, J DENT RES, V58, P1093, DOI 10.1177/00220345790580031101; Van Landuyt KL, 2005, J DENT RES, V84, P183; Nezu T, 2000, BIOMATERIALS, V21, P415, DOI 10.1016/S0142-9612(99)00204-5; Lohbauer U, 2008, J ADHES DENT, V10, P97; Van Landuyt KL, 2007, BIOMATERIALS, V28, P3757, DOI 10.1016/j.biomaterials.2007.04.044; Miguez PA, 2003, J ADHES DENT, V5, P107; De Munck J, 2005, OPER DENT, V30, P39; Barkmeier WW, 2009, DENT MATER, V25, P1527, DOI 10.1016/j.dental.2009.07.005; Bittencourt DD, 2005, ACTA ODONTOL SCAND, V63, P173, DOI 10.1080/00016350510019874; Brackett WW, 2006, OPER DENT, V31, P332, DOI 10.2341/05-39; Erickson RL, 2006, DENT MATER, V22, P981, DOI 10.1016/j.dental.2005.11.021; Goracci C, 2004, J ADHES DENT, V6, P313; Longuercio AD, 2008, OPERATIVE DENT, V33, P79; Lonnroth EC, 2003, EUR J ORAL SCI, V111, P440, DOI 10.1034/j.1600-0722.2003.00064.x; Loquercio AD, 2007, J AM DENT ASSOC, V138, P507; Perdigão Jorge, 2003, J Esthet Restor Dent, V15, P32, DOI 10.1111/j.1708-8240.2003.tb00280.x; Perdigao J, 2003, J ESTHET RESTOR DENT, V15, P42; Tay Franklin R, 2002, J Adhes Dent, V4, P255; Toledano M, 2004, AM J DENT, V17, P310; Torkabadi S, 2008, J DENT, V36, P80, DOI 10.1016/j.jdent.2007.11.001; Van Landuyt KL, 2011, EUR J ORAL SCI, V119, P511, DOI 10.1111/j.1600-0722.2011.00855.x	54	1	1	OPERATIVE DENTISTRY INC	INDIANAPOLIS	INDIANA UNIV SCHOOL DENTISTRY, ROOM S411, 1121 WEST MICHIGAN ST, INDIANAPOLIS, IN 46202-5186 USA	0361-7734	1559-2863		OPER DENT	Oper. Dent.	JUL-AUG	2015	40	4					379	395		10.2341/13-252-L		17	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM7KI	WOS:000357870500007		
J	Furukawa, M; K-Kaneyama, JR; Yamada, M; Senda, A; Manabe, A; Miyazaki, A				Furukawa, M.; K-Kaneyama, J. R.; Yamada, M.; Senda, A.; Manabe, A.; Miyazaki, A.			Cytotoxic Effects of Hydrogen Peroxide on Human Gingival Fibroblasts In Vitro	OPERATIVE DENTISTRY			English	Article							CLINICAL-EVALUATION; BLEACHING TREATMENTS; AT-HOME; OFFICE; INFLAMMATION; SENSITIVITY; ACTIVATION; IL-1-BETA; PROMOTION; EFFICACY	In-office bleaching is a popular treatment in modern esthetic dentistry. However, bleaching agents sometimes accidentally adhere to the gingiva and peripheral tissues, even when applied by well-trained dentists. This can lead to transient pain and whitish changes in the gingiva. Although these symptoms disappear within several hours, the effects of bleaching agents on gingiva have not been well described in the literature. The present study aimed to elucidate the cytotoxic effects of a bleaching agent on cultured human gingival fibroblasts (HGFs). We performed a comprehensive analysis of the toxic effects of in-office bleaching agents on gingiva using cultured HGFs and DNA microarray. Survival rates of HGFs decreased with increases in the concentration of hydrogen peroxide, which became significant at concentrations of 1.5 x 10(-3)% or higher at every time point. Concentrations lower than 1.5 x 10(-3)% did not affect survival rates of HGFs. Cytotoxicity of hydrogen peroxide was significantly weakened by the addition of vitamin E. Stimulation by in-office bleaching agents triggered the proinflammatory cytokine tumor necrosis factor (TNF)-alpha cascade in gingival fibroblasts. As the TNF-alpha cascade can be inhibited by vitamin E additives, treatment with vitamin E may protect gingival fibroblasts against the toxic effects of an in-office bleaching agent. The present results suggest that local administration of vitamin E to gingiva before in-office bleaching may be useful for preventing gingival irritation due to accidental adhesion of a bleaching agent.	[Furukawa, M.] Showa Univ, Sch Dent, Dept Clin Cariol & Aesthet Dent, Tokyo 142, Japan; [K-Kaneyama, J. R.; Miyazaki, A.] Showa Univ, Sch Dent, Dept Biochem, Tokyo 142, Japan; [Yamada, M.; Senda, A.] Aichi Gakuin Univ, Dept Operat Dent, Sch Dent, Nagoya, Aichi 464, Japan; [Manabe, A.] Showa Univ, Sch Dent, Dept Clin Cariol & Aesthet Dent, Tokyo 142, Japan	Furukawa, M (reprint author), 2-1-1 Kitasenzoku,Ohta Ku, Tokyo 1458515, Japan.	masae@dent.showa-u.ac.jp					Al Shethri S, 2003, OPER DENT, V28, P488; Marson FC, 2008, OPER DENT, V33, P15, DOI 10.2341/07-57; Auschill TM, 2005, OPER DENT, V30, P156; Walsh LJ, 2000, AUST DENT J, V45, P257, DOI 10.1111/j.1834-7819.2000.tb00261.x; Zekonis R, 2003, OPER DENT, V28, P114; Minoux M, 2008, QUINTESSENCE INT, V39, P645; Sulieman M, 2003, J DENT, V31, P415, DOI 10.1016/S0300-5712(03)00069-1; Palmqvist P, 2008, J DENT RES, V87, P558; [Anonymous], COMPENDIUM CONTINUIN; Charakorn P, 2009, OPER DENT, V34, P131, DOI 10.2341/08-33; Tay LY, 2009, J AM DENT ASSOC, V140, P1245; Kiyoshima T, 2012, INT J MOL MED, V30, P1007, DOI 10.3892/ijmm.2012.1102; Armenio RV, 2008, J AM DENT ASSOC, V139, P592; BAUMGARTNER JC, 1983, J ENDODONT, V9, P527, DOI 10.1016/S0099-2399(83)80055-7; Bruzell EM, 2013, BRIT DENT J, V215, DOI 10.1038/sj.bdj.2013.1047; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Cohen S C, 1979, J Endod, V5, P134, DOI 10.1016/S0099-2399(79)80033-3; Cook-Mills JM, 2006, CELL MOL BIOL, V52, P8, DOI 10.1170/T721; DORMAN HL, 1970, ORAL SURG ORAL MED O, V29, P38, DOI 10.1016/0030-4220(70)90409-3; Dutra FF, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00115; Firat E, 2011, OPER DENT, V36, P572, DOI 10.2341/10-058-C; Gerlach R W, 2001, J Contemp Dent Pract, V2, P1; Ghalili KM, 2014, CLIN COSMETIC INVEST, V21, P15; Gomes D C, 1984, Clin Prev Dent, V6, P21; Haywood V B, 1992, Quintessence Int, V23, P471; Haywood Van B, 2005, Compend Contin Educ Dent, V26, P11; Haywood V B, 1989, Quintessence Int, V20, P173; HOFFMANN ME, 1979, PHOTOCHEM PHOTOBIOL, V30, P151, DOI 10.1111/j.1751-1097.1979.tb07128.x; Howard AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1594; HUBER M, 1988, EUR J IMMUNOL, V18, P2085, DOI 10.1002/eji.1830181233; KEYES P H, 1985, General Dentistry, V33, P105; Kirsten GA, 2009, QUINTESSENCE INT, V40, P195; KLEINSZANTO AJP, 1982, J INVEST DERMATOL, V79, P30, DOI 10.1111/1523-1747.ep12510444; Leonard R H Jr, 1998, Compend Contin Educ Dent, V19, P766; Leonard Jr RH, 1998, COMPENDIUM CONTINUIN, V19, P772; Leonard R H Jr, 1997, Quintessence Int, V28, P527; Leonard Jr RH, 1998, COMPENDIUM CONTINUIN, V19, P774; Leonard R H Jr, 2001, J Esthet Restor Dent, V13, P357, DOI 10.1111/j.1708-8240.2001.tb01021.x; MARTIN JH, 1968, J PERIODONTOL, V39, P208; MARUNIAK J, 1992, J CLIN PERIODONTOL, V19, P19, DOI 10.1111/j.1600-051X.1992.tb01143.x; MEYDANI M, 1992, ANN NY ACAD SCI, V669, P363; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; Papathanasiou A, 2001, Compend Contin Educ Dent, V22, P289; Pohjola Randall M, 2002, J Esthet Restor Dent, V14, P85, DOI 10.1111/j.1708-8240.2002.tb00156.x; ROTSTEIN I, 1993, ORAL SURG ORAL MED O, V75, P744, DOI 10.1016/0030-4220(93)90434-6; SIMON RH, 1981, J BIOL CHEM, V256, P7181; Sulieman M, 2005, J DENT, V33, P33, DOI 10.1016/j.jdent.2004.07.008; Svec T A, 1977, J Endod, V3, P49, DOI 10.1016/S0099-2399(77)80015-0; Tam L, 1999, J Can Dent Assoc, V65, P201; TIPTON DA, 1995, J PERIODONTOL, V66, P7; WEITZMAN SA, 1986, J PERIODONTOL, V57, P685; Ziebolz D, 2007, CLIN ORAL INVEST, V11, P267, DOI 10.1007/s00784-007-0108-1	52	1	1	OPERATIVE DENTISTRY INC	INDIANAPOLIS	INDIANA UNIV SCHOOL DENTISTRY, ROOM S411, 1121 WEST MICHIGAN ST, INDIANAPOLIS, IN 46202-5186 USA	0361-7734	1559-2863		OPER DENT	Oper. Dent.	JUL-AUG	2015	40	4					430	439		10.2341/14-059-L		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM7KI	WOS:000357870500012		
J	Handa, N; Nakatsukasa, M; Kunimatsu, Y; Tsubamoto, T; Nakaya, H				Handa, Naoto; Nakatsukasa, Masato; Kunimatsu, Yutaka; Tsubamoto, Takehisa; Nakaya, Hideo			New specimens of Chilotheridium (Perissodactyla, Rhinocerotidae) from the Upper Miocene Namurungule and Nakali Formations, northern Kenya	PALEONTOLOGICAL RESEARCH			English	Article						Chilotheridium; Kenya; Late Miocene; Nakali; Rhinocerotidae; Samburu Hills	SAMBURU HILLS; SAMBURUPITHECUS; MAMMALIA; REVISION; BULUK; RIFT; AGES; MA	Rhinocerotid fossils from the lower upper Miocene Namurungule and Nakali Formations, northern Kenya, are described. These materials reveal the following diagnostic characters of Chilotheridium pattersoni: a strongly constricted protocone with a flattened lingual wall, a hypocone groove, a developed crochet, and an antecrochet curved toward the entrance of the medisinus. Specimens previously described from the Namurungule Formation as rhinocerotids are re-identified as C. pattersoni. The Nakali Formation specimens presented in this study are the first discovery of C. pattersoni from this locality. In addition, deciduous teeth of C. pattersoni, which were unknown previously, are reported for the first time. This discovery of C. pattersoni extends its temporal range to the early late Miocene.	[Handa, Naoto] Shinshushinmachi Fossil Museum, Nagano 3812404, Japan; [Nakatsukasa, Masato] Kyoto Univ, Grad Sch Sci, Lab Phys Anthropol, Sakyo Ku, Kyoto 6068502, Japan; [Kunimatsu, Yutaka] Ryukoku Univ, Fac Business Adm, Fushimi Ku, Kyoto 6128577, Japan; [Tsubamoto, Takehisa] Ehime Univ, Fac Sci, Dept Earth Sci, Matsuyama, Ehime 7908577, Japan; [Nakaya, Hideo] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan	Handa, N (reprint author), Shinshushinmachi Fossil Museum, 88-3 Kamijo, Nagano 3812404, Japan.	k1552325@kadai.jp			Fujiwara Natural History Foundation; Sasakawa Research Grant from the Japan Science Society; JSPS KAKENHI grant [22255006, 25257408]	The authors wish to thank the Government of Kenya and the National Museums of Kenya for research permission. The first author thanks Naomichi Ogihara (Keio University, Tokyo) for assistance in the National Museums of Kenya. He also thanks Akira Fukuchi (Hanshin Consultants Co., Ltd., Satsumasendai) for providing references and Hiroshi Tsujikawa (Tohoku Bunka Gakuen University, Sendai) for providing his helpful comments. We are grateful to Emma Bernard (Natural History Museum, London), Patricia Perez Dios (Museo Nacional de Ciencias Naturales, Madrid), Christine Argot (Museum National d'Histoire Naturelle, Paris), Mitsuharu Oshima and Hiroko Hirotani (Kanagawa Prefectural Museum of Natural History, Odawara), and Hiroyuki Taruno (Osaka Museum of Natural History, Osaka) for providing access to specimens for the comparative work. This research was supported in part by grants from the Fujiwara Natural History Foundation, by a Sasakawa Research Grant from the Japan Science Society, and by the JSPS KAKENHI grant (22255006 and 25257408) award to M. Nakatsukasa.	Aguirre E., 1974, Estudios geol Inst Invest geol Lucas Mallada, V30, P229; Aguirre E., 1974, Estudios geol Inst Invest geol Lucas Mallada, V30, P219; Sawada Y, 1998, CR ACAD SCI II A, V326, P445, DOI 10.1016/S1251-8050(98)80069-4; Antoine Pierre-Olivier, 2002, Memoires du Museum National d'Histoire Naturelle, V188, P1; Antoine PO, 2010, ZOOL J LINN SOC-LOND, V160, P139, DOI 10.1111/j.1096-3642.2009.00597.x; Arambourg C., 1959, Pub Carte geol Alger Pal Mem, V4, P1; Cerdeno E, 2000, ZOOL SCR, V29, P275, DOI 10.1046/j.1463-6409.2000.00047.x; Cerdeno Esperanza, 1995, American Museum Novitates, V3143, P1; Deng T, 2013, J VERTEBR PALEONTOL, V33, P977, DOI 10.1080/02724634.2013.748058; Deng T., 2006, CAINOZOIC RES, V5, P93; DERANIYAGALA P.E.P, 1951, SPOLIA ZEYLANDICA, V26, P133; Dollo L., 1885, REV QUESTIONS SCI, V17, P293; Fortelius M., 1982, P163; Fukuchi A., 2008, REG M AFR STUD SOC J, P7; Geraads D, 2012, J MAMM EVOL, V19, P57, DOI 10.1007/s10914-011-9183-9; Geraads Denis, 2010, P669; Geraads D, 2005, J VERTEBR PALEONTOL, V25, P451, DOI 10.1671/0272-4634(2005)025[0451:PRMFHA]2.0.CO;2; Geraads D, 2013, GEODIVERSITAS, V35, P359, DOI 10.5252/g2013n2a5; Giaourtsakis I. X., 2009, ARDIPITHECUS KADABBA, V2, P429; Guerin C., 1966, Documents du Laboratoire de Geologie de la Faculte des Sciences de Lyon, V16, P1; Guerin Claude, 2003, Annales de Paleontologie, V89, P1, DOI 10.1016/S0753-3969(03)00004-1; Guerin C., 1980, DOCUMENTS LAB GEOLOG, V79, P1; Guerin Claude, 2000, Palaeontologia Africana, V36, P119; Guerin C, 2011, ESTUD GEOL-MADRID, V67, P333, DOI 10.3989/egeol.40627.192; Guerin C., 2003, GEOLOGICAL SURVEY NA, V2, P257; Guerin Claude, 2008, Geological Survey of Namibia Memoir, V20, P331; Hamilton W. R., 1973, B BRIT MUS NAT HIST, V24, P349; Handa N, 2012, J VERTEBR PALEONTOL, V32, P106; Heissig K., 1989, OXFORD MONOGRAPHS GE, V15, P399; HEISSIG K, 1973, Saeugetierkundliche Mitteilungen, V21, P25; Heissig K, 2012, MEM MUS NAT HIST NAT, V203, P317; Hillman-Smith K, 1986, J ZOOLOGY LONDON, V210, P355; HUNERMANN K A, 1989, Andrias, V6, P5; HOOIJER D A, 1971, Bulletin of the Museum of Comparative Zoology, V142, P339; Hooijer D. A., 1963, MUSEE ROYAL AFRIQU 8, V46, P1; Hooijer D. A., 1966, Bulletin of the British Museum (Natural History) Geology, V13, P117; Hooijer D. A., 1959, PALAEONTOLOGIA AFRIC, V6, P1; Hooijer D. A., 1968, ZOOLOGISCHE MEDEDELI, V43, P77; Hooijer D. A., 1968, Zoologische Mededeelingen Leiden, V42, P231; Hooijer D. A., 1973, ZOOLOGISCHE MEDEDELI, V59, P151; HOOIJER D A, 1972, Bulletin of the Museum of Comparative Zoology, V144, P1; Ishida H, 1997, CR ACAD SCI II A, V325, P823, DOI 10.1016/S1251-8050(97)82762-0; Kunimatsu Y, 2007, P NATL ACAD SCI USA, V104, P19220, DOI 10.1073/pnas.0706190104; Leakey M, 2011, EVOL ANTHROPOL, V20, P238, DOI 10.1002/evan.20338; LEAKEY REF, 1985, NATURE, V318, P173, DOI 10.1038/318173a0; Morales Jorge, 2006, Annales de Paleontologie, V92, P359, DOI 10.1016/j.annpal.2006.07.004; Nakaya H., 1984, AFR STUDY MONOGR S, V2, P87; Nakaya Hideo, 1994, African Study Monographs Supplementary Issue, V20, P1; Nakaya Hideo, 1987, African Study Monographs Supplementary Issue, V5, P79; Owen R, 1845, ODONTOGRAPHY TREATIS; Ringstrom T. J., 1924, GEOLOGICAL SURVEY C, V11, P1; Sakai T, 2010, GEOL SOC SPEC PUBL, V342, P109, DOI 10.1144/SP342.9; Saneyoshi M, 2006, SEDIMENT GEOL, V186, P111, DOI 10.1016/j.sedgeo.2005.11.012; Sawada Y, 2006, DEV PRIMATOL, P71, DOI 10.1007/0-387-29798-7_6; Tsujikawa H., 2011, 65 ANN M ANTHR SOC N, P74; Tsujikawa Hiroshi, 2005, African Study Monographs Supplementary Issue, V32, P1; Walker A., 1968, Uganda Journal, V32, P149; Yan D., 1986, ZITTELIANA, V14, P81	58	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	JUL	2015	19	3					181	194		10.2517/2014PR035		14	Paleontology	Paleontology	CM5SL	WOS:000357748800001		
J	Ohno, R; Sentoku, A; Masumoto, S; Ezaki, Y				Ohno, Rie; Sentoku, Asuka; Masumoto, Shinji; Ezaki, Yoichi			Morphological variability in azooxanthellate scleractinian dendrophylliids governed by regular modes of asexual reproduction: A computer simulation approach	PALEONTOLOGICAL RESEARCH			English	Article						Azooxanthellate Scleractinia; branching; budding; computer modelling; voxel model	GROWTH; FORM; SHAPE	Morphogenetic mechanisms in modern Scleractinia provide insights into the habitats and growth forms of corals living in different environmental conditions. Scleractinian morphogenesis has been studied primarily in relation to extrinsic (e.g. environmental) factors, irrespective of specific regularities in budding and their impacts on growth forms. Morphogenesis in colonial dendrophylliids can be modelled by taking these developmental traits into account, so as to understand how intrinsic developmental factors affect morphologies resulting from colonial growth. We used a simple, voxel-based program to simulate the morphogenesis of dendrophylliid corals. Three parameters (budding orientation, inclination of budding, and interval of budding) were adopted to simulate a range of colonial growth forms, regardless of whether the forms exist in nature or not. The regularity of budding was fully taken into account, and various colonial morphologies were gained, even under strict regularity. The regulation of two of the parameters (inclination of budding and budding interval) gives rise to two distinct types of morphologies (branching and massive forms) that are represented by the extant taxa Dendrophyllia arbuscula and Tubastraea coccinea, respectively. This suggests that the growth forms of individual dendrophylliid colonies vary according to habitat conditions, and that they can be simulated by modifying only a few parameters, even given rigid developmental constraints on budding.	[Ohno, Rie; Masumoto, Shinji; Ezaki, Yoichi] Osaka City Univ, Grad Sch Sci, Dept Geosci, Sumiyoshi Ku, Osaka 5588585, Japan; [Sentoku, Asuka] Kyoto Univ, Field Sci Educ & Res Ctr, Seto Marine Biol Lab, Wakayama 6492211, Japan	Ohno, R (reprint author), Osaka City Univ, Grad Sch Sci, Dept Geosci, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	ohno.archen@gmail.com			Scientific Research Fund of the Japan Society for the Promotion of Science [24340130, 25610151, 15H03744]	We are grateful to Takao Ubukata (Kyoto University) and an anonymous reviewer for their useful comments on the manuscript. This study was supported by grants (24340130, 25610151, and 15H03744) from the Scientific Research Fund of the Japan Society for the Promotion of Science.	OKAMOTO T, 1988, PALAEONTOLOGY, V31, P35; HONDA H, 1971, J THEOR BIOL, V31, P331, DOI 10.1016/0022-5193(71)90191-3; CHAPPELL J, 1980, NATURE, V286, P249, DOI 10.1038/286249a0; Cairns S. D., 2001, GENERIC REVISION PHY; Cairns S. D., 1994, SCLERACTINIA TEMPERA; CHEETHAM AH, 1983, PALEOBIOLOGY, V9, P240; Chindapol N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002849; Filatov MV, 2010, P ROY SOC B-BIOL SCI, V277, P3555, DOI 10.1098/rspb.2010.0957; Geister J., 1977, P 3 INT COR REEF S, V1, P23; GRAUS RR, 1976, SCIENCE, V193, P895, DOI 10.1126/science.193.4256.895; Merks RMH, 2004, J THEOR BIOL, V228, P559, DOI 10.1016/j.jtbi.2004.02.020; NIKLAS KJ, 1984, PALEOBIOLOGY, V10, P79; RYLAND JS, 1986, PHILOS T ROY SOC B, V313, P53; Sentoku A, 2012, CORAL REEFS, V31, P67, DOI 10.1007/s00338-011-0808-5	14	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	JUL	2015	19	3					195	203		10.2517/2015PR002		9	Paleontology	Paleontology	CM5SL	WOS:000357748800002		
J	Tomita, T; Yokoyama, K				Tomita, Taketeru; Yokoyama, Kiyoko			The first Cenozoic record of a fossil megamouth shark (Lamniformes, Megachasmidae) from Asia	PALEONTOLOGICAL RESEARCH			English	Article						Cenozoic; lamniform shark; Megachasma; megamouth shark; Okinawa; Pacific distribution	BONY FISHES; MIOCENE; NEOGENE; JAPAN; RAYS	The megamouth shark (Lamniformes, Megachasmidae) is one of four extant planktivorous elasmobranch lineages, but its fossil record is quite limited. In the present study, we report a new discovery of a rare megachasmid shark fossil from the late Miocene-early Pleistocene interval of Okinawa Island, Japan. To date, this specimen represents the only reliable record of a megachasmid fossil from Asia.	[Tomita, Taketeru] Hokkaido Univ Museum, Hakodate, Hokkaido 0419611, Japan; [Yokoyama, Kiyoko] Okinawa Churaumi Aquarium, Okinawa 9050206, Japan	Tomita, T (reprint author), Hokkaido Univ Museum, 3-1-1 Minato Cho, Hakodate, Hokkaido 0419611, Japan.	teruteru-saurus@hotmail.co.jp					COMPAGNO LJV, 1977, AM ZOOL, V17, P303; Imai R, 2013, ISL ARC, V22, P522, DOI 10.1111/iar.12046; Friedman M, 2010, SCIENCE, V327, P990, DOI 10.1126/science.1184743; Purdy RW, 2001, SM C PALEOB, V90, P71; Iryu Y, 2006, ISL ARC, V15, P393, DOI 10.1111/j.1440-1738.2006.00537.x; Berg L. S., 1958, SYSTEM REZENTEN FOSS; Berra TM, 1997, ENVIRON BIOL FISH, V50, P1, DOI 10.1023/A:1007354702142; Cappetta H., 2012, HDB PALEOICHTHYOLO E, V3E; Compagno L, 2002, SHARKS WORLD ANNOTAT, V2; De Schutter P, 2009, GEOL BELG, V12, P179; Gonzalez-Barba G., 2000, PROFIL, V18, P1; Hay O. P., 1902, B US GEOLOGICAL SURV, V179, P1, DOI DOI 10.1017/S0016756800181567; KARASAWA H, 1989, Science Reports of Kanazawa University, V34, P1; Keupp H., 2002, FOSSILIEN, V19, P34; Kikuchi Y., 1979, Journal of the Geological Society of Japan, V85, P97; Kuga N., 1985, THESIS KYOTO U KYOTO; Nakagawa T., 1985, Earth Science (Tokyo), V39, P234; Nakaya K., 2010, P INT S UNKN RES MYS, P69; Phillips F. J., 1976, NEOGENE S SAN FRANCI, P137; Shimada K, 2014, J VERTEBR PALEONTOL, V34, P281, DOI 10.1080/02724634.2013.803975; Shimada K, 2007, J VERTEBR PALEONTOL, V27, P512, DOI 10.1671/0272-4634(2007)27[512:MOFMSL]2.0.CO;2; Shimada K., 2014, J VERTEBR PALEONTOL, P229; TANAKA Y, 1984, Bulletin of the National Science Museum Series C (Geology and Paleontology), V10, P141; TAYLOR L R, 1983, Proceedings of the California Academy of Sciences, V43, P87; Tomita T, 2010, PALEONTOL RES, V14, P69, DOI 10.2517/1342-8144-14.1.069; Uyeno T., 1983, B SAITAMA MUSEUM NAT, V1, P27; Uyeno T., 1982, B OKINAWA PREFECTURA, V8, P1; Uyeno T., 1984, B KITAKYUSHU MUSEUM, V5, P135; Yabumoto Yoshitaka, 1997, P63	29	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	JUL	2015	19	3					204	207		10.2517/2015PR004		4	Paleontology	Paleontology	CM5SL	WOS:000357748800003		
J	Ishida, Y; Fujita, T; Thuy, B				Ishida, Yoshiaki; Fujita, Toshihiko; Thuy, Ben			Two ophiuroid species (Echinodermata, Ophiuroidea) from lower Miocene deep-sea sediments Japan	PALEONTOLOGICAL RESEARCH			English	Article						bathyal; Oi Formation; Ophiomusium lymani; Ophiosphalma cancellata; Shida Formation		Well preserved specimens of two ophiuroid species, both assignable to an unknown family (formerly Ophiolepididae) and here placed in Ophiomusium and Ophiosphalma have been recovered from lower Miocene deep-sea formations in Japan. The material consists of an assemblage of over 75 articulated body fossils and numerous semiarticulated arm segments from the lower Miocene Oi Formation (Ichishi Group), Mie Prefecture, central Japan, identified as the extant species Ophiomusium lymani Wyville Thomson and a single articulated body fossil assigned to the extant Ophiosphalma cancellata (Lyman) from the lower Miocene Shida Formation (Oigawa Group), Shizuoka Prefecture, central Japan. These occurrences constitute the oldest fossil record of these present-day brittlestar species. The latter is the first fossil record for the genus Ophiosphalma. The new material documents that the closely related genera Ophiomusium and Ophiosphalma had already diverged by the early Miocene. Furthermore our findings suggest that the ancient Ophiomusium lymani and Ophiosphalma cancellata inhabited the same upper bathyal environment as their Recent counterparts.	[Fujita, Toshihiko] Natl Museum Nat & Sci, Tsukuba, Ibaraki 3050005, Japan; [Thuy, Ben] Nat Hist Museum Luxembourg, Dept Palaeontol, L-2160 Luxembourg, Luxembourg	Ishida, Y (reprint author), 2-20-13 Kamiogi,Suginami Ku, Tokyo 1670043, Japan.	y-ishida@msi.biglobe.ne.jp			Japan Society for the Promotion of Science [25440226]	We thank Hakuyu Okada (Emeritus Professor of Kyushu University), Kiichiro Hachiya, Yoshiaki Mizuno, Kazuo Yano of the Tokai Fossil Society, Hisao Ishii (visiting researcher of the Osaka Museum of Natural History) and Yoshiaki Okamura of the Shiga Fossil Footprint Research Group, who donated the fossil ophiuroids. Our deep gratitude is expressed to Keiichi Takahashi of the Lake Biwa Museum and to Hiroaki Karasawa and Yusuke Ando of the Mizunami Fossil Museum for kindly providing the opportunity to examine the specimens. We also thank Yasunari Shigeta of the National Museum of Nature and Science for his kind help in taking photos. John W. M. Jagt of the Natuurhistorisch Museum Maastricht, the Netherlands and Frederick H. C. Hotchkiss of the Marine and Paleobiological Research Institute, USA greatly improved an earlier draft of this manuscript. This work was partly supported by a grant from the Japan Society for the Promotion of Science (Scientific Research [C] 25440226).	Thuy B, 2011, ZOOTAXA, P1; O'Hara TD, 2014, CURR BIOL, V24, P1874, DOI 10.1016/j.cub.2014.06.060; BAKER AN, 1979, NEW ZEAL J ZOOL, V6, P21; BARTSCH I, 1983, Meteor Forschungsergebnisse Reihe D - Biologie, P13; Berry C. T., 1939, NOTULAE NATURAE, P1; Boehm G., 1889, BERICHTE NATURFORSCH, V4, P232; Brett Carlton E., 1997, Paleontological Society Papers, V3, P147; Clark H. L., 1911, US NATIONAL MUSEUM B, V75, P1; CLARK HUBERT LYMAN, 1941, MEM SOC CUBANA HIST NAT, V15, P1; Damon R., 1880, GEOLOGY WEYMOUTH I S; FUJITA T., 1992, OTSUCHI MAR RES CENT, V18, P25; Gage J.D., 1983, Bulletin of the British Museum (Natural History) Zoology, V45, P263; Guille A., 1981, MEMOIRES ORSTOM, V91, P413; Hess H., 1985, Taetigkeitsberichte der Naturforschenden Gesellschaft Baselland, V33, P141; Hess H., 1962, ECLOGAE GEOL HELV, V55, P609; HESS HANS, 1964, ECLOGAE GEOL HELV, V57, P755; Hess H., 1966, Eclogae Geologicae Helvetiae, V59, P1025; Hotchkiss F.H.C., 2004, P425; Irimura S., 1990, ECHINODERMS CONTINEN, V1, P65; Irimura S., 1991, ECHINODERMS CONTINEN, V2, P111; Irimura S., 1995, CATALOGUE SPECIMENS; Ishida Y., 1993, FOSSILS MIOCENE MORO, P123; Ishida Yoshiaki, 2001, Journal of the Geological Society of Japan, V107, P784; Ishida Y, 2001, ECHINODERMS 2000, P285; Ishida Y., 2013, KASEKI NO TOMO, P24; Ishida Y., 1999, MEMOIRS GEOLOGICAL S, V54, P161; Ishida Y., 1988, KASEKI NO TOMO, P4; Ishida Y., 2004, B FOSSA MAGNA MUSEUM, P17; Ishida Yoshiaki, 2004, Bulletin of Gunma Museum of Natural History, V8, P21; Ishida Y., 2004, MONOGRAPH ASS GEOLOG, V51, P1; Ishida Yoshiaki, 2003, P53; Jagt J. W. M., 2000, SCRIPTA GEOLOGICA, P1; Jagt J. W. M., 2012, ROCZNIK MUZEUM EWOLU, V4, P27; Kato Susumu, 1992, Bulletin of the Mizunami Fossil Museum, V19, P379; Kerr T.J.V., 2004, P439; Koehler R., 1904, EXPEDITION SIBOGA A, V45a, P1; Koehler R., 1896, ANN U LYON, P33; Koehler R., 1896, MEMOIRES SOC ZOOLOGI, V9, P203; Koehler R., 1909, RESULTATS CAMPAGNES, V34, P1; Kristan- Tollmann E., 1979, MITT OSTERR GEOL GES, V70, P119; Kutscher M., 1991, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V182, P37; Kutscher M., 1992, Archaeopteryx, V10, P25; Lutken C. F., 1899, MEMOIRS MUSEUM COMP, V23, P96; Lyman T., 1883, B MUS COMP ZOOL HARV, V10, P227; Lyman T., 1878, B MUS COMP ZOOL HARV, V5, P65; Lyman T., 1869, B MUS COMP ZOOL HARV, V1, P309; Lyman T., 1882, REPORT SCI RESULTS V, V5, P1; Matsumoto H, 1917, J COLL SCI IMP U TOK, V38, P1; McClendon J. F., 1909, U CALIFORNIA PUBLICA, V6, P33; MURAKAMI SHIRO, 1942, JOUR DEPT AGRIC KYUSYU IMP UNIV, V7, P1; Paleontological subgroup of Itsukaichi Basin Research Group, 1985, EARTH SCI, V39, P186; Paterson G.L.J., 1985, Bulletin of the British Museum (Natural History) Zoology, V49, P1; Roemer F.A., 1841, VERSTEINERUNGEN NORD, P49; Rowe FWE, 1995, ZOOLOGICAL CATALOGUE, V33, P1; Saba M., 1982, B MIE PREF MUS NAT S, P1; Shibata H., 1980, B MIZUNAMI FOSSIL MU, P1; Shibata H., 1975, B MIZUNAMI FOSSIL MU, P75; Spencer W. K., 1907, MONOGRAPH PALAEONTOG, P91; Stohr S, 2014, WORLD OPHIUROIDEA DA; Storc R, 2008, B GEOSCI, V83, P123, DOI 10.3140/bull.geosci.2008.02.123; Sugiyama Y., 1980, J GEOL SOC JAPAN, V86, P673; Thomson C. W., 1873, DEPTHS SEA, P1; Thurmann J., 1851, ARCH SOC JURASSIENNE; Thuy Ben, 2011, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V113A, P777; Valette A., 1914, B SOC SCI HIST NATUR, V68, P125; Yoshida Fumio, 1991, Bulletin of the Mizunami Fossil Museum, V18, P19; Yoshida F., 1994, GEOLOGY TSU SEIBU DI	67	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	JUL	2015	19	3					208	218		10.2517/2015PR005		11	Paleontology	Paleontology	CM5SL	WOS:000357748800004		
J	Shigeta, Y; Kumagae, T				Shigeta, Yasunari; Kumagae, Taro			Churkites, a trans-Panthalassic Early Triassic ammonoid genus from South Primorye, Russian Far East	PALEONTOLOGICAL RESEARCH			English	Article						ammonoid; Churkites; Panthalassa; Smithian; South Primorye; Triassic	MASS EXTINCTION; FAUNAS; GRADIENTS; RECOVERY; DEPOSITS; RECORDS; NEVADA; FLOWS; WATER	The taxonomy, biostratigraphy and paleobiogeographic origin of Churkites, an Early Triassic acute-ventered arctoceratid ammonoid genus, are reported based on carefully controlled bed-by-bed sampling of several sections in South Primorye, Russian Far East. Churkites syaskoi is herein regarded as a synonym of the type species, C. egregius, which was described from the upper Smithian (loewr Olenekian) Anasibirites Zone of Russia. C. egregius is relatively abundant in sandstone laminae in the laminated mudstone beds of distal turbidites, but rare in the sandstone beds of relatively proximal turbidites. In contrast, Anasibirites is abundant in the sandstone beds, but very rare in the mudstone beds. This disparity in occurrence makes a precise biostratigraphic correlation difficult for the upper Smithian Anasibirites Zone in the mudstone facies, but C. egregius makes it possible to correlate the zone in the mudstone facies. The different modes of occurrence among ammonoid taxa strongly suggest that they either were preserved by different taphonomic processes or had different habitats. Churkites most likely evolved from Arctoceras tuberculatum on the eastern side of the Panthalassa during the middle Smithian and then crossed the Panthalassa and gave rise to C. egregius on the western side of the Panthalassa during the late Smithian. This westward dispersal across the Panthalassa was likely aided by westward equatorial currents as well as by stepping stones provided by the shallow waters around reefs and island terranes.	[Shigeta, Yasunari] Natl Museum Nat & Sci, Dept Geol & Paleontol, Tsukuba, Ibaraki 3050005, Japan; [Kumagae, Taro] Japan Petr Explorat Corp, Chiyoda Ku, Tokyo 1000005, Japan	Shigeta, Y (reprint author), Natl Museum Nat & Sci, Dept Geol & Paleontol, 4-1-1 Amakubo, Tsukuba, Ibaraki 3050005, Japan.	shigeta@kahaku.go.jp			National Museum of Nature and Science; Ministry of Education, Science and Culture of Japan [22540481]	We are deeply indebted to the Central Scientific-Research Geological-Prospecting Museum (TsNIGR Museum, St. Petersburg) and the Far Eastern Geological Institute (DVGI, Vladivostok) for kindly providing the first author with the opportunity to examine type specimens and comparative specimens. We are very grateful to Yuri D. Zakharov and Alexander M. Popov (DVGI, Vladivostok) for their help during our field work in South Primorye. We thank Arnaud Brayard (Universite de Bourgogne, Dijon) and Daniel A. Stephen (Utah Valley University, Orem) for valuable comments on the first draft. Thanks are extended to Jim Jenks (West Jordan, Utah) for his helpful suggestions and improvement of the English text. This study was financially supported by grants of the National Museum of Nature and Science in 2011-2014, as well as a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (No. 22540481) to Y. Shigeta.	WIGNALL PB, 1992, PALAEOGEOGR PALAEOCL, V93, P21, DOI 10.1016/0031-0182(92)90182-5; Brayard A, 2007, GEOBIOS-LYON, V40, P749, DOI 10.1016/j.geobios.2007.06.002; Brayard A, 2009, J ASIAN EARTH SCI, V36, P420, DOI 10.1016/j.jseaes.2008.05.004; Twitchett RJ, 1999, PALAEOGEOGR PALAEOCL, V154, P27, DOI 10.1016/S0031-0182(99)00085-1; Brayard A, 2006, PALAEOGEOGR PALAEOCL, V239, P374, DOI 10.1016/j/palaeo.2006.02.003; Wignall PB, 2002, GEOL SOC AM SPEC PAP, V356, P395, DOI 10.1130/0-8137-2356-6.395; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; Brayard Arnaud, 2013, Swiss Journal of Palaeontology, V132, P141, DOI 10.1007/s13358-013-0058-y; Twitchett RJ, 1996, PALAEOGEOGR PALAEOCL, V124, P137, DOI 10.1016/0031-0182(96)00008-9; JABLONSKI D, 1983, BIOL REV, V58, P21, DOI 10.1111/j.1469-185X.1983.tb00380.x; Mulder T, 2001, SEDIMENTOLOGY, V48, P269, DOI 10.1046/j.1365-3091.2001.00360.x; Arthaber G. V., 1911, BEITRAGE PALAONTOLOG, V24, P169; Bando Y., 1964, Science Reports of the Tohoku University Ser 2 Geol, V36, P1; Bondarenko L. G., 2013, B NEW NEXICO MUS NAT, V61, P55; Bouma A. H., 1962, SEDIMETNOLOGY SOME F; Brayard A, 2008, FOSS STRATA, P1; Burij I. V., 1972, NEW SPECIES ANCIENT, V3, P150; CECCA F, 1992, LETHAIA, V25, P257, DOI 10.1111/j.1502-3931.1992.tb01394.x; Chao K. K., 1959, PALAEONTOL SINICA, V9, P1; Diener C., 1895, MEMOIRES COMITE GEOL, V14, P1; Haggart J. W., 1989, GEOLOGICAL SURVEY CA, V396, P181; HALLAM A, 1997, MASS EXTINCTIONS THE; HYATT A., 1883, P BOSTON SOC NATURAL, V22, P253; Hyatt A., 1990, TXB PALAEONTOLOGY, P502; Hyatt A., 1905, US GEOLOGICAL SURVEY, P1; Jablonski D., 1980, SKELETAL GROWTH AQUA, P323; Jenks James F., 2007, Bulletin of the New Mexico Museum of Natural History and Science, V40, P81; Jenks J. F., 2010, B NEW MEXICO MUSEUM, V48, P1; Kambe N., 1963, GEOLOGICAL SURVEY JA, P1; Khanchuk A. I., 2001, EARTH SCI, V55, P275; Kiparisova L. D., 1947, ATLAS GUIDE FORMS FO; Kiparisova L. D., 1961, Trudy Vsesoyuznogo Nauchno-Issledovatelskogo Geologicheskogo Instituta NS, V48, P1; KUMMEL BERNHARD, 1960, BREVIORA MUS COMP ZOOL [HARVARD], V126, P1; KUMMEL B, 1962, J PALEONTOL, V36, P638; LOWE DR, 1982, J SEDIMENT PETROL, V52, P279; Maeda H., 2009, NATL MUSEUM NATURE S, V38, P36; Matsumoto T., 1954, CRETACEOUS SYSTEM JA; Mojsisovics E., 1896, DENKSCHR AKAD WISS W, V63, P575; Monnet C, 2013, FOSS REC, V16, P197, DOI 10.1002/mmng.201300010; Moore R. C., 1957, TREATISE INVERTEBRAT; MULLER KJ, 1956, J PALEONTOL, V30, P818; Okuneva T. M., 1990, NEW DATA PALEOZOIC M, P125; Okuneva T.M., 1976, Trudy Vsesoyuznogo Nauchno-Issledovatel'skogo Geologicheskogo Instituta (Biostratigraficheskii Sbornik) (Novaya Seriya), V263, P28; Peron S, 2005, GEODIN ACTA, V18, P431, DOI 10.3166/ga.18.431-446; SCHELTEM.RS, 1971, BIOL BULL, V140, P284, DOI 10.2307/1540075; SCOTT GAYLE, 1940, JOUR PALEONTOL, V14, P299; Shigeta Y., 2009, NATL MUSEUM NATURE S, V38, P38; Shigeta Y., 2009, NATL MUSEUM NATURE S, V38, P3; Shigeta Y., 2014, NATL MUSEUM NATURE S, V45, P57; Shigeta Y., 2009, NATL MUSEUM NATURE S, V38, P36; SMITH JAMES PERRIN, 1932, U S DEPT INTERIOR GEOL SURVEY PROF PAPER, V167, P1; Spath L. F., 1934, CATALOGUE FOSSIL C 4; SPATH L. F., 1930, MEDDEL OM GRONLAND, V83, P1; Tanabe K., 1979, Palaeontology (Oxford), V22, P609; TOZER ET, 1982, GEOL RUNDSCH, V71, P1077, DOI 10.1007/BF01821119; Tozer E.T., 1981, AMMONOIDEA, V18, P65; Tozer E.T., 1994, Geological Survey of Canada Bulletin, V467, P1; Waagen W., 1895, PALAEONTOLOGIA INDIC, V13, P1; Westermann G. E. G., 1996, AMMONOID PALEOBIOLOG, V13, P607; Yokoyama K., 2009, NATL MUSEUM NATURE S, V38, P34; Yokoyama K., 2009, NATL MUSEUM NATURE S, V38, P30; Zakharov Y. D., 2013, B NEW MEXICO MUS NAT, V61, P597; Zakharov Yuri D., 1997, Memoires de Geologie (Lausanne), V30, P121; Zakharov Y. D., 1978, LOWER TRIASSIC AMMON; Zakharov YD, 2014, RUSS J PAC GEOL, V8, P391, DOI 10.1134/S1819714014060086; Zakharov Y. D., 2004, TRIASSIC JURASSIC SH, V1, P58; Zakharov Yu. D., 1968, LOWER TRIASSIC BIOST	67	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	JUL	2015	19	3					219	236		10.2517/2015PR006		18	Paleontology	Paleontology	CM5SL	WOS:000357748800005		
J	Wang, Y; Du, W; Komiya, T; Wang, XL; Wang, Y				Wang, Yue; Du, Wei; Komiya, Tsuyoshi; Wang, Xun Lian; Wang, Ye			Macroorganism paleoecosystems during the middle-late Ediacaran Period in the Yangtze Block, South China	PALEONTOLOGICAL RESEARCH			English	Article						bioenergy transformation; environmental factors; middle-late Ediacaran macrobiota; paleoecosystem; South China	NEOPROTEROZOIC DOUSHANTUO FORMATION; NORTH CHINA; CARBONACEOUS COMPRESSIONS; NORTHEASTERN GUIZHOU; SNOWBALL EARTH; FOSSIL RECORD; OXYGEN; EVOLUTION; EUKARYOTES; ASSEMBLAGE	The evolution of paleoecosystems was often accompanied by the expansion of ecological niches; organismal habitats extended from the sediment surface to the water column, and then to the interior part of the sediment. A major step in ecosystem innovation was recorded in the macrobiota of the upper Doushantuo Formation during the middle-late Ediacaran Period, including the Miaohe biota from western Hubei and the Wenghui biota from northeastern Guizhou, in the Yangtze Block, South China. The macrobiota was dominated by branching and unbranching macroalgae, with abundant metazoans (including worms or vermiform animals, trilobozoans, poriferans, and medusiform animals) and ichnofossils. They lived in a warm and calm tropical ocean, with plentiful sunlight, oxygen, and nutrients. The habitats of the organisms can be subdivided into three layers of morphology and paleoecology: the epibenthic layer, the erect-benthic layer, and the plankton layer. In the case of the epibenthic and erect-benthic layers, the organisms lived on the depositional surface, or were fixed on the seafloor; in the plankton layer, the organisms floated in the water column or on the water surface. In middle-late Ediacaran macroorganism paleoecosystems, the following changes occurred: diversification, the intensification of competition between organisms, a reinforcement of the ability of organisms to change their surroundings, and the effective conversion of bioenergy. The macroorganism paleoecosystem was a key transition in the establishment of a complicated and multilayered ecological pyramid and increasing atmospheric oxygen, and a prelude to the Cambrian explosion.	[Wang, Yue] Guizhou Univ, Sch Resources & Environm, Guiyang 550025, Peoples R China; [Du, Wei; Wang, Xun Lian; Wang, Ye] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Du, Wei; Komiya, Tsuyoshi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan	Du, W (reprint author), China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China.	duwei@ea.c.u-tokyo.ac.jp	Komiya, Tsuyoshi/A-3704-2009	Komiya, Tsuyoshi/0000-0002-4000-0617	National Science Foundation of China [41162003]; Science and Technology Foundation of Guizhou Province [J-2010-2030]; Fundamental Research Funds for the Central Universities [2-9-2014-053]	We thank Akihiro Kano (Kyushu University) and an anonymous reviewer for enlightening discussions and constructive comments, as well as improved the English writing. This research is supported by the National Science Foundation of China (No. 41162003), the Science and Technology Foundation of Guizhou Province (No. J-2010-2030) and the Fundamental Research Funds for the Central Universities (2-9-2014-053).	Wang YP, 2009, ADV ENG MATER, V11, P641, DOI 10.1002/adem.200900057; Zhu B, 2013, PRECAMBRIAN RES, V225, P67, DOI 10.1016/j.precamres.2012.02.002; Droser ML, 2006, PALAEOGEOGR PALAEOCL, V232, P131, DOI 10.1016/j.palaco.2005.12.015; RUNNEGAR B, 1982, ALCHERINGA, V6, P223, DOI 10.1080/03115518208565415; Xiao SH, 2002, J PALEONTOL, V76, P347, DOI 10.1666/0022-3360(2002)076<0347:MCCIAT>2.0.CO;2; BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; NURSALL JR, 1959, NATURE, V183, P1170, DOI 10.1038/1831170b0; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; Halverson GP, 2007, EARTH PLANET SC LETT, V263, P32, DOI 10.1016/j.epsl.2007.08.022; Tang F, 2011, EVOL DEV, V13, P408, DOI 10.1111/j.1525-142X.2011.00499.x; Seilacher A, 1999, PALAIOS, V14, P86, DOI 10.2307/3515363; Droser ML, 2002, PALAIOS, V17, P3, DOI 10.1669/0883-1351(2002)017<0003:LCIFTC>2.0.CO;2; Yuan XL, 2011, NATURE, V470, P390, DOI 10.1038/nature09810; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; McCall GJH, 2006, EARTH-SCI REV, V77, P1, DOI 10.1016/j.earscirev.2005.08.004; Bouougri E, 2002, SEDIMENT GEOL, V153, P85, DOI 10.1016/S0037-0738(02)00103-3; Jiang GQ, 2011, GONDWANA RES, V19, P831, DOI 10.1016/j.gr.2011.01.006; CRIMES TP, 1987, GEOL MAG, V124, P97; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Butterfield NJ, 2000, PALEOBIOLOGY, V26, P386, DOI 10.1666/0094-8373(2000)026<0386:BPNGNS>2.0.CO;2; Wang Y, 2011, LETHAIA, V44, P275, DOI 10.1111/j.1502-3931.2010.00241.x; SEILACHER A, 1989, LETHAIA, V22, P229, DOI 10.1111/j.1502-3931.1989.tb01332.x; Macouin M, 2004, EARTH PLANET SC LETT, V224, P387, DOI 10.1016/j.epsl.2004.05.015; AWRAMIK SM, 1971, SCIENCE, V174, P825, DOI 10.1126/science.174.4011.825; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Noffke N, 2003, EARTH-SCI REV, V62, P163, DOI 10.1016/S0012-8252(02)00158-7; Banks N. L., 1970, GEOL J, P19; Bottjer David J., 2006, V27, P91; BUSS LW, 1994, PALEOBIOLOGY, V20, P1; Chen J., 1996, CHENGJIANG BIOTA UNI; Chen J.-y., 1991, P57; Chen L., 2002, EARLY CAMBRIAN CHENG, P1, DOI 10.4324/9780203361849_chapter_1; Chen M., 1994, CHINESE ACAD SCI I G, V7, P252; Chen Meng-e, 1992, Acta Palaeontologica Sinica, V31, P513; Chen M., 1991, SCI GEOL SINICA, V4, P317; Chen M. E., 2000, SCI GEOL SINICA, V35, P1; Chen M. E., 1994, ACTA PALAEONTOLOGICA, V33, P392; Ding L, 1996, SINIAN MIAOHE BIOTA, P1; Droser ML, 1999, GEOLOGY, V27, P625, DOI 10.1130/0091-7613(1999)027<0625:WTWTCO>2.3.CO;2; Du Rulin, 1982, Geological Review (Beijing), V28, P1; DU RL, 1985, ACTA GEOL SIN-ENGL, V59, P183; Du W, 2015, GONDWANA RES, V28, P1246, DOI 10.1016/j.gr.2014.08.012; Du W, 2012, PALEONTOL RES, V16, P199, DOI 10.2517/1342-8144-16.3.199; FEDONKIN MA, 1985, PHILOS T ROY SOC B, V311, P27, DOI 10.1098/rstb.1985.0136; Fedonkin M.A., 1990, VENDIAN SYSTEM, V2, P71; Finks R. M., 2004, TREATISE INVERTEBR E, V3, P9; Hofmann H.J., 1992, P349; HOU XG, 1995, GFF, V117, P163; Jiang Zhiwen, 2002, P47; Kasting J. F., 1992, PROTEROZOIC BIOSPHER, P159; Keller B. M., 1974, IZV AN SSSR GEOL, V12, P130; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Ling HF, 2004, PROG NAT SCI, V14, P77, DOI 10.1080/10020070412331343181; McFadden K. A., 2008, PROGR NATURAL SCI, V105, P3107; Olcott A., 2002, GEOL SOC AM ABSTR, V34, P271; Peng Yong-bo, 2007, Acta Micropalaeontologica Sinica, V24, P194; Pfluger F, 1999, PALAIOS, V14, P25, DOI 10.2307/3515359; Qin S., 1984, UPPER PRECAMBRIAN SI, P37; SCHOPF JW, 1992, MAJOR EVENTS IN THE HISTORY OF LIFE, P29; Seilacher A., 1994, BIOSTABILIZATION SED, P97; Shi XY, 2008, J CHINA UNIV GEOSCI, V19, P549, DOI 10.1016/S1002-0705(08)60060-6; Sprigg R. C., 1947, Transactions of the Royal Society of South Australia, V71, P212; Steiner M., 1992, BERLINER GEOWISSENSC, V3, P305; Steiner Michael, 1994, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V15, P1; Stiling P. D., 1996, ECOLOGY THEORIES APP, P323; Feng T, 2008, ACTA GEOL SIN-ENGL, V82, P27; Tang Feng, 1997, Acta Geologica Sinica, V71, P289; Tang F., 1999, GEOL REV, V45, P50; Tang Feng, 2009, Acta Geoscientia Sinica, V30, P543; TOWE KM, 1970, P NATL ACAD SCI USA, V65, P781, DOI 10.1073/pnas.65.4.781; Walter C. D., 1990, AM J SCI A, V290-A, P133; Wang Y, 2011, ACTA GEOL SIN-ENGL, V85, P533, DOI 10.1111/j.1755-6724.2011.00448.x; Wang Y., 2006, ACTA MICROPALAEONTOL, V32, P154; [王约 Wang Yue], 2007, [古地理学报, Journal of Palaeogeography], V9, P407; Wang Y., 2007, J CHINA UNIV GEOSCI, V32, P828; [王约 Wang Yue], 2005, [古地理学报, Journal of palaeogeography], V7, P327; Wang Y., 2007, J CHINA UNIV GEOSCI, V32, P41; Wang Y, 2008, ACTA GEOL SIN-ENGL, V82, P257; Wang Y., 2012, J JILIN U EARTH SCI, V42, P328; Wang Y., 1987, REGIONAL GEOLOGY GUI, P26; Wang Y, 2008, J CHINA UNIV GEOSCI, V19, P200, DOI 10.1016/S1002-0705(08)60039-4; Wu K, 2006, J E CHINA I TECHNOLO, V29, P108; Xiao Shuhai, 2006, V27, P57; Xunlai YUAN, 1995, ACTA PALAEONTOLOGICA, V34, P90; Yan Yu-Zhong, 1993, Acta Micropalaeontologica Sinica, V10, P167; Yan Yu, 1997, ACTA PALAEONTOLOGICA, V36, P18; Yang S., 1993, PALAEOECOLOGY THEORY; Yuan X., 2002, DOUSHANTUO FOSSILS L, P26; Yuan XL, 1999, LETHAIA, V32, P143; Zhang P., 1979, ACTA GEOL SINICA, V53, P87; Zhang TG, 2003, CHINESE SCI BULL, V48, P1375, DOI 10.1360/02wd0434; Zhu MY, 2007, PALAEOGEOGR PALAEOCL, V254, P1, DOI 10.1016/j.palaco.2007.03.026; Zhu SX, 2000, CHINESE SCI BULL, V45, P841, DOI 10.1007/BF02887415; ZHU SX, 1995, SCIENCE, V270, P620; ZHU W-Q, 1984, Acta Botanica Sinica, V26, P558	95	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	JUL	2015	19	3					237	250		10.2517/2015PR009		14	Paleontology	Paleontology	CM5SL	WOS:000357748800006		
J	Matsui, K; Kawabe, S				Matsui, Kumiko; Kawabe, Soichiro			The oldest record of Paleoparadoxia from the Northwest Pacific with an implication on the early evolution of Paleoparadoxiinae (Mammalia: Desmostylia)	PALEONTOLOGICAL RESEARCH			English	Article						Desmostylia; early Miocene; Paleoparadoxia; Sankebetsu Formation		A new specimen of Paleoparadoxia found from a marine lower Miocene deposit in the Chikubetsu area, Hokkaido, Japan, is described. The material consists of a distal part of the scapula, proximal end of the humerus from the right side, as well as a fragmentary rib, preserved in a float of calcareous fine sandstone. The specimen is referred to the order Desmostylia and subsequently to the genus Paleoparadoxia sp. The well preserved shoulder girdle of this specimen provides the first detailed morphology of this anatomical region in Paleoparadoxia. We compared the specimen with a wide range of desmostylid samples to reveal new diagnostic characters for the genus, such as the greater tubercle extending toward the proximal side above the head and the distinct lesser tubercle located on the medial side, projected medially. The lower Miocene Sankebetsu Formation outcrops in the area where the float was found, and the lithology and associated fossil fauna of the float indicate that it was derived from there. The fossil pollen assemblages and molluscs found in the formation indicate that it was deposited under cool to temperate conditions. The new specimen thus suggests that Paleoparadoxia had inhabited a cool environment in addition to warm areas, as suggested in previous studies. The published age estimate of the formation places the present specimen between 23.8 +/- 1.5 and 20.6 +/- 1.0 Ma. This represents the oldest record of the genus Paleoparadoxia, exceeding the previous record of ca. 19 Ma for a specimen found from the Chichibu Basin, and nearly matches the oldest record of Paleoparadoxiinae in the Northwestern Pacific. This indicates that the ages of the oldest occurrences of basal and derived paleoparadoxiines overlapped (i.e., Archaeoparadoxia from the Northeastern Pacific Region and Paleoparadoxia from the Northwestern Pacific, respectively). It is also likely that the geographic range of Paleoparadoxiinae had already expanded from the Northeast Pacific to the Northwest Pacific in the early stage of their evolution.	[Matsui, Kumiko] Kyoto Univ, Grad Sch Sci, Div Earth & Planetary Sci, Dept Geol & Mineral,Sakyo Ku, Kyoto 6068502, Japan; [Matsui, Kumiko] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kawabe, Soichiro] Gifu Prefectural Museum, Seki, Gifu 5013941, Japan; [Kawabe, Soichiro] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan	Matsui, K (reprint author), Kyoto Univ, Grad Sch Sci, Div Earth & Planetary Sci, Dept Geol & Mineral,Sakyo Ku, Kyoto 6068502, Japan.	kawabe_soichiro@yahoo.co.jp					Barnes Lawrence G., 2013, Contributions in Science (Los Angeles), P51; Beatty BL, 2009, J VERTEBR PALEONTOL, V29, P894; Arai J., 1953, B CHICHIBU MUSEUM NA, V3, P65; Barnes Lawrence G., 1997, Journal of Vertebrate Paleontology, V17, p30A; Chinzei K., 1984, MONOGRAPH ASS GEOLOG, V28, P13; Clark J.M., 1991, Journal of Vertebrate Paleontology, V11, P490; Domning D. P., 1996, SMITHSONIAN CONTRIBU, V80, P1; Domning D. P., 1986, SMITHSONIAN CONTRIBU, V59, P1; Fujii N., 1987, B FACULTY ED KANAZAW, V34, P85; Fujimoto H., 1978, BULLETIN OF THE CHICHIBU MUSEUM OF NATURAL HISTORY, V18, P1; Hasegawa Y., 2006, B GUNMA MUSEUM NATUR, V10, P37; Hasegawa Y., 2008, B GUNMA MUSEUM NATUR, P15; Hasegawa Yoshikazu, 1994, Island Arc, V3, P513, DOI 10.1111/j.1440-1738.1994.tb00130.x; Hasegawa Y., 1994, RES REPORT FUKUSHIMA, V30, P1; Hata M., 1988, ANN M GEOL SOC JAP, V95, P139; Hayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059146; Horiuchi S., 1994, B GEOLOGICAL SURVEY, V45, P655; Ijiri S., 1961, Earth Science Tokyo, V53, P1; Inuzuka N., 2006, ANN REPORT AKITA PRE, V31, P1; Inuzuka Norihisa, 2009, Bulletin of the Geological Survey of Japan, V60, P257; Inuzuka N., 2011, B ASHORO MUS PAL, V6, P3; Inuzuka N., 2006, B ASHORO MUS PAL, V4, P3; Inuzuka N., 1982, Earth Science (Tokyo), V36, P117; Inuzuka N., 1986, Earth Science (Tokyo), V40, P294; Inuzuka Norihisa, 2000, Bulletin of Ashoro Museum of Paleontology, V1, P9; Inuzuka N., 1980, Earth Science (Tokyo), V34, P105; Inuzuka N., 2013, J FOSSIL RES, V45, P31; Inuzuka N, 2005, B ASHORO MUSEUM PALE, V3, P3; Inuzuka Norihisa, 2000, Bulletin of Ashoro Museum of Paleontology, V1, P91; Inuzuka N., 1984, MONOGRAPH ASS GEOLOG, V28, P1; Inuzuka Norihisa, 1994, Island Arc, V3, P522, DOI 10.1111/j.1440-1738.1994.tb00131.x; Irizuki T., 1990, J GEOLOGICAL SOC JAP, V96, P759; Ito C, 1999, J GEOLOGICAL SOC JAP, V105, P152, DOI [10.5575/geosoc.105.152, DOI 10.5575/GE0S0C.105.152]; Itoigawa J., 1984, MONOGR ASS GEOL COLL, V28, P35; Kafanov Alexander I., 2005, Science Reports of the Institute of Geoscience University of Tsukuba Section B Geological Sciences, V26, P1; Kamei T., 1989, B TSUYAMA CITY MUSEU, V1, P1; Kamei T., 1977, B MIZUNAMI FOSSIL MU, V4, P9; Kami S., 1981, COLL LIBERAL ARTS KA, V18, P47; Kaneko K., 1992, Earth Science (Tokyo), V46, P153; Kanno S., 1964, B CHICHIBU MUSEUM NA, V12, P1; Kanno S., 1960, TERTIARY SYSTEM CH 2, P123; Kato K., 1995, DOMESTIC ANIMAL COMP, V1; Kimura M., 1985, B HOBETSU MUSEUM 2, V2, P51; Kimura M., 1984, B HOBETSU MUSEUM 1, V2, P11; Kimura M, 1998, EARTH SCI, V52, P44; Kohno Naoki, 2000, Bulletin of Ashoro Museum of Paleontology, V1, P137; Konno Y., 1984, MONOGRAPH ASS GEOLOG, V28, P69; Kurihara Y., 2000, THESIS U TSUKUBA TSU; Kurita H, 1992, J GEOLOGICAL SOC JAP, V98, P259; Kurita N., 1994, J GEOLOGICAL SOC JAP, V100, P292; Lyman RL, 1994, VERTEBRATE TAPHONOMY; Marsh O. C., 1888, AM J SCI, V35, P94; Masuda K., 1990, B IWATE PREFECTURAL, V8, P17; Masuda K., 1969, FOSSILS PALAEONTOLOG, V17, P29; MITCHELL EDW. D., 1963, BULL S CALIF ACAD SCT, V62, P192; Mitchell E. D., 1963, Contributions in Science Los Angeles, VNo. 78, P1; Moriya K., 2004, J GEOLOGICAL SOC JAP, V107, P199; Nagao T., 1935, Journal of the Geological Society of Japan, V42, P822; NAKAGAWA T, 1985, Journal of the Geological Society of Japan, V91, P389; NODA Y, 1992, Science Reports of the Tohoku University Second Series (Geology), V62, P1; Nomura S., 1940, SCI REPORTS TOHOKU I, V27, P1; Ogasawara K., 1977, K HUZIOKA MEMORIAL V, P367; Ogasawara K., 2006, ANN M PAL SOC JAP, P37; Ogasawara Kenshiro, 2000, Bulletin of Ashoro Museum of Paleontology, V1, P25; Ohkubo M., 1980, EARTH SCI, V34, P350; Oishi M., 1990, B IWATE PREFECTURAL, V8, P1; Okamoto Takashi, 2003, Journal of the Geological Society of Japan, V109, P363; REINHART R, 1953, J GEOL, V61, P187; REINHART ROY H., 1959, UNIV CALIFORNIA PUBL GEOL SCI, V36, P1; Saegusa Haruo, 2002, Nature and Human Activities, V7, P1; Saito T., 1973, Transactions Proc Palaeont Soc Japan, VNo. 91, P113; Sakamoto O., 1983, B SAITAMA MUSEUM NAT, V1, P17; Sakanoue Hajime, 2000, Science Report of the Toyohashi Museum of Natural History, V10, P13; Shikama T., 1966, PALAEONTOLOGICAL SOC, V12, P1; Shimaguchi A., 2008, J FOSSIL RES, V41, P41; Suzuki Akihiko, 2000, Bulletin of Ashoro Museum of Paleontology, V1, P57; Suzuki S., 2003, J GEOGRAPHY TOAYO GE, V112, P35; Taguchi E., 1984, MONOGRAPH ASS GEOLOG, V28, P81; Takahashi M., 1992, B SAITAMA MUSEUM NAT, V10, P29; Tanaka G., 2002, ANN M GEOL SOC JAP, V109, P145; Taru Hajime, 2000, Bulletin of Ashoro Museum of Paleontology, V1, P125; Thewissen J.G.M., 1992, Journal of Vertebrate Paleontology, V12, P494; Tokunaga S., 1939, JUBILEE PUBLICATION, V1, P289; Ujihara A., 1988, B MIZUNAMI FOSSIL MU, V14, P13; Urabe A., 2003, J GEOLOGICAL SOC JAP, V109, P399; Vanderhoof V. L., 1937, University of California Publications in Geology, V24, P169; Yahata M., 1988, EARTH SCI, V42, P155; Yanagawa City Board of Education, 1986, RES REP PAL SPEC YAN; Yanagisawa Y., 1999, B GEOLOGICAL SURVEY, V50, P139; Yanagisawa Y., 2012, OPEN FILE REPORT GEO, P1	90	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	JUL	2015	19	3					251	265		10.2517/2015PR007		15	Paleontology	Paleontology	CM5SL	WOS:000357748800007		
J	Eamudomkarn, C; Sithithaworn, P; Sithithaworn, J; Kaewkes, S; Sripa, B; Itoh, M				Eamudomkarn, Chatanun; Sithithaworn, Paiboon; Sithithaworn, Jiraporn; Kaewkes, Sasithorn; Sripa, Banchob; Itoh, Makoto			Comparative evaluation of Strongyloides ratti and S-stercoralis larval antigen for diagnosis of strongyloidiasis in an endemic area of opisthorchiasis	PARASITOLOGY RESEARCH			English	Article						Enzyme-linked immunosorbent assay; Heterologous antigen; Serodiagnosis; Sensitivity and specificity; Strongyloides ratti; Strongyloides stercoralis	LINKED-IMMUNOSORBENT-ASSAY; NORTHEAST THAILAND; INFECTION; COMMUNITY; ANTIBODIES; SEROEPIDEMIOLOGY; AGGLUTINATION; HELMINTHIASIS; VIVERRINI; RESPONSES	The use of Strongyloides ratti as heterologous antigen for serodiagnosis of strongyloidiasis is preferable to Strongyloides from humans due to the ease and safety of antigen preparation. In Southeast Asia where Opisthorchis viverrini coexists with Strongyloides stercoralis, there has been no report in using S. ratti for serodiagnosis of S. stercoralis. In this study, performance of an enzyme-linked immunosorbent assay (ELISA) based on S. ratti was compared with that based on S. stercoralis for diagnosis of strongyloidiasis in areas where O. viverrini is co-endemic in Thailand. Of the 107 individuals, 50 (46.7 %) were positive for S. stercoralis by agar culture method and by ELISA; 82 (76.6 %) and 81 (75.7 %) were seropositive using S. ratti and S. stercoralis antigens, respectively. The levels of parasite-specific IgG to S. ratti and S. stercoralis antigen were significantly proportionally correlated (P < 0.001). Mixed infections with O. viverrini have little effect on diagnosis of strongyloidiasis. Of 42 subjects who were infected with other parasites, there were no cross-reaction with Angiostrongylus cantonensis, Taenia spp., hookworms, Paragonimus spp., Clonorchis sinensis, Ascaris lumbricoides except for Fasciola spp. (1 of 5), and Opisthorchis viverrini (5 of 20). In spite of cross-reactivities, the results suggest that the S. ratti antigen provides an useful option for diagnosis of strongyloidiasis in an endemic area of opisthorchiasis with high sensitivity comparable to the S. stercoralis antigen and provide a basis for effective control strategies for strongyloidiasis.	[Eamudomkarn, Chatanun; Sithithaworn, Paiboon; Kaewkes, Sasithorn] Khon Kaen Univ, Dept Parasitol, Fac Med, Khon Kaen 40002, Thailand; [Sithithaworn, Paiboon; Kaewkes, Sasithorn; Sripa, Banchob] Khon Kaen Univ, Liver Fluke & Cholangiocarcinoma Res Ctr, Fac Med, Khon Kaen 40002, Thailand; [Sithithaworn, Jiraporn] Khon Kaen Univ, Fac Associated Med Sci, Dept Clin Microscopy, Khon Kaen 40002, Thailand; [Sripa, Banchob] Khon Kaen Univ, Dept Pathol, Fac Med, Khon Kaen 40002, Thailand; [Itoh, Makoto] Aichi Med Univ, Dept Infect & Immunol, Sch Med, Nagakute, Aichi 4801195, Japan	Sithithaworn, P (reprint author), Khon Kaen Univ, Dept Parasitol, Fac Med, Khon Kaen 40002, Thailand.	paib_sit@kku.ac.th			Office of the Higher Education Commission (CHE program); Higher Education Research Promotion; office of the Higher Education Commission, through health cluster (SHeP-GMS)	This work was supported by the Office of the Higher Education Commission (CHE program) for the joint Ph.D. program Thai doctoral degree and the Higher Education Research Promotion and office of the Higher Education Commission, through health cluster (SHeP-GMS). We acknowledge the assistance and English editing by the Publication Clinic, Faculty of Medicine, Khon Kaen University, Thailand.	Anderson NW, 2014, CLIN VACCINE IMMUNOL, V21, P732, DOI 10.1128/CVI.00041-14; Sayasone S, 2009, T ROY SOC TROP MED H, V103, P247, DOI 10.1016/j.trstmh.2008.10.011; Sawangsoda P, 2012, PARASITOL INT, V61, P196, DOI 10.1016/j.parint.2011.06.009; Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707; Paula FM, 2011, PARASITOLOGY, V138, P1331, DOI 10.1017/S003118201100120X; Sithithaworn P, 2003, T ROY SOC TROP MED H, V97, P398, DOI 10.1016/S0035-9203(03)90069-1; Krolewiecki AJ, 2010, CLIN VACCINE IMMUNOL, V17, P1624, DOI 10.1128/CVI.00259-10; KOGA K, 1991, AM J TROP MED HYG, V45, P518; LINDO JF, 1994, AM J TROP MED HYG, V51, P175; Jongsuksuntigul P, 2003, ACTA TROP, V88, P229, DOI 10.1016/j.actatropica.2003.01.002; Ravi V, 2002, MOL BIOCHEM PARASIT, V125, P73, DOI 10.1016/S0166-6851(02)00214-1; Janwan P, 2011, PARASITOL RES, V109, P1593, DOI 10.1007/s00436-011-2419-z; Ahmad AF, 2013, PARASITOL RES, V112, P2811, DOI 10.1007/s00436-013-3450-z; GENTA RM, 1986, J CLIN MICROBIOL, V23, P1099; ELKINS DB, 1990, T ROY SOC TROP MED H, V84, P715, DOI 10.1016/0035-9203(90)90159-C; Olsen A, 2009, T ROY SOC TROP MED H, V103, P967, DOI 10.1016/j.trstmh.2009.02.013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Bisoffi Z, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002640; Boonjaraspinyo S, 2013, KOREAN J PARASITOL, V51, P727, DOI 10.3347/kjp.2013.51.6.727; CONWAY DJ, 1994, EXP PARASITOL, V79, P99, DOI 10.1006/expr.1994.1069; DOUCE RW, 1987, INT J PARASITOL, V17, P1343, DOI 10.1016/0020-7519(87)90101-9; GAM AA, 1987, AM J TROP MED HYG, V37, P157; GROVE DI, 1981, AM J TROP MED HYG, V30, P344; Huaman MC, 2003, T ROY SOC TROP MED H, V97, P535, DOI 10.1016/S0035-9203(03)80017-2; Kaewpitoon SJ, 2012, ASIAN PAC J CANCER P, V13, P4285, DOI 10.7314/APJCP.2012.13.9.4285; Khieu V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002035; Kimura E, 1999, PARASITOLOGY, V119, P221, DOI 10.1017/S0031182099004631; KOBAYASHI J, 1994, DIAGN MICR INFEC DIS, V18, P19, DOI 10.1016/0732-8893(94)90129-5; Koosha S, 2004, Indian J Gastroenterol, V23, P214; Krolewiecki AJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002165; Minato K, 2008, PARASITOL RES, V102, P315, DOI 10.1007/s00436-007-0773-7; Mounsey Kate, 2014, Acta Trop, V138, P78, DOI 10.1016/j.actatropica.2014.07.007; NEVA FA, 1981, J INFECT DIS, V144, P427; Nontasut Ponganant, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P442; Pak BJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003002; Rodrigues RM, 2007, PARASITOL RES, V101, P1209, DOI 10.1007/s00436-007-0602-z; Sakolvaree Y, 1997, ASIAN PAC J ALLERGY, V15, P115; Sato Yoshiya, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P35; SATO Y, 1990, INT J PARASITOL, V20, P1025, DOI 10.1016/0020-7519(90)90045-O; Schar F, 2013, PLOS NEGLECT TROP D, V7, P7, DOI DOI 10.1371/JOURNAL.PNTD.0002288; Siddiqui AA, 1997, PARASITOL RES, V83, P655, DOI 10.1007/s004360050314; Silva LP, 2003, MEM I OSWALDO CRUZ, V98, P687, DOI 10.1590/S0074-02762003000500017; Sithithaworn J, 2005, J CLIN MICROBIOL, V43, P3278, DOI 10.1128/JCM.43.7.3278-3282.2005; Sultana Y, 2012, PARASITOLOGY, V139, P1513, DOI 10.1017/S0031182012000753; van Doorn HR, 2007, J CLIN MICROBIOL, V45, P438, DOI 10.1128/JCM.01735-06; Viney ME, 2007, STRONGYLOIDES SPP, P1, DOI [10.1895/wormbook.1.141.1, DOI 10.1895/1.141.1]; Wongsaroj T., 2008, Journal of Tropical Medicine & Parasitology, V31, P6	47	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	JUL	2015	114	7					2543	2551		10.1007/s00436-015-4458-3		9	Parasitology	Parasitology	CL2US	WOS:000356801700017		
J	Li, J; Chen, F; Sugiyama, H; Blair, D; Lin, RQ; Zhu, XQ				Li, Juan; Chen, Fen; Sugiyama, Hiromu; Blair, David; Lin, Rui-Qing; Zhu, Xing-Quan			A specific indel marker for the Philippines Schistosoma japonicum revealed by analysis of mitochondrial genome sequences	PARASITOLOGY RESEARCH			English	Article						Schistosoma japonicum; Schistosomiasis; Mitochondrial (mt) genome; The Philippines; Indel marker; Comparative analyses; Phylogeny	MAINLAND CHINA; TRANSMISSION; PROTEIN; PHYLOGENIES; NEMATODA; MODELS; JAPAN; TALE	In the present study, near-complete mitochondrial (mt) genome sequences for Schistosoma japonicum from different regions in the Philippines and Japan were amplified and sequenced. Comparisons among S. japonicum from the Philippines, Japan, and China revealed a geographically based length difference in mt genomes, but the mt genomic organization and gene arrangement were the same. Sequence differences among samples from the Philippines and all samples from the three endemic areas were 0.57-2.12 and 0.76-3.85 %, respectively. The most variable part of the mt genome was the non-coding region. In the coding portion of the genome, protein-coding genes varied more than rRNA genes and tRNAs. The near-complete mt genome sequences for Philippine specimens were identical in length (14,091 bp) which was 4 bp longer than those of S. japonicum samples from Japan and China. This indel provides a unique genetic marker for S. japonicum samples from the Philippines. Phylogenetic analyses based on the concatenated amino acids of 12 protein-coding genes showed that samples of S. japonicum clustered according to their geographical origins. The identified mitochondrial indel marker will be useful for tracing the source of S. japonicum infection in humans and animals in Southeast Asia.	[Li, Juan] Guangdong Acad Agr Sci, Inst Anim Hlth, Guangzhou 510640, Guangdong, Peoples R China; [Li, Juan; Zhu, Xing-Quan] CAAS, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou 730046, Gansu, Peoples R China; [Chen, Fen] Xiangnan Univ, Dept Basic Med, Chenzhou 423000, Hunan, Peoples R China; [Sugiyama, Hiromu] Natl Inst Infect Dis, Dept Parasitol, Tokyo 1138421, Japan; [Blair, David] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Lin, Rui-Qing] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China	Zhu, XQ (reprint author), CAAS, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou 730046, Gansu, Peoples R China.	xingquanzhu1@hotmail.com	Research ID, CTBCC /O-3564-2014		Pearl River Science and Technology New Star Project [2014J2200096]; President's Foundation of Guangdong Academy of Agricultural Sciences [201413]; Science Fund for Creative Research Groups of Gansu Province [1210RJIA006]; Special Fund for Agro-scientific Research in the Public Interest [201303037]	This work is supported, in part, by the Pearl River Science and Technology New Star Project (Grant No. 2014J2200096), the President's Foundation of Guangdong Academy of Agricultural Sciences (Grant No. 201413), the Science Fund for Creative Research Groups of Gansu Province (Grant No. 1210RJIA006), and the "Special Fund for Agro-scientific Research in the Public Interest" (Grant No. 201303037).	Zhou YB, 2011, AM J TROP MED HYG, V85, P83, DOI 10.4269/ajtmh.2011.10-0574; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; CHILTON NB, 1995, INT J PARASITOL, V25, P647, DOI 10.1016/0020-7519(94)00171-J; Strimmer K, 1996, MOL BIOL EVOL, V13, P964; Zhao GH, 2012, INFECT GENET EVOL, V12, P1027, DOI 10.1016/j.meegid.2012.02.020; Le TH, 2000, MOL BIOL EVOL, V17, P1123; BOWLES J, 1993, ACTA TROP, V55, P217, DOI 10.1016/0001-706X(93)90079-Q; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Talavera G, 2007, SYSTEMATIC BIOL, V56, P564, DOI 10.1080/10635150701472164; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Zhao GH, 2012, PARASITOL RES, V111, P1467, DOI 10.1007/s00436-012-2981-z; Mullaney JM, 2010, HUM MOL GENET, V19, pR131, DOI 10.1093/hmg/ddq400; Beltran S, 2008, MEM I OSWALDO CRUZ, V103, P501, DOI 10.1590/S0074-02762008000500017; Leonardo LR, 2008, PARASITOL INT, V57, P246, DOI 10.1016/j.parint.2008.04.006; Sugiyama H, 1997, INT J PARASITOL, V27, P811, DOI 10.1016/S0020-7519(97)00028-3; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Chen F, 2011, J ANIM VET ADV, V10, P2010, DOI 10.3923/javaa.2011.2010.2015; Wang W, 2009, ANN TROP MED PARASIT, V103, P17, DOI 10.1179/136485909X384974; Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Liu GH, 2012, INFECT GENET EVOL, V12, P1635, DOI 10.1016/j.meegid.2012.08.005; Chen F, 2015, MITOCHONDR DNA, V26, P35, DOI 10.3109/19401736.2013.814110; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140; Bergquist R, 2010, ADV PARASIT, V72, P109, DOI 10.1016/S0065-308X(10)72005-4; Blas BL, 2004, PARASITOL INT, V53, P127, DOI 10.1016/j.parint.2004.01.003; Gray DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004058; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Le TH, 2002, ANN TROP MED PARASIT, V96, P155, DOI 10.1179/000349802125000268; Lv ZY, 2015, PARASITOL RES, V114, P399, DOI 10.1007/s00436-014-4299-5; Nairz Knud, 2007, V396, P419; Olveda DU, 2014, INT J INFECT DIS, V18, P52, DOI 10.1016/j.ijid.2013.09.011; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; Wu W, 2015, PARASITOL RES, V114, P17, DOI 10.1007/s00436-014-4225-x; Xianyi Chen, 2005, Bulletin of the World Health Organization, V83, P43; Zarowlecki MZ, 2007, INT J PARASITOL, V37, P1401, DOI 10.1016/j.ijpara.2007.04.014; Zhao GH, 2012, INFECT GENET EVOL, V30, P1381	38	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	JUL	2015	114	7					2697	2704		10.1007/s00436-015-4475-2		8	Parasitology	Parasitology	CL2US	WOS:000356801700033		
J	Khalil, AM; Yasuda, M; Farid, AS; Desouky, MI; Mohi-Eldin, MM; Haridy, M; Horii, Y				Khalil, Atef Mohammed; Yasuda, Masahiro; Farid, Ayman Samir; Desouky, Mohamed Ibrahim; Mohi-Eldin, Mouchira Mohammed; Haridy, Mohie; Horii, Yoichiro			Immunomodulatory and antiparasitic effects of garlic extract on Eimeria vermiformis-infected mice	PARASITOLOGY RESEARCH			English	Article						Eimeria vermiformis; Garlic; Intraepithelial lymphocytes; CD8(+) T; Coccidiosis; Immunohistochemistry	INTESTINAL EPITHELIAL-CELLS; LEISHMANIA-MAJOR; ALLIUM-SATIVUM; ANTIMICROBIAL PROPERTIES; ENTAMOEBA-HISTOLYTICA; IMMUNE-RESPONSES; IFN-GAMMA; IN-VITRO; ALLICIN; COCCIDIOSIS	We investigated the immunomodulatory and parasiticidal effects of garlic extract on coccidiosis caused by Eimeria vermiformis infection in male ICR mice. One group received garlic extract daily until the end of the experiment by the oral route from 10 days prior to oral infection with 300 sporulated E. vermiformis oocysts (infected-garlic(+)). The other group served as a control positive with E. vermiformis infection alone (infected-garlic(-)). In the infected-garlic(+) group, garlic extract treatment induced a significant reduction in fecal oocyst output when compared with the infected-garlic(-) group. Histopathological, immunohistochemical, and gene expression analysis for inflammatory cytokines in ileal tissues showed that the garlic extract treatment impaired intracellular development of E. vermiformis during the early stages by increasing the number of intraepithelial CD8(+) T cells and decreasing IL-10 expression. This induced cell cytotoxicity which was reflected by a decrease in oocyst numbers in the intestinal villi and the feces, indicating anticoccidial effects of the garlic extract. However, further studies to explore the precise mechanism of the observed effects of garlic treatment during Eimeria infection are needed to verify our results.	[Khalil, Atef Mohammed; Farid, Ayman Samir; Horii, Yoichiro] Miyazaki Univ, Lab Vet Parasit Dis, Fac Agr, Miyazaki 8892192, Japan; [Khalil, Atef Mohammed; Farid, Ayman Samir; Horii, Yoichiro] Miyazaki Univ, Ctr Anim Dis Control, Miyazaki 8892192, Japan; [Khalil, Atef Mohammed; Mohi-Eldin, Mouchira Mohammed; Haridy, Mohie] South Valley Univ, Dept Pathol & Clin Pathol, Fac Vet Med, Qena 83523, Egypt; [Yasuda, Masahiro] Miyazaki Univ, Dept Vet Anat, Fac Agr, Miyazaki 8892192, Japan; [Farid, Ayman Samir] Benha Univ, Dept Clin Pathol, Fac Vet Med, Toukh 13736, Qalyubia, Egypt; [Desouky, Mohamed Ibrahim] Cairo Univ, Fac Vet Med, Dept Clin Pathol, Giza 12211, Egypt	Horii, Y (reprint author), Miyazaki Univ, Lab Vet Parasit Dis, Fac Agr, Gakuen Kibanadai Nishi 1-1, Miyazaki 8892192, Japan.	horii@cc.miyazaki-u.ac.jp			Egyptian government for Channel System Program; Project for Zoonoses Education and Research, University of Miyazaki, Japan	One of the authors, A.M. Khalil, received financial support from the Egyptian government for Channel System Program towards a PhD. This work was supported by the Project for Zoonoses Education and Research, University of Miyazaki, Japan.	Shadkchan Y, 2004, J ANTIMICROB CHEMOTH, V53, P832, DOI 10.1093/jac/dkh174; Ghazanfari T, 2006, J ETHNOPHARMACOL, V103, P333, DOI 10.1016/j.jep.2005.08.026; Mantawy MM, 2011, REV INST MED TROP SP, V53, P155, DOI 10.1590/S0036-46652011000300007; Jenkins MC, 2001, VET PARASITOL, V101, P291, DOI 10.1016/S0304-4017(01)00557-X; Coppi A, 2006, ANTIMICROB AGENTS CH, V50, P1731, DOI 10.1128/AAC.50.5.1731-1737.2006; Hershberg RM, 2000, IMMUNOL TODAY, V21, P123, DOI 10.1016/S0167-5699(99)01575-3; Dommels YEM, 2007, GENES NUTR, V2, P209, DOI 10.1007/s12263-007-0051-4; Rothwell L, 2004, J IMMUNOL, V173, P2675; Kyung KH, 2012, CURR OPIN BIOTECH, V23, P142, DOI 10.1016/j.copbio.2011.08.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Williams RB, 1999, INT J PARASITOL, V29, P1209, DOI 10.1016/S0020-7519(99)00086-7; Inagaki-Ohara K, 2006, INFECT IMMUN, V74, P5292, DOI 10.1128/IAI.02024-05; Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Chung LY, 2006, J MED FOOD, V9, P205, DOI 10.1089/jmf.2006.9.205; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Shibata Y, 1998, J IMMUNOL, V161, P4283; Kondo M, 2002, AM J RESP CELL MOL, V27, P536, DOI 10.1165/rcmb.4682; Metwaly MS, 2012, PARASITOL RES, V111, P681, DOI 10.1007/s00436-012-2887-9; Ankri S, 1997, ANTIMICROB AGENTS CH, V41, P2286; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Cao HX, 2014, ANTI-CANCER AGENT ME, V14, P793; Anthony JP, 2005, TRENDS PARASITOL, V21, P462, DOI 10.1016/j.pt.2005.08.004; Yun CH, 2003, FEMS IMMUNOL MED MIC, V35, P67, DOI 10.1016/S0928-8244(02)00460-1; Chapman HD, 1997, AVIAN PATHOL, V26, P221, DOI 10.1080/03079459708419208; Balasenthil S, 1999, CANCER DETECT PREV, V23, P534, DOI 10.1046/j.1525-1500.1999.99050.x; Feng YH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-268; Ford JT, 2001, IMMUNOL CELL BIOL, V79, P23, DOI 10.1046/j.1440-1711.2001.00788.x; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Ghazanfari T, 2000, SCAND J IMMUNOL, V52, P491, DOI 10.1046/j.1365-3083.2000.00803.x; HAN J, 1995, ANAL BIOCHEM, V225, P157, DOI 10.1006/abio.1995.1124; Ibarra-Velarde F, 2007, PARASITOL RES, V101, P613, DOI 10.1007/s00436-007-0523-x; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kyo E, 2001, J NUTR, V131, p1075S; Linh B, 2009, PARASITOL RES, V104, P789, DOI 10.1007/s00436-008-1256-1; Ishikawa H, 2006, J NUTR, V136, p816S; LUN ZR, 1994, ANN SOC BELG MED TR, V74, P51; ROSE ME, 1984, PARASITOLOGY, V88, P45; ROSE ME, 1992, PARASITOLOGY, V105, P349; Shields JA, 2003, INT J PARASITOL, V33, P371, DOI 10.1016/S0020-7519(02)00268-0; Smith AL, 1998, INT J PARASITOL, V28, P1061, DOI 10.1016/S0020-7519(98)00081-2; SOFFAR S A, 1991, Journal of the Egyptian Society of Parasitology, V21, P497; Waag T, 2010, BIOORG MED CHEM LETT, V20, P5541, DOI 10.1016/j.bmcl.2010.07.062; Wabwoba BW, 2010, J VECTOR DIS, V47, P160; Yasuda M, 1998, COMP IMMUNOL MICROB, V21, P179, DOI 10.1016/S0147-9571(98)00007-1	44	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	JUL	2015	114	7					2735	2742		10.1007/s00436-015-4480-5		8	Parasitology	Parasitology	CL2US	WOS:000356801700037		
J	Treloar, A; Stone, TE; McMillan, M; Flakus, K				Treloar, Anna; Stone, Teresa Elizabeth; McMillan, Margaret; Flakus, Kirstin			A Narrative in Search of a Methodology	PERSPECTIVES IN PSYCHIATRIC CARE			English	Article						Case study; mental health nursing; research design; research qualitative; story; teaching; learning strategy	NURSING-RESEARCH; CRITICAL REFLECTION; DISCOURSE ANALYSIS; EDUCATION; METAPHOR; PLACE	PurposeResearch papers present us with the summaries of scholars' work; what we readers do not see are the struggles behind the decision to choose one methodology over another. Design and MethodsA student's mental health portfolio contained a narrative that led to an exploration of the most appropriate methodology for a projected study of clinical anecdotes told by nurses who work in mental health settings to undergraduates and new recruits about mental health nursing. This paper describes the process of struggle, beginning with the student's account, before posing a number of questions needing answers before the choice of the most appropriate methodology. FindingsWe argue, after discussing the case for the use of literary analysis, discourse analysis, symbolic interactionism, hermeneutics, and narrative research, that case study research is the methodology of choice. Practice ImplicationsCase study is frequently used in educational research and is sufficiently flexible to allow for an exploration of the phenomenon.	[Treloar, Anna; McMillan, Margaret] Univ Newcastle, Sch Nursing & Midwifery, Callaghan, NSW 2308, Australia; [Treloar, Anna] Integral Hlth, Armidale, NSW, Australia; [Stone, Teresa Elizabeth] Yamaguchi Univ, Grad Sch Med, Fac Hlth Sci, Int Nursing, Yamaguchi, Japan; [Flakus, Kirstin] Port Macquarie Base Hosp, ICU, Port Macquarie, NSW, Australia	Treloar, A (reprint author), Univ Newcastle, Sch Nursing & Midwifery, Callaghan, NSW 2308, Australia.	anna.treloar@newcastle.edu.au					Smith JL, 2007, NURS INQ, V14, P60, DOI 10.1111/j.1440-1800.2007.00355.x; Darke P, 1998, INFORM SYST J, V8, P273, DOI 10.1046/j.1365-2575.1998.00040.x; Thomas G, 2011, QUAL INQ, V17, P511, DOI 10.1177/1077800411409884; Thomas G, 2010, QUAL INQ, V16, P575, DOI 10.1177/1077800410372601; Brookfield S, 2009, EUR J SOC WORK, V12, P293, DOI 10.1080/13691450902945215; Asp M, 2002, SCAND J CARING SCI, V16, P115, DOI 10.1046/j.1471-6712.2002.00068.x; Bazeley P., 2009, MALAYSIAN J QUALITAT, V2, P6; Burke K., 1984, PERMANENCE CHANGE AN; Chang KH, 2008, INT J NURS PRACT, V14, P383, DOI 10.1111/j.1440-172X.2008.00702.x; Chase S, 2005, SAGE HDB QUALITATIVE, P651; Crowe M, 1998, J ADV NURS, V28, P339, DOI 10.1046/j.1365-2648.1998.00780.x; Crowe M, 2005, J ADV NURS, V51, P55, DOI 10.1111/j.1365-2648.2005.03461.x; Cutcliffe JR, 2000, J ADV NURS, V31, P590, DOI 10.1046/j.1365-2648.2000.01314.x; Denzin N. K., 2005, SAGE HDB QUALITATIVE, P1; Dibley Lesley, 2011, Nurse Res, V18, P13; EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557; Geanellos R, 1995, Aust N Z J Ment Health Nurs, V4, P87; Goffman Erving, 1961, ASYLUMS; Green J, 2004, QUALITATIVE METHODS; Hamel J., 1993, CASE STUDY METHODS, DOI [10.4135/9781412983587, DOI 10.4135/9781412983587]; Hammersley M., 2009, CASE STUDY METHOD, DOI [10.4135/9780857024367, DOI 10.4135/9780857024367]; Kangas S, 1998, NURS RES, V47, P190, DOI 10.1097/00006199-199805000-00010; Kear T., 2012, TEACHING LEARNING NU, V7, P32, DOI [10.1016/j.teln.2011.07.003, DOI 10.1016/J.TELN.2011.07.003]; Kelly T, 2007, INT J MENT HEALTH NU, V16, P136, DOI 10.1111/j.1447-0349.2007.00457.x; Lai Claudia K Y, 2010, Nurse Res, V17, P72; McCloskey Rose, 2008, Nurse Res, V16, P24; MCCORMACK C, 2000, FIELD METHOD, V12, P282; McCormack C., 2000, FIELD METHOD, V12, P298, DOI [10.1177/1525822X0001200403, DOI 10.1177/1525822X0001200403]; McMillan M., 2006, BOUNDARIES PROFESSIO; McQueen L, 2006, J NURS EDUC, V45, P475; MEZIROW J, 1981, ADULT ED, V32, P3, DOI 10.1177/074171368103200101; Miley F., 2012, USING STORIES TEACHI; Morse J. M., 2002, READ ME 1 USERS GUID; Platt J, 2007, SAGE HDB SOCIAL SCI, DOI [10.4135/9781848607958, DOI 10.4135/9781848607958]; Hardy Sally, 2009, Nurse Res, V16, P7; Rice P. L., 1999, QUALITATIVE RES METH; Snyder C., 2012, QUALITATIVE REPORT, V17, P1; Stake R. E., 1995, ART CASE STUDY RES; Stake R.E., 2005, SAGE HDB QUALITATIVE, P443; Thorne S, 2012, NURS INQ, V19, P281, DOI 10.1111/nin.12009; Thorne S, 2000, EVIDENCE BASED NURSI, V3, P68, DOI DOI 10.1136/EBN.3.3.68; Travers M, 2001, QUALITATIVE RES CASE, DOI [10.4135/9781849209724, DOI 10.4135/9781849209724]; Tripp D, 1994, C P MINI C QUALITATI, P27; van Manen M., 1990, RES LIVED EXPERIENCE; Widdershoven G, 1993, NARRATIVE STUDY LIVE, V1, P1; Williams B, 2001, J ADV NURS, V34, P27, DOI 10.1046/j.1365-2648.2001.3411737.x; Yin R. K., 2004, CASE STUDY ANTHOLOGY; Yin R.K., 1994, CASE STUDY RES DESIG	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-5990	1744-6163		PERSPECT PSYCHIATR C	Perspect. Psychiatr. Care	JUL	2015	51	3					202	210		10.1111/ppc.12081		9	Nursing; Psychiatry	Nursing; Psychiatry	CM9GW	WOS:000358016700007		
J	Matsui, M; Habuka, H				Matsui, Misako; Habuka, Hitoshi			Numerical evaluation of silicon epitaxial growth on a 450 mm diameter substrate	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						epitaxial growth; epitaxial reactors; silicon; substrates; wafers		Silicon epitaxial growth on a 450 mm diameter silicon substrate and the related transport phenomena in a trichlorosilane-hydrogen system were numerically evaluated. In order to minimize the gas species transport distance, the single-wafer high-speed rotation vertical epitaxial reactor was studied assuming the future conditions and geometry. The edge of the large diameter substrate moves very quickly and induces a horizontal gas flow. The temperature gradient near the substrate surface significantly increases with the substrate rotation rate. The induced gas flow forms a thin boundary layer for effectively transporting the gas species to the substrate surface. A uniform film thickness profile is produced, consuming a high amount of trichlorosilane by the large substrate surface. (C) 2015 WILEY - VCH Verlag GmbH & Co. KGaA, Weinheim	[Matsui, Misako; Habuka, Hitoshi] Yokohama Natl Univ, Dept Chem & Energy Engn, Yokohama, Kanagawa 2408501, Japan	Habuka, H (reprint author), Yokohama Natl Univ, Dept Chem & Energy Engn, Yokohama, Kanagawa 2408501, Japan.	habuka1@ynu.ac.jp					[Anonymous], 2013, INF 450 MM WAF ACT; Habuka H, 1996, J CRYST GROWTH, V169, P61, DOI 10.1016/0022-0248(96)00376-4; Chaturvedi A., 2012, INT J COMP TECHNOL A, V3, P1077; Habuka H, 2011, J CRYST GROWTH, V327, P1, DOI 10.1016/j.jcrysgro.2011.05.006; Hattori T., 2014, P 78 HAND SHUS KAIR; Santen H. V., 1989, COMPUTATIONAL TECHNO, P211; Sato Y., 1991, 1991 INT C SOL STAT, P717; Sze S. M., 2008, SEMICONDUCTOR DEVICE; Takaishi K., 2014, P FOR SCI TECHN SIL, P257; Thakur R., 2012, 2012 INV AN M WASH D	10	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	JUL	2015	212	7					1539	1543		10.1002/pssa.201532362		5	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CM4UA	WOS:000357679200021		
J	Kakiuchi, H; Ohmi, H; Yamada, T; Tamaki, S; Sakaguchi, T; Lin, WC; Yasutake, K				Kakiuchi, Hiroaki; Ohmi, Hiromasa; Yamada, Takahiro; Tamaki, Shogo; Sakaguchi, Takayuki; Lin, WeiCheng; Yasutake, Kiyoshi			Characterization of Si and SiOx films deposited in very high-frequency excited atmospheric-pressure plasma and their application to bottom-gate thin film transistors	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						atmospheric-pressure plasma; silicon; silicon oxide; thin film transistors	CHEMICAL-VAPOR-DEPOSITION; AMORPHOUS-SILICON; GLOW-DISCHARGES; ASSISTED OXIDATION; OXIDE-FILMS; LOW-K; ORGANOSILICON; SPECTROSCOPY; GROWTH	Silicon (Si) and its alloys, such as silicon oxides (SiOx) and silicon nitrides, are indispensable thin film materials for the fabrication of large-area electronic devices. The goal of the present study is to develop a highly efficient deposition technology for good-quality hydrogenated amorphous Si (a-Si), microcrystalline Si (mu c-Si), and SiOx films onflexible polymer substrates. For this purpose, we have been using atmospheric-pressure (AP) plasma excited by a 150MHz very high-frequency (VHF) power. The changes of thickness and structure of the Si and SiOx films in the gas flow direction were studied as a function of distance from the plasma entrance, VHF power density, and gas flow rates. Based on the results, the performance of bottom-gate TFTs with the Si channel and SiOx gate insulator layers being deposited using AP-VHF plasma were examined to test the applicability of the Si and SiOx films to actual TFTs. A TFT with a field-effect mobility of similar to 1.7 cm(2)V(-1)s(-1) was obtained at a temperature of 120 degrees C. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Kakiuchi, Hiroaki; Ohmi, Hiromasa; Yamada, Takahiro; Tamaki, Shogo; Sakaguchi, Takayuki; Lin, WeiCheng; Yasutake, Kiyoshi] Osaka Univ, Grad Sch Engn, Dept Precis Sci & Technol, Suita, Osaka 5650871, Japan	Kakiuchi, H (reprint author), Osaka Univ, Grad Sch Engn, Dept Precis Sci & Technol, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	kakiuchi@prec.eng.osaka-u.ac.jp			KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology [20676003, 26249010]	This work was carried out in Ultra Clean Room of Department of Precision Science and Technology, Osaka University. The experiments were supported by KAKENHI (20676003 and 26249010) from the Ministry of Education, Culture, Sports, Science, and Technology. The authors would like to thank A. Takeuchi of Osaka University for his technical assistance.	Matsuda A, 2003, SOL ENERG MAT SOL C, V78, P3, DOI 10.1016/S0927-0248(02)00431-2; DESHMUKH SC, 1994, APPL PHYS LETT, V65, P3185, DOI 10.1063/1.112475; Chow MJ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4811271; Fanelli F, 2010, PLASMA PROCESS POLYM, V7, P535, DOI 10.1002/ppap.200900159; IQBAL Z, 1982, J PHYS C SOLID STATE, V15, P377, DOI 10.1088/0022-3719/15/2/019; Merche D, 2012, THIN SOLID FILMS, V520, P4219, DOI 10.1016/j.tsf.2012.01.026; Grill A, 2003, J APPL PHYS, V94, P6697, DOI 10.1063/1.1618358; Bardos L, 2010, THIN SOLID FILMS, V518, P6705, DOI 10.1016/j.tsf.2010.07.044; Massines F, 2012, PLASMA PROCESS POLYM, V9, P1041, DOI 10.1002/ppap.201200029; Borvon G, 2002, PLASMAS POLYM, V7, P341, DOI 10.1023/A:1021381003259; Creatore M, 2002, PLASMAS POLYM, V7, P291, DOI 10.1023/A:1019942625607; Demsar A, 1996, THIN SOLID FILMS, V281, P409, DOI 10.1016/0040-6090(96)08690-7; Han L, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3298364; Kakiuchi H, 2012, PLASMA CHEM PLASMA P, V32, P533, DOI 10.1007/s11090-012-9363-2; Kakiuchi H, 2009, J APPL PHYS, V106, DOI 10.1063/1.3159887; Kakiuchi H, 2013, SURF COAT TECH, V234, P2, DOI 10.1016/j.surfcoat.2013.06.108; Kakiuchi H, 2014, J VAC SCI TECHNOL A, V32, DOI 10.1116/1.4828369; Kakiuchi H, 2005, J NON-CRYST SOLIDS, V351, P741, DOI 10.1016/j.jnoncrysol.2004.08.271; Kakiuchi H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2710190; KAWAI Y, 1994, APPL PHYS LETT, V64, P2223, DOI 10.1063/1.111680; Milella A, 2006, J ELECTROCHEM SOC, V153, pF106, DOI 10.1149/1.2192729; Milella A, 2007, PLASMA PROCESS POLYM, V4, P425, DOI 10.1002/ppap.200600186; Ohmi H, 2007, J APPL PHYS, V102, DOI 10.1063/1.2753675; Ohmi H, 2006, JPN J APPL PHYS 1, V45, P8488, DOI 10.1143/JJAP.45.8488; Pappas D, 2011, J VAC SCI TECHNOL A, V29, DOI 10.1116/1.3559547; SAHLI S, 1994, THIN SOLID FILMS, V250, P206, DOI 10.1016/0040-6090(94)90187-2; Teshima K, 2001, THIN SOLID FILMS, V390, P88, DOI 10.1016/S0040-6090(01)00943-9; YASUDA T, 1992, APPL PHYS LETT, V60, P434, DOI 10.1063/1.106626	28	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	JUL	2015	212	7					1571	1577		10.1002/pssa.201532328		7	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CM4UA	WOS:000357679200026		
J	Noguchi, T; Morita, K; Simanullang, M; Xu, ZY; Usami, K; Kawano, Y; Kodera, T; Oda, S				Noguchi, Tomohiro; Morita, Koudai; Simanullang, Marolop; Xu, Zhengyu; Usami, Koichi; Kawano, Yukio; Kodera, Tetsuo; Oda, Shunri			Ge/Si core/shell nanowires with controlled low temperature grown Si shell thickness	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						chemical vapor deposition; core/shell structures; germanium; nanowires; semiconductors; silicon	CHEMICAL-VAPOR-DEPOSITION; FIELD-EFFECT TRANSISTORS; GERMANIUM NANOWIRES; CORE-SHELL; HOLE GAS; HETEROSTRUCTURES; PERFORMANCE; DEVICES	Ge/Si core/shell nanowires are fabricated with narrow (20 nm) Ge core and thin (2 nm) Si shell. Ge nanowires are prepared by vapor- liquid- solid (VLS) chemical vapor deposition (CVD). The low- temperature (450 degrees C) process by using Si2H6 gas as a Si CVD source is essential to form ultrathin layer of epitaxial Si film onto very narrow Ge nanowires. Accumulation of holes in Ge nanowires confined in the Si shell is confirmed by electrical measurement. (C) 2015 WILEY - VCH Verlag GmbH & Co. KGaA, Weinheim	[Noguchi, Tomohiro; Morita, Koudai; Simanullang, Marolop; Xu, Zhengyu; Usami, Koichi; Kawano, Yukio; Kodera, Tetsuo; Oda, Shunri] Tokyo Inst Technol, Dept Phys Elect, Quantum Nanoelect Res Ctr, Meguro Ku, Tokyo 152, Japan	Noguchi, T (reprint author), Tokyo Inst Technol, Dept Phys Elect, Quantum Nanoelect Res Ctr, Meguro Ku, Tokyo 152, Japan.	noguchi.t.ab@m.titech.ac.jp; soda@pe.titech.ac.jp	Simanullang, Marolop/M-7858-2015; 	Simanullang, Marolop/0000-0002-9953-7232	KAKENHI [26249048, 26630151, 26709023]; Murata Science Foundation	This work was financially supported by KAKENHI (grant no. 26249048, 26630151, 26709023) and the Murata Science Foundation. TEM was taken in Center for Advanced Materials Analysis in Tokyo Institute of Technology.	Akhtar S, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.014003; Lauhon LJ, 2002, NATURE, V420, P57, DOI 10.1038/nature01141; Singh N, 2006, IEEE ELECTR DEVICE L, V27, P383, DOI 10.1109/LED.2006.873381; Dayeh SA, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3567932; Lu W, 2005, P NATL ACAD SCI USA, V102, P10046, DOI 10.1073/pnas.0504581102; Markussen T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.055502; Ionescu AM, 2011, NATURE, V479, P329, DOI 10.1038/nature10679; Xiang J, 2006, NATURE, V441, P489, DOI 10.1038/nature04796; Moon J, 2013, NANO LETT, V13, P1196, DOI 10.1021/nl304619u; Law M, 2005, NAT MATER, V4, P455, DOI 10.1038/nmat1387; Hochbaum AI, 2008, NATURE, V451, P163, DOI 10.1038/nature06381; Dayeh SA, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3574537; Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047; Schaffler F, 1997, SEMICOND SCI TECH, V12, P1515, DOI 10.1088/0268-1242/12/12/001; Wu YY, 2001, ADV MATER, V13, P520, DOI 10.1002/1521-4095(200104)13:7<520::AID-ADMA520>3.0.CO;2-W; VAN DE WALLE CG, 1986, PHYS REV B, V34, P5621, DOI 10.1103/PhysRevB.34.5621; Higginbotham AP, 2014, NANO LETT, V14, P3582, DOI 10.1021/nl501242b; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Chen L, 2013, NANO LETT, V13, P5521, DOI 10.1021/nl403112a; Dayeh SA, 2010, ECS TRANSACTIONS, V33, P681, DOI 10.1149/1.3487598; Doerk GS, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3374328; Higginbotham AP, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.216806; Hu YJ, 2012, NAT NANOTECHNOL, V7, P47, DOI [10.1038/nnano.2011.234, 10.1038/NNANO.2011.234]; Kloeffel C, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195314; Li CB, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2968201; Simanullang M, 2011, J NANOSCI NANOTECHNO, V11, P8163, DOI 10.1166/jnn.2011.5049; Simanullang M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JG04; Simanullang M, 2013, J CRYST GROWTH, V384, P77, DOI 10.1016/j.jcrysgro.2013.09.009	28	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	JUL	2015	212	7					1578	1581		10.1002/pssa.201532340		4	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CM4UA	WOS:000357679200027		
J	Zrelli, H; Kusunoki, M; Miyazaki, H				Zrelli, Houda; Kusunoki, Miki; Miyazaki, Hitoshi			Role of Hydroxytyrosol-dependent Regulation of HO-1 Expression in Promoting Wound Healing of Vascular Endothelial Cells via Nrf2 De Novo Synthesis and Stabilization	PHYTOTHERAPY RESEARCH			English	Article						hydroxytyrosol; heme oxygenase-1; nuclear factor-E2 regulated factor 2; wound healing; vascular endothelial cells; atherosclerosis	HEME OXYGENASE-1 INDUCTION; MEDIATED NQO1 EXPRESSION; SMOOTH-MUSCLE-CELLS; OLIVE OIL; PHENOLIC-COMPOUNDS; OXIDATIVE STRESS; ACTIVATION; PATHWAY; KEAP1; ATHEROSCLEROSIS	Hydroxytyrosol (HT), an olive plant (Olea europaea L.) polyphenol, has proven atheroprotective effects. We previously demonstrated that heme oxygenase-1 (HO-1) is involved in the HT dependent prevention of dysfunction induced by oxidative stress in vascular endothelial cells (VECs). Here, we further investigated the signaling pathway of HT-dependent HO-1 expression in VECs. HT dose- and time-dependently increased HO-1 mRNA and protein levels through the PI3K/Akt and ERK1/2 pathways. Cycloheximide and actinomycin D inhibited both increases, suggesting that HT-triggered HO-1 induction is transcriptionally regulated and that de novo protein synthesis is necessary for this HT effect. HT stimulated nuclear accumulation of nuclear factor E2-related factor 2 (Nrf2). This Nrf2 accumulation was blocked by actinomycin D and cycloheximide whereas HT in combination with the 26S proteasome inhibitor MG132 enhanced the accumulation. HT also extended the half-life of Nrf2 proteins by decelerating its turnover. Moreover, HO-1 inhibitor, ZnppIX and CO scavenger, hemoglobin impaired HT-dependent wound healing while CORM-2, a CO generator, accelerated wound closure. Together, these data demonstrate that HT upregulates HO-1 expression by stimulating the nuclear accumulation and stabilization of Nrf2, leading to the wound repair of VECs crucial in the prevention of atherosclerosis. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Zrelli, Houda; Kusunoki, Miki; Miyazaki, Hitoshi] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan	Miyazaki, H (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan.	miyazaki.hitoshi.gb@u.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [24-02089]	This study was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Houda Zrelli is grateful for a JSPS Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science, grant-in-aid for JSPS fellows no. 24-02089. We thank Ms Norma Foster for the help in preparing the manuscript.	Halilovic A, 2011, J CELL PHYSIOL, V226, P1732, DOI 10.1002/jcp.22502; Zhang HP, 2013, ARCH MED RES, V44, P13, DOI 10.1016/j.arcmed.2012.12.001; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Cornwell DG, 2008, J AGR FOOD CHEM, V56, P8774, DOI 10.1021/jf8015877; Parzonko A, 2013, PHYTOMEDICINE, V20, P1088, DOI 10.1016/j.phymed.2013.05.002; Satoh T, 2008, J NEUROCHEM, V104, P1116, DOI 10.1111/j.1471-4159.2007.05039.x; Juan SH, 2001, CIRCULATION, V104, P1519, DOI 10.1161/hc3801.095663; Zrelli H, 2011, J AGR FOOD CHEM, V59, P4473, DOI 10.1021/jf104151d; Cicerale S, 2010, INT J MOL SCI, V11, P458, DOI 10.3390/ijms11020458; Misirli G, 2012, AM J EPIDEMIOL, V176, P1185, DOI 10.1093/aje/kws205; Motterlini R, 2007, BIOCHEM SOC T, V35, P1142; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; Patil K, 2008, INVEST OPHTH VIS SCI, V49, P3379, DOI 10.1167/iovs.07-1515; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Zrelli H, 2011, EUR J PHARMACOL, V660, P275, DOI 10.1016/j.ejphar.2011.03.045; Miro-Casas E, 2003, CLIN CHEM, V49, P945, DOI 10.1373/49.6.945; Li TT, 2011, EUR J PHARMACOL, V672, P143, DOI 10.1016/j.ejphar.2011.09.188; Dreger H, 2010, CARDIOVASC RES, V85, P395, DOI 10.1093/cvr/cvp279; Giannotti G, 2007, HERZ, V32, P568, DOI 10.1007/s00059-007-3073-1; Grochot-Przeczek A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005803; Hou DX, 2011, J AGR FOOD CHEM, V59, P11975, DOI 10.1021/jf2032439; Kim N, 2013, PHYTOTHER RES, V27, P1700, DOI 10.1002/ptr.4924; Marcantoni E, 2012, INT J HYPERTENS, DOI [.1155/2012/127910, DOI 10.1155/2012/127910]; Sahni SK, 2008, THROMB RES, V122, P820, DOI 10.1016/j.thromres.2008.01.011; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Turner R, 2005, INT J VITAM NUTR RES, V75, P61, DOI 10.1024/0300-9831.75.1.61; Valls RM, 2015, FOOD CHEM, V167, P30, DOI 10.1016/j.foodchem.2014.06.107; Zrelli H, 2011, PLANTA MED, V77, P1680, DOI 10.1055/s-0030-1271073; Zrelli H, 2013, BIOMED RES INT, DOI 10.1155/2013/912431	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	JUL	2015	29	7					1011	1018		10.1002/ptr.5339		8	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CM7FH	WOS:000357855300007		
J	Fujita, K; Chavasiri, W; Kubo, I				Fujita, Ken-ichi; Chavasiri, Warinthorn; Kubo, Isao			Anti-Salmonella Activity of Volatile Compounds of Vietnam Coriander	PHYTOTHERAPY RESEARCH			English	Article						Salmonella choleraesuis; bactericidal activity; dodecanol; surfactants; Polygonum odoratum; Vietnam coriander	LONG-CHAIN ALCOHOLS; ANTIBACTERIAL ACTIVITY; AGENTS; ANESTHESIA; ANETHOLE	Essential oil derived from the fresh leaves of Polygonum odoratum Lour was tested for their effects on a foodborne bacterium Salmonella choleraesuis subsp. choleraesuis ATCC 35640 using a broth dilution method. This essential oil showed a significant antibacterial activity against S. choleraesuis at the concentration of 200 mu g/mL. Twenty-five volatile compounds were characterized from this essential oil by GC-MS, and aldehyde compounds were found abundant and accounted for more than three-fourths of the essential oil. Among the compounds characterized, dodecanal (C-12) was the most abundant (55.5%), followed by decanal (C-10) (11.6%). Both alkanals were effective against S. choleraesuis with the minimum growth inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of 100 mu g/mL. The most potent antibacterial activity against this bacterium was found with two minor compounds, dodecanol (lauryl alcohol) and 2E-dodecenal, both with each MBC of 6.25 mu g/mL. Their primary antibacterial action against S. choleraesuis provably comes from their ability to function as nonionic surface-active agents (surfactants), disrupting the native function of integral membrane proteins nonspecifically. Thus, the antibacterial activity is mediated by biophysical processes. In the case of 2E-alkenals, a biochemical mechanism is also somewhat involved, depending on their alkyl chain length. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Fujita, Ken-ichi; Kubo, Isao] Univ Calif Berkeley, Dept Environm Policy & Management, Berkeley, CA 94720 USA; [Fujita, Ken-ichi] Osaka City Univ, Grad Sch Sci, Sumiyoshi Ku, Osaka 5588585, Japan; [Chavasiri, Warinthorn] Chulalongkorn Univ, Fac Sci, Dept Chem, Nat Prod Res Unit, Bangkok 10330, Thailand	Kubo, I (reprint author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	ikubo@berkeley.edu					Balgavy P, 1996, ADV COLLOID INTERFAC, V66, P23, DOI 10.1016/0001-8686(96)00295-3; KUBO I, 1995, BIOORGAN MED CHEM, V3, P873, DOI 10.1016/0968-0896(95)00081-Q; Kubo I, 2001, J AGR FOOD CHEM, V49, P5750, DOI 10.1021/jf010728e; HEIDMANN T, 1983, BIOCHEMISTRY-US, V22, P3112, DOI 10.1021/bi00282a014; Nanasombat S, 2009, J MED PLANTS RES, V3, P443; Kubo I, 2004, J AGR FOOD CHEM, V52, P3329, DOI 10.1021/jf0354186; BARNES CS, 1962, AUST J CHEM, V15, P322; FRANKS NP, 1986, P NATL ACAD SCI USA, V83, P5116, DOI 10.1073/pnas.83.14.5116; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Bisignano G, 2001, FEMS MICROBIOL LETT, V198, P9, DOI 10.1016/S0378-1097(01)00089-1; CHAUHAN VPS, 1984, BIOCHIM BIOPHYS ACTA, V772, P239, DOI 10.1016/0005-2736(84)90139-1; CHIOU JS, 1990, SCIENCE, V248, P583, DOI 10.1126/science.2159183; DAOUD NN, 1983, MICROBIOS, V37, P73; Davies RH, 2003, J APPL MICROBIOL, V94, P191, DOI 10.1046/j.1365-2672.2003.01817.x; Frazier WC, 1988, FOODMICROBIOLOGY, P39; Fujita K, 2005, J AGR FOOD CHEM, V53, P5187, DOI 10.1021/jf0500987; HANSCH C, 1972, J PHARM SCI, V61, P1, DOI 10.1002/jps.2600610102; HIMEJIMA M, 1993, J AGR FOOD CHEM, V41, P1776, DOI 10.1021/jf00034a048; Kubo A, 1995, J NAT PROD, V58, P1565, DOI 10.1021/np50124a013; Kubo I, 2003, BIOORGAN MED CHEM, V11, P1117, DOI 10.1016/S0968-0896(02)00453-4; Kubo I, 2008, J SCI FOOD AGR, V88, P242, DOI 10.1002/jsfa.3079; Kubo I, 2004, J APPL MICROBIOL, V96, P693, DOI 10.1111/j.1365-2672.2003.02175.x; Nikaido H., 1994, SCIENCE, V264, P383; Norden CW, 1979, J INFECT DIS, V140, P441; Ohsuka A., 1963, NIPPON KAGAKU ZASSHI, V84, P757; Sasongko P, 2011, AGR SCI J S, V42, P333; Schauenstein E, 1977, ALDEHYDES BIOL SYSTE, P172; Schulz GE, 1996, CURR OPIN STRUC BIOL, V6, P485, DOI 10.1016/S0959-440X(96)80113-8; Sofos JN, 1983, ANTIMICROBIALS FOODS, P141; Starkenmann C, 2006, J AGR FOOD CHEM, V54, P3067, DOI 10.1021/jf0531611; Xuan Dung N, 1995, J ESSENT OIL RES, V7, P339	31	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	JUL	2015	29	7					1081	1087		10.1002/ptr.5351		7	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CM7FH	WOS:000357855300016		
J	Fukui, M; Yamabe, N; Choi, HJ; Polireddy, K; Chen, Q; Zhu, BT				Fukui, Masayuki; Yamabe, Noriko; Choi, Hye-Joung; Polireddy, Kishore; Chen, Qi; Zhu, Bao Ting			Mechanism of Ascorbate-Induced Cell Death in Human Pancreatic Cancer Cells: Role of Bcl-2, Beclin 1 and Autophagy	PLANTA MEDICA			English	Article						ascorbate; pancreatic cancer; cell death; autophagy	RECOMMENDED DIETARY ALLOWANCE; VITAMIN-C PHARMACOKINETICS; SIGNALING PATHWAYS; OXIDATIVE STRESS; PROSTATE-CANCER; IN-VITRO; APOPTOSIS; CYTOTOXICITY; INDUCTION; GROWTH	The present study investigates the anticancer effect of ascorbate in MIA-PaCa-2 human pancreatic cancer cells using both in vitro and in vivo models, with a focus on assessing the role of oxidative stress and autophagy as important mechanistic elements in its anticancer actions. We showed that ascorbate suppresses the growth of human pancreatic cancer cells via the induction of oxidative stress and caspase-independent cell death. Ascorbate induces the formation of autophagosomes and the presence of autophagy inhibitors suppresses ascorbate-induced cell death. These data suggest that the induction of autophagosome formation contributes to ascorbate-induced pancreatic cancer cell death.	[Fukui, Masayuki; Yamabe, Noriko; Choi, Hye-Joung; Polireddy, Kishore; Chen, Qi; Zhu, Bao Ting] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Sch Med, Kansas City, KS 66103 USA; [Fukui, Masayuki] Univ Ryukyus, Trop Biosphere Res Ctr, Dept Microbiol, Nishihara, Okinawa 90301, Japan; [Zhu, Bao Ting] South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Guangdong, Peoples R China	Zhu, BT (reprint author), South Univ Sci & Technol China, Dept Biol, 1088 Xueyuan Rd, Shenzhen 518055, Guangdong, Peoples R China.	BTZhu@SUSTC.edu.cn			National Institutes of Health [CA97109]	This work was supported, in part, by a grant from the National Institutes of Health (Grant No. CA97109).	Hong SW, 2007, ONCOL REP, V18, P811; Padayatty SJ, 2004, ANN INTERN MED, V140, P533; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Cullen JJ, 2010, AUTOPHAGY, V6, P421; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Giansanti V, 2011, APOPTOSIS, V16, P321, DOI 10.1007/s10495-011-0589-x; Yo YT, 2009, J AGR FOOD CHEM, V57, P8266, DOI 10.1021/jf901054c; Verrax J, 2004, APOPTOSIS, V9, P223, DOI 10.1023/B:APPT.0000018804.26026.1a; Taper HS, 2001, J HISTOCHEM CYTOCHEM, V49, P109; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Lin SY, 2006, MELANOMA RES, V16, P509, DOI 10.1097/01.cmr.0000232297.99160.9e; Gilloteaux J, 2001, ULTRASTRUCT PATHOL, V25, P183; Levine M, 2001, P NATL ACAD SCI USA, V98, P9842, DOI 10.1073/pnas.171318198; Eguchi Y, 1997, CANCER RES, V57, P1835; Kang JS, 2003, CANCER IMMUNOL IMMUN, V52, P693, DOI 10.1007/s00262-003-0407-6; Nagai H, 2007, J BIOCHEM MOL BIOL, V40, P1; Fukui M, 2013, J CELL BIOCHEM, V114, P192, DOI 10.1002/jcb.24354; Eguchi Y, 1999, CANCER RES, V59, P2174; Ha YM, 2009, CANCER LETT, V277, P48, DOI 10.1016/j.canlet.2008.11.020; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; McGregor GP, 2006, CURR OPIN CLIN NUTR, V9, P697, DOI 10.1097/01.mco.0000247478.79779.8f; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Vainio H, 2006, NUTR CANCER, V54, P111, DOI 10.1207/s15327914nc5401_13; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Padayatty SJ, 2003, J AM COLL NUTR, V22, P18; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Fukui M, 2010, FREE RADICAL BIO MED, V49, P800, DOI 10.1016/j.freeradbiomed.2010.06.002; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Bravi F, 2001, ANN ONCOL, V22, P202; Carosio R, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-55; Chen P, 2012, ANTI-CANCER DRUG, V23, P437, DOI 10.1097/CAD.0b013e32834fd01f; Colas S, 2005, NUTR CANCER, V51, P178, DOI 10.1207/s15327914nc5102_8; Fromberg A, 2011, CANCER CHEMOTH PHARM, V67, P1157, DOI 10.1007/s00280-010-1418-6; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; Jamison JM, 2001, J NUTR, V131, p158S; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Verrax Julian, 2005, Free Radical Research, V39, P649, DOI 10.1080/10715760500097906	40	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	JUL	2015	81	10					838	846		10.1055/s-0035-1546132		9	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CM4SQ	WOS:000357675400009		
J	Fukushima, K; Tsai, MY; Ota, T; Haga, Y; Matsuzaki, K; Inoue, Y; Tanaka, M				Fukushima, Kazuki; Tsai, Meng-Yu; Ota, Takayuki; Haga, Yuta; Matsuzaki, Kodai; Inoue, Yuto; Tanaka, Masaru			Evaluation of the hemocompatibility of hydrated biodegradable aliphatic carbonyl polymers with a subtle difference in the backbone structure based on the intermediate water concept and surface hydration	POLYMER JOURNAL			English	Article							PROTEIN ADSORPTION; DRUG-DELIVERY; DEVICES; PMEA		[Fukushima, Kazuki; Haga, Yuta; Matsuzaki, Kodai; Tanaka, Masaru] Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, Yonezawa, Yamagata, Japan; [Tsai, Meng-Yu; Ota, Takayuki; Inoue, Yuto; Tanaka, Masaru] Yamagata Univ, Dept Biochem Engn, Grad Sch Sci & Engn, Yonezawa, Yamagata, Japan	Fukushima, K (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, Yonezawa, Yamagata, Japan.	fukushima@yz.yamagata-u.ac.jp; tanaka@yz.yamagata-u.ac.jp			JSPS [25870078]; National Taiwan University; Funding Program for the Next Generation World-Leading Researchers (NEXT Program) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This study was financially supported by a JSPS Grant-in-Aid for Young Scientists (B) #25870078. MYT thanks the National Taiwan University for the travel grants. This work was also supported by the Funding Program for the Next Generation World-Leading Researchers (NEXT Program) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Palermo EF, 2010, APPL MICROBIOL BIOT, V87, P1605, DOI 10.1007/s00253-010-2687-z; Lohmeijer BGG, 2006, MACROMOLECULES, V39, P8574, DOI 10.1021/ma0619381; Hatakeyama T, 2010, J BIOMAT SCI-POLYM E, V21, P1865, DOI 10.1163/092050610X486946; Tanaka M, 2013, POLYM J, V45, P701, DOI 10.1038/pj.2012.229; Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088; Hatakeyma T, 2007, THERMOCHIM ACTA, V465, P59, DOI 10.1016/j.tca.2007.09.005; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Hirata T, 2011, PHYS CHEM CHEM PHYS, V13, P4928, DOI 10.1039/c0cp02101f; Nederberg F, 2011, NAT CHEM, V3, P409, DOI [10.1038/nchem.1012, 10.1038/NCHEM.1012]; Morita S, 2014, LANGMUIR, V30, P10698, DOI 10.1021/la502550d; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Tateishi Y, 2010, POLYM CHEM-UK, V1, P303, DOI 10.1039/b9py00227h; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4; Bai W, 2009, J BIOMED MATER RES B, V90B, P945, DOI 10.1002/jbm.b.31367; Furuhashi Y, 2001, J POLYM SCI POL PHYS, V39, P2622, DOI 10.1002/polb.10024; Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3; Morita S, 2010, J BIOMAT SCI-POLYM E, V21, P1925, DOI 10.1163/092050610X494613; SCHOMAKER E, 1989, MACROMOLECULES, V22, P3337, DOI 10.1021/ma00198a025; Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4; Tzoneva R, 2012, CLIN HEMORHEOL MICRO, V52, P337, DOI 10.3233/CH-2012-1609	20	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JUL	2015	47	7					469	473		10.1038/pj.2015.22		5	Polymer Science	Polymer Science	CM4DD	WOS:000357633500001		
J	Ito, S; Wang, WH; Nozaki, K				Ito, Shingo; Wang, Wenhan; Nozaki, Kyoko			Formal aryne/ethylene copolymerization to form polyethylene containing o-arylene units in the main chain	POLYMER JOURNAL			English	Article							COORDINATION-INSERTION COPOLYMERIZATION; TRANSFER CONDENSATION POLYMERIZATION; METAL-CATALYZED POLYMERIZATION; RING-OPENING POLYMERIZATION; PI-CONJUGATED POLYMERS; POLAR VINYL MONOMERS; ALTERNATING COPOLYMERIZATION; METATHESIS POLYMERIZATION; STEREOREGULAR PRECURSORS; PALLADIUM COMPLEXES	As chain-growth polymerization generally forms aliphatic main chains containing units such as alkylene and alkenylene, the method has rarely been applied to the construction of arylene units. Thus, the formation/introduction of arylene groups via chain-growth polymerization remains a challenging subject in polymer chemistry. In this study, we report a formal aryne/ethylene copolymerization using [2.2.1] oxabicyclic alkenes as aryne equivalents. A palladium-catalyzed copolymerization of [2.2.1] oxabicyclic alkenes with ethylene followed by acid-promoted dehydration produced novel aryne/ethylene copolymers. The use of a bulky phosphine-sulfonate ligand was essential to obtain the desired copolymers with high molecular weight.	[Ito, Shingo; Wang, Wenhan; Nozaki, Kyoko] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan	Nozaki, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.	ito_shingo@chembio.t.u-tokyo.ac.jp; nozaki@chembio.t.u-tokyo.ac.jp	Nozaki, Kyoko/E-8779-2010		Funding Program for Next Generation World-Leading Researchers, Green Innovation; Global COE Program 'Chemistry Innovation through Cooperation of Science and Engineering'; MEXT/JSPS, Japan [24655096]	This work was supported by the Funding Program for Next Generation World-Leading Researchers, Green Innovation, the Global COE Program 'Chemistry Innovation through Cooperation of Science and Engineering' and a Grant-in-Aid for Exploratory Research (SI; 24655096) from MEXT/JSPS, Japan. We are grateful to Mr Y. Mitsushige (UTokyo) and Mr Y. Ota (UTokyo) for the kind supply of catalysts 6 and 7, respectively, and Japan Polychem Corporation for GPC analysis.	Drent E, 1996, CHEM REV, V96, P663, DOI 10.1021/cr940282j; Ito S, 2009, J AM CHEM SOC, V131, P14606, DOI 10.1021/ja9050839; Segura JL, 1999, CHEM REV, V99, P3199, DOI 10.1021/cr990011e; Ito S, 2011, J AM CHEM SOC, V133, P1232, DOI 10.1021/ja1092216; Johnson LK, 1996, J AM CHEM SOC, V118, P267, DOI 10.1021/ja953247i; Itoh T, 2001, PROG POLYM SCI, V26, P1019, DOI 10.1016/S0079-6700(01)00012-0; Mori H, 2010, MACROMOLECULES, V43, P7011, DOI 10.1021/ma100820z; Mizukoshi Y, 2015, J AM CHEM SOC, V137, P74, DOI 10.1021/ja5112207; Ito SG, 2014, J AM CHEM SOC, V136, P7547, DOI 10.1021/ja502073k; Carrow BP, 2012, J AM CHEM SOC, V134, P8802, DOI 10.1021/ja303507t; Nakabayashi K, 2013, MACROMOLECULES, V46, P4790, DOI 10.1021/ma400525m; Nakamura A, 2009, CHEM REV, V109, P5215, DOI 10.1021/cr900079r; Younkin TR, 2000, SCIENCE, V287, P460, DOI 10.1126/science.287.5452.460; ITO Y, 1992, ANGEW CHEM INT EDIT, V31, P1509, DOI 10.1002/anie.199215091; Nakamura A, 2013, ACCOUNTS CHEM RES, V46, P1438, DOI 10.1021/ar300256h; Ito S, 2012, DALTON T, V41, P13807, DOI 10.1039/c2dt31771k; Yokozawa T, 2009, CHEM REV, V109, P5595, DOI 10.1021/cr900041c; Skupov KM, 2007, MACROMOL RAPID COMM, V28, P2033, DOI 10.1002/marc.200700370; Carrow BP, 2014, MACROMOLECULES, V47, P2541, DOI 10.1021/ma500034g; Tritto I, 2006, COORDIN CHEM REV, V250, P212, DOI 10.1016/j.ccr.2005.06.019; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Ito S, 2010, CHEM REC, V10, P315, DOI 10.1002/tcr.201000032; Bianchini C, 2002, COORDIN CHEM REV, V225, P35, DOI 10.1016/S0010-8545(01)00405-2; LEHOULLIER CS, 1983, J ORG CHEM, V48, P2364, DOI 10.1021/jo00162a013; Ota Y, 2014, J AM CHEM SOC, V136, P11898, DOI 10.1021/ja505558e; Durand J, 2006, COORDIN CHEM REV, V250, P542, DOI 10.1016/j.ccr.2005.08.012; Wang CM, 1998, ORGANOMETALLICS, V17, P3149, DOI 10.1021/om980176y; Li XF, 2008, COORDIN CHEM REV, V252, P1842, DOI 10.1016/j.ccr.2007.11.027; HOSODA S, 1988, POLYM J, V20, P383, DOI 10.1295/polymj.20.383; Nanashima Y, 2012, MACROMOLECULES, V45, P2609, DOI 10.1021/ma202756y; Mecking S, 1998, J AM CHEM SOC, V120, P888, DOI 10.1021/ja964144i; Yokozawa T, 2013, CHEM COMMUN, V49, P8281, DOI 10.1039/c3cc43603a; ITO Y, 1990, J AM CHEM SOC, V112, P6446, DOI 10.1021/ja00173a070; Bunz UHF, 2012, MACROMOL RAPID COMM, V33, P886, DOI 10.1002/marc.201200001; Chino K, 2008, J POLYM SCI POL CHEM, V46, P844, DOI 10.1002/pola.22428; CONTICELLO VP, 1992, J AM CHEM SOC, V114, P9708, DOI 10.1021/ja00050a088; GIN DL, 1994, J AM CHEM SOC, V116, P10934, DOI 10.1021/ja00103a008; GIN DL, 1994, J AM CHEM SOC, V116, P10507, DOI 10.1021/ja00102a018; GRINSHPUN V, 1985, MAKROMOL CHEM-RAPID, V6, P219; HUANG DJ, 1995, J ORGANOMET CHEM, V490, pC1, DOI 10.1016/0022-328X(94)05335-9; Ihara E, 2005, MACROMOLECULES, V38, P2167, DOI 10.1021/ma048668b; Itoh T, 1997, J POLYM SCI POL CHEM, V35, P741; Kalashnikova IP, 2003, RUSS CHEM B+, V52, P1709, DOI 10.1023/A:1026036100317; Liu S, 2007, ORGANOMETALLICS, V26, P210, DOI 10.1021/om0607402; Murarka S, 2012, ANGEW CHEM INT EDIT, V51, P12362, DOI 10.1002/anie.201206096; Nomura K, 2013, CATALYSTS, V3, P157, DOI 10.3390/catal3010157; Oshimizu K., 2011, J POLYM SCI A, V49, P2709; Peacock A.J., 2000, HDB POLYETHYLENE STR; Pu L, 1996, MACROMOLECULES, V29, P1138, DOI 10.1021/ma9500143; QUIJADA R, 1995, POLYM BULL, V35, P299, DOI 10.1007/BF00963127; Ravasio A, 2011, MACROMOLECULES, V44, P4180, DOI 10.1021/ma2006427; Rodrigues AS, 2008, COORDIN CHEM REV, V252, P2137, DOI 10.1016/j.ccr.2007.11.023; Skupov KM, 2006, MACROMOLECULES, V39, P4279, DOI 10.1021/ma061089h; Starck P, 2002, EUR POLYM J, V38, P97, DOI 10.1016/S0014-3057(01)00174-4; Waghray D, 2011, ORG LETT, V13, P5516, DOI 10.1021/ol202236r; Yokozawa T, 2013, PURE APPL CHEM, V85, P573, DOI 10.1351/PAC-CON-12-03-13	56	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JUL	2015	47	7					474	480		10.1038/pj.2015.27		7	Polymer Science	Polymer Science	CM4DD	WOS:000357633500002		
J	Hashimoto, M; O'ishi, J; Moriya, S; Fujiwara, S				Hashimoto, Masato; O'ishi, Junko; Moriya, Sayoko; Fujiwara, Susumu			Melt memory of a spherulite nucleus formed through a seeding process in the crystal growth of isotactic polystyrene	POLYMER JOURNAL			English	Article							POLYPROPYLENE ALPHA-PHASE; LOW-DENSITY POLYETHYLENE; SELF-NUCLEATION; CRYSTALLIZATION KINETICS; POLYMER CRYSTALLIZATION; THERMAL HISTORY; RECRYSTALLIZATION; NUMBER	The melt memory effect on the crystal growth of isotactic polystyrene is investigated using optical microscopy. After a spherulite is melted at a slightly higher temperature than the melting point and completely disappears, a polymer crystal nucleates and grows at the same position as the original spherulite when the temperature is decreased below the melting point. After the melting-recrystallization processes are repeated by raising and lowering the temperature, the melt memory effect becomes weak. This effect completely disappears at similar to 40 degrees C above the equilibrium melting point when the melt temperature is gradually increased during the melting-recrystallization processes. The formation of spherulite nuclei is promoted by the seeding process, which consists of the following consecutive procedures: quenching a sample to a temperature below the glass transition temperature and annealing the sample slightly above the glass transition temperature. At the initial stage, the number density of spherulites rapidly decreases with the cumulative melting time. After the initial stage, the number density of spherulites exponentially decays with the cumulative melting time and approaches a finite value. This asymptotic value decreases with the melt temperature.	[Hashimoto, Masato; O'ishi, Junko; Moriya, Sayoko; Fujiwara, Susumu] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Macromol Sci & Engn, Kyoto 6068585, Japan	Hashimoto, M (reprint author), Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Macromol Sci & Engn, Sakyo Ku, Kyoto 6068585, Japan.	hashima@kit.ac.jp					Alfonso GC, 1997, MACROMOL SYMP, V118, P323, DOI 10.1002/masy.19971180143; KHANNA YP, 1988, J APPL POLYM SCI, V35, P2259, DOI 10.1002/app.1988.070350824; FILLON B, 1993, J POLYM SCI POL PHYS, V31, P1407, DOI 10.1002/polb.1993.090311015; FILLON B, 1993, J POLYM SCI POL PHYS, V31, P1383, DOI 10.1002/polb.1993.090311013; Lorenzo AT, 2006, J POLYM SCI POL PHYS, V44, P1738, DOI 10.1002/polb.20832; Hayashi Y, 2009, POLYMER, V50, P2095, DOI 10.1016/j.polymer.2009.03.008; Martins JA, 2010, POLYMER, V51, P4185, DOI 10.1016/j.polymer.2010.07.010; FILLON B, 1993, J POLYM SCI POL PHYS, V31, P1395, DOI 10.1002/polb.1993.090311014; BOON J, 1967, J POLYM SCI POL SYM, P1739; BOON J, 1968, J POLYM SCI A2, V6, P1835, DOI 10.1002/pol.1968.160061102; CARFAGNA C, 1984, POLYMER, V25, P1462, DOI 10.1016/0032-3861(84)90110-1; CHIVERS RA, 1982, J POLYM SCI POL PHYS, V20, P1717, DOI 10.1002/pol.1982.180200921; Hafele A, 2005, EUR PHYS J E, V16, P217, DOI 10.1140/epje/e2005-00023-0; HAY JN, 1965, J POLYM SCI PART A, V3, P433, DOI 10.1002/pol.1965.100030203; Mamun A, 2007, MACROMOLECULES, V40, P6296, DOI 10.1021/ma070963j; Mamun A, 2006, POLYMER, V47, P5531, DOI 10.1016/j.polymer.2005.04.110; Moser K., 1991, J APPL POLYM SCI APP, V48, P459, DOI 10.1002/app.1991.070480034; Overbergh N., 1972, J POLYM SCI C, V38, P237; Suzuki T., 1970, POLYM J, V1, P82, DOI 10.1295/polymj.1.82; TURSKA E, 1975, J APPL POLYM SCI, V19, P637, DOI 10.1002/app.1975.070190301; Zhang WD, 2006, MACROMOL RAPID COMM, V27, P1067, DOI 10.1002/marc.200600079; Zhang WD, 2007, POLYMER, V48, P6215, DOI 10.1016/j.polymer.2007.08.029	22	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JUL	2015	47	7					481	486		10.1038/pj.2015.23		6	Polymer Science	Polymer Science	CM4DD	WOS:000357633500003		
J	Ono, Y; Ida, D				Ono, Yuki; Ida, Daichi			A Monte Carlo study of the intrinsic viscosity of semiflexible ring polymers	POLYMER JOURNAL			English	Article							TRANSPORT-COEFFICIENTS; DILUTE-SOLUTION; WORMLIKE RINGS; MOMENTS; CHAINS	A Monte Carlo study is made of the intrinsic viscosity [eta] of semiflexible ring polymers by the use of a discrete version of the Kratky-Porod (KP) wormlike ring without excluded volume. The values of [eta] are evaluated in the Kirkwood-Riseman approximation. The ratio of [eta] of the rings of the trivial knot to that of the rings without the topological constraint is found to become a function only of the reduced contour length lambda L, where lambda(-1) is the stiffness parameter of the KP chain and L is the total contour length. It is then shown that the ratio is almost equal to unity for lambda L less than or similar to 10 and increases monotonically with increasing lambda L for lambda L greater than or similar to 10.	[Ono, Yuki; Ida, Daichi] Kyoto Univ, Dept Polymer Chem, Kyoto, Japan	Ida, D (reprint author), Kyoto Univ, Dept Polymer Chem, Katsura, Kyoto 6158510, Japan.	ida@molsci.polym.kyoto-u.ac.jp					KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; YOSHIZAKI T, 1988, MACROMOLECULES, V21, P165, DOI 10.1021/ma00179a033; Ida D, 2010, POLYM J, V42, P735, DOI 10.1038/pj.2010.61; Takano A, 2009, POLYMER, V50, P1300, DOI 10.1016/j.polymer.2009.01.019; FUKATSU M, 1966, J CHEM PHYS, V44, P4539, DOI 10.1063/1.1726671; Grosberg AY, 2000, PHYS REV LETT, V85, P3858, DOI 10.1103/PhysRevLett.85.3858; SHIMADA J, 1988, BIOPOLYMERS, V27, P657, DOI 10.1002/bip.360270409; ZIMM BH, 1949, J CHEM PHYS, V17, P1301, DOI 10.1063/1.1747157; KRAMERS HA, 1946, J CHEM PHYS, V14, P415, DOI 10.1063/1.1724163; Terao K, 2012, ACS MACRO LETT, V1, P1291, DOI 10.1021/mz3004506; KIRKWOOD JG, 1948, J CHEM PHYS, V16, P565, DOI 10.1063/1.1746947; FLORY PJ, 1951, J AM CHEM SOC, V73, P1904, DOI 10.1021/ja01149a002; FUJII M, 1975, MACROMOLECULES, V8, P792, DOI 10.1021/ma60048a022; Tsubouchi R, 2014, MACROMOLECULES, V47, P1449, DOI 10.1021/ma402572k; Crowell R., 1963, INTRO KNOT THEORY; DESCLOIZEAUX J, 1981, J PHYS LETT-PARIS, V42, pL433; Deutsch JM, 1999, PHYS REV E, V59, pR2539, DOI 10.1103/PhysRevE.59.R2539; FRANKKAMENETSKII MD, 1985, J BIOMOL STRUCT DYN, V2, P1005; Ida D, 2014, POLYM J, V46, P399, DOI 10.1038/pj.2014.17; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, DOI 10.1145/272991.272995; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; VOLOGODS.AV, 1974, ZH EKSP TEOR FIZ+, V66, P2153; Yamakawa H., 1997, HELICAL WORMLIKE CHA; Yamakawa H., 1971, MODERN THEORY POLYM; BLOOMFIE.V, 1966, J CHEM PHYS, V44, P315, DOI 10.1063/1.1726463	25	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JUL	2015	47	7					487	492		10.1038/pj.2015.20		6	Polymer Science	Polymer Science	CM4DD	WOS:000357633500004		
J	Zhang, X; Ejima, H; Yoshie, N				Zhang, Xin; Ejima, Hirotaka; Yoshie, Naoko			Periodic nanopatterns from polymer blends via directional solidification and subsequent epitaxial crystallization	POLYMER JOURNAL			English	Article							THIN-FILMS; ORIENTATION; BEHAVIOR; SOLVENT; POLY(VINYLPHENOL); SEMICONDUCTOR; MISCIBILITY; TRANSISTORS; COPOLYMERS; DEPOSITION	Lamellar patterns with periodicities from several tens to hundreds of nanometers were created by directional solidification and epitaxial crystallization of blends of poly(L-lactide) (PLLA) and poly(vinyl phenol) (PVPh) using hexamethylbenzene as a crystallizable solvent. The effects of blend composition and annealing conditions on both morphologies and periodicities of the patterns were systematically investigated. We show that the morphologies change with the blend composition because the miscibility of the blends and the strength of the hydrogen bonding interaction between PLLA and PVPh depend on the composition and affect the nanoscale phase separation during directional solidification and crystallization. The annealing time required to form well-ordered patterns also depends on the annealing temperature. Overall, we found that blends with 20-30 wt% PVPh annealed at 80 or 100 degrees C for 30-60 min resulted in well-ordered nanopatterns with tunable periodicity.	[Zhang, Xin; Ejima, Hirotaka; Yoshie, Naoko] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan	Yoshie, N (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	yoshie@iis.u-tokyo.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [25600023]	This work was financially supported by a grant-in-aid for Scientific Research from Japan Society for the Promotion of Science (KAKENHI No. 25600023). XZ thanks the MEXT Scholarship.	Keen I, 2014, MACROMOLECULES, V47, P276, DOI 10.1021/ma4019735; Boltau M, 1998, NATURE, V391, P877; Cartier L, 2000, POLYMER, V41, P8909, DOI 10.1016/S0032-3861(00)00234-2; ZWIERS RJM, 1983, POLYMER, V24, P167, DOI 10.1016/0032-3861(83)90128-3; Cheng JY, 2001, ADV MATER, V13, P1174, DOI 10.1002/1521-4095(200108)13:15<1174::AID-ADMA1174>3.0.CO;2-Q; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; BATES FS, 1990, ANNU REV PHYS CHEM, V41, P525, DOI 10.1146/annurev.pc.41.100190.002521; Liu SH, 2009, ADV MATER, V21, P1217, DOI 10.1002/adma.200802202; Jeong JW, 2012, ADV MATER, V24, P3526, DOI 10.1002/adma.201200356; Tseng WH, 2006, MACROMOLECULES, V39, P7071, DOI 10.1021/ma0608929; Matsushita Y, 2007, MACROMOLECULES, V40, P771, DOI 10.1021/ma062266h; De Rosa C, 2000, NATURE, V405, P433; Zhao Y, 2009, NAT MATER, V8, P979, DOI [10.1038/nmat2565, 10.1038/NMAT2565]; Segalman RA, 2005, MAT SCI ENG R, V48, P191, DOI 10.1016/j.mser.2004.12.003; Park C, 2001, MACROMOLECULES, V34, P2602, DOI 10.1021/ma0018603; Ejima H, 2007, MACROMOLECULES, V40, P6445, DOI 10.1021/ma0711543; Zhou TY, 2013, MACROMOLECULES, V46, P7745, DOI 10.1021/ma401570g; De Rosa C, 2000, MACROMOLECULES, V33, P4871, DOI 10.1021/ma992132m; WITTMANN JC, 1990, PROG POLYM SCI, V15, P909, DOI 10.1016/0079-6700(90)90025-V; Ling MM, 2004, CHEM MATER, V16, P4824, DOI 10.1021/cm0496117; Stoykovich MP, 2005, SCIENCE, V308, P1442, DOI 10.1126/science.1111041; Coffey DC, 2005, J AM CHEM SOC, V127, P4564, DOI 10.1021/ja0428917; Meaurio E, 2005, MACROMOLECULES, V38, P9221, DOI 10.1021/ma051591m; Zhang KD, 2013, J AM CHEM SOC, V135, P17913, DOI 10.1021/ja4086935; Kim A, 2013, ADV MATER, V25, P6219, DOI 10.1002/adma.201302719; Zhang LL, 1998, POLYMER, V39, P4841, DOI 10.1016/S0032-3861(97)10167-7; Rockford L, 1999, PHYS REV LETT, V82, P2602, DOI 10.1103/PhysRevLett.82.2602; Black CT, 2001, APPL PHYS LETT, V79, P409, DOI 10.1063/1.1383805; Bertrand A, 2013, J AM CHEM SOC, V135, P10918, DOI 10.1021/ja4050532; Jang SG, 2012, MACROMOLECULES, V45, P1553, DOI 10.1021/ma202391k; Lonsdale K, 1929, P R SOC LOND A-CONTA, V123, P494, DOI 10.1098/rspa.1929.0081; Byun M, 2008, MACROMOLECULES, V41, P9312, DOI 10.1021/ma801864n; Da Costa V, 1998, MACROMOLECULES, V31, P1635, DOI 10.1021/ma971177p; Fang L, 2012, LANGMUIR, V28, P10238, DOI 10.1021/la3008409; Meaurio E, 2005, MACROMOLECULES, V38, P1207, DOI 10.1021/ma047818f; Wu KH, 2006, LANGMUIR, V22, P8029, DOI 10.1021/la060418w; Zuo ZC, 2011, J COLLOID INTERF SCI, V356, P86, DOI 10.1016/j.jcis.2010.12.036	37	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JUL	2015	47	7					498	504		10.1038/pj.2015.26		7	Polymer Science	Polymer Science	CM4DD	WOS:000357633500006		
J	Matsuno, H; Matsuyama, R; Yamamoto, A; Tanaka, K				Matsuno, Hisao; Matsuyama, Ruriko; Yamamoto, Arisa; Tanaka, Keiji			Enhanced cellular affinity for poly(lactic acid) surfaces modified with titanium oxide	POLYMER JOURNAL			English	Article							POLYMER SURFACES; PROLIFERATION; ADHESION; CRYSTALLINITY; BIOMATERIALS; ORGANIZATION; POLYLACTIDE; COATINGS; CELLS; TIO2	A surface modification method of biocompatible poly(lactic acid) (PLA) with titanium oxide (TiOx) is proposed. Tetraethoxytitanium(IV) (TEOT) was used to construct a TiOx network with a few residual ethyl groups via an acid-catalyzed sol-gel reaction exploiting surface segregation. The surface of the resulting PLA-TiOx composite films was flat and homogeneous when the TEOT loading was <5 wt%. The properties of the PLA-TiOx composite films were examined by microscopy to explore the fibroblast affinity for the scaffold surface. The number of cells attached to the PLA-TiOx composite films increased with increasing surface TiOx content. Cell morphology was also dependent upon the surface TiOx content, and the attached cells on the composite film were better spread than those on the pristine PLA film. These results clearly show that our proposed method is a useful technique to improve the affinity of cells for PLA surfaces.	[Matsuno, Hisao; Matsuyama, Ruriko; Tanaka, Keiji] Kyushu Univ, Dept Appl Chem, Fukuoka 8190395, Japan; [Yamamoto, Arisa; Tanaka, Keiji] Kyushu Univ, Dept Automot Sci, Fukuoka 8190395, Japan; [Tanaka, Keiji] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8190395, Japan	Matsuno, H (reprint author), Kyushu Univ, Dept Appl Chem, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	h-matsuno@cstf.kyushu-u.ac.jp; k-tanaka@cstf.kyushu-u.ac.jp			JST SENTANKEISOKU [13A0004]; JSPS KAKENHI Scientific Research on Innovative Area 'New Polymeric Materials Based on Element-Blocks' [25102535]; 'Molecular Soft-Interface Science' programs [23106716];  [24350061]	This research was partly supported by JST SENTANKEISOKU (13A0004) and JSPS KAKENHI Scientific Research on Innovative Area 'New Polymeric Materials Based on Element-Blocks' (No. 25102535), 'Molecular Soft-Interface Science' (No. 23106716) programs, and a Grant-in-Aid for Scientific Research (B) (No. 24350061).	ALBERTSSON AC, 1995, J MACROMOL SCI PURE, VA32, P41, DOI 10.1080/10601329508011063; Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002; Jacobs T, 2013, J MATER SCI-MATER M, V24, P469, DOI 10.1007/s10856-012-4807-z; Park A, 1996, J BIOMED MATER RES, V31, P117; Wang SG, 2005, ANAL BIOANAL CHEM, V381, P547, DOI 10.1002/s00216-004-27712; Bagherifard S, 2014, ACS APPL MATER INTER, V6, P7963, DOI 10.1021/am501119k; Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027; MAYER JT, 1995, J ELECTRON SPECTROSC, V73, P1, DOI 10.1016/0368-2048(94)02258-5; Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0; Sato M, 2008, J BIOMED MATER RES A, V84A, P265, DOI 10.1002/jbm.a.31469; Lendlein A, 2010, ADV MATER, V22, P3344, DOI 10.1002/adma.201002520; SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1; TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044; Tresohlava E, 2010, BIOMACROMOLECULES, V11, P68, DOI 10.1021/bm900889b; Yang J, 2002, POLYM ADVAN TECHNOL, V13, P220, DOI 10.1002/pat.177; Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043; Gentleman MM, 2014, INT MATER REV, V59, P417, DOI 10.1179/1743280414Y.0000000038; TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705; Kim HW, 2005, J BIOMED MATER RES B, V72B, P1, DOI 10.1002/jbm.b.30073; Kulkarni M, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/6/062002; Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023; Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688; Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027; Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6; VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2; Greco F, 2013, ACS APPL MATER INTER, V5, P573, DOI 10.1021/am301908w; Alves CM, 2008, J BIOMED MATER RES B, V87B, P59, DOI 10.1002/jbm.b.31068; BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2; Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233; Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Diebold U., 1996, Surface Science Spectra, V4, DOI 10.1116/1.1247794; Fujiwara T, 2002, MACROMOL BIOSCI, V2, P11, DOI 10.1002/1616-5195(20020101)2:1<11::AID-MABI11>3.3.CO;2-H; Jokinen M, 1998, J BIOMED MATER RES, V42, P295, DOI 10.1002/(SICI)1097-4636(199811)42:2<295::AID-JBM15>3.0.CO;2-I; KIMURA Y, 1989, POLYMER, V30, P1342, DOI 10.1016/0032-3861(89)90058-X; Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.0.CO;2-G; Oh SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014101; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Saulnier B, 2004, MACROMOL BIOSCI, V4, P232, DOI 10.1002/mabi.200300087; Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200; Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050; Tsuji H., 2002, BIOPOLYMERS, V4, P129; Tsuruta H, 2013, APPL SURF SCI, V264, P589, DOI 10.1016/j.apsusc.2012.10.070; Tsuruta H, 2012, POLYM CHEM-UK, V3, P319, DOI 10.1039/c1py00488c; Ventrelli L, 2014, J BIOMED MATER RES A, V102, P2652, DOI 10.1002/jbm.a.34935; Verket A., 2012, BIOINTERPHASES, V7, P36; Vert M., 2002, BIOPOLYMERS, V4, P179	47	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JUL	2015	47	7					505	512		10.1038/pj.2015.30		8	Polymer Science	Polymer Science	CM4DD	WOS:000357633500007		
J	Fukuta, S; Wang, ZQ; Miyane, S; Koganezawa, T; Sano, T; Kido, J; Mori, H; Ueda, M; Higashihara, T				Fukuta, Seijiro; Wang, Zhongqiang; Miyane, Satoshi; Koganezawa, Tomoyuki; Sano, Takeshi; Kido, Junji; Mori, Hideharu; Ueda, Mitsuru; Higashihara, Tomoya			Synthesis of 1,3,4-thiadiazole-based donor-acceptor alternating copolymers for polymer solar cells with high open-circuit voltage	POLYMER JOURNAL			English	Article							PI-CONJUGATED POLYMERS; THIN-FILM TRANSISTORS; CONVERSION EFFICIENCY; ORGANIC PHOTOVOLTAICS; STRUCTURAL ORDER; PERFORMANCE; CHAIN; SEMICONDUCTORS; THIOPHENE; MOBILITY	We report the synthesis and characterization of novel 1,3,4-thiadiazole (TDz)-containing pi-conjugated alternating copolymers with donor units, such as thiophene (PTDzTh), selenophene (PTDzSe), thieno[3,4-b]thiophene (PTDzTT), 3,3'-didodecyl-2,2'-bithiophene (PTDzBTh) and (E)-1,2-di-(3-dodecylthiophene)vinylene (PTDzTV). The TDz-containing polymers show deep highest occupied molecular orbital (HOMO) energy levels at approximately -5.50 to -5.20 eV due to the electron deficiency of the TDz unit. In addition, PTDzTV shows a relatively extended absorption wavelength (lambda(onset)=629 nm). The microstructures of the film state are primarily influenced by the interdigitation of the side chains, and PTDzTT with a rigid backbone forms a densely packed crystalline structure, as evidenced by grazing incident wide-angle X-ray scattering experiments. Polymer solar cells using the TDz polymers showed high open-circuit voltages up to 0.965 V based on the deep HOMO energy levels, and PTDzTV showed the highest power conversion efficiency of 0.529% among the polymers.	[Fukuta, Seijiro; Miyane, Satoshi; Mori, Hideharu; Higashihara, Tomoya] Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, Yonezawa, Yamagata 9928510, Japan; [Fukuta, Seijiro; Miyane, Satoshi; Higashihara, Tomoya] Yamagata Univ, Grad Sch Sci & Engn, Innovat Flex Course Frontier Organ Mat Syst, Yonezawa, Yamagata 9928510, Japan; [Wang, Zhongqiang; Kido, Junji; Mori, Hideharu] Yamagata Univ, Grad Sch Sci & Engn, Dept Organ Device Engn, Yonezawa, Yamagata 9928510, Japan; [Wang, Zhongqiang; Kido, Junji; Mori, Hideharu] Yamagata Univ, Res Ctr Organ Elect ROEL, Yonezawa, Yamagata 9928510, Japan; [Koganezawa, Tomoyuki] Japan Synchrotron Radiat Res Inst, Nishinomiya, Hyogo, Japan; [Sano, Takeshi] Yamagata Univ, Innovat Ctr Organ Elect INOEL, Yonezawa, Yamagata 9928510, Japan; [Ueda, Mitsuru] Kanagawa Univ, Dept Chem, Yokohama, Kanagawa, Japan; [Higashihara, Tomoya] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	Higashihara, T (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, 4-3-16 Jyonan, Yonezawa, Yamagata 9928510, Japan.	thigashihara@yz.yamagata-u.ac.jp			Japan Science and Technology Agency (JST), PRESTO program [JY 220176]; KAKENHI [24655097]; Innovative Flex Course for Frontier Organic Material Systems (iFront) at Yamagata University	This study was supported by the Japan Science and Technology Agency (JST), PRESTO program (JY 220176). The authors also thank the Japan Society for the Promotion of Science for the partial financial support by KAKENHI (#24655097). SF and SM thank Innovative Flex Course for Frontier Organic Material Systems (iFront) at Yamagata University for their financial support. GIWAXS experiments were performed at the BL46XU of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; Proposal No. 2014B1590). We thank Professor Itaru Osaka (RIKEN) for conducting the GIWAXS experiments.	Krebs FC, 2014, ADV MATER, V26, P29, DOI 10.1002/adma.201302031; Yang XN, 2005, NANO LETT, V5, P579, DOI 10.1021/nl048120i; Mei JG, 2014, CHEM MATER, V26, P604, DOI 10.1021/cm4020805; Haid S, 2012, ADV FUNCT MATER, V22, P4322, DOI 10.1002/adfm.201201018; Scharber MC, 2006, ADV MATER, V18, P789, DOI 10.1002/adma.200501717; Zhang XR, 2011, J AM CHEM SOC, V133, P15073, DOI 10.1021/ja204515s; Li G, 2005, NAT MATER, V4, P864, DOI 10.1038/nmat1500; Osaka I, 2014, ADV MATER, V26, P331, DOI 10.1002/adma.201303059; Higashihara T, 2012, MACROMOLECULES, V45, P9046, DOI 10.1021/ma302005j; Allard S, 2008, ANGEW CHEM INT EDIT, V47, P4070, DOI 10.1002/anie.200701920; Dang MT, 2011, ADV MATER, V23, P3597, DOI 10.1002/adma.201100792; Rogers JT, 2011, ADV MATER, V23, P2284, DOI 10.1002/adma.201003690; Graham KR, 2014, J AM CHEM SOC, V136, P9608, DOI 10.1021/ja502985g; Guo X, 2013, PROG POLYM SCI, V38, P1832, DOI 10.1016/j.progpolymsci.2013.09.005; Brabec CJ, 2010, ADV MATER, V22, P3839, DOI 10.1002/adma.200903697; Yook KS, 2014, ADV MATER, V26, P4218, DOI 10.1002/adma.201306266; Pan H, 2007, ADV FUNCT MATER, V17, P3574, DOI 10.1002/adfm.200601242; Chen W, 2011, NANO LETT, V11, P3707, DOI 10.1021/nl201715q; Ko SW, 2011, J AM CHEM SOC, V133, P16722, DOI 10.1021/ja207429s; Kim G, 2014, J AM CHEM SOC, V136, P9477, DOI 10.1021/ja504537v; Guo Z, 2014, J AM CHEM SOC, V136, P10024, DOI 10.1021/ja503465s; Yiu AT, 2012, J AM CHEM SOC, V134, P2180, DOI 10.1021/ja2089662; Zhou HX, 2012, MACROMOLECULES, V45, P607, DOI 10.1021/ma201648t; Guo Z, 2014, PHYS CHEM CHEM PHYS, V16, P7764, DOI 10.1039/c4cp00393d; Cheng YJ, 2009, CHEM REV, V109, P5868, DOI 10.1021/cr900182s; Rivnay J, 2012, CHEM REV, V112, P5488, DOI 10.1021/cr3001109; Fukuta S, 2014, J PHOTOPOLYM SCI TEC, V27, P351; Higashihara T, 2013, J PHOTOPOLYM SCI TEC, V26, P185; Kim D. Y., Polymer containing thiophene unit and thienylenevinylene unit, and organic field effect transistor and organic solar cell containing the polymer, Patent No. [US 8466239 B2, 8466239]; Noriega Rodrigo, 2013, Nat Mater, V12, P1038, DOI [10.1038/nmat3722, 10.1038/NMAT3722]; Pang H, 2007, MACROMOLECULES, V40, P6585, DOI 10.1021/ma071242n; Patil PS, 2012, J APPL POLYM SCI, V125, P1882, DOI 10.1002/app.36238; Shi QQ, 2011, J POLYM SCI POL CHEM, V49, P4875, DOI 10.1002/pola.24938; Smith C. D., 2015, ADV ENERGY MATER, DOI [10.1002/aenm.201401778), DOI 10.1002/AENM.201401778)]; Umeyama T, 2012, CHEM LETT, V41, P354, DOI 10.1246/cl.2012.354; Yasuda T, 2005, MACROMOLECULES, V38, P4687, DOI 10.1021/ma050398p; You JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2411; Zhang GB, 2011, SOL ENERG MAT SOL C, V95, P1168, DOI 10.1016/j.solmat.2010.12.049	38	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JUL	2015	47	7					513	521		10.1038/pj.2015.19		9	Polymer Science	Polymer Science	CM4DD	WOS:000357633500008		
J	Ichikawa, S; Toshima, N				Ichikawa, Shoko; Toshima, Naoki			Improvement of thermoelectric properties of composite films of PEDOT-PSS with xylitol by means of stretching and solvent treatment	POLYMER JOURNAL			English	Article							POLYANILINE FILMS; POLYMERS; POLY(3,4-ETHYLENEDIOXYTHIOPHENE)/POLY(4-STYRENE-SULFONATE); ENHANCEMENT; ACID	Organic thermoelectric materials have advantages, such as their use in the easy and low-cost fabrication of flexible devices with a large area that can convert waste heat energy into electricity and vice versa. The critical point of the materials is their electroconductivity and flexibility for practical applications. Stiff and brittle poly(3,4-ethylenedioxythiophene) poly(4-styrenesulfonate) films are known to become flexible by forming composites with xylitol. Thus, we prepared flexible poly(3,4-ethylenedioxythiophene) poly(4-styrenesulfonate)/xylitol composite films and evaluated their thermoelectric properties. Stretching the composite films, fabricating composite films by adding dimethyl sulfoxide, and treating the films with dimethyl sulfoxide and/or pure water were found to increase the electrical conductivity and improve the thermoelectric properties of the films.	[Ichikawa, Shoko; Toshima, Naoki] Tokyo Univ Sci Yamaguchi, Adv Mat Inst, Div Mat Energy Convers, Yamaguchi 7560884, Japan; [Toshima, Naoki] Tokyo Univ Sci Yamaguchi, Dept Appl Chem, Sanyoonoda, Yamaguchi 7560884, Japan	Toshima, N (reprint author), Tokyo Univ Sci Yamaguchi, Dept Appl Chem, Sanyoonoda, Yamaguchi 7560884, Japan.	toshima@rs.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	The present research was financially supported by the Regional Innovation Cluster Program (Global type), 'Yamaguchi Green Materials Cluster,' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Yan H, 2001, MACROMOL MATER ENG, V286, P139, DOI 10.1002/1439-2054(20010301)286:3<139::AID-MAME139>3.3.CO;2-6; Wei QS, 2013, ADV MATER, V25, P2831, DOI 10.1002/adma.201205158; He HX, 2001, APPL PHYS LETT, V78, P811, DOI 10.1063/1.1335551; Yan H, 2002, J THERM ANAL CALORIM, V69, P881, DOI 10.1023/A:1020612123826; Kim GH, 2013, NAT MATER, V12, P719, DOI [10.1038/nmat3635, 10.1038/NMAT3635]; Bubnova O, 2014, NAT MATER, V13, P190, DOI [10.1038/nmat3824, 10.1038/NMAT3824]; Chiang CH, 2013, ORG ELECTRON, V14, P1769, DOI 10.1016/j.orgel.2013.03.020; Louwet F, 2003, SYNTHETIC MET, V135, P115, DOI 10.1016/S0379-6779(02)00518-0; Ashizawa S, 2005, SYNTHETIC MET, V153, P5, DOI 10.1016/j.synthmet.2005.07.214; DeLongchamp DM, 2005, LANGMUIR, V21, P11480, DOI 10.1021/la051403l; Hiroshige Y, 2007, SYNTHETIC MET, V157, P467, DOI 10.1016/j.synthmet.2007.05.003; Kim JY, 2002, SYNTHETIC MET, V126, P311, DOI 10.1016/S0379-6779(01)00576-8; Li Y, 2012, T MAT RES SOC JAPAN, V37, P303; Okuzaki H., 2012, PEDOT MAT PROPERTIES; SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578; Terasaki I., 2008, HDB THERMOELECTRIC C, P17; Toshima N, 2015, J ELECTRON MATER, V44, P384, DOI 10.1007/s11664-014-3312-1; Toshima N, 2002, MACROMOL SYMP, V186, P81, DOI 10.1002/1521-3900(200208)186:1<81::AID-MASY81>3.0.CO;2-S; Toshima N., 2014, KOBUNSHI POLYM, V63, P782; Yan H, 1999, CHEM LETT, P1217, DOI 10.1246/cl.1999.1217	20	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JUL	2015	47	7					522	526		10.1038/pj.2015.28		5	Polymer Science	Polymer Science	CM4DD	WOS:000357633500009		
J	Shiratori, T; Nakayama, T; Ishida, K				Shiratori, Takashi; Nakayama, Takeshi; Ishida, Ken-ichiro			A New Deep-branching Stramenopile, Platysulcus tardus gen. nov., sp nov.	PROTIST			English	Article						Flagellar apparatus; MAST; phylogenetic analysis; stramenopiles; ultrastructure	MARINE STRAMENOPILES; FLAGELLAR APPARATUS; SEQUENCE ALIGNMENT; MIXED MODELS; PHYLOGENY; HETEROKONT; AUSTRALIA; ALGAE; OCEAN	A novel free-living heterotrophic stramenopile, Platysulcus tardus gen. nov., sp. nov. was isolated from sedimented detritus on a seaweed collected near the Ngeruktabel Island, Palau. P. tardus is a gliding flagellate with tubular mastigonemes on the anterior short flagellum and a wide, shallow ventral furrow. Although the flagellar apparatus of P. tardus is typical of stramenopiles, it shows novel ultrastructural combinations that are not applied to any groups of heterotrophic stramenopiles. Phylogenetic analysis using SSU rRNA genes revealed that P. tardus formed a clade with stramenopiles with high support. However, P. tardus did not form a subclade with any species or environmental sequences within the stramenopiles, and no close relative was suggested by the phylogenetic analysis. Therefore, we concluded that P. tardus should be treated as a new genus and species of stramenopiles and have proposed a new family, Platysulcidae fam. nov., for this phylogenetically distinct organism. (C) 2015 Elsevier GmbH. All rights reserved.	[Shiratori, Takashi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Nakayama, Takeshi; Ishida, Ken-ichiro] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Ishida, K (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	ken@biol.tsukuba.ac.jp			JSPS KAKENHI [13J00587, 23405013]	We thank the Ministry of Natural Resources, Environment, and Tourism, Palau for providing permits for collecting marine resources (permit number, RE-11-18). We thank Dr. Naoto Hanzawa at Yamagata University for trip management for sampling. This work was supported by JSPS KAKENHI Grant Numbers 13J00587 and 23405013.	ANDERSEN RA, 1991, PROTOPLASMA, V164, P143, DOI 10.1007/BF01320820; Yabuki A, 2010, PROTIST, V161, P523, DOI 10.1016/j.protis.2010.03.001; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Massana R, 2002, APPL ENVIRON MICROB, V68, P4554, DOI 10.1128/AEM.68.9.4554-4558.2002; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Cavalier-Smith T, 2013, EUR J PROTISTOL, V49, P328, DOI 10.1016/j.ejop.2012.09.002; Takishita K, 2005, EXTREMOPHILES, V9, P185, DOI 10.1007/s00792-005-0432-9; Kolodziej K, 2007, APPL ENVIRON MICROB, V73, P2718, DOI 10.1128/AEM.02158-06; Gomez F, 2011, ENVIRON MICROBIOL, V13, P193, DOI 10.1111/j.1462-2920.2010.02320.x; Riisberg I, 2009, PROTIST, V160, P191, DOI 10.1016/j.protis.2008.11.004; Andersen RA, 2004, AM J BOT, V91, P1508, DOI 10.3732/ajb.91.10.1508; Lin YC, 2012, APPL ENVIRON MICROB, V78, P3387, DOI 10.1128/AEM.06952-11; Lee WJ, 2002, ACTA PROTOZOOL, V41, P375; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; BARR DJS, 1985, CAN J BOT, V63, P138; Barr DJS, 1989, SYST ASS SPEC, V38, P343; CavalierSmith T, 1997, ARCH PROTISTENKD, V148, P253; Hanaichi T, 1986, P 11 INT C EL MICR K, P2181; Karpov Serguei A., 2001, Protistology, V2, P34; Kasai F., 2009, JPN J PHYCOL S, V57, P1; Massana R, 2014, ISME J, V8, P854, DOI 10.1038/ismej.2013.204; Moestrup O., 2000, FLAGELLATES UNITY DI, P69; MOESTRUP O, 1976, PROTISTOLOGICA, V12, P101; MOESTRUP O, 1991, SYST ASSOC SPEC VOL, V45, P333; Moriya M, 2002, PROTIST, V153, P143, DOI 10.1078/1434-4610-00093; Moriya M, 2000, PROTIST, V151, P41, DOI 10.1078/1434-4610-00006; O'Kelly CJ, 1998, EUR J PROTISTOL, V34, P369; Patterson DJ, 1996, EUR J PROTISTOL, V32, P423; PATTERSON D J, 1985, Protistologica, V21, P413; PATTERSON DJ, 1990, J PROTOZOOL, V37, P449, DOI 10.1111/j.1550-7408.1990.tb01245.x; PREISIG HR, 1989, SYST ASSOC SPEC VOL, V38, P167; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; VORS N, 1992, OPHELIA, V36, P1; Yubuki N, 2010, PROTIST, V161, P264, DOI 10.1016/j.protis.2009.10.004	38	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1434-4610			PROTIST	Protist	JUL	2015	166	3					337	348		10.1016/j.protis.2015.05.001		12	Microbiology	Microbiology	CN0ED	WOS:000358085700004		
J	Nakamura, Y; Imai, I; Yamaguchi, A; Tuji, A; Not, F; Suzuki, N				Nakamura, Yasuhide; Imai, Ichiro; Yamaguchi, Atsushi; Tuji, Akihiro; Not, Fabrice; Suzuki, Noritoshi			Molecular Phylogeny of the Widely Distributed Marine Protists, Phaeodaria (Rhizaria, Cercozoa)	PROTIST			English	Article						Phaeodaria; Cercozoa; Rhizaria; 18S rDNA; single-cell PCR	HAECKELS RADIOLARIA; SEQUENCES; EUKARYOTES	Phaeodarians are a group of widely distributed marine cercozoans. These plankton organisms can exhibit a large biomass in the environment and are supposed to play an important role in marine ecosystems and in material cycles in the ocean. Accurate knowledge of phaeodarian classification is thus necessary to better understand marine biology, however, phylogenetic information on Phaeodaria is limited. The present study analyzed 18S rDNA sequences encompassing all existing phaeodarian orders, to clarify their phylogenetic relationships and improve their taxonomic classification. The monophyly of Phaeodaria was confirmed and strongly supported by phylogenetic analysis with a larger data set than in previous studies. The phaeodarian clade contained 11 subclades which generally did not correspond to the families and orders of the current classification system. Two families (Challengeriidae and Aulosphaeridae) and two orders (Phaeogromida and Phaeocalpida) are possibly polyphyletic or paraphyletic, and consequently the classification needs to be revised at both the family and order levels by integrative taxonomy approaches. Two morphological criteria, 1) the scleracoma type and 2) its surface structure, could be useful markers at the family level. (C) 2015 Elsevier GmbH. All rights reserved.	[Nakamura, Yasuhide; Imai, Ichiro; Yamaguchi, Atsushi] Hokkaido Univ, Grad Sch Fisheries Sci, Plankton Lab, Hakodate, Hokkaido 0418611, Japan; [Tuji, Akihiro] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki 3050005, Japan; [Not, Fabrice] CNRS, UMR 7144, F-29682 Roscoff, France; [Not, Fabrice] Univ Paris 06, Stn Biol Roscoff, Equipe EPPO, F-29682 Roscoff, France; [Suzuki, Noritoshi] Tohoku Univ, Grad Sch Sci, Inst Geol & Paleontol, Sendai, Miyagi 9808578, Japan	Nakamura, Y (reprint author), Hokkaido Univ, Grad Sch Fisheries Sci, Plankton Lab, Hakodate, Hokkaido 0418611, Japan.	y.nakamura@fish.hokudai.ac.jp	Yamaguchi, Atsushi/A-8613-2012		Centre National de la Recherche Scientifique (CNRS); Japan Science and Technology Agency (JST); National Museum of Nature and Science;  [26-2889]	We thank the captains and crews of the T/S Oshoro-maru (Hokkaido University), T/S Ushio-maru (Hokkaido University) and T/S Toyoshio-maru (Hiroshima University) for their assistance in sampling. We also thank the members of the oceanicplankton group of Station Biologique de Roscoff for their kind technical advice. Appreciation is also due to the members of Plankton laboratory of Hokkaido University for their help in analysis. The comments of two anonymous reviewers and the editor also greatly improved the manuscript. This study was financially supported by Grant-in-Aid for JSPS Fellows (no. 26-2889, Y. Nakamura), by the Cooperative Research Project with Centre National de la Recherche Scientifique (CNRS), "Morpho-molecular Diversity Assessment of Ecologically, Evolutionally, and Geologically Relevant Marine Plankton (Radiolaria)" by the Strategic International Research Cooperative Program hosted by the Japan Science and Technology Agency (JST) (N. Suzuki and F. Not), and by "Integrated Research on Biodiversity of Interspecies Relationships" of the National Museum of Nature and Science (A. Tuji).	Howe AT, 2011, PROTIST, V162, P332, DOI 10.1016/j.protis.2010.10.002; Steinberg DK, 2008, DEEP-SEA RES PT II, V55, P1615, DOI 10.1016/j.dsr2.2008.04.025; Sierra R, 2013, MOL PHYLOGENET EVOL, V67, P53, DOI 10.1016/j.ympev.2012.12.011; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Pawlowski J, 2013, MAR MICROPALEONTOL, V100, P1, DOI 10.1016/j.marmicro.2013.04.002; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Borgert A, 1901, NORDISCHES PLANKTON, V15, P1; Cachon J., 1985, P283; Campbell AS, 1954, TREATISE INVERTEBR D, pD1; Decelle J, 2012, PROTIST, V163, P435, DOI 10.1016/j.protis.2011.10.002; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Gowing MM, 1989, DEEP-SEA RES, V36, P550; Haeckel E., 1887, ZOOLOGY, V18, P1; Kling SA, 1999, S ATLANTIC ZOOPLANKT, P231; Kunitomo Y, 2006, EUR J PROTISTOL, V42, P143, DOI 10.1016/j.ejop.2006.04.001; Lampitt RS, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003221; Nakamura Y, 2015, MARINE PROT IN PRESS; Nakamura Yasuhide, 2013, Plankton & Benthos Research, V8, P107; Polet S, 2004, PROTIST, V155, P53, DOI 10.1078/1434461000164; Rambaut A, 2009, TRACER VERSION 1 6; Rambaut A, 2012, FIGTREE VERSION 1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Takahashi K, 1991, OCEAN BIOCOENOSIS SE, V3; TAKAHASHI K, 1983, DEEP-SEA RES, V30, P543, DOI 10.1016/0198-0149(83)90088-2; Takahashi Kozo, 2002, P981; Yuasa T, 2006, MAR MICROPALEONTOL, V59, P104, DOI 10.1016/j.marmicro.2006.01.003	28	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1434-4610			PROTIST	Protist	JUL	2015	166	3					363	373		10.1016/j.protis.2015.05.004		11	Microbiology	Microbiology	CN0ED	WOS:000358085700006		
J	Biard, T; Pillet, L; Decelle, J; Poirier, C; Suzuki, N; Not, F				Biard, Tristan; Pillet, Loic; Decelle, Johan; Poirier, Camille; Suzuki, Noritoshi; Not, Fabrice			Towards an Integrative Morpho-molecular Classification of the Collodaria (Polycystinea, Radiolaria)	PROTIST			English	Article						Collodaria; integrative taxonomy; molecular phylogeny; polycystine; Radiolaria; single-cell	MAXIMUM-LIKELIHOOD; COLONIAL RADIOLARIAN; SEQUENCE ALIGNMENT; SURFACE WATERS; FINE-STRUCTURE; DNA-SEQUENCES; PHYLOGENY; TREES; REPRODUCTION; PSEUDOGENES	Collodaria are ubiquitous and abundant marine radiolarian (Rhizaria) protists. They occur as either large colonies or solitary specimens, and, unlike most radiolarians, some taxa lack silicified structures. Collodarians are known to play an important role in oceanic food webs as both active predators and hosts of symbiotic microalgae, yet very little is known about their diversity and evolution. Taxonomic delineation of collodarians is challenging and only a few species have been genetically characterized. Here we investigated collodarian diversity using phylogenetic analyses of both nuclear small (18S) and large (28S) subunits of the ribosomal DNA, including 124 new sequences from 75 collodarians sampled worldwide. The resulting molecular phylogeny was compared to morphology-based classification. Our analyses distinguished the monophyletic clade of skeleton-less and spicule-bearing Sphaerozoidae from the sister clades Collosphaeridae (skeleton-bearing) and Collophidiidae (skeleton-less), while the Thalassicollidae was not retrieved as a monophyletic clade. Detailed morphological examination with electron microscopy combined with molecular analyses revealed many discrepancies, such as a mix between solitary and colonial species, co-existence of skeleton-less and skeleton-bearing specimens within the Collosphaeridae, as well as complex intraspecific variability in silicified structures. Such observations challenge a morphology-based classification and highlight the pertinence of an integrative taxonomic approach to study collodarian diversity. (C) 2015 Elsevier GmbH. All rights reserved.	[Biard, Tristan; Pillet, Loic; Not, Fabrice] Univ Paris 06, Univ Paris 04, Stn Biol Roscoff, Team Div & Interact Ocean Plankton,UMR 7144, F-29688 Roscoff, France; [Biard, Tristan; Pillet, Loic; Decelle, Johan; Not, Fabrice] CNRS, Lab Adaptat & Diversite Milieu Marin, UMR 7144, F-29688 Roscoff, France; [Decelle, Johan] Univ Paris 06, Univ Paris 04, Team Evolut Plankton & Pelag Ecosyst, Stn Biol Roscoff,UMR 7144, F-29688 Roscoff, France; [Poirier, Camille] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Suzuki, Noritoshi] Tohoku Univ, Grad Sch Sci, Inst Geol & Paleontol, Aoba Ku, Sendai, Miyagi 9808578, Japan	Biard, T (reprint author), Univ Paris 06, Univ Paris 04, Stn Biol Roscoff, Team Div & Interact Ocean Plankton,UMR 7144, F-29688 Roscoff, France.	tristan.biard@sb-roscoff.fr			"DESIR" Project Emergence-UPMC from Universite Pierre et Marie Curie; JST-CNRS exchange program; Swiss National Science Foundation [P2GEP3_148800]; "Bibliotheque du Vivant" network - CNRS; Museum National d'Histoire Naturelle; INRA; CEA (Centre National de Sequencage)	This study was supported by the "DESIR" Project Emergence-UPMC from Universite Pierre et Marie Curie, the JST-CNRS exchange program to Dr. Not and Dr. Suzuki, the Swiss National Science Foundation grant P2GEP3_148800, the "Bibliotheque du Vivant" network funded by the CNRS, the Museum National d'Histoire Naturelle, the INRA and the CEA (Centre National de Sequencage). We are grateful to the Biogenouest Genomics and Genomer plate-forme core facility for its technical support. We would like to thank staff members of the Laboratoire d'Oceanographie de Villefranche-sur-Mer (UPMC-CNRS, in particular John Dolan and Fabien Lombard), of the Station Biologique de Roscoff (UPMC-CNRS, in particular Sarah Romac) and of the Sesoko Marine Station (University of Ryukyus) as well as the Tara-Oceans Expedition for providing sampling facilities. We are grateful to Ian Probert for valuable comments on English language.	ANDERSON OR, 1981, MAR MICROPALEONTOL, V6, P385, DOI 10.1016/0377-8398(81)90008-6; Anderson OR, 1983, RADIOLARIA; Anderson OR, 2002, ILLUSTRATED GUIDE PR, V2nd, P944; ANDERSON OR, 1978, TISSUE CELL, V10, P401; ANDERSON OR, 1976, MAR MICROPALEONTOL, V1, P287, DOI 10.1016/0377-8398(76)90012-8; Anderson OR, 1999, MAR MICROPALEONTOL, V36, P81, DOI 10.1016/S0377-8398(98)00029-2; Anderson OR, 1998, PALAEONTOL ELECTRON, V1, P1; Sauvadet AL, 2010, ENVIRON MICROBIOL, V12, P2946, DOI 10.1111/j.1462-2920.2010.02272.x; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Jungbluth SP, 2013, ISME J, V7, P161, DOI 10.1038/ismej.2012.73; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; MICHAELS AF, 1995, J PLANKTON RES, V17, P131, DOI 10.1093/plankt/17.1.131; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Santos SR, 2003, J EUKARYOT MICROBIOL, V50, P417, DOI 10.1111/j.1550-7408.2003.tb00264.x; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Bachy C, 2012, PROTIST, V163, P873, DOI 10.1016/j.protis.2012.01.001; BJORKLUND KR, 1979, J PALEONTOL, V53, P1293; Brandt K, 1881, MONATSBER KGL PREUSS, V1881, P388; Brandt K, 1885, MONOGR FAUNA FLORA G, V13, P1; Brandt K, 1902, ARCH PROTISTENKD, V1, P59; De Vever P., 2001, RADIOLARIANS SEDIMEN; Decelle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053598; Decelle J, 2012, PROTIST, V163, P435, DOI 10.1016/j.protis.2011.10.002; Dennett MR, 2002, J PLANKTON RES, V24, P797, DOI 10.1093/plankt/24.8.797; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Guindon S, 2003, SYST BIOL, V52, P694; Haeckel E., 1887, ZOOLOGY, V18, P1; Haeckel E, 1862, RADIOLARIEN RHIZOPOD, P572; Hilmers K, 1906, THESIS CHRISTIAN ALB, P93; HOLLANDE ANDRE, 1953, ANN SCI NAT ZOOL 11ESER, V15, P99; Huth Walther, 1913, Archiv fuer Protistenkunde Jena, V30; International Code of Zoological Nomenclature (ICZN), 1999, INT COD ZOOL NOM, V4<SUP>th</SUP>, p[xxix, 306]; Ishitani Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035775; KHMELEVA NN, 1967, DOKL AKAD NAUK SSSR+, V172, P1430; Krabberod AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023526; Kunitomo Y, 2006, EUR J PROTISTOL, V42, P143, DOI 10.1016/j.ejop.2006.04.001; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Nylander JAA, 2004, MRAIC PL 1 4 3; Polet S, 2004, PROTIST, V155, P53, DOI 10.1078/1434461000164; Popofsky A, 1920, ZOOLOGIE 2, V16, P541; Probert I, 2014, J PHYCOL, V50, P388, DOI 10.1111/jpy.12174; Rambaut A, 2010, FIGTREE 1 3 1; Strelkov AA, 1971, ISSLED FAUNY MOREI, V9, P295; Suzuki Noritoshi, 2011, Plankton & Benthos Research, V6, P69; Suzuki Noritoshi, 2009, Bulletin of the National Museum of Nature and Science Series B-Botany, V35, P169; SWANBERG NR, 1980, DEEP-SEA RES, V27, P715, DOI 10.1016/0198-0149(80)90024-2; Swanberg NR, 1979, THESIS MIT; SWANBERG NR, 1991, J PLANKTON RES, V13, P287, DOI 10.1093/plankt/13.2.287; Tsagkogeorga G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-187; Vargas C, SCIENCE IN PRESS; Yuasa T, 2005, EUR J PROTISTOL, V41, P287, DOI 10.1016/j.ejop.2005.06.001; Zettler LAA, 1999, MAR MICROPALEONTOL, V36, P67, DOI 10.1016/S0377-8398(98)00028-0	61	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1434-4610			PROTIST	Protist	JUL	2015	166	3					374	388		10.1016/j.protis.2015.05.002		15	Microbiology	Microbiology	CN0ED	WOS:000358085700007		
J	Irie, M				Irie, Masahiro			Discovery and development of photochromic diarylethenes	PURE AND APPLIED CHEMISTRY			English	Article						diarylethene; photochromism; photoresponsive polymer; single-crystal; XXV IUPAC Photochemistry	SINGLE-CRYSTALLINE PHOTOCHROMISM; PENDANT AZOBENZENE GROUPS; PHOTORESPONSIVE POLYMERS; REVERSIBLE PHOTOCYCLIZATION; CONFORMATIONAL-CHANGES; DERIVATIVES; SYSTEMS; POLYSTYRENE; 1,2-BIS(2,5-DIMETHYL-3-THIENYL)PERFLUOROCYCLOPENTENE; PHOTOIRRADIATION	A new family of thermally irreversible photochromic molecules, named "diarylethene," was serendipitously discovered a quarter of a century ago. The diarylethenes undergo thermally irreversible, fatigue resistant, ultrafast and highly sensitive photochromic reactions. Many of diarylethenes can undergo photochromic reactions even in the single-crystalline phase. The outstanding photochromic performance attracts considerable attention from both scientific and technological points of view, and stimulates research from fundamental physico-chemical aspects to various applications. Here, it is reported how such thermally irreversible photochromic diarylethenes were discovered and developed.	Rikkyo Univ, Res Ctr Smart Mol, Toshima Ku, Tokyo 1718501, Japan	Irie, M (reprint author), Rikkyo Univ, Res Ctr Smart Mol, Toshima Ku, Nishi Ikebukuro 3-34-1, Tokyo 1718501, Japan.	iriem@rikkyo.ac.jp			Japan Scientific and Technology Agency (CREST); Ministry of Education, Culture, Sports, Science and Technology	The author is grateful for the support from the Japan Scientific and Technology Agency (CREST) and from the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research in Priority Area "New Frontiers in Photochromism (471)" and Strategic Research Foundation at Private Universities). The author also wishes to express sincere thanks to colleagues and students for their extraordinary efforts to accomplish this research.	IRIE M, 1986, MACROMOLECULES, V19, P2480, DOI 10.1021/ma00164a004; Kobatake S, 1999, J AM CHEM SOC, V121, P2380, DOI 10.1021/ja983717j; IRIE M, 1988, J ORG CHEM, V53, P803, DOI 10.1021/jo00239a022; NAKAMURA S, 1988, J ORG CHEM, V53, P6136, DOI 10.1021/jo00261a035; Bouas-Laurent H, 2001, PURE APPL CHEM, V73, P639, DOI 10.1351/pac200173040639; Morimoto M, 2005, CHEM COMMUN, P3895, DOI 10.1039/b505256d; IRIE M, 1990, ADV POLYM SCI, V94, P27; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Takagi Y, 2012, PHOTOCH PHOTOBIO SCI, V11, P1661, DOI 10.1039/c2pp25078k; Terao F, 2012, ANGEW CHEM INT EDIT, V51, P901, DOI 10.1002/anie.201105585; Kuroki L, 2010, PHOTOCH PHOTOBIO SCI, V9, P221, DOI 10.1039/b9pp00093c; Kobatake S, 2007, NATURE, V446, P778, DOI 10.1038/nature05669; Irie M, 2014, CHEM REV, V114, P12174, DOI 10.1021/cr500249p; Uno K, 2011, J AM CHEM SOC, V133, P13558, DOI 10.1021/ja204583e; Morimoto M, 2010, J AM CHEM SOC, V132, P14172, DOI 10.1021/ja105356w; Crano J. C., 1998, ORGANIC PHOTOCHROMIC; Durr H., 2003, PHOTOCHROMISM MOL SY; HANAZAWA M, 1992, J CHEM SOC CHEM COMM, P206, DOI 10.1039/c39920000206; Irie M., 1994, PHOTOREACTIVE MAT UL; IRIE M, 1983, MACROMOLECULES, V16, P210, DOI 10.1021/ma00236a011; IRIE M, 1979, J MACROMOL SCI CHEM, VA13, P511, DOI 10.1080/00222337908066609; Irie M, 2013, NEW FRONTIERS PHOTOC; Irie M, 1997, TETRAHEDRON, V53, P12263, DOI 10.1016/S0040-4020(97)00558-9; IRIE M, 1995, CHEM LETT, P899, DOI 10.1246/cl.1995.899; IRIE M, 1985, MACROMOLECULES, V18, P394, DOI 10.1021/ma00145a016; IRIE M, 1981, MACROMOLECULES, V14, P262, DOI 10.1021/ma50003a007; IRIE M, 1982, EUR POLYM J, V18, P15, DOI 10.1016/0014-3057(82)90125-2; IRIE M, 1981, MACROMOLECULES, V14, P1246, DOI 10.1021/ma50006a021; Kobatake S, 1999, J AM CHEM SOC, V121, P8450, DOI 10.1021/ja991013j; Kobatake S, 2004, B CHEM SOC JPN, V77, P195, DOI 10.1246/bcsj.77.195; Shoji Y, 2013, ISR J CHEM, V53, P303, DOI 10.1002/ijch.201300018; Takami S, 2003, CHEM LETT, V32, P892, DOI 10.1246/cl.2003.892; Uchida K, 1999, CHEM LETT, P835; Woodward R. B., 1970, CONSERVATION ORBITAL; Yamada T, 2000, B CHEM SOC JPN, V73, P2179, DOI 10.1246/bcsj.73.2179; Yamada T, 2000, J AM CHEM SOC, V122, P1589, DOI 10.1021/ja993289x	36	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0033-4545	1365-3075		PURE APPL CHEM	Pure Appl. Chem.	JUL	2015	87	7					617	626		10.1515/pac-2015-0208		10	Chemistry, Multidisciplinary	Chemistry	CM9VP	WOS:000358057700001		
J	Shizu, K; Lee, J; Tanaka, H; Nomura, H; Yasuda, T; Kaji, H; Adachi, C				Shizu, Katsuyuki; Lee, Jiyoung; Tanaka, Hiroyuki; Nomura, Hiroko; Yasuda, Takuma; Kaji, Hironori; Adachi, Chihaya			Highly efficient electroluminescence from purely organic donor-acceptor systems	PURE AND APPLIED CHEMISTRY			English	Article						donor-acceptor system; HOMO-LUMO overlap density; materials chemistry; organic light-emitting diode; organic materials; quantum chemistry; thermally activated delayed fluorescence; XXV IUPAC Photochemistry	ACTIVATED DELAYED-FLUORESCENCE; LIGHT-EMITTING-DIODES; EXTERNAL QUANTUM EFFICIENCY; HOST MATERIAL; COPPER(I) COMPLEXES; CU(I) COMPLEXES; TRIPLET-STATES; EMITTERS; SINGLET; OLEDS	Thermally activated delayed fluorescence (TADF) emitters are third-generation electroluminescent materials that realize highly efficient organic light-emitting diodes (OLEDs) without using rare metals. Here, after briefly reviewing the principles of TADF and its use in OLEDs, we report a sky-blue TADF emitter, 9-(4-(benzo[d] thiazol-2-yl) phenyl)-N-3, N-3, N-6, N-6-tetraphenyl-9H-carbazole-3,6-diamine (DAC-BTZ). DAC-BTZ is a purely organic donor-acceptor-type molecule with a small energy difference between its lowest excited singlet state and lowest triplet state of 0.18-0.22 eV according to fluorescence and phosphorescence spectra of a DAC-BTZ-doped film. In addition, the doped film exhibits a high photoluminescence quantum yield of 0.82. Time-resolved photoluminescence measurements of the doped film confirm that DAC-BTZ emits TADF. An OLED containing DAC-BTZ as an emitter exhibits a maximum external quantum efficiency (EQE) of 10.3 %, which exceeds those obtained with conventional fluorescent emitters (5-7.5 %). TADF from DAC-BTZ makes a large contribution to the high EQE of its OLED.	[Shizu, Katsuyuki; Tanaka, Hiroyuki; Nomura, Hiroko; Yasuda, Takuma; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, Fukuoka 8190395, Japan; [Shizu, Katsuyuki; Adachi, Chihaya] Japan Sci & Technol Agcy JST, ERATO, Adachi Mol Exciton Engn Project, Nishi Ku, Fukuoka 8190395, Japan; [Adachi, Chihaya] Kyushu Univ, Int Inst Carbon Neutral Energy Res, WPI, I2CNER,Nishi Ku, Fukuoka 8190395, Japan; [Shizu, Katsuyuki; Kaji, Hironori] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Lee, Jiyoung; Yasuda, Takuma] Kyushu Univ, Grad Sch Integrated Frontier Sci, Dept Automot Sci, Nishi Ku, Fukuoka 8190395, Japan; [Yasuda, Takuma] Kyushu Univ, INAMORI Frontier Res Ctr, Nishi Ku, Fukuoka 8190395, Japan	Adachi, C (reprint author), Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	adachi@cstf.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST - Program)"	This research was funded by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST - Program)". Computations were partly carried out using computer facilities at the Research Institute for Information Technology, Kyushu University, and the Academic Center for Computing and Media Studies (ACCMS), Kyoto University. Computation time was provided by the Super Computer System, Institute for Chemical Research, Kyoto University.	Hirata S, 2015, NAT MATER, V14, P330, DOI [10.1038/nmat4154, 10.1038/NMAT4154]; Ohkuma H, 2014, CHEM LETT, V43, P1017, DOI 10.1246/cl.140360; Tanaka H, 2012, CHEM COMMUN, V48, P11392, DOI 10.1039/c2cc36237f; Tanaka H, 2014, J PHYS CHEM C, V118, P15985, DOI 10.1021/jp501017f; Uoyama H, 2012, NATURE, V492, P234, DOI 10.1038/nature11687; Linfoot CL, 2014, INORG CHEM, V53, P10854, DOI 10.1021/ic500889s; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Czerwieniec R, 2013, DALTON T, V42, P9826, DOI 10.1039/c3dt51006a; Cho YJ, 2014, ADV MATER, V26, P4050, DOI 10.1002/adma.201400347; Deaton JC, 2010, J AM CHEM SOC, V132, P9499, DOI 10.1021/ja1004575; Bauernschmitt R, 1996, CHEM PHYS LETT, V256, P454, DOI 10.1016/0009-2614(96)00440-X; Igawa S, 2013, J MATER CHEM C, V1, P542, DOI 10.1039/c2tc00263a; Gneuss T, 2015, DALTON T, V44, P8506, DOI 10.1039/c4dt02631d; Shizu K, 2015, J PHYS CHEM C, V119, P1291, DOI 10.1021/jp511061t; Czerwieniec R, 2011, INORG CHEM, V50, P8293, DOI 10.1021/ic200811a; Nishide J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4882456; Adachi C, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.060101; Xu H, 2006, J PHYS CHEM B, V110, P3023, DOI 10.1021/jp055355p; Endo A, 2009, ADV MATER, V21, P4802, DOI 10.1002/adma.200900983; Xiong XQ, 2014, J AM CHEM SOC, V136, P9590, DOI 10.1021/ja502292p; Tanaka H, 2013, CHEM MATER, V25, P3766, DOI 10.1021/cm402428a; Li J, 2013, ADV MATER, V25, P3319, DOI 10.1002/adma.201300575; Kim BS, 2014, ADV FUNCT MATER, V24, P3970, DOI 10.1002/adfm.201303730; Lee J, 2015, J MATER CHEM C, V3, P2175, DOI 10.1039/c4tc02530j; Sasabe H, 2013, J MATER CHEM C, V1, P1699, DOI 10.1039/c2tc00584k; Nakagawa T, 2012, CHEM COMMUN, V48, P9580, DOI 10.1039/c2cc31468a; Nasu K, 2013, CHEM COMMUN, V49, P10385, DOI 10.1039/c3cc44179b; Osawa M, 2015, DALTON T, V44, P8369, DOI 10.1039/c4dt02853h; Osawa M, 2013, J MATER CHEM C, V1, P4375, DOI 10.1039/c3tc30524d; Mehes G, 2012, ANGEW CHEM INT EDIT, V51, P11311, DOI 10.1002/anie.201206289; Li J, 2014, CHEM COMMUN, V50, P6174, DOI 10.1039/c4cc01590h; Ishimatsu R, 2014, ANGEW CHEM INT EDIT, V53, P6993, DOI 10.1002/anie.201402615; Suzuki Y, 2015, J MATER CHEM C, V3, P1700, DOI 10.1039/c4tc02211d; Gaj MP, 2015, ORG ELECTRON, V16, P109, DOI 10.1016/j.orgel.2014.10.049; Lewis GN, 1941, J AM CHEM SOC, V63, P3005, DOI 10.1021/ja01856a043; Zhang QS, 2014, NAT PHOTONICS, V8, P326, DOI 10.1038/NPHOTON.2014.12; Casida ME, 1998, J CHEM PHYS, V108, P4439, DOI 10.1063/1.475855; Zhang QS, 2014, J AM CHEM SOC, V136, P18070, DOI 10.1021/ja510144h; Lee SY, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4749285; Sun JW, 2014, ADV MATER, V26, P5684, DOI 10.1002/adma.201401407; Wu SH, 2014, J MATER CHEM C, V2, P421, DOI 10.1039/c3tc31936a; Kawano K, 2014, ORG ELECTRON, V15, P1695, DOI 10.1016/j.orgel.2014.04.035; BerberanSantos MN, 1996, J AM CHEM SOC, V118, P9391, DOI 10.1021/ja961782s; Mayr C, 2014, ADV FUNCT MATER, V24, P5232, DOI 10.1002/adfm.201400495; Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498; Endo A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3558906; Zhang QS, 2012, J AM CHEM SOC, V134, P14706, DOI 10.1021/ja306538w; Reineke S, 2013, REV MOD PHYS, V85, P1245, DOI 10.1103/RevModPhys.85.1245; Yao L, 2014, ANGEW CHEM INT EDIT, V53, P2119, DOI 10.1002/anie.201308486; Wang H, 2014, ADV MATER, V26, P5198, DOI 10.1002/adma.201401393; Lee J, 2013, J MATER CHEM C, V1, P4599, DOI 10.1039/c3tc30699b; Serevicius T, 2013, PHYS CHEM CHEM PHYS, V15, P15850, DOI 10.1039/c3cp52255e; Sato T, 2015, J MATER CHEM C, V3, P870, DOI 10.1039/c4tc02320j; Takahashi T, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/3/034202; Borowicz P, 2000, PHYS CHEM CHEM PHYS, V2, P4275, DOI 10.1039/b005058j; Chen XL, 2013, CHEM MATER, V25, P3910, DOI 10.1021/cm4024309; Cho YJ, 2014, ADV MATER, V26, P6642, DOI 10.1002/adma.201402188; Dunning J. T. H., 1989, J CHEM PHYS, V90, P1007, DOI DOI 10.1063/1.456153; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Herbich J, 1996, CHEM PHYS LETT, V262, P633, DOI 10.1016/S0009-2614(96)01122-0; Hofbeck T., 2014, J AM CHEM SOC, V137, P399; JONES PF, 1971, CHEM PHYS LETT, V10, P438, DOI 10.1016/0009-2614(71)80329-9; Kapturkiewicz A, 1997, CHEM PHYS LETT, V275, P355, DOI 10.1016/S0009-2614(97)00775-6; Komino T, 2014, CHEM MATER, V26, P3665, DOI 10.1021/cm500802p; Lee S. Y., 2014, ANGEW CHEM, V126, P6520; Li J, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4887346; MACIEJEWSKI A, 1986, J PHYS CHEM-US, V90, P6314, DOI 10.1021/j100281a051; Nakanotani H., 2014, NAT COMMUN, V5; Nakanotani H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02127; Osawa M, 2014, CHEM COMMUN, V50, P1801, DOI 10.1039/c3cc47871h; PARKER CA, 1962, J PHYS CHEM-US, V66, P2506, DOI 10.1021/j100818a043; Sagara Y, 2015, CHEM LETT, V44, P360, DOI 10.1246/cl.141054; Sakai Y, 2015, CHEM COMMUN, V51, P3181, DOI 10.1039/c4cc09403d; Salazar FA, 1997, CHEM PHYS LETT, V271, P361, DOI 10.1016/S0009-2614(97)00469-7; Sato K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.247401; Shizu K., 2015, ITE T MTA, V3, P108; Shizu K, 2015, PHYS REV APPL, V3, DOI 10.1103/PhysRevApplied.3.014001; Tanaka H, 2015, J PHYS CHEM C, V119, P2948, DOI 10.1021/jp510751n; Taneda M, 2015, CHEM COMMUN, V51, P5028, DOI 10.1039/c5cc00511f; Valchanov G, 2013, ORG ELECTRON, V14, P2727, DOI 10.1016/j.orgel.2013.07.023; Yao L., 2014, ANGEW CHEM, V126, P2151; Zhang DD, 2014, ADV MATER, V26, P5050, DOI 10.1002/adma.201401476	82	2	2	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0033-4545	1365-3075		PURE APPL CHEM	Pure Appl. Chem.	JUL	2015	87	7					627	638		10.1515/pac-2015-0301		12	Chemistry, Multidisciplinary	Chemistry	CM9VP	WOS:000358057700002		
J	Kawashima, A; Sekizawa, A; Koide, K; Hasegawa, J; Satoh, K; Arakaki, T; Takenaka, S; Matsuoka, R				Kawashima, Akihiro; Sekizawa, Akihiko; Koide, Keiko; Hasegawa, Junichi; Satoh, Kazue; Arakaki, Tatsuya; Takenaka, Shin; Matsuoka, Ryu			Vitamin C Induces the Reduction of Oxidative Stress and Paradoxically Stimulates the Apoptotic Gene Expression in Extravillous Trophoblasts Derived From First-Trimester Tissue	REPRODUCTIVE SCIENCES			English	Article						vitamin C; apoptosis; extravillous trophoblasts; RT-PCR; ESR	ACTIVATED PROTEIN-KINASE; EARLY-PREGNANCY FAILURE; WEEKS GESTATION; 1ST TRIMESTER; PREECLAMPSIA; CELLS; ACID; INVASION; PATHWAYS; WOMEN	Aim: To investigate the effects of vitamin C on the expression of the genes related to apoptosis in extravillous trophoblasts (EVTs) in the first trimester. Methods: Extravillous trophoblasts were cultured under 2% O-2 followed by 2% O-2 or 8% O-2 with or without vitamin C. The level of reactive oxygen species (ROS) in the cultured medium was estimated using electron spin resonance spectroscopy. The expression levels of the genes TP53, BCL2, and BAX were quantified using real-time quantitative polymerase chain reaction. Results: Reactive oxygen species were found to be decreased after adding vitamin C under increasing oxygen concentrations. In addition, the ratio of BAX/BCL2 also increased after adding vitamin C under conditions of 2% O-2, while the gene expression level of BCL2 increased after adding vitamin C under increasing oxygen concentrations. In contrast, the gene expression level of TP53 and the ratio of BAX/BCL2 both decreased. Conclusion: We have revealed that vitamin C reduces ROS and may promote the apoptosis of EVTs under conditions of 2% O-2 while paradoxically preventing apoptosis under increasing oxygen concentrations.	[Kawashima, Akihiro; Sekizawa, Akihiko; Koide, Keiko; Hasegawa, Junichi; Arakaki, Tatsuya; Takenaka, Shin; Matsuoka, Ryu] Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa, Japan; [Satoh, Kazue] Showa Univ, Sch Med, Dept Anat, Shinagawa, Japan	Kawashima, A (reprint author), Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa, Japan.	kurobei343@mac.com			Ministry of Education, Science, Sport and Culture of Japan [26462501]; Smoking Research Foundation; Ogyaa Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sport and Culture of Japan (grant number 26462501); Smoking Research Foundation and Ogyaa Foundation.	Lee SK, 2008, J CELL PHYSIOL, V216, P180, DOI 10.1002/jcp.21391; Padayatty SJ, 2004, ANN INTERN MED, V140, P533; Hempstock J, 2003, HUM PATHOL, V34, P1265, DOI 10.1016/j.humpath.2003.08.006; Lin FL, 2011, EUR J PHARMACOL, V650, P120, DOI 10.1016/j.ejphar.2010.10.005; Tjoa ML, 2006, AM J PATHOL, V169, P400, DOI 10.2353/ajpath.2006.060161; Lee SH, 2001, SCIENCE, V292, P2083, DOI 10.1126/science.1059501; Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906; Dohi K, 2006, J NEUROTRAUM, V23, P1591, DOI 10.1089/neu.2006.23.1591; Naruse K, 2010, J REPROD IMMUNOL, V86, P148, DOI 10.1016/j.jri.2010.04.004; Lash GE, 2010, HUM REPROD, V25, P1137, DOI 10.1093/humrep/deq050; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Levy R, 2002, AM J OBSTET GYNECOL, V186, P1056, DOI 10.1067/mob.2002.122250; Jauniaux E, 2004, J CLIN ENDOCR METAB, V89, P1452, DOI 10.1210/jc.2003-031332; Onogi A, 2011, PLACENTA, V32, P665, DOI 10.1016/j.placenta.2011.06.023; Dhar-Mascareno M, 2005, FREE RADICAL BIO MED, V38, P1311, DOI 10.1016/j.freeradbiomed.2005.01.017; Farina A, 2008, PRENATAL DIAG, V28, P956, DOI 10.1002/pd.2109; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; GERRETSEN G, 1981, BRIT J OBSTET GYNAEC, V88, P876, DOI 10.1111/j.1471-0528.1981.tb02222.x; HUSTIN J, 1987, AM J OBSTET GYNECOL, V157, P162; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Gupta S, 2009, OBSTET GYNECOL SURV, V64, P750, DOI 10.1097/OGX.0b013e3181bea0ac; Park S, 2004, INT J BIOCHEM CELL B, V36, P2180, DOI 10.1016/j.biocel.2004.04.005; Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; Nagaoka S, 2007, CHEM PHYS LIPIDS, V146, P26, DOI 10.1016/j.chemphyslip.2006.12.001; Basaran A, 2010, OBSTET GYNECOL SURV, V65, P653, DOI 10.1097/OGX.0b013e3182095366; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; Burscha W, 2008, TOXICOLOGY, V254, P147, DOI 10.1016/j.tox.2008.07.048; Carter AM, 2000, PLACENTA, V21, pS31, DOI 10.1053/plac.1999.0513; Catani MV, 2001, BIOCHEM J, V356, P77, DOI 10.1042/0264-6021:3560077; CHAN AC, 1993, CAN J PHYSIOL PHARM, V71, P725; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; Dohi K, 2010, ACT NEUR S, V106, P315, DOI 10.1007/978-3-211-98811-4_59; Hung TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040957; Hung TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012202; Jauniaux E, 2001, AM J OBSTET GYNECOL, V184, P998, DOI 10.1067/mob.2001.111935; Klemmensen AK, 2009, BJOG-INT J OBSTET GY, V116, P964, DOI 10.1111/j.1471-0528.2009.02150.x; Lash GE, 2010, PLACENTA, V31, P545, DOI 10.1016/j.placenta.2010.02.020; Lee SA, 2011, ARCH DERMATOL RES, V303, P669, DOI 10.1007/s00403-011-1158-4; Pavan L, 2004, J CLIN ENDOCR METAB, V89, P1969, DOI 10.1210/jc.2003-032042; Roberts JM, 1999, LANCET, V354, P788; Sharp AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087621; Wang YJ, 2014, MOL HUM REPROD, V20, P799, DOI 10.1093/molehr/gau036; Xu H, 2010, AM J OBSTET GYNECOL, V202; Zhang CL, 2002, EPIDEMIOLOGY, V13, P409, DOI 10.1097/00001648-200207000-00008	46	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	JUL	2015	22	7					783	790		10.1177/1933719114561561		8	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CN0BF	WOS:000358076100003		
J	Takahashi, H; Ohkubo, Y; Sato, A; Takezawa, M; Fujino, Y; Yanagi, Y; Kawashima, H				Takahashi, Hidenori; Ohkubo, Yuko; Sato, Aya; Takezawa, Mikiko; Fujino, Yujiro; Yanagi, Yasuo; Kawashima, Hidetoshi			RELATIONSHIP BETWEEN VISUAL PROGNOSIS AND DELAY OF INTRAVITREAL INJECTION OF RANIBIZUMAB WHEN TREATING AGE-RELATED MACULAR DEGENERATION	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						age-related macular degeneration; intravitreal injection; pro re nata; ranibizumab; visual prognosis	VEGF TRAP; ENDOPHTHALMITIS; PHARMACOKINETICS; PROPHYLAXIS; BEVACIZUMAB; THERAPY; SAFETY	Background:In age-related macular degeneration, various factors in clinical practice cause delays to arise between the time exudative change is observed and the time anti-vascular endothelial growth factor drugs are actually injected. We investigated the influence of injection delay on prognosis.Methods:Subjects were 50 eyes (50 patients from 2 hospitals) that were administered ranibizumab monotherapy for age-related macular degeneration for 1 year since exudative change was first observed. We investigated the mean number of delay days for each injection.Results:Mean injection delay was between 0 and 104 days. Significant prognostic factors for visual acuity were initial best-corrected visual acuity (P < 0.01) and mean injection delay (P = 0.03). We estimated that for an initial best-corrected visual acuity of 0.40 logMAR unit (20/50 Snellen equivalent), the respective best-corrected visual acuity values after 1 year for mean injection delays of 0, 7, 14, 28, and 56 days would be 0.22 (20/33), 0.24 (20/35), 0.26 (20/37), 0.31 (20/40), and 0.39 (20/49). For an initial best-corrected visual acuity of 0.097 (20/25), the respective values would be 0.054 (20/23), 0.075 (20/24), 0.10 (20/25), 0.14 (20/28), and 0.22 (20/33).Conclusion:Long-term visual acuity prognosis worsened when scheduling problems delayed intravitreal injection of anti-vascular endothelial growth factor drugs.	[Takahashi, Hidenori; Ohkubo, Yuko; Sato, Aya; Takezawa, Mikiko; Kawashima, Hidetoshi] Jichi Med Univ, Shimotsuke, Tochigi 3290431, Japan; [Takahashi, Hidenori; Fujino, Yujiro] Japan Community Hlth Care Org Tokyo Shinjuku Med, Dept Ophthalmol, Tokyo, Japan; [Takahashi, Hidenori; Yanagi, Yasuo] Univ Tokyo, Dept Ophthalmol, Tokyo 113, Japan	Takahashi, H (reprint author), Jichi Med Univ, Dept Ophthalmol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290431, Japan.	takahah-tky@umin.ac.jp			Jichi Medical University; Novartis Pharmaceuticals; Santen Pharmaceutical; Bayer Healthcare	Supported by the research funds of Jichi Medical University.; H. Takahashi and H. Kawashima received lecturer's fees from Novartis Pharmaceuticals and Santen Pharmaceutical. Y. Yanagi received lecturer's fees from Novartis Pharmaceuticals, Bayer Healthcare, and Santen Pharmaceutical. He is also an advisory board member for Novartis Pharmaceuticals and Bayer Healthcare. The remaining authors have no conflicting interests to disclose.	Mordenti J, 1999, TOXICOL PATHOL, V27, P536, DOI 10.1177/019262339902700507; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Muether PS, 2013, GRAEF ARCH CLIN EXP, V251, P453, DOI 10.1007/s00417-012-2038-0; Busbee BG, 2013, OPHTHALMOLOGY, V120, P1046, DOI 10.1016/j.ophtha.2012.10.014; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Park Y, 2013, J OCUL PHARMACOL TH, V29, P900, DOI 10.1089/jop.2013.0052; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Cheung CSY, 2012, OPHTHALMOLOGY, V119, P1609, DOI 10.1016/j.ophtha.2012.02.014; Oubraham H, 2011, RETINA-J RET VIT DIS, V31, P26, DOI 10.1097/IAE.0b013e3181de5609; Engelbert M, 2009, RETINA-J RET VIT DIS, V29, P1424, DOI 10.1097/IAE.0b013e3181bfbd46; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Xu L, 2013, INVEST OPHTH VIS SCI, V54, P1616, DOI 10.1167/iovs.12-10260; Fung AE, 2007, AM J OPHTHALMOL, V143, P566, DOI 10.1016/j.ajo.2007.01.028; Barry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032; Iida T, 2014, J HLTH EC OUTCOMES R, V2, P41; Japanese Study Group of Polypoidal Choroidal Vasculopathy, 2005, NIPPON GANKA GAKKAI, V109, P417; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	JUL	2015	35	7					1331	1338		10.1097/IAE.0000000000000513		8	Ophthalmology	Ophthalmology	CM2AA	WOS:000357480600006		
J	Okamoto, F; Sugiura, Y; Okamoto, Y; Hiraoka, T; Oshika, T				Okamoto, Fumiki; Sugiura, Yoshimi; Okamoto, Yoshifumi; Hiraoka, Takahiro; Oshika, Tetsuro			STEREOPSIS AND OPTICAL COHERENCE TOMOGRAPHY FINDINGS AFTER EPIRETINAL MEMBRANE SURGERY	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						epiretinal membrane; stereopsis; optical coherence tomography	BINOCULAR VISUAL FUNCTION; UNILATERAL MACULAR HOLE; OUTER SEGMENT TIPS; PROGNOSTIC-FACTORS; TIME-COURSE; FOLLOW-UP; ACUITY; METAMORPHOPSIA; STEREOACUITY; VITRECTOMY	Purpose:To evaluate stereopsis in patients undergoing vitrectomy for epiretinal membrane and to investigate the relationship between stereopsis and foveal microstructures.Methods:This study included 55 eyes of 55 patients who underwent vitrectomy for unilateral epiretinal membrane and 27 age-matched normal subjects. We examined stereopsis using the Titmus Stereo Test, TNO stereotest, and, optical coherence tomography before surgery and 6 months after surgery. Central foveal thickness, central retinal thickness at the parafovea (CRT-3 mm), macular volume, and retinal layer thickness were measured with the optical coherence tomography software and an image-processing program.Results:Epiretinal membrane surgery significantly improved stereopsis in Titmus Stereo Test and in TNO. Stereopsis after surgery was significantly worse than in normal subjects. In stepwise multiple regression analysis, preoperative stereopsis showed a significant association with preoperative CRT-3 mm. Postoperative stereopsis was significantly correlated with postoperative inner nuclear layer thickness. Postoperative Titmus Stereo Test and TNO were significantly related to preoperative CRT-3 mm and preoperative macular volume and inner nuclear layer thickness, respectively.Conclusion:Vitrectomy for epiretinal membrane improved stereopsis, albeit not to a normal level. Titmus Stereo Test, a stereotest with a smaller index, was related to CRT-3 mm, whereas TNO with a larger index was correlated with retinal volume of the entire posterior pole and mean inner nuclear layer thickness.	[Okamoto, Fumiki; Sugiura, Yoshimi; Okamoto, Yoshifumi; Hiraoka, Takahiro; Oshika, Tetsuro] Univ Tsukuba, Fac Med, Dept Ophthalmol, Tsukuba, Ibaraki 3058575, Japan	Okamoto, F (reprint author), Univ Tsukuba, Fac Med, Dept Ophthalmol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	fumiki-o@md.tsukuba.ac.jp					AMEMIYA T, 1982, GRAEF ARCH CLIN EXP, V218, P304, DOI 10.1007/BF02150444; Arichika S, 2010, RETINA-J RET VIT DIS, V30, P503, DOI 10.1097/IAE.0b013e3181bd2d65; Mitamura Y, 2009, BRIT J OPHTHALMOL, V93, P171, DOI 10.1136/bjo.2008.146381; Michalewski J, 2007, GRAEF ARCH CLIN EXP, V245, P1623, DOI 10.1007/s00417-007-0579-4; Itoh Y, 2013, INVEST OPHTH VIS SCI, V54, P7302, DOI 10.1167/iovs.13-12702; Okamoto F, 2012, INVEST OPHTH VIS SCI, V53, P6770, DOI 10.1167/iovs.12-9683; Kinoshita T, 2012, INVEST OPHTH VIS SCI, V53, P3592, DOI 10.1167/iovs.12-9493; Kim J, 2010, AM J OPHTHALMOL, V150, P701, DOI 10.1016/j.ajo.2010.05.037; Wong JG, 2005, CLIN EXP OPHTHALMOL, V33, P373, DOI 10.1111/j.1442-9071.2005.01025.x; Ooto S, 2011, OPHTHALMOLOGY, V118, P873, DOI 10.1016/j.ophtha.2010.08.032; Shiono A, 2013, OPHTHALMOLOGY, V120, P788, DOI 10.1016/j.ophtha.2012.09.044; Bouwens MD, 2003, GRAEF ARCH CLIN EXP, V241, P89, DOI 10.1007/s00417-002-0613-5; DONZIS PB, 1983, ARCH OPHTHALMOL-CHIC, V101, P930; Tanikawa A, 1999, AM J OPHTHALMOL, V127, P559, DOI 10.1016/S0002-9394(98)00447-4; Fawcett SL, 2001, J AAPOS, V5, P342, DOI 10.1067/mpa.2001.119785; Asaria R, 2008, OPHTHALMOLOGY, V115, P1930, DOI 10.1016/j.ophtha.2008.05.020; Kim JH, 2013, GRAEF ARCH CLIN EXP, V251, P1055, DOI 10.1007/s00417-012-2120-7; Shimozono M, 2012, AM J OPHTHALMOL, V153, P698, DOI 10.1016/j.ajo.2011.09.011; Shimada H, 2009, OPHTHALMOLOGY, V116, P1370, DOI 10.1016/j.ophtha.2009.01.024; Suh MH, 2009, AM J OPHTHALMOL, V147, P473, DOI 10.1016/j.ajo.2008.09.020; PESIN SR, 1991, OPHTHALMOLOGY, V98, P1109; Watanabe K, 2013, JAMA OPHTHALMOL, V131, P172, DOI 10.1001/jamaophthalmol.2013.686; Falkner-Radler CI, 2010, OPHTHALMOLOGY, V117, P798, DOI 10.1016/j.ophtha.2009.08.034; Watanabe A, 2009, OPHTHALMOLOGY, V116, P1788, DOI 10.1016/j.ophtha.2009.04.046; Niwa T, 2003, INVEST OPHTH VIS SCI, V44, P1652, DOI 10.1167/iovs.02-0404; GOODWIN RT, 1985, INVEST OPHTH VIS SCI, V26, P917; Inoue M, 2011, RETINA-J RET VIT DIS, V31, P1366, DOI 10.1097/IAE.0b013e318203c156; LEVY NS, 1974, AM J OPHTHALMOL, V78, P722; Inoue M, 2010, AM J OPHTHALMOL, V150, P834, DOI 10.1016/j.ajo.2010.06.006; Hibi N, 2013, INVEST OPHTH VIS SCI, V54, P7207, DOI 10.1167/iovs.13-12884; Bae SH, 2013, AM J OPHTHALMOL, V155, P109, DOI 10.1016/j.ajo.2012.07.007; ERICKSON P, 1992, OPTOMETRY VISION SCI, V69, P761, DOI 10.1097/00006324-199210000-00003; Hikichi T, 2001, GRAEF ARCH CLIN EXP, V239, P128, DOI 10.1007/s004170100257; KANI W, 1978, BRIT J OPHTHALMOL, V62, P756, DOI 10.1136/bjo.62.11.756; LOVASIK JV, 1985, INVEST OPHTH VIS SCI, V26, P741; Mireskandari K, 2004, BRIT J OPHTHALMOL, V88, P1320, DOI 10.1136/bjo.2004.042093; PIERCE DM, 1975, OPHTHALMOLOGICA, V171, P224; PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217; Rutstein Robert P, 2012, Optom Vis Sci, V89, pe50; Watanabe H, 2014, GRAEF ARCH CLIN EXP, V252, P1207, DOI 10.1007/s00417-014-2566-x; WEINMAN J, 1982, PERCEPTION, V11, P207, DOI 10.1068/p110207; Wilkins JR, 1996, OPHTHALMOLOGY, V103, P2142	42	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	JUL	2015	35	7					1415	1421		10.1097/IAE.0000000000000470		7	Ophthalmology	Ophthalmology	CM2AA	WOS:000357480600017		
J	Kumagai, K; Hangai, M; Ogino, N; Larson, E				Kumagai, Kazuyuki; Hangai, Masanori; Ogino, Nobuchika; Larson, Eric			EFFECT OF INTERNAL LIMITING MEMBRANE PEELING ON LONG-TERM VISUAL OUTCOMES FOR DIABETIC MACULAR EDEMA	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						diabetic macular edema; internal limiting membrane; vitrectomy	PARS-PLANA VITRECTOMY; OPTICAL COHERENCE TOMOGRAPHY; GRID LASER PHOTOCOAGULATION; POSTERIOR HYALOID MEMBRANE; RETINAL VEIN OCCLUSION; TRIAMCINOLONE ACETONIDE; VITREOMACULAR TRACTION; SURGICAL-PROCEDURES; FOLLOW-UP; REMOVAL	Purpose:To evaluate the effect of internal limiting membrane (ILM) peeling on the long-term visual outcomes in eyes with diffuse, nontractional diabetic macular edema.Methods:One hundred and sixteen eyes of 58 patients with the same degree of diabetic macular edema in both eyes underwent pars plana vitrectomy with the creation of a posterior vitreous detachment in both eyes. Internal limiting membrane peeling was performed in one randomly selected eye (ILM-off group), and ILM peeling was not performed (ILM-on group) in the fellow eye. The postoperative follow-up period ranged from 12 months to 161 months (average, 80.4 months).Results:In the ILM-off group, the mean best-corrected visual acuity in logMAR units (Snellen equivalent) increased from 0.55 0.31 (20/71) before surgery to 0.35 +/- 0.35 (20/45) at 1 year (P < 0.0001) and 0.46 +/- 0.43 (20/59) at the final visit (P = 0.058). In the ILM-on group, the mean best-corrected visual acuity increased from 0.55 +/- 0.41 (20/71) before surgery to 0.43 +/- 0.38 (20/54) at 1 year (P = 0.010) and 0.44 +/- 0.45 (20/56) at the final visit (P = 0.043). The differences in the best-corrected visual acuity between the two groups were not significant at any time point.Conclusion:Pars plana vitrectomy with or without ILM peeling improves the long-term visual acuity of nontractional diabetic macular edema. Internal limiting membrane peeling does not affect the postoperative best-corrected visual acuity significantly.	[Kumagai, Kazuyuki; Ogino, Nobuchika] Shinjo Ophthalmol Inst, Miyazaki 8800035, Japan; [Hangai, Masanori] Saitama Med Univ, Dept Ophthalmol, Fac Med, Iruma, Saitama, Japan; [Larson, Eric] Miyazaki Prefectural Nursing Univ, Miyazaki, Japan	Kumagai, K (reprint author), Shinjo Ophthalmol Inst, 889-1 Mego Shimokitakata Machi, Miyazaki 8800035, Japan.	kazukuma3313@yahoo.co.jp					Abe S, 2013, JPN J OPHTHALMOL, V57, P553, DOI 10.1007/s10384-013-0275-3; Yamamoto T, 2001, AM J OPHTHALMOL, V132, P369, DOI 10.1016/S0002-9394(01)01050-9; Yanyali A, 2006, EUR J OPHTHALMOL, V16, P573; Kumagai K, 2009, RETINA-J RET VIT DIS, V29, P464, DOI 10.1097/IAE.0b013e31819c632f; LEWIS H, 1992, OPHTHALMOLOGY, V99, P753; Sonoda KH, 2004, OPHTHALMOLOGY, V111, P226, DOI 10.1016/j.ophtha.2003.05.034; Thomas D, 2005, BRIT J OPHTHALMOL, V89, P81, DOI 10.1136/bjo.2004.044966; Kamura Y, 2005, JPN J OPHTHALMOL, V49, P297, DOI 10.1007/s10384-005-0199-7; Pendergast SD, 2000, AM J OPHTHALMOL, V130, P178, DOI 10.1016/S0002-9394(00)00472-4; Kumagai K, 2007, RETINA-J RET VIT DIS, V27, P584, DOI 10.1097/01.iae.0000249576.98520.25; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; Gandorfer A, 2000, RETINA-J RET VIT DIS, V20, P126, DOI 10.1097/00006982-200003000-00003; Hartley KL, 2008, RETINA-J RET VIT DIS, V28, P410, DOI 10.1097/IAE.0b013e31816102f2; Tachi N, 1996, AM J OPHTHALMOL, V122, P258; Radetzky S, 2004, GRAEF ARCH CLIN EXP, V242, P273, DOI 10.1007/s00417-003-0731-8; Jonas JB, 2001, AM J OPHTHALMOL, V132, P425, DOI 10.1016/S0002-9394(01)01010-8; Johnson MW, 2009, AM J OPHTHALMOL, V147, P11, DOI 10.1016/j.ajo.2008.07.024; La Heij EC, 2001, GRAEF ARCH CLIN EXP, V239, P264, DOI 10.1007/s004170000251; Kimura T, 2005, RETINA-J RET VIT DIS, V25, P454, DOI 10.1097/00006982-200506000-00010; Gaucher D, 2005, AM J OPHTHALMOL, V139, P807, DOI 10.1016/j.ajopht.2004.12.084; Haritoglou C, 2006, RETINA-J RET VIT DIS, V26, P999, DOI 10.1097/01.iae.0000247165.38655.bf; Massin P, 2003, AM J OPHTHALMOL, V135, P169, DOI 10.1016/S0002-9394(02)01837-8; Shah SP, 2006, BRIT J OPHTHALMOL, V90, P33, DOI 10.1136/bjo.2005.072934; Dillinger P, 2004, GRAEF ARCH CLIN EXP, V242, P630, DOI 10.1007/s00417-003-0849-8; Harbour JW, 1996, AM J OPHTHALMOL, V121, P405; Arai M, 2009, OPHTHALMOLOGICA, V223, P172, DOI 10.1159/000197113; Avci R, 2004, GRAEF ARCH CLIN EXP, V242, P845, DOI 10.1007/s00417-004-0939-2; Bahadir Mehmet, 2005, International Ophthalmology, V26, P3; Bardak Y, 2006, EYE, V20, P1357, DOI 10.1038/sj.eye.6702152; Dehghan Mohammad-Hossein, 2010, J Ophthalmic Vis Res, V5, P162; Flaxel CJ, 2010, RETINA-J RET VIT DIS, V30, P1488, DOI 10.1097/IAE.0b013e3181e7974f; Furukawa M, 2004, JPN J CLIN OPHTHAL, V58, P2275; Haller JA, 2010, OPHTHALMOLOGY, V117, P1087, DOI 10.1016/j.ophtha.2009.10.040; Higuchi A, 2006, JPN J OPHTHALMOL, V50, P529, DOI 10.1007/s10384-006-0366-5; Hoerauf H, 2011, GRAEF ARCH CLIN EXP, V249, P997, DOI 10.1007/s00417-010-1610-8; Ikeda T, 1999, BRIT J OPHTHALMOL, V83, P12, DOI 10.1136/bjo.83.1.12; Jahn CE, 2004, OPHTHALMOLOGICA, V218, P378, DOI 10.1159/000080940; Kalvoda J, 2009, GRAEF ARCH CLIN EXP, V247, P1307, DOI 10.1007/s00417-009-1100-z; KLEIN R, 1989, OPHTHALMOLOGY, V96, P1501; KOHNO T, 1987, INVEST OPHTH VIS SCI, V28, P515; Kojima T, 2003, OPHTHALMIC RES, V35, P192, DOI 10.1159/000071170; Kralinger MT, 2006, OPHTHALMOLOGICA, V220, P147, DOI 10.1159/000091756; Kuhn F, 2004, GRAEF ARCH CLIN EXP, V242, P402, DOI 10.1007/s00417-004-0876-0; Kumagai K, 2010, JPN J OPHTHALMOL, V54, P61, DOI 10.1007/s10384-009-0750-z; Kumagai Kazuyuki, 2002, Nippon Ganka Gakkai Zasshi, V106, P590; Matsunaga N, 2005, RETINA-J RET VIT DIS, V25, P311, DOI 10.1097/00006982-200504000-00010; Mirza RG, 2007, SURV OPHTHALMOL, V52, P397, DOI 10.1016/j.survophthal.2007.04.007; Mochizuki Y, 2006, RETINA-J RET VIT DIS, V26, P143, DOI 10.1097/00006982-200602000-00003; Otani T, 2002, AM J OPHTHALMOL, V134, P214, DOI 10.1016/S0002-9394(02)01548-9; Parolini B, 2004, Semin Ophthalmol, V19, P1; Patel JI, 2006, RETINA-J RET VIT DIS, V26, P5, DOI 10.1097/00006982-200601000-00002; Recchia FM, 2005, AM J OPHTHALMOL, V139, P447, DOI 10.1016/j.ajo.2004.09.076; Rosenblatt BJ, 2005, GRAEF ARCH CLIN EXP, V243, P20, DOI 10.1007/s00417-004-0958-z; Sato Y, 2002, JPN J OPHTHALMOL, V46, P315, DOI 10.1016/S0021-5155(02)00471-9; Shiba T, 2009, JPN J OPHTHALMOL, V53, P120, DOI 10.1007/s10384-008-0639-2; Shimonagano Y, 2007, JPN J OPHTHALMOL, V51, P204, DOI 10.1007/s10384-007-0423-8; Shimonagano Y, 2007, JPN J OPHTHALMOL, V51, P278, DOI 10.1007/s10384-007-0443-4; Stefaniotou M, 2004, EUR J OPHTHALMOL, V14, P137; Stolba U, 2005, AM J OPHTHALMOL, V140, P295, DOI 10.1016/j.ajo.2005.03.045; Tamura K, 2012, JPN J OPHTHALMOL, V56, P280, DOI 10.1007/s10384-012-0130-y; Yamada Y, 2013, CURR EYE RES, V38, P1261, DOI 10.3109/02713683.2013.820327; Yamamoto T, 2005, OPHTHALMOLOGICA, V219, P206, DOI 10.1159/000085729; Yamamoto T, 2003, AM J OPHTHALMOL, V135, P14, DOI 10.1016/S0002-9394(02)01819-6; Yamamoto T, 2007, JPN J OPHTHALMOL, V51, P285, DOI 10.1007/s10384-007-0448-z; Yanyali A, 2005, AM J OPHTHALMOL, V139, P795, DOI 10.1016/j.ajo.2004.12.017; Yanyali A, 2007, RETINA-J RET VIT DIS, V27, P557, DOI 10.1097/01.iae.0000249390.61854.d5	66	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	JUL	2015	35	7					1422	1428		10.1097/IAE.0000000000000497		7	Ophthalmology	Ophthalmology	CM2AA	WOS:000357480600018		
J	Seno, Y; Shimada, Y; Mizuguchi, T; Tanikawa, A; Horiguchi, M				Seno, Yui; Shimada, Yoshiaki; Mizuguchi, Tadashi; Tanikawa, Atsuhiro; Horiguchi, Masayuki			COMPLIANCE WITH THE FACE-DOWN POSITIONING AFTER VITRECTOMY AND GAS TAMPONADE FOR RHEGMATOGENOUS RETINAL DETACHMENTS	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						compliance; face-down positioning; gas tamponade; retinal detachment; vitrectomy	MACULAR HOLE SURGERY; AUTOMATED ENDOTHELIAL KERATOPLASTY; DURATION; OUTCOMES	Purpose:To determine the compliance with the face-down positioning (FDP) of the patients who had undergone vitrectomy and gas tamponade.Methods:One hundred and twenty-seven patients, 45 females and 82 males, who had undergone primary vitrectomy and gas tamponade for rhegmatogenous retinal detachments were studied. The FDP score was determined as 4 per day for 3 days after the surgery. The patient was given a score of one if the nurse found that the patient was in the FDP and zero if not in the FDP. A perfect FDP score was 12.Results:The mean SD FDP score was 10.2 +/- 1.8 with a range of 3 to 12. Females (10.7 +/- 1.2) scored significantly higher than males (9.9 +/- 2.1) (Mann-Whitney U test: P < 0.05). Patients who scored a perfect 12 were 38 (29.9%; female, 14:31.1%; male 24:29.3%). Low scorers <8 were all males (12:14.6%) and no females (0:0.0%). Age did not seem to be related. Only 1 patient failed to achieve retinal attachment, although she had scored a perfect 12.Conclusion:The compliance was considerably varied among patients. Some patients failed nearly or more than half times, and they were mostly males. The significance of the FDP to treat rhegmatogenous retinal detachment needs to be examined in a further investigation.	[Seno, Yui; Mizuguchi, Tadashi; Tanikawa, Atsuhiro; Horiguchi, Masayuki] Fujita Hlth Univ, Dept Ophthalmol, Sch Med, Nagoya, Aichi 4548509, Japan; [Shimada, Yoshiaki] Fujita Hlth Univ, Banbuntane Hotokukai Hosp, Dept Ophthalmol, Nagoya, Aichi 4548509, Japan	Shimada, Y (reprint author), Fujita Hlth Univ, Banbuntane Hotokukai Hosp, Dept Ophthalmol, Nakagawa Ku, 3-6-10 Otobashi, Nagoya, Aichi 4548509, Japan.	ysmd@za2.so-net.ne.jp					Academy American, 2010, FAC DOWN REC RET SUR, P1; Almeida DRP, 2012, RETINA-J RET VIT DIS, V32, P506, DOI 10.1097/IAE.0b013e3182219abd; Lange CAK, 2012, EYE, V26, P272, DOI 10.1038/eye.2011.221; Chandra A, 2011, OPHTHALMOLOGICA, V226, P3, DOI 10.1159/000328204; Conart JB, 2014, OPHTHALMOLOGY, V121, P1263, DOI 10.1016/j.ophtha.2013.12.005; Forsaa VA, 2013, ACTA OPHTHALMOL, V91, P547, DOI 10.1111/j.1755-3768.2012.02464.x; Hayes DD, 2010, AM J OPHTHALMOL, V150, P790, DOI 10.1016/j.ajo.2010.06.008; Hood CT, 2014, CORNEA, V33, P628, DOI 10.1097/ICO.0000000000000105; Krohn J, 2005, ACTA OPHTHALMOL SCAN, V83, P289, DOI 10.1111/j.1600-0420.2005.00462.x; Leitritz MA, 2014, GRAEF ARCH CLIN EXP, V252, P739, DOI 10.1007/s00417-013-2517-y; Malik A, 2012, EUR J OPHTHALMOL, V22, P456, DOI 10.5301/ejo.5000039; Nadal Jeroni, 2012, Retina, V32, P918, DOI 10.1097/IAE.0b013e318229b20e; Schaefer H, 2012, KLIN MONATSBL AUGENH, V229, P928, DOI 10.1055/s-0031-1299529; Solebo AL Lange CA Bunce C, 2011, COCHRANE DATABASE SY; Tatham A, 2010, BRIT J OPHTHALMOL, V94, P626, DOI 10.1136/bjo.2009.163741; Thompson JT, 1996, RETINA-J RET VIT DIS, V16, P373, DOI 10.1097/00006982-199616050-00002; Verma D, 2002, EYE, V16, P701, DOI 10.1038/sj.eye.6700209; Xirou Tina, 2012, Clin Ophthalmol, V6, P1107, DOI 10.2147/OPTH.S32077	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	JUL	2015	35	7					1436	1440		10.1097/IAE.0000000000000479		5	Ophthalmology	Ophthalmology	CM2AA	WOS:000357480600020		
J	Fujikawa, M; Ohji, M				Fujikawa, Masato; Ohji, Masahito			Untitled Reply	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Letter							SCLERAL BUCKLING SURGERY		[Fujikawa, Masato; Ohji, Masahito] Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga 52021, Japan	Fujikawa, M (reprint author), Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga 52021, Japan.						Cetin E, 2006, J REFRACT SURG, V22, P494; Fujikawa M, 2014, RETINA-J RET VIT DIS, V34, P2451, DOI 10.1097/IAE.0000000000000246; Malukiewicz-Wisniewska G, 1999, EUR J OPHTHALMOL, V9, P115; Okada Y, 2000, JPN J OPHTHALMOL, V44, P132, DOI 10.1016/S0021-5155(99)00183-5; Thompson JT., 2013, RETINA, V5th, P1656	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	JUL	2015	35	7					E35	E36		10.1097/IAE.0000000000000638		2	Ophthalmology	Ophthalmology	CM2AD	WOS:000357481000004		
J	Manova, K; Wei, SJ; Zhang, ZW				Manova, Kalina; Wei, Shang-Jin; Zhang, Zhiwei			FIRM EXPORTS AND MULTINATIONAL ACTIVITY UNDER CREDIT CONSTRAINTS	REVIEW OF ECONOMICS AND STATISTICS			English	Article							FOREIGN DIRECT-INVESTMENT; IMPERFECT CAPITAL-MARKETS; GLOBAL FINANCIAL CRISIS; INTERNATIONAL-TRADE; COMPARATIVE ADVANTAGE; HETEROGENEOUS FIRMS; PROPERTY-RIGHTS; GROWTH; FLOWS; CHINA	We provide firm-level evidence that credit constraints restrict international trade and affect the pattern of multinational activity. We show that foreign affiliates and joint ventures in China have better export performance than private domestic firms in financially more vulnerable sectors. These results are stronger for destinations with higher trade costs and not driven by firm size or other sector characteristics. Our findings are consistent with multinational subsidiaries being less liquidity constrained because they can access foreign capital markets or funding from their parent company. They further suggest that FDI can alleviate the impact of domestic financial market imperfections on trade.	[Manova, Kalina] Stanford Univ, Stanford, CA 94305 USA; [Manova, Kalina; Wei, Shang-Jin] NBER, Cambridge, MA 02138 USA; [Wei, Shang-Jin] Columbia Univ, New York, NY 10027 USA; [Wei, Shang-Jin] CEPR, London, England; [Wei, Shang-Jin] CIER, Bonn, Germany; [Zhang, Zhiwei] Nomura Secur, Tokyo, Japan	Manova, K (reprint author), Stanford Univ, Stanford, CA 94305 USA.						Alfaro L, 2012, AM ECON J-ECON POLIC, V4, P30, DOI 10.1257/pol.4.3.30; Amiti M, 2011, Q J ECON, V126, P1841, DOI 10.1093/qje/qjr033; Manova K, 2008, J INT ECON, V76, P33, DOI 10.1016/j.jinteco.2008.03.008; Helpman E, 2004, AM ECON REV, V94, P300, DOI 10.1257/000282804322970814; Bernard AB, 2007, J ECON PERSPECT, V21, P105, DOI 10.1257/jep.21.3.105; Fisman R, 2003, J FINANC, V58, P353, DOI 10.1111/1540-6261.00527; Ju JD, 2011, J INT ECON, V84, P178, DOI 10.1016/j.jinteco.2011.03.004; Berman N, 2010, J DEV ECON, V93, P206, DOI 10.1016/j.jdeveco.2009.11.006; Melitz MJ, 2003, ECONOMETRICA, V71, P1695, DOI 10.1111/1468-0262.00467; Beck T, 2008, J MONEY CREDIT BANK, V40, P1379, DOI 10.1111/j.1538-4616.2008.00164.x; La Porta R, 1998, J POLIT ECON, V106, P1113; Ahn J, 2011, J INT ECON, V84, P73, DOI 10.1016/j.jinteco.2010.12.003; La Porta R, 2002, J FINANC, V57, P1147, DOI 10.1111/1540-6261.00457; Poncet S, 2010, CHINA ECON REV, V21, P411, DOI 10.1016/j.chieco.2010.03.001; Desai MA, 2004, J FINANC, V59, P2451, DOI 10.1111/j.1540-6261.2004.00706.x; Desai MA, 2008, REV FINANC STUD, V21, P2857, DOI 10.1093/rfs/hhm017; Minetti R, 2011, J INT ECON, V83, P109, DOI 10.1016/j.jinteco.2010.12.004; Bricongne JC, 2012, J INT ECON, V87, P134, DOI 10.1016/j.jinteco.2011.07.002; Raddatz C, 2006, J FINANC ECON, V80, P677, DOI 10.1016/j.jfineco.2005.03.012; Girma S, 2008, WORLD BANK ECON REV, V22, P367, DOI 10.1093/wber/lhn009; Rajan RG, 1998, AM ECON REV, V88, P559; Claessens S, 2003, J FINANC, V58, P2401, DOI 10.1046/j.1540-6261.2003.00610.x; Greenaway D, 2007, J INT ECON, V73, P377, DOI 10.1016/j.jinteco.2007.04.002; Markusen JR, 2000, J INT ECON, V52, P209, DOI 10.1016/S0022-1996(99)00055-0; Manova K, 2013, REV ECON STUD, V80, P711, DOI 10.1093/restud/rds036; Chor D, 2012, J INT ECON, V87, P117, DOI 10.1016/j.jinteco.2011.04.001; Javorcik BS, 2009, J INT MONEY FINANC, V28, P605, DOI 10.1016/j.jimonfin.2009.01.003; Song Z, 2011, AM ECON REV, V101, P196, DOI 10.1257/aer.101.1.196; Harrison AE, 2004, J DEV ECON, V75, P269, DOI 10.1016/j.jdeveco.2003.10.002; Kroszner RS, 2007, J FINANC ECON, V84, P187, DOI 10.1016/j.jfineco.2006.05.001; Svaleryd H, 2005, EUR ECON REV, V49, P113, DOI 10.1016/S0014-2921(03)00030-8; KLETZER K, 1987, J DEV ECON, V27, P57, DOI 10.1016/0304-3878(87)90006-X; Yeaple SR, 2003, REV ECON STAT, V85, P726, DOI 10.1162/003465303322369849; MARKUSEN JR, 1984, J INT ECON, V16, P205, DOI 10.1016/S0022-1996(84)80001-X; Khandelwal AK, 2013, AM ECON REV, V103, P2169, DOI 10.1257/aer.103.6.2169; Beck T, 2002, J INT ECON, V57, P107, DOI 10.1016/S0022-1996(01)00131-3; Antras P, 2003, Q J ECON, V118, P1375, DOI 10.1162/003355303322552829; Antras P, 2009, Q J ECON, V124, P1171; Auboin M., 2009, 35 CEPR; Beck T., 2003, REV INT ECON, V11, P296, DOI DOI 10.1111/1467-9396.00384; Becker B., 2013, REV CORPORATE FINANC, V2, P1; Bertrand M, 2002, Q J ECON, V117, P121, DOI 10.1162/003355302753399463; Bilir K., 2013, 20046 NBER; Brainard L. S., 1997, AM ECON REV, V87, P520; Branstetter LG, 2006, Q J ECON, V121, P321; Braun M., 2003, FINANCIAL CONTRACTIB; Buch C., 2009, 7444 CEPR; Bustos P., 2007, FDI SOURCE FINANCE I; Carluccio J, 2012, REV ECON STAT, V94, P740; Chaney T, 2013, 19170 NBER; Desai MA, 2004, J PUBLIC ECON, V88, P2727, DOI 10.1016/j.jpubeco.2003.08.004; Dollar D., 2007, 13103 NBER; Feenstra RC, 2014, REV ECON STAT, V96, P729, DOI 10.1162/REST_a_00405; Feinberg S., 2004, 9252 NBER; Freund C., 2009, HAS DECLINE SUPPLY F; GERTLER M, 1994, Q J ECON, V109, P309, DOI 10.2307/2118465; Gompers P, 2003, Q J ECON, V118, P107, DOI 10.1162/00335530360535162; Guiso L, 2004, Q J ECON, V119, P929, DOI 10.1162/0033553041502162; HELPMAN E, 1984, J POLIT ECON, V92, P451, DOI 10.1086/261236; Hericourt J., 2009, EC SYSTEMS, V33, P1, DOI 10.1016/j.ecosys.2008.07.001; Huang Y., 2008, 471308 MIT SLOAN, V4713-08; Hur J, 2006, WORLD DEV, V34, P1728, DOI 10.1016/j.worlddev.2006.02.003; Iacovone L., 2009, 5016 WORLD BANK; Jarreau J., 2012, CREDIT CONSTRAINTS F; Javorcik BS, 2009, WORLD BANK ECON REV, V23, P323, DOI 10.1093/wber/lhp002; Ju J., 2005, 5109 CEPR; Ju JD, 2010, AM ECON J-ECON POLIC, V2, P173, DOI 10.1257/pol.2.4.173; Manova K., 2011, 16905 NBER; Manova K., 2009, 15249 NBER; Manova K, 2012, 18561 NBER; Matsuyama K, 2005, J EUR ECON ASSOC, V3, P714, DOI 10.1162/1542476054473332; MOULTON BR, 1990, REV ECON STAT, V72, P334, DOI 10.2307/2109724; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Muuls M, 2008, 139 NAT BANK BELG; Nunn N, 2007, Q J ECON, V122, P569, DOI 10.1162/qjec.122.2.569; Paravisini D., 2012, 16975 NBER; Tong H., 2010, REV FINANC STUD, V24, P2023	77	1	1	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0034-6535	1530-9142		REV ECON STAT	Rev. Econ. Stat.	JUL	2015	97	3					574	588		10.1162/REST_a_00480		15	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	CM8EB	WOS:000357928900004		
J	Ohi, K; Hashimoto, R; Ikeda, M; Yamamori, H; Yasuda, Y; Fujimoto, M; Umeda-Yano, S; Fukunaga, M; Fujino, H; Watanabe, Y; Iwase, M; Kazui, H; Iwata, N; Weinberger, DR; Takeda, M				Ohi, Kazutaka; Hashimoto, Ryota; Ikeda, Masashi; Yamamori, Hidenaga; Yasuda, Yuka; Fujimoto, Michiko; Umeda-Yano, Satomi; Fukunaga, Masaki; Fujino, Haruo; Watanabe, Yoshiyuki; Iwase, Masao; Kazui, Hiroaki; Iwata, Nakao; Weinberger, Daniel R.; Takeda, Masatoshi			Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes	SCHIZOPHRENIA BULLETIN			English	Article						schizophrenia; genome-wide association study; cognitive phenotypes; glutamate receptor activity; immune function; functional gene network	MHC CLASS-I; BRAIN-DEVELOPMENT; GENETIC-VARIATION; BIPOLAR DISORDER; D-SERINE; RECEPTOR; RISK; VARIANT; TRAITS; LOCI	Cognitive impairments are a core feature in patients with schizophrenia. These deficits could serve as effective tools for understanding the genetic architecture of schizophrenia. This study investigated whether genetic variants associated with cognitive impairments aggregate in functional gene networks related to the pathogenesis of schizophrenia. Here, genome-wide association studies (GWAS) of a range of cognitive phenotypes relevant to schizophrenia were performed in 411 healthy subjects. We attempted to replicate the GWAS data using 257 patients with schizophrenia and performed a meta-analysis of the GWAS findings and the replicated results. Because gene networks, rather than a single gene or genetic variant, may be strongly associated with the susceptibility to schizophrenia and cognitive impairments, gene-network analysis for genes in close proximity to the replicated variants was performed. We observed nominal associations between 3054 variants and cognitive phenotypes at a threshold of P < 1.0 x 10(-4). Of the 3054 variants, the associations of 191 variants were replicated in the replication samples (P < .05). However, no variants achieved genome-wide significance in a meta-analysis (P > 5.0 x 10(-8)). Additionally, 115 of 191 replicated single nucleotide polymorphisms (SNPs) have genes located within 10 kb of the SNPs (60.2%). These variants were moderately associated with cognitive phenotypes that ranged from P = 2.50 x 10(-5) to P = 9.40 x 10(-8). The genes located within 10 kb from the replicated SNPs were significantly grouped in terms of glutamate receptor activity (false discovery rate (FDR) q = 4.49 x 10(-17)) and the immune system related to major histocompatibility complex class I (FDR q = 8.76 x 10(-11)) networks. Our findings demonstrate that genetic variants related to cognitive trait impairment in schizophrenia are involved in the N-methyl-D-aspartate glutamate network.	[Ohi, Kazutaka; Hashimoto, Ryota; Yamamori, Hidenaga; Yasuda, Yuka; Fujimoto, Michiko; Iwase, Masao; Kazui, Hiroaki; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Suita, Osaka 5650871, Japan; [Ohi, Kazutaka; Weinberger, Daniel R.] Johns Hopkins Univ, Lieber Inst Brain Dev, Baltimore, MD USA; [Hashimoto, Ryota; Takeda, Masatoshi] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka 5650871, Japan; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan; [Yamamori, Hidenaga; Umeda-Yano, Satomi] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Suita, Osaka 5650871, Japan; [Fukunaga, Masaki] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan; [Fujino, Haruo] Grad Sch Human Sci, Suita, Osaka, Japan; [Watanabe, Yoshiyuki] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka 5650871, Japan	Hashimoto, R (reprint author), Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, D3,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hashimor@psy.med.osaka-u.ac.jp			Japanese Ministry of Health, Labor and Welfare [H22-seishin-ippan-001]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (KAKENHI) [22390225, 23659565]; Japan Foundation for Neuroscience and Mental Health	Japanese Ministry of Health, Labor and Welfare (H22-seishin-ippan-001); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (KAKENHI, 22390225-Grant-in-Aid for Scientific Research (B), 23659565-Grant-in-Aid for Challenging Exploratory Research, Grant-in-Aid for Scientific Research on Innovative Areas [Comprehensive Brain Science Network]); Japan Foundation for Neuroscience and Mental Health.	Amitai N, 2010, BIOL PSYCHIAT, V68, P5, DOI 10.1016/j.biopsych.2010.03.004; Luciano M, 2011, BIOL PSYCHOL, V86, P193, DOI 10.1016/j.biopsycho.2010.11.008; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Kahn RS, 2013, JAMA PSYCHIAT, V70, P1107, DOI 10.1001/jamapsychiatry.2013.155; Chen WJ, 1998, AM J PSYCHIAT, V155, P1214; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Kakegawa W, 2011, NAT NEUROSCI, V14, P603, DOI 10.1038/nn.2791; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Green MF, 2006, J CLIN PSYCHIAT, V67, P3; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Hashimoto R, 2010, AM J MED GENET B, V153B, P1459, DOI 10.1002/ajmg.b.31123; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Toulopoulou T, 2010, ARCH GEN PSYCHIAT, V67, P905, DOI 10.1001/archgenpsychiatry.2010.99; Coyle Joseph T, 2006, Cell Mol Neurobiol, V26, P365, DOI 10.1007/s10571-006-9062-8; Das S, 1998, NATURE, V393, P377; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; McAllister AK, 2014, BIOL PSYCHIAT, V75, P262, DOI 10.1016/j.biopsych.2013.10.003; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Fourgeaud L, 2010, P NATL ACAD SCI USA, V107, P22278, DOI 10.1073/pnas.0914064107; Akbarian S, 1996, J NEUROSCI, V16, P19; Takata A, 2013, BIOL PSYCHIAT, V73, P532, DOI 10.1016/j.biopsych.2012.10.024; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Berrettini Wade H, 2005, Dialogues Clin Neurosci, V7, P95; Cox AJ, 2014, NEUROBIOL AGING, V35; Green MF, 2006, J CLIN PSYCHIAT S9, V67, P36; Hasan Kamrul, 2009, J Biol Chem, V284, P1664, DOI 10.1074/jbc.M805778200; Hashimoto R, 2013, AM J PSYCHIAT, V170, P683, DOI 10.1176/appi.ajp.2013.12091228; Hill WD, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.114; Husted JA, 2009, AM J MED GENET B, V150B, P845, DOI 10.1002/ajmg.b.30907; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Krystal JH, 2002, ARCH GEN PSYCHIAT, V59, P663, DOI 10.1001/archpsyc.59.7.663; Lencz T, 2014, MOL PSYCHIATR, V19, P168, DOI 10.1038/mp.2013.166; Mueller HT, 2004, SCHIZOPHR RES, V71, P361, DOI 10.1016/j.schres.2004.02.016; Ohi K, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-40; Ohi K, 2009, GENES BRAIN BEHAV, V8, P473, DOI 10.1111/j.1601-183X.2009.00497.x; Pilowsky LS, 2006, MOL PSYCHIATR, V11, P118, DOI 10.1038/sj.mp.4001751; Posthuma D, 2001, BEHAV GENET, V31, P593, DOI 10.1023/A:1013349512683; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Tarabeux J, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.52; Van Horn MR, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00039; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	47	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	JUL	2015	41	4					909	918		10.1093/schbul/sbu171		10	Psychiatry	Psychiatry	CM7QV	WOS:000357891500018		
J	Adams, AA; Ferryman, JM				Adams, Andrew A.; Ferryman, James M.			The future of video analytics for surveillance and its ethical implications	SECURITY JOURNAL			English	Article						surveillance; CCTV; video analytics; ethics; regulation; computer vision	VISUAL SURVEILLANCE; FACE HALLUCINATION; MECHANISMS; PRIVACY; MODEL	The current state of the art and direction of research in computer vision aimed at automating the analysis of CCTV images is presented. This includes low level identification of objects within the field of view of cameras, following those objects over time and between cameras, and the interpretation of those objects' appearance and movements with respect to models of behaviour (and therefore intentions inferred). The potential ethical problems (and some potential opportunities) such developments may pose if and when deployed in the real world are presented, and suggestions made as to the necessary new regulations which will be needed if such systems are not to further enhance the power of the surveillers against the surveilled.	[Adams, Andrew A.] Meiji Univ, Ctr Business Informat Eth, Chiyoda Ku, Tokyo To 1018301, Japan; [Ferryman, James M.] Univ Reading, Sch Syst Engn, Computat Vis Grp, Reading RG6 6AY, Berks, England	Adams, AA (reprint author), Meiji Univ, Ctr Business Informat Eth, Chiyoda Ku, 1-1 Kanda Surugadai, Tokyo To 1018301, Japan.	aaa@meiji.ac.jp; james@computer.org			UK's EPSRC [EP/G069808/1]; Japan's JSPS (Kakenhi) [24330127]; European Union [FP7-SEC-2010-1: 261658]	This work was supported by the UK's EPSRC (EP/G069808/1) and Japan's JSPS (Kakenhi (B) 24330127). This work was supported by the European Union project ARENA (FP7-SEC-2010-1: 261658). However, this paper does not necessarily represent the opinion of the European Community, and the European Community is not responsible for any use which may be made of its contents.	Adams A. A., 2007, ETH 2007 P 9 INT C T; Annesley J., 2007, P IEEE C ADV VID SIG, P482, DOI 10.1109/AVSS.2007.4425358; Jia K, 2008, IEEE T IMAGE PROCESS, V17, P873, DOI 10.1109/TIP.2008.922421; Bazzani L, 2012, PATTERN RECOGN LETT, V33, P898, DOI 10.1016/j.patrec.2011.11.016; Welsh BC, 2009, JUSTICE Q, V26, P716, DOI 10.1080/07418820802506206; Zhan BB, 2008, MACH VISION APPL, V19, P345, DOI 10.1007/s00138-008-0132-4; [Anonymous], 2006, BBC; [Anonymous], 2011, GLOB VID SURV MARK A; [Anonymous], 2012, ECONOMIST; Hu WM, 2004, IEEE T SYST MAN CY C, V34, P334, DOI 10.1109/TSMCC.2004.829274; Dee HM, 2008, MACH VISION APPL, V19, P329, DOI 10.1007/s00138-007-0077-z; [Anonymous], 2003, BBC; Dufaux F, 2008, IEEE T CIRC SYST VID, V18, P1168, DOI 10.1109/TCSVT.2008.928225; [Anonymous], 2000, The Economist, Patent No. 6067399; Park JS, 2008, IEEE T IMAGE PROCESS, V17, P1806, DOI 10.1109/TIP.2008.2001394; Lee SW, 2006, PATTERN RECOGN, V39, P1809, DOI 10.1016/j.patcog.2006.04.033; Armstrong Gary, 1999, MAXIMUM SURVEILLANCE; BBC, 2012, BBC; Ben Shitrit H, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P137, DOI 10.1109/ICCV.2011.6126235; Bremond F., 2012, P IEEE 9 INT C ADV V, P126, DOI [10.1109/AVS5.2012.1, DOI 10.1109/AVS5.2012.1]; Brin D., 1998, TRANSPARENT SOC; Coetzer Bennie, 2011, Video Surveillance; Coudert F., 2011, IM CRIM DET PREV 201, P1, DOI [10.1049/ic.2011.0130, DOI 10.1049/IC.2011.0130]; Dee H., 2004, P BRIT MACH VIS C BR, P73; Dee HM, 2009, ARTIF INTELL, V173, P329, DOI 10.1016/j.artint.2008.10.011; Dick A. R., 2003, P 7 INT C DIG IM COM, P195; Dollar P, 2012, IEEE T PATTERN ANAL, V34, P743, DOI 10.1109/TPAMI.2011.155; Donald C., 2005, CCTV IMAGE       SPR, P35; Evans Murray, 2012, Proceedings of the 1st International Conference on Pattern Recognition Applications and Methods. ICPRAM 2012; Florence J, 2006, YALE LAW J, V115, P2148; Goold B., 2002, CRIMINAL JUSTICE ETH, V21, P21; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Hempel L., 2004, HPSECT200100094 URB; Independent Police Complaints Commission (UK), 2007, STOCKW ON INV SHOOT; Introna L., 2004, SURVEILLANCE SOC, V2, P177; Introna L. D., 2000, ACM SIGCAS COMPUTERS, V30, P33, DOI 10.1145/572260.572267; Ko T., 2011, SURVEY BEHAV ANAL VI; Lewis Paul, 2009, GUARDIAN; Liu C, 2007, INT J COMPUT VISION, V75, P115, DOI 10.1007/s11263-006-0029-5; Lyall S., 2009, NY TIMES; Moussaid M., 2010, PLOS ONE, V5; Musse S. R., 2010, IEEE SIGNAL PROCESSI, V27, P66; Onto Y., 2010, POLICY INTERNET, V2, P93, DOI 10.2202/1944-2866.1038; Orrite C., 2008, P 1 INT WORKSH MACH; Patino L, 2010, Proceedings 7th IEEE International Conference on Advanced Video and Signal Based Surveillance (AVSS 2010), DOI 10.1109/AVSS.2010.74; PETS, 2006, P IEEE 2006 9 INT WO; PETS, 2009, P IEEE 2009 12 INT W; PETS, 2007, P IEEE 2007 10 INT W; Pham Q.-C., 2007, P IEEE C COMP VIS PA, P1, DOI 10.1109/CVPR.2007.383496; Ragheb H., 2008, P ACM INT WORKSH VIS; Reeves B., 2002, THE MEDIA EQUATION; Rowlands M., 2011, STATEWATCH ANAL 6 MO; Senior A, 2005, IEEE SECUR PRIV, V3, P50, DOI 10.1109/MSP.2005.65; Shah M., 2010, EUR C COMP VIS ECCV; Sochman J, 2011, P 2011 IEEE INT C CO, P830, DOI DOI 10.1109/1CCVW.2011.6130338; Spindler T., 2008, COMPUTER SECURITY, V16, P199; TICKNER AH, 1973, ERGONOMICS, V16, P381; Tweed D., 2008, P 1 ACM INT WORKSH V; Valera M, 2011, IEEE T CIRC SYST VID, V21, P1795, DOI 10.1109/TCSVT.2011.2133850; Xiang T., 2011, SECURITY SURVEILLANC; Yilmaz A, 2006, ACM COMPUT SURV, V38, DOI 10.1145/1177352.1177355	61	0	0	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	0955-1662	1743-4645		SECUR J	Secur. J.	JUL	2015	28	3					272	289		10.1057/sj.2012.48		18	Criminology & Penology	Criminology & Penology	CM8PR	WOS:000357964600004		
J	Choi, J				Choi, Jaedong			Fire, Arson and Fire Insurance in Late Imperial Russia	SLAVONIC AND EAST EUROPEAN REVIEW			English	Article									Keio Univ, Econ, Tokyo 108, Japan	Choi, J (reprint author), Keio Univ, Econ, Tokyo 108, Japan.						Anfimov A. M., 1965, KRESTIANSKOE DVIZHEN; [Anonymous], 1916, 1911 14 STAT OTCHET, P64; [Anonymous], 1892, T PERVOGO VYSOCHAISH, V1, P588; [Anonymous], 1916, STRAKHOVOI B MOSKOVS, V17, P7; [Anonymous], 1906, OTCHET MGZU 1905 GOD; [Anonymous], 1916, POZHARNOE DELO, V2, P62; [Anonymous], 1911, STRAKHOVOE DELO, V14, P428; [Anonymous], 1914, OTCHET MGZU 1913 GOD, V2-4; [Anonymous], 1911, OTCHET MGZU 1910 GOD, V2-4; [Anonymous], 1912, POZHARNOE DELO, V2, P47; [Anonymous], 1917, ZEMSKII STRAKHOVYI V, V24, P4; [Anonymous], 1915, MAT DLIA OTSENKI ZEM, V13, P177; [Anonymous], 1917, ZEMSKII STRAKHOVYI V, p[17, 15]; [Anonymous], 1912, GUBERNII EVROPEISKOI, P128; [Anonymous], 1915, PRILOZHENIE ZEMSKOGO, P6; [Anonymous], 1916, STRAKHOVOE DELO, V1, P4; [Anonymous], 1916, STRAKHOVOE DELO, V12, P336; [Anonymous], 1903, T VSEROSSIISKOGO POZ, V2, P221; [Anonymous], 1916, STRAKHOVOE DELO, V11, P307; [Anonymous], 1914, POZHARNOE DELO, V24, P870; [Anonymous], 1905, POZHARNOE DELO, V31, P484; [Anonymous], 1917, STRAKHOVOI B MOSKOVS, P7; [Anonymous], 1916, STRAKHOVOE DELO, V11, P307; [Anonymous], 1892, T PERVOGO VYSOCHAISH, V1, P587; [Anonymous], 1904, OTCHET REVIZII ZEMSK, V2, P96; [Anonymous], 1904, POZHARNOE DELO, V13, P199; [Anonymous], 1916, STRAKHOVOE DELO, V7-8, P182; [Anonymous], 1914, ZEMSKOE DELO, V5, P338; [Anonymous], 1911, STAT OTCHET VZAIMNOM, P7; [Anonymous], 1912, 1895 1910 STAT POZHA, P139; [Anonymous], 1915, T SHESTOGO MEZHDUNAR, V2, P95; [Anonymous], 1910, OTCHET MGZU 1909 GOD, V2-4; [Anonymous], 1916, STAT OTCHET VZAIMNOM, P64; [Anonymous], 1912, POZHARNOE DELO, V2, P48; [Anonymous], 1916, STRAKHOVOI B MOSKOVS, V16, P7; [Anonymous], 1912, ZEMSKOE DELO, V23, P1536; [Anonymous], 1915, T SHESTOGO MEZHDUNAR, V2, P126; [Anonymous], 1908, POZHARNOE DELO, V10, P167; [Anonymous], 1914, ZEMSKOE DELO, V4, P233; [Anonymous], 1905, POZHARNOE DELO, V17, P269; [Anonymous], 1900, SBORN STAT SVED GUB, P2; [Anonymous], 1912, POZHARNOE DELO, V18, P609; [Anonymous], 1918, ZEMSKII STRAKHOVYI V, V9-10, P144; [Anonymous], 1917, STRAKHOVOE DELO, V9-10, P169; [Anonymous], 1892, T PERVOGO VYSOCHAISH, V1, P583; [Anonymous], 1916, STAT OTCHET VZAIMNOM, p[38, 68]; [Anonymous], 1912, ZEMSKOE DELO, V24, P1635; [Anonymous], 1918, ZEMSKII STRAKHOVYI V, V4, P26; [Anonymous], 1910, MAT PERESMOTRU POLOZ; [Anonymous], 1917, ZEMSKII STRAKHOVYI V, V15-16, P40; [Anonymous], 1918, ZEMSKII STRAKHOVYI V, V5-6, P100; [Anonymous], 1889, POZHARY ROSSIISKOI I, P134; [Anonymous], 1917, STRAKHOVOE DELO, V2, P36; [Anonymous], 1907, MAT STAT ORG VZAIMNO, V5; [Anonymous], 1913, OTCHET MGZU 1912 GOD, V2-4; [Anonymous], 1918, ZEMSKII STRAKHOVYI V, V9-10, P142; [Anonymous], 1915, OTCHET MGZU 1914 GOD, V2-4; [Anonymous], 1917, TEKUSHAIA STAT TSEN, P6; [Anonymous], 1917, OTCHET MGZU VZAIMNOM; [Anonymous], 1916, ZEMSKII STRAKHOVYI V, V3-4, P18; [Anonymous], 1916, STAT OTCHET VZAIMNOM, P18; [Anonymous], 1913, STAT EZHEGODNIK KOST; [Anonymous], 1915, OBIASNITELNAIA ZAPIS; [Anonymous], 1916, ZEMSKII STRAKHOVYI V, V10-11, P124; [Anonymous], 1897, POZHARY ROSSIISKOI I, P69; [Anonymous], 1908, OTCHET MGZU 1907 GOD; [Anonymous], 1916, STAT OTCHET VZAIMNOM, P95; [Anonymous], 1916, OTCHET MGZU 1915 GOD, V2-4; [Anonymous], 1917, ZEMSKII STRAKHOVYI V, V15-16, P33; [Anonymous], 1916, STRAKHOVOE OBOZRENIE, V7-8, P181; [Anonymous], 1907, OTCHET MGZU VZAIMNOM, pii; [Anonymous], 1908, OTCHET MGZU VZAIMNOM; [Anonymous], 1905, OTCHET MGZU VZAIMNOM; [Anonymous], 1909, STRAKHOVOE DELO, V13, P410; [Anonymous], 1912, OTCHET MGZU 1911 GOD, V2-4; [Anonymous], 1900, SBORNIK STAT SVEDENI, P20; [Anonymous], 1903, T VSEROSSIISKOGO POZ, V2, P23; [Anonymous], 1918, ZEMSKII STRAKHOVYI V, V9-10, P8; [Anonymous], 1917, OTCHET MGZU VZAIMNOM, P5; [Anonymous], 1903, T VSEROSSIISKOGO POZ, V2, p[60, 81, 143, 207]; [Anonymous], 1908, POZHARNOE DELO, V3, P43; [Anonymous], 1911, OBSHCHAIA STAT AKTSI, P8; [Anonymous], 1915, STRAKHOVOE OBOZRENIE, P10; [Anonymous], 1917, ZEMSKII STRAKHOVYI V, V1-2, P104; [Anonymous], 1918, ZEMSKII STRAKHOVYI V, V9-10, P138; [Anonymous], 1892, T PERVOGO VYSOCHAISH, V1, P589; [Anonymous], 1916, STRAKHOVOI B MOSKOVS, V15, P7; [Anonymous], 1909, OTCHET MGZU VZAIMNOM, pii; [Anonymous], 1909, OTCHET MGZU 1908 GOD; [Anonymous], 1895, OTCHET MGZU 1894 GOD, V2-4; [Anonymous], 1912, ZEMSKOE DELO, V23, P1535; [Anonymous], 1914, STRAKHOVOE DELO, V4, P122; [Anonymous], 1916, ZEMSKII STRAKHOVYI V, V10-11, P124; [Anonymous], 1879, VZAIMNOE ZEMSKOE STR, P270; [Anonymous], 1916, STAT OTCHET VZAIMNOM, P78; [Anonymous], 1916, POZHARNOE DELO, V21, P777; [Anonymous], 1907, OTCHET MGZU 1906 GOD; [Anonymous], 1915, T SHESTOGO MEZHDUNAR, V2, P146; [Anonymous], 1916, STAT OTCHET VZAIMNOM, P66; [Anonymous], 1916, ZEMSKII STRAKHOVYI V, p[1, iii, 14]; [Anonymous], 1912, STRAKHOVOE DELO, V7, P202; [Anonymous], 1916, ZEMSKII STRAKHOVYI V, V5-6, P1; Burbank Jane, 2004, RUSSIAN PEASANTS GO; Denisov V. I., 1911, LESA ROSSII IKH EKSP, P144; Dubrovskii S. M., 1956, KRESTIANSKOE DVIZHEN, P59; Dubrovskii S. M., 1956, KRESTIANSKOE DVIZHEN; Emmons Terence, 1982, ZEMSTVO RUSSIA; EVTUHOV C, 2011, PORTRAIT RUSSIAN PRO; Figes Orlando, 1991, PEASANT EC CULTURE P; Frank Stephen, 1999, CRIME CULTURAL CONFL; Frierson Cathy A., 2002, ALL RUSSIA IS BURNIN; Gerasimenko G. A., 1985, BORBA KRESTIAN PROTI; Gerasimov IV, 2009, MODERNISM AND PUBLIC REFORM IN LATE IMPERIAL RUSSIA: RURAL PROFESSIONALS AND SELF-ORGANIZATION, 1905-30, P1, DOI 10.1057/9780230250901; Iordanskii M. A., 1913, CHTO TAKOE ZEMSKAIA, P17; Kingston-Mann E., 1991, PEASANT EC CULTURE P; Korelin A. P., 2005, PERVAIA REVOLIUTSIIA; Kravchuk N. A., 1971, MASSOVOE KRESTIANSKO; Kuzmin V. Iu., 2003, VLAST OBSHCHESTVO ZE; Makiavskii A. D., 1981, KRESTIANSKOE DVIZHEN; Pallot Judith, 1999, LAND REFORM RUSSIA 1; Porter Thomas E., 2005, ZEMSKOE SAMOUPRAVLEN; Porter Thomas Earl, 1991, ZEMSTVO EMERGENCE CI; Rudnev S. F., 1884, OTCHET MOSKOVSKOI GU; Rudnev S. F., 1892, OBZOR DVATSATIPIATIL, P26; Senchakovskii L. T., 1989, KRESTIANSKOE DVIZHEN; Shanin Teodor, 1986, RUSSIA 1905 1907 REV, V2; Shapkarin A. V., 1966, KRESTIANSKOE DVIZHEN; Smolensk province, 1917, ZEMSKII STRAKHOVYI V, V24, P51; Worobec Christine D., 1995, PEASANT RUSSIA	129	0	0	MODERN HUMANITIES RESEARCH ASSOCIATION	LONDON	1 CARLTON HOUSE TERRACE, LONDON SW1Y 5AF, ENGLAND	0037-6795	2222-4327		SLAVON E EUR REV	Slav. East Eur. Rev.	JUL	2015	93	3					451	492		10.5699/slaveasteurorev2.93.3.0451		42	Humanities, Multidisciplinary	Arts & Humanities - Other Topics	CM5RW	WOS:000357747300003		
J	Nakashima, H; Yukawa, Y; Suda, K; Yamagata, M; Ueta, T; Kato, F				Nakashima, Hiroaki; Yukawa, Yasutsugu; Suda, Kota; Yamagata, Masatsune; Ueta, Takayoshi; Kato, Fumihiko			Cervical Disc Protrusion Correlates With the Severity of Cervical Disc Degeneration	SPINE			English	Article						cervical; disc degeneration; disc protrusion; asymptomatic; magnetic resonance images; cross-sectional study; aging	ASYMPTOMATIC SUBJECTS; NATURAL-HISTORY; RESONANCE; CLASSIFICATION; PREVALENCE; PATHOLOGY	Study Design. Cross-sectional study. Objective. The purposes of this study were (1) to investigate the frequency and degree of cervical disc degeneration and protrusion on cervical spine magnetic resonance (MR) images and (2) to analyze the correlation between the severity of disc degeneration and disc protrusion. Summary of Background Data. Cervical disc degenerative changes or protrusion is commonly observed on MR images in healthy subjects. However, there are few large-scale studies, and the frequency and range of these findings in healthy subjects have not been clarified. Moreover, there are no reports regarding the correlation between cervical disc degeneration and disc protrusion. Methods. Cervical disc degeneration and protrusion were prospectively measured using magnetic resonance imaging in 1211 relatively healthy volunteers. These included at least 100 males and 100 females in each decade of life between the 20s and the 70s. Cervical disc degeneration was defined according to the modified Pfirrmann classification system, and the amount of disc protrusion was evaluated using the anteroposterior diameter of disc protrusion on sagittal MR image. Results. Mild disc degeneration was very common, including 98.0% of both sexes in their 20s. The severity of cervical disc degeneration significantly increased with age in both sexes at every level. The disc degeneration predominantly occurred at C5-C6 and C6-C7. The difference between sexes was not significant except for individuals in their 50s. The average anteroposterior diameter of disc protrusion increased with aging, especially from the 20s to the 40s. The anteroposterior diameter of disc protrusion increased with a progression in the disc degeneration grade. Conclusion. Cervical disc degeneration and protrusion were frequently observed in healthy subjects even in their 20s and deteriorated with age. Cervical disc protrusion was significantly correlated with cervical disc degeneration, and spatial cervical disc protrusion was affected by biochemical degenerative changes as observed on MR images. Level of Evidence: 2	[Nakashima, Hiroaki] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Showa Ku, Nagoya, Aichi 4668560, Japan; [Yukawa, Yasutsugu; Kato, Fumihiko] Chubu Rosai Hosp, Dept Orthoped Surg, Nagoya, Aichi, Japan; [Suda, Kota] Hokkaido Chuo Rosai Hosp Sekison Ctr, Dept Orthoped Surg, Sapporo, Hokkaido, Japan; [Yamagata, Masatsune] Chiba Rosai Hosp, Dept Orthoped Surg, Chiba, Japan; [Ueta, Takayoshi] Spinal Injuries Ctr, Dept Orthoped Surg, Izuka, Japan	Nakashima, H (reprint author), Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668560, Japan.	hirospine@gmail.com			Japan Labor Health and Welfare Organization (Kawasaki, Japan)	Institutional funds and by grant research funds, which are intended for promoting hospital functions, of the Japan Labor Health and Welfare Organization (Kawasaki, Japan) funds were received to support this work.	ADAMS MA, 1982, SPINE, V7, P184, DOI 10.1097/00007632-198205000-00002; TERTTI M, 1991, SPINE, V16, P629, DOI 10.1097/00007632-199106000-00006; MILLER JM, 1988, SYST BOT, V13, P173, DOI 10.1097/00007632-198802000-00008; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Matsumoto M, 1998, J BONE JOINT SURG BR, V80B, P19, DOI 10.1302/0301-620X.80B1.7929; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Vernon-Roberts B, 2007, SPINE, V32, P2797, DOI 10.1097/BRS.0b013e31815b64d2; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Fardon DF, 2001, SPINE, V26, P461, DOI 10.1097/00007632-200103010-00007; Łebkowski Wojciech J, 2002, Pol Merkur Lekarski, V13, P188; Masui T, 2005, J SPINAL DISORD TECH, V18, P121, DOI 10.1097/01.bsd.0000154452.13579.b2; Fardon D F, 2001, Spine (Phila Pa 1976), V26, pE93, DOI 10.1097/00007632-200103010-00006; Takatalo J, 2009, SPINE, V34, P1716, DOI 10.1097/BRS.0b013e3181ac5fec	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	JUL 1	2015	40	13					E774	E779		10.1097/BRS.0000000000000953		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CM8JL	WOS:000357946200005		
J	Yamanaka, K; Mori, M; Yamazaki, K; Kumagai, R; Doita, M; Chiba, A				Yamanaka, Kenta; Mori, Manami; Yamazaki, Ken; Kumagai, Ruriko; Doita, Minoru; Chiba, Akihiko			Analysis of the Fracture Mechanism of Ti-6Al-4V Alloy Rods That Failed Clinically After Spinal Instrumentation Surgery	SPINE			English	Article						spinal instrumentation surgery; Ti-6Al-4V alloy; rod fracture; metallurgical failure analysis; materials science; fatigue cracking; external stress; pseudarthrosis; growing-rod method; rod material selection; Co-Cr alloy; surface treatment	FATIGUE CRACKS; TITANIUM; FUSION; COMPLICATIONS; PROPAGATION; SCOLIOSIS; DEFORMITY; STRENGTH	Study Design. Retrieval analysis of 2 Ti-6Al-4V alloy rods that fractured after spinal instrumentation surgery. Objective. To determine the mechanism that underlies fractures of Ti-6Al-4V alloy rods after spinal instrumentation surgery from a materials science viewpoint. Summary of Background Data. Rod failures after spinal instrumentation surgery are often reported and many case-based studies have been published. However, the details of the mechanism that underlies the fractures have not yet been fully elucidated. Methods. Two patients, a 71-year-old female and an 11-year-old male, underwent radiography and removal of their fractured rods. The latter patient had been treated using the growing-rod method. Metallurgical failure analysis of the retrieved rods was conducted, and material properties were compared between the unused and fractured rods. Results. The microstructures and mechanical properties of the Ti-6Al-4V alloy rods that failed after spinal instrumentation surgery were similar to those of unused rods. Analysis of the fracture surfaces clearly identified fatigue cracking in both cases that would have lowered the resistance of the rods to failures caused by external stresses. Shot blasting the surfaces of Ti-6Al-4V alloy rods and bending the rods to fit particular contours, which is always conducted during spinal instrumentation surgery, probably introduced fatigue cracking because the alloy is highly notch sensitive. Conclusion. Improvements should be made to rod design and/or rod material, because the fatigue resistance of titanium alloys is intrinsically lower than that of other commercially available rod materials, including cobalt-chromium alloys. These imperfections may have greater consequences for the growing-rod method and pseudarthrosis, where the rods are not completely fixed, and they subsequently suffer from severe long-arm moments. Level of Evidence: N/A	[Yamanaka, Kenta; Mori, Manami; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan; [Yamazaki, Ken] Sendai Natl Coll Technol, Dept Mat & Environm Engn, Natori, Miyagi, Japan; [Kumagai, Ruriko; Doita, Minoru; Chiba, Akihiko] Iwate Med Univ, Sch Med, Dept Orthoped Surg, Morioka, Iwate 020, Japan	Yamanaka, K (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	k_yamanaka@imr.tohoku.ac.jp			Project for the Promotion of Indigenous Creation and Development of Innovative Medical Devices in the Tohoku Area from the Ministry of Health, Labour and Welfare, Japan	Project for the Promotion of Indigenous Creation and Development of Innovative Medical Devices in the Tohoku Area from the Ministry of Health, Labour and Welfare, Japan, funds were received to support this work.	Akazawa T, 2013, J ORTHOP SCI, V18, P926, DOI 10.1007/s00776-013-0464-4; Akahori T, 1998, MAT SCI ENG A-STRUCT, V243, P237, DOI 10.1016/S0921-5093(97)00807-1; Bess S, 2010, J BONE JOINT SURG AM, V92A, P2533, DOI 10.2106/JBJS.I.01471; Yang JS, 2011, SPINE, V36, P1639, DOI 10.1097/BRS.0b013e31822a982f; Oguma H, 2013, INT J FATIGUE, V50, P89, DOI 10.1016/j.ijfatigue.2012.02.012; Yoshihara H, 2013, SPINE J, V13, P1350, DOI 10.1016/j.spinee.2013.04.022; Suresh S., 1984, International Metals Reviews, V29; HARRINGTON PR, 1962, J BONE JOINT SURG AM, V44, P591; Nalla RK, 2002, METALL MATER TRANS A, V33, P899, DOI 10.1007/s11661-002-1023-3; Benedetti M, 2008, ENG FRACT MECH, V75, P169, DOI 10.1016/j.engfracmech.2007.03.037; Dick JC, 2001, SPINE, V26, P1668, DOI 10.1097/00007632-200108010-00008; Farooq N, 2010, SPINE, V35, P2252, DOI 10.1097/BRS.0b013e3181ecf41a; Hassanzadeh H, 2012, SPINE J, V12, pS160; Hurley PJ, 2008, INT J FATIGUE, V30, P623, DOI 10.1016/j.ijfatigue.2007.05.013; Lindsey C, 2006, SPINE, V31, P1680, DOI 10.1097/01.brs.0000224177.97846.00; Nguyen TQ, 2011, P I MECH ENG H, V225, P194, DOI 10.1243/09544119JEIM763; Pope MH, 2007, MUSCULOSKELETAL DISO, P107, DOI 10.1016/B978-0-323-02622-2.50012-1; Ravichandran KS, 1997, FATIGUE FRACT ENG M, V20, P1423, DOI 10.1111/j.1460-2695.1997.tb01500.x; Slivka M. A., 2013, SPINE DEFORM, V1, P395; Smith JS, 2012, NEUROSURGERY, V71, P862, DOI 10.1227/NEU.0b013e3182672aab	20	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	JUL 1	2015	40	13					E767	E773		10.1097/BRS.0000000000000881		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CM8JL	WOS:000357946200004		
J	Nakamura, H				Nakamura, Hiroyuki			C(sp(3))-H versus C(sp(3))-C(sp) in Activation of Propargylic Amines under Transition-Metal Catalysis	SYNLETT			English	Article						propargylic amines; C-H activation; C-C activation; palladium; copper; zinc; allenes; 1,6-enynes	HYDRIDE-TRANSFER REACTION; EGFR TYROSINE KINASE; TERTIARY-AMINES; ALLENES; BONDS; INHIBITION; ALKYNE	Transition-metal-catalyzed C-H and C-C bond activation procedures have attracted significant interest as environmentally friendly processes for organic synthesis. This account summarizes transition-metal-catalyzed transformations of propargylic amines through C(sp(3))-H and C(sp(3))-C(sp) activation, including hydrogen transfer, deacetylenative homocoupling, fragment exchange, and redox cross-dehydrogenative coupling (CDC). The generation of iminium intermediates is essential for the current transformations based on propargylic amines. 1 Introduction 2 Synthesis of Allenes from Propargylic Amines through Palladium-Catalyzed Hydrogen-Transfer Reactions 2.1 Propargylic Amines as Allenyl Anion Equivalents 2.2 Synthesis of Allenyl Carbinols 2.3 Synthesis of Heterocyclic Allenes 2.4 Mechanistic Study 2.5 One-Pot Synthesis of Allenes from Aryl Halides 3 Substitution Reactions of Propargylic Amines through Copper(I)-Catalyzed C(sp)-C(sp(3)) Bond Activation 3.1 Substitution Reactions of Propargylic Amines with Secondary Amines 3.2 Substitution Reactions of Propargylic Amines with 1-Alkynes 3.3 Deacetylenative Coupling with Various Propargylic Amines 4 Zinc(II)-Catalyzed Redox Cross-Dehydrogenative Coupling of Propargylic Amines and Terminal Alkynes 5 Conclusion	Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Nakamura, H (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	hiro@res.titech.ac.jp	Nakamura, Hiroyuki/E-8627-2014	Nakamura, Hiroyuki/0000-0002-4511-2984			Gommermann N, 2003, ANGEW CHEM INT EDIT, V42, P5763, DOI 10.1002/anie.200352578; Zeni G, 2004, CHEM REV, V104, P2285, DOI 10.1021/cr020085h; MURAHASHI SI, 1979, J AM CHEM SOC, V101, P7429, DOI 10.1021/ja00518a062; Peshkov VA, 2012, CHEM SOC REV, V41, P3790, DOI 10.1039/c2cs15356d; Li ZP, 2006, P NATL ACAD SCI USA, V103, P8928, DOI 10.1073/pnas.0601687103; Linardou H, 2009, NAT REV CLIN ONCOL, V6, P352, DOI 10.1038/nrclinonc.2009.62; MURAHASHI SI, 1978, J AM CHEM SOC, V100, P348, DOI 10.1021/ja00469a093; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kim Y, 2011, CHEM-EUR J, V17, P12561, DOI 10.1002/chem.201102710; Murahashi SI, 2008, CHEM SOC REV, V37, P1490, DOI 10.1039/b706709g; Sugiishi T, 2012, J AM CHEM SOC, V134, P2504, DOI 10.1021/ja211092q; Jia CG, 2001, ACCOUNTS CHEM RES, V34, P633, DOI 10.1021/ar000209h; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Sugiishi T, 2010, J AM CHEM SOC, V132, P5332, DOI 10.1021/ja9109055; Nakamura H, 2008, ORG BIOMOL CHEM, V6, P1471, DOI 10.1039/b718298h; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Ritleng V, 2002, CHEM REV, V102, P1731, DOI 10.1021/cr0104330; Ban HS, 2010, BIOORGAN MED CHEM, V18, P870, DOI 10.1016/j.bmc.2009.11.035; Ban HS, 2008, CHEMMEDCHEM, V3, P1094, DOI 10.1002/cmdc.200800073; Carvalho MFNN, 2000, J ORGANOMET CHEM, V598, P318, DOI 10.1016/S0022-328X(99)00730-5; CRABBE P, 1979, J CHEM SOC CHEM COMM, P859, DOI 10.1039/c39790000859; Dyker G., 1999, ANGEW CHEM INT EDIT, V38, P1698, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1698::AID-ANIE1698>3.0.CO;2-6; Li C. J., 2009, J ACC CHEM RES, V42, P335; Nakamura H, 2005, TETRAHEDRON LETT, V46, P8333, DOI 10.1016/j.tetlet.2005.09.169; Nakamura H, 2005, J ORG CHEM, V70, P2357, DOI 10.1021/jo0479664; Nakamura H, 2004, J AM CHEM SOC, V126, P5958, DOI 10.1021/ja039175+; Nakamura H, 2006, ORG LETT, V8, P2095, DOI 10.1021/ol060538v	27	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUL	2015	26	12					1649	1664		10.1055/s-0034-1380462		16	Chemistry, Organic	Chemistry	CM8IX	WOS:000357944300002		
J	Okada, A; Yuasa, H; Fujiya, A; Tada, N; Miura, T; Itoh, A				Okada, Akifumi; Yuasa, Hiroki; Fujiya, Akitoshi; Tada, Norihiro; Miura, Tsuyoshi; Itoh, Akichika			Aerobic Photooxidative Synthesis of Secondary Aldimines from Benzylamines by Using Methylene Blue	SYNLETT			English	Article						aerobic; methylene blue; photooxidation; singlet oxygen; primary amine; imine	VISIBLE-LIGHT IRRADIATION; SINGLET OXYGEN; MOLECULAR-OXYGEN; PRIMARY AMINES; CATALYTIC-SYSTEM; DEHYDROGENATIVE OXIDATION; ORGANIC-SYNTHESIS; FLUORESCENT LAMP; PHENACYL IODIDES; NEAT CONDITIONS	We have developed a concise oxidative coupling of primary benzylamines to yield secondary aldimines catalyzed by methylene blue by using molecular oxygen as the oxidant in the presence of visible-light irradiation from fluorescent lamps.	[Okada, Akifumi; Yuasa, Hiroki; Fujiya, Akitoshi; Tada, Norihiro; Itoh, Akichika] Gifu Pharmaceut Univ, Gifu 5011196, Japan; [Miura, Tsuyoshi] Tokyo Univ Pharm & Life Sci, Hachioji, Tokyo 1920392, Japan	Itoh, A (reprint author), Gifu Pharmaceut Univ, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	itoha@gifu-pu.ac.jp					Furukawa S, 2011, ACS CATAL, V1, P1150, DOI 10.1021/cs200318n; Hoffmann N, 2008, CHEM REV, V108, P1052, DOI 10.1021/cr0680336; Ho HA, 2012, ANGEW CHEM INT EDIT, V51, P8607, DOI 10.1002/anie.201203556; To WP, 2013, CHEM-EUR J, V19, P5654, DOI 10.1002/chem.201203774; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; Su FZ, 2011, ANGEW CHEM INT EDIT, V50, P657, DOI 10.1002/anie.201004365; Jiang G, 2009, ORG LETT, V11, P4568, DOI 10.1021/ol9018166; Kang N, 2013, ANGEW CHEM INT EDIT, V52, P6228, DOI 10.1002/anie.201300655; Ahmad S, 2014, INORG CHEM, V53, P2030, DOI 10.1021/ic403166q; Rueping M, 2012, ACS CATAL, V2, P2810, DOI 10.1021/cs300604k; Lang XJ, 2011, ANGEW CHEM INT EDIT, V50, P3934, DOI 10.1002/anie.201007056; Nobuta T, 2012, TETRAHEDRON LETT, V53, P5306, DOI 10.1016/j.tetlet.2012.07.091; Kodama S, 2010, TETRAHEDRON LETT, V51, P2450, DOI 10.1016/j.tetlet.2010.02.150; Wendlandt AE, 2012, ORG LETT, V14, P2850, DOI 10.1021/ol301095j; Adam W, 1996, ACCOUNTS CHEM RES, V29, P275, DOI 10.1021/ar950164y; Huang H, 2012, GREEN CHEM, V14, P930, DOI 10.1039/c2gc16681j; Jin XK, 2013, ORG BIOMOL CHEM, V11, P3776, DOI 10.1039/c3ob40388b; Ushakov DB, 2014, ANGEW CHEM INT EDIT, V53, P557, DOI 10.1002/anie.201307778; Nakayama H, 2007, TETRAHEDRON LETT, V48, P1131, DOI 10.1016/j.tetlet.2006.12.065; Stratakis M, 2000, TETRAHEDRON, V56, P1595, DOI 10.1016/S0040-4020(99)00950-3; Prades A, 2011, ORGANOMETALLICS, V30, P1162, DOI 10.1021/om101145y; He LP, 2012, ORGANOMETALLICS, V31, P5208, DOI 10.1021/om300422v; Eissen M, 2002, ANGEW CHEM INT EDIT, V41, P414, DOI 10.1002/1521-3773(20020201)41:3<414::AID-ANIE414>3.0.CO;2-N; Jin J, 2013, ORGANOMETALLICS, V32, P3954, DOI 10.1021/om4004412; Liu LH, 2011, CHEM COMMUN, V47, P10148, DOI 10.1039/c1cc13202d; Largeron M, 2013, SCIENCE, V339, P43, DOI 10.1126/science.1232220; Zhang EL, 2013, ORG LETT, V15, P2704, DOI 10.1021/ol4010118; Hu ZZ, 2012, ORG BIOMOL CHEM, V10, P1618, DOI 10.1039/c2ob06670j; Largeron M, 2012, ANGEW CHEM INT EDIT, V51, P5409, DOI 10.1002/anie.201200587; Li N, 2013, CHEM COMMUN, V49, P5034, DOI 10.1039/c3cc41407h; Su YH, 2014, CHEM-EUR J, V20, P10562, DOI 10.1002/chem.201400283; Clennan EL, 2000, TETRAHEDRON, V56, P9151, DOI 10.1016/S0040-4020(00)00794-8; Miyamura H, 2011, B CHEM SOC JPN, V84, P588, DOI 10.1246/bcsj.20100300; FOOTE CS, 1964, J AM CHEM SOC, V86, P3879, DOI 10.1021/ja01072a060; Prein M, 1996, ANGEW CHEM INT EDIT, V35, P477, DOI 10.1002/anie.199604771; To WP, 2012, ANGEW CHEM INT EDIT, V51, P2654, DOI 10.1002/anie.201108080; Huang L, 2013, J ORG CHEM, V78, P5627, DOI [10.1021/jo400769u, 10.1021/ju769u]; Huang B, 2013, TETRAHEDRON LETT, V54, P2861, DOI 10.1016/j.tetlet.2013.03.098; Lang XJ, 2012, CHEM-EUR J, V18, P2624, DOI 10.1002/chem.201102779; Tada N, 2013, TETRAHEDRON LETT, V54, P256, DOI 10.1016/j.tetlet.2012.11.014; Chu GB, 2010, ORG BIOMOL CHEM, V8, P4716, DOI 10.1039/c0ob00043d; Patil RD, 2011, ADV SYNTH CATAL, V353, P1695, DOI 10.1002/adsc.201100100; Yuan H, 2012, J AM CHEM SOC, V134, P13970, DOI 10.1021/ja306934b; Park JH, 2012, ORG LETT, V14, P5502, DOI 10.1021/ol302584y; Liu LH, 2012, ORG LETT, V14, P5692, DOI 10.1021/ol302708r; Aschwanden L, 2009, CHEMCATCHEM, V1, P111, DOI 10.1002/cctc.200900085; Aschwanden L, 2010, CHEMCATCHEM, V2, P666, DOI 10.1002/cctc.201000092; Chi KW, 2009, SYNTHETIC MET, V159, P26, DOI 10.1016/j.synthmet.2008.07.009; Dhakshinamoorthy A, 2010, CHEMCATCHEM, V2, P1438, DOI 10.1002/cctc.201000175; Haines A. H., 1988, METHODS OXIDATION OR; Hirao T, 1998, J ORG CHEM, V63, P7534, DOI 10.1021/jo980884t; Kanai N, 2010, ORG LETT, V12, P1948, DOI 10.1021/ol1003675; Klan P., 2009, PHOTOCHEMISTRY ORGAN; Mitsumoto Y, 2004, J ORG CHEM, V69, P1256, DOI 10.1021/jo035336g; Nakayama H, 2006, CHEM PHARM BULL, V54, P1620, DOI 10.1248/cpb.54.1620; Naya S, 2005, TETRAHEDRON, V61, P7384, DOI 10.1016/j.tet.2005.05.069; Nobuta T, 2010, SYNLETT, P2335; Nobuta T, 2012, SYNLETT, P2975, DOI 10.1055/s-0032-1317508; Nobuta T, 2011, ORG LETT, V13, P2576, DOI 10.1021/ol200681k; Sheldon R. A., 1981, METAL CATALYZED OXID; Smith M. B., 2007, MARCHS ADV ORGANIC C; So MH, 2011, CHEMCATCHEM, V3, P386, DOI 10.1002/cctc.201000312; Talla A., 2015, ADV SYNTH CATAL, P357, DOI [10.1002/adsc.201401010, DOI 10.1002/ADSC.201401010]; Ushakov DB, 2014, CHEM COMMUN, V50, P12649, DOI 10.1039/c4cc04932b; WASSERMAN HH, 1981, TETRAHEDRON, V37, P1825, DOI 10.1016/S0040-4020(01)97932-3	65	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUL	2015	26	12					1705	1709		10.1055/s-0034-1379923		5	Chemistry, Organic	Chemistry	CM8IX	WOS:000357944300011		
J	Manabe, A; Matsumoto, R; Shinada, T				Manabe, Atsushi; Matsumoto, Ryotaro; Shinada, Tetsuro			Cyclopropanation of (E)-Dehydroaspartic Acid Esters with Furan Derivatives: The Synthesis of Highly Functionalized alpha-2,3-Methanoamino Acid Esters	SYNLETT			English	Article						cyclopropanation; -2; 3-methanoamino acids; furans; dehydroaspartic acid ester	DONOR-SUBSTITUTED FURANS; 2,3-METHANOAMINO ACIDS; AMINO-ACIDS; 2-METHOXYFURAN; 1,2-BIS(TRIFLUOROMETHYL)ETHYLENE-1,2-DICARBONITRILE; CATALYST	Highly functionalized -2,3-methanoamino acid esters were prepared by the cyclopropanation of dehydroaspartic acid esters with 2-methoxyfuran or 2-siloxyfuran derivatives. These reactions proceed smoothly in the absence of any catalysts, bases, additives, or solvents.	[Manabe, Atsushi; Matsumoto, Ryotaro; Shinada, Tetsuro] Osaka City Univ, Grad Sch Sci, Osaka 5588585, Japan	Shinada, T (reprint author), Osaka City Univ, Grad Sch Sci, Osaka 5588585, Japan.	shinada@sci.osaka-cu.ac.jp			MEXT-Japan [23102009]; JSPS KAKENHI-Japan [23228001, 25282233]	This study was financially supported by MEXT-Japan (Grant No. 23102009) and JSPS KAKENHI-Japan (Grant No. 23228001 and 25282233).	ALAMI A, 1993, B SOC CHIM FR, V130, P5; Brackmann F, 2007, CHEM REV, V107, P4493, DOI 10.1021/cr078376j; Maurya RA, 2013, RSC ADV, V3, P15600, DOI 10.1039/c3ra42374c; STAMMER CH, 1990, TETRAHEDRON, V46, P2231; Barluenga J, 2007, CHEM-EUR J, V13, P1326, DOI 10.1002/chem.200601332; BURGESS K, 1994, SYNLETT, P575; Cruz DC, 2005, ARKIVOC, P211; Gaspar P. P., 1971, CARBENE CHEM, V2nd; HUISGEN R, 1994, B SOC CHIM BELG, V103, P349; HUISGEN R, 1994, TETRAHEDRON LETT, V35, P4981, DOI 10.1016/S0040-4039(00)73298-9; Itoh K, 2009, NEW J CHEM, V33, P1127, DOI 10.1039/b814841d; Itoh K, 2006, HETEROCYCLES, V68, P395; Karthik G, 2014, TETRAHEDRON LETT, V55, P7064, DOI 10.1016/j.tetlet.2014.10.137; Kessler SN, 2012, J AM CHEM SOC, V134, P17885, DOI 10.1021/ja308858y; Kusama H, 2002, CHEM LETT, P124, DOI 10.1246/cl.2002.124; MLOSTON G, 1994, J HETEROCYCLIC CHEM, V31, P1279; Sato Y, 2011, TETRAHEDRON LETT, V52, P626, DOI 10.1016/j.tetlet.2010.11.153; Scola PM, 2014, J MED CHEM, V57, P1708, DOI 10.1021/jm401840s; URRUTIADESMAISON G, 1994, TETRAHEDRON LETT, V35, P4977, DOI 10.1016/S0040-4039(00)73297-7	19	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUL	2015	26	12					1710	1714		10.1055/s-0034-1380812		5	Chemistry, Organic	Chemistry	CM8IX	WOS:000357944300012		
J	Kuki, S; Futamura, T; Suzuki, R; Yamamoto, M; Minakawa, M; Kawatsura, M				Kuki, Shihori; Futamura, Takashi; Suzuki, Ryo; Yamamoto, Mitsuaki; Minakawa, Maki; Kawatsura, Motoi			Palladium-Catalyzed Regioselective Hydroalkylation of 2-Fluoroallyl Acetates: Synthesis of Vinylmalonic Acid Ester Derivatives	SYNLETT			English	Article						palladium; catalysis; fluorine; regioselectivity; coupling	ASYMMETRIC ALLYLIC ALKYLATION; KETENE SILYL ACETALS; NUCLEOPHILIC-ATTACK; (PI-ALLYL)PALLADIUM COMPLEXES; CENTRAL CARBON; 2-BROMO(PI-ALLYL)PALLADIUM COMPLEXES; PHENOXIDE ION; FORMIC-ACID; CYCLOPROPANATION; LIGAND	The palladium-catalyzed hydroalkylation of 2-fluoroallyl acetates with the malonate anion and hydride was developed. The reaction proceeded through the C-F bond activation and provided vinylmalonic acid ester derivatives by the regioselective substitutions with the carbon nucleophile and hydride.	[Kuki, Shihori; Futamura, Takashi; Suzuki, Ryo; Yamamoto, Mitsuaki; Minakawa, Maki; Kawatsura, Motoi] Nihon Univ, Coll Humanities & Sci, Dept Chem, Setagaya Ku, Tokyo 1568550, Japan	Kawatsura, M (reprint author), Nihon Univ, Coll Humanities & Sci, Dept Chem, Setagaya Ku, Tokyo 1568550, Japan.	kawatsur@chs.nihon-u.ac.jp			Individual Research Expense of College of Humanities and Sciences at Nihon University	This work was supported by Individual Research Expense of College of Humanities and Sciences at Nihon University for 2014.	Helmchen G, 2000, ACCOUNTS CHEM RES, V33, P336, DOI 10.1021/ar9900865; Hayashi T, 1999, J ORGANOMET CHEM, V576, P195, DOI 10.1016/S0022-328X(98)01058-4; Lu Z, 2008, ANGEW CHEM INT EDIT, V47, P258, DOI 10.1002/anie.200605113; Johannsen M, 1998, CHEM REV, V98, P1689, DOI 10.1021/cr970343o; Trost BM, 2004, J ORG CHEM, V69, P5813, DOI 10.1021/jo0491004; Trost BM, 1996, CHEM REV, V96, P395, DOI 10.1021/cr9409804; Trost BM, 2006, ACCOUNTS CHEM RES, V39, P747, DOI 10.1021/ar040063c; Dai LX, 2003, ACCOUNTS CHEM RES, V36, P659, DOI 10.1021/ar020153m; Shintani R, 2007, J AM CHEM SOC, V129, P14866, DOI 10.1021/ja077236o; Trost BM, 2003, CHEM REV, V103, P2921, DOI 10.1021/cr020027w; Liu W, 2009, J AM CHEM SOC, V131, P8734, DOI 10.1021/ja902410w; Aranyos A, 1997, ORGANOMETALLICS, V16, P1058, DOI 10.1021/om960950m; CARFAGNA C, 1991, J ORG CHEM, V56, P3924, DOI 10.1021/jo00012a027; CARFAGNA C, 1992, J MOL CATAL, V72, P19, DOI 10.1016/0304-5102(92)80026-D; CASTANO AM, 1995, ANGEW CHEM INT EDIT, V34, P2551, DOI 10.1002/anie.199525511; Dieguez M, 2010, ACCOUNTS CHEM RES, V43, P312, DOI 10.1021/ar9002152; FORMICA M, 1993, J ORGANOMET CHEM, V448, pC6, DOI 10.1016/0022-328X(93)80095-S; Grigg R, 2001, EUR J ORG CHEM, P707; Hartwig J. F., 2010, ORGANOTRANSITION MET, P967; Hayashi T, 1996, CHEM COMMUN, P1767, DOI 10.1039/cc9960001767; HEGEDUS LS, 1980, J ORG CHEM, V45, P5193, DOI 10.1021/jo01313a034; HOFFMANN HMR, 1992, ANGEW CHEM INT EDIT, V31, P234, DOI 10.1002/anie.199202341; HOFFMANN HMR, 1995, ANGEW CHEM INT EDIT, V34, P100, DOI 10.1002/anie.199501001; Kadota J, 2000, ORGANOMETALLICS, V19, P979, DOI 10.1021/om990838z; Kawatsura M, 2000, TETRAHEDRON, V56, P2247, DOI 10.1016/S0040-4020(99)01107-2; Nomada E, 2014, SYNLETT, V25, P1725, DOI 10.1055/s-0033-1339106; Organ MG, 2003, J ORG CHEM, V68, P3918, DOI 10.1021/jo034119c; Organ MG, 1998, J AM CHEM SOC, V120, P9283, DOI 10.1021/ja9801442; Organ MG, 2002, TETRAHEDRON LETT, V43, P8989, DOI 10.1016/S0040-4039(02)02183-4; Organ MG, 1997, TETRAHEDRON LETT, V38, P8181, DOI 10.1016/S0040-4039(97)10252-0; OTTE AR, 1994, ANGEW CHEM INT EDIT, V33, P1280, DOI 10.1002/anie.199412801; Satake A, 1999, CHEM LETT, P49; Satake A, 1998, J AM CHEM SOC, V120, P10391, DOI 10.1021/ja982269c; Trost B. M., 2000, CATALYTIC ASYMMETRIC, P593; Tsuji J., 2004, PALLADIUM REAGENTS C, P431; Yamamoto M, 2014, ORG LETT, V16, P700, DOI 10.1021/ol500121z	36	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUL	2015	26	12					1715	1719		10.1055/s-0034-1380747		5	Chemistry, Organic	Chemistry	CM8IX	WOS:000357944300013		
J	Cheng, JW; Mitomo, H; Otsuka, T; Jeon, SY				Cheng, John W.; Mitomo, Hitoshi; Otsuka, Tokio; Jeon, Stefan Y.			The effects of ICT and mass media in post-disaster recovery - A two model case study of the Great East Japan Earthquake	TELECOMMUNICATIONS POLICY			English	Article						Great East Japan Earthquake; Post-disaster recovery; Mass media; Social media; ICT media; Social capital	CIVIC ENGAGEMENT; INTERNET USE; PANEL-DATA; PARTICIPATION; TRUST; COMMUNICATION; TELEVISION; DISASTER	Acknowledging that both ICT and mass media had played an influential role after the Great East Japan Earthquake, this study explores if they can also contribute to longer term post-disaster recovery. From the literature review, it is anticipated that the use of both media can positively effect social capital and civic participation, which are essential for an efficient recovery. However, as this can be questioned it is important to understand and demonstrate how media can affect people's perception and behaviour in post-disaster recovery, especially considering the current complex media environment. The two media in consideration are very different, but at the same time are highly intertwined. Currently, few previous studies on this question can be found because suitable case studies limited as nature disaster of such a scale rarely occur and the media environment is rapidly changing. This study proposes a two-model approach to examine the effects of ICT and mass media in post-disaster recovery from two different perspectives in media studies: the active and passive audience perspectives. Using data collected from the three prefectures that were directly hit by the disaster, the results of the two models demonstrate a consistent pattern that the use of both ICT and mass media can create positive effects in post-disaster recovery. They increase the level of social capital through building bonding trust, network bridging and civic participation, as well as increase a person's intention to participate in post-disaster related activities. Thus, it can now be argued that both ICT and mass media can have positively contributed to the recovery. These findings have important implications for NGOs as well as policy makers that are working on the recovery. The two models also serve as the foundation for future studies that would further explore the underlying mechanisms of the media's effect and role in post-disaster recovery. (C) 2015 Elsevier Ltd. All rights reserved.	[Mitomo, Hitoshi] Waseda Univ, Grad Sch Asia Pacific Studies, Shinjuku Ku, Tokyo 1690051, Japan; [Otsuka, Tokio] Shumei Univ, Fac English & IT Management, Yachiyo City, Chiba 2760003, Japan; [Cheng, John W.; Jeon, Stefan Y.] Waseda Univ, Inst Asia Pacific Studies, Shinjuku Ku, Tokyo 1690051, Japan	Cheng, JW (reprint author), Waseda Univ, Inst Asia Pacific Studies, Shinjuku Ku, Nishi Waseda Bldg 7F,1-21-1 Nishi Waseda, Tokyo 1690051, Japan.	cwljwc@aoni.waseda.jp; mitomo@waseda.jp; tokio.otsuka@gmail.com; garomin21@gmail.com			Japan Commercial Broadcasters Association	The Internet survey in this study is sponsored by the Japan Commercial Broadcasters Association.	Aldrich D. P., 2012, BUILDING RESILIENCE; Beaudoin CE, 2007, COMMUN RES, V34, P637, DOI 10.1177/0093650207307902; Hawkins RL, 2010, BRIT J SOC WORK, V40, P1777, DOI 10.1093/bjsw/bcp087; Valenzuela S, 2009, J COMPUT-MEDIAT COMM, V14, P875, DOI 10.1111/j.1083-6101.2009.01474.x; Yabe Hirooki, 2014, Fukushima J Med Sci, V60, P57, DOI 10.5387/fms.2014-1; [Anonymous], 2014, NHK NEWSWEB     0308; Shah DV, 2007, J COMMUN, V57, P676, DOI 10.1111/j.1460-2466.2007.00363.x; Sobel J, 2002, J ECON LIT, V40, P139; Quan-Haase A, 2014, HBK COMMUN MEDIA, P269; Shah DV, 1998, POLIT PSYCHOL, V19, P469, DOI 10.1111/0162-895X.00114; Shaw R, 2004, DISASTERS, V28, P16, DOI 10.1111/j.0361-3666.2004.00241.x; Boulianne S, 2009, POLIT COMMUN, V26, P193, DOI 10.1080/10584600902854363; Putnam RD, 2007, SCAND POLIT STUD, V30, P137, DOI 10.1111/j.1467-9477.2007.00176.x; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; [Anonymous], 2011, BBC NEWS ASIA   1224; Portes A, 2000, SOCIOL FORUM, V15, P1, DOI 10.1023/A:1007537902813; GERBNER G, 1980, J COMMUN, V30, P10, DOI 10.1111/j.1460-2466.1980.tb01987.x; Eveland WP, 2005, POLIT COMMUN, V22, P423, DOI 10.1080/10584600500311345; Biocca F. A., 1988, COMMUNICATION YB, V11, P51; BOLLEN KA, 1992, SOCIOL METHOD RES, V21, P205, DOI 10.1177/0049124192021002004; Cabinet Office, 2013, SAIG YOENG NO HIN SH; CASTELLS M, 2007, INT J COMMUNICATION, V0001; Cheng J. W., 2014, J INFORM COMMUNICATI, V32, P51; Couper MP, 2000, PUBLIC OPIN QUART, V64, P464, DOI 10.1086/318641; Deguchi X., 2011, KOREIKA TO JINKO GEN; Dentsu Marketing Insight, 2013, SEIK ISH TEIT KANS C; Ellison N., 2011, NEW MEDIA SOC, P1; Everitt B. S, 2002, CAMBRIDGE DICT STAT; George Darren, 2013, IBM SPSS STAT 21 STE; Gerbner G., 2002, MEDIA EFFECTS ADV TH; Gerbner G., 1988, VIOLENCE TERROR MASS; Goggin G., 2012, NEW TECHNOLOGIES MED; GSMA, 2013, SMART CIT RES LEARN; Halpern D., 2005, SOCIAL CAPITAL; Hill A., 2012, DICT MEDIA COMMUNICA, V8th; Hooghe M, 2002, HARV INT J PRESS-POL, V7, P84, DOI 10.1177/1081180X02007002006; Ichikawa Y., 2013, J POLITICAL SCI SOCI, V18, P93; Impress Japan, 2012, INT HAK 2012 MOB TO; Inoguchi T., 2000, JAPANESE J POLITICAL, V1, P73, DOI 10.1017/S1468109900000141; Inoue T., 2012, JOHO SHORI GAKKAI KE, P1; Katz JE, 2002, SOCIAL CONSEQUENCES; Kenny D. A., 2014, MEASURING MODEL FIT; Kittilson M. C., 2010, POLITICAL BEHAV, V33, P625; Kweit MG, 2004, AM REV PUBLIC ADM, V34, P354, DOI 10.1177/0275074004268573; Lowrey W., 2004, MASS COMMUNICATION S, V7, P339, DOI DOI 10.1207/S15327825MCS0703_5; Manabe N., 2013, ASIA PACIFIC J, V11, P3; Mayunga J. S., 2007, UNDERSTANDING APPL C; McQuail D., 1972, SOCIOLOGY MASS COMMU; MIC, 2012, WHIT PAP INF COMM JA; MIC, 2007, 2007 EMPL STAT SURV; MIC, 2010, 2010 POP CENS; MIC, 2011, 2011 WHIT PAP INF CO; Mitomo H., 2012, ITS 2012 19 BIENN C; Mitomo H., 2013, INT TEL SOC ITS 24 E; Miyata K, 2008, ASIAN J SOC PSYCHOL, V11, P42, DOI 10.1111/j.1467-839X.2007.00242.x; Miyata K., 2008, SOCIAL CAPITAL INT R, P206; Nakagawa Yuko, 2004, INT J MASS EMERGENCI, V22, P5; Nakayachi K., 2014, J RISK RES; Nanba Y., 2011, TOYO DAIGAKU PPP KEN, V2, P118; O&rsquo;reilly T., 2005, WHAT IS WEB 2 0 DESI; Otani Yuki, 2012, Keio J Med, V61, P35; Putnam R., 2000, BOWLING ALONE COLLAP; Putnam RD, 1993, MAKING DEMOCRACY WOR; Rainie L., 2012, SOCIAL MEDIA POLITIC; Rainie L., 2011, SOCIAL SIDE INTERNET; Reconstruction Agency, 2013, CURR STAT PATH REC M; Reconstruction Agency, 2014, FUKK NO GENJ 26 AUG; Riad J. K., 1998, HURRICANE THREAT EVA; Sakamoto M., 2012, JAPAN SOCIAL INNOVAT, V2, P26; Samuels R. J., 2013, DISASTER CHANGE JAPA; Shah DV, 2005, COMMUN RES, V32, P531, DOI 10.1177/0093650505279209; Shaw R, 2004, DISASTER PREVENTION, V13, P39, DOI 10.1108/09653560410521689; Shaw R, 2014, ENVIR HAZARD, P391, DOI 10.1007/978-3-319-04468-2_22; Slater D. H., 2012, NATURAL DISASTER NUC, P94; Tabachnick B. G., 2013, USING MULTIVARIATE S; Tanaka M., 2012, SAIGAI JAKUSHA TO JO; Todd H., 2011, NATURAL DISASTER RES; Uslaner EM, 2004, POLIT COMMUN, V21, P223, DOI 10.1080/10584600490443895; Watson J., 1998, MEDIA COMMUNICATION; Yamamoto K., 2013, J EARTH SCI ENG, V3, P190; Yamamura E., 2014, EFFECT MAJOR DISASTE; Yang S., 2009, SOCIAL CAPITAL INFOR, V25, P183; Yates D., 2010, INTERNATIONAL JOURNA, V31, P6, DOI DOI 10.1016/J.IJINF0MGT.2010.10.001; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102497	84	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0308-5961	1879-3258		TELECOMMUN POLICY	Telecommun. Policy	JUL	2015	39	6			SI		515	532		10.1016/j.telpol.2015.03.006		18	Communication; Information Science & Library Science; Telecommunications	Communication; Information Science & Library Science; Telecommunications	CN0GI	WOS:000358091700007		
J	Cato, S				Cato, Susumu			Conditions on social-preference cycles	THEORY AND DECISION			English	Article						Voting mechanism; Social-preference cycle; Voting paradox; Decisiveness; Generalization	COLLECTIVE CHOICE RULES; CONDORCETS-PARADOX; ACYCLIC CHOICE; VETO	Since Condorcet discovered the voting paradox in the simple majority rule, many scholars have tried to investigate conditions that yield "social-preference cycles". The paradox can be extended to two main approaches. On the one hand, Kenneth Arrow developed a general framework of social choice theory; on the other hand, direct generalizations of the paradox were offered. The motivation and surface meaning of the two approaches are different, as are the assumed background conditions. In this paper, we investigate the relationship between the two approaches by taking a close look at two works, Ferejohn and Fishburn (J Econ Theory 21:28-45, 1979) and Schwartz (J Econ Theory 137:688-695, 2007).	Univ Tokyo, Inst Social Sci, Bunkyo Ku, Tokyo 1130033, Japan	Cato, S (reprint author), Univ Tokyo, Inst Social Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	susumu.cato@gmail.com			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology	I am grateful to anonymous referees, Tomohiko Kawamori, Toyotaka Sakai, Tomoichi Shinotsuka, and Kotaro Suzumura for helpful comments. This paper was financially supported by Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology.	SUZUMURA K, 1976, ECONOMICA, V43, P381, DOI 10.2307/2553273; YOUNG HP, 1974, J ECON THEORY, V9, P43, DOI 10.1016/0022-0531(74)90073-8; SEN A, 1979, ECON J, V89, P537, DOI 10.2307/2231867; KELSEY D, 1985, SOC CHOICE WELFARE, V2, P131, DOI 10.1007/BF00437313; BLAIR DH, 1982, ECONOMETRICA, V50, P931, DOI 10.2307/1912770; LEBRETON M, 1995, SOC CHOICE WELFARE, V12, P43; Arrow K. J., 1951, 1963 SOCIAL CHOICE I; BANKS JS, 1995, SOC CHOICE WELFARE, V12, P293; Bossert W, 2008, J ECON THEORY, V138, P311, DOI 10.1016/j.jet.2007.05.004; Brams S., 2002, HDB SOCIAL CHOICE WE, V1, P173, DOI 10.1016/S1574-0110(02)80008-X; BROWN DJ, 1975, Q J ECON, V89, P456, DOI 10.2307/1885263; Cato S, 2010, SOC CHOICE WELFARE, V34, P611, DOI 10.1007/s00355-009-0420-6; FEREJOHN JA, 1979, J ECON THEORY, V21, P28, DOI 10.1016/0022-0531(79)90004-8; GEHRLEIN WV, 1983, THEOR DECIS, V15, P161, DOI 10.1007/BF00143070; GEHRLEIN WV, 1976, PUBLIC CHOICE, V26, P1, DOI 10.1007/BF01725789; Gibbard AF, 2014, ECON PHILOS, V30, P269, DOI 10.1017/S026626711400025X; KELSEY D, 1984, REV ECON STUD, V51, P693, DOI 10.2307/2297787; MASCOLEL.A, 1972, REV ECON STUD, V39, P185, DOI 10.2307/2296870; Nakamura K., 1979, International Journal of Game Theory, V8, DOI 10.1007/BF01763051; RIKER WH, 1961, AM POLIT SCI REV, V55, P900, DOI 10.2307/1952537; Sanver MR, 2010, ECON LETT, V107, P354, DOI 10.1016/j.econlet.2010.03.002; Schwartz T, 2007, J ECON THEORY, V137, P688, DOI 10.1016/j.jet.2006.06.002; Sen A, 1970, COLLECTIVE CHOICE SO; Szpilrajn S., 1930, FUND MATH, V16, P386; TRUCHON M, 1995, MATH SOC SCI, V29, P165, DOI 10.1016/0165-4896(94)00770-9; Truchon M., 1996, J ECON THEORY, V69, P447, DOI 10.1006/jeth.1996.0063; Tullock G, 2005, PUBLIC CHOICE, V123, P49, DOI 10.1007/s11127-005-7905-3; Ward B., 1961, J CONFLICT RESOLUT, V5, P380; WEBER JS, 1993, PUBLIC CHOICE, V77, P415, DOI 10.1007/BF01047879; YOUNG HP, 1988, AM POLIT SCI REV, V82, P1231, DOI 10.2307/1961757	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0040-5833	1573-7187		THEOR DECIS	Theory Decis.	JUL	2015	79	1					1	13		10.1007/s11238-014-9457-9		13	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	CM9ZM	WOS:000358070200001		
J	Ida, Y; Yofune, M; Ahn, CJ; Matsumoto, T; Matsufuji, S				Ida, Yuta; Yofune, Masanori; Ahn, Chang-Jun; Matsumoto, Takahiro; Matsufuji, Shinya			Estimation based on weighted channel variance for HTRCI-MIMO/OFDM with QRM-MLD and channel ranking under fast fading Channel	TRANSACTIONS ON EMERGING TELECOMMUNICATIONS TECHNOLOGIES			English	Article							OFDM SYSTEMS	To achieve more high-speed communication systems, multiple-input multiple-output orthogonal frequency division multiplexing (MIMO/OFDM) is adopted in several standardisations. On the other hand, the conventional MIMO/OFDM requires many pilot signals to estimate the channel state information (CSI). To achieve an accurate CSI with the small number of pilot signals, high time resolution carrier interferometry (HTRCI) for MIMO/OFDM has been proposed. Moreover, QR decomposition with M-algorithm maximum likelihood detection (QRM-MLD) and channel ranking has been proposed to achieve both the reducing complexity and the improving system performance. However, the conventional HTRCI-MIMO/OFDM with the QRM-MLD and channel ranking did not consider the problem of the fast fading channel. In the fast fading environment, many errors are caused in the last part of the packet. To overcome this problem, the decision-direct method has been proposed. However, it requires large complexity because of the iterative processing. Therefore, in this paper, we propose the non-linear prediction method for an HTRCI-MIMO/OFDM with the QRM-MLD and channel ranking. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ida, Yuta; Matsumoto, Takahiro; Matsufuji, Shinya] Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan; [Yofune, Masanori] Hiroshima City Univ, Grad Sch Informat Sci, Asaminami Ku, Hiroshima 7313194, Japan; [Ahn, Chang-Jun] Chiba Univ, Grad Sch Engn, Inage Ku, Chiba 2638522, Japan	Ida, Y (reprint author), Yamaguchi Univ, Grad Sch Sci & Engn, 2-16-1 Tokiwadai, Ube, Yamaguchi 7558611, Japan.	y.ida@yamaguchi-u.ac.jp					Abeta S., 2010, P IEEE INT C COMM SY, P146; Ahn CJ, 2010, WIRELESS PERS COMMUN, V55, P485, DOI 10.1007/s11277-009-9811-3; Kim KJ, 2005, IEEE T WIREL COMMUN, V4, P710, DOI 10.1109/TWC.2004.842951; Zhang ZS, 2009, IEEE T VEH TECHNOL, V58, P3447, DOI 10.1109/TVT.2009.2016345; Akino TK, 2008, IEEE T WIREL COMMUN, V7, P4248, DOI 10.1109/T-WC.2008.070497; CIMINI LJ, 1985, IEEE T COMMUN, V33, P665, DOI 10.1109/TCOM.1985.1096357; Zhang ZS, 2009, IEEE T WIREL COMMUN, V8, P4450, DOI 10.1109/TWC.2009.081525; Ghosh A, 2010, IEEE WIREL COMMUN, V17, P10, DOI 10.1109/MWC.2010.5490974; Ahn CJ, 2010, DIGIT SIGNAL PROCESS, V20, P1447, DOI 10.1016/j.dsp.2010.01.005; Ida Y, 2012, J ELECT COMPUTER ENG, V2012, P1; Ishigami H, 2009, IEICE T COMMUN, VJ92-B, P424; Kim J, 2005, IEEE T WIREL COMMUN, V4, P550, DOI 10.1109/TWC.2004.843042; Kuchi Kiran, 2012, IEEE Wireless Communications Letters, V1, DOI 10.1109/WCL.2012.050112.120189; Lee KI, 2007, IEICE T COMMUN, VE90B, P2964, DOI 10.1093/ietcom/e90-b.10.2964; Nojima D., 2012, P INT C ADV COMM TEC, P804; Radji D, 2012, T EMERG TELECOMMUN T, V24, P166; Sasaki S, 2011, IEICE T COMMUN, VJ94-B, P245; Shen Z, 2006, EURASIP J WIREL COMM, V2006, P1, DOI 10.1155/WCN/2006/16281; Soejima S, 2013, J SIGNAL PROCESSING, V17, P41; Takahashi M, 2008, IEICE TECHICAL R RCS, VRCS2008, P37; Yofune M, 2009, FAR E J ELECT COMMUN, V3, P35; Yofune M, 2009, P WPMC 09 S26 4 SEP, P1; Yoshimura T, 2013, IEICE TECHNICAL R CS, VCS2012, P9; Zelst A.V., 2000, P IEEE VTC 2000 SPRI, P1070; Zhang ZS, 2008, IEEE T WIREL COMMUN, V7, P2329, DOI 10.1109/TWC.2008.070044	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2161-3915			T EMERG TELECOMMUN T	Trans. Emerg. Telecommun. Technol.	JUL	2015	26	7					1050	1059		10.1002/ett.2807		10	Telecommunications	Telecommunications	CM7PC	WOS:000357886000005		
J	Nam, E; Fujita, N; Morita, M; Tsuzuki, K; Lin, HY; Chung, CS; Nakagawa, T; Nishimura, R				Nam, Eunryel; Fujita, Naoki; Morita, Maresuke; Tsuzuki, Keiko; Lin, Hsing Yi; Chung, Cheng Shu; Nakagawa, Takayuki; Nishimura, Ryohei			Comparison of the canine corneal epithelial cell sheets cultivated from limbal stem cells on canine amniotic membrane, atelocollagen gel, and temperature-responsive culture dish	VETERINARY OPHTHALMOLOGY			English	Article						amniotic membrane; collagen gel; corneal epithelium; dog; limbus; temperature-responsive culture dish	EX-VIVO; TRANSPLANTATION; TISSUE; GLUTARALDEHYDE; DEFICIENCY; NICHE; DIFFERENTIATION; PRESERVATION; EXPANSION; EXPOSURE	ObjectiveThe current study compared canine corneal epithelial cell sheets cultivated from limbal stem cells on amniotic membrane, atelocollagen gel, and temperature-responsive culture dish. ProceduresWe collected limbal epithelial cells from the intact eyes of beagles and cultivated the cells on denuded canine amniotic membranes, temperature-responsive cell culture labware, and collagen gel with 3T3 feeder cells. Immunofluorescence staining for Ki-67 was used to analyze the capacity of cell proliferation in the sheets. Immunofluorescence staining was also performed for the corneal epithelium-specific marker cytokeratin 3 and putative stem cell markers ABCG2 and p63. Reverse-transcription polymerase chain reaction (RT-PCR) was performed to detect ABCG2 and p63. ResultsThe growth rates of the cultivated cells, or the times it took them to reach confluency, were different for the three scaffolds. The cultivated sheet on the temperature-responsive dish consisted of 2-3 layers, while those on the collagen gel and on the amniotic membrane consisted of 5-8 layers. The basal layer cells grown on all three scaffolds expressed putative stem cell markers. In real-time RT-PCR analysis, the highest level of p63 was observed in the sheets grown on collagen gel. ConclusionsIn this study, the cells cultured on the collagen gel demonstrated a capacity for cell proliferation, and the expressions of stem cells in the sheets suggested that collagen gel is the most suitable carrier for clinical use.	[Nam, Eunryel; Fujita, Naoki; Morita, Maresuke; Tsuzuki, Keiko; Lin, Hsing Yi; Chung, Cheng Shu; Nakagawa, Takayuki; Nishimura, Ryohei] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Surg, Tokyo, Japan	Nam, E (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Surg, Tokyo, Japan.	eunryelnam@gmail.com					Nam E, 2013, VET OPHTHALMOL, V16, P263, DOI 10.1111/j.1463-5224.2012.01070.x; Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Tseng SCG, 2002, ADV EXP MED BIOL, V506, P1323; Du YQ, 2003, MOL VIS, V9, P635; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Castro-Munozledo F, 2013, MOL VIS, V19, P1600; Grueterich M, 2002, OPHTHALMOLOGY, V109, P1547, DOI 10.1016/S0161-6420(02)01105-3; Pauklin M, 2010, DEV OPHTHALMOL, V45, P57, DOI 10.1159/000315020; Takigawa T, 2006, J OCCUP HEALTH, V48, P75, DOI 10.1539/joh.48.75; Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Shah A, 2008, PEDIATR RES, V63, P535, DOI 10.1203/PDR.0b013e31816bdf54; Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5130, DOI 10.1167/iovs.03-0584; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Ballantyne B, 2001, VET HUM TOXICOL, V43, P193; Galindo EEH, 2003, INVEST OPHTH VIS SCI, V44, P2959, DOI 10.1167/iovs.02-0776; HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96; Ke QC, 2011, J TISSUE ENG REGEN M, V5, P138, DOI 10.1002/term.298; Krishnan S, 2012, ARTIF ORGANS, V36, P829, DOI 10.1111/j.1525-1594.2012.01452.x; Li W, 2008, INVEST OPHTH VIS SCI, V49, P154, DOI 10.1167/iovs.07-0883; Mi Shengli, 2013, Methods Mol Biol, V1014, P143, DOI 10.1007/978-1-62703-432-6_9; Nagayasu A, 2008, CURR EYE RES, V33, P727, DOI 10.1080/02713680802326606; Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002.0109; Schantz B, 1977, BIBLIOTHECA ANATOM 2, p[16, 269]; Schwab IR, 2000, AM J OPHTHALMOL, V130, P543, DOI 10.1016/S0002-9394(00)00747-9; Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8; Tsai RJ, 2000, AM J OPHTHALMOL, V130, P543, DOI 10.1016/S0002-9394(00)00746-7; Wang DY, 2003, INVEST OPHTH VIS SCI, V44, P4698, DOI 10.1167/iovs.03-0272; Yang J, 2006, J DRUG TARGET, V14, P471, DOI 10.1080/10611860600847997; Zhang Y, 2012, INVEST OPHTH VIS SCI, V53, P2414, DOI 10.1167/iovs.11-8869	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1463-5216	1463-5224		VET OPHTHALMOL	Vet. Ophthalmol.	JUL	2015	18	4					317	325		10.1111/vop.12241		9	Veterinary Sciences	Veterinary Sciences	CM8UN	WOS:000357977700009		
J	Key, TJ; Appleby, PN; Reeves, GK; Travis, RC; Brinton, LA; Dallal, CM; Helzlsouer, KJ; Hoffman-Bolton, J; Visvanathan, K; Dorgan, JF; Falk, RT; Gapstur, SM; Gaudet, MM; Kaaks, R; Riboli, E; Rinaldi, S; Key, T; Manjer, J; Hallmans, G; Giles, GG; Le Marchand, L; Kolonel, LN; Henderson, BE; Tworoger, SS; Hankinson, SE; Zeleniuch-Jacquotte, A; Koenig, K; Krogh, V; Sieri, S; Muti, P; Ziegler, RG; Schairer, C; Fuhrman, BJ; Barrett-Connor, E; Laughlin, GA; Grant, EJ; Cologne, J; Ohishi, W; Hida, A; Cauley, JA; Fourkala, EO; Rohan, TE; Strickler, HD; Gunter, MJ				Key, T. J.; Appleby, P. N.; Reeves, G. K.; Travis, R. C.; Brinton, L. A.; Dallal, C. M.; Helzlsouer, K. J.; Hoffman-Bolton, J.; Visvanathan, K.; Dorgan, J. F.; Falk, R. T.; Gapstur, S. M.; Gaudet, M. M.; Kaaks, R.; Riboli, E.; Rinaldi, S.; Key, T.; Manjer, J.; Hallmans, G.; Giles, G. G.; Le Marchand, L.; Kolonel, L. N.; Henderson, B. E.; Tworoger, S. S.; Hankinson, S. E.; Zeleniuch-Jacquotte, A.; Koenig, K.; Krogh, V.; Sieri, S.; Muti, P.; Ziegler, R. G.; Schairer, C.; Fuhrman, B. J.; Barrett-Connor, E.; Laughlin, G. A.; Grant, E. J.; Cologne, J.; Ohishi, W.; Hida, A.; Cauley, J. A.; Fourkala, E.-O.; Rohan, T. E.; Strickler, H. D.; Gunter, M. J.		Endogenous Hormones & Breast	Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies	STEROIDS			English	Article						Breast cancer; Estradiol; Body mass index; Extraction immunoassay; Direct immunoassay; Mass spectrometry	ESTROGEN METABOLISM; SERUM ESTRADIOL; TESTOSTERONE; ANDROGEN; SHBG	Epidemiological studies have examined breast cancer risk in relation to sex hormone concentrations measured by different methods: "extraction" immunoassays (with prior purification by organic solvent extraction, with or without column chromatography), "direct" immunoassays (no prior extraction or column chromatography), and more recently with mass spectrometry-based assays. We describe the associations of estradiol, estrone and testosterone with both body mass index and breast cancer risk in postmenopausal women according to assay method, using data from a collaborative pooled analysis of 18 prospective studies. In general, hormone concentrations were highest in studies that used direct assays and lowest in studies that used mass spectrometry-based assays. Estradiol and estrone were strongly positively associated with body mass index, regardless of the assay method; testosterone was positively associated with body mass index for direct assays, but less clearly for extraction assays, and there were few data for mass spectrometry assays. The correlations of estradiol with body mass index, estrone and testosterone were lower for direct assays than for extraction and mass spectrometry assays, suggesting that the estimates from the direct assays were less precise. For breast cancer risk, all three hormones were strongly positively associated with risk regardless of assay method (except for testosterone by mass spectrometry where there were few data), with no statistically significant differences in the trends, but differences may emerge as new data accumulate. Future epidemiological and clinical research studies should continue to use the most accurate assays that are feasible within the design characteristics of each study. (C) 2014 The Authors. Published by Elsevier Inc.	[Key, T. J.; Appleby, P. N.; Reeves, G. K.; Travis, R. C.; Key, T.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford OX3 7LF, England; [Brinton, L. A.] Natl Canc Inst, Hormonal & Reproduct Epidemiol Branch, Bethesda, MD USA; [Dallal, C. M.] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD USA; [Helzlsouer, K. J.] Mercy Med Ctr, Prevent & Res Ctr, Baltimore, MD USA; [Hoffman-Bolton, J.; Visvanathan, K.] Johns Hopkins Univ, George W Comstock Ctr Public Hlth Res & Prevent, Hagerstown, MD USA; [Dorgan, J. F.] Univ Maryland, Sch Med, Baltimore, MD USA; [Falk, R. T.] Natl Canc Inst, Div Canc Epidemiol & Genet, Hormonal & Reproduct Epidemiol Branch, Bethesda, MD USA; [Gapstur, S. M.; Gaudet, M. M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA USA; [Kaaks, R.] DKFZ, Heidelberg, Germany; [Riboli, E.; Gunter, M. J.] Imperial Coll, Sch Publ Hlth, London, England; [Rinaldi, S.] Int Agcy Res Canc, Lyon, France; [Manjer, J.] Malmo Univ Hosp, Dept Surg, Malmo, Sweden; [Hallmans, G.] Umea Univ Hosp, Dept Clin Med & Publ Hlth, Umea, Sweden; [Giles, G. G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Le Marchand, L.; Kolonel, L. N.] Univ Hawaii Canc Ctr, Epidemiol Program, Honolulu, HI USA; [Henderson, B. E.] Univ So Calif, Los Angeles, CA USA; [Tworoger, S. S.; Hankinson, S. E.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA USA; [Tworoger, S. S.; Hankinson, S. E.] Harvard Med Sch, Boston, MA USA; [Tworoger, S. S.; Hankinson, S. E.] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hankinson, S. E.] Univ Massachusetts, Div Biostat & Epidemiol, Amherst, MA USA; [Zeleniuch-Jacquotte, A.; Koenig, K.] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Krogh, V.; Sieri, S.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Muti, P.] McMaster Univ, Dept Oncol, Hamilton, ON, Canada; [Ziegler, R. G.; Schairer, C.] Natl Canc Inst, Div Canc Epidemiol & Genet, Epidemiol & Biostat Program, Bethesda, MD USA; [Fuhrman, B. J.] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Epidemiol, Little Rock, AR USA; [Barrett-Connor, E.; Laughlin, G. A.] Univ Calif San Diego, Dept Family & Prevent Med, Div Epidemiol, San Diego, CA USA; [Grant, E. J.] Radiat Effects Res Fdn, Dept Epidemiol, Hiroshima, Nagasaki, Japan; [Cologne, J.] Radiat Effects Res Fdn, Dept Stat, Hiroshima, Nagasaki, Japan; [Ohishi, W.; Hida, A.] Radiat Effects Res Fdn, Dept Clin Studies, Hiroshima, Nagasaki, Japan; [Cauley, J. A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA USA; [Fourkala, E.-O.] UCL, Inst Womens Hlth, Womens Canc, London, England; [Rohan, T. E.; Strickler, H. D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA	Key, TJ (reprint author), Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Endogenous Hormones & Breast Canc Collaborat Grp, Richard Doll Bldg,Roosevelt Dr, Oxford OX3 7LF, England.	tim.key@ceu.ox.ac.uk	Cauley, Jane A/N-4836-2015	Fuhrman, Barbara/0000-0002-1777-9888; Cauley, Jane A/0000-0003-0752-4408	Cancer Research UK [C570/A5028]; National Cancer Institute [R01 CA098661, P30 CA016087]; National Institute of Environmental Health Sciences [ES000260]; National Institute for Health Research University College London Hospitals Biomedical Research Centre	The central pooling and analysis of these data was supported by Cancer Research UK (C570/A5028). Details of funding for the original studies are in the relevant publications. The NYU WHS was supported by National Cancer Institute Grants R01 CA098661 and P30 CA016087 and National Institute of Environmental Health Sciences center grant ES000260.; UKCTOCS researchers were supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.	Dallal CM, 2014, CARCINOGENESIS, V35, P346, DOI 10.1093/carcin/bgt367; Missmer SA, 2004, J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Cauley JA, 1999, ANN INTERN MED, V130, P270; Kaaks R, 2005, ENDOCR-RELAT CANCER, V12, P1071, DOI 10.1677/erc.1.01038; Rosner W, 2013, J CLIN ENDOCR METAB, V98, P1376, DOI 10.1210/jc.2012-3780; Rinaldi S, 2001, CANCER EPIDEM BIOMAR, V10, P757; Hankinson SE, 1998, J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; Berrino F, 1996, J NATL CANCER I, V88, P291, DOI 10.1093/jnci/88.5.291; Stanczyk FZ, 2003, STEROIDS, V68, P1173, DOI 10.1016/j.steroids.2003.08.012; Lee JS, 2006, J CLIN ENDOCR METAB, V91, P3791, DOI 10.1210/jc.2005-2378; Kabuto M, 2000, CANCER EPIDEM BIOMAR, V9, P575; Baglietto L, 2009, BREAST CANCER RES TR, V115, P171, DOI 10.1007/s10549-008-0069-3; Fourkala EO, 2012, ENDOCR-RELAT CANCER, V19, P137, DOI 10.1530/ERC-11-0310; Thomas HV, 1997, BRIT J CANCER, V76, P401, DOI 10.1038/bjc.1997.398; Woolcott CG, 2010, ENDOCR-RELAT CANCER, V17, P125, DOI 10.1677/ERC-09-0211; Fuhrman BJ, 2012, J NATL CANCER I, V104, P326, DOI 10.1093/jnci/djr531; Gunter MJ, 2009, J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Dorgan JF, 1996, CANCER EPIDEM BIOMAR, V5, P533; The Endogenous Hormones and Breast Cancer Collaborative Group, 2002, JNCI-J NATL CANCER I, V94, P606; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Falk RT, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3416; GARLAND CF, 1992, AM J EPIDEMIOL, V135, P1220; Gaudet Mia M, 2013, Int J Mol Epidemiol Genet, V4, P156; Grant EJ, 2011, RADIAT RES, V176, P678, DOI 10.1667/RR2631.1; HELZLSOUER KJ, 1994, CANCER DETECT PREV, V18, P79; Key TJ, 2011, BRIT J CANCER, V105, P709, DOI [10.1038/bjc.2011.254, DOI 10.1038/BJC.2011.254]; Manjer J, 2003, CANCER CAUSE CONTROL, V14, P599, DOI 10.1023/A:1025671317220; Stanczyk FZ, 2007, CANCER EPIDEM BIOMAR, V16, P1713, DOI 10.1158/1055-9965.EPI-06-0765; TONIOLO PG, 1995, J NATL CANCER I, V87, P190, DOI 10.1093/jnci/87.3.190; Zeleniuch-Jacquotte A, 2004, BRIT J CANCER, V90, P153, DOI 10.1038/sj.bjc.6601517; ZeleniuchJacquotte A, 1997, AM J EPIDEMIOL, V145, P1030	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0039-128X	1878-5867		STEROIDS	Steroids	JUL	2015	99		A		SI		49	55		10.1016/j.steroids.2014.09.001		7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CL5FH	WOS:000356984700009		
J	Sekine, K; Yamada, A; Kageyama, H; Igarashi, T; Yamamoto, N; Asami, K				Sekine, Katsuhisa; Yamada, Ayumi; Kageyama, Hitomi; Igarashi, Takahiro; Yamamoto, Nana; Asami, Koji			Numerical calculations for effects of structure of skeletal muscle on frequency-dependence of its electrical admittance and impedance	JOURNAL OF PHYSICS D-APPLIED PHYSICS			English	Article						bio-impedance; finite difference method; dielectric relaxation; interfacial polarization; skeletal muscle	ANISOTROPY; MEAT; CONDUCTIVITY; QUALITY; TISSUE; MODEL	Numerical calculations were carried out by the finite difference method using three-dimensional models to examine effects of the structure of skeletal muscle on the frequency-dependence of its electrical admittance Y and impedance Z in transversal and longitudinal directions. In the models, the muscle cell was represented by a rectangular solid surrounded by a smooth surface membrane, and the cells were assumed to be distributed periodically. The width of the cross section of the cell, thickness of the intercellular medium, and the relative permittivities and the conductivities of the cell interior, the intercellular medium and the surface membrane were changed. Based on the results of the calculations, reported changes in Y and Z of the muscles from 1 kHz to 1 MHz were analyzed. The analyses revealed that a decreased cell radius was reasonable to explain the Y and Z of the muscles of immature rats, rats subjected to sciatic nerve crush at chronic stage and the amyotrophic lateral sclerosis (ALS) mice. Changes in Y and Z due to the sciatic nerve crush at acute stage were attributable to the decreased cell radius, the increased space between the cells, the increased permittivity of the surface membrane and the increased conductivity of the cell interior. The changes in Z due to contraction were explained by the changes in the cell radius, and the conductivities of the cell interior and the intercellular medium. The changes in Z of meat due to aging were compared with the effects of the increase in the conductivity of the surface membrane.	[Sekine, Katsuhisa; Yamada, Ayumi; Kageyama, Hitomi; Igarashi, Takahiro; Yamamoto, Nana] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Asami, Koji] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan	Sekine, K (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Hlth Sci, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9200942, Japan.	sekine@kenroku.kanazawa-u.ac.jp					Ahad MA, 2010, CLIN NEUROPHYSIOL, V121, P882, DOI 10.1016/j.clinph.2010.01.017; Ahad MA, 2009, PHYSIOL MEAS, V30, P1415, DOI 10.1088/0967-3334/30/12/009; Li J, 2012, CLIN NEUROPHYSIOL, V123, P206, DOI 10.1016/j.clinph.2011.06.002; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; Damez JL, 2008, FOOD CONTROL, V19, P931, DOI 10.1016/j.foodcont.2007.09.005; Zagar T, 2008, PHYSIOL MEAS, V29, pS365, DOI 10.1088/0967-3334/29/6/S30; Pliquett U, 2010, FOOD ENG REV, V2, P74, DOI 10.1007/s12393-010-9019-z; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Asami K, 2006, J PHYS D APPL PHYS, V39, P492, DOI 10.1088/0022-3727/39/3/012; FATT P, 1964, PROC R SOC SER B-BIO, V159, P606, DOI 10.1098/rspb.1964.0023; Damez JL, 2013, MEAT SCI, V95, P879, DOI 10.1016/j.meatsci.2013.04.037; Shiffman CA, 2013, PHYSIOL MEAS, V34, P1513, DOI 10.1088/0967-3334/34/11/1513; Asami K, 2007, J PHYS D APPL PHYS, V40, P1128, DOI 10.1088/0022-3727/40/4/033; Bisegna P, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/11/115506; Burkitt H G, 1993, WHEATERS FUNCTIONAL; Chin AB, 2008, MUSCLE NERVE, V37, P560, DOI 10.1002/mus.20981; EPSTEIN BR, 1983, MED BIOL ENG COMPUT, V21, P51, DOI 10.1007/BF02446406; Foster Kenneth R., 1996, P25; Ito Masamitsu, 1998, Journal of Applied Physiology, V85, P1230; GIELEN FLH, 1986, MED BIOL ENG COMPUT, V24, P34, DOI 10.1007/BF02441603; Hart FX, 1999, PHYS MED BIOL, V44, P413, DOI 10.1088/0031-9155/44/2/009; Ishikawa H, 1983, HDB PHYSL 10, P1; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045004; Lieber RL, 2010, SKELETAL MUSCLE STRU; Martini F H, 2000, HUMAN ANATOMY; Nakamura T, 2013, J PHYS CONF SER, V434, DOI 10.1088/1742-6596/434/1/012070; Pliquett U, 2003, MEAT SCI, V65, P1429, DOI 10.1016/S0309-1740(03)00066-4; ROTH BJ, 1988, MATH BIOSCI, V88, P159, DOI 10.1016/0025-5564(88)90041-7; SCHWAN H, 1954, Z NATURFORSCH B, V9, P245; Shiffman CA, 2003, PHYSIOL MEAS, V24, P213, DOI 10.1088/0967-3334/24/1/316; Stratton J. A., 1941, ELECTROMAGNETIC THEO; Vanysek P, 1998, CRC HDB CHEM PHYSICS, P5; von Hippel A, 1995, DIELECTRIC MAT APPL, P291; Wang LL, 2011, IEEE T BIO-MED ENG, V58, P1585, DOI 10.1109/TBME.2011.2104957	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0022-3727	1361-6463		J PHYS D APPL PHYS	J. Phys. D-Appl. Phys.	JUL 1	2015	48	25							255401	10.1088/0022-3727/48/25/255401		15	Physics, Applied	Physics	CJ1HC	WOS:000355233600012		
J	Sawamura, K; Furuhata, T; Sekine, Y; Kikuchi, E; Subramanian, B; Matsukata, M				Sawamura, Ken-ichi; Furuhata, Taisuke; Sekine, Yasushi; Kikuchi, Eiichi; Subramanian, Bharathi; Matsukata, Masahiko			Zeolite Membrane for Dehydration of Isopropylalcohol-Water Mixture by Vapor Permeation	ACS APPLIED MATERIALS & INTERFACES			English	Article						zeolite membrane; pervaporation; vapor permeation; separation and purification	FAUJASITE MEMBRANES; SEPARATION; PERVAPORATION; PERFORMANCE; PARAMETERS; OPERATION; SOLVENTS	Highly stable FAU-type zeolite membrane for the separation of isopropanol (IPA)-water mixture by pervaporation is described. FAU membrane showed high water permselectivity and permeance. Comparison of FAU membrane with a conventional LTA-type zeolite membrane revealed superior stability of FAU zeolite membrane in a mixture containing a large water content.	[Sawamura, Ken-ichi; Furuhata, Taisuke; Sekine, Yasushi; Kikuchi, Eiichi; Subramanian, Bharathi; Matsukata, Masahiko] Waseda Univ, Dept Appl Chem, Shinjuku Ku, Tokyo 1698555, Japan; [Sekine, Yasushi; Kikuchi, Eiichi; Subramanian, Bharathi; Matsukata, Masahiko] Waseda Univ, Adv Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Matsukata, Masahiko] Waseda Univ, CREST, JST, Shinjuku Ku, Tokyo 1698555, Japan	Matsukata, M (reprint author), Waseda Univ, Dept Appl Chem, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	mmatsu@waseda.jp		Subramanian, Bharathi/0000-0002-6870-2645	NEDO; CREST, Japan	This work was performed as a part of a research project "Green and sustainable chemistry/fundamental development of ordered-nanoporous membranes for highly-refined separation technology" supported by NEDO, and CREST, Japan.	Sato K, 2007, MICROPOR MESOPOR MAT, V101, P312, DOI 10.1016/j.micromeso.2006.12.021; Kita H, 2001, SEP PURIF TECHNOL, V25, P261, DOI 10.1016/S1383-5866(01)00110-1; Gu XH, 2005, IND ENG CHEM RES, V44, P937, DOI 10.1021/ie049263i; Kondo M, 2010, J MEMBRANE SCI, V361, P223, DOI 10.1016/j.memsci.2010.05.048; Algieri C, 2009, MICROPOR MESOPOR MAT, V119, P129, DOI 10.1016/j.micromeso.2008.10.008; Sato K, 2008, J MEMBRANE SCI, V310, P161, DOI 10.1016/j.memsci.2007.10.047; Kumakiri I, 1999, IND ENG CHEM RES, V38, P4682, DOI 10.1021/ie9902683; Sommer S, 2005, CHEM ENG SCI, V60, P4509, DOI 10.1016/j.ces.2005.02.059; Kusakabe K, 1997, IND ENG CHEM RES, V36, P649, DOI 10.1021/ie960519x; Hasegawa Y, 2001, SEP PURIF TECHNOL, V22-3, P319, DOI 10.1016/S1383-5866(00)00154-4; Kondo M, 2003, SEP PURIF TECHNOL, V32, P191, DOI 10.1016/S1383-5866(03)00033-9; Sato K, 2008, MICROPOR MESOPOR MAT, V115, P184, DOI 10.1016/j.micromeso.2007.10.053; Sato K, 2008, MICROPOR MESOPOR MAT, V115, P170, DOI 10.1016/j.micromeso.2007.10.054; VANLEEUWEN ME, 1994, FLUID PHASE EQUILIBR, V99, P1, DOI 10.1016/0378-3812(94)80018-9; Guillou F, 2009, MICROPOR MESOPOR MAT, V119, P1, DOI 10.1016/j.micromeso.2008.11.030; Li SG, 2001, IND ENG CHEM RES, V40, P4577, DOI 10.1021/ie010140x; Origami Y., 2001, SEP PURIF TECHNOL, V25, P251; SANDER U, 1988, J MEMBRANE SCI, V36, P463, DOI 10.1016/0376-7388(88)80036-X	18	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244			ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	JUL 1	2015	7	25					13728	13730		10.1021/acsami.5b04085		3	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CM1JI	WOS:000357436800002		
J	Shimoi, N; Abe, D				Shimoi, Norihiro; Abe, Daisuke			Method for Measuring the Distribution of Adhesion Forces on Continuous Nanoscale Protrusions Using Carbon Nanofiber Tip on a Scanning Probe Microscope Cantilever	ACS APPLIED MATERIALS & INTERFACES			English	Article						carbon nanofiber; Pd nanoparticle; scanning probe microscope; adhesion force; nanonewton	CAPILLARY FORCE; SURFACE-ROUGHNESS; ANTIREFLECTION; NANOPARTICLE; NANOTUBES; HUMIDITY; CALIBRATION; PARAMETERS; PARTICLES; FRICTION	The adhesion force on surfaces has received attention in numerous scientific and technological fields, including catalysis, thin-film growth, and tribology. Many applications require knowledge of the strength of these forces as a function of position in three dimensions, but until now such information has only been theoretically proposed. Here, we demonstrate an approach based on scanning probe microscopy that can obtain such data and be used to image the three-dimensional surface force field of continuous nanoscale protrusions. We present adhesion force maps with nanometer and nanonewton resolution that allow detailed characterization of the interaction between a surface and a thin carbon nanofiber (CNF) rod synthesized by plasma-enhanced chemical vapor deposition (PECVD) at the end of a tip on a scanning probe microscope cantilever in three dimensions. In these maps, the positions of all continuous nanoscale protrusions are identified and the differences in the adhesive forces among limited areas at inequivalent sites are quantified.	[Shimoi, Norihiro; Abe, Daisuke] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan	Shimoi, N (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-20 Aoba, Sendai, Miyagi 9808579, Japan.	shimoi@mail.kankyo.tohoku.ac.jp			Global COE Program "Materials Integration International Center of Education and Research, Tohoku University," of MEXT, Japan	This work was partially supported by the Global COE Program "Materials Integration International Center of Education and Research, Tohoku University," of MEXT, Japan. The authors are indebted to members of the Technical Division, School of Engineering of Tohoku University, for discussions on the SPM experimental data. The motheye structures were prepared by DOWA Co., Ltd., who kindly donated some samples for measurements.	Ando Y, 2000, WEAR, V238, P12, DOI 10.1016/S0043-1648(99)00334-8; Slattery AD, 2013, ULTRAMICROSCOPY, V131, P46, DOI 10.1016/j.ultramic.2013.03.009; Feiler AA, 2007, LANGMUIR, V23, P517, DOI 10.1021/la060456f; Butt HJ, 2009, ADV COLLOID INTERFAC, V146, P48, DOI 10.1016/j.cis.2008.10.002; Asay DB, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2192510; Farshchi-Tabrizi M, 2006, LANGMUIR, V22, P2171, DOI 10.1021/la052760z; Macdonald T, 2012, APPL SURF SCI, V258, P2836, DOI 10.1016/j.apsusc.2011.10.144; He MY, 2001, J CHEM PHYS, V114, P1355, DOI 10.1063/1.1331298; Pakarinen OH, 2005, MODEL SIMUL MATER SC, V13, P1175, DOI 10.1088/0965-0393/13/7/012; BERNHARD CG, 1962, ACTA PHYSIOL SCAND, V56, P385, DOI 10.1111/j.1748-1716.1962.tb02515.x; Gombert A, 1999, THIN SOLID FILMS, V351, P73, DOI 10.1016/S0040-6090(98)01780-5; Nakanishi T, 2006, MICROELECTRON ENG, V83, P1503, DOI 10.1016/j.mee.2006.01.193; Paajanen M, 2006, J COLLOID INTERF SCI, V304, P518, DOI 10.1016/j.jcis.2006.09.017; Chen SH, 2008, INT J SOLIDS STRUCT, V45, P3122, DOI 10.1016/j.ijsolstr.2008.01.014; Fukunishi A, 2006, ADV POWDER TECHNOL, V17, P567, DOI 10.1163/156855206778440552; SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439; Persson BNJ, 2001, J CHEM PHYS, V115, P5597, DOI 10.1063/1.1398300; Colak A, 2012, APPL SURF SCI, V258, P6938, DOI 10.1016/j.apsusc.2012.03.138; CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209; Delrio FW, 2005, NAT MATER, V4, P629, DOI 10.1038/nmat1431; Watson GS, 2004, APPL SURF SCI, V235, P139, DOI 10.1016/j.apsusc.2004.05.129; Schulz U, 2007, OPT EXPRESS, V15, P13108, DOI 10.1364/OE.15.013108; Duner G, 2012, SOFT MATTER, V8, P8312, DOI 10.1039/c2sm26086g; Weeks BL, 2005, LANGMUIR, V21, P8096, DOI 10.1021/la0512087; Sababi M, 2012, ACS APPL MATER INTER, V4, P5534, DOI 10.1021/am301439k; Ferreira OD, 2010, APPL SURF SCI, V257, P48, DOI 10.1016/j.apsusc.2010.06.031; Chau A, 2010, J ADHES SCI TECHNOL, V24, P2499, DOI 10.1163/016942410X508307; Chunder A, 2008, SID INT SYMP DIG TEC, V39, P557; Endoh S, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.06FD04; Gibson CT, 2007, ULTRAMICROSCOPY, V107, P1118, DOI 10.1016/j.ultramic.2007.02.045; Kanamori Y, 2003, JPN J APPL PHYS 1, V42, P4020, DOI 10.1143/JJAP.42.4020; Kita S, 2004, APPL PHYS LETT, V85, P4478, DOI 10.1063/1.1814424; Kurihara K., 2007, 14 INT DISPL WORKSH, P1001; Li ZX, 2007, CHINESE PHYS LETT, V24, P2289, DOI 10.1088/0256-307X/24/8/037; Slattery AD, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/33/335705; Slattery AD, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/23/235705; Slattery AD, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/28/285704; Slattery AD, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/1/015710; Tanemura M, 2001, J APPL PHYS, V90, P1529, DOI 10.1063/1.1382848	39	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244			ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	JUL 1	2015	7	25					13776	13781		10.1021/acsami.5b01307		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CM1JI	WOS:000357436800007		
J	Oikawa, Y; Saito, T; Yamada, S; Sugiya, M; Sawada, H				Oikawa, Yuri; Saito, Tomoya; Yamada, Satoshi; Sugiya, Masashi; Sawada, Hideo			Preparation and Surface Property of Fluoroalkyl End-Capped Vinyltriniethoxysilane Oligomer/Talc Composite-Encapsulated Organic Compounds: Application for the Separation of Oil and Water	ACS APPLIED MATERIALS & INTERFACES			English	Article						fluorinated oligomer; silica; talc composite; cross-linked polystyrene particle; superhydrophobic-superoleophilic characteristic; superhydrophilic-superoleophobic characteristic; superamphiphobic characteristic; separataion of oil-water	MECHANICAL-PROPERTIES; POLYPROPYLENE COMPOSITES; FACILE CREATION; SUPERHYDROPHILIC SURFACE; OIL/WATER SEPARATION; REPELLENT SURFACES; TALC; NANOCOMPOSITES; COATINGS; CRYSTALLIZATION	Fluoroalkyl end-capped vinyltrimethoxysilane oligomer [RF-(CH2-CHSi(OMe)(3))(n)-RF; n = 2, 3; RF = CF(CF3)OC3F7 (RF-VM oligomer)] can undergo the sol-gel reaction in the presence of talc particles under alkaline conditions at room temperature to provide the corresponding fluorinated oligomeric silica/talc nanocomposites (RF-VM-SiO2/Talc). A variety of guest molecules such as 2-hydroxy-4-methoxybenzophenone (HMB), bisphenol A (BPA), bisphenol AF, 3-(hydroxysilyl)-1-propanesulfonic acid (THSP), and perfluoro-2-methyl-3-oxahexanoic acid (RF-COOH) are effectively encapsulated into the RF-VM-SiO2/Talc composite cores to afford the corresponding fluorinated nanocomposites-encapsulated these guest molecules. The RF-VM-SiO2/Talc composites encapsulated low molecular weight aromatic compounds such as HMB and BPA can exhibit a superoleophilic-superhydrophobic characteristic on the surfaces; however, the RF-VM-SiO2/Talc composite-encapsulated THSP and RF-COOH exhibit a superoleophobic-superhydrophilic characteristic on the modified surfaces. In these nanocomposites, the RF-VM-SiO2/Talc/THSP composites are applicable to the surface modification of polyester fabric, and the modified polyester fabric possessing a superoleophobic-superhydrophilic characteristic on the surface can be used for the membrane for oil (dodecane)/water separation. In addition, the RF-VM-SiO2/Talc composites-encapsulated micrometer-size controlled cross-linked polystyrene particles can be also prepared under similar conditions, and the obtained composite white-colored particle powders are applied to the packing material for the column chromatography to separate water-in-oil (W/O) emulsion.	[Oikawa, Yuri; Saito, Tomoya; Sawada, Hideo] Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan; [Yamada, Satoshi; Sugiya, Masashi] Nippon Chem Ind Co Ltd, Div Res & Dev, Koto Ku, Tokyo 1368515, Japan	Sawada, H (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan.	hideosaw@hirosaki-u.ac.jp					Alonso M, 1997, EUR POLYM J, V33, P255, DOI 10.1016/S0014-3057(96)00159-0; Huda MS, 2007, COMPOS PART B-ENG, V38, P367, DOI 10.1016/j.compositesb.2006.06.010; Sunny S, 2014, ADV FUNCT MATER, V24, P6658, DOI 10.1002/adfm.201401289; Ye HH, 2013, J APPL POLYM SCI, V127, P402, DOI 10.1002/app.37632; Goto Y, 2011, J COLLOID INTERF SCI, V362, P375, DOI 10.1016/j.jcis.2011.06.045; MITSUDA T, 1977, CEMENT CONCRETE RES, V7, P223, DOI 10.1016/0008-8846(77)90083-7; MURTHY NS, 1986, J APPL POLYM SCI, V31, P2569, DOI 10.1002/app.1986.070310816; Yao X, 2011, ADV MATER, V23, P719, DOI 10.1002/adma.201002689; An QF, 2013, J APPL POLYM SCI, V127, P1519, DOI 10.1002/app.37553; Zhang JP, 2011, ADV FUNCT MATER, V21, P4699, DOI 10.1002/adfm.201101090; Mertaniemi H, 2011, ADV MATER, V23, P2911, DOI 10.1002/adma.201100461; Tsujii K, 1997, ANGEW CHEM INT EDIT, V36, P1011, DOI 10.1002/anie.199710111; Clerc L, 2005, POLYM DEGRAD STABIL, V88, P504, DOI 10.1016/j.polymdegradstab.2004.12.010; Allan SE, 2012, ENVIRON SCI TECHNOL, V46, P2033, DOI 10.1021/es202942q; Furukawa Y, 2003, J APPL POLYM SCI, V87, P1085, DOI 10.1002/app.11505; Leong YW, 2004, J APPL POLYM SCI, V91, P3315, DOI 10.1002/app.13542; Garcia-Martinez JM, 2002, J POLYM SCI POL PHYS, V40, P1371, DOI 10.1002/polb.10197; Shibuichi S, 1998, J COLLOID INTERF SCI, V208, P287, DOI 10.1006/jcis.1998.5813; Ceria A, 2010, SURF COAT TECH, V204, P1535, DOI 10.1016/j.surfcoat.2009.09.077; Zhang WB, 2013, ADV MATER, V25, P2071, DOI 10.1002/adma.201204520; Xue ZX, 2011, ADV MATER, V23, P4270, DOI 10.1002/adma.201102616; Lee SG, 2013, LANGMUIR, V29, P15051, DOI 10.1021/la404005b; Jain S, 2010, MACROMOL MATER ENG, V295, P750, DOI 10.1002/mame.201000063; Huda MS, 2005, IND ENG CHEM RES, V44, P5593, DOI 10.1021/ie0488849; Gui XC, 2010, ADV MATER, V22, P617, DOI 10.1002/adma.200902986; Wang K, 2013, POLYM DEGRAD STABIL, V98, P1275, DOI 10.1016/j.polymdegradstab.2013.04.006; Yang J, 2014, CELLULOSE, V21, P1851, DOI 10.1007/s10570-014-0244-0; Duquesne S, 2008, POLYM ADVAN TECHNOL, V19, P620, DOI 10.1002/pat.1127; Feng J, 2009, J COLLOID INTERF SCI, V336, P268, DOI 10.1016/j.jcis.2009.03.025; Wang HD, 2013, ACS APPL MATER INTER, V5, P10221, DOI 10.1021/am4029679; Liu KS, 2013, PROG MATER SCI, V58, P503, DOI 10.1016/j.pmatsci.2012.11.001; Wang CX, 2009, ACS APPL MATER INTER, V1, P2613, DOI 10.1021/am900520z; Douillard JM, 2007, J COLLOID INTERF SCI, V305, P352, DOI 10.1016/j.jcis.2006.08.010; Fowlks AC, 2010, J APPL POLYM SCI, V118, P2810, DOI 10.1002/app.32380; HARGARTER N, 1993, COMPOS SCI TECHNOL, V46, P229, DOI 10.1016/0266-3538(93)90157-C; Hsu SH, 2013, ACS APPL MATER INTER, V5, P2991, DOI 10.1021/am302446t; Lapcik L, 2008, J APPL POLYM SCI, V110, P2742, DOI 10.1002/app.28797; Lefebvre G, 2011, POWDER TECHNOL, V208, P372, DOI 10.1016/j.powtec.2010.08.031; Qin YY, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40016; RAMOS MA, 1991, POLYM ENG SCI, V31, P245, DOI 10.1002/pen.760310407; RAYNER JH, 1973, CLAY CLAY MINER, V21, P103, DOI 10.1346/CCMN.1973.0210206; Saito T, 2015, COLLOID POLYM SCI, V293, P65, DOI 10.1007/s00396-014-3387-5; Sawada H, 2010, B CHEM SOC JPN, V83, P75, DOI 10.1246/bcsj.20090204; Sawada H, 2011, J POLYM SCI POL CHEM, V49, P1070, DOI 10.1002/pola.24516; Sawada H, 2011, MACROMOLECULES, V44, P1114, DOI 10.1021/ma102532k; Sawada H, 2007, PROG POLYM SCI, V32, P509, DOI 10.1016/j.progpolymsci.2007.02.002; SAWADA H, 1991, J CHEM SOC CHEM COMM, P677, DOI 10.1039/c39910000677; Sawada H, 2008, COLLOID POLYM SCI, V286, P1569, DOI 10.1007/s00396-008-1926-7; Sawada H., 1996, CHEM REV, V96, P1979; Sawada H, 2012, POLYM CHEM-UK, V3, P46, DOI 10.1039/c1py00325a; Suh CH, 1996, J NON-NEWTON FLUID, V62, P175, DOI 10.1016/0377-0257(95)01382-2; Sumino E, 2015, POLYM ADVAN TECHNOL, V26, P345, DOI 10.1002/pat.3459; Unal H, 2004, MATER DESIGN, V25, P483, DOI 10.1016/j.matdes.2004.01.007; Whaling A, 2006, IND ENG CHEM RES, V45, P7497, DOI 10.1021/ie060604x; Zhao G, 2012, APPL SURF SCI, V258, P3557, DOI 10.1016/j.apsusc.2011.11.113	55	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244			ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	JUL 1	2015	7	25					13782	13793		10.1021/acsami.5b01588		12	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CM1JI	WOS:000357436800008		
J	Kato, K; Ueno, K; Kawai, K				Kato, Kosuke; Ueno, Kanako; Kawai, Keiji			Effect of Room Acoustics on Musicians' Performance. Part II: Audio Analysis of the Variations in Performed Sound Signals	ACTA ACUSTICA UNITED WITH ACUSTICA			English	Article							VOICE LEVEL; FREQUENCY; LOUDNESS; TIMBRE; SCALE; MODEL	This study addresses the question of whether musicians adjust their performance to suit room acoustics. In order to quantify the variations in musician performance as a function of room acoustics, this paper analyzes the audio features of the music signals produced by four professional instrumentalists and an operatic baritone singer under five different simulated room acoustic conditions. The results for a number of performers showed that the audio features quantifying the tempo, the length of notes, the silence between notes, articulation, dynamic level, dynamic range, harmonics strength, pitch tuning, and/or vibrato extent, varied significantly with room acoustic conditions. These changes in the audio features showed considerable agreement with the statements of performers elicited through interviews. For some of the performers, the following effects of room acoustic conditions on their performances were found: The reverberation time had a positive correlation with the degree of staccato, with the silence duration between adjacent tones, and with the intensity vibrato extent. The reverberation time had a negative correlation with the frequency vibrato extent. The tempo was reduced for short and long reverberation times. For sound fields with larger reflection energies, the loudness was reduced in accordance with the decrease in the harmonics strength.	[Kato, Kosuke] Osaka Univ, Off Univ Ind Collaborat, Suita, Osaka 5650871, Japan; [Ueno, Kanako] Meiji Univ, Sch Sci & Technol, Tokyo 101, Japan; [Kawai, Keiji] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 860, Japan	Kato, K (reprint author), Osaka Univ, Off Univ Ind Collaborat, 2-8 Yamada Oka, Suita, Osaka 5650871, Japan.	kato@uic.osaka-u.ac.jp			Sound Technology Promotion Foundation; Japan Society for the Promotion of Science [19860046]	The authors are grateful to Ken-Ichi Sakakibara for many helpful suggestions and stimulating discussions. The authors would like to thank all the musicians who participated in this study for their cooperation. The authors also thank Atsushi Marui for providing MATLAB programs for the analysis of the Gated loudness [13] and the Loudness Range [14]. This work was supported in part by the Sound Technology Promotion Foundation and a Grant-in-Aid for Young Scientists (Start-up, 19860046) from the Japan Society for the Promotion of Science. A part of this work was presented at the 19th International Congress on Acoustics (2007) [26, 27], at Acoustics '08 Paris (2008) [28], and at the 39th International Congress and Exposition on Noise Control Engineering (Inter Noise 2010) (2010) [23].	Ueno K, 2010, ACTA ACUST UNITED AC, V96, P505, DOI 10.3813/AAA.918303; Schubert E, 2006, ACTA ACUST UNITED AC, V92, P820; Caclin A, 2005, J ACOUST SOC AM, V118, P471, DOI 10.1121/1.1929229; [Anonymous], 2013, BS20543 ITUR; GADE AC, 1989, ACUSTICA, V69, P193; Kalkandjiev ZS, 2013, ACTA ACUST UNITED AC, V99, P433, DOI 10.3813/AAA.918624; [Anonymous], 2012, BS17703 ITUR; Marozeau J, 2007, J ACOUST SOC AM, V121, P383, DOI 10.1121/1.2384910; Moore BCJ, 1996, ACUSTICA, V82, P335; Bolzinger S., 1994, J PHYS IV S, V111; Bolzinger S., 1992, J PHYS IV S, V111; Brunskog J, 2009, J ACOUST SOC AM, V125, P2072, DOI 10.1121/1.3081396; Fastl H., 1990, PSYCHOACOUSTICS FACT; Friberg A., 1993, SPEECH TRANSMISSION, V34, P49; Friberg A, 2007, ACTA ACUST UNITED AC, V93, P411; Jarvelainen H., 2002, P INT COMP MUS C GOT, P287; Kato K., 2007, P 19 INT C AC; Kato K., 2008, MUSICIANS ADJUSTMENT, P4533; Kawai K., 2013, P INT S ROOM AC; LANE HL, 1961, J ACOUST SOC AM, V33, P160, DOI 10.1121/1.1908608; Meyer J., 2009, ACOUSTICS PERFORMANC; Prame E, 1997, J ACOUST SOC AM, V102, P616, DOI 10.1121/1.419735; SCHROEDER MR, 1981, ACUSTICA, V49, P179; Ueno K., 2003, Acoustical Science and Technology, V24; Ternstrom S., 1993, VOICE, V2, P55; Ueno K., 2010, P 39 INT C EXP NOIS; Ueno K., 2007, P 19 INT C AC; Yokoyama S., 2002, Acoustical Science and Technology, V23, DOI 10.1250/ast.23.97	28	1	1	S HIRZEL VERLAG	STUTTGART	POSTFACH 10 10 61, D-70 009 STUTTGART, GERMANY	1610-1928	1861-9959		ACTA ACUST UNITED AC	Acta Acust. United Acust.	JUL-AUG	2015	101	4					743	759		10.3813/AAA.918870		17	Acoustics	Acoustics	CM5EM	WOS:000357709600010		
J	Yokote, H; Nose, Y; Ishibashi, S; Tanaka, K; Takahashi, T; Fujihara, K; Yokota, T; Mizusawa, H				Yokote, H.; Nose, Y.; Ishibashi, S.; Tanaka, K.; Takahashi, T.; Fujihara, K.; Yokota, T.; Mizusawa, H.			Spinal cord ring enhancement in patients with neuromyelitis optica	ACTA NEUROLOGICA SCANDINAVICA			English	Article						demyelination; magnetic resonance imaging; multiple sclerosis; myelin basic protein; neuromyelitis optica; ring enhancement; spinal cord	MULTIPLE-SCLEROSIS LESIONS; ANTI-AQUAPORIN-4 ANTIBODY; ASTROCYTIC DAMAGE; PATHOGENESIS; DEMYELINATION; EVOLUTION; NMO	Objectives - Clinical and pathological significance of gadolinium (Gd)-enhancing pattern on magnetic resonance imaging (MRI), including ring enhancement (RE), is well documented in multiple sclerosis but not in neuromyelitis optica (NMO), especially in the spinal cord. The purpose of this study is to examine the prevalence of spinal cord RE in NMO and to determine the association between clinical characteristics and spinal cord RE. Materials and methods We retrospectively examined Gd-enhanced spinal cord MRI scans, during the acute phase, in patients with anti-aquaporin 4-positive NMO, including NMO spectrum disorder. We then analysed their clinical features and MRI imaging characteristics of spinal cord lesions. Results - Of the 30 patients with NMO, we enrolled 12 patients with 16 Gd-enhanced spinal cord MRI scans in this study. Five scans revealed RE (31.2%). Male ratio, as well as myelin basic protein (MBP) levels, in the cerebrospinal fluid (CSF) of patients with RE was significantly higher than those of patients without RE (P = 0.018, P = 0.026, respectively). Conclusions - Spinal cord RE is common in patients with NMO. Higher MBP levels in the CSF of patients with RE can be associated with a higher degree of myelin damage.	[Yokote, H.] Musashino Red Cross Hosp, Dept Neurol, Musashino, Tokyo, Japan; [Yokote, H.; Nose, Y.; Ishibashi, S.; Yokota, T.; Mizusawa, H.] Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Tanaka, K.] Kanazawa Med Univ, Dept Neurol, Kanazawa, Tokyo, Japan; [Takahashi, T.; Fujihara, K.] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Sendai, Tokyo, Japan	Mizusawa, H (reprint author), Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	h-mizusawa.nuro@tmd.ac.jp					Ito S, 2009, ANN NEUROL, V66, P425, DOI 10.1002/ana.21753; He J, 2001, AM J NEURORADIOL, V22, P664; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Gaitan MI, 2011, ANN NEUROL, V70, P22, DOI 10.1002/ana.22472; Takano R, 2010, NEUROLOGY, V75, P208, DOI 10.1212/WNL.0b013e3181e2414b; Fujihara K, 2011, J NEUROL SCI, V306, P183, DOI 10.1016/j.jns.2011.02.018; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Misu T, 2013, ACTA NEUROPATHOL, V125, P815, DOI 10.1007/s00401-013-1116-7; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Davis M, 2010, NEUROLOGY, V74, P851, DOI 10.1212/WNL.0b013e3181d31df5; Gajofatto A, 2013, ACTA NEUROL SCAND, V128, P336, DOI 10.1111/ane.12123; Klawiter EC, 2010, ARCH NEUROL-CHICAGO, V67, P1395, DOI 10.1001/archneurol.2010.271; Morgen K, 2001, MULT SCLER, V7, P167; Tanaka K, 2007, MULT SCLER, V13, P850, DOI 10.1177/1352458507076976	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	JUL	2015	132	1					37	41		10.1111/ane.12354		5	Clinical Neurology	Neurosciences & Neurology	CM5NI	WOS:000357734600006		
J	Shigematsu, K; Watanabe, Y; Nakano, H				Shigematsu, K.; Watanabe, Y.; Nakano, H.		Kyoto Stroke Registry Comm	Lower hazard ratio for death in women with cerebral hemorrhage	ACTA NEUROLOGICA SCANDINAVICA			English	Article						cerebrovascular diseases; neuroepidemiology; strokes; sex, early outcome	SEX-DIFFERENCES; STROKE INCIDENCE; CASE-FATALITY; RISK-FACTORS; LIVE LONGER; MORTALITY; SURVIVAL; REGISTER; RATES; MEN	Objectives - The aim of the study was to clarify the hazard ratio for death within 30 days after stroke comparing women to men. Material and methods - We reviewed all stroke patients registered in the Kyoto Stroke Registry (from January 1999 to December 2009) in Japan. Hazard ratio (HR) for death and 95% confidence interval were calculated by the Cox regression in stroke and in each stroke subtype: cerebral infarction (CI), cerebral hemorrhage, (CH) and subarachnoid hemorrhage (SAH). We also evaluated HR for death in women in each consciousness level at the onset of stroke: the Japan Coma Scale (JCS) 0 (alert), JCS 1-digit code (disoriented but awake), JCS 2-digit code (arousable with stimulation), and JCS 3-digit code (unarousable). Results - A total of 13,788 patients were analyzed. HR for death comparing women to men were 1.04 (0.88-1.23, P = 0.66 in stroke as a whole), 0.91 (0.69-1.21, P = 0.51 in CI), 0.53 (0.41-0.71, P < 0.01 in CH), and 0.89 (0.60-1.30, P = 0.535 in SAH) after adjustment for age and histories of hypertension, arrhythmia, diabetes mellitus and hyperlipemia and uses of tobacco and alcohol. Stratified by JCS, HR for death in women with CH were 0.32 (0.11-0.94 in JCS0), 0.48 (0.28-0.82 in JCS1), 0.49 (0.28-0.83 in JCS2), and 0.79 (0.65-0.97 in JCS3), respectively. HR for death in women with CI in JCS3 was significantly lower than in men (0.71; 0.52-0.98). Conclusion - We evaluated HR for death comparing men to women in stroke and in each stroke subtype. Women with CH had lower HR for death within 30 days after stroke than men.	[Shigematsu, K.] Minami Kyoto Hosp, Natl Hosp Org, Dept Neurol, Kyoto 6100113, Japan; [Watanabe, Y.] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Epidemiol Community Hlth & Med, Kyoto, Japan; [Nakano, H.] Kyoto Kidugawa Hosp, Dept Neurosurg, Kyoto, Japan	Shigematsu, K (reprint author), Minami Kyoto Hosp, Natl Hosp Org, Dept Neurol, Kyoto 6100113, Japan.	neuron.k07@gmail.com			Kyoto Medical Association	The study was supported by the Kyoto Medical Association.	HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Ayala CN, 2002, STROKE, V33, P1197, DOI 10.1161/01.STR.0000015028.52.771.D1; Roquer J, 2003, STROKE, V34, P1581, DOI 10.1161/01.STR.0000078562.82918.F6; Wityk RJ, 1996, STROKE, V27, P1974; Zhou G, 2013, ACTA NEUROL SCAND, V128, P1, DOI 10.1111/ane.12091; Soerjomataram I, 2008, BREAST CANCER RES TR, V107, P309, DOI 10.1007/s10549-007-9556-1; Brown RD, 1996, STROKE, V27, P373; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; Turin TC, 2008, STROKE, V39, P745, DOI 10.1161/STROKEAHA.107.495929; Eskes T, 2007, EUR J OBSTET GYN R B, V133, P126, DOI 10.1016/j.ejogrb.2007.01.006; Shigematsu K, 2013, EMERG MED J, V30, P728, DOI 10.1136/emermed-2012-201586; Holroyd-Leduc JM, 2000, STROKE, V31, P1833; Olsen TS, 2007, NEUROEPIDEMIOLOGY, V29, P218, DOI 10.1159/000112464; Appelros P, 2010, ACTA NEUROL SCAND, V121, P359, DOI 10.1111/j.1600-0404.2009.01258.x; Baturova MA, 2014, ACTA NEUROL SCAND, V129, P412, DOI 10.1111/ane.12203; BONITA R, 1993, LANCET, V342, P1470, DOI 10.1016/0140-6736(93)92938-P; FEIGIN VL, 1995, STROKE, V26, P924; Gjerde G, 2014, ACTA NEUROL SCAND, V129, P173, DOI 10.1111/ane.12159; HERMAN B, 1982, STROKE, V13, P629; Holtermann A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000279; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Kim HC, 2013, NEUROEPIDEMIOLOGY, V41, P131, DOI 10.1159/000353186; Kulshreshtha A, 2012, NEUROEPIDEMIOLOGY, V38, P123, DOI 10.1159/000336230; Kvistad CE, 2014, ACTA NEUROL SCAND, V130, P299, DOI 10.1111/ane.12225; Lewsey JD, 2009, STROKE, V40, P1038, DOI 10.1161/STROKEAHA.108.542787; Loikas D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002378; Lujic S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005768; Moura MAD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003736; Nielsen S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004598; Ovesen C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003724; Rantakomi SH, 2014, ACTA NEUROL SCAND, V130, P118, DOI 10.1111/ane.12243; Shigematsu K, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-87; Shigematsu K, 2013, BMJ OPEN, V3; Specogna AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096743; WALDRON I, 1978, NEW ENGL J MED, V298, P57; Wu SH, 2012, NEUROEPIDEMIOLOGY, V38, P69, DOI 10.1159/000335040	37	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	JUL	2015	132	1					59	64		10.1111/ane.12359		6	Clinical Neurology	Neurosciences & Neurology	CM5NI	WOS:000357734600009		
J	Kim, JM; Lee, KP; Park, SJ; Kang, S; Huang, J; Lee, JM; Sato, K; Chung, HY; Okajima, F; Im, DS				Kim, Jung-Min; Lee, Kyoung-Pil; Park, Soo-Jin; Kang, Saeromi; Huang, Jin; Lee, Jung-Min; Sato, Koichi; Chung, Hae-Young; Okajima, Fumikazu; Im, Dong-Soon			Omega-3 fatty acids induce Ca2+ mobilization responses in human colon epithelial cell lines endogenously expressing FFA4	ACTA PHARMACOLOGICA SINICA			English	Article						long-chain fatty acid; omega-3; alpha-linolenic acid; FFA4; Ca2+ mobilization; cADPR; human colon epithelial cells	ALPHA-LINOLENIC ACID; PROTEIN-COUPLED RECEPTORS; ADP-RIBOSYL CYCLASE; DSS-INDUCED COLITIS; FATTY-ACIDS; INSULIN-SECRETION; 4 FFA4/GPR120; CANCER CELLS; GPR120; IDENTIFICATION	Aim: Free fatty acid receptor 4 (FFA4; formerly known as GPR120) is the G protein-coupled receptor (GPCR) for omega-3 polyunsaturated fatty acids. FFA4 has been found to express in the small intestines and colons of mice and humans. In this study we investigate the effects of omega-3 polyunsaturated fatty acids on FFA4 in human colon epithelial cells in vitro. Methods: HCT116 and HT-29 human colon epithelial cell lines endogenously expressing FFA4 were used. Intracellular Ca2+ concentration ([Ca2+](i)) was measured in fura 2-AM-loaded cells with fluorescence spectrophotometry. RT-PCR and immunohistochemistry were used to detect FFA4. Results: Ten to 100 mu mol/L of omega-3 polyunsaturated fatty acids alpha-linolenic acid (alpha LA) or eicosapentaenoic acid (EPA) induced dose-dependent [Ca2+]i increase in HCT116 and HT-29 cells, whereas docosahexaenoic acid (DHA) had no effect. In addition, the omega-6 fatty acids linoleic acid and gamma-linoleic acid also dose-dependently increase [Ca2+](i), but the mono-unsaturated fatty acid oleic acid and saturated fatty acids such as stearic acid and palmitic acid had no effect. In HCT116 and HT-29 cells, the alpha LA-induced [Ca2+](i) increase was partially inhibited by pretreatment with EGTA, phospholipase C inhibitor edelfosine, cADPR inhibitors 8-bro-cADPR or DAB, and abolished by pretreatment with Ca2+ ATPase inhibitor thapsigargin, but was not affected by G(i/o) protein inhibitor PTX or IP3R inhibitor 2-APB. Conclusion: Omega-3 and omega-6 long-chain polyunsaturated fatty acids (C18-20) induce Ca2+ mobilization responses in human colonic epithelial cells in vitro through activation of FFA4 and PTX-insensitive G(i/o) protein, followed by Ca2+ release from thapsigargin-sensitive Ca2+ stores and Ca2+ influx across the plasma membrane.	[Kim, Jung-Min; Lee, Kyoung-Pil; Park, Soo-Jin; Kang, Saeromi; Huang, Jin; Lee, Jung-Min; Chung, Hae-Young; Im, Dong-Soon] Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan 609735, South Korea; [Sato, Koichi; Okajima, Fumikazu] Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gumma 3718512, Japan	Im, DS (reprint author), Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan 609735, South Korea.	imds@pusan.ac.kr			Korean National Research Foundation - Korean government (MSIP) [2009-0083538]	This research was supported by the Korean National Research Foundation, which is funded by the Korean government (MSIP) (Grant No 2009-0083538).	Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Hassan A, 2010, J NUTR, V140, P1714, DOI 10.3945/jn.109.119768; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Wu Q, 2013, ONCOGENE, V32, P5541, DOI 10.1038/onc.2013.264; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Ibrahim A, 2012, NUTRITION, V28, P799, DOI 10.1016/j.nut.2011.10.008; Davenport AP, 2013, PHARMACOL REV, V65, P967, DOI 10.1124/pr.112.007179; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Moore K, 2009, COMP BIOCHEM PHYS B, V154, P419, DOI 10.1016/j.cbpb.2009.08.005; Camuesco D, 2005, J NUTR, V135, P687; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Burns RN, 2010, BIOCHEM BIOPH RES CO, V396, P1030, DOI 10.1016/j.bbrc.2010.05.057; Fredriksson R, 2003, FEBS LETT, V554, P381, DOI 10.1016/S0014-5793(03)01196-7; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Miyauchi S, 2009, N-S ARCH PHARMACOL, V379, P427, DOI 10.1007/s00210-008-0390-8; Sparks SM, 2014, BIOORG MED CHEM LETT, V24, P3100, DOI 10.1016/j.bmcl.2014.05.012; Davidson MH, 2007, CLIN THER, V29, P1354, DOI 10.1016/j.clinthera.2007.07.018; Galindo MM, 2012, CHEM SENSES, V37, P123, DOI 10.1093/chemse/bjr069; Suzuki T, 2008, J MED CHEM, V51, P7640, DOI 10.1021/jm800970b; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; Hoy SM, 2009, DRUGS, V69, P1077, DOI 10.2165/00003495-200969080-00008; Park SJ, 2014, BIOMOL THER, V22, P129, DOI 10.4062/biomolther.2013.110; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Zhao YJ, 2015, BBA-MOL CELL RES, V1853, P2095, DOI 10.1016/j.bbamcr.2014.10.028; DYERBERG J, 1975, AM J CLIN NUTR, V28, P958; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Arafa ESA, 2014, ACTA PHARMACOL SIN, V35, P394, DOI 10.1038/aps.2013.183; Im DS, 2012, PROG LIPID RES, V51, P232, DOI 10.1016/j.plipres.2012.02.003; Ji XK, 2015, ACTA PHARMACOL SIN, V36, P334, DOI 10.1038/aps.2014.150; Kim SY, 2009, AM J PHYSIOL-RENAL, V296, pF291, DOI 10.1152/ajprenal.90381.2008; LANDS WEM, 1992, FASEB J, V6, P2530; Lopatina O, 2010, NEUROPHARMACOLOGY, V58, P50, DOI 10.1016/j.neuropharm.2009.06.012; Matsunaga H, 2008, INFLAMM BOWEL DIS, V14, P1348, DOI 10.1002/ibd.20491; Mobraten K, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-101; Moss NG, 2013, AM J PHYSIOL-RENAL, V305, pF830, DOI 10.1152/ajprenal.00048.2013; Turovsky EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063483; Wei JC, 2015, ACTA PHARMACOL SIN, V36, P241, DOI 10.1038/aps.2014.122; Zarepoor L, 2014, AM J PHYSIOL-GASTR L, V306, pC1042, DOI 10.1152/ajpgi.00253.2013	43	0	0	ACTA PHARMACOLOGICA SINICA	SHANGHAI	294 TAI-YUAN RD, SHANGHAI, 200031, PEOPLES R CHINA	1671-4083	1745-7254		ACTA PHARMACOL SIN	Acta Pharmacol. Sin.	JUL	2015	36	7					813	820		10.1038/aps.2015.29		8	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	CM1YW	WOS:000357477600005		
J	Fukumori, N; Yamamoto, Y; Takegami, M; Yamazaki, S; Onishi, Y; Sekiguchi, M; Otani, K; Konno, S; Kikuchi, S; Fukuhara, S				Fukumori, Norio; Yamamoto, Yosuke; Takegami, Misa; Yamazaki, Shin; Onishi, Yoshihiro; Sekiguchi, Miho; Otani, Koji; Konno, Shin-ichi; Kikuchi, Shin-ichi; Fukuhara, Shunichi			Association between hand-grip strength and depressive symptoms: Locomotive Syndrome and Health Outcomes in Aizu Cohort Study (LOHAS)	AGE AND AGEING			English	Article						hand-grip strength; depressive symptoms; mental health; muscular weakness; older patients; population-based study	PHYSICAL-ACTIVITY; POPULATION; MORTALITY; WOMEN; RISK; DISABILITY; AGE	Objective: we investigated the relationship between baseline hand-grip strength and the risk of depressive symptoms. Design: a prospective cohort study. Setting and Subjects: a prospective cohort study with a 1-year follow-up was conducted using 4,314 subjects from community-dwelling individuals aged 40-79 years in two Japanese municipalities, based on the Locomotive Syndrome and Health Outcomes in Aizu Cohort Study (LOHAS, 2008-10). Methods: we assessed baseline hand-grip strength standardised using national representative data classified by age and gender, and depressive symptoms at baseline and after the follow-up using the five-item version of the Mental Health Inventory (MHI-5). Results: the 4,314 subjects had a mean age of 66.3 years, 58.5% were women, and mean unadjusted hand-grip strength was 29.8 kg. Multivariable random-effect logistic regression analysis revealed that subjects with lower hand-grip strength (per 1SD decrease) had higher odds of having depressive symptoms at baseline [adjusted odds ratio (AOR) 1.15, 95% confidence interval (CI) 1.06-1.24; P = 0.001]. Further, lower hand-grip strength (per 1SD decrease) was associated with the longitudinal development of depressive symptoms after 1 year (AOR 1.13, 95% CI 1.01-1.27; P = 0.036). Conclusions: using a large population-based sample, our results suggest that lower hand-grip strength, standardised using age and gender, is both cross-sectionally and longitudinally associated with depressive symptoms.	[Fukumori, Norio; Yamamoto, Yosuke; Yamazaki, Shin; Fukuhara, Shunichi] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol,Sakyo Ku, Kyoto 6068501, Japan; [Fukumori, Norio] Saga Univ, Fac Med, Community Med Support Inst, Saga 840, Japan; [Yamamoto, Yosuke] Kyoto Univ Hosp, Inst Advancement Clin & Translat Sci, Kyoto 606, Japan; [Takegami, Misa] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka, Japan; [Onishi, Yoshihiro] Inst Hlth Outcomes & Proc Evaluat Res IHope Int, Kyoto, Japan; [Sekiguchi, Miho; Otani, Koji; Konno, Shin-ichi; Kikuchi, Shin-ichi] Fukushima Med Univ, Sch Med, Dept Orthoped Surg, Fukushima, Japan; [Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Clin Res, Fukushima, Japan	Fukuhara, S (reprint author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol,Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fukuhara.shunichi.6m@kyoto-u.ac.jp					Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168; Ono R, 2012, SPINE, V37, P1130, DOI 10.1097/BRS.0b013e31824231b8; Brown WJ, 2005, AM J PREV MED, V29, P265, DOI 10.1016/j.amepre.2005.06.009; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Ling CHY, 2010, CAN MED ASSOC J, V182, P429, DOI 10.1503/cmaj.091278; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Nakamura K, 2008, J ORTHOP SCI, V13, P1, DOI 10.1007/s00776-007-1202-6; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Kaneko Y, 2007, J EPIDEMIOL, V17, P114, DOI 10.2188/jea.17.114; Mehta KM, 2002, J AM GERIATR SOC, V50, P1045, DOI 10.1046/j.1532-5415.2002.50259.x; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Buigues C, 2014, AGING MENT HEALTH, P1; Demakakos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068632; Gale CR, 2011, PSYCHOL MED, V41, P2057, DOI 10.1017/S0033291711000195; Japanese Ministry of Health Labour and Welfare, 2008, SURV PHYS STRENGTH P; Massy-Westropp Nicola M, 2011, BMC Res Notes, V4, P127, DOI 10.1186/1756-0500-4-127; Otani K, 2012, J ORTHOP SCI, V17, P261, DOI 10.1007/s00776-012-0200-5; Puh U, 2009, INT J REHABIL RES, V33, P4; Russo A, 2006, OCCUP ENVIRON MED, V63, P438, DOI 10.1136/oem.2005.023549; Stordal E, 2003, ACTA PSYCHIAT SCAND, V107, P132, DOI 10.1034/j.1600-0447.2003.02056.x; van Milligen BA, 2011, J AFFECT DISORDERS, V136, P828; van Milligen BA, 2011, J AFFECT DISORDERS, V131, P193, DOI 10.1016/j.jad.2010.12.005; Yamazaki Shin, 2005, Health Qual Life Outcomes, V3, P48, DOI 10.1186/1477-7525-3-48; Yanagita M, 2006, AM J GERIAT PSYCHIAT, V14, P1060, DOI 10.1097/01.JGP.0000224364.70515.12	26	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0002-0729	1468-2834		AGE AGEING	Age Ageing	JUL	2015	44	4					592	598		10.1093/ageing/afv013		7	Geriatrics & Gerontology	Geriatrics & Gerontology	CM1DK	WOS:000357420400012		
J	Nishiaki, Y; Guliyev, F; Kadowaki, S				Nishiaki, Yoshihiro; Guliyev, Farhad; Kadowaki, Seiji			Chronological Contexts of the Earliest Pottery Neolithic in the South Caucasus: Radiocarbon Dates for Goytepe and Haci Elamxanli Tepe, Azerbaijan	AMERICAN JOURNAL OF ARCHAEOLOGY			English	Article							SETTLEMENT; AGRICULTURE; ARMENIA; ORIGINS; PLAIN; BP	Research on the earliest Neolithic in the South Caucasus is still in its early stages. Establishing a solid chronological framework will help determine the timing of the emergence and subsequent development of regional Neolithic societies. This article reports on 46 radiocarbon dates obtained from the two recently excavated Early Pottery Neolithic sites of Goytepe and Haci Elamxanli Tepe, the oldest farming villages known to date in West Azerbaijan. Comparing the dates from other related sites demonstrates that several settlements representing the earliest Pottery Neolithic emerged almost simultaneously at the beginning of the sixth millennium B.C.E. in the northern and southern foothills of the Lesser Caucasus Mountains. The lack of evidence for plant cultivation or animal husbandry at earlier sites suggests a foreign origin for agricultural economies in the South Caucasus. However, cultural items characterizing the initial agropastoral communities were not brought to the region as a package. Instead, we suggest that these early farming communities that is, the Shomutepe-Shulaveri-underwent gradual but significant autochthonous developments likely deriving from the aceramic stage. The chronological framework provided by Goytepe and Haci Elamxanli Tepe serves as a reference point for identifying details of early farmers' cultural developments in the South Caucasus.(1)	[Nishiaki, Yoshihiro] Univ Tokyo, Univ Museum, Tokyo 1130033, Japan; [Guliyev, Farhad] Natl Acad Sci Azerbaijan, Inst Archaeol & Ethnol, AZ-1143 Baku, Azerbaijan; [Kadowaki, Seiji] Nagoya Univ, Nagoya Univ Museum, Nagoya, Aichi 4648601, Japan	Nishiaki, Y (reprint author), Univ Tokyo, Univ Museum, Tokyo 1130033, Japan.	nishiaki@um.u-tokyo.ac.jp; fred_amea@mail.ru; kadowaki@num.nagoya-u.ac.jp					Abibullayev A.O., 1959, ARCHAEOLOGICAL EXCAV; Akkermans P. M. M. G., 2003, ARCHAEOLOGY SYRIA CO; Aliyev T., 2012, ARCHAOLOGISCHE MITTE, V44, P4; Zeder MA, 2011, CURR ANTHROPOL, V52, pS221, DOI 10.1086/659307; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Reimer PJ, 2013, RADIOCARBON, V55, P1869; van der Plicht J, 2011, RADIOCARBON, V53, P229; Willcox G, 2013, SCIENCE, V341, P39, DOI 10.1126/science.1240496; Arimatsu Y., 2014, NEOLITHIC POTTERY GO; Arimura M., 2010, NEOLITHICS, V1, P77; Arimura M., 2009, NEO LITHICS, V2, P17; Badalyan R, 2007, CULTURES CAUCASE 6 3, P37; Badalyan RS, 2010, TUBA-AR-TURK ACAD SC, V13, P185; Bellwood P., 2005, 1 FARMERS ORIGINS AG; Bocquet-Appel J.-P., 2008, NEOLITHIC DEMOGRAPHI, P239; Ramsey CB, 2009, RADIOCARBON, V51, P337; Bronk Ramsey C., 2013, OXCAL ONLINE RADIOCA; Campbell S, 2007, PALEORIENT, V33, P103, DOI 10.3406/paleo.2007.5209; Chataigner C., 2012, ARCHAEOLOGY ARMENIA, P37; Chataigner C., 1995, BARIS624; Gronenborn D, 2009, DOC PRAEHIST, V36, P97, DOI 10.4312/dp.36.5; Hamon C., 2008, PALEORIENT, V34, P85; Hansen S., 2012, ARCHAOLOGISCHE MITTE, V44, P58; Hansen S., 2007, NEOLITHICS, V1, P13; Hansen S., 2006, ARCHAOLOGISCHE MITTE, V38, P1; Hovsepyan R, 2008, VEG HIST ARCHAEOBOT, V17, pS63, DOI 10.1007/s00334-008-0158-6; Joannin S, 2014, J QUATERNARY SCI, V29, P70, DOI 10.1002/jqs.2679; Kadowaki S, 2015, J ARCHAEOL SCI, V53, P408, DOI 10.1016/j.jas.2014.10.021; Kiguradze K, 2004, ANCIENT NEAR E S S12, V12, P345; Kiguradze T, 1986, MAT ALLGEMEINEN VERG, V29; Korobkova G.F, 1996, STUDIES EARLY NEAR E, V3, P57; Kozlowski S.K, 1996, STUDIES EARLY NEAR E, V3, P161; Lyonnet B, 2007, CULTURES CAUCASE 6 3, P11; Lyonnet B, 2010, TUBA-AR-TURK ACAD SC, V13, P219; Lyonnet B, 2012, ARCHAOL MITT AUS IRA, V44, P86; Martirosyan-Olshansky K, 2013, BACKDIRT, V2013, P142; Meshveliani T, 2013, ARCHAEOLOGY ETHNOLOG, V41, P61; Meshveliani T, 2007, PALEORIENT, V33, P47, DOI 10.3406/paleo.2007.5220; Molist M, 2013, INTERPRETING LATE NE, P443; Munchaev R.M, 1982, ENEOLIT SSSR, P100; Museibli N, 2011, INT C NEW RES NEOL C; Narimanov I, 1987, CULTURE MOST ANCIENT; Nebieridze L, 1978, DARKVETI MULTILAYER; Nishiaki Y., 2012, P 7 INT C ARCH ANC N, V3, P71; Nishiaki Y, 2010, IRAN, V48, P1; Nishiaki Y, 2001, TELL KOSAK SHAMALI A, V1, P153; Nishiaki Y, ARCHAOLOGISCHE MITTE, V45; Sagona A., 2007, CULTURES CAUCASE 6 8, P21; Zamanov O., 2011, AZARBAYCANDA ARXEOLO, P52; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	50	0	0	ARCHAEOLOGICAL INST AMERICA	BOSTON	656 BEACON STREET, BOSTON, MA 02215 USA	0002-9114	1939-828X		AM J ARCHAEOL	Am. J. Archaeol.	JUL	2015	119	3					279	294		10.3764/aja.119.3.0279		16	Archaeology	Archaeology	CL8PF	WOS:000357235900001		
J	Goggins, WB; Yang, C; Hokama, T; Law, LSK; Chan, EYY				Goggins, William B.; Yang, Chunyuh; Hokama, Tomiko; Law, Lewis S. K.; Chan, Emily Y. Y.			Using Annual Data to Estimate the Public Health Impact of Extreme Temperatures	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						ambient temperature; biometeorology; climate change; mortality; time series	MORTALITY DISPLACEMENT; UNITED-STATES; HEAT WAVES; US CITIES; HONG-KONG; POPULATION; WEATHER; DEATHS; COLD	Short-term associations between both hot and cold ambient temperatures and higher mortality have been found worldwide. Few studies have examined these associations on longer time scales. Age-standardized mortality rates (ASMRs) were calculated for 1976-2012 for Hong Kong SAR, People's Republic of China, defining "annual" time periods in 2 ways: from May through April of the following year and from November through October. Annual frequency and severity of extreme temperatures were summarized by using a degree-days approach with extreme heat expressed as annual degree-days > 29.3A degrees C and cold as annual degree-days < 27.5A degrees C. For example, a day with a mean temperature of 25.0A degrees C contributes 2.5 cold degree-days to the annual total. Generalized additive models were used to estimate the association between annual hot and cold degree-days and the ASMR, with adjustment for long-term trends. Increases of 10 hot or 200 cold degree-days in an annual period, the approximate interquartile ranges for these variables, were significantly (all P's a parts per thousand currency sign 0.011) associated with 1.9% or 3.1% increases, respectively, in the annual ASMR for the May-April analyses and with 2.2% or 2.8% increases, respectively, in the November-October analyses. Associations were stronger for noncancer and elderly mortality. Mortality increases associated with extreme temperature are not simply due to short-term forward displacement of deaths that would have occurred anyway within a few weeks.	[Goggins, William B.; Law, Lewis S. K.] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Biostat, Shatin, Hong Kong, Peoples R China; [Yang, Chunyuh] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Hokama, Tomiko] Univ Ryukyus, Grad Sch Hlth Sci, Okinawa, Japan; [Chan, Emily Y. Y.] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Family Med, Shatin, Hong Kong, Peoples R China	Goggins, WB (reprint author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.	wgoggins@cuhk.edu.hk			Hong Kong Food and Health Bureau [10110681]	This study was supported by a Health and Medical Research Fund (formerly Health and Health Services Research Fund) grant (project 10110681) from the Hong Kong Food and Health Bureau.	Ahmad O, 2001, GPE DISCUSSION PAPER, V31; Chung JY, 2009, SCI TOTAL ENVIRON, V408, P390, DOI 10.1016/j.scitotenv.2009.09.009; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P87, DOI 10.1097/00001648-200201000-00014; Kysely J, 2004, INT J BIOMETEOROL, V49, P91, DOI 10.1007/s00484-004-0218-2; Saha MV, 2014, AM J EPIDEMIOL, V179, P467, DOI 10.1093/aje/kwt264; Chan EYY, 2012, J EPIDEMIOL COMMUN H, V66, P322, DOI 10.1136/jech.2008.085167; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; McGeehin MA, 2001, ENVIRON HEALTH PERSP, V109, P185, DOI 10.2307/3435008; Le Tertre A, 2006, EPIDEMIOLOGY, V17, P75, DOI 10.1097/01.ede.0000187650.36636.1f; Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Rocklov J, 2009, EUR RESPIR J, V33, P245, DOI 10.1183/09031936.00037808; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Goggins WB, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-59; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Wood S. N, 2006, GEN ADDITIVE MODELS	18	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	JUL 1	2015	182	1					80	87		10.1093/aje/kwv013		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CM1DQ	WOS:000357421100011		
J	Kim, J; Procknow, JD; Yanagisawa, H; Wagenseil, JE				Kim, Jungsil; Procknow, Jesse D.; Yanagisawa, Hiromi; Wagenseil, Jessica E.			Differences in genetic signaling, and not mechanical properties of the wall, are linked to ascending aortic aneurysms in fibulin-4 knockout mice	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						fibulin-4; elastin; mechanics; gene array; aneurysm	SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASE-2 AND-9; GROWTH-FACTOR-BETA; MARFAN-SYNDROME; VIII COLLAGEN; ANGIOTENSIN-II; CUTIS-LAXA; NEUTROPHIL COLLAGENASE; EXPRESSION PROFILES; ARTERIAL INJURY	Fibulin-4 is an extracellular matrix protein that is essential for proper assembly of arterial elastic fibers. Mutations in fibulin-4 cause cutis laxa with thoracic aortic aneurysms (TAAs). Sixty percent of TAAs occur in the ascending aorta (AA). Newborn mice lacking fibulin-4 (Fbln4(-/-)) have aneurysms in the AA, but narrowing in the descending aorta (DA), and are a unique model to investigate locational differences in aneurysm susceptibility. We measured mechanical behavior and gene expression of AA and DA segments in newborn Fbln4(-/-) and Fbln4(+/+) mice. Fbln4(-/-) AA has increased diameters compared with Fbln4(+/+) AA and Fbln4(-/-) DA at most applied pressures, confirming genotypic and locational specificity of the aneurysm phenotype. When diameter compliance and tangent modulus were calculated from the mechanical data, we found few significant differences between genotypes, suggesting that the mechanical response to incremental diameter changes is similar, despite the fragmented elastic fibers in Fbln4(-/-) aortas. Fbln4(-/-) aortas showed a trend toward increased circumferential stretch, which may be transmitted to smooth muscle cells (SMCs) in the wall. Gene expression data suggest activation of pathways for SMC proliferation and inflammation in Fbln4(-/-) aortas compared with Fbln4(+/+). Additional genes in both pathways, as well as matrix metalloprotease-8 (Mmp8), are upregulated specifically in Fbln4(-/-) AA compared with Fbln4(+/+) AA and Fbln4(-/-) DA. Mmp8 is a neutrophil collagenase that targets type 1 collagen, and upregulation may be necessary to allow diameter expansion in Fbln4(-/-) AA. Our results provide molecular and mechanical targets for further investigation in aneurysm pathogenesis.	[Kim, Jungsil; Procknow, Jesse D.; Wagenseil, Jessica E.] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Yanagisawa, Hiromi] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Yanagisawa, Hiromi] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan	Wagenseil, JE (reprint author), Washington Univ, Dept Mech Engn & Mat Sci, One Brookings Dr,CB 1185, St Louis, MO 63130 USA.	jessica.wagenseil@wustl.edu			National Heart, Lung, and Blood Institute [R01-HL-115560, R01-HL-105314, R01-HL-106305]	This work was supported, in part, by National Heart, Lung, and Blood Institute Grants R01-HL-115560 (to J. E. Wagenseil), R01-HL-105314 (to J. E. Wagenseil), and R01-HL-106305 (to H. Yanagisawa).	Absi TS, 2003, J THORAC CARDIOV SUR, V126, P344, DOI 10.1016/S0022-5223(02)73576-9; Adiguzel E, 2006, ARTERIOSCL THROM VAS, V26, P56, DOI 10.1161/1.ATV.0000194155.96456.b7; Ahimastos AA, 2010, ATHEROSCLEROSIS, V209, P211, DOI 10.1016/j.atherosclerosis.2009.08.003; Amin M, 2012, J VIS EXP, V60, P3733; Amin M, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004415; Dinardo CL, 2014, AM J PHYSIOL-HEART C, V306, pH505, DOI 10.1152/ajpheart.00655.2013; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Anwar MA, 2012, J VASC RES, V49, P463, DOI 10.1159/000339151; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Inamoto S, 2010, CARDIOVASC RES, V88, P520, DOI 10.1093/cvr/cvq230; Topouzis S, 1996, DEV BIOL, V178, P430, DOI 10.1006/dbio.1996.0229; Wilson WRW, 2005, BRIT J SURG, V92, P828, DOI 10.1002/bjs.4993; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721; Guo X, 2002, AM J PHYSIOL-HEART C, V283, pH1829, DOI 10.1152/ajpheart.00224.2002; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Hanada K, 2007, CIRC RES, V100, P738, DOI 10.1161/01.RES.0000260181.19449.95; Dasouki M, 2007, AM J MED GENET A, V143A, P2635, DOI 10.1002/ajmg.a.31980; Wagenseil JE, 2009, CIRC RES, V104, P1217, DOI 10.1161/CIRCRESAHA.108.192054; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.000011013.72016.ea; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028; HAN HC, 1995, J BIOMECH, V28, P637, DOI 10.1016/0021-9290(94)00091-H; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Muller BT, 2002, EUR J VASC ENDOVASC, V24, P356, DOI 10.1053/ejvs.2002.1731; Isselbacher EM, 2005, CIRCULATION, V111, P816, DOI 10.1161/01.CIR.0000154569.08857.7A; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Cheng JZ, 2007, ARTERIOSCL THROM VAS, V27, P1744, DOI 10.1161/ATVBAHA.107.147371; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Huang JB, 2010, CIRC RES, V106, P583, DOI 10.1161/CIRCRESAHA.109.207852; Hou GP, 2000, AM J PATHOL, V156, P467, DOI 10.1016/S0002-9440(10)64751-7; Renard M, 2010, EUR J HUM GENET, V18, P895, DOI 10.1038/ejhg.2010.45; He RM, 2008, J THORAC CARDIOV SUR, V136, P922, DOI 10.1016/j.jtcvs.2007.12.063; Guo XM, 2003, AM J PHYSIOL-HEART C, V285, pH2614, DOI 10.1152/ajpheart.00567.2003; Chung AWY, 2008, CIRC RES, V102, pE73, DOI 10.1161/CIRCRESAHA.108.174367; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Fonck E, 2007, AM J PHYSIOL-HEART C, V292, pH2754, DOI 10.1152/ajpheart.01108.2006; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; Greenwald SE, 1997, J BIOMECH ENG-T ASME, V119, P438, DOI 10.1115/1.2798291; Wagenseil JE, 2005, AM J PHYSIOL-HEART C, V289, pH1209, DOI 10.1152/ajpheart.00046.2005; Le VP, 2014, BIOMECH MODEL MECHAN, V13, P1081, DOI 10.1007/s10237-014-0556-x; BESNER G, 1990, CELL REGUL, V1, P811; Cheuk BLY, 2011, J VASC SURG, V53, P1071, DOI 10.1016/j.jvs.2010.11.035; CHU W, 1995, J BIOL CHEM, V270, P10236; CHUONG CJ, 1986, J BIOMECH ENG-T ASME, V108, P189; DAVIS EC, 1995, J HISTOCHEM CYTOCHEM, V43, P1115; de Waard V, 2003, ARTERIOSCL THROM VAS, V23, P64, DOI 10.1161/01.ATV.0000042218.13101.50; Lindsay ME, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015909; Dobrin P B, 1994, Cardiovasc Surg, V2, P484; Huang J, 2013, SCI TRANSL MED, V5, P181; Humphrey JD, 2014, SCIENCE, V344, P476, DOI 10.1126/science.1253026; Kanai H, 2001, CIRC RES, V88, P30; KATORA ME, 1976, EXP MOL PATHOL, V24, P23, DOI 10.1016/0014-4800(76)90054-X; Kim JH, 2010, ANN VASC SURG, V24, P538, DOI 10.1016/j.avsg.2010.01.007; Komurasaki T, 1997, ONCOGENE, V15, P2841, DOI 10.1038/sj.onc.1201458; Koo BH, 2003, J BIOL CHEM, V278, P52578, DOI 10.1074/jbc.M310007200; Lopes J, 2013, AM J PATHOL, V182, P2241, DOI 10.1016/j.ajpath.2013.02.011; Matsuki H, 1996, CLIN CHIM ACTA, V244, P129, DOI 10.1016/0009-8981(95)06197-5; MIYAGAWA J, 1995, J CLIN INVEST, V95, P404, DOI 10.1172/JCI117669; Moltzer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023411; Owens AP, 2010, CIRC RES, V106, P611, DOI 10.1161/CIRCRESAHA.109.212837; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pfaltzgraff ER, 2014, J MOL CELL CARDIOL, V69, P88, DOI 10.1016/j.yjmcc.2014.01.016; Ramnath NWM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106054; Reynolds CM, 2002, HYPERTENSION, V39, P525, DOI 10.1161/hy0202.103076; Riese DJ, 2014, SEMIN CELL DEV BIOL, V28, P49, DOI 10.1016/j.semcdb.2014.03.005; Schwill S, 2013, J VASC SURG, V57, P1628; Shuttleworth CA, 1997, INT J BIOCHEM CELL B, V29, P1145, DOI 10.1016/S1357-2725(97)00033-2; Sibinga NES, 1997, CIRC RES, V80, P532; Simon Lee S., 1999, American Journal of Medicine, V106, p37S, DOI 10.1016/S0002-9343(99)00115-1; Stacey M, 2001, J BIOL CHEM, V276, P18863, DOI 10.1074/jbc.M101147200; Takahashi M, 2003, CIRCULATION, V108, P2524, DOI 10.1161/01.CIR.0000096482.02567.8C; Takamiya A, 2001, INVEST OPHTH VIS SCI, V42, P2427; Taylor DS, 1999, P NATL ACAD SCI USA, V96, P1633, DOI 10.1073/pnas.96.4.1633; Wan W, 2013, AM J PHYSIOL-HEART C, V304, pH674, DOI 10.1152/ajpheart.00459.2012; Xiong WF, 2012, CIRC RES, V110, pE92, DOI 10.1161/CIRCRESAHA.112.268268	89	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	JUL 1	2015	309	1					H103	H113		10.1152/ajpheart.00178.2015		11	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Physiology	CM2IG	WOS:000357502700010		
J	Ogino, A; Takemura, G; Hashimoto, A; Kanamori, H; Okada, H; Nakagawa, M; Tsujimoto, A; Goto, K; Kawasaki, M; Nagashima, K; Miyakoda, G; Fujiwara, T; Yabuuchi, Y; Fujiwara, H; Minatoguchi, S				Ogino, Atsushi; Takemura, Genzou; Hashimoto, Ayako; Kanamori, Hiromitsu; Okada, Hideshi; Nakagawa, Munehiro; Tsujimoto, Akiko; Goto, Kazuko; Kawasaki, Masanori; Nagashima, Kenshi; Miyakoda, Goro; Fujiwara, Takako; Yabuuchi, Youichi; Fujiwara, Hisayoshi; Minatoguchi, Shinya			OPC-28326, a selective peripheral vasodilator with angiogenic activity, mitigates postinfarction cardiac remodeling	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						angiogenesis; late reperfusion; myocardial infarction; remodeling	ACUTE MYOCARDIAL-INFARCTION; FEMORAL ARTERIAL VASODILATOR; NITRIC-OXIDE SYNTHASE; TISSUE CELL APOPTOSIS; GRANULATION-TISSUE; CORONARY-ARTERY; HEART-FAILURE; REPERFUSION; ISCHEMIA; DYSFUNCTION	Although OPC-28326, 4-(N-methyl-2-phenylethylamino)-1-(3,5-dimethyl-4-propionyl-aminobenzoyl) piperidine hydrochloride monohydrate, was developed as a selective peripheral vasodilator with alpha(2)-adrenergic antagonist properties, it also reportedly exhibits angiogenic activity in an ischemic leg model. The purpose of this study was to examine the effect of OPC-28326 on the architectural dynamics and function of the infarcted left ventricle during the chronic stage of myocardial infarction. Myocardial infarction was induced in male C3H/He mice, after which the mice were randomly assigned into two groups: a control group receiving a normal diet and an OPC group whose diet contained 0.05% OPC-28326. The survival rate among the mice (n = 18 in each group) 4 wk postinfarction was significantly greater in the OPC than control group (83 vs. 44%; P < 0.05), and left ventricular remodeling and dysfunction were significantly mitigated. Histologically, infarct wall thickness was significantly greater in the OPC group, due in part to an abundance of nonmyocyte components, including blood vessels and myofibroblasts. Five days postinfarction, Ki-67-positive proliferating cells were more abundant in the granulation tissue in the OPC group, and there were fewer apoptotic cells. These effects were accompanied by activation of myocardial Akt and endothelial nitric oxide synthase. Hypoxia within the infarct issue, assessed using pimonidazole staining, was markedly attenuated in the OPC group. In summary, OPC-28326 increased the nonmyocyte population in infarct tissue by increasing proliferation and reducing apoptosis, thereby altering the tissue dynamics such that wall stress was reduced, which might have contributed to a mitigation of postinfarction cardiac remodeling and dysfunction.	[Ogino, Atsushi; Takemura, Genzou; Kanamori, Hiromitsu; Okada, Hideshi; Nakagawa, Munehiro; Tsujimoto, Akiko; Goto, Kazuko; Kawasaki, Masanori; Nagashima, Kenshi; Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan; [Takemura, Genzou] Asahi Univ, Dept Internal Med, Mizuho, Japan; [Hashimoto, Ayako; Miyakoda, Goro; Yabuuchi, Youichi] Otsuka Pharmaceut Co Ltd, Res Inst Pharmacol & Therapeut Dev, Tokushima 77101, Japan; [Fujiwara, Takako] Sonoda Womens Univ, Dept Food & Nutr, Amagasaki, Hyogo, Japan; [Fujiwara, Hisayoshi] Hyogo Kenritsu Amagasaki Hosp, Dept Cardiovasc Med, Amagasaki, Hyogo, Japan	Takemura, G (reprint author), Asahi Univ, Sch Dent, Dept Internal Med, 1851 Hozumi, Mizuho 5010296, Japan.	gt@dent.asahi-u.ac.jp			Asahi University; Gifu University	This study was supported in part by the grants from Asahi University and Gifu University.	Abbate A, 2002, CIRCULATION, V106, P1051, DOI 10.1161/01.CIR.0000030936.97158.C4; Li YW, 2004, CIRC RES, V95, P627, DOI 10.1161/01.RES.0000141528.54850.bd; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656; HAMMERMAN H, 1984, CIRCULATION, V69, P611; Murohara T, 1999, ARTERIOSCL THROM VAS, V19, P1156; von Harsdorf R, 2004, CIRC RES, V95, P554, DOI 10.1161/01.RES.0000143717.70275.8f; PFEFFER MA, 1995, ANNU REV MED, V46, P455; Laifenfeld D, 2010, TOXICOL SCI, V113, P254, DOI 10.1093/toxsci/kfp213; Hayakawa K, 2003, CIRCULATION, V108, P104, DOI 10.1161/01.CIR.0000074225.62168.68; Uusimaa P, 1997, CIRCULATION, V96, P2565; Kawaguchi T, 2012, CARDIOVASC RES, V96, P456, DOI 10.1093/cvr/cvs282; KIM CB, 1993, CIRCULATION, V88, P2426; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Arteel GE, 1996, AM J PHYSIOL-GASTR L, V271, pG494; Cheng XW, 2007, CIRC RES, V100, P904, DOI 10.1161/01.RES.0000260801.12916.b5; Ogino A, 2007, AM J PHYSIOL-HEART C, V293, pH2271, DOI 10.1152/ajpheart.00303.2007; Nakano M, 2007, CIRC RES, V100, P662, DOI 10.1161/01.RES.0000260179.43672.fe; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; BRAUNWALD E, 1989, CIRCULATION, V79, P441; Calvillo L, 2003, CARDIOVASC DRUG THER, V17, P199, DOI 10.1023/A:1026182404805; Fenton BM, 1999, BRIT J CANCER, V79, P464, DOI 10.1038/sj.bjc.6690072; HALE SL, 1988, AM HEART J, V116, P1508, DOI 10.1016/0002-8703(88)90736-3; HOCHMAN JS, 1987, CIRCULATION, V75, P299; Kanamori H, 2007, AM J PHYSIOL-HEART C, V292, pH2184, DOI 10.1152/ajpheart.01235.2006; Kloner RA, 2008, CIRC RES, V103, P1, DOI 10.1161/CIRCRESAHA.108.180216; KLONER RA, 1992, J AM COLL CARDIOL, V20, P314; Li LH, 2009, AM J PHYSIOL-HEART C, V297, pH1504, DOI 10.1152/ajpheart.00194.2009; Marroquin OC, 2004, PROG CARDIOVASC DIS, V42, P471; Nakagawa M, 2008, CIRC RES, V103, P98, DOI 10.1161/CIRCRESAHA.108.177568; Orito K, 1999, J PHARMACOL EXP THER, V291, P604; Orito K, 2002, JPN J PHARMACOL, V88, P119, DOI 10.1254/jjp.88.119; PFEFFER MA, 1988, NEW ENGL J MED, V319, P80, DOI 10.1056/NEJM198807143190204; PIRZADA FA, 1978, CHEST, V74, P190, DOI 10.1378/chest.74.2.190; REIMER KA, 1993, AM J CARDIOL, V72, pG13, DOI 10.1016/0002-9149(93)90102-I; Sumi M, 2007, BIOMED PHARMACOTHER, V61, P209, DOI 10.1016/j.biopha.2006.12.004; Sun B, 2001, J PHARMACOL EXP THER, V299, P652; Takemura G, 1998, CIRC RES, V82, P1130; Wang B, 2005, AM J PHYSIOL-HEART C, V289, pH108, DOI 10.1152/ajpheart.00001.2005; WHITE HD, 1994, CIRCULATION, V89, P61; YIN FCP, 1981, CIRC RES, V49, P829	40	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	JUL 1	2015	309	1					H213	H221		10.1152/ajpheart.00062.2015		9	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Physiology	CM2IG	WOS:000357502700021		
J	Itoi, E; Kitamura, T; Hitachi, S; Hatta, T; Yamamoto, N; Sano, H				Itoi, Eiji; Kitamura, Toshio; Hitachi, Shin; Hatta, Taku; Yamamoto, Nobuyuki; Sano, Hirotaka			Arm Abduction Provides a Better Reduction of the Bankart Lesion During Immobilization in External Rotation After an Initial Shoulder Dislocation	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						shoulder dislocation; immobilization; external rotation; abduction; Bankart lesion; capsulolabral complex	ACUTE ANTERIOR DISLOCATIONS; RANDOMIZED CONTROLLED-TRIAL; RECURRENCE; RISK; POSITION	Background: Shoulder dislocation often recurs, especially in the younger population. Immobilization in external rotation, in which a Bankart lesion is displaced in the anterior, medial, and inferior directions, was introduced as a new method of nonoperative treatment, but its clinical efficiency is controversial. In terms of reducing the lesion, it is reasonable to incorporate not only external rotation, which makes the anterior soft tissues tight to push the lesion posteriorly and laterally, but also abduction, which makes the inferior soft tissues tight to push the lesion superiorly. Hypothesis: Abducting the arm during immobilization in external rotation will improve the reduction of a Bankart lesion. Study Design: Controlled laboratory study. Methods: There were 37 patients with initial shoulder dislocation enrolled in this study. After reduction, MRI was taken in 4 positions of the shoulder: adduction and internal rotation (Add-IR), adduction and external rotation (Add-ER), 30 degrees of abduction and 30 degrees of external rotation (Abd-30ER), and 30 degrees of abduction and 60 degrees of external rotation (Abd-60ER). On radial slices, the separation, displacement of the labrum, and opening angle of the capsule were measured. Results: Add-ER improved the reduction of the anterior labrum but not the inferior labrum when compared with Add-IR. Both Abd-30ER and Abd-60ER improved the reduction of the inferior labrum as compared with Add-IR. Furthermore, Abd-60ER improved the reduction more than Add-ER. Conclusion: Among the 4 positions tested, Abd-60ER is the best position in terms of reducing the Bankart lesion. Clinical Relevance: Abducting the shoulder during immobilization in external rotation is demonstrated to improve the reduction of the Bankart lesion. Therefore, this position is expected to reduce the recurrence rate after initial dislocation of the shoulder. Future clinical trials are necessary.	[Itoi, Eiji; Kitamura, Toshio; Hitachi, Shin; Hatta, Taku; Yamamoto, Nobuyuki; Sano, Hirotaka] Tohoku Univ, Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 9808574, Japan	Itoi, E (reprint author), Tohoku Univ, Sch Med, Dept Orthopaed Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	itoi-eiji@med.tohoku.ac.jp					Itoi E, 2001, J BONE JOINT SURG AM, V83A, P661; Liavaag S, 2011, J BONE JOINT SURG AM, V93A, P897, DOI 10.2106/JBJS.J.00416; Scheibel M, 2009, AM J SPORT MED, V37, P1309, DOI 10.1177/0363546509331943; Whelan DB, 2014, CLIN ORTHOP RELAT R, V472, P2380, DOI 10.1007/s11999-013-3432-6; Itoi E, 2007, J BONE JOINT SURG AM, V89A, P2124, DOI 10.2106/JBJS.F.00654; Vavken P, 2014, J SHOULDER ELB SURG, V23, P13, DOI 10.1016/j.jse.2013.07.037; Heidari K, 2014, J SHOULDER ELB SURG, V23, P759, DOI 10.1016/j.jse.2014.01.018; Finestone A, 2009, J BONE JOINT SURG BR, V91B, P918, DOI 10.1302/0301-620X.91B7.22263; Hart WJ, 2005, J SHOULDER ELB SURG, V14, P134, DOI 10.1016/j.jse.2004.07.002; Hatta T, 2013, UPSALA J MED SCI, V118, P105, DOI 10.3109/03009734.2012.744374; Itoi E, 1999, J BONE JOINT SURG AM, V81A, P385; Miller BS, 2004, J SHOULDER ELB SURG, V13, P589, DOI 10.1016/j.jse.2004.03.006; Pennekamp W, 2006, ROFO-FORTSCHR RONTG, V178, P410, DOI 10.1055/s-2006-926476; ROWE C R, 1961, Clin Orthop, V20, P40; Schliemann B, 2009, SPORTVERLETZ SPORTSC, V23, P100, DOI 10.1055/s-0028-1109418; Seybold D, 2006, CHIRURG, V77, P821, DOI 10.1007/s00104-006-1181-8; Taskoparan H, 2010, ACTA ORTHOP TRAUMATO, V44, P278, DOI 10.3944/AOTT.2010.2274	17	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2015	43	7					1731	1736		10.1177/0363546515577782		6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CM2UG	WOS:000357537200027		
J	Mihata, T; McGarry, MH; Neo, M; Ohue, M; Lee, TQ				Mihata, Teruhisa; McGarry, Michelle H.; Neo, Masashi; Ohue, Mutsumi; Lee, Thay Q.			Effect of Anterior Capsular Laxity on Horizontal Abduction and Forceful Internal Impingement in a Cadaveric Model of the Throwing Shoulder	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						anterior; capsular laxity; internal impingement; throwing; biomechanics	CAPSULOLABRAL RECONSTRUCTION; GLENOHUMERAL LAXITY; EXTERNAL ROTATION; SLAP LESIONS; TRANSLATION; INSTABILITY	Background: Excessive anterior capsular laxity (elongation of the anterior capsular ligaments) causes shoulder subluxation during acceleration of the throwing motion, leading to a disabled throwing shoulder. Few biomechanical studies have investigated the relationship between anterior capsular laxity and internal impingement, another cause of the disabled throwing shoulder. Purpose/Hypothesis: The purpose of this study was to assess the effect of anterior capsular laxity on forceful internal impingement during the late cocking phase. The hypothesis was that excessive anterior shoulder laxity caused by elongation of the anterior capsular ligaments will increase the horizontal abduction angle to increase glenohumeral contact pressure. Study Design: Controlled laboratory study. Methods: Eight fresh-frozen cadaveric shoulders were tested with the shoulder abducted to 90 degrees and at maximal external rotation to simulate the late cocking phase of the throwing motion. The angle of external rotation, anterior translation, angle of horizontal abduction, locations of the articular insertion of the rotator cuff tendons (supraspinatus and infraspinatus) on the greater tuberosity relative to the glenoid, and the glenohumeral contact pressure and area during internal impingement were measured. All data were compared between intact and elongated anterior capsule, which was created by repeatedly applying external rotational stretching. Results: Elongation of the anterior capsular ligaments was confirmed by the increase in glenohumeral external rotation and anterior translation after our stretching technique. Location data showed that the posterior half of supraspinatus tendon, the entire infraspinatus tendon, and the posterosuperior labrum were impinged between the greater tuberosity and glenoid. Maximal glenohumeral horizontal abduction (2.2% increase; P = .003) and glenohumeral contact pressure (27.3% increase; P = .04) were significantly increased in the shoulder joint with increased anterior capsular laxity as compared with the intact condition. Conclusion: Increased anterior capsular laxity created by applying repetitive excessive external rotational torque significantly increased horizontal abduction and contact pressure in the glenohumeral joint. Concurrently, the supraspinatus and infraspinatus tendons and posterosuperior labrum were impinged between the greater tuberosity and glenoid. Clinical Relevance: Increased anterior capsular laxity may exacerbate forceful internal impingement during the late cocking phase of the throwing motion.	Long Beach VA Healthcare Syst, Orthopaed Biomech Lab, Irvine, CA USA; Univ Calif Irvine, Irvine, CA USA	Mihata, T (reprint author), Osaka Med Coll, Dept Orthoped Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	tmihata@yahoo.co.jp					Mihata T, 2004, AM J SPORT MED, V32, P1278, DOI 10.1177/0363546503262188; Lee TQ, 2001, J SHOULDER ELB SURG, V10, P68, DOI 10.1067/mse.2001.111138; Mihata T, 2012, J BONE JOINT SURG AM, V94A, P1576, DOI 10.2106/JBJS.J.01972; Mihata T, 2010, AM J SPORT MED, V38, P369, DOI 10.1177/0363546509346408; Jobe CM, 1996, CLIN ORTHOP RELAT R, P98; JOBE FW, 1991, AM J SPORT MED, V19, P428, DOI 10.1177/036354659101900502; BROWN LP, 1988, AM J SPORT MED, V16, P577, DOI 10.1177/036354658801600604; Alberta FG, 2006, J BONE JOINT SURG AM, V88A, P179, DOI 10.2106/JBJS.D.02974; Laudner K, 2012, AM J SPORT MED, V40, P1133, DOI 10.1177/0363546512437522; Jobe F W, 1989, Orthop Rev, V18, P963; Kibler W Ben, 2013, Arthroscopy, V29, P141, DOI 10.1016/j.arthro.2012.10.009; Mihata T, 2008, AM J SPORT MED, V36, P1604, DOI 10.1177/0363546508315198; Mihata T, 2009, AM J SPORT MED, V37, P2222, DOI 10.1177/0363546509337450; Mihata T, 2015, KNEE SURG SPORT TR A, V23, P548, DOI 10.1007/s00167-013-2381-7; Mihata T, 2005, J SHOULDER ELB SURG, V14, p19S, DOI 10.1016/j.jse.2004.10.004; MONTGOMERY WH, 1994, AM J SPORT MED, V22, P352, DOI 10.1177/036354659402200310; Owens BD, 2012, J AM ACAD ORTHOP SUR, V20, P518, DOI 10.5435/JAAOS-20-08-518; Ryu RKN, 2002, ARTHROSCOPY, V18, P70, DOI 10.1053/jars.2002.36510; Savoie FH, 2014, SPORTS MED ARTHROSC, V22, P117, DOI 10.1097/JSA.0000000000000021; Tibone JE, 1998, AM J SPORT MED, V26, P495	20	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2015	43	7					1758	1763		10.1177/0363546515582025		6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CM2UG	WOS:000357537200031		
J	Mekky, MA; Tolba, M; Abdel-Malek, MO; Abbas, WA; Zidan, M				Mekky, Mohamed A.; Tolba, Mohammed; Abdel-Malek, Mohamed O.; Abbas, Wael A.; Zidan, Mohamed			Human Fascioliasis: A Re-emerging Disease in Upper Egypt	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							ANIMAL FASCIOLIASIS; NILE DELTA; GIGANTICA; TRICLABENDAZOLE; OPISTHORCHIASIS; SCHISTOSOMIASIS; CLONORCHIASIS; EPIDEMIOLOGY; HEPATICA	In recent years, the number of humans infected with Fasciola has risen rapidly. Diagnosis is based mainly on detection of eggs in stool analysis. The rate of infection in Egypt is unknown. In this retrospective study, we describe 23 cases of hepatic fascioliasis, and only 2 of these cases showed eggs in stools. The symptoms of infection, such as pyrexia of unknown origin, epigastric pain, and abdominal distension, were suggestive. Imaging techniques, including abdominal ultrasonography and computed tomography, were very helpful in detecting hepatic changes. An indirect hemagglutination assay proved to be of value for diagnosis. Treatment using a 2-day triclabendazole regimen cured the infection and signs of hepatic involvement disappeared. Combining both imaging techniques and laboratory tests is essential for diagnosis of fascioliasis in the early stage.	[Mekky, Mohamed A.; Abdel-Malek, Mohamed O.] Assiut Univ, Fac Med, Dept Gastroenterol & Trop Med, Assiut 71515, Egypt; [Tolba, Mohammed] Assiut Univ, Dept Parasitol, Fac Med, Assiut 71515, Egypt; Fac Med, Dept Internal Med, Assiut, Egypt; [Zidan, Mohamed] Assiut Univ, Fac Med, Dept Diagnost Radiol, Assiut 71515, Egypt; [Tolba, Mohammed] Univ Tokyo, Inst Med Sci, Sugano Lab, Ctr Human Genome, Tokyo, Japan; [Abbas, Wael A.] Assiut Univ, Dept Internal Med, Assiut 71515, Egypt	Tolba, M (reprint author), Assiut Univ, Dept Parasitol, Fac Med, Assiut 71515, Egypt.	mekky0000@yahoo.com; essa3eg@yahoo.com; momar7619@gmail.com; drwaelabbas@yahoo.com; mzidan74@yahoo.com					Abdel-Aziz NM, 1993, THESIS ASSIUT U EGYP; Abdel-Hafeez EH, 2012, KOREAN J PARASITOL, V50, P57, DOI 10.3347/kjp.2012.50.1.57; Marcos LA, 2008, CURR OPIN INFECT DIS, V21, P523, DOI 10.1097/QCO.0b013e32830f9818; Valero MA, 2009, ACTA TROP, V111, P150, DOI 10.1016/j.actatropica.2009.04.005; Esteban JG, 2003, AM J TROP MED HYG, V69, P429; Soliman MFM, 2008, J INFECT DEV COUNTR, V2, P182; Periago MV, 2008, INFECT GENET EVOL, V8, P51, DOI 10.1016/j.meegid.2007.10.001; Mas-Coma S, 2009, ADV PARASIT, V69, P41, DOI 10.1016/S0065-308X(09)69002-3; El-Khoby T, 2000, AM J TROP MED HYG, V62, P88; Arafa MI, 2008, ASSIUT U B ENV RES, V11, P57; Barakat Rashida M R, 2013, J Adv Res, V4, P425, DOI 10.1016/j.jare.2012.07.003; Fang Wen, 2014, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V26, P106; Lim JH, 2008, ABDOM IMAGING, V33, P157, DOI 10.1007/s00261-007-9326-x; Lotfy WM, 2002, VET PARASITOL, V103, P323, DOI 10.1016/S0304-4017(01)00613-6; Marcos LA, 2008, AM J TROP MED HYG, V78, P222; Mas-Coma M. S., 1999, Bulletin of the World Health Organization, V77, P340; TRENT SC, 1963, AM J TROP MED HYG, V12, P877; Vatsal Devendra K, 2006, Neurosurgery, V59, pE706, DOI 10.1227/01.NEU.0000230247.42067.6C; Youssef Ahmed I, 2014, Trop Med Health, V42, P3, DOI 10.2149/tmh.2013-23; Zali MR, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-15	20	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUL	2015	93	1					76	79		10.4269/ajtmh.15-0030		4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CM5YG	WOS:000357764300015		
J	Okuchi, T; Purevjav, N; Tomioka, N; Lin, JF; Kuribayashi, T; Schoneveld, L; Hwang, H; Sakamoto, N; Kawasaki, N; Yurimoto, H				Okuchi, Takuo; Purevjav, Narangoo; Tomioka, Naotaka; Lin, Jung-Fu; Kuribayashi, Takahiro; Schoneveld, Louise; Hwang, Huijeong; Sakamoto, Naoya; Kawasaki, Noriyuki; Yurimoto, Hisayoshi			Synthesis of large and homogeneous single crystals of water-bearing minerals by slow cooling at deep-mantle pressures	AMERICAN MINERALOGIST			English	Article						Hydrous minerals; single-crystal growth; phase E; wadsleyite; ringwoodite; bridgmanite; slow-cooling method	PULSED-NEUTRON DIFFRACTION; HYDROUS RINGWOODITE; TRANSITION-ZONE; EARTHS INTERIOR; MGSIO3 PEROVSKITE; FTIR SPECTROSCOPY; SOUND VELOCITIES; OXIDATION-STATE; GAMMA-PHASE; WADSLEYITE	The presence of water in the Earth's deep mantle is an issue of increasing interest in the field of high-pressure mineralogy. An important task for further advancing research in the field is to create homogeneous single crystals of candidate deep-mantle water-bearing minerals of 1 mm or larger in size, which is required for applying them for the time-of-flight (TOE) single-crystal Laue diffraction method with a third-generation neutron instrument. In this study, we perform several experiments to demonstrate an improved methodology for growing hydrous crystals of such large sizes at relevant transition zone and lower-mantle conditions via very slow cooling over a maximum period of 1 day. Successfully synthesized crystals using this methodology include dense hydrous magnesium silicate (DHMS) phase E, hydrous wadsleyite, hydrous ringwoodite, and bridgmanite (silicate perovskite). It is also demonstrated that these hydrous crystals can be grown from deuterium enriched starting materials in addition to those having a natural hydrogen isotope ratio. Magnitudes of chemical and crystallographic heterogeneities of the product crystals were characterized by comprehensive analysis of X-ray precession photography, single-crystal X-ray diffraction (SCXRD), field-emission scanning electron microscope (FE-SEM), electron probe microanalyzer (EPMA), secondary ion mass spectroscopy (SIMS)(,) powder X-ray diffraction (PXRD), and TOF neutron powder diffraction (TOF-NPD). The product crystals were confirmed to be inclusion free and crystallographically homogeneous. Compositional and isotopic differences of major elements and hydrogen isotope abundances were lower than 1 and 3%, respectively, among intracrystals and intercrystals within each recovered sample capsule. Phase E crystals up to 600 mu m in the largest dimension were grown at a constant temperature of 1100 degrees C kept for 3 h. Using a lattice parameter-to-temperature relation of phase E, the thermal gradient in the sample capsules for the phase E synthesis has been evaluated to be 20 degrees C/mm. Hydrous wadsleyite crystals up to 1100 gm in the largest dimension were grown at 1390 degrees C with a temperature reduction of 70 degrees C during heating for 10 h. Hydrous ringwoodite crystals up to 1000 mu m in the largest dimension were grown at around 1400 degrees C with a temperature reduction of 110 degrees C during heating for 12 h. Bridgmanite crystals up to 600 mu m in the largest dimension were grown at 1700 degrees C with a temperature reduction of 30 degrees C during heating for 12 h. A TOF single-crystal diffraction instrument has been successfully used for analyzing one of the hydrous wadsleyite crystals, which demonstrated that single crystals appropriate for their expected usage are created using the method proposed in the present study.	[Okuchi, Takuo; Purevjav, Narangoo; Tomioka, Naotaka] Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan; [Lin, Jung-Fu] Univ Texas Austin, Jackson Sch Geosci, Dept Geol Sci, Austin, TX 78712 USA; [Kuribayashi, Takahiro] Tohoku Univ, Grad Sch Sci, Dept Earth Sci, Sendai, Miyagi 9808578, Japan; [Schoneveld, Louise] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Hwang, Huijeong] Yonsei Univ, Dept Earth Syst Sci, Seoul 120749, South Korea; [Sakamoto, Naoya] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido 0010021, Japan; [Kawasaki, Noriyuki; Yurimoto, Hisayoshi] Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan	Okuchi, T (reprint author), Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan.	okuchi@misasa.okayama-u.ac.jp	OKUCHI, Takuo/B-1884-2011; Lin, Jung-Fu/B-4917-2011; Tomioka, Naotaka/B-1888-2011	OKUCHI, Takuo/0000-0001-6907-0945; 	JSPS [23340161, 23540558, 26287135]; Ministry of Education, Culture, Sports, Science and Technology; J-PARC through MLF [2012B0016]; Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy; X-ray Free Electron Laser Priority Strategy Program (MEXT); U.S. National Science Foundation Geophysics Program (NSF EAR Early Career); Energy Frontier Research in Extreme Environments (EFree); Center for High Pressure Science and Advanced Technology (HPSTAR)	This work was supported by JSPS grants-in-aid for Scientific Research (No. 23340161, 23540558, and 26287135). Visits to the Institute for Study of the Earth's Interior by J.F. Lin, L. Schoneveld, and H. Hwang were supported by a special grant from the Ministry of Education, Culture, Sports, Science and Technology. Part of the research conducted at J-PARC was through MLF user program (No. 2012B0016), where S. Harjo and J. Abe are acknowledged for technical supports. Part of the research conducted at SNS, Oak Ridge National Laboratory was sponsored by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy, where C. Hoffman and X. Wang are acknowledged for technical supports. T. Okuchi acknowledges support from X-ray Free Electron Laser Priority Strategy Program (MEXT) for part of the research. J.F. Lin acknowledges support from the U.S. National Science Foundation Geophysics Program (NSF EAR Early Career), Energy Frontier Research in Extreme Environments (EFree), and Center for High Pressure Science and Advanced Technology (HPSTAR) for part of the research. The authors thank Chikako Oka and Eiji Ito for technical supports and discussion in conducting Kawai-type experiments, Megan Matheney for manuscript editing, and Anton Shatskiy and one anonymous reviewer for providing constructive comments to improve the manuscript.	Jacobsen SD, 2005, AM MINERAL, V90, P61, DOI 10.2138/am.2005.1624; INOUE T, 1995, GEOPHYS RES LETT, V22, P117, DOI 10.1029/94GL02965; Bercovici D, 2003, NATURE, V425, P39, DOI 10.1038/nature01918; Hofmeister AM, 2005, J GEODYN, V40, P51, DOI 10.1016/j.jog.2005.06.001; Kubo T, 1998, SCIENCE, V281, P85, DOI 10.1126/science.281.5373.85; KUDOH Y, 1993, PHYS CHEM MINER, V19, P357; Litasov KD, 2011, PHYS CHEM MINER, V38, P75, DOI 10.1007/s00269-010-0382-3; Schultz AJ, 2014, J APPL CRYSTALLOGR, V47, P915, DOI 10.1107/S1600576714006372; Greenwood JP, 2011, NAT GEOSCI, V4, P79, DOI [10.1038/ngeo1050, 10.1038/NGEO1050]; Mao Z, 2012, EARTH PLANET SC LETT, V331, P112, DOI 10.1016/j.epsl.2012.03.001; Ohtani E, 2000, PHYS CHEM MINER, V27, P533, DOI 10.1007/s002690000097; Pearson DG, 2014, NATURE, V507, P221, DOI 10.1038/nature13080; Holland TJB, 1997, MINERAL MAG, V61, P65, DOI 10.1180/minmag.1997.061.404.07; Shibazaki Y, 2009, EARTH PLANET SC LETT, V287, P463, DOI 10.1016/j.epsl.2009.08.034; Shatskiy A, 2009, AM MINERAL, V94, P1130, DOI 10.2138/am.2009.3150; Litasov K, 2003, EARTH PLANET SC LETT, V211, P189, DOI 10.1016/S0012-821X(03)00200-0; Frost DJ, 2004, PHYS EARTH PLANET IN, V143, P507, DOI 10.1016/j.pepi.2004.03.003; Chen JH, 1998, GEOPHYS RES LETT, V25, P575, DOI 10.1029/98GL00043; Okuchi T, 1997, SCIENCE, V278, P1781, DOI 10.1126/science.278.5344.1781; Ghosh S, 2013, EARTH PLANET SC LETT, V371, P103, DOI 10.1016/j.epsl.2013.04.011; KANZAKI M, 1991, PHYS EARTH PLANET IN, V66, P307, DOI 10.1016/0031-9201(91)90085-V; TAMURA S, 1974, Z ANORG ALLG CHEM, V410, P313, DOI 10.1002/zaac.19744100311; McCammon CA, 2004, PHYS EARTH PLANET IN, V143, P157, DOI 10.1016/j.pepi.2003.08.009; Ohtani E, 2004, PHYS EARTH PLANET IN, V143, P255, DOI 10.1016/j.pepi.2003.09.015; Bolfan-Casanova N, 2000, EARTH PLANET SC LETT, V182, P209, DOI 10.1016/S0012-821X(00)00244-2; Ye Y, 2012, AM MINERAL, V97, P573, DOI 10.2138/am.2012.4010; Shatskiy A, 2010, AM MINERAL, V95, P135, DOI 10.2138/am.2010.3255; INOUE T, 1994, PHYS EARTH PLANET IN, V85, P237, DOI 10.1016/0031-9201(94)90116-3; Inoue T, 1998, EARTH PLANET SC LETT, V160, P107, DOI 10.1016/S0012-821X(98)00077-6; Shatskiy A, 2007, AM MINERAL, V92, P1744, DOI 10.2138/am.2007.2415; Inoue T, 2010, PHYS EARTH PLANET IN, V183, P245, DOI 10.1016/j.pepi.2010.08.003; ARTIOLI G, 1995, ACTA CRYSTALLOGR B, V51, P733, DOI 10.1107/S0108768194014631; Chakoumakos BC, 2013, AM MINERAL, V98, P1, DOI 10.2138/am.2013.4202; Goncharov A.F., 2015, PHYS EARTH IN PRESS; Harjo S, 2006, MATER SCI FORUM, V524-525, P199; Horita J, 2010, PHYS CHEM MINER, V37, P741, DOI 10.1007/s00269-010-0372-5; Inoue T., 2012, JOINT S MIS 2012 GEO, pP21; ITO E, 1986, GEOPHYS RES LETT, V13, P464, DOI 10.1029/GL013i005p00464; Jacobsen SD, 2004, PHYS EARTH PLANET IN, V143, P47, DOI 10.1016/j.pepi.2003.07.019; Jorgensen MRV, 2014, ACTA CRYSTALLOGR A, V70, P679, DOI 10.1107/S2053273314015599; Keppler H., 2006, REV MINERALOGY GEOCH, V62; Kleppe AK, 2001, AM MINERAL, V86, P1275; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; Kudoh Y, 2000, PHYS CHEM MINER, V27, P474, DOI 10.1007/s002690000091; Loeffert A, 2002, J PHYS-CONDENS MAT, V14, P11161, DOI 10.1088/0953-8984/14/44/445; Mao Z, 2011, AM MINERAL, V96, P1606, DOI 10.2138/am.2011.3807; Miyagi I., 1995, B VOLCANOL SOC JPN, V40, P349; Mrosko M, 2013, AM MINERAL, V98, P629, DOI 10.2138/am.2013.4245; Okuchi T, 2014, HIGH PRESSURE RES, V34, P273, DOI 10.1080/08957959.2014.909931; Panero WR, 2013, AM MINERAL, V98, P637, DOI 10.2138/am.2013.3978; Purevjav N., 2014, JAP SOC NEUTR SCI 20; Purevjav N, 2014, GEOPHYS RES LETT, V41, P6718, DOI 10.1002/2014GL061448; Rudolph P., 2010, SPRINGER HDB CRYSTAL, P159, DOI DOI 10.1007/978-3-540-74761-1_6; Sano-Furukawa A, 2011, PHYS EARTH PLANET IN, V189, P56, DOI 10.1016/j.pepi.2011.07.003; Schmandt B, 2014, SCIENCE, V344, P1265, DOI [10.1126/science.1253358, 10.1126/science.1253258]; Shatskiy A, 2011, PHYS EARTH PLANET IN, V189, P92, DOI 10.1016/j.pepi.2011.08.001; Smyth JR, 2014, AM MINERAL, V99, P458, DOI 10.2138/am.2014.4520; Smyth JR, 2003, AM MINERAL, V88, P1402; Tomioka N., 2014, PULSED NEUTRON DIFFR; Wenk H.-R., 2006, REV MINERALOGY GEOCH, V63; Yang XZ, 2014, AM MINERAL, V99, P724, DOI 10.2138/am.2014.4634	61	0	0	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	JUL	2015	100	7					1483	1492				10	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CM1HK	WOS:000357431700014		
J	Kars, M; Lerouge, C; Grangeon, S; Aubourg, C; Tournassat, C; Made, B; Claret, F				Kars, Myriam; Lerouge, Catherine; Grangeon, Sylvain; Aubourg, Charles; Tournassat, Christophe; Made, Benoit; Claret, Francis			Identification of nanocrystalline goethite in reduced clay formations: Application to the Callovian-Oxfordian formation of Bure (France)	AMERICAN MINERALOGIST			English	Article						Goethite; nanoparticles; Callovian-Oxfordian clay formation; Paris Basin	TEMPERATURE MAGNETIC-PROPERTIES; PORE-WATER CHEMISTRY; PARIS BASIN; SEDIMENTARY BASINS; ROCK; TRANSITION; PYRRHOTITE; RHODOCHROSITE; EQUILIBRIUM; COERCIVITY	The Callovian-Oxfordian (COx) clay formation in the Paris Basin (France) has been the target of many studies investigating the feasibility of deep nuclear waste disposal in a reduced clay formation. To determine the mobility of radionuclides in the host rock formation, modeling of the porewater chemistry, particularly iron solute concentrations, is necessary. Notably, this study aims to understand the supersaturation of Fe(III) oxyhydroxides given by models. Fe(III) oxyhydroxides have been identified magnetically in unpreserved Callovian-Oxfordian samples. In this study, a set of magnetic measurements are used to detect the Fe-bearing magnetic minerals present in the COx clay formation. A core sample from the borehole FOR 1118, preserved from air since its collection, is the target of this study. The magnetic measurements performed show that magnetite and goethite are the main magnetic minerals (<0.2%), together with probable greigite, and occur in low concentrations. Goethite occurs as nanoparticles dispersed in the clayey matrix, and not enclosed in other minerals or in organic matter. It is unlikely that the goethite is an alteration by-product, as particular care was undertaken. This finding resolves the discrepancies between observations and previous modeling results.	[Kars, Myriam; Aubourg, Charles] Univ Pau & Pays Adour, Lab Fluides Complexes & Leurs Reservoirs, F-64013 Pau, France; [Lerouge, Catherine; Grangeon, Sylvain; Tournassat, Christophe; Claret, Francis] Bur Rech Geol & Minieres, Water Environm & Ecotechnol Div, F-45060 Orleans 2, France; [Made, Benoit] Andra Parc Croix Blanche, F-92298 Chatenay Malabry, France	Kars, M (reprint author), Kochi Univ, Ctr Adv Marine Core Res, B200 Monobe, Nankoku, Kochi 7838502, Japan.	jm-mkars@kochi-u.ac.jp			ANDRA-BRGM scientific partnership (THERMOAR project); Conseil Regional d'Ile de France [I-06-206/R]; INSU-CNRS; IPGP; ANR	This research has been financially supported by the ANDRA-BRGM scientific partnership (THERMOAR project). We are grateful to France Lagroix from the Institut de Physique du Globe de Paris (IPGP) for her help during our stays and for fruitful discussions. Data from Figures 1, 4, and 6 were obtained by using the MPMS from IPGP. The MPMS XL5Evercool used was financed by the Conseil Regional d'Ile de France (No. I-06-206/R), INSU-CNRS, IPGP, and ANR. We also thank the Institute for Rock Magnetism, University of Minnesota, Minneapolis, and the Universite de Montpellier 2, France, for their instrumental facilities. This paper benefited from the constructive reviews of Simo Spassov and an anonymous reviewer. We thank Joshua Feinberg for editorial handling.	Andra (French National Radioactive Waste Management Agency), 2005, ANDRA COLL RAPP; Muxworthy AR, 2000, GEOPHYS J INT, V140, P101, DOI 10.1046/j.1365-246x.2000.00999.x; Lerouge C, 2011, GEOCHIM COSMOCHIM AC, V75, P2633, DOI 10.1016/j.gca.2011.02.025; Ozdemir O, 1996, GEOPHYS RES LETT, V23, P921, DOI 10.1029/96GL00904; DEKKERS MJ, 1989, GEOPHYS J INT, V97, P341, DOI 10.1111/j.1365-246X.1989.tb00505.x; ROCHETTE P, 1990, EARTH PLANET SC LETT, V98, P319, DOI 10.1016/0012-821X(90)90034-U; Claret F, 2004, CLAY CLAY MINER, V52, P515, DOI 10.1346/CCN=MN.2004.0520501; Blaise T, 2014, MAR PETROL GEOL, V53, P71, DOI 10.1016/j.marpetgeo.2013.08.019; DEKKERS MJ, 1989, GEOPHYS RES LETT, V16, P855, DOI 10.1029/GL016i008p00855; Vinsot A, 2008, PHYS CHEM EARTH, V33, pS75, DOI 10.1016/j.pce.2008.10.048; Rochette P, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024196; Pearson FJ, 2011, APPL GEOCHEM, V26, P990, DOI 10.1016/j.apgeochem.2011.03.008; Wolfers P, 2011, SOLID STATE PHENOMEN, V170, P174, DOI 10.4028/www.scientific.net/SSP.170.174; Heslop D, 2002, GEOPHYS J INT, V148, P58, DOI 10.1046/j.0956-540x.2001.01558.x; Gaucher E, 2004, PHYS CHEM EARTH, V29, P55, DOI 10.1016/j.pce.2003.11.006; Ozdemir O, 2002, EARTH PLANET SC LETT, V194, P343, DOI 10.1016/S0012-821X(01)00562-3; LOWRIE W, 1990, GEOPHYS RES LETT, V17, P159, DOI 10.1029/GL017i002p00159; Gaucher EC, 2009, GEOCHIM COSMOCHIM AC, V73, P6470, DOI 10.1016/j.gca.2009.07.021; Egli R, 2004, STUD GEOPHYS GEOD, V48, P391, DOI 10.1023/B:SGEG.0000020839.45304.6d; Tournassat C, 2008, APPL GEOCHEM, V23, P641, DOI 10.1016/j.apgeochem.2007.11.002; Aubourg C, 2010, EARTH PLANET SC LETT, V294, P47, DOI 10.1016/j.epsl.2010.02.045; Aubourg C, 2012, GEOL SOC SPEC PUBL, V371, P181, DOI 10.1144/SP371.4; Clauer N., 2007, MEM SOC GEOL FRANCE, V178, P59; Dunlop D., 1997, ROCK MAGNETISM FUNDA; Ozdemir O, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006756; Esteban L, 2006, CR GEOSCI, V338, P867, DOI 10.1016/j.crte.2006.03.011; Esteban L., 2006, THESIS U TOULOUSE 3; Frederichs T, 2003, PHYS CHEM EARTH, V28, P669, DOI 10.1016/S1474-7065(03)00121-9; Guyodo Y, 2006, EARTH PLANET SC LETT, V251, P168, DOI 10.1016/j.epsl.2006.09.005; Hey M.H., 1954, MINERAL MAG, V30, P277, DOI DOI 10.1180/MINMAG.1954.030.224.01; Housen BA, 1996, GEOPHYS RES LETT, V23, P2843, DOI 10.1029/96GL01197; HROUDA F, 1986, STUD GEOPHYS GEOD, V30, P39, DOI 10.1007/BF01630853; Kars M, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004104; Kosterov A, 2006, PHYS EARTH PLANET IN, V154, P234, DOI 10.1016/j.pepi.2005.09.01; Lerouge C, 2013, PROCED EARTH PLAN SC, V7, P475, DOI 10.1016/j.proeps.2013.03.133; Maher B.A., 1999, QUATERNARY CLIMATES, P1, DOI 10.1017/CBO9780511535635.002; Moreau MG, 2005, EARTH PLANET SC LETT, V230, P193, DOI 10.1016/j.epsl.2004.11.013; Ozdemir O., 2008, GEOCHEM GEOPHY GEOSY, V9; Pellenard P, 2006, CR GEOSCI, V338, P854, DOI 10.1016/j.crte.2006.05.008; Pellenard P, 1999, CR ACAD SCI II A, V328, P807, DOI 10.1016/S1251-8050(99)80196-7; Roberts AP, 2011, REV GEOPHYS, V49, DOI 10.1029/2010RG000336; Tournassat C, 2007, GEOCHIM COSMOCHIM AC, V71, P1098, DOI 10.1016/j.gca.2006.11.018; Truche L, 2010, GEOCHIM COSMOCHIM AC, V74, P2894, DOI 10.1016/j.gca.2010.02.027	43	0	0	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	JUL	2015	100	7					1544	1553				10	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CM1HK	WOS:000357431700021		
J	Sugiura, Y; Onuma, K; Nagao, M; Yamazaki, A				Sugiura, Yuki; Onuma, Kazuo; Nagao, Masahiro; Yamazaki, Atsushi			The effects of immobilized carboxylic-functional groups on the dynamics of phase transformation from amorphous to octacalcium phosphate	AMERICAN MINERALOGIST			English	Article						Biomineralization; calcium phosphate; phase transformation; early tooth formation; intermediate phase	LIGHT-SCATTERING TECHNIQUE; CALCIUM-PHOSPHATE; APATITE NANOCRYSTALS; 3-DIMENSIONAL VISUALIZATION; INTERMOLECULAR INTERACTION; CRYSTAL-GROWTH; IN-VITRO; BIOMINERALIZATION; HYDROXYAPATITE; MORPHOLOGY	The influence of carboxylic-functional-groups (-COOH) on the phase transformation from amorphous calcium phosphate (ACP) to octacalcium phosphate (OCP) was investigated. 11-Mercaptoun-decanoic acid, a carboxylic thiol, was immobilized on gold nanoparticles via covalent bond formation. Time-resolved static light scattering measurements indicated that a structural-reconstruction-type phase transformation occurred with or without the presence of -COOH on the nanoparticles. When it dispersed in calcium phosphate solutions, these nanoparticles inhibited the phase transformation dynamics and also changed the reaction path, forming HPO4-OH-layer-deficient OCP at pH 6.5 an intermediate phase, which did not show the typical OCP X-ray diffraction (XRD) peak at 2 theta = 4.7 degrees. This phase was not observed in the reference solution containing gold nanoparticles without bound -COOH. The HPO4-OH-layer-deficient OCP transformed to conventional OCP gradually, as revealed by XRD, nuclear magnetic resonance, and Raman analyses. Thus, the immobilized -COOH appeared to behave as a negative catalyst, resulting in the formation of the intermediate phase. Such a mechanism partially clarifies complex biomineralization processes, for example teeth enamel and dentin formation, in vivo.	[Sugiura, Yuki; Nagao, Masahiro; Yamazaki, Atsushi] Waseda Univ, Sch Creat Sci & Engn, Dept Resources & Environm Engn, Shinjuku Ku, Tokyo 1860049, Japan; [Sugiura, Yuki; Onuma, Kazuo] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan; [Sugiura, Yuki] Kyushu Univ, Fac Dent Sci, Dept Biomat, Higashi Ku, Fukuoka 8120054, Japan	Sugiura, Y (reprint author), Waseda Univ, Sch Creat Sci & Engn, Dept Resources & Environm Engn, Shinjuku Ku, 3-1-4 Okubo, Tokyo 1860049, Japan.	ysugiura@dent.kyushu-u.ac.jp; k.onuma@aist.go.jp			Material Characterization Central Laboratory (MCCL) of Waseda University; Japan Society for the Promotion of Science (JSPS), the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25-2283]; Nano Processing Facility of the National Institute of Advanced Industrial Science and Technology (AIST)	We thank A. Ito and Y. Sogo for their help in conducting the XRD analyses, T. Goto and D. Fukagawa for helping with the TEM observations and TEM sample preparation, T. Shimada and A. Tanaka for helping with the visible-light absorption spectroscopy experiments, and N. Sugimura for his help with the Raman, in situ FTIR, and NMR spectroscopic measurements. This study was partially supported by the Material Characterization Central Laboratory (MCCL) of Waseda University and by a grant-in-aid for Doctoral Course Students (DC2) (number 25-2283) from the Japan Society for the Promotion of Science (JSPS), the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and by the Nano Processing Facility of the National Institute of Advanced Industrial Science and Technology (AIST).	BERRY EE, 1967, SPECTROCHIM ACTA A-M, VA 23, P1781, DOI 10.1016/0584-8539(67)80061-8; POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Dey A, 2010, NAT MATER, V9, P1010, DOI [10.1038/nmat2900, 10.1038/NMAT2900]; Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574; Delgado-Lopez JM, 2012, ACTA BIOMATER, V8, P3491, DOI 10.1016/j.actbio.2012.04.046; Delgado-Lopez JM, 2014, ADV FUNCT MATER, V24, P1090, DOI 10.1002/adfm.201302075; BROWN WE, 1962, NATURE, V196, P1050, DOI 10.1038/1961050a0; Tseng YH, 2006, J AM CHEM SOC, V128, P6909, DOI 10.1021/ja060336u; Zhao J, 2012, J DENT SCI, V7, P316, DOI 10.1016/j.jds.2012.09.001; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; Xie BQ, 2010, P NATL ACAD SCI USA, V107, P22369, DOI 10.1073/pnas.1017493108; CHRISTOFFERSEN MR, 1990, J CRYST GROWTH, V106, P349, DOI 10.1016/0022-0248(90)90079-Z; Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Tsai TWT, 2011, ANNU REP NMR SPECTRO, V73, P1, DOI 10.1016/B978-0-08-097074-5.00001-3; Izumi F, 2007, SOL ST PHEN, V130, P15; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c; Hamm LM, 2014, P NATL ACAD SCI USA, V111, P1304, DOI 10.1073/pnas.1312369111; Tsai TWT, 2010, PHYS CHEM CHEM PHYS, V12, P6692, DOI 10.1039/b923338e; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Veis A, 2003, REV MINERAL GEOCHEM, V54, P249, DOI 10.2113/0540249; Davies E, 2014, P NATL ACAD SCI USA, V111, pE1354, DOI 10.1073/pnas.1315080111; Nudelman F, 2013, J STRUCT BIOL, V183, P258, DOI 10.1016/j.jsb.2013.04.003; Frazier A. W., 1991, TVANFERC914; Hu YY, 2010, P NATL ACAD SCI USA, V107, P22425, DOI 10.1073/pnas.1009219107; Kamitakahara M, 2008, J CERAM SOC JPN, V116, P481, DOI 10.2109/jcersj2.116.481; Kanzaki N, 2006, J PHYS CHEM B, V110, P2881, DOI [10.1021/jp054865g, 10.1021/jp054865a]; Kozawa Y., 2009, ENAMEL STRUCTURE AME, P187; IIJIMA M, 1992, J CRYST GROWTH, V116, P319, DOI 10.1016/0022-0248(92)90639-Z; Mann S., 2001, BIOMINERALIZATION PR; NELSON DGA, 1989, J COLLOID INTERF SCI, V130, P467, DOI 10.1016/0021-9797(89)90124-0; Nonoyama T, 2011, LANGMUIR, V27, P7077, DOI 10.1021/la2006953; NYLEN MU, 1963, J CELL BIOL, V18, P109, DOI 10.1083/jcb.18.1.109; Onuma K, 2000, J PHYS CHEM B, V104, P10563, DOI 10.1021/jp002697g; Onuma K, 2009, CRYST GROWTH DES, V9, P2517, DOI 10.1021/cg900019e; Provencher S. W., 1982, EMBLDAO5 QUEENS U; Sunagawa I., 2005, CRYSTALS GROWTH MORP; Tsuji T, 2008, P NATL ACAD SCI USA, V105, P16866, DOI 10.1073/pnas.0804277105; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Wu W, 1997, LANGMUIR, V13, P861, DOI 10.1021/la960689e	43	0	0	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	JUL	2015	100	7					1624	1632				9	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CM1HK	WOS:000357431700031		
J	Bindi, L; Sirotkina, EA; Bobrov, AV; Irifune, T				Bindi, Luca; Sirotkina, Ekaterina A.; Bobrov, Andrey V.; Irifune, Tetsuo			Structural and chemical characterization of Mg[(Cr,Mg)(Si,Mg)]O-4, a new post-spinel phase with sixfold-coordinated silicon	AMERICAN MINERALOGIST			English	Article						Calcium titanate structure; chromium; spinel; post-spinel phases; crystal structure; microprobe analysis; synthesis	ULTRAHIGH-PRESSURE CHROMITITES; HIGH-TEMPERATURE; CRYSTAL-STRUCTURES; LUOBUSA OPHIOLITE; DEGREES-C; GPA; MGCR2O4; DIAMOND; PARAMETERS; CONVERSION	The crystal structure and chemical composition of a crystal of Mg(Mg,Cr,Si)(2)O-4 post-spinel phase synthesized in the model system MgCr2O4-Mg2SiO4 at 16 GPa and 1600 degrees C have been investigated. The compound was found to crystallize with a distorted orthorhombic calcium-titanate (CaTi2O4) structure type, space group Cmc2(1), with lattice parameters a = 2.8482(1), b = 9.4592(5), c = 9.6353(5) angstrom, V = 259.59(1) angstrom(3), and Z = 4. The structure was refined to R-1 = 0.018 using 345 independent reflections. The loss of the inversion center is due to the ordering of cations at the octahedral sites: Cr is mainly hosted at the M1 site, whereas Si at the M2 site. Such an ordered distribution induces a distortion thus provoking a change in coordination of Mg, which becomes sevenfold-coordinated instead of the usual eightfold coordination observed in post-spinel phases. Electron microprobe analysis gave the Mg[(Cr0.792Mg0.208) (Si0.603Mg0.397)]O-4 stoichiometry for the studied phase. The successful synthesis of this phase can provide new constraints on thermobarometry of wadsleyite/ringwoodite-bearing assemblages.	[Bindi, Luca] Univ Florence, Dipartimento Sci Terra, I-50121 Florence, Italy; [Bindi, Luca] CNR, Ist Geosci & Georisorse, Sez Firenze, I-50121 Florence, Italy; [Sirotkina, Ekaterina A.; Bobrov, Andrey V.] Moscow MV Lomonosov State Univ, Geol Fac, Dept Petrol, Moscow 119234, Russia; [Sirotkina, Ekaterina A.; Bobrov, Andrey V.] Russian Acad Sci, Vernadsky Inst Geochem & Analyt Chem, Moscow 119991, Russia; [Irifune, Tetsuo] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan; [Irifune, Tetsuo] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 1528550, Japan	Bindi, L (reprint author), Univ Florence, Dipartimento Sci Terra, Via La Pira 4, I-50121 Florence, Italy.	luca.bindi@unifi.it			"progetto di Ateneo, University of Firenze" by C.N.R., Istituto di Geoscienze e Georisorse sezione di Firenze, Italy, the Russian Foundation for Basic Research [15-55-50033 YaF]; Geodynamics Research Center, Ehime University, Matsuyama, Japan	The paper benefited by the official reviews made by Matteo Alvaro and two anonymous reviewers. Thanks are also due to the Editor Ian Swainson for his efficient handling of the manuscript. The research was supported by "progetto di Ateneo 2013, University of Firenze" to L.B., by C.N.R., Istituto di Geoscienze e Georisorse sezione di Firenze, Italy, the Russian Foundation for Basic Research (project no. 15-55-50033 YaF) to E.S. and A.B. E.S. thanks Geodynamics Research Center, Ehime University, Matsuyama, Japan, for support of her visit in 2014.	Albec A.L., 1970, ANAL CHEM, V48, P1408; ANGEL RJ, 1989, AM MINERAL, V74, P509; FLACK HD, 1983, ACTA CRYSTALLOGR A, V39, P876, DOI 10.1107/S0108767383001762; Wang Z, 2002, J PHYS CHEM SOLIDS, V63, P2057, DOI 10.1016/S0022-3697(02)00194-4; Yamanaka T, 2008, AM MINERAL, V93, P1874, DOI 10.2138/am.2008.2934; KATSURA T, 1989, J GEOPHYS RES-SOLID, V94, P15663, DOI 10.1029/JB094iB11p15663; Angel RJ, 2014, AM MINERAL, V99, P2146, DOI 10.2138/am-2014-5047; Biagioni C, 2014, AM MINERAL, V99, P1254, DOI 10.2138/am.2014.4816; ONEILL HS, 1994, PHYS CHEM MINER, V20, P541, DOI 10.1007/BF00211850; BENCE AE, 1968, J GEOL, V76, P382; Yang JS, 2007, GEOLOGY, V35, P875, DOI 10.1130/G23766A.1; Dobrzhinetskaya LF, 2009, P NATL ACAD SCI USA, V106, P19233, DOI 10.1073/pnas.0905514106; Yamamoto S, 2009, LITHOS, V109, P314, DOI 10.1016/j.lithos.2008.05.003; Lenaz D, 2009, AM MINERAL, V94, P1067, DOI 10.2138/am.2009.3165; Irifune T, 2004, PHYS EARTH PLANET IN, V143, P593, DOI 10.1016/j.pepi.2003.06.004; ROBINSON K, 1971, SCIENCE, V172, P567, DOI 10.1126/science.172.3983.567; Arai S, 2013, EARTH PLANET SC LETT, V379, P81, DOI 10.1016/j.epsl.2013.08.006; Bindi L, 2011, AM MINERAL, V96, P447, DOI 10.2138/am.2011.3716; Bindi L, 2014, J PHYS CHEM SOLIDS, V75, P638, DOI 10.1016/j.jpcs.2014.01.008; BRESE NE, 1991, ACTA CRYSTALLOGR B, V47, P192, DOI 10.1107/S0108768190011041; Dobson DP, 2004, AM MINERAL, V89, P807; HILL RJ, 1983, J SOLID STATE CHEM, V47, P185, DOI 10.1016/0022-4596(83)90007-5; IRIFUNE T, 1991, NATURE, V349, P409, DOI 10.1038/349409a0; Ishii T, 2015, AM MINERAL, V100, P59, DOI 10.2138/am-2015-4818; Kojitani H, 2007, PHYS CHEM MINER, V34, P257, DOI 10.1007/s00269-007-0144-z; lbers J.A., 1974, INTERNATIONAL TABLES, VIV; Ovsyannikov SV, 2011, HIGH PRESSURE RES, V31, P23, DOI 10.1080/08957959.2010.520108; Oxford Diffraction, 2006, CRYSALIS RED VERSION; Robinson P.T., 2004, JOURNAL OF GEOLOGICA, V226, P247; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sirotkina E.A., 2015, CONTRIBUTIONS TO MIN, V169; Yamada A, 2004, PHYS EARTH PLANET IN, V147, P45, DOI 10.1016/j.pepi.2004.05.005; Yong WJ, 2012, PHYS EARTH PLANET IN, V196, P75, DOI 10.1016/j.pepi.2012.02.011	34	0	0	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	JUL	2015	100	7					1633	1636				4	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CM1HK	WOS:000357431700032		
J	Bindi, L; Nishi, M; Irifune, T				Bindi, Luca; Nishi, Masayuki; Irifune, Tetsuo			Partition of Al between Phase D and Phase H at high pressure: Results from a simultaneous structure refinement of the two phases coexisting in a unique grain	AMERICAN MINERALOGIST			English	Article						Phase D; Phase H; aluminum; dense hydrous magnesium silicates; lower mantle; crystal structure; synthesis	HYDROUS-MAGNESIUM-SILICATE; LOWER MANTLE; WATER TRANSPORT; STABILITY; MICROANALYSIS; OXIDES; MORB; GPA	The crystal structure of the two dense hydrous magnesium silicates Phase D, MgSi2H2O6, and Phase H, MgSiH2O4, synthesized at 45 GPa and 1000 degrees C and coexisting in the same micrometer-sized grain, was investigated by single-crystal X-ray diffraction to study the preferential partition of A I between the two structures. In agreement with the literature, Phase D was found to be trigonal, space group P (3) over bar 1m, with lattice parameters a = 4.752(2), c = 4.314(2) angstrom, V = 84.37(6) angstrom(3) (R-1 = 0.020), and Phase H was found to be orthorhombic, space group Pnnm, with lattice parameters a = 4.730(2), b = 4.324(2), c = 2.843(2) angstrom, V = 58.15(5) angstrom(3) (R-1 = 0.024). The estimated proportion (vol%) of the two phases from the refinement is 27(2)(PHD) - 73(PhH). The analysis of the geometric details of the two structures shows that Phase D hosts almost all the Al available, whereas Phase H is nearly identical to pure MgSiH2O4. Overexposed electron-microprobe X-ray maps of the same grain used for the X-ray diffraction study together with WDS spots on the two phases confirmed the structural results. Thus, our results suggest that when Phase D and Phase H coexist, Al is strongly partitioned into Phase D at the expense of coexisting Phase H. At pressure above similar to 50 GPa, where Phase D is no longer stable, Phase H is able to incorporate the high aluminum contents present in hydrous peridotitic compositions in the deep lower mantle and be stabilized at the expense of Phase D and magnesium silicate perovskite.	[Bindi, Luca] Univ Florence, Dipartimento Sci Terra, I-50121 Florence, Italy; [Bindi, Luca] CNR, Ist Geosci & Georisorse, Sez Firenze, I-50121 Florence, Italy; [Nishi, Masayuki; Irifune, Tetsuo] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan; [Nishi, Masayuki; Irifune, Tetsuo] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 1528550, Japan	Bindi, L (reprint author), Univ Florence, Dipartimento Sci Terra, Via La Pira 4, I-50121 Florence, Italy.	luca.bindi@unifi.it			"progetto di Ateneo, University of Firenze" by C.N.R., Istituto di Geoscienze e Georisorse sezione di Firenze, Italy	The paper benefited by the official reviews made by two anonymous reviewers. Thanks are also due to the Editor Ian Swainson for his efficient handling of the manuscript. The research was supported by "progetto di Ateneo 2013, University of Firenze" to L.B., by C.N.R., Istituto di Geoscienze e Georisorse sezione di Firenze, Italy.	ALBEE AL, 1970, ANAL CHEM, V42, P1408, DOI 10.1021/ac60294a030; Litasov KD, 2005, PHYS EARTH PLANET IN, V150, P239, DOI 10.1016/j.pepi.2004.10.010; Shieh SR, 1998, EARTH PLANET SC LETT, V159, P13, DOI 10.1016/S0012-821X(98)00062-4; Tsuchiya J, 2013, GEOPHYS RES LETT, V40, P4570, DOI 10.1002/grl.50875; Komatsu K, 2011, PHYS CHEM MINER, V38, P727, DOI 10.1007/s00269-011-0445-0; BENCE AE, 1968, J GEOL, V76, P382; Ohtani E, 2014, GEOPHYS RES LETT, V41, P8283, DOI 10.1002/2014GL061690; [Anonymous], 2006, CRYSALIS RED VERS 1; Yang HX, 1997, AM MINERAL, V82, P651; Bindi L, 2014, AM MINERAL, V99, P1802, DOI 10.2138/am.2014.4994; Pamato MG, 2015, NAT GEOSCI, V8, P75, DOI [10.1038/ngeo2306, 10.1038/NGEO2306]; Frost DJ, 1998, J GEOPHYS RES-SOL EA, V103, P7463, DOI 10.1029/98JB00077; Hirose K, 2005, EARTH PLANET SC LETT, V237, P239, DOI 10.1016/j.epsl.2005.06.035; ROBINSON K, 1971, SCIENCE, V172, P567, DOI 10.1126/science.172.3983.567; Ballaran TB, 2010, AM MINERAL, V95, P1113, DOI 10.2138/am.2010.3462; Ghosh S, 2014, GEOCHIM COSMOCHIM AC, V145, P72, DOI 10.1016/j.gca.2014.06.025; Ibers JA, 1974, INT TABLES XRAY CRYS, VIV; Nishi M, 2014, NAT GEOSCI, V7, P224, DOI [10.1038/ngeo2074, 10.1038/NGEO2074]; Ohira I, 2014, EARTH PLANET SC LETT, V401, P12, DOI 10.1016/j.epsl.2014.05.059; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930	21	0	0	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	JUL	2015	100	7					1637	1640				4	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CM1HK	WOS:000357431700033		
J	Isobe, T; Ikebata, Y; Do, LTK; Tanihara, F; Taniguchi, M; Otoi, T				Isobe, Tomohiro; Ikebata, Yoshihisa; Lanh Thi Kim Do; Tanihara, Fuminori; Taniguchi, Masayasu; Otoi, Takeshige			In vitro development of OPU-derived bovine embryos cultured either individually or in groups with the silk protein sericin and the viability of frozen-thawed embryos after transfer	ANIMAL SCIENCE JOURNAL			English	Article						bovine embryos; in vitro development; ovum pick-up; pregnancy; silk protein	OVUM PICK-UP; OOCYTES; COMPETENCE; BLASTOCYSTS; MATURATION; COCULTURE; QUALITY; MORULAE	The optimization of single-embryo culture conditions is very important, particularly in the in vitro production of bovine embryos using the ovum pick-up (OPU) procedure. The purpose of this study was to examine the development of embryos derived from oocytes obtained by OPU that were cultured either individually or in groups in medium supplemented with or without sericin and to investigate the viability of the frozen-thawed embryos after a direct transfer. When two-cell-stage embryos were cultured either individually or in groups for 7 days in CR1aa medium supplemented with or without 0.5% sericin, the rates of development to blastocysts and freezable blastocysts were significantly lower for the embryos cultured individually without sericin than for the embryos cultured in groups with or without sericin. Moreover, the rate of development to freezable blastocysts of the embryos cultured individually with sericin was significantly higher than that of the embryos cultured without sericin. When the frozen-thawed embryos were transferred directly to recipients, the rates of pregnancy, abortion, stillbirth and normal calving in the recipients were similar among the groups, irrespective of the culture conditions and sericin supplementation. Our findings indicate that supplementation with sericin during embryo culture improves the quality of the embryos cultured individually but not the viability of the frozen-thawed embryos after transfer to recipients.	[Isobe, Tomohiro; Lanh Thi Kim Do; Tanihara, Fuminori; Taniguchi, Masayasu; Otoi, Takeshige] Yamaguchi Univ, United Grad Sch Vet Sci, Lab Anim Reprod, Yamaguchi 7538515, Japan; [Ikebata, Yoshihisa] Cattle Breeding Dev Inst, Kagoshima, Kagoshima, Japan; [Isobe, Tomohiro] Kagoshima Prefectural Govt Livestock Div, Kagoshima, Kagoshima, Japan	Otoi, T (reprint author), Yamaguchi Univ, United Grad Sch Vet Sci, Lab Anim Reprod, Yamaguchi 7538515, Japan.	otoi@yamaguchi-u.ac.jp					Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145; GARDNER DK, 1993, BIOL REPROD, V48, P377, DOI 10.1095/biolreprod48.2.377; Takuma T, 2010, J REPROD DEVELOP, V56, P55, DOI 10.1262/jrd.09-071H; Fujita T, 2006, J REPROD DEVELOP, V52, P137, DOI 10.1262/jrd.16084; Mapletoft RJ, 2005, REV SCI TECH OIE, V24, P393; Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4; Isobe T, 2012, THERIOGENOLOGY, V78, P747, DOI 10.1016/j.theriogenology.2012.03.021; Galli C, 2001, THERIOGENOLOGY, V55, P1341, DOI 10.1016/S0093-691X(01)00486-1; Merton JS, 2013, THERIOGENOLOGY, V80, P365, DOI 10.1016/j.theriogenology.2013.04.025; Dash R, 2008, BMB REP, V41, P236; Ward FA, 2000, THERIOGENOLOGY, V54, P433, DOI 10.1016/S0093-691X(00)00360-5; ODoherty EM, 1997, THERIOGENOLOGY, V48, P161, DOI 10.1016/S0093-691X(97)00200-8; Aramwit P, 2009, J BIOMAT SCI-POLYM E, V20, P1295, DOI 10.1163/156856209X453006; Donnay I, 1997, THERIOGENOLOGY, V47, P1549, DOI 10.1016/S0093-691X(97)00160-X; Feng WG, 2007, THERIOGENOLOGY, V67, P1339, DOI 10.1016/j.theriogenology.2007.01.017; Goovaerts IGF, 2009, THERIOGENOLOGY, V71, P729, DOI 10.1016/j.theriogenology.2008.09.038; Lee ES, 1996, BIOL REPROD, V55, P1383, DOI 10.1095/biolreprod55.6.1383; Matoba S, 2010, REPROD FERT DEVELOP, V22, P839, DOI 10.1071/RD09277; PARIA BC, 1990, P NATL ACAD SCI USA, V87, P4756, DOI 10.1073/pnas.87.12.4756; VanSoom A, 1996, THERIOGENOLOGY, V46, P1131, DOI 10.1016/S0093-691X(96)00285-3; vansWagtendonk-de Leeuw AM, 2006, THERIOGENOLOGY, V65, P914; Wagyu Registry Association, 2009, HDB WAG REG	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	JUL	2015	86	7					661	665		10.1111/asj.12341		5	Agriculture, Dairy & Animal Science	Agriculture	CM2MQ	WOS:000357515000002		
J	Wang, M; Ikeda, S; Yoshioka, H; Nagase, H; Kitamura, S; Itoyama, E; Murakami, H; Sugimoto, M; Kume, S				Wang, Mengdong; Ikeda, Shuntaro; Yoshioka, Hidetugu; Nagase, Hiroshi; Kitamura, Shoko; Itoyama, Erina; Murakami, Hiroaki; Sugimoto, Miki; Kume, Shinichi			Relationships between immunoglobulin and fat-soluble vitamins in colostrum of Japanese Black multiparous cows	ANIMAL SCIENCE JOURNAL			English	Article						-carotene; colostral IgA; colostral IgG; Japanese Black cow; vitamin A	SUPPLEMENTAL BETA-CAROTENE; MUCOSAL IGA INDUCTION; SECRETING CELLS; NEWBORN CALVES; MICE; IMMUNITY; HEALTH; MILK	Data from 19 Japanese Black multiparous cows were collected to clarify the relationships among immunoglobulin (Ig) G, IgA, -carotene, vitamin A and -tocopherol contents in colostrum of cows in order to evaluate the role of fat-soluble vitamins on colostral IgG and IgA production. Mean colostral IgG was 141mg/mL, ranging from 65 to 208mg/mL, whereas mean colostral IgA was 8.7mg/mL, ranging from 1.0 to 34.6mg/mL. Colostral IgG increased with aging in multiparous cows. There were positive correlations between colostral IgG and colostral vitamin A or colostral -tocopherol in cows, and the higher adjusted R-2 was obtained in the prediction model of colostral IgG from age and colostral vitamin A. Colostral vitamin A was positively correlated with colostral -carotene or colostral -tocopherol in cows, but there were no relationships between colostral IgA and colostral IgG or colostral fat-soluble vitamins. These results indicate that fat-soluble vitamin contents in colostrum of cows may change in similar patterns and high colostral vitamin A is related with high colostral IgG.	[Wang, Mengdong; Ikeda, Shuntaro; Sugimoto, Miki; Kume, Shinichi] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan; [Yoshioka, Hidetugu; Nagase, Hiroshi; Kitamura, Shoko; Itoyama, Erina; Murakami, Hiroaki] Kyoto Univ Livestock Farm, Kyotanba, Japan	Kume, S (reprint author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	kume@kais.kyoto-u.ac.jp					Agriculture Forestry and Fisheries Research Council Secretariat (AFFRCS), 2008, JAP FEED STAND BEEF; Quigley JD, 1998, J DAIRY SCI, V81, P2779; Webb AL, 2007, NUTR REV, V65, P181, DOI 10.1301/nr.2007.may.181-217; DEVERYPOCIUS JE, 1983, J DAIRY SCI, V66, P221; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Morteau O, 2008, J IMMUNOL, V181, P6309; KUME S, 1993, J DAIRY SCI, V76, P1654, DOI 10.3168/jds.S0022-0302(93)77499-8; FOLEY JA, 1978, J DAIRY SCI, V61, P1033; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Wang MD, 2013, ANIM SCI J, V84, P322, DOI 10.1111/asj.12007; Stelwagen K, 2009, J ANIM SCI, V87, P3, DOI 10.2527/jas.2008-1377; Blum JW, 2006, J ANIM PHYSIOL AN N, V90, P1, DOI 10.1111/j.1439-0396.2005.00614.x; Ruhl R, 2007, P NUTR SOC, V66, P458, DOI 10.1017/S002966510600509X; Chew BP, 2004, J NUTR, V134, P257; Ishikawa Hidetoshi, 1992, Animal Science and Technology, V63, P1153; Johansson B, 2014, J DAIRY SCI, V97, P1682, DOI 10.3168/jds.2013-7388; Kume S, 2001, LIVEST PROD SCI, V68, P61, DOI 10.1016/S0301-6226(00)00214-1; Kume Shin-Ichi, 1993, Animal Science and Technology, V64, P987; Maydani SN, 2005, IMMUNOL REV, V205, P269; Nishida K, 2014, BRIT J NUTR, V111, P247, DOI 10.1017/S0007114513002195; Nishiyama Y, 2011, LIVEST SCI, V137, P95, DOI 10.1016/j.livsci.2010.10.007; Nishiyama Y, 2011, BRIT J NUTR, V105, P24, DOI 10.1017/S0007114510003089; Nonnecke BJ, 2012, J DAIRY SCI, V95, P221, DOI 10.3168/jds.2011-4712; SAS Institute, 1997, SAS STAT SOFTW CHANG; Yasumatsuya K, 2013, NIHON CHIKUSAN GAKKA, V84, P389; Yasumatsuya K, 2012, LIVEST SCI, V143, P210, DOI 10.1016/j.livsci.2011.09.015	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	JUL	2015	86	7					673	678		10.1111/asj.12351		6	Agriculture, Dairy & Animal Science	Agriculture	CM2MQ	WOS:000357515000004		
J	Nakano, M; Yayota, M; Ohtani, S				Nakano, Miwa; Yayota, Masato; Ohtani, Shigeru			Nutrient sufficiency in beef cows grazing on a dwarf bamboo-dominated forestland pasture in Japan	ANIMAL SCIENCE JOURNAL			English	Article						alpine forestland pasture; extensive grazing; Japanese Black cow; nutrient intake; Sasa senanensis	ARGENTEOSTRIATUS-F-GLABER; DAIRY-COWS; DIGESTIBILITY; RUMINANTS; PROTEIN; REPRODUCTION; PERFORMANCE; DIGESTION; NITROGEN; HERBAGE	The nutritional status of cows grazing on a 120-ha public alpine forestland pasture dominated by the dwarf bamboo Sasa senanensis located in central Japan was evaluated over the course of 2 years. Data were collected during grazing seasons in three periods: early (June), mid- (August) and late (late September-early October) periods. During these periods, the number of experimental Japanese Black cows varied between three and six. With the exception of the dry matter (DM) intake in 2005 and the crude protein (CP) digestibility in 2006, the DM and CP intake and digestibility were lower in the mid- and late periods than in the early period for both years (P<0.05). Metabolizable energy intake was slightly insufficient for the requirement of the cows in the late period of 2005; in the mid- and late periods of 2006, the metabolizable energy intake was 0.4 to 0.5 times the requirement. These results suggest that the energy intake of cows grazing on forestland pasture dominated by S. senanensis would not satisfy their requirements starting in the mid-period (August) grazing, even though the pasture had abundant herbage resources during these periods.	[Nakano, Miwa] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Yayota, Masato; Ohtani, Shigeru] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan	Yayota, M (reprint author), Gifu Univ, Fac Appl Biol Sci, 1-1 Yanagido, Gifu 5011193, Japan.	yayo@gifu-u.ac.jp					Agriculture Forestry and Fisheries Research Council Secretariat MAFF (AFFRCS), 2000, JAP FEED STAND BEEF; Agriculture Forestry and Fisheries Research Council Secretariat MAFF (AFFRCS), 1987, TOT RES EST MAN SYST, P30; BAILE CA, 1974, PHYSIOL REV, V54, P160; FERGUSON JD, 1989, J DAIRY SCI, V72, P746; VANSOEST PJ, 1965, J ANIM SCI, V24, P834; JUNG HG, 1995, J ANIM SCI, V73, P2774; Berry NR, 2002, J AGR SCI, V139, P437, DOI 10.1017/S002185960200271X; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Das M, 2008, ADV BOT RES, V47, P225, DOI 10.1016/S0065-2296(08)00005-0; AOAC, 1995, OFFICIAL METHODS ANA; ELLIS WC, 1979, FED PROC, V38, P2702; Embaye K, 2003, BIORESOURCE TECHNOL, V88, P33, DOI 10.1016/S0960-8524(02)00265-1; Environment Agency of Japan, 1994, 4 NAT SURV NAT ENV; FERGUSON JD, 1993, J DAIRY SCI, V76, P3742, DOI 10.3168/jds.S0022-0302(93)77716-4; Hoover WH, 1991, ANIM SCI MIMEOGRAPH, V150, P1; Johnson JA, 1998, J ANIM SCI, V76, P1682; Kaneko JJ, 1989, CLIN BIOCH DOMESTIC, V4th, P876; Kimura Y, 1978, B NAT I ANIM HLTH, V76, P43; Koyama Nobuaki, 1993, Journal of Japanese Society of Grassland Science, V39, P28; KRISHNAMOORTHY U, 1982, J DAIRY SCI, V65, P217; KRYSL LJ, 1988, J AGR SCI, V111, P19; Kushibiki S, 1991, B NATL GRASSLAND RES, V45, P93; Kyuma T, 1979, B TOHOKU NATL AGR EX, V60, P73; MADER TL, 1984, J ANIM SCI, V58, P208; Matsui T, 1987, ANIM SCI J, V58, P432; McCormick ME, 1999, J DAIRY SCI, V82, P2697; McDowell LR, 1983, MINERALS GRAZING RUM, P54; Moore KJ, 2005, P 20 INT GRASSL C 26, P268; Nakano Miwa, 2007, Grassland Science, V53, P69, DOI 10.1111/j.1744-697X.2007.00075.x; Nakano M., 2008, Grassland Science, V54, P62, DOI 10.1111/j.1744-697X.2008.00107.x; Nakano M., 2009, Japanese Journal of Grassland Science, V55, P21; National Agriculture and Food Research Organization (NARO), 2009, STAND TABL FEED COMP; NRC - National Research Council, 1996, NUTR REQ BEEF CATTL; Robertson J. B., 1981, ANAL DIETARY FIBRE F, V9, P123; ROE MB, 1991, J DAIRY SCI, V74, P1632; SAS, 2002, JMP US GUID VERS 5 0; Shibayashi K., 1972, Japanese Journal of Zootechnical Science, V43, P677; Simesen MG, 1980, CLIN BIOCH DOMESTIC, P575; Sonoda M, 1982, CLIN CATTLE BASED MA, P750; Susmel P, 1996, BRIT J NUTR, V75, P521, DOI 10.1079/BJN19960156; Suzuki S, 1978, INDEX JAPANESE BAMBU, P384; Underwood EJ, 1981, MINERAL NUTR LIVESTO, V2nd, P54; Usui H, 1961, SPECIAL B COLL AGR U, V11, P1; Van Soest J.P., 1991, J DAIRY SCI, V74, P3583, DOI DOI 10.3168/JDS.S0022-0302(91)78551; Yayota M, 2009, ANIM FEED SCI TECH, V149, P89, DOI 10.1016/j.anifeedsci.2008.05.006	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	JUL	2015	86	7					689	697		10.1111/asj.12348		9	Agriculture, Dairy & Animal Science	Agriculture	CM2MQ	WOS:000357515000006		
J	Watanabe, H; Chen, XN; Shoji, N; Saito, R; Nakano, T; Saito, K; Sumiyoshi, K; Rose, MT; Okada, N; Watanabe, K; Aso, H				Watanabe, Hitoshi; Chen, Xiangning; Shoji, Noriaki; Saito, Ryo; Nakano, Tatsuya; Saito, Kazuki; Sumiyoshi, Keisuke; Rose, Michael T.; Okada, Natumi; Watanabe, Kouichi; Aso, Hisashi			Stimulatory effect of plasma samples from fattening cattle on adipogenesis-related gene expression in preadipocyte cells	ANIMAL SCIENCE JOURNAL			English	Article						adipogenesis; BIP cell; meat quality; NEFA; unsaturated fatty acid	FATTY-ACID-COMPOSITION; SUBCUTANEOUS ADIPOSE-TISSUE; STEAROYL-COA DESATURASE; JAPANESE BLACK CATTLE; NECROSIS-FACTOR-ALPHA; BEEF-CATTLE; STEERS; SERUM; DIFFERENTIATION; ADIPOCYTES	It is desirable to produce beef with high levels of monounsaturated fatty acids (MUFA), as this is related to fat softness and palatability. However, the physiology of MUFA synthesis in bovine fat during the fattening process remains to be established. In this study, in order to elucidate the relationship between plasma components and the fatty acid composition of intramuscular fat, we investigated the effect of plasma obtained from fattening cattle on the messenger RNA (mRNA) expressions of the adipogenesis-related gene in a clonal bovine intramuscular preadipocyte line (BIP cells). The mRNA expressions of stearoyl-CoA desaturase, adipocyte Protein 2, peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein 1 in BIP cells were significantly higher following treatment with those plasma samples collected from the cattle with the highest diaphragmatic unsaturated fatty acids to saturated fatty acids ratio (US/S). Furthermore, the concentration of nonesterified fatty acid (NEFA) in the plasma samples had an inverse correlation with carcass diaphragmatic US/S. These results indicate that cattle with a low ratio of US/S in fat may be discriminated from the population of fattening cattle before slaughter by measuring the effect of their plasma on gene expression in BIP cells as well as their plasma concentration and composition of NEFA.	[Watanabe, Hitoshi; Chen, Xiangning; Saito, Ryo; Nakano, Tatsuya; Saito, Kazuki; Sumiyoshi, Keisuke; Okada, Natumi; Watanabe, Kouichi; Aso, Hisashi] Tohoku Univ, Grad Sch Agr Sci, Cellar Biol Lab, Sendai, Miyagi 9818555, Japan; [Shoji, Noriaki] Yamagata Gen Agr Res Ctr, Dept Livestock Sci, Shinjo, Japan; [Rose, Michael T.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3FG, Dyfed, Wales	Aso, H (reprint author), Tohoku Univ, Grad Sch Agr Sci, Cellar Biol Lab, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	asosan@bios.tohoku.ac.jp					Adachi K, 1999, J VET MED SCI, V61, P961, DOI 10.1292/jvms.61.961; Cartier A, 2010, CLIN ENDOCRINOL, V72, P349, DOI 10.1111/j.1365-2265.2009.03671.x; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Brandebourg TD, 2005, J ANIM SCI, V83, P98; Muchenje V, 2009, FOOD CHEM, V112, P279, DOI 10.1016/j.foodchem.2008.05.103; Wood JD, 2004, MEAT SCI, V66, P21, DOI 10.1016/S0309-1740(03)00022-6; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; ZEMBAYASHI M, 1995, J ANIM SCI, V73, P3325; Chung KY, 2006, MEAT SCI, V73, P432, DOI 10.1016/j.meatsci.2006.01.002; Rowe A, 1999, MEAT SCI, V51, P283, DOI 10.1016/S0309-1740(98)00063-1; Taniguchi M, 2004, MAMM GENOME, V15, P142, DOI 10.1007/s00335-003-2286-8; Smith SB, 2009, J ANIM SCI, V87, pE72, DOI 10.2527/jas.2008-1340; Taniguchi M, 2004, LIVEST PROD SCI, V87, P215, DOI 10.1016/j.livprodsci.2003.07.008; Ardiyanti A, 2009, ANIM SCI J, V80, P62, DOI 10.1111/j.1740-0929.2008.00594.x; ASO H, 1995, BIOCHEM BIOPH RES CO, V213, P369, DOI 10.1006/bbrc.1995.2141; Bauchart D, 1996, P NUTR SOC, V55, P39, DOI 10.1079/PNS19960010; GRUNDY SM, 1990, J LIPID RES, V31, P1149; KATAN MB, 1994, AM J CLIN NUTR, V60, p1017S; Kobayashi M, 2006, JAPANESE J ZOOTECHNI, V77, P521; Oka A., 1999, P JAPANESE SOC ANIMA, V43, P137; RHEE KS, 1988, MEAT SCI, V23, P293, DOI 10.1016/0309-1740(88)90013-7; Sanosaka M, 2008, COMP BIOCHEM PHYS B, V149, P285, DOI 10.1016/j.cbpb.2007.09.019; Sasazaki S, 2014, ANIM SCI J, V85, P499, DOI 10.1111/asj.12167; Smith SB, 2006, ANIM SCI J, V77, P478, DOI 10.1111/j.1740-0929.2006.00375.x; Torii S, 1996, ANIM SCI, V63, P73; Yamasaki T, 2006, CELL TISSUE RES, V326, P139, DOI 10.1007/s00441-006-0194-4; Yang A, 1999, LIPIDS, V34, P971, DOI 10.1007/s11745-999-0447-8	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	JUL	2015	86	7					698	706		10.1111/asj.12344		9	Agriculture, Dairy & Animal Science	Agriculture	CM2MQ	WOS:000357515000007		
J	Iida, F; Saitou, K; Kawamura, T; Yamaguchi, S; Nishimura, T				Iida, Fumiko; Saitou, Kaoru; Kawamura, Tadashi; Yamaguchi, Shizuko; Nishimura, Toshihide			Effect of fat content on sensory characteristics of marbled beef from Japanese Black steers	ANIMAL SCIENCE JOURNAL			English	Article						appropriate fat content; beef flavor; marbled beef; sensory characteristics; umami	MEAT CONSUMPTION; LONGISSIMUS MUSCLE; LOIN STEAKS; PALATABILITY; TENDERNESS; TRAITS; FLAVOR; ACCEPTANCE; COMPONENTS; CATTLE	To analyze the sensory characteristics of meat samples with a crude fat content between 23.8% and 48.6% taken from 34 Japanese Black steers, we grilled the meat and subjected it to analytical sensory evaluation. We also measured the amounts of moisture, protein, nucleic acid and glutamic acid. An increase in crude fat content increased the tenderness, juiciness, and fattiness in the meat quality evaluation. An increase in crude fat content reduced the crude protein and moisture contents; it also slightly reduced the nucleic acid and glutamic acid contents, although when the reductions in these umami components were assessed relative to the moisture content they changed little. Increasing the fat content up to a certain point greatly enhanced the umami intensity and beef flavor intensity in the meat quality evaluation and raised the overall evaluation score; the peak of the appropriate crude fat content for these purposes was about 36%.	[Iida, Fumiko] Japan Womens Univ, Dept Food & Nutr, Tokyo 1128681, Japan; [Yamaguchi, Shizuko] Nippon Vet & Life Sci Univ, Taste & Food Preference Lab, Tokyo, Japan; [Nishimura, Toshihide] Nippon Vet & Life Sci Univ, Dept Food Sci & Technol, Tokyo, Japan; [Saitou, Kaoru; Kawamura, Tadashi] Natl Livestock Breeding Ctr, Fukushima, Japan	Iida, F (reprint author), Japan Womens Univ, Dept Food & Nutr, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.	iida-fu@fc.jwu.ac.jp					Killinger KM, 2004, J ANIM SCI, V82, P3294; Ueda Y, 2007, ANIM SCI J, V78, P189, DOI 10.1111/j.1740-0929.2007.00424.x; SUZUKI A, 1994, MEAT SCI, V37, P369, DOI 10.1016/0309-1740(94)90053-1; RICHARDSON NJ, 1993, APPETITE, V21, P41, DOI 10.1006/appe.1993.1035; CAMERON PJ, 1994, MEAT SCI, V38, P361, DOI 10.1016/0309-1740(94)90125-2; Lea E, 2001, APPETITE, V36, P127, DOI 10.1006/appe.2000.0386; Platter WJ, 2003, J ANIM SCI, V81, P2741; Holm L, 2000, APPETITE, V34, P277, DOI 10.1006/appe.2000.0324; NISHIMURA T, 1988, AGR BIOL CHEM TOKYO, V52, P2323; Nishimura T, 1999, J ANIM SCI, V77, P93; Verbeke W, 1999, FOOD QUAL PREFER, V10, P437, DOI 10.1016/S0950-3293(99)00031-2; Association of Official Analytical Chemists, 1990, OFFICIAL METHODS ANA; BERRY BW, 1990, J ANIM SCI, V68, P666; BLUMER TN, 1959, J ANIM SCI, V18, P959; BLUMER TN, 1963, J ANIM SCI, V22, P771; BLUMER TN, 1962, J ANIM SCI, V21, P935; COVER S, 1956, J ANIM SCI, V15, P464; Garmyn AJ, 2011, J ANIM SCI, V89, P2849, DOI 10.2527/jas.2010-3497; Grunert KG, 1997, FOOD QUAL PREFER, V8, P157, DOI 10.1016/S0950-3293(96)00038-9; Hong JH, 2012, J FOOD SCI, V77, pS233, DOI 10.1111/j.1750-3841.2012.02724.x; Horii M., 2009, ANIM SCI J, V80, P55; Iida F., 2014, J HOME EC JAPAN, V65, P3; Inoue K., 2002, NIHON CHIKUSAN GAKKA, V73, P381, DOI 10.2508/chikusan.73.381; Kunieda S, 2006, JAPANESE J SENSORY E, V10, P19; Maruyama I, 1994, P 24 S SENS EV JAP U, V181-186; Maruyama I, 1996, JPN J TASTE SMELL RE, V3, P632; Matsuishi M, 2004, JAPANESE J ZOOTECHNI, V75, P409; MAY SG, 1992, J ANIM SCI, V70, P444; MORGAN JB, 1991, J ANIM SCI, V69, P3274; Nishimura T., 2012, JAPANESE J TASTE SME, V19, P167; Okita M, 1999, UNION JAPANESE SCI E, V29, P113; OKITANI A, 1993, J JPN SOC FOOD SCI, V40, P535; OZUTSUMI K, 1985, Japanese Journal of Zootechnical Science, V56, P1; Ozutsumi K, 1989, NIPPON SHOKUHIN KOGY, V36, P857; Sasaki K, 2012, ANIM SCI J, V83, P338, DOI 10.1111/j.1740-0929.2011.00946.x; SHACKELFORD SD, 1994, J ANIM SCI, V72, P1502; Yamaguchi S, 2009, JAPANESE J TASTE SME, V16, P441; Yamaguchi S, 1998, FOOD REV INT, V14, P139; Yamaguchi S., 1987, UMAMI A BASIC TASTE, P48; Yamaguchi S., 2011, JAPANESE J TASTE SME, V18, P409; Yamaguchi S., 2008, JAPANESE J TASTE SME, V15, P145; Yamamoto T., 2012, JAPANESE J TASTE SME, V19, P189	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	JUL	2015	86	7					707	715		10.1111/asj.12342		9	Agriculture, Dairy & Animal Science	Agriculture	CM2MQ	WOS:000357515000008		
J	Sato, I; Okada, K; Sasaki, J; Chida, H; Satoh, H; Miura, K; Kikuchi, K; Otani, K; Sato, S				Sato, Itaru; Okada, Keiji; Sasaki, Jun; Chida, Hiroyuki; Satoh, Hiroshi; Miura, Kiyoshi; Kikuchi, Kaoru; Otani, Kumiko; Sato, Shusuke			Distribution of radioactive cesium and stable cesium in cattle kept on a highly contaminated area of Fukushima nuclear accident	ANIMAL SCIENCE JOURNAL			English	Article						cattle; cesium; distribution; radioactive contamination	RADIOCESIUM; POTASSIUM; RETENTION; MICE	Radioactivity inspection of slaughtered cattle is generally conducted using a portion of the neck muscle; however, there is limited information about the distribution of radioactive cesium in cattle. In this study, therefore, we measured not only radioactive cesium but also stable cesium in various tissues of 19 cattle that had been kept in the area highly contaminated by the Fukushima nuclear accident. Skeletal muscles showed approximately 1.5-3.0 times higher concentration of radioactive cesium than internal organs. Radioactive cesium concentration in the tenderloin and top round was about 1.2 times as high as that in the neck muscle. The kidney showed the highest concentration of radioactive cesium among internal organs, whereas the liver was lowest. Radioactive cesium concentration in the blood was about 8% of that in the neck muscle. Characteristics of stable cesium distribution were almost the same as those of radioactive cesium. Correlation coefficient between radioactive cesium and stable cesium in tissues of individual cattle was 0.981 +/- 0.012. When a suspicious level near 100 Bq/kg is detected in the neck of slaughtered cattle, re-inspection should be conducted using a different region of muscle, for example top round, to prevent marketing of beef that violates the Food Sanitation Act.	[Sato, Itaru; Okada, Keiji; Sasaki, Jun; Chida, Hiroyuki; Satoh, Hiroshi] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Miura, Kiyoshi; Kikuchi, Kaoru] Tanko Dist Agr Mutual Aid Assoc, Oshu, Japan; [Otani, Kumiko] NTT Advertising Inc, Tokyo, Japan; [Sato, Shusuke] Tohoku Univ, Grad Sch Agr Sci, Osaki, Japan	Sato, I (reprint author), Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan.	satoital@iwate-u.ac.jp					Kaikkonen M, 2005, ACTA PHYSIOL SCAND, V183, P321, DOI 10.1111/j.1365-201X.2004.01391.x; HOOD SL, 1953, ARCH BIOCHEM BIOPHYS, V45, P423, DOI 10.1016/S0003-9861(53)80018-4; Leggett RW, 2003, SCI TOTAL ENVIRON, V317, P235, DOI 10.1016/S0048-9697(03)00333-4; BALLOU J E, 1958, Health Phys, V1, P85, DOI 10.1097/00004032-195801000-00013; CHERTOK RJ, 1973, HEALTH PHYS, V24, P43, DOI 10.1097/00004032-197301000-00006; Fukuda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054312; FURCHNER JE, 1964, P SOC EXP BIOL MED, V116, P375; Futatsugawa S, 1993, INT J PIXE, V3-4, P319, DOI 10.1142/S012908359300029X; ICRP, 1980, LIM INT RAD WORK; Inaba J, 1968, RADIOISOTOPES, V17, P151; Matsusaka N, 1971, HOKEN BUTSURI, V6, P15; Ministry of Agriculture Forestry and Fisheries (MAFF), 2014, RES INSP RAD LEV LIV; Nabeshi Hiromi, 2013, Shokuhin Eiseigaku Zasshi, V54, P415; Okada K, 2013, ANIM SCI J, V84, P798, DOI 10.1111/asj.12075; Sasaki K, 2012, BIOSCI BIOTECH BIOCH, V76, P1596, DOI 10.1271/bbb.120424; Sato I, 1997, RADIAT RES, V148, P98, DOI 10.2307/3579543; Skuterud L, 2004, RADIAT ENVIRON BIOPH, V43, P293, DOI 10.1007/s00411-004-0257-4	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	JUL	2015	86	7					716	720		10.1111/asj.12345		5	Agriculture, Dairy & Animal Science	Agriculture	CM2MQ	WOS:000357515000009		
J	Kawai, K; Sasaki, T; Noda, K; Sakamoto, M; Kawatsuki, N; Ono, H				Kawai, Kotaro; Sasaki, Tomoyuki; Noda, Kohei; Sakamoto, Moritsugu; Kawatsuki, Nobuhiro; Ono, Hiroshi			Holographic binary grating liquid crystal cells fabricated by one-step exposure of photocrosslinkable polymer liquid crystalline alignment substrates to a polarization interference ultraviolet beam	APPLIED OPTICS			English	Article							SURFACE-RELIEF GRATINGS; HIGH-EFFICIENCY; DIFFRACTION; AZOBENZENE; FILMS	Holographic binary grating liquid crystal (LC) cells, in which the optical anisotropy was rectangularly modulated even as the grating was fabricated using holographic exposure, were fabricated by one-step polarization holographic exposure of an empty glass cell, the interior of which was coated with a photocrosslinkable polymer LC (PCLC). The present study is of great significance in that three types of holographic binary grating LC cells containing twisted alignments can be fabricated by simultaneous exposure of two PCLC substrates to the UV interference beams, which are sinusoidally modulated. The polarization conversion properties of the diffracted beams are explained well by theoretical analysis based on Jones calculus. (C) 2015 Optical Society of America	[Kawai, Kotaro; Sasaki, Tomoyuki; Noda, Kohei; Sakamoto, Moritsugu; Ono, Hiroshi] Nagaoka Univ Technol, Dept Elect Engn, Nagaoka, Niigata 9402188, Japan; [Kawatsuki, Nobuhiro] Univ Hyogo, Dept Appl Chem, Himeji, Hyogo 6712280, Japan	Kawai, K (reprint author), Nagaoka Univ Technol, Dept Elect Engn, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	s135016@stn.nagaokaut.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [25289097]	Ministry of Education, Culture, Sports, Science, and Technology (25289097).	Honma M, 2012, OPT EXPRESS, V20, P18449, DOI 10.1364/OE.20.018449; Kawatsuki N, 2002, MACROMOLECULES, V35, P706, DOI 10.1021/ma011439u; Crawford GP, 2005, J APPL PHYS, V98, DOI 10.1063/1.2146075; Yu CJ, 2004, MAT SCI ENG C-BIO S, V24, P247, DOI 10.1016/j.msec.2003.09.016; Kuzuwata M, 2012, OPT LETT, V37, P1115, DOI 10.1364/OL.37.001115; Sasaki T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.042503; Sun J, 2013, OPT LETT, V38, P2342, DOI 10.1364/OL.38.002342; Ono H, 2003, J APPL PHYS, V94, P1298, DOI 10.1063/1.1587269; Li YM, 2012, APPL OPTICS, V51, P8236, DOI 10.1364/AO.51.008236; Park JH, 2003, APPL PHYS LETT, V83, P1918, DOI 10.1063/1.1609042; Kim J, 2011, APPL OPTICS, V50, P2636, DOI 10.1364/AO.50.002636; TODOROV T, 1984, APPL OPTICS, V23, P4588; Kawai K, 2014, APPL OPTICS, V53, P3679, DOI 10.1364/AO.53.003679; Jiang XL, 1996, APPL PHYS LETT, V68, P2618, DOI 10.1063/1.116200; Choi H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2162672; Honma M, 2004, APPL OPTICS, V43, P5193, DOI 10.1364/AO.43.005193; Honma M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737945; Yu CJ, 2005, OPT LETT, V30, P1995, DOI 10.1364/OL.30.001995; Komanduri RK, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3197011; Gorkhali SP, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2214176; Oh C, 2008, OPT LETT, V33, P2287, DOI 10.1364/OL.33.002287; Provenzano C, 2007, OPT EXPRESS, V15, P5872, DOI 10.1364/OE.15.005872; Nicolescu E, 2010, APPL OPTICS, V49, P3900, DOI 10.1364/AO.49.003900; Kapoustine V, 2006, OPT COMMUN, V266, P1, DOI 10.1016/j.optcom.2006.04.037; de Lozar Munoz A., 2005, LIQUID CRYSTAL DYNAM; Leopold A, 2000, J CHEM PHYS, V113, P833, DOI 10.1063/1.481858; Scharf T., 2007, POLARIZED LIGHT LIQU, P307; Sheremet N, 2013, APPL OPTICS, V52, pE40, DOI 10.1364/AO.52.000E40	28	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	JUL 1	2015	54	19					6010	6018		10.1364/AO.54.006010		9	Optics	Optics	CL9ZY	WOS:000357339200019		
J	Matsui, T; Nakajima, K; Yamamoto, F				Matsui, Takashi; Nakajima, Kazuhide; Yamamoto, Fumihiko			Guided acoustic-wave Brillouin scattering characteristics of few-mode fiber	APPLIED OPTICS			English	Article								We experimentally investigate the modal dependence of the guided-acoustic wave Brillouin scattering (GAWBS) characteristics in a few-mode fiber (FMF). We clarify that launching higher-order modes into FMF induces different peak frequencies from those of single-mode fiber (SMF) in the GAWBS spectrum and that the GAWBS spectrum strongly depends on the mode excitation power ratio between the LP01 and LP11 modes. We evaluate the mode excitation power ratio at a splice between an FMF and an SMF by utilizing the GAWBS spectrum, which we realize by detecting only the fundamental mode at the output of the FMF and without the use of a mode demultiplexer. (C) 2015 Optical Society of America	[Matsui, Takashi; Nakajima, Kazuhide; Yamamoto, Fumihiko] NTT Corp, Access Network Serv Syst Labs, Tsukuba, Ibaraki 3050805, Japan	Matsui, T (reprint author), NTT Corp, Access Network Serv Syst Labs, 1-7-1 Hanabatake, Tsukuba, Ibaraki 3050805, Japan.	matsui.takashi@lab.ntt.co.jp			National Institute of Information and Communications Technology (NICT) (R&D of Innovative Optical Fiber and Communication Technology)	National Institute of Information and Communications Technology (NICT) (R&D of Innovative Optical Fiber and Communication Technology).	Koshiba M, 2011, OPT EXPRESS, V19, P102, DOI 10.1364/OE.19.00B102; Nicholson JW, 2009, IEEE J SEL TOP QUANT, V15, P61, DOI 10.1109/JSTQE.2008.2010239; Matsui T, 2007, APPL OPTICS, V46, P6912, DOI 10.1364/AO.46.006912; Hanzawa N, 2013, OPT EXPRESS, V21, P25752, DOI 10.1364/OE.21.025752; Tanaka Y, 1998, IEEE PHOTONIC TECH L, V10, P1769, DOI 10.1109/68.730497; Hanzawa N., 2011, P OFC NFOEC2011 LOS; Kobayashi T., 2013, P ECOC2013 LOND; Matsui T., 2014, P IEEE SUMM TOP MONT; Ohashi M., 1992, P OFC1992 WASH DC, P143; Shelby R., 1985, PHYS REV, V15, P127; Watase A., 2013, IEICE ELECTRON EXPR, V10, P1	11	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	JUL 1	2015	54	19					6093	6097		10.1364/AO.54.006093		5	Optics	Optics	CL9ZY	WOS:000357339200031		
J	Watanabe, Y; Takakura, K; Kurotani, R; Abe, H				Watanabe, Yuuki; Takakura, Kei; Kurotani, Reiko; Abe, Hiroyuki			Optical coherence tomography imaging for analysis of follicular development in ovarian tissue	APPLIED OPTICS			English	Article							RETINAL BLOOD-FLOW; IN-VIVO; DOPPLER TOMOGRAPHY; VELOCITY; MICROVASCULATURE	We describe the application of optical coherence tomography (OCT) for noninvasive analysis of follicular development in mouse ovaries. Ovaries contain many follicles and oocytes. Quantification of follicles at various developmental stages is an indication of the ability of an ovary to provide oocytes capable of fertilization. Three-dimensional structural OCT images identified each developmental stage, from a primary follicle (50 mu m in diameter) to an antral follicle (350 mu m in diameter), in the ovary of a 25.5-day-old mouse. We discovered time-varying OCT signals at the oocytes that differentiated them from surrounding tissues. These signals were clearly enhanced by interframe intensity-based Doppler OCT techniques. The OCT technology was effective in analyzing the development of follicles and oocytes in ovaries. (C) 2015 Optical Society of America	[Watanabe, Yuuki] Yamagata Univ, Grad Sch Sci & Engn, Dept Biosyst Engn, Yonezawa, Yamagata 9928510, Japan; [Takakura, Kei; Kurotani, Reiko; Abe, Hiroyuki] Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, Yonezawa, Yamagata 9928510, Japan	Watanabe, Y (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Biosyst Engn, 4-3-16 Johnan, Yonezawa, Yamagata 9928510, Japan.	ywata@yz.yamagata-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23658220, 25350519]; Research Foundation for Opto-Science and Technology; Tateisi Science and Technology Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI (23658220, 25350519); Research Foundation for Opto-Science and Technology; Tateisi Science and Technology Foundation.	An L, 2010, OPT EXPRESS, V18, P8220, DOI 10.1364/OE.18.008220; Leitgeb RA, 2003, OPT EXPRESS, V11, P3116; Yang VXD, 2002, OPT COMMUN, V208, P209, DOI 10.1016/S0030-4018(02)01501-8; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Wang TH, 2015, WIRES NANOMED NANOBI, V7, P1, DOI 10.1002/wnan.1306; Watanabe Y, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275463; Liu GJ, 2011, OPT EXPRESS, V19, P3657, DOI 10.1364/OE.19.003657; White BR, 2003, OPT EXPRESS, V11, P3490, DOI 10.1364/OE.11.003490; Mariampillai A, 2008, OPT LETT, V33, P1530, DOI 10.1364/OL.33.001530; Chen ZP, 1997, OPT LETT, V22, P64, DOI 10.1364/OL.22.000064; Chen ZP, 1997, OPT LETT, V22, P1119, DOI 10.1364/OL.22.001119; Fawcett D. W., 1986, TXB HISTOLOGY, V11th, P851; Hariri LP, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12531; Liu GJ, 2012, OPT EXPRESS, V20, P7694, DOI 10.1364/OE.20.007694; Vakoc BJ, 2005, OPT EXPRESS, V13, P5483, DOI 10.1364/OPEX.13.005483; Watanabe Y, 2010, APPL OPTICS, V49, P4756, DOI 10.1364/AO.49.004756; Watanabe Y, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.2.021105	17	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	JUL 1	2015	54	19					6111	6115		10.1364/AO.54.006111		5	Optics	Optics	CL9ZY	WOS:000357339200034		
J	Momose, M; Hirasaka, M; Furukawa, Y				Momose, Miho; Hirasaka, Masao; Furukawa, Yukio			Raman Spectroscopic Study on Phosphorous-Doped Silicon Nanoparticles	APPLIED SPECTROSCOPY			English	Article						P-doped silicon; Nanoparticles; Vibrational spectroscopy; Raman spectroscopy; Temperature measurements; Amorphous; Crystallinity	CHEMICAL-VAPOR-DEPOSITION; MICROCRYSTALLINE SILICON; SI NANOPARTICLES; FILMS; TRANSITION; SCATTERING; SPECTRA	The Raman spectra of films prepared from 8, 19, and 30 nm nanoparticles of silicon doped with phosphorous were measured with excitation at 514.5 nm. The observed spectra were analyzed by decomposing the observed Raman bands into three symmetric Voigt function bands, which were assigned to the Si Si stretching modes of crystalline, boundary, and amorphous-like components. The fractions of crystalline, boundary, and amorphous-like regions were estimated from the obtained components. The obtained fractions can be explained as a sphere-like nanoparticle consisting of a crystalline core surrounded with boundary and amorphous-like shells, which is consistent with the transmission electron microscope images showing a sphere-like shape. The observed spectral shape of the 8 nm nanoparticle film showed significant changes upon light irradiation with a power density of 5.5 kW cm(-2), i.e., the amorphous-like region converted to a crystalline one. The temperature of the film under laser irradiation was estimated to be lower than 1041 degrees C from the anti-Stokes to the Stokes Raman bands due to the Si Si stretching mode. The observed partial crystallization is probably induced by heating associated with light irradiation.	[Momose, Miho] Teijin Ltd, Mat Anal Res Ctr, Tokyo 1918512, Japan; [Hirasaka, Masao] Teijin Intellectual Property Ctr Ltd, IP Strategy Planning Dept, Chiyoda Ku, Tokyo 1008585, Japan; [Furukawa, Yukio] Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Shinjuku Ku, Tokyo 1698555, Japan	Furukawa, Y (reprint author), Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Shinjuku Ku, Tokyo 1698555, Japan.	furukawa@waseda.jp					Han DX, 2003, J APPL PHYS, V94, P2930, DOI 10.1063/1.1598298; Han DX, 2003, J APPL PHYS, V93, P3776, DOI 10.1063/1.1555680; Yue GZ, 1999, APPL PHYS LETT, V75, P492, DOI 10.1063/1.124426; Hirasawa M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2182018; Hirasawa M, 2004, APPL PHYS A-MATER, V79, P1421, DOI 10.1007/s00339-004-2800-1; Houben L, 1998, PHILOS MAG A, V77, P1447; IQBAL Z, 1981, SOLID STATE COMMUN, V37, P993, DOI 10.1016/0038-1098(81)91202-3; Voutsas AT, 1995, J APPL PHYS, V78, P6999, DOI 10.1063/1.360468; Wei WS, 2007, VACUUM, V81, P656, DOI 10.1016/j.vacuum.2006.09.006; Saleh R, 2003, THIN SOLID FILMS, V427, P266, DOI 10.1016/S0040-6090(02)01203-8; Smit C, 2003, J APPL PHYS, V94, P3582, DOI 10.1063/1.1596364; CHANDRASEKHAR M, 1978, PHYS REV B, V17, P1623, DOI 10.1103/PhysRevB.17.1623; CANNON WR, 1982, J AM CERAM SOC, V65, P324, DOI 10.1111/j.1151-2916.1982.tb10464.x; CERDEIRA F, 1973, PHYS REV B, V8, P4734, DOI 10.1103/PhysRevB.8.4734; Li XG, 2003, LANGMUIR, V19, P8490, DOI 10.1021/la034487b; Schierning G, 2008, J APPL PHYS, V103, DOI 10.1063/1.2903908; Sugiyama T, 2008, CHEM PHYS LETT, V453, P238, DOI 10.1016/j.cplett.2008.01.038; Touir H, 1998, J NON-CRYST SOLIDS, V227, P906, DOI 10.1016/S0022-3093(98)00222-1; VEPREK S, 1987, PHYS REV B, V36, P3344, DOI 10.1103/PhysRevB.36.3344; Wolf I.D., 1999, ANAL APPL RAMAN SPEC, P435	20	0	0	SOC APPLIED SPECTROSCOPY	FREDERICK	5320 SPECTRUM DRIVE SUITE C, FREDERICK, MD 21703 USA	0003-7028	1943-3530		APPL SPECTROSC	Appl. Spectrosc.	JUL	2015	69	7					877	882		10.1366/13-07431		6	Instruments & Instrumentation; Spectroscopy	Instruments & Instrumentation; Spectroscopy	CM5ZF	WOS:000357766800013		
J	Toushmalani, R; Saibi, H				Toushmalani, Reza; Saibi, Hakim			Fast 3D inversion of gravity data using Lanczos bidiagonalization method	ARABIAN JOURNAL OF GEOSCIENCES			English	Article						Inverse problem; 3D modeling; Lanczos bidiagonalization; Gravity anomaly; Bandar Charak	MAGNETIC DATA; GEOPHYSICAL INVERSIONS; EULER DECONVOLUTION; ALGORITHM; COSIMULATION; EXPLORATION; COVARIANCE; MODEL	This paper describes the application of a new inversion method to recover a three-dimensional density model from measured gravity anomalies. To attain this, the survey area is divided into a large number of rectangular prisms in a mesh with unknown densities. The results show that the application of the Lanczos bidiagonalization algorithm in the inversion helps to solve a Tikhonov cost function in a short time. The performance time of the inverse modeling greatly decreases by substituting the forward operator matrix with a matrix of lower dimension. A least-squares QR (LSQR) method is applied to select the best value of a regularization parameter. A Euler deconvolution method was used to avoid the natural trend of gravity structures to concentrate at shallow depth. Finally, the newly developed method was applied to synthetic data to demonstrate its suitability and then to real data from the Bandar Charak region (Hormozgan, south Iran). The 3D gravity inversion results were able to detect the location of the known salt dome (density contrast of -0.2 g/cm(3)) intrusion in the study area.	[Toushmalani, Reza] Islamic Azad Univ, Dept Comp, Fac Engn, Kangavar Branch, Kangavar, Iran; [Saibi, Hakim] Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Lab Explorat Geophys,Nishi Ku, Fukuoka 8190395, Japan	Saibi, H (reprint author), Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Lab Explorat Geophys,Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	saibi-hakim@mine.kyushu-u.ac.jp					Shamsipour P, 2011, J APPL GEOPHYS, V73, P336, DOI 10.1016/j.jappgeo.2011.02.005; Li YG, 2003, GEOPHYS J INT, V152, P251, DOI 10.1046/j.1365-246X.2003.01766.x; Nabighian MN, 2005, GEOPHYSICS, V70, p33ND, DOI 10.1190/1.2133784; Chasseriau P, 2003, J APPL GEOPHYS, V52, P59, DOI 10.1016/S0926-9851(02)00240-9; Gallardo-Delgado LA, 2003, GEOPHYSICS, V68, P949, DOI 10.1190/1.1581067; BARBOSA VCF, 1994, GEOPHYSICS, V59, P57, DOI 10.1190/1.1443534; Bosch M, 2006, GEOPHYSICS, V71, pG153, DOI 10.1190/1.2209952; Zhdanov MS, 2004, GEOPHYSICS, V69, P925, DOI 10.1190/1.1778236; Camacho AG, 2002, COMPUT GEOSCI-UK, V28, P191, DOI 10.1016/S0098-3004(01)00039-5; Hansen PC, 2007, NUMER ALGORITHMS, V46, P189, DOI 10.1007/s11075-007-9136-9; Abedi M, 2013, J APPL GEOPHYS, V90, P126, DOI 10.1016/j.jappgeo.2013.01.008; Camacho AG, 2011, COMPUT GEOSCI-UK, V37, P621, DOI 10.1016/j.cageo.2010.12.003; Portniaguine O, 2002, GEOPHYSICS, V67, P1532, DOI 10.1190/1.1512749; Li YG, 1998, GEOPHYSICS, V63, P109, DOI 10.1190/1.1444302; GUILLEN A, 1984, GEOPHYSICS, V49, P1354, DOI 10.1190/1.1441761; Eidsvik J, 2004, GEOPHYSICS, V69, P978, DOI 10.1190/1.1778241; LAST BJ, 1983, GEOPHYSICS, V48, P713, DOI 10.1190/1.1441501; Shamsipour P, 2010, GEOPHYSICS, V75, pI1, DOI 10.1190/1.3295745; Fuentes M, 2001, ENVIRONMETRICS, V12, P469, DOI 10.1002/env.473; Paciorek CJ, 2006, ENVIRONMETRICS, V17, P483, DOI 10.1002/env.785; Camacho AG, 2000, GEOPHYSICS, V65, P95, DOI 10.1190/1.1444729; Pilkington M, 1997, GEOPHYSICS, V62, P1132, DOI 10.1190/1.1444214; Asli M, 2000, P 6 INT GEOST C GEOS, P64; Barbosa VCF, 1997, GEOPHYSICS, V62, P1745, DOI 10.1190/1.1444275; Bosak P, 1998, CEOLINES, V7, P178; Bott MHP, 1959, GEOPHYS PROSPECT, V7, P45, DOI 10.1111/j.1365-2478.1959.tb01452.x; Cheng D, 2003, 73 ANN INT M SEG; Danes Z. F, 1960, GEOPHYSICS, V25, P1215, DOI 10.1190/1.1438809; Dias FJSS, 2011, GEOPHYSICS, V76, P149, DOI 10.1190/1.3555078; Dias FJSS, 2009, GEOPHYSICS, V74, pI9, DOI 10.1190/1.3092775; Esmaeil Zadeh A., 2010, RUSS J EARTH SCI, V11, DOI [10.2205/2009ES000375, DOI 10.2205/2009ES000375]; FRANKLIN JN, 1970, J MATH ANAL APPL, V31, P682, DOI 10.1016/0022-247X(70)90017-X; Giroux B, 2007, COMPUT GEOSCI-UK, V33, P126, DOI 10.1016/j.cageo.2006.05.014; Gloaguen E, 2005, J APPL GEOPHYS, V57, P242, DOI 10.1016/j.jappgeo.2005.01.001; GREEN WR, 1975, GEOPHYSICS, V40, P763, DOI 10.1190/1.1440566; Haas A., 1994, 1 BREAK, V12, P561; Hansen TM, 2006, GEOPHYSICS, V71, pR101, DOI 10.1190/1.2345195; Higdon D. M., 1999, BAYESIAN STAT, V6, P761; Krahenbuhl R., 2002, 72 ANN INT M SEG, P755; Krahenbuhl RA, 2004, SEG INT EXP 74 ANN M, P782; Lelievre PG, 2009, GEOPHYS J INT, V178, P623, DOI [10.1111/J.1365-246X.2009.04188.x, 10.1111/j.1365-246X.2009.04188.x]; Li YG, 2000, GEOPHYSICS, V65, P148, DOI 10.1190/1.1444705; Li Y., 2001, SEG EXP ABSTR, V20, P1470, DOI DOI 10.1190/1.1816383; Menke W., 1989, GEOPHYS DATA ANAL DI; Moraes RAV, 2001, GEOPHYSICS, V66, P501, DOI 10.1190/1.1444940; MOSEGAARD K, 1995, J GEOPHYS RES-SOL EA, V100, P12431, DOI 10.1029/94JB03097; Nagy D, 2000, J GEODESY, V74, P552, DOI 10.1007/s001900000116; OLDENBUR.DW, 1974, GEOPHYSICS, V39, P526, DOI 10.1190/1.1440444; PAIGE CC, 1982, ACM T MATH SOFTWARE, V8, P43, DOI 10.1145/355984.355989; Parker R. L., 1972, Geophysical Journal of the Royal Astronomical Society, V31; Pedersen L.B., 1977, GEOPHYS PROSPECT, V25, P199, DOI DOI 10.1111/J.1365-2478.1977.TB01164.X; Prakash J, 2013, MED PHYS, V40, DOI 10.1118/1.4792459; REID AB, 1990, GEOPHYSICS, V55, P80, DOI 10.1190/1.1442774; RENE RM, 1986, GEOPHYSICS, V51, P988; Saibi H, 2012, ACTA GEOPHYS, V60, P318, DOI 10.2478/s11600-011-0061-x; Saibi H., 2006, J EXP GEOPHYS JPN, V59, P275, DOI [10.3124/segj.59.275, DOI 10.3124/SEGJ.59.275]; Shamsipour P, 2012, J APPL GEOPHYS, V79, P27, DOI 10.1016/j.jappgeo.2011.12.012; Shamsipour P, 2013, GEOPHYSICS, V78, pG15, DOI 10.1190/GEO2012-0122.1; Tarantola A., 2005, SOC IND APPL MATH; TARANTOLA A., 1988, INVERSE PROBLEM THEO; Torres-Verdin C., 1999, LEADING EDGE, V18, P1070, DOI DOI 10.1190/1.1438434; TOUSHMALANI R, 2013, J APPL SCI AGRIC, V8, P696; Uieda L, 2011, 73 EAGE C EXH VIENN; Zhang J, 2004, GEOPHYSICS, V69, P917, DOI 10.1190/1.1778235	64	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1866-7511	1866-7538		ARAB J GEOSCI	Arab. J. Geosci.	JUL	2015	8	7					4969	4981		10.1007/s12517-014-1534-4		13	Geosciences, Multidisciplinary	Geology	CL6TV	WOS:000357101200052		
J	Ibrahim, WS; Watanabe, K; Ibrahim, ME; Yonezu, K				Ibrahim, W. S.; Watanabe, K.; Ibrahim, M. E.; Yonezu, K.			Controls on quartzite bearing base-metal sulfide and invisible gold mineralization at Gabal Abu Houdied area, South Eastern Desert, Egypt	ARABIAN JOURNAL OF GEOSCIENCES			English	Article						Gabal Abu Houdied; Hamisana; Pyrite; Invisible gold	ARABIAN-NUBIAN SHIELD; RED-SEA HILLS; AFRICAN OROGEN; STRUCTURAL CONTROLS; SHEAR ZONE; EVOLUTION; SUDAN; MINE; CLASSIFICATION; TECTONICS	The Neoproterozoic basement rocks cropping out in the Gabal Abu Houdied (GAH) area comprises mainly three lithotectonic assemblages; mafic-ultramafic ophiolitic rocks, island arc-related metasediment-metavolcanic rocks and syn-and post-tectonic intrusions. The base-metal sulfide and invisible gold mineralization are restricted to quartzites, which are considered as member of island arc-related metasediment rocks. The mineralized quartzite rocks are cropped out at three localities, at Wadi El Haussioum where cover a small area (0.25 km(2)), at Bir Abu Houdeid, cover small area (0.5 km(2)), and at Bir Shani (3.5 km long with different width ranging from 4 to 75 m). Based on textural characteristics and chemical features, documented by electron probe microanalysis (EPMA) and inductively coupled plasma mass spectrometry analyses (ICP-MS), two phases of sulfide minerals assemblages in the investigated quartzites of GAH area. An early mineralization phase includes pyrite, pyrrhotite, argentite (acanthite) and invisible gold, and the late phase, dominated by pyrite, galena, sphalerite, chalcopyrite, covelite, and +/- invisible gold. Analyses of the structural data collected from the quartzite rocks and surroundings indicated that the base-metal sulfide and associated gold mineralization in the GAH area are mostly controlled by D3 transperssional deformation event. This event is main Hamisana shear zone (HSZ) deformation event and characterized by transperssional stress regime, with sigma 1 trending E-W and sigma 3 trending N-S governed conjugate NNW sinistral and NNE-SSW dextral strike slip faulting.	[Ibrahim, W. S.; Watanabe, K.; Yonezu, K.] Kyushu Univ, Dept Earth Resources Engn, Fac Engn, Fukuoka 8190395, Japan; [Ibrahim, W. S.; Ibrahim, M. E.] Nucl Mat Author, Cairo, Egypt	Ibrahim, WS (reprint author), Nucl Mat Author, Cairo, Egypt.	W-Ibrahim@mine.kyushu-u.ac.jp			Japan MEXT Scholarship program; Egyptian Nuclear Materials Authority (NMA); Global Centre of Excellence (GCOE) program of Kyushu University, Japan	This study was supported by the Japan MEXT Scholarship program (PhD scholarship to the first author) and Egyptian Nuclear Materials Authority (NMA). This project was financially supported by the Global Centre of Excellence (GCOE) program of Kyushu University, Japan. We are grateful to all members of the Abu Rushied project of the NMA for their assistance in the fieldwork. Many thanks to Dr. Jillian Gabo, Kyushu University for the improvement of the English phrasing.	Almond O, 1987, GEOL J, V22, P175; Kusky TM, 2002, J AFR EARTH SCI, V35, P107, DOI 10.1016/S0899-5362(02)00029-5; Johnson PR, 2003, GEOL SOC SPEC PUBL, P289; STERN RJ, 1989, J GEOL SOC LONDON, V146, P1017, DOI 10.1144/gsjgs.146.6.1017; STERN RJ, 1990, GEOLOGY, V18, P1103, DOI 10.1130/0091-7613(1990)018<1103:OOLPSI>2.3.CO;2; KRONER A, 1992, PRECAMBRIAN RES, V59, P15, DOI 10.1016/0301-9268(92)90049-T; Abdelsalam MG, 2003, PRECAMBRIAN RES, V124, P87, DOI 10.1016/S0301-9268(03)00080-9; ROBINSON BW, 1975, ANAL CHEM, V47, P1179, DOI 10.1021/ac60357a026; Abdelsalam MG, 1996, J AFR EARTH SCI, V23, P289, DOI 10.1016/S0899-5362(97)00003-1; Kusky TM, 2003, PRECAMBRIAN RES, V123, P81, DOI 10.1016/S0301-9268(03)00062-7; Gu XX, 2002, J SEDIMENT RES, V72, P393, DOI 10.1306/081601720393; Goldfarb RJ, 2001, ORE GEOL REV, V18, P1, DOI 10.1016/S0169-1368(01)00016-6; Ghebreab W, 1998, EARTH-SCI REV, V45, P1, DOI 10.1016/S0012-8252(98)00036-1; Johnson PR, 2011, J AFR EARTH SCI, V61, P167, DOI 10.1016/j.jafrearsci.2011.07.003; Botros NS, 2004, ORE GEOL REV, V25, P1, DOI 10.1016/j/oregeorev.2003.07.022; Burke K., 1986, AM GEOPHYS UNION GEO, V14, P41; Chouinard A, 2005, CAN MINERAL, V43, P951, DOI 10.2113/gscanmin.43.3.951; Coelho CES, 1998, REV ESCOL MINAS OURO, V50, P42; de Wall H, 2001, PRECAMBRIAN RES, V107, P179, DOI 10.1016/S0301-9268(00)00141-8; Elsamani Y, 2001, INT GEOL REV, V43, P1117; Groves DI, 2003, ECON GEOL BULL SOC, V98, P1, DOI 10.2113/98.1.1; Helmy HM, 2004, MINER DEPOSITA, V39, P495, DOI 10.1007/s00126-004-0426-z; Kroner A., 1987, AM GEOPHYS UNION GEO, V17, P235; Loizenbauer J, 1996, P GEOL SURV EG CENT, P447; MILLER MM, 1992, J GEOL SOC LONDON, V149, P743, DOI 10.1144/gsjgs.149.5.0743; Ohmoto H., 1979, GEOCHEMISTRY HYDROTH, P509; STERN RJ, 1994, ANNU REV EARTH PL SC, V22, P319, DOI 10.1146/annurev.ea.22.050194.001535; Zoheir B, 2011, J GEOCHEM EXPLOR, V111, P23, DOI 10.1016/j.gexplo.2011.07.003; Zoheir BA, 2008, MINER DEPOSITA, V43, P79, DOI 10.1007/s00126-007-0156-0; Zoheir BA, 2008, ORE GEOL REV, V34, P445, DOI 10.1016/j.oregeorev.2008.05.003	30	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1866-7511	1866-7538		ARAB J GEOSCI	Arab. J. Geosci.	JUL	2015	8	7					4983	4997		10.1007/s12517-014-1563-z		15	Geosciences, Multidisciplinary	Geology	CL6TV	WOS:000357101200053		
J	Hirata, K; Nishihara, M; Shiraishi, J; Hirano, S; Matsunami, K; Sumi, K; Wada, N; Kawamoto, Y; Nishikawa, M; Nakayama, M; Kanazawa, T; Kitajima, H; Fujimura, M				Hirata, Katsuya; Nishihara, Masahiro; Shiraishi, Jun; Hirano, Shinya; Matsunami, Katsura; Sumi, Kiyoaki; Wada, Norihisa; Kawamoto, Yutaka; Nishikawa, Masanori; Nakayama, Masahiro; Kanazawa, Tadahiro; Kitajima, Hiroyuki; Fujimura, Masanori			Perinatal factors associated with long-term respiratory sequelae in extremely low birthweight infants	ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION			English	Article							WILSON-MIKITY-SYNDROME; CHRONIC LUNG-DISEASE; BRONCHOPULMONARY DYSPLASIA; EXTREMELY PRETERM; IMMATURE INFANTS; SCHOOL-AGE; PREMATURE-INFANTS; CHILDREN BORN; SURVIVORS; OUTCOMES	Objective To assess lung function at 8 years old in extremely low birthweight (ELBW) survivors and to identify perinatal determinants associated with impaired lung function. Design Retrospective cohort study. Setting Level III neonatal intensive care unit. Patients ELBW survivors born in 1990-2004 with available spirometry at 8 years old were studied. Children were excluded if they had a Wechsler Intelligence Scale for Children Third Edition full IQ < 70. Main outcome measures Multivariate logistic regression analysis was used to identify perinatal determinants associated with airway obstruction (forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ratio <80%) at school age and the predictive power of potential determinants. Potential risk factors and predictors assessed in this study were gestational age, birth weight, small for gestational age, sex, chorioamnionitis, premature rupture of membranes, antenatal steroids, surfactant administration, respiratory distress syndrome, postnatal steroids, severe bronchopulmonary dysplasia and bubbly/cystic appearances of the lungs by X-ray during the neonatal period. Results Of 656 ELBW survivors, 301 (45.9%) had attended a school-age follow-up at 8 years old. A total of 201 eligible children completed the lung function test. Bubbly/cystic appearance of the lungs (OR 4.84, 95% CI 1.26 to 18.70) was associated with a low FEV1/FVC ratio. Children with bubbly/cystic appearance had characteristics of immaturity and intrauterine inflammation. Conclusions Within a cohort of ELBW infants, a bubbly/cystic appearance of the lungs in the neonatal period was the strongest determinant of a low FEV1/FVC ratio at school age.	[Hirata, Katsuya; Nishihara, Masahiro; Shiraishi, Jun; Hirano, Shinya; Matsunami, Katsura; Sumi, Kiyoaki; Wada, Norihisa; Kawamoto, Yutaka; Kitajima, Hiroyuki; Fujimura, Masanori] Osaka Med Ctr, Dept Neonatal Med, Izumi, Osaka 5941101, Japan; [Hirata, Katsuya; Nishihara, Masahiro; Shiraishi, Jun; Hirano, Shinya; Matsunami, Katsura; Sumi, Kiyoaki; Wada, Norihisa; Kawamoto, Yutaka; Nishikawa, Masanori; Nakayama, Masahiro; Kitajima, Hiroyuki; Fujimura, Masanori] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan; [Nishikawa, Masanori] Osaka Med Ctr, Dept Radiol, Izumi, Osaka 5941101, Japan; [Nakayama, Masahiro] Osaka Med Ctr, Clin Lab Med & Anat Pathol, Izumi, Osaka 5941101, Japan; [Kanazawa, Tadahiro] Osaka Univ, Grad Sch Human Sci, Dept Comparat & Dev Psychol, Suita, Osaka, Japan	Hirata, K (reprint author), Osaka Med Ctr, Dept Neonatal Med, 840 Murodo Cho, Izumi, Osaka 5941101, Japan.	khirata0513@gmail.com					Gibson AM, 2014, SEMIN FETAL NEONAT M, V19, P105, DOI 10.1016/j.siny.2013.10.006; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Ehrenkranz RA, 2005, PEDIATRICS, V116, P1353, DOI 10.1542/peds.2005-0249; Kusuda S, 2012, PEDIATR RES, V72, P531, DOI 10.1038/pr.2012.114; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Moya MP, 2001, PEDIATR RADIOL, V31, P339, DOI 10.1007/s002470000420; Fitzgerald DA, 1996, J PAEDIATR CHILD H, V32, P491, DOI 10.1111/j.1440-1754.1996.tb00960.x; Palta M, 1998, J PEDIATR-US, V132, P57, DOI 10.1016/S0022-3476(98)70485-8; Breysem L, 1997, PEDIATR RADIOL, V27, P642, DOI 10.1007/s002470050203; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Takase M, 2013, PEDIATR PULM, V48, P35, DOI 10.1002/ppul.22536; Wong PM, 2008, EUR RESPIR J, V32, P321, DOI 10.1183/09031936.00127107; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; Doyle LW, 2006, PEDIATR PULM, V41, P570, DOI 10.1002/ppul.20412; Hennessy EM, 2008, ARCH DIS CHILD, V93, P1037, DOI 10.1136/adc.2008.140830; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Filippone M, 2003, LANCET, V361, P753, DOI 10.1016/S0140-6736(03)12633-5; Bancalari E, 2014, ARCH DIS CHILD-FETAL, V99, pF254, DOI 10.1136/archdischild-2013-305768; Binet ME, 2012, AM J PERINAT, V29, P159, DOI 10.1055/s-0031-1284225; Britt RD, 2013, EXPERT REV RESP MED, V7, P515, DOI 10.1586/17476348.2013.838020; Draper ES, 2009, ARCH DIS CHILD-FETAL, V94, pF158, DOI 10.1136/adc.2008.141531; FUJIMURA M, 1989, ARCH DIS CHILD, V64, P1379; FUJIMURA M, 1993, PEDIATRICS, V92, P564; Hacking DF, 2012, PEDIAT PULMONOL, V48, P449; Hjalmarson O, 2014, ARCH DIS CHILD-FETAL, V99, pF257, DOI 10.1136/archdischild-2013-304625; Hodgman JE, 2003, PEDIATRICS, V112, P1414, DOI 10.1542/peds.112.6.1414; HODGMAN JE, 1969, PEDIATRICS, V44, P179; Hoepker A, 2008, PEDIATR PULM, V43, P1004, DOI 10.1002/ppul.20900; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jobe A H, 2012, Early Hum Dev, V88 Suppl 2, pS27, DOI 10.1016/S0378-3782(12)70009-9; Kilbride HW, 2003, J PEDIATR-US, V143, P488, DOI 10.1067/S0022-3476(03)00413-X; Ogawa Yunosuke, 1992, Acta Paediatrica Japonica, V34, P663; Philip AGS, 2009, SEMIN FETAL NEONAT M, V14, P333, DOI 10.1016/j.siny.2009.07.013; Schmalisch G, 2013, PEDIATR PULM, V48, P1214, DOI 10.1002/ppul.22770; SWYER PR, 1965, PEDIATRICS, V36, P374; Theilen U., 2004, Archives of Disease in Childhood, V89, pF163, DOI 10.1136/adc.2003.026013; vom Hove M, 2014, J PEDIATR-US, V164, P40, DOI 10.1016/j.jpeds.2013.07.045; Weinstein M R, 1994, Pediatr Pulmonol, V18, P284, DOI 10.1002/ppul.1950180504; WILSON MG, 1960, AMA J DIS CHILD, V99, P489	39	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1359-2998	1468-2052		ARCH DIS CHILD-FETAL	Arch. Dis. Child.-Fetal Neonatal Ed.	JUL	2015	100	4					F314	F319		10.1136/archdischild-2014-306931		6	Pediatrics	Pediatrics	CM2RD	WOS:000357528600009		
J	Khosroshahi, A; Wallace, ZS; Crowe, JL; Akamizu, T; Azumi, A; Carruthers, MN; Chari, ST; Della-Torre, E; Frulloni, L; Goto, H; Hart, PA; Kamisawa, T; Kawa, S; Kawano, M; Kim, MH; Kodama, Y; Kubota, K; Lerch, MM; Lohr, M; Masaki, Y; Matsui, S; Mimori, T; Nakamura, S; Nakazawa, T; Ohara, H; Okazaki, K; Ryu, JH; Saeki, T; Schleinitz, N; Shimatsu, A; Shimosegawa, T; Takahashi, H; Takahira, M; Tanaka, A; Topazian, M; Umehara, H; Webster, GJ; Witzig, TE; Yamamoto, M; Zhang, W; Chiba, T; Stone, JH				Khosroshahi, A.; Wallace, Z. S.; Crowe, J. L.; Akamizu, T.; Azumi, A.; Carruthers, M. N.; Chari, S. T.; Della-Torre, E.; Frulloni, L.; Goto, H.; Hart, P. A.; Kamisawa, T.; Kawa, S.; Kawano, M.; Kim, M. H.; Kodama, Y.; Kubota, K.; Lerch, M. M.; Lohr, M.; Masaki, Y.; Matsui, S.; Mimori, T.; Nakamura, S.; Nakazawa, T.; Ohara, H.; Okazaki, K.; Ryu, J. H.; Saeki, T.; Schleinitz, N.; Shimatsu, A.; Shimosegawa, T.; Takahashi, H.; Takahira, M.; Tanaka, A.; Topazian, M.; Umehara, H.; Webster, G. J.; Witzig, T. E.; Yamamoto, M.; Zhang, W.; Chiba, T.; Stone, J. H.			International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease	ARTHRITIS & RHEUMATOLOGY			English	Article							IMMUNOGLOBULIN G4-ASSOCIATED CHOLANGITIS; IGG4-POSITIVE PLASMA-CELLS; CHURG-STRAUSS-SYNDROME; SERUM IGG4 LEVELS; AUTOIMMUNE PANCREATITIS; SYSTEMIC-DISEASE; CORTICOSTEROID-TREATMENT; DIAGNOSTIC-CRITERIA; CLINICOPATHOLOGICAL-ENTITY; RETROSPECTIVE MULTICENTER		[Khosroshahi, A.] Emory Univ, Sch Med, Atlanta, GA USA; [Wallace, Z. S.; Stone, J. H.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Crowe, J. L.] Univ Tennessee, Coll Med, Chattanooga, TN USA; [Akamizu, T.] Wakayama Med Univ, Tokyo, Japan; [Azumi, A.] Kobe Kaisei Hosp, Kobe, Hyogo, Japan; [Carruthers, M. N.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Chari, S. T.; Ryu, J. H.; Topazian, M.; Witzig, T. E.] Mayo Clin, Rochester, MN USA; [Della-Torre, E.] Ist Sci San Raffaele, I-20132 Milan, Italy; [Frulloni, L.] Univ Verona, I-37100 Verona, Italy; [Goto, H.] Tokyo Med Univ, Tokyo 1608402, Japan; [Hart, P. A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Hart, P. A.] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Kamisawa, T.] Tokyo Metropolitan Komagome Hosp, Tokyo, Japan; [Kawa, S.] Shinshu Univ, Matsumoto, Nagano 390, Japan; [Kawano, M.; Takahira, M.] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Kawano, M.; Takahira, M.] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan; [Kim, M. H.] Univ Ulsan, Coll Med, Ulsan 680749, South Korea; [Kim, M. H.] Asan Med Ctr, Ulsan, South Korea; [Kodama, Y.; Mimori, T.; Chiba, T.] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Kubota, K.] Yokohama City Univ, Yokohama, Kanagawa 232, Japan; [Kubota, K.] Yokohama City Univ Med, Yokohama, Kanagawa, Japan; [Lerch, M. M.] Ernst Moritz Arndt Univ Greifswald, Sch Med, Greifswald, Germany; [Lohr, M.] Karolinska Inst, Stockholm, Sweden; [Masaki, Y.; Umehara, H.] Kanazawa Med Univ, Kanazawa, Ishikawa, Japan; [Matsui, S.] Toyama Univ, Toyama 930, Japan; [Nakamura, S.] Kyushu Univ, Fukuoka 812, Japan; [Nakamura, S.] Kyushu Univ, Dent Hosp, Fukuoka 812, Japan; [Nakazawa, T.; Ohara, H.] Nagoya City Univ, Grad Sch Med, Nagoya, Aichi, Japan; [Okazaki, K.] Kansai Med Univ, Hirakata, Osaka, Japan; [Saeki, T.] Nagaoka Red Cross Hosp, Nagaoka, Niigata, Japan; [Schleinitz, N.] Aix Marseille Univ, Assistance Publ Hop Marseille, Marseille, France; [Shimatsu, A.] Natl Hosp Org Kyoto Med Ctr, Kyoto, Japan; [Shimosegawa, T.] Tohoku Univ, Tokyo, Japan; [Takahashi, H.; Yamamoto, M.] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan; [Tanaka, A.] Teikyo Univ, Sch Med, Tokyo 173, Japan; [Webster, G. J.] UCL, London, England; [Webster, G. J.] Univ Coll London Hosp, London, England; [Zhang, W.] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhang, W.] Beijing Union Med Coll Hosp, Beijing, Peoples R China	Chiba, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.	chiba@kuhp.kyoto-u.ac.jp; jhstone@mgh.harvard.edu		Frulloni, Luca/0000-0001-7417-2655	Chiesi Pharmaceuticals; Genentech; Japanese Ministry of Health, Labor, and Welfare; Amgen	The Second International Symposium on IgG4-Related Disease was funded by the Japanese Ministry of Health, Labor, and Welfare, Amgen, and Genentech.Dr. Frulloni has received consulting fees, speaking fees, and/or honoraria from Chiesi Pharmaceuticals (less than $10,000). Dr. Stone has received consulting fees, speaking fees, and/or honoraria from Genentech (less than $10,000).	Kamisawa T, 2009, GUT, V58, P1504, DOI 10.1136/gut.2008.172908; Kim HM, 2010, PANCREAS, V39, P555, DOI 10.1097/MPA.0b013e3181c8b4a5; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Carruthers MN, 2012, CURR OPIN RHEUMATOL, V24, P60, DOI 10.1097/BOR.0b013e32834ddb4a; Plaza JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P421, DOI 10.1001/archophthalmol.2011.16; Bosco JJ, 2013, INTERN MED J, V43, P417, DOI 10.1111/j.1445-5994.2012.02964.x; Tabata T, 2011, INTERNAL MED, V50, P69, DOI 10.2169/internalmedicine.50.4321; Sato Y, 2010, J CLIN PATHOL, V63, P1084, DOI 10.1136/jcp.2010.082958; Vaglio A, 2012, ANN RHEUM DIS, V71, P390, DOI 10.1136/ard.2011.155382; Chang SY, 2013, HUM PATHOL, V44, P2432, DOI 10.1016/j.humpath.2013.05.023; Raina A, 2009, AM J GASTROENTEROL, V104, P2295, DOI 10.1038/ajg.2009.325; Mattoo H, 2014, J ALLERGY CLIN IMMUN, V134, P679, DOI 10.1016/j.jaci.2014.03.034; Kamisawa T, 2013, GUT, V62, P1373, DOI 10.1136/gutjnl-2012-304224; Kawa S, 2014, J GASTROENTEROL, V49, P765, DOI 10.1007/s00535-014-0944-0; Khosroshahi A, 2012, MEDICINE, V91, P57, DOI 10.1097/MD.0b013e3182431ef6; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Okazaki K, 2014, J GASTROENTEROL, V49, P567, DOI 10.1007/s00535-014-0942-2; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Uchida K, 2009, J GASTROENTEROL, V44, P726, DOI 10.1007/s00535-009-0049-3; Brenner I, 2013, MODERN PATHOL, V26, P1568, DOI 10.1038/modpathol.2013.106; Ebbo M, 2014, ARTHRIT CARE RES, V66, P86, DOI 10.1002/acr.22058; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Topazian M, 2008, CLIN GASTROENTEROL H, V6, P364, DOI 10.1016/j.cgh.2007.12.020; Saeki T, 2013, KIDNEY INT, V84, P826, DOI 10.1038/ki.2013.191; Yamamoto M, 2010, INTERNAL MED, V49, P1365, DOI 10.2169/internalmedicine.49.3532; Chen H, 2014, SCAND J RHEUMATOL, V43, P70, DOI 10.3109/03009742.2013.822094; Sandanayake NS, 2009, CLIN GASTROENTEROL H, V7, P1089, DOI 10.1016/j.cgh.2009.03.021; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Ghazale A, 2007, GUT, V56, P1650, DOI 10.1136/gut.2007.129833; Chari ST, 2009, CLIN GASTROENTEROL H, V7, P1097, DOI 10.1016/j.cgh.2009.04.020; Ebbo M, 2012, MEDICINE, V91, P49, DOI 10.1097/MD.0b013e3182433d77; Okazaki K, 2010, J GASTROENTEROL, V45, P249, DOI 10.1007/s00535-009-0184-x; Cheuk W, 2010, ADV ANAT PATHOL, V17, P303, DOI 10.1097/PAP.0b013e3181ee63ce; Shimizu Y, 2013, RHEUMATOLOGY, V52, P679, DOI 10.1093/rheumatology/kes358; Takuma K, 2011, EUR J GASTROEN HEPAT, V23, P146, DOI 10.1097/MEG.0b013e3283431e23; Strehl JD, 2011, J CLIN PATHOL, V64, P237, DOI 10.1136/jcp.2010.085613; Kamisawa T, 2014, J GASTROENTEROL, V49, P961, DOI 10.1007/s00535-014-0945-z; Kamisawa T, 2005, PANCREAS, V31, P28, DOI 10.1097/01.mpa.0000167000.11889.3a; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Takahashi H, 2014, JOINT BONE SPINE, V81, P331, DOI 10.1016/j.jbspin.2014.01.010; Saeki T, 2010, KIDNEY INT, V78, P1016, DOI 10.1038/ki.2010.271; Khosroshahi A, 2010, ARTHRITIS RHEUM-US, V62, P1755, DOI 10.1002/art.27435; Ghazale A, 2008, GASTROENTEROLOGY, V134, P706, DOI 10.1053/j.gastro.2007.12.009; Hart PA, 2013, GUT, V62, P1607, DOI 10.1136/gutjnl-2012-302886; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Kanno A, 2012, PANCREAS, V41, P835, DOI 10.1097/MPA.0b013e3182480c99; Tomiyama T, 2011, J GASTROENTEROL, V46, P696, DOI 10.1007/s00535-010-0361-y; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Hirano K, 2007, GUT, V56, P1719, DOI 10.1136/gut.2006.115246; Buechter M, 2014, Z GASTROENTEROL, V52, P564, DOI 10.1055/s-0034-1366331; Caputo C, 2014, PITUITARY, V17, P251, DOI 10.1007/s11102-013-0498-9; Carruthers MN, 2015, ANN RHEUM DIS; Carruthers MN, 2012, INT J RHEUMATOL, V2012, DOI DOI 10.1155/2012/259408; Carruthers MN, 2015, ANN RHEUM DIS, V74, P14, DOI 10.1136/annrheumdis-2013-204907; Ebbo M, 2012, INT J RHEUMATOL, V2012, DOI DOI 10.1155/2012/602809.EPUB; Ghazale Amaar H, 2008, Curr Gastroenterol Rep, V10, P115, DOI 10.1007/s11894-008-0031-x; Kamisawa T, 2008, SCAND J GASTROENTERO, V43, P609, DOI 10.1080/00365520701731263; Kawa S, 2003, J GASTROENTEROL, V38, P1201, DOI 10.1007/s00535-003-1213-9; Kawakami H, 2010, J GASTROEN HEPATOL, V25, P1648, DOI 10.1111/j.1440-1746.2010.06346.x; Liu B, 2013, WORLD J GASTROENTERO, V19, P569, DOI 10.3748/wjg.v19.i4.569; Miura Hideaki, 2009, JOP, V10, P432; Mizushima I, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4671; Moriyama M, 2014, INT J ORAL MAX SURG, V43, P1276, DOI 10.1016/j.ijom.2014.06.014; Ohshima Koh-Ichi, 2013, J Clin Exp Hematop, V53, P53; Patel H, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-168; Ryu JH, 2012, INT J RHEUMATOL, V2012, DOI DOI 10.1155/2012/232960; Seki N, 2012, AURIS NASUS LARYNX, V39, P212, DOI 10.1016/j.anl.2011.01.025; Song Y, 2008, WORLD J GASTROENTERO, V14, P601, DOI 10.3748/wjg.14.601; Stone JH, 2012, NEW ENGL J MED, V367, P2335, DOI 10.1056/NEJMcpc1209330; Takahira M, 2012, INT J RHEUMATOL, V2012, DOI DOI 10.1155/2012/635473; Takayama M, 2004, AM J GASTROENTEROL, V99, P932, DOI 10.1111/j.1572-0241.2004.04162.x; Tanaka A, 2014, J HEPATO-BIL-PAN SCI, V21, P43, DOI 10.1002/jhbp.50; Wallace ZS, 2015, ANN RHEUM DIS, V74, P190, DOI 10.1136/annrheumdis-2014-205233; Wallace ZS, 2013, MEDICINE, V92, P206, DOI 10.1097/MD.0b013e31829cce35; Witzig TE, 2007, MAYO CLIN PROC, V82, P692; Yoo JJ, 2011, JCR-J CLIN RHEUMATOL, V17, P392, DOI 10.1097/RHU.0b013e31823262d5	78	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	JUL	2015	67	7					1688	1699		10.1002/art.39132		12	Rheumatology	Rheumatology	CL5QA	WOS:000357013500002		
J	Terao, C; Yano, K; Ikari, K; Furu, M; Yamakawa, N; Yoshida, S; Hashimoto, M; Ito, H; Fujii, T; Ohmura, K; Yurugi, K; Miura, Y; Maekawa, T; Taniguchi, A; Momohara, S; Yamanaka, H; Mimori, T; Matsuda, F				Terao, Chikashi; Yano, Koichiro; Ikari, Katsunori; Furu, Moritoshi; Yamakawa, Noriyuki; Yoshida, Shinji; Hashimoto, Motomu; Ito, Hiromu; Fujii, Takao; Ohmura, Koichiro; Yurugi, Kimiko; Miura, Yasuo; Maekawa, Taira; Taniguchi, Atsuo; Momohara, Shigeki; Yamanaka, Hisashi; Mimori, Tsuneyo; Matsuda, Fumihiko			Brief Report: Main Contribution of DRB1*04:05 Among the Shared Epitope Alleles and Involvement of DRB1 Amino Acid Position 57 in Association With Joint Destruction in Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis	ARTHRITIS & RHEUMATOLOGY			English	Article							HLA-DRB1 ALLELES; SUSCEPTIBILITY; CLASSIFICATION; HYPOTHESIS	ObjectiveThe shared epitope is associated with increased joint destruction in rheumatoid arthritis (RA) as well as susceptibility to RA and the production of anti-citrullinated protein antibody (ACPA). However, previous studies addressing whether the association of the shared epitope with joint destruction is independent of ACPA have shown different results in different populations. Different allele distributions in the shared epitope may explain this ethnic heterogeneity. This study was undertaken to assess the associations of the shared epitope and HLA-DRB1*04:05, the most common shared epitope allele in the Japanese population, with joint destruction in patients with ACPA-positive RA. MethodsA total of 861 patients with ACPA-positive RA who had not received any biologic agents were recruited from the institute of Rheumatology, Rheumatoid Arthritis cohort (sets 1 and 2) and the Kyoto University Rheumatoid Arthritis Management Alliance cohort (set 3). Joint destruction was assessed using the modified Sharp/van der Heijde score (SHS). The associations of the shared epitope alleles, HLA-DRB1*04:05, and other shared epitope allele groups with the SHS were analyzed in a linear regression analysis. Amino acid variations associated with the SHS were also analyzed. ResultsThe shared epitope was significantly associated with an increased SHS (P=0.0017). Although HLA-DRB1*04:05 was significantly associated with an increased SHS (P=2.7 x 10(-5)), the group of other shared epitope alleles, including HLA-DRB1*01:01, did not show an association with the SHS in spite of sufficient power (P=0.67). HLA-DRB1*04:05 was associated with joint destruction in a dose-dependent manner. Analyses of amino acid associations of HLA-DRB1 revealed that serine at position 57, recently shown to have a susceptibility effect for ACPA-positive RA in Asian populations, showed a significant association (P=5.0 x 10(-6)). ConclusionHLA-DRB1*04:05, characterized by serine at position 57, accounts for the detrimental association between the shared epitope and SHS in Japanese patients with ACPA-positive RA.	[Terao, Chikashi; Furu, Moritoshi; Yamakawa, Noriyuki; Hashimoto, Motomu; Ito, Hiromu; Fujii, Takao; Ohmura, Koichiro; Mimori, Tsuneyo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Kyoto 6068507, Japan; [Yano, Koichiro; Ikari, Katsunori; Yoshida, Shinji; Taniguchi, Atsuo; Momohara, Shigeki; Yamanaka, Hisashi] Tokyo Womens Med Univ, Tokyo, Japan; [Yurugi, Kimiko; Miura, Yasuo; Maekawa, Taira] Kyoto Univ Hosp, Kyoto 606, Japan	Terao, C (reprint author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Sakyo Ku, Shogoin Kawahara Cho 54, Kyoto 6068507, Japan.	a0001101@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Ohmura K, 2010, RHEUMATOLOGY, V49, P2298, DOI 10.1093/rheumatology/keq273; van der Heijde D, 1999, J RHEUMATOL, V26, P743; du Montcel ST, 2005, ARTHRITIS RHEUM, V52, P1063, DOI 10.1002/art.20989; Scherer HU, 2011, ANN RHEUM DIS, V70, P1461, DOI 10.1136/ard.2010.146506; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Terao C, 2011, ANN RHEUM DIS, V70, P2134, DOI 10.1136/annrheumdis-2011-200353; Knevel R, 2012, ANN RHEUM DIS, V71, P707, DOI 10.1136/annrheumdis-2011-200627; Terao C, 2012, ANN RHEUM DIS, V71, P1095, DOI 10.1136/annrheumdis-2011-200907; Balandraud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064108; GAO XJ, 1991, J RHEUMATOL, V18, P801; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061045; Terao C, 2013, RHEUMATOLOGY, V52, P1769, DOI 10.1093/rheumatology/ket241; Terao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059341; Terao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020457; Vander Cruyssen B, 2007, ANN RHEUM DIS, V66, P364; Yamanaka H, 2006, MOD RHEUMATOL, V16, P75	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	JUL	2015	67	7					1744	1750		10.1002/art.39105		7	Rheumatology	Rheumatology	CL5QA	WOS:000357013500009		
J	Struglics, A; Larsson, S; Kumahashi, N; Frobell, R; Lohmander, LS				Struglics, Andre; Larsson, Staffan; Kumahashi, Nobuyuki; Frobell, Richard; Lohmander, L. Stefan			Changes in Cytokines and Aggrecan ARGS Neoepitope in Synovial Fluid and Serum and in C-Terminal Crosslinking Telopeptide of Type II Collagen and N-Terminal Crosslinking Telopeptide of Type I Collagen in Urine Over Five Years After Anterior Cruciate Ligament Rupture: An Exploratory Analysis in the Knee Anterior Cruciate Ligament, Nonsurgical Versus Surgical Treatment Trial	ARTHRITIS & RHEUMATOLOGY			English	Article							PROTEOGLYCAN FRAGMENTS; TISSUE INHIBITOR; CTX-II; INFLAMMATORY CYTOKINES; BIOCHEMICAL MARKERS; JOINT INFLAMMATION; RANDOMIZED-TRIAL; DEFICIENT KNEE; OSTEOARTHRITIS; INJURY	ObjectiveTo prospectively monitor levels of proinflammatory cytokines and aggrecan ARGS neoepitope in synovial fluid and serum as well as levels of C-terminal crosslinking telopeptide of type II collagen (CTX-II) and N-terminal crosslinking telopeptide of type I collagen (NTX-I) in urine after acute anterior cruciate ligament (ACL) rupture. MethodsSynovial fluid, serum, and urine were collected from 121 adults on 6 occasions over 5 years after acute ACL injury. Reference samples were obtained from subjects without knee injury. Concentrations of interleukin-6 (IL-6), IL-8, IL-10, interferon- (IFN), tumor necrosis factor (TNF), aggrecan ARGS neoepitope, CTX-II, and NTX-I were measured by enzyme-linked immunosorbent assay. ResultsShortly after ACL injury, cytokine concentrations in synovial fluid were elevated 6-fold (TNF) to 1,050-fold (IL-6) compared to reference levels, while concentrations of aggrecan ARGS neoepitope in synovial fluid and serum and CTX-II in urine were elevated 1.4-fold to 8-fold. Thereafter, concentrations of cytokines and aggrecan ARGS neoepitope in synovial fluid decreased with different half-lives (in years: IL-6 0.9, IL-8 2.2, IL-10 2.3, IFN 3.1, TNF 3.6, aggrecan ARGS neoepitope 4.0). After 5 years, the TNF concentration in synovial fluid remained higher than the reference level. There was a correlation between the concentrations of aggrecan ARGS neoepitope in synovial fluid and serum (r(s)=0.36). Concentrations of aggrecan ARGS neoepitope in synovial fluid and of CTX-II and NTX-I in urine were correlated with concentrations of cytokines in synovial fluid (r(s)=0.41-0.49 and r(s)=0.21-0.31, respectively). ConclusionAcute ACL injury induced highly increased levels of inflammatory cytokines in the joint, and these were associated with proteolysis of aggrecan and type II collagen. Cytokine levels remained increased up to 5 years after injury, indicative of extended local inflammation in the joint.	[Struglics, Andre; Larsson, Staffan; Kumahashi, Nobuyuki; Frobell, Richard; Lohmander, L. Stefan] Lund Univ, SE-22184 Lund, Sweden; [Kumahashi, Nobuyuki] Shimane Univ, Sch Med, Izumo, Shimane, Japan; [Lohmander, L. Stefan] Univ Southern Denmark, Odense, Denmark	Struglics, A (reprint author), Lund Univ, Orthopaed, Dept Clin Sci Lund, BMC C12, SE-22184 Lund, Sweden.	andre.struglics@med.lu.se			Swedish Research Council; Swedish Rheumatism Association; Kock Foundation; King Gustaf V's 80-Year Anniversary Foundation; Medical Faculty of Lund University; Region Skane; Osterlunds Foundation; Crafoord Foundation; Thelma Zoegas Fund; Stig and Ragna Gorthon Research Foundation; Swedish National Centre for Research in Sports; Tore Nilsson Research Fund	Supported by grants from the Swedish Research Council (to Drs. Frobell and Lohmander), the Swedish Rheumatism Association (to Drs. Struglics and Lohmander), the Kock Foundation (to Drs. Struglics and Lohmander), King Gustaf V's 80-Year Anniversary Foundation (to Drs. Struglics and Lohmander), the Medical Faculty of Lund University (to Drs. Struglics, Frobell, and Lohmander), Region Skane (to Drs. Frobell and Lohmander), the Osterlunds Foundation (to Dr. Struglics), the Crafoord Foundation (to Drs. Struglics and Frobell), the Thelma Zoegas Fund (to Dr. Frobell), the Stig and Ragna Gorthon Research Foundation (to Dr. Frobell), the Swedish National Centre for Research in Sports (to Dr. Frobell), and the Tore Nilsson Research Fund (to Dr. Frobell).	Chmielewski TL, 2012, OSTEOARTHR CARTILAGE, V20, P1294, DOI 10.1016/j.joca.2012.07.014; Kraus VB, 2012, OSTEOARTHR CARTILAGE, V20, P271, DOI 10.1016/j.joca.2011.12.009; Irie K, 2003, KNEE, V10, P93, DOI 10.1016/S0968-0160(02)00083-2; Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Sward P, 2012, OSTEOARTHR CARTILAGE, V20, P1302, DOI 10.1016/j.joca.2012.07.021; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; Struglics A, 2011, OSTEOARTHR CARTILAGE, V19, P1047, DOI 10.1016/j.joca.2011.05.006; Lohmander LS, 2003, ARTHRITIS RHEUM, V48, P3130, DOI 10.1002/art.11326; Cameron M, 1997, AM J SPORT MED, V25, P751, DOI 10.1177/036354659702500605; Larsson S, 2014, OSTEOARTHR CARTILAGE, V22, P242, DOI 10.1016/j.joca.2013.12.010; Stevens AL, 2009, MOL CELL PROTEOMICS, V8, P1475, DOI 10.1074/mcp.M800181-MCP200; Bateman JF, 2013, ARTHRITIS RHEUM-US, V65, P1547, DOI 10.1002/art.37900; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P181; Lee JH, 2009, ARCH BIOCHEM BIOPHYS, V489, P118, DOI 10.1016/j.abb.2009.07.006; van Spil WE, 2013, ANN RHEUM DIS, V72, P29, DOI 10.1136/annrheumdis-2011-201177; Beekhuizen M, 2013, OSTEOARTHR CARTILAGE, V21, P918, DOI 10.1016/j.joca.2013.04.002; Hunter DJ, 2014, OSTEOARTHR CARTILAGE, V22, P959, DOI 10.1016/j.joca.2014.05.014; Garnero P, 2001, ANN RHEUM DIS, V60, P619, DOI 10.1136/ard.60.6.619; Simkin PA, 2013, OSTEOARTHR CARTILAGE, V21, P7, DOI 10.1016/j.joca.2012.09.015; Marks PH, 2005, ARTHROSCOPY, V21, P1342, DOI 10.1016/j.arthro.2005.08.034; Schulze-Tanzil G, 2009, CURR GENE THER, V9, P306; Frobell RB, 2010, NEW ENGL J MED, V363, P331, DOI 10.1056/NEJMoa0907797; LOHMANDER LS, 1993, J RHEUMATOL, V20, P1362; DINGLE JT, 1987, ANN RHEUM DIS, V46, P527, DOI 10.1136/ard.46.7.527; Lohmander LS, 1999, ARTHRITIS RHEUM, V42, P534, DOI 10.1002/1529-0131(199904)42:3<534::AID-ANR19>3.0.CO;2-J; Elsaid KA, 2008, ARTHRITIS RHEUM, V58, P1707, DOI 10.1002/art.23495; Larsson S, 2012, OSTEOARTHR CARTILAGE, V20, P388, DOI 10.1016/j.joca.2012.02.001; Elsaid KA, 2009, ARTHRITIS RHEUM-US, V60, P2997, DOI 10.1002/art.24800; Bigoni M, 2013, J ORTHOP RES, V31, P315, DOI 10.1002/jor.22208; Kraus VB, 2011, OSTEOARTHR CARTILAGE, V19, P515, DOI 10.1016/j.joca.2010.08.019; Higuchi H, 2006, INT ORTHOP, V30, P43, DOI 10.1007/s00264-005-0023-5; Sward P, 2014, AM J SPORT MED, V42, P1096, DOI 10.1177/0363546514524924; Reijman M, 2004, ARTHRITIS RHEUM, V50, P2471, DOI 10.1002/art.20332; Chubinskaya S, 2013, CARTILAGE, V4, p13S, DOI 10.1177/1947603513487457; DAHLBERG L, 1994, BRIT J RHEUMATOL, V33, P1107; Eckstein F, 2015, ARTHRITIS RHEUMATOL, V67, P152, DOI 10.1002/art.38881; Frobell RB, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f232; Goldring MB, 2000, ARTHRITIS RHEUM-US, V43, P1916, DOI 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I; Ishijima M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3246; Jordan KM, 2006, ANN RHEUM DIS, V65, P871, DOI 10.1136/ard.2005.042895; Larsson S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2735; Le Graverand MPH, 2000, MATRIX BIOL, V19, P431; Loeser RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054633; LOHMANDER LS, 1989, ARTHRITIS RHEUM, V32, P1434, DOI 10.1002/anr.1780321113; Mouritzen U, 2003, ANN RHEUM DIS, V62, P332, DOI 10.1136/ard.62.4.332; Pratta MA, 2006, OSTEOARTHR CARTILAGE, V14, P702, DOI 10.1016/j.joca.2006.01.012; Sohn DH, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3555; SONE T, 1995, BONE, V17, P335, DOI 10.1016/S8756-3282(95)00243-X; Wassilew GI, 2010, ARTHROSCOPY, V26, P1096, DOI 10.1016/j.arthro.2009.12.018	50	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	JUL	2015	67	7					1816	1825		10.1002/art.39146		10	Rheumatology	Rheumatology	CL5QA	WOS:000357013500017		
J	Saito, K; Hatayama, K; Terauchi, M; Hagiwara, K; Higuchi, H; Takagishi, K				Saito, Kenichi; Hatayama, Kazuhisa; Terauchi, Masanori; Hagiwara, Keiichi; Higuchi, Hiroshi; Takagishi, Kenji			Clinical Outcomes After Anatomic Double-Bundle Anterior Cruciate Ligament Reconstruction: Comparison of Extreme Knee Hyperextension and Normal to Mild Knee Hyperextension	ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY			English	Article							FEMORAL TUNNEL PLACEMENT; TIBIAL TUNNEL; INTERCONDYLAR ROOF; JOINT LAXITY; STABILITY; IMPINGEMENT; OBLIQUITY; GRAFTS; EXTENSION; POSITION	Purpose: The aim of this study was to compare postoperative outcomes after anatomic double-bundle anterior cruciate ligament reconstruction (ACLR) in extreme knee hyperextension versus normal to mild knee hyperextension. Methods: For 100 patients who underwent anatomic double-bundle ACLR using semitendinosus tendon, we evaluated the side-to-side difference (SSD) in anterior tibial translation (measured on stress radiographs) and rotational stability (assessed by the pivot-shift test) 2 years after surgery. Loss of extension (LOE) was evaluated on lateral radiographs of both knees in full extension, and graft integrity was assessed during second-look arthroscopy 1 to 2 years after surgery. In accordance with the Beighton and Honan criteria, patients with an extension angle less than or equal to 10 degrees in the contralateral uninjured knee composed the group with 10 degrees or less hyperextension (N group), and those with an extension angle of greater than 10 degrees composed the group with more than 10 degrees hyperextension (H group). Postoperative results were compared between these groups. Results: Mean extension angles in the N and H groups were 5.8 degrees +/- 2.9 degrees and 14.7 degrees +/- 3.0 degrees, respectively. The mean SSD in anterior translation was 2.2 +/- 2.9 mm for the N group and 2.8 +/- 2.9 mm for the H group, with no significant difference. The positive ratios on the pivot-shift test were not significantly different between the groups. Mean LOE in the N and H groups was -0.7 degrees +/- 3.7 degrees and 1.3 degrees +/- 3.3 degrees, respectively, with a significant difference (P = .007). During second-look arthroscopy, 6 of 58 knees in the N group and 13 of 42 knees in the H group had superficial graft laceration of the anteromedial bundle graft, with a significant difference (P = .01) seen between groups. Conclusions: Anatomic double-bundle ACLR for extreme knee hyperextension may attain the same postoperative anterior and rotational stability as seen in knees with normal to mild hyperextension. However, it increased superficial graft laceration.	[Saito, Kenichi; Takagishi, Kenji] Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gunma, Japan; [Saito, Kenichi; Hatayama, Kazuhisa; Terauchi, Masanori; Hagiwara, Keiichi] Gunma Cent Hosp, Dept Orthopaed Surg, Japan Community Hlth Care Org, Maebashi, Gunma 3710025, Japan; [Higuchi, Hiroshi] Asakura Sports Rehabil Clin, Dept Orthopaed Sports Surg, Maebashi, Gunma, Japan	Hatayama, K (reprint author), Gunma Cent Hosp, Dept Orthopaed Surg, Japan Community Hlth Care Org, 1-7-13 Koun, Maebashi, Gunma 3710025, Japan.	kazuhisa@zg7.so-net.ne.jp					Almekinders LC, 2001, ARTHROSCOPY, V17, P960, DOI 10.1053/jars.2001.25248; Amis A A, 1998, Knee Surg Sports Traumatol Arthrosc, V6 Suppl 1, pS2, DOI 10.1007/s001670050215; Lee MC, 2007, ARTHROSCOPY, V23, P771, DOI 10.1016/j.arthro.2007.04.016; Ferretti M, 2007, ARTHROSCOPY, V23, P1218, DOI 10.1016/j.arthro.2007.09.008; HOWELL SM, 1995, AM J SPORT MED, V23, P288, DOI 10.1177/036354659502300306; Hatayama K, 2013, ARTHROSCOPY, V29, P1072, DOI 10.1016/j.arthro.2013.02.003; Jagodzinski M, 2000, KNEE SURG SPORT TR A, V8, P11, DOI 10.1007/s001670050004; Tsai AG, 2010, AM J SPORT MED, V38, P263, DOI 10.1177/0363546509348053; Toritsuka Y, 2004, ARTHROSCOPY, V20, P287, DOI 10.1016/j.arthro.2003.11.031; Shelbourne KD, 2012, AM J SPORT MED, V40, P108, DOI 10.1177/0363546511423639; Yasuda K, 2006, ARTHROSCOPY, V22, P240, DOI 10.1016/j.arthro.2005.12.017; Bach JM, 1997, J BIOMECH, V30, P281, DOI 10.1016/S0021-9290(96)00132-7; Loh JC, 2003, ARTHROSCOPY, V19, P297, DOI 10.1053/jars.2003.50084; Yagi M, 2007, CLIN ORTHOP RELAT R, P100, DOI 10.1097/BLO.0b013e31802ba45c; Kim SJ, 2010, CLIN ORTHOP RELAT R, V468, P1136, DOI 10.1007/s11999-009-0961-0; Mall NA, 2012, ARTHROSCOPY, V28, P1104, DOI 10.1016/j.arthro.2011.12.018; Austin JC, 2007, J BONE JOINT SURG AM, V89A, P1565, DOI 10.2106/JBJS.F.00370; Ayerza MA, 2003, ARTHROSCOPY, V19, P257, DOI 10.1053/jars.2003.50066; Bedi A, 2011, AM J SPORT MED, V39, P366, DOI 10.1177/0363546510388157; BEIGHTON P, 1969, Journal of Bone and Joint Surgery British Volume, V51-B, P444; Doi M, 2009, KNEE SURG SPORT TR A, V17, P347, DOI 10.1007/s00167-008-0668-x; Iriuchishima T, 2011, KNEE SURG SPORT TR A, V19, pS22, DOI 10.1007/s00167-011-1504-2; Iriuchishima T, 2010, AM J SPORT MED, V38, P1611, DOI 10.1177/0363546510363461; Jaureguito JW, 1996, CLIN ORTHOP RELAT R, P25; Kim SJ, 2008, J BONE JOINT SURG AM, V90A, P735, DOI 10.2106/JBJS.F.01173; Matsubara H, 2013, AM J SPORT MED, V41, P2819, DOI 10.1177/0363546513505073; Pearle AD, 2008, AM J SPORT MED, V36, P1534, DOI 10.1177/0363546508315536; Stäubli H U, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P138, DOI 10.1007/BF01467915; Yoshiya S, 2002, CLIN ORTHOP RELAT R, P154	29	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-8063	1526-3231		ARTHROSCOPY	Arthroscopy	JUL	2015	31	7					1310	1317		10.1016/j.arthro.2015.01.022		8	Orthopedics; Surgery	Orthopedics; Surgery	CM2PQ	WOS:000357524100014		
J	Yamasaki, T; Yasunaga, Y; Shoji, T; Izumi, S; Hachisuka, S; Ochi, M				Yamasaki, Takuma; Yasunaga, Yuji; Shoji, Takeshi; Izumi, Sotaro; Hachisuka, Susumu; Ochi, Mitsuo			Inclusion and Exclusion Criteria in the Diagnosis of Femoroacetabular Impingement	ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY			English	Review							HEAD-NECK OFFSET; HIP PAIN; FEMORAL-HEAD; RADIOGRAPHIC PREDICTORS; ACETABULAR RETROVERSION; ARTHROSCOPIC MANAGEMENT; HERNIATION PITS; CAM IMPINGEMENT; ALPHA ANGLE; PREVALENCE	Purpose: The purpose of this study was to clarify the criteria for femoroacetabular impingement (FAI) by way of a systematic review of FAI-related articles, as well as to define more appropriate inclusion or exclusion criteria in the diagnosis of FAI. Methods: A systematic review of FAI-related articles was performed using Web of Science. Thirty-two articles met the inclusion and exclusion criteria. In these articles we investigated radiographic findings for the diagnosis of FAI and the prevalence of each FAI-related finding. Results: The crossover sign was used in 22 articles (69%); acetabular index, 9 articles (28%); posterior wall sign, 7 articles (22%); and prominence of the ischial spine sign, 3 articles (7%). Regarding acetabular coverage, the lateral center-edge (LCE) angle was described in 13 articles (41%), in which an LCE angle either of more than 40 degrees or of more than 30 degrees combined with an acetabular index of less than 0 degrees was considered an inclusion criterion for pincer impingement. Meanwhile, the alpha angle was used in 28 articles (88%), in which 50 degrees or 55 degrees was recommended as a positive finding of cam impingement. Conclusions: Common findings of pincer or cam deformity were used to select FAI patients with sufficient coverage of the acetabulum with an LCE angle of more than 25 degrees. Patients with an LCE angle of less than 25 degrees or those with local acetabular deficiency regardless of having a normal LCE angle should be excluded from the FAI criteria, even if the FAI-related findings are positive.	[Yamasaki, Takuma; Shoji, Takeshi; Izumi, Sotaro; Hachisuka, Susumu; Ochi, Mitsuo] Hiroshima Univ, Dept Orthopaed Surg, Grad Sch Biomed Sci, Hiroshima 7348551, Japan; [Yasunaga, Yuji] Hiroshima Prefectural Rehabil Ctr, Hiroshima, Japan	Yamasaki, T (reprint author), Hiroshima Univ, Dept Orthopaed Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	tacyama@hiroshima-u.ac.jp					Tannast M, 2007, AM J ROENTGENOL, V188, P1540, DOI 10.2214/AJR.06.0921; Ganz R, 2008, CLIN ORTHOP RELAT R, V466, P264, DOI 10.1007/s11999-007-0060-z; Beaule PE, 2012, CLIN ORTHOP RELAT R, V470, P3361, DOI 10.1007/s11999-012-2601-3; Kalberer F, 2008, CLIN ORTHOP RELAT R, V466, P677, DOI 10.1007/s11999-007-0058-6; Hartofilakidis G, 2011, J BONE JOINT SURG BR, V93B, P580, DOI 10.1302/0301-620X.93B5.25236; Larson CM, 2008, ARTHROSCOPY, V24, P540, DOI 10.1016/j.arthro.2007.11.007; Monazzam S, 2013, BONE JOINT J, V95B, P598, DOI 10.1302/0301-620X.95B5.30118; Beck M, 2005, J BONE JOINT SURG BR, V87B, P1012, DOI 10.1302/0301-620X.87B7.15203; Gosvig KK, 2007, J BONE JOINT SURG BR, V89B, P1309, DOI 10.1302/0301-620X.89B10.19405; Philippon MJ, 2009, J BONE JOINT SURG BR, V91B, P16, DOI 10.1302/0301-620X.91B1.21329; Horisberger M, 2010, CLIN ORTHOP RELAT R, V468, P182, DOI 10.1007/s11999-009-1005-5; Paliobeis CP, 2011, HIP INT, V21, P141, DOI 10.5301/HIP.2011.7422; Steppacher SD, 2013, CLIN ORTHOP RELAT R, V471, P1937, DOI 10.1007/s11999-013-2863-4; Ito H, 2009, SKELETAL RADIOL, V38, P131, DOI 10.1007/s00256-008-0601-x; Notzli HP, 2002, J BONE JOINT SURG BR, V84B, P556, DOI 10.1302/0301-620X.84B4.12014; Larson CM, 2011, CLIN ORTHOP RELAT R, V469, P1667, DOI 10.1007/s11999-010-1741-6; Mori R, 2014, BONE JOINT J, V96B, P172, DOI 10.1302/0301-620X.96B2.32680; Nepple JJ, 2011, AM J SPORT MED, V39, P296, DOI 10.1177/0363546510384787; Allen D, 2009, J BONE JOINT SURG BR, V91B, P589, DOI 10.1302/0301-620X.91B5.22028; Lohan DG, 2009, SKELETAL RADIOL, V38, P855, DOI 10.1007/s00256-009-0745-3; Pollard TCB, 2010, J BONE JOINT SURG BR, V92B, P209, DOI 10.1302/0301-620X.92B2.22850; Kivlan BR, 2011, ARTHROSCOPY, V27, P619, DOI 10.1016/j.arthro.2010.12.009; [Anonymous], 2003, CLIN OTHROP RELAT RE, DOI 10.1097/00003086-200302000-00033; Tannast M, 2008, CLIN ORTHOP RELAT R, V466, P273, DOI 10.1007/s11999-007-0061-y; Panzer S, 2008, EUR RADIOL, V18, P1869, DOI 10.1007/s00330-008-0952-7; Laborie LB, 2011, RADIOLOGY, V260, P494, DOI 10.1148/radiol.11102354; Klingenstein GG, 2013, AM J SPORT MED, V41, P762, DOI 10.1177/0363546513476854; KLAUE K, 1991, J BONE JOINT SURG BR, V73, P423; Jung KA, 2011, J BONE JOINT SURG BR, V93B, P1303, DOI 10.1302/0301-620X.93B10.26433; Ito K, 2001, J BONE JOINT SURG BR, V83B, P171, DOI 10.1302/0301-620X.83B2.11092; Reynolds D, 1999, J BONE JOINT SURG BR, V81B, P281, DOI 10.1302/0301-620X.81B2.8291; Fujii M, 2010, J BONE JOINT SURG AM, V92A, P895, DOI 10.2106/JBJS.I.00046; Impellizzeri FM, 2012, OSTEOARTHR CARTILAGE, V20, P638, DOI 10.1016/j.joca.2012.03.019; Kim JA, 2011, SKELETAL RADIOL, V40, P167, DOI 10.1007/s00256-010-0962-9; Ezoe M, 2006, J BONE JOINT SURG AM, V88A, P372, DOI 10.2106/JBJS.D.02385; Brunner A, 2009, AM J SPORT MED, V37, P917, DOI 10.1177/0363546508330144; Byrd JWT, 2011, AM J SPORT MED, V39, p7S, DOI 10.1177/0363546511404144; Chen GX, 2011, HIP INT, V21, P146, DOI 10.5301/HIP.2011.7420; Diaz-Ledezma C, 2013, QUAL LIFE RES, V22, P2323, DOI 10.1007/s11136-013-0359-z; Domayer SE, 2011, EUR J RADIOL, V80, P805, DOI 10.1016/j.ejrad.2010.10.016; Ejnisman L, 2013, ORTHOPEDICS, V36, P293; Fraitzl CR, 2013, KNEE SURG SPORT TR A, V21, P1212, DOI 10.1007/s00167-012-2042-2; Ganz R, 2003, CLIN ORTHOP RELAT R, V417, P111; Kappe T, 2011, CLIN ORTHOP RELAT R, V469, P3241, DOI 10.1007/s11999-011-1978-8; Kapron Ashley L, 2011, J Bone Joint Surg Am, V93, DOI 10.2106/JBJS.K.00544; MURPHY SB, 1990, CLIN ORTHOP RELAT R, P214; Palmer DH, 2012, ARTHROSCOPY, V28, P1671, DOI 10.1016/j.arthro.2012.04.154; Philippon MJ, 2012, ARTHROSCOPY, V28, P1255, DOI 10.1016/j.arthro.2012.02.006; Siebenrock KA, 2011, CLIN ORTHOP RELAT R, V469, P1945; Takeyama A, 2009, INT ORTHOP, V33, P1229, DOI 10.1007/s00264-009-0742-0; Tibor LM, 2013, CLIN ORTHOP RELAT R, V471, P3762, DOI 10.1007/s11999-013-2918-6; Yasunaga Y, 2010, J ORTHOP SCI, V15, P463, DOI 10.1007/s00776-010-1489-6	52	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-8063	1526-3231		ARTHROSCOPY	Arthroscopy	JUL	2015	31	7					1403	1410		10.1016/j.arthro.2014.12.022		8	Orthopedics; Surgery	Orthopedics; Surgery	CM2PQ	WOS:000357524100028		
J	Ito, T; Iwata, K; Mckenzie, C; Urata, S				Ito, Takatoshi; Iwata, Kazumasa; Mckenzie, Colin; Urata, Shujiro			Social Security in Ageing Asia: Editors' Overview	ASIAN ECONOMIC POLICY REVIEW			English	Editorial Material									[Ito, Takatoshi] Columbia Univ, New York, NY 10027 USA; [Iwata, Kazumasa] Japan Ctr Econ Res, Fukushima, Japan; [Mckenzie, Colin] Keio Univ, Tokyo 108, Japan; [Urata, Shujiro] Waseda Univ, Tokyo, Japan	Ito, T (reprint author), Columbia Univ, New York, NY 10027 USA.						Cai F, 2015, ASIAN ECON POLICY R, V10, P250, DOI 10.1111/aepr.12103; Asher M, 2015, ASIAN ECON POLICY R, V10, P225, DOI 10.1111/aepr.12100; Chomik R, 2015, ASIAN ECON POLICY R, V10, P199, DOI 10.1111/aepr.12098; Gruber J., 2007, SOCIAL SECURITY PROG; Hill H, 2015, ASIAN ECON POLICY R, V10, P223, DOI 10.1111/aepr.12099; Hinz R., 2013, MATCHING CONTRIBUTIO; Horie S, 2015, ASIAN ECON POLICY R, V10, P299, DOI 10.1111/aepr.12108; Huang YP, 2015, ASIAN ECON POLICY R, V10, P271, DOI 10.1111/aepr.12104; Iizuka T, 2015, ASIAN ECON POLICY R, V10, P326, DOI 10.1111/aepr.12111; Ke L, 2015, ASIAN ECON POLICY R, V10, P273, DOI 10.1111/aepr.12105; Kondo A, 2015, ASIAN ECON POLICY R, V10, P324, DOI 10.1111/aepr.12110; Noguchi H, 2015, ASIAN ECON POLICY R, V10, P301, DOI 10.1111/aepr.12109; Noland M, 2015, ASIAN ECON POLICY R, V10, P246, DOI 10.1111/aepr.12101; Orszag PR, 2015, ASIAN ECON POLICY R, V10, P296, DOI 10.1111/aepr.12107; Park D., 2012, PENSION SYSTEMS E SE; Rozanov A, 2015, ASIAN ECON POLICY R, V10, P275, DOI 10.1111/aepr.12106; Sussangkarn C, 2015, ASIAN ECON POLICY R, V10, P248, DOI 10.1111/aepr.12102; Wise D., 2006, HLTH CARE ISSUES US	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1832-8105	1748-3131		ASIAN ECON POLICY R	Asian Econ. Policy. Rev.	JUL	2015	10	2					179	198		10.1111/aepr.12097		20	Economics	Business & Economics	CM2LX	WOS:000357512900001		
J	Ke, L				Ke, Long			Comment on "The Social Protection System in Ageing China"	ASIAN ECONOMIC POLICY REVIEW			English	Editorial Material									[Ke, Long] FRI, Tokyo 1050022, Japan	Ke, L (reprint author), FRI, Minato Ku, 1-16-1 Kaigan, Tokyo 1050022, Japan.	kelong1029@yahoo.co.jp					Cai F, 2015, ASIAN ECON POLICY R, V10, P250, DOI 10.1111/aepr.12103	1	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1832-8105	1748-3131		ASIAN ECON POLICY R	Asian Econ. Policy. Rev.	JUL	2015	10	2					273	274		10.1111/aepr.12105		2	Economics	Business & Economics	CM2LX	WOS:000357512900009		
J	Horie, S				Horie, Sadayuki			Comment on "Public Pension Fund Management: Best Practice and International Experience"	ASIAN ECONOMIC POLICY REVIEW			English	Editorial Material									[Horie, Sadayuki] Nomura Res Inst, Tokyo 1000005, Japan	Horie, S (reprint author), Nomura Res Inst, Chiyoda Ku, 7th Floor,Kitaguchi Bldg,1-6-5 Marunouchi, Tokyo 1000005, Japan.	s-horie@nri.co.jp					Rozanov A, 2015, ASIAN ECON POLICY R, V10, P275, DOI 10.1111/aepr.12106	1	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1832-8105	1748-3131		ASIAN ECON POLICY R	Asian Econ. Policy. Rev.	JUL	2015	10	2					299	300		10.1111/aepr.12108		2	Economics	Business & Economics	CM2LX	WOS:000357512900012		
J	Noguchi, H				Noguchi, Haruko			How does the Price Regulation Policy Impact on Patient-Nurse Ratios and the Length of Hospital Stays in Japanese Hospitals?	ASIAN ECONOMIC POLICY REVIEW			English	Review						fee-for-service (FFS) system; kernel propensity score matching difference-in-difference estimation; length of hospital stay; natural experiment; patient-nurse ratio; price regulation	UNIVERSAL HEALTH-CARE; COVERAGE; DEMAND; SYSTEM; COSTS	This study examines how the 2000 and 2006 revisions of the fee-for-service system have affected patient-nurse ratios and the average length of hospital stays in Japan. The empirical results show that hospitals are quite responsive to changes in price policy. The fee revisions have certainly achieved the policy objectives of reducing patient-nurse ratios and the length of hospital stays. As a result, hospitals have responded by greatly increasing the number of expensive beds for acute care. However, this was not exactly predicted by the Japanese government, which has aimed to reallocate health-care resources, such as beds, to subacute or long-term care.	[Noguchi, Haruko] Waseda Univ, Tokyo 1698050, Japan	Noguchi, H (reprint author), Waseda Univ, Sch Polit Sci & Econ, Shinjuku Ku, 1-6-1 Nishiwaseda, Tokyo 1698050, Japan.	h.noguchi@waseda.jp			Ministry of Health, Labour and Welfare [H26-chikyukibo-ippan-009]	This research is funded in part by the generous support of a research grant from the Ministry of Health, Labour and Welfare (Principal investigator: Shibuya Kenji, Graduate School of Medicine, University of Tokyo, H26-chikyukibo-ippan-009). I am grateful to the two designated discussants, Toshiaki Iizuka and Ayako Kondo, who provided comments that have led to a significant improvement in this paper. I also thank Siow Yue Chia, Jong-Wha Lee, Naoyuki Yoshino, Naohiro Yashiro, Yasushi Iwamoto, Peter Orszag, Shujiro Urata, Takatoshi Ito, Colin McKenzie, and all the participants of the Asian Economic Policy Review Conference on October 18, 2014 for their helpful comments. Especially, I appreciate Colin McKenzie, who spent tremendous time to go through my draft in detail and improve the readability of the English. All remaining errors are my own.	Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Shibuya K, 2011, LANCET, V378, P1265, DOI 10.1016/S0140-6736(11)61098-2; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; Shigeoka H, 2014, J HEALTH ECON, V35, P162, DOI 10.1016/j.jhealeco.2014.03.003; Ikegami N, 2004, HEALTH AFFAIR, V23, P26, DOI 10.1377/hlthaff.23.3.26; Evans RG., 1974, EC HLTH MED CARE, P162; FUCHS VR, 1978, J HUM RESOUR, V13, P35, DOI 10.2307/145247; Iizuka T., 2014, JAP EC ASS C HELD SE; Ikegami N, 2012, HEALTH AFFAIR, V31, P1049, DOI 10.1377/hlthaff.2011.1037; Japanese Nursing Association (JNA), 2009, 60 YEARS HIST ACT PU; Kadoya Y., 2014, JAPANESE J HLTH EC P, V25, P114; Kawai H., 2000, JAPANESE J HLTH EC P, V7, P37; Kishida S., 2001, Q SOCIAL SECURITY RE, V37, P246; McGuire TG, 2000, HANDB ECON, V17, P461; Ministry of Health Labour and Welfare (MHLW), 2015, OUTL JAP MED SYST; Ministry of Health Labour and Welfare (MHLW), 2012, INP HOSP FEE; Ministry of Health Labour and Welfare (MHLW), 2010, VIT STAT; Ministry of Health Labour and Welfare (MHLW), 2014, JOB EMPL PLAC SERV S; Moriyama H., 2009, 60 YEARS HIST ACT PU, P250; Nagata S., 2012, BMC HEALTH SERV RES, V2, P237; Nakata Y., 2010, J CLIN NURS, V20, P4; National Institute of Population and Social Security Research (NIPSSR), 2012, POP PROJ JAP JAN 201; Noguchi H., 2014, EFECTS REVISIONS FFS; OECD, 2014, OECD HLTH STAT 2014; Ogata H., 2003, HLTH CARE REFORM FUN, P43; Pauly MV, 1980, DOCTORS THEIR WORKSH; Schwartz John, 2013, NY TIMES; Suzuki W., 2005, IRYO TO KAIGO NO SED, P97; Tokita T., 2004, JAPANESE HLTH CARE R; Wagstaff A., 2005, 3790 WORLD BANK; WHO, 2000, WORLD HLTH REP 2000	31	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1832-8105	1748-3131		ASIAN ECON POLICY R	Asian Econ. Policy. Rev.	JUL	2015	10	2					301	323		10.1111/aepr.12109		23	Economics	Business & Economics	CM2LX	WOS:000357512900013		
J	Kondo, A				Kondo, Ayako			Comment on "How does the Price Regulation Policy Impact on Patient-Nurse Ratios and the Length of Hospital Stays in Japanese Hospitals?"	ASIAN ECONOMIC POLICY REVIEW			English	Editorial Material									[Kondo, Ayako] Yokohama Natl Univ, Yokohama, Kanagawa 2408501, Japan	Kondo, A (reprint author), Yokohama Natl Univ, Fac Int Social Sci, 79-4 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	akondo@ynu.ac.jp					Noguchi H, 2015, ASIAN ECON POLICY R, V10, P301, DOI 10.1111/aepr.12109	1	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1832-8105	1748-3131		ASIAN ECON POLICY R	Asian Econ. Policy. Rev.	JUL	2015	10	2					324	325		10.1111/aepr.12110		2	Economics	Business & Economics	CM2LX	WOS:000357512900014		
J	Iizuka, T				Iizuka, Toshiaki			Comment on "How does the Price Regulation Policy Impact on Patient-Nurse Ratios and the Length of Hospital Stays in Japanese Hospitals?"	ASIAN ECONOMIC POLICY REVIEW			English	Editorial Material									[Iizuka, Toshiaki] Univ Tokyo, Tokyo 1130033, Japan	Iizuka, T (reprint author), Univ Tokyo, Fac Econ, Bunkyo Ku, 7-3-1 Hongyo, Tokyo 1130033, Japan.	toshi.iizuka@gmail.com					Noguchi H, 2015, ASIAN ECON POLICY R, V10, P301, DOI 10.1111/aepr.12109	1	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1832-8105	1748-3131		ASIAN ECON POLICY R	Asian Econ. Policy. Rev.	JUL	2015	10	2					326	327		10.1111/aepr.12111		2	Economics	Business & Economics	CM2LX	WOS:000357512900015		
J	Loveland, KL; Major, AT; Butler, R; Young, JC; Jans, DA; Miyamoto, Y				Loveland, Kate L.; Major, Andrew T.; Butler, Romaly; Young, Julia C.; Jans, David A.; Miyamoto, Yoichi			Putting things in place for fertilization: discovering roles for importin proteins in cell fate and spermatogenesis	ASIAN JOURNAL OF ANDROLOGY			English	Review						cell fate; cell stress; importin; karyopherin; nucleocytoplasmic transport; spermatid; spermatocyte; spermatogenesis	REGULATED NUCLEOCYTOPLASMIC TRANSPORT; EMBRYONIC STEM-CELLS; NUCLEAR IMPORT; ALPHA-IMPORTOME; EXPRESSION; MOUSE; DIFFERENTIATION; LOCALIZATION; SPERMIOGENESIS; FLEXIBILITY	Importin proteins were originally characterized for their central role in protein transport through the nuclear pores, the only intracellular entry to the nucleus. This vital function must be tightly regulated to control access by transcription factors and other nuclear proteins to genomic DNA, to achieve appropriate modulation of cellular behaviors affecting cell fate. Importin-mediated nucleocytoplasmic transport relies on their specific recognition of cargoes, with each importin binding to distinct and overlapping protein subsets. Knowledge of importin function has expanded substantially in regard to three key developmental systems: embryonic stem cells, muscle cells and the germ line. In the decade since the potential for regulated nucleocytoplasmic transport to contribute to spermatogenesis was proposed, we and others have shown that the importins that ferry transcription factors into the nucleus perform additional roles, which control cell fate. This review presents key findings from studies of mammalian spermatogenesis that reveal potential new pathways by which male fertility and infertility arise. These studies of germline genesis illuminate new ways in which importin proteins govern cellular differentiation, including via directing proteins to distinct intracellular compartments and by determining cellular stress responses.	[Loveland, Kate L.; Young, Julia C.; Jans, David A.; Miyamoto, Yoichi] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Loveland, Kate L.; Major, Andrew T.; Butler, Romaly; Young, Julia C.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Loveland, Kate L.; Young, Julia C.] Monash Med Ctr, Hudson Inst Med Res, Clayton, Vic 3168, Australia; [Loveland, Kate L.] Monash Univ, Sch Clin Sci, Clayton, Vic, Australia; [Miyamoto, Yoichi] Natl Inst Biomed Innovat Hlth & Nutr, Lab Nucl Transport Dynam, Osaka, Japan	Loveland, KL (reprint author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	kate.loveland@monash.edu			COE [348239, DPO878102]; NHMRC [545916, 334013]	The work described in this manuscript received research project and fellowship support (COE#348239 and #DPO878102) and fellowship support from the NHMRC (ID 545916 and ID 334013).	Song HW, 2014, SEMIN CELL DEV BIOL, V30, P14, DOI 10.1016/j.semcdb.2014.02.005; Kappel C, 2010, BIOPHYS J, V99, P1596, DOI 10.1016/j.bpj.2010.06.032; Sekimoto T, 2011, J BIOL CHEM, V286, P15126, DOI 10.1074/jbc.M110.213579; Arjomand A, 2014, FASEB J, V28, P3480, DOI 10.1096/fj.13-244913; Loveland KL, 2006, BIOL REPROD, V74, P67, DOI 10.1095/biolreprod.105.042341; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Whiley PAF, 2012, INT J ANDROL, V35, P158, DOI 10.1111/j.1365-2605.2011.01202.x; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Yasuhara N, 2013, DEV CELL, V26, P123, DOI 10.1016/j.devcel.2013.06.022; Major AT, 2011, BBA-MOL CELL RES, V1813, P1668, DOI 10.1016/j.bbamcr.2011.03.008; Christiansen A, 2013, CANCER LETT, V331, P18, DOI 10.1016/j.canlet.2012.12.013; Senapedis WT, 2014, SEMIN CANCER BIOL, V27, P74, DOI 10.1016/j.semcancer.2014.04.005; Miyamoto Y, 2013, BBA-MOL CELL RES, V1833, P731, DOI 10.1016/j.bbamcr.2012.11.005; Young JC, 2013, BBA-MOL CELL RES, V1833, P2348, DOI 10.1016/j.bbamcr.2013.06.007; Wang GG, 2013, J PROTEOMICS, V79, P114, DOI 10.1016/j.jprot.2012.12.008; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; Forwood JK, 2010, STRUCTURE, V18, P1171, DOI 10.1016/j.str.2010.06.015; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Hogarth CA, 2007, DEV DYNAM, V236, P2311, DOI 10.1002/dvdy.21238; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Barakat B, 2012, MOL CELL ENDOCRINOL, V359, P66, DOI 10.1016/j.mce.2012.02.018; Hogarth CA, 2006, DEV DYNAM, V235, P253, DOI 10.1002/dvdy.20569; Adam SA, 2008, J BIOL CHEM, V283, P8462, DOI 10.1074/jbc.M709572200; Kimura M, 2014, TRAFFIC, V15, P727, DOI 10.1111/tra.12174; Ly-Huynh JD, 2011, BIOL REPROD, V85, P1191, DOI 10.1095/biolreprod.111.091686; Kerr JB, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P827; Bello OD, 2012, EXP CELL RES, V318, P478, DOI 10.1016/j.yexcr.2012.01.002; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; Yasuda Y, 2012, EMBO J, V31, P83, DOI 10.1038/emboj.2011.360; Anway MD, 2003, J ANDROL, V24, P173; Hachet V, 2004, EMBO J, V23, P1526, DOI 10.1038/sj.emboj.7600154; Hall MN, 2011, DEV BIOL, V357, P248, DOI 10.1016/j.ydbio.2011.06.032; Ho HC, 2010, J ANAT, V216, P525, DOI 10.1111/j.1469-7580.2009.01204.x; Hogarth C, 2005, BIOESSAYS, V27, P1011, DOI 10.1002/bies.20289; Major AT, 2015, MOL BIOL CELL, V26, P1543, DOI 10.1091/mbc.E14-01-0678; Miyamoto Yoichi, 2012, Commun Integr Biol, V5, P220, DOI [10.4161/cib.19194, 10.1007/s12328-012-0302-9]; Miyamoto Y, 2012, BBA-GENE REGUL MECH, V1819, P616, DOI 10.1016/j.bbagrm.2012.01.015; Pradeepa MM, 2008, MOL CELL BIOL, V28, P4331, DOI 10.1128/MCB.00519-07; Tran EJ, 2014, BBA-MOL CELL RES, V1843, P2784, DOI 10.1016/j.bbamcr.2014.08.003; Tran MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096842; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Wettersten HI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113867; Yamaguchi YL, 2006, DEV BIOL, V297, P350, DOI 10.1016/j.ydbio.2006.04.465; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Young JC, 2011, FASEB J, V25, P3958, DOI 10.1096/fj.10-176941	52	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1008-682X	1745-7262		ASIAN J ANDROL	Asian J. Androl.	JUL	2015	17	4					537	544		10.4103/1008-682X.154310		8	Andrology; Urology & Nephrology	Endocrinology & Metabolism; Urology & Nephrology	CL9HR	WOS:000357288800004		
J	Young, SAM; Aitken, RJ; Ikawa, M				Young, Samantha A. M.; Aitken, R. John; Ikawa, Masahito			Advantages of using the CRISPR/Cas9 system of genome editing to investigate male reproductive mechanisms using mouse models	ASIAN JOURNAL OF ANDROLOGY			English	Editorial Material							ONE-STEP GENERATION; MALE-FERTILITY; MAMMALIAN REPRODUCTION; MALE-INFERTILITY; MICE LACKING; HUMAN-CELLS; SPERM; RNA; CAS9; DNA	Gene disruption technology has long been beneficial for the study of male reproductive biology. However, because of the time and cost involved, this technology was not a viable method except in specialist laboratories. The advent of the CRISPR/Cas9 system of gene disruption has ushered in a new era of genetic investigation. Now, it is possible to generate gene-disrupted mouse models in very little time and at very little cost. This Highlight article discusses the application of this technology to study the genetics of male fertility and looks at some of the future uses of this system that could be used to reveal the essential and nonessential genetic components of male reproductive mechanisms.	[Young, Samantha A. M.; Aitken, R. John] Univ Newcastle, Prior Res Ctr Reprod Sci, Discipline Biol Sci, Fac Sci & IT, Callaghan, NSW 2308, Australia; [Young, Samantha A. M.; Ikawa, Masahito] Osaka Univ, Microbial Dis Res Inst, Anim Resource Ctr Infect Dis, Suita, Osaka 565, Japan	Ikawa, M (reprint author), Osaka Univ, Microbial Dis Res Inst, Anim Resource Ctr Infect Dis, Suita, Osaka 565, Japan.	ikawa@biken.osaka-u.ac.jp	Ikawa, Masahito/A-5315-2009	Ikawa, Masahito/0000-0001-9859-6217			Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Menke DB, 2013, GENESIS, V51, P605, DOI 10.1002/dvg.22422; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Alasmari W, 2013, J BIOL CHEM, V288, P6248, DOI 10.1074/jbc.M112.439356; Baker MA, 2012, J PROTEOME RES, V11, P5252, DOI 10.1021/pr300468m; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Jamsai D, 2011, ASIAN J ANDROL, V13, P139, DOI 10.1038/aja.2010.101; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Escalier D, 2006, HUM REPROD UPDATE, V12, P449, DOI 10.1093/humupd/dml013; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Klinovska K, 2014, INT J MOL SCI, V15, P10652, DOI 10.3390/ijms150610652; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Tanaka SS, 2000, GENE DEV, V14, P841; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Aitken RJ, 2013, MOL HUM REPROD, V19, P785, DOI 10.1093/molehr/gat067; Roy A, 2006, REPRODUCTION, V131, P207, DOI 10.1530/rep.1.00530; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Ostrowski LE, 2010, AM J RESP CELL MOL, V43, P55, DOI 10.1165/rcmb.2009-0118OC; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Mashiko D, 2014, DEV GROWTH DIFFER, V56, P122, DOI 10.1111/dgd.12113; Archambeault DR, 2014, ANN ENDOCRINOL-PARIS, V75, P101, DOI 10.1016/j.ando.2014.04.006; Chung JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1153; Fujihara Y, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.112888; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Inoue Naokazu, 2007, Soc Reprod Fertil Suppl, V65, P363; Lee AYF, 2014, FEBS OPEN BIO, V4, P637, DOI 10.1016/j.fob.2014.06.007; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Okabe M, 2014, EXP ANIM TOKYO, V63, P357; Sun FY, 2010, DEVELOPMENT, V137, P1699, DOI 10.1242/dev.043125; Tamowski S, 2010, SYST BIOL REPROD MED, V56, P260, DOI 10.3109/19396368.2010.485244; Vernon GG, 2005, CELL MOTIL CYTOSKEL, V61, P65, DOI 10.1002/cm.20066; Young SA, 2015, TARGETED GENOME EDIT, P151	48	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1008-682X	1745-7262		ASIAN J ANDROL	Asian J. Androl.	JUL	2015	17	4					623	627		10.4103/1008-682X.153851		5	Andrology; Urology & Nephrology	Endocrinology & Metabolism; Urology & Nephrology	CL9HR	WOS:000357288800016		
J	Okabe, M				Okabe, Masaru			Mechanisms of fertilization elucidated by gene-manipulated animals	ASIAN JOURNAL OF ANDROLOGY			English	Editorial Material							SPERM-EGG FUSION; ANGIOTENSIN-CONVERTING ENZYME; ZONA-PELLUCIDA; MOUSE SPERM; MALE-FERTILITY; ACROSOME REACTION; HAMSTER EGGS; IN-VITRO; MAMMALIAN FERTILIZATION; DIFFERENTIAL RELEASE	Capacitation and the acrosome reaction are key phenomena in mammalian fertilization. These phenomena were found more than 60 years ago. However, fundamental questions regarding the nature of capacitation and the timing of the acrosome reaction remain unsolved. Factors were postulated over time, but as their roles were not verified by gene-disruption experiments, widely accepted notions concerning the mechanism of fertilization are facing modifications. Today, although in vitro fertilization systems remain our central research tool, the importance of in vivo observations must be revisited. Here, primarily focusing on our own research, I summarize how in vivo observations using gene-manipulated animals have elucidated new concepts in the mechanisms of fertilization.	Osaka Univ, Ctr Genet Anal Biol Responses, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Okabe, M (reprint author), Osaka Univ, Ctr Genet Anal Biol Responses, Microbial Dis Res Inst, Yamadaoka 3-1, Suita, Osaka 5650871, Japan.	okabe@biken.osaka-u.ac.jp					BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; UEHARA T, 1976, BIOL REPROD, V15, P467, DOI 10.1095/biolreprod15.4.467; Shamsadin R, 1999, BIOL REPROD, V61, P1445, DOI 10.1095/biolreprod61.6.1445; Smithies O, 2001, NAT MED, V7, P1083, DOI 10.1038/nm1001-1083; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; BRAUN T, 1995, EMBO J, V14, P1176; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; PATAPOUTIAN A, 1995, DEVELOPMENT, V121, P3347; Takeo T, 2008, BIOL REPROD, V78, P546, DOI 10.1095/biolreprod.107.065359; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; GONG XH, 1995, SCIENCE, V269, P1718, DOI 10.1126/science.7569899; Inoue N, 2011, P NATL ACAD SCI USA, V108, P20008, DOI 10.1073/pnas.1116965108; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Toshimori K, 2011, J ELECTRON MICROSC, V60, pS31, DOI 10.1093/jmicro/dfr036; Fujihara Y, 2013, P NATL ACAD SCI USA, V110, P8111, DOI 10.1073/pnas.1222166110; Inoue N, 2013, DEVELOPMENT, V140, P3221, DOI 10.1242/dev.094854; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; Gahlay G, 2010, SCIENCE, V329, P216, DOI 10.1126/science.1188178; Marcello MR, 2011, J BIOL CHEM, V286, P13060, DOI 10.1074/jbc.M110.175463; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Da Ros VG, 2008, DEV BIOL, V320, P12, DOI 10.1016/j.ydbio.2008.03.015; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Baba D, 2002, J BIOL CHEM, V277, P30310, DOI 10.1074/jbc.M204596200; Nakanishi T, 2004, BIOL REPROD, V71, P959, DOI 10.1095/biolreprod.104.028647; HARDY DM, 1991, BIOCHEM J, V275, P759; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Yamaguchi R, 2009, BIOL REPROD, V81, P142, DOI 10.1095/biolreprod.108.074021; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; ZHANG W, 1995, GENE DEV, V9, P1388, DOI 10.1101/gad.9.11.1388; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581; Satouh Y, 2012, J CELL SCI, V125, P4985, DOI 10.1242/jcs.100867; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Ikawa M, 2011, J BIOL CHEM, V286, P5639, DOI 10.1074/jbc.M110.140152; Inoue N, 2003, MOL CELL BIOL, V23, P2614, DOI 10.1128/MCB.23.7.2614-2622.2003; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Tokuhiro K, 2012, P NATL ACAD SCI USA, V109, P3850, DOI 10.1073/pnas.1117963109; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Okabe M, 2013, DEVELOPMENT, V140, P4471, DOI 10.1242/dev.090613; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Capecchi MR, 2001, NAT MED, V7, P1086, DOI 10.1038/nm1001-1086; Sutton KA, 2008, P NATL ACAD SCI USA, V105, P8661, DOI 10.1073/pnas.0800603105; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Baibakov B, 2007, DEVELOPMENT, V134, P933, DOI 10.1242/dev.02752; BABA T, 1994, J BIOL CHEM, V269, P31845; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; Brookfield John, 1992, Current Biology, V2, P553, DOI 10.1016/0960-9822(92)90036-A; DAN JC, 1952, BIOL BULL, V103, P54, DOI 10.2307/1538405; Fujihara Y, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.112888; HARTMANN JF, 1972, P NATL ACAD SCI USA, V69, P2767, DOI 10.1073/pnas.69.10.2767; Ikawa M, 1997, NATURE, V387, P607; Kim E, 2006, J BIOL CHEM, V281, P5634, DOI 10.1074/jbc.M510558200; Kim KS, 2001, BIOL REPROD, V64, P148, DOI 10.1095/biolreprod64.1.148; Krutskikh A, 2012, FASEB J, V26, P4198, DOI 10.1096/fj.12-205211; Lu QX, 1997, DEVELOPMENT, V124, P4121; Muro Yuko, 2012, Biol Reprod, V86, P1, DOI 10.1095/biolreprod.111.095877; OKABE M, 1987, J REPROD IMMUNOL, V11, P91, DOI 10.1016/0165-0378(87)90014-3; OKABE M, 1988, J REPROD IMMUNOL, V13, P211, DOI 10.1016/0165-0378(88)90002-2; Osokine I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040034; REED SI, 1991, TRENDS GENET, V7, P95, DOI 10.1016/0168-9525(91)90064-W; Shen CL, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107086; Tardif S, 2010, J BIOL CHEM, V285, P24863, DOI 10.1074/jbc.M110.123125; Toyoda Y, 1971, JPN J ANIM REPROD, V16, P147; Valdivia M, 1999, ZYGOTE, V7, P143, DOI 10.1017/S0967199499000507; Yamaguchi R, 2012, MOL BIOL CELL, V23, P2671, DOI 10.1091/mbc.E11-12-1025; YANAGIMACHI R, 1963, NATURE, V200, P281, DOI 10.1038/200281b0	75	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1008-682X	1745-7262		ASIAN J ANDROL	Asian J. Androl.	JUL	2015	17	4					646	652		10.4103/1008-682X.153299		7	Andrology; Urology & Nephrology	Endocrinology & Metabolism; Urology & Nephrology	CL9HR	WOS:000357288800020		
J	Kotani, S; Moritani, M; Nakajima, M				Kotani, Shunsuke; Moritani, Miyuki; Nakajima, Makoto			Chiral Lithium Binaphtholate for Enantioselective Michael Addition of Acyclic alpha-Alkyl-beta-Keto Esters to Vinyl Ketones	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						alpha-alkyl-beta-keto esters; Bronsted bases; lithium binaphtholates; Michael addition; vinyl ketones	QUATERNARY CARBON CENTERS; ASYMMETRIC CONJUGATE ADDITIONS; TRIMETHOXYSILYL ENOL ETHERS; ALDOL-TISHCHENKO REACTION; MANNICH-TYPE REACTION; 1,3-DICARBONYL COMPOUNDS; PALLADIUM ENOLATE; BINOL COMPLEX; CONSTRUCTION; STEREOCENTERS	Asymmetric Michael addition of acyclic alpha-alkyl-beta-keto esters with vinyl ketones catalyzed by a chiral lithium binaphtholate is described. Lithium binaphtholates, prepared from BINOL derivatives and inexpensive LiOH, effectively promoted the transformation of acyclic alpha-alkyl-beta-keto esters in a highly enantioselective manner, affording Michael adducts bearing chiral quaternary carbon centers.	[Kotani, Shunsuke; Moritani, Miyuki; Nakajima, Makoto] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan; [Kotani, Shunsuke] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8620973, Japan	Kotani, S (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	skotani@gpo.kumamoto-u.ac.jp; nakajima@gpo.kumamoto-u.ac.jp			JSPS KAKENHI grant from The Ministry of Education, Culture, Sports, Science and Technology, Japan [25860008]	This work was partially supported by JSPS KAKENHI grant number 25860008 from The Ministry of Education, Culture, Sports, Science and Technology, Japan.	Hamashima Y, 2005, ADV SYNTH CATAL, V347, P1576, DOI 10.1002/adsc.200505199; Hamashima Y, 2003, ORG LETT, V5, P3225, DOI 10.1021/o1035053a; Ichibakase T, 2011, ORG LETT, V13, P1579, DOI 10.1021/ol103156h; Christoffers J, 2007, SYNTHESIS-STUTTGART, P1279, DOI 10.1055/s-2007-966005; Santoro F, 2008, ORGANOMETALLICS, V27, P3866, DOI 10.1021/om800197y; FUJI K, 1993, CHEM REV, V93, P2037, DOI 10.1021/cr00022a005; Almasi D, 2007, TETRAHEDRON-ASYMMETR, V18, P299, DOI 10.1016/j.tetasy.2007.01.023; Holmes IP, 2000, TETRAHEDRON LETT, V41, P7453, DOI 10.1016/S0040-4039(00)01275-2; Kotani S, 2014, J ORG CHEM, V79, P4817, DOI 10.1021/jo5005394; Tanaka K, 2011, CHEM COMMUN, V47, P5614, DOI 10.1039/c1cc10734h; Shibasaki M, 2002, CHEM REV, V102, P2187, DOI 10.1021/cr010297z; Denissova I, 2003, TETRAHEDRON, V59, P10105, DOI 10.1016/j.tet.2003.10.039; Das JP, 2011, CHEM COMMUN, V47, P4593, DOI 10.1039/c0cc05222a; SASAI H, 1994, J AM CHEM SOC, V116, P1571, DOI 10.1021/ja00083a053; Hamashima Y, 2002, J AM CHEM SOC, V124, P11240, DOI 10.1021/ja027075i; Wu FH, 2006, ANGEW CHEM INT EDIT, V45, P947, DOI 10.1002/anie.200502658; Wang Z, 2010, CHEM-EUR J, V16, P10130, DOI 10.1002/chem.201001129; Sibi MP, 2000, TETRAHEDRON, V56, P8033; Hatano M, 2010, J AM CHEM SOC, V132, P56, DOI 10.1021/ja909874b; Douglas CJ, 2004, P NATL ACAD SCI USA, V101, P5363, DOI 10.1073/pnas.0307113101; Peterson EA, 2004, P NATL ACAD SCI USA, V101, P11943, DOI 10.1073/pnas.0402416101; Bella M, 2009, SYNTHESIS-STUTTGART, P1583, DOI 10.1055/s-0029-1216796; Belokon YN, 2011, TETRAHEDRON-ASYMMETR, V22, P167, DOI 10.1016/j.tetasy.2010.12.003; Berner OM, 2002, EUR J ORG CHEM, P1877; Corey EJ, 1998, ANGEW CHEM INT EDIT, V37, P388, DOI 10.1002/(SICI)1521-3773(19980302)37:4<388::AID-ANIE388>3.0.CO;2-V; Corey E. J., 1998, ANGEW CHEM, V110, P2092, DOI 10.1002/(SICI)1521-3757(19980803)110:15<2092::AID-ANGE2092>3.0.CO;2-M; Hatano M, 2005, J AM CHEM SOC, V127, P10776, DOI 10.1021/ja051125c; Hatano M, 2010, SYNTHESIS-STUTTGART, P3785, DOI 10.1055/s-0030-1258296; Holmes IP, 2000, TETRAHEDRON LETT, V41, P7457, DOI 10.1016/S0040-4039(00)01276-4; Ichibakase T, 2012, SYNTHESIS-STUTTGART, V44, P3145, DOI 10.1055/s-0031-1291138; Ichibakase T, 2012, TETRAHEDRON, V68, P4210, DOI 10.1016/j.tet.2012.03.096; Ichibakase T, 2008, TETRAHEDRON LETT, V49, P4427, DOI 10.1016/j.tetiet.2008.05.004; Ichibakase T, 2011, MOLECULES, V16, P5008, DOI 10.3390/molecules16065008; Krause N., 2001, SYNTHESIS-STUTTGART, P0171; Loog O, 1999, TETRAHEDRON-ASYMMETR, V10, P2411, DOI 10.1016/S0957-4166(99)00219-0; Matsunaga S., 2012, COMPREHENSIVE CHIRAL, V4, P243; Nakajima M, 2004, ORG LETT, V6, P3763, DOI 10.1021/ol048485+; Sasai H, 1996, TETRAHEDRON LETT, V37, P5561, DOI 10.1016/0040-4039(96)01156-2; Schiffers R, 1997, SYNLETT, P1175; Tanaka K, 2010, TETRAHEDRON LETT, V51, P2168, DOI 10.1016/j.tetlet.2010.02.084; Trost BM, 2006, SYNTHESIS-STUTTGART, P369, DOI 10.1055/s-2006-926302; Tsogoeva SB, 2007, EUR J ORG CHEM, P1701, DOI 10.1002/ejoc.200600653; Ueda T, 2010, TETRAHEDRON, V66, P7726, DOI 10.1016/j.tet.2010.07.080; Wu F., 2006, ANGEW CHEM, V118, P961, DOI 10.1002/ange.200502658; Yamaguchi M., 1999, COMPREHENSIVE ASYMME, V3, P1121; Yoshida M, 2013, CHEM LETT, V42, P180, DOI 10.1246/cl.2013.180	46	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	JUL	2015	4	7					616	618		10.1002/ajoc.201500122		3	Chemistry, Organic	Chemistry	CM0RO	WOS:000357386200003		
J	Wang, CY; Yamashita, M; Hu, BL; Zhou, Y; Wang, JX; Wu, J; Huo, FW; Lee, PS; Aratani, N; Yamada, H; Zhang, QC				Wang, Chengyuan; Yamashita, Masataka; Hu, Benlin; Zhou, Yi; Wang, Jiangxin; Wu, Jin; Huo, Fengwei; Lee, Pooi See; Aratani, Naoki; Yamada, Hiroko; Zhang, Qichun			Synthesis, Characterization, and Memory Performance of Two Phenazine/Triphenylamine-Based Organic Small Molecules through Donor-Acceptor Design	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						atomic force microscopy; 4,11-bis((triisopropylsilyl)ethynyl)-1H-imidazo[4,5-b]phenazines; DFT calculations; organic resistive random access memory; triphenylamines	NONVOLATILE MEMORY; PHYSICAL-PROPERTIES; THIN-FILM; DATA-STORAGE; DEVICE; BEHAVIOR; DERIVATIVES; NANOELECTRONICS; TRIPHENYLAMINE; NANOPARTICLES	Two organic small molecule memory materials, TPA-2BIPs and TPA-3BIPs, containing triphenylamine (TPA) as a donor and 4,11-bis((triisopropylsilyl)ethynyl)-1H-imidazo[4,5-b]phenazine (BIP) units as acceptors have been synthesized and characterized. Sandwich-structure memory devices based on these two molecules have been fabricated and the as-fabricated devices displayed similar switching behavior but different ON/OFF ratios. The analysis of AFM images indicates that increasing the numbers of acceptors changes the stacking of molecules in the solid state, which results in different morphology and microstructures in films. Although the switching behavior is not significantly different with increasing acceptor moieties, more acceptor groups do help to enhance the stacking of the molecules in the solid state to generate more consistent switching performance.	[Wang, Chengyuan; Hu, Benlin; Zhou, Yi; Wang, Jiangxin; Wu, Jin; Huo, Fengwei; Lee, Pooi See; Zhang, Qichun] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Yamashita, Masataka; Aratani, Naoki; Yamada, Hiroko] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma 6300192, Japan; [Zhang, Qichun] Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore 637371, Singapore	Zhang, QC (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.	qczhang@ntu.edu.sg	zhang, qichun/A-2253-2011; Huo, Fengwei/A-2243-2011	Huo, Fengwei/0000-0001-8990-6973	AcRF Tier 1 from the MOE [RG 16/12, R/G 133/14]; AcRF Tier 2 from the MOE [ARC 20/12, ARC 2/13]; CREATE program (Nanomaterials for Energy and Water Management) from NRF; New Initiative Fund from NTU, Singapore; MEXT [22350083, 26288038]; JSPS [26105004]	Q.Z. acknowledges the financial support from AcRF Tier 1 (RG 16/12 and R/G 133/14) and Tier 2 (ARC 20/12 and ARC 2/13) from the MOE, CREATE program (Nanomaterials for Energy and Water Management) from NRF, and the New Initiative Fund from NTU, Singapore. The work at NAIST was supported by Grants-in-Aid (no. 22350083 to H.Y. and no. 26288038 to N.A.) supported by MEXT and by Grants-in-Aid (no. 26105004 to H.Y.) supported by JSPS.	Chu CW, 2005, ADV MATER, V17, P1440, DOI 10.1002/adma.200500225; Li JB, 2013, SYNLETT, V24, P686, DOI 10.1055/s-0032-1318157; Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028; Ye CQ, 2012, J AM CHEM SOC, V134, P20053, DOI 10.1021/ja305354y; Chau R, 2007, NAT MATER, V6, P810, DOI 10.1038/nmat2014; Wang CY, 2015, ANGEW CHEM INT EDIT, V54, P6292, DOI 10.1002/anie.201500972; Gu PY, 2014, MATER HORIZONS, V1, P446, DOI 10.1039/c4mh00022f; Lee WY, 2011, CHEM MATER, V23, P4487, DOI 10.1021/cm201665g; Bozano LD, 2005, ADV FUNCT MATER, V15, P1933, DOI 10.1002/adfm.200500130; Li JB, 2014, J ORG CHEM, V79, P4438, DOI 10.1021/jo500400d; Ouyang JY, 2004, NAT MATER, V3, P918, DOI 10.1038/nmat1269; Zhang QC, 2011, CHEM-ASIAN J, V6, P856, DOI 10.1002/asia.201000659; Lundstrom M, 2003, SCIENCE, V299, P210, DOI 10.1126/science.1079567; Ling QD, 2006, J AM CHEM SOC, V128, P8732, DOI 10.1021/ja062489n; Lindner BD, 2011, ANGEW CHEM INT EDIT, V50, P8588, DOI 10.1002/anie.201103676; Li G, 2013, ACS APPL MATER INTER, V5, P6458, DOI 10.1021/am4023434; Hu BL, 2014, CHEM SCI, V5, P3404, DOI 10.1039/c4sc00823e; Yang Y, 2006, ADV FUNCT MATER, V16, P1001, DOI 10.1002/adfm.200500429; Shang YL, 2007, J AM CHEM SOC, V129, P11674, DOI 10.1021/ja074226e; Lee JS, 2011, ADV MATER, V23, P2064, DOI 10.1002/adma.201004150; Ling QD, 2008, PROG POLYM SCI, V33, P917, DOI 10.1016/j.progpolymsci.2008.08.001; Tseng RJ, 2005, NANO LETT, V5, P1077, DOI 10.1021/nl050587l; Ling QD, 2006, ANGEW CHEM INT EDIT, V45, P2947, DOI 10.1002/anie.200504365; Gudeika D, 2012, J PHYS CHEM C, V116, P14811, DOI 10.1021/jp303172b; Li G, 2013, CHEM-ASIAN J, V8, P1574, DOI 10.1002/asia.201300208; Wu YC, 2012, ACS APPL MATER INTER, V4, P1883, DOI 10.1021/am3003389; Chen Y, 2012, CHEM SOC REV, V41, P4688, DOI 10.1039/c2cs35043b; Li G, 2014, CHEM COMMUN, V50, P7656, DOI 10.1039/c4cc02908a; Miao SF, 2012, ADV MATER, V24, P6210, DOI 10.1002/adma.201202319; Zhao JF, 2013, CHEM-ASIAN J, V8, P665, DOI 10.1002/asia.201201152; Hu BL, 2012, J AM CHEM SOC, V134, P17408, DOI 10.1021/ja307933t; Li JB, 2013, J ORG CHEM, V78, P12760, DOI 10.1021/jo402338n; Wang CY, 2014, CHEM-ASIAN J, V9, P779, DOI 10.1002/asia.201301547; Fang YK, 2010, ADV FUNCT MATER, V20, P3012, DOI 10.1002/adfm.201000879; Li H, 2010, J AM CHEM SOC, V132, P5542, DOI 10.1021/ja910243f; Gu PY, 2013, J AM CHEM SOC, V135, P14086, DOI 10.1021/ja408208c; Tseng RJ, 2006, NAT NANOTECHNOL, V1, P72, DOI 10.1038/nnano.2006.55; Jiang GY, 2008, ADV MATER, V20, P2888, DOI 10.1002/adma.200800666; Lindner B. D., 2011, ANGEW CHEM, V123, P8747; Ling Q.-D., 2006, ANGEW CHEM, V118, P3013, DOI 10.1002/ange.200504365; Liu ZC, 2006, IEEE ELECTR DEVICE L, V27, P151, DOI 10.1109/LED.2005.863568; Wang C., 2015, ANGEW CHEM, DOI [10.1002/ange.201500972, DOI 10.1002/ANGE.201500972]; Wang CY, 2015, CHEM-ASIAN J, V10, P116, DOI 10.1002/asia.201402899; Xiao K, 2006, ADV MATER, V18, P2184, DOI 10.1002/adma.200600621	44	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	JUL	2015	4	7					646	651		10.1002/ajoc.201500087		6	Chemistry, Organic	Chemistry	CM0RO	WOS:000357386200009		
J	Tsuji, M				Tsuji, Motonori			Geometrical Dependence of the Highest Occupied Molecular Orbital in Bicyclic Systems: -Facial Stereoselectivity of Bicyclic and Tricyclic Olefins	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						homoaromaticity; hyperconjugation; stereoselectivity; through-bond interactions; through-space interactions	NUCLEAR-MAGNETIC-RESONANCE; BRIDGED RING-SYSTEMS; GAS ELECTRON-DIFFRACTION; C-13 NMR-SPECTROSCOPY; PI-FACE SELECTIVITY; PHOTOELECTRON-SPECTROSCOPY; DOUBLE-BONDS; TRICYCLO<3.2.1.02,4>OCTANE DERIVATIVES; CYCLOPROPANE RING; DIASTEREOFACIAL SELECTIVITY	Sterically unbiased bicyclic and tricyclic olefins were reacted with electrophiles to assess the -facial stereoselectivity. The stereochemical preference of the reactions of these olefins with electrophiles is attributed to the HOMO, which is derived from the interaction between a higher-lying orbital and particular lower-lying sigma orbitals. The selectivity of electrophilic reactions of these olefinic molecules is thought to be controlled by two types of HOMO, which are formed by a combination of different orbitals, depending on the geometrical conditions. A novel interpretation of orbital interactions enabled us to account for the facial selectivity in a unified manner.	[Tsuji, Motonori] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Tsuji, Motonori] Inst Mol Funct, Misato, Saitama 3410037, Japan	Tsuji, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	motonori@molfunction.com					Adcock W, 1999, CHEM REV, V99, P1415, DOI 10.1021/cr980380v; Kaselj M, 1999, CHEM REV, V99, P1387, DOI 10.1021/cr980364y; SALEM L, 1969, J AM CHEM SOC, V91, P5947, DOI 10.1021/ja01050a004; MEINWALD JS, 1963, J AM CHEM SOC, V85, P582, DOI 10.1021/ja00888a022; FUKUI K, 1982, SCIENCE, V218, P747, DOI 10.1126/science.218.4574.747; Ohwada T, 1999, CHEM REV, V99, P1337, DOI 10.1021/cr980371m; MEHTA G, 1994, J ORG CHEM, V59, P1953, DOI 10.1021/jo00087a001; INAGAKI S, 1976, J AM CHEM SOC, V98, P4054, DOI 10.1021/ja00430a006; Ess DH, 2008, J AM CHEM SOC, V130, P10187, DOI 10.1021/ja800009z; CIEPLAK AS, 1989, J AM CHEM SOC, V111, P8447, DOI 10.1021/ja00204a018; Gung BW, 1999, CHEM REV, V99, P1377, DOI 10.1021/cr980365q; TROST BM, 1993, J AM CHEM SOC, V115, P8831, DOI 10.1021/ja00072a043; Tomoda S, 1999, CHEM REV, V99, P1243, DOI 10.1021/cr980374z; RONDAN NG, 1981, J AM CHEM SOC, V103, P2436, DOI 10.1021/ja00399a063; Wipf P, 1999, CHEM REV, V99, P1469, DOI 10.1021/cr9803838; Cieplak AS, 1999, CHEM REV, V99, P1265, DOI 10.1021/cr980381n; CHRISTL M, 1979, CHEM BER-RECL, V112, P2022, DOI 10.1002/cber.19791120612; MEHTA G, 1994, ANGEW CHEM INT EDIT, V33, P1390, DOI 10.1002/anie.199413901; REPPE W, 1948, LIEBIGS ANN CHEM, V560, P1; BAIRD MS, 1972, J CHEM SOC CHEM COMM, P523, DOI 10.1039/c39720000523; BATTISTE MA, 1967, J AM CHEM SOC, V89, P1954, DOI 10.1021/ja00984a037; BECHERER J, 1978, TETRAHEDRON, V34, P1193, DOI 10.1016/0040-4020(78)80144-6; Benet-Buchholz J., 1998, J CHEM SOC CHEM COMM, P2003; BICKER R, 1978, CHEM BER-RECL, V111, P3215, DOI 10.1002/cber.19781110925; BICKER R, 1978, CHEM BER-RECL, V111, P3200, DOI 10.1002/cber.19781110924; BIERI G, 1976, HELV CHIM ACTA, V59, P2657, DOI 10.1002/hlca.19760590805; BISCHOF P, 1971, HELV CHIM ACTA, V54, P1072, DOI 10.1002/hlca.19710540415; Bischof P., 1970, ANGEW CHEM, V82, P952, DOI 10.1002/ange.19700822304; Bischof P., 1970, ANGEW CHEM INT EDIT, V9, P953, DOI 10.1002/anie.197009531; BISCHOF P, 1969, HELV CHIM ACTA, V52, P1745, DOI 10.1002/hlca.19690520631; BROUGHTON HB, 1992, J CHEM SOC CHEM COMM, P998, DOI 10.1039/c39920000998; BRUCKMAN.P, 1972, ANGEW CHEM INT EDIT, V11, P524, DOI 10.1002/anie.197205241; Bruckmann P., 1972, ANGEW CHEM, V84, P543, DOI 10.1002/ange.19720841119; Burkert U., 1981, ANGEW CHEM, V93, P602, DOI 10.1002/ange.19810930628; BURKERT U, 1981, ANGEW CHEM INT EDIT, V20, P572, DOI 10.1002/anie.198105721; BURNELL EE, 1972, CAN J CHEMISTRY, V50, P3566, DOI 10.1139/v72-570; CHENG AK, 1977, ORG MAGN RESONANCE, V9, P355, DOI 10.1002/mrc.1270090615; CHRISTL M, 1975, CHEM BER-RECL, V108, P2781, DOI 10.1002/cber.19751080836; CLARKE SC, 1969, TETRAHEDRON, V25, P1265, DOI 10.1016/S0040-4020(01)82700-9; Closs L. G., 1966, J ORG CHEM, V31, P638; Dannenberg JJ, 1999, CHEM REV, V99, P1225, DOI 10.1021/cr980382f; DEWAR MJS, 1970, J AM CHEM SOC, V92, P3506, DOI 10.1021/ja00714a068; Diels O, 1928, LIEBIGS ANN CHEM, V460, P98; Epiotis N. D., 1977, STRUCTURAL THEORY OR, P7; Foresman J. B., 1993, EXPLORING CHEM ELECT, V2nd, P64; Freccero M, 2002, J ORG CHEM, V67, P8519, DOI 10.1021/jo026141w; FRISCH MJ, 1998, GAUSSIAN 98 REVISION; GAGNEUX A, 1959, HELV CHIM ACTA, V42, P2006, DOI 10.1002/hlca.19590420632; GALASSO V, 1989, CHEM PHYS, V138, P231, DOI 10.1016/0301-0104(89)87130-7; Gandolfi R, 1996, TETRAHEDRON LETT, V37, P1321, DOI 10.1016/0040-4039(95)02384-4; GLEITER R, 1983, J ORG CHEM, V48, P796, DOI 10.1021/jo00154a008; Glendening E.D., 1998, NBO VERSION 3 1; GOLDSTEI.MJ, 1973, HELV CHIM ACTA, V56, P294, DOI 10.1002/hlca.19730560120; GUNTHER H, 1980, J ORG CHEM, V45, P4329; HAYWOODF.J, 1974, CHEM REV, V74, P315, DOI 10.1021/cr60289a002; HAYWOODF.J, 1966, TETRAHEDRON, V22, P2007, DOI 10.1016/S0040-4020(01)82119-0; HAYWOODF.JS, 1969, J AM CHEM SOC, V91, P3020, DOI 10.1021/ja01039a033; Hehre W. J., 1986, AB INITIO MOL ORBITA, P275; HEILBRON.E, 1972, ISRAEL J CHEM, V10, P143; HEILBRON.E, 1972, HELV CHIM ACTA, V55, P1490, DOI 10.1002/hlca.19720550514; HEILBRONNER E, 1975, HELV CHIM ACTA, V58, P936, DOI 10.1002/hlca.19750580331; HIBINO J, 1985, TETRAHEDRON LETT, V26, P5579, DOI 10.1016/S0040-4039(01)80892-3; HOFFMANN R, 1971, ACCOUNTS CHEM RES, V4, P1, DOI 10.1021/ar50037a001; HOFFMANN R, 1970, J AM CHEM SOC, V92, P706, DOI 10.1021/ja00706a051; HOFFMANN R, 1971, J AM CHEM SOC, V93, P5699, DOI 10.1021/ja00751a021; Hoffmann R. W., 1972, ANGEW CHEM, V84, P533, DOI 10.1002/ange.19720841110; HOFFMANN RW, 1979, TETRAHEDRON LETT, P4959; HOFFMANN RW, 1978, CHEM BER-RECL, V111, P1275, DOI 10.1002/cber.19781110407; HOFFMANN RW, 1975, CHEM BER-RECL, V108, P119, DOI 10.1002/cber.19751080115; HOFFMANN RW, 1978, CHEM BER-RECL, V111, P1264, DOI 10.1002/cber.19781110406; HOFFMANN RW, 1972, ANGEW CHEM INT EDIT, V11, P512, DOI 10.1002/anie.197205121; HOFFMANN RW, 1983, CHEM BER-RECL, V116, P389, DOI 10.1002/cber.19831160140; INAGAKI S, 1977, J AM CHEM SOC, V99, P7418, DOI 10.1021/ja00465a003; IRNGARTINGER H, 1992, CHEM BER-RECL, V125, P2067, DOI 10.1002/cber.19921250914; IWAMURA H, 1979, TETRAHEDRON LETT, V20, P3449, DOI 10.1016/S0040-4039(01)95432-2; JEFFORD CW, 1976, HELV CHIM ACTA, V59, P2355, DOI 10.1002/hlca.19760590708; JEFFORD CW, 1980, TETRAHEDRON LETT, V21, P755, DOI 10.1016/S0040-4039(00)71464-X; JEFFORD CW, 1985, HELV CHIM ACTA, V68, P1557, DOI 10.1002/hlca.19850680607; JEFFREY GA, 1988, J AM CHEM SOC, V110, P7218, DOI 10.1021/ja00229a049; JONES GR, 1993, J CHEM SOC CHEM COMM, P769, DOI 10.1039/c39930000769; Jorgensen W. L., 1973, ORGANIC CHEM BOOK OR, P11; JORGENSEN WL, 1975, J AM CHEM SOC, V97, P3082, DOI 10.1021/ja00844a027; JORGENSEN WL, 1976, J AM CHEM SOC, V98, P6784, DOI 10.1021/ja00438a002; KELLY DP, 1988, J ORG CHEM, V53, P2497, DOI 10.1021/jo00246a019; KNOTHE L, 1977, LIEBIGS ANN CHEM, P709; KOBAYASHI T, 1987, J AM CHEM SOC, V109, P5103, DOI 10.1021/ja00251a009; KOBAYASHI T, 1986, CHEM PHYS LETT, V125, P586, DOI 10.1016/0009-2614(86)87104-4; KOBAYASHI T, 1988, J AM CHEM SOC, V110, P5622, DOI 10.1021/ja00225a005; Kolakowski RV, 2010, NAT CHEM, V2, P303, DOI [10.1038/nchem.577, 10.1038/NCHEM.577]; LEROY G, 1974, J CHIM PHYS PCB, V71, P475; LI HF, 1992, RECL TRAV CHIM PAY B, V111, P199; LUMB JT, 1964, J CHEM SOC, P1189; Marchand AP, 1999, TETRAHEDRON, V55, P8313, DOI 10.1016/S0040-4020(99)00464-0; MARTIN HD, 1977, CHEM BER-RECL, V110, P3010, DOI 10.1002/cber.19771100906; MASAMUNE S, 1974, CAN J CHEM, V52, P858, DOI 10.1139/v74-136; MAZZOCCHI PH, 1980, J AM CHEM SOC, V102, P6482, DOI 10.1021/ja00541a017; Mehta G, 2002, ORG LETT, V4, P2297, DOI 10.1021/ol026005d; Mehta G, 1999, CHEM REV, V99, P1437, DOI 10.1021/cr980369v; MEHTA G, 1991, J CHEM SOC CHEM COMM, P18, DOI 10.1039/c39910000018; Mehta G, 1998, CHEM COMMUN, P975, DOI 10.1039/a802089b; Mehta G., 1994, ANGEW CHEM, V106, P1433, DOI 10.1002/ange.19941061317; MEINWALD J, 1965, TETRAHEDRON LETT, P1789; MULLER E, 1976, CHEM BER-RECL, V109, P3793, DOI 10.1002/cber.19761091206; MUSSO H, 1975, CHEM BER-RECL, V108, P337, DOI 10.1002/cber.19751080143; Ohwada T, 1996, CHEM PHARM BULL, V44, P296; OKADA K, 1978, J AM CHEM SOC, V100, P6509, DOI 10.1021/ja00488a045; OKADA K, 1979, TETRAHEDRON LETT, V20, P3429, DOI 10.1016/S0040-4039(01)95427-9; OLAH GA, 1973, J AM CHEM SOC, V95, P8698, DOI 10.1021/ja00807a032; OLAH GA, 1975, J AM CHEM SOC, V97, P6803, DOI 10.1021/ja00856a033; PADDONROW MN, 1990, J AM CHEM SOC, V112, P1710, DOI 10.1021/ja00161a010; Paquette L. A., 1978, ANGEW CHEM, V90, P114, DOI 10.1002/ange.19780900208; PAQUETTE LA, 1978, ANGEW CHEM INT EDIT, V17, P106, DOI 10.1002/anie.197801061; PAQUETTE LA, 1981, J AM CHEM SOC, V103, P7106, DOI 10.1021/ja00414a014; Piccolini R. J., 1963, TETRAHEDRON        S, V19, P423, DOI 10.1016/S0040-4020(63)80031-9; POULTER CD, 1972, J AM CHEM SOC, V94, P2291, DOI 10.1021/ja00762a021; Rademacher P, 2003, CHEM REV, V103, P933, DOI 10.1021/cr0100143; RAPOPORT H, 1963, J AM CHEM SOC, V85, P1636, DOI 10.1021/ja00894a022; Rome W. D., 1971, TETRAHEDRON, V27, P2271; SAKAI M, 1970, J AM CHEM SOC, V92, P4452, DOI 10.1021/ja00717a052; SCHUELER PE, 1974, J ORG CHEM, V39, P2063, DOI 10.1021/jo00928a020; Sen A, 2010, TETRAHEDRON LETT, V51, P143, DOI 10.1016/j.tetlet.2009.10.100; Sen A, 2011, TETRAHEDRON, V67, P3754, DOI 10.1016/j.tet.2011.02.022; Szabo KJ, 1996, J ORG CHEM, V61, P2783, DOI 10.1021/jo951927y; TANIDA H, 1967, J AM CHEM SOC, V89, P1953, DOI 10.1021/ja00984a036; TORI K, 1965, J AM CHEM SOC, V87, P386, DOI 10.1021/ja01080a046; TORI K, 1966, TETRAHEDRON LETT, P2921; TORI K, 1964, TETRAHEDRON LETT, P559; TORI K, 1974, TETRAHEDRON LETT, P327; Tsuji M, 1997, TETRAHEDRON LETT, V38, P6693, DOI 10.1016/S0040-4039(97)01567-0; Tsuji M., 1998, THESIS U TOKYO JAPAN; Tsuji M, 2004, J ORG CHEM, V69, P4063, DOI 10.1021/jo049854i; VOLZ H, 1975, TETRAHEDRON LETT, P1665; WIBERG KB, 1965, J ORG CHEM, V30, P2278, DOI 10.1021/jo01018a039; Williams RV, 1999, TETRAHEDRON LETT, V40, P2689, DOI 10.1016/S0040-4039(99)00333-0; WINSTEIN S, 1969, Q REV CHEM SOC, V23, P141, DOI 10.1039/qr9692300141; WIPFF G, 1980, TETRAHEDRON LETT, V21, P4445, DOI 10.1016/S0040-4039(00)92195-6; WU YD, 1993, J ORG CHEM, V58, P4625, DOI 10.1021/jo00069a025; YOKOZEKI A, 1971, B CHEM SOC JPN, V44, P2356, DOI 10.1246/bcsj.44.2356; YOKOZEKI A, 1971, B CHEM SOC JPN, V44, P1783, DOI 10.1246/bcsj.44.1783; ZIMMERMA.D, 1974, ORG MAGN RESONANCE, V6, P492, DOI 10.1002/mrc.1270060908	140	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	JUL	2015	4	7					659	673		10.1002/ajoc.201500054		15	Chemistry, Organic	Chemistry	CM0RO	WOS:000357386200011		
J	Fukui, Y; Harada, R; Tokuda, K; Morioka, Y; Onishi, T; Torii, K; Ohama, A; Hattori, Y; Nayak, O; Meixner, M; Sewilo, M; Indebetouw, R; Kawamura, A; Saigo, K; Yamamoto, H; Tachihara, K; Minamidani, T; Inoue, T; Madden, S; Galametz, M; Lebouteiller, V; Mizuno, N; Chen, CHR				Fukui, Yasuo; Harada, Ryohei; Tokuda, Kazuki; Morioka, Yuuki; Onishi, Toshikazu; Torii, Kazufumi; Ohama, Akio; Hattori, Yusuke; Nayak, Omnarayani; Meixner, Margaret; Sewilo, Marta; Indebetouw, Remy; Kawamura, Akiko; Saigo, Kazuya; Yamamoto, Hiroaki; Tachihara, Kengo; Minamidani, Tetsuhiro; Inoue, Tsuyoshi; Madden, Suzanna; Galametz, Maud; Lebouteiller, Vianney; Mizuno, Norikazu; Chen, C. -H. Rosie			HIGH-MASS STAR FORMATION TRIGGERED BY COLLISION BETWEEN CO FILAMENTS IN N159 WEST IN THE LARGE MAGELLANIC CLOUD	ASTROPHYSICAL JOURNAL LETTERS			English	Article						ISM: clouds; ISM: kinematics and dynamics; ISM: molecules; stars: formation	YOUNG STELLAR OBJECTS; SPECTRAL ENERGY-DISTRIBUTIONS; MOLECULAR CLOUDS; CLUSTER FORMATION; WESTERLUND 2; N 159; CATALOG; NANTEN; GAS; LMC	We have carried out (CO)-C-13(J = 2-1) observations of the active star-forming region N159 west in the Large Magellanic Cloud with ALMA. We have found that the CO distribution at a sub-parsec scale is highly elongated with a small width. These elongated clouds called "filaments" show straight or curved distributions with a typical width of 0.5-1.0 pc and a length of 5-10 pc. All the known infrared young stellar objects are located toward the filaments. We have found broad CO wings of two molecular outflows toward young high-mass stars in N159W-N and N159W-S, whose dynamical timescale is similar to 10(4) years. This is the first discovery of protostellar outflow in external galaxies. For N159W-S, which is located toward an intersection of two filaments, we set up a hypothesis that the two filaments collided with each other similar to 10(5) years ago and triggered the formation of the high-mass star having similar to 37 M-circle dot. The colliding clouds show significant enhancement in linewidth in the intersection, suggesting excitation of turbulence in the shocked interface layer between them, as is consistent with the magnetohydrodynamical numerical simulations. This turbulence increases the mass accretion rate to similar to 6 x 10(-4) M(circle dot)yr(-1), which is required to overcome the stellar feedback to form the high-mass star.	[Fukui, Yasuo; Torii, Kazufumi; Ohama, Akio; Hattori, Yusuke; Yamamoto, Hiroaki; Tachihara, Kengo] Nagoya Univ, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Harada, Ryohei; Tokuda, Kazuki; Morioka, Yuuki; Onishi, Toshikazu] Osaka Prefecture Univ, Grad Sch Sci, Dept Phys Sci, Naka Ku, Sakai, Osaka 5998531, Japan; [Nayak, Omnarayani; Meixner, Margaret; Sewilo, Marta] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Meixner, Margaret] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Sewilo, Marta] Space Sci Inst, Boulder, CO 80301 USA; [Indebetouw, Remy; Mizuno, Norikazu] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Indebetouw, Remy] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Kawamura, Akiko; Saigo, Kazuya] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Inoue, Tsuyoshi] Natl Astron Observ, Div Theoret Astron, Tokyo, Japan; [Minamidani, Tetsuhiro] Natl Inst Nat Sci, Natl Astron Observ Japan, Nobeyama Radio Observ, Minamimaki, Nagano 3841305, Japan; [Madden, Suzanna; Lebouteiller, Vianney] Univ Paris 07, CEA, IRFU, Lab AIM,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Galametz, Maud] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Galametz, Maud] European So Observ, D-85748 Garching, Germany; [Mizuno, Norikazu] Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1330033, Japan; [Chen, C. -H. Rosie] Max Planck Inst Radioastron, D-53121 Bonn, Germany	Fukui, Y (reprint author), Nagoya Univ, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648602, Japan.				JSPS KAKENHI [22244014, 22540250, 22740127, 23403001, 24224005, 26247026]; JSPS; Mitsubishi Foundation; NSF grant [1312902]	The authors thank the anonymous referee for helpful comments. This paper makes use of the following ALMA data: ADS/JAO.ALMA#2012.1.00554.S. ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada), NSC and ASIAA (Taiwan), and KASI (Republic of Korea), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. This work was supported by JSPS KAKENHI grant numbers 22244014, 22540250, 22740127, 23403001, 24224005, 26247026; by JSPS; and by the Mitsubishi Foundation. M.M. and O.N. are grateful for support from NSF grant 1312902.	Andre P., 2013, PROTOSTARS PLANETS, P27; Robitaille TP, 2007, ASTROPHYS J SUPPL S, V169, P328, DOI 10.1086/512039; Furukawa N, 2009, ASTROPHYS J LETT, V696, pL115, DOI 10.1088/0004-637X/696/2/L115; Robitaille TP, 2006, ASTROPHYS J SUPPL S, V167, P256, DOI 10.1086/508424; Fukui Y, 1999, PUBL ASTRON SOC JPN, V51, P745; Vaidya B, 2013, MON NOT R ASTRON SOC, V433, P1258, DOI 10.1093/mnras/stt800; Szewczyk O, 2009, ASTRON J, V138, P1661, DOI 10.1088/0004-6256/138/6/1661; Yamaguchi R, 2001, PUBL ASTRON SOC JPN, V53, P985; Carlson LR, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118627; Chen CHR, 2010, ASTROPHYS J, V721, P1206, DOI 10.1088/0004-637X/721/2/1206; Fukui Y, 2008, ASTROPHYS J SUPPL S, V178, P56, DOI 10.1086/589833; Fukui Y, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/36; Fukui Y, 2010, ANNU REV ASTRON ASTR, V48, P547, DOI 10.1146/annurev-astro-081309-130854; Fukui Y., 2015, ARXIV150405391; Inoue T, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L31; Jones TJ, 2005, ASTROPHYS J, V620, P731, DOI 10.1086/427159; Mizuno N, 2001, PUBL ASTRON SOC JPN, V53, P971; Mizuno Y, 2010, PUBL ASTRON SOC JPN, V62, P51; Molinari S, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014659; Nishimura A, 2015, ASTROPHYS J SUPPL S, V216, DOI 10.1088/0067-0049/216/1/18; Ohama A, 2010, ASTROPHYS J, V709, P975, DOI 10.1088/0004-637X/709/2/975; Peretto N, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321318; Schaefer BE, 2008, ASTRON J, V135, P112, DOI 10.1088/0004-6256/135/1/112; Seale JP, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/6/124; Seale JP, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/42; Seale JP, 2009, ASTROPHYS J, V699, P150, DOI 10.1088/0004-637X/699/1/150; Subramanian S, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/201014201; Tan J. C., 2014, PROTOSTARS PLANETS, P149; Testor G, 2006, ASTRON ASTROPHYS, V453, P517, DOI 10.1051/0004-6361:20054697; Torii K, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/46; Torii K, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/1/7; WOLFIRE MG, 1986, ASTROPHYS J, V310, P207, DOI 10.1086/164676; Wong T, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/16; Zinnecker H., 2007, ARA A, V481, P563	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	JUL 1	2015	807	1							L4	10.1088/2041-8205/807/1/L4		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CL8YY	WOS:000357262100004		
J	Koda, J; Yagi, M; Yamanoi, H; Komiyama, Y				Koda, Jin; Yagi, Masafumi; Yamanoi, Hitomi; Komiyama, Yutaka			APPROXIMATELY A THOUSAND ULTRA-DIFFUSE GALAXIES IN THE COMA CLUSTER	ASTROPHYSICAL JOURNAL LETTERS			English	Article						galaxies: clusters: individual (Coma); galaxies: evolution; galaxies: structure	SURFACE BRIGHTNESS GALAXIES; DWARF GALAXIES; LUMINOSITY FUNCTIONS; VIRGO CLUSTER; SUPRIME-CAM; LOCAL GROUP; EVOLUTION; ORIGIN; SPECTRA; MATTER	We report the discovery of 854 ultra-diffuse galaxies (UDGs) in the Coma cluster using deep R band images, with partial B, i, and H alpha band coverage, obtained with the Subaru telescope. Many of them (332) are Milky Way (MW) sized with very large effective radii of r(e) > 1.5 kpc. This study was motivated by the recent discovery of 47 UDGs by Dokkum et al.; our discovery suggests > 1000 UDGs after accounting for the smaller Subaru field (4.1 degree(2); about one-half of Dragonfly). The new Subaru UDGs show a distribution concentrated around the cluster center, strongly suggesting that the great majority are (likely longtime) cluster members. They are a passively evolving population, lying along the red sequence in the color-magnitude diagram with no signature of H alpha emission. Star formation was, therefore, quenched in the past. They have exponential light profiles, effective radii r(e) similar to 800 pc-5 kpc, effective surface brightnesses mu(e) (R) = 25-28 mag arcsec(-2), and stellar masses similar to 1 x 10(7)M(circle dot)-5 x 10(8)M(circle dot). There is also a population of nucleated UDGs. Some MW-sized UDGs appear closer to the cluster center than previously reported; their survival in the strong tidal field, despite their large sizes, possibly indicates a large dark matter fraction protecting the diffuse stellar component. The indicated baryon fraction less than or similar to 1% is less than the cosmic average, and thus the gas must have been removed (from the possibly massive dark halo). The UDG population is elevated in the Coma cluster compared to the field, indicating that the gas removal mechanism is related primarily to the cluster environment.	[Koda, Jin] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Yagi, Masafumi; Yamanoi, Hitomi; Komiyama, Yutaka] Natl Inst Nat Sci, Natl Astron Observ Japan, Opt & Infrared Astron Div, Mitaka, Tokyo 1818588, Japan; [Yagi, Masafumi] Hosei Univ, Dept Adv Sci, Koganei, Tokyo 1848584, Japan; [Komiyama, Yutaka] Grad Univ Adv Studies, SOKENDAI, Mitaka, Tokyo 1818588, Japan	Koda, J (reprint author), SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA.	jin.koda@stonybrook.edu			NASA grant [NNX14AF74G]; NSF grant [AST-1211680]	We thank Alessandro Boselli, Samuel Boissier, Jim Barrett, and an anonymous referee for helpful comments. This research utilized facilities and resources provided by the National Astronomical Observatory of Japan (NAOJ), including the Subaru Telescope, the SMOKA data archive system, and computers at the Astronomy Data Center. J.K. acknowledges support from NASA grant NNX14AF74G and NSF grant AST-1211680.	Okabe N, 2010, ASTROPHYS J, V713, P291, DOI 10.1088/0004-637X/713/1/291; Yagi M, 2002, ASTRON J, V123, P66, DOI 10.1086/324731; GUNN JE, 1972, ASTROPHYS J, V176, P1, DOI 10.1086/151605; Impey C, 2001, ASTRON J, V122, P2341, DOI 10.1086/323537; Blanton MR, 2001, ASTRON J, V121, P2358, DOI 10.1086/320405; WHITE SDM, 1993, MON NOT R ASTRON SOC, V261, pL8; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Miyazaki S, 2002, PUBL ASTRON SOC JPN, V54, P833; Moore B, 1996, NATURE, V379, P613, DOI 10.1038/379613a0; Yagi M, 2007, ASTROPHYS J, V660, P1209, DOI 10.1086/512359; Abraham RG, 2014, PUBL ASTRON SOC PAC, V126, P55, DOI 10.1086/674875; Tolstoy E, 2009, ANNU REV ASTRON ASTR, V47, P371, DOI 10.1146/annurev-astro-082708-101650; LARSON RB, 1980, ASTROPHYS J, V237, P692, DOI 10.1086/157917; DEKEL A, 1986, ASTROPHYS J, V303, P39, DOI 10.1086/164050; Peng CY, 2002, ASTRON J, V124, P266, DOI 10.1086/340952; Baba H., 2002, Report of the National Astronomical Observatory of Japan, V6; BINGGELI B, 1991, ASTRON ASTROPHYS, V252, P27; BOTHUN GD, 1991, ASTROPHYS J, V376, P404, DOI 10.1086/170290; Dalcanton JJ, 1997, ASTRON J, V114, P635, DOI 10.1086/118499; Ferrarese L, 2012, ASTROPHYS J SUPPL S, V200, DOI 10.1088/0067-0049/200/1/4; Kashikawa N, 2004, PUBL ASTRON SOC JPN, V56, P1011; Kodama T, 1997, ASTRON ASTROPHYS, V320, P41; Komiyama Y, 2002, ASTROPHYS J SUPPL S, V138, P265, DOI 10.1086/324644; Larson D, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/16; McConnachie AW, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/1/4; Mink DJ, 2002, ASTR SOC P, V281, P169; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Sersic J. L., 1968, ATLAS GALAXIAS AUSTR; Ulmer MP, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015413; Ulmer MP, 1996, ASTRON J, V112, P2517, DOI 10.1086/118198; van Dokkum PG, 2015, ASTROPHYS J LETT, V798, DOI 10.1088/2041-8205/798/2/L45; Yagi M, 2010, ASTRON J, V140, P1814, DOI 10.1088/0004-6256/140/6/1814; Yagi M, 2013, PUBL ASTRON SOC JPN, V65; Yamanoi H, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/2/40; Yoshida M, 2008, ASTROPHYS J, V688, P918, DOI 10.1086/592430	35	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	JUL 1	2015	807	1							L2	10.1088/2041-8205/807/1/L2		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CL8YY	WOS:000357262100002		
J	Niinuma, K; Kino, M; Doi, A; Hada, K; Nagai, H; Koyama, S				Niinuma, K.; Kino, M.; Doi, A.; Hada, K.; Nagai, H.; Koyama, S.			DISCOVERY OF A WANDERING RADIO JET BASE AFTER A LARGE X-RAY FLARE IN THE BLAZAR MARKARIAN 421	ASTROPHYSICAL JOURNAL LETTERS			English	Article						BL Lacertae objects: individual (Markarian 421); galaxies: active; galaxies: jets	ACTIVE GALACTIC NUCLEI; INTERNAL SHOCKS; PROPER MOTION; LAC OBJECTS; BLACK-HOLE; QUASARS; KINEMATICS; ASTROMETRY; LOCATION; STATE	We investigate the location of the radio jet bases ("radio cores") of blazars in radio images and their stationarity by means of dense very long baseline interferometry (VLBI) observations. In order to measure the position of a radio core, we conducted a 12 epoch astrometric observation of the blazar Markarian 421 with the VLBI Exploration of Radio Astrometry at 22 GHz immediately after a large X-ray flare, which occurred in the middle of 2011 September. For the first time, we find that the radio core is not stationary but rather changes its location toward 0.5 mas downstream. This angular scale corresponds to the de-projected length of a scale of 10(5) Schwarzschild radii (R-s) at the distance of Markarian 421. This radio-core wandering may be a new type of manifestation associated with the phenomena of large X-ray flares.	[Niinuma, K.] Yamaguchi Univ, Grad Sch Sci & Engn, Yamaguchi, Yamaguchi 7538512, Japan; [Kino, M.] Korea Astron & Space Sci Inst, Korean VLBI Network, Taejon 305348, South Korea; [Doi, A.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuou Ku, Sagamihara, Kanagawa 2298510, Japan; [Hada, K.] Natl Astron Observ Japan, Mizusawa VLBI Observ, Mitaka, Tokyo 1818588, Japan; [Nagai, H.] Natl Astron Observ Japan, Chile Observ, Mitaka, Tokyo 1818588, Japan; [Koyama, S.] Max Planck Inst Radioastron, D-53121 Bonn, Germany	Niinuma, K (reprint author), Yamaguchi Univ, Grad Sch Sci & Engn, Yoshida 1677-1, Yamaguchi, Yamaguchi 7538512, Japan.	niinuma@yamaguchi-u.ac.jp			KAKENHI [24340042, 24540240, 26800109]	We thank T. Oyama, K. Fujisawa, K. Motogi, and T. Kawaguchi for discussions. We also thank E. Ros for comments on the paper. VERA is operated by the National Astronomical Observatory of Japan. This work was partially supported by KAKENHI (24340042, A.D., and 24540240, M.K., 26800109, K.H.).	Potter WJ, 2013, MON NOT R ASTRON SOC, V436, P304, DOI 10.1093/mnras/stt1569; PUNCH M, 1992, NATURE, V358, P477, DOI 10.1038/358477a0; Marscher AP, 2008, NATURE, V452, P966, DOI 10.1038/nature06895; Ghisellini G, 2005, ASTRON ASTROPHYS, V432, P401, DOI 10.1051/0004-6361:20041404; Hada K, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/165; Kellermann KI, 2004, ASTROPHYS J, V609, P539, DOI 10.1086/421289; Orienti M, 2013, MON NOT R ASTRON SOC, V428, P2418, DOI 10.1093/mnras/sts201; Honma M, 2008, PUBL ASTRON SOC JPN, V60, P951; REES MJ, 1971, NATURE, V229, P312, DOI 10.1038/229312a0; Hada K, 2011, NATURE, V477, P185, DOI 10.1038/nature10387; BARTEL N, 1986, NATURE, V319, P733, DOI 10.1038/319733a0; Abdo AA, 2010, NATURE, V463, P919, DOI 10.1038/nature08841; MARCAIDE JM, 1983, ASTRON J, V88, P1133, DOI 10.1086/113402; Lister ML, 2009, ASTRON J, V138, P1874, DOI 10.1088/0004-6256/138/6/1874; Blasi M. G., 2013, ASTRON ASTROPHYS, V559, P75; Cohen MH, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/151; Fey AL, 1997, ASTRON J, V114, P2284, DOI 10.1086/118648; Fromm CM, 2015, ASTRON ASTROPHYS, V576, DOI 10.1051/0004-6361/201322836; Gomez JL, 1997, ASTROPHYS J, V482, pL33, DOI 10.1086/310671; Guetta D, 2004, ASTRON ASTROPHYS, V421, P877, DOI 10.1051/0004-6361:20040235; Hada K, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/70; Hiroi K., 2011, ATEL, V3637, P1; Honma M, 2008, PUBL ASTRON SOC JPN, V60, P935; Itoh R., 2015, ARXIV150206174; Kirk JG, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/104; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Koyama S., 2015, ARXIV150103498; Lico R, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219870; Lico R., 2014, ASTRON ASTROPHYS, V571, pAA54; Lister ML, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/5/120; Rieger FM, 2012, MOD PHYS LETT A, V27, DOI 10.1142/S0217732312300303; Ros E, 1999, ASTRON ASTROPHYS, V348, P381; Shepherd MC, 1997, ASTR SOC P, V125, P77; Spada M, 2001, MON NOT R ASTRON SOC, V325, P1559, DOI 10.1046/j.1365-8711.2001.04557.x; Wagner RM, 2008, MON NOT R ASTRON SOC, V385, P119, DOI 10.1111/j.1365-2966.2008.12850.x	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	JUL 1	2015	807	1							L14	10.1088/2041-8205/807/1/L14		5	Astronomy & Astrophysics	Astronomy & Astrophysics	CL8YY	WOS:000357262100014		
J	Nobukawa, KK; Nobukawa, M; Uchiyama, H; Tsuru, TG; Torii, K; Tanaka, T; Chernyshov, DO; Fukui, Y; Dogiel, VA; Koyama, K				Nobukawa, K. K.; Nobukawa, M.; Uchiyama, H.; Tsuru, T. G.; Torii, K.; Tanaka, T.; Chernyshov, D. O.; Fukui, Y.; Dogiel, V. A.; Koyama, K.			ENHANCEMENT OF THE 6.4 keV LINE IN THE INNER GALACTIC RIDGE: PROTON-INDUCED FLUORESCENCE?	ASTROPHYSICAL JOURNAL LETTERS			English	Article						cosmic rays; Galaxy: disk; X-rays: ISM	X-RAY-EMISSION; K-SHELL EMISSION; ARCHES CLUSTER; CENTER REGION; COSMIC-RAYS; A-ASTERISK; SUZAKU; GALAXY; DISCOVERY; SPECTRUM	A common idea for the origin of the Galactic diffuse X-ray emission, particularly that of the iron lines from neutral and highly ionized atoms, is a superposition of many cataclysmic variables and coronally active binaries. In this scenario, the flux should symmetrically distribute between the east and west on the plane with respect to Sagittarius A* because the stellar mass distribution determined by infrared observations is nearly symmetric. This symmetry is confirmed for the highly ionized iron line as well as the continuum emission. However, a clear excess of the neutral iron line in the near east of the Galactic center compared to the near-west side is found. The flux distribution of the excess emission well correlates with the molecular column density. The X-ray spectrum of the excess emission is described by a power-law continuum plus a 6.4 keV line with a large equivalent width of similar to 1.3 keV, which is hardly explained by the low-energy electron bombardment scenario. The longitudinal and latitudinal distribution of the excess emission disfavors the X-ray irradiation, either by Sagittarius A* or by nearby X-ray binaries. Then, the low-energy proton bombardment is the most probable origin, although the high-energy density similar to 80 eV cm(-3) in 0.1-1000 MeV is required and there is no conventional proton source in the vicinity.	[Nobukawa, K. K.; Nobukawa, M.; Tsuru, T. G.; Tanaka, T.; Koyama, K.] Kyoto Univ, Grad Sch Sci, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan; [Nobukawa, M.] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068302, Japan; [Uchiyama, H.] Shizuoka Univ, Fac Educ, Suruga Ku, Shizuoka 4228529, Japan; [Torii, K.; Fukui, Y.] Nagoya Univ, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Chernyshov, D. O.; Dogiel, V. A.] PN Lebedev Inst, Moscow 119991, Russia; [Dogiel, V. A.] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow Region, Russia; [Koyama, K.] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan	Nobukawa, KK (reprint author), Kyoto Univ, Grad Sch Sci, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan.	kumiko@cr.scphys.kyoto-u.ac.jp	Chernyshov, Dmitry/L-8936-2013; XRAY, SUZAKU/A-1808-2009	Chernyshov, Dmitry/0000-0003-0716-5951; 	JSPS; MEXT KAKENHI [24740123, 25887028, 23340047, 25109004, 15H02090, 23740149, 24540229]; RFFI grants [15-52-52004, 15-02-02358]; Dynasty foundation	The authors thank all the members of the Suzaku team and the NANTEN consortium. K.K.N. is supported by Research Fellowships of JSPS for Young Scientists. This study was also supported by JSPS and MEXT KAKENHI grants 24740123 (M.N.), 25887028 (H.U.), 23340047, 25109004, 15H02090 (T.G.T.), 23740149 (K.T.), and 24540229 (K.K.). V.A.D. and D.O.C acknowledge partial support from the RFFI grants 15-52-52004 and 15-02-02358. D.O.C. is partially supported by the Dynasty foundation.	Martin RP, 2015, MON NOT R ASTRON SOC, V449, P4071, DOI 10.1093/mnras/stv590; Nobukawa M, 2010, PUBL ASTRON SOC JPN, V62, P423; Inui T, 2009, PUBL ASTRON SOC JPN, V61, pS241; Su M, 2010, ASTROPHYS J, V724, P1044, DOI 10.1088/0004-637X/724/2/1044; Ponti G, 2010, ASTROPHYS J, V714, P732, DOI 10.1088/0004-637X/714/1/732; Giveon U, 2002, ASTROPHYS J, V566, P880, DOI 10.1086/338125; Neronov A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.051105; Launhardt R, 2002, ASTRON ASTROPHYS, V384, P112, DOI 10.1051/0004-6361:20020017; Dogiel V, 2011, PUBL ASTRON SOC JPN, V63, P535; SUNYAEV RA, 1993, ASTROPHYS J, V407, P606, DOI 10.1086/172542; Kaneda H, 1997, ASTROPHYS J, V491, P638, DOI 10.1086/304965; Amano T, 2011, PUBL ASTRON SOC JPN, V63, pL63; Smith RK, 2001, ASTROPHYS J, V556, pL91, DOI 10.1086/322992; Revnivtsev M, 2006, ASTRON ASTROPHYS, V452, P169, DOI 10.1051/0004-6361:20054268; Kushino A, 2002, PUBL ASTRON SOC JPN, V54, P327; Uchiyama H, 2011, PUBL ASTRON SOC JPN, V63, pS903; Valinia A, 2000, ASTROPHYS J, V543, P733, DOI 10.1086/317133; PAUL H, 1989, ATOM DATA NUCL DATA, V42, P105, DOI 10.1016/0092-640X(89)90033-8; Cunha K, 2007, ASTROPHYS J, V669, P1011, DOI 10.1086/521813; Dogiel V. A., 2013, ASTROPHYS J LETT, V771, P43; Koyama K, 2007, PUBL ASTRON SOC JPN, V59, pS23; Mitsuda K, 2007, PUBL ASTRON SOC JPN, V59, pS1; Molaro M., 2014, ASTRON ASTROPHYS, V561, P107; Muno MP, 2004, ASTROPHYS J, V613, P326, DOI 10.1086/422865; Nakashima S, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/20; Nobukawa M, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L52; Predehl P, 2003, ASTRON NACHR, V324, P73, DOI 10.1002/asna.200310019; Sawada M, 2011, PUBL ASTRON SOC JPN, V63, pS849; Tatischeff V, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219016; Tawa N, 2008, PUBL ASTRON SOC JPN, V60, pS11; Torii K, 2010, PUBL ASTRON SOC JPN, V62, P1307; Tsujimoto M, 2007, PUBL ASTRON SOC JPN, V59, pS229; Warwick RS, 2014, MON NOT R ASTRON SOC, V438, P2967, DOI 10.1093/mnras/stt2413; Yusef-Zadeh F., 2002, Astrophysical Journal, Letters, V568, DOI 10.1086/340379	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	JUL 1	2015	807	1							L10	10.1088/2041-8205/807/1/L10		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CL8YY	WOS:000357262100010		
J	Karino, S				Karino, Shigeyuki			Numerical modeling of clump accretion onto neutron star	ASTROPHYSICS AND SPACE SCIENCE			English	Article						Accretion; Accretion disks; Stars: neutron; X-ray: stars	X-RAY TRANSIENT; FLIP-FLOP INSTABILITY; DRIVEN STELLAR WINDS; IGR J11215-5952; XTE J1739-302; VELA X-1; O-STAR; SIMULATIONS; BINARIES; OUTBURST	Observationally and theoretically, it is suggested that stellar wind from a massive star is not uniform but highly structured. The classical Bondi-Hoyle-Lyttleton accretion theory is no longer able to be applied to investigate such inhomogeneous wind accretion phenomena, and instead, non-linear numerical studies are required. In this paper, we introduce the first attempt of numerical study of clump accretion onto a compact object. We apply a simple numerical hydro-simulation code in 2D to investigate accretion events of structured wind onto a compact object. We find that a gas clump in stellar wind makes a large temporal increase and associated oscillations of mass accretion rate. Furthermore, we show that even a glancing off of a clump can induce a flip-flop instability of the accretion flow. Inhomogeneous wind accretion could be a key to understand complex behaviors of X-ray light curves in high mass X-ray binaries. Assuming that obtained mass accretion rate resembles to X-ray light curves, we discuss the origin of X-ray flares in supergiant fast X-ray transients.	Kyushu Sangyo Univ, Fukuoka 8138503, Japan	Karino, S (reprint author), Kyushu Sangyo Univ, 2-3-1 Matsukadai, Fukuoka 8138503, Japan.	karino@ip.kyusan-u.ac.jp					Oskinova LM, 2007, ASTRON ASTROPHYS, V476, P1331, DOI 10.1051/0004-6361:20066377; CASTOR JI, 1975, ASTROPHYS J, V195, P157, DOI 10.1086/153315; MATSUDA T, 1992, MON NOT R ASTRON SOC, V255, P183; Romano P, 2008, ASTROPHYS J LETT, V680, pL137, DOI 10.1086/590082; Kreykenbohm I, 2008, ASTRON ASTROPHYS, V492, P511, DOI 10.1051/0004-6361:200809956; Hoyle F, 1939, P CAMB PHILOS SOC, V35, P405; TAAM RE, 1988, ASTROPHYS J, V327, pL73, DOI 10.1086/185143; Sidoli L, 2012, MON NOT R ASTRON SOC, V420, P554, DOI 10.1111/j.1365-2966.2011.20063.x; Bondi H, 1944, MON NOT R ASTRON SOC, V104, P0273; Oskinova LM, 2012, MON NOT R ASTRON SOC, V421, P2820, DOI 10.1111/j.1365-2966.2012.20507.x; Bozzo E, 2008, ASTROPHYS J, V683, P1031, DOI 10.1086/589990; Leyder JC, 2007, ASTRON ASTROPHYS, V465, pL35, DOI 10.1051/0004-6361:20066317; Watanabe S, 2006, ASTROPHYS J, V651, P421, DOI 10.1086/507458; Blondin JM, 2009, ASTROPHYS J, V700, P95, DOI 10.1088/0004-637X/700/1/95; MACGREGOR KB, 1979, ASTROPHYS J, V231, P514, DOI 10.1086/157213; MATSUDA T, 1987, MON NOT R ASTRON SOC, V226, P785; Kudritzki RP, 2000, ANNU REV ASTRON ASTR, V38, P613, DOI 10.1146/annurev.astro.38.1.613; Lepine S, 2008, ASTRON J, V136, P548, DOI 10.1088/0004-6256/136/2/548; Sguera V, 2008, ASTRON ASTROPHYS, V487, P619, DOI 10.1051/0004-6361:20079195; Negueruela I, 2006, ASTROPHYS J, V638, P982, DOI 10.1086/498935; Smith DM, 2006, ASTROPHYS J, V638, P974, DOI 10.1086/498936; SAWADA K, 1989, ASTRON ASTROPHYS, V221, P263; Walter R, 2007, ASTRON ASTROPHYS, V476, P335, DOI 10.1051/0004-6361:20078353; Sidoli L, 2010, MON NOT R ASTRON SOC, V409, P611, DOI 10.1111/j.1365-2966.2010.17320.x; Repolust T, 2004, ASTRON ASTROPHYS, V415, P349, DOI 10.1051/0004-6361:20034594; FRYXELL BA, 1988, ASTROPHYS J, V335, P862, DOI 10.1086/166973; Puls J, 2006, ASTRON ASTROPHYS, V454, P625, DOI 10.1051/0004-6361:20065073; Dessart L, 2005, ASTRON ASTROPHYS, V437, P657, DOI 10.1051/0004-6361:20052778; OWOCKI SP, 1984, ASTROPHYS J, V284, P337, DOI 10.1086/162412; Owocki SP, 2006, ASTROPHYS J, V648, P565, DOI 10.1086/505698; Ducci L, 2009, MON NOT R ASTRON SOC, V398, P2152, DOI 10.1111/j.1365-2966.2009.15265.x; Ducci L, 2010, MON NOT R ASTRON SOC, V408, P1540, DOI 10.1111/j.1365-2966.2010.17216.x; CORBET RHD, 1984, ASTRON ASTROPHYS, V141, P91; Benensohn JS, 1997, ASTROPHYS J, V478, P723, DOI 10.1086/303835; Bozzo E., 2011, ASTRON ASTROPHYS, V531, P130, DOI DOI 10.1051/0004-6361/201116726.ARXIV:1106.5125; FURST F, 2010, ASTRON ASTROPHYS, V519, P37; in 't Zand JJM, 2005, ASTRON ASTROPHYS, V441, pL1, DOI 10.1051/0004-6361:200500162; ISHII T, 1993, ASTROPHYS J, V404, P706, DOI 10.1086/172324; Karino S, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/201014917; Karino S., 2014, PUBL ASTRON SOC JPN, V66, p34K; LIVIO M, 1991, MON NOT R ASTRON SOC, V253, P633; MATSUDA T, 1991, ASTRON ASTROPHYS, V248, P301; Rahoui F, 2008, ASTRON ASTROPHYS, V492, P163, DOI 10.1051/0004-6361:200810695; Romano P, 2009, ASTROPHYS J, V696, P2068, DOI 10.1088/0004-637X/696/2/2068; Romano P, 2007, ASTRON ASTROPHYS, V469, pL5, DOI 10.1051/0004-6361:20077383; Ruffert M, 1999, ASTRON ASTROPHYS, V346, P861; Runacres MC, 2002, ASTRON ASTROPHYS, V381, P1015, DOI 10.1051/0004-6361:20011526; Sguera V, 2005, ASTRON ASTROPHYS, V444, P221, DOI 10.1051/0004-6361:20053103; Sidoli L, 2007, ASTRON ASTROPHYS, V476, P1307, DOI 10.1051/0004-6361:20078137; STEVENS IR, 1991, ASTROPHYS J, V379, P310, DOI 10.1086/170506; Toro E.F., 2003, NI03037NPA U CAMBR I; Toro E.F., 2004, NI04008NPA U CAMBR I	52	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0004-640X	1572-946X		ASTROPHYS SPACE SCI	Astrophys. Space Sci.	JUL	2015	358	1							21	10.1007/s10509-015-2420-6		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CL9ZW	WOS:000357339000021		
J	Morimoto, K; Nishikaze, T; Yoshizawa, AC; Kajihara, S; Aoshima, K; Oda, Y; Tanaka, K				Morimoto, Kentaro; Nishikaze, Takashi; Yoshizawa, Akiyasu C.; Kajihara, Shigeki; Aoshima, Ken; Oda, Yoshiya; Tanaka, Koichi			GlycanAnalysis Plug-in: a database search tool for N-glycan structures usingmass spectrometry	BIOINFORMATICS			English	Article							LIQUID MATRIX; NEGATIVE-IONS; MASS-SPECTROMETRY; LINKED GLYCANS; MALDI-MS; FRAGMENTATION; SPECTRA	Tandem mass spectrometry (MS/MS or MS n) is a potent technique for characterizing N-glycan structures. GlycanAnalysis searches a glycan database to support the identification of glycan structures from MS/MS spectra. It also calculates diagnostic ions of glycan structures registered in a glycan database (GlycomeDB or KEGG GLYCAN) and searches for MS/MS spectra of N-glycans that match diagnostic ions to determine the structures. This program functions as a plug-in for Mass++, a freeware mass spectrum visualization and analysis program.	[Morimoto, Kentaro; Nishikaze, Takashi; Yoshizawa, Akiyasu C.; Kajihara, Shigeki; Tanaka, Koichi] Shimadzu Co Ltd, Koichi Tanaka Lab Adv Sci & Technol, Kyoto, Japan; [Aoshima, Ken; Oda, Yoshiya] Eisai & Co Ltd, Eisai Prod Creat Syst, Tsukuba, Ibaraki, Japan	Morimoto, K (reprint author), Shimadzu Co Ltd, Koichi Tanaka Lab Adv Sci & Technol, Kyoto, Japan.	k-morimt@shimadzu.co.jp; nishikaz@shimadzu.co.jp; acyshzw@shimadzu.co.jp			Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	This study was funded by the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program).	Nishikaze T, 2012, ANAL CHEM, V84, P9453, DOI 10.1021/ac302286e; Ranzinger R, 2011, NUCLEIC ACIDS RES, V39, pD373, DOI 10.1093/nar/gkq1014; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P622, DOI 10.1016/j.jasms.2005.01.004; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Kaneshiro K, 2011, ANAL CHEM, V83, P3663, DOI 10.1021/ac103203v; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P647, DOI 10.1016/j.jasms.2005.01.006; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P631, DOI 10.1016/j.jasms.2005.01.005; Rohmer M, 2010, ANAL CHEM, V82, P3719, DOI 10.1021/ac1001096; Hashimoto K., 2006, GLYCOBIOLOGY, V16, p63R, DOI DOI 10.1093/GLYCOB/CWJ010; Nishikaze T, 2012, ANAL CHEM, V84, P6097, DOI 10.1021/ac3009803; Tanaka S, 2014, J PROTEOME RES, V13, P3846, DOI 10.1021/pr500155z	11	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	JUL 1	2015	31	13					2217	2219		10.1093/bioinformatics/btv110		3	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	CM1FG	WOS:000357425800024		
J	Tsukimoto, M				Tsukimoto, Mitsutoshi			Purinergic Signaling Is a Novel Mechanism of the Cellular Response to Ionizing Radiation	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Review						radiation; ATP; P2 receptor; DNA repair; bystander effect	INDUCED DNA-DAMAGE; MEDIATED INTERCELLULAR COMMUNICATION; ATP RELEASE; ALPHA-PARTICLES; GROWTH-FACTOR; POLY(ADP-RIBOSE) POLYMERASE; GAMMA-IRRADIATION; EXTRACELLULAR ATP; HUMAN FIBROBLASTS; OXIDATIVE STRESS	Recent studies suggest the effect of radiation is observed not only in irradiated cells but also in adjacent non-irradiated cells (bystander effect), although the mechanism has not yet been fully revealed. This bystander effect may be caused by intercellular communication via a gap junction or by messengers released from irradiated cells, such as reactive oxygen species, nitric oxide, or cytokines. However, an unknown mechanism is also possible in the bystander effect. On the other hand, it is known that extracellular ATP, ADP, uridine 5'-triphosphate (UTP), and uridine 5'-diphosphate (UDP), which are released from cells, act as intercellular signaling molecules by activating purinergic P2X and P2Y receptors (purinergic signaling). Recently, I have suggested these extracellular nucleotides may be novel mediators of a radiation-induced bystander effect, because our recent studies indicated that purinergic signaling is involved in important cellular responses to radiation. Our data indicate that ionizing irradiation causes activation of the transient receptor potential melastatin type 2 (TRPM2) channel, and then ATP is released from cells through the anion channel or connexin43 hemichannel mediated by the activation of a P2X7 receptor. The released nucleotides activate P2Y6 and P2Y12 receptors, which are involved in the DNA damage response after irradiation. Activation of the P2Y6 receptor is also involved in radiation-induced activation of the epithelial growth factor receptor-extracellular signal regulated protein kinase (EGFR-ERK)1/2 pathway and subsequent nuclear translocation of EGFR, which plays a role in DNA repair. Further, the induction of an antioxidant after irradiation is also mediated by the activation of the P2Y receptor. In conclusion, purinergic signaling could play an important role in the protective cellular response to ionizing irradiation.	Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Radiat Biosci, Noda, Chiba 2788510, Japan	Tsukimoto, M (reprint author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Radiat Biosci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	tsukim@rs.noda.tus.ac.jp					Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pearson RA, 2005, NEURON, V46, P731, DOI 10.1016/j.neuron.2005.04.024; Li ZP, 2006, BIOCHEM BIOPH RES CO, V341, P363, DOI 10.1016/j.bbrc.2005.12.193; Nishimaki N, 2012, DNA REPAIR, V11, P657, DOI 10.1016/j.dnarep.2012.05.005; Zimmermann H, 1999, PROG BRAIN RES, V120, P371; Erlinge D, 1998, GEN PHARMACOL-VASC S, V31, P1, DOI 10.1016/S0306-3623(97)00420-5; Tsukimoto M, 2010, RADIAT RES, V173, P298, DOI 10.1667/RR1732.1; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Azzam EI, 2002, CANCER RES, V62, P5436; Zhou HN, 2000, P NATL ACAD SCI USA, V97, P2099, DOI 10.1073/pnas.030420797; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; Bell PD, 2003, P NATL ACAD SCI USA, V100, P4322, DOI 10.1073/pnas.0736323100; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Mancuso M, 2011, ONCOGENE, V30, P4601, DOI 10.1038/onc.2011.176; Burnstock G, 2006, BRIT J PHARMACOL, V147, pS172, DOI 10.1038/sj.bjp.0706429; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; SchmidtUllrich RK, 1997, ONCOGENE, V15, P1191, DOI 10.1038/sj.onc.1201275; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Naziroglu M, 2012, J RECEPT SIG TRANSD, V32, P134, DOI 10.3109/10799893.2012.672994; Amantini C, 2009, CARCINOGENESIS, V30, P1320, DOI 10.1093/carcin/bgp138; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421; Tokunaga A, 2010, J BIOL CHEM, V285, P17406, DOI 10.1074/jbc.M110.112417; Li SQ, 2011, CARCINOGENESIS, V32, P779, DOI 10.1093/carcin/bgr037; Ohshima Y, 2011, FREE RADICAL BIO MED, V51, P1240, DOI 10.1016/j.freeradbiomed.2011.06.014; Kriegs M, 2010, DNA REPAIR, V9, P889, DOI 10.1016/j.dnarep.2010.05.005; Vodenicharov MD, 2000, NUCLEIC ACIDS RES, V28, P3887, DOI 10.1093/nar/28.20.3887; ABRAHAM EH, 1993, P NATL ACAD SCI USA, V90, P312, DOI 10.1073/pnas.90.1.312; Burnstock G, 2009, BRAZ J MED BIOL RES, V42, P3, DOI 10.1590/S0100-879X2008005000037; Solini A, 2008, ENDOCRINOLOGY, V149, P389, DOI 10.1210/en.2007-1223; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Masumoto K, 2013, BBA-GEN SUBJECTS, V1830, P3382, DOI 10.1016/j.bbagen.2013.02.020; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Balaban N, 1996, BBA-MOL CELL RES, V1314, P147, DOI 10.1016/S0167-4889(96)00068-7; BORST MM, 1991, CIRC RES, V68, P797; Burnstock G, 2004, CURR TOP MED CHEM, V4, P793, DOI 10.2174/1568026043451014; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; DARIUS H, 1987, J PHARMACOL EXP THER, V240, P542; Deli T, 2007, INT J CANCER, V121, P55, DOI 10.1002/ijc.22621; Derangeon M, 2008, J BIOL CHEM, V283, P30754, DOI 10.1074/jbc.M801556200; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Fortes FSA, 2004, J CELL SCI, V117, P4717, DOI 10.1242/jcs.01345; Ide S, 2014, J TOXICOL SCI, V39, P15; Lakshmi S, 2005, CELL MOL NEUROBIOL, V25, P819, DOI 10.1007/s10571-005-4936-8; Lavin MF, 2005, ADV EXP MED BIOL, V570, P457, DOI 10.1007/1-4020-3764-3_16; Lazarowski ER, 2001, NEWS PHYSIOL SCI, V16, P1; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Ohshima Y, 2012, J RADIAT RES, V53, P551, DOI 10.1093/jrr/rrs014; Ohshima Y, 2010, BBA-GEN SUBJECTS, V1800, P40, DOI 10.1016/j.bbagen.2009.10.008; PADDLE BM, 1974, BLOOD VESSELS, V11, P110; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Tamaishi N, 2011, RADIAT RES, V175, P193, DOI 10.1667/RR2191.1; Zhou HN, 2001, P NATL ACAD SCI USA, V98, P14410, DOI 10.1073/pnas.251524798	61	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JUL	2015	38	7					951	959				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL8SQ	WOS:000357244800001		
J	Hwang, GW				Hwang, Gi-Wook			Current Research Trends in the Exploration of Therapeutic Targets for Liver Disease Foreword	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Editorial Material									Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan	Hwang, GW (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan.	gwhwang@m.tohoku.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JUL	2015	38	7					960	960				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL8SQ	WOS:000357244800002		
J	Kurohane, K; Kimura, A; Terasawa, R; Sahara, Y; Kobayashi, K; Suzuki, W; Matsuoka, T; Watanabe, T; Imai, Y				Kurohane, Kohta; Kimura, Ayako; Terasawa, Rie; Sahara, Yurina; Kobayashi, Kamiyu; Suzuki, Wakana; Matsuoka, Takeshi; Watanabe, Tatsuo; Imai, Yasuyuki			Adjuvant Effect of an Alternative Plasticizer, Diisopropyl Adipate, on a Contact Hypersensitivity Mouse Model: Link with Sensory Ion Channel TRPA1 Activation	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						adipate ester; adjuvant; contact hypersensitivity; transient receptor potential	C-TYPE LECTIN; FLUORESCEIN-ISOTHIOCYANATE; SENSITIZATION PHASE; PHTHALATE-ESTERS; SKIN SENSITIZATION; DENDRITIC CELL; MICE; TRAFFICKING; ASSOCIATION; INVOLVEMENT	Due to health concerns about phthalate esters, the use of alternative plasticizers is being considered. Phthalate esters enhance skin sensitization to fluorescein isothiocyanate (FITC) in mouse models. We have demonstrated that phthalate esters stimulate transient receptor potential ankyrin 1 (TRPA1) cation channels expressed on sensory neurons. We also found a correlation between TRPA1 activation and the enhancing effect on FITC-induced contact hypersensitivity (CHS) when testing various types of phthalate esters. Here we investigated the effects of an alternative plasticizer, diisopropyl adipate (DIA). Activation of TRPA1 by DIA was demonstrated by calcium mobilization using Chinese hamster ovary cells expressing TRPA1 in vitro. The effect of DIA was inhibited by a TRPA1-specific antagonist, HC-030031. The presence of DIA or dibutyl phthalate (DBP; positive control) during skin sensitization of BALB/c mice to FITC augmented the CHS response, as revealed by the level of ear-swelling. The enhancing effect of DIA was inhibited by in vivo pretreatment with HC-030031. FITC-presenting CD11c(+) dendritic cell (DC)-trafficking to draining lymph nodes was facilitated both by DIA and by DBP. DBP and DIA were similarly active in the enhancement of interferon-gamma production by draining lymph nodes, but the effect on interleukin-4 production was weaker with DIA. Overall, DIA activated TRPA1 and enhanced FITC-induced CHS, as DBP did. The adjuvant effects of adipate esters may need to be considered because they are used as ingredients in cosmetics and drug formulations topically applied to the skin.	[Kurohane, Kohta; Kimura, Ayako; Terasawa, Rie; Sahara, Yurina; Kobayashi, Kamiyu; Suzuki, Wakana; Matsuoka, Takeshi; Imai, Yasuyuki] Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Suruga Ku, Shizuoka 4228526, Japan; [Watanabe, Tatsuo] Univ Shizuoka, Sch Food & Nutr Sci, Food Chem Lab, Suruga Ku, Shizuoka 4228526, Japan	Imai, Y (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	imai@u-shizuoka-ken.ac.jp	Imai, Yasuyuki/E-8701-2010		Japan Society for the Promotion of Science [23390031, 15K14990]	We thank Miss Erina Ogawa for technical assistance and Mr. Nicholas J. Halewood for providing language help. This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 23390031) and a Grant-in-Aid for Challenging Exploratory Research (No. 15K14990) from the Japan Society for the Promotion of Science to YI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen Alan, 2006, Int J Toxicol, V25 Suppl 1, P129; Matsuda T, 2010, FOOD CHEM TOXICOL, V48, P1704, DOI 10.1016/j.fct.2010.03.049; Zhou SN, 2013, J TOXICOL ENV HEAL A, V76, P157, DOI 10.1080/15287394.2012.738598; Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498; Imai Y, 2006, CLIN EXP ALLERGY, V36, P1462, DOI 10.1111/j.1365-2222.2006.02574.x; Shiba T, 2012, TOXICOL APPL PHARM, V264, P370, DOI 10.1016/j.taap.2012.08.012; Levi K, 2010, BRIT J DERMATOL, V163, P695, DOI 10.1111/j.1365-2133.2010.09937.x; Schecter A, 2013, ENVIRON HEALTH PERSP, V121, P473, DOI 10.1289/ehp.1206367; Dearman RJ, 2000, IMMUNOLOGY, V101, P442, DOI 10.1046/j.1365-2567.2000.00126.x; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Shirai MA, 2013, CARBOHYD POLYM, V92, P19, DOI 10.1016/j.carbpol.2012.09.038; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Kueseng P, 2007, J ENVIRON SCI HEAL B, V42, P569, DOI 10.1080/03601230701389488; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Takeshita K, 2004, INT IMMUNOL, V16, P685, DOI 10.1093/intimm/dxh073; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Kobayashi C, 2012, BIOL PHARM BULL, V35, P532, DOI 10.1248/bpb.35.532; Larson RP, 2010, J IMMUNOL, V184, P2974, DOI 10.4049/jimmunol.0803478; Chowdhury MMU, 2002, CONTACT DERMATITIS, V46, P57, DOI 10.1034/j.1600-0536.2002.460115.x; Chun KH, 2000, J LEUKOCYTE BIOL, V68, P471; Chun KH, 2000, INT IMMUNOL, V12, P1695, DOI 10.1093/intimm/12.12.1695; Denda-Nagai K, 2002, GLYCOBIOLOGY, V12, P443, DOI 10.1093/glycob/cwf061; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; Kurohane K, 2013, TOXICOL LETT, V217, P192, DOI 10.1016/j.toxlet.2012.12.025; Lanigan Rebecca S., 2001, International Journal of Toxicology, V20, P91; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Maruyama T, 2007, INT ARCH ALLERGY IMM, V143, P144, DOI 10.1159/000099081; Maruyama T, 2007, MICROBIOL IMMUNOL, V51, P321; Matsuda T, 2010, TOXICOL LETT, V192, P97, DOI 10.1016/j.toxlet.2009.10.009; Remitz A, 1999, BRIT J DERMATOL, V141, P103; Saarnilehto M, 2014, ALLERGY, V69, P1424, DOI 10.1111/all.12488; Sato K, 1998, J IMMUNOL, V161, P6835; Shiba T, 2009, J NEUROIMMUNOL, V207, P66, DOI 10.1016/j.jneuroim.2008.12.001; Simonsson C, 2012, TOXICOL APPL PHARM, V264, P114, DOI 10.1016/j.taap.2012.07.023; Takahashi K, 2002, DRUG DEV IND PHARM, V28, P1285, DOI 10.1081/DDC-120015362	37	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JUL	2015	38	7					1054	1062				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL8SQ	WOS:000357244800018		
J	Nagai, N; Ogata, F; Kawasaki, N; Ito, Y; Funakami, Y; Okamoto, N; Shimomura, Y				Nagai, Noriaki; Ogata, Fumihiko; Kawasaki, Naohito; Ito, Yoshimasa; Funakami, Yoshinori; Okamoto, Norio; Shimomura, Yoshikazu			Hypercalcemia Leads to Delayed Corneal Wound Healing in Ovariectomized Rats	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						calcium; corneal wound healing; cell viability; ovariectomized rat; hypercalcemia	EPITHELIAL-CELLS; BONE METABOLISM; CALCIUM INTAKE; EYE DROPS; EXPRESSION; SERICIN; MODEL; PERMEABILITY; OSTEOPOROSIS; HOMEOSTASIS	Hypercalcemia is often observed in postmenopausal women as well as in patients with primary hyperparathyroidism or malignant tumors. In this study, we investigated the relationship between calcium ion (Ca2+) levels in lacrimal fluid and the rate of corneal wound healing in hypercalcemia using ovariectomized (OVX) rat debrided corneal epithelium. We also determined the effects of Ca2+ levels on cell adhesion, proliferation and viability in a human cornea epithelial cell line (HCE-T). The calcium content in bones of OVX rats decreased after ovariectomy. Moreover, the Ca2+ content in the blood of OVX rats was increased 1 month after ovariectomy, and decreased. The Ca2+ content in the lacrimal fluid of OVX rats was also increased after ovariectomy, and then decreased similarly as in blood. Corneal wound healing in OVX rats was delayed in comparison with Sham rats (control rats), and a close relationship was observed between the Ca2+ levels in lacrimal fluid and the rate of corneal wound healing in Sham and OVX rats (y=-0.7863x+8.785, R=0.78, n=25). In addition, an enhancement in Ca2+ levels caused a decrease in the viability in HCE-T cells. It is possible that enhanced Ca2+ levels in lacrimal fluid may cause a decrease in the viability of corneal epithelial cells, resulting in a delay in corneal wound healing. These findings provide significant information that can be used to design further studies aimed at reducing corneal damage of patients with hypercalcemia.	[Nagai, Noriaki; Ogata, Fumihiko; Kawasaki, Naohito; Ito, Yoshimasa; Funakami, Yoshinori] Kinki Univ, Fac Pharm, Higashiosaka, Osaka 5778502, Japan; [Okamoto, Norio; Shimomura, Yoshikazu] Kinki Univ, Dept Ophthalmol, Fac Med, Osaka 5898511, Japan	Nagai, N (reprint author), Kinki Univ, Fac Pharm, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	nagai_n@phar.kindai.ac.jp					Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; CHEN JJY, 1990, INVEST OPHTH VIS SCI, V31, P1301; Nagai N, 2014, J OLEO SCI, V63, P177, DOI 10.5650/jos.ess13082; Nagai N, 2009, BIOL PHARM BULL, V32, P933; SPECTOR A, 1995, FASEB J, V9, P1173; Ensrud KE, 2000, ANN INTERN MED, V132, P345; Agata U, 2013, J NUTR SCI VITAMINOL, V59, P29, DOI 10.3177/jnsv.59.29; Danjo Y, 1998, J CELL SCI, V111, P3323; Renkema KY, 2008, ANN MED, V40, P82, DOI 10.1080/07853890701689645; Chung EH, 1999, INVEST OPHTH VIS SCI, V40, P1952; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; SHARPE GR, 1989, FEBS LETT, V254, P25, DOI 10.1016/0014-5793(89)81002-6; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz; Fujihara T, 2001, INVEST OPHTH VIS SCI, V42, P96; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1; Song XJ, 2014, INVEST OPHTH VIS SCI, V55, P745, DOI 10.1167/iovs.12-10457; Bonjour JP, 2011, J AM COLL NUTR, V30, p438S; Gropper SS, 2007, ADV NUTR HUMAN METAB; Heaney R.P., 2000, J AM COLL NUTR S, V19, P83; Montalcini T, 2013, NUTR METAB CARDIOVAS, V23, P1141, DOI 10.1016/j.numecd.2012.12.004; Nagai N, 2009, BIOL PHARM BULL, V32, P1594, DOI 10.1248/bpb.32.1594; Nagai N, 2013, J OLEO SCI, V62, P159, DOI 10.5650/jos.62.159; Nagai N, 2012, CURR EYE RES, V37, P889, DOI 10.3109/02713683.2012.689070; Nagai N, 2014, TOXICOLOGY, V319, P53, DOI 10.1016/j.tox.2014.02.012; OMI N, 1995, BONE, V17, pS163, DOI 10.1016/8756-3282(95)00329-C; Ozcura F, 2012, INT J OPHTHALMOL-CHI, V5, P64, DOI 10.3980/j.issn.2222-3959.2012.01.13; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P2577, DOI 10.1167/iovs.04-0001; SHEARER TR, 1992, CURR EYE RES, V11, P357, DOI 10.3109/02713689209001789; STEPP MA, 1993, INVEST OPHTH VIS SCI, V34, P1829; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; TILYARD MW, 1992, NEW ENGL J MED, V326, P357, DOI 10.1056/NEJM199202063260601; Zhang XH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001087	33	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JUL	2015	38	7					1063	1069				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL8SQ	WOS:000357244800019		
J	Aikawa, N; Suzuki, Y; Takaba, K				Aikawa, Nobuo; Suzuki, Yui; Takaba, Katsumi			A Simple Protocol for the Myocardial Differentiation of Human iPS Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						human induced pluripotent stem cell; myocardial differentiation; embryonic body	EMBRYONIC STEM-CELLS; MESODERM; CARDIOMYOCYTES; INDUCTION; BLOCK	We have developed a simple protocol for inducing the myocardial differentiation of human induced pluripotent stem (iPS) cells. Human iPS cell-derived embryonic bodies (EBs) were treated with a combination of activin-A, bone morphogenetic protein-4 and wnt-3a for one day in serum-free suspension culture, and were subsequently treated with noggin for three days. Thereafter, the EBs were subjected to adherent culture in media with 5% serum. All EBs were differentiated into spontaneously beating EBs, which were identified by the presence of striated muscles in transmission electron microscopy and the expression of the specific cardiomyocyte markers, NKX2-5 and TNNT2. The beating rate of the beating EBs was decreased by treatment with a rapidly activating delayed rectifier potassium current (Ikr) channel blocker, E-4031, an Ikr trafficking inhibitor, pentamidin, and a slowly activating delayed rectifier potassium current (Iks) channel blocker, chromanol 293B, and was increased by treatment with a beta-receptor agonist, isoproterenol. At a low concentration, verapamil, a calcium channel blocker, increased the beating rate of the beating EBs, while a high concentration decreased this rate. These findings suggest that the spontaneously beating EBs were myocardial cell clusters. This simple protocol for myocardial differentiation would be useful in providing a sufficient number of the beating myocardial cell clusters for studies requiring human myocardium.	[Aikawa, Nobuo; Suzuki, Yui; Takaba, Katsumi] Kyowa Hakko Kirin Co Ltd, R&D Div, Translat Res Unit, Nagaizumi, Shizuoka 4118731, Japan	Aikawa, N (reprint author), Kyowa Hakko Kirin Co Ltd, R&D Div, Translat Res Unit, 1188 Shimotogari, Nagaizumi, Shizuoka 4118731, Japan.	nobuo.aikawa@kyowa-kirin.co.jp					Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Chan SSK, 2013, CELL STEM CELL, V12, P587, DOI 10.1016/j.stem.2013.03.004; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang ST, 1999, CIRC RES, V84, P989; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Kunisato A, 2011, STEM CELLS DEV, V20, P159, DOI 10.1089/scd.2010.0063; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JUL	2015	38	7					1070	1075				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL8SQ	WOS:000357244800020		
J	Shirai, Y; Mori, A; Nakahara, T; Sakamoto, K; Ishii, K				Shirai, Yousuke; Mori, Asami; Nakahara, Tsutomu; Sakamoto, Kenji; Ishii, Kunio			Deferiprone Protects against Photoreceptor Degeneration Induced by Tunicamycin in the Rat Retina	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						deferiprone; tunicamycin; endoplasmic reticulum stress; iron chelation	ENDOPLASMIC-RETICULUM STRESS; BLOOD-BRAIN-BARRIER; NEURONAL CELL-DEATH; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; IRON CHELATOR; NEUROPROTECTION; DESFERRIOXAMINE; PROSPECTS; ACID	Endoplasmic reticulum stress has been reported to be involved in the pathogenesis of retinitis pigmentosa, macular degeneration and diabetic retinopathy. In the present study, we examined the effects of deferiprone, an iron chelator, on photoreceptor degeneration induced by tunicamycin (300 nmol/eye), an endoplasmic reticulum stress inducer, in the rat retina. Scotopic electroretinogram measurement and morphometric evaluation were done 7d after the injection of tunicamycin. In the scotopic electroretinogram, intravitreal deferiprone (5 nmol/eye) injected simultaneously with tunicamycin significantly reduced the decreases in a- and b-wave amplitudes induced by tunicamycin. Morphometric evaluation showed that deferiprone significantly reduced thinning of the outer nuclear layer, the inner segment and the outer segment. These results suggest that iron chelation therapy may be a good candidate for the treatment of eye diseases related to endoplasmic reticulum stress.	[Shirai, Yousuke; Mori, Asami; Nakahara, Tsutomu; Sakamoto, Kenji; Ishii, Kunio] Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, Tokyo 1088641, Japan	Sakamoto, K (reprint author), Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	sakamotok@pharm.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24590329]	This work is supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aid for Scientific Research (C) #24590329 (KS).	Abbruzzese G, 2011, HAEMATOL-HEMATOL J, V96, P1708, DOI 10.3324/haematol.2011.043018; ANDERSON DH, 1988, VISUAL NEUROSCI, V1, P153; Sakamoto K, 2010, EUR J PHARMACOL, V635, P56, DOI 10.1016/j.ejphar.2010.03.001; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Li CZ, 2012, INVEST OPHTH VIS SCI, V53, P3241, DOI 10.1167/iovs.11-8406; Sakamoto K, 2009, EXP EYE RES, V88, P974, DOI 10.1016/j.exer.2008.12.011; Gorbatyuk M, 2013, MOL VIS, V19, P1985; Zhu W, 2007, FASEB J, V21, P3835, DOI 10.1096/fj.07-8386com; Yang LP, 2008, J NEUROSCI RES, V86, P910, DOI 10.1002/jnr.21535; Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P959, DOI 10.1167/iovs.10-6207; Yefimova MG, 2002, INVEST OPHTH VIS SCI, V43, P537; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Steuer H, 2005, INVEST OPHTH VIS SCI, V46, P1047, DOI 10.1167/iovs.04-0925; Jellinger KA, 1999, DRUG AGING, V14, P115, DOI 10.2165/00002512-199914020-00004; Fredenburg AM, 1996, TOXICOLOGY, V108, P191, DOI 10.1016/0300-483X(95)03301-U; Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270; Zhang X, 2005, BIOCHEM BIOPH RES CO, V333, P544, DOI 10.1016/j.bbrc.2005.05.150; Sakamoto K, 2011, J OCUL PHARMACOL TH, V27, P419, DOI 10.1089/jop.2010.0141; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Obolensky A, 2011, FREE RADICAL BIO MED, V51, P1482, DOI 10.1016/j.freeradbiomed.2011.07.014; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; Berkowitz BA, 1998, INVEST OPHTH VIS SCI, V39, P391; Dureau P, 2001, CURR EYE RES, V22, P74, DOI 10.1076/ceyr.22.1.74.6974; FLIESLER SJ, 1984, NATURE, V311, P575, DOI 10.1038/311575a0; HARTLEY A, 1993, BRAIN RES, V627, P349, DOI 10.1016/0006-8993(93)90341-J; Nakamura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060517; Diaz MLN, 1998, NEPHROL DIAL TRANSPL, V13, P23, DOI 10.1093/ndt/13.suppl_3.23; Olanow CW, 1996, NEUROS PER, P55, DOI 10.1016/B978-012525445-8/50006-0; Rana T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.539; Sakamoto K, 2014, EXP EYE RES, V120, P90, DOI 10.1016/j.exer.2014.01.008; Sakamoto K, 2015, BIOL PHARM BULL, V38, P139, DOI 10.1248/bpb.b14-00491; Sakamoto K, 2010, J PHARMACOL SCI, V112, P327, DOI 10.1254/jphs.09302FP; Shachar Dorit Ben, 2004, Neuropharmacology, V46, P254, DOI 10.1016/j.neuropharm.2003.09.005; Shoham S, 2000, CELL MOL BIOL, V46, P743; TAKATSUK.A, 1971, J ANTIBIOT, V24, P215; Tsuruma K, 2012, MOL NUTR FOOD RES, V56, P713, DOI 10.1002/mnfr.201100607	36	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JUL	2015	38	7					1076	1080				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL8SQ	WOS:000357244800021		
J	Sakurai, T; Akanuma, S; Usui, T; Kubo, Y; Tachikawa, M; Hosoya, K				Sakurai, Tatsuhiko; Akanuma, Shin-ichi; Usui, Takuya; Kubo, Yoshiyuki; Tachikawa, Masanori; Hosoya, Ken-ichi			Excitatory Amino Acid Transporter 1-Mediated L-Glutamate Transport at the Inner Blood-Retinal Barrier: Possible Role in L-Glutamate Elimination from the Retina	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						excitatory amino acid transporter 1; inner blood-retinal barrier; L-glutamate	CARRIER-MEDIATED TRANSPORT; HIGH-AFFINITY GLUTAMATE; L-CYSTINE; FUNCTIONAL-CHARACTERIZATION; SYSTEM X(C)(-); GLIAL-CELLS; EXPRESSION; BRAIN; CLONING; RAT	The purpose of this study was to elucidate the transport mechanism(s) of L-glutamate (L-Glu), a neuro-excitatory neurotransmitter, in the inner blood-retinal barrier (BRB). The L-Glu transport was evaluated by an in vitro uptake study with a conditionally-immortalized rat retinal capillary endothelial cell line, TR-iBRB2 cells. L-Glu uptake by TR-iBRB2 exhibited time- and concentration-dependence, and was composed of high- and low-affinity processes with Michaelis-Menten constants (K-m) of 19.3 mu m and 275 mu m, respectively. Under Na+-free conditions, L-Glu uptake by TR-iBRB2 involved one-saturable kinetics with a K-m of 190 mu m, which is similar to that of the low-affinity process of L-Glu uptake under normal conditions. Moreover, substrates/inhibitors of system X-c(-),which is involved in blood-to-retina transport of compounds across the inner BRB, strongly inhibited the L-Glu uptake under Na+-free conditions, suggesting that Na+-independent low-affinity L-Glu transport at the inner BRB is carried out by system X-c(-). Regarding the Na+-dependent high affinity process of L-Glu transport at the inner BRB, L-Glu uptake by TR-iBRB2 under normal conditions was significantly inhibited by substrates/inhibitors of excitatory amino acid transporter (EAAT) 1-5, but not alanine-serine-cysteine transporters. Reverse-transcription polymerase chain reaction (RT-PCR) analysis and immunoblot analysis demonstrated that mRNA and protein of EAAT1 are expressed in TR-iBRB2 cells, whereas mRNAs and/or proteins of EAAT2-5 are not. Immunohistochemical analysis revealed that EAAT1 protein is localized on the abluminal membrane of the retinal capillaries. In conclusion, EAAT1 most likely mediates Na+-dependent high-affinity L-Glu transport at the inner BRB and appears to take part in L-Glu elimination from the retina across the inner BRB.	[Sakurai, Tatsuhiko; Akanuma, Shin-ichi; Usui, Takuya; Kubo, Yoshiyuki; Tachikawa, Masanori; Hosoya, Ken-ichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut, Toyama 9300194, Japan	Hosoya, K (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut, 2630 Sugitani, Toyama 9300194, Japan.	hosoyak@pha.u-toyama.ac.jp			Japan Society for the Promotion of Sciences (JSPS)	The authors wish to thank Dr. Masahiko Watanabe (Hokkaido University, Sapporo, Japan) for kindly supplying anti-EAAT1 and anti-GLUT1 antibodies. This study was supported, in part, by a Grain-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Sciences (JSPS).	Akanuma Shin-Ichi, 2013, Fluids Barriers CNS, V10, P29, DOI 10.1186/2045-8118-10-29; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Patel SA, 2004, NEUROPHARMACOLOGY, V46, P273, DOI 10.1016/j.neuropharm.2003.08.006; Bridges R, 2012, PHARMACOL REV, V64, P780, DOI 10.1124/pr.110.003889; Kanai Y, 2013, MOL ASPECTS MED, V34, P108, DOI 10.1016/j.mam.2013.01.001; Levy LM, 1998, J NEUROSCI, V18, P9620; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Hosoya K, 2001, EXP EYE RES, V72, P163, DOI 10.1006/exer.2000.0941; Shibata T, 1997, J NEUROSCI, V17, P9212; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883; Sakai K, 2003, J NEUROSCI, V23, P550; Holmseth S, 2012, J NEUROSCI, V32, P6000, DOI 10.1523/JNEUROSCI.5347-11.2012; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Dreyer EB, 1996, ARCH OPHTHALMOL-CHIC, V114, P299; Hosoya K, 2005, BIOL PHARM BULL, V28, P1, DOI 10.1248/bpb.28.1; Bridges CC, 2001, INVEST OPHTH VIS SCI, V42, P47; Cederberg HHC, 2014, ARCH MED RES, V45, P639, DOI 10.1016/j.arcmed.2014.11.004; Forrester JV, 2002, EYE BASIC SCI PRACTI, V2nd; Gameiro A, 2011, BIOPHYS J, V100, P2623, DOI 10.1016/j.bpj.2011.04.034; Hosoya Ken-ichi, 2012, Adv Exp Med Biol, V763, P85; Hosoya K, 2001, MICROVASC RES, V62, P136, DOI 10.1006/mvre.2001.2328; KLOCKNER U, 1993, J BIOL CHEM, V268, P14594; Lin CLG, 1998, MOL BRAIN RES, V63, P174, DOI 10.1016/S0169-328X(98)00256-3; Ohgoh M, 2002, J NEUROIMMUNOL, V125, P170, DOI 10.1016/S0165-5728(02)00029-2; Okamoto M, 2009, NEUROCHEM INT, V55, P789, DOI 10.1016/j.neuint.2009.08.001; Rauen T, 2000, NEUROCHEM INT, V37, P179, DOI 10.1016/S0197-0186(00)00021-8; Tachikawa M, 2011, J PHARM SCI-US, V100, P3892, DOI 10.1002/jps.22626; TAKATA K, 1992, INVEST OPHTH VIS SCI, V33, P377; Tetsuka K, 2003, J NEUROCHEM, V87, P891, DOI 10.1046/j.1471-4159.2003.02063.x; Tomi M, 2002, INVEST OPHTH VIS SCI, V43, P774; TORNQUIST P, 1986, GRAEF ARCH CLIN EXP, V224, P21, DOI 10.1007/BF02144127; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879; Yoneyama D, 2010, EXP EYE RES, V90, P507, DOI 10.1016/j.exer.2010.01.003	34	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JUL	2015	38	7					1087	1091				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL8SQ	WOS:000357244800023		
J	Oishi, Y; Yoshida, K; Scammell, TE; Urade, Y; Lazarus, M; Saper, CB				Oishi, Yo; Yoshida, Kyoko; Scammell, Thomas E.; Urade, Yoshihiro; Lazarus, Michael; Saper, Clifford B.			The roles of prostaglandin E-2 and D-2 in lipopolysaccharide-mediated changes in sleep	BRAIN BEHAVIOR AND IMMUNITY			English	Article						EEG; Delta power; Nestin-Cre; LoxP; Thromboxane A; Prostacyclin; Cytokine; Nonsteroidal anti-inflammatory drugs; Sleepiness; Fever	NECROSIS-FACTOR-ALPHA; BACTERIAL LIPOPOLYSACCHARIDE; PHYSIOLOGICAL SLEEP; SYSTEMIC INFLAMMATION; BODY-TEMPERATURE; FEVER RESPONSES; NERVOUS-SYSTEM; DEFICIENT MICE; IMMUNE-SYSTEM; RAT-BRAIN	When living organisms become sick as a result of a bacterial infection, a suite of brain-mediated responses occur, including fever, anorexia and sleepiness. Systemic administration of lipopolysaccharide (LPS), a common constituent of bacterial cell walls, increases body temperature and non-rapid eye movement (NREM) sleep in animals and induces the production of pro-inflammatory prostaglandins (PGs). PGE(2) is the principal mediator of fever, and both PGE(2) and PGD(2) regulate sleep-wake behavior. The extent to which PGE(2) and PGD(2) are involved in the effect of LPS on NREM sleep remains to be clarified. Therefore, we examined LPS-induced changes in body temperature and NREM sleep in mice with nervous system-specific knockouts (KO) for the PGE(2) receptors type EP3 or EP4, in mice with total body KO of microsomal PGE synthase-1 or the PGD(2) receptor type DP, and in mice treated with the cyclooxygenase (COX) inhibitor meloxicam. We observed that LPS-induced NREM sleep was slightly attenuated in mice lacking EP4 receptors in the nervous system, but was not affected in any of the other KO mice or in mice pretreated with the COX inhibitor. These results suggest that the effect of LPS on NREM sleep is partially dependent on PGs and is likely mediated mainly by other pro-inflammatory substances. In addition, our data show that the main effect of LPS on body temperature is hypothermia in the absence of nervous system EP3 receptors or in the presence of a COX inhibitor. (C) 2014 Elsevier Inc. All rights reserved.	[Oishi, Yo; Yoshida, Kyoko; Scammell, Thomas E.; Saper, Clifford B.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Oishi, Yo; Yoshida, Kyoko; Scammell, Thomas E.; Saper, Clifford B.] Harvard Univ, Sch Med, Boston, MA USA; [Oishi, Yo; Urade, Yoshihiro; Lazarus, Michael] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan; [Urade, Yoshihiro; Lazarus, Michael] Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka 565, Japan	Lazarus, M (reprint author), Univ Tsukuba, Int Inst Integrat Sleep Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	lazarus.michael.ka@u.tsukuba.ac.jp; csaper@bidmc.harvard.edu			Japan Society for the Promotion of Science (JSPS) [24300129, 25890005]; G. Harold and Leila Y. Mathers Foundation; Nestle Nutrition Council of Japan; VA merit Grant [DK37097]; National Institutes of Health [NS072337]; World Premier International Research Center Initiative (WPI) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	We thank Matthew and Richard Breyer (Vanderbilt University) for providing EP<INF>4</INF> fox mice, Shuh Narumiya (Kyoto university) for providing DPR KO mice and Takatoshi Mochizuki (Beth Israel Deaconess Medical Center) for technical advice. This work was supported by a Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Research Abroad (to Y.O.), the G. Harold and Leila Y. Mathers Foundation (to C.B.S.), Nestle Nutrition Council of Japan (to M.L.), VA merit Grant DK37097 (to Richard M. Breyer, Vanderbilt University, for EP4 fox mouse development), National Institutes of Health Grant NS072337 (to C.B.S.), JSPS Grant 24300129 (to M.L.) and 25890005 (to Y.O.) and World Premier International Research Center Initiative (WPI) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M.L., Y.O. and Y.U.).	Ram A, 1997, BRAIN RES, V751, P81, DOI 10.1016/S0006-8993(96)01401-1; MATSUMURA H, 1989, BRAIN RES, V481, P242, DOI 10.1016/0006-8993(89)90800-7; Huang ZL, 2007, CURR OPIN PHARMACOL, V7, P33, DOI 10.1016/j.coph.2006.09.004; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Zielinski MR, 2013, SLEEP, V36, P1227, DOI 10.5665/sleep.2892; Kabashima K, 2003, PROSTAG LEUKOTR ESS, V69, P187, DOI 10.1016/S0952-3278(03)00080-2; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Morrow JD, 2005, BRAIN BEHAV IMMUN, V19, P40, DOI 10.1016/j.bbi.2004.04.001; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; ONOE H, 1988, P NATL ACAD SCI USA, V85, P4082, DOI 10.1073/pnas.85.11.4082; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Jakubcakova V, 2011, BRAIN BEHAV IMMUN, V25, P1626, DOI 10.1016/j.bbi.2011.06.008; Schneider A, 2004, GENESIS, V40, P7, DOI 10.1002/gene.20048; Urade Y, 2011, SLEEP MED REV, V15, P411, DOI 10.1016/j.smrv.2011.08.003; Oka T, 2000, J COMP NEUROL, V428, P20, DOI 10.1002/1096-9861(20001204)428:1<20::AID-CNE3>3.0.CO;2-X; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Zager A, 2009, EUR NEUROPSYCHOPHARM, V19, P589, DOI 10.1016/j.euroneuro.2009.03.005; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159; Nguyen MT, 1997, NATURE, V390, P78; Oishi Y, 2013, J NEUROSCI, V33, P9743, DOI 10.1523/JNEUROSCI.0499-13.2013; Breder CD, 1996, BRAIN RES, V713, P64, DOI 10.1016/0006-8993(95)01474-8; Fitzgerald KA, 2000, MICROBES INFECT, V2, P933, DOI 10.1016/S1286-4579(00)00396-8; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Huang ZL, 2003, J NEUROSCI, V23, P5975; Kaushik MK, 2014, EXP NEUROL, V253, P82, DOI 10.1016/j.expneurol.2013.12.002; Kozak W, 1997, ANN NY ACAD SCI, V813, P264, DOI 10.1111/j.1749-6632.1997.tb51704.x; Krueger JM, 2003, ANN NY ACAD SCI, V992, P9; MATSUMURA H, 1989, P NATL ACAD SCI USA, V86, P5666, DOI 10.1073/pnas.86.14.5666; Mullington JM, 2001, ANN NY ACAD SCI, V933, P201; Simons CT, 1998, AM J PHYSIOL-REG I, V275, pR63; Toth LA, 2001, AM J PHYSIOL-REG I, V280, pR1806; UENO R, 1982, BIOCHEM BIOPH RES CO, V109, P576, DOI 10.1016/0006-291X(82)91760-0; UENO R, 1982, P NATL ACAD SCI-BIOL, V79, P6093, DOI 10.1073/pnas.79.19.6093; Urade Y, 2013, GENETIC BASIS OF SLEEP AND SLEEP DISORDERS, P73; URADE Y, 1985, J BIOL CHEM, V260, P2410; Vane J.R., 1971, NATURE-NEW BIOL, V231, P232; Zhang J, 1999, EUR J NEUROSCI, V11, P2651, DOI 10.1046/j.1460-9568.1999.00682.x	43	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JUL	2015	47				SI		172	177		10.1016/j.bbi.2014.11.019		6	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	CL8NM	WOS:000357231400020		
J	Mishima, C; Kagara, N; Tanei, T; Naoi, Y; Shimoda, M; Shimomura, A; Shimazu, K; Kim, SJ; Noguchi, S				Mishima, Chieko; Kagara, Naofumi; Tanei, Tomonori; Naoi, Yasuto; Shimoda, Masafumi; Shimomura, Atsushi; Shimazu, Kenzo; Kim, Seung Jin; Noguchi, Shinzaburo			Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing	BREAST CANCER RESEARCH AND TREATMENT			English	Article						MED12; Somatic mutation; Next-generation sequencing; Fibroepithelial tumor	PROTEIN EXPRESSION; C-KIT; P53; FEATURES; PROGRESSION; GENE	We aimed to analyze MED12 mutation in fibroadenomas (FAs) and phyllodes tumors (PTs) of the breast, which are closely related and consist of epithelial and stromal components. Targeted deep-sequencing using next-generation sequencing was performed in FAs (n = 58) and PTs (n = 27). The frequency of MED12 mutant tumors was significantly higher (P = 0.016) in PTs (74.1 %) than in FAs. (46.6 %). As for FAs, this frequency was significantly higher (P = 0.001) for intracanalicular type (69.0 %) than for other histological subtypes such as pericanalicular, organoid, and mastopathic types (24.1 %). Laser microdissection study revealed that stromal cells, but not epithelial cells, harbored MED12 mutations in both FAs and PTs. MED12 mutation is implicated in the pathogenesis of both FAs and PTs. The similarly high frequency of MED12 mutation in intracanalicular type FAs suggests that they are most closely related to PTs. It is thus speculated that FAs with MED12 mutation are more likely to progress to PTs.	[Mishima, Chieko; Kagara, Naofumi; Tanei, Tomonori; Naoi, Yasuto; Shimoda, Masafumi; Shimomura, Atsushi; Shimazu, Kenzo; Kim, Seung Jin; Noguchi, Shinzaburo] Osaka Univ, Grad Sch Med, Fac Med, Dept Breast & Endocrine Surg, Suita, Osaka, Japan	Kagara, N (reprint author), Osaka Univ, Grad Sch Med, Fac Med, Dept Breast & Endocrine Surg, 2-2-E10 Yamadaoka, Suita, Osaka, Japan.	kagaran@onsurg.med.osaka-u.ac.jp					Feakins RM, 1999, HISTOPATHOLOGY, V35, P162, DOI 10.1046/j.1365-2559.1999.00682.x; Yoshida M, 2015, BRIT J CANCER, V112, P1703, DOI 10.1038/bjc.2015.116; Sawyer EJ, 2003, J PATHOL, V200, P59, DOI 10.1002/path.1318; Lim WK, 2014, NAT GENET, V46, P877, DOI 10.1038/ng.3037; Giri D, 2009, ARCH PATHOL LAB MED, V133, P713, DOI 10.1043/1543-2165-133.5.713; Abe M, 2011, BREAST CANCER-TOKYO, V18, P268, DOI 10.1007/s12282-009-0185-x; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Kleer CG, 2001, MODERN PATHOL, V14, P185, DOI 10.1038/modpathol.3880282; Kuijper A, 2002, J PATHOL, V197, P575, DOI 10.1002/path.1161; Piscuoglio S, 2015, HISTOPATHOLOGY, V67, P719, DOI 10.1111/his.12712; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Tan PH, 2005, MODERN PATHOL, V18, P1527, DOI 10.1038/modpathol.3800488; NOGUCHI S, 1995, CANCER, V76, P1779, DOI 10.1002/1097-0142(19951115)76:10<1779::AID-CNCR2820761015>3.0.CO;2-0; Turunen M, 2014, CELL REP, V7, P654, DOI 10.1016/j.celrep.2014.03.047; Cani AK, 2015, MOL CANCER RES, V13, P613, DOI 10.1158/1541-7786.MCR-14-0578; CARTY NJ, 1995, ANN ROY COLL SURG, V77, P127; DIXON JM, 1991, BRIT MED BULL, V47, P258; Gatalica Z, 2001, PATHOL RES PRACT, V197, P183, DOI 10.1078/0344-0338-00031; Graham JM, 2013, AM J MED GENET A, V161, P2734, DOI 10.1002/ajmg.a.36183; Kuijper A, 2006, PATHOGENESIS PROGRES; Kuroda H, 2006, SURG TODAY, V36, P590, DOI 10.1007/s00595-006-3206-9; Mori I, 2006, CYTOPATHOLOGY, V17, P233, DOI 10.1111/j.1365-2303.2006.00333.x; Nagasawa S, 2015, CANC MED, DOI [10.1002/cam4.462, DOI 10.1002/CAM4.462]; Noguchi S, 1996, BREAST CANC, V3, P79, DOI 10.1007/BF02966968; Pfarr N, 2015, GENE CHROMOSOME CANC, V54, P444, DOI 10.1002/gcc.22256; Yang S, 2014, ARCH PATHOL LAB MED, V138, P25; Yonemori K, 2006, PATHOL RES PRACT, V202, P705, DOI 10.1016/j.prp.2006.05.006	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	JUL	2015	152	2					305	312		10.1007/s10549-015-3469-1		8	Oncology	Oncology	CM1FO	WOS:000357426700009		
J	Chiang, YZ; Zhao, C; Melbourne, W; Wijayanti, A; Tran, K; Kim, J; Ishii, N; Legaspi, K; Koga, H; Schmidt, E; Zillikens, D; Hashimoto, T; Murrell, D				Chiang, Y. Z.; Zhao, C.; Melbourne, W.; Wijayanti, A.; Tran, K.; Kim, J.; Ishii, N.; Legaspi, K.; Koga, H.; Schmidt, E.; Zillikens, D.; Hashimoto, T.; Murrell, D.			Biochip immunofluorescence microscopy as a new diagnostic tool for autoimmune blistering skin diseases	BRITISH JOURNAL OF DERMATOLOGY			English	Meeting Abstract	95th Annual Meeting of the British-Association-of-Dermatologists	JUL 07-09, 2015	Manchester, ENGLAND	British Assoc Dermatologists					[Chiang, Y. Z.; Zhao, C.; Wijayanti, A.; Tran, K.; Legaspi, K.; Murrell, D.] St George Hosp, Dept Dermatol, Sydney, NSW, Australia; [Melbourne, W.; Kim, J.] St George Hosp, Anat Pathol, Sydney, NSW, Australia; [Ishii, N.; Koga, H.; Hashimoto, T.] Kurume Univ, Fukuoka, Japan; [Schmidt, E.; Zillikens, D.] Med Univ Lubeck, D-23538 Lubeck, Germany								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	JUL	2015	173			1	SI	O11	7	8				2	Dermatology	Dermatology	CM5LL	WOS:000357729300013		
J	Imafuku, K; Nomura, Y; Nakayama, C; Abe, R; Endo, T; Shimizu, H				Imafuku, Keisuke; Nomura, Yukiko; Nakayama, Chihiro; Abe, Riichiro; Endo, Tomoyuki; Shimizu, Hiroshi			Erythema annulare centrifugum-like mycosis fungoides after unrelated bone marrow transplantation	BRITISH JOURNAL OF HAEMATOLOGY			English	Article									[Imafuku, Keisuke; Nomura, Yukiko; Nakayama, Chihiro; Abe, Riichiro; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan; [Endo, Tomoyuki] Hokkaido Univ, Grad Sch Med, Dept Haematol, Sapporo, Hokkaido, Japan	Imafuku, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan.	yukira0423@gmail.com						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	JUL	2015	170	2					140	140		10.1111/bjh.13489		1	Hematology	Hematology	CM2NB	WOS:000357516200002		
J	Takeuchi, M; Taguchi, M				Takeuchi, Mitchie; Taguchi, Miyako			Mitchie Takeuchi and Miyako Taguchi: Second-generation survivors of the atomic bomb	BULLETIN OF THE ATOMIC SCIENTISTS			English	Editorial Material						atomic bomb survivors; hibakusha; Hibakusha Stories; Hiroshima; Nagasaki; second-generation hibakusha		Mitchie Takeuchi's mother and grandfather survived the atomic bombing of Hiroshima 70 years ago. Miyako Taguchi's parents survived the bombing of Nagasaki three days later. Takeuchi and Taguchi both are part of the second generation (and in Takeuchi's case also the third generation) of hibakushathe Japanese term for people who were exposed directly to one of the two bombings or their radioactive fallout or who were exposed while still in their mothers' wombs. Although many hibakusha have been reluctant or unwilling to discuss the bombings with their children, some have not only talked about their experiences with family members but also become active in groups such as Hibakusha Storieswhich brings survivors into New York City schools to discuss their experiences with students. In this pair of interviews, Takeuchi and Taguchi talk about what it's like to be the child of a survivor and why they feel a responsibility to share their family stories and to speak out about nuclear weapons.	[Takeuchi, Mitchie] Hiroshima Red Cross Hosp, Hiroshima, Japan; [Takeuchi, Mitchie] Arc Media Inc, Waterloo, ON, Canada; [Takeuchi, Mitchie] World Friendship Ctr, Hiroshima, Japan; [Taguchi, Miyako] Miyako & Studio, Oss, Netherlands								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0096-3402	1938-3282		B ATOM SCI	Bull. Atom. Scient.	JUL-AUG	2015	71	4					1	9		10.1177/0096340215590797		9	International Relations; Social Issues	International Relations; Social Issues	CL9LC	WOS:000357298800001		
J	Hou, B; Ishinaga, H; Midorikawa, K; Shah, SA; Nakamura, S; Hiraku, Y; Oikawa, S; Murata, M; Takeuchi, K				Hou, Bo; Ishinaga, Hajime; Midorikawa, Kaoru; Shah, Said Ahmad; Nakamura, Satoshi; Hiraku, Yusuke; Oikawa, Shinji; Murata, Mariko; Takeuchi, Kazuhiko			Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma	CANCER BIOLOGY & THERAPY			English	Article						biomarker; circulating miRNA; head and neck squamous cell carcinoma; miR-99a; miR-223	DOWN-REGULATION; CANCER; EXPRESSION; MIRNAS	Circulating microRNAs (miRNAs) are emerging as promising non-invasive biomarkers for human cancer. Head and neck squamous cell carcinoma (HNSCC) is a prevalent malignancy worldwide, but its overall survival has remained unchanged in the past 3 decades. Biomarkers for evaluating efficacy of cancer therapy are urgently needed. To explore circulating miRNAs as cancer therapy biomarkers, we initially identified that 8 miRNAs were distinctly dysregulated in cancerous tissues compared with adjacent non-cancerous counterparts from 16 patients, using microarray and real-time PCR. Based on this discovery, the comparison study was performed between pre- and 6 months post-operative paired plasma samples on 9 patients. MiR-99a, which was down-regulated in cancerous tissues, was significantly increased in plasma after operation. Meanwhile, oncomiR miR-21 and miR-223 that were up-regulated in cancerous tissues, were significantly reduced in post-operative plasma samples. We firstly report the significant changes of miR-99a in plasma of HNSCC patients after surgery. Furthermore, plasma miR-223 was inversely increased in a patient whose cancer relapsed within 6 months after operation. We conclude that these circulating miRNAs may serve as biomarkers to evaluate the efficacy of therapy and the prognosis of HNSCC.	[Hou, Bo; Ishinaga, Hajime; Shah, Said Ahmad; Nakamura, Satoshi; Takeuchi, Kazuhiko] Dept Otolaryngol Head & Neck Surg, Tsu, Mie, Japan; [Hou, Bo; Midorikawa, Kaoru; Hiraku, Yusuke; Oikawa, Shinji; Murata, Mariko] Mie Univ, Grad Sch Med, Dept Environm & Mol Med, Tsu, Mie 514, Japan	Murata, M (reprint author), Mie Univ, Grad Sch Med, Dept Environm & Mol Med, Tsu, Mie 514, Japan.	mmurata@doc.medic.mie-u.ac.jp; kazuhiko@clin.medic.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25293149, 23659327]; Mie University	This work was partly supported by Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 25293149 and No. 23659327) and Mie University Hospital Seed Grant Program 2012, 2013, 2014.	Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Kuo YZ, 2014, ORAL DIS, V20, pe65, DOI 10.1111/odi.12133; Liu M, 2009, CELL RES, V19, P828, DOI 10.1038/cr.2009.72; Li JH, 2012, J CANCER RES CLIN, V138, P763, DOI 10.1007/s00432-012-1154-x; Polanska H, 2014, ORAL ONCOL, V50, P168, DOI 10.1016/j.oraloncology.2013.12.008; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Hsu CM, 2012, TUMOR BIOL, V33, P1933, DOI 10.1007/s13277-012-0454-8; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Stamatopoulos B, 2009, BLOOD, V113, P5237, DOI 10.1182/blood-2008-11-189407; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; MacLellan SA, 2012, CANCER MED-US, V1, P268, DOI 10.1002/cam4.17; Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-14; Yen YC, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-6	22	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4047	1555-8576		CANCER BIOL THER	Cancer Biol. Ther.	JUL	2015	16	7					1042	1046		10.1080/15384047.2015.1045692		5	Oncology	Oncology	CM5AW	WOS:000357699300006		
J	Al Olama, AA; Benlloch, S; Antoniou, AC; Giles, GG; Severi, G; Neal, DE; Hamdy, FC; Donovan, JL; Muir, K; Schleutker, J; Henderson, BE; Haiman, CA; Schumacher, FR; Pashayan, N; Pharoah, PDP; Ostrander, EA; Stanford, JL; Batra, J; Clements, JA; Chambers, SK; Weischer, M; Nordestgaard, BG; Ingles, SA; Sorensen, KD; Orntoft, TF; Park, JY; Cybulski, C; Maier, C; Doerk, T; Dickinson, JL; Cannon-Albright, L; Brenner, H; Rebbeck, TR; Zeigler-Johnson, C; Habuchi, T; Thibodeau, SN; Cooney, KA; Chappuis, PO; Hutter, P; Kaneva, RP; Foulkes, WD; Zeegers, MP; Lu, YJ; Zhang, HW; Stephenson, R; Cox, A; Southey, MC; Spurdle, AB; FitzGerald, L; Leongamornlert, D; Saunders, E; Tymrakiewicz, M; Guy, M; Dadaev, T; Little, SJ; Govindasami, K; Sawyer, E; Wilkinson, R; Herkommer, K; Hopper, JL; Lophatonanon, A; Rinckleb, AE; Kote-Jarai, Z; Eeles, RA; Easton, DF				Al Olama, Ali Amin; Benlloch, Sara; Antoniou, Antonis C.; Giles, Graham G.; Severi, Gianluca; Neal, David E.; Hamdy, Freddie C.; Donovan, Jenny L.; Muir, Kenneth; Schleutker, Johanna; Henderson, Brian E.; Haiman, Christopher A.; Schumacher, Fredrick R.; Pashayan, Nora; Pharoah, Paul D. P.; Ostrander, Elaine A.; Stanford, Janet L.; Batra, Jyotsna; Clements, Judith A.; Chambers, Suzanne K.; Weischer, Maren; Nordestgaard, Borge G.; Ingles, Sue A.; Sorensen, Karina D.; Orntoft, Torben F.; Park, Jong Y.; Cybulski, Cezary; Maier, Christiane; Doerk, Thilo; Dickinson, Joanne L.; Cannon-Albright, Lisa; Brenner, Hermann; Rebbeck, Timothy R.; Zeigler-Johnson, Charnita; Habuchi, Tomonori; Thibodeau, Stephen N.; Cooney, Kathleen A.; Chappuis, Pierre O.; Hutter, Pierre; Kaneva, Radka P.; Foulkes, William D.; Zeegers, Maurice P.; Lu, Yong-Jie; Zhang, Hong-Wei; Stephenson, Robert; Cox, Angela; Southey, Melissa C.; Spurdle, Amanda B.; FitzGerald, Liesel; Leongamornlert, Daniel; Saunders, Edward; Tymrakiewicz, Malgorzata; Guy, Michelle; Dadaev, Tokhir; Little, Sarah J.; Govindasami, Koveela; Sawyer, Emma; Wilkinson, Rosemary; Herkommer, Kathleen; Hopper, John L.; Lophatonanon, Aritaya; Rinckleb, Antje E.; Kote-Jarai, Zsofia; Eeles, Rosalind A.; Easton, Douglas F.		British Assoc Urological Surgeons; UK ProtecT Study Collaborators; PRACTICAL Consortium	Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER; MULTIPLE LOCI; PREDICTION; VARIANTS; IDENTIFICATION; BRCA2	Background: Genome-wide association studies have identified multiple genetic variants associated with prostate cancer risk which explain a substantial proportion of familial relative risk. These variants can be used to stratify individuals by their risk of prostate cancer. Methods: We genotyped 25 prostate cancer susceptibility loci in 40,414 individuals and derived a polygenic risk score (PRS). We estimated empirical odds ratios (OR) for prostate cancer associated with different risk strata defined by PRS and derived age-specific absolute risks of developing prostate cancer by PRS stratum and family history. Results: The prostate cancer risk for men in the top 1% of the PRS distribution was 30.6 (95% CI, 16.4-57.3) fold compared with men in the bottom 1%, and 4.2 (95% CI, 3.2-5.5) fold compared with the median risk. The absolute risk of prostate cancer by age of 85 years was 65.8% for a man with family history in the top 1% of the PRS distribution, compared with 3.7% for a man in the bottom 1%. The PRS was only weakly correlated with serum PSA level (correlation = 0.09). Conclusions: Risk profiling can identify men at substantially increased or reduced risk of prostate cancer. The effect size, measured by OR per unit PRS, was higher in men at younger ages and in men with family history of prostate cancer. Incorporating additional newly identified loci into a PRS should improve the predictive value of risk profiles. Impact: We demonstrate that the risk profiling based on SNPs can identify men at substantially increased or reduced risk that could have useful implications for targeted prevention and screening programs. (C) 2015 AACR.	[Al Olama, Ali Amin; Benlloch, Sara; Antoniou, Antonis C.; Pashayan, Nora; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Ctr Canc Genet Epidemiol, Cambridge, England; [Giles, Graham G.; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [Giles, Graham G.; Hopper, John L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 2QQ, England; [Neal, David E.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Hamdy, Freddie C.] Univ Oxford, John Radcliffe Hosp, Fac Med Sci, Oxford OX3 9DU, England; [Donovan, Jenny L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Muir, Kenneth] Univ Manchester, Ctr Epidemiol, Inst Populat Hlth, Manchester, Lancs, England; [Muir, Kenneth; Lophatonanon, Aritaya] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Schleutker, Johanna; Lophatonanon, Aritaya] Univ Tampere, Inst Biomed Technol, BioMediTech, FIN-33101 Tampere, Finland; [Schleutker, Johanna] FimLab Labs, Tampere, Finland; [Schleutker, Johanna] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Henderson, Brian E.; Haiman, Christopher A.; Schumacher, Fredrick R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Pashayan, Nora] UCL, Dept Appl Hlth Res, London, England; [Ostrander, Elaine A.] NHGRI, NIH, Bethesda, MD 20892 USA; [Stanford, Janet L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Stanford, Janet L.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Batra, Jyotsna; Clements, Judith A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Australian Prostate Canc Res Ctr Qld, Brisbane, Qld 4001, Australia; [Batra, Jyotsna; Clements, Judith A.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4001, Australia; [Chambers, Suzanne K.] Griffith Univ, Griffith Hlth Inst, Gold Coast, Qld, Australia; [Chambers, Suzanne K.] Canc Council Queensland, Brisbane, Qld, Australia; [Chambers, Suzanne K.] Prostate Canc Fdn Australia, Sydney, NSW, Australia; [Weischer, Maren; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark; [Sorensen, Karina D.; Orntoft, Torben F.] Aarhus Univ Hosp, Dept Mol Med MOMA, Aarhus N, Denmark; [Park, Jong Y.] Univ S Florida, H Lee Moffitt Canc Ctr, Div Canc Prevent & Control, Tampa, FL 33682 USA; [Cybulski, Cezary] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [Maier, Christiane; Rinckleb, Antje E.] Univ Hosp Ulm, Dept Urol, Ulm, Germany; [Doerk, Thilo] Hannover Biomed Res Sch, Hannover, Germany; [Dickinson, Joanne L.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Cannon-Albright, Lisa] Univ Utah, Sch Med, Dept Med, Div Genet Epidemiol, Salt Lake City, UT USA; [Cannon-Albright, Lisa] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA; [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Ageing Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Consortium DKTK, Heidelberg, Germany; [Rebbeck, Timothy R.] Univ Penn, Philadelphia, PA 19104 USA; [Zeigler-Johnson, Charnita] Thomas Jefferson Univ, Dept Med Oncol, Div Populat Sci, Philadelphia, PA 19107 USA; [Habuchi, Tomonori] Akita Univ, Sch Med, Dept Urol, Akita 010, Japan; [Thibodeau, Stephen N.] Mayo Clin, Rochester, MN USA; [Cooney, Kathleen A.] Univ Michigan, Sch Med, Div Hematol Oncol, Ann Arbor, MI USA; [Chappuis, Pierre O.] Univ Hosp Geneva, Div Oncol Med, Geneva, Switzerland; [Chappuis, Pierre O.] Univ Hosp Geneva, Dept Med Genet, Geneva, Switzerland; [Hutter, Pierre] Univ Geneva, Hop Cantonal, CH-1211 Geneva, Switzerland; [Kaneva, Radka P.] Med Univ Sofia, Mol Med Ctr, Dept Med Chem & Biochem, Sofia, Bulgaria; [Foulkes, William D.] McGill Univ, Montreal, PQ, Canada; [Zeegers, Maurice P.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Complex Genet,Cluster Genet & Cell Biol, NL-6200 MD Maastricht, Netherlands; [Lu, Yong-Jie] Queen Mary Univ London, John Vane Sci Ctr, Barts Canc Inst, London, England; [Zhang, Hong-Wei] Second Mil Med Univ, Shanghai, Peoples R China; [Stephenson, Robert] Univ Utah, Sch Med, Dept Surg, Div Urol, Salt Lake City, UT USA; [Cox, Angela] Univ Sheffield, CR UK YCR Sheffield Canc Res Ctr, Sheffield, S Yorkshire, England; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Spurdle, Amanda B.] Queensland Inst Med Res, Mol Canc Epidemiol Lab, Brisbane, Qld 4006, Australia; [FitzGerald, Liesel] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Leongamornlert, Daniel; Saunders, Edward; Tymrakiewicz, Malgorzata; Guy, Michelle; Dadaev, Tokhir; Little, Sarah J.; Govindasami, Koveela; Sawyer, Emma; Wilkinson, Rosemary; Kote-Jarai, Zsofia; Eeles, Rosalind A.] Inst Canc Res, London SW3 6JB, England; [Herkommer, Kathleen] Tech Univ Munich, Dept Urol, D-80290 Munich, Germany; [Eeles, Rosalind A.] Royal Marsden NHS Fdn Trust, London, England; [Eeles, Rosalind A.] Royal Marsden NHS Fdn Trust, Surrey, England	Al Olama, AA (reprint author), Ctr Canc Genet Epidemiol, Strangeways Res Lab, Worts Causeway, Cambridge CB1 8RN, England.	aa461@medschl.cam.ac.uk; dfe20@medschl.cam.ac.uk	Dork, Thilo/J-8620-2012; Chambers, Suzanne/H-5957-2012; 	Beltcheva, Olga/0000-0001-6748-9726; Cox, Angela/0000-0002-5138-1099	CR-UK [C1287/A10118, C5047/A10692]; NIH [1U19CA148537-01]	D.F. Easton was recipient of the CR-UK grant C1287/A10118. R.A. Eeles was recipient of the CR-UK grant C5047/A10692 and B.E. Henderson was recipient of the NIH grant 1U19CA148537-01.	Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; MacInnis RJ, 2010, GENET EPIDEMIOL, V34, P42, DOI 10.1002/gepi.20433; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Antoniou AC, 2010, CANCER RES, V70, P9742, DOI 10.1158/0008-5472.CAN-10-1907; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Pashayan N, 2011, BRIT J CANCER, V104, P1656, DOI 10.1038/bjc.2011.118; Aly M, 2011, EUR UROL, V60, P21, DOI 10.1016/j.eururo.2011.01.017; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; MacInnis RJ, 2011, GENET EPIDEMIOL, V35, P549, DOI 10.1002/gepi.20605; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Whitaker HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013363	22	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1055-9965	1538-7755		CANCER EPIDEM BIOMAR	Cancer Epidemiol. Biomarkers Prev.	JUL	2015	24	7					1121	1129		10.1158/1055-9965.EPI-14-0317		9	Oncology; Public, Environmental & Occupational Health	Oncology; Public, Environmental & Occupational Health	CM1FF	WOS:000357425700015		
J	Kameoka, S; Wakabayashi, S; Ohshima, K; Tsai, AP				Kameoka, Satoshi; Wakabayashi, Satoru; Ohshima, Kazuki; Tsai, An Pang			A Composite Catalyst with a Lamellar Fe3O4/Pt/Fe3O4 Structure and Complementary Dual Catalytic Functions	CATALYSIS LETTERS			English	Article						Eutectic alloy; Al2Pt; Al5Fe2; Leaching; Lamellar Fe3O4/Pt/Fe3O4; Steam reforming of methanol; Complementary catalytic functions	REACTION-MECHANISM; OXIDATION; METHANOL; ALLOY; WGS; FE; CO	A composite catalyst with a lamellar Fe3O4/Pt/Fe3O4 structure has been prepared from an Al67Pt7Fe26 (at.%) alloy by leaching with an aqueous 10 % NaOH solution. The lamellar Fe3O4/Pt/Fe3O4 phase exhibits significant catalytic performance as measured by activity and selectivity during the steam reforming of methanol superior to the catalytic performance of Pt obtained from Al2Pt and a conventional impregnated Pt/Fe3O4 catalyst under the same reaction conditions. It is clear that the Pt and Fe3O4 were primarily responsible for the catalysis of the decomposition of methanol and the water gas shift reaction , respectively. These two reactions work together in a complementary manner to facilitate the overall SRM reaction due to efficient the heat transfer characteristics of the lamellar Fe3O4/Pt/Fe3O4 structure. In this study, we demonstrate that a lamellar structure is available to couple two separate reactions to obtain a new catalytic function. In order to improve catalytic properties (stability, functionality), we combined with eutectic alloys and leaching treatment to obtain alternately binary phases with nano-architecture for catalytic materials. [GRAPHICS] .	[Kameoka, Satoshi; Wakabayashi, Satoru; Ohshima, Kazuki; Tsai, An Pang] Tohoku Univ, IMRAM, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Tsai, An Pang] NIMS, Tsukuba, Ibaraki 3050047, Japan	Kameoka, S (reprint author), Tohoku Univ, IMRAM, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	kameoka@tagen.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [(A) 23,247,117, (B) 24,360,329]	The authors are grateful to Dr. Masahiko Shimoda (NIMS) for helpful discussions, Mr. Eiji Aoyagi (IMR Tohoku University) for SEM-EDS observations and to Dr. Yoshitaka Matsushita, Dr. Masahiko Tanaka and Dr. Yoshiyuki Yamashita (NIMS) for assistance during the powder XRD and HEXPS measurements at SPring-8 (beam line 15XU: Proposal Nos. 2010B4500, 2011A4501, 2012A4500 and 2012B4502). This work was supported in part by Grant-in-Aid for Scientific Research [(A) 23,247,117 and (B) 24,360,329] from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Ito S, 2003, CATAL COMMUN, V4, P499, DOI 10.1016/S1566-7367(03)00132-8; Sun YN, 2009, J CATAL, V266, P359, DOI 10.1016/j.jcat.2009.07.002; Tanaka M, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2956972; RHODES C, 1995, CATAL TODAY, V23, P43, DOI 10.1016/0920-5861(94)00135-O; Raney M, 1940, IND ENG CHEM, V32, P1199, DOI 10.1021/ie50369a030; BURKHARDT U, 1994, ACTA CRYSTALLOGR B, V50, P313, DOI 10.1107/S0108768193013989; Takezawa N, 1997, CATAL TODAY, V36, P45, DOI 10.1016/S0920-5861(96)00195-2; Kotobuki M, 2005, J CATAL, V236, P262, DOI 10.1016/j.jcat.2005.09.026; Tanaka KI, 2006, CATAL LETT, V110, P185, DOI 10.1007/s10562-006-0107-x; Yamada Y, 2011, NAT CHEM, V3, P372, DOI [10.1038/nchem.1018, 10.1038/NCHEM.1018]; Xu LS, 2013, PHYS CHEM CHEM PHYS, V15, P12068, DOI 10.1039/c3cp50292a; Elliott R., 1983, EUTECTIC SOLIDIFICAT; Grondilova J, 2002, J APPL PHYS, V91, P8246, DOI 10.1063/1.1452224; Kameoka S, 2010, J MATER CHEM, V20, P7348, DOI 10.1039/c0jm01708f; Massalski TB, 1990, BINARY ALLOY PHASE D, V1, P147; Ohshima K, 2013, 153 ANN M JIM KAN, P562; Panagiotopoulou P, 2007, CATAL TODAY, V127, P319, DOI 10.1016/j.cattod.2007.05.010; Paniago R, 1997, PHYS REV B, V56, P13442, DOI 10.1103/PhysRevB.56.13442; Raney M., 1927, U. S. Patent, Patent No. [1628190, 1,628,190]; TAKANASHI K, 1995, APPL PHYS LETT, V67, P1016, DOI 10.1063/1.114715; Tsai AP, 2001, APPL CATAL A-GEN, V214, P237, DOI 10.1016/S0926-860X(01)00500-2; Wainwright MS, 1997, HDB HETEROGENEOUS CA, V1, P64; Wang XQJ, 2013, TOP CATAL, V56, P1899, DOI 10.1007/s11244-013-0126-y; Xu Y, 2010, J PHYS CHEM C, V114, P6047, DOI 10.1021/jp911626w	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1011-372X	1572-879X		CATAL LETT	Catal. Lett.	JUL	2015	145	7					1457	1463		10.1007/s10562-015-1553-0		7	Chemistry, Physical	Chemistry	CM2AM	WOS:000357481900012		
J	Deng, W; Wu, J; Wang, F; Kanoh, J; Dehe, PM; Inoue, H; Chen, J; Lei, M				Deng, Wei; Wu, Jian; Wang, Feng; Kanoh, Junko; Dehe, Pierre-Marie; Inoue, Haruna; Chen, Juan; Lei, Ming			Fission yeast telomere-binding protein Taz1 is a functional but not a structural counterpart of human TRF1 and TRF2	CELL RESEARCH			English	Letter							DNA; DOMAIN; LENGTH; RAP1; END		[Deng, Wei; Wu, Jian; Chen, Juan; Lei, Ming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai,State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Wang, Feng; Lei, Ming] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Wang, Feng; Lei, Ming] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kanoh, Junko; Inoue, Haruna] Osaka Univ, Inst Biol Sci, Suita, Osaka, Japan; [Dehe, Pierre-Marie] Canc Res UK, Telomere Biol Lab, London WC2A 3PX, England	Lei, M (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai,State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	leim@sibcb.ac.cn					Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Tomita K, 2003, MOL CELL BIOL, V23, P5186, DOI 10.1128/MCB.23.15.5186-5197.2003; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Li B, 2005, MOL CELL BIOL, V25, P5011, DOI 10.1128/MCB.25.12.5011-5021.2005; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Spink KG, 2000, NUCLEIC ACIDS RES, V28, P527, DOI 10.1093/nar/28.2.527	15	0	0	INST BIOCHEMISTRY & CELL BIOLOGY	SHANGHAI	SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA	1001-0602	1748-7838		CELL RES	Cell Res.	JUL	2015	25	7					881	884		10.1038/cr.2015.76		4	Cell Biology	Cell Biology	CM2MZ	WOS:000357516000014		
J	Derbalah, A; El-Safty, SA; Shenashen, MA; Ghany, NAA				Derbalah, Aly; El-Safty, Sherif A.; Shenashen, Mohamed A.; Ghany, Nabil A. Abdel			Mesoporous Alumina Nanoparticles as Host Tunnel-like Pores for Removal and Recovery of Insecticides from Environmental Samples	CHEMPLUSCHEM			English	Article						adsorption; green chemistry; insecticides; mesoporous materials; nanoparticles	LARGE PARTICLE MORPHOLOGY; TOXIC METAL-IONS; WASTE-WATER; AQUEOUS-SOLUTIONS; AROMATIC-AMINES; ORGANOPHOSPHORUS PESTICIDES; ORGANOCHLORINE PESTICIDES; BIOLOGICAL MACROMOLECULES; MESOSTRUCTURED MONOLITHS; ALUMINOSILICA MONOLITHS	Water contamination with lindane, which is a persistent, toxic, and priority insecticide, is a major problem worldwide. This study presents the fabrication of mesoporous alumina nanoparticles (MA-NPs) with a large surface-area-to-volume ratio, active surface sites, and open channel pores to trap/adsorb insecticide molecules, such as lindane. Key factors, such as temperature, pH (i.e., 4.5), adsorbate-adsorbent concentration, and contact time, influence the thermodynamics and kinetics of heterogeneous lindane-MA-NP adsorption. Results show that the maximum adsorption capacity (q(m)) of lindane is 25.54mgg(-1) at 20 degrees C. MA-NPs also exhibits a high uptake efficiency (>80%) of lindane after 20cycles, which results in effective regeneration and reusability characteristics. MA-NPs were also applied in real environmental samples from tap and lake water sources contaminated with lindane. The results indicate that the MA-NPs show evidence of their environmental impact, their potential influence on the removal and recovery of lindane, and their possible contribution to waste management.	[Derbalah, Aly; El-Safty, Sherif A.; Shenashen, Mohamed A.; Ghany, Nabil A. Abdel] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [El-Safty, Sherif A.] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	El-Safty, SA (reprint author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	sherif.elsafty@nims.go.jp					Abhilash PC, 2008, CHEMOSPHERE, V72, P79, DOI 10.1016/j.chemosphere.2008.01.056; Addorisio V, 2011, J HAZARD MATER, V196, P242, DOI 10.1016/j.jhazmat.2011.09.022; Al-Rashed SM, 2012, J SAUDI CHEM SOC, V16, P209, DOI 10.1016/j.jscs.2011.01.002; Yazdanbakhsh M, 2010, J HAZARD MATER, V184, P684, DOI 10.1016/j.jhazmat.2010.08.092; El-Safty SA, 2008, APPL CATAL A-GEN, V337, P121, DOI 10.1016/j.apcata.2007.11.039; Lan S, 2013, APPL SURF SCI, V283, P1032, DOI 10.1016/j.apsusc.2013.07.064; Shenashen MA, 2014, PART PART SYST CHAR, V31, P293, DOI 10.1002/ppsc.201300181; Shenashen MA, 2014, ANALYST, V139, P6393, DOI [10.1039/c4an00980k, 10.1039/C4AN00980K]; Chen H, 2009, APPL CLAY SCI, V46, P102, DOI 10.1016/j.clay.2009.07.006; Khairy M, 2012, APPL CATAL B-ENVIRON, V127, P1, DOI 10.1016/j.apcatb.2012.07.036; Khairy M, 2013, RSC ADV, V3, P23801, DOI 10.1039/c3ra44465a; Ada K, 2009, J HAZARD MATER, V165, P637, DOI 10.1016/j.jhazmat.2008.10.036; Khairy M, 2012, CHEM COMMUN, V48, P10832, DOI 10.1039/c2cc35638d; Maqueda C, 2013, APPL CLAY SCI, V72, P175, DOI 10.1016/j.clay.2012.10.017; Shenashen MA, 2013, SEP PURIF TECHNOL, V116, P73, DOI 10.1016/j.seppur.2013.05.011; Das SK, 2013, CHEMCATCHEM, V5, P3050, DOI 10.1002/cctc.201300192; El-Safty SA, 2012, SENSOR ACTUAT B-CHEM, V166, P253, DOI 10.1016/j.snb.2012.02.055; Gupta VK, 2002, WATER RES, V36, P2483, DOI 10.1016/S0043-1354(01)00474-2; Evans J, 2000, J PHYS CHEM B, V104, P10271, DOI 10.1021/jp000564p; Derbalah A, 2013, POL J CHEM TECHNOL, V15, P25, DOI 10.2478/pjct-2013-0040; Keiluweit M, 2009, ENVIRON SCI TECHNOL, V43, P3421, DOI 10.1021/es8033044; Khairy M, 2013, COLLOID SURFACE B, V111, P460, DOI 10.1016/j.colsurfb.2013.06.037; El-Safty SA, 2007, CHEM-EUR J, V13, P9245, DOI 10.1002/chem.200700499; El-Safty SA, 2013, ADV HEALTHC MATER, V2, P854, DOI 10.1002/adhm.201200326; Gupta PK, 2004, TOXICOLOGY, V198, P83, DOI 10.1016/j.tox.2004.01.021; El-Safty SA, 2011, SMALL, V7, P62, DOI 10.1002/smll.201001303; El-Safty SA, 2008, J PHYS CHEM C, V112, P5476, DOI 10.1021/jp0760096; Sidhoum DA, 2013, APPL CLAY SCI, V83-84, P441, DOI 10.1016/j.clay.2013.07.007; Gupta VK, 2011, WATER RES, V45, P4047, DOI 10.1016/j.watres.2011.05.016; El-Safty SA, 2012, TRAC-TREND ANAL CHEM, V38, P98, DOI 10.1016/j.trac.2012.05.002; El-Safty SA, 2013, MICROPOR MESOPOR MAT, V166, P195, DOI 10.1016/j.micromeso.2012.03.021; El-Safty SA, 2012, APPL CATAL B-ENVIRON, V123, P162, DOI 10.1016/j.apcatb.2012.04.021; Kaushik P, 2007, J HAZARD MATER, V143, P102, DOI 10.1016/j.jhazmat.2006.08.073; Elshehy EA, 2014, SENSOR ACTUAT B-CHEM, V203, P363, DOI 10.1016/j.snb.2014.06.055; Balaji T, 2006, ANGEW CHEM INT EDIT, V45, P7202, DOI 10.1002/anie.200602453; El-Safty S, 2011, J MATER CHEM, V21, P5593, DOI 10.1039/c0jm03269g; Bai P, 2009, MICROPOR MESOPOR MAT, V118, P288, DOI 10.1016/j.micromeso.2008.08.047; Zaki AB, 2000, J COLLOID INTERF SCI, V221, P58, DOI 10.1006/jcis.1999.6553; Ma XD, 2012, MICROPOR MESOPOR MAT, V158, P214, DOI 10.1016/j.micromeso.2012.03.044; El-Safty SA, 2008, CHEM MATER, V20, P2644, DOI 10.1021/cm701966c; El-Safty SA, 2010, CHEM COMMUN, V46, P3917, DOI 10.1039/c001654c; Phillips TM, 2005, BIODEGRADATION, V16, P363, DOI 10.1007/s10532-004-2413-6; Chaurasia AK, 2013, BIORESOURCE TECHNOL, V149, P439, DOI 10.1016/j.biortech.2013.09.084; Shenashen MA, 2013, J POROUS MAT, V20, P679, DOI 10.1007/s10934-012-9642-6; El-Safty SA, 2013, ENVIRON SCI POLLUT R, V20, P3863, DOI 10.1007/s11356-012-1309-y; Lai YS, 2013, J CHEM ENG DATA, V58, P2290, DOI 10.1021/je400399x; El-Safty SA, 2013, COLLOID SURFACE B, V103, P288, DOI 10.1016/j.colsurfb.2012.10.040; El-Safty SA, 2012, CHEM COMMUN, V48, P6708, DOI 10.1039/c2cc30725a; El-Safty SA, 2008, J POROUS MAT, V15, P369, DOI 10.1007/s10934-007-9157-8; El-Safty SA, 2008, J PHYS CHEM C, V112, P4825, DOI 10.1021/jp0764283; Hoa ND, 2011, CHEM-EUR J, V17, P12896, DOI 10.1002/chem.201101122; Kitous O, 2012, CHEM ENG PROCESS, V55, P20, DOI 10.1016/j.cep.2012.02.005; Khairy M, 2014, CHEM COMMUN, V50, P1356, DOI 10.1039/c3cc48155g; El-Safty SA, 2011, J COLLOID INTERF SCI, V359, P9, DOI 10.1016/j.jcis.2011.01.006; Walcarius A, 2010, J MATER CHEM, V20, P4478, DOI 10.1039/b924316j; El-Safty SA, 2007, ADV FUNCT MATER, V17, P3731, DOI 10.1002/adfm.200700447; El-Safty S, 2011, ANAL CHIM ACTA, V694, P151, DOI 10.1016/j.aca.2011.03.035; Peng XJ, 2009, J HAZARD MATER, V168, P210, DOI 10.1016/j.jhazmat.2009.02.021; El-Safty SA, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/37/375603; El-Safty SA, 2012, ADV FUNCT MATER, V22, P3013, DOI 10.1002/adfm.201200393; El-Safty SA, 2005, J PHYS CHEM B, V109, P9255, DOI 10.1021/jp050304d; Khairy M, 2013, NANOSCALE, V5, P7920, DOI 10.1039/c3nr02403b; Musbah I, 2013, DESALINATION, V313, P51, DOI 10.1016/j.desal.2012.11.016; Ajitha S, 2010, J POROUS MAT, V17, P341, DOI 10.1007/s10934-009-9298-z; El-Safty SA, 2012, TALANTA, V98, P69, DOI 10.1016/j.talanta.2012.06.046; Sarkar B, 2007, DESALINATION, V212, P129, DOI 10.1016/j.desal.2006.09.021; El-Safty SA, 2008, ADV FUNCT MATER, V18, P1739, DOI 10.1002/adfm.200800035; El-Safty SA, 2011, TALANTA, V83, P1341, DOI 10.1016/j.talanta.2010.11.008; Zaki AB, 2000, POLYHEDRON, V19, P1317, DOI 10.1016/S0277-5387(00)00401-0; El-Safty SA, 2008, J COLLOID INTERF SCI, V319, P477, DOI 10.1016/j.jcis.2007.12.010; El-Safty SA, 2013, SMALL, V9, P2288, DOI 10.1002/smll.201202407; Ezemonye LI, 2008, ARH HIG RADA TOKSIKO, V59, P261, DOI 10.2478/10004-1254-59-2008-1906; Abhilash PC, 2009, J HAZARD MATER, V165, P1, DOI 10.1016/j.jhazmat.2008.10.061; Groen JC, 2007, J AM CHEM SOC, V129, P355, DOI 10.1021/ja065737o; Kah M, 2006, REV ENVIRON CONTAM T, V188, P149, DOI 10.1007/978-0-387-32964-2_5; El-Safty S, 2011, COLLOID SURFACE A, V377, P44, DOI 10.1016/j.colsurfa.2010.12.015; Jeyakumar T, 2014, INT J ENVIRON RES, V8, P493; Ignatowicz K, 2009, J HAZARD MATER, V169, P953, DOI 10.1016/j.jhazmat.2009.04.061; Mekawy MM, 2011, J COLLOID INTERF SCI, V355, P348, DOI 10.1016/j.jcis.2010.11.056; El-Safty SA, 2013, SENSOR ACTUAT B-CHEM, V183, P58, DOI 10.1016/j.snb.2013.03.041; El-Safty SA, 2012, J HAZARD MATER, V201, P23, DOI 10.1016/j.jhazmat.2011.10.088; Jung BK, 2013, CHEM ENG J, V234, P99, DOI 10.1016/j.cej.2013.08.110; Du ZW, 2014, J HAZARD MATER, V274, P443, DOI 10.1016/j.jhazmat.2014.04.038; Lemic J, 2006, WATER RES, V40, P1079, DOI 10.1016/j.watres.20006.01.001; Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002; El-Safty S, 2011, MICROPOR MESOPOR MAT, V138, P51, DOI 10.1016/j.micromeso.2010.09.030; Marquez-Alvarez C, 2008, CATAL REV, V50, P222, DOI 10.1080/01614940701804042; Shenashen MA, 2013, J HAZARD MATER, V260, P833, DOI 10.1016/j.jhazmat.2013.06.025; Shenashen MA, 2013, J HAZARD MATER, V244, P726, DOI 10.1016/j.jhazmat.2012.11.006; Salman JM, 2010, J HAZARD MATER, V176, P814, DOI 10.1016/j.jhazmat.2009.11.107; El-Safty SA, 2012, CHEM COMMUN, V48, P9652, DOI 10.1039/c2cc34788a; El-Safty SA, 2004, CHEM MATER, V16, P384, DOI 10.1021/cm034282o; Ara A. G., 2014, Research Journal of Environmental and Earth Sciences, V6, P85; Balaji T., 2006, ANGEW CHEM, V118, P7360, DOI 10.1002/ange.200602453; Blin J.-L., 2003, ANGEW CHEM, V115, P2978, DOI DOI 10.1002/ANGE.200250816; Blin JL, 2003, ANGEW CHEM INT EDIT, V42, P2872, DOI 10.1002/anie.200250816; Chang K. L., 2011, WORLD ACAD SCI ENG T, V76, P348; Delle Site A, 2001, J PHYS CHEM REF DATA, V30, P187, DOI 10.1063/1.1347984; Delval F, 2006, BIORESOURCE TECHNOL, V97, P2173, DOI 10.1016/j.biortech.2005.09.022; El-Safty SA, 2012, EUR J INORG CHEM, P5439, DOI 10.1002/ejic.201200629; El-Kady A.A., 2013, WORLD APPL SCI J, V27, P269; El-Safty A., 2013, SENSOR ACTUAT B-CHEM, V176, P1015; El-Safty S. A., 2012, ANALYST, V137, P5208; El-Safty SA, 2003, J COLLOID INTERF SCI, V260, P184, DOI 10.1016/S0021-9797(02)00212-6; El-Safty SA, 2011, TRAC-TREND ANAL CHEM, V30, P447, DOI 10.1016/j.trac.2011.01.004; El-Safty SA, 2006, ACTA MATER, V54, P899, DOI 10.1016/j.actamat.2005.10.034; El-Safty SA, 2008, INT J ENVIRON POLLUT, V34, P97, DOI 10.1504/IJEP.2008.020785; El-Safty SA, 2011, J POROUS MAT, V18, P259, DOI 10.1007/s10934-010-9390-4; El-Safty SA, 2005, CHEM MATER, V17, P3137, DOI 10.1021/cm050013h; El-Safty SA, 2005, STUD SURF SCI CATAL, V158, P431; El-Safty SA, 2002, COLLOID SURFACE A, V203, P217, DOI 10.1016/S0927-7757(01)01102-5; El-Safty SA, 2001, INT J CHEM KINET, V33, P617, DOI 10.1002/kin.1059; El-Safty SA, 2003, STUD SURF SCI CATAL, V146, P173; Foo K.Y., 2009, ADV COLLOID INTERFAC, V149, P19; Garcia-Rivero M, 2007, J ENVIRON ENG SCI, V6, P389, DOI 10.1139/S06-061; Ghosh S, 2009, J HAZARD MATER, V172, P485, DOI 10.1016/j.jhazmat.2009.06.156; Gilliom Robert J, 2007, Environ Sci Technol, V41, P3408, DOI 10.1021/es072531u; Hoa ND, 2011, ANAL METHODS-UK, V3, P1948, DOI 10.1039/c1ay05333g; Jalil MER, 2013, APPL CLAY SCI, V71, P55, DOI 10.1016/j.clay.2012.11.005; Khairy M, 2013, ADV MATER RES-SWITZ, V685, P139, DOI 10.4028/www.scientific.net/AMR.685.139; Khairy M., 2013, CURR CATAL, V2, P17; Khairy M., 2014, J LIFE CYCLE ASS JAP, V10, P126; Khairy M, 2014, TRAC-TREND ANAL CHEM, V62, P56, DOI 10.1016/j.trac.2014.06.013; Khairy M, 2014, SENSOR ACTUAT B-CHEM, V193, P644, DOI 10.1016/j.snb.2013.11.113; Khairy M, 2015, J ENERGY CHEM, V24, P31, DOI 10.1016/S2095-4956(15)60281-9; Kushwaha S, 2011, J CHEM ENG DATA, V56, P2407, DOI 10.1021/je1013334; Liu HP, 2009, CATAL COMMUN, V10, P1324, DOI 10.1016/j.catcom.2009.02.014; Salam J. A., 2013, INT J PHARM PHARM SC, V5, P987; Sankararamakrishnan N, 2005, ENVIRON INT, V31, P113, DOI 10.1016/j.envint.2004.08.001; Selim MS, 2015, RSC ADV, V5, P19933, DOI 10.1039/c5ra01597a; Shenashen M. A., 2015, J INORG CHEM, P179; Somorjai G. A., 2010, INTRO SURFACE CHEM C; Sousa S, 2011, ENVIRON TECHNOL, V32, P673, DOI 10.1080/09593330.2010.510535; Srivastava B, 2009, J SCI IND RES INDIA, V68, P839; Su YH, 2006, ENVIRON SCI TECHNOL, V40, P6949, DOI 10.1021/es0609809; Tavakkoli H, 2013, MICROPOR MESOPOR MAT, V176, P86, DOI 10.1016/j.micromeso.2013.03.043; Timofeeva MN, 2011, APPL CATAL B-ENVIRON, V102, P433, DOI 10.1016/j.apcatb.2010.12.020; Yanez-Ocampo G., 2011, BIODEGRADATION, V22, P1203	138	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2192-6506			CHEMPLUSCHEM	ChemPlusChem	JUL	2015	80	7					1119	1126		10.1002/cplu.201500098		8	Chemistry, Multidisciplinary	Chemistry	CM3XD	WOS:000357617800006		
J	Zhang, Y; Zhao, HF; Hu, ZJ; Chen, H; Zhang, XJ; Huang, Q; Wo, QZ; Zhang, SG				Zhang, Yan; Zhao, Huifang; Hu, Zhijun; Chen, Hua; Zhang, Xuejin; Huang, Qi; Wo, Qizhong; Zhang, Shiguo			Protic Salts of High Nitrogen Content as Versatile Precursors for Graphitic Carbon Nitride: Anion Effect on the Structure, Properties, and Photocatalytic Activity	CHEMPLUSCHEM			English	Article						absorption; carbon nitride; guanidine; photocatalysis; protic salts	METAL-FREE CATALYSTS; VISIBLE-LIGHT; HYDROGEN EVOLUTION; IONIC LIQUIDS; SURFACE-AREA; MELEM ADDUCT; WATER; MELAMINE; G-C3N4; PHOTOSYNTHESIS	Graphitic carbon nitride (g-C3N4) is traditionally obtained by thermal polycondensation of nitrogen-rich organic nonionic precursors. Herein, we provide a new and simple strategy for the synthesis of g-C3N4 through direct thermal condensation of single protic guanidine salts with various anions. The thermal condensation process, and the structure and photophysical properties (optical properties, thermal stabilities, morphology and porosity, and photocatalytic activity) of the obtained g-C3N4 materials are investigated intensively through thermogravimetric analysis, powder X-ray diffraction, X-ray photoelectron spectroscopy, UV/Vis diffuse reflectance spectroscopy, nitrogen adsorption isotherms, and photodegradation of RhodamineB. The results reveal that during thermal condensation, the nitrogen-rich basic core in the guanidine salts serves as a carbon and nitrogen source to form the skeleton of g-C3N4, and the counter anions mediate the thermal condensation insitu and modify slightly the structure and properties of g-C3N4, even though they are not incorporated into the final structure. Among all g-C3N4 materials, including the pristine g-C3N4 from melamine, the g-C3N4 derived from guanidine thiocyanate exhibits a high activity toward the photocatalytic degradation of RhodamineB dye because of its relatively high surface area, enhanced absorption, small bandgap, and low photoluminescence intensity.	[Zhang, Yan; Zhao, Huifang; Hu, Zhijun; Chen, Hua; Zhang, Xuejin; Huang, Qi; Wo, Qizhong] Zhejiang Univ Sci & Technol, Sch Light Ind, Sch Biol & Chem Engn, Hangzhou 310023, Zhejiang, Peoples R China; [Zhang, Shiguo] Yokohama Natl Univ, Dept Chem & Biotechnol, Hodogaya ku, Yokohama, Kanagawa 2408501, Japan	Zhang, SG (reprint author), Yokohama Natl Univ, Dept Chem & Biotechnol, Hodogaya ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	sgzhang1981@gmail.com			National Natural Sciences Foundation of China [21203219, 21103208]; Zhejiang Province Key Discipline of Pulp and Paper in Zhejiang University of Science and Technology; School cross project [2014JC08Y]; Zhejiang Provincial Natural Science Foundation of China [LY13C160006]	This study was supported by the National Natural Sciences Foundation of China (no. 21203219 and 21103208), Zhejiang Province Key Discipline of Pulp and Paper in Zhejiang University of Science and Technology, School cross project (2014JC08Y), and Zhejiang Provincial Natural Science Foundation of China (LY13C160006).	Ge L, 2012, APPL CATAL B-ENVIRON, V117, P268, DOI 10.1016/j.apcatb.2012.01.021; Holst JR, 2008, J AM CHEM SOC, V130, P7373, DOI 10.1021/ja709992s; Wang XC, 2009, NAT MATER, V8, P76, DOI [10.1038/nmat2317, 10.1038/NMAT2317]; Liu G, 2010, J AM CHEM SOC, V132, P11642, DOI 10.1021/ja103798k; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Wang XC, 2009, J AM CHEM SOC, V131, P1680, DOI 10.1021/ja809307s; Zhang SG, 2014, J AM CHEM SOC, V136, P1690, DOI 10.1021/ja411981c; Zhang JS, 2012, ACS CATAL, V2, P940, DOI 10.1021/cs300167b; Long BH, 2014, J MATER CHEM A, V2, P2942, DOI 10.1039/c3ta14339b; Liu S, 2011, J MATER CHEM, V21, P11726, DOI 10.1039/c1jm12149a; Talapaneni SN, 2012, CHEMSUSCHEM, V5, P700, DOI 10.1002/cssc.201100626; Thomas A, 2008, J MATER CHEM, V18, P4893, DOI 10.1039/b800274f; Niu P, 2012, J PHYS CHEM C, V116, P11013, DOI 10.1021/jp301026y; Yan HJ, 2012, INT J HYDROGEN ENERG, V37, P125, DOI 10.1016/j.ijhydene.2011.09.072; Wang Y, 2010, CHEMSUSCHEM, V3, P435, DOI 10.1002/cssc.200900284; Lotsch BV, 2006, CHEM MATER, V18, P1891, DOI 10.1021/cm052342f; Zhang YJ, 2009, J AM CHEM SOC, V131, P50, DOI 10.1021/ja808329f; Cui YJ, 2011, J MATER CHEM, V21, P13032, DOI 10.1039/c1jm11961c; Vinu A, 2008, ADV FUNCT MATER, V18, P816, DOI 10.1002/adfm.200700783; Wirnhier E, 2013, CHEM-EUR J, V19, P2041, DOI 10.1002/chem.201203340; Jun YS, 2013, ADV FUNCT MATER, V23, P3661, DOI 10.1002/adfm.201203732; KIM YI, 1993, J PHYS CHEM-US, V97, P11802, DOI 10.1021/j100147a038; Wang Y, 2010, ANGEW CHEM INT EDIT, V49, P3356, DOI 10.1002/anie.201000120; Groenewolt M, 2005, ADV MATER, V17, P1789, DOI 10.1002/adma.200401756; KNOX JH, 1986, J CHROMATOGR, V352, P3, DOI 10.1016/S0021-9673(01)83368-9; Zhang C, 2005, CHEM MATER, V17, P3537, DOI 10.1021/cm0501517; Zhang SG, 2015, ANGEW CHEM INT EDIT, V54, P1302, DOI 10.1002/anie.201410234; Cui YJ, 2012, ANGEW CHEM INT EDIT, V51, P11814, DOI 10.1002/anie.201206534; Bojdys MJ, 2013, MACROMOL RAPID COMM, V34, P850, DOI 10.1002/marc.201300086; Dong F, 2011, J MATER CHEM, V21, P15171, DOI 10.1039/c1jm12844b; Chen XB, 2010, CHEM REV, V110, P6503, DOI 10.1021/cr1001645; Liu G, 2010, J MATER CHEM, V20, P831, DOI 10.1039/B909930A; Zhang YJ, 2010, J AM CHEM SOC, V132, P6294, DOI 10.1021/ja101749y; Jurgens B, 2003, J AM CHEM SOC, V125, P10288, DOI 10.1021/ja0357689; Li XH, 2011, CHEM MATER, V23, P4344, DOI 10.1021/cm201688v; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Yan SC, 2009, LANGMUIR, V25, P10397, DOI 10.1021/la900923z; Zhang GG, 2012, J MATER CHEM, V22, P8083, DOI 10.1039/c2jm00097k; Zhang SG, 2014, CHEM MATER, V26, P2915, DOI 10.1021/cm5006168; Wang XC, 2012, ACS CATAL, V2, P1596, DOI 10.1021/cs300240x; Singh JA, 2012, ACS CATAL, V2, P1138, DOI 10.1021/cs3001094; Dong GH, 2012, CHEM COMMUN, V48, P6178, DOI 10.1039/c2cc32181e; Shalom M, 2013, J AM CHEM SOC, V135, P7118, DOI 10.1021/ja402521s; Hong JD, 2012, J MATER CHEM, V22, P15006, DOI 10.1039/c2jm32053c; Chen XF, 2009, CHEM MATER, V21, P4093, DOI 10.1021/cm902130z; Lin ZZ, 2013, ANGEW CHEM INT EDIT, V52, P1735, DOI 10.1002/anie.201209017; Mane GP, 2013, J MATER CHEM A, V1, P2913, DOI 10.1039/c2ta01215d; Lee SC, 2012, CHEM-ASIAN J, V7, P2139, DOI 10.1002/asia.201200383; Xu J, 2013, PHYS CHEM CHEM PHYS, V15, P4510, DOI 10.1039/c3cp44402c; Liu JH, 2011, J MATER CHEM, V21, P14398, DOI 10.1039/c1jm12620b; Liu JH, 2012, CHEM COMMUN, V48, P8826, DOI 10.1039/c2cc33644h; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; WATANABE T, 1977, J PHYS CHEM-US, V81, P1845, DOI 10.1021/j100534a012; Yan HJ, 2012, CHEM COMMUN, V48, P3430, DOI 10.1039/c2cc00001f; Bojdys MJ, 2008, CHEM-EUR J, V14, P8177, DOI 10.1002/chem.200800190; Sattler A, 2009, CHEM-EUR J, V15, P13161, DOI 10.1002/chem.200901518; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Wang Y, 2012, ANGEW CHEM INT EDIT, V51, P68, DOI 10.1002/anie.201101182; Zou XX, 2011, CHEM COMMUN, V47, P1066, DOI 10.1039/c0cc03530k; Braml NE, 2012, CHEM-EUR J, V18, P1811, DOI 10.1002/chem.201101885; Cui Y, 2012, ANGEW CHEM, V124, P11984; Lin Z. Z., 2013, ANGEW CHEM, V125, P1779; Schwarzer A, 2013, COORDIN CHEM REV, V257, P2032, DOI 10.1016/j.ccr.2012.12.006; Wang Y., 2010, ANGEW CHEM, V49, p[3356, 3428]; Wang Y., 2012, ANGEW CHEM, V124, P70; Zhang S., 2015, ANGEW CHEM, V127, P1318; Zhang S., CHEMSUSCHEM, DOI [10.1002/cssc.201403320, DOI 10.1002/CSSC.201403320;]; Zhang SG, 2015, MATER HORIZ, V2, P168, DOI 10.1039/c4mh00141a; Zhang SG, 2015, NANO ENERGY, V13, P376, DOI 10.1016/j.nanoen.2015.03.006; Zhang YW, 2012, NANOSCALE, V4, P5300, DOI 10.1039/c2nr30948c	70	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2192-6506			CHEMPLUSCHEM	ChemPlusChem	JUL	2015	80	7					1139	1147		10.1002/cplu.201500029		9	Chemistry, Multidisciplinary	Chemistry	CM3XD	WOS:000357617800009		
J	Nonoguchi, Y; Hata, K; Kawai, T				Nonoguchi, Yoshiyuki; Hata, Kenji; Kawai, Tsuyoshi			Dispersion of Synthetic MoS2 Flakes and Their Spontaneous Adsorption on Single-Walled Carbon Nanotubes	CHEMPLUSCHEM			English	Article						adsorption; carbon nanotubes; molybdenum disulfide; noncovalent interactions; thermoelectric properties	THERMOELECTRIC-POWER FACTORS; LITHIUM ION BATTERIES; LAYER MOS2; ADVANCED COMPOSITES; POLYMER COMPOSITES; TRANSISTORS; STABILIZER; COMPLEX; POLY(3,4-ETHYLENEDIOXYTHIOPHENE); FUNCTIONALIZATION	Noncovalent interactions play a critical, but not yet understood, role in enhancing the thermoelectric properties of carbon nanotube composites. We herein report the dispersion of synthetic MoS2 flakes and their self-assembly with single-walled carbon nanotubes via in-plane and multipoint S- interactions. The hybridization of MoS2 and carbon nanotubes leads to improved electrical and thermoelectric transport, and resulted in a tenfold enhancement of the thermoelectric figure-of-merit of nanotube-based films. The present technique could contribute to advancing the flexible energy materials that harvest abundant waste heat.	[Nonoguchi, Yoshiyuki; Kawai, Tsuyoshi] Nara Inst Sci & Technol NAIST, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan; [Hata, Kenji] Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, Tsukuba, Ibaraki 3058565, Japan	Nonoguchi, Y (reprint author), Nara Inst Sci & Technol NAIST, Grad Sch Mat Sci, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	nonoguchi@ms.naist.jp; tkawai@ms.naist.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23810021, 26790014]; NAIST Green Photonics Research Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT Nanotechnology Platform Japan program	We thank Leigh McDowell (NAIST) for his careful English proofreading of the manuscript. This work was supported by Grant-in-Aid for Research Activity start-up (No. 23810021, to Y.N.), Grant-in-Aid for Young Scientist (B) (No. 26790014, to Y.N.), and NAIST Green Photonics Research Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT, to Y.N. and T.K.). This work made use of NAIST common facilities supported by MEXT Nanotechnology Platform Japan program.	Iwaoka M, 2002, J AM CHEM SOC, V124, P10613, DOI 10.1021/ja026472q; Kobashi K, 2013, CHEM SCI, V4, P727, DOI 10.1039/c2sc21266h; Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100; Yu CH, 2012, ENERG ENVIRON SCI, V5, P9481, DOI 10.1039/c2ee22838f; Lembke D, 2012, ACS NANO, V6, P10070, DOI 10.1021/nn303772b; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Bubnova O, 2011, NAT MATER, V10, P429, DOI [10.1038/nmat3012, 10.1038/NMAT3012]; Matsuoka R, 2015, CHEM SCI, V6, P2853, DOI 10.1039/c5sc00273g; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; Ata S, 2012, NANO LETT, V12, P2710, DOI 10.1021/nl204221y; Liu KK, 2012, NANO LETT, V12, P1538, DOI 10.1021/nl2043612; Chen J, 2002, J AM CHEM SOC, V124, P9034, DOI 10.1021/ja026104m; Nobusawa K, 2008, ANGEW CHEM INT EDIT, V47, P4577, DOI 10.1002/anie.200800095; Moriarty GP, 2012, CARBON, V50, P885, DOI 10.1016/j.carbon.2011.09.050; Lu CX, 2014, CHEM COMMUN, V50, P3338, DOI 10.1039/c3cc49647c; Wei QS, 2013, ADV MATER, V25, P2831, DOI 10.1002/adma.201205158; Stejskal J, 2002, PURE APPL CHEM, V74, P857, DOI 10.1351/pac200274050857; Star A, 2001, ANGEW CHEM INT EDIT, V40, P1721, DOI 10.1002/1521-3773(20010504)40:9<1721::AID-ANIE17210>3.0.CO;2-F; Choi SH, 2009, ADV FUNCT MATER, V19, P1645, DOI 10.1002/adfm.200800832; Yu C, 2011, ACS NANO, V5, P7885, DOI 10.1021/nn202868a; Ringer AL, 2007, PROTEIN SCI, V16, P2216, DOI 10.1110/ps.073002307; Zhang YJ, 2012, NANO LETT, V12, P1136, DOI 10.1021/nl2021575; HEYWANG G, 1992, ADV MATER, V4, P116, DOI 10.1002/adma.19920040213; Matte HSSR, 2010, ANGEW CHEM INT EDIT, V49, P4059, DOI 10.1002/anie.201000009; Chen GH, 2013, ACS NANO, V7, P10218, DOI 10.1021/nn404504f; Yin ZY, 2012, ACS NANO, V6, P74, DOI 10.1021/nn2024557; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Xu ZC, 2009, CHEM MATER, V21, P1778, DOI 10.1021/cm802978z; Wu J, 2014, NANO LETT, V14, P2730, DOI 10.1021/nl500666m; Altavilla C, 2011, CHEM MATER, V23, P3879, DOI 10.1021/cm200837g; Curran SA, 1998, ADV MATER, V10, P1091, DOI 10.1002/(SICI)1521-4095(199810)10:14<1091::AID-ADMA1091>3.0.CO;2-L; Hecht D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2356999; Ito M, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.065102; Korneva G, 2005, NANO LETT, V5, P879, DOI 10.1021/nl0502928; Chhowalla M, 2013, NAT CHEM, V5, P263, DOI [10.1038/nchem.1589, 10.1038/NCHEM.1589]; Kiriya D, 2014, J AM CHEM SOC, V136, P7853, DOI 10.1021/ja5033327; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Pernstich KP, 2008, NAT MATER, V7, P321, DOI 10.1038/nmat2120; Radisavljevic B, 2011, ACS NANO, V5, P9934, DOI 10.1021/nn203715c; Moriarty GP, 2013, ENERGY TECHNOL-GER, V1, P265, DOI 10.1002/ente.201300018; Naito M, 2008, J AM CHEM SOC, V130, P16697, DOI 10.1021/ja806109z; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Kim D, 2010, ACS NANO, V4, P513, DOI 10.1021/nn9013577; Thomson JW, 2011, J AM CHEM SOC, V133, P5036, DOI 10.1021/ja1109997; Choi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044977; Hansen C M, 2007, HANSEN SOLUBILITY PA; King EM, 2001, J PHYS CHEM B, V105, P641, DOI 10.1021/jp0012810; Che GL, 1998, NATURE, V393, P346; Nakashima N, 2002, CHEM LETT, P638, DOI 10.1246/cl.2002.638; Nobusawa K., 2008, ANGEW CHEM, V120, P4653, DOI 10.1002/ange.200800095; Nonoguchi Y, 2013, SCI REP-UK, V3, DOI [10.1038/srep03344, 10.1038/srep03344(2013)]; Nonoguchi Y, 2014, CHEM LETT, V43, P1254, DOI 10.1246/cl.140265; Ramakrishna Matte H. S. S., 2010, ANGEW CHEM, V122, P4153; Shi YM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02169; Star A., 2001, ANGEW CHEM, V113, P1771, DOI 10.1002/1521-3757(20010504)113:9<1771::AID-ANGE17710>3.0.CO;2-Y; Toshima N, 2015, ADV MATER, V27, P2246, DOI 10.1002/adma.201405463; VOORHOEV.RJ, 1970, Z ANORG ALLG CHEM, V376, P165, DOI 10.1002/zaac.19703760210; Yoon H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03907	58	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2192-6506			CHEMPLUSCHEM	ChemPlusChem	JUL	2015	80	7					1158	1163		10.1002/cplu.201500084		6	Chemistry, Multidisciplinary	Chemistry	CM3XD	WOS:000357617800012		
J	Ijichi, S; Ijichi, N; Ishida, A; Yotsumoto, M; Nagata, J; Tanuma, R; Imamura, C; Toki, A; Sakajiri, T; Hirotsune, H; Nakadoi, Y; Tanaka, S; Kimura, K; Tanaka, K				Ijichi, Shinji; Ijichi, Naomi; Ishida, Ai; Yotsumoto, Mayumi; Nagata, Junko; Tanuma, Rie; Imamura, Chikako; Toki, Atsushi; Sakajiri, Tsunehisa; Hirotsune, Hideto; Nakadoi, Yoshihiro; Tanaka, Satoshi; Kimura, Kazumasa; Tanaka, Kiwamu			Ethical fallacies, tricky ambiguities, and the misinterpretation of the outcomes in the cranioplasty for mild trigonocephaly	CHILDS NERVOUS SYSTEM			English	Letter							CLINICAL SYMPTOMS; CHILDREN		[Ijichi, Shinji; Ishida, Ai; Yotsumoto, Mayumi; Nagata, Junko; Tanuma, Rie] Kagoshima Univ, Hlth Serv Ctr, Kagoshima 8908580, Japan; [Ijichi, Naomi] Inst EGT, Kagoshima, Kagoshima 8910144, Japan; [Imamura, Chikako] Kagoshima Univ, Support Ctr Students Disabil, Kagoshima 8900065, Japan; [Toki, Atsushi] Kagoshima Univ, Profess Grad Sch Clin Psychol, Kagoshima 8900065, Japan; [Sakajiri, Tsunehisa] Fukui Prefectural Rehabil Ctr Children Disabil, Fukui 9100846, Japan; [Hirotsune, Hideto] Osaka Natl Hosp, Dept Psychiat, Chuo Ku, Osaka 5400006, Japan; [Nakadoi, Yoshihiro] Shikoku Med Ctr Children & Adults, Dept Child Psychiat, Zentsuji, Kagawa 7658507, Japan; [Tanaka, Satoshi] Tokyo Metropolitan Childrens Med Ctr, Fuchu, Tokyo 1838561, Japan; [Kimura, Kazumasa] Shirayuri Coll, Chofu, Tokyo 1820001, Japan; [Tanaka, Kiwamu] Hyogo Prefectural Kofu Hosp, Kita Ku, Kobe, Hyogo 6511242, Japan	Ijichi, S (reprint author), Kagoshima Univ, Hlth Serv Ctr, 1-21-24 Korimoto, Kagoshima 8908580, Japan.	jiminy@hsc.kagoshima-u.ac.jp					Jonsdottir SL, 2007, J AUTISM DEV DISORD, V37, P1361, DOI 10.1007/s10803-006-0282-z; Wing L, 1997, LANCET, V350, P1761, DOI 10.1016/S0140-6736(97)09218-0; Collmann H, 1996, CHILD NERV SYST, V12, P664, DOI 10.1007/BF00366148; Garza Rebecca M, 2012, Semin Plast Surg, V26, P53, DOI 10.1055/s-0032-1320063; Hiraiwa M, 2012, SHOUNIKA SHINRYO, V75, P159; Ijichi S, 2004, AUTISM, V8, P111, DOI 10.1177/1362361304040644; Ijichi S, 2015, GENETIC BASIS PHENOT; Ijichi S, 2002, SHOUNI NO NOUSHINKEI, V27, P397; Ijichi S, 2003, CHILD NERV SYST, V19, P711, DOI 10.1007/s00381-003-0846-6; Ijichi S, 2002, CHILD NERV SYST, V18, P659, DOI 10.1007/s00381-002-0677-x; Ijichi S, 2002, LANCET, V360, P415, DOI 10.1016/S0140-6736(02)09587-9; Juneja Monica, 2012, J Pediatr Neurosci, V7, P16, DOI 10.4103/1817-1745.97612; Kelleher MO, 2006, J NEUROSURG, V105, P382, DOI 10.3171/ped.2006.105.5.382; Miyajima M, 2014, PATHOLOGY DIAGNOSIS; Oi S, 2009, SHOUNI NO NOSHINKEI, V34, P320; Oi S, 2011, SHOUNI NO NOSHINKEI, V36, P528; Oi S, 2010, SHOUNI NO NOSHINKEI, V35, P29; Papauasiliou AS, 2011, EUR J PAEDIATR NEURO, V15, P338, DOI 10.1016/j.ejpn.2011.02.004; Shimabukuro Satoshi, 2001, No To Hattatsu, V33, P487; Shimoji T, 2015, CHILD NERV SYST, V31, P433, DOI 10.1007/s00381-014-2595-0; Shimoji T, 2002, SHOUNI NO NOSHINKEI, V27, P331; Shimoji T, 2002, CHILD NERV SYST, V18, P661, DOI 10.1007/s00381-002-0678-9; Takahashi S, 2010, SHOUNI NO NOSHINKEI, V35, P213	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2015	31	7					1009	1012		10.1007/s00381-015-2714-6		4	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CM2BA	WOS:000357483400002		
J	Shimoji, T				Shimoji, Takeyoshi			Ethical fallacies, tricky ambiguities, and the misinterpretation of the outcomes in the cranioplasty for mild trigonocephaly Reply	CHILDS NERVOUS SYSTEM			English	Letter									[Shimoji, Takeyoshi] Okinawa Pref Nanbu Med Ctr, Dept Neurosurg, Haebaru, Okinawa, Japan; [Shimoji, Takeyoshi] Childrens Med Ctr, Haebaru, Okinawa, Japan	Shimoji, T (reprint author), Okinawa Pref Nanbu Med Ctr, Dept Neurosurg, Haebaru, Okinawa, Japan.	tk_simoji2008@angel.ocn.ne.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2015	31	7					1013	1015		10.1007/s00381-015-2752-0		3	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CM2BA	WOS:000357483400003		
J	Kawano, H; Kimura, T; Iwata, K; Furukawa, M; Nomura, S; Ishii, A; Tanaka, S; Hoshii, Y; Suzuki, M; Ikeda, E				Kawano, Hiroo; Kimura, Tokuhiro; Iwata, Koji; Furukawa, Matakazu; Nomura, Sadahiro; Ishii, Aya; Tanaka, Shinsuke; Hoshii, Yoshinobu; Suzuki, Michiyasu; Ikeda, Eiji			Atypical extraventricular neurocytoma in a 3-year-old girl: case report with radiological-pathological correlation	CHILDS NERVOUS SYSTEM			English	Article						Extraventricular neurocytoma; Child; Neuroimaging; Angiography; Histology; Radiological-pathological correlation	OF-THE-LITERATURE; FEATURES; CHILD	Extraventricular neurocytoma (EVN) is a rare neuronal tumor histologically similar to central neurocytoma but arising in the brain parenchyma outside the ventricles. The minority of EVNs show atypical features including increased proliferative index, microvascular proliferation, or necrosis, and are called atypical EVN. Most of atypical EVNs occur in adults, and the tumors in children are extremely rare. A radiological-pathological correlation and radiological clue to atypical EVNs have not been clarified. We report a case of atypical EVN in a 3-year-old girl. Magnetic resonance imaging (MRI) revealed an extraventricular intraparenchymal tumor in the left frontal lobe, which was composed of homogeneous well-demarcated cystic component and peripheral ill-delineated solid component with enhancement. Angiography demonstrated vascular proliferation and arteriovenous shunting in the tumor. Histologically, the resected tumor was diagnosed as atypical EVN. Types of the tumor borders (well-circumscribed or infiltrative) and MRI findings correlated closely. Morphology of the tumor vasculature was remarkable for microvascular proliferation and dilated, thickened veins, which corresponded to the angiographic features. Although rare, atypical EVN should be included in the differential diagnosis of a cystic mass in the cerebral hemispheres in children. Radiological evaluation of tumor borders and angiographic characteristics might be useful for predicting atypicality of the tumor.	[Kawano, Hiroo] Yamaguchi Univ, Grad Sch Med, Dept Basic Lab Sci, Ube, Yamaguchi 7558505, Japan; [Kimura, Tokuhiro; Ishii, Aya; Ikeda, Eiji] Yamaguchi Univ, Grad Sch Med, Dept Pathol, Ube, Yamaguchi 7558505, Japan; [Iwata, Koji] Yamaguchi Univ, Ube, Yamaguchi, Japan; [Furukawa, Matakazu] Yamaguchi Univ, Grad Sch Med, Dept Radiol, Ube, Yamaguchi 7558505, Japan; [Nomura, Sadahiro; Suzuki, Michiyasu] Yamaguchi Univ, Grad Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan; [Tanaka, Shinsuke; Hoshii, Yoshinobu] Yamaguchi Univ, Div Surg Pathol, Ube, Yamaguchi, Japan	Kimura, T (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Pathol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	tkimura@yamaguchi-u.ac.jp					Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Brat DJ, 2001, AM J SURG PATHOL, V25, P1252, DOI 10.1097/00000478-200110000-00005; Yang GF, 2009, AM J NEURORADIOL, V30, P581, DOI 10.3174/ajnr.A1279; Ghosal N, 2011, CYTOPATHOLOGY, V23, P270; Han L, 2013, ONCOL LETT, V6, P1397, DOI 10.3892/ol.2013.1583; Huang WY, 2013, CLIN RADIOL, V68, pE206, DOI 10.1016/j.crad.2012.11.009; Kane AJ, 2012, J NEUROSURG, V116, P349, DOI 10.3171/2011.9.JNS10783; Louis DN, 2007, WHO CLASSIFICATION T; Mariani L, 2001, NEUROSURGERY, V48, P353, DOI 10.1097/00006123-200102000-00022; Mpairamidis E, 2009, J CHILD NEUROL, V24, P491, DOI 10.1177/0883073808324534; Myung JK, 2012, NEUROPATHOLOGY, V33, P111; Patil AS, 2014, ACTA NEUROCHIR, V156, P349, DOI 10.1007/s00701-013-1971-y; Raja AI, 2008, J NEUROS-PEDIATR, V2, P63, DOI 10.3171/PED/2008/2/7/063; Singh A, 2007, CHILD NERV SYST, V23, P207, DOI 10.1007/s00381-006-0141-4	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2015	31	7					1189	1193		10.1007/s00381-015-2706-6		5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CM2BA	WOS:000357483400028		
J	Matsuoka, G; Aihara, Y; Yamaguchi, K; Ishikawa, T; Kawashima, A; Kawamata, T; Okada, Y				Matsuoka, Go; Aihara, Yasuo; Yamaguchi, Koji; Ishikawa, Tatsuya; Kawashima, Akitsugu; Kawamata, Takakazu; Okada, Yoshikazu			Early surgical treatment benefits early staged pediatric moyamoya disease-single case report	CHILDS NERVOUS SYSTEM			English	Article						Pediatric moyamoya disease; Surgical revascularization; Superficial temporal artery-middle cerebral artery (STA-MCA) bypass; Headache; Cerebral blood flow	CLINICAL-FEATURES; OUTCOMES; SURGERY	Surgical revascularization for pediatric moyamoya disease improves cerebral blood flow (CBF) and consequently may prevent further ischemic events. However, the timing of the treatment is controversial especially for patients with no ischemic symptom and normal CBF. The purpose of this case report is to inform and infer the surgical treatment timing for pediatric moyamoya disease patients. A 10-year-old female patient with unilateral moyamoya disease complaining of only headache as a symptom and whose Suzuki stage was II or in transition to III by angiography and CBF was almost normal was admitted to Tokyo Women's Medical University Hospital. We performed superficial temporal artery-middle cerebral artery (STA-MCA) double anastomoses for the patient because we estimated her headache was derived from low perfusion in the brain. STA-MCA bypass surgery was not only effective for relief of her severe headache but also valid for her cerebral perfusion. Her angiography showed much supply from external carotid artery to intracranial arteries via bypass grafts in 7 months. Our case showed early surgical treatment was beneficial for relief of severe headache even for early staged pediatric moyamoya disease patients by improving perfusion pressure and cerebral circulation.	[Matsuoka, Go; Aihara, Yasuo; Yamaguchi, Koji; Ishikawa, Tatsuya; Kawashima, Akitsugu; Kawamata, Takakazu; Okada, Yoshikazu] Tokyo Womens Med Univ Hosp, Dept Neurosurg, Shinjuku Ku, Tokyo 1628666, Japan	Aihara, Y (reprint author), Tokyo Womens Med Univ Hosp, Dept Neurosurg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yaihara@nij.twmu.ac.jp			Department of Neurosurgery, Tokyo Women's Medical University	This study was supported by research funds of the Department of Neurosurgery, Tokyo Women's Medical University.	Williams TS, 2012, DEV MED CHILD NEUROL, V54, P30, DOI 10.1111/j.1469-8749.2011.04144.x; Weinberg DG, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1150; Choi JU, 1997, CLIN NEUROL NEUROSUR, V99, pS11, DOI 10.1016/S0303-8467(97)00033-4; Hashimoto N, 2012, NEUROL MED CHIR TOKY, V52, P245; Hayashi K, 2010, NEUROL MED-CHIR, V50, P378; Houkin K, 2004, CHILD NERV SYST, V20, P734, DOI 10.1007/s00381-004-0971-x; Houkin K, 1996, J NEUROSURG, V85, P772, DOI 10.3171/jns.1996.85.5.0772; Imaizumi C, 1999, NEUROPEDIATRICS, V30, P294, DOI 10.1055/s-2007-973508; Seol HJ, 2005, J NEUROSURG, V103, P439; Yamada M, 2005, NEUROL SURG TOKYO, V33, P337	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2015	31	7					1195	1199		10.1007/s00381-015-2709-3		5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CM2BA	WOS:000357483400029		
J	Tanimoto, K; Sumi, K; Yoshioka, M; Oki, N; Tanne, Y; Awada, T; Kato, Y; Sugiyama, M; Tanne, K				Tanimoto, Kotaro; Sumi, Keisuke; Yoshioka, Motoko; Oki, Nanae; Tanne, Yuki; Awada, Tetsuya; Kato, Yukio; Sugiyama, Masaru; Tanne, Kazuo			Experimental Tooth Movement Into New Bone Area Regenerated by Use of Bone Marrow-Derived Mesenchymal Stem Cells	CLEFT PALATE-CRANIOFACIAL JOURNAL			English	Article						bone regeneration; cleft; mesenchymal stem cells	ILIAC CREST; ALVEOLAR; ANGIOGENESIS; MORBIDITY; ERUPTION; DEFECTS	Objective: The aim of this study was to examine experimental tooth movement into regenerated bone in alveolar cleft with mesenchymal stem cells and a granulated carbonated hydroxyapatite scaffold. Design: An artificial bone defect was created bilaterally in upper incisor regions of beagle dogs to simulate alveolar clefts in patients with cleft palate. The mesenchymal stem cells derived from the iliac bone marrow were cultured and transplanted with carbonated hydroxyapatite into the bone defect area. Carbonated hydroxyapatite alone was transplanted on the control side. Six months after the transplantation, multi-bracket appliances were attached to the lateral incisors and canines on both sides of the maxilla to exert an orthodontic force of 100 x g using an elastic chain. The distance between lateral incisor and canine was measured, and standardized x-ray images were taken every month. The tissue after tooth movement was evaluated by histological observation. Results: The experimental tooth movement, accompanied by resorption of regenerated bone and new bone formation, was achieved on the experimental and control sides. Although there was no difference in the amount of tooth movement obtained on the experimental and control sides during the 6-month experimental period, the rate of tooth movement varied on the control side; whereas, the rate was consistent on the experimental side. Root resorption of the tooth was observed on the control side in one dog. Conclusion: It is suggested that mesenchymal/carbonated hydroxyapatite transplantation therapy has great potential as a new treatment modality for bone regeneration in patients with cleft palate.	[Tanimoto, Kotaro; Tanne, Yuki; Tanne, Kazuo] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Orthodont Appl Life Sci, Hiroshima 7348553, Japan; [Sumi, Keisuke; Oki, Nanae; Awada, Tetsuya] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Orthodont, Div Dent Sci Biomed Sci Major, Hiroshima 7348553, Japan; [Yoshioka, Motoko] Hiroshima Univ Hosp, Orthodont Clin, Hiroshima, Japan; [Kato, Yukio] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dent & Med Biochem, Hiroshima 7348553, Japan; [Sugiyama, Masaru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Oral Hlth, Hiroshima 7348553, Japan	Tanimoto, K (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Orthodont Appl Life Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	tkotaro@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23593029]	Funding provided by Grant No. 23593029, Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Heary RF, 2002, NEUROSURGERY, V50, P510, DOI 10.1097/00006123-200203000-00015; Matsuo A, 2008, J CRANIOFAC SURG, V19, P693, DOI 10.1097/SCS.0b013e318163f2cc; ROBERTS WE, 1981, DENT CLIN N AM, V25, P3; Gimbel M, 2007, J CRANIOFAC SURG, V18, P895, DOI 10.1097/scs.0b013e3180a771af; Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120; Kagiwada H, 2008, J TISSUE ENG REGEN M, V2, P184, DOI 10.1002/term.79; Bueno DF, 2009, TISSUE ENG PT A, V15, P427, DOI 10.1089/ten.tea.2007.0417; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Hibi H, 2006, INT J ORAL MAX SURG, V35, P551, DOI 10.1016/j.ijom.2005.12.007; Fang TD, 2005, J BONE MINER RES, V20, P1114, DOI 10.1359/JBMR.050301; BOYNE PJ, 1972, J ORAL SURG, V30, P87; FEINBERG SE, 1988, J ORAL MAXIL SURG, V46, P124, DOI 10.1016/0278-2391(88)90263-7; GOZ G, 1989, Fortschritte der Kieferorthopaedie, V50, P196, DOI 10.1007/BF02168741; Joshi A, 2004, BRIT DENT J, V196, P167, DOI 10.1038/sj.bdj.4810945; Linton JL, 2002, CLEFT PALATE-CRAN J, V39, P197, DOI 10.1597/1545-1569(2002)039<0197:EOCPCB>2.0.CO;2; Nelson DGA, 1982, CALCIFIED TISSUE INT, V34, P69; Roberts WE, 2000, ORTHODONTICS CURRENT, P193; Shimakura Y, 2003, J CRANIOFAC SURG, V14, P108, DOI 10.1097/00001665-200301000-00021; VIGNERY A, 1980, ANAT REC, V196, P191, DOI 10.1002/ar.1091960210; Yoshioka M., 2012, INT J DENT, V2012; Zijderveld SA, 2004, J ORAL MAXIL SURG, V62, P781, DOI 10.1016/j.joms.2003.12.018	21	0	0	ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	1545-1569	1055-6656		CLEFT PALATE-CRAN J	Cleft Palate-Craniofac. J.	JUL	2015	52	4					386	394		10.1597/12-232		9	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CM4ZP	WOS:000357696000006		
J	Terasaki, H; Nakao, K; Fujiwara, K; Hiraki, T; Shirasawa, W; Abematsu, N; Yonezawa, S; Sakamoto, T				Terasaki, Hiroto; Nakao, Kumiko; Fujiwara, Kazuki; Hiraki, Tsubasa; Shirasawa, Wakako; Abematsu, Noriko; Yonezawa, Suguru; Sakamoto, Taiji			Non-rhegmatogenous retinal detachment associated with hair-like object in vitreous: a case report	CLINICAL AND EXPERIMENTAL OPTOMETRY			English	Article						children's vision; retina; retinal detachment; vitreous	CILIA		[Terasaki, Hiroto; Nakao, Kumiko; Fujiwara, Kazuki; Shirasawa, Wakako; Abematsu, Noriko; Sakamoto, Taiji] Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Hiraki, Tsubasa; Yonezawa, Suguru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Field Oncol, Kagoshima 890, Japan	Terasaki, H (reprint author), Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp					Wood JM, 1999, EXP DERMATOL, V8, P153, DOI 10.1111/j.1600-0625.1999.tb00365.x; GOTTLIEB F, 1982, ANN OPHTHALMOL, V14, P541; HUMAYUN M, 1993, ARCH OPHTHALMOL-CHIC, V111, P1396; Oh KT, 1996, OPHTHALMIC SURG LAS, V27, P243; Sakamoto T, 2011, RETINA-J RET VIT DIS, V31, P222, DOI 10.1097/IAE.0b013e3181facfa9; Stewart JM, 2005, RETINA-J RET VIT DIS, V25, P1005, DOI 10.1097/00006982-200512000-00009	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0816-4622	1444-0938		CLIN EXP OPTOM	Clin. Exp. Optom.	JUL	2015	98	4					379	380		10.1111/cxo.12280		2	Ophthalmology	Ophthalmology	CM6NR	WOS:000357806000016		
J	Yoshihara, A; Nobuhira, N; Narahara, H; Toyoda, S; Tokumoto, H; Konishi, Y; Nomura, T				Yoshihara, Akinori; Nobuhira, Noritaka; Narahara, Hisaya; Toyoda, Syunsuke; Tokumoto, Hayato; Konishi, Yasuhiro; Nomura, Toshiyuki			Estimation of the adhesive force distribution for the flagellar adhesion of Escherichia coli on a glass surface	COLLOIDS AND SURFACES B-BIOINTERFACES			English	Article						Microbial adhesion; Parallel plate flow chamber; Drag force distribution; Weibull distribution function; Hydrodynamic force; Soft particle theory	SENSITIVE HYDROGEL LAYERS; PLATE FLOW CHAMBER; BIOFILM FORMATION; SOFT PARTICLES; ELECTROPHORETIC MOBILITY; BACTERIAL ADHESION; ABIOTIC SURFACES; CELL; HYDROPHOBICITY; MICROSCOPY	The effects of the presence or absence of microbial flagella and the microbial motility on the colloidal behaviors of microbial cells were quantitatively evaluated. The microbial cell attachment and detachment processes on a glass surface were observed directly using a parallel-plate flow chamber. Wild-type, flagellar paralyzed, and nonflagellated Escherichia coli strains were used as model microbial cells. In the cell attachment tests, the microbial adhesion rate in a 160 mM NaCl solution was approximately 10 times higher than that in a 10 mM solution, for all E. coli strains. The colloidal behavior of the microbial cells agreed well with the predictions of the DLVO theory. In addition, the microbial flagella and motility did not significantly affect the cell attachment, regardless of the existence of a potential barrier between the cell and the glass substratum. In the cell detachment tests, the cumulative number of microbial cells detached from the glass substratum with increasing flow rate was fit well with the Weibull distribution function. The list of strains arranged in order of increasing median drag force required to remove them was nonflagellated strain, flagellar paralyzed strain, and wild-type strain. These results indicated that the flagella and the flagellar motility inhibited the cell detachment from the glass substratum. Furthermore, a large external force would likely be required to inhibit the microbial adhesion in the early stage of the biofilm formation. (C) 2015 Elsevier B.V. All rights reserved.	[Yoshihara, Akinori; Nobuhira, Noritaka; Narahara, Hisaya; Toyoda, Syunsuke; Tokumoto, Hayato; Konishi, Yasuhiro; Nomura, Toshiyuki] Osaka Prefecture Univ, Dept Chem Engn, Naka Ku, Sakai, Osaka 5998531, Japan; [Yoshihara, Akinori] Sumitomo Bakelite Co Ltd, Corp Engn Ctr, Corp Prod Management & Engn Div, Fujieda, Shizuoka 4260041, Japan	Yoshihara, A (reprint author), Osaka Prefecture Univ, Dept Chem Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	ayoshihara@sumibe.co.jp; nomura@chemeng.osakafu-u.ac.jp			COE program [24403]; Japan Society for the Promotion of Science (JSPS) [21241022]	This work was supported by a Grant-in-Aid for 21st Century, COE program, 24403, E-1 (Science and Engineering for Water-Assisted Evolution of Valuable Resources and Energy from Organic Wastes) and a Grant-in-Aid for Scientific Research (A) (General) (Grant No. 21241022) from the Japan Society for the Promotion of Science (JSPS). The authors thank Ms. A. Yasui for her laboratory work.	Kirov SM, 2004, INFECT IMMUN, V72, P1939, DOI 10.1128/IAI.72.4.1939-1945.2004; Conrad JC, 2012, RES MICROBIOL, V163, P619, DOI 10.1016/j.resmic.2012.10.016; Tuson HH, 2013, SOFT MATTER, V9, P4368, DOI 10.1039/c3sm27705d; Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2; Dorobantu LS, 2008, LANGMUIR, V24, P4944, DOI 10.1021/la7035295; Evans LDB, 2014, TRENDS MICROBIOL, V22, P566, DOI 10.1016/j.tim.2014.05.009; LEIFSON E, 1951, J BACTERIOL, V62, P377; Kim TJ, 2008, APPL ENVIRON MICROB, V74, P5466, DOI 10.1128/AEM.00222-08; Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0; van Ditmarsch D, 2013, CELL REP, V4, P697, DOI 10.1016/j.celrep.2013.07.026; van der Mei HC, 2010, COLLOID SURFACE B, V78, P372, DOI 10.1016/j.colsurfb.2010.03.018; Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014; Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006; Wu BG, 2014, BIORESOURCE TECHNOL, V157, P305, DOI 10.1016/j.biortech.2014.01.088; Ohshima H, 2007, COLLOID POLYM SCI, V285, P1411, DOI 10.1007/s00396-007-1740-7; Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X; Abdallah M, 2014, ARCH MICROBIOL, V196, P453, DOI 10.1007/s00203-014-0983-1; Ohshima H, 1995, ADV COLLOID INTERFAC, V62, P189, DOI 10.1016/0001-8686(95)00279-Y; Srey S, 2013, FOOD CONTROL, V31, P572, DOI 10.1016/j.foodcont.2012.12.001; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; McClaine JW, 2002, BIOTECHNOL BIOENG, V78, P179, DOI 10.1002/bit.10192; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Farahat M, 2009, COLLOID SURFACE B, V74, P140, DOI 10.1016/j.colsurfb.2009.07.009; Bonin M.M., 2011, INT J FOOD MICROBIOL, V146, P182; Boulbene B, 2012, AICHE J, V58, P3614, DOI 10.1002/aic.13747; BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980; Edwards SJ, 2013, APPL MICROBIOL BIOT, V97, P9909, DOI 10.1007/s00253-013-5216-z; Goulter RM, 2014, COLLOID SURFACE B, V119, P90, DOI 10.1016/j.colsurfb.2014.04.003; Hanuszkiewicz A, 2014, J BIOL CHEM, V289, P19231, DOI 10.1074/jbc.M114.562603; Jacobs A, 2007, COLLOID SURFACE B, V59, P35, DOI 10.1016/j.colsurfb.2007.04.008; Liu Y, 2008, BIOMATERIALS, V29, P4374, DOI 10.1016/j.biomaterials.2008.07.044; MAKINO K, 1994, J COLLOID INTERF SCI, V166, P251, DOI 10.1006/jcis.1994.1291; Mao YJ, 2011, J ADHES SCI TECHNOL, V25, P2155, DOI 10.1163/016942411X574880; Moreira JMR, 2014, COLLOID SURFACE B, V123, P1, DOI 10.1016/j.colsurfb.2014.08.016; Mori S., 1980, J FLOTATION RES ASS, V27, P117; Morisaki H., 1991, MICROBIOLOGY, V137, P2649; Nejadnik M.R., 2008, APPL ENVIRON MICROB, V74, P916; Nomura T, 2012, ADV POWDER TECHNOL, V23, P532, DOI 10.1016/j.apt.2012.05.003; Nomura T, 2014, INT J HYDROGEN ENERG, V39, P1280, DOI 10.1016/j.ijhydene.2013.10.166; OHSHIMA H, 1993, J COLLOID INTERF SCI, V159, P512, DOI 10.1006/jcis.1993.1356; Ohshima H, 2006, INTERFACE SCI TECHNO, V12, P203; OHSHIMA H, 1994, J COLLOID INTERF SCI, V163, P474, DOI 10.1006/jcis.1994.1126; Park BJ, 2009, COLLOID SURFACE B, V73, P237, DOI 10.1016/j.colsurfb.2009.05.027; Qu WW, 2011, J COLLOID INTERF SCI, V358, P430, DOI 10.1016/j.jcis.2011.03.062; Sun JK, 2004, J COLLOID INTERF SCI, V280, P387, DOI 10.1016/j.jcis.2004.08.014; van der Mei HC, 1998, COLLOID SURFACE B, V11, P213, DOI 10.1016/S0927-7765(98)00037-X; van Oss C.J., 2006, INTERFACIAL FORCES A, Vsecond, P9; Wang H, 2013, COLLOID SURFACE B, V109, P32, DOI 10.1016/j.colsurfb.2013.03.016; Haiko Johanna, 2013, Biology (Basel), V2, P1242, DOI 10.3390/biology2041242; Yoshihara A, 2014, J COLLOID INTERF SCI, V432, P77, DOI 10.1016/j.jcis.2014.06.052	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-7765	1873-4367		COLLOID SURFACE B	Colloid Surf. B-Biointerfaces	JUL 1	2015	131						67	72		10.1016/j.colsurfb.2015.04.038		6	Biophysics; Chemistry, Physical; Materials Science, Biomaterials	Biophysics; Chemistry; Materials Science	CM0FW	WOS:000357354800009		
J	Oshiro, W; Ayukawa, Y; Atsuta, I; Furuhashi, A; Yamazoe, J; Kondo, R; Sakaguchi, M; Matsuura, Y; Tsukiyama, Y; Koyano, K				Oshiro, Wakana; Ayukawa, Yasunori; Atsuta, Ikiru; Furuhashi, Akihiro; Yamazoe, Jyunichi; Kondo, Ryosuke; Sakaguchi, Mami; Matsuura, Yuri; Tsukiyama, Yoshihiro; Koyano, Kiyoshi			Effects of CaCl2 hydrothermal treatment of titanium implant surfaces on early epithelial sealing	COLLOIDS AND SURFACES B-BIOINTERFACES			English	Article						Calcium hydrothermal treatment; Dental implant; Epithelial cell; Titanium; Adhesion structure	CELL-ADHESION; LAMININ-5; CALCIUM; CHAIN; EXPRESSION; BEHAVIOR; DOMAIN	Improvement of oral epithelial adhesion to titanium (Ti) may significantly enhance the efficacy of dental implants. We aimed to investigate whether calcium chloride (CaCl2) hydrothermally treated (HT) Ti could promote sealing of the pen-implant epithelium (PIE) around the implant. Right maxillary first molars were extracted from rats and replaced with either CaCl2-HT implants (Ca-HT group), distilled water-HT implants (DW-HT group), or untreated implants (Cont group). After 4 weeks, the implant PIE interface of the Ca-HT group exhibited a band of immunoreactive laminin-332, similar to the tooth junctional epithelium interface, which was absent in the Cont and DW-HT groups at the upper portion. We also investigated the effect of Ca-HT on the attachment of rat oral epithelial cells (OECs). OEC adherence onto Ca-HT Ti plates was stronger with higher expression levels of adhesion proteins compared with Cont and DW-HT groups. These results indicate that HT with CaCl2 improves the integration of soft tissue cells with the Ti implant at 4 weeks after implantation, which might facilitate the development of a soft tissue barrier around the implant. (C) 2015 Elsevier B.V. All rights reserved.	[Oshiro, Wakana; Ayukawa, Yasunori; Atsuta, Ikiru; Furuhashi, Akihiro; Yamazoe, Jyunichi; Kondo, Ryosuke; Sakaguchi, Mami; Matsuura, Yuri; Tsukiyama, Yoshihiro; Koyano, Kiyoshi] Kyushu Univ, Sect Implant & Rehabil Dent, Div Oral Rehabil, Fac Dent Sci, Fukuoka 8128582, Japan	Ayukawa, Y (reprint author), Kyushu Univ, Sect Implant & Rehabil Dent, Div Oral Rehabil, Fac Dent Sci,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ayukawa@dent.kyushu-u.ac.jp			JSPS KAKENHI grant from the Ministry of Education, Science, Sports, Culture and Technology of Japan [24249089, 24792122, 25861854]	This work was supported by JSPS KAKENHI grant (24249089 to K. Koyano, 24792122 to J. Yamazoe, 25861854 to A. Furuhashi) from the Ministry of Education, Science, Sports, Culture and Technology of Japan.	NAGAFUCHI A, 1988, EMBO J, V7, P3679; Ikeda H, 2000, J PERIODONTOL, V71, P961, DOI 10.1902/jop.2000.71.6.961; Diener A, 2005, BIOMATERIALS, V26, P383, DOI 10.1016/j.biomaterials.2004.02.019; Carulli S, 2012, J BIOL CHEM, V287, P12204, DOI 10.1074/jbc.M111.300061; Berglundh T, 2007, CLIN ORAL IMPLAN RES, V18, P655, DOI 10.1111/j.1600-0501.2007.01397.x; Atsuta I, 2013, J BIOMED MATER RES A, V101, P2896, DOI 10.1002/jbm.a.34608; Furuhashi A, 2012, ODONTOLOGY, V100, P199, DOI 10.1007/s10266-011-0029-y; Mizushima H, 1997, CELL GROWTH DIFFER, V8, P979; Atsuta I, 2005, BIOMATERIALS, V26, P6280, DOI 10.1016/j.biomaterials.2005.03.046; Hamada K, 2002, BIOMATERIALS, V23, P2265, DOI 10.1016/S0142-9612(01)00361-1; Yanez-Mo M, 2001, J CELL SCI, V114, P577; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Zhang L, 2010, J BIOMED MATER RES A, V95A, P33, DOI 10.1002/jbm.a.32763; Atsuta I, 2005, BIOMATERIALS, V26, P1751, DOI 10.1016/j.biomaterials.2004.05.033; Atsuta I, 2014, CLIN IMPLANT DENT R, V16, P772, DOI 10.1111/cid.12043; Atsuta I., 1998, J HISTOCHEM CYTOCHEM, V46, P353; Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231; Coreno J, 2005, J BIOMED MATER RES A, V75A, P478, DOI 10.1002/jbm.a.30447; Cranin A N, 1997, J Oral Implantol, V23, P21; Feng B, 2003, MATER CHARACT, V49, P129, DOI DOI 10.1016/S1044-5803(02)00341-8; Nakagawa M, 2005, J MATER SCI-MATER M, V16, P985, DOI 10.1007/s10856-005-4753-0; Okawachi H, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0027-9; OrianRousseau V, 1996, DEV DYNAM, V206, P12, DOI 10.1002/(SICI)1097-0177(199605)206:1<12::AID-AJA2>3.0.CO;2-3; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Shiraiwa M, 2002, J PERIODONTOL, V73, P852, DOI 10.1902/jop.2002.73.8.852; VARANI J, 1991, AM J PATHOL, V138, P887; Yamaza T, 1997, J PERIODONTAL RES, V32, P651, DOI 10.1111/j.1600-0765.1997.tb00575.x; ZUK A, 1989, J CELL BIOL, V108, P903, DOI 10.1083/jcb.108.3.903	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-7765	1873-4367		COLLOID SURFACE B	Colloid Surf. B-Biointerfaces	JUL 1	2015	131						141	147		10.1016/j.colsurfb.2015.04.025		7	Biophysics; Chemistry, Physical; Materials Science, Biomaterials	Biophysics; Chemistry; Materials Science	CM0FW	WOS:000357354800019		
J	Koshiyama, K; Wada, S				Koshiyama, Kenichiro; Wada, Shigeo			Mathematical model of a heterogeneous pulmonary acinus structure	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Pulmonary biomechanics; Biological microstructure; Pulmonary physiology; Gas exchange; Computational geometry; Structure modeling; Rat acinus	AEROSOL DEPOSITION; HUMAN LUNG; RAT LUNG; MORPHOMETRY; TOMOGRAPHY; RECONSTRUCTION; OPTIMIZATION; MULTISCALE; MORPHOLOGY; MECHANICS	The pulmonary acinus is a gas exchange unit distal to the terminal bronchioles. A model of its structure is important for the computational investigation of mechanical phenomena at the acinus level. We propose a mathematical model of a heterogeneous acinus structure composed of alveoli of irregular sizes, shapes, and locations. The alveoli coalesce into an intricately branched ductal tree, which meets the space-filling requirement of the acinus structure. Our model uses Voronoi tessellation to generate an assemblage of the alveolar or ductal airspace, and Delaunay tessellation and simulated annealing for the ductal tree structure. The modeling condition is based on average acinar and alveolar volume characteristics from published experimental information. By applying this modeling technique to the acinus of healthy mature rats, we demonstrate that the proposed acinus structure model reproduces the available experimental information. In the model, the shape and size of alveoli and the length, generation, tortuosity, and branching angle of the ductal paths are distributed in Several ranges. This approach provides a platform for investigating the heterogeneous nature of the acinus structure and its relationship with mechanical phenomena at the acinus level. (C) 2015 Elsevier Ltd. All rights reserved.	[Koshiyama, Kenichiro; Wada, Shigeo] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Koshiyama, K (reprint author), Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan.	koshiyama@me.es.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [24240073]	We would especially like to thank Prof. R.C. Schroter and Dr. T. Sera for their useful comments and suggestions. We also thank M. Yasui, A. Mizuno, T. Nishimura, and L. Xiao for their technical assistance. This work was partly supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (24240073).	HAEFELIBLEUER B, 1988, ANAT REC, V220, P401, DOI 10.1002/ar.1092200410; Burrowes KS, 2008, PHILOS T R SOC A, V366, P3247, DOI 10.1098/rsta.2008.0073; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Pugin J, 2003, CRIT CARE MED, V31, pS200, DOI 10.1097/01.CCM.0000057844.31307.ED; JOHNSON DS, 1989, OPER RES, V37, P865, DOI 10.1287/opre.37.6.865; WEST JB, 1978, CHEST, V74, P426, DOI 10.1378/chest.74.4.426; Sznitman J, 2013, J BIOMECH, V46, P284, DOI 10.1016/j.jbiomech.2012.10.028; Rausch SMK, 2011, ANN BIOMED ENG, V39, P2835, DOI 10.1007/s10439-011-0328-z; Suki B, 2011, COMPR PHYSIOL, V1, P1317, DOI 10.1002/cphy.c100033; Haberthur D, 2013, J APPL PHYSIOL, V115, P1379, DOI 10.1152/japplphysiol.00642.2013; Patton JS, 1999, ADV DRUG DELIVER REV, V35, P235, DOI 10.1016/S0169-409X(98)00074-X; Labiris NR, 2003, BRIT J CLIN PHARMACO, V56, P588, DOI 10.1046/j.1365-2125.2003.01892.x; Roan E, 2011, AM J PHYSIOL-LUNG C, V301, pL625, DOI 10.1152/ajplung.00105.2011; Delank KW, 2000, LARYNGO RHINO OTOL, V79, P226; Denny E, 2006, J BIOMECH, V39, P652, DOI 10.1016/j.jbiomech.2005.01.010; Denny E, 1996, J BIOMECH ENG-T ASME, V118, P210, DOI 10.1115/1.2795961; Ethier CR, 2007, CAMB TEXT BIOMED ENG, P1, DOI 10.2277/ 0521841127; Felici M, 2005, RESP PHYSIOL NEUROBI, V145, P279, DOI 10.1016/j.resp.2004.10.012; FUNG YC, 1988, J APPL PHYSIOL, V64, P2132; HANSEN JE, 1975, J APPL PHYSIOL, V38, P990; HANSEN JE, 1975, J APPL PHYSIOL, V38, P983; Harrington L, 2006, J AEROSOL SCI, V37, P37, DOI 10.1016/j.jaerosci.2005.03.005; Kitaoka H, 2007, J PHYSIOL SCI, V57, P175, DOI 10.2170/physiolsci.RP000807; Kitaoka H, 2000, J APPL PHYSIOL, V88, P2260; Kumar H, 2009, J BIOMECH, V42, P1635, DOI 10.1016/j.jbiomech.2009.04.046; Leeming A, 2008, P I MECH ENG H, V222, P429, DOI 10.1243/09544119JEIM309; Ma BS, 2011, J APPL PHYSIOL, V110, P1271, DOI 10.1152/japplphysiol.00735.2010; Mercer R.R., 1987, APPL PHYSL, V63, P785; MERCER RR, 1994, J APPL PHYSIOL, V77, P1060; MERCER RR, 1987, J APPL PHYSIOL, V62, P1480; Okabe A., 2000, WILEY SERIES PROBABI; Parameswaran H, 2009, J APPL PHYSIOL, V107, P583, DOI 10.1152/japplphysiol.91227.2008; Parameswaran H., 2011, PLOS COMPUT BIOL, V7, P4; RODRIGUEZ M, 1987, AM J ANAT, V180, P143, DOI 10.1002/aja.1001800204; Sera T, 2013, J APPL PHYSIOL, V115, P219, DOI 10.1152/japplphysiol.01105.2012; Suki B., 2007, DRUG DISCOV TODAY DI, V4, P139, DOI 10.1016/j.ddmod.2007.10.002; Swan AJ, 2011, J APPL PHYSIOL, V110, P528, DOI 10.1152/japplphysiol.00888.2010; Sznitman J., 2009, BIOMECH ENG T ASME, V131, P3; Tsuda A, 2008, J APPL PHYSIOL, V105, P964, DOI 10.1152/japplphysiol.90546.2008; Vasilescu DM, 2012, P NATL ACAD SCI USA, V109, P17105, DOI 10.1073/pnas.1215112109; Xiao LS, 2013, COMPUT MATH METHOD M, DOI 10.1155/2013/575086	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	JUL 1	2015	62						25	32		10.1016/j.compbiomed.2015.03.032		8	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	CL8OG	WOS:000357233400003		
J	Rashed, EA; al-Shatouri, M; Kudo, H				Rashed, Essam A.; al-Shatouri, Mohammad; Kudo, Hiroyuki			Sparsity-constrained three-dimensional image reconstruction for C-arm angiography	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Image reconstruction; Computed tomography; C-arm angiography; Sparsity; ADMM	CONE-BEAM CT; X-RAY CT; COMPUTED-TOMOGRAPHY; PROJECTIONS; ALGORITHM; MOBILE; CONVERGENCE; DETECTOR; PRIORS	X-ray C-arm is an important imaging tool in interventional radiology, road-mapping and radiation therapy because it provides accurate descriptions of vascular anatomy and therapeutic end point. In common interventional radiology, the C-arm scanner produces a set of two-dimensional (2D) X-ray projection data obtained with a detector by rotating the scanner gantry around the patient. Unlike conventional fluoroscopic imaging, three-dimensional (3D) C-arm computed tomography (CT) provides more accurate cross-sectional images, which are helpful for therapy planning, guidance and evaluation in interventional radiology. However, 3D vascular imaging using the conventional C-arm fluoroscopy encounters some geometry challenges. Inspired by the theory of compressed sensing, we developed an image reconstruction algorithm for conventional angiography C-arm scanners. The main challenge in this image reconstruction problem is the projection data limitations. We consider a small number of views acquired from a short rotation orbit with offset scan geometry. The proposed method, called sparsity-constrained angiography (SCAN), is developed using the alternating direction method of multipliers, and the results obtained from simulated and real data are encouraging. SCAN algorithm provides a framework to generate 3D vascular images using the conventional C-arm scanners in lower cost than conventional 3D imaging scanners. (C) 2015 Elsevier Ltd. All rights reserved.	[Rashed, Essam A.] Suez Canal Univ, Dept Math, Image Sci Lab, Ismailia 41522, Egypt; [al-Shatouri, Mohammad] Suez Canal Univ, Fac Med, Dept Radiol, Ismailia 41522, Egypt; [Kudo, Hiroyuki] Univ Tsukuba, Fac Engn Informat & Syst, Div Informat Engn, Tsukuba, Ibaraki 3058573, Japan; [Kudo, Hiroyuki] JST, ERATO, Quantum Beam Phase Imaging Project, Aoba Ku, Sendai, Miyagi 9808577, Japan	Rashed, EA (reprint author), Suez Canal Univ, Dept Math, Image Sci Lab, Ismailia 41522, Egypt.	erashed@science.suez.edu.eg	Rashed, Essam/F-4320-2012		Applied Scientific Research Projects (ASRP) program, Ministry of Higher Education, Egypt [ASRP1-008-SUE]	This work is partially supported by the Applied Scientific Research Projects (ASRP) program, Ministry of Higher Education, Egypt under Grant no. ASRP1-008-SUE.	Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; HEBERT T, 1989, IEEE T MED IMAGING, V8, P194, DOI 10.1109/42.24868; Li MH, 2002, PHYS MED BIOL, V47, P2599, DOI 10.1088/0031-9155/47/15/303; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Mueller K, 1999, IEEE T MED IMAGING, V18, P538, DOI 10.1109/42.781018; Byrne CL, 1998, IEEE T IMAGE PROCESS, V7, P100, DOI 10.1109/83.650854; Ramani S, 2012, IEEE T MED IMAGING, V31, P677, DOI 10.1109/TMI.2011.2175233; Leng S, 2008, PHYS MED BIOL, V53, P5653, DOI 10.1088/0031-9155/53/20/006; Hansis E, 2008, IEEE T MED IMAGING, V27, P1548, DOI 10.1109/TMI.2008.2006514; Rashed EA, 2012, PHYS MED BIOL, V57, P2039, DOI 10.1088/0031-9155/57/7/2039; Alenius S, 1997, EUR J NUCL MED, V24, P258, DOI 10.1007/BF01728761; HERMAN GT, 1993, IEEE T MED IMAGING, V12, P600, DOI 10.1109/42.241889; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; Siewerdsen JH, 2005, MED PHYS, V32, P241, DOI 10.1118/1.1836331; Baraniuk R.G., 2007, IEEE SIGNAL PROCESS, V24; Boyd S., 2011, FDN TRENDS MACH LEAR, V3, P1, DOI DOI 10.1561/2200000016; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Chen GH, 2006, P SOC PHOTO-OPT INS, V6142, P14210, DOI 10.1117/12.653197; Cho PS, 1996, COMPUT MED IMAG GRAP, V20, P49, DOI 10.1016/0895-6111(96)00031-6; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; ELSNER L, 1991, NUMER MATH, V59, P91, DOI 10.1007/BF01385772; Fornasier M., 2011, HDB MATH METHODS IMA, V1, P187; Gabay D., 1976, Computers & Mathematics with Applications, V2, DOI 10.1016/0898-1221(76)90003-1; GUAN HQ, 1994, PHYS MED BIOL, V39, P2005, DOI 10.1088/0031-9155/39/11/013; Han X, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/16/5245; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; Kak A.C., 2001, PRINCIPLES COMPUTERI, P275; Kaufman J.A., 2013, VASCULAR INTERVENTIO; Liu V, 2003, MED PHYS, V30, P2758, DOI 10.1118/1.1609058; Rashed E., 2011, NUCL SCI S MED IM C, P3966; Rashed E.A., 2013, MED IMAGING TECHNOL, V31, P9; Ritter D, 2007, COMPUT MED IMAG GRAP, V31, P91, DOI 10.1016/j.compmedimag.2006.11.003; Rockafellar R. T., 1997, CONVEX ANAL; Sawatzky A, 2014, IEEE T MED IMAGING, V33, P1657, DOI 10.1109/TMI.2014.2321098; Sorensen S, 2007, PHYS MED BIOL, V52, P3389, DOI 10.1088/0031-9155/52/12/005; Strobel N., 2009, MULTISLICE CT, P33, DOI 10.1007/978-3-540-33125-4_3	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	JUL 1	2015	62						141	153		10.1016/j.compbiomed.2015.04.014		13	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	CL8OG	WOS:000357233400014		
J	Ohata, C; Imamura, T; Nakama, T				Ohata, Chika; Imamura, Taichi; Nakama, Takekuni			Cutaneous Metastasis of Cecal Carcinoma With Epidermotropism	DERMATOLOGIC SURGERY			English	Letter									[Ohata, Chika; Imamura, Taichi; Nakama, Takekuni] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan	Ohata, C (reprint author), Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan.						Ivan D, 2005, MODERN PATHOL, V18, P137, DOI 10.1038/modpathol.3800263; LEENEN LPH, 1990, J SURG ONCOL, V44, P171, DOI 10.1002/jso.2930440309; Mishin Igor, 2012, J Gastrointest Cancer, V43, P349, DOI 10.1007/s12029-010-9181-9; Salemis Nikolaos S, 2007, J Gastrointest Cancer, V38, P131, DOI 10.1007/s12029-008-9024-0; Tanaka S, 2007, ONCOL REP, V18, P87	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-0512	1524-4725		DERMATOL SURG	Dermatol. Surg.	JUL	2015	41	7					854	856				3	Dermatology; Surgery	Dermatology; Surgery	CM2AI	WOS:000357481500015		
J	Nishi, T; Kinoshita, C				Nishi, Tatzu; Kinoshita, Chieko			"Funnily, brutal and sexy. It's easy to remember, or?"	DU			German	Article									[Kinoshita, Chieko] Osaka Univ, Zentrum Kommunikat Design, Suita, Osaka 565, Japan								0	0	0	DU VERLAG	SULGEN	STEINACKERSTRASSE 8, SULGEN, CH 8583, SWITZERLAND	0012-6837			DU-Z KULTUR	Du	JUL-AUG	2015		858					46	51				6	Art	Art	CM7CA	WOS:000357846800004		
J	Katsumata, S; Hobara, S; Osono, T; Takeda, H				Katsumata, Shingo; Hobara, Satoru; Osono, Takashi; Takeda, Hiroshi			Mass, nitrogen content, and decomposition of woody debris in forest stands affected by excreta deposited in nesting colonies of Great Cormorant	ECOLOGICAL RESEARCH			English	Article						Chamaecyparis obtusa; Coarse woody debris; Decomposition; Exogenous nitrogen; Phalacrocorax carbo	LIGNIN DECOMPOSITION; PHALACROCORAX-CARBO; CONIFEROUS FOREST; NUTRIENT DYNAMICS; AVIAN EXCRETA; GROWTH; LITTER; FUNGI; ABUNDANCE; ECOLOGY	Great Cormorant (Phalacrocorax carbo), a piscivorous bird, has established breeding colonies in a coniferous forest near Lake Biwa in central Japan. This study investigated the possible effects of the colony's excreta on the mass, nitrogen (N) content, and decomposition of woody debris. Study plots were established in forest stands representing four stages from breeding colony establishment to post-abandonment. The mass of fallen branches (diameter 1-5 cm) and coarse woody debris (logs, snags, and stumps; diameter >= 10 cm) was greater in forest stands colonized by Cormorants than a control stand never colonized by Cormorants. This was primarily attributed to Cormorant activity that caused increased mortality of standing trees and by Cormorants breaking branches for nesting materials. Nitrogen content of branches and logs that had fallen to the forest floor was negatively correlated with the relative density of wood. Nitrogen content of branches was consistently higher (at a given value of relative density) in the colonized stands than in the control stand. The increase of branch N content was possibly caused by the incorporation of N into decomposing branches with excreta-derived N supplied as throughfall and/or soil solution. The mean value of 2-year mass loss of recently dead branches and logs was significantly greater for woody debris in the smallest diameter class but was not significantly different among the forest stands. This suggests that the excessive supply of excreta-derived N and concomitant enrichment of N in soil had negligible effects on the initial stages of decomposition of woody debris.	[Katsumata, Shingo] Kyoto Univ, Lab Forest Ecol, Grad Sch Agr, Kyoto 6068502, Japan; [Hobara, Satoru] Rakuno Gakuen Univ, Dept Environm Symbiot Sci, Ebetsu, Hokkaido 0698501, Japan; [Osono, Takashi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Takeda, Hiroshi] Doshisha Univ, Fac Engn, Wild Life Preservat Lab, Kyoto 6100394, Japan	Osono, T (reprint author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.	tosono@ecology.kyoto-u.ac.jp	Osono, Takashi/N-9580-2014	Osono, Takashi/0000-0001-8552-7490	ESPEC Foundation for Global Environment Research and Technology (Charitable Trust; ESPEC Prize for the Encouragement of Environmental Studies); Research Institute for Humanity and Nature	We thank Dr. K. Kameda, Dr. K. Koba, Dr. A. Takayanagi, Ms. S. Fujiwara, and Mrs. H. Katsumata for help with fieldwork; Dr. M. Ando, Dr. R. Fujimaki, and Dr. T. Hishi for help with chemical and data analyses; and Dr. Elizabeth Nakajima for critical reading of the manuscript. This study received partial financial support from the ESPEC Foundation for Global Environment Research and Technology (Charitable Trust; ESPEC Prize for the Encouragement of Environmental Studies) and from the domain-based project ''Ecological Recycling Project,'' Research Institute for Humanity and Nature.	Allison SD, 2009, SOIL BIOL BIOCHEM, V41, P293, DOI 10.1016/j.soilbio.2008.10.032; Osono T, 2007, ECOL RES, V22, P955, DOI 10.1007/s11284-007-0390-z; Fukasawa Y, 2014, ECOL RES, V29, P257, DOI 10.1007/s11284-013-1120-3; Weedon JT, 2009, ECOL LETT, V12, P45, DOI 10.1111/j.1461-0248.2008.01259.x; Siitonen J, 2000, FOREST ECOL MANAG, V128, P211, DOI 10.1016/S0378-1127(99)00148-6; Holub SM, 2001, CAN J FOREST RES, V31, P1894, DOI 10.1139/cjfr-31-11-1894; Osono T, 2006, SOIL BIOL BIOCHEM, V38, P517, DOI 10.1016/j.soilbio.2005.05.022; Osono T, 2006, SOIL BIOL BIOCHEM, V38, P1623, DOI 10.1016/j.soilbio.2005.12.001; Bebber DP, 2011, OECOLOGIA, V167, P1177, DOI 10.1007/s00442-011-2057-2; Hobbie SE, 2008, ECOLOGY, V89, P2633, DOI 10.1890/07-1119.1; Hobara S, 2005, PLANT SOIL, V268, P89, DOI 10.1007/s11104-004-0231-6; Takahashi T, 2006, FISHERIES SCI, V72, P477, DOI 10.1111/j.1444-2906.2006.01175.x; Hobara S, 2001, WATER AIR SOIL POLL, V130, P679, DOI 10.1023/A:1013869115132; Mackensen J, 2003, AUST J BOT, V51, P27, DOI 10.1071/BT02014; Hyvonen R, 2000, FOREST ECOL MANAG, V126, P97, DOI 10.1016/S0378-1127(99)00092-4; Frangi JL, 1997, CAN J FOREST RES, V27, P1095, DOI 10.1139/cjfr-27-7-1095; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Osono T, 2002, SOIL BIOL BIOCHEM, V34, P1537, DOI 10.1016/S0038-0717(02)00123-2; Fukasawa Y, 2009, J FOREST RES-JPN, V14, P20, DOI 10.1007/s10310-008-0098-0; Laiho R, 2004, CAN J FOREST RES, V34, P763, DOI 10.1139/X03-241; Kameda K, 2006, HYDROBIOLOGIA, V567, P69, DOI 10.1007/s10750-006-0052-0; Fukasawa Y, 2012, ECOL RES, V27, P211, DOI 10.1007/s11284-011-0890-8; Brown S, 1996, CAN J FOREST RES, V26, P954, DOI 10.1139/x26-105; Eriksson K., 1990, MICROBIAL ENZYMATIC; Fujiwara S, 2001, APPL FOREST SCI, V10, P85; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Inagaki Y, 2003, APPL FOR SCI, V12, P159; Ishida A, 2003, VOGELWELT, V124, P331; Kameda K., 2003, VOGELWELT S, V124, P27; Kameda K., 2000, SYLVIA S, V36, P54; Ranius T, 2003, FOR ECOL MANAG, V182, P12; Sokal RR, 1995, BIOMETRY; Stokland JN, 2012, ECOL BIODIVERS CONS, P1, DOI 10.1017/CBO9781139025843	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	JUL	2015	30	4					555	561		10.1007/s11284-015-1256-4		7	Ecology	Environmental Sciences & Ecology	CM4TY	WOS:000357679000001		
J	Senga, Y; Hiroki, M; Terui, S; Nohara, S				Senga, Yukiko; Hiroki, Mikiya; Terui, Shigeharu; Nohara, Seiichi			Variation in microbial function through soil depth profiles in the Kushiro Wetland, northeastern Hokkaido, Japan	ECOLOGICAL RESEARCH			English	Article						Soil microbial function; Decomposition; Phosphate production; Denitrification; Wetland	NITROUS-OXIDE REDUCTION; ACETYLENE INHIBITION; ENZYME-ACTIVITIES; NUTRIENT RELEASE; ORGANIC-MATTER; SEDIMENT; DENITRIFICATION; PHOSPHORUS; BIOMASS; MIRE	To provide new insights into microbial functions in the Kushiro Wetland, Japan, we measured vertical profiles of fluorescein diacetate hydrolysis (total microbial activity), beta-glucosidase and xylosidase (organic matter decomposition), acid phosphatase (phosphate production) and potential denitrifying (denitrification) activities as microbial enzyme activities in soil to depths of approximately 1.5 m from two sites with different vegetation in November 2008 (winter) and August 2009 (summer). Active organic matter decomposition, phosphate production and denitrification were evident in shallow litter and peat layers, and total microbial activity was high. Almost no differences in decomposition and total microbial activity were observed between seasons, whereas phosphate production and denitrification were higher in summer. All activities were low in mid-depth volcanic-ash and clay layers because of low carbon, nitrogen and phosphorus levels. Surprisingly, the total microbial activity and decomposition in deep clay & peat and peat layers were the same as or higher than in shallow layers. However, denitrification was limited, probably because dissolved organic matter containing humic-like substances was unsuitable as a substrate. Moreover, total soil phosphorus levels, acid phosphatase activity and multiple linear regression analysis revealed that the soil in the Kushiro Wetland is likely P limited.	[Senga, Yukiko] Toho Univ, Dept Chem, Fac Sci, Funabashi, Chiba 2748510, Japan; [Hiroki, Mikiya; Nohara, Seiichi] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Terui, Shigeharu] Nonprofit Org, Environm Grasp Promot Network PEG, Kushiro, Hokkaido 0850816, Japan	Senga, Y (reprint author), Toho Univ, Dept Chem, Fac Sci, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan.	yukiko.senga@sci.toho-u.ac.jp			Pollution Control Research Fund of the Japanese Ministry of the Environment; Ministry of Education, Culture, Sports, Science and Technology of Japan [23710018]	We thank G. Morimoto and Y. Osawa for their helpful suggestions regarding statistical analysis. This study was supported by the Pollution Control Research Fund of the Japanese Ministry of the Environment, and a Grant-in-Aid for Exploratory Research (No. 23710018) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Anderson D, 2001, B ECOL SOC AM, V82, P160; TARAFDAR JC, 1988, BIOL FERT SOILS, V5, P308; DANGELO EM, 1994, J ENVIRON QUAL, V23, P937; Hill BH, 2010, BIOGEOCHEMISTRY, V97, P195, DOI 10.1007/s10533-009-9366-0; Dodla SK, 2008, SCI TOTAL ENVIRON, V407, P471, DOI 10.1016/j.scitotenv.2008.08.022; Sinsabaugh RL, 2001, FRESHWATER BIOL, V46, P1239; YOSHINARI T, 1977, SOIL BIOL BIOCHEM, V9, P177, DOI 10.1016/0038-0717(77)90072-4; MEYERREIL LA, 1991, BROCK SPR S, P84; Kang HJ, 1999, SOIL BIOL BIOCHEM, V31, P449, DOI 10.1016/S0038-0717(98)00150-3; Prenger JP, 2004, SOIL SCI SOC AM J, V68, P1796; PAYNE WJ, 1973, BACTERIOL REV, V37, P409; FREEMAN C, 1995, PLANT SOIL, V175, P147, DOI 10.1007/BF02413020; Karjalainen H, 2001, AQUAT BOT, V69, P1, DOI 10.1016/S0304-3770(00)00138-8; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Wright AL, 2001, SOIL SCI SOC AM J, V65, P1856; Hakulinen R, 2005, WATER RES, V39, P2319, DOI 10.1016/j.watres.2005.04.037; Ahn YS, 2008, ENVIRON MONIT ASSESS, V145, P267, DOI 10.1007/s10661-007-0036-1; White JR, 2000, SOIL SCI SOC AM J, V64, P1525; Nakamura F, 2004, CATENA, V55, P213, DOI 10.1016/S0341-8162(03)00119-X; Fritze H, 2000, EUR J SOIL SCI, V51, P565, DOI 10.1046/j.1365-2389.2000.00346.x; Nakamura F, 2002, RIVER RES APPL, V18, P65, DOI 10.1002/rra.621; Senga Y, 2006, ESTUAR COAST SHELF S, V67, P231, DOI 10.1016/j.ecss.2005.11.021; McLatchey GP, 1998, J ENVIRON QUAL, V27, P1268; Lu YN, 2013, ECOL RES, V28, P447, DOI 10.1007/s11284-013-1033-1; Hill BH, 2006, FRESHWATER BIOL, V51, P1670, DOI 10.1111/j.1365-2427.2006.01606.x; Blume E, 2002, APPL SOIL ECOL, V592, P1; Horiuchi Eiko, 1999, Japanese Journal of Limnology, V60, P291; JORGENSEN KS, 1984, CAN J MICROBIOL, V30, P1073; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; MARTENS R, 1995, BIOL FERT SOILS, V19, P87, DOI 10.1007/BF00336142; Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI DOI 10.1016/S0003-2670(00)88444-5; O'Halloran IP, 1993, SOIL SAMPLING METHOD, P213; R Development Core Team, 2012, R LANG ENV STAT COMP; RisgaardPetersen N, 1997, LIMNOL OCEANOGR, V42, P529; Schnurer J, 1982, APPL ENVIRON MICROB, V43, P1256; Senga Y, 2011, LIMNOLOGY, V12, P17, DOI 10.1007/s10201-010-0316-2; Senga Yukiko, 2001, Limnology, V2, P129, DOI 10.1007/s102010170008; Senga Yukiko, 2002, Limnology, V3, P21, DOI 10.1007/s102010200002; Sinsabaugh RL, 2002, BOOK SOIL P, P249; Takada E, 2002, CHISHITU NEWS, V579, P12; YOSHINARI T, 1976, BIOCHEM BIOPH RES CO, V69, P705, DOI 10.1016/0006-291X(76)90932-3	41	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	JUL	2015	30	4					563	572		10.1007/s11284-015-1257-3		10	Ecology	Environmental Sciences & Ecology	CM4TY	WOS:000357679000002		
J	Hattori, A; Shibuno, T				Hattori, Akihisa; Shibuno, Takuro			Total volume of 3D small patch reefs reflected in aerial photographs can predict total species richness of coral reef damselfish assemblages on a shallow back reef	ECOLOGICAL RESEARCH			English	Article						Meso-scale rugosity; Metacommunity; Seascape structure; SLOSS; Species-area relationships	FISH COMMUNITIES; SHELTER SPACE; AMPHIPRION-CLARKII; AREA RELATIONSHIP; RANDOM PLACEMENT; SEA-ANEMONE; POPULATIONS; COMPETITION; ECOLOGY; DETERMINANTS	Because fish have a high dispersal ability, an understanding coral reef fish metacommunity structure is vital for effective conservation. Coral reefs provide patchy habitat of various sizes and scales. We examined the species-area relationship (SAR) of damselfish (Pomacentridae) assemblages over 81 environmentally homogenous patch reefs ranging 0.07-45.4 m(2) with low coral cover. Patch reefs were located in the shallow back reef (< 2.5 m deep) off Ishigaki Island, Japan. Reef area was measured by performing image analysis of enlarged sections of a high-resolution (> 1/2500) color aerial photograph used as a fine-scale seascape map. To assess the effects of three-dimensional meso-scale rugosity on species richness, we assumed that all reefs had a cylindrical shape and examined species by volume (area x height) relationships (SVR). Patch reef volume was a better determinant of species richness than area, and the regression functions of SVR provided better estimates of patch reef species richness. Neither the observed SVRs nor SARs, however, could be explained by a random placement model alone. Our results suggest that several small reefs are likely to have higher species richness than a single large reef of equivalent area in the shallow back reef where large patch reefs are flat. Thus, total patch reef volume (area x height) better reflects meso-scale rugosity and is a useful indicator of total species richness relative to the total amount of essential habitat in shallow back reefs.	[Hattori, Akihisa] Shiga Univ Med Sci, Fac Liberal Arts & Educ, Otsu, Shiga 5200862, Japan; [Shibuno, Takuro] SE Asian Fisheries Dev Ctr, Dept Aquaculture, Iloilo 5021, Philippines	Hattori, A (reprint author), Shiga Univ Med Sci, Fac Liberal Arts & Educ, 2-5-1 Hiratsu, Otsu, Shiga 5200862, Japan.	hattori@edu.shiga-u.ac.jp			Japan Ministry of Education, Culture, Sports, Science and Technology [23570022, 20570020, 15K07218]	We are grateful to David Price and anonymous reviewers for valuable advice on the manuscript. Fumitoshi Iwasaki provided assisted with the references. This work was supported in part by Grants-in-Aid for Science Research from the Japan Ministry of Education, Culture, Sports, Science and Technology (nos. 23570022, 20570020, 15K07218). A. H. is an Affiliated Scientist at the Center for Ecological Research, Kyoto University.	Acosta CA, 2002, MAR ECOL PROG SER, V227, P87, DOI 10.3354/meps227087; Allen GR., 1991, DAMSELFISHES WORLD; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Ault TR, 1998, ECOL MONOGR, V68, P25, DOI 10.1890/0012-9615(1998)068[0025:SATPFO]2.0.CO;2; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Bostrom C, 2011, MAR ECOL PROG SER, V427, P191, DOI 10.3354/meps09051; MCCLANAHAN TR, 1994, CORAL REEFS, V13, P231, DOI 10.1007/BF00303637; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; HATTORI A, 1995, ENVIRON BIOL FISH, V42, P345, DOI 10.1007/BF00001464; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; SIMBERLOFF D, 1984, BIOL CONSERV, V29, P27, DOI 10.1016/0006-3207(84)90012-0; Tamura H, 2007, CORAL REEFS, V26, P17, DOI 10.1007/s00338-006-0164-z; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Schmitt RJ, 1999, OECOLOGIA, V118, P76, DOI 10.1007/s004420050705; HATTORI A, 1994, JPN J ICHTHYOL, V41, P159; SALE PF, 1986, MAR ECOL PROG SER, V28, P165, DOI 10.3354/meps028165; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Hattori A, 2012, BEHAV ECOL, V23, P512, DOI 10.1093/beheco/arr217; COLEMAN BD, 1981, MATH BIOSCI, V54, P191, DOI 10.1016/0025-5564(81)90086-9; Dengler J, 2009, J BIOGEOGR, V36, P728, DOI 10.1111/j.1365-2699.2008.02038.x; Hattori A, 2002, J ANIM ECOL, V71, P824, DOI 10.1046/j.1365-2656.2002.00649.x; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Mumby PJ, 2011, ECOL LETT, V14, P132, DOI 10.1111/j.1461-0248.2010.01562.x; CHAVE EH, 1974, PAC SCI, V28, P297; Pittman SJ, 2004, MAR ECOL PROG SER, V283, P233, DOI 10.3354/meps283233; Jones GP, 1998, AUST J ECOL, V23, P287, DOI 10.1111/j.1442-9993.1998.tb00733.x; Pinsky ML, 2012, ECOL APPL, V22, P1257; Hattori A, 2013, J MAR BIOL ASSOC UK, V93, P2265, DOI 10.1017/S0025315413000829; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Pittman SJ, 2011, MAR ECOL PROG SER, V427, P187, DOI 10.3354/meps09139; Hattori A, 2007, ECOL RES, V22, P575, DOI 10.1007/s11284-006-0054-4; Hattori A, 2010, ECOL RES, V25, P457, DOI 10.1007/s11284-009-0675-5; Chittaro PM, 2002, MAR ECOL PROG SER, V233, P253, DOI 10.3354/meps233253; Ries L, 2010, OIKOS, V119, P1636, DOI 10.1111/j.1600-0706.2010.18414.x; Hattori A, 2009, ECOL RES, V24, P415, DOI 10.1007/s11284-008-0518-9; Belmaker J, 2007, CORAL REEFS, V26, P103, DOI 10.1007/s00338-006-0162-1; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; ELLIOTT JK, 1995, MAR BIOL, V122, P377, DOI 10.1007/BF00350870; Lehman CL, 1997, SPATIAL ECOLOGY ROLE, P185; LOWE-MCCONNELL R.H., 1987, ECOLOGICAL STUDIES T; R Development Core Team, 2013, R LANG ENV STAT COMP; Roff JC, 2011, MARINE CONSERVATION, P439; Rosenzweig M. L., 1995, SPECIES DIVERSITY SP; Rosenzweig ML, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P325; Sale P. F., 1991, ECOLOGY FISHES CORAL; Sale PF, 2002, CORAL REEF FISHES DY; Sano M, 1987, MAR ECOL PROG SER, V35, P267; Smith AB, 2010, BIOL CONSERV, V143, P555, DOI 10.1016/j.biocon.2009.11.003; Spalding M.D., 2001, WORLD ATLAS CORAL RE; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tsuchiya M, 2004, CORAL REEFS JAPAN	54	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	JUL	2015	30	4					675	682		10.1007/s11284-015-1268-0		8	Ecology	Environmental Sciences & Ecology	CM4TY	WOS:000357679000013		
J	Miyakawa, H; Sugimoto, N; Kohyama, TI; Iguchi, T; Miura, T				Miyakawa, Hitoshi; Sugimoto, Naoki; Kohyama, Tetsuo I.; Iguchi, Taisen; Miura, Toru			Intra-specific variations in reaction norms of predator-induced polyphenism in the water flea Daphnia pulex	ECOLOGICAL RESEARCH			English	Article						Phenotypic plasticity; Reaction norm; Daphnia pulex; Neckteeth; Intra-specific variation	PHENOTYPIC PLASTICITY; LIFE-HISTORY; INTRODUCED PREDATORS; CHAOBORUS-AMERICANUS; MEDIATED PLASTICITY; INDUCIBLE DEFENSES; EVOLUTION; SYSTEMATICS; INVASION; VARIABILITY	Phenotypic plasticity is considered an important factor leading to phenotypic evolution through adaptations to changing environments. Interactions between environmental inputs and expressed phenotypes can be evaluated as "reaction norms". Comparisons of these reaction norms among geographically distinct populations may provide evidence for genetic diversity and, moreover, important clues into understanding how the interactions affect evolutionary processes. The water flea Daphnia pulex exhibits predator-induced polyphenism in response to a kairomone released by predatory phantom midge larvae (Chaoborus spp.). The polyphenism, a defensive structure formed on the head that enables juvenile larvae to avoid predation, is referred to as neckteeth. Differences in shape and/or plasticity of defensive structures have also been reported among related Daphnia species, suggesting that the species-specific variation in defensive morphology is derived from intra-specific differences in reaction norms. By determining reaction norms based on the incidence and number of neckteeth, we clarified differences in patterns of neckteeth formation in response to varying concentrations of Chaoborus kairomone. We then compared these differences among populations (strains) collected from six locations in Japan. Our findings showed that the reaction norms of both traits differed among strains. Furthermore, a molecular phylogeny using mitochondrial ND5 and COI sequences suggested that differences in the reaction norms of Japanese strains corresponded to their genetically different lineages, which likely originated from North American populations that were probably introduced to Japan independently.	[Miyakawa, Hitoshi; Sugimoto, Naoki; Kohyama, Tetsuo I.; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Miyakawa, Hitoshi; Iguchi, Taisen] Natl Inst Basic Biol, Okazaki, Aichi 4448787, Japan; [Miyakawa, Hitoshi; Iguchi, Taisen] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Iguchi, Taisen] SOKENDAI, Fac Life Sci, Dept Basic Biol, Okazaki, Aichi 4448787, Japan	Miura, T (reprint author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan.	miu@ees.hokudai.ac.jp		Kohyama, Tetsuo/0000-0002-4567-2893	Ministry of Education, Culture, Sports, Science and Technology of Japan [21677001]; Japan Society for the Promotion of Science (JSPS)	We are grateful to K. Takamura for his assistance with collecting Chaoborus larvae. This work was supported by Grants-in-Aid for Young Scientists (S) (No. 21677001) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. HM was supported by a research fellowship for young scientists from the Japan Society for the Promotion of Science (JSPS).	ADLER FR, 1990, TRENDS ECOL EVOL, V5, P407, DOI 10.1016/0169-5347(90)90025-9; Omilian AR, 2006, P NATL ACAD SCI USA, V103, P18638, DOI 10.1073/pnas.0606435103; Hammill E, 2008, J EVOLUTION BIOL, V21, P705, DOI 10.1111/j.1420-9101.2008.01520.x; Schwenk K, 2000, P ROY SOC B-BIOL SCI, V267, P1833, DOI 10.1098/rspb.2000.1218; TOLLRIAN R, 1993, J PLANKTON RES, V15, P1309, DOI 10.1093/plankt/15.11.1309; Moczek AP, 2006, HEREDITY, V97, P168, DOI 10.1038/sj.hdy.6800871; MCQUEEN DJ, 1986, CAN J FISH AQUAT SCI, V43, P1571, DOI 10.1139/f86-195; Colbourne JK, 2006, BIOL J LINN SOC, V89, P469, DOI 10.1111/j.1095-8312.2006.00687.x; Mergeay J, 2006, P R SOC B, V273, P2839, DOI 10.1098/rspb.2006.3661; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Lehman N, 1995, MOL PHYLOGENET EVOL, V4, P395, DOI 10.1006/mpev.1995.1037; PAREJKO K, 1991, EVOLUTION, V45, P1665, DOI 10.2307/2409787; Frankham R, 2005, HEREDITY, V94, P385, DOI 10.1038/sj.hdy.6800634; Boersma M, 1998, AM NAT, V152, P237, DOI 10.1086/286164; Miyakawa H, 2013, J EXP ZOOL PART A, V319, P440, DOI 10.1002/jez.1807; Cristescu MEA, 2006, GENOMICS, V88, P415, DOI 10.1016/j.ygeno.2006.03.007; TEMPLETON AR, 1992, GENETICS, V132, P619; Weber A, 1997, HYDROBIOLOGIA, V360, P89, DOI 10.1023/A:1003188331933; Pfrender ME, 2000, MOL ECOL, V9, P1717, DOI 10.1046/j.1365-294x.2000.01062.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Colbourne JK, 1996, PHILOS T ROY SOC B, V351, P349, DOI 10.1098/rstb.1996.0028; HEBERT PDN, 1983, HEREDITY, V51, P353, DOI 10.1038/hdy.1983.40; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; HANAZATO T, 1990, J PLANKTON RES, V12, P1287, DOI 10.1093/plankt/12.6.1287; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Nijhout HF, 2003, DEVELOPMENT, V130, P5863, DOI 10.1242/dev.00902; Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1111/j.1095-8312.1998.tb01146.x; TOLLRIAN R, 1995, OECOLOGIA, V101, P151, DOI 10.1007/BF00317278; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Imai M, 2009, J EXP ZOOL PART A, V311A, P788, DOI 10.1002/jez.565; Crease TJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-212; Crease TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046620; Gilbert SF, 2009, ECOLOGICAL DEV BIOL; Latta LC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-21; Miyakawa H, 2010, DEV BIOL, V10, P45, DOI DOI 10.1186/1471-213X-10-45; Mizuno T, 2000, ILLUSTRATED GUIDE FR; R Core Team, 2012, R LANG ENV STAT COMP; Schlichting C.D., 1998, PHENOTYPIC EVOLUTION; Scoville AG, 2010, P NATL ACAD SCI USA, V107, P4260, DOI 10.1073/pnas.0912748107; SPITZE K, 1992, AM NAT, V139, P229, DOI 10.1086/285325; Tollrian Ralph, 1999, P177; Wells Carolyn L., 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P1, DOI 10.1078/1433-8319-00001; West-Eberhard M. J., 2003, DEV PLASTICITY EVOLU; Woltereck R., 1909, VERH DTSCH ZOOL GES, V19, P110	46	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	JUL	2015	30	4					705	713		10.1007/s11284-015-1272-4		9	Ecology	Environmental Sciences & Ecology	CM4TY	WOS:000357679000016		
J	Yoon, TK; Noh, NJ; Kim, S; Han, S; Son, Y				Yoon, Tae Kyung; Noh, Nam Jin; Kim, Seongjun; Han, Saerom; Son, Yowhan			Coarse woody debris respiration of Japanese red pine forests in Korea: controlling factors and contribution to the ecosystem carbon cycle	ECOLOGICAL RESEARCH			English	Article						Coarse woody debris decomposition; Gwangneung; Pinus densiflora; Mt. Jumbong; Net ecosystem production	OLYMPIC PENINSULA; DENSIFLORA FOREST; SOIL RESPIRATION; TEMPERATE FOREST; DYNAMICS; MOISTURE; GROWTH; STAND; LOGS; CHRONOSEQUENCE	Coarse woody debris (CWD) respiration (R (CWD)) has strengths in efficient investigation of CWD decomposition rate and application into studies on ecosystem carbon (C) processes. Here, R (CWD) was investigated in two Japanese red pine forests to determine its response to environmental factors and CWD properties, and its contribution to the ecosystem C budget. Samples were collected based on CWD position (log or snag), species (pine or deciduous), and decay class in the Gwangneung pine forest (GPF) and the Mt. Jumbong pine forest (JPF), Korea. R (CWD) was measured at different incubation temperatures using a closed chamber system. Annual R (CWD) was estimated by developing and applying air temperature-R (CWD) regressions to air temperature data. In the GPF, annual estimated R (CWD) (g C kg(-1) year(-1)) was 29.54, 3.90, and 158.95 for pine logs, pine snags, and deciduous logs, respectively. In the JPF, R (CWD) was 49.09 for pine logs and 14.55 for pine snags. Temperature and CWD moisture were the main drivers of R (CWD). CWD species also influenced R (CWD), possibly by supporting different habitats for microbes and invertebrates. R (CWD) in the GPF accounted for approximately 4 % of heterotrophic respiration and 54 % of the CWD decomposition rate. In the JPF, R (CWD) was approximately equal to the CWD decomposition rate. R (CWD) might constitute a minor portion of the net ecosystem production (4 % in the GPF), because of the relatively high stand productivities and small CWD masses. In the GPF, the major factor influencing R (CWD) was mortality, whereas moisture had the greatest influence on R (CWD) in the JPF.	[Yoon, Tae Kyung] Ewha Womans Univ, Dept Environm Sci & Engn, Seoul 120750, South Korea; [Noh, Nam Jin] Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan; [Kim, Seongjun; Han, Saerom; Son, Yowhan] Korea Univ, Grad Sch, Dept Environm Sci & Ecol Engn, Seoul 136713, South Korea; [Son, Yowhan] Qatar Univ, Dept Biol & Environm Sci, Doha, Qatar	Son, Y (reprint author), Korea Univ, Grad Sch, Dept Environm Sci & Ecol Engn, Seoul 136713, South Korea.	yson@korea.ac.kr			Forest Practice Research Center, Korea Forest Research Institute; Korea Environmental Industry and Technology Institute [C314-00131-0408, G214-00181-0402]	This work was supported by research grants from the Forest Practice Research Center, Korea Forest Research Institute, and the Korea Environmental Industry and Technology Institute (C314-00131-0408, G214-00181-0402). We appreciate the Mt. Jumbong forest, which has supported a long history of natural habitats, as well as various ecological studies in Korea. In addition, we would like to celebrate the 10th anniversary of long-term CWD monitoring in Mt. Jumbong, which has been conducted since 2003 by the Ecosystem Ecology Laboratory at Korea University.	Kato J, 2006, ECOL RES, V21, P503, DOI 10.1007/s11284-005-0145-7; Stokland JN, 2012, ECOL BIODIVERS CONS, P82; Li QL, 2012, FOREST ECOL MANAG, V279, P1, DOI 10.1016/j.foreco.2012.05.011; Liu WH, 2006, OECOLOGIA, V148, P108, DOI 10.1007/s00442-006-0356-9; Herrmann S, 2013, SCAND J FOREST RES, V28, P346, DOI 10.1080/02827581.2012.747622; MARRA JL, 1994, CAN J FOREST RES, V24, P1811, DOI 10.1139/x94-234; Herrmann S, 2008, CAN J FOREST RES, V38, P2738, DOI 10.1139/X08-115; Rowland L, 2013, ECOSYSTEMS, V16, P1294, DOI 10.1007/s10021-013-9684-x; Pichler V, 2012, ECOHYDROLOGY, V5, P424, DOI 10.1002/eco.235; Bond-Lamberty B, 2008, ECOSYSTEMS, V11, P831, DOI 10.1007/s10021-008-9163-y; Jomura M, 2008, FOREST ECOL MANAG, V255, P149, DOI 10.1016/j.foreco.2007.09.002; Gough CM, 2007, FOREST ECOL MANAG, V244, P60, DOI 10.1016/j.foreco.2007.03.039; Jomura M, 2007, TELLUS B, V59, P211, DOI 10.1111/j.1600-0889.2006.00234.x; Mackensen J, 2003, SOIL BIOL BIOCHEM, V35, P177, DOI 10.1016/S0038-0717(02)00255-9; Ohtsuka T, 2014, ECOL RES, V29, P91, DOI 10.1007/s11284-013-1102-5; Yoon TK, 2014, J FOREST RES-JPN, V19, P249, DOI 10.1007/s10310-013-0412-3; Forrester JA, 2012, FOREST ECOL MANAG, V265, P124, DOI 10.1016/j.foreco.2011.10.038; Wu JB, 2010, SCAND J FOREST RES, V25, P500, DOI 10.1080/02827581.2010.524166; Noh NJ, 2010, J PLANT RES, V123, P411, DOI 10.1007/s10265-010-0331-8; Kim C, 2009, FOREST ECOL MANAG, V257, P1420, DOI 10.1016/j.foreco.2008.12.015; Marra JL, 1996, CAN J FOREST RES, V26, P1337, DOI 10.1139/x26-149; Lee J, 2014, BIOGEOSCIENCES, V11, P4637, DOI 10.5194/bg-11-4637-2014; Kurz WA, 2009, ECOL MODEL, V220, P480, DOI 10.1016/j.ecolmodel.2008.10.018; Chambers JQ, 2001, BIOGEOCHEMISTRY, V52, P115, DOI 10.1023/A:1006473530673; Bond-Lamberty B, 2010, BIOGEOSCIENCES, V7, P1915, DOI 10.5194/bg-7-1915-2010; Noh NJ, 2013, J PLANT ECOL, V6, P368, DOI 10.1093/jpe/rtt007; Bond-Lamberty B, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000839; Choi S, 2010, SCI CHINA LIFE SCI, V53, P784, DOI 10.1007/s11427-010-4025-1; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hwang HyeJin, 2011, Forest Science and Technology, V7, P184; Kim H, 2015, FOREST SCI TECHNOL, P1; Ko S, 2014, J KOREAN FOR SOC, V103, P30; Korea Forest Research Institute, 2010, SURV MAN BIOM SOIL C; Kwak DooAhn, 2012, Forest Science and Technology, V8, P105; Kwak TB, 2008, THESIS GANGNEUNG NAT; Lim HyungWoo, 2012, Forest Science and Technology, V8, P192, DOI 10.1080/21580103.2012.704977; Noh NamJin, 2012, Forest Science and Technology, V8, P47; Noh NJ, 2011, THESIS KOREA U; Olajuyigbe S, 2012, FORESTRY, V85, P485, DOI 10.1093/forestry/cps045; R Development Core Team, 2011, R LANG ENV STAT COMP; Raupach MR, 2005, GLOBAL CHANGE BIOL, V11, P378, DOI 10.1111/j.1365-2486.2005.00917.x; SAS Institute Inc, 2009, SAS STAT 9 2 US GUID; Spiess A-N, 2014, PROPAGATE PROPAGATIO; Yang ARam, 2011, Forest Science and Technology, V7, P168; Yoon T. K., 2011, J ECOL FIELD BIOL, V34, P115; Yu YJ, 2011, THESIS KONKUK U	46	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	JUL	2015	30	4					723	734		10.1007/s11284-015-1275-1		12	Ecology	Environmental Sciences & Ecology	CM4TY	WOS:000357679000018		
J	Takatsu, K; Kishida, O				Takatsu, Kunio; Kishida, Osamu			Predator cannibalism can intensify negative impacts on heterospecific prey	ECOLOGY			English	Article						cannibalism; gigantism; Hynobius retardatus; inducible defenses; inducible offenses; intrapopulation trait variation; phenotypic plasticity; predator-prey interaction; Rana pirica; top-down effect	SALAMANDER HYNOBIUS-RETARDATUS; COMMUNITY-LEVEL CONSEQUENCES; SIZE-STRUCTURED POPULATIONS; LIFE-HISTORY PLASTICITY; PHENOTYPIC PLASTICITY; INTRAGUILD PREDATION; SPECIES INTERACTIONS; DEPENDENT CANNIBALISM; INDUCIBLE DEFENSE; ADULT FITNESS	Although natural populations consist of individuals with different traits, and the degree of phenotypic variation varies among populations, the impact of phenotypic variation on ecological interactions has received little attention, because traditional approaches to community ecology assume homogeneity of individuals within a population. Stage structure, which is a common way of generating size and developmental variation within predator populations, can drive cannibalistic interactions, which can affect the strength of predatory effects on the predator's heterospecific prey. Studies have shown that predator cannibalism weakens predatory effects on heterospecific prey by reducing the size of the predator population and by inducing less feeding activity of noncannibal predators. We predict, however, that predator cannibalism, by promoting rapid growth of the cannibals, can also intensify predation pressure on heterospecific prey, because large predators have large resource requirements and may utilize a wider variety of prey species. To test this hypothesis, we conducted an experiment in which we created carnivorous salamander (Hynobius retardatus) populations with different stage structures by manipulating the salamander's hatch timing (i.e., populations with large or small variation in the timing of hatching), and explored the resultant impacts on the abundance, behavior, morphology, and life history of the salamander's large heterospecific prey, Rana pirica frog tadpoles. Cannibalism was rare in salamander populations having small hatch-timing variation, but was frequent in those having large hatch-timing variation. Thus, giant salamander cannibals occurred only in the latter. We clearly showed that salamander giants exerted strong predation pressure on frog tadpoles, which induced large behavioral and morphological defenses in the tadpoles and caused them to metamorphose late at large size. Hence, predator cannibalism arising from large variation in the timing of hatching can strengthen predatory effects on heterospecific prey and can have impacts on various traits of both predator and prey. Because animals commonly broaden their diet as they grow, such negative impacts of predator cannibalism on the heterospecific prey may be common in interactions between predators and prey species of similar size.	[Takatsu, Kunio] Hokkaido Univ, Grad Sch Environm Sci, Horonobe, Hokkaido 0982943, Japan; [Kishida, Osamu] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Teshio Expt Forest, Horonobe, Hokkaido 0982943, Japan	Takatsu, K (reprint author), Hokkaido Univ, Grad Sch Environm Sci, Horonobe, Hokkaido 0982943, Japan.	oniku@fsc.hokudai.ac.jp			JSPS KAKENHI [24370004, 13J03564]	We thank Ayumi Tezuka, Tomoko Sato, Mieko Taniguchi, and staff members of Teshio Experimental Forest of Hokkaido University for their support in setting up the experiments and in rearing animals. We are also grateful to Iwao Takatsu and Keiko Takatsu for their support. We also thank Takashi Saitoh, Shunsuke Utsumi, and two anonymous reviewers for constructive comments on our manuscript. This work was supported by JSPS KAKENHI Grant Number 24370004 and 13J03564.	Rudolf VHW, 2007, ECOLOGY, V88, P2991, DOI 10.1890/07-0179.1; Rudolf VHW, 2006, ECOLOGY, V87, P362, DOI 10.1890/05-0961; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Pruitt JN, 2011, ECOLOGY, V92, P1902; DEANGELIS DL, 1980, ECOL MODEL, V8, P133, DOI 10.1016/0304-3800(80)90033-2; Rasmussen NL, 2014, J ANIM ECOL, V83, P1206, DOI 10.1111/1365-2656.12203; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Crumrine PW, 2010, J N AM BENTHOL SOC, V29, P636, DOI 10.1899/09-006.1; Pakes D, 2010, J EVOLUTION BIOL, V23, P1613, DOI 10.1111/j.1420-9101.2010.02026.x; Kishida O, 2011, J ANIM ECOL, V80, P1278, DOI 10.1111/j.1365-2656.2011.01871.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Claessen D, 2004, P ROY SOC B-BIOL SCI, V271, P333, DOI 10.1098/rspb.2003.2555; Urban MC, 2007, OECOLOGIA, V154, P571, DOI 10.1007/s00442-007-0856-2; Walsh MR, 2011, P ROY SOC B-BIOL SCI, V278, P2628, DOI 10.1098/rspb.2010.2634; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; Law YH, 2011, ECOLOGY, V92, P333, DOI 10.1890/10-0156.1; Persson L, 2003, P NATL ACAD SCI USA, V100, P4035, DOI 10.1073/pnas.0636404100; Hoffman EA, 1999, ECOLOGY, V80, P1076, DOI 10.1890/0012-9658(1999)080[1076:PCOCPI]2.0.CO;2; Post DM, 2008, ECOLOGY, V89, P2019, DOI 10.1890/07-1216.1; Schreiber S, 2008, ECOL LETT, V11, P576, DOI 10.1111/j.1461-0248.2008.01171.x; Miller TEX, 2011, TRENDS ECOL EVOL, V26, P457, DOI 10.1016/j.tree.2011.05.005; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; Wildy EL, 1998, J HERPETOL, V32, P286, DOI 10.2307/1565312; Kishida O, 2004, OECOLOGIA, V140, P414, DOI 10.1007/s00442-004-1609-0; HOLM S, 1979, SCAND J STAT, V6, P65; Kishida O, 2006, ECOLOGY, V87, P1599, DOI 10.1890/0012-9658(2006)87[1599:RPPIAP]2.0.CO;2; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; De Block M, 2004, OIKOS, V106, P587; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; Van Buskirk J, 2002, ECOLOGY, V83, P1580, DOI 10.2307/3071977; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; WAKAHARA M, 1995, ZOOL SCI, V12, P467, DOI 10.2108/zsj.12.467; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Kishida O, 2010, POPUL ECOL, V52, P37, DOI 10.1007/s10144-009-0182-0; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; ARMSTRONG JT, 1964, ECOLOGY, V45, P361, DOI 10.2307/1933849; Banerji A, 2009, FUNCT ECOL, V23, P427, DOI 10.1111/j.1365-2435.2008.01499.x; Claessen D, 2000, AM NAT, V155, P219, DOI 10.1086/303315; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; Crumrine PW, 2005, OECOLOGIA, V145, P132, DOI 10.1007/s00442-005-0084-6; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Fujimoto S, 2012, POPUL ECOL, V54, P275, DOI 10.1007/s10144-011-0297-y; GILBERT JJ, 1973, SCIENCE, V181, P63, DOI 10.1126/science.181.4094.63; Gosner K. L., 1960, Herpetologica, V16, P183; Huss M, 2010, OIKOS, V119, P2000, DOI 10.1111/j.1600-0706.2010.18454.x; Kidder GW, 1940, BIOL BULL-US, V78, P9, DOI 10.2307/1537795; Kishida O, 2014, J ANIM ECOL, V83, P899, DOI 10.1111/1365-2656.12186; Kishida O, 2009, ECOLOGY, V90, P1217, DOI 10.1890/08-0238.1; Kishida O, 2015, FUNCT ECOL, V29, P469, DOI 10.1111/1365-2435.12361; Kishida O, 2009, ECOLOGY, V90, P3150, DOI 10.1890/08-2158.1; IWASAWA H, 1991, Japanese Journal of Herpetology, V14, P39; McCoy MW, 2009, OIKOS, V118, P87, DOI 10.1111/j.1600-0706.2008.16878.x; MEFFE GK, 1987, AM NAT, V129, P203, DOI 10.1086/284630; Michimae H, 2006, BEHAV ECOL SOCIOBIOL, V60, P205, DOI 10.1007/s00265-005-0157-x; Nosaka M, 2015, OIKOS, V124, P225, DOI 10.1111/oik.01662; Ohlberger J, 2012, AM NAT, V180, P791, DOI 10.1086/668080; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Orrock J. L., 2010, OPEN ECOLOGY J, V3, P22; Persson L, 2004, ECOL MONOGR, V74, P135, DOI 10.1890/02-4092; Pettersson LB, 1997, ECOLOGY, V78, P1805; PFENNIG D, 1990, OECOLOGIA, V85, P101, DOI 10.1007/BF00317349; Qin JG, 1996, AQUACULTURE, V144, P313, DOI 10.1016/0044-8486(96)01299-9; Rudolf VHW, 2007, ECOLOGY, V88, P2697, DOI 10.1890/06-1266.1; SOGARD SM, 1994, ENVIRON BIOL FISH, V39, P183, DOI 10.1007/BF00004936; Takatsu K, 2013, EVOL ECOL, V27, P1, DOI 10.1007/s10682-012-9572-4; UCHMANSKI J, 1985, PHILOS T ROY SOC B, V310, P1, DOI 10.1098/rstb.1985.0099; Wissinger S, 2004, OECOLOGIA, V138, P39, DOI 10.1007/s00442-003-1397-y	74	0	0	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	0012-9658	1939-9170		ECOLOGY	Ecology	JUL	2015	96	7					1887	1898		10.1890/14-1616.1		12	Ecology	Environmental Sciences & Ecology	CM2QF	WOS:000357525800016		
J	Shirota, T				Shirota, Toyoichiro			Flattening of the Phillips curve under low trend inflation	ECONOMICS LETTERS			English	Article						Sticky prices; Trend inflation; Kinked demand curve	STAGGERED PRICES	This study indicates why the Phillips curve is flattened in an environment of low trend inflation. The key is the curvature of the demand curve. (C) 2015 Elsevier B.V. All rights reserved.	Bank Japan, Chuo Ku, Tokyo 1038660, Japan	Shirota, T (reprint author), Bank Japan, Chuo Ku, 2-1-1 Hongokucho Nihonbashi, Tokyo 1038660, Japan.	s95491ts@gmail.com					Akerlof G. A., 1996, BROOKINGS PAPERS EC, V1996, P1, DOI 10.2307/2534646; Sweezy PM, 1939, J POLIT ECON, V47, P568, DOI 10.1086/255420; Kimball MS, 1995, J MONEY CREDIT BANK, V27, P1241, DOI 10.2307/2078048; Dotsey M, 2005, J MONETARY ECON, V52, P213, DOI 10.1016/j.jmoneco.2004.10.004; Ascari G, 2004, REV ECON DYNAM, V7, P642, DOI 10.1016/j.red.2004.01.002; Ascari G, 2000, ECON J, V110, P664, DOI 10.1111/1468-0297.00560; Ascari G, 2014, J ECON LIT, V52, P679, DOI 10.1257/jel.52.3.679; Bakhshi H, 2007, J MACROECON, V29, P37, DOI 10.1016/j.jmacro.2005.03.004; Bakhshi H, 2007, J MONETARY ECON, V54, P2321, DOI 10.1016/j.jmoneco.2007.07.001; Ball L, 1988, BROOKINGS PAPERS EC, V1, P1; Benati L, 2007, J MONEY CREDIT BANK, V39, P1275, DOI 10.1111/j.1538-4616.2007.00066.x; CALVO GA, 1983, J MONETARY ECON, V12, P383, DOI 10.1016/0304-3932(83)90060-0; Levin Andrew, 2007, KIEL WORKING PAPERS, V1355; ROMER D, 1990, ECON LETT, V32, P205, DOI 10.1016/0165-1765(90)90098-L; TOBIN J, 1972, AM ECON REV, V62, P1; Woodford M, 2003, INTEREST AND PRICES: FOUNDATIONS OF A THEORY OF MONETARY POLICY, P1	16	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	JUL	2015	132						87	90		10.1016/j.econlet.2015.04.027		4	Economics	Business & Economics	CM2YC	WOS:000357547200021		
J	Carroll, CD; Slacalek, J; Tokuoka, K				Carroll, Christopher D.; Slacalek, Jiri; Tokuoka, Kiichi			Buffer-stock saving in a Krusell-Smith world	ECONOMICS LETTERS			English	Article						Household income process; Wealth inequality; Household heterogeneity		We modify the widely-used Krusell and Smith (1998) model (KS) to accommodate an income process with permanent and transitory components. Appropriately calibrated permanent shocks help explain a substantial part of the empirical wealth heterogeneity unexplained in the baseline KS model. (C) 2015 Elsevier B.V. All rights reserved.	[Carroll, Christopher D.] Johns Hopkins Univ, Dept Econ, Baltimore, MD USA; [Slacalek, Jiri] European Cent Bank, DG Res, D-60640 Frankfurt, Germany; [Tokuoka, Kiichi] Minist Finance, Tokyo, Japan	Slacalek, J (reprint author), European Cent Bank, DG Res, D-60640 Frankfurt, Germany.	ccarroll@jhu.edu; jiri.slacalek@ecb.europa.eu; kiichi.tokuoka@mof.go.jp					Den Haan WJ, 2010, J ECON DYN CONTROL, V34, P1, DOI 10.1016/j.jedc.2009.07.001; Debacker J, 2013, BROOKINGS PAP ECO AC, P67; BLANCHARD OJ, 1985, J POLIT ECON, V93, P223, DOI 10.1086/261297; Meghir C, 2011, HBK ECON, V4, P773, DOI 10.1016/S0169-7218(11)02407-5; Krusell P, 1998, J POLIT ECON, V106, P867, DOI 10.1086/250034; Carroll Christopher D, 2014, 1633 EUR CENTR BANK; Carroll Christopher D., 1992, BROOKINGS PAPERS EC, V1992, P61; Carroll Christopher D, 2015, DISTRIBUTION W UNPUB; Friedman M., 1957, THEORY CONSUMPTION F	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	JUL	2015	132						97	100		10.1016/j.econlet.2015.04.021		4	Economics	Business & Economics	CM2YC	WOS:000357547200023		
J	Yamaguchi, H; Kitayama, J; Emoto, S; Ishigami, H; Ito, T; Hanafusa, N; Watanabe, T				Yamaguchi, H.; Kitayama, J.; Emoto, S.; Ishigami, H.; Ito, T.; Hanafusa, N.; Watanabe, T.			Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1	EJSO			English	Article						Stomach neoplasm; Peritoneal neoplasm; Ascites; Abdominal cavity; Intraperitoneal chemotherapy	REFRACTORY ASCITES; COMPLICATIONS; TRIAL	Background: Massive malignant ascites originating from peritoneal metastasis of gastric cancer is difficult to control and resistant to chemotherapy. Cell-free and Concentrated Ascites Reinfusion Therapy (CART) is one of the types of apheresis therapy, by which filtered and concentrated ascites containing albumin and globulin is reinfused intravenously to patients. We retrospectively studied the feasibility of intraperitoneal (IP) chemotherapy combined with CART in gastric cancer patients with massive malignant ascites. Methods: Paclitaxel (PTX) was administered via an FP access port implanted in the subcutaneous space. If patient had massive ascites at the start of treatment, paracentesis was performed through a percutaneous IP catheter and then CART was performed. PTX was administered through the catheter until the ascites diminished. Results: A total of 127 CART procedures in 30 patients were analyzed. The average volume of processed ascites was 3.1 L, which was concentrated to 0.33 L containing 85.5 g protein on average. Significant increases in urine volume, serum total protein and albumin level were found after the CART. Increase in body temperature (0.3 degrees C), decrease in platelet count (3.8 x 10(4)/mu l), and changes in blood pressure (2 mm Hg) were found after the CART procedure, but no clinically significant adverse event was experienced. The median survival time and 1-year survival of 30 patients who received IP chemotherapy combined with the CART procedure was 10.2 months and 43.3% respectively. Conclusions: IP chemotherapy combined with CART might be a promising strategy for patients with massive malignant ascites originating from peritoneal metastasis of gastric cancer. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamaguchi, H.; Kitayama, J.; Emoto, S.; Ishigami, H.; Watanabe, T.] Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, Tokyo 1138655, Japan; [Ito, T.] Tokyo Univ Hosp, Dept Palliat Med, Bunkyo Ku, Tokyo 1138655, Japan; [Hanafusa, N.] Tokyo Univ Hosp, Dept Hemodialysis & Apheresis, Bunkyo Ku, Tokyo 1138655, Japan	Kitayama, J (reprint author), Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	Kitayama-1SU@h.u-tokyo.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [24390310]; Ministry of Health and Welfare of Japan [H25-iryougijutsu-ippan-003]	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (Grant No. 24390310) and a Grant from the Ministry of Health and Welfare of Japan (Grant No. H25-iryougijutsu-ippan-003).	Ishigami H, 2009, ONCOLOGY-BASEL, V76, P311, DOI 10.1159/000209277; Ishigami H, 2010, ANN ONCOL, V21, P67, DOI 10.1093/annonc/mdp260; Yamaguchi H, 2013, CANCER-AM CANCER SOC, V119, P3354, DOI 10.1002/cncr.28204; D'Amico G, 2005, GASTROENTEROLOGY, V129, P1282, DOI 10.1053/j.gastro.2005.07.031; Lebrec D, 1996, J HEPATOL, V25, P135, DOI 10.1016/S0168-8278(96)80065-1; Emoto S, 2012, JPN J CLIN ONCOL, V42, P1013, DOI 10.1093/jjco/hys129; Ito T, 2014, THER APHER DIAL, V18, P87, DOI 10.1111/1744-9987.12049; Kitayama J, 2014, ANN SURG ONCOL, V21, P539, DOI 10.1245/s10434-013-3208-y; BRITTON RICHARD C., 1960, CLEVELAND CLIN QUART, V27, P82; GREIG PD, 1980, AM J SURG, V139, P125, DOI 10.1016/0002-9610(80)90241-X; Inoue N, 1977, Trans Am Soc Artif Intern Organs, V23, P699; Ito T, 2014, INT J CLIN ONCOL; Japanese CSG, 2011, INT J CLIN ONCOL, V16, P395; KATOH S, 1991, JPN J MED, V30, P311	14	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	JUL	2015	41	7					875	880		10.1016/j.ejso.2015.04.013		6	Oncology; Surgery	Oncology; Surgery	CL8ME	WOS:000357228000010		
J	Coccolini, F; Catena, F; Glehen, O; Yonemura, Y; Sugarbaker, PH; Piso, P; Montori, G; Ansaloni, L				Coccolini, F.; Catena, F.; Glehen, O.; Yonemura, Y.; Sugarbaker, P. H.; Piso, P.; Montori, G.; Ansaloni, L.			Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis	EJSO			English	Article						Gastric cancer; Cytoreduction; Carcinosis; Surgery; Meta-analysis	HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; ADVANCED ESOPHAGOGASTRIC CANCER; BIDIRECTIONAL CHEMOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; SEROSAL INVASION; CLINICAL-TRIALS; PHASE-III; SURGERY; CARCINOMATOSIS; DISSEMINATION	Introduction: The completeness of cytoreduction has been considerated as fundamental in increasing the life expectancy in patients with peritoneal carcinosis (PC) in gastric cancer. However no defintive data about the real effect of complete cytoreduction (CC) have still been published. Moreover. the PCI cut-off to attempt CC with a reasonable-risk-benefit ratio still lacks. Material and methods: A systematic review with meta-analysis of trials of complete vs incomplete cytoreduction in patients with peritoneal carcinosis from GC was performed. Results: Nine trials have been included (748 patients: 417 with CC0-CC1 and 324 with CC2-CC3 cytoreduction). 1, 2, 3 and 5 years survival is favorable to CC0-CC1 (Risk Ratio: 2.41, 8.18, 8.66, and 7.96 respectively). CC0 vs. CC1 survival benefit at 1 and 3 years: RR 2.28 and 6.36 respectively, favoring CC0. 1, 2, 3 and 5 years survival changes significantly above and below a PCI of 12. Conclusions: 1, 2, 3 and 5-year overall survival is increased by CC0-CC1 cytoreduction in patients with PC from gastric origin. Moreover CC0 increases the 1 and 3 years survival when compared to CC1 cytoreduction. (C) 2015 Elsevier Ltd. All rights reserved.	[Coccolini, F.; Montori, G.; Ansaloni, L.] Papa Giovanni XXIII Hosp, Dept Gen Surg, I-24127 Bergamo, Italy; [Catena, F.] Osped Maggiore Parma, Dept Gen Surg, Parma, Italy; [Glehen, O.] Hosp Civils Lyon, Dept Gen Surg, Ctr Hosp Lyon Sud, Lyon, France; [Glehen, O.] Univ Lyon 1, EMR 3738, F-69622 Villeurbanne, France; [Yonemura, Y.] Kusatsu Gen Hosp, Dept Gen Surg, Yabase 1660, Japan; [Sugarbaker, P. H.] Washington Canc Inst, Washington, DC USA; [Piso, P.] Univ Regensburg, Dept Surg, D-93053 Regensburg, Germany	Coccolini, F (reprint author), Papa Giovanni XXIII Hosp, Dept Gen Surg, Piazza OMS 1, I-24127 Bergamo, Italy.	federico.coccolini@gmail.com		Ansaloni, Luca/0000-0001-6427-0307			Al-Shammaa HA, 2008, WORLD J GASTROENTERO, V14, P11; Yang XJ, 2010, J SURG ONCOL, V101, P457, DOI 10.1002/jso.21519; Schuhmacher C, 2010, J CLIN ONCOL, V28, P5210, DOI 10.1200/JCO.2009.26.6114; Roth AD, 2007, J CLIN ONCOL, V25, P3217, DOI 10.1200/JCO.2006.08.0135; Rudloff U, 2014, J SURG ONCOL, V110, P275, DOI 10.1002/jso.23633; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; Yang XJ, 2011, ANN SURG ONCOL, V18, P1575, DOI 10.1245/s10434-011-1631-5; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; IKEGUCHI M, 1994, ANTICANCER RES, V14, P2131; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; NAKAMURA K, 1992, CANCER, V70, P1030, DOI 10.1002/1097-0142(19920901)70:5<1030::AID-CNCR2820700504>3.0.CO;2-C; Ross P, 2002, J CLIN ONCOL, V20, P1996, DOI 10.1200/JCO.2002.08.105; Yonemura Y, 2005, BRIT J SURG, V92, P370, DOI 10.1002/bjs.4695; Yonemura Y, 2006, EJSO, V32, P661, DOI 10.1016/j.ejso.2006.03.007; Yan TD, 2007, ANN SURG ONCOL, V14, P2702, DOI 10.1245/s10434-007-9487-4; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Coccolini F, 2014, EJSO-EUR J SURG ONC, V40, P12, DOI 10.1016/j.ejso.2013.10.019; Kuramoto M, 2009, ANN SURG, V250, P242, DOI 10.1097/SLA.0b013e3181b0c80e; Roviello F, 2013, EJSO-EUR J SURG ONC, V39, P1309, DOI 10.1016/j.ejso.2013.10.010; Canbay E, 2014, ANN SURG ONCOL, V21, P1147, DOI 10.1245/s10434-013-3443-2; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Gill RS, 2011, J SURG ONCOL, V104, P692, DOI 10.1002/jso.22017; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; Baba Hideo, 2003, Gastric Cancer, V6 Suppl 1, P45, DOI 10.1007/s10120-003-0222-y; Cheong JH, 2007, ANN SURG ONCOL, V14, P61, DOI 10.1245/s10434-006-9205-7; DEMETS DL, 1987, STAT MED, V6, P341, DOI 10.1002/sim.4780060325; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Glehen O, 2010, CANCER-AM CANCER SOC, V116, P5608, DOI 10.1002/cncr.25356; Glehen O, 2004, ARCH SURG-CHICAGO, V139, P20, DOI 10.1001/archsurg.139.1.20; Glehen O, 2010, ANN SURG ONCOL, V17; GUNDERSON LL, 1982, INT J RADIAT ONCOL, V8, P1; HAGIWARA A, 1992, LANCET, V339, P629, DOI 10.1016/0140-6736(92)90792-2; Hall JY, 2004, J GASTROINTEST SURG, V8, P454, DOI 10.1016/j.gassur.2003.12.014; HAMAZOE R, 1994, CANCER, V73, P2048, DOI 10.1002/1097-0142(19940415)73:8<2048::AID-CNCR2820730806>3.0.CO;2-Q; IKEGUCHI M, 1995, EUR J SURG, V161, P581; Jacquet P, 1996, Cancer Treat Res, V82, P359; KOGA S, 1988, CANCER, V61, P232, DOI 10.1002/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U; Montori G, 2014, INT J SURG ONCOL, P912; PREUSSER P, 1989, J CLIN ONCOL, V7, P1310; Scaringi S, 2008, EJSO-EUR J SURG ONC, V34, P1246, DOI 10.1016/j.ejso.2007.12.003; Schumacher C, 2010, J CLIN ONCOL, V28, P296; Wagner AD, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004064.PUB3; Yabusaki Hiroshi, 2003, Gan To Kagaku Ryoho, V30, P1933; Yamamura Y, 2007, GASTRIC CANCER, V10, P4; Yonemura Yutaka, 2010, World J Gastrointest Oncol, V2, P85, DOI 10.4251/wjgo.v2.i2.85; Yonemura Y, 2008, GASTROENTEROLOGICAL, V31, P802; Yonemura Y, 1996, SURGERY, V119, P437, DOI 10.1016/S0039-6060(96)80145-0; Yonemura Y, 2009, J SURG ONCOL, V100, P311, DOI 10.1002/jso.21324	49	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	JUL	2015	41	7					911	919		10.1016/j.ejso.2015.03.231		9	Oncology; Surgery	Oncology; Surgery	CL8ME	WOS:000357228000016		
J	Kunugi, Y; Fujita, Y; Tsutsui, M; Okamoto, K				Kunugi, Yoshihito; Fujita, Yuki; Tsutsui, Masanori; Okamoto, Kazuo			Organic Field-effect Transistors Based on Alkylphenyl-substituted Dinaphtho[2,1-b:2 ',1 '-f]thieno[3,2-b]thiophenes	ELECTROCHEMISTRY			English	Article						Organic Field-effect Transistor; Carrier Mobility; Dinaphthothienothiophene Derivatives	SEMICONDUCTORS; ELECTRONICS	We investigated the characteristics of organic thin-film transistors based on alkylphenyl-substituted dinaphtho[2,1-b:2',1'-f]thieno[3,2-b]thiophenes (21DNTT) called 4,4'-nP-21DNTT and 6,6'-nP-21DNTT. We found that field-effect characteristics were strongly influenced by the position of the alkyl substituent on the 21DNTT core. An optimal field-effect mobility of 0.46 cm(2) V-1 s(-1) was obtained for the 6,6'-8P-21DNTT-based transistor. (C) The Electrochemical Society of Japan, All rights reserved.	[Kunugi, Yoshihito; Fujita, Yuki] Tokai Univ, Dept Appl Chem, Fac Engn, Hiratsuka, Kanagawa 2591292, Japan; [Tsutsui, Masanori; Okamoto, Kazuo] Ushio ChemiX Corp, Res Lab, Omaezaki 4371613, Japan	Kunugi, Y (reprint author), Tokai Univ, Dept Appl Chem, Fac Engn, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	kunugi@tokai-u.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was financially supported in part by a Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Wang CL, 2012, CHEM REV, V112, P2208, DOI 10.1021/cr100380z; Mei JG, 2013, J AM CHEM SOC, V135, P6724, DOI 10.1021/ja400881n; Stalder R, 2014, CHEM MATER, V26, P664, DOI 10.1021/cm402219v; Irimia-Vladu M, 2014, CHEM SOC REV, V43, P588, DOI 10.1039/c3cs60235d; Lin P, 2012, ADV MATER, V24, P34, DOI 10.1002/adma.201103334; Guo X, 2013, PROG POLYM SCI, V38, P1832, DOI 10.1016/j.progpolymsci.2013.09.005; Sirringhaus H, 2014, ADV MATER, V26, P1319, DOI 10.1002/adma.201304346; Kang MJ, 2011, ADV MATER, V23, P1222, DOI 10.1002/adma.201001283; Yamamoto T, 2010, B CHEM SOC JPN, V83, P120, DOI 10.1246/bcsj.20090230; Jang M, 2013, J PHYS CHEM C, V117, P25290, DOI 10.1021/jp408097p; Kunigi Y., 2010, J PHOTOPOLYM SCI TEC, V23, P323; Kunugi Y, 2012, J PHOTOPOLYM SCI TEC, V25, P285, DOI 10.2494/photopolymer.25.285; Lee Jeong-Hwan, 2013, Journal of Information Display, V14, P39, DOI 10.1080/15980316.2013.779324; Takimiya K, 2014, ACCOUNTS CHEM RES, V47, P1493, DOI 10.1021/ar400282g; Yoo M.-H., 2006, J AM CHEM SOC, V128, P12851	15	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	JUL	2015	83	7					526	528		10.5796/electrochemistry.83.526		3	Electrochemistry	Electrochemistry	CM5ZM	WOS:000357767500001		
J	Deng, X; Nakamura, R; Hashimoto, K; Okamoto, A				Deng, Xiao; Nakamura, Ryuhei; Hashimoto, Kazuhito; Okamoto, Akihiro			Electron Extraction from an Extracellular Electrode by Desulfovibrio ferrophilus Strain IS5 Without Using Hydrogen as an Electron Carrier	ELECTROCHEMISTRY			English	Article						Sulfate-reducing Bacteria; Direct Electron Uptake; Whole-cell Voltammetry; Anaerobic Iron Corrosion	SULFATE-REDUCING BACTERIA; CORROSION; IRON; SHEWANELLA	We report that an intensely iron-corroding microbe, Desulfovibrio ferrophilus strain IS5, is capable of extracting electrons from an indium tin-doped oxide electrode without consuming electrochemically generated hydrogen as an electron carrier. When sulfate was presented as a metabolic electron acceptor, significant cathodic current production was observed at an onset potential of -200 mV vs. SHE, which was approximately 750 mV more positive than the onset for hydrogen evolution in our experimental condition. This finding indicates that hydrogen is not required for the cathodic reaction of IS5, suggesting that IS5 accelerates anaerobic iron corrosion through direct electron uptake. (C) The Electrochemical Society of Japan, All rights reserved.	[Deng, Xiao; Hashimoto, Kazuhito; Okamoto, Akihiro] Univ Tokyo, Dept Appl Chem, Bunkyo Ku, Tokyo 1138654, Japan; [Nakamura, Ryuhei] RIKEN, Biofunct Catalyst Res Team, Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan	Hashimoto, K (reprint author), Univ Tokyo, Dept Appl Chem, Bunkyo Ku, Tokyo 1138654, Japan.	hashimoto@light.t.u-tokyo.ac.jp; okamoto@light.t.u-tokyo.ac.jp	Hashimoto, Kazuhito/C-5011-2012; nakamura, ryuhei/C-9729-2014	Hashimoto, Kazuhito/0000-0002-8384-8749; nakamura, ryuhei/0000-0003-0743-8534	Japan Society for Promotion of Science (JSPS) KAKENHI Grant [24000010]	This work was financially supported by a Grant-in-Aid for Specially Promoted Research from the Japan Society for Promotion of Science (JSPS) KAKENHI Grant Number 24000010.	Dinh HT, 2004, NATURE, V427, P829, DOI 10.1038/nature02321; Okamoto A, 2013, P NATL ACAD SCI USA, V110, P7856, DOI 10.1073/pnas.1220823110; Okamoto A, 2011, ELECTROCHIM ACTA, V56, P5526, DOI 10.1016/j.electacta.2011.03.076; Venzlaff H, 2013, CORROS SCI, V66, P88, DOI 10.1016/j.corsci.2012.09.006; Shi LA, 2009, ENV MICROBIOL REP, V1, P220, DOI 10.1111/j.1758-2229.2009.00035.x; Enning D, 2012, ENVIRON MICROBIOL, V14, P1772, DOI 10.1111/j.1462-2920.2012.02778.x; Benck JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107942; Enning D, 2014, APPL ENVIRON MICROB, V80, P1226, DOI 10.1128/AEM.02848-13; HAMILTON WA, 1985, ANNU REV MICROBIOL, V39, P195, DOI 10.1146/annurev.mi.39.100185.001211; IVERSON WARREN P., 1966, SCIENCE, V151, P986, DOI 10.1126/science.151.3713.986; von Wolzogen KUhr C. A. H., 1934, WATER, V18, P195	11	1	1	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	JUL	2015	83	7					529	531		10.5796/electrochemistry.83.529		3	Electrochemistry	Electrochemistry	CM5ZM	WOS:000357767500002		
J	Shibata, H; Hayashi, H; Koyama, T				Shibata, Hiroki; Hayashi, Hirokazu; Koyama, Tadafumi			Evaluation of Apparent Standard Potentials of Curium in LiCl-KCI Eutectic Melt	ELECTROCHEMISTRY			English	Article						Apparent Standard Potentials; Gibbs Free Energy of Formation; Curium Chloride; Pyrometallurgical Reprocessing	ELECTROCHEMICAL-BEHAVIOR; ELECTRODE-REACTION; LIQUID CADMIUM; DEGREES C; COUPLE; TRICHLORIDE; NP; ACTINIDES; AMERICIUM; NEPTUNIUM	Electrochemical properties of curium (Cm-244) dissolved in LiCI-KCI eutectic melt were studied in the temperature range of 718-823 K. A small electrochemical cell used in the present study was designed to measure electrochemical properties of highly radioactive Cm-244, the maximum handling amount of which is 30 mg in our hot cells, dissolved in molten salts. Apparent standard potentials of Cm3+/Cm couple obtained in the present study, E degrees* (Cm3+/Cm) = (-3.23 +/- 0.011) + (4.8 +/- 0.14) x 10(-4)T, reasonably agree with Osipenko's data (2011) and are lower than Martinot's data (1975). The validity of the data obtained in the present study was discussed by comparing with the reported data of other transuranic elements. (C) The Electrochemical Society of Japan, All rights reserved.	[Shibata, Hiroki; Hayashi, Hirokazu] Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Tokai, Ibaraki 3191195, Japan; [Koyama, Tadafumi] Cent Res Inst Elect Power Ind, Nucl Technol Res Lab, Komae, Tokyo 2018511, Japan	Shibata, H (reprint author), Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, 24 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	shibata.hiroki@jaea.go.jp					Masset P, 2005, J NUCL MATER, V344, P173, DOI 10.1016/j.jnucmat.2005.04.038; Shirai O, 2001, ANAL SCI, V17, P51, DOI 10.2116/analsci.17.51; Serp J, 2004, J ELECTROANAL CHEM, V561, P143, DOI [10.1016/j.jelechem.2003.07.027, 10.1016/j.jelchem.2003.07.027]; Castrillejo Y, 2003, J ELECTROANAL CHEM, V545, P141, DOI 10.1016/S0022-0728(03)00092-5; Osipenko A, 2011, J ELECTROANAL CHEM, V651, P67, DOI 10.1016/j.jelechem.2010.10.027; Masset P, 2007, J ELECTROANAL CHEM, V603, P166, DOI 10.1016/j.jelechem.2007.01.028; Shibata H, 2014, J PHYS CHEM SOLIDS, V75, P972, DOI 10.1016/j.jpcs.2014.04.004; Roy JJ, 1996, J ELECTROCHEM SOC, V143, P2487, DOI 10.1149/1.1837035; Campbell G. M., 1966, LA3399 LOS AL NAT LA; De Cordoba G, 2007, J ELECTROCHEM SOC, V154, pF16, DOI 10.1149/1.2388871; Finne J, 2005, J NUCL MATER, V344, P165, DOI 10.1016/j.jnucmat.2005.04.036; FUGER J, 1975, INORG NUCL CHEM LETT, V11, P265, DOI 10.1016/0020-1650(75)80034-1; Guillaumont R., 2003, CHEM THERMODYNAMICS; Hayashi H, 2013, J RADIOANAL NUCL CH, V297, P139, DOI 10.1007/s10967-012-2413-7; Hayashi H, 2013, J NUCL MATER, V440, P477, DOI 10.1016/j.jnucmat.2013.01.316; Hayashi H, 2008, J ALLOY COMPD, V456, P243, DOI 10.1016/j.jallcom.2007.02.011; Hayashi H, 2008, NUCL TECHNOL, V162, P129; Hayashi H., 2005, P INT C FUT NUCL SYS; Konings RJM, 2001, J NUCL MATER, V295, P57, DOI 10.1016/S0022-3115(01)00485-8; Kruger C. L., 1991, J ELECTROCHEM SOC, V138, P1186; Lambertin D., 2000, PLASMA IONS, V3, P65, DOI 10.1016/S1288-3255(00)01023-6; Lantelme F, 2001, J ELECTROCHEM SOC, V148, pC604, DOI 10.1149/1.1385819; Laplace A., 2014, P ATALANTE2004 ADV F; Lemire R. J., 2001, CHEM THERMODYNAMICS; MARTINOT L, 1974, B PSYCHONOMIC SOC, V83, P449; MARTINOT L, 1971, B SOC CHIM BELG, V80, P299; MARTINOT L, 1975, B SOC CHIM BELG, V84, P657; MARTINOT L, 1969, B SOC CHIM BELG, V78, P495; Minato K., 2005, 2005059 JAERI; Nash K. L., 2011, ADV SEPARATION TECHN, P267; Scrp J., 2006, ELECTROCHIM ACTA, V51, P4024; Shirai O, 2001, J APPL ELECTROCHEM, V31, P1055, DOI 10.1023/A:1017987110008; Takano M, 2001, J NUCL MATER, V294, P24, DOI 10.1016/S0022-3115(01)00463-9; Takano M, 2009, J NUCL MATER, V389, P89, DOI 10.1016/j.jnucmat.2009.01.012; YANG L, 1959, J ELECTROCHEM SOC, V106, P986, DOI 10.1149/1.2427195	35	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	JUL	2015	83	7					532	536		10.5796/electrochemistry.83.532		5	Electrochemistry	Electrochemistry	CM5ZM	WOS:000357767500003		
J	Oshikiri, Y; Aogaki, R; Miura, M; Sugiyama, A; Morimoto, R; Miura, M; Mogi, I; Yamauchi, Y				Oshikiri, Yoshinobu; Aogaki, Ryoichi; Miura, Makoto; Sugiyama, Atsushi; Morimoto, Ryoichi; Miura, Miki; Mogi, Iwao; Yamauchi, Yusuke			Microbubble Formation from Ionic Vacancies in Copper Anodic Dissolution under a High Magnetic Field	ELECTROCHEMISTRY			English	Article						Ionic Vacancy; Nanobubble; Anodic Dissolution; Magnetic Field	PARTIAL MOLAR VOLUME; HYDRATED ELECTRON; MHD ELECTRODE; DYNAMICS	Ionic vacancies created in copper anodic dissolution has been firstly observed by the conversion to microbubbles using both of cyclotron effect and pinch effect under a vertical magnetic field; in a circulating solution induced by Lorentz force, ionic vacancies collide with each other, changing to nanobubbles. Then, the circulation of the nanobubbles with solution makes further collisions, yielding microbubbles. Based on this result, the lifetimes of ionic vacancy formed in copper electrodeposition were finally determined. (C) The Electrochemical Society of Japan, All rights reserved.	[Oshikiri, Yoshinobu] Yamagata Coll Ind & Technol, Matsuei, Yamagata 9902473, Japan; [Aogaki, Ryoichi] Polytech Univ, Tokyo, Tokyo 1300026, Japan; [Aogaki, Ryoichi; Yamauchi, Yusuke] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Miura, Makoto] Hokkaido Polytech Coll, Otaru, Hokkaido 0470292, Japan; [Sugiyama, Atsushi] Waseda Univ, Inst Nanosci & Nanotechnol, Shinjuku Ku, Tokyo 1620041, Japan; [Morimoto, Ryoichi] Saitama Prefecture Showa Water Filtrat Plant, Kasukabe, Saitama 3440113, Japan; [Miura, Miki] Yokohama Habor Polytech Coll, Honmo Ku, Yokohama, Kanagawa 2310811, Japan; [Mogi, Iwao] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Oshikiri, Y (reprint author), Yamagata Coll Ind & Technol, Matsuei, Yamagata 9902473, Japan.	oshikiri@astro.yamagata-cit.ac.jp	Mogi, Iwao/A-9989-2011; Yamauchi, Yusuke/D-2780-2015		Tsukuba Magnet Laboratory, National Institute for Materials Science (NIMS), Tsukuba Japan; High Field Laboratory for Superconducting Materials, Institute for Materials Research (IMR), Tohoku University	The authors thank the Tsukuba Magnet Laboratory, National Institute for Materials Science (NIMS), Tsukuba Japan and the High Field Laboratory for Superconducting Materials, Institute for Materials Research (IMR), Tohoku University for financial support and access to superconducting magnets.	Aogaki R, 2012, MAGNETOHYDRODYNAMICS, V48, P289; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; Jordan KD, 2010, SCIENCE, V329, P42, DOI 10.1126/science.1191707; Monzon LMA, 2014, ELECTROCHEM COMMUN, V42, P38, DOI 10.1016/j.elecom.2014.02.006; Elkins MH, 2013, SCIENCE, V342, P1496, DOI 10.1126/science.1246291; Aogaki R, 2008, ELECTROCHEMISTRY, V76, P458; Sugiyama A, 2013, ELECTROCHEMISTRY, V81, P890, DOI 10.5796/electrochemistry.81.890; Miura M, 2014, ELECTROCHEMISTRY, V82, P654, DOI 10.5796/electrochemistry.82.654; Larsen RE, 2010, SCIENCE, V329, P65, DOI 10.1126/science.1189588; Bragg AE, 2004, SCIENCE, V306, P669, DOI 10.1126/science.1103527; Sugiyama A, 2004, ELECTROCHIM ACTA, V49, P5115, DOI 10.1016/j.electacta.2004.06.024; Aogaki R., 2009, ECS T, V16, P181; Aogaki R, 2012, RUSS J ELECTROCHEM+, V48, P636, DOI 10.1134/S102319351206002X; Aogaki R., 2013, ECS T, V45, P9; Conway B. E., 1972, MOD ASPECT ELECTROC, P83; LIPSCOMB WN, 1953, J CHEM PHYS, V21, P52, DOI 10.1063/1.1698621; Miura M., UNPUB; Oshikiri Y, 2012, RUSS J ELECTROCHEM+, V48, P643, DOI 10.1134/S1023193512060080; Oshikiri Y., 2013, INT J ELECTROCHEM, V2013; Sugiyama A., UNPUB	20	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	JUL	2015	83	7					549	553		10.5796/electrochemistry.83.549		5	Electrochemistry	Electrochemistry	CM5ZM	WOS:000357767500006		
J	Kitaori, N; Yoshioka, R; Ohnishi, N				Kitaori, Noriyuki; Yoshioka, Risa; Ohnishi, Norihiko			Comparison of the Stainless Steel Discoloration Caused by the Laser Beam and the Arc-welding	ELECTROCHEMISTRY			Japanese	Article						Discoloration; Arc-Welding; Laser Beam; Stainless Steel		The removal of stainless steel discoloration caused by the laser beam was tried using a scale remover with the arc-welding, but it was not removed. Therefore, comparison analysis about a color change of the stainless steel surface with the laser beam and the arc-welding was investigated. As a result, the main composition of discoloration caused by the arc-welding was Fe2O3 and that of the laser beam processing was Fe3O4. And the thickness of oxidation layer caused by the laser beam was 17 times of that of the arc-welding. (C) The Electrochemical Society of Japan, All rights reserved.	[Kitaori, Noriyuki; Yoshioka, Risa] Tokyo Natl Coll Technol, Dept Chem Sci & Engn, Hachioji, Tokyo 1930997, Japan; [Ohnishi, Norihiko] Hakuto Co Ltd, Yokkaich Lab, Yokkaich, Mie 5100007, Japan	Kitaori, N (reprint author), Tokyo Natl Coll Technol, Dept Chem Sci & Engn, 1220-2 Kunugida, Hachioji, Tokyo 1930997, Japan.	kitaori@tokyo-ct.ac.jp					Kladnig WF, 2008, J IRON STEEL RES INT, V15, P1, DOI 10.1016/S1006-706X(08)60134-X; Galvez JL, 2008, CHEM ENG J, V136, P116, DOI 10.1016/j.cej.2007.03.014; Harada W., 2001, NISSIN SEIKOU GIHOU, V82, P16; Hill JW, 2002, WELD J, V81, P40; Matsuishi S, 2013, ELECTROCHEMISTRY, V81, P623, DOI 10.5796/electrochemistry.81.623; Nagahori M., 2010, WELDING, V79, P24; Shimomura T., Japanese Unexamined Patent Application Publication, Patent No. [2001-49474, 200149474]; Takahashi S., 2008, SAITAMA KEN SANGYOU, V6, P153; Uesugi H, 2002, TETSU TO HAGANE, V88, P580; Yamamoto M., 2001, YOUSETSU GIJUTSU, V49, P94	10	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	JUL	2015	83	7					554	556		10.5796/electrochemistry.83.554		3	Electrochemistry	Electrochemistry	CM5ZM	WOS:000357767500007		
J	Hyodo, F				Hyodo, Fujio			Use of stable carbon and nitrogen isotopes in insect trophic ecology	ENTOMOLOGICAL SCIENCE			English	Review						above and belowground; aquatic subsidy; carbon and nitrogen cycles; detrital subsidy; food web; humification; trophic level	N-15 NATURAL-ABUNDANCE; FUNGUS-GROWING TERMITES; TROPICAL RAIN-FOREST; GUT-CONTENT-ANALYSIS; FOOD-WEB ANALYSIS; FEEDING ECOLOGY; GENERALIST PREDATORS; PLANT NITROGEN; AMINO-ACIDS; HYMENOPTERA-FORMICIDAE	Insects are the most diverse organisms and often the most abundant animals in some ecosystems. Despite the importance of their functional roles and of the knowledge for conservation, the trophic ecology of many insect species is not fully understood. In this review, I present how stable carbon (C) and nitrogen (N) isotopes have been used to reveal the trophic ecology of insects over the last 30years. The isotopic studies on insects have used differences in C isotope ratios between C-3 and C-4 plants, along vertical profiles of temperate and tropical forest stands, and between terrestrial and aquatic resources. These differences enable exploration of the relative importance of the food resources, as well as movement and dispersal of insects across habitats. The C-13-enrichment (approximately 3 parts per thousand) caused by saprotrophic fungi can allow the estimation of the importance of fungi in insect diets. Stable N isotopes have revealed food resource partitioning across diverse insect species above and belowground. Detritivorous insects often show a large trophic enrichment in C-13 (up to 3 parts per thousand) and N-15 (up to 10 parts per thousand) relative to the food substrates, soil organic matter. These values are greater than those commonly used for estimation of trophic level. This enrichment likely reflects the prevalence of soil microbial processes, such as fungal development and humification, influencing the isotopic signatures of diets in detritivores. Isotope analysis can become an essential tool in the exploration of insect trophic ecology in terms of biogeochemical C and N cycles, including trophic interactions, plant physiological and soil microbial processes.	[Hyodo, Fujio] Okayama Univ, Res Core Interdisciplinary Sci, Okayama 7008530, Japan	Hyodo, F (reprint author), Okayama Univ, Res Core Interdisciplinary Sci, Kita Ku, 3-1-1 Tsushimanaka, Okayama 7008530, Japan.	fhyodo@cc.okayama-u.ac.jp			Japan Society of Promotion of Science; Okayama University	This work was supported by Japan Society of Promotion of Science, and partly by a grant for research promotion from Okayama University.	Abe T, 2000, TERMITES EVOLUTION S; ANDERSON JM, 1972, J ANIM ECOL, V41, P359, DOI 10.2307/3473; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Houlton BZ, 2007, P NATL ACAD SCI USA, V104, P8902, DOI 10.1073/pnas.0609935104; Hanba YT, 1997, OECOLOGIA, V110, P253, DOI 10.1007/s004420050158; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; Gibb H, 2013, J APPL ECOL, V50, P449, DOI 10.1111/1365-2664.12054; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Forbes KJ, 2011, ECOL ENTOMOL, V36, P396, DOI 10.1111/j.1365-2311.2011.01268.x; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Handley LL, 1999, AUST J PLANT PHYSIOL, V26, P185; SUGIMOTO A, 1993, GEOCHIM COSMOCHIM AC, V57, P4015, DOI 10.1016/0016-7037(93)90350-6; Kohzu A, 1999, NEW PHYTOL, V144, P323, DOI 10.1046/j.1469-8137.1999.00508.x; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Chahartaghi M, 2005, SOIL BIOL BIOCHEM, V37, P1718, DOI 10.1016/j.soilbio.2005.02.006; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; MATTHEWS DE, 1978, ANAL CHEM, V50, P1465, DOI 10.1021/ac50033a022; GARTEN CT, 1992, OECOLOGIA, V90, P1, DOI 10.1007/BF00317801; TAYASU I, 1994, NATURWISSENSCHAFTEN, V81, P229, DOI 10.1007/s001140050063; Webb SC, 1998, J EXP BIOL, V201, P2903; Jones RI, 2011, FRESHWATER BIOL, V56, P213, DOI 10.1111/j.1365-2427.2010.02494.x; Okuzaki Y, 2009, ECOL RES, V24, P1351, DOI 10.1007/s11284-009-0619-0; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Akamatsu F, 2004, ECOL RES, V19, P655, DOI 10.1111/j.1440-1703.2004.00680.x; Hyodo F, 2003, FUNCT ECOL, V17, P186, DOI 10.1046/j.1365-2435.2003.00718.x; BOUTTON TW, 1983, OECOLOGIA, V59, P1, DOI 10.1007/BF00388065; Juen A, 2005, OECOLOGIA, V142, P344, DOI 10.1007/s00442-004-1736-7; Coplen TB, 2006, ANAL CHEM, V78, P2439, DOI 10.1021/ac052027c; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Klarner B, 2013, SOIL BIOL BIOCHEM, V57, P327, DOI 10.1016/j.soilbio.2012.08.013; Brenna JT, 1997, MASS SPECTROM REV, V16, P227, DOI 10.1002/(SICI)1098-2787(1997)16:5<227::AID-MAS1>3.0.CO;2-J; O'Brien DM, 2002, P NATL ACAD SCI USA, V99, P4413, DOI 10.1073/pnas.072346699; Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Haraguchi TF, 2013, OECOLOGIA, V171, P935, DOI 10.1007/s00442-012-2446-1; Uchida T, 2004, APPL SOIL ECOL, V27, P153, DOI 10.1016/j.apsoil.2004.04.003; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Kramer MG, 2003, ECOLOGY, V84, P2021, DOI 10.1890/02-3097; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; O'Brien DM, 2000, ECOLOGY, V81, P2822, DOI 10.1890/0012-9658(2000)081[2822:ATRIAH]2.0.CO;2; Levin I, 2010, TELLUS B, V62, P26, DOI 10.1111/j.1600-0889.2009.00446.x; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Hobbie EA, 2002, NEW PHYTOL, V156, P129, DOI 10.1046/j.1469-8137.2002.00496.x; GLEIXNER G, 1993, PLANT PHYSIOL, V102, P1287; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.arplant.40.1.503; Hobbie EA, 2004, NEW PHYTOL, V161, P371, DOI [10.1046/j.1469-8137.2004.00970.x, 10.1111/j.1469-8137.2004.00970.x]; Potapov AM, 2013, ECOL RES, V28, P1069, DOI 10.1007/s11284-013-1088-z; Crowley BE, 2010, OECOLOGIA, V164, P611, DOI 10.1007/s00442-010-1701-6; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Cerling TE, 2004, OECOLOGIA, V138, P5, DOI 10.1007/s00442-003-1375-4; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; LEPAGE M, 1993, J TROP ECOL, V9, P303; Konig T, 2011, PEDOBIOLOGIA, V54, P147, DOI 10.1016/j.pedobi.2010.12.004; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Ponsard S, 2000, ECOLOGY, V81, P852, DOI 10.1890/0012-9658(2000)081[0852:WCSINA]2.0.CO;2; Dijkstra P, 2006, SOIL BIOL BIOCHEM, V38, P3257, DOI 10.1016/j.soilbio.2006.04.005; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Paetzold A, 2005, ECOSYSTEMS, V8, P748, DOI 10.1007/s10021-005-0004-y; Scheu S, 2000, OECOLOGIA, V123, P285, DOI 10.1007/s004420051015; O'Brien DM, 2003, P ROY SOC B-BIOL SCI, V270, P2631, DOI 10.1098/rspb.2003.2552; SHEARER G, 1986, AUST J PLANT PHYSIOL, V13, P699; Scheu S, 2004, FUNCT ECOL, V18, P94, DOI 10.1046/j.0269-8463.2004.00807.x; Karpestam E, 2011, EVOL ECOL RES, V13, P461; Feldhaar H, 2010, MYRMECOL NEWS, V13, P3; Gratton C, 2009, ECOLOGY, V90, P2689, DOI 10.1890/08-1546.1; Briones MJI, 2002, SOIL BIOL BIOCHEM, V34, P881, DOI 10.1016/S0038-0717(02)00010-X; Maraun M, 2011, SOIL BIOL BIOCHEM, V43, P877, DOI 10.1016/j.soilbio.2011.01.003; Wilson ACC, 2011, P NATL ACAD SCI USA, V108, P10220, DOI 10.1073/pnas.1007065108; Michelsen A, 1998, OECOLOGIA, V115, P406, DOI 10.1007/s004420050535; Tibbets TM, 2008, FUNCT ECOL, V22, P109, DOI 10.1111/j.1365-2435.2007.01342.x; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Traugott M, 2008, SOIL BIOL BIOCHEM, V40, P342, DOI 10.1016/j.soilbio.2007.08.013; Hood-Nowotny R, 2007, ENTOMOL EXP APPL, V124, P3, DOI 10.1111/j.1570-7458.2007.00572.x; Voigt CC, 2010, BIOTROPICA, V42, P634, DOI 10.1111/j.1744-7429.2010.00703.x; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Tayasu I, 1997, ECOL ENTOMOL, V22, P343, DOI 10.1046/j.1365-2311.1997.00070.x; Doi H, 2007, RAPID COMMUN MASS SP, V21, P997, DOI 10.1002/rcm.2925; Sollins P, 2009, BIOGEOCHEMISTRY, V96, P209, DOI 10.1007/s10533-009-9359-z; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Grey J, 2004, LIMNOL OCEANOGR, V49, P239; Kiyashko SI, 2001, AQUAT MICROB ECOL, V24, P203, DOI 10.3354/ame024203; Wilder SM, 2011, P NATL ACAD SCI USA, V108, P20639, DOI 10.1073/pnas.1115263108; Nardi JB, 2002, J INSECT PHYSIOL, V48, P751, DOI 10.1016/S0022-1910(02)00105-1; Kato C, 2004, ECOL RES, V19, P633, DOI 10.1111/j.1440-1703.2004.00678.x; Halaj J, 2005, PEDOBIOLOGIA, V49, P109, DOI 10.1016/j.pedobi.2004.09.002; Sleaford F, 1996, ECOL ENTOMOL, V21, P279; Nadelhoffer K, 1996, OECOLOGIA, V107, P386, DOI 10.1007/BF00328456; Pollierer MM, 2009, SOIL BIOL BIOCHEM, V41, P1221, DOI 10.1016/j.soilbio.2009.03.002; AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; Tayasu I, 2011, LIMNOLOGY, V12, P261, DOI 10.1007/s10201-011-0345-5; Briones MJI, 2005, SOIL BIOL BIOCHEM, V37, P2145, DOI 10.1016/j.soilbio.2005.03.001; Ikeda H, 2010, ECOL ENTOMOL, V35, P307, DOI 10.1111/j.1365-2311.2010.01182.x; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Gratton C, 2008, ECOSYSTEMS, V11, P764, DOI 10.1007/s10021-008-9158-8; Donovan SE, 2001, ECOL ENTOMOL, V26, P356, DOI 10.1046/j.1365-2311.2001.00342.x; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Hobbie EA, 1999, OECOLOGIA, V118, P353, DOI 10.1007/s004420050736; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Begon M, 1996, ECOLOGY INDIVIDUALS; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bourguignon T, 2009, SOIL BIOL BIOCHEM, V41, P2038, DOI 10.1016/j.soilbio.2009.07.005; BOUTTON TW, 1978, OECOLOGIA, V36, P21, DOI 10.1007/BF00344568; Briones MJI, 1999, RAPID COMMUN MASS SP, V13, P1300, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1300::AID-RCM628>3.3.CO;2-A; Caut S, 2010, J APPL ECOL, V47, P948, DOI 10.1111/j.1365-2664.2010.0183.x; Chikaraishi Y, 2011, ECOL RES, V26, P835, DOI 10.1007/s11284-011-0844-1; Compton SG, 2000, BIOTROPICA, V32, P515, DOI 10.1111/j.1744-7429.2000.tb00497.x; Crotty FV, 2014, ECOL EVOL, V4, P1, DOI 10.1002/ece3.905; Darlington Johanna P. E. C., 1994, P105; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dijkstra P, 2008, ECOL LETT, V11, P389, DOI 10.1111/j.1461-0248.2008.01154.x; Fiedler K, 2007, INSECT SOC, V54, P393, DOI 10.1007/s00040-007-0959-0; Fry B., 2006, STABLE ISOTOPE ECOLO; FRY B, 1978, ECOLOGY, V59, P498, DOI 10.2307/1936580; Gibb H, 2010, J ANIM ECOL, V80, P119; Gratton C, 2006, OECOLOGIA, V147, P615, DOI 10.1007/s00442-005-0322-y; Grimaldi David, 2005, pi; HIGASHI M, 1992, P ROY SOC B-BIOL SCI, V249, P303, DOI 10.1098/rspb.1992.0119; Hishi T, 2007, SOIL BIOL BIOCHEM, V39, P1820, DOI 10.1016/j.soilbio.2007.01.028; Hobbie EA, 2013, BIOGEOCHEMISTRY, V114, P381, DOI 10.1007/s10533-012-9779-z; Hobbie EA, 2005, OECOLOGIA, V146, P258, DOI 10.1007/s00442-005-0208-z; Hyodo F, 2008, FUNCT ECOL, V22, P516, DOI 10.1111/j.1365-2435.2008.01386.x; Hyodo F, 2010, J TROP ECOL, V26, P205, DOI 10.1017/S0266467409990502; Hyodo F, 2009, RAPID COMMUN MASS SP, V23, P1892, DOI 10.1002/rcm.4095; Hyodo F, 2015, FUNCT ECOL, V29, P423, DOI 10.1111/1365-2435.12357; Hyodo F, 2011, INSECT SOC, V58, P417, DOI 10.1007/s00040-011-0159-9; Hyodo F, 2013, PLANT SOIL, V367, P111, DOI 10.1007/s11104-013-1667-3; Hyodo F, 2006, FUNCT ECOL, V20, P385, DOI 10.1111/j.1365-2435.2006.01081.x; Hyodo F, 2010, ECOL RES, V25, P745, DOI 10.1007/s11284-010-0719-x; Jacquemin J, 2012, SOIL BIOL BIOCHEM, V46, P10, DOI 10.1016/j.soilbio.2011.11.007; KANEKO N, 1988, REV ECOL BIOL SOL, V25, P353; Kishimoto-Yamada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074426; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Koba K, 1998, SOIL SCI SOC AM J, V62, P778; Kohzu A, 2000, SOIL SCI PLANT NUTR, V46, P733; Kohzu A, 2004, AQUAT MICROB ECOL, V36, P189, DOI 10.3354/ame036189; Langellotto GA, 2006, OECOLOGIA, V150, P291, DOI 10.1007/s00442-006-0514-0; Larsen T, 2009, FUNCT ECOL, V23, P745, DOI 10.1111/j.1365-2435.2009.01564.x; Larsen T, 2012, RAPID COMMUN MASS SP, V26, P1541, DOI 10.1002/rcm.6259; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Martins DJ, 2013, BIOL J LINN SOC, V109, P302, DOI 10.1111/bij.12037; McNabb DM, 2001, PEDOBIOLOGIA, V45, P289, DOI 10.1078/0031-4056-00087; Meehan CJ, 2009, CURR BIOL, V19, pR892, DOI 10.1016/j.cub.2009.08.049; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Ostrom PH, 1997, OECOLOGIA, V109, P108, DOI 10.1007/s004420050064; Patt JM, 2003, ECOL ENTOMOL, V28, P717, DOI 10.1111/j.1365-2311.2003.00556.x; Perga ME, 2010, J APPL ECOL, V47, P942, DOI 10.1111/j.1365-2664.2009.01730.x; Pfeiffer M, 2014, MYRMECOL NEWS, V19, P31; Prasifka JR, 2004, ECOL ENTOMOL, V29, P226, DOI 10.1111/j.0307-6946.2004.00585.x; Sagers CL, 2007, OECOLOGIA, V151, P464, DOI 10.1007/s00442-006-0603-0; Sanders D, 2007, OECOLOGIA, V150, P611, DOI 10.1007/s00442-006-0538-5; Schallhart N, 2009, AGR FOREST ENTOMOL, V11, P333, DOI 10.1111/j.1461-9563.2009.00428.x; Scheu S, 2001, BASIC APPL ECOL, V2, P3, DOI 10.1078/1439-1791-00031; Schmidt O, 2004, PEDOBIOLOGIA, V48, P171, DOI 10.1016/j.pedoli.2003.12.003; Schmidt O, 1997, SOIL BIOL BIOCHEM, V29, P1301, DOI 10.1016/S0038-0717(97)00108-9; Semenina EE, 2011, PEDOBIOLOGIA, V54, P101, DOI 10.1016/j.pedobi.2010.10.004; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Spence KO, 2005, OECOLOGIA, V146, P89, DOI 10.1007/s00442-005-0170-9; Steffan SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076152; STORK NE, 1988, BIOL J LINN SOC, V35, P321, DOI 10.1111/j.1095-8312.1988.tb00474.x; Swift M.J., 1979, DECOMPOSITION TERRES; Takebayashi Y, 2010, RAPID COMMUN MASS SP, V24, P1001, DOI 10.1002/rcm.4469; TAKEDA H, 1983, PEDOBIOLOGIA, V25, P373; Tayasu I, 1998, ECOL RES, V13, P377, DOI 10.1046/j.1440-1703.1998.00268.x; Tayasu I, 2002, ECOL ENTOMOL, V27, P355, DOI 10.1046/j.1365-2311.2002.00414.x; Tayasu I, 2002, ECOL RES, V17, P195, DOI 10.1046/j.1440-1703.2002.00479.x; TIESSEN H, 1984, SOIL SCI SOC AM J, V48, P312; Tillberg CV, 2007, P NATL ACAD SCI USA, V104, P20856, DOI 10.1073/pnas.0706903105; Tobin John E., 1995, P129; Toyota A, 2010, RADIOCARBON, V52, P1471; Vitousek PM, 2004, NUTR CYCLING LIMITAT; Voigt CC, 2008, OECOLOGIA, V157, P31, DOI 10.1007/s00442-008-1057-3; WADA E, 1991, CRIT REV FOOD SCI, V30, P361; Wang A, 2014, OECOLOGIA, V174, P567, DOI 10.1007/s00442-013-2778-5; Wise DH, 2006, ECOL APPL, V16, P865, DOI 10.1890/1051-0761(2006)016[0865:USITRS]2.0.CO;2; Woodcock P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060756; Yamada A, 2005, ECOL RES, V20, P453, DOI 10.1007/s11284-005-0062-9; Yoneyama T, 1997, NEW PHYTOL, V137, P205, DOI 10.1046/j.1469-8137.1997.00809.x	186	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	JUL	2015	18	3					295	312		10.1111/ens.12128		18	Entomology	Entomology	CM3QY	WOS:000357599600001		
J	Omura, H; Itoh, T; Wright, DM; Pavulaan, H; Schroder, S				Omura, Hisashi; Itoh, Takao; Wright, David M.; Pavulaan, Harry; Schroeder, Stefan			Morphological study of alar androconia in Celastrina butterflies	ENTOMOLOGICAL SCIENCE			English	Article						battledore scale; lamellar form; longitudinal ridge; Lycaenidae; male wing		Morphological studies of androconia were performed for 13 Celastrina species using a digital microscope with Z-stacking mode. Whereas C.ladon lacked androconia, the remaining 12 species were found to possess fan-shaped androconia on the dorsal wing surfaces. The androconia of these species shared the following common features: smaller size than standard color-producing scales, absence of dentate termini and presence of crossrib perforations. In addition, some species were characterized by unique microstructures in their androconia. The androconia of C.argiolus iynteana possessed a rounded lamellar contour, while those of C.lavendularis himilcon and C.echo cinerea were tapered on the basal end. The average number of longitudinal ridges of C.argiolus ladonides and C.filipjevi (17.1) were greater than the average number of 12 species (14.3). These results suggest that the morphological traits of androconia in microdomain, such as the shape of the lamellar form and the average number of longitudinal ridges, are useful to identify species in the genus Celastrina.	[Omura, Hisashi] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Itoh, Takao] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Higashihiroshima 7398528, Japan	Omura, H (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Dept Biofunct Sci & Technol, 1-4-4 Kagamiyama, Higashihiroshima 7398528, Japan.	homura@hiroshima-u.ac.jp			Japan Society of the Promotion of the Sciences [25450487]	We sincerely thank Dr Takao Mukuda (Hiroshima University) for technical guidance in microscopic observations. This study was supported in part by a Grant-in-Aid for Scientific Research from Japan Society of the Promotion of the Sciences to HO (No. 25450487).	Vila R, 2011, P ROY SOC B-BIOL SCI, V278, P2737, DOI 10.1098/rspb.2010.2213; CLENCH H K, 1980, Journal of the Lepidopterists' Society, V34, P103; Courvoisier LG, 1916, VERHANDLUNGEN NATURF, V29, P11; Eliot JN, 1983, BLUE BUTTERFLIES LYC; ELIOT J N, 1973, Bulletin of the British Museum (Natural History) Entomology, V28, P371; Faynel C., 2012, LEPIDOPTERES GUYANE, V5, P46; FORSTER WALTER, 1941, MITTEIL MUNCHNER ENT GES, V31, P593; Kristensen NP, 2003, HDB ZOOLOGIE, V2, P9; Lee Jong-Wook, 1998, Korean Journal of Applied Entomology, V37, P39; Lundgren L, 1975, J CHEM ECOL, V1, P399; Omura H, 2013, NATURWISSENSCHAFTEN, V100, P373, DOI 10.1007/s00114-013-1030-9; PRATT GF, 1994, P ENTOMOL SOC WASH, V96, P566; R Core Team, 2012, R LANG ENV STAT COMP; Tilley R.J.D., 2002, Transactions of the Lepidopterological Society of Japan, V53, P153; Wright David M., 1999, Taxonomic Report of the International Lepidoptera Survey, V1, P1	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	JUL	2015	18	3					353	359		10.1111/ens.12126		7	Entomology	Entomology	CM3QY	WOS:000357599600006		
J	Shintani, Y; Kawazu, K; Hirose, Y				Shintani, Yoshinori; Kawazu, Kei; Hirose, Yuzuru			Photoperiodic induction of prepupal diapause and its role in synchronization with host phenology in the hibiscus caterpillar, Xanthodes transversa	ENTOMOLOGICAL SCIENCE			English	Article						developmental parameters; host-plant phenology; photoperiodism; seasonal adaptation	PLANT QUALITY; LEPIDOPTERA; PAPILIONIDAE; TEMPERATURE; MORTALITY; GROWTH	The hibiscus caterpillar, Xanthodes transversa (Lepidoptera: Noctuidae), is a multivoltine insect that is an important pest of Malvaceae plants such as the okra, Abelmoschus esculentus, and the common rose mallow, Hibiscus mutabilis, in Japan. In the present study, the effects of photoperiod and temperature on the induction of prepupal diapause and the adaptive significance of this diapause were examined in a local population of X.transversa in Miyazaki, Kyushu, southwestern Japan. Larvae showed a long-day photoperiodic response for controlling the induction of prepupal diapause with a critical day length between 13 and 14h at 20 to 25 degrees C. Under long-day conditions larvae rapidly pupated from the sixth instar, but under short-day conditions they entered diapause in the prepupal stage. Diapause occurrence in the field increased in late September, which was consistent with the laboratory results in terms of the photoperiodic response. Non-diapause development after this time is maladaptive because most larvae of the next generation could not reach the critical stage (prepupae) before winter and died during early winter in outdoor experiments. Larvae suffered from a high rate of mortality when fed leaves collected late in autumn. The photoperiodic response for controlling the induction of diapause in this insect may play an important role in synchronizing the life cycle with the seasonal changes in food and temperature conditions.	[Shintani, Yoshinori; Hirose, Yuzuru] Minami Kyushu Univ, Dept Environm & Hort Sci, Entomol Lab, Miyakonojo, Miyazaki 8850035, Japan; [Kawazu, Kei] Kyoyu Agri Co Ltd, Nagano, Japan	Shintani, Y (reprint author), Minami Kyushu Univ, Dept Environm & Hort Sci, Entomol Lab, 3764-1 Tateno, Miyakonojo, Miyazaki 8850035, Japan.	shintani@nankyudai.ac.jp			Minami Kyushu University	We are very grateful to Dr S. Kawanobu (Minami Kyushu University) for providing a research site. This study was supported in part by a grant from Minami Kyushu University from 2006 to 2010.	Gomi T, 1997, OECOLOGIA, V111, P160, DOI 10.1007/s004420050220; Ishihara M, 2006, ENVIRON ENTOMOL, V35, P524; MASAKI S, 1980, ANNU REV ENTOMOL, V25, P1, DOI 10.1146/annurev.en.25.010180.000245; Takagi S, 2008, ANN ENTOMOL SOC AM, V101, P392, DOI 10.1603/0013-8746(2008)101[392:HPQIDI]2.0.CO;2; HAGGSTROM H, 1995, OECOLOGIA, V104, P308, DOI 10.1007/BF00328366; SIMS SR, 1980, AM MIDL NAT, V103, P375, DOI 10.2307/2424637; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.1890/0012-9658(1997)078[0987:TSGHMH]2.0.CO;2; Ikemoto T, 2000, ENVIRON ENTOMOL, V29, P671; Armack CS, 2002, ANNU REV ENTOMOL, V47, P817; Beck S.D., 1980, INSECT PHOTOPERIODIS; Bradshaw WE, 2000, ECOLOGY, V81, P1262; Danks HV, 1987, INSECT DORMANCY ECOL; Japan Meteorological Agency, 2010, MET DAT; Kot'al V., 2006, J INSECT PHYSL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Makino T, 1996, REVISED MAKINOS ILLU, P540; Ministry of Agriculture Forestry and Fisheries of Japan, 2013, RES PROD SPEC VEG; Okada T, 2003, AGR INSECT PESTS JAP, P180; Saunders D.S., 2002, INSECT CLOCKS; Schoonhoven L. M., 1998, INSECT PLANT BIOL PH; Shimizu T, 2003, NATURALIZED PLANTS J; Tauber MJ, 1986, SEASONAL ADAPTATIONS; Yoshio M, 1998, APPL ENTOMOL ZOOL, V33, P281; ZAR J.H., 2009, BIOSTATISTICAL ANAL	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	JUL	2015	18	3					360	367		10.1111/ens.12135		8	Entomology	Entomology	CM3QY	WOS:000357599600007		
J	Inoda, T; Miyazaki, Y; Kitano, T; Kubota, S				Inoda, Toshio; Miyazaki, Yusuke; Kitano, Tadashi; Kubota, Souichirou			Noninvasive sampling of DNA from larval exuvia in diving beetles of the genera Cybister and Dytiscus	ENTOMOLOGICAL SCIENCE			English	Article						COI; Coleoptera; Dytiscidae; identification of larvae	CONSERVATION	Nonlethal DNA sampling is a highly recommendable method in molecular genetic studies of protected and endangered species. To develop a demonstrably nonlethal method of obtaining DNA from larvae of endangered diving beetles (Cybister brevis, C.lewisianus, C.limbatus, C.rugosus, Dytiscus sharpi sharpi and D.sharpi validus), we obtained the larval exuvia (molted skin) of these endangered diving beetles under laboratory conditions. A single exuvia 24h after molting was sufficient to allow polymerase chain reaction (PCR) detection of a mitochondrial DNA gene, cytochrome-c oxidase subunitI (COI), and the sequence of the COI gene could be determined directly. Sequences obtained from the exuvial samples were used to further find similarities within DDBJ/EMBL/GenBank. Genomic DNA from the samples was successfully isolated, and we identified the species. This process suggests that exuvia provides a good sample for extracting DNA from endangered diving beetle larvae without killing them.	[Inoda, Toshio; Miyazaki, Yusuke] Conservat Lab Rare Water Insects, Katsushika, Tokyo 1250052, Japan; [Inoda, Toshio; Kubota, Souichirou] Toho Univ, Fac Sci, Dept Biol, Funabashi, Chiba 274, Japan; [Kitano, Tadashi] Tokai Univ, Dept Human Dev, Course Environm & Resources, Hiratsuka, Kanagawa 25912, Japan	Inoda, T (reprint author), Conservat Lab Rare Water Insects, 5-17-10 Shibamata, Katsushika, Tokyo 1250052, Japan.	inoda@kxb.biglobe.ne.jp					Truett GE, 2000, BIOTECHNIQUES, V29, P52; Lefort MC, 2012, MOL ECOL RESOUR, V12, P389, DOI 10.1111/j.1755-0998.2011.03103.x; ALLAN JD, 1993, BIOSCIENCE, V43, P32, DOI 10.2307/1312104; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651; Keyghobadi N, 1999, MOL ECOL, V8, P1481, DOI 10.1046/j.1365-294x.1999.00726.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Hamm CA, 2010, J INSECT CONSERV, V14, P11, DOI 10.1007/s10841-009-9219-0; Ichikawa N., 1984, INSECTARIUM, V21, P8; Inoda T, 2013, APPL ENTOMOL ZOOL, V48, P397, DOI 10.1007/s13355-013-0176-4; Inoda T, 2004, COLEOPTS BULL, V58, P37, DOI 10.1649/591; Kamite Y, 2008, B HOSHIZAKI GREEN FD, V11, P125; Lai BCG, 2004, J INSECT CONSERV, V8, P27, DOI 10.1023/B:JICO.0000027478.35309.46; Ministry of the Environment Government of Japan, 2011, NAT END SPEC WILD FA; Ministry of the Environment Government of Japan, 2012, RED LIST OF JAP; Mori M, 2002, DYTISCOIDEA OF JAPAN; Serjeant AF, 2013, J INSECT CONSERV, V17, P1191, DOI 10.1007/s10841-013-9600-x; Suzuki G, 2012, ENTOMOL SCI, V15, P352, DOI 10.1111/j.1479-8298.2012.00523.x; Takahashi J, 2009, JAPANESE J CONSERVAT, V14, P73; Tsuzuki Y, 1999, PERFECT MANUALS BREE; Vila M, 2009, ECOL ENTOMOL, V34, P356, DOI 10.1111/j.1365-2311.2008.01084.x	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	JUL	2015	18	3					403	406		10.1111/ens.12129		4	Entomology	Entomology	CM3QY	WOS:000357599600013		
J	Rahayu, SR; Katsuyama, H; Demura, M; Katsuyama, M; Ota, Y; Tanii, H; Higashi, T; Semadi, NPD; Saijoh, K				Rahayu, Sri Ratna; Katsuyama, Hironobu; Demura, Masashi; Katsuyama, Midori; Ota, Yoko; Tanii, Hideji; Higashi, Tomomi; Semadi, Ngakan Putu Djaja; Saijoh, Kiyofumi			Factors associated with tuberculosis cases in Semarang District, Indonesia: case-control study performed in the area where case detection rate was extremely low	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Tuberculosis; Case detection rate; Risk factors; Indonesia; DOTS	PULMONARY TUBERCULOSIS; METAANALYSIS; DIAGNOSIS; PROVINCE; QUALITY; HIV	Indonesia is ranked as the 4th highest contributor to tuberculosis (TB) in the world. Semarang District in Central Java displays extremely low case detection rate (CDR), possibly contributing to the local prevalence of TB. A case-control study was performed to explore the factors that cause such low CDR. We recruited 129 TB cases and 83 controls that visited the same centers and were not diagnosed with TB. The cases had 7.5 +/- A 2.3 symptoms/person on average, indicating the delay in diagnosis because the controls only displayed 1.0 +/- A 1.7. The multiple logistic regression analysis comparing the cases/controls extracted following factors as a risk to have TB: farmer, close contact with TB patients, ignorance of whether Bacillus Calmette-Gu,rin (BCG) was accepted or no, smoking, low income, a lot of people living in the same room, irregular hand wash before meals, not wash hands after blow, soil floor, and no sunlight and no ventilation in the house. Neither the cases nor the controls knew the symptoms and how to avoid TB infection, which probably caused the delay in diagnosis. It is difficult to change the current living conditions. Thus, the amendment of the community-based education program of TB seems to be required.	[Rahayu, Sri Ratna; Demura, Masashi; Katsuyama, Midori; Ota, Yoko; Tanii, Hideji; Higashi, Tomomi; Saijoh, Kiyofumi] Kanazawa Univ, Sch Med, Kanazawa, Ishikawa 9208640, Japan; [Katsuyama, Hironobu] Kawasaki Med Univ, Dept Publ Hlth, Kurashiki, Okayama 7011092, Japan; [Semadi, Ngakan Putu Djaja] Hlth Dept Semarang Dist, Ungaran, Semarang, Indonesia	Saijoh, K (reprint author), Kanazawa Univ, Sch Med, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	saijohk@med.kanazawa-u.ac.jp	DEMURA, Masashi/E-1278-2011	DEMURA, Masashi/0000-0003-4156-1640	Semarang State University; Directorate General of Higher Education (DGHE or DIKTI); Health Department Semarang District	We would like to thank to Semarang State University, Directorate General of Higher Education (DGHE or DIKTI), and Health Department Semarang District for all their support.	Ahmad RA, 2011, TROP MED INT HEALTH, V16, P412, DOI 10.1111/j.1365-3156.2010.02713.x; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Sarmiento OL, 2003, J CLIN MICROBIOL, V41, P3233, DOI 10.1128/JCM.41.7.3233-3240.2003; Ismail I, 2013, PREV MED, V57, pS27, DOI 10.1016/j.ypmed.2012.12.023; Buregyeya E, 2011, INT J TUBERC LUNG D, V15, P938, DOI 10.5588/ijtld.10.0211; Bauer M, 2013, QUAL LIFE RES, V22, P2213, DOI 10.1007/s11136-012-0329-x; Clark M, 2002, INT J EPIDEMIOL, V31, P940, DOI 10.1093/ije/31.5.940; Sacchi FPC, 2013, T ROY SOC TROP MED H, V107, P152, DOI 10.1093/trstmh/trs089; Kanaya AM, 2001, CHEST, V120, P349, DOI 10.1378/chest.120.2.349; Putra IWGAE, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-445; Batra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040880; Bhopal Raj S., 2002, CONCEPTS EPIDEMIOLOG; Davies PDO, 2008, CLIN TUBERCULOSIS, V4th; Dye C, 2000, INT J TUBERC LUNG D, V4, pS146; Health Department S.D, 2011, REP TB CAS SEM DISTR; Health Minister of The Republic of Indonesia N.M.S.V, 2009, TUB CONTR GUID; Jensen P.A., 2005, MMWR RECOMM REP, P141; Ministry of Health R.I, 2012, CURR REP DEV TUB IND; Ministry of Health R.o.I, 2012, PROF HLTH DAT IND 20; Ministry of Health R.O.I Directorate General of Disease Control and Environmental Health National, 2011, STRAT CONTR TB IND 2; Notoatmodjo S., 2007, HLTH PROMOTION BEHAV; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Saxena Shailly, 2012, Indian J Tuberc, V59, P65; Shen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051133; Tasnim S, 2012, PULM MED, V2012; WHO, 2013, SYST SCREEN ACT TB; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wu Jie, 2012, Int J Prev Med, V3, P8; Yang YR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1110	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	JUL	2015	20	4					253	261		10.1007/s12199-015-0443-9		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CM2AK	WOS:000357481700003		
J	Onizuka, C; Niimi, Y; Sato, M; Sugenoya, J				Onizuka, Chisato; Niimi, Yuki; Sato, Motohiko; Sugenoya, Junichi			Arterial blood pressure response to head-up tilt test and orthostatic tolerance in nurses	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Baroreflex; Blood pressure; Head-up tilt; Nurse; Orthostatic tolerance	SYMPATHETIC NEURAL-CONTROL; BAROREFLEX SENSITIVITY; HEALTHY-SUBJECTS; CARDIOVASCULAR REGULATION; BARORECEPTOR SENSITIVITY; PLASMA-VOLUME; HUMANS; EXERCISE; MEN; INTOLERANCE	High tolerance to postural changes was examined in nurses. Twelve female nurses and 12 healthy controls underwent a 70A degrees head-up tilt (HUT) test for 10 min. Blood pressure (BP), heart rate (HR), pulse pressure, and hormone levels were measured. Baroreceptor sensitivity (BRS) was calculated using a sequence technique. HR increased during HUT in both subject groups, with no difference between groups. Systolic BP was rapidly increased by HUT in both subject groups, and was higher in the nurse group than in the control group during the first 2 min of HUT. Pulse pressure decreased during 1-2.5 min of HUT in the control group, but there was no decrease in the nurse group. BRS was decreased by HUT in the nurse group, while it tended to be decreased in the control group. Both during baseline and HUT, BRS was lower in the nurse group than in the control group. Plasma noradrenaline increased with HUT, and the increase was greater in the nurse group than in the control group. Although nurse subjects had a lower BRS during HUT than control subjects, they were able to effectively maintain BP during HUT, suggesting that nurse subjects had higher orthostatic tolerance. The better maintenance of BP in nurse subjects appeared to be associated with a compensatory mechanism other than the arterial baroreflex and/or a hemodynamic mechanism.	[Onizuka, Chisato; Sato, Motohiko; Sugenoya, Junichi] Aichi Med Univ, Dept Physiol, Nagakute, Aichi 4801195, Japan; [Niimi, Yuki] Japanese Red Cross Nagoya First Hosp, Div Neurol, Nagoya, Aichi 4538511, Japan; [Sugenoya, Junichi] Sugiyama Jogakuen Univ, Sch Nursing, Nagoya, Aichi 4648662, Japan	Onizuka, C (reprint author), Aichi Med Univ, Dept Physiol, Nagakute, Aichi 4801195, Japan.	onizuka@aichi-med-u.ac.jp			Department of Nursing, Japanese Red Cross Nagoya First Hospital; Daiko Foundation; Policy-Based Medical Service Foundation	The authors would like to express their thanks to Prof. Humio Kobayashi, Department of Health and Psychosocial Medicine, Aichi Medical University, and Prof. Satoshi Iwase, Department of Physiology, Aichi Medical University, for helpful advice and for providing the facilities for the experiments. This study was conducted under the auspices of nurses of the Department of Nursing, Japanese Red Cross Nagoya First Hospital. It was supported in part by Academic Research Grants from the Daiko Foundation (2010) and Policy-Based Medical Service Foundation (2010).	Abbey M, 2012, AUST CRIT CARE, V25, P13, DOI 10.1016/j.aucc.2011.08.002; O'Leary DD, 2003, EXP PHYSIOL, V88, P769, DOI 10.1113/eph8802632; Douglas S, 2013, NURS RES, V62, P50, DOI 10.1097/NNR.0b013e318270714b; PAWELCZYK JA, 1989, AM J PHYSIOL, V257, pH1389; TATRO DL, 1992, MED SCI SPORT EXER, V24, P789; ZIEGLER MG, 1977, NEW ENGL J MED, V296, P293, DOI 10.1056/NEJM197702102960601; Laitinen T, 1998, J APPL PHYSIOL, V84, P576; PARATI G, 1989, HYPERTENSION, V13, P647; Kardos A, 1997, CLIN AUTON RES, V7, P143, DOI 10.1007/BF02308842; Benditt DG, 1996, J AM COLL CARDIOL, V28, P263; Fu Q, 2006, J PHYSIOL-LONDON, V577, P679, DOI 10.1113/jphysiol.2006.118158; Sato T, 1999, AM J PHYSIOL-HEART C, V276, pH2251; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; Raven PB, 2006, EXP PHYSIOL, V91, P37, DOI 10.1113/expphysiol.2005.032250; Schwartz CE, 2013, AM J PHYSIOL-REG I, V304, pR1107, DOI 10.1152/ajpregu.00559.2012; McCarthy JP, 1997, EUR J APPL PHYSIOL O, V76, P32, DOI 10.1007/s004210050209; Fu Q, 2004, CIRCULATION, V110, P2931, DOI 10.1161/01.CIR.0000146384.91715.B5; Folino AF, 2007, PROG CARDIOVASC DIS, V50, P49, DOI 10.1016/j.pcad.2007.01.001; Cooper VL, 2002, CLIN SCI, V103, P221; Kamiya A, 2005, J PHYSIOL-LONDON, V566, P237, DOI 10.1113/jphysiol.2005.086512; Carter JR, 2008, AM J PHYSIOL-REG I, V294, pR681, DOI 10.1152/ajpregu.00896.2007; Convertino VA, 2000, CLIN PHYSIOL, V20, P177; Convertino VA, 2006, J TRAUMA, V61, P629, DOI 10.1097/01.ta.0000196663.34175.33; Cote AT, 2012, CLIN INVEST MED, V35, pE65; DiCarlo SE, 2001, ANN NY ACAD SCI, V940, P324; Di Rienzo M, 2008, J APPL PHYSIOL, V105, P1569, DOI 10.1152/japplphysiol.90625.2008; ESLER M, 1981, HYPERTENSION, V3, P149; Fauvel JP, 2000, HYPERTENSION, V35, P887; Gabbett TJ, 2001, CLIN SCI, V100, P199, DOI 10.1042/CS20000066; Harms MPM, 2000, STROKE, V31, P1608; HENRIKSEN O, 1977, ACTA PHYSIOL SCAND, V99, P19, DOI 10.1111/j.1748-1716.1977.tb10347.x; Laszlo Z, 2001, PHYSIOL RES, V50, P71; Lee Yuh-Shwu, 2005, J Nurs Res, V13, P281; LEVINE BD, 1991, J APPL PHYSIOL, V70, P112; LUDWIG DA, 1994, AVIAT SPACE ENVIR MD, V65, P404; Mtinangi BL, 1999, EXP PHYSIOL, V84, P121; ROWELL LB, 1990, J APPL PHYSIOL, V69, P407; Rowell LB, 1993, HUMAN CARDIOVASCULAR; Sagawa K., 1983, HDB PHYSL 2, VIII, P453; ELSAYED H, 1995, CLIN SCI, V88, P463; Schwartz CE, 2012, FRONT PHYSIOL, V3, P1; VICTOR RG, 1985, J CLIN INVEST, V76, P1592, DOI 10.1172/JCI112142; WALLIN BG, 1987, ACTA PHYSIOL SCAND, V129, P489, DOI 10.1111/j.1748-1716.1987.tb08088.x; Wieling W, 1992, AUTONOMIC FAILURE TX, P291; Wieling W, 2008, CLIN AUTONOMIC DISOR, P57	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	JUL	2015	20	4					262	270		10.1007/s12199-015-0455-5		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CM2AK	WOS:000357481700004		
J	Qi, GY; Zuo, XX; Zhou, LH; Aoki, E; Okamula, A; Watanebe, M; Wang, HP; Wu, QH; Lu, HL; Tuncel, H; Watanabe, H; Zeng, S; Shimamoto, F				Qi, Guangying; Zuo, Xiaoxu; Zhou, Lihua; Aoki, Eriko; Okamula, Aya; Watanebe, Mika; Wang, Haipeng; Wu, Qiuhui; Lu, Huiling; Tuncel, Handan; Watanabe, Hiromitsu; Zeng, Sien; Shimamoto, Fumio			Effects of extremely low-frequency electromagnetic fields (ELF-EMF) exposure on B6C3F1 mice	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						ELF-EMF; Long-term exposure; Chronic myeloid leukemia; Fertility; B6C3F1 mice	MAGNETIC-FIELDS; CHILDHOOD LEUKEMIA; OXIDATIVE STRESS; POOLED ANALYSIS; BRAIN-TUMORS; MALE RATS; CANCER; CELLS; RADIATION; RISK	Long-term exposure study was conducted to investigate the effects of extremely low-frequency electromagnetic field on the tumor promotion process and fertility. Ten pregnant C57BL/6NCrj mice were exposed to 50 Hz field 500 mG for 1 week (12 h per day), and 24 male and 42 female B6C3F1mice born from them were further exposed up to 15.5 months. As a control group, 10 pregnant mice were bred without exposure, and 30 produced male and 32 female mice were observed without exposure for the same period. Mean body weights of exposed groups of male and female mice were decreased significantly than those of the control groups. In exposed mice, there was no increased incidence of liver and lung tumor. In female mice, the incidence of chronic myeloid leukemia [3/42 (7 %)] in the exposed group was significantly greater than in the control group. The size of seminiferous tubules in the EMF exposed groups were significantly less than the control group. These data support the hypothesis that long-term exposure of 50 Hz magnetic fields is a significant risk factor for neoplastic development and fertility in mice.	[Qi, Guangying; Zuo, Xiaoxu; Zhou, Lihua; Wang, Haipeng; Wu, Qiuhui; Lu, Huiling; Zeng, Sien] Guilin Med Univ, Dept Physiopathol & Gastrointestinal Surg, Guilin, Guangxi 541004, Japan; [Qi, Guangying; Zhou, Lihua; Aoki, Eriko; Okamula, Aya; Watanebe, Mika; Shimamoto, Fumio] Prefectural Univ Hiroshima, Fac Human Culture & Sci, Dept Hlth Sci, Minami Ku, Hiroshima 7348558, Japan; [Tuncel, Handan] Istanbul Univ, Cerrahpasa Med Fac, Dept Biophys, TR-34303 Istanbul, Turkey; [Watanabe, Hiromitsu] Hiroshima Univ, Dept Res Inst Radiat Biol & Med, Minami Ku, Hiroshima 7348551, Japan	Zeng, S (reprint author), Guilin Med Univ, Dept Physiopathol & Gastrointestinal Surg, Guilin, Guangxi 541004, Japan.	zse@glmc.edu.cn; simamoto@pu-hiroshima.ac.jp			National Natural Science Foundation of China [81460411, 81160256]; Prefectural University of Hiroshima, Hiroshima Tsuchiya General Hospital, Hiroshima	This research was supported in part by The National Natural Science Foundation of China (No. 81460411 and 81160256) and in part by the Important Research Grant from the Prefectural University of Hiroshima, Hiroshima Tsuchiya General Hospital, Hiroshima. We thank them for their technical and materials assistance.	WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273; Linet MS, 1997, NEW ENGL J MED, V337, P1, DOI 10.1056/NEJM199707033370101; Chung MK, 2005, ASIAN J ANDROL, V7, P189, DOI 10.1111/j.1745-7262.2005.00007.x; LOSCHER W, 1994, LIFE SCI, V54, P1531, DOI 10.1016/0024-3205(94)90024-8; Naziroglu M, 2012, INT J RADIAT BIOL, V88, P449, DOI 10.3109/09553002.2012.682192; Tokalov SV, 2004, ENVIRON RES, V94, P145, DOI 10.1016/S0013-9351(03)00088-4; Greenland S, 2000, EPIDEMIOLOGY, V11, P624, DOI 10.1097/00001648-200011000-00003; Al-Akhras MA, 2006, BIOELECTROMAGNETICS, V27, P127, DOI 10.1002/bem.20186; Lacy-Hulbert A, 1998, FASEB J, V12, P395; Esmekaya MA, 2011, GEN PHYSIOL BIOPHYS, V30, P84, DOI 10.4149/gpb_2011_01_84; Saygin M, 2011, TOXICOL IND HEALTH, V27, P455, DOI 10.1177/0748233710389851; Ahlbom A, 2000, BRIT J CANCER, V83, P692, DOI 10.1054/bjoc.2000.1376; SAVITZ DA, 1988, AM J EPIDEMIOL, V128, P21; Lai H, 2004, ENVIRON HEALTH PERSP, V112, P687, DOI 10.1289/ehp.6355; OLSEN JH, 1993, BRIT MED J, V307, P891; MATANOSKI GM, 1991, LANCET, V337, P737, DOI 10.1016/0140-6736(91)90325-J; Gutschi T, 2011, ANDROLOGIA, V43, P312, DOI 10.1111/j.1439-0272.2011.01075.x; ANTONOPOULOS A, 1995, MUTAT RES LETT, V346, P151, DOI 10.1016/0165-7992(95)90047-0; Bediz CS, 2006, TOHOKU J EXP MED, V208, P133, DOI 10.1620/tjem.208.133; Charles LE, 2003, AM J EPIDEMIOL, V157, P683, DOI 10.1093/aje/kwg044; Fam WZ, 1996, CANCER LETT, V105, P257, DOI 10.1016/0304-3835(96)04324-8; FLODERUS B, 1993, CANCER CAUSE CONTROL, V4, P465, DOI 10.1007/BF00050866; Greenland S, 2009, SCAND J PUBLIC HEALT, V37, P83, DOI 10.1177/1403494808097253; Hardell Lennart, 2013, Reviews on Environmental Health, V28, P97, DOI 10.1515/reveh-2013-0006; Heifets L, 2010, BRIT J CANCER, V103, P1128; Kim YW, 2009, BIOELECTROMAGNETICS, V30, P66, DOI 10.1002/bem.20448; Miyakoshi J, 1997, INT J RADIAT BIOL, V71, P75, DOI 10.1080/095530097144445; MURPHY JC, 1993, MUTAT RES, V296, P221, DOI 10.1016/0165-1110(93)90013-D; Muscat JE, 1999, AM J EPIDEMIOL, V149, P831; Otaka Y, 2002, BIOELECTROMAGNETICS, V23, P206, DOI 10.1002/bem.10012; Rajaei Farzad, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P56; Savitz DA, 2003, EPIDEMIOLOGY, V14, P15, DOI 10.1097/00001648-200301000-00008; Taherianfard M, 2013, INT J ENDOCRINOL MET, V11; Thalau HP, 2013, RADIAT RES, V159, P685; Yang QW, 2004, CANCER RES, V64, P4531, DOI 10.1158/0008-5472.CAN-04-0956; Yousif L, 2010, J RADIOL PROT, V30, P389, DOI 10.1088/0952-4746/30/3/R01; Zeng LH, 2011, ELECTROMAGN BIOL MED, V30, P205, DOI 10.3109/15368378.2011.587929	37	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	JUL	2015	20	4					287	293		10.1007/s12199-015-0463-5		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CM2AK	WOS:000357481700007		
J	Nakatsuka, H; Kim, ES; Ko, YS; Yang, HR; Moon, CS; Watanabe, T; Shimbo, S; Ikeda, M				Nakatsuka, Haruo; Kim, Eul-Sang; Ko, Yang-Sook; Yang, Hye-Ran; Moon, Chan-Seok; Watanabe, Takao; Shimbo, Shinichiro; Ikeda, Masayuki			Food intake survey of kindergarten children in Korea: Part 1 food, energy, and nutrient intake	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Children; Food intake; Kindergarten; Korea; Nutrient intake	NATIONAL-HEALTH; JAPAN	Nutrient intakes of children were surveyed at the time when a nation-wide shift took place in the Republic of Korea from agriculture-based to industrialized society. Taking advantage of the survey locations (see below), possible delay in nutritional improvement in rural areas (as compared with that in an urban area) was also examined. In total, 108 4- to 6-year-old children (boys and girls in combination) in 4 kindergartens (KGs; 1 in Seoul and 3 in Jeju Island) participated in the survey in 2003-2004. 24-h food duplicate samples were prepared by the mother of each child. Food items in each duplicate sample were separated and coded with reference to the Dietary Reference Intake for Koreans (the 2005 version). Nutrient intake of the day was estimated from the code and weight followed by summation for daily intake. The children in the KG in Seoul studied were younger, and therefore were smaller in body size than those in other KGs. Thus, it was considered necessary to evaluate nutrient intake not only on a daily basis, but after adjustment for body weight. The AM daily intake of energy (protein in parenthesis) for the 108 children was 1479 kcal (55 g)/day or 69.8 kcal (2.6 g)/kg body weight/day. Evaluation by individual nutrient suggested that the intake was sufficient for almost all nutrients except for sodium and potassium. Sodium and potassium intake (2285 and 1840 mg/day, respectively) was in excess and insufficient, respectively, with potential risk of inducing hypertension later in life. Inter-KG difference was not remarkable and therefore urban-rural difference was not apparent. Nutrient intakes as a whole appeared to be sufficient urban and rural areas. Nevertheless, excess Na intake coupled with insufficient K intake was a common problem.	[Nakatsuka, Haruo] Miyagi Univ, Sch Nursing, Taiwa, Miyagi 9813298, Japan; [Kim, Eul-Sang] Dankook Univ, Dept Food & Nutr, Yongin 448701, Gyeonggi, South Korea; [Ko, Yang-Sook] Jeju Natl Univ, Dept Food & Nutr, Jeju 690756, South Korea; [Yang, Hye-Ran] Seoul Metropolitan Govt, Res Inst Publ Hlth & Environm, Seoul 137734, South Korea; [Moon, Chan-Seok] Catholic Univ Pusan, Dept Ind Hlth, Busan 609757, South Korea; [Watanabe, Takao] Tohoku Bunkyo Univ, Fac Human Sci, Dept Childhood Educ, Yamagata 9902316, Japan; [Shimbo, Shinichiro] Kyoto Womens Univ, Kyoto 6058501, Japan; [Ikeda, Masayuki] Kyoto Ind Hlth Assoc, Kyoto 6048472, Japan	Ikeda, M (reprint author), Kyoto Ind Hlth Assoc, Kyoto 6048472, Japan.	m-71-ikeda@nifty.com			Ministry of Education, Culture, Sports, Science and Technology, Japan [22500755, 26350150]	The authors are grateful to Dr. K. Jung (the General Director) and Dr. J.-H. Kim (the Director of the Food and Drug Division) of Seoul Metropolitan Government Research Institute of Public Health and Environment, Seoul, Korea, for their interest and support to this work. Thanks are also due to the participating children and their guardians, and administrations and staff of the kindergartens participated in the study. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan: Grant-in-Aid for Scientific Research C: 22500755 (Head Investigator; T. Watanabe for fiscal years 2010-2012), and Grant-in-Aid for Scientific Research C; 26350150 (Head Investigator; H. Nakatsuka for fiscal years 2014-2016).	Watanabe T, 2013, INT ARCH OCC ENV HEA, V86, P865, DOI 10.1007/s00420-012-0821-1; Baek YJ, 2014, NUTR RES PRACT, V8, P463, DOI 10.4162/nrp.2014.8.4.463; ACHESON KJ, 1980, AM J CLIN NUTR, V33, P1147; Kim S, 2000, AM J CLIN NUTR, V71, P44; Institute of Medicine, 1997, DIET REF INT CALC OT, P28; Institute of Medicine, 2004, DIET REF INT WAT POT, p[186, 269]; Institute of Medicine, 2000, DIET REF INT VIT C O, V3, P58; Institute of Medicine, 2002, DIET REF INT IR OTH, V9, P290; Institute of Medicine of the National Academies Food and Nutrition Board, 2005, DIET REF INT EN CARB, P107; Ju JS, 2000, BR J CNUTR S2, V84, P8195; Korean Nutrition Society, 2010, DIET REF INT KOR 201; Korean Nutrition Society, 2005, DIET REF INT KOR 200; Lee JS, 2010, BRIT J NUTR, V103, P1499, DOI 10.1017/S0007114509993527; Lee K, 2013, ASIA PAC J CLIN NUTR, V22, P69, DOI 10.6133/apjcn.2013.22.1.14; Medicine Institute of, 2000, DIET REF INT THIAM O, V4, P58; Nakatsuka H, 2013, J TRACE ELEM MED BIO, V27, P339, DOI 10.1016/j.jtemb.2013.02.002; National Institute of Health and Nutrition Japan, 2015, NAT HLTH NUTR SURV 2, p[46, 56, 115]; Shimbo S, 2013, ENVIRON HEALTH PREV, V18, P230, DOI 10.1007/s12199-012-0311-9; Watanabe T, ENV HLTH PR IN PRESS; Yang HR, ENV HLTH PR IN PRESS	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	JUL	2015	20	4					294	301		10.1007/s12199-015-0465-3		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CM2AK	WOS:000357481700008		
J	Yang, HR; Kim, ES; Ko, YS; Jung, K; Kim, JH; Watanabe, T; Nakatsuka, H; Moon, CS; Shimbo, S; Ikeda, M				Yang, Hye-Ran; Kim, Eul-Sang; Ko, Yang-Sook; Jung, Kweon; Kim, Jung-Hun; Watanabe, Takao; Nakatsuka, Haruo; Moon, Chan-Seok; Shimbo, Shinichiro; Ikeda, Masayuki			Food intake survey of kindergarten children in Korea: Part 2 increased dietary intake of tin possibly associated with canned foods	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Canned foods; Children; Dietary intake; Korea; Tin	CADMIUM; JAPAN; LEAD	Dietary intake of tin (Sn) may be increased in some children in kindergartens in Korea. The present study was intended to examine this possibility and clarify the extent of the elevation. 24-hour food duplicate and spot urine samples were collected in 2003-2004 from 108 4-6-year-old children (boys and girls combined) in 4 kindergartens (1 in Seoul and 3 in Jeju Island), as reported in a previous publication. These samples were employed in the present analyses to examine tin levels in the diet (including beverages) (Sn-D). A portion of the samples were wet-ashed, and the liquid samples were analyzed for Sn by the ICP-MS method. For statistical evaluation, chi (2) method and Smirnov's test for extreme value were used. Sn-D in the 108 cases distributed as extremely biased, and could be divided into two groups, i.e., those with < 10 mu g Sn/day (accounting for 90 % of the cases), and those with > 10 mu g/day (for 10 %). Sn-D in the former group was distributed quasi-normally with an AM (median) of 2.9 (2.5) mu g/day. The maximum in the latter group was 3012 mu g/day. No correlation was detected between Sn-D and Sn in urine (Sn-U). Comparison of the findings with published articles strongly suggested that the high Sn-D was due to consumption of foods (including beverages) preserved in tin-plated cans. No positive confirmation was however possible due to insufficient information on food records. About 10 % of children surveyed had elevated Sn-D (up to 3 mg/day). It was quite possible that high Sn-D was associated with tin-canned food intake.	[Yang, Hye-Ran; Jung, Kweon; Kim, Jung-Hun] Seoul Metropolitan Govt, Res Inst Publ Hlth & Environm, Seoul 137734, South Korea; [Kim, Eul-Sang] Dankook Univ, Dept Food & Nutr, Yongin 448701, Gyeonggi, South Korea; [Ko, Yang-Sook] Jeju Natl Univ, Dept Food & Nutr, Jeju 690756, South Korea; [Watanabe, Takao] Tohoku Bunkyo Univ, Fac Human Sci, Dept Childhood Educ, Yamagata 9902316, Japan; [Nakatsuka, Haruo] Miyagi Univ, Sch Nursing, Taiwa, Miyagi 9813298, Japan; [Moon, Chan-Seok] Catholic Univ Pusan, Dept Ind Hlth, Busan 609757, South Korea; [Shimbo, Shinichiro] Kyoto Womens Univ, Kyoto 6058501, Japan; [Ikeda, Masayuki] Kyoto Ind Hlth Assoc, Kyoto 6048472, Japan	Ikeda, M (reprint author), Kyoto Ind Hlth Assoc, Kyoto 6048472, Japan.	m-71-ikeda@nifty.com			Ministry of Education, Culture, Sports, Science and Technology, Japan [22500755, 26350150]	The authors are grateful to the participating children and their guardians, and administrations and staff of the kindergartens for their participation in the study. This work was supported in part by Grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan: Grant-in-Aid for Scientific Research C: 22500755 (Head Investigator; T. Watanabe for fiscal years 2010-2012), and Grant-in-Aid for Scientific Research C; 26350150 (Head Investigator; H. Nakatsuka for fiscal years 2014-2016).	Olmedo P, 2013, ENVIRON INT, V59, P63, DOI 10.1016/j.envint.2013.05.005; ACHESON KJ, 1980, AM J CLIN NUTR, V33, P1147; Blunden S, 2003, FOOD CHEM TOXICOL, V41, P1651, DOI 10.1016/S0278-6915(03)00217-5; Bautakhrit K, 2011, FOOD ADDIT CONTAM A, V28, P173; International Programme on Chemical Safety, 1980, ENV HLTH CRIT, P19; Japan Society for Analytical Chemistry (ed.), 1998, AN REL AN RES, P52; Kassouf A, 2013, FOOD ADDIT CONTAM A, V30, P1987, DOI 10.1080/19440049.2013.832399; Nakatsuka H, ENG HLTH PR IN PRESS; Nakatsuka H, 2013, J TRACE ELEM MED BIO, V27, P339, DOI 10.1016/j.jtemb.2013.02.002; Shimbo S, 2013, ENVIRON HEALTH PREV, V18, P230, DOI 10.1007/s12199-012-0311-9; Shimbo S, 2007, FOOD ADDIT CONTAM, V24, P535, DOI 10.1080/02652030601134517; World Health Organization (WHO), WHO OFFS PUBL, V87; World Health Organization (WHO) Concise International Assessment Document. No. 65, 2005, 65 WHO CONC INT, P17	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	JUL	2015	20	4					302	306		10.1007/s12199-015-0466-2		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CM2AK	WOS:000357481700009		
J	Watanabe, T; Kim, ES; Ko, YS; Yang, HR; Moon, CS; Nakatsuka, H; Shimbo, S; Ikeda, M				Watanabe, Takao; Kim, Eul-Sang; Ko, Yang-Sook; Yang, Hye-Ran; Moon, Chan-Seok; Nakatsuka, Haruo; Shimbo, Shinichiro; Ikeda, Masayuki			Food intake survey of kindergarten children in Korea: Part 3 cadmium and lead burden	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Cadmium; Children; Daily foods; Korea; Lead	MIDDLE-AGED WOMEN; BACKGROUND EXPOSURE; URINARY CADMIUM; DIETARY-INTAKE; ASIA; POPULATION; AREAS; BLOOD; RICE; MARKERS	This study was initiated to elucidate the extent of dietary exposure of children in Korea to two pollutant metals of cadmium (Cd) and lead (Pb). Possible urban-rural difference was also examined. Food duplicate and morning spot urine samples were collected from 108 children in 4 kindergartens (KG) (1 KG in Seoul and 3 KGs in Jeju Island), as reported in a previous publication. The samples were analyzed for Cd and Pb by ICP-MS. Cd and Pb in food duplicate and urine samples were distributed approximately log-normally. Geometric means for Cd and Pb in food duplicate samples were 12.4 and 5.8 mu g/day, or 0.58 and 0.27 mu g/kg body weight/day, respectively, and the values for Cd and Pb in urine (as observed, i.e., with no correction for urine density) were 0.91 and 1.64 mu g/L, respectively. 2.41 and 0.30 mu g/day of Cd and Pb (accounting for 19.5 and 5.1 %) came from boiled rice, the staple food. The levels of Cd and Pb burden among the children in the present survey were essentially the same with the levels reported for children in Pusan. The reasons for difference in the rank in Cd-D and Cd-U among the 4 KGs need further study. The observed levels of Cd and Pb exposure were more or less similar to what were reported for children in Pusan. No apparent urban-rural difference could be detected.	[Watanabe, Takao] Tohoku Bunkyo Univ, Fac Human Sci, Dept Childhood Educ, Yamagata 9902316, Japan; [Kim, Eul-Sang] Dankook Univ, Dept Food & Nutr, Yongin 448701, Gyeonggi, South Korea; [Ko, Yang-Sook] Jeju Natl Univ, Dept Food & Nutr, Jeju 690756, South Korea; [Yang, Hye-Ran] Seoul Metropolitan Govt, Res Inst Publ Hlth & Environm, Seoul 137734, South Korea; [Moon, Chan-Seok] Catholic Univ Pusan, Dept Ind Hlth, Busan 609757, South Korea; [Nakatsuka, Haruo] Miyagi Univ, Sch Nursing, Taiwa, Miyagi 9813298, Japan; [Shimbo, Shinichiro] Kyoto Womens Univ, Kyoto 6058501, Japan; [Ikeda, Masayuki] Kyoto Ind Hlth Assoc, Kyoto 6048472, Japan	Ikeda, M (reprint author), Kyoto Ind Hlth Assoc, Kyoto 6048472, Japan.	m-71-ikeda@nifty.com			Ministry of Education, Culture, Sports, Science and Technology, Japan [22500755, 26350150]	The authors are grateful to Dr. K. Jung (the General Director) and Dr. J.-H. Kim (the Director of the Food and Drug Division) of Seoul Metropolitan Government Research Institute of Public Health and Environment, Seoul, Korea, for their interest and support to this work. Thanks are also due to the participating children and their guardians, and administrators and staff of the kindergartens that participated in the study. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan: Grant-in-Aid for Scientific Research C: 22500755 (Head Investigator; T. Watanabe for fiscal years 2010-2012), and Grant-in-Aid for Scientific Research C; 26350150 (Head Investigator; H. Nakatsuka for fiscal years 2014-2016).	Yamagami T, 2008, INT ARCH OCC ENV HEA, V81, P263, DOI 10.1007/s00420-007-0206-z; Lee JW, 2012, INT J HYG ENVIR HEAL, V215, P449, DOI 10.1016/j.ijheh.2012.01.002; Watanabe T, 1996, SCI TOTAL ENVIRON, V184, P191, DOI 10.1016/0048-9697(96)05100-5; Higashikawa K, 2000, SCI TOTAL ENVIRON, V246, P97, DOI 10.1016/S0048-9697(99)00415-5; Ha M, 2014, INT J HYG ENVIR HEAL, V217, P260, DOI 10.1016/j.ijheh.2013.06.001; Ikeda M, 2000, SCI TOTAL ENVIRON, V249, P373, DOI 10.1016/S0048-9697(99)00527-6; BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701; ACHESON KJ, 1980, AM J CLIN NUTR, V33, P1147; Moon CS, 1995, ENVIRON RES, V71, P46, DOI 10.1006/enrs.1995.1066; Jedrychowski W, 2009, NEUROEPIDEMIOLOGY, V32, P270, DOI 10.1159/000203075; Moon CS, 2003, INT ARCH OCC ENV HEA, V76, P282, DOI 10.1007/s00420-002-0415-4; Shimbo S, 2001, SCI TOTAL ENVIRON, V281, P165, DOI 10.1016/S0048-9697(01)00844-0; Ikeda M, 2000, AM J IND MED, V38, P271, DOI 10.1002/1097-0274(200009)38:3<271::AID-AJIM5>3.0.CO;2-3; International Programme on Chemical Safety (IPCS), 1989, ENV HLTH CRIT; International Programme on Chemical Safety (IPCS), 1992, ENV HLTH CRIT; International Programme on Chemical Safety (IPCS), 1995, ENV HLTH CRIT; International Programme on Chemical Safety (IPCS), 1992, ENV HLTH CRIT; International Programme on Cheniical Safety (IPCS), 1977, ENV HLTH CRIT; Japan Society for Analytical Chemistry (ed.), 1998, AN REL AN RES, P52; Kim JH, 2012, FOOD ADDIT CONTAM B, V5, P260, DOI 10.1080/19393210.2012.703699; Lauwerys RR, 2001, IND CHEM EXPOSURE GU, V3rd, p[54, 104]; Moon CS, 2012, TOXICOL RES-UK, V1, P145, DOI 10.1039/c2tx00002d; Moon CS, 2014, ASIA PAC J CLIN NUTR, V23, P219, DOI 10.6133/apjcn.2014.23.2.10; Moon CS, 1999, TOXICOL LETT, V108, P173, DOI 10.1016/S0378-4274(99)00086-7; Moon CS, 1998, INT ARCH OCC ENV HEA, V71, P251, DOI 10.1007/s004200050277; Mutlu A, 2012, ENVIRON SCI POLLUT R, V19, P2125, DOI 10.1007/s11356-011-0712-0; Nakatsuka H, ENV HLTH PR IN PRESS; Nakatsuka H, 2013, J TRACE ELEM MED BIO, V27, P339, DOI 10.1016/j.jtemb.2013.02.002; WATANABE T, 1989, SCI TOTAL ENVIRON, V80, P175, DOI 10.1016/0048-9697(89)90073-9; Yang HR, ENV HLTH PR IN PRESS	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	JUL	2015	20	4					307	313		10.1007/s12199-015-0467-1		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CM2AK	WOS:000357481700010		
J	Horiguchi, H				Horiguchi, Hyogo			Biomonitoring of metal exposure in children in a northern city of Japan	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Letter							CADMIUM		Kitasato Univ, Dept Hyg, Sch Med, Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Horiguchi, H (reprint author), Kitasato Univ, Dept Hyg, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	hhyogo@med.kitasato-u.ac.jp					Horiguchi H, 2013, ENVIRON INT, V56, P1, DOI 10.1016/j.envint.2013.03.001; Jarrett JM, 2008, J ANAL ATOM SPECTROM, V23, P962, DOI 10.1039/b801927d; Gordis L., 2013, EPIDEMIOLOGY, P189; Ilmiawati C, 2015, ENVIRON HEALTH PREV, V20, P18, DOI 10.1007/s12199-014-0416-4; Kayama F, 2012, COMBINED EXPOSURE AR	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	JUL	2015	20	4					314	315		10.1007/s12199-015-0460-8		2	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CM2AK	WOS:000357481700011		
J	Kayama, F				Kayama, Fujio			Biomonitoring of metal exposure in children in a northern city of Japan Reply	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Letter									Jichi Med Univ, Sch Med, Dept Environm & Prevent Med, Shimotsuke, Tochigi 3290498, Japan	Kayama, F (reprint author), Jichi Med Univ, Sch Med, Dept Environm & Prevent Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	kayamaf@jichi.ac.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	JUL	2015	20	4					316	316		10.1007/s12199-015-0461-7		1	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CM2AK	WOS:000357481700012		
J	Bortey-Sam, N; Nakayama, SMM; Ikenaka, Y; Akoto, O; Baidoo, E; Mizukawa, H; Ishizuka, M				Bortey-Sam, Nesta; Nakayama, Shouta M. M.; Ikenaka, Yoshinori; Akoto, Osei; Baidoo, Elvis; Mizukawa, Hazuki; Ishizuka, Mayumi			Health risk assessment of heavy metals and metalloid in drinking water from communities near gold mines in Tarkwa, Ghana	ENVIRONMENTAL MONITORING AND ASSESSMENT			English	Article						Heavy metal; Metalloid; Tarkwa; Health risk; Hazard index	SHALLOW GROUNDWATER; CONTAMINATION; CHINA; AREA; RESIDENTS; REGION; SOIL	Concentrations of heavy metals and metalloid in borehole drinking water from 18 communities in Tarkwa, Ghana, were measured to assess the health risk associated with its consumption. Mean concentrations of heavy metals (mu g/L) exceeded recommended values in some communities. If we take into consideration the additive effect of heavy metals and metalloid, then oral hazard index (HI) results raise concerns about the noncarcinogenic adverse health effects of drinking groundwater in Huniso. According to the US Environmental Protection Agency's (USEPA) guidelines, HI values indicating noncarcinogenic health risk for adults and children in Huniso were 0.781 (low risk) and 1.08 (medium risk), respectively. The cancer risk due to cadmium (Cd) exposure in adults and children in the sampled communities was very low. However, the average risk values of arsenic (As) for adults and children through drinking borehole water in the communities indicated medium cancer risk, but high cancer risk in some communities such as Samahu and Mile 7. Based on the USEPA assessment, the average cancer risk values of As for adults (3.65E-05) and children (5.08E-05) indicated three (adults) and five (children) cases of neoplasm in a hundred thousand inhabitants. The results of this study showed that residents in Tarkwa who use and drink water from boreholes could be at serious risk from exposure to these heavy metals and metalloid.	[Bortey-Sam, Nesta; Nakayama, Shouta M. M.; Ikenaka, Yoshinori; Ishizuka, Mayumi] Hokkaido Univ, Grad Sch Vet Med, Toxicol Lab, Dept Environm Vet Sci,Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Akoto, Osei; Baidoo, Elvis] Kwame Nkrumah Univ Sci & Technol, Dept Chem, Kumasi, Ghana; [Mizukawa, Hazuki] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Kita Ku, Sapporo, Hokkaido 0600818, Japan	Ishizuka, M (reprint author), Hokkaido Univ, Grad Sch Vet Med, Toxicol Lab, Dept Environm Vet Sci,Kita Ku, Kita 18,Nishi 9, Sapporo, Hokkaido 0600818, Japan.	ishizum@vetmed.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; foundation of JSPS Core to Core Program (AA Science Platforms); Mitsui & Co., Ltd. Environment Fund; Akiyama Life Science Foundation; Nihon Seimei Foundation	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan awarded to M. Ishizuka and Y. Ikenaka and the foundation of JSPS Core to Core Program (AA Science Platforms). We would like to acknowledge the financial support by the Mitsui & Co., Ltd. Environment Fund, the Akiyama Life Science Foundation, and the Nihon Seimei Foundation. We also express our sincere gratitude and thanks to Mr. Joseph Prah and Mr. Joseph Addae who in various ways assisted to carry out this research. We would like to thank Mr. Takahiro Ichise for helping with the maintenance of the instrument.	Akabzaa T., 2001, HLTH IMPACTS, V6, P60; AMASA S K, 1975, Environmental Health Perspectives, V12, P131, DOI 10.2307/3428223; AmonooNeizer EH, 1996, WATER AIR SOIL POLL, V91, P363, DOI 10.1007/BF00666270; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Obiri S, 2007, ENVIRON MONIT ASSESS, V130, P455, DOI 10.1007/s10661-006-9435-y; Apambire WB, 1997, ENVIRON GEOL, V33, P13; Wongsasuluk P, 2014, ENVIRON GEOCHEM HLTH, V36, P169, DOI 10.1007/s10653-013-9537-8; Liu JL, 2009, ECOTOXICOLOGY, V18, P748, DOI 10.1007/s10646-009-0345-y; Wcislo E, 2002, CHEMOSPHERE, V47, P507, DOI 10.1016/S0045-6535(01)00301-0; Roychowdhury T, 2003, SCI TOTAL ENVIRON, V308, P15, DOI 10.1016/S0048-9697(02)00612-5; Asante KA, 2007, CHEMOSPHERE, V66, P1513, DOI 10.1016/j.chemosphere.2006.08.022; Montuori P, 2013, ECOTOXICOLOGY, V22, P295, DOI 10.1007/s10646-012-1026-9; Lim HS, 2008, J GEOCHEM EXPLOR, V96, P223, DOI 10.1016/j.gexplo.2007.04.008; Bortey-Sam N, 2015, ECOTOX ENVIRON SAFE, V111, P160, DOI 10.1016/j.ecoenv.2014.09.008; [Anonymous], 2000, ENVIRON IMPACT ASSES, DOI 10.1016/S0195-9255(00)00068-8; Smedley PL, 1996, J AFR EARTH SCI, V22, P459, DOI 10.1016/0899-5362(96)00023-1; Rapant S, 2007, ENVIRON GEOCHEM HLTH, V29, P131, DOI 10.1007/s10653-006-9072-y; ECETOC (European Centre for Ecotoxicology of Chemicals), 2001, 80 ECETOC; European Environment and Health Information System (ENHIS), 2007, EXP CHILDR CHEM HAZ; Ghana Statistical Service, 2010, POP HOUS CENS; Giri S, 2012, ENVIRON MONIT ASSESS, V184, P1351, DOI 10.1007/s10661-011-2045-3; Hayford E.K., 2008, W AFR J APPL ECOL, V14, P1; Kacmaz H, 2010, B ENVIRON CONTAM TOX, V85, P37, DOI 10.1007/s00128-010-0009-x; Kramer ML, 2001, J BIOL CHEM, V276, P16711, DOI 10.1074/jbc.M006554200; Li YL, 2008, B ENVIRON CONTAM TOX, V81, P36, DOI 10.1007/s00128-008-9447-0; Mead M.N., 2005, ENV HLTH PERSPECT, V113, P379; Neves O, 2008, ENVIRON GEOL, V53, P1799, DOI 10.1007/s00254-007-0785-8; PCD (Pollution Control Department), 2004, DRINK WAT STAND; PCD (Pollution Control Department), 2000, GROUNDW STAND DRINK; Peplow D, 2004, ENVIRON GEOCHEM HLTH, V26, P69, DOI 10.1023/B:EGAH.0000020974.52087.cb; Pokkamthanam A. S., 2011, BLACKSMITH I J HLTH, V1, P8; Saipan Piyawat, 2009, Journal of the Medical Association of Thailand, V92, P849; Smedley P. L., 1996, ENVIRON GEOCHEM HLTH, V113, P163; USEPA (US Environmental Protection Agency), 1997, EPA600P95002FA; USEPA (US Environmental Protection Agency), 1992, DEF GEN PRINC EXP AS; USEPA (US Environmental Protection Agency), 2012, GROUND WAT DRINK WAT; USEPA (US Environmental Protection Agency), 1980, FED REGISTER, V45, P79318; USEPA (US Environmental Protection Agency), 1999, RISK ASS MULT EXP SP; USEPA (US Environmental Protection Agency), 2001, BAS HUM HLTH RISK AS; USEPA (US Environmental Protection Agency), 2009, NAT PRIM SEC DRINK W; Volety AK, 2008, ECOTOXICOLOGY, V17, P579, DOI 10.1007/s10646-008-0242-9; Wayne RO., 1990, J AIR WASTE MANAGEME, V40, P1378; WHO, 2011, GUID DRINK WAT QUAL; World Health Organization (WHO), 2001, ENV HLTH CRIT 224 AR; Zhang GS, 2012, ECOTOXICOLOGY, V21, P1726, DOI 10.1007/s10646-012-0958-4; Zhang NN, 2014, ECOTOXICOLOGY, V23, P518, DOI 10.1007/s10646-014-1183-0	46	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6369	1573-2959		ENVIRON MONIT ASSESS	Environ. Monit. Assess.	JUL	2015	187	7							397	10.1007/s10661-015-4630-3		12	Environmental Sciences	Environmental Sciences & Ecology	CM0AL	WOS:000357340500005		
J	Ishida, T; Tayasu, I; Takenaka, C				Ishida, Takuya; Tayasu, Ichiro; Takenaka, Chisato			Characterization of sulfur deposition over the period of industrialization in Japan using sulfur isotope ratio in Japanese cedar tree rings taken from stumps	ENVIRONMENTAL MONITORING AND ASSESSMENT			English	Article						Air pollution; Dendrochemistry; Heartwood formation; Sulfur isotope; Tree ring	ATMOSPHERIC SULFUR; HISTORICAL CHANGES; STABLE-ISOTOPES; ACID DEPOSITION; EMISSIONS; SULFATE; POLLUTION; SOIL; WOOD; VARIABILITY	We characterized the sulfur deposition history over the period of industrialization in Japan based on the sulfur isotope ratio (delta S-34) in tree rings of Japanese cedar (Cryptomeria japonica D. Don) stumps. We analyzed and compared delta S-34 values in the rings from two types of disk samples from 170-year-old stumps that had been cut 5 years earlier (older forest stand) and from 40-year-old living trees (younger forest stand) in order to confirm the validity of using stump disks for delta S-34 analysis. No differences in delta S-34 values by age were found between the sample types, indicating that stump disks can be used for delta S-34 analysis. The delta S-34 profile in tree rings was significantly correlated with anthropogenic SO2 emissions in Japan (r = -0.76, p < 0.05) and, thus, tree rings serve as a record of anthropogenic sulfur emissions. In addition, the values did not change largely from pre-industrialization to the 1940s (+ 4.2 to + 6.1%). The values before the 1940s are expected to reflect the background sulfur conditions in Japan and, thus, disks containing rings formed before the 1940s contain information about the natural environmental sulfur, which is useful for biogeochemical studies.	[Ishida, Takuya; Takenaka, Chisato] Nagoya Univ, Grad Sch Bioagri Sci, Lab Forest Environm & Resources, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Tayasu, Ichiro] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Ishida, Takuya; Tayasu, Ichiro] Natl Inst Humanities, Res Inst Humanity & Nat, Kita Ku, Kyoto 6038047, Japan	Ishida, T (reprint author), Nagoya Univ, Grad Sch Bioagri Sci, Lab Forest Environm & Resources, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	isshinjo@gmail.com; ichirotayasu@chikyu.ac.jp; chisato@agr.nagoya-u.ac.jp	Tayasu, Ichiro/A-9924-2009	Tayasu, Ichiro/0000-0002-3006-7973	Joint Research Grant for the Environmental Isotope Study of Research Institute for Humanity and Nature and Joint Usage/Research Grant of Center for Ecological Research, Kyoto University [2014-A-2]	We thank G. Furuhashi and Dr. Y. Yamada (Nagoya University) for providing the ring sample, Dr. H. Yamamoto, Dr. H. Yokochi, and N. Yamaguchi (Nagoya University) for their support during the sample preparation, Drs. T. Nakano, Y. Tada (Research Institute for Humanity and Nature), and J. Matsubayashi (Kyoto University) for IRMS measurement. We additionally thank Dr. T. Tanikawa and Dr. J. Takahashi for their invaluable suggestions. This study was supported by Joint Research Grant for the Environmental Isotope Study of Research Institute for Humanity and Nature and Joint Usage (2014-A-2)/Research Grant of Center for Ecological Research, Kyoto University.	Akerblom S, 2013, GEOCHIM COSMOCHIM AC, V102, P1, DOI 10.1016/j.gca.2012.10.025; Barrelet T, 2008, ENVIRON POLLUT, V156, P1007, DOI 10.1016/j.envpol.2008.05.004; Tcherkez G, 2013, NEW PHYTOL, V200, P44, DOI 10.1111/nph.12314; Meerts P, 2002, ANN FOR SCI, V59, P713, DOI 10.1051/forest:2002059; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; Leavitt SW, 2010, SCI TOTAL ENVIRON, V408, P5244, DOI 10.1016/j.scitotenv.2010.07.057; Johnson JA, 2013, BIOGEOCHEMISTRY, V116, P15, DOI 10.1007/s10533-013-9889-2; Sano M, 2013, J GEOPHYS RES-ATMOS, V118, P8399, DOI 10.1002/jgrd.50664; Thomas RB, 2013, P NATL ACAD SCI USA, V110, P15319, DOI 10.1073/pnas.1308115110; Grudd H, 2002, HOLOCENE, V12, P657, DOI 10.1191/0959683602hl578rp; Penninckx V, 2001, ANN FOR SCI, V58, P253, DOI 10.1051/forest:2001124; Palmer SM, 2013, EUR J SOIL SCI, V64, P537, DOI 10.1111/ejss.12048; Wynn PM, 2014, ENVIRON POLLUT, V187, P98, DOI 10.1016/j.envpol.2013.12.017; Monaghan JM, 1999, PLANT CELL ENVIRON, V22, P831, DOI 10.1046/j.1365-3040.1999.00445.x; KROUSE HR, 1977, NATURE, V265, P45, DOI 10.1038/265045a0; Tejnecky V, 2013, SCI TOTAL ENVIRON, V442, P165, DOI 10.1016/j.scitotenv.2012.10.053; Savard MM, 2010, ENVIRON POLLUT, V158, P2007, DOI 10.1016/j.envpol.2009.11.031; Kawamura H, 2006, ENVIRON SCI TECHNOL, V40, P5750, DOI 10.1021/es060321w; Smith SJ, 2011, ATMOS CHEM PHYS, V11, P1101, DOI 10.5194/acp-11-1101-2011; Rennenberg H, 2007, PLANT BIOLOGY, V9, P620, DOI 10.1055/s-2007-965248; Watmough SA, 1999, ENVIRON POLLUT, V106, P391, DOI 10.1016/S0269-7491(99)00102-5; Oulehle F, 2013, BIOGEOCHEMISTRY, V116, P83, DOI 10.1007/s10533-013-9865-x; Treydte KS, 2006, NATURE, V440, P1179, DOI 10.1038/nature04743; Fairchild IJ, 2009, ENVIRON SCI TECHNOL, V43, P1310, DOI 10.1021/es8029297; Stern DI, 2005, CHEMOSPHERE, V58, P163, DOI 10.1016/j.chemosphere.2004.08.022; Bellis DJ, 2002, SCI TOTAL ENVIRON, V295, P91, DOI 10.1016/S0048-9697(02)00054-2; Core Team R, 2012, R LANG ENV STAT COMP; FREYER HD, 1979, TELLUS, V31, P124; GRAY J, 1984, EARTH PLANET SC LETT, V70, P129, DOI 10.1016/0012-821X(84)90216-4; Hietz P, 2010, ENVIRON SCI TECHNOL, V44, P1191, DOI 10.1021/es901383g; Imai T, 2012, MOKUZAI GAKKAISHI, V58, P11; Iwata T., 1981, GIFUKENRINGYOSENTAKE, V9, P49; JANSEN HS, 1962, NATURE, V196, P84, DOI 10.1038/196084a0; Lipp L., 1993, P INT S APPL IS TECH, P395; MARUYAMA T, 2000, NIPPON KAGAKU KA JAN, P45; Mayer B, 2001, APPL GEOCHEM, V16, P1003, DOI 10.1016/S0883-2927(01)00010-5; Ministry of the Environment Government of Japan, 2012, STAT AIR POLL JAP; Nakai N., 1991, STABLE ISOTOPES NATU, P352; OHIZUMI T, 1991, NIPPON KAGAKU KAISHI, P675; Okita T., 1997, SANSEIU CHIKYUKANKYO, P21; Prietzel J, 2004, ENVIRON POLLUT, V132, P129, DOI 10.1016/j.envpol.2004.03.016; Robison AL, 2013, BIOGEOCHEMISTRY, V116, P119, DOI 10.1007/s10533-013-9921-6; Sakai Y, 2013, FOREST ECOL MANAG, V295, P228, DOI 10.1016/j.foreco.2013.01.030; Tomlinson G, 2014, RAPID COMMUN MASS SP, V28, P1258, DOI 10.1002/rcm.6897; Visser P. H. B. D., 1992, CANADIAN J FOREST RE, V22, P1824; Xiao HY, 2012, ENVIRON POLLUT, V162, P80, DOI 10.1016/j.envpol.2011.11.006	46	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6369	1573-2959		ENVIRON MONIT ASSESS	Environ. Monit. Assess.	JUL	2015	187	7							459	10.1007/s10661-015-4678-0		10	Environmental Sciences	Environmental Sciences & Ecology	CM0AL	WOS:000357340500067		
J	Nguyen, OV; Kawamura, K; Trong, DP; Gong, Z; Suwandana, E				Nguyen, On Van; Kawamura, Kensuke; Dung Phan Trong; Gong, Zhe; Suwandana, Endan			Temporal change and its spatial variety on land surface temperature and land use changes in the Red River Delta, Vietnam, using MODIS time-series imagery	ENVIRONMENTAL MONITORING AND ASSESSMENT			English	Article						HANTS algorithm; Land surface temperature; MODIS time-series data; Red river delta	LST DATA; ALGORITHM; TOOL	Temporal changes in the land surface temperature (LST) in urbanization areas are important for studying an urban heat island (UHI) and regional climate change. This study examined the LST trends under different land use categories in the Red River Delta, Vietnam, using the Moderate Resolution Imaging Spectroradiometer (MODIS) LST product (MOD11A2) and land cover type product (MCD12Q1) for 11 years (2002-2012). Smoothened time-series MODIS LST data were reconstructed by the Harmonic Analysis of Time Series (HANTS) algorithm. The reconstructed LST (maximum and minimum temperatures) was assessed using the hourly air temperature dataset in two landbased meteorological stations provided by the National Climatic Data Center (NCDC). Significant correlation was obtained between MODIS LST and the air temperature for the daytime (R-2=0.73, root mean square error [RMSE]=1.66 degrees C) and night time (R-2=0.84, RMSE=1.79 degrees C). Statistical analysis also showed that LST trends vary strongly depending on the land cover type. Forest, wetland, and cropland had a slight tendency to decline, whereas cropland and urban had sharper increases. In urbanized areas, these increasing trends are even more obvious. This is undeniable evidence of the negative impact of urbanization on a surface urban heat island (SUHI) and global warming.	[Nguyen, On Van; Kawamura, Kensuke; Dung Phan Trong; Gong, Zhe] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Hiroshima 7398529, Japan; [Suwandana, Endan] Educ & Training Ctr Banten Prov, Banten, Indonesia	Kawamura, K (reprint author), Hiroshima Univ, Grad Sch Int Dev & Cooperat, 1-5-1 Kagamiyama, Hiroshima 7398529, Japan.	kamuken@hiroshima-u.ac.jp	Kawamura, Kensuke/E-2431-2011	Kawamura, Kensuke/0000-0002-2824-1266	Japanese Grant Aid for Human Resource Development Scholarship (JDS); Japan International Cooperation Agency (JICA)	This work was partially supported by the Japanese Grant Aid for Human Resource Development Scholarship (JDS), Japan International Cooperation Agency (JICA), for financial support to the first author (Nguyen Van On) for the field survey in Hanoi, Vietnam.	Wan ZM, 1997, IEEE T GEOSCI REMOTE, V35, P980; Voogt JA, 2003, REMOTE SENS ENVIRON, V86, P370, DOI 10.1016/S0034-4257(03)00079-8; Roerink GJ, 2000, INT J REMOTE SENS, V21, P1911, DOI 10.1080/014311600209814; Crosson WL, 2012, REMOTE SENS ENVIRON, V119, P315, DOI 10.1016/j.rse.2011.12.019; Miliaresis GC, 2014, PHOTOGRAMM ENG REM S, V80, P423; Voogt JA, 1998, INT J REMOTE SENS, V19, P895, DOI 10.1080/014311698215784; Neteler M, 2010, REMOTE SENS-BASEL, V2, P333, DOI 10.3390/rs1020333; Wan ZM, 1996, IEEE T GEOSCI REMOTE, V34, P892, DOI 10.1109/36.508406; Sobrino JA, 2004, REMOTE SENS ENVIRON, V90, P434, DOI 10.1016/j.rse.2004.02.003; Dwyer J., 2006, MODIS REPROJECTION T, P162; General Statistical Office of Viet Nam, 2012, POP EMPL, P33; GRASS Developement Team, 2012, GEOGR RES AN SUPP SY; Houghton J, 2001, CLIMATE CHANGE 2001, P881; Jimenez-Munoz, 2003, J GEOPHYS RES, V108, P4688, DOI [10.1029/2003JD003480, DOI 10.1029/2003JD003480]; [柯灵红 KE Linghong], 2011, [高原气象, Plateau Meteorology], V30, P277; Lei Z., 2010, ADV ATMOSPHERIC SCI, V27, P1110, DOI [10.1007/s00376-009-9133-0.1.Introduction, DOI 10.1007/S00376-009-9133-0.1.]; Miliaresis GC, 2010, ENVIRON MONIT ASSESS, V164, P561, DOI 10.1007/s10661-009-0913-x; Miliaresis GC, 2009, INT J REMOTE SENS, V30, P2429, DOI 10.1080/01431160802562271; Miliaresis GC, 2013, ENVIRON MONIT ASSESS, V185, P1601, DOI 10.1007/s10661-012-2654-5; Neteler M., 2008, OPEN SOURCE GIS GRAS; Pinheiro ACT, 2006, REMOTE SENS ENVIRON, V103, P153, DOI 10.1016/j.rse.2006.03.009; PRICE JC, 1984, J GEOPHYS RES-ATMOS, V89, P7231, DOI 10.1029/JD089iD05p07231; Quattrochi DA, 1999, LANDSCAPE ECOL, V14, P577, DOI 10.1023/A:1008168910634; SOBRINO JA, 1991, REMOTE SENS ENVIRON, V38, P19, DOI 10.1016/0034-4257(91)90069-I; Soria G, 2007, REMOTE SENS ENVIRON, V111, P409, DOI 10.1016/j.rse.2007.03.017; University of Georgia, 2002, SCI DAILY; Xu YM, 2013, COMPUT GEOSCI-UK, V61, P126, DOI 10.1016/j.cageo.2013.08.009	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6369	1573-2959		ENVIRON MONIT ASSESS	Environ. Monit. Assess.	JUL	2015	187	7							464	10.1007/s10661-015-4691-3		11	Environmental Sciences	Environmental Sciences & Ecology	CM0AL	WOS:000357340500072		
J	Suzuki, E				Suzuki, Etsuji			Generalized Causal Measure The Beauty Lies in Its Generality	EPIDEMIOLOGY			English	Article							SUFFICIENT CAUSE INTERACTIONS; PRINCIPAL-STRATIFICATION; ORGANIZATIONAL SCHEMA; DEATH; BIAS; INFERENCE; OUTCOMES; MEDIATION; EXAMPLE; MODELS		[Suzuki, Etsuji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama 7008558, Japan	Suzuki, E (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	etsuji-s@cc.okayama-u.ac.jp					Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Greenland S, 1999, STAT SCI, V14, P29; VanderWeele TJ, 2009, EUR J EPIDEMIOL, V24, P217, DOI 10.1007/s10654-009-9331-1; Rubin DB, 2006, STAT SCI, V21, P299, DOI 10.1214/088342306000000114; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P6, DOI 10.1097/EDE.0b013e31818f69e7; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Chaix B, 2012, EPIDEMIOLOGY, V23, P129, DOI 10.1097/EDE.0b013e3182319159; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greenland S, 2002, INT J EPIDEMIOL, V31, P1030, DOI 10.1093/ije/31.5.1030; Suzuki E, 2011, EUR J EPIDEMIOL, V26, P347, DOI 10.1007/s10654-011-9568-3; Greenland S, 2003, EPIDEMIOLOGY, V14, P300, DOI 10.1097/00001648-200305000-00009; Greenland S, 2001, ANNU REV PUBL HEALTH, V22, P189, DOI 10.1146/annurev.publhealth.22.1.189; VanderWeele TJ, 2006, EUR J EPIDEMIOL, V21, P855, DOI 10.1007/s10654-006-9075-0; Maldonado G, 2002, INT J EPIDEMIOL, V31, P422, DOI 10.1093/ije/31.2.422; Weuve J, 2012, EPIDEMIOLOGY, V23, P119, DOI 10.1097/EDE.0b013e318230e861; Zhang JNL, 2003, J EDUC BEHAV STAT, V28, P353, DOI 10.3102/10769986028004353; GREENLAND S, 1986, INT J EPIDEMIOL, V15, P413, DOI 10.1093/ije/15.3.413; Flanders WD, 2006, EUR J EPIDEMIOL, V21, P847, DOI 10.1007/s10654-006-9048-3; Chiba Y, 2011, AM J EPIDEMIOL, V173, P745, DOI 10.1093/aje/kwq418; Cole SR, 2015, AM J EPIDEMIOL, V181, P246, DOI 10.1093/aje/kwv001; Egleston BL, 2007, BIOSTATISTICS, V8, P526, DOI 10.1093/biostatistics/kxl027; Flanders WD, 2015, EPIDEMIOLOGY, V26, P481, DOI 10.1097/EDE.0000000000000286; Frangakis CE, 2007, BIOMETRICS, V63, P641, DOI 10.1111/j.1541-0420.2007.00847.x; Gatto NM, 2014, EPIDEMIOLOGY, V25, P88, DOI 10.1097/EDE.0000000000000005; Glymour MM, 2008, MODERN EPIDEMIOLOGY, P183; Glymour MM, 2006, METHODS SOCIAL EPIDE, P393; Greene T, 2013, INT J BIOSTAT, V9, P291, DOI 10.1515/ijb-2012-0013; Greenland Sander, 2009, Epidemiol Perspect Innov, V6, P4, DOI 10.1186/1742-5573-6-4; Hafeman DM, 2008, EUR J EPIDEMIOL, V23, P711, DOI 10.1007/s10654-008-9286-7; Joffe M, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1367; Pearl J, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1322; Sjolander A., 2012, CAUSALITY STAT PERSP, P114; Sjolander A, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1324; Suzuki E, 2011, EPIDEMIOLOGY, V22, P131, DOI 10.1097/EDE.0b013e3181febc5c; Suzuki E, 2014, ANN EPIDEMIOL, V24, P560, DOI 10.1016/j.annepidem.2014.04.003; Suzuki E, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-101; Suzuki E, 2012, AM J EPIDEMIOL, V175, P567, DOI 10.1093/aje/kwr333; Suzuki E, 2014, EPIDEMIOLOGY, V25, P618, DOI 10.1097/EDE.0000000000000114; Vanderweele TJ, 2008, BIOMETRIKA, V95, P49, DOI 10.1093/biomet/asm090; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P612, DOI 10.1097/EDE.0b013e31821db393; VanderWeele TJ, 2011, INT J BIOSTAT, P1	41	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1044-3983	1531-5487		EPIDEMIOLOGY	Epidemiology	JUL	2015	26	4					490	495		10.1097/EDE.0000000000000304		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CL7YR	WOS:000357189400007		
J	Okumura, A; Nakazawa, M; Abe, S; Ikeno, M; Igarashi, A; Shimizu, T				Okumura, Akihisa; Nakazawa, Mika; Abe, Shinpei; Ikeno, Mitsuru; Igarashi, Ayuko; Shimizu, Toshiaki			Sustained improvement of attitudes about epilepsy following a reduction in media coverage of car accidents involving persons with epilepsy	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Car accidents; Media coverage; Familiarity; Attitude	YOUTUBE VIDEOS; KNOWLEDGE; SEIZURES; PEOPLE	To evaluate changes in the attitudes of nonmedical students about epilepsy, the present study compared the results of a questionnaire that was completed in three different time periods: before media coverage of car accidents associated with epilepsy, during a period of abundant media coverage about epilepsy-related accidents, and after media coverage of epilepsy-related accidents. The nonmedical students who completed the questionnaire were divided into three groups: Years 08-10 (preaccident era), Years 11-12 (media coverage era), and Years 13-14 (postmedia coverage era). The rates of students who had read or heard about epilepsy and of students who did not think that epilepsy was a mental disorder increased annually throughout the study period. There was an improvement in attitudes about epilepsy after the media coverage era, and this change was not altered even after a decrease in the media coverage of epilepsy-related car accidents. Additionally, the rate of positive answers did not differ between Years 11-12 and Years 13-14. These findings demonstrate that the familiarity with and improved attitudes about epilepsy were sustained even after the media coverage of car accidents involving persons with epilepsy had decreased. (C) 2015 Elsevier Inc. All rights reserved.	[Okumura, Akihisa; Abe, Shinpei; Ikeno, Mitsuru; Igarashi, Ayuko; Shimizu, Toshiaki] Juntendo Univ, Fac Med, Dept Pediat, Tokyo, Japan; [Okumura, Akihisa; Nakazawa, Mika] Aichi Med Univ, Dept Pediat, Nagakute, Aichi 4801195, Japan	Okumura, A (reprint author), Aichi Med Univ, Dept Pediat, 1-1 Yazako Karimata, Nagakute, Aichi 4801195, Japan.	okumura.akihisa.479@mail.aichi-med-u.ac.jp			Ministry of Health, Labour and Welfare [H26-Nanji-Ippan-051]	This study was partially supported by the grant from the Ministry of Health, Labour and Welfare (H26-Nanji-Ippan-051).	Mecarelli O, 2011, EPILEPSY BEHAV, V22, P285, DOI 10.1016/j.yebeh.2011.06.019; Fat MJL, 2011, J CHILD NEUROL, V26, P804, DOI 10.1177/0883073811402345; McNeil K, 2012, EPILEPSY BEHAV, V23, P127, DOI 10.1016/j.yebeh.2011.10.020; Lo AS, 2010, EPILEPSY BEHAV, V17, P541, DOI 10.1016/j.yebeh.2010.02.004; Mecarelli O, 2010, EPILEPSY BEHAV, V18, P110, DOI 10.1016/j.yebeh.2010.03.004; McEwan L, 2007, EPILEPSY BEHAV, V11, P13, DOI 10.1016/j.yebeh.2007.02.019; Hills MD, 2002, EPILEPSIA, V43, P1583, DOI 10.1046/j.1528-1157.2002.32002.x; Aragon CE, 2009, J CAN DENT ASSOC, V75, P450; England Mary Jane, 2014, Health Promot Pract, V15, P313, DOI 10.1177/1524839914523779; Mott J, 2013, J CHILD NEUROL, V28, P737, DOI 10.1177/0883073812451775; Okumura A, 2013, EPILEPSY BEHAV, V27, P264, DOI 10.1016/j.yebeh.2013.01.012; Rafael F, 2010, EPILEPSY BEHAV, V17, P82, DOI 10.1016/j.yebeh.2009.10.014; Wong VSS, 2013, EPILEPSY BEHAV, V27, P247, DOI 10.1016/j.yebeh.2013.01.017	13	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	JUL	2015	48						41	44		10.1016/j.yebeh.2015.04.053		4	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CM4UP	WOS:000357680800007		
J	Ogawa, H; Uchino, K; Tanaka, Y; Shimizu, N; Okuda, Y; Tane, K; Hokka, D; Tane, S; Tauchi, S; Nishio, W; Maniwa, Y; Yoshimura, M				Ogawa, Hiroyuki; Uchino, Kazuya; Tanaka, Yugo; Shimizu, Nahoko; Okuda, Yusuke; Tane, Kenta; Hokka, Daisuke; Tane, Shinya; Tauchi, Shunsuke; Nishio, Wataru; Maniwa, Yoshimasa; Yoshimura, Masahiro			Outcomes of segmentectomy for cT1bN0M0 lung adenocarcinoma and squamous cell carcinoma: a possible association with pathological invasion	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Lobectomy; Segmentectomy; Wedge resection; Lung cancer surgery; Lung cancer; Diagnosis	RESOLUTION COMPUTED-TOMOGRAPHY; SUBLOBAR RESECTION; TUMOR SIZE; CANCER; MULTICENTER; LOBECTOMY; SURVIVAL; GRADE	We evaluated the clinical benefit of segmentectomy for patients with cT1bN0M0 lung cancer. We retrospectively reviewed the medical records of 178 patients who underwent lobectomy or segmentectomy for cT1bN0M0 lung adenocarcinoma and squamous cell carcinoma from January 1995 to December 2005. We investigated the association of surgical outcomes with the presence of pathological invasion. The median follow-up period was 93.4 months. Of 178 patients, 37 were scheduled for segmentectomy, but 6 of these patients were switched to receive lobectomy due to surgical N1 or N2 in 3 patients and insufficient surgical margins in 3 patients. In total, 31 patients underwent segmentectomy, and 147 underwent lobectomy. The 5-year overall survival (OS) was similar between the patients who underwent lobectomy (5-year OS, 81.6%) and segmentectomy (5-year OS, 77.4%, P = 0.73). Among pN0 patients without pathological invasion, there was no difference in OS between patients who underwent lobectomy (5-year OS, 89.9%) and segmentectomy (5-year OS, 88.9%, P = 0.80). In contrast, among pN0 patients with pathological invasion, OS was greater in patients who underwent lobectomy (5-year OS, 80.9%) than in those who underwent segmentectomy (5-year OS, 54.6%; P = 0.19). Moreover, a significantly higher rate of local and local + distant recurrence was observed in patients who underwent segmentectomy (45%) than in those who underwent lobectomy (15%) in this group (P = 0.02). The results of our study suggest that segmentectomy may not be recommended for cT1b tumours if pathological invasion is suspected before surgery.	[Ogawa, Hiroyuki; Uchino, Kazuya; Shimizu, Nahoko; Okuda, Yusuke; Tane, Kenta; Nishio, Wataru; Yoshimura, Masahiro] Hyogo Canc Ctr, Dept Thorac Surg, Akashi, Hyogo 6738558, Japan; [Ogawa, Hiroyuki; Tanaka, Yugo; Hokka, Daisuke; Tane, Shinya; Tauchi, Shunsuke; Maniwa, Yoshimasa; Yoshimura, Masahiro] Kobe Univ Hosp, Dept Thorac Surg, Kobe, Hyogo, Japan	Uchino, K (reprint author), Hyogo Canc Ctr, Dept Thorac Surg, 13-70 Kitaoji Cho, Akashi, Hyogo 6738558, Japan.	kazuya-uchino@hp.pref.hyogo.jp			National Cancer Center Research and Development Funds [23-A-18]	This work was supported in part by Grants 23-A-18 from the National Cancer Center Research and Development Funds.	Okada M, 2011, J THORAC CARDIOV SUR, V141, P1384, DOI 10.1016/j.jtcvs.2011.02.007; Koike T, 2013, J THORAC CARDIOV SUR, V146, P372, DOI 10.1016/j.jtcvs.2013.02.057; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; Tsubota N, 1998, ANN THORAC SURG, V66, P1787, DOI 10.1016/S0003-4975(98)00819-4; Harada H, 2005, ANN THORAC SURG, V80, P2041, DOI 10.1016/j.athoracsur.2005.06.010; Okada M, 2000, SURG TODAY, V30, P506; Carr SR, 2012, J THORAC CARDIOV SUR, V143, P390, DOI 10.1016/j.jtcvs.2011.10.023; Tsutani Y, 2012, J THORAC CARDIOV SUR, V144, P1365, DOI 10.1016/j.jtcvs.2012.07.012; Wolf AS, 2011, ANN THORAC SURG, V92, P1819, DOI 10.1016/j.athoracsur.2011.06.099; Tsutani Y, 2013, J THORAC CARDIOV SUR, V146, P358, DOI 10.1016/j.jtcvs.2013.02.008; Tsutani Y, 2012, J THORAC CARDIOV SUR, V143, P607, DOI 10.1016/j.jtcvs.2011.10.037; Schuchert MJ, 2012, ANN THORAC SURG, V93, P1780, DOI 10.1016/j.athoracsur.2011.11.074; Yoshikawa K, 2002, ANN THORAC SURG, V73, P1055, DOI 10.1016/S0003-4975(01)03466-X; Nomori H, 2012, J THORAC CARDIOV SUR, V144, P87, DOI 10.1016/j.jtcvs.2012.03.034; Chang MY, 2007, J THORAC CARDIOV SUR, V134, P850, DOI 10.1016/j.jtcvs.2007.03.044; Tsutani Y, 2013, J THORAC CARDIOV SUR, V146, P17, DOI 10.1016/j.jtcvs.2012.11.019; Zhang J, 2013, J THORAC ONCOL, V8, P1196, DOI 10.1097/JTO.0b013e31829f09a7; Whitson BA, 2011, ANN THORAC SURG, V92, P1943, DOI 10.1016/j.athoracsur.2011.05.091; Okada M, 2007, J THORAC CARDIOV SUR, V133, P1448, DOI 10.1016/j.jtcvs.2007.02.023; Okada M, 2006, J THORAC CARDIOV SUR, V132, P769, DOI 10.1016/j.jtcvs.2006.02.063; Keenan RJ, 2004, ANN THORAC SURG, V78, P228, DOI 10.1016/j.athoracsur.2004.01.024; Nakayama H, 2010, CANCER-AM CANCER SOC, V116, P3170, DOI 10.1002/cncr.25244; HOLMES CE, 1995, ANN THORAC SURG, V60, P615; Ginsberg RJ, 1995, ANN THORAC SURG, V60, P22, DOI DOI 10.1016/0003-4975(95)00537-U; Keenan RJ, 2004, ANN THORAC SURG, V78, P28; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Schuchert MJ, 2012, ANN THORAC SURG, V93, P86; Travis WD, 2013, J THORAC ONCOL, V6, P224; Wolf AS, 2011, ANN THORAC SURG, V92, P24; Yoshikawa K, 2002, ANN THORAC SURG, V73, P58	30	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	JUL	2015	48	1					77	82		10.1093/ejcts/ezu429		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CM2NH	WOS:000357516800015		
J	Saito, T; Toda, K; Takewa, Y; Tsukiya, T; Mizuno, T; Taenaka, Y; Tatsumi, E				Saito, Tomohiro; Toda, Koichi; Takewa, Yoshiaki; Tsukiya, Tomonori; Mizuno, Toshihide; Taenaka, Yoshiyuki; Tatsumi, Eisuke			Alternative approach for right ventricular failure after left ventricular assist device placement in animal model	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Circulatory assist device; Animal model; Heart failure; extracorporeal membrane oxygenation	EXTRACORPOREAL MEMBRANE-OXYGENATION; MECHANICAL CIRCULATORY SUPPORT; PRIMARY PULMONARY-HYPERTENSION; ATRIAL SEPTOSTOMY; TRANSCATHETER CLOSURE; HEART-FAILURE; RECIPIENTS; HYPOXEMIA; EXCHANGE; DATABASE	Right ventricular failure after left ventricular assist device (LVAD) implantation is associated with high mortality. This study was designed to evaluate the effectiveness of an atrial septostomy with a membrane oxygenator incorporated in an LVAD as a novel approach for right ventricular failure after LVAD implantation. The outflow and inflow cannulae were placed in the carotid artery and left ventricular apex, respectively. A centrifugal pump and an oxygenator were sequentially placed between the inflow and outflow cannulae in seven anesthetized goats. While right ventricular failure was induced by pulmonary artery banding, a balloon atrial septostomy was performed using a 19-mm balloon catheter under echocardiographic guidance. We investigated the effects of the interatrial shunt on LVAD flow and haemodynamics. Development of right ventricular failure decreased LVAD flow (2.7 +/- 0.6-0.9 +/- 0.6 l/min), causing a state of shock [mean arterial pressure (MAP) of 41 +/- 12 mmHg]. Following a balloon atrial septostomy, LVAD flow and MAP were significantly improved to 2.7 +/- 0.4 l/min (P < 0.001) and 53 +/- 18 mmHg (P = 0.006), respectively, while right atrial pressure decreased from 18 +/- 5 to 15 +/- 5 mmHg (P = 0.001). Furthermore, arterial blood oxygenation was maintained by the membrane oxygenator incorporated in the LVAD. In the present model of right ventricular failure after LVAD implantation, LVAD flow was significantly increased and haemodynamics improved without compromising systemic oxygenation by the use of an interatrial shunt and a membrane oxygenator incorporated in the LVAD. Our results indicate that this novel approach may be less invasive for a right ventricular failure after LVAD implantation.	[Saito, Tomohiro; Takewa, Yoshiaki; Tsukiya, Tomonori; Mizuno, Toshihide; Taenaka, Yoshiyuki; Tatsumi, Eisuke] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Artificial Organs, Osaka, Japan; [Toda, Koichi] Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Osaka, Japan	Toda, K (reprint author), 2-2 Yamada Oka, Suita, Osaka 5658565, Japan.	ktoda2002@yahoo.co.jp			Japan Society for the Promotion of Science [23592051]	This work was supported by a Grant-in-Aid for Scientific Research (c) (no. 23592051) from the Japan Society for the Promotion of Science.	Deng MC, 2005, J HEART LUNG TRANSPL, V24, P1182, DOI 10.1016/j.healun.2005.07.002; Kurzyna M, 2007, CHEST, V131, P977, DOI 10.1378/chest.06-1227; Fitzpatrick JR, 2009, J THORAC CARDIOV SUR, V137, P971, DOI 10.1016/j.jtcvs.2008.09.021; Takayama H, 2012, EUR J CARDIO-THORAC, V41, P423, DOI 10.1016/j.ejcts.2011.05.041; Kavarana MN, 2002, ANN THORAC SURG, V73, P745, DOI 10.1016/S0003-4975(01)03406-3; Tedford RJ, 2008, CIRC-HEART FAIL, V1, P213, DOI 10.1161/CIRCHEARTFAILURE.108.796789; Garcia JP, 2011, J THORAC CARDIOV SUR, V142, P755, DOI 10.1016/j.jtcvs.2011.07.029; Camboni D, 2011, ANN THORAC SURG, V91, P144, DOI 10.1016/j.athoracsur.2010.07.036; Cleveland JC, 2011, J HEART LUNG TRANSPL, V30, P862, DOI 10.1016/j.healun.2011.04.004; RASHKIND WJ, 1968, CIRCULATION, V38, P453; Sandoval J, 1998, J AM COLL CARDIOL, V32, P297, DOI 10.1016/S0735-1097(98)00238-1; Argenziano M, 1998, ANN THORAC SURG, V65, P340, DOI 10.1016/S0003-4975(97)01307-6; RICH S, 1983, AM J CARDIOL, V51, P1560, DOI 10.1016/0002-9149(83)90678-1; Arrigoni SC, 2011, INTERACT CARDIOV TH, V12, P891, DOI 10.1510/icvts.2010.257576; Baker JE, 2004, ANESTH ANALG, V98, P937, DOI 10.1213/01.ANE.0000105861.99795.00; FRAZIER OH, 1992, ANN THORAC SURG, V53, P1080; Fukui S, 2006, J HEART LUNG TRANSPL, V25, P248, DOI 10.1016/j.healun.2005.08.010; KAWAGUCHI AT, 1993, J THORAC CARDIOV SUR, V106, P1072; Kennedy JL, 2012, ECHOCARDIOGR-J CARD, V29, pE22, DOI 10.1111/j.1540-8175.2011.01521.x; Khoshbin E, 2005, ASAIO J, V51, P281, DOI 10.1097/01.MAT.0000159741.33681.F1; Nguyen DQ, 1999, J HEART LUNG TRANSPL, V18, P1021, DOI 10.1016/S1053-2498(99)00064-9; Ochiai Y, 2002, CIRCULATION, V106, pI198, DOI 10.1161/01.cir.0000032906.33237.1c; Schubert S, 2005, CATHETER CARDIO INTE, V64, P333, DOI 10.1002/ccd.20292; Takewa Y, 1997, ASAIO J, V43, pM494; Tsukui H, 2005, CIRCULATION, V112, P65	25	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	JUL	2015	48	1					98	103		10.1093/ejcts/ezu364		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CM2NH	WOS:000357516800018		
J	Fukunaga, N; Okada, Y; Konishi, Y; Murashita, T; Koyama, T				Fukunaga, Naoto; Okada, Yukikatsu; Konishi, Yasunobu; Murashita, Takashi; Koyama, Tadaaki			The number of valves requiring surgery does not affect early and late survival in redo valvular surgery	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Number of valves; Survival; Redo valvular surgery	TRICUSPID REGURGITATION; ELDERLY-PATIENTS; OPERATIVE RISK; MORTALITY; REPLACEMENT	The purpose of this study was to determine whether the number of operated valves affects early and late outcomes in redo valvular surgery. We analysed 328 consecutive patients who underwent a total of 431 redo valvular surgeries from January 1990 to December 2010. The mean age was 61.5 +/- 13.0 years. The main indication for redo surgery was structural valve deterioration (66.1%). We divided these patients into the redo single valvular surgery group (Group S, n = 175; 231 redo surgeries) and the redo multivalvular surgery group (Group M, n = 153; 201 redo surgeries). The mean follow-up period was 6.4 +/- 5.8 years. The follow-up rate for late survival was 98.3%. The hospital mortality rate was 6.5% in Group S and 7.0% in Group M (P = 0.85). Logistic regression analysis revealed that advanced age and New York Heart Association (NYHA) functional class III or IV were statistically significant independent risk factors for hospital mortality. Re-exploration for bleeding was more likely to occur in Group M than in Group S. The 5- and 10-year survival rates were 84.8 +/- 3.0 and 70.8 +/- 4.6% in Group S and 82.0 +/- 3.5 and 70.2 +/- 4.9% in Group M, respectively, with no statistical difference. Cox regression analysis revealed that advanced age, a left ventricular ejection fraction rate of < 60% and redo surgery beyond the first redo were independent negative predictors of late mortality. NYHA functional class I or II was a statistically significant positive predictor of late survival. The number of valves requiring redo surgery does not negatively impact early or late survival. Mortality is not different whether one or multiple valves need to be tackled in a redo scenario.	[Fukunaga, Naoto; Okada, Yukikatsu; Konishi, Yasunobu; Murashita, Takashi; Koyama, Tadaaki] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Surg, Chuo Ku, Kobe, Hyogo 6500047, Japan	Fukunaga, N (reprint author), Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Surg, Chuo Ku, 2-1-1 Minatojimaminamimachi, Kobe, Hyogo 6500047, Japan.	naotowakimachi@hotmail.co.jp					Luciani N, 2006, ANN THORAC SURG, V81, P1279, DOI 10.1016/j.athoracsur.2005.11.030; Jones JM, 2001, J THORAC CARDIOV SUR, V122, P913, DOI 10.1067/mtc.2001.116470; Maganti M, 2009, ANN THORAC SURG, V87, P521, DOI 10.1016/j.athoracsur.2008.09.030; Akins CW, 1998, ANN THORAC SURG, V65, P1545, DOI 10.1016/S0003-4975(98)00301-4; LYTLE BW, 1986, ANN THORAC SURG, V42, P632; Akins CW, 2008, ANN THORAC SURG, V85, P1490, DOI 10.1016/j.athoracsur.2007.12.082; Jamieson WRE, 2003, CIRCULATION, V108, P98, DOI 10.1161/01.cir.0000089184.46999.f4; Tang GHL, 2007, ANN THORAC SURG, V83, P938, DOI 10.1016/j.athoracsur.2006.07.047; Potter DD, 2005, J THORAC CARDIOV SUR, V129, P94, DOI 10.1016/j.jtcvs.2004.08.023; COHN LH, 1993, ANN THORAC SURG, V56, P15; Fukunaga N, 2014, J THORAC CARDIOV SUR, V148, P1983, DOI 10.1016/j.jtcvs.2013.08.089; Fukunaga N, 2012, ANN THORAC SURG, V94, P2011, DOI 10.1016/j.athoracsur.2012.06.045; Fukunaga N, 2014, J HEART VALVE DIS, V23, P228; Holst Kimberly A, 2013, Ann Thorac Surg, V95, P1383, DOI 10.1016/j.athoracsur.2012.12.009; Izumi C, 2011, CIRC J, V75, P2902, DOI 10.1253/circj.CJ-11-0718	15	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	JUL	2015	48	1					123	128		10.1093/ejcts/ezu403		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CM2NH	WOS:000357516800023		
J	Minami, H; Miyahara, S; Okada, K; Matsumori, M; Kano, H; Inoue, T; Sakamoto, T; Okita, Y				Minami, Hitoshi; Miyahara, Shunsuke; Okada, Kenji; Matsumori, Masamichi; Kano, Hiroya; Inoue, Takeshi; Sakamoto, Toshihito; Okita, Yutaka			Clinical outcomes of combined aortic root reimplantation technique and total arch replacement	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Aortic root replacement; Total arch replacement; Valve-sparing operation; Marfan syndrome; Aortic dissection	ELEPHANT TRUNK TECHNIQUE; BENTALL PROCEDURE; MARFAN PATIENTS; VALVE; DISSECTION; REPAIR; EXPERIENCE; SURVIVAL; ANEURYSM; PROLAPSE	The goal of this study was to evaluate early and late outcomes of combined valve-sparing aortic root replacement and total arch replacement (TAR). From October 1999 to May 2014, 195 patients underwent valve-sparing operations using the David reimplantation technique. Thirty-one patients underwent combined TAR for aortic regurgitation (AR) with extended aortic aneurysm from the aortic root to the aortic arch. Aetiologies included acute type A aortic dissection in 12 cases, chronic aortic dissection in 8 cases and non-dissecting aneurysm in 11 cases. There were 9 patients with Marfan syndrome. The preoperative severity of AR was mild in 4, moderate in 16 and severe in 11. Even though half of those were emergent operations for acute aortic dissection, preoperative haemodynamic conditions were stable in all patients. No hospital deaths occurred. Postoperative complications included prolonged mechanical ventilation (> 48 h) in 1 case and re-exploration for bleeding in 2 cases. Other complications, such as neurological dysfunction or low cardiac output syndrome, were not observed. At hospital discharge, 2 patients had mild AR, 22 had trace AR and 7 had no AR. During follow-up, 2 patients had moderate AR, 7 had mild AR, 18 had trace AR and 3 had no AR. Follow-up was completed in 95.1% of patients, and the mean follow-up period was 60.5 +/- 9.1 months. No late death and thromboembolic complication occurred during follow-up. One patient required reoperation for AR. Freedom from reoperation at 5 and 10 years was 100 +/- 0 and 83.3 +/- 3.5%, respectively. Freedom from moderate or severe AR at 3 and 5 years was 83.3 +/- 3.5 and 83.3 +/- 3.5%, respectively. Early outcomes of combined aortic root reimplantation and TAR were satisfactory and provided excellent freedom from thromboembolic complication. The rate of freedom from reoperation during long-term follow-up was acceptable. Further follow-up is required to evaluate this procedure.	[Minami, Hitoshi; Miyahara, Shunsuke; Okada, Kenji; Matsumori, Masamichi; Kano, Hiroya; Inoue, Takeshi; Sakamoto, Toshihito; Okita, Yutaka] Kobe Univ, Grad Sch Med, Dept Surg, Div Cardiovasc Surg, Kobe, Hyogo 6500017, Japan	Okita, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Surg,Div Cardiovasc Surg, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yokita@med.kobe-u.ac.jp					Amano Jun, 2013, Gen Thorac Cardiovasc Surg, V61, P578, DOI 10.1007/s11748-013-0289-2; David TE, 2014, J THORAC CARDIOV SUR, V148, P872, DOI 10.1016/j.jtcvs.2014.04.048; Aicher D, 2007, J THORAC CARDIOV SUR, V134, P909, DOI 10.1016/j.jtcvs.2007.05.052; Etz CD, 2007, ANN THORAC SURG, V84, P1186, DOI 10.1016/j.athoracsur.2007.03.057; Aicher D, 2011, CIRCULATION, V123, P178, DOI 10.1161/CIRCULATIONAHA.109.934679; Etz CD, 2010, J THORAC CARDIOV SUR, V140, pS64, DOI 10.1016/j.jtcvs.2010.07.033; Boodhwani M, 2011, J THORAC CARDIOV SUR, V141, P917, DOI 10.1016/j.jtcvs.2010.12.006; Uchida N, 2011, EUR J CARDIO-THORAC, V40, P1066, DOI 10.1016/j.ejcts.2011.02.074; Subramanian S, 2012, ANN THORAC SURG, V94, P1230, DOI 10.1016/j.athoracsur.2012.04.094; Okada K, 2012, J THORAC CARDIOV SUR, V144, P139, DOI 10.1016/j.jtcvs.2011.08.039; Bachet J, 2007, ANN THORAC SURG, V83, pS774, DOI 10.1016/j.athoracsur.2006.10.085; DAVID TE, 1992, J THORAC CARDIOV SUR, V103, P617; El Khoury G, 2004, EUR J CARDIO-THORAC, V26, P628, DOI 10.1016/j.ejcts.2004.05.027; Estrera AL, 2004, ANN THORAC SURG, V78, P837, DOI 10.1016/j.athoracsur.2004.03.085; Etz CD, 2008, EUR J CARDIO-THORAC, V34, P605, DOI 10.1016/j.ejcts.2008.04.045; Girdauskas E, 2008, ANN THORAC SURG, V86, P1815, DOI 10.1016/j.athoracsur.2008.07.104; Halstead JC, 2007, J THORAC CARDIOV SUR, V133, P127, DOI 10.1016/j.jctvs.2006.07.043; Kallenbach K, 2005, CIRCULATION S1, V112; Kazui T, 2000, ANN THORAC SURG, V70, P3, DOI 10.1016/S0003-4975(00)01535-6; Kerendi F, 2010, ANN THORAC SURG, V89, P471, DOI 10.1016/j.athoracsur.2009.10.030; Kim JB, 2012, EUR J CARDIO-THORAC, V42, P851, DOI 10.1093/ejcts/ezs157; Leyh RG, 2002, CIRCULATION S1, V106; Oka T, 2011, ANN THORAC SURG, V92, P1639, DOI 10.1016/j.athoracsur.2011.06.080; Omura A, 2012, ANN THORAC SURG, V94, P759, DOI 10.1016/j.athoracsur.2012.04.061; Song SW, 2010, J THORAC CARDIOV SUR, V139, P841, DOI 10.1016/j.jtcvs.2009.12.007	25	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	JUL	2015	48	1					152	157		10.1093/ejcts/ezu387		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CM2NH	WOS:000357516800028		
J	Mukaihara, K; Yotsumoto, G; Matsumoto, K; Imoto, Y				Mukaihara, Kosuke; Yotsumoto, Goichi; Matsumoto, Kazuhisa; Imoto, Yutaka			Migration of a retained temporary epicardial pacing wire into an abdominal aortic aneurysm	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Editorial Material						Temporary epicardial pacing wire; Migration; Aorta		A 69-year old male was referred to our hospital for the treatment of coronary artery disease. Preoperative computed tomography (CT) revealed an abdominal aortic aneurysm (AAA) and a giant tumour of the left kidney. He underwent off-pump coronary artery bypass grafting (OPCAB) prior to aneurysmectomy and nephrectomy. Temporary epicardial pacing wires (TEPWs) were placed on the right atrium and right ventricle. The bipolar ventricular wire was removed and the unipolar atrial wire was cut flush with the skin surface on postoperative day 5. CT 7 days after the OPCAB procedure revealed a retained TEPW sutured to the right atrial wall. One month later, the patient underwent a repair of the AAA and left nephrectomy. We found that a TEPW had migrated inside the AAA intraoperatively. The retained TEPW was thus no longer observed on postoperative CT. Migration of the atrial pacing wire through the aortic lumen was suspected, although the detailed mechanism is unknown. This is the first reported case of a migrated temporary pacing wire into the aorta under noninfectious conditions.	[Mukaihara, Kosuke; Yotsumoto, Goichi; Matsumoto, Kazuhisa; Imoto, Yutaka] Kagoshima Univ, Dept Cardiovasc & Gastroenterol Surg, Kagoshima, Kagoshima 8908520, Japan	Mukaihara, K (reprint author), Kagoshima Univ, Dept Cardiovasc & Gastroenterol Surg, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 8908520, Japan.	kousuke@m3.kufm.kagoshima-u.ac.jp					Carroll K C, 1998, Am J Crit Care, V7, P444; Del Nido P, 1989, J Card Surg, V4, P99; Wolf LG, 2013, ANN THORAC SURG, V96, pE7, DOI 10.1016/j.athoracsur.2012.12.056; Juchem G, 2008, EUROPACE, V10, P1348, DOI 10.1093/europace/eun269; Shaikhrezai K, 2012, INTERACT CARDIOV TH, V15, P1047, DOI 10.1093/icvts/ivs397	5	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	JUL	2015	48	1					169	170		10.1093/ejcts/ezu334		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CM2NH	WOS:000357516800032		
J	Yoshioka, K; Tanaka, R; Ueyama, Y; Abiko, A				Yoshioka, Kunihiro; Tanaka, Ryoichi; Ueyama, Yutaka; Abiko, Akihiko			Three-dimensional demonstration of the collateral circulation to the artery of Adamkiewicz via inferior epigastric artery with computed tomography angiography	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Editorial Material						The artery of Adamkiewicz; Aorta; Aneurysm; Computed tomography			[Yoshioka, Kunihiro; Tanaka, Ryoichi] Iwate Med Univ Hosp, Dept Radiol, Div Cardiovasc Radiol, Morioka, Iwate 0208505, Japan; [Ueyama, Yutaka] Iwate Med Univ Hosp, Ctr Radiol Sci, Morioka, Iwate 0208505, Japan; [Abiko, Akihiko] Iwate Med Univ, Dept Internal Med, Div Cardiol, Morioka, Iwate 020, Japan	Yoshioka, K (reprint author), Iwate Med Univ Hosp, Dept Radiol, Div Cardiovasc Radiol, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	kyoshi@iwate-med.ac.jp						0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	JUL	2015	48	1					175	175		10.1093/ejcts/ezu400		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CM2NH	WOS:000357516800036		
J	Matsunaga, T; Suzuki, K; Takamochi, K; Oh, S				Matsunaga, Takeshi; Suzuki, Kenji; Takamochi, Kazuya; Oh, Shiaki			N2 involvement in lung cancer: the Danaides' barrel Reply to Riquet et al.	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Letter						Lung cancer; N2			[Matsunaga, Takeshi; Suzuki, Kenji; Takamochi, Kazuya; Oh, Shiaki] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo 1138431, Japan	Suzuki, K (reprint author), Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Bunkyo Ku, 1-3 Hongo 3 Chome, Tokyo 1138431, Japan.	kjsuzuki@juntendo.ac.jp					Matsunaga T, 2014, EUR J CARDIO-THORAC, V46, P86, DOI 10.1093/ejcts/ezt550; Riquet M, 2015, EUR J CARDIO-THORAC, V47, P543, DOI 10.1093/ejcts/ezu226; Riquet M, 2015, EUR J CARDIO-THORAC, V48, P176, DOI 10.1093/ejcts/ezu369	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	JUL	2015	48	1					176	177		10.1093/ejcts/ezu374		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CM2NH	WOS:000357516800038		
J	Frasca, P; Ishii, H; Ravazzi, C; Tempo, R				Frasca, Paolo; Ishii, Hideaki; Ravazzi, Chiara; Tempo, Roberto			Distributed randomized algorithms for opinion formation, centrality computation and power systems estimation: A tutorial overview	EUROPEAN JOURNAL OF CONTROL			English	Article						Networked control systems; Distributed randomized algorithms; Opinion formation; Centrality computation; PageRank; Power systems estimation	MULTIAREA STATE ESTIMATION; ANTAGONISTIC INTERACTIONS; DYNAMICAL-SYSTEMS; CONSENSUS; NETWORKS; CONVERGENCE; BETWEENNESS; GRAPHS; OPTIMIZATION; THEOREMS	In this tutorial paper, we study three specific applications: opinion formation in social networks, centrality measures in complex networks and estimation problems in large-scale power systems. These applications fall under a general framework which aims at the construction of algorithms for distributed computation over a network. The two key ingredients of randomization and time-averaging are used, together with a local gossip communication protocol, to obtain convergence of these distributed algorithms to the global synchronous dynamics. (c) 2015 European Control Association. Published by Elsevier Ltd. All rights reserved.	[Frasca, Paolo] Univ Twente, Dept Appl Math, NL-7500 AE Enschede, Netherlands; [Ishii, Hideaki] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Tokyo, Japan; [Ravazzi, Chiara] Politecn Torino, DET, I-10129 Turin, Italy; [Tempo, Roberto] Politecn Torino, CNR IEIIT, I-10129 Turin, Italy	Tempo, R (reprint author), Politecn Torino, CNR IEIIT, I-10129 Turin, Italy.	p.frasca@utwente.nl; ishii@dis.titech.ac.jp; chiara.ravazzi@polito.it; roberto.tempo@polito.it			CNR Joint International Lab COOPS; Japan Science and Technology Agency; CNR	Partial funding for this research is provided by the CNR Joint International Lab COOPS, by Japan Science and Technology Agency under the EMS-CREST program, and by CNR under the Short Term Mobility Program.	Abelson RP, 1964, CONTRIBUTIONS MATH P; Altafini C, 2015, IEEE T AUTOMAT CONTR, V60, P342, DOI 10.1109/TAC.2014.2343371; Boyd S, 2006, IEEE T INFORM THEORY, V52, P2508, DOI 10.1109/TIT.2006.874516; Chiuso A, 2011, IEEE J-STSP, V5, P691, DOI 10.1109/JSTSP.2011.2123079; DEGROOT MH, 1974, J AM STAT ASSOC, V69, P118, DOI 10.2307/2285509; Valcher ME, 2014, SYST CONTROL LETT, V66, P94, DOI 10.1016/j.sysconle.2014.01.006; Ishii H, 2010, IEEE T AUTOMAT CONTR, V55, P1987, DOI 10.1109/TAC.2010.2042984; Acemoglu D, 2013, MATH OPER RES, V38, P1, DOI 10.1287/moor.1120.0570; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Bryan K, 2006, SIAM REV, V48, P569, DOI 10.1137/050623280; Mirtabatabaei A, 2012, SIAM J CONTROL OPTIM, V50, P2763, DOI 10.1137/11082751X; Baillieul J, 2007, P IEEE, V95, P9, DOI 10.1109/JPROC.2006.887290; Petersen IR, 2014, AUTOMATICA, V50, P1315, DOI 10.1016/j.automatica.2014.02.042; Bullo F, 2012, SIAM J CONTROL OPTIM, V50, P419, DOI 10.1137/100806370; POLYAK BT, 1992, SIAM J CONTROL OPTIM, V30, P838, DOI 10.1137/0330046; Friedkin NE, 1999, ADV GROUP, V16, P1; WHITE DR, 1994, SOC NETWORKS, V16, P335, DOI 10.1016/0378-8733(94)90015-9; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Canuto C, 2012, SIAM J CONTROL OPTIM, V50, P243, DOI 10.1137/100793177; Nedic A, 2009, IEEE T AUTOMAT CONTR, V54, P48, DOI 10.1109/TAC.2008.2009515; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Korres GN, 2011, IEEE T POWER SYST, V26, P73, DOI 10.1109/TPWRS.2010.2047030; Monticelli A, 2000, P IEEE, V88, P262, DOI 10.1109/5.824004; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6; Blondel VD, 2010, SIAM J CONTROL OPTIM, V48, P5214, DOI 10.1137/090766188; Lopes CG, 2008, IEEE T SIGNAL PROCES, V56, P3122, DOI 10.1109/TSP.2008.917383; CHATTERJEE S, 1977, J APPL PROBAB, V14, P89, DOI 10.2307/3213262; Pasqualetti F, 2012, AUTOMATICA, V48, P747, DOI 10.1016/j.automatica.2012.02.025; Blondel VD, 2009, IEEE T AUTOMAT CONTR, V54, P2586, DOI 10.1109/TAC.2009.2031211; FRENCH JRP, 1956, PSYCHOL REV, V63, P181, DOI 10.1037/h0046123; Lin F, 2014, IEEE T AUTOMAT CONTR, V59, P1789, DOI 10.1109/TAC.2014.2314223; Marelli DE, 2015, AUTOMATICA, V51, P27, DOI 10.1016/j.automatica.2014.10.077; Freris NM, 2011, IEEE T AUTOMAT CONTR, V56, P1352, DOI 10.1109/TAC.2010.2089210; Friedkin NE, 2011, ADMIN SCI QUART, V56, P501, DOI 10.1177/0001839212441349; Barooah P, 2007, IEEE CONTR SYST MAG, V27, P57, DOI 10.1109/MCS.2007.384125; BERTSEKAS D.P., 1989, PARALLEL DISTRIBUTED; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bullo F., 2009, APPL MATH SERIES; Carron Andrea, 2014, IEEE Transactions on Control of Network Systems, V1, DOI 10.1109/TCNS.2014.2353512; Ceragioli F, 2012, NONLINEAR ANAL-REAL, V13, P1239, DOI 10.1016/j.nonrwa.2011.10.002; Chakhchoukh Y., IEEE T POWE IN PRESS; CHASPARIS GC, 2010, IEEE C DEC COTR ATL, P6651; Christie R.D., POWER SYSTEMS TEST; Como G, 2011, ANN APPL PROBAB, V21, P1537, DOI 10.1214/10-AAP739; Conejo AJ, 2007, IEEE T POWER SYST, V22, P213, DOI 10.1109/TPWRS.2006.887964; DEFFUANT G., 2000, ADV COMPLEX SYST, V3, P87, DOI [10.1037/0022-3514.63.5.754, DOI 10.1142/S0219525900000078]; Easley D., 2010, NETWORKS CROWDS MARK; Fitch K., JOINT CENTRALITY DIS; Frasca P., 2013, IFAC WORKSH EST CONT, V4, P212; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FRIEDKIN NE, 1991, AM J SOCIOL, V96, P1478, DOI 10.1086/229694; Ghaderi J., 2013, AM CONTR C WASH DC J, P1985; Gomez-Exposito A., 2004, POWER SYSTEM STATE E; Gtimez-Exposito A., 2011, P IEEE, V99, P652; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5, P1; Ishii H, 2014, IEEE CONTR SYST MAG, V34, P34, DOI 10.1109/MCS.2014.2308672; Jia P., SIAM REV IN PRESS; Jiang WQ, 2007, IEEE T POWER SYST, V22, P563, DOI 10.1109/TPWRS.2007.894859; Kekatos V., 2012, IEEE T POWER SYST, V28, P1617; Levin D. A., 2009, MARKOV CHAINS MIXING; Liu Y., 2009, P 16 ACM C COMP COMM, P21, DOI 10.1145/1653662.1653666; Mesbahi M., 2010, APPL MATH SERIES; Mo Y., 2012, P IEEE, V100, P262; Mobilia M., 2007, J STAT MECH-THEORY E, V2007, P8; Patterson S., IN NETWORK LEADER SE; RAVAZZI C, 2013, EUR CONTR C ZUR SWIT, P1776; Ravazzi C., 2013, IEEE C DEC CONTR FLO, P4778; Ravazzi C, 2015, IEEE TRANS CONTROL N, V2, P78, DOI 10.1109/TCNS.2014.2367571; Sandberg H., 2010, P 1 WORKSH SEC CONTR; Tempo R., 2013, RANDOMIZED ALGORITHM; Todescato M., 2014, IEEE C DEC CONTR LOS; Vassio Luca, 2014, IEEE Transactions on Control of Network Systems, V1, DOI 10.1109/TCNS.2014.2304870; WAGNER C, 1978, PHILOS STUD, V34, P335, DOI 10.1007/BF00364701; Wang W, 2013, IEEE DECIS CONTR P, P43; Yildiz E., 2013, ACM T EC COMP, V1, P1; Zhang J., 2012, WORLD C INT CONTR AU, P4010; Zhang JB, 2012, CHIN CONT DECIS CONF, P2394; Zimmerman R. D., MATPOWER MATLAB POWE	79	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0947-3580	1435-5671		EUR J CONTROL	Eur. J. Control	JUL	2015	24				SI		2	13		10.1016/j.ejcon.2015.04.002		12	Automation & Control Systems	Automation & Control Systems	CL8KX	WOS:000357224700002		
J	Mebazaa, A; Longrois, D; Metra, M; Mueller, C; Richards, AM; Roessig, L; Seronde, MF; Sato, N; Stockbridge, NL; Stough, WG; Alonso, A; Cody, RJ; Bruns, NC; Gheorghiade, M; Holzmeister, J; Laribi, S; Zannad, F				Mebazaa, Alexandre; Longrois, Dan; Metra, Marco; Mueller, Christian; Richards, Arthur Mark; Roessig, Lothar; Seronde, Marie France; Sato, Naoki; Stockbridge, Norman L.; Stough, Wendy Gattis; Alonso, Angeles; Cody, Robert J.; Bruns, Nancy Cook; Gheorghiade, Mihai; Holzmeister, Johannes; Laribi, Said; Zannad, Faiez			Agents with vasodilator properties in acute heart failure: how to design successful trials	EUROPEAN JOURNAL OF HEART FAILURE			English	Review						Acute heart failure; Vasodilator; Clinical trials	PULMONARY ARTERIAL-HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; ACUTE MYOCARDIAL-INFARCTION; SOLUBLE GUANYLATE-CYCLASE; SYSTOLIC BLOOD-PRESSURE; ARRESTIN-BIASED LIGAND; QUALITY-OF-CARE; RENAL-FUNCTION; RELAX-AHF; SODIUM-NITROPRUSSIDE	Agents with vasodilator properties (AVDs) are frequently used in the treatment of acute heart failure (AHF). AVDs rapidly reduce preload and afterload, improve left ventricle to aorta and right ventricle to pulmonary artery coupling, and may improve symptoms. Early biomarker changes after AVD administration have suggested potentially beneficial effects on cardiac stretch, vascular tone, and renal function. AVDs that reduce haemodynamic congestion without causing hypoperfusion might be effective in preventing worsening organ dysfunction. Existing AVDs have been associated with different results on outcomes in randomized clinical trials, and observational studies have suggested that AVDs may be associated with a clinical outcome benefit. Lessons have been learned from past AVD trials in AHF regarding preventing hypotension, selecting the optimal endpoint, refining dyspnoea measurements, and achieving early randomization and treatment initiation. These lessons have been applied to the design of ongoing pivotal clinical trials, which aim to ascertain if AVDs improve clinical outcomes. The developing body of evidence suggests that AVDs may be a clinically effective therapy to reduce symptoms, but more importantly to prevent end-organ damage and improve clinical outcomes for specific patients with AHF. The results of ongoing trials will provide more clarity on the role of AVDs in the treatment of AHF.	[Mebazaa, Alexandre] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Mebazaa, Alexandre] AP HP, INSERM, U942, Paris, France; [Mebazaa, Alexandre] Hop Univ St Louis Lariboisiere, AP HP, Dept Anesthesia & Crit Care, Paris, France; [Longrois, Dan] Univ Paris Diderot, Hop Bichat Claude Bernard, Sorbonne Paris Cite, Dept Anesthesie Reanimat,INSERM,U1148, Paris, France; [Metra, Marco] Univ Brescia, Cardiol, Brescia, Italy; [Mueller, Christian] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; [Richards, Arthur Mark] Natl Univ Singapore, Cardiovasc Res Inst, Singapore 117548, Singapore; [Richards, Arthur Mark] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Roessig, Lothar; Bruns, Nancy Cook] Bayer Pharma AG, Global Clin Dev, Berlin, Germany; [Seronde, Marie France] Univ Hosp Besancon, Dept Cardiol, INSERM, U942, Besancon, France; [Sato, Naoki] Musashi Kosugi Hosp, Nippon Med Sch, Internal Med Cardiol & Intens Care Med, Kawasaki, Kanagawa, Japan; [Stockbridge, Norman L.] US FDA, Div Cardiovasc & Renal Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Stough, Wendy Gattis] Campbell Univ, Coll Pharm & Hlth Sci, Buies Creek, NC 27506 USA; [Alonso, Angeles] Sci Advice Working Party European Med Agcy, Madrid, Spain; [Cody, Robert J.] Janssen Res & Dev, Raritan, NJ USA; [Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Dept Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Holzmeister, Johannes] Cardiorentis AG, Zug, Switzerland; [Laribi, Said] Hop Univ St Louis Lariboisiere, AP HP, Dept Emergency Med, INSERM,U942, Paris, France; [Zannad, Faiez] Univ Lorraine, Nancy Univ, INSERM, Ctr Invest Clin 9501, Nancy, France; [Zannad, Faiez] Univ Lorraine, Nancy Univ, Ctr Hosp Univ, Unite 961, Nancy, France; [Zannad, Faiez] Univ Lorraine, Nancy Univ, Dept Cardiol, Nancy, France	Mebazaa, A (reprint author), Univ Paris Diderot, Hop Univ St Louis Lariboisiere, AP HP, Dept Anesthesiol & Crit Care Med,PRES Sorbonne Pa, Paris, France.	alexandre.mebazaa@lrb.aphp.fr					McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Allen LA, 2008, J CARD FAIL, V14, P661, DOI 10.1016/j.cardfail.2008.05.004; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Boerrigter G, 2011, CIRC-HEART FAIL, V4, P770, DOI 10.1161/CIRCHEARTFAILURE.111.962571; Piper S, 2014, EUR J HEART FAIL, V16, P827, DOI 10.1002/ejhf.123; Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4; Cotter G, 2008, J CARD FAIL, V14, P631, DOI 10.1016/j.cardfail.2008.08.010; Follath F, 2011, INTENS CARE MED, V37, P619, DOI 10.1007/s00134-010-2113-0; Nikolaou M, 2013, EUR HEART J, V34, P742, DOI 10.1093/eurheartj/ehs332; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Givertz MM, 2013, J CARD FAIL, V19, P371, DOI 10.1016/j.cardfail.2013.04.002; Sato N, 2013, CIRC J, V77, P944, DOI 10.1253/circj.CJ-13-0187; Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Jeyabalan A, 2007, ADV EXP MED BIOL, V612, P65; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Guarracino F, 2007, ACTA ANAESTH SCAND, V51, P1217, DOI 10.1111/j.1399-6576.2007.01428.x; Zannad F, 2013, EUR J HEART FAIL, V15, P1082, DOI 10.1093/eurjhf/hft095; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068; Zannad F, 2006, EUR J HEART FAIL, V8, P697, DOI 10.1016/j.ejheart.2006.01.001; Allen LA, 2009, J AM COLL CARDIOL, V53, P2248, DOI 10.1016/j.jacc.2008.12.079; Boerrigter G, 2012, CIRC-HEART FAIL, V5, P627, DOI 10.1161/CIRCHEARTFAILURE.112.969220; McMurray JJV, 2007, JAMA-J AM MED ASSOC, V298, P2009, DOI 10.1001/jama.298.17.2009; Teichman SL, 2009, HEART FAIL REV, V14, P321, DOI 10.1007/s10741-008-9129-3; COHN JN, 1982, NEW ENGL J MED, V306, P1129, DOI 10.1056/NEJM198205133061902; Metra M, 2013, J AM COLL CARDIOL, V61, P196, DOI 10.1016/j.jacc.2012.11.005; Fonarow GC, 2007, ARCH INTERN MED, V167, P1493, DOI 10.1001/archinte.167.14.1493; Cohen-Solal A, 2009, J AM COLL CARDIOL, V53, P2343, DOI 10.1016/j.jacc.2009.02.058; O'Connor CM, 2003, J AM COLL CARDIOL, V41, P1452, DOI 10.1016/S0735-1097(03)00194-3; Mentz RJ, 2014, EUR J HEART FAIL, V16, P471, DOI 10.1002/ejhf.74; Cotter G, 1998, LANCET, V351, P389, DOI 10.1016/S0140-6736(97)08417-1; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; SWEDBERG K, 1992, NEW ENGL J MED, V327, P678, DOI 10.1056/NEJM199209033271002; Gheorghiade M, 2010, EUR J HEART FAIL, V12, P423, DOI 10.1093/eurjhf/hfq045; Felker GM, 2010, CIRC-HEART FAIL, V3, P314, DOI 10.1161/CIRCHEARTFAILURE.109.893222; Mebazaa A, 2010, EUR HEART J, V31, P832, DOI 10.1093/eurheartj/ehp458; Hernandez AF, 2009, AM HEART J, V157, P271, DOI 10.1016/j.ahj.2008.07.031; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; Khot UN, 2003, NEW ENGL J MED, V348, P1756, DOI 10.1056/NEJMoa022021; Teerlink JR, 2005, AM HEART J, V150, P46, DOI 10.1016/j.ahj.2005.04.035; Ponikowski P, 2014, EUR HEART J, V35, P431, DOI 10.1093/eurheartj/eht459; Felker GM, 2003, J AM COLL CARDIOL, V41, P997, DOI 10.1016/S0735-1097(02)02968-6; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Voors AA, 2011, EUR J HEART FAIL, V13, P961, DOI 10.1093/eurjhf/hfr060; Gheorghiade M, 2012, EUR J HEART FAIL, V14, P1056, DOI 10.1093/eurjhf/hfs093; Mitrovic V, 2006, EUR HEART J, V27, P2823, DOI 10.1093/eurheartj/ehl337; Sharon A, 2000, J AM COLL CARDIOL, V36, P832, DOI 10.1016/S0735-1097(00)00785-3; Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Toba M, 2014, AM J PATHOL, V184, P369, DOI 10.1016/j.ajpath.2013.10.008; Violin JD, 2013, TRENDS CARDIOVAS MED, V23, P242, DOI 10.1016/j.tcm.2013.01.002; Metra M, 2009, HEART FAIL REV, V14, P299, DOI 10.1007/s10741-008-9127-5; Colombo PC, 2014, EUR HEART J, V35, P448, DOI 10.1093/eurheartj/eht456; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Cowie MR, 2002, EUR HEART J, V23, P877, DOI 10.1053/euhj.2001.2973; Cleland JGF, 2000, EUR J HEART FAIL, V2, P123, DOI 10.1016/S1388-9842(00)00081-7; Givertz MM, 2007, J AM COLL CARDIOL, V50, P1551, DOI 10.1016/j.jacc.2007.07.019; Ponikowski P, 2012, AM HEART J, V163, P149, DOI 10.1016/j.ahj.2011.10.009; Pagnamenta A, 2010, J APPL PHYSIOL, V109, P1080, DOI 10.1152/japplphysiol.00467.2010; Mullens W, 2008, J AM COLL CARDIOL, V52, P200, DOI 10.1016/j.jacc.2008.02.083; Gheorghiade M, 2009, AM HEART J, V157, P957, DOI 10.1016/j.ahj.2009.04.010; BANISACCHI T, 1995, BRIT J PHARMACOL, V116, P1589; Breidthardt T, 2010, J INTERN MED, V267, P322, DOI 10.1111/j.1365-2796.2009.02146.x; Colombo Paolo C, 2015, Curr Heart Fail Rep, V12, P215, DOI 10.1007/s11897-015-0254-8; Colombo PP, 2009, RIV PSICHIATR, V44, P15; Ezekowitz JA, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0329-z; Fedele F, 2014, EUR J HEART FAIL, V16, P281, DOI 10.1002/ejhf.9; Felker GM, 2014, J AM COLL CARDIOL, V64, P1591, DOI 10.1016/j.jacc.2014.05.071; Gheorghiade M, 2005, AM J CARDIOL, V96, p11G, DOI 10.1016/j.amjcard.2005.07.016; Guinot PG, 2014, EUR J ANAES IN PRESS; Ponikowski P, 2015, REV ESP CARDIOL, V68, P331, DOI 10.1016/j.rec.2015.02.001; Jelinic M, 2014, FASEB J, V28, P275, DOI 10.1096/fj.13-233429; Levy PD, 2014, CURR EMERG HOSP MED, V2, P126; Maron B, 2011, GOODMAN GILMANS PHAR, V12th; Martin FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052422; Massie BM, 2010, NEW ENGL J MED, V363, P1419, DOI 10.1056/NEJMoa0912613; Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P1883, DOI 10.1001/jama.297.17.1883; Mebazaa Alexandre, 2008, Crit Care Med, V36, pS129, DOI 10.1097/01.CCM.0000296274.51933.4C; Mentz RJ, 2013, AM HEART J, V166, P629, DOI 10.1016/j.ahj.2013.08.001; Nahar K, 2014, MOL PHARMACEUT, V11, P4374, DOI 10.1021/mp500456k; Packer M, 2013, JACC-HEART FAIL, V1, P103, DOI 10.1016/j.jchf.2012.12.004; Pang CCY, 2001, PHARMACOL THERAPEUT, V90, P179, DOI 10.1016/S0163-7258(01)00138-3; Patel PA, 2014, CIRC-HEART FAIL, V7, P918, DOI 10.1161/CIRCHEARTFAILURE.113.000872; Peacock WF, 2014, AM HEART J, V167, P529, DOI 10.1016/j.ahj.2013.12.023; Popovic ZB, 2005, AM J PHYSIOL-HEART C, V288, pH416, DOI 10.1152/ajpheart.00615.2004; Singh A, 2015, EUR HEART J IN PRESS; Tavares Miguel, 2008, Crit Care Med, V36, pS112, DOI 10.1097/01.CCM.0000296810.74724.8D; Teichman Sam L, 2010, Curr Heart Fail Rep, V7, P75, DOI 10.1007/s11897-010-0010-z; Rekowski MV, 2013, J MED CHEM, V56, P8948, DOI 10.1021/jm400539d; Wakai A, 2013, COCHRANE DB SYST REV, V8; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531; Zamani Payman, 2013, Curr Heart Fail Rep, V10, P1, DOI 10.1007/s11897-012-0126-4	94	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1388-9842	1879-0844		EUR J HEART FAIL	Eur. J. Heart Fail.	JUL	2015	17	7					652	664		10.1002/ejhf.294		13	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CM2OC	WOS:000357519700005		
J	Saito, K; Kukita, K; Kutomi, G; Okuya, K; Asanuma, H; Tabeya, T; Naishiro, Y; Yamamoto, M; Takahashi, H; Torigoe, T; Nakai, A; Shinomura, Y; Hirata, K; Sato, N; Tamura, Y				Saito, Keita; Kukita, Kazuharu; Kutomi, Goro; Okuya, Koichi; Asanuma, Hiroko; Tabeya, Tetsuya; Naishiro, Yasuka; Yamamoto, Motohisa; Takahashi, Hiroki; Torigoe, Toshihiko; Nakai, Akira; Shinomura, Yasuhisa; Hirata, Koichi; Sato, Noriyuki; Tamura, Yasuaki			Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						Hsp90; IFN-alpha; Plasmacytoid DC; SLE; TLR	SYSTEMIC-LUPUS-ERYTHEMATOSUS; PLASMACYTOID DENDRITIC CELLS; ACTIVATE B-CELLS; I INTERFERON; CROSS-PRESENTATION; IMMUNE-RESPONSES; GENE-EXPRESSION; HSP90 INHIBITOR; ELEVATED LEVELS; RNA	Systemic lupus erythematosus (SLE) is a prototype systemic autoimmune disease, and disease activity is associated with serum IFN-alpha level. Plasmacytoid dendritic cells (pDCs) sense microbial as well as self-nucleic acids by TLRs 7 and 9 and produce a large amount of IFN-alpha. Here, we show that heat shock protein 90 (Hsp90) associates with and delivers TLR7/9 from the ER to early endosomes for ligand recognition. Inhibition of Hsp90 by various approaches including the use of Hsp90 inhibitor, a geldanamycin derivative, suppressed the Hsp90 association with TLR7/9, which resulted in inhibition of IFN-alpha production, leading to improvement of SLE symptoms in mice. Notably, we observed that serum Hsp90 is clearly increased in patients with active SLE compared with that in patients with inactive disease. Furthermore, we demonstrated that serum Hsp90 detected in SLE patients binds to self-DNA and/or anti-DNA Ab, thus leading to stimulation of pDCs to produce IFN-alpha. Our data demonstrate that Hsp90 plays a crucial role in the pathogenesis of SLE and that an Hsp90 inhibitor will therefore provide a new therapeutic approach to SLE and other nucleic acid-related autoimmune diseases.	[Saito, Keita; Kukita, Kazuharu; Asanuma, Hiroko; Torigoe, Toshihiko; Sato, Noriyuki; Tamura, Yasuaki] Sapporo Med Univ, Dept Pathol, Sch Med, Sapporo, Hokkaido, Japan; [Saito, Keita; Kukita, Kazuharu; Kutomi, Goro; Okuya, Koichi; Hirata, Koichi] Sapporo Med Univ, Dept Surg, Sch Med, Sapporo, Hokkaido, Japan; [Tabeya, Tetsuya; Naishiro, Yasuka; Yamamoto, Motohisa; Takahashi, Hiroki; Shinomura, Yasuhisa] Sapporo Med Univ, Dept Internal Med, Sch Med, Sapporo, Hokkaido, Japan; [Nakai, Akira] Yamaguchi Univ, Sch Med, Dept Biochem & Mol Biol, Yamaguchi, Japan; [Tamura, Yasuaki] Hokkaido Univ, Ctr Food & Med Innovat, Dept Mol Therapeut, Sapporo, Hokkaido 0010021, Japan	Tamura, Y (reprint author), Hokkaido Univ, Dept Mol Therapeut, Ctr Food & Med Innovat, Kita Ku, Kita 21 Nishi 11, Sapporo, Hokkaido 0010021, Japan.	ytamura3566@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by a program for developing a supporting system for upgrading the education and research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Stephanou A, 1997, BIOCHEM J, V321, P103; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Stephanou A, 1998, BIOCHEM J, V330, P189; Hua J, 2006, ARTHRITIS RHEUM, V54, P1906, DOI 10.1002/art.21890; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; LINKERISRAELI M, 1991, J IMMUNOL, V147, P117; Shimp SK, 2012, CELL MOL IMMUNOL, V9, P255, DOI 10.1038/cmi.2012.5; Hahn BH, 1998, NEW ENGL J MED, V338, P1359; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Hornung V, 2002, J IMMUNOL, V168, P4531; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Linker-Israeli M, 1999, GENES IMMUN, V1, P45, DOI 10.1038/sj.gene.6363631; Ronnblom L, 2003, ARTHRITIS RES THER, V5, P68, DOI 10.1186/ar625; Lovgren T, 2004, ARTHRITIS RHEUM, V50, P1861, DOI 10.1002/art.20254; Dong L, 2005, ARTHRITIS RHEUM, V52, P651, DOI 10.1002/art.20810; Sausville EA, 2003, CURR CANCER DRUG TAR, V3, P377, DOI 10.2174/1568009033481831; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Kadowaki N, 2001, J IMMUNOL, V166, P2291; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Waza M, 2006, ANN NY ACAD SCI, V1086, P21, DOI 10.1196/annals.1377.012; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Workman P, 2004, TRENDS MOL MED, V10, P47, DOI 10.1016/j.molmed.2003.12.005; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Ichiyanagi T, 2010, J IMMUNOL, V185, P2693, DOI 10.4049/jimmunol.1000821; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; LATCHMAN DS, 1994, AUTOIMMUNITY, V19, P211, DOI 10.3109/08916939408995696; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Ochel HJ, 2001, CELL STRESS CHAPERON, V6, P105, DOI 10.1379/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2; Okuya K, 2010, J IMMUNOL, V184, P7092, DOI 10.4049/jimmunol.1000490; Olesińska Marzena, 2007, Pol Arch Med Wewn, V117, P312; Ripley BJM, 2001, J AUTOIMMUN, V17, P341, DOI 10.1006/jaut.2001.0549; Stephanou A, 1998, J AUTOIMMUN, V11, P249, DOI 10.1006/jaut.1998.0194; Xu WP, 2002, CELL STRESS CHAPERON, V7, P91, DOI 10.1379/1466-1268(2002)007<0091:HNGRTI>2.0.CO;2; Zheng H, 2004, J IMMUNOL, V173, P5929	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	JUL	2015	45	7					2028	2041		10.1002/eji.201445293		14	Immunology	Immunology	CM4WY	WOS:000357687700017		
J	Uchimura, M; Nakano, T; Morito, Y; Ando, H; Kitazawa, S				Uchimura, Motoaki; Nakano, Tamami; Morito, Yusuke; Ando, Hiroshi; Kitazawa, Shigeru			Automatic representation of a visual stimulus relative to a background in the right precuneus	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						adaptation; background; egocentric; fMRI; precuneus	POSTERIOR PARIETAL CORTEX; PRIMARY SOMATOSENSORY CORTEX; LATERAL OCCIPITAL COMPLEX; FUNCTIONAL-ORGANIZATION; NEURONAL MECHANISMS; CORTICAL ACTIVITY; PRISM ADAPTATION; REFERENCE FRAMES; REACH REGIONS; DEFAULT MODE	Our brains represent the position of a visual stimulus egocentrically, in either retinal or craniotopic coordinates. In addition, recent behavioral studies have shown that the stimulus position is automatically represented allocentrically relative to a large frame in the background. Here, we investigated neural correlates of the background coordinate' using an fMRI adaptation technique. A red dot was presented at different locations on a screen, in combination with a rectangular frame that was also presented at different locations, while the participants looked at a fixation cross. When the red dot was presented repeatedly at the same location relative to the rectangular frame, the fMRI signals significantly decreased in the right precuneus. No adaptation was observed after repeated presentations relative to a small, but salient, landmark. These results suggest that the background coordinate is implemented in the right precuneus.	[Uchimura, Motoaki; Nakano, Tamami; Kitazawa, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Dynam Brain Network Lab, Suita, Osaka 5650871, Japan; [Uchimura, Motoaki; Nakano, Tamami; Kitazawa, Shigeru] Osaka Univ, Grad Sch Med, Dept Brain Physiol, Suita, Osaka 5650871, Japan; [Uchimura, Motoaki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Nakano, Tamami; Morito, Yusuke; Ando, Hiroshi; Kitazawa, Shigeru] Osaka Univ, Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks CiNet, Suita, Osaka 5650871, Japan; [Ando, Hiroshi] Natl Inst Informat & Commun Technol, Multisensory Cognit & Computat Lab, Kyoto 6190289, Japan	Kitazawa, S (reprint author), Osaka Univ, Grad Sch Frontier Biosci, Dynam Brain Network Lab, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	kitazawa@fbs.osaka-u.ac.jp			Ministry of Health Labour and Welfare; Japan Society for the Promotion of Science;  [25119002];  [251195040];  [25240022]	The study was supported by Grants-in-Aid for Scientific Research on Innovative Areas 25119002 to S.K., 251195040 to T.N., and (A) 25240022 to S.K., a Health Labour Sciences Research Grant from the Ministry of Health Labour and Welfare to S.K, and a Japan Society for the Promotion of Science Research Fellowships for Young Scientists award to M.U. The authors declare no competing financial interests.	Luaute J, 2009, J NEUROSCI, V29, P169, DOI 10.1523/JNEUROSCI.3054-08.2009; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; Obhi SS, 2005, EXP BRAIN RES, V167, P335, DOI 10.1007/s00221-005-0055-5; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Kim JG, 2009, VISION RES, V49, P2297, DOI 10.1016/j.visres.2009.06.020; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Uchimura M, 2013, J NEUROSCI, V33, P7595, DOI 10.1523/JNEUROSCI.5702-12.2013; BALOH RW, 1975, NEUROLOGY, V25, P1065; Szczepanski SM, 2013, P NATL ACAD SCI USA, V110, P15806, DOI 10.1073/pnas.1313903110; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Filimon F, 2009, J NEUROSCI, V29, P2961, DOI 10.1523/JNEUROSCI.3211-08.2009; Deubel H, 2004, VIS COGN, V11, P173, DOI 10.1080/13506280344000284; Byrne PA, 2010, VISION RES, V50, P2661, DOI 10.1016/j.visres.2010.08.038; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Sheth BR, 2004, J COGNITIVE NEUROSCI, V16, P339, DOI 10.1162/089892904322984616; Medendorp WP, 2011, PHILOS T R SOC B, V366, P476, DOI 10.1098/rstb.2010.0089; Konen CS, 2013, J NEUROPHYSIOL, V109, P2897, DOI 10.1152/jn.00657.2012; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Nakano T, 2013, P NATL ACAD SCI USA, V110, P702, DOI 10.1073/pnas.1214804110; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Chafee MV, 2007, CEREB CORTEX, V17, P2914, DOI 10.1093/cercor/bhm017; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Vesia M, 2010, J NEUROSCI, V30, P13053, DOI 10.1523/JNEUROSCI.1644-10.2010; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Karn KS, 1997, EXP BRAIN RES, V115, P267, DOI 10.1007/PL00005696; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021; OLSON CR, 1995, SCIENCE, V269, P985, DOI 10.1126/science.7638625; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Boi M, 2011, CURR BIOL, V21, P1732, DOI 10.1016/j.cub.2011.08.059; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Pitzalis S, 2013, NEUROIMAGE, V82, P517, DOI 10.1016/j.neuroimage.2013.06.026; Kansaku K, 2005, NEUROIMAGE, V28, P669, DOI 10.1016/j.neuroimage.2005.06.022; Kroliczak G, 2007, J NEUROPHYSIOL, V97, P2410, DOI 10.1152/jn.00778.2006; Bays PM, 2007, NEUROREPORT, V18, P1207, DOI 10.1097/WNR.0b013e328244e6c3; Bernier PM, 2010, NEURON, V68, P776, DOI 10.1016/j.neuron.2010.11.002; Blankenburg F, 2003, CEREB CORTEX, V13, P987, DOI 10.1093/cercor/13.9.987; Cavina-Pratesi C, 2007, PLOS ONE, V9, pe424, DOI DOI 10.1371/J0URNAL.P0NE.0000424; Crespi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021661; Germeys F, 2004, VIS COGN, V11, P203, DOI 10.1080/13506280344000301; Golomb JD, 2012, P NATL ACAD SCI USA, V109, P1796, DOI 10.1073/pnas.1113168109; HECAEN H, 1954, BRAIN, V77, P373, DOI 10.1093/brain/77.3.373; Knauff M, 2003, J COGNITIVE NEUROSCI, V15, P559, DOI 10.1162/089892903321662949; Kraft A, 2015, BRAIN STIMUL, V8, P216, DOI 10.1016/j.brs.2014.11.004; Lin ZC, 2012, J VISION, V12, DOI 10.1167/12.11.24; McKyton A, 2007, CEREB CORTEX, V17, P1164, DOI 10.1093/cercor/bhl027; Melcher D, 2011, PHILOS T R SOC B, V366, P468, DOI 10.1098/rstb.2010.0277; Monaco S, 2011, J NEUROPHYSIOL, V106, P2248, DOI 10.1152/jn.01069.2010; Perna A, 2005, NEURON, V47, P645, DOI 10.1016/j.neuron.2005.07.012; Suchan B, 2002, BEHAV BRAIN RES, V136, P533, DOI 10.1016/S0166-4328(02)00204-8; VansPelt S., 2010, J NEUROPHYSIOL, p[104, 1239]; Weibull A, 2008, MAGN RESON IMAGING, V26, P1342, DOI 10.1016/j.mri.2008.04.007	56	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUL	2015	42	1					1651	1659		10.1111/ejn.12935		9	Neurosciences	Neurosciences & Neurology	CM1IA	WOS:000357433300004		
J	Tamura, Y; Kimura, M; Takei, M; Ono, T; Kuwana, M; Satoh, T; Fukuda, K; Humbert, M				Tamura, Yuichi; Kimura, Mai; Takei, Makoto; Ono, Tomohiko; Kuwana, Masataka; Satoh, Toru; Fukuda, Keiichi; Humbert, Marc			Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertension	EUROPEAN RESPIRATORY JOURNAL			English	Letter							ARTERIAL-HYPERTENSION		[Tamura, Yuichi; Kimura, Mai; Takei, Makoto; Ono, Tomohiko; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan; [Tamura, Yuichi; Humbert, Marc] Univ Paris Sud, Fac Med, F-94275 Le Kremlin Bicetre, France; [Tamura, Yuichi; Humbert, Marc] Hop Bicetre, AP HP, DHU Thorax Innovat, Serv Pneumol, Le Kremlin Bicetre, France; [Tamura, Yuichi; Humbert, Marc] INSERM, UMR_ S 999, LabExLERMIT, Ctr Chirurg Marie Lannelongue, Le Plessis Robinson, France; [Kuwana, Masataka] Nippon Med Sch, Dept Allergy & Rheumatol, Tokyo 113, Japan; [Satoh, Toru] Kyorin Univ, Sch Med, Dept Cardiol, Tokyo, Japan	Tamura, Y (reprint author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	u1@ta-mu.net					Mielniczuk LM, 2008, J CARD FAIL, V14, P388, DOI 10.1016/j.cardfail.2008.01.015; McKinley MJ, 2004, J NEUROENDOCRINOL, V16, P340, DOI 10.1111/j.0953-8194.2004.01184.x; Gupta S, 2005, EUR HEART J, V26, P644, DOI 10.1093/eurheartj/ehi176; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; Vonk-Noordegraaf A, 2013, J AM COLL CARDIOL, V62, pD22, DOI 10.1016/j.jacc.2013.10.027; Vonk-Noordegraaf A, 2013, EUR RESPIR J, V41, P1419, DOI 10.1183/09031936.00160712; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Neuberg GW, 2002, AM HEART J, V144, P31, DOI 10.1067/mhj.2002.123144; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; BOLDT J, 1995, CHEST, V107, P787, DOI 10.1378/chest.107.3.787	13	0	0	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	JUL	2015	46	1					283	286		10.1183/09031936.00044915		4	Respiratory System	Respiratory System	CL7FG	WOS:000357137300039		
J	Scully, OJ; Yu, YN; Salim, A; Thike, AA; Yip, GWC; Baeg, GH; Tan, PH; Matsumoto, K; Bay, BH				Scully, Olivia Jane; Yu, Yingnan; Salim, Agus; Thike, Aye Aye; Yip, George Wai-Cheong; Baeg, Gyeong Hun; Tan, Puay-Hoon; Matsumoto, Ken; Bay, Boon Huat			Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer	EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						Breast cancer; tissue microarray; C1QBP; immunohistochemistry; gene modulation; proliferation	FACTOR-I RECEPTOR; P-32 PROTEIN; OXIDATIVE-PHOSPHORYLATION; CELL-PROLIFERATION; MESSENGER-RNA; CYCLIN D1; HYALURONAN; EXPRESSION; HABP1/P32/GC1QR; METASTASIS	Complement component 1, q subcomponent binding protein (C1QBP), is a multi-compartmental protein with higher mRNA expression reported in breast cancer tissues. This study evaluated the association between immunohistochemical expression of the C1QBP protein in breast cancer tissue microarrays (TMAs) and clinicopathological parameters, in particular tumor size. In addition, an in vitro study was conducted to substantiate the breast cancer TMA findings. Breast cancer TMAs were constructed from pathological specimens of patients diagnosed with invasive ductal carcinoma. C1QBP protein and proliferating cell nuclear antigen (PCNA) immunohistochemical analyses were subsequently performed in the TMAs. C1QBP immunostaining was detected in 131 out of 132 samples examined. The C1QBP protein was predominantly localized in the cytoplasm of the breast cancer cells. Univariate analysis revealed that a higher C1QBP protein expression was significantly associated with older patients (P = 0.001) and increased tumor size (P = 0.002). Multivariate analysis showed that C1QBP is an independent predictor of tumor size in progesterone-positive tumors. Furthermore, C1QBP was also significantly correlated with expression of PCNA, a known marker of proliferation. Inhibition of C1QBP expression was performed by transfecting C1QBP siRNA into T47D breast cancer cells, a progesterone receptor-positive breast cancer cell line. C1QBP gene expression was analyzed by real-time RT-PCR, and protein expression by Western blot. Cell proliferation assays were also performed by commercially available assays. Down-regulation of C1QBP expression significantly decreased cell proliferation and growth in T47D cells. Taken together, our findings suggest that the C1QBP protein could be a potential proliferative marker in breast cancer.	[Scully, Olivia Jane; Yu, Yingnan; Yip, George Wai-Cheong; Baeg, Gyeong Hun; Bay, Boon Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117594, Singapore; [Salim, Agus] La Trobe Univ, Dept Math & Stat, Bundoora, Vic 3086, Australia; [Thike, Aye Aye; Tan, Puay-Hoon] Singapore Gen Hosp, Dept Pathol, Singapore 169856, Singapore; [Matsumoto, Ken] RIKEN, Inst Phys & Chem Res, Chem Genet Lab, Wako, Saitama 3510198, Japan	Bay, BH (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117594, Singapore.	antbaybh@nus.edu.sg	Matsumoto, Ken/F-9083-2013	Matsumoto, Ken/0000-0002-7864-3394	Singapore Ministry of Education [MOE2013-T2-1-129]; Biomedical Research Council [BMRC/10/1/21/24/638]; National University Singapore	This work was supported by Singapore Ministry of Education MOE2013-T2-1-129 Grant and Biomedical Research Council BMRC/10/1/21/24/638 Grant. OJS is the recipient of a graduate research scholarship from the National University Singapore.	Agarwal S, 1997, Indian J Pathol Microbiol, V40, P11; Agemy L, 2013, MOL THER, V21, P2195, DOI 10.1038/mt.2013.191; Ahlin C, 2009, CANCER EPIDEM BIOMAR, V18, P2501, DOI 10.1158/1055-9965.EPI-09-0169; Zhang XF, 2013, MOL CELL PROTEOMICS, V12, P3199, DOI 10.1074/mcp.M113.029413; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Lwin ZM, 2010, MODERN PATHOL, V23, P1559, DOI 10.1038/modpathol.2010.173; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; Malkas LH, 2006, P NATL ACAD SCI USA, V103, P19472, DOI 10.1073/pnas.0604614103; Ghebrehiwet B, 1998, IMMUNOBIOLOGY, V199, P225; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Amamoto R, 2011, CANCER SCI, V102, P639, DOI 10.1111/j.1349-7006.2010.01828.x; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Soltys BJ, 2000, HISTOCHEM CELL BIOL, V114, P245; Haluska P, 2008, MOL CANCER THER, V7, P2589, DOI 10.1158/1535-7163.MCT-08-0493; Muta T, 1997, J BIOL CHEM, V272, P24363, DOI 10.1074/jbc.272.39.24363; Gombos A, 2012, INVEST NEW DRUG, V30, P2433, DOI 10.1007/s10637-012-9811-0; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Chen YB, 2009, J SURG ONCOL, V100, P382, DOI 10.1002/jso.21329; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Luporsi E, 2012, BREAST CANCER RES TR, V132, P895, DOI 10.1007/s10549-011-1837-z; Kim KB, 2011, J BIOL CHEM, V286, P23093, DOI 10.1074/jbc.M111.233304; McGee AM, 2011, CELL CYCLE, V10, P4119, DOI 10.4161/cc.10.23.18287; Agarwal R, 2009, CLIN CANCER RES, V15, P3654, DOI 10.1158/1078-0432.CCR-08-3293; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Beresford MJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1618; Chakraborty AK, 2008, CANCER RES, V68, P1538, DOI 10.1158/0008-5472.CAN-07-5935; Dembitzer FR, 2012, J HISTOCHEM CYTOCHEM, V60, P467, DOI 10.1369/0022155412440882; Hui R, 1996, CLIN CANCER RES, V2, P923; Kaul R, 2012, J BIOL CHEM, V287, P19750, DOI 10.1074/jbc.M111.266270; Matsumoto K, 2005, MOL CELL BIOL, V25, P1779, DOI 10.1128/MCB.25.5.1779-1792.2005; Nilsson C, 2013, MODERN PATHOL, V26, P87, DOI 10.1038/modpathol.2012.145; Prakash M, 2011, CELL SIGNAL, V23, P1563, DOI 10.1016/j.cellsig.2011.04.009; Sanchez-Martin D, 2011, J BIOL CHEM, V286, P5197, DOI 10.1074/jbc.M110.161927; Schonborn I, 1994, BREAST, V3, P97, DOI 10.1016/0960-9776(94)90007-8; STORRS SB, 1981, J BIOL CHEM, V256, P924; Wernicke M, 2003, MODERN PATHOL, V16, P99, DOI 10.1097/01.MP.0000051582.75890.2D; WRBA F, 1989, ONCOLOGY, V46, P255; Yu G, 2013, EXP MOL PATHOL, V94, P210, DOI 10.1016/j.yexmp.2012.06.007; Zhao HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029416	43	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1535-3702	1535-3699		EXP BIOL MED	Exp. Biol. Med.	JUL	2015	240	7					846	853		10.1177/1535370214565075		8	Medicine, Research & Experimental	Research & Experimental Medicine	CM5PI	WOS:000357740100002		
J	Yang, C; Hashimoto, K				Yang, Chun; Hashimoto, Kenji			Peripheral IL-6 signaling: a promising therapeutic target for depression?	EXPERT OPINION ON INVESTIGATIONAL DRUGS			English	Letter									[Yang, Chun; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan	Hashimoto, K (reprint author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan.	hashimoto@faculty.chiba-u.jp					Young JJ, 2014, J AFFECT DISORDERS, V169, P15, DOI 10.1016/j.jad.2014.07.032; Black C, 2015, BIOL PSYCHIAT, V78, P28, DOI 10.1016/j.biopsych.2014.10.014; Fonseka TM, 2015, EXPERT OPIN INV DRUG, V24, P459, DOI 10.1517/13543784.2014.998334; Yang C, 2015, ACTA NEUROPSYCHIATR, DOI [10.1017/neu.2015.36, DOI 10.1017/NEU.2015.36]; Yang JJ, 2015, BIOL PSYCHIAT, V77, pE19, DOI 10.1016/j.biopsych.2014.06.021	5	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1354-3784	1744-7658		EXPERT OPIN INV DRUG	Expert Opin. Investig. Drugs	JUL	2015	24	7					989	990		10.1517/13543784.2015.1055669		2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CM5XO	WOS:000357762500012		
J	Kobayashi, T; Higuchi-Watanabe, N; Shiraishi, A; Uno, T; Ohashi, Y				Kobayashi, Takeshi; Higuchi-Watanabe, Narumi; Shiraishi, Atsushi; Uno, Toshihiko; Ohashi, Yuichi			Miraflow, Soft Contact Lens Cleaner: Activity Against Acanthamoeba Spp	EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE			English	Article							MULTIPURPOSE SOLUTIONS; DISINFECTION SYSTEMS; CASTELLANII; KERATITIS; CYSTS; DIFFERENTIATION; CONTAMINATION; ENCYSTMENT; RESISTANCE; EFFICACY	Objective: Miraflow is a cleaner for soft contact lens which contains 20% isopropyl alcohol. The purpose of this study was to determine the activity against Acanthamoeba trophozoites and cysts for Miraflow. In addition, to determine the activity of combined Miraflow and multipurpose solutions (MPSs) against Acanthamoeba cysts. Methods: Two simulated-use studies were conducted. The significance in the log reduction in the number of trophozoites and cysts of A. castellanii strains ATCC 50514 and ATCC 50370 or A. polyphaga ATCC 30461 after exposure to Miraflow alone was determined by the Spearman-Karber method. To examine the activity against Acanthamoeba of combined Miraflow and an MPS, the log reduction in the number of cysts after a 1-min exposure to Miraflow followed by a 4-hr exposure to MPS (ReNu fresh) was also determined. Results: Short-time exposure of 30 sec to Miraflow demonstrated activity against the Acanthamoeba trophozoites. However, a 1-min treatment was only relatively effective (1.1 log reduction) against the cysts of A. castellanii ATCC 50514, but no statistically significant reduction was observed for the cysts of the other 2 strains. The combined use with Miraflow and MPS demonstrated activity against the cysts, and a 3.0, 1.0, or 1.5 log reduction in the numbers was obtained for A. castellanii ATCC 50514, A. castellanii ATCC 50370, and A. polyphaga ATCC 30461, respectively. Conclusions: Exposure to combined Miraflow and MPS resulted in reductions in the number of Acanthamoeba cysts.	[Kobayashi, Takeshi] Ehime Univ, Sch Med, Dept Ophthalmol & Regenerat Med, Toon, Ehime 7910295, Japan; [Higuchi-Watanabe, Narumi; Shiraishi, Atsushi; Uno, Toshihiko; Ohashi, Yuichi] Ehime Univ, Sch Med, Dept Ophthalmol, Toon, Ehime 7910295, Japan	Kobayashi, T (reprint author), Ehime Univ, Grad Sch Med, Dept Ophthalmol & Regenerat Med, Toon, Ehime 7910295, Japan.	takeshi8@m.ehime-u.ac.jp			CIBA Vision (Tokyo, Japan)	The Department of Ophthalmology, Ehime University School of Medicine, has received research funding from CIBA Vision (Tokyo, Japan).	Ajello L, 1995, INT CONTACT LENS CLI, V22, P156, DOI 10.1016/0892-8967(95)00054-X; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; Niszl IA, 1998, BRIT J OPHTHALMOL, V82, P1033, DOI 10.1136/bjo.82.9.1033; Lonnen J, 2010, EYE CONTACT LENS, V36, P26, DOI 10.1097/ICL.0b013e3181c6e184; Turner NA, 2000, J ANTIMICROB CHEMOTH, V46, P27, DOI 10.1093/jac/46.1.27; Khunkitti W, 1998, J INFECTION, V36, P43, DOI 10.1016/S0163-4453(98)93054-7; MAYO MS, 1987, J CLIN MICROBIOL, V25, P1398; Beattie TK, 2003, J CLIN MICROBIOL, V41, P2992, DOI 10.1128/JCM.41.7.2992-3000.2003; WEISMAN RA, 1976, ANNU REV MICROBIOL, V30, P189, DOI 10.1146/annurev.mi.30.100176.001201; Aksozek A, 2002, J PARASITOL, V88, P621, DOI 10.1645/0022-3395(2002)088[0621:ROACCT]2.0.CO;2; GRAY TB, 1995, BRIT J OPHTHALMOL, V79, P601, DOI 10.1136/bjo.79.6.601; Radford CF, 1998, BRIT J OPHTHALMOL, V82, P1387, DOI 10.1136/bjo.82.12.1387; Kobayashi T, 2011, JPN J OPHTHALMOL, V55, P547, DOI 10.1007/s10384-011-0062-y; Borazjani R N, 2005, Cont Lens Anterior Eye, V28, P169, DOI 10.1016/j.clae.2005.10.001; BRANDT FH, 1989, APPL ENVIRON MICROB, V55, P1144; Butcko V, 2007, EYE CONTACT LENS, V33, P424; Butcko Victoria, 2007, Eye Contact Lens, V33, P421, DOI 10.1097/ICL.0b013e318157f3df; Chavez-Munguia B, 2005, J EUKARYOT MICROBIOL, V52, P153, DOI 10.1111/j.1550-7408.2005.04-3273.x; CONNOR CG, 1991, OPTOMETRY VISION SCI, V68, P138, DOI 10.1097/00006324-199102000-00009; Ghajar M, 1989, J Am Optom Assoc, V60, P592; Kilvington S, 2004, CONTACT LENS ANTERIO, V27, P209, DOI 10.1016/j.clae.2004.09.001; KILVINGTON S, 1991, REV INFECT DIS, V13, pS414; LARKIN DFP, 1990, BRIT J OPHTHALMOL, V74, P133, DOI 10.1136/bjo.74.3.133; Mowrey-McKee Mary, 2007, Eye Contact Lens, V33, P211, DOI 10.1097/ICL.0b013e31805d8662; NAUHEIM RC, 1990, CORNEA, V9, P290; Neff R, 1964, METHODS CELL PHYSL, V1, P55, DOI 10.1016/S0091-679X(08)62086-5; Santos L, 2011, CONTACT LENS ANTERIO, V34, P179, DOI 10.1016/j.clae.2011.02.002; Seal DV, 2003, EYE, V17, P893, DOI 10.1038/sj.eye.6700563; Shiraishi A, 2011, J JPN CONT LENS SOC, V53, pS34; SILVANY RE, 1991, OPHTHALMOLOGY, V98, P854; SILVANY RE, 1990, OPHTHALMOLOGY, V97, P286; Simmons PA, 1996, ICLC, V23, P94, DOI 10.1016/0892-8967(96)00029-6; STEHRGREEN JK, 1987, JAMA-J AM MED ASSOC, V258, P57, DOI 10.1001/jama.258.1.57; SUTTON SVW, 1991, J APPL BACTERIOL, V70, P351, DOI 10.1111/j.1365-2672.1991.tb02948.x; Takahashi K, 1986, IYAKU J, V22, P2229; Thebpatiphat Nuthida, 2007, Cornea, V26, P701, DOI 10.1097/ICO.0b013e31805b7e63; UNO T, 2011, SURVEY SEVERE CONTAC, V115, P107; Weisbarth RE, 2005, CLIN CONTACT LENS PR, P381	38	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1542-2321	1542-233X		EYE CONTACT LENS	Eye Contact Lens-Sci. Clin. Pra.	JUL	2015	41	4					240	244		10.1097/ICL.0000000000000112		5	Ophthalmology	Ophthalmology	CM1ZM	WOS:000357479200008		
J	Orabi, MAA; Yoshimura, M; Amakura, Y; Hatano, T				Orabi, Mohamed A. A.; Yoshimura, Mono; Amakura, Yoshiaki; Hatano, Tsutomu			Ellagitannins, gallotannins, and gallo-ellagitannins from the galls of Tamarix aphylla	FITOTERAPIA			English	Article						Tamaricaceae; Tamarix aphylla; Gall; Gallotannins; Ellagitannins; Gallo-ellagitannins	HYDROLYZABLE TANNINS; ACID; POLYPHENOLICS; DERIVATIVES; PLANTS	Chromatographic separation of an aqueous acetone extract of the galls from Tamarix aphylla using gels resulted in isolation of an ellagitannin, phyllagallin M1 (13), a gallo-ellagitannin, phyllagallin D1 (14), and four gallotannins, phyllagallin M2 (15) and phyllagallins D2-D4 (16-18), in addition to four known ellagitannins and three phenolics of lower molecular weight structurally related to hydrolyzable tannins. The structures of the six new tannins were elucidated based on spectroscopic and chemical data. Among the phenolics, flavogallonic acid dilactone (8), which is presumed to be biogenetically produced by C-C oxidative coupling of an ellagic acid unit with a galloyl residue, shows an exceptional oxidative pattern of gallic acid residues in plants of the family Tamaricaceae. Although the ellagitannin tamarixellagic acid (4) was reported to be a constituent of the galls of T. aphylla, such compounds with anomalous location of the DHDG moiety at O-3 on the glucopyranose core have not been observed among the tannins of tamaricaceous plants. (C) 2015 Elsevier B.V. All rights reserved.	[Orabi, Mohamed A. A.; Hatano, Tsutomu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan; [Yoshimura, Mono; Amakura, Yoshiaki] Matsuyama Univ, Coll Pharmaceut Sci, Matsuyama, Ehime 7908578, Japan	Hatano, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan.	hatano@pharm.okayama-u.ac.jp			Ministry of Higher Education and State for Scientific Research, Egypt;  [25450170]	M. A.A. O. thanks the Ministry of Higher Education and State for Scientific Research, Egypt for the post-doctoral scholarship. This study was supported in part by Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (No. 25450170). The NMR instrument used in this study is the property of the SC-NMR Laboratory of Okayama University.	Ahmad M., 2009, PAK J NUTR, V8, P542; Akhlaq M., 2011, INT RES J PHARM, V4, P222; OKUDA T, 1989, J NAT PROD, V52, P1, DOI 10.1021/np50061a001; OKUDA T, 1982, TETRAHEDRON LETT, V23, P3937, DOI 10.1016/S0040-4039(00)87748-5; Shuaibu MN, 2008, PARASITOL RES, V102, P1119, DOI 10.1007/s00436-008-0879-6; Ye G, 2007, CHEM NAT COMPD+, V43, P125, DOI 10.1007/s10600-007-0060-y; Nawwar MAM, 2009, PHARMAZIE, V64, P342, DOI 10.1691/ph.2009.8822; Ibrahim MA, 2014, J ETHNOPHARMACOL, V154, P26, DOI 10.1016/j.jep.2014.04.012; Feldman KS, 2005, PHYTOCHEMISTRY, V66, P1984, DOI 10.1016/j.phytochem.2004.11.015; WILKINS CK, 1976, PHYTOCHEMISTRY, V15, P211, DOI 10.1016/S0031-9422(00)89087-1; Barakat H. H., 1997, NAT PROD SCI, V2, P96; Bolous L., 1999, FLORA EGYPT, V2, P124; ISHAK MS, 1972, PLANTA MED, V21, P246; ISHAK MS, 1972, PLANTA MED, V21, P374; Kinjo J, 2001, BIOL PHARM BULL, V24, P1443, DOI 10.1248/bpb.24.1443; Han JW, 2012, J APPL PHYCOL, V24, P1279, DOI 10.1007/s10811-011-9776-y; Laaroussi I., 2013, European patent, Patent No. [EP 2629751 A1, 2629751]; Mahfoudhi A, 2014, J PHARMACEUT BIOMED, V99, P97, DOI 10.1016/j.jpba.2014.07.013; Miyamoto K. I., 1993, CANCER SCI, V84, P99, DOI 10.1111/j.1349-7006.1993.tb02790.x; Muddathir AM, 2013, J WOOD SCI, V59, P426, DOI 10.1007/s10086-013-1344-4; Nawwar MA, 2012, FITOTERAPIA, V83, P1256, DOI 10.1016/j.fitote.2012.06.007; NAWWAR MAM, 1994, PHYTOCHEMISTRY, V35, P1349, DOI 10.1016/S0031-9422(06)80123-8; Orabi M. A. A., 2010, J NAT PRODUCTS, V75, P870; Orabi M. A. A., 2010, HETEROCYCLES, V1, P463; Orabi MAA, 2013, J NAT PROD, V76, P947, DOI 10.1021/np4001625; Orabi MAA, 2011, PHYTOCHEMISTRY, V72, P1978, DOI 10.1016/j.phytochem.2011.07.011; Orabi MAA, 2009, PHYTOCHEMISTRY, V70, P1286, DOI 10.1016/j.phytochem.2009.07.019; Qadir MI, 2014, PAK J PHARM SCI, V27, P1985; Quideau S., 2008, CHEM BIOL ELLAGITANN, P203; TANAKA T, 1986, CHEM PHARM BULL, V34, P1039; YOSHIDA T, 1993, CHEM PHARM BULL, V41, P672	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0367-326X	1873-6971		FITOTERAPIA	Fitoterapia	JUL	2015	104						55	63		10.1016/j.fitote.2015.05.008		9	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CM2YB	WOS:000357547100009		
J	Yamauchi, K; Mitsunaga, T; Itakura, Y; Batubara, I				Yamauchi, Kosei; Mitsunaga, Tohru; Itakura, Yuki; Batubara, Irmanida			Extracellular melanogenesis inhibitory activity and the structure-activity relationships of ugonins from Helminthostachys zeylanica roots	FITOTERAPIA			English	Article						Helminthostachys zeylanica; Tyrosinase; B16 melanoma cell; Ugonin J; Ugonin K	B16 MELANOMA-CELLS; SIGNALING PATHWAY; P38 MAPK; FLAVONOIDS; QUERCETIN; BIOSYNTHESIS; EXPRESSION; COMPONENTS; RHIZOMES; ERK	Ugonin J, K, and L, which are luteolin derivatives, were isolated from Helminthostachys zeylanica roots by a series of chromatographic separations of a 50% ethanol/water extract. They were identified using nuclear magnetic resonance (NMR), ultraviolet (UV) spectra, and ultra-performance liquid chromatography coupled to time-of-flight mass spectrometry (UPLC-TOF-MS). In this study, the intra and extracellular melanogenic activity of the ugonins were determined using B16 melanoma cells. The results showed that ugonin J at 12.5, 25, and 50 mu M reduced extracellular melanin contents to 75, 16, and 14%, respectively, compared to the control. This indicates that ugonin J showed a stronger activity than arbutin, used as the positive control. Moreover, ugonin K showed a more potent inhibition with 19, 8, and 9% extracellular melanin reduction at the same concentrations, than that shown by ugonin J. In contrast, ugonin L did not inhibit intra- or extracellular melanogenic activity. Furthermore, in order to investigate the structure-activity relationships of the ugonins, the intra- and extacellular melanogenic activity of luteolin, methylluteolin, quercetin, eriodictyol, apigenin, and chrysin were determined. Consequently, it was suggested that the catechol and flavone skeleton of ugonin K is essential for the extracellular melanogenic inhibitory activity, and the low polarity substituent groups on the A ring of ugonin K may increase the activity. (C) 2015 Elsevier B.V. All rights reserved.	[Yamauchi, Kosei; Mitsunaga, Tohru] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Itakura, Yuki] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan; [Batubara, Irmanida] Bogor Agr Univ, Biopharmaca Res Ctr, Fac Math & Nat Sci, Dept Chem, Bogor 16151, Indonesia	Mitsunaga, T (reprint author), Gifu Univ, United Grad Sch Agr Sci, 1-1 Yanagido, Gifu 5011193, Japan.	mitunaga@gifu-u.ac.jp; ime@ipb.ac.id			Japan Society for the Promotion of Science (JSPS) for Research Fellowship	This research was supported by Japan Society for the Promotion of Science (JSPS) for Research Fellowship.	Alvaro S.F., 1995, BIOCHIM BIOPHYS ACTA, V1247, P1; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Jang JY, 2011, J ETHNOPHARMACOL, V137, P1207, DOI 10.1016/j.jep.2011.07.047; Ye Y, 2010, J ETHNOPHARMACOL, V132, P533, DOI 10.1016/j.jep.2010.09.007; Lan WC, 2013, PHYTOCHEMISTRY, V89, P78, DOI 10.1016/j.phytochem.2013.01.011; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Lee CH, 2011, EUR J PHARMACOL, V668, P383, DOI 10.1016/j.ejphar.2011.06.059; Wang HS, 2006, LWT-FOOD SCI TECHNOL, V39, P496, DOI 10.1016/j.lwt.2005.04.001; Jang JY, 2012, J ETHNOPHARMACOL, V141, P338, DOI 10.1016/j.jep.2012.02.043; Arung ET, 2011, FOOD CHEM, V124, P1024, DOI 10.1016/j.foodchem.2010.07.067; Arung T.E., 2011, FITOTERAPIA, V82, P198; Batubara I., 2011, J BIOL SCI, V8, P475; Batubara I., 2010, J BIOL SCI, V2, P138; Chan YY, 2011, J ETHNOPHARMACOL, V137, P1183, DOI 10.1016/j.jep.2011.07.050; Chiu N.Y., 1992, ILLUSTRATED MED PLAN, V3, P18; Diwakar G, 2012, FITOTERAPIA, V83, P989, DOI 10.1016/j.fitote.2012.06.004; Hirata N, 2007, BIOORGAN MED CHEM, V15, P4897, DOI 10.1016/j.bmc.2007.04.046; Huang YC, 2009, J NAT PROD, V72, P1273, DOI 10.1021/np900148a; Huang YL, 2003, PHYTOCHEMISTRY, V64, P1277, DOI 10.1016/j.phytochem.2003.09.009; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; LUKIEWICZ S, 1972, Folia Histochemica et Cytochemica, V10, P93; MURAKAMI T, 1973, CHEM PHARM BULL, V21, P1849; Suja SR, 2004, J ETHNOPHARMACOL, V92, P61, DOI 10.1016/j.jep.2004.01.019; Yamauchi K, 2013, J NAT MED-TOKYO, V67, P369, DOI 10.1007/s11418-012-0672-9; Yamauchi K, 2014, BIOORGAN MED CHEM, V22, P3331, DOI 10.1016/j.bmc.2014.04.053; Ye Y, 2010, PHYTOMEDICINE, V18, P32, DOI 10.1016/j.phymed.2010.06.004	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0367-326X	1873-6971		FITOTERAPIA	Fitoterapia	JUL	2015	104						69	74		10.1016/j.fitote.2015.05.006		6	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CM2YB	WOS:000357547100011		
J	Onodera, T; Kasahara, Y; Kasemura, T; Suzuki, Y; Kondo, E; Iwasaki, N				Onodera, Tomohiro; Kasahara, Yasuhiko; Kasemura, Toshiyuki; Suzuki, Yuki; Kondo, Eiji; Iwasaki, Norimasa			A Comparative Study With In Vitro Ultrasonographic and Histologic Grading of Metatarsal Head Cartilage in Rheumatoid Arthritis	FOOT & ANKLE INTERNATIONAL			English	Article						rheumatoid arthritis; forefoot deformity; articular cartilage; ultrasonography; histology	FEMORAL CONDYLAR CARTILAGE; FOREFOOT DEFORMITIES; FINGER JOINTS; FOLLOW-UP; FOOT PAIN; RECONSTRUCTION; RADIOGRAPHY; DISABILITY; OSTEOTOMY; VALIDITY	Background: Ultrasonography is among the valid methods to assess articular cartilage in the foot. This study aimed to evaluate the validity of ultrasonographic grading to assess metatarsal head articular cartilage for rheumatoid forefoot deformity in vivo and to compare the findings with in vitro ultrasonographic and histologic gradings. Methods: Participants were 15 patients scheduled to undergo resection arthroplasty of the metatarsal heads of the lesser toes because of rheumatoid arthritis of the metatarsophalangeal joints. Ultrasonographic examination was performed in vivo the day before surgery. Specimens of the second to fifth metatarsal heads taken intraoperatively were graded from in vitro ultrasonographic and histologic evaluations. Correlations among in vivo ultrasonographic, in vitro ultrasonographic, and histologic gradings were analyzed. Results: In 46 metatarsal heads, the distribution of grading ranged from grade 1 to 6 for in vivo ultrasonographic examinations and from grade 1 to 4 for histologic examinations. In vivo ultrasonographic grading showed significant correlation to both in vitro ultrasonographic grading (P < .001, R = 0.74) and histologic grading (P < .001, R = 0.67). Conclusions: The significant correlations between in vivo ultrasonographic and histologic gradings suggest that a semiquantitative in vivo ultrasonographic assessment of forefoot deformity in rheumatoid arthritis may be possible. Ultrasonographic grading may prove useful for pre- and postoperative evaluation of remaining joint function in rheumatoid forefoot deformity. An ultrasonographic grading system for remaining joint surfaces might be helpful in selecting surgical procedures such as joint-sparing osteotomy and metatarsal head resection. Level of Evidence: Level IV, case series.	[Onodera, Tomohiro; Kasahara, Yasuhiko; Kasemura, Toshiyuki; Suzuki, Yuki; Iwasaki, Norimasa] Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido 0608638, Japan; [Kondo, Eiji] Hokkaido Univ, Grad Sch Med, Dept Adv Therapeut Res Sports Med, Sapporo, Hokkaido 0608638, Japan	Onodera, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	tomozou@med.hokudai.ac.jp					Disler DG, 2000, RADIOLOGY, V215, P846; Lee CL, 2008, OSTEOARTHR CARTILAGE, V16, P352, DOI 10.1016/j.joca.2007.07.013; Tsai CY, 2007, OSTEOARTHR CARTILAGE, V15, P245, DOI 10.1016/j.joca.2006.08.009; Backhaus M, 1999, ARTHRITIS RHEUM, V42, P1232, DOI 10.1002/1529-0131(199906)42:6<1232::AID-ANR21>3.0.CO;2-3; Scheel AK, 2006, ANN RHEUM DIS, V65, P595, DOI 10.1136/ard.2005.041814; Coughlin MJ, 2000, J BONE JOINT SURG AM, V82A, P322; van der Leeden M, 2006, RHEUMATOLOGY, V45, P465, DOI 10.1093/rheumatology/kei186; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481; Baan H, 2011, J RHEUMATOL, V38, P1003, DOI 10.3899/jrheum.100906; FLEMING A, 1976, ANN RHEUM DIS, V35, P361, DOI 10.1136/ard.35.4.361; Hanyu T, 1997, CLIN ORTHOP RELAT R, P131; HASSELO LG, 1987, FOOT ANKLE, V8, P148; JONSSON K, 1992, ACTA RADIOL, V33, P234; MANN RA, 1995, FOOT ANKLE INT, V16, P1; MARTEL W, 1991, J RHEUMATOL, V18, P32; McCune WJ, 1990, CLIN ORTHOP RELAT RE, P230; MICHELSON J, 1994, FOOT ANKLE INT, V15, P608; Mulcahy D, 2003, J RHEUMATOL, V30, P1440; Nagashima M, 2007, CLIN RHEUMATOL, V26, P748, DOI 10.1007/s10067-006-0514-9; Otter SJ, 2010, CLIN RHEUMATOL, V29, P255, DOI 10.1007/s10067-009-1312-y; Siddle HJ, 2014, RHEUMATOLOGY, V53, P932, DOI 10.1093/rheumatology/ket478; VAINIO K, 1956, Ann Chir Gynaecol Fenn Suppl, V45, P1; Van Der Leeden M, 2008, ARTHRIT RHEUM-ARTHR, V59, P1257, DOI 10.1002/art.24016	23	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1071-1007	1944-7876		FOOT ANKLE INT	Foot Ankle Int.	JUL	2015	36	7					774	779		10.1177/1071100715575021		6	Orthopedics	Orthopedics	CL9KA	WOS:000357295900005		
J	Yamaguchi, S; Endo, J; Yamamoto, Y; Sasho, T				Yamaguchi, Satoshi; Endo, Jun; Yamamoto, Yohei; Sasho, Takahisa			Double-Row Bridging Suture Fixation Augmented With Double Krackow Suture for the Repair of Avulsion of the Ossified Achilles Tendon: A Technical Tip	FOOT & ANKLE INTERNATIONAL			English	Article						Achilles tendon; ossification; bridging suture; Krackow suture	SINGLE-ROW; SURGICAL-TREATMENT; FRACTURE; TENDINOSIS; STRENGTH		[Yamaguchi, Satoshi; Endo, Jun; Yamamoto, Yohei; Sasho, Takahisa] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chiba 2608670, Japan	Yamaguchi, S (reprint author), Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	y-satoshi@mvb.biglobe.ne.jp					Akizuki KH, 2001, BRIT J SPORT MED, V35, P329, DOI 10.1136/bjsm.35.5.329; Aksoy M C, 1998, Acta Orthop Belg, V64, P418; Rigby RB, 2013, J FOOT ANKLE SURG, V52, P575, DOI 10.1053/j.jfas.2012.11.004; Goyal S, 1997, ARCH ORTHOP TRAUM SU, V116, P312, DOI 10.1007/BF00390061; Parton MJ, 1998, CLIN RADIOL, V53, P538, DOI 10.1016/S0009-9260(98)80179-7; Lee SJ, 2008, FOOT ANKLE INT, V29, P427, DOI 10.3113/FAI.2008.0427; Benjamin M, 2006, J ANAT, V208, P471, DOI 10.1111/j.1469-7580.2006.00540.x; McCoy BW, 2010, FOOT ANKLE INT, V31, P701, DOI 10.3113/FAI.2010.0701; Battaglia TC, 2006, ORTHOPEDICS, V29, P453; Beitzel K, 2013, AM J SPORT MED, V41, P1642, DOI 10.1177/0363546513487061; Blitz Neal M, 2007, J Foot Ankle Surg, V46, P133, DOI 10.1053/j.jfas.2007.01.004; Cox JT, 2014, AM J SPORT MED, V42, P2727, DOI 10.1177/0363546514549004; Greenhagen Robert M, 2013, Foot Ankle Spec, V6, P185, DOI 10.1177/1938640012473150; Lui T H, 2009, Foot Ankle Surg, V15, P58, DOI 10.1016/j.fas.2008.06.004; Pilson H, 2012, J FOOT ANKLE SURG, V51, P762, DOI 10.1053/j.jfas.2012.07.001; Vaishnav Suketu, 2010, J Shoulder Elbow Surg, V19, P83, DOI 10.1016/j.jse.2009.12.012; Witt BL, 2012, J FOOT ANKLE SURG, V51, P487, DOI 10.1053/j.jfas.2012.03.006; Xu CQ, 2014, J SHOULDER ELB SURG, V23, P182, DOI 10.1016/j.jse.2013.08.005	18	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1071-1007	1944-7876		FOOT ANKLE INT	Foot Ankle Int.	JUL	2015	36	7					849	852		10.1177/1071100715575001		4	Orthopedics	Orthopedics	CL9KA	WOS:000357295900016		
J	Mochizuki, H; Yamagishi, K; Suzuki, K; Kim, YS; Kimata, K				Mochizuki, Hideo; Yamagishi, Kiwamu; Suzuki, Kiyoshi; Kim, Yeong Shik; Kimata, Koji			Heparosan-glucuronate 5-epimerase: Molecular cloning and characterization of a novel enzyme	GLYCOBIOLOGY			English	Article						acharan sulfate; Achatina fulica; 5-epimerase; heparan sulfate; iduronic acid	SNAIL ACHATINA-FULICA; AUG INITIATOR CODON; SULFATE IN-VIVO; HEPARAN-SULFATE; HEPARIN/HEPARAN SULFATE; ACHARAN SULFATE; CAPSULAR POLYSACCHARIDE; SUBSTRATE-SPECIFICITY; C-5 EPIMERASE; BIOSYNTHESIS	Iduronic acid (IdoA) is a critical component of heparan sulfate in its interaction with functional proteins. Heparosan-N-sulfate-glucuronate 5-epimerase (HNSG-5epi) converts d-glucuronic acid (GlcA) residues in N-sulfated heparosan (NS-heparosan), as an intermediate in heparan sulfate biosynthesis, to IdoA. In the present study, the authors discovered a different 5-epimerase, designated HG-5epi (heparosan-glucuronate 5-epimerase), that is involved in acharan sulfate biosynthesis and possesses novel substrate specificity. A candidate cDNA of HG-5epi was cloned from the cDNA library of Achatina fulica. The cloned cDNA contained a whole coding region that predicts a type II transmembrane protein composed of 601 amino acid residues. The amino acid sequence of HG-5epi is homologous to that of HNSG-5epi. Recombinant HG-5epi was expressed in insect cells and its enzymatic properties characterized. As expected, HG-5epi epimerizes GlcA residues in heparosan, but not in NS-heparosan. Conversion of IdoA to GlcA was also catalyzed by HG-5epi when completely desulfated N-acetylated heparin was used as the substrate, indicating a reversible reaction mechanism. At equilibrium of the epimerization, the proportion of IdoA in the reaction product reached up to 30% of total hexuronic acid. To our knowledge, this is the first report to describe an enzyme that catalyzes the epimerization of non-sulfated heparosan. This new enzyme may be applied to the study of synthetic heparan sulfate-related polysaccharides having certain biological and pharmacological activities. In addition, a new method using anion-exchange HPLC connected to a post-column fluorescent labeling system was developed for analyzing hexuronic acid isomers.	[Mochizuki, Hideo; Yamagishi, Kiwamu; Suzuki, Kiyoshi] Seikagaku Corp, Cent Res Labs, Tokyo 2070021, Japan; [Kim, Yeong Shik] Seoul Natl Univ, Coll Pharm, Inst Nat Prod Res, Seoul 151742, South Korea; [Kimata, Koji] Aichi Med Univ, Adv Med Res Ctr, Nagakute, Aichi 4801195, Japan	Mochizuki, H (reprint author), Seikagaku Corp, Cent Res Labs, 3-1253 Tateno, Tokyo 2070021, Japan.	hideo.mochizuki@seikagaku.co.jp					Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI13530; Kim YS, 1996, J BIOL CHEM, V271, P11750; MERCHANT ZM, 1985, BIOCHEM J, V229, P369; Mochizuki H, 2003, J BIOL CHEM, V278, P26780, DOI 10.1074/jbc.M301861200; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; SHAKLEE PN, 1984, BIOCHEM J, V217, P187; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Ghosh AK, 2002, BRIT J PHARMACOL, V137, P441, DOI 10.1038/sj.bjp.0704886; CASU B, 1988, TRENDS BIOCHEM SCI, V13, P221, DOI 10.1016/0968-0004(88)90088-6; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200; OCHMAN H, 1988, GENETICS, V120, P621; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; Shim JY, 2002, ARCH PHARM RES, V25, P889, DOI 10.1007/BF02977010; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; Rostand KS, 1997, INFECT IMMUN, V65, P1; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Lee YS, 2003, EUR J PHARMACOL, V465, P191, DOI 10.1016/S0014-2999(03)01458-4; Li DW, 2004, THROMB RES, V113, P67, DOI 10.1016/j.thromres.2004.02.003; Liu CH, 2014, J BIOL CHEM, V289, P13407, DOI 10.1074/jbc.M113.530535; Qin Y, 2015, J BIOL CHEM, V290, P4620, DOI 10.1074/jbc.M114.602201; Hagner-McWhirter A, 2000, BIOCHEM J, V347, P69, DOI 10.1042/0264-6021:3470069; Babu P, 2011, ANAL BIOANAL CHEM, V401, P237, DOI 10.1007/s00216-011-5087-z; CAMPBELL P, 1994, J BIOL CHEM, V269, P26953; Chappell EP, 2013, BIOORGAN MED CHEM, V21, P4786, DOI 10.1016/j.bmc.2012.11.053; Crawford BE, 2001, J BIOL CHEM, V276, P21538; GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9; Hagner-McWhirter A, 2000, GLYCOBIOLOGY, V10, P159, DOI 10.1093/glycob/10.2.159; HOOK M, 1974, BIOCHEM J, V137, P33; JACOBSSON I, 1979, BIOCHEM J, V179, P77; JACOBSSON I, 1979, J BIOL CHEM, V254, P2975; JENSEN JW, 1983, CARBOHYD RES, V117, P241, DOI 10.1016/0008-6215(83)88090-2; Jeong J, 2001, COMP BIOCHEM PHYS B, V130, P513, DOI 10.1016/S1096-4959(01)00468-7; Leali D, 2001, J BIOL CHEM, V276, P37900; Li JP, 2001, J BIOL CHEM, V276, P20069, DOI 10.1074/jbc.M011783200; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; PRIHAR HS, 1980, BIOCHEMISTRY-US, V19, P495, DOI 10.1021/bi00544a016; Raedts J, 2013, J BIOL CHEM, V288, P24332, DOI 10.1074/jbc.M113.476440; Raedts J, 2011, GLYCOCONJUGATE J, V28, P57, DOI 10.1007/s10719-011-9324-7; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Suzuki K, 2008, GLYCOCONJUGATE J, V25, P703, DOI 10.1007/s10719-008-9130-z	46	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	JUL	2015	25	7					735	744		10.1093/glycob/cwv013		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CM2PD	WOS:000357522600005		
J	Nonaka, Y; Ogawa, T; Yoshida, H; Shoji, H; Nishi, N; Kamitori, S; Nakamura, T				Nonaka, Yasuhiro; Ogawa, Takashi; Yoshida, Hiromi; Shoji, Hiroki; Nishi, Nozomu; Kamitori, Shigehiro; Nakamura, Takanori			Crystal structure of a Xenopus laevis skin proto-type galectin, close to but distinct from galectin-1	GLYCOBIOLOGY			English	Article						amphibian skin secretion; galectin; Xenopus laevis; X-ray crystallography	GALACTOSIDE-BINDING LECTINS; CONGER EEL; FUNGAL GALECTIN; LACTOSE-BINDING; CROSS-LINKING; BALL SPONGE; FAMILY; RECOGNITION; EVOLUTION; PURIFICATION	Xenopus laevis (African clawed frog) has two types of proto-type galectins that are similar to mammalian galectin-1 in amino acid sequence. One type, comprising xgalectin-Ia and -Ib, is regarded as being equivalent to galectin-1, and the other type, comprising xgalectin-Va and -Vb, is expected to be a unique galectin subgroup. The latter is considerably abundant in frog skin; however, its biological function remains unclear. We determined the crystal structures of two proto-type galectins, xgalectin-Ib and -Va. The structures showed that both galectins formed a mammalian galectin-1-like homodimer, and furthermore, xgalectin-Va formed a homotetramer. This tetramer structure has not been reported for other galectins. Gel filtration and other experiments indicated that xgalectin-Va was in a dimer-tetramer equilibrium in solution, and lactose binding enhanced the tetramer formation. The residues involved in the dimer-dimer association were conserved in xgalectin-Va and -Vb, and one of the Xenopus (Silurana) tropicalis proto-type galectins, but not in xgalectin-Ia and -Ib, and other galectin-1-equivalent proteins. Xgalectin-Va preferred Gal beta 1-3GalNAc and not Gal beta 1-4GlcNAc, while xgalectin-Ib preferred Gal beta 1-4GlcNAc as well as human galectin-1. Xgalectin-Va/Vb would have diverged from the galectin-1 group with accompanying acquisition of the higher oligomer formation and altered ligand selectivity.	[Nonaka, Yasuhiro; Ogawa, Takashi; Shoji, Hiroki; Nakamura, Takanori] Kagawa Univ, Fac Med, Dept Endocrinol, Kagawa, Japan; [Yoshida, Hiromi; Nishi, Nozomu; Kamitori, Shigehiro] Kagawa Univ, Life Sci Res Ctr, Kagawa, Japan; [Shoji, Hiroki] Kanazawa Med Univ, Dept Biol, Kanazawa, Ishikawa, Japan	Nakamura, T (reprint author), Kagawa Univ, Fac Med, Dept Endocrinol, Kagawa, Japan.	tnaka@med.kagawa-u.ac.jp			Kagawa University	This research is supported by Kagawa University Scientific Research encourages research funding 2014.	Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Nesmelova IV, 2010, J MOL BIOL, V397, P1209, DOI 10.1016/j.jmb.2010.02.033; NOWAK TP, 1976, BIOCHEM BIOPH RES CO, V68, P650, DOI 10.1016/0006-291X(76)91195-5; BOURNE Y, 1994, NAT STRUCT BIOL, V1, P863, DOI 10.1038/nsb1294-863; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Conlon JM, 2014, PEPTIDES, V57, P67, DOI 10.1016/j.peptides.2014.04.019; Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089; Whelan S, 2001, MOL BIOL EVOL, V18, P691; Shirai T, 1999, STRUCTURE, V7, P1223, DOI 10.1016/S0969-2126(00)80056-8; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Shoji H, 2003, J BIOL CHEM, V278, P12285, DOI 10.1074/jbc.M209008200; Than NG, 2012, TRENDS ENDOCRIN MET, V23, P23, DOI 10.1016/j.tem.2011.09.003; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; KAMIYA H, 1988, DEV COMP IMMUNOL, V12, P309, DOI 10.1016/0145-305X(88)90007-9; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275; Brewer CF, 2002, BBA-GEN SUBJECTS, V1572, P255; Diehl C, 2010, J AM CHEM SOC, V132, P14577, DOI 10.1021/ja105852y; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; MARSCHAL P, 1992, J BIOL CHEM, V267, P12942; Ermakova E, 2013, GLYCOBIOLOGY, V23, P508, DOI 10.1093/glycob/cwt005; Cooper DNW, 1999, GLYCOBIOLOGY, V9, P979, DOI 10.1093/glycob/9.10.979; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Leonidas DD, 1998, BIOCHEMISTRY-US, V37, P13930, DOI 10.1021/bi981056x; Ahmed H, 1996, J BIOL CHEM, V271, P33083; Copits BA, 2014, J PHYSIOL-LONDON, V592, P2079, DOI 10.1113/jphysiol.2013.269597; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; Ban M, 2005, J MOL BIOL, V351, P695, DOI 10.1016/j.jmb.2005.06.045; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Cardoso M. H., 2014, Journal of Clinical Toxicology, V4, P205; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Earl LA, 2011, GLYCOBIOLOGY, V21, P6, DOI 10.1093/glycob/cwq144; Freymann DM, 2012, ACTA CRYSTALLOGR D, V68, P1163, DOI 10.1107/S0907444912022834; Hamelryck TW, 2000, J MOL BIOL, V299, P875, DOI 10.1006/jmbi.2000.3785; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; Iwaki J, 2011, BBA-GEN SUBJECTS, V1810, P643, DOI 10.1016/j.bbagen.2011.04.001; MARSCHAL P, 1994, GLYCOBIOLOGY, V4, P297, DOI 10.1093/glycob/4.3.297; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura O, 2007, FISH SHELLFISH IMMUN, V23, P683, DOI 10.1016/j.fsi.2007.01.018; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Shoji H, 2002, GLYCOBIOLOGY, V12, P163, DOI 10.1093/glycob/12.3.163; TRACEY BM, 1992, J BIOL CHEM, V267, P10342; Uchiyama H, 1997, GLYCOBIOLOGY, V7, P1159, DOI 10.1093/glycob/7.8.1159; Ueda T, 2013, GLYCOBIOLOGY, V23, P412, DOI 10.1093/glycob/cws165; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780	50	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	JUL	2015	25	7					792	803		10.1093/glycob/cwv020		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CM2PD	WOS:000357522600011		
J	Yuzhe, H; Kamijo, Y; Hashimoto, K; Harada, M; Kanno, T; Sugiyama, E; Kyogashima, M; Oguchi, T; Nakajima, T; Kanno, Y; Aoyama, T				Yuzhe, Huang; Kamijo, Yuji; Hashimoto, Koji; Harada, Makoto; Kanno, Taro; Sugiyama, Eiko; Kyogashima, Mamoru; Oguchi, Tomomasa; Nakajima, Takero; Kanno, Yutaka; Aoyama, Toshifumi			Serum sulfatide abnormality is associated with increased oxidative stress in hemodialysis patients	HEMODIALYSIS INTERNATIONAL			English	Article						Cardiovascular disease; hemodialysis; malondialdehyde; oxidative stress; serum sulfatide level	CARDIOVASCULAR-DISEASE; CEREBROSIDE SULFOTRANSFERASE; RENAL-FAILURE; ANTICOAGULANT; EXPRESSION; PREVENTION; TISSUES; RABBIT; KIDNEY; TIME	Sulfatides are major glycosphingolipids of lipoproteins that influence atherosclerosis and blood coagulation. Our previous cross-sectional study of hemodialysis patients showed that serum sulfatide levels decreased markedly with increasing duration of hemodialysis treatment, which may contribute to the development of cardiovascular disease. However, this past study could not demonstrate the time-dependent change in serum sulfatide levels in each patient, and the underlying mechanism is unknown. To confirm the time-dependent aggravation of serum sulfatide abnormality, 95 stable hemodialysis outpatients were followed up for 3 years. To show the underlying mechanisms, we statistically analyzed correlations between serum sulfatide levels and clinical factors, including an oxidative stress marker, malondialdehyde. Serum sulfatides were quantified by mass spectrometry after conversion to lysosulfatides. Malondialdehyde was measured using a colorimetric assay. The results showed a time-dependent decrease in serum sulfatide levels associated with increased malondialdehyde levels, although the absolute level of serum malondialdehyde does not determine the baseline level of serum sulfatides. Multiple linear regression analysis showed a significant correlation only between the time-dependent change in serum sulfatide levels and the time-dependent change in serum malondialdehyde levels. This study demonstrated, for the first time, a time-dependent aggravation of serum sulfatide abnormality in hemodialysis patients, as well as the potential relationship between serum sulfatide abnormality and increasing oxidative stress. These findings suggest that oxidative stress might be an aggravating factor in serum sulfatide abnormality. As continuation of hemodialysis treatment hardly improves abnormal serum sulfatide levels or increased oxidative stress, development of novel therapeutic strategies may be important.	[Yuzhe, Huang; Kamijo, Yuji; Harada, Makoto; Sugiyama, Eiko; Nakajima, Takero; Aoyama, Toshifumi] Shinshu Univ, Grad Sch Med, Dept Metab Regulat, Inst Pathogenesis & Dis Prevent, Matsumoto, Nagano 3908621, Japan; [Yuzhe, Huang] Hebei Med Univ, Dept Human Anat, Shijiazhuang, Hebei, Peoples R China; [Kamijo, Yuji; Hashimoto, Koji; Harada, Makoto; Kanno, Taro] Shinshu Univ, Sch Med, Dept Nephrol, Matsumoto, Nagano 3908621, Japan; [Sugiyama, Eiko] Nagano Prefectural Coll, Dept Nutr Sci, Nagano, Nagano, Japan; [Kyogashima, Mamoru] Nihon Pharmaceut Univ, Dept Microbiol & Mol Cell Biol, Ina, Saitama, Japan; [Oguchi, Tomomasa] Aizawa Hosp, Kidney Dis & Dialysis Ctr, Matsumoto, Nagano, Japan; [Kanno, Yutaka] Kanno Dialysis & Vasc Access Clin, Dept Nephrol, Matsumoto, Nagano, Japan	Kamijo, Y (reprint author), Shinshu Univ, Sch Med, Dept Nephrol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	yujibeat@shinshu-u.ac.jp			GL Sciences (Tokyo, Japan)	This work was supported by GL Sciences (Tokyo, Japan) who supplied MonoTip C18, an essential material for measuring serum sulfatides. We would like to thank Ms Takayo Maruyama (Aizawa Hospital, Matsumoto, Japan) for collecting serum samples.	Locatelli F, 2000, NEPHROL DIAL TRANSPL, V15, P69, DOI 10.1093/ndt/15.suppl_5.69; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Coombes JS, 2012, KIDNEY INT, V81, P233, DOI 10.1038/ki.2011.341; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Lekawanvijit S, 2012, CIRC RES, V111, P1470, DOI 10.1161/CIRCRESAHA.112.278457; AOYAMA T, 1989, J BIOL CHEM, V264, P10388; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; Hara A, 1996, GLYCOCONJUGATE J, V13, P187, DOI 10.1007/BF00731493; HARA A, 1991, J BIOCHEM-TOKYO, V109, P904; HARA A, 1987, J BIOCHEM-TOKYO, V102, P83; Hu R, 2007, GLYCOCONJUGATE J, V24, P565, DOI 10.1007/s10719-007-9053-0; Kamijo Y, 2012, CLIN EXP NEPHROL, V16, P959, DOI 10.1007/s10157-012-0634-2; Kanbe H, 2014, ARCH TOXICOL, V88, P367, DOI 10.1007/s00204-013-1132-3; Kyogashima M, 1998, ACTA BIOCHIM POL, V45, P493; Li G, 2007, ANAL BIOCHEM, V362, P1, DOI 10.1016/j.ab.2006.12.024; Lopez-Hernandez FJ, 2009, KIDNEY INT, V76, P1022, DOI 10.1038/ki.2009.229; Nakajima T, 2013, GLYCOCONJUGATE J, V30, P553, DOI 10.1007/s10719-012-9454-6; Wang LX, 2011, GLYCOCONJUGATE J, V28, P125, DOI 10.1007/s10719-011-9329-2; Zhang XW, 2009, BIOCHEM BIOPH RES CO, V390, P1382, DOI 10.1016/j.bbrc.2009.10.164; ZHU XH, 1991, J BIOCHEM-TOKYO, V110, P241	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1492-7535	1542-4758		HEMODIAL INT	Hemodial. Int.	JUL	2015	19	3					429	438		10.1111/hdi.12270		10	Urology & Nephrology	Urology & Nephrology	CM0TB	WOS:000357390300013		
J	Ono, M				Ono, Masafumi			Is non-alcoholic fatty liver disease a systemic disease that promotes extrahepatic cancer development?	HEPATOLOGY RESEARCH			English	Editorial Material							HELICOBACTER-PYLORI INFECTION; CLINICAL-IMPLICATIONS; HEPATITIS-C; OBESITY; STEATOHEPATITIS; LUNG		Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan	Ono, M (reprint author), Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan.						Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974; Polyzos SA, 2013, METABOLISM, V62, P121, DOI 10.1016/j.metabol.2012.06.007; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103; Yang Y, 2013, INT J CANCER, V132, P1162, DOI 10.1002/ijc.27719; Hashimoto E, 2009, J GASTROENTEROL, V44, P89, DOI 10.1007/s00535-008-2262-x; Eshraghian A, 2009, DIGEST DIS SCI, V54, P1966, DOI 10.1007/s10620-008-0557-7; Arase Y, 2012, HEPATOL RES, V42, P264, DOI 10.1111/j.1872-034X.2011.00915.x; BENS Q, 2011, EUR J CANCER, V47, P1928; Goto K, 2001, MODERN PATHOL, V14, P1237, DOI 10.1038/modpathol.3880468; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; KAWAMURA M, 1994, THORAX, V49, P144, DOI 10.1136/thx.49.2.144; Lins XJ, 2014, JPN J CLIN ONCOL, V44, P783; ohlunds D, 2013, BMC CANCER, V13, P154; Seko Y, 2015, HEPATOL RES, V45, P728, DOI 10.1111/hepr.12407	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUL	2015	45	7					711	713		10.1111/hepr.12435		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4WB	WOS:000357684900001		
J	Suzuki, K; Kataoka, K; Miyamoto, Y; Miyasaka, A; Kumagai, I; Takikawa, Y; Takahashi, M; Okamoto, H				Suzuki, Kazuyuki; Kataoka, Kojiro; Miyamoto, Yasuhiro; Miyasaka, Akio; Kumagai, Ichiro; Takikawa, Yasuhiro; Takahashi, Masaharu; Okamoto, Hiroaki			Clinical and molecular analyses of sporadic acute hepatitis A and E and the specific viral genotypes isolated in Iwate and three neighboring prefectures in the northern part of Honshu, Japan, between 2004 and 2013	HEPATOLOGY RESEARCH			English	Article						acute liver injury; acute viral hepatitis; genotype; hepatitis A virus; hepatitis E virus	E VIRUS-INFECTION; NON-B HEPATITIS; SUBGENOTYPE IIIA; PIG-LIVER; WILD BOAR; STRAINS; EPIDEMIOLOGY; PREGNANCY; HOKKAIDO; ENCEPHALOPATHY	AimTo examine the prevalence and characteristics of hepatitis A virus (HAV) and hepatitis E virus (HEV) infections in the northern part of Honshu, Japan, during the last decade. MethodsUsing the registration system of a prospective cohort study for acute liver injury (ALI) in Iwate and three neighboring prefectures, we examined the prevalence of sporadic acute hepatitis (AH) with HAV (AH-A) and HEV (AH-E) and the distribution of viral genotypes in 487 patients diagnosed with ALI between 2004 and 2013. ResultsAmong all 487 patients, 135 (28%) had ALI with viral infection. In the cases with viral ALI, the prevalence of hepatitis B virus-related AH was highest (55.6%). AH-E was seen in 23 patients (17.0%) and its prevalence was higher than that of AH-A (10 patients, 7.4%). There were no appreciable differences in the prevalence of AH-A and AH-E between 2004-2008 and 2009-2013. However, subgenotype IIIA HAV homologous to Korean strains has recently emerged, and the number of AH-E cases seems to be increasing. HEV genotype 3 was predominant throughout the observation period, but HEV genotype 4 was found in three patients after 2010. The transmission routes of HAV and HEV infections were unknown in approximately 60% of the patients. ConclusionIn the northern part of Honshu, Japan, HEV has been more frequently implicated in the development of AH than HAV, and HEV genotype 4 has been recently increasing. To provide an effective prophylactic management for HAV and HEV infections, further clarification of the transmission routes is needed.	[Suzuki, Kazuyuki] Morioka Univ, Dept Nutr Sci, Takizawa, Iwate 0200694, Japan; [Suzuki, Kazuyuki; Kataoka, Kojiro; Miyamoto, Yasuhiro; Miyasaka, Akio; Takikawa, Yasuhiro] Iwate Med Univ, Dept Internal Med, Div Hepatol, Morioka, Iwate 020, Japan; [Kumagai, Ichiro] Morioka City Hosp, Dept Internal Med, Morioka, Iwate, Japan; [Takahashi, Masaharu; Okamoto, Hiroaki] Jichi Med Univ, Sch Med, Div Virol, Dept Infect & Immun, Shimotsuke, Japan	Suzuki, K (reprint author), Morioka Univ, Dept Nutr Sci, 808 Sunagomi, Takizawa, Iwate 0200694, Japan.	kasuzuki@morioka-u.ac.jp	Okamoto, Hiroaki/H-4371-2011	Okamoto, Hiroaki/0000-0003-0827-0964	Ministry of Health, Labor and Welfare of Japan [H24-Hepatitis-General-002]	WE EXPRESS OUR deep gratitude to the many physicians who participated in this prospective cohort study of acute liver injury in the northern part of Honshu, Japan. We also thank Miss Kouko Motodate for the preparation of serum samples. This study was supported in part by a grant from the Ministry of Health, Labor and Welfare of Japan (H24-Hepatitis-General-002).	Abes T, 2006, KANZO, V47, P384; Matsuda H, 2003, J INFECT DIS, V188, P944, DOI 10.1086/378074; Endo K, 2007, J MED VIROL, V79, P8, DOI 10.1002/jmv.20757; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Zhou XY, 2013, REV MED VIROL, V23, P295, DOI 10.1002/rmv.1751; Suzuki K, 2002, NEW ENGL J MED, V347, P1456, DOI 10.1056/NEJM200210313471819; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; Kiyohara T, 2007, MICROBIOL IMMUNOL, V51, P185; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Tamada Y, 2004, J HEPATOL, V40, P869, DOI 10.1016/j.jhep.2003.12.026; Takahashi M, 2010, J MED VIROL, V82, P271, DOI 10.1002/jmv.21678; Takahashi M, 2005, J CLIN MICROBIOL, V43, P49, DOI 10.1128/JCM.43.1.49-56.2005; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; Yazaki Y, 2003, J GEN VIROL, V84, P2351, DOI 10.1099/vir.0.19242-0; Patra S, 2007, ANN INTERN MED, V147, P28; ROBERTSON BH, 1992, J GEN VIROL, V73, P1365, DOI 10.1099/0022-1317-73-6-1365; Mitsui T, 2006, J MED VIROL, V78, P1015, DOI 10.1002/jmv.20657; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Gerolami R, 2011, J CLIN VIROL, V52, P60, DOI 10.1016/j.jcv.2011.06.004; Matsubayashi K, 2004, TRANSFUSION, V44, P934, DOI 10.1111/j.1537-2995.2004.03300.x; Yano K, 2010, INTERVIROLOGY, V53, P70, DOI 10.1159/000252788; Takahashi M, 2003, J GEN VIROL, V84, P851, DOI 10.1099/vir.0.18918-0; Mizuo H, 2005, J MED VIROL, V76, P341, DOI 10.1002/jmv.20364; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0; Kamar N, 2013, CURR OPIN GASTROEN, V29, P271, DOI 10.1097/MOG.0b013e32835ff238; Sugawara K, 2012, J GASTROENTEROL, V47, P849, DOI 10.1007/s00535-012-0624-x; Mochida S, 2014, HEPATOL RES, V44, P365, DOI 10.1111/hepr.12295; Wedemeyer H, 2012, GASTROENTEROLOGY, V142, P1388, DOI 10.1053/j.gastro.2012.02.014; Mizuo H, 2002, J CLIN MICROBIOL, V40, P3209, DOI 10.1128/JCM.40.9.3209-3218.2002; Takikawa Y, 2009, J HEPATOL, V51, P1021, DOI 10.1016/j.jhep.2009.09.011; Endo K, 2007, VIRUS RES, V126, P116, DOI 10.1016/j.virusres.2007.02.005; Fujimotos S, 2014, KANZO, V55, P405; Gonzalez TA, 2011, GASTROENTEROL HEPATO, V34, P398; Grewal P, 2014, HEPATOLOGY, V59, P347, DOI 10.1002/hep.26636; Ishiis K, 2012, J CLIN VIROL, V53, P219; Kwon SY, 2014, J KOREAN MED SCI, V29, P248, DOI 10.3346/jkms.2014.29.2.248; Lees H, 2012, J CLIN MICROBIOL, V50, P1252; Lis TC, 2005, EMERG INFECT DIS, V11, P1958; Lus L, 2006, REV MED VIROL, V16, P5; Lus L, 2004, J GEN VIROL, V85, P2943; Miyamura T, 2012, HEPATOL RES, V42, P248, DOI 10.1111/j.1872-034X.2011.00919.x; NAYAK NC, 1989, J GASTROEN HEPATOL, V4, P345, DOI 10.1111/j.1440-1746.1989.tb00846.x; Okamoto H, 2003, INTERNAL MED, V42, P1065, DOI 10.2169/internalmedicine.42.1065; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Sainokami S, 2004, J GASTROENTEROL, V39, P640, DOI 10.1007/s00535-003-1359-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Takahashi M, 2014, HEPATOL RES, V44, P43, DOI 10.1111/hepr.12175; Takahashi H, 2006, J GASTROENTEROL, V41, P981, DOI 10.1007/s00535-006-1888-9; Takikawa Y, 2007, HEPATOL RES, V37, P158, DOI 10.1111/j.1872-034X.2007.00021.x; Takikawa Y, 2006, DIGEST DIS SCI, V51, P359, DOI 10.1007/s10620-006-3138-7; Teis S, 2003, LANCET, V362, P371; Toyodas H, 2009, J CLIN VIROL, V44, P145; Umemuras M, 2014, KANZO, V55, P349; Watanabe S, 2014, HEPATOL RES, V44, P270, DOI 10.1111/hepr.12124	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUL	2015	45	7					714	727		10.1111/hepr.12406		14	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4WB	WOS:000357684900002		
J	Seko, Y; Sumida, Y; Tanaka, S; Taketani, H; Kanemasa, K; Ishiba, H; Okajima, A; Nishimura, T; Yamaguchi, K; Moriguchi, M; Mitsuyoshi, H; Yasui, K; Minami, M; Itoh, Y				Seko, Yuya; Sumida, Yoshio; Tanaka, Saiyu; Taketani, Hiroyoshi; Kanemasa, Kazuyuki; Ishiba, Hiroshi; Okajima, Akira; Nishimura, Takeshi; Yamaguchi, Kanji; Moriguchi, Michihisa; Mitsuyoshi, Hironori; Yasui, Kohichiroh; Minami, Masahito; Itoh, Yoshito			Predictors of malignancies and overall mortality in Japanese patients with biopsy-proven non-alcoholic fatty liver disease	HEPATOLOGY RESEARCH			English	Article						hepatocellular carcinoma; mortality; non-alcoholic fatty liver disease; type IV collagen 7s	IV COLLAGEN 7S; III PROCOLLAGEN PEPTIDE; TERM-FOLLOW-UP; HEPATOCELLULAR-CARCINOMA; SCORING SYSTEM; CANCER; STEATOHEPATITIS; SERUM; RISK; CIRRHOSIS	AimSome patients with non-alcoholic fatty liver disease (NAFLD) develop hepatocellular carcinoma (HCC) and have higher mortality than others. The evidence causally linking NAFLD to extrahepatic malignancies is scarce. Our aim was to determine the incidence of and risk factors for HCC, extrahepatic cancer and mortality in Japanese patients with biopsy-proven NAFLD. MethodsThis retrospective cohort study analyzed outcomes including onset of malignant tumors and death in 312 patients with NAFLD diagnosed by liver biopsy. ResultsOf 312 patients, 176 (56.4%) were diagnosed with non-alcoholic steatohepatitis. During a median follow-up period of 4.8 years (range, 0.3-15.8), six patients (1.9%) developed HCC, and 20 (6.4%) developed extrahepatic cancer. Multivariate analysis identified fibrosis stage (3; hazard ratio [HR], 12.3; 95% confidence interval [CI], 1.11-136.0; P=0.041) as a predictor for HCC and type IV collagen 7s (>5ng/mL; HR, 1.74; 95% CI, 1.08-2.79; P=0.022) as a predictor for extrahepatic cancer. Eight patients (2.6%) died during the follow-up period. The most common cause of death was extrahepatic malignancy. None died of cardiovascular disease. Multivariate analysis identified type IV collagen 7s (>5ng/mL; HR, 3.38; 95% CI, 1.17-9.76; P=0.024) as a predictor for mortality. ConclusionThe incidence of extrahepatic cancer was higher than that of HCC. Severe fibrosis was a predictor for HCC. Patients with NAFLD and elevated type IV collagen 7s levels are at increased risk for extrahepatic cancer and overall mortality.	[Seko, Yuya; Sumida, Yoshio; Ishiba, Hiroshi; Okajima, Akira; Nishimura, Takeshi; Yamaguchi, Kanji; Moriguchi, Michihisa; Mitsuyoshi, Hironori; Yasui, Kohichiroh; Minami, Masahito; Itoh, Yoshito] Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Kyoto 6028566, Japan; [Tanaka, Saiyu; Taketani, Hiroyoshi; Kanemasa, Kazuyuki] Nara City Hosp, Ctr Digest & Liver Dis, Nara, Japan	Sumida, Y (reprint author), Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kamigyou Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	sumida@koto.kpu-m.ac.jp					AMBIRU S, 1995, AM J GASTROENTEROL, V90, P783; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Sato Y, 1997, HEART, V78, P505; Sorensen HT, 1998, HEPATOLOGY, V28, P921, DOI 10.1002/hep.510280404; Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491; Burchardt ER, 2003, CLIN EXP DERMATOL, V28, P515, DOI 10.1046/j.1365-2230.2003.01326.x; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Sumida Y, 2011, J GASTROENTEROL, V46, P257, DOI 10.1007/s00535-010-0305-6; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Ohlund D, 2009, BRIT J CANCER, V101, P91, DOI 10.1038/sj.bjc.6605107; Stepanova M, 2013, DIGEST DIS SCI, V58, P3017, DOI 10.1007/s10620-013-2743-5; Kawamura Y, 2012, AM J GASTROENTEROL, V107, P253, DOI 10.1038/ajg.2011.327; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268; Hashimoto E, 2009, J GASTROENTEROL, V44, P89, DOI 10.1007/s00535-008-2262-x; Castro-Sanchez L, 2010, EUR J CELL BIOL, V89, P843, DOI 10.1016/j.ejcb.2010.07.004; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Arase Y, 2012, HEPATOL RES, V42, P264, DOI 10.1111/j.1872-034X.2011.00915.x; Choi SY, 2009, AM J GASTROENTEROL, V104, P1953, DOI 10.1038/ajg.2009.238; Donghees K, 2013, HEPATOLOGY, V57, P1357; Goto K, 2001, MODERN PATHOL, V14, P1237, DOI 10.1038/modpathol.3880468; Hirashima K, 2013, J SURG ONCOL, V107, P402, DOI 10.1002/jso.23225; KAWAMURA M, 1994, THORAX, V49, P144, DOI 10.1136/thx.49.2.144; Kims D, 2012, HEPATOLOGY, V56, P605; Kinoshita J, 2010, ONCOL LETT, V1, P989, DOI 10.3892/ol.2010.181; Kodama K, 2013, ALCOHOL CLIN EXP RES, V37, pE247, DOI 10.1111/j.1530-0277.2012.01900.x; Leeming DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071050; MURAWAKI Y, 1994, HEPATOLOGY, V20, P780, DOI 10.1002/hep.1840200403; Nystrom H, 2011, EJSO-EUR J SURG ONC, V37, P611, DOI 10.1016/j.ejso.2011.04.010; Ohlund D, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-154; Ongs JP, 2008, J HEPATOL, V49, P608; Tilg H, 2011, GUT, V60, P745, DOI 10.1136/gut.2011.239392; Yoneda M, 2007, J GASTROENTEROL, V42, P375, DOI 10.1007/s00535-007-2014-3	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUL	2015	45	7					728	738		10.1111/hepr.12407		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4WB	WOS:000357684900003		
J	Umemura, T; Shibata, S; Sekiguchi, T; Kitabatake, H; Nozawa, Y; Okuhara, S; Kimura, T; Morita, S; Komatsu, M; Matsumoto, A; Tanaka, E				Umemura, Takeji; Shibata, Soichiro; Sekiguchi, Tomohiro; Kitabatake, Hiroyuki; Nozawa, Yuichi; Okuhara, Sadahisa; Kimura, Takefumi; Morita, Susumu; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji			Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis	HEPATOLOGY RESEARCH			English	Article						Liver cirrhosis; MELD-Na; mortality; sodium	CHRONIC HEPATITIS-C; B-VIRUS INFECTION; REFRACTORY ASCITES; HEPATOCELLULAR-CARCINOMA; CLINICAL-SIGNIFICANCE; HYPONATREMIA; THERAPY; FAILURE; PATHOGENESIS; MANAGEMENT	AimAlthough hyponatremia is associated with a poor prognosis in liver cirrhosis, little is known about the clinical significance of serum sodium concentration in cirrhosis in Japan. This study investigated associations of mortality in Japanese cirrhosis patients taking conventional diuretics with serum sodium concentration and other clinical characteristics. MethodsA total of 171 consecutive patients with cirrhosis who were taking diuretic medication were enrolled retrospectively. We determined the prevalence of low serum sodium concentration and searched for associations with age, sex, etiology, complications of cirrhosis, liver function tests and Model for End-Stage Liver Disease (MELD) and MELD-Na scores. The predictive ability of sodium level on mortality was also investigated. ResultsMedian serum sodium concentration was 139mEq/L (interquartile range, 137-141). Only eight of 171 (4.7%) patients had low serum sodium (<130mEq/L). Median MELD-Na score was 10.5 (interquartile range, 8.0-14.3). Cumulative survival rates were significantly lower in patients with Na of less than 139mEq/L or MELD-Na score of 10.5 or more (log-rank test, P=0.017 and P=0.0002, respectively). Several liver function tests, MELD and MELD-Na scores, and the incidence of ascites were all significantly associated with patients having Na of less than 139mEq/L. ConclusionSerum sodium concentration below 139mEq/L and MELD-Na score above 10.5 may be predictive markers for mortality in patients with cirrhosis despite being within normal ranges. These markers may help to better assess and manage the prognosis of patients with cirrhosis in Japan.	[Umemura, Takeji; Shibata, Soichiro; Sekiguchi, Tomohiro; Kitabatake, Hiroyuki; Nozawa, Yuichi; Okuhara, Sadahisa; Kimura, Takefumi; Morita, Susumu; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji] Shinshu Univ, Dept Med, Sch Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano 3908621, Japan	Umemura, T (reprint author), Shinshu Univ, Dept Med, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	tumemura@shinshu-u.ac.jp					Nishikawa H, 2014, HEPATOL RES, V44, P149, DOI 10.1111/hepr.12194; Mohan S, 2013, AM J MED, V126, P1127, DOI 10.1016/j.amjmed.2013.07.021; Serste T, 2012, J HEPATOL, V57, P274, DOI 10.1016/j.jhep.2012.03.018; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Gines P, 2008, HEPATOLOGY, V48, P1002, DOI 10.1002/hep.22418; Angeli P, 2006, HEPATOLOGY, V44, P1535, DOI 10.1002/hep.21412; Umemura T, 2007, HEPATOLOGY, V46, P463, DOI 10.1002/hep.21700; Sanyal AJ, 2003, GASTROENTEROLOGY, V124, P634, DOI 10.1053/gast.2003.50088; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; Arroyo V, 2003, J HEPATOL, V38, pS69, DOI 10.1016/S0168-8278(03)00007-2; GINES P, 1991, NEW ENGL J MED, V325, P829, DOI 10.1056/NEJM199109193251201; ARROYO V, 1988, J HEPATOL, V6, P239, DOI 10.1016/S0168-8278(88)80038-2; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Biggins SW, 2006, GASTROENTEROLOGY, V130, P1652, DOI 10.1053/j.gastro.2006.02.010; Gines P, 1998, HEPATOLOGY, V28, P851, DOI 10.1002/hep.510280337; Heuman DM, 2004, HEPATOLOGY, V40, P802, DOI 10.1002/hep.20405; Umemura T, 2012, HEPATOLOGY, V55, P506, DOI 10.1002/hep.24705; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; GUARDIOLA J, 1995, AM J GASTROENTEROL, V90, P2097; Kims WR, 2008, NEW ENGL J MED, V359, P1018; Sakaida I, 2014, HEPATOL RES, V44, P73, DOI 10.1111/hepr.12098; Umemura T, 2008, CLIN INFECT DIS, V47, pE52, DOI 10.1086/590968; Umemura T, 2003, J INFECT DIS, V188, P1545, DOI 10.1086/379216; Umemura T, 2006, HEPATOLOGY, V43, P91, DOI 10.1002/hep.20917; Yuns BC, 2009, HEPATOLOGY, V49, P1610	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUL	2015	45	7					739	744		10.1111/hepr.12412		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4WB	WOS:000357684900004		
J	Kumada, H; Sato, K; Takehara, T; Nakamuta, M; Ishigami, M; Chayama, K; Toyota, J; Suzuki, F; Nakayasu, Y; Ochi, M; Yamada, I; Okanoue, T				Kumada, Hiromitsu; Sato, Ken; Takehara, Tetsuo; Nakamuta, Makoto; Ishigami, Masatoshi; Chayama, Kazuaki; Toyota, Joji; Suzuki, Fumitaka; Nakayasu, Yoshiyuki; Ochi, Miyoko; Yamada, Ichimaro; Okanoue, Takeshi			Efficacy of telaprevir-based therapy for difficult-to-treat patients with genotype 2 chronic hepatitis C in Japan	HEPATOLOGY RESEARCH			English	Article						genotype 2; peginterferon; ribavirin; sustained virological response; telaprevir; treatment failure	HCV GENOTYPE-2; RIBAVIRIN; PEGINTERFERON; INFECTION; SIMEPREVIR; SOFOSBUVIR	AimThis study assessed the efficacy and safety of telaprevir in combination with peginterferon--2b (PEG IFN) and ribavirin (RBV), for Japanese difficult-to-treat patients with hepatitis C virus (HCV) genotype 2 who had not achieved sustained virological response (SVR) during prior treatment. MethodsIn total, 108 relapsed (median age, 59.0 years) and 10 non-responding (median age, 59.0 years) patients with genotype 2 HCV participated. Patients received telaprevir (750mg, every 8h) for 12 weeks and PEG IFN/RBV for 24 weeks. ResultsThe SVR rates for relapsers and non-responders were 88.0% (95/108) and 50.0% (5/10), respectively. The SVR rates did not differ significantly between patients with rs8099917 TT and non-TT. The SVR rates for relapsers and non-responders with extended rapid viral response (eRVR) were 97.6% (82/84) and 100% (5/5), respectively. On the other hand, the SVR rates for relapsers and non-responders completing the treatment protocol were 98.4% (61/62) and 100% (5/5), respectively. The overall safety profiles of telaprevir-based regimens were similar for Japanese patients with genotype 1 and 2 HCV infection who experienced treatment failure. ConclusionTelaprevir, in combination with PEG IFN/RBV, provided a high SVR rate for genotype 2 HCV, difficult-to-treat patients who had not achieved SVR during prior IFN-based treatment. The eRVR had a strong influence on the cure rate of telaprevir-based therapy. In addition, the continuation of telaprevir-based treatment for up to 24 weeks was a significant predictor of SVR.	[Kumada, Hiromitsu; Suzuki, Fumitaka] Toranomon Gen Hosp, Dept Hepatol, Kawasaki, Kanagawa 2138587, Japan; [Nakayasu, Yoshiyuki; Ochi, Miyoko; Yamada, Ichimaro] Mitsubishi Tanabe Pharma Corp, Dev Div, Tokyo, Japan; [Sato, Ken] Gunma Univ, Dept Med & Mol Sci, Grad Sch Med, Gunma, Japan; [Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Osaka, Japan; [Okanoue, Takeshi] Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan; [Nakamuta, Makoto] Natl Hosp Org, Dept Gastroenterol, Kyushu Med Ctr, Fukuoka, Japan; [Ishigami, Masatoshi] Nagoya Univ, Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 466, Japan; [Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Div Frontier Med Sci,Programs Biomed Res, Hiroshima, Japan; [Toyota, Joji] Sapporo Kosei Gen Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan	Kumada, H (reprint author), Toranomon Gen Hosp, Dept Hepatol, Takatsu Ku, 1-3-1 Kajigaya, Kawasaki, Kanagawa 2138587, Japan.	kumahiro@toranomon.gr.jp			Mitsubishi Tanabe Pharma	Conflict of interest: These clinical trials were funded by Mitsubishi Tanabe Pharma. The sponsor was involved in the trial design, conduct and data analysis. Several authors are employees of the sponsor.	Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000; Kanda T, 2011, DIGEST DIS SCI, V56, P3335, DOI 10.1007/s10620-011-1750-7; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Izumi N, 2014, J GASTROENTEROL, V49, P941, DOI 10.1007/s00535-014-0949-8; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kawaoka T, 2011, J HEPATOL, V54, P408, DOI 10.1016/j.jhep.2010.07.032; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Rangnekar AS, 2013, J VIRAL HEPATITIS, V20, P377, DOI 10.1111/jvh.12039; Sezaki H, 2014, HEPATOL RES, V44, pE163, DOI 10.1111/hepr.12268; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Simmonds P, 1996, J GEN VIROL, V77, P3013, DOI 10.1099/0022-1317-77-12-3013; Suzuki F, 2011, HEPATOLOGY, V53, P415, DOI 10.1002/hep.24058; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Foster GR, 2011, GASTROENTEROLOGY, V141, P881, DOI 10.1053/j.gastro.2011.05.046; European Assoc Study L, 2011, J HEPATOL, V55, P245, DOI DOI 10.1016/J.JHEP.2011.02.023]; Hayashi N, 2012, J VIRAL HEPATITUS, V19, P134; Meyers SD, 2013, J VIRAL HEPATITUS, V20, P395; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Ozes T, 2014, J GASTROENTEROL; Sato K, 2012, HEPATOL RES, V42, P854, DOI 10.1111/j.1872-034X.2012.00997.x; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Wartelle-Bladou C, 2012, J VIRAL HEPATITIS, V19, P525, DOI 10.1111/j.1365-2893.2012.01634.x	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUL	2015	45	7					745	754		10.1111/hepr.12416		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4WB	WOS:000357684900005		
J	Tajiri, K; Kawai, K; Minemura, M; Yasumura, S; Hosokawa, A; Kawabe, H; Tomizawa, G; Sugiyama, T				Tajiri, Kazuto; Kawai, Kengo; Minemura, Masami; Yasumura, Satoshi; Hosokawa, Ayumu; Kawabe, Hideto; Tomizawa, Gakuto; Sugiyama, Toshiro			Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5-fluorouracil	HEPATOLOGY RESEARCH			English	Article						5-fluorouracil; arterial cisplatin; hepatic arterial infusion chemotherapy; neutrophil; lymphocyte ratio	ADVANCED HEPATOCELLULAR-CARCINOMA; VEIN TUMOR THROMBOSIS; TO-LYMPHOCYTE RATIO; TRANSARTERIAL CHEMOEMBOLIZATION; ANTIANGIOGENIC THERAPY; PHASE-II; CANCER; SURVIVAL; PREDICTOR; RECURRENCE	AimHepatic arterial infusion (HAIC) therapy may be a therapeutic option for advanced hepatocellular carcinoma (HCC) in addition to administration of sorafenib, which is the only currently established standard regimen for this disease. Survival benefit of HAIC has been reported in patients positive for antitumor response. Therefore, the prediction of antitumor response is important in decision-making for HAIC treatment. MethodsTwenty-six consecutive patients with advanced HCC treated by HAIC using arterial cisplatin plus continuous 5-fluorouracil were retrospectively analyzed in this study. Neutrophil/lymphocyte ratio (NLR) was assessed to determine its effectiveness as a prognostic indicator of HAIC. ResultsThe median time to progression and overall survival time (OS) were 5.0 and 17.0 months, respectively. The overall response rate (RR) among the 26 patients was 42.3%, and RR was independent of liver function. Interestingly, RR was significantly lower in patients with NLR of 4 or more (odds ratio, 0.49; P=0.04). When we investigated factors that influenced OS, treatment effect and NLR of less than 4 were associated with prolonged OS. No serious adverse events were found in treatment with HAIC. ConclusionHAIC is a candidate for treatment of advanced HCC, and NLR may be a useful prognostic indicator for suitability of HAIC.	[Tajiri, Kazuto; Kawai, Kengo; Minemura, Masami; Yasumura, Satoshi; Hosokawa, Ayumu; Sugiyama, Toshiro] Toyama Univ Hosp, Dept Internal Med 3, Toyama 9300194, Japan; [Kawabe, Hideto; Tomizawa, Gakuto] Toyama Univ Hosp, Dept Radiol, Toyama 9300194, Japan	Tajiri, K (reprint author), Toyama Univ Hosp, Dept Internal Med 3, 2630 Sugitani, Toyama 9300194, Japan.	tajikazu@med.u-toyama.ac.jp					Kerbel RS, 2006, SCIENCE, V312, P1171, DOI 10.1126/science.1125950; Ando E, 2002, CANCER, V95, P588, DOI 10.1002/cncr.10694; Ikeda M, 2013, CANCER CHEMOTH PHARM, V72, P463, DOI 10.1007/s00280-013-2222-x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Yamasaki T, 2005, J GASTROENTEROL, V40, P70, DOI 10.1007/s00535-004-1494-7; Mano Y, 2013, ANN SURG, V258, P301, DOI 10.1097/SLA.0b013e318297ad6b; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Yoshikawa M, 2008, HEPATOL RES, V38, P474, DOI 10.1111/j.1872-034X.2008.00338.x; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; SVENNEVIG JL, 1984, BRIT J CANCER, V49, P375, DOI 10.1038/bjc.1984.60; Huang ZL, 2011, J VASC INTERV RADIOL, V22, P702, DOI 10.1016/j.jvir.2010.12.041; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Nouso K, 2013, BRIT J CANCER, V109, P1904, DOI 10.1038/bjc.2013.542; Harimoto N, 2013, TRANSPLANTATION, V96, P1008, DOI 10.1097/TP.0b013e3182a53f2b; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; SCANLON KJ, 1986, P NATL ACAD SCI USA, V83, P8923, DOI 10.1073/pnas.83.23.8923; Miyaki D, 2012, J GASTROEN HEPATOL, V27, P1850, DOI 10.1111/j.1440-1746.2012.07276.x; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; CALABROJONES PM, 1982, CANCER RES, V42, P4413; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Euns JR, 2009, SCAND J GASTROENTERO, V44, P1477; Kims BK, 2011, J CANCER RES CLIN, V137, P659; Kims HY, 2010, KOREAN J HEPATOL, V16, P355; Kirikoshi H, 2012, WORLD J GASTROENTERO, V18, P1933, DOI 10.3748/wjg.v18.i16.1933; Kudo Masatoshi, 2012, Liver Cancer, V1, P62, DOI 10.1159/000342402; Lais YC, 2003, WORLD J GASTROENTERO, V9, P2666; Lims TY, 2006, KOREAN J HEPATOL, V12, P65; Nagamatsu H, 2010, ALIMENT PHARM THER, V32, P543, DOI 10.1111/j.1365-2036.2010.04379.x; Nagano H, 2010, ONCOLOGY-BASEL, V78, P142, DOI 10.1159/000315243; Niizeki T, 2012, J GASTROENTEROL, V47, P686, DOI 10.1007/s00535-012-0555-6; Ohs MJ, 2013, CLIN MOL HEPATOL, V19, P288; Okuda K, 1999, ONCOL REP, V6, P587; Park JY, 2007, CANCER, V110, P129, DOI 10.1002/cncr22759; Shao YY, 2010, ASIA-PAC J CLIN ONCO, V6, P80, DOI 10.1111/j.1743-7563.2010.01287.x; Shao YY, 2013, LIVER INT, V33, P1413, DOI 10.1111/liv.12207; Shindoh N, 1999, CARDIOVASC INTER RAD, V22, P344, DOI 10.1007/s002709900404; SHIRASAKA T, 1993, CANCER CHEMOTH PHARM, V32, P167, DOI 10.1007/BF00685830; TOYODA H, 1995, ONCOLOGY, V52, P295; Ueshimas K, 2012, ONCOLOGY S1, V78, P148; Woos HY, 2010, CANCER CHEMOTH PHARM, V65, P373; Xiao WK, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-117; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; Zaitsu J, 2014, HEPATOL RES, V44, P481, DOI 10.1111/hepr.12141	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUL	2015	45	7					755	763		10.1111/hepr.12417		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4WB	WOS:000357684900006		
J	Hara, Y; Kawagishi, N; Nakanishi, W; Tokodai, K; Nakanishi, C; Miyagi, S; Ohuchi, N				Hara, Yasuyuki; Kawagishi, Naoki; Nakanishi, Wataru; Tokodai, Kazuaki; Nakanishi, Chikashi; Miyagi, Shigehito; Ohuchi, Noriaki			Prevalence and risk factors of obesity, hypertension, dyslipidemia and diabetes mellitus before and after adult living donor liver transplantation	HEPATOLOGY RESEARCH			English	Article						diabetes mellitus; dyslipidemia; hypertension; living donor liver transplantation; obesity	POSTTRANSPLANT METABOLIC SYNDROME; HEPATITIS-C; STABLE LIVER; RECIPIENTS; CYCLOSPORINE; TACROLIMUS; MANAGEMENT; HYPERLIPIDEMIA; COMPLICATIONS; IMPACT	AimThe development of metabolic abnormalities after liver transplantation (LTx) contributes to cardiovascular events and mortality. We analyzed the prevalence and risk factors of obesity, hypertension, dyslipidemia and diabetes mellitus (DM) after adult living donor liver transplantation. MethodsFifty-four adult recipients with a minimum follow up of 6 months receiving living donor liver transplantation between 2001 and 2012 at the Tohoku University Hospital were retrospectively analyzed. ResultsThe prevalence of hypertension increased from 18.5% before transplantation to 35.2% post-transplantation, and new-onset hypertension after transplantation was 57.9% of post-transplant hypertension. Univariate analysis showed that risk factors of post-transplant hypertension were age (>50 years, P=0.0023), pretransplant body mass index (BMI) of 25 or more (P=0.0123), pretransplant hypertension (P=0.0012) and cyclosporin A (61.5% vs tacrolimus 25.0%, P=0.0248). The incidence of obesity, dyslipidemia and DM did not change from before to after transplantation. LTx was curative in 77.8% of cases of pretransplant dyslipidemia and 20% of cases of pretransplant DM. Primary biliary cirrhosis cases comprised 85.7% of cases of pretransplant dyslipidemia that were cured by LTx. In univariate analysis, pretransplant BMI of 25 or more was the only risk factor of post-transplant dyslipidemia (P=0.0098). The incidence of new-onset DM after transplantation was 20%. Risk factors of post-transplant DM were male sex (P=0.0156), pretransplant DM (P<0.0001), alcohol abuse (P=0.0248) and mycophenolate mofetil (P=0.0181) by univariate analysis. ConclusionThe prevalence of hypertension increased after LTx and pretransplant obesity was associated with several post-transplant metabolic abnormalities.	[Hara, Yasuyuki; Kawagishi, Naoki; Nakanishi, Wataru; Tokodai, Kazuaki; Nakanishi, Chikashi; Miyagi, Shigehito; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Div Adv Surg Sci & Technol, Sendai, Miyagi 9808574, Japan	Hara, Y (reprint author), Tohoku Univ, Grad Sch Med, Div Adv Surg Sci & Technol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	yasuhara@med.tohoku.ac.jp					Adam René, 2003, Liver Transpl, V9, P1231, DOI 10.1016/j.lts.2003.09.018; Laryea M, 2007, LIVER TRANSPLANT, V13, P1109, DOI 10.1002/lt.21126; Charlton M, 2009, LIVER TRANSPLANT, V15, pS83, DOI 10.1002/lt.21914; [Anonymous], 2002, CIRCULATION, V106, P3143; Johnston SD, 2002, TRANSPLANTATION, V73, P901, DOI 10.1097/00007890-200203270-00012; Laish I, 2011, LIVER TRANSPLANT, V17, P15, DOI 10.1002/lt.22198; Hanouneh IA, 2008, LIVER TRANSPLANT, V14, P1287, DOI 10.1002/lt.21524; Roberts MS, 2004, LIVER TRANSPLANT, V10, P886, DOI 10.1002/lt.20137; Baid S, 2001, TRANSPLANTATION, V72, P1066, DOI 10.1097/00007890-200109270-00015; Rabkin JM, 2002, AM J SURG, V183, P595, DOI 10.1016/S0002-9610(02)00826-7; Pfitzmann R, 2008, TRANSPL INT, V21, P234, DOI 10.1111/j.1432-2277.2007.00596.x; John PR, 2002, LIVER TRANSPLANT, V8, P708, DOI 10.1053/jlts.2002.34638; Pagadala M, 2009, LIVER TRANSPLANT, V15, P1662, DOI 10.1002/lt.21952; Honda M, 2013, CLIN TRANSPLANT, V27, P426, DOI 10.1111/ctr.12103; Ling Q, 2012, WORLD J GASTROENTERO, V18, P7033, DOI 10.3748/wjg.v18.i47.7033; Reuben A, 2001, LIVER TRANSPLANT, V7, pS13, DOI 10.1053/jlts.2001.29167; Curtis JJ, 2002, CURR HYPERTENS REP, V4, P377, DOI 10.1007/s11906-002-0067-5; Everhart JE, 1998, LIVER TRANSPLANT SUR, V4, P285; Stegall MD, 1997, TRANSPLANTATION, V64, P1755, DOI 10.1097/00007890-199712270-00023; Manzarbeitia C, 2001, LIVER TRANSPLANT, V7, P93, DOI 10.1053/jlts.2001.21289; McAlister VC, 2006, AM J TRANSPLANT, V6, P1578, DOI 10.1111/j.1600-6143.2006.01360.x; Yoshida R, 2012, J HEPATO-BIL-PAN SCI, V19, P438, DOI 10.1007/s00534-011-0459-5; Watt KDS, 2010, J HEPATOL, V53, P199, DOI 10.1016/j.jhep.2010.01.040; STEGALL MD, 1995, TRANSPLANTATION, V60, P1057; Levy G, 2004, TRANSPLANTATION, V77, P1632, DOI 10.1097/01.TP.0000129095.51031.42; Neal DAJ, 2001, LIVER TRANSPLANT, V7, P533, DOI 10.1053/jlts.2001.24637; Khalili M, 2004, LIVER TRANSPLANT, V10, P349, DOI 10.1002/lt.20092; Canzanello V J, 1997, Liver Transpl Surg, V3, P1; Dharancy S, 2008, TRANSPLANTATION, V86, P1077, DOI 10.1097/TP.0b013e318187758b; Fernandez-Miranda C, 1998, CLIN TRANSPLANT, V12, P136; Fernandez LA, 1999, TRANSPLANTATION, V68, P1532, DOI 10.1097/00007890-199911270-00017; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kuos HT, 2010, TRANSPLANTATION, V89, P1134; Muñoz Santiago J, 2005, Liver Transpl, pS52; Navasa M, 1996, J HEPATOL, V25, P64, DOI 10.1016/S0168-8278(96)80329-1; Satapathy SK, 2011, LIVER TRANSPLANT, V17, P1, DOI 10.1002/lt.22222; Sheiner PA, 2000, TRANSPLANTATION, V69, P781; Tueche SG, 2003, TRANSPLANT P, V35, P1466, DOI 10.1016/S0041-1345(03)00528-1; Uranos E, 2013, HEPATOL RES; Yadav AD, 2013, J TRANSPLANT, V2013	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUL	2015	45	7					764	770		10.1111/hepr.12418		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4WB	WOS:000357684900007		
J	Sumida, Y; Yonei, Y; Tanaka, S; Mori, K; Kanemasa, K; Imai, S; Taketani, H; Hara, T; Seko, Y; Ishiba, H; Okajima, A; Yamaguchi, K; Moriguchi, M; Mitsuyoshi, H; Yasui, K; Minami, M; Itoh, Y				Sumida, Yoshio; Yonei, Yoshikazu; Tanaka, Saiyu; Mori, Kojiroh; Kanemasa, Kazuyuki; Imai, Shunsuke; Taketani, Hiroyoshi; Hara, Tasuku; Seko, Yuya; Ishiba, Hiroshi; Okajima, Akira; Yamaguchi, Kanji; Moriguchi, Michihisa; Mitsuyoshi, Hironori; Yasui, Kohichiroh; Minami, Masahito; Itoh, Yoshito			Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease	HEPATOLOGY RESEARCH			English	Article						fibrosis; insulin like growth factor-1; insulin resistance; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis	NECROSIS-FACTOR-ALPHA; IGF-I; HEPATIC STEATOSIS; REDUCES FIBROGENESIS; AGING RATS; STEATOHEPATITIS; HORMONE; RESISTANCE; GH; POPULATION	AimGrowth hormone (GH) deficiency may be associated with histological progression of non-alcoholic fatty liver disease (NAFLD) which includes non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). Insulin-like growth factor 1 (IGF-1) is mainly produced by hepatocytes and its secretion is stimulated by GH. Our aim was to determine whether more histologically advanced NAFLD is associated with low circulating levels of IGF-1 in Japanese patients. MethodsSerum samples were obtained in 199 Japanese patients with biopsy-proven NAFLD and in 2911 sex- and age-matched healthy people undergoing health checkups. The serum levels of IGF-1 were measured using a commercially available immunoradiometric assay. The standard deviation scores (SDS) of IGF-1 according to age and sex were also calculated in NAFLD patients. ResultsThe serum IGF-1 levels in NAFLD patients were significantly lower (median, 112ng/mL) compared with the control population (median, 121ng/mL, P<0.0001). IGF-1 SDS less than -2.0 SD from median were found in 11.6% of 199 patients. NASH patients exhibited significantly lower levels of IGF-1 SDS (n=130; median, -0.7) compared with NAFL patients (n=69; median, -0.3; P=0.026). The IGF-1 SDS values decreased significantly with increasing lobular inflammation (P<0.001) and fibrosis (P<0.001). In multiple regressions, the association between the IGF-1 SDS values and the severity of NAFLD persisted after adjusting for age, sex and insulin resistance. ConclusionLow levels of circulating IGF-1 may have a role in the development of advanced NAFLD, independent of insulin resistance. Supplementation with GH/IGF-1 may be a candidate for the treatment of NASH.	[Sumida, Yoshio; Taketani, Hiroyoshi; Hara, Tasuku; Seko, Yuya; Ishiba, Hiroshi; Okajima, Akira; Yamaguchi, Kanji; Moriguchi, Michihisa; Mitsuyoshi, Hironori; Yasui, Kohichiroh; Minami, Masahito; Itoh, Yoshito] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto 6028566, Japan; [Yonei, Yoshikazu] Doshisha Univ, Fac Life & Med Sci, Antiaging Med Res Ctr, Kyotanabe, Japan; [Tanaka, Saiyu; Mori, Kojiroh; Kanemasa, Kazuyuki] Nara City Hosp, Ctr Digest & Liver Dis, Nara, Japan; [Imai, Shunsuke] Nara City Hosp, Dept Pathol, Nara, Japan	Sumida, Y (reprint author), Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	sumida@koto.kpu-m.ac.jp			Chiyoda Mutual Life Foundation	THIS STUDY WAS supported by a grant from the Chiyoda Mutual Life Foundation.	Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Thissen JP, 1997, ENDOCRINOLOGY, V138, P1078, DOI 10.1210/en.138.3.1078; Colak Y, 2012, EUR J GASTROEN HEPAT, V24, P255, DOI 10.1097/MEG.0b013e32834e8041; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Sumida Y, 2003, J HEPATOL, V38, P32, DOI 10.1016/S0168-8278(02)00331-8; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Garcia-Galiano D, 2007, OBES SURG, V17, P493, DOI 10.1007/s11695-007-9087-1; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Sanz S, 2005, GUT, V54, P134, DOI 10.1136/gut.2003.024505; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Leung KC, 2000, J CLIN ENDOCR METAB, V85, P4712, DOI 10.1210/jc.85.12.4712; Brown-Borg HM, 2002, EXP BIOL MED, V227, P94; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Nishizawa H, 2012, EUR J ENDOCRINOL, V167, P67, DOI 10.1530/EJE-12-0252; Fusco A, 2012, CLIN ENDOCRINOL, V77, P531, DOI 10.1111/j.1365-2265.2011.04291.x; Garcia-Fernandez M, 2008, ENDOCRINOLOGY, V149, P2433, DOI 10.1210/en.2007-1190; Puche JE, 2008, ENDOCRINOLOGY, V149, P2620, DOI 10.1210/en.2007-1563; Takahashi Y, 2012, ENDOCR J, V59, P955; Anwar A, 2002, CIRCULATION, V105, P1220, DOI 10.1161/hc1002.105187; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Volzke H, 2009, EUR J ENDOCRINOL, V161, P705, DOI 10.1530/EJE-09-0374; Isojima T, 2012, ENDOCR J, V59, P771; Dominici FP, 2005, GROWTH HORM IGF RES, V15, P324, DOI 10.1016/j.ghir.2005.07.001; Takahashi Y, 2007, GASTROENTEROLOGY, V132, P938, DOI 10.1053/j.gastro.2006.12.024; Sandhu MS, 2002, LANCET, V359, P1740, DOI 10.1016/S0140-6736(02)08655-5; Oliveira CPMS, 2002, J CELL MOL MED, V6, P399, DOI 10.1111/j.1582-4934.2002.tb00518.x; Arturi F, 2011, J CLIN ENDOCR METAB, V96, pE1640, DOI 10.1210/jc.2011-1227; Cianfaranis S, 2014, J PEDIAT; Gavin JR, 1997, DIABETES CARE, V20, P1183; Friedrich N, 2012, DIABETES CARE, V35, P768, DOI 10.2337/dc11-1833; Haos CN, 2011, APOPTOSIS, V16, P1118; Hribal ML, 2013, J CLIN ENDOCR METAB, V98, pE304, DOI 10.1210/jc.2012-3290; Ichikawa T, 2007, HEPATOL INT, V1, P287, DOI 10.1007/s12072-007-9007-4; Japanese Society for the Study of Obesity, 2000, J JPN SOC STUDY OBES, V6, P18; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Khoshnood A, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.6181; Kokoszko A, 2008, EXP TOXICOL PATHOL, V60, P453, DOI 10.1016/j.etp.2008.04.012; Lelbachs A, 2011, J HEPATOL, V35, P558; Mallea-Gil María Susana, 2012, Acta Gastroenterol Latinoam, V42, P20; Neys DM, 1995, METABOLISM, V44, P152; Nishizawa H, 2012, BIOCHEM BIOPH RES CO, V423, P295, DOI 10.1016/j.bbrc.2012.05.115; Nomotos K, 2011, ANTIAGING MED, V8, P69; Saibara T, 2005, HEPATOL RES, V33, P64, DOI 10.1016/j.hepres.2005.09.005; Savastano S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-136; Sesti G, 2005, DIABETES CARE, V28, P120, DOI 10.2337/diacare.28.1.120; SHMUELI E, 1994, HEPATOLOGY, V19, P322; Sirbu A, 2013, GROWTH HORM IGF RES, V23, P2, DOI 10.1016/j.ghir.2012.10.001; Sobrevals L, 2010, HEPATOLOGY, V51, P912, DOI 10.1002/hep.23412; Tachibanas K, 1999, HORUMON TO RINSHO, V47, P903; Takadas M, 1999, IGAKU TO YAKUGAKU, V41, P761; Takasus S, 1996, HORUMON TO RINSHO, V44, P383	54	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUL	2015	45	7					771	781		10.1111/hepr.12408		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4WB	WOS:000357684900008		
J	Mishima-Iwai, M; Takahashi, K; Yokode, M; Kimura, Y; Sawai, Y; Ueda, Y; Chiba, T				Mishima-Iwai, Masako; Takahashi, Ken; Yokode, Masataka; Kimura, Yoshito; Sawai, Yugo; Ueda, Yoshihide; Chiba, Tsutomu			Late-onset acetaminophen-induced allergic hepatitis with progression to chronicity	HEPATOLOGY RESEARCH			English	Article						acetaminophen; allergic reaction; drug-induced lymphocyte stimulation test; drug-induced hepatitis; idiosyncrasy	INDUCED LIVER-INJURY; LYMPHOCYTE-TRANSFORMATION TEST; UNITED-STATES; PARACETAMOL; HEPATOTOXICITY; METABOLISM; FAILURE	Acetaminophen (paracetamol), a widely used antipyretic/analgesic, is a well-known agent causing acute hepatic injury. Whereas most cases are caused by its intrinsic hepatotoxicity, idiosyncratic hepatitis by the allergic mechanism is extremely rare. We herein report a case of late-onset acetaminophen-induced allergic hepatitis with progression to chronicity. This unique case extends the spectrum of acetaminophen-induced liver injury. Clinicians should be aware of this unusual clinical manifestation. The mechanism underlying the immunological reaction to acetaminophen remains to be elucidated.	[Mishima-Iwai, Masako; Takahashi, Ken; Yokode, Masataka; Kimura, Yoshito; Sawai, Yugo; Ueda, Yoshihide; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068507, Japan	Takahashi, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, 54 Kawara Cho, Kyoto 6068507, Japan.	takaken@kuhp.kyoto-u.ac.jp					Andrade RJ, 1998, J HEPATOL, V28, P1078, DOI 10.1016/S0168-8278(98)80361-9; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; WHITCOMB DC, 1994, JAMA-J AM MED ASSOC, V272, P1845, DOI 10.1001/jama.272.23.1845; Bjornsson E, 2007, ALIMENT PHARM THERAP, V25, P1411, DOI 10.1111/j.1365-2036.2007.03330.x; Kaplowitz N, 2004, CLIN INFECT DIS, V38, pS44, DOI 10.1086/381446; [Anonymous], 2012, MACSWEENS PATHOLOGY, P467; Luque I, 2001, ALLERGY, V56, P611, DOI 10.1034/j.1398-9995.2001.000115.x; Miyake Y, 2010, DIGEST LIVER DIS, V42, P51, DOI 10.1016/j.dld.2009.04.009; Nyfeler B, 1997, CLIN EXP ALLERGY, V27, P175; CRITCHLEY JAJH, 1986, BRIT J CLIN PHARMACO, V22, P649; Chalasani N, 2008, GASTROENTEROLOGY, V135, P1924, DOI 10.1053/j.gastro.2008.09.011; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; EVERNESS KM, 1990, BRIT J DERMATOL, V122, P293, DOI 10.1111/j.1365-2133.1990.tb08276.x; Fabris P, 2001, ANN INTERN MED, V134, P345; Grieco A, 2008, J CLIN PHARM THER, V33, P315, DOI 10.1111/j.1365-2710.2008.00918.x; Lauterburg Bernhard H, 2002, Am J Ther, V9, P225, DOI 10.1097/00045391-200205000-00008; Linden C H, 1984, Emerg Med Clin North Am, V2, P103; Lucena MI, 2008, FUND CLIN PHARMACOL, V22, P141, DOI 10.1111/j.1472-8206.2008.00566.x; Oslens NJ., 2004, BEST PRACT RES CLIN, V5, P677; Shinzawa H, 2001, TOHOKU J EXP MED, V193, P255, DOI 10.1620/tjem.193.255; Ueshima Y, 1996, ALCOHOL CLIN EXP RES, V20, pA25, DOI 10.1111/j.1530-0277.1996.tb01722.x; WARRINGTON RJ, 1982, CLIN ALLERGY, V12, P217, DOI 10.1111/j.1365-2222.1982.tb02521.x	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUL	2015	45	7					814	817		10.1111/hepr.12399		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4WB	WOS:000357684900012		
J	Mukai, S; Onoe, T; Tashiro, H; Ohdan, H				Mukai, Shoichiro; Onoe, Takashi; Tashiro, Hirotaka; Ohdan, Hideki			Small bowel obstruction due to an unconjugated ursodeoxycholic acid enterolith following living donor liver transplantation: Report of a case	HEPATOLOGY RESEARCH			English	Article						enterolith; living donor liver transplantation; Roux-en-Y anastomosis; small bowel obstruction; ursodeoxycholic acid	POSTOPERATIVE ABDOMINAL ADHESIONS; JEJUNAL ENTEROLITH; PREVENTION; TACROLIMUS; INTESTINE; DIARRHEA; STONE	We report an unusual case of small bowel obstruction due to an ursodeoxycholic acid (UDCA) enterolith that occurred 7years after liver transplantation. A 70-year-old man had undergone multiple operations, including a living donor liver transplantation (LDLT) and hepaticojejunostomy. Four years after the LDLT, cholestasis developed, for which oral UDCA was administrated. Seven years after the LDLT, he was admitted to our hospital because of pneumonia; intestinal obstruction occurred following its resolution. A radiographic contrast study and computed tomographic scan indicated a movable mass as the cause of the ileus, suggesting a giant stone. We were unable to observe or remove the stone by double balloon enteroscopy owing to the presence of severe adhesion; thus, we surgically removed the mass. The patient's postoperative course was uneventful. He was discharged 20days after the operation. An infrared spectrophotometric analysis revealed that the stone was a true enterolith, primarily composed of unconjugated UDCA. An ileus caused by a true enterolith is a rare clinical complication of LDLT. Nevertheless, it must be considered in the differential diagnosis of intestinal obstructions in liver transplant recipients with Roux-en-Y hepaticojejunostomies and/or bowel stasis.	[Mukai, Shoichiro; Onoe, Takashi; Tashiro, Hirotaka; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Hiroshima, Hiroshima 7348551, Japan; [Onoe, Takashi] Natl Hosp Org Kure Med Ctr, Chugoku Canc Ctr, Inst Clin Res, Kure, Japan	Onoe, T (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Appl Life Sci,Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan.	tonoemd@gmail.com			BSE from Japanese Ministry of Health, Labor and Welfare	THIS WORK WAS supported by a Grant-in-Aid for the Research on Hepatitis and BSE from the Japanese Ministry of Health, Labor and Welfare.	Catena F, 2012, J GASTROINTEST SURG, V16, P382, DOI 10.1007/s11605-011-1736-y; Tatekawa Y, 1996, SURG TODAY, V26, P68; Yamamoto H, 2001, GASTROINTEST ENDOSC, V53, P216, DOI 10.1067/mge.2001.112181; Cohen Z, 2005, DIS COLON RECTUM, V48, P1130, DOI 10.1007/s10350-004-0954-8; REISNER RM, 1994, AM SURGEON, V60, P441; HOFMANN AF, 1992, J LIPID RES, V33, P617; ATWELL JD, 1960, BRIT J SURG, V47, P367, DOI 10.1002/bjs.18004720405; Baiocchi L, 2006, TRANSPLANT INT, V19, P389, DOI 10.1111/j.1432-2277.2006.00296.x; Caos S, 1997, DIGEST DIS SCI, V42, P1409; De Moor V, 2003, TRANSPLANTATION, V75, P416, DOI 10.1097/01.TP.000044701.46034.C6; Ginsburg PM, 2005, LIVER TRANSPLANT, V11, P881, DOI 10.1002/lt.20500; GRETTVE S, 1947, Acta Chir Scand, V95, P387; Heinzow Hauke Sebastian, 2010, World J Gastrointest Endosc, V2, P321, DOI 10.4253/wjge.v2.i9.321; Jones Mark W, 2005, JSLS, V9, P339; Khalaf H, 2005, LIVER TRANSPLANT, V11, P1448, DOI 10.1002/lt.20553; Kornprat P, 2005, WIEN KLIN WOCHENSCHR, V117, P297, DOI 10.1007/s00508-004-0277-8; Leow CK, 1997, SURGERY, V122, P977, DOI 10.1016/S0039-6060(97)90349-4; Mack DR, 1998, LIVER TRANSPLANT SUR, V4, P166; Milanchi S, 2007, J AM COLL SURGEONS, V205, P377, DOI 10.1016/j.jamcollsurg.2006.09.011; Mizuta K, 2003, TRANSPLANT P, V35, P437, DOI 10.1016/S0041-1345(02)03794-6; Nijhof HW, 2009, ANZ J SURG, V79, P77, DOI 10.1111/j.1445-2197.2008.04805.x; SINGLETO.JM, 1970, BRIT J SURG, V57, P234; vans Hillos M, 1987, SURGERY, V101, P273	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUL	2015	45	7					818	822		10.1111/hepr.12401		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4WB	WOS:000357684900013		
J	Ogawa, S; Wada, M; Fukushima, M; Shimeno, N; Inoue, S; Chung, H; Fujita, M; Suginoshita, Y; Okada, A; Inokuma, T; Yagi, S; Ito, K; Imai, Y				Ogawa, Satoshi; Wada, Masaya; Fukushima, Masashi; Shimeno, Naoto; Inoue, Satoko; Chung, Hobyung; Fujita, Mikio; Suginoshita, Yoshiki; Okada, Akihiko; Inokuma, Tetsuro; Yagi, Shintaro; Ito, Kyo; Imai, Yukihiro			Case of primary hepatic gastrinoma: Diagnostic usefulness of the selective arterial calcium injection test	HEPATOLOGY RESEARCH			English	Article						gastrinoma; liver; selective arterial calcium injection test; Zollinger-Ellison syndrome	LOCALIZATION	Gastrinomas mainly occur in the duodenum and pancreas. Primary hepatic gastrinoma is rare and difficult to diagnose because the liver is a frequent site of metastatic gastrinomas. Clinical factors were assessed in a 28-year-old man with diarrhea and heartburn who was hospitalized for recurrent duodenal ulcers. Abdominal ultrasound, endoscopic ultrasound and computed tomography (CT) could not detect a tumor in the duodenum or pancreas. His gastrin level was 846pg/mL and magnetic resonance imaging showed a mass 12mm in diameter in the right robe of the liver. A selective intra-arterial calcium injection (SACI) test and 68-gallium edotreotide positron emission tomography CT (Ga-DOTATOC PET-CT) were therefore performed. Calcium gluconate injection into the proper hepatic artery resulted in a marked increase in serum gastrin concentration in the right hepatic vein, with Ga-DOTATOC PET-CT showing uptake only by the liver mass. Following a diagnosis of primary hepatic gastrinoma, the tumor was resected. A histopathological examination indicated gastrinoma. Six months postoperatively, he has no symptoms, is not taking proton-pump inhibitors and his gastrin level remains within the normal range. The SACI test and the clinical course of this patient strongly suggest that the tumor was a primary hepatic gastrinoma. The SACI test is helpful in the diagnosis of primary hepatic gastrinoma.	[Ogawa, Satoshi; Wada, Masaya; Fukushima, Masashi; Shimeno, Naoto; Inoue, Satoko; Chung, Hobyung; Fujita, Mikio; Suginoshita, Yoshiki; Okada, Akihiko; Inokuma, Tetsuro] Kobe City Med Ctr Gen Hosp, Dept Gastroenterol & Hepatol, Kobe, Hyogo 6500047, Japan; [Yagi, Shintaro] Kobe City Med Ctr Gen Hosp, Dept Surg, Kobe, Hyogo 6500047, Japan; [Ito, Kyo] Kobe City Med Ctr Gen Hosp, Dept Radiol, Kobe, Hyogo 6500047, Japan; [Imai, Yukihiro] Kobe City Med Ctr Gen Hosp, Dept Pathol, Kobe, Hyogo 6500047, Japan	Ogawa, S (reprint author), Kobe City Med Ctr Gen Hosp, Dept Gastroenterol & Hepatol, Chuo Ku, 2-1-1 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	aragorn_sato@yahoo.co.jp					Diaz R, 2003, DIGEST DIS SCI, V48, P1665, DOI 10.1023/A:1024700831418; Fendrich V, 2007, BRIT J SURG, V94, P1331, DOI 10.1002/bjs.5987; Harvey Adrian, 2012, Cancers (Basel), V4, P130, DOI 10.3390/cancers4010130; IMAMURA M, 1987, ANN SURG, V205, P230, DOI 10.1097/00000658-198703000-00003; Kuipers P, 2009, BMJ CASE REP, V2009, P1529; MORIURA S, 1993, CANCER, V72, P1547, DOI 10.1002/1097-0142(19930901)72:5<1547::AID-CNCR2820720510>3.0.CO;2-C; Naoe Hideaki, 2012, Case Rep Gastroenterol, V6, P590, DOI 10.1159/000343157; Shibata C, 2006, DIGEST DIS SCI, V51, P1122, DOI 10.1007/s10620-006-8018-7; Turner JJO, 2002, CLIN ENDOCRINOL, V57, P821, DOI 10.1046/j.1365-2265.2002.01655.x; Wus PC, 1997, SURGERY, V122, P1176	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUL	2015	45	7					823	826		10.1111/hepr.12404		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4WB	WOS:000357684900014		
J	Iizuka, T; Kamiya, K; Gotoh, S; Sugitani, Y; Suzuki, M; Noda, T; Minowa, O; Ikeda, K				Iizuka, Takashi; Kamiya, Kazusaku; Gotoh, Satoru; Sugitani, Yoshinobu; Suzuki, Masaaki; Noda, Tetsuo; Minowa, Osamu; Ikeda, Katsuhisa			Perinatal Gjb2 gene transfer rescues hearing in a mouse model of hereditary deafness	HUMAN MOLECULAR GENETICS			English	Article							IN-VIVO DELIVERY; STRIA VASCULARIS; GAP-JUNCTIONS; INNER-EAR; CELLULAR DEGENERATION; POSTNATAL-DEVELOPMENT; SUPPORTING CELLS; CONNEXIN30 NULL; TIGHT JUNCTIONS; MICE REVEALS	Hearing loss is the most widespread sensory disorder, with an incidence of congenital genetic deafness of 1 in 1600 children. For many ethnic populations, the most prevalent form of genetic deafness is caused by recessive mutations in the gene gap junction protein, beta 2, 26 kDa (GJB2), which is also known as connexin 26 (Cx26). Despite this knowledge, existing treatment strategies do not completely recover speech perception. Here we used a gene delivery system to rescue hearing in a mouse model of Gjb2 deletion. Mice lacking Cx26 are characterized by profound deafness from birth and improper development of cochlear cells. Cochlear delivery of Gjb2 using an adeno-associated virus significantly improved the auditory responses and development of the cochlear structure. Using gene replacement to restore hearing in a new mouse model of Gjb2-related deafness may lead to the development of therapies for human hereditary deafness.	[Iizuka, Takashi; Kamiya, Kazusaku; Ikeda, Katsuhisa] Juntendo Univ, Fac Med, Dept Otorhinolaryngol, Tokyo 1138421, Japan; [Gotoh, Satoru; Sugitani, Yoshinobu; Noda, Tetsuo; Minowa, Osamu] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 1358550, Japan; [Suzuki, Masaaki] Teikyo Univ, Chiba Med Ctr, Dept Otolaryngol, Ichihara, Chiba 2990111, Japan; [Noda, Tetsuo; Minowa, Osamu] RIKEN, BioResource Ctr, Team Adv Dev & Evaluat Human Dis Models, Tsukuba, Ibaraki 3050074, Japan	Ikeda, K (reprint author), Juntendo Univ, Fac Med, Dept Otorhinolaryngol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ike@juntendo.ac.jp			Ministry of Education, Sports, Science and Culture of Japan [20390445, 25293351, 12480253]; MEXT; Ministry of Health, Labor and Welfare of Japan	This work was supported in part by grants-in-aid (20390445 and 25293351) to K.I. and by grant-in-aid (12480253) to O.M. from the Ministry of Education, Sports, Science and Culture of Japan, the MEXT-support program for the Strategic Research Foundation at Private Universities, 2011-2013 to K.I. and a research grant from the Ministry of Health, Labor and Welfare of Japan to K.K.	Ahmad S, 2003, BIOCHEM BIOPH RES CO, V307, P362, DOI 10.1016/S0006-291X(03)01166-5; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Kudo T, 2003, HUM MOL GENET, V12, P995, DOI 10.1093/hmg/ddg116; Duan M, 2004, GENE THER, V11, pS51, DOI 10.1038/sj.gt.3302369; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Bedrosian JC, 2006, MOL THER, V14, P328, DOI 10.1016/j.ymthe.2006.04.003; Ahmad S, 2007, P NATL ACAD SCI USA, V104, P1337, DOI 10.1073/pnas.0606855104; Wang YF, 2009, BIOCHEM BIOPH RES CO, V385, P33, DOI 10.1016/j.bbrc.2009.05.023; Minekawa A, 2009, NEUROSCIENCE, V164, P1312, DOI 10.1016/j.neuroscience.2009.08.043; Kamiya K, 2014, J CLIN INVEST, V124, P1598, DOI 10.1172/JCI67621; Sun Y, 2009, J COMP NEUROL, V516, P569, DOI 10.1002/cne.22117; Majumder P, 2010, PURINERG SIGNAL, V6, P167, DOI 10.1007/s11302-010-9192-9; Akil O, 2012, NEURON, V75, P283, DOI 10.1016/j.neuron.2012.05.019; Lentz JJ, 2013, NAT MED, V19, P345, DOI 10.1038/nm.3106; Gabriel HD, 1998, J CELL BIOL, V140, P1453, DOI 10.1083/jcb.140.6.1453; Manthey D, 2001, J MEMBRANE BIOL, V181, P137; Chen S, 2014, BIOCHEM BIOPH RES CO, V445, P71, DOI 10.1016/j.bbrc.2014.01.154; Gow A, 2004, J NEUROSCI, V24, P7051, DOI 10.1523/JNEUROSCI.1640-04.2004; Iizuka T, 2008, HUM GENE THER, V19, P384, DOI 10.1089/hum.2007.167; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Inoshita A, 2008, NEUROSCIENCE, V156, P1039, DOI 10.1016/j.neuroscience.2008.08.027; Kitajiri SI, 2004, J CELL SCI, V117, P5087, DOI 10.1242/jcs.01393; Yum SW, 2007, AM J PHYSIOL-CELL PH, V293, pC1032, DOI 10.1152/ajpcell.00011.2007; Nin F, 2008, P NATL ACAD SCI USA, V105, P1751, DOI 10.1073/pnas.0711463105; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Boulay AC, 2013, J NEUROSCI, V33, P430, DOI 10.1523/JNEUROSCI.4240-12.2013; Chang Q, 2015, NEUROBIOL DIS, V73, P418, DOI 10.1016/j.nbd.2014.09.005; Chang Q, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004088; Crispino G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023279; Degen J, 2011, EUR J CELL BIOL, V90, P817, DOI 10.1016/j.ejcb.2011.05.001; Hasegawa S, 2002, P NATL ACAD SCI USA, V99, P297, DOI 10.1073/pnas.012264999; Konishi T, 1966, Acta Otolaryngol, V62, P393, DOI 10.3109/00016486609119584; Kral A, 2010, NEW ENGL J MED, V363, P1438, DOI 10.1056/NEJMra0911225; Maeda Y, 2005, HUM MOL GENET, V14, P1641, DOI 10.1093/hmg/ddi172; Miwa T, 2013, MOL THER, V21, P1142, DOI 10.1038/mt.2013.62; Sacheli R, 2013, GENE THER, V20, P237, DOI 10.1038/gt.2012.51; SALT AN, 1986, HEARING RES, V23, P141, DOI 10.1016/0378-5955(86)90011-0; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Yu Q, 2014, GENE THER, V21, P71, DOI 10.1038/gt.2013.59; Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102	44	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	JUL 1	2015	24	13					3651	3661		10.1093/hmg/ddv109		11	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CM2PO	WOS:000357523900005		
J	Li, Z; Allingham, RR; Nakano, M; Jia, LY; Chen, YH; Ikeda, Y; Mani, B; Chen, LJ; Kee, C; Garway-Heath, DF; Sripriya, S; Fuse, N; Abu-Amero, KK; Huang, CK; Namburi, P; Burdon, K; Perera, SA; Gharahkhani, P; Lin, Y; Ueno, M; Ozaki, M; Mizoguchi, T; Krishnadas, SR; Osman, EA; Lee, MC; Chan, ASY; Tajudin, LSA; Do, T; Goncalves, A; Reynier, P; Zhang, H; Bourne, R; Goh, D; Broadway, D; Husain, R; Negi, AK; Su, DH; Ho, CL; Blanco, AA; Leung, CKS; Wong, TT; Yakub, A; Liu, YT; Nongpiur, ME; Han, JC; Hon, DN; Shantha, B; Zhao, BW; Sang, JH; Zhang, NH; Sato, R; Yoshii, K; Panda-Jonas, S; Koch, AEA; Herndon, LW; Moroi, SE; Challa, P; Foo, JN; Bei, JX; Zeng, YX; Simmons, CP; Chau, TNB; Sharmila, PF; Chew, M; Lim, B; Tam, POS; Chua, E; Ng, XY; Yong, VHK; Chong, YF; Meah, WY; Vijayan, S; Seongsoo, S; Xu, W; Teo, YY; Bailey, JNC; Kang, JH; Haines, JL; Cheng, CY; Saw, SM; Tai, ES; Richards, JE; Ritch, R; Gaasterland, DE; Pasquale, LR; Liu, JJ; Jonas, JB; Milea, D; George, R; Al-Obeidan, SA; Mori, K; Macgregor, S; Hewitt, AW; Girkin, CA; Zhang, MZ; Sundaresan, P; Vijaya, L; Mackey, DA; Wong, TY; Craig, JE; Sun, XH; Kinoshita, S; Wiggs, JL; Khor, CC; Yang, ZL; Pang, CP; Wang, NL; Hauser, MA; Tashiro, K; Aung, T; Vithana, EN				Li, Zheng; Allingham, R. Rand; Nakano, Masakazu; Jia, Liyun; Chen, Yuhong; Ikeda, Yoko; Mani, Baskaran; Chen, Li-Jia; Kee, Changwon; Garway-Heath, David F.; Sripriya, Sarangapani; Fuse, Nobuo; Abu-Amero, Khaled K.; Huang, Chukai; Namburi, Prasanthi; Burdon, Kathryn; Perera, Shamira A.; Gharahkhani, Puya; Lin, Ying; Ueno, Morio; Ozaki, Mineo; Mizoguchi, Takanori; Krishnadas, Subbiah Ramasamy; Osman, Essam A.; Lee, Mei Chin; Chan, Anita S. Y.; Tajudin, Liza-Sharmini A.; Do, Tan; Goncalves, Aurelien; Reynier, Pascal; Zhang, Hong; Bourne, Rupert; Goh, David; Broadway, David; Husain, Rahat; Negi, Anil K.; Su, Daniel H.; Ho, Ching-Lin; Blanco, Augusto Azuara; Leung, Christopher K. S.; Wong, Tina T.; Yakub, Azhany; Liu, Yutao; Nongpiur, Monisha E.; Han, Jong Chul; Hon, Do Nhu; Shantha, Balekudaru; Zhao, Bowen; Sang, Jinghong; Zhang, NiHong; Sato, Ryuichi; Yoshii, Kengo; Panda-Jonas, Songhomita; Koch, Allison E. Ashley; Herndon, Leon W.; Moroi, Sayoko E.; Challa, Pratap; Foo, Jia Nee; Bei, Jin-Xin; Zeng, Yi-Xin; Simmons, Cameron P.; Tran Nguyen Bich Chau; Sharmila, Philomenadin Ferdinamarie; Chew, Merwyn; Lim, Blanche; Tam, Pansy O. S.; Chua, Elaine; Ng, Xiao Yu; Yong, Victor H. K.; Chong, Yaan Fun; Meah, Wee Yang; Vijayan, Saravanan; Seongsoo, Sohn; Xu, Wang; Teo, Yik Ying; Bailey, Jessica N. Cooke; Kang, Jae H.; Haines, Jonathan L.; Cheng, Ching Yu; Saw, Seang-Mei; Tai, E-Shyong; Richards, Julia E.; Ritch, Robert; Gaasterland, Douglas E.; Pasquale, Louis R.; Liu, Jianjun; Jonas, Jost B.; Milea, Dan; George, Ronnie; Al-Obeidan, Saleh A.; Mori, Kazuhiko; Macgregor, Stuart; Hewitt, Alex W.; Girkin, Christopher A.; Zhang, Mingzhi; Sundaresan, Periasamy; Vijaya, Lingam; Mackey, David A.; Wong, Tien Yin; Craig, Jamie E.; Sun, Xinghuai; Kinoshita, Shigeru; Wiggs, Janey L.; Khor, Chiea-Chuen; Yang, Zhenglin; Pang, Chi Pui; Wang, Ningli; Hauser, Michael A.; Tashiro, Kei; Aung, Tin; Vithana, Eranga N.		ICAARE-Glaucoma Consortium; NEIGHBORHOOD Consortium	A common variant near TGFBR3 is associated with primary open angle glaucoma	HUMAN MOLECULAR GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CENTRAL CORNEAL THICKNESS; SUSCEPTIBILITY LOCI; MULTIPLE-SCLEROSIS; RISK-FACTORS; IDENTIFICATION; GENE; NUMBER; POPULATION; WORLDWIDE	Primary open angle glaucoma (POAG), a major cause of blindness worldwide, is a complex disease with a significant genetic contribution. We performed Exome Array (Illumina) analysis on 3504 POAG cases and 9746 controls with replication of the most significant findings in 9173 POAG cases and 26 780 controls across 18 collections of Asian, African and European descent. Apart from confirming strong evidence of association at CDKN2B-AS1 (rs2157719 [G], odds ratio [OR] = 0.71, P = 2.81 x 10(-33)), we observed one SNP showing significant association to POAG (CDC7-TGFBR3 rs1192415, ORG-allele = 1.13, P-meta = 1.60 x 10(-8)). This particular SNP has previously been shown to be strongly associated with optic disc area and vertical cup-to-disc ratio, which are regarded as glaucoma-related quantitative traits. Our study now extends this by directly implicating it in POAG disease pathogenesis.	[Khor, Chiea-Chuen; Vithana, Eranga N.] Academia, Singapore 169856, Singapore; [Li, Zheng; Mani, Baskaran; Perera, Shamira A.; Lee, Mei Chin; Chan, Anita S. Y.; Wong, Tina T.; Nongpiur, Monisha E.; Chew, Merwyn; Lim, Blanche; Chua, Elaine; Ng, Xiao Yu; Yong, Victor H. K.; Chong, Yaan Fun; Cheng, Ching Yu; Saw, Seang-Mei; Milea, Dan; Wong, Tien Yin; Aung, Tin; Vithana, Eranga N.] Singapore Eye Res Inst, Singapore, Singapore; [Perera, Shamira A.; Chan, Anita S. Y.; Goh, David; Husain, Rahat; Su, Daniel H.; Ho, Ching-Lin; Wong, Tina T.; Foo, Jia Nee; Cheng, Ching Yu; Milea, Dan; Wong, Tien Yin; Aung, Tin] Singapore Natl Eye Ctr, Singapore, Singapore; [Li, Zheng; Foo, Jia Nee; Meah, Wee Yang; Teo, Yik Ying; Liu, Jianjun; Khor, Chiea-Chuen] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Allingham, R. Rand; Herndon, Leon W.; Challa, Pratap; Hauser, Michael A.] Duke Univ, Ctr Eye, Dept Ophthalmol, Durham, NC 27710 USA; [Nakano, Masakazu; Sato, Ryuichi; Mori, Kazuhiko; Tashiro, Kei] Kyoto Prefectural Univ Med, Dept Genom Med Sci, Kyoto, Japan; [Ikeda, Yoko; Ueno, Morio; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Yoshii, Kengo] Kyoto Prefectural Univ Med, Dept Med Stat, Kyoto, Japan; [Jia, Liyun; Zhao, Bowen; Sang, Jinghong; Zhang, NiHong; Wang, Ningli] Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Chen, Yuhong; Sun, Xinghuai] Fudan Univ, Eye & ENT Hosp, Shanghai Med Sch, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China; [Sun, Xinghuai] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China; [Mani, Baskaran; Nongpiur, Monisha E.; Cheng, Ching Yu; Wong, Tien Yin; Khor, Chiea-Chuen; Aung, Tin; Vithana, Eranga N.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Xu, Wang; Teo, Yik Ying; Saw, Seang-Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Mani, Baskaran; Perera, Shamira A.; Wong, Tina T.; Nongpiur, Monisha E.; Cheng, Ching Yu; Milea, Dan; Aung, Tin; Vithana, Eranga N.] Duke NUS Grad Med Sch, Singapore, Singapore; [Chen, Li-Jia; Leung, Christopher K. S.; Tam, Pansy O. S.; Pang, Chi Pui] Chinese Univ Hong Kong, Hosp Eye, Dept Ophthalmol & Visual Sci, Hong Kong, Peoples R China; [Kee, Changwon; Han, Jong Chul; Seongsoo, Sohn] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Garway-Heath, David F.] UCL, Nat Inst Hlth Res Biomed Res Ctr, Moorfields Eye Hosp NHS Fdn Trust, London, England; [Garway-Heath, David F.] UCL, Inst Ophthalmol, London, England; [Sripriya, Sarangapani; Sharmila, Philomenadin Ferdinamarie] SNONGC, Sankara Nethralaya, Dept Mol Biol & Genet, Vision Res Fdn, Madras, Tamil Nadu, India; [Fuse, Nobuo] Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi, Japan; [Abu-Amero, Khaled K.; Osman, Essam A.; Al-Obeidan, Saleh A.] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh, Saudi Arabia; [Abu-Amero, Khaled K.] Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL USA; [Huang, Chukai; Zhang, Mingzhi] Shantou Univ, Chinese Univ Hong Kong Joint Shantou Int Eye Ctr, Shantou, Peoples R China; [Namburi, Prasanthi; Vijayan, Saravanan; Sundaresan, Periasamy] Aravind Med Res Fdn, Dept Genet, Madurai, Tamil Nadu, India; [Burdon, Kathryn; Hewitt, Alex W.; Mackey, David A.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Burdon, Kathryn; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA, Australia; [Gharahkhani, Puya; Macgregor, Stuart] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia; [Lin, Ying; Yang, Zhenglin] Hosp Univ Elect Sci & Technol China, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China; [Lin, Ying; Yang, Zhenglin] Hosp Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Lin, Ying; Yang, Zhenglin] Univ Elect Sci & Technol China, Sch Med, Chengdu, Peoples R China; [Ozaki, Mineo] Ozaki Eye Hosp, Hyuga, Miyazaki 8830066, Japan; [Mizoguchi, Takanori] Mizoguchi Eye Hosp, Sasebo, Nagasaki 8570016, Japan; [Krishnadas, Subbiah Ramasamy] Aravind Eye Hosp, Glaucoma Serv, Madurai, Tamil Nadu, India; [Tajudin, Liza-Sharmini A.; Yakub, Azhany] Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Kota Baharu, Kelantan, Malaysia; [Do, Tan; Hon, Do Nhu] Vietnam Natl Inst Ophthalmol, Hanoi, Vietnam; [Goncalves, Aurelien] Angers Univ Hosp, Dept Ophthalmol, Angers, France; [Zhang, Hong] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Ophthalmol, Wuhan 430074, Peoples R China; [Bourne, Rupert] Hinchingbrooke Hosp, Huntingdon Glaucoma Diagnost & Res Ctr, Huntingdon, England; [Broadway, David] Norfolk & Norwich Univ Hosp NHS Trust, Norwich, Norfolk, England; [Negi, Anil K.] Heart UK NHS Fdn Trust, Birmingham, W Midlands, England; [Blanco, Augusto Azuara] Queens Univ Belfast, Ctr Med Expt, Sch Med Dent & Biomed Sci, Belfast BT7 1NN, Antrim, North Ireland; [Liu, Yutao; Koch, Allison E. Ashley; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Liu, Yutao] Georgia Regents Univ, Dept Cell Biol & Anat, Augusta, GA USA; [Shantha, Balekudaru; George, Ronnie; Vijaya, Lingam] Sankara Nethralaya, Med Res Fdn, Madras, Tamil Nadu, India; [Panda-Jonas, Songhomita; Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Moroi, Sayoko E.; Richards, Julia E.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Richards, Julia E.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Bei, Jin-Xin; Zeng, Yi-Xin] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Bei, Jin-Xin; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Simmons, Cameron P.; Tran Nguyen Bich Chau] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Simmons, Cameron P.] Univ Oxford, Ctr Trop Med, Nuffield Dept Clin Med, Oxford OX3 7LJ, England; [Bailey, Jessica N. Cooke; Haines, Jonathan L.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Kang, Jae H.; Pasquale, Louis R.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Tai, E-Shyong] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore; [Tai, E-Shyong] Natl Univ Singapore, Singapore 117548, Singapore; [Ritch, Robert] New York Eye & Ear Infirm, Einhorn Clin Res Ctr, Dept Ophthalmol, New York, NY 10003 USA; [Ritch, Robert; Gaasterland, Douglas E.] Eye Doctors Washington DC, Washington, DC USA; [Pasquale, Louis R.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [Hewitt, Alex W.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, CERA, Melbourne, Vic, Australia; [Girkin, Christopher A.; Wiggs, Janey L.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL USA; [Mackey, David A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Lions Eye Inst, Perth, WA 6009, Australia; [Sun, Xinghuai] Minist Hlth China, Myopia Key Lab, Shanghai, Peoples R China; [Yang, Zhenglin] Chinese Acad Sci, Sichuan Translat Med Hosp, Chengdu, Peoples R China; [Reynier, Pascal] Angers Univ Hosp, Dept Biochem, Angers, France	Vithana, EN (reprint author), Academia, 20 Coll Rd,Discovery Tower Level 6, Singapore 169856, Singapore.	khorcc@gis.a-star.edu.sg; eranga.n.v@sericom.sg	Reynier, Pascal/K-3677-2015; Macgregor, Stuart/C-6442-2009; 	Macgregor, Stuart/0000-0001-6731-8142; Simmons, Cameron P./0000-0002-9039-7392; Liza-Sharmini, Ahmad Tajudin/0000-0001-8144-8816	Biomedical Research Council (BMRC) grant in Singapore [BMRC 10/1/35/19/675]; Singapore National Research Foundation under its Translational and Clinical Research Flagship Programme [NMRC/TCR/008-SERI/2013]; National Medical Research Council, Singapore [NMRC/TCR/002-SERI/2008, (R626/47/2008TCR), CSA R613/34/2008, NMRC 0796/2003, STaR/0003/2008]; National Research Foundation of Singapore; Biomedical Research Council, Singapore [BMRC 09/1/35/19/616, 08/1/35/19/550]; Genome Institute of Singapore [GIS/12-AR2105]; NIH [R01 EY023646, P30-EY005722, HHSN268200782096C, EY015543, EY006827, HL73042, HL073389, EY13315, EY023646, CA87969, CA49449, UM1 CA167552, EY009149]; Collaborative Development of Innovative Seeds of Japan Science and Technology Agency (JST); Ministry of Health, Labor and Welfare of Japan; Santen Pharmaceutical Co. Ltd.; National Natural Science Foundation of China [81030016, 81200723, 81170883, 81430008]; Special Scientific Research Project of Health Professions [201302015]; Health and Medical Research Fund (HMRF), Hong Kong [01122236, 11120801]; General Research Fund from the Research Grants Council, Hong Kong [468810]; National Health and Medical Research Council of Australia [535074, 1023911]; NHMRC [1031362, 1037838, 1048037, 1009844, 1031920]; Alcon Research Institute; BrightFocus Foundation; Ramaciotti Establishment Grant; Australian Research Council (ARC); Queensland Cancer Fund; National Health and Medical Research Council (NHMRC) of Australia [199600, 552429]; National Cancer Institute [5 RO1 CA 001833, R01 CA136725]; Glaucoma Research Chair at College of Medicine, King Saud University, Riyadh, Saudi Arabia; NEI [HG005259-01]; NEI through American Recovery and Reinvestment Act (ARRA) [3R01EY015872-05S1, 3R01EY019126-02S1]; Harvard Glaucoma Center for Excellence; Research to Prevent Blindness; NIH GEI [U01HG04424, U01HG004728]; Singapore Eye Research Institute; The NIH [EY022305, HG004608, EY008208, EY015473, EY012118, EY015682, EY011671, EY09580, EY013178, RR015574, EY015872, EY010886, EY009847, EY014104, EY011008, EY144428, EY144448, EY18660, T32 EY007157, T32 EY21453-2, P30 014104]	We thank all the study participants, the staff from all involved studies and sites who contributed to this study. The authors J.E.C., K.P.B., D.A.M., and others acknowledge the support of Ms Bronwyn Usher-Ridge in patient recruitment and data collection, and Dr Patrick Danoy and Dr Johanna Hadler for genotyping of the ANZRAG cohort. They also acknowledge David C. Whiteman and Graham Radford-Smith for providing access to the control samples used with the ANZRAG glaucoma cases. The authors D.M. thank Dr Philippe Gohier and Dr Ghislaine Jallet for patient recruitment and data collection and acknowledge the technical assistance provided by the Centre de Recherche Biologique (Dr Odile Blanchet) and Centre de Recherche Clinique (Pr Marc-Antoine Custeau), University Hospital, Angers, France. The Singapore study of E.N.V., T.A. and C.C.K was supported by a Biomedical Research Council (BMRC) grant in Singapore, Ref: BMRC 10/1/35/19/675. This research was also partly supported by a grant (NMRC/TCR/008-SERI/2013) from the Singapore National Research Foundation under its Translational and Clinical Research Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council. We also acknowledge the following source of funding support for recruitment and genotyping of population-based cohorts SIMES and SCES: National Medical Research Council, Singapore (NMRC/TCR/002-SERI/2008, (R626/47/2008TCR), CSA R613/34/2008, NMRC 0796/2003, STaR/0003/2008), the National Research Foundation of Singapore, the Biomedical Research Council, Singapore (BMRC 09/1/35/19/616 and 08/1/35/19/550) and Genome Institute of Singapore (GIS/12-AR2105). The Singapore Tissue Network and the Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services. The research of M.A.H. was supported by NIH R01 EY023646, EY13315 (MAH) and by P30-EY005722. The Japanese sample collection from Kyoto was supported by the grants from the Collaborative Development of Innovative Seeds of Japan Science and Technology Agency (JST) to M.K. and K.T., from the Ministry of Health, Labor and Welfare of Japan to M.N., K.M., K.T. and S.K., and from Santen Pharmaceutical Co. Ltd. to S.K. and K.T. The collection of Japanese POAG cases by N.F. was supported by a grant provided by the Ministry of Health, Labor and Welfare of Japan. The glaucoma research of WNL is supported by National Natural Science Foundation of China project (81030016). The research of Y. Chen was supported by National Natural Science Foundation of China (81200723) and glaucoma research of Xinghuai Sun was supported by Special Scientific Research Project of Health Professions (201302015). This research project was supported by the National Natural Science Foundation of China (81170883 (Z. Y.) and 81430008 (Z. Y.)). The glaucoma research of C.P.P. is supported by the Health and Medical Research Fund (HMRF, Ref: 01122236 and 11120801), Hong Kong and the General Research Fund from the Research Grants Council (grant number 468810), Hong Kong. Support for recruitment of Australian & New Zealand Registry of Advanced Glaucoma (ANZRAG) was provided by the Royal Australian and New Zealand College of Ophthalmology (RANZCO) Eye Foundation. Genotyping was funded by the National Health and Medical Research Council of Australia (#535074 and #1023911). This workwas also supported by funding from NHMRC #1031362 awarded to Jamie E. Craig, NHMRC #1037838 awarded to Alex W. Hewitt, NHMRC # 1048037 awarded to Stuart L. Graham, NHMRC # 1009844 awarded to Robert J.; Casson and Ivan Goldberg, NHMRC # 1031920 and an Alcon Research Institute grant awarded to David A. Mackey, an Allergan Unrestricted grant awarded to Andrew J. White, the BrightFocus Foundation and a Ramaciotti Establishment Grant. S.M. is supported by Australian Research Council (ARC) and Australian National Health & Medical Research Council (NHMRC) Fellowships. Controls for the ANZRAG discovery cohort were drawn from the Australian Cancer Study, the Study of Digestive Health, and from a study of inflammatory bowel diseases. The Australian Cancer Study was supported by the Queensland Cancer Fund and the National Health and Medical Research Council (NHMRC) of Australia (Program no. 199600, awarded to David C. Whiteman, Adele C. Green, Nicholas K. Hayward, Peter G. Parsons, David M. Purdie and Penelope M. Webb, and program number 552429, awarded to David C. Whiteman). The Study of Digestive Health was supported by grant number 5 RO1 CA 001833 from the National Cancer Institute (awarded to David C. Whiteman). The Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS) sponsored the genotyping of oesophageal cancer and Barrett's oesophagus cases, which were used as unscreened controls in the ANZRAG discovery cohort. BEAGESS was funded by grant R01 CA136725 from the National Cancer Institute Collection of Saudi POAG cases and controls was supported by the Glaucoma Research Chair at College of Medicine, King Saud University, Riyadh, Saudi Arabia. NEI Glaucoma Human Genetics Collaboration (NEIGHBOR): genotyping services for the NEIGHBOR study were provided by the CIDR and were supported by the NEI through grant HG005259-01 (J.L.W.). Additionally, CIDR is funded through a federal contract from the NIH to The Johns Hopkins University, contract number HHSN268200782096C. Collecting and processing samples for the NEIGHBOR data set was supported by the NEI through American Recovery and Reinvestment Act (ARRA) grants 3R01EY015872-05S1 (J.L.W.) and 3R01EY019126-02S1 (M.A.H.). Genotype imputation and meta-analysis were supported by EY022305 (J.L.W.). Funding for the collection of cases and controls was provided by the following NIH grants: EY015543 (R.R. Allingham); EY006827 (D. Gaasterland); HL73042, HL073389, EY13315, EY023646 (M. A. H.); CA87969, CA49449, UM1 CA167552 (J.H. Kang); EY009149 (P.R. Lichter); HG004608 (C. McCarty); EY008208 (F.A. Medeiros); EY015473 (L.R.P.); EY012118 (M. Pericak-Vance); EY015682 (A. Realini); EY011671, EY09580 (J.E. Richards); EY013178 (J. S. Schuman); RR015574, EY015872, EY010886, EY009847, EY014104 (J.L.W.); EY011008, EY144428, EY144448 and EY18660 (K. Zhang). J.L.W. and L.R.P. are also supported by the Harvard Glaucoma Center for Excellence and Research to Prevent Blindness. J.N.C.B. is supported by NIH T32 EY007157 (CWRU) and T32 EY21453-2 (VUMC). MEEI case-control sample: genotyping for the Massachusetts Eye and Ear Infirmary (MEEI) case-control sample was performed at the Broad Institute of MIT and Harvard with funding support fromthe NIH GEI (Gene Environment Initiative) (U01HG04424 and U01HG004728). The GENEVA Coordinating Center (U01HG004446) assisted with genotype cleaning. Imputation was supported by NIH EY022305 (JLW). Collection of cases and controls was supported by NIH EY015872 (JLW) and NIH P30 014104 (JLW). Funding to pay the Open Access publication charges for this article was provided by Singapore Eye Research Institute.	Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Khor CC, 2011, HUM MOL GENET, V20, P1864, DOI 10.1093/hmg/ddr060; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Pena JDO, 1999, BRIT J OPHTHALMOL, V83, P209, DOI 10.1136/bjo.83.2.209; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P1118, DOI 10.1136/bjo.82.10.1118; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Bonnefond A, 2013, NAT GENET, V45, P1040, DOI 10.1038/ng.2700; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; PASQUALE LR, 1993, INVEST OPHTH VIS SCI, V34, P23; Fan BJ, 2004, CHINESE MED J-PEKING, V117, P706; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Kang JH, 2010, INVEST OPHTH VIS SCI, V51, P971, DOI 10.1167/iovs.09-4266; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Vithana EN, 2011, HUM MOL GENET, V20, P649, DOI 10.1093/hmg/ddq511; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Cai CL, 2012, CELL CYCLE, V11, P1773, DOI 10.4161/cc.20121; Fuchshofer R, 2011, EXP EYE RES, V93, P165, DOI 10.1016/j.exer.2010.07.014; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Cao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039278; Chen YH, 2014, NAT GENET, V46, P1115, DOI 10.1038/ng.3078; Diestel U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067214; Gharahkhani P, 2014, NAT GENET, V46, P1120, DOI 10.1038/ng.3079; Hysi PG, 2014, NAT GENET, V46, P1126, DOI 10.1038/ng.3087; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Nakano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033389; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Springelkamp H., 2015, NAT COMMUN, V5, P4883; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wiggs JL, 1996, AM J HUM GENET, V58, P243	54	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	JUL 1	2015	24	13					3880	3892		10.1093/hmg/ddv128		13	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CM2PO	WOS:000357523900023		
J	Caceres, MLL; Takakai, F; Iwahana, G; Fedorov, AN; Iijima, Y; Hatano, R; Fukuda, M				Caceres, M. L. Lopez; Takakai, F.; Iwahana, G.; Fedorov, A. N.; Iijima, Y.; Hatano, R.; Fukuda, M.			Snowmelt and the hydrological interaction of forest-grassland ecosystems in Central Yakutia, eastern Siberia	HYDROLOGICAL PROCESSES			English	Article						climate change; forest-grassland ecosystem; permafrost; snowmelt; water flow	SOIL TEMPERATURES; WATER-MOVEMENT; LARCH FOREST; PERMAFROST; DYNAMICS; ENERGY; EVAPOTRANSPIRATION; MANIPULATION; VARIABILITY; MOISTURE	In the last two decades the major focus of study in forest water and carbon balances in eastern Siberia has been on the effect of rain during the growing season. Little attention has been paid to the contribution of snowmelt water. The results of the present study indicate that weather conditions during the snowmelt period as well as the soil moisture conditions carried from the previous year's growing season strongly determined the water availability for the forest ecosystem at the beginning of the next growing season. In the forest-grassland intermingled ecosystem of lowland Central Yakutia, gradual snowmelt water flow from the forest into the adjacent grassland depressions increased when soil moisture was high and air temperature was low, whereas low soil moisture and high air temperatures accelerated soil thawing and consequently snowmelt water infiltration into the forest soil. We found that snow depth did not determine the volume of snowmelt water moving to the grassland depression since the thermokarst lake water level in the adjacent grassland was about 25 cm lower in 2005 than in May 2006, even though maximum snow depth reached 57 cm and 43 cm in the winter of 2004-05 and 2005-06, respectively. The contribution of snowmelt water to forest growth as well as the flow of water from the forest to the grasslands showed a strong annual variability. We conclude that warmer springs and high variability in precipitation regimes as a result of climate change will result in more snowmelt water infiltration into the forest soil when the previous year's precipitation is low while more snowmelt water will flow into the thermokarst lake when the previous year's precipitation is high. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Caceres, M. L. Lopez] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata 9978555, Japan; [Takakai, F.] Akita Prefectural Univ, Fac Bioresource Sci, Akita, Japan; [Iwahana, G.] Univ Alaska, Int Res Arctic Ctr, Fairbanks, AK 99701 USA; [Fedorov, A. N.] Russian Acad Sci, Melnikov Permafrost Inst, Siberian Branch, Yakutsk, Russia; [Iijima, Y.] JAMSTEC, Res & Dev Ctr Global Change, Yokosuka, Kanagawa, Japan; [Hatano, R.] Hokkaido Univ, Fac Agr, Sapporo, Hokkaido 060, Japan; [Fukuda, M.] Fukuyama City Univ, Fac Urban Dev, Fukuyama, Hiroshima, Japan	Caceres, MLL (reprint author), Yamagata Univ, Fac Agr, Wakabamachi 1-23, Tsuruoka, Yamagata 9978555, Japan.	larry@tds1.tr.yamagata-u.ac.jp	Iijima, Yoshihiro/N-3237-2015		Ministry of Education Sports and Science of Japan [RR2002]	This study was supported by the Ministry of Education Sports and Science of Japan through the Project RR2002. We thank Dr. Oliver Wright and Dr. Glen Hill for the English correction of the text. We are also grateful to all the personnel from the Permafrost Institute in Yakutsk for their constant help and support during the field work. We also thank Dr Felix Seidel for his valuable advice with the GIS analysis.	Frauenfeld OW, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004245; Ohta T, 2001, HYDROL PROCESS, V15, P1459, DOI 10.1002/hyp.219; PILON CE, 1994, PLANT SOIL, V162, P81, DOI 10.1007/BF01416092; Ohta T, 2008, AGR FOREST METEOROL, V148, P1941, DOI 10.1016/j.agrformet.2008.04.012; Mellander PE, 2004, FOREST ECOL MANAG, V195, P15, DOI 10.1016/j.foreco.2004.02.051; Ishikawa M., 2006, Water Resources Research, V42, pW04401, DOI 10.1029/2005WR004200; Smol JP, 2007, P NATL ACAD SCI USA, V104, P12395, DOI 10.1073/pnas.0702777104; Hardy JP, 2001, BIOGEOCHEMISTRY, V56, P151, DOI 10.1023/A:1013036803050; Dolman AJ, 2004, BIOGEOSCIENCES, V1, P133; Smith LC, 2005, SCIENCE, V308, P1429, DOI 10.1126/science.1108142; Yoshikawa K, 2003, PERMAFROST PERIGLAC, V14, P151, DOI 10.1002/ppp.451; Vaganov EA, 1999, NATURE, V400, P149, DOI 10.1038/22087; HINKEL KM, 1994, PERMAFROST PERIGLAC, V5, P217, DOI 10.1002/ppp.3430050403; Bosikovs NP, 1991, PERMAFROST I YAKUTSK, V127, P128; Czudek T., 1970, QUATERNARY RES, V1, P103, DOI DOI 10.1016/0033-5894(70)90013-X; Forkel M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044021; Iijima Y, 2010, PERMAFROST PERIGLAC, V21, P30, DOI 10.1002/ppp.662; Iijima Y, 2007, INT J CLIMATOL, V27, P169, DOI 10.1002/joc.1382; Iwahana G, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000039; Joness BM, 2011, J GEOPHYS RES-BIOGEO, V116, P1; Jorgenson MT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024960; Kagawa A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003019; KANE DL, 1983, WATER RESOUR RES, V19, P1547, DOI 10.1029/WR019i006p01547; Katamuras F, 2004, ARCT ANTARCT ALP RES, V38, P561; Katasonovs EM, 1979, FACTORS AFFECTING AC, P64; Lis Z, 2011, QUATERN INT, V236, P127; Lopez CML, 2007, J HYDROL, V338, P251, DOI [DOI 10.1016/J.JHYDROL, 10.1016/j.jhydrol.2007.02.039]; Lopezs CML, 2008, AGR FOR METEOROL, V148, P1968, DOI DOI 10.1016/J.AGRFORMET.2008.09.013; Lopez C. M. L., 2012, Eurasian Journal of Forest Research, V15-1, P9; Lopez C. M. L., 2010, Journal of Forest Research, V15, P365, DOI 10.1007/s10310-010-0196-7; Lopez CML, 2007, HYDROL PROCESS, V21, P103, DOI 10.1002/hyp.6224; Machimura T, 2005, J AGR METEOROL, V60, P653; McCarthys JJ, 2001, CLIMATE CHANGE 2001; Parka H, 2008, AGR FOREST METEOROL, V148, P1990, DOI 10.1016/j.agrformet.2008.06.018; Pestryakova LA, 2012, QUATERNARY SCI REV, V51, P56, DOI 10.1016/j.quascirev.2012.06.020; Sokratov SA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000489; Strand M, 2002, TREE PHYSIOL, V22, P839; Takakai F, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000521; Waqas Ahmad, 2014, Global and Planetary Change, V122, P282, DOI 10.1016/j.gloplacha.2014.09.007; Wetterich S, 2008, HYDROBIOLOGIA, V614, P171, DOI 10.1007/s10750-008-9505-y; Zhang YS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003779; Zhongs X, 2013, CRYOSPHERE DISCUSSIO, V7, P3379	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6087	1099-1085		HYDROL PROCESS	Hydrol. Process.	JUL 1	2015	29	14					3074	3083		10.1002/hyp.10424		10	Water Resources	Water Resources	CM2NZ	WOS:000357519300003		
J	Yano, Y; Fujimoto, S; Kramer, H; Sato, Y; Konta, T; Iseki, K; Iseki, C; Moriyama, T; Yamagata, K; Tsuruya, K; Narita, I; Kondo, M; Kimura, K; Asahi, K; Kurahashi, I; Ohashi, Y; Watanabe, T				Yano, Yuichiro; Fujimoto, Shouichi; Kramer, Holly; Sato, Yuji; Konta, Tsuneo; Iseki, Kunitoshi; Iseki, Chiho; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Narita, Ichiei; Kondo, Masahide; Kimura, Kenjiro; Asahi, Koichi; Kurahashi, Issei; Ohashi, Yasuo; Watanabe, Tsuyoshi			Long-Term Blood Pressure Variability, New-Onset Diabetes Mellitus, and New-Onset Chronic Kidney Disease in the Japanese General Population	HYPERTENSION			English	Article						blood pressure; chronic renal disease; diabetes mellitus; epidemiology	TO-VISIT VARIABILITY; YOUNG ADULTHOOD; ORGAN DAMAGE; HYPERTENSION; RISK; NEPHROPATHY; MORTALITY; RELEVANCE; OUTCOMES; DECLINE	Whether long-term blood pressure (BP) variability among individuals without diabetes mellitus is associated with new-onset chronic kidney disease (CKD) risk, independently of other BP parameters (eg, mean BP, cumulative exposure to BP) and metabolic profile changes during follow-up, remains uncertain. We used data from a nationwide study of 48587 Japanese adults aged 40 to 74 years (mean age, 61.7 years; 39% men) without diabetes mellitus or CKD (estimated glomerular filtration rate <60 mL/min per 1.73 m2 or proteinuria by dipstick). BP was measured at baseline and during 3 annual follow-up visits (4 visits). BP variability was defined as standard deviation (SD) and average real variability during the 4 visits. At the year 3 follow-up visit, 6.3% of the population had developed CKD. In multivariable-adjusted logistic regression models, 1 SD increases in SDSBP (per 5 mmHg), SDDBP (per 3 mmHg), average real variability(SBP) (per 6 mmHg), and average real variability(DBP) (per 4 mmHg) were associated with new-onset CKD (odds ratios [ORs] and 95% confidence intervals, 1.15 [1.11-1.20], 1.08 [1.04-1.12], 1.13 [1.09-1.17], 1.06 [1.02-1.10], respectively; all P<0.01) after adjustment for clinical characteristics, and with mean BP from year 0 to year 3. The associations of SDBP and average real variability(BP) with CKD remained significant after additional adjustments for metabolic parameter changes during follow-up (ORs, 1.06-1.15; all P<0.01). Sensitivity analyses by sex, antihypertensive medication use, and the presence of hypertension showed similar conclusions. Among those in the middle-aged and elderly general population without diabetes mellitus, long-term BP variability during 3 years was associated with new-onset CKD risk, independently of mean or cumulative exposure to BP and metabolic profile changes during follow-up.	[Yano, Yuichiro] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Fujimoto, Shouichi] Miyazaki Univ, Fac Med, Dept Hemovasc Med & Artificial Organs, Kiyotake, Miyazaki 8891692, Japan; [Sato, Yuji] Miyazaki Univ, Univ Miyazaki Hosp, Dialysis Div, Kiyotake, Miyazaki 8891692, Japan; [Kramer, Holly] Loyola Med Ctr, Dept Publ Hlth Sci, Maywood, IL USA; [Kramer, Holly] Loyola Med Ctr, Div Nephrol & Hypertens, Maywood, IL USA; [Konta, Tsuneo] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Iseki, Kunitoshi; Iseki, Chiho] Univ Hosp Ryukyus, Dialysis Unit, Okinawa, Japan; [Moriyama, Toshiki] Osaka Univ, Hlth Care Ctr, Osaka, Japan; [Yamagata, Kunihiro] Univ Tsukuba, Fac Med, Dept Nephrol, Ibarak, Japan; [Kondo, Masahide] Univ Tsukuba, Fac Med, Dept Hlth Care Policy & Hlth Econ, Ibarak, Japan; [Tsuruya, Kazuhiko] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka, Japan; [Narita, Ichiei] Niigata Univ, Sch Med, Div Clin Nephrol & Rheumatol, Niigata, Japan; [Kimura, Kenjiro] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan; [Asahi, Koichi; Watanabe, Tsuyoshi] Fukushima Med Univ, Sch Med, Dept Nephrol Hypertens Diabetol Endocrinol & Meta, Fukushima, Japan; [Iseki, Kunitoshi] iAnal LLC, Tokyo, Japan; [Ohashi, Yasuo] Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan	Yano, Y (reprint author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 North Lake Shore Dr,Suite 1400, Chicago, IL 60611 USA.	yyano@jichi.jp; fujimos@med.miyazaki-u.ac.jp			Ministry of Health, Labor and Welfare of Japan	This work was supported by Health and Labor Sciences Research Grants for Research on the Positioning of Chronic Kidney Disease (CKD) in Specific Health Check and Guidance in Japan, Study on the Appropriate States of Specific Health Checkups and Specific Health Guidance for Prevention of CKD Progression, and Design of a Comprehensive Health Care System for CKD Based on the Individual Risk Assessment by Specific Health Checkups from the Ministry of Health, Labor and Welfare of Japan.	Okada H, 2013, DIABETES CARE, V36, P1908, DOI 10.2337/dc12-2087; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Wei FF, 2014, HYPERTENSION, V63, P790, DOI 10.1161/HYPERTENSIONAHA.113.02681; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Paulis L, 2010, NAT REV CARDIOL, V7, P431, DOI 10.1038/nrcardio.2010.85; Kallianos A, 2013, EUR REV MED PHARMACO, V17, P1932; Chen W, 2012, AM J EPIDEMIOL, V176, pS99, DOI 10.1093/aje/kws298; Kilpatrick ES, 2010, DIABETES CARE, V33, P2442, DOI 10.2337/dc10-1000; Hill GS, 2008, CURR OPIN NEPHROL HY, V17, P266, DOI 10.1097/MNH.0b013e3282f88a1f; Chappell DC, 1998, CIRC RES, V82, P532; Yokota K, 2013, HYPERTENS RES, V36, P151, DOI 10.1038/hr.2012.145; Webb AJS, 2011, STROKE, V42, P2860, DOI 10.1161/STROKEAHA.110.611566; Miao CY, 2006, J HYPERTENS, V24, P1125, DOI 10.1097/01.hjh.0000226203.57818.88; Yano Y, 2014, HYPERTENSION, V64, P983, DOI 10.1161/HYPERTENSIONAHA.114.03978; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rifkin DE, 2008, ARCH INTERN MED, V168, P2212, DOI 10.1001/archinte.168.20.2212; Agrawal V, 2009, NAT REV CARDIOL, V6, P301, DOI 10.1038/nrcardio.2009.11; Yano Y, 2012, KIDNEY INT, V81, P293, DOI 10.1038/ki.2011.346; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Aoki Y, 2014, CIRC J, V78, P2284, DOI 10.1253/circj.CJ-14-0027; Faramawi MF, 2014, HYPERTENS RES, V37, P875, DOI 10.1038/hr.2014.89; Hastie CE, 2013, HYPERTENSION, V62, P698, DOI 10.1161/HYPERTENSIONAHA.113.01343; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Li ZB, 2010, J HYPERTENS, V28, P715, DOI 10.1097/HJH.0b013e328336ed5b; McMullan CJ, 2014, AM J KIDNEY DIS, V64, P714, DOI 10.1053/j.ajkd.2014.06.008; Parati G, 2014, J HUM HYPERTENS, V28, P403, DOI 10.1038/jhh.2013.96; Parati G, 2013, HYPERTENSION, V62, P682, DOI 10.1161/HYPERTENSIONAHA.113.01801; Silacci P, 2001, HYPERTENSION, V38, P1162, DOI 10.1161/hy1101.095993; Yano Y, 2014, J HYPERTENS, V32, P2371, DOI 10.1097/HJH.0000000000000344; Zemaitis P, 2014, CLIN J AM SOC NEPHRO, V9, P1922, DOI 10.2215/CJN.02450314	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	JUL	2015	66	1					30	36		10.1161/HYPERTENSIONAHA.115.05472		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CL6MD	WOS:000357080300008		
J	Hashimoto, J; Ito, S				Hashimoto, Junichiro; Ito, Sadayoshi			Aortic Blood Flow Reversal Determines Renal Function Potential Explanation for Renal Dysfunction Caused by Aortic Stiffening in Hypertension	HYPERTENSION			English	Article						aorta; blood flow velocity; hemodynamics; kidney; pathophysiology; vascular stiffness	CHRONIC KIDNEY-DISEASE; CENTRAL PULSE PRESSURE; SUSTAINED ESSENTIAL-HYPERTENSION; ALL-CAUSE MORTALITY; ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; CARDIORENAL SYNDROME; DESCENDING AORTA; CARDIAC-OUTPUT; HEMODYNAMICS	Aortic stiffness determines the glomerular filtration rate (GFR) and predicts the progressive decline of the GFR. However, the underlying pathophysiological mechanism remains obscure. Recent evidence has shown a close link between aortic stiffness and the bidirectional (systolic forward and early diastolic reverse) flow characteristics. We hypothesized that the aortic stiffening-induced renal dysfunction is attributable to altered central flow dynamics. In 222 patients with hypertension, Doppler velocity waveforms were recorded at the proximal descending aorta to calculate the reverse/forward flow ratio. Tonometric waveforms were recorded to measure the carotid-femoral (aortic) and carotid-radial (peripheral) pulse wave velocities, to estimate the aortic pressure from the radial waveforms, and to compute the aortic characteristic impedance. In addition, renal hemodynamics was evaluated by duplex ultrasound. The estimated GFR was inversely correlated with the aortic pulse wave velocity, reverse/forward flow ratio, pulse pressure, and characteristic impedance, whereas it was not correlated with the peripheral pulse wave velocity or mean arterial pressure. The association between aortic pulse wave velocity and estimated GFR was independent of age, diabetes mellitus, hypercholesterolemia, and antihypertensive medication. However, further adjustment for the aortic reverse/forward flow ratio and pulse pressure substantially weakened this association, and instead, the reverse/forward flow ratio emerged as the strongest determinant of estimated GFR (P=0.001). A higher aortic reverse/forward flow ratio was also associated with lower intrarenal forward flow velocities. These results suggest that an increase in aortic flow reversal (ie, retrograde flow from the descending thoracic aorta toward the aortic arch), caused by aortic stiffening and impedance mismatch, reduces antegrade flow into the kidney and thereby deteriorates renal function.	[Hashimoto, Junichiro; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Dept Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 9808574, Japan	Hashimoto, J (reprint author), Tohoku Univ, Grad Sch Med, Dept Med, Div Nephrol Endocrinol & Vasc Med,Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.	hashimoto@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [C-26461248]	This work was supported by a Grant-in-Aid for Scientific Research (C-26461248) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (J. Hashimoto).	Amirbekian S, 2009, AM J PHYSIOL-HEART C, V297, pH1290, DOI 10.1152/ajpheart.00889.2008; LEITHE ME, 1984, CIRCULATION, V69, P57; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; LONDON GM, 1984, KIDNEY INT, V26, P342, DOI 10.1038/ki.1984.179; MESSERLI FH, 1978, CIRCULATION, V58, P441; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Harloff A, 2010, STROKE, V41, P1145, DOI 10.1161/STROKEAHA.109.577775; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Harloff A, 2009, STROKE, V40, P1505, DOI 10.1161/STROKEAHA.108.530030; Briet M, 2006, KIDNEY INT, V69, P350, DOI 10.1038/sj.ki.5000047; Schillaci G, 2006, HYPERTENSION, V48, P616, DOI 10.1161/01.HYP.0000240346.42873.f6; Briet M, 2011, J AM SOC NEPHROL, V22, P967, DOI 10.1681/ASN.2010080863; Guerin AP, 2001, CIRCULATION, V103, P987; Hashimoto J, 2011, HYPERTENSION, V58, P839, DOI 10.1161/HYPERTENSIONAHA.111.177469; Verhave JC, 2005, HYPERTENSION, V45, P586, DOI 10.1161/01.HYP.0000158843.60830.cf; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Hashimoto J, 2010, HYPERTENSION, V56, P926, DOI 10.1161/HYPERTENSIONAHA.110.159368; Ford ML, 2010, HYPERTENSION, V55, P1110, DOI 10.1161/HYPERTENSIONAHA.109.143024; Karras A, 2012, HYPERTENSION, V60, P1451, DOI 10.1161/HYPERTENSIONAHA.112.197210; Safar ME, 2015, AM J HYPERTENS, V28, P561, DOI 10.1093/ajh/hpu206; Davies JE, 2006, CIRCULATION, V113, P1768, DOI 10.1161/CIRCULATIONAHA.105.603050; Damman K, 2007, EUR J HEART FAIL, V9, P872, DOI 10.1016/j.ejheart.2007.05.010; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; BELZ GG, 1995, CARDIOVASC DRUG THER, V9, P73, DOI 10.1007/BF00877747; BENCHIMO.A, 1972, AM J MED, V52, P467, DOI 10.1016/0002-9343(72)90037-X; Bensalah MZ, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00647.2013; BOGREN HG, 1994, JMRI-J MAGN RESON IM, V4, P119, DOI 10.1002/jmri.1880040204; Garwood S, 2009, ANESTH ANALG, V108, P1371, DOI 10.1213/ane.0b013e31819ed3f6; Hashimoto J, 2013, HYPERTENSION, V62, P542, DOI 10.1161/HYPERTENSIONAHA.113.01318; Hashimoto J, 2014, J HYPERTENS, V32, P1665, DOI 10.1097/HJH.0000000000000242; HOLENSTEIN R, 1988, BIORHEOLOGY, V25, P835; Ito S, 2012, HYPERTENSION, V60, P589, DOI 10.1161/HYPERTENSIONAHA.111.188706; LONDON GM, 1984, HYPERTENSION, V6, P743; Mockel M, 2001, KIDNEY INT, V59, P1439, DOI 10.1046/j.1523-1755.2001.0590041439.x; ROSANSKY SJ, 1983, AM J KIDNEY DIS, V3, P229; TAKENAKA K, 1986, AM J CARDIOL, V57, P1340, DOI 10.1016/0002-9149(86)90215-8; Temmar M, 2010, HYPERTENSION, V55, P327, DOI 10.1161/HYPERTENSIONAHA.109.142851; TEMMAR MM, 1981, CLIN SCI, V60, P653; Townsend RR, 2010, HYPERTENSION, V56, P518, DOI 10.1161/HYPERTENSIONAHA.110.153924; Tsuji Yuji, 2001, International Urology and Nephrology, V32, P307, DOI 10.1023/A:1017531210552	41	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	JUL	2015	66	1					61	67		10.1161/HYPERTENSIONAHA.115.05236		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CL6MD	WOS:000357080300012		
J	Sullivan, CA; Kahn, SE; Fujimoto, WY; Hayashi, T; Leonetti, DL; Boyko, EJ				Sullivan, Catherine A.; Kahn, Steven E.; Fujimoto, Wilfred Y.; Hayashi, Tomoshige; Leonetti, Donna L.; Boyko, Edward J.			Change in Intra-Abdominal Fat Predicts the Risk of Hypertension in Japanese Americans	HYPERTENSION			English	Article						adiposity; Asian Americans; hypertension; intra-abdominal fat	VISCERAL ADIPOSE-TISSUE; IMPAIRED GLUCOSE-TOLERANCE; METABOLIC SYNDROME; INCIDENT HYPERTENSION; INSULIN-RESISTANCE; LIPOPROTEIN LEVELS; MEN; ASSOCIATION; PREVALENCE; OBESITY	In Japanese Americans, intra-abdominal fat area measured by computed tomography is positively associated with the prevalence and incidence of hypertension. Evidence in other populations suggests that other fat areas may be protective. We sought to determine whether a change in specific fat depots predicts the development of hypertension. We prospectively followed up 286 subjects (mean age, 49.5 years; 50.4% men) from the Japanese American Community Diabetes Study for 10 years. At baseline, subjects did not have hypertension (defined as blood pressure 140/90 mmHg) and were not taking blood pressure or glucose-lowering medications. Mid-thigh subcutaneous fat area, abdominal subcutaneous fat area, and intra-abdominal fat area were directly measured by computed tomography at baseline and 5 years. Logistic regression was used to estimate odds of incident hypertension over 10 years in relation to a 5-year change in fat area. The relative odds of developing hypertension for a 5-year increase in intra-abdominal fat was 1.74 (95% confidence interval, 1.28-2.37), after adjusting for age, sex, body mass index, baseline intra-abdominal fat, alcohol use, smoking status, and weekly exercise energy expenditure. This relationship remained significant when adjusted for baseline fasting insulin and 2-hour glucose levels or for diabetes mellitus and pre-diabetes mellitus classification. There were no significant associations between baseline and change in thigh or abdominal subcutaneous fat areas and incident hypertension. In conclusion, in this cohort of Japanese Americans, the risk of developing hypertension is related to the accumulation of intra-abdominal fat rather than the accrual of subcutaneous fat in either the thigh or the abdominal areas.	[Kahn, Steven E.; Boyko, Edward J.] Vet Affairs Puget Sound Hlth Care Syst, Gen Med & Hosp Serv, Seattle, WA USA; [Kahn, Steven E.; Boyko, Edward J.] Vet Affairs Puget Sound Hlth Care Syst, Specialty Med Serv, Seattle, WA USA; [Sullivan, Catherine A.; Kahn, Steven E.] Univ Washington, Dept Med, Div Endocrinol Metab & Nutr, Seattle, WA USA; [Leonetti, Donna L.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Hayashi, Tomoshige] Osaka City Univ, Grad Sch Med, Dept Prevent Med & Environm Hlth, Osaka 558, Japan; [Boyko, Edward J.] Vet Affairs Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA	Boyko, EJ (reprint author), VA Puget Sound S 123 PCC, 1660 S Columbian Way, Seattle, WA 98108 USA.	eboyko@uw.edu	Hayashi, Tomoshige/N-8508-2015		Medical Research Service and Cooperative Studies Program of the Department of Veterans Affairs, Seattle, WA; National Institutes of Health [DK-031170, HL-049293, DK-002654, DK-017047, DK-035816, RR-000037]	This study was supported, in part, by the Medical Research Service and Cooperative Studies Program of the Department of Veterans Affairs, Seattle, WA, as well as National Institutes of Health grants DK-031170, HL-049293, DK-002654, DK-017047, DK-035816, and RR-000037.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amati F, 2012, OBESITY, V20, P1115, DOI 10.1038/oby.2011.401; FUJIMOTO WY, 1987, DIABETES, V36, P721, DOI 10.2337/diabetes.36.6.721; [Anonymous], 2004, DIABETES CARE S1, V27, pS5; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Chandra A, 2014, J AM COLL CARDIOL, V64, P997, DOI 10.1016/j.jacc.2014.05.057; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Wajchenberg BL, 2002, HORM METAB RES, V34, P616, DOI 10.1055/s-2002-38256; FUJIMOTO WY, 1987, DIABETES, V36, P730, DOI 10.2337/diabetes.36.6.730; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Boyko EJ, 1996, INT J OBESITY, V20, P801; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Ding JZ, 2004, AM J HYPERTENS, V17, P971, DOI 10.1016/j.amjhyper.2004.05.001; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Hayashi T, 2004, ANN INTERN MED, V140, P992; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161; Schoen RE, 1998, INT J OBESITY, V22, P338, DOI 10.1038/sj.ijo.0800591; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761; De Larochelliere E, 2014, ATHEROSCLEROSIS, V234, P23, DOI 10.1016/j.atherosclerosis.2014.01.053; Björntorp P, 1993, Obes Res, V1, P206; Hairston KG, 2009, DIABETES CARE, V32, P1553, DOI 10.2337/dc09-0336; Han TS, 1997, INT J OBESITY, V21, P1161, DOI 10.1038/sj.ijo.0800530; Hayashi T, 2003, CIRCULATION, V108, P1718, DOI 10.1161/01.CIR.0000087597.59169.8D; Koh H, 2011, HYPERTENS RES, V34, P565, DOI 10.1038/hr.2010.271; Lee CG, 2010, DIABETES RES CLIN PR, V89, P58, DOI 10.1016/j.diabres.2010.03.006; Lee Y, 2012, ATHEROSCLEROSIS, V224, P258, DOI 10.1016/j.atherosclerosis.2012.07.013; Leff T, 2010, ADIPOSE TISSUE IN HEALTH AND DISEASE, P245; Leonetti Donna L., 1992, Ethnicity and Disease, V2, P326; POULIOT MC, 1991, EUR J CLIN INVEST, V21, P398, DOI 10.1111/j.1365-2362.1991.tb01387.x; Rheaume C, 2011, J CLIN ENDOCR METAB, V96, P1462, DOI 10.1210/jc.2010-2432; Sakai Y, 2005, J INTERN MED, V257, P194, DOI 10.1111/j.1365-2796.2004.01432.x; SHUMAN WP, 1986, INVEST RADIOL, V21, P483, DOI 10.1097/00004424-198606000-00007; Stanton A., 1990, PRIMER APPL REGRESSI; TSUNEHARA CH, 1990, AM J CLIN NUTR, V52, P731; Van Pelt RE, 2005, J CLIN ENDOCR METAB, V90, P4573, DOI 10.1210/jc.2004-1764	39	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	JUL	2015	66	1					134	140		10.1161/HYPERTENSIONAHA.114.04990		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CL6MD	WOS:000357080300021		
J	Koriyama, H; Nakagami, H; Nakagami, F; Osako, MK; Kyutoku, M; Shimamura, M; Kurinami, H; Katsuya, T; Rakugi, H; Morishita, R				Koriyama, Hiroshi; Nakagami, Hironori; Nakagami, Futoshi; Osako, Mariana Kiomy; Kyutoku, Mariko; Shimamura, Munehisa; Kurinami, Hitomi; Katsuya, Tomohiro; Rakugi, Hiromi; Morishita, Ryuichi			Long-Term Reduction of High Blood Pressure by Angiotensin II DNA Vaccine in Spontaneously Hypertensive Rats	HYPERTENSION			English	Article						allergy and immunology; angiotensin II; genetic therapy; hypertension; vaccine therapy	VIRUS-LIKE PARTICLES; PHASE-I; DOUBLE-BLIND; CORE PARTICLES; CELL EPITOPES; IMMUNIZATION; TRIAL; IMMUNOGENICITY; INJECTION; ANTIBODY	Recent research on vaccination has extended its scope from infectious diseases to chronic diseases, including Alzheimer disease, dyslipidemia, and hypertension. The aim of this study was to design DNA vaccines for high blood pressure and eventually develop human vaccine therapy to treat hypertension. Plasmid vector encoding hepatitis B core-angiotensin II (Ang II) fusion protein was injected into spontaneously hypertensive rats using needleless injection system. Anti-Ang II antibody was successfully produced in hepatitis B core-Ang II group, and antibody response against Ang II was sustained for at least 6 months. Systolic blood pressure was consistently lower in hepatitis B core-Ang II group after immunization, whereas blood pressure reduction was continued for at least 6 months. Perivascular fibrosis in heart tissue was also significantly decreased in hepatitis B core-Ang II group. Survival rate was significantly improved in hepatitis B core-Ang II group. This study demonstrated that Ang II DNA vaccine to spontaneously hypertensive rats significantly lowered high blood pressure for at least 6 months. In addition, Ang II DNA vaccines induced an adequate humoral immune response while avoiding the activation of self-reactive T cells, assessed by ELISPOT assay. Future development of DNA vaccine to treat hypertension may provide a new therapeutic option to treat hypertension.	[Koriyama, Hiroshi; Nakagami, Hironori; Osako, Mariana Kiomy; Shimamura, Munehisa; Kurinami, Hitomi] Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Suita, Osaka 5650871, Japan; [Nakagami, Futoshi; Kyutoku, Mariko; Katsuya, Tomohiro; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka 5650871, Japan; [Nakagami, Futoshi; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan	Morishita, R (reprint author), Osaka Univ, Grad Sch Med, Div Clin Gene Therapy, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	nakagami@gts.med.osaka-u.ac.jp; morishita@cgt.med.osaka-u.ac.jp			Japan Society for the Promotion of Science; Japan Science and Technology Agency; Osaka Medical Research Foundation for Intractable Diseases	This work was partly supported by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science, the Adaptive and Seamless Technology Transfer Program (A-step) by the Japan Science and Technology Agency, and The Osaka Medical Research Foundation for Intractable Diseases.	Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; Kharfan-Dabaja MA, 2012, LANCET INFECT DIS, V12, P290, DOI 10.1016/S1473-3099(11)70344-9; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Ludwig C, 2007, CURR OPIN BIOTECH, V18, P537, DOI 10.1016/j.copbio.2007.10.013; Ambuhl PM, 2007, J HYPERTENS, V25, P63; Orgogozo JM, 2003, NEUROLOGY, V61, P46; Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054; Fehr T, 1998, P NATL ACAD SCI USA, V95, P9477, DOI 10.1073/pnas.95.16.9477; Shedlock DJ, 2000, J LEUKOCYTE BIOL, V68, P793; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; Brown MJ, 2004, CLIN SCI, V107, P167; Cattamanchi A, 2008, CLIN VACCINE IMMUNOL, V15, P1638, DOI 10.1128/CVI.00167-08; Do TH, 2010, EXPERT OPIN BIOL TH, V10, P1077, DOI 10.1517/14712598.2010.487060; Ferreira AJ, 2012, INT J HYPERTENS, V2012, DOI DOI 10.1155/2012/147825; Gregson AL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001556; Kunugiza Y, 2006, GENE THER, V13, P1143, DOI 10.1038/sj.gt.3302767; MICHEL JB, 1987, P NATL ACAD SCI USA, V84, P4346, DOI 10.1073/pnas.84.12.4346; Nardin EH, 2004, INFECT IMMUN, V72, P6519, DOI 10.1128/IAI.72.11.6519-6529.2004; Oliveira GA, 2005, INFECT IMMUN, V73, P3587, DOI 10.1128/IAI.73.6.3587-3597.2005; Rohn TA, 2010, CURR OPIN IMMUNOL, V22, P391, DOI 10.1016/j.coi.2010.02.009; Sawamura D, 1999, GENE THER, V6, P1785, DOI 10.1038/sj.gt.3301002; Tanabe A, 2004, J HYPERTENS, V22, P1017, DOI 10.1097/01.hjh.0000125401.50839.db; Xing YP, 2005, WORLD J GASTROENTERO, V11, P4583; Zhu F, 2006, CELL MOL IMMUNOL, V3, P107	26	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	JUL	2015	66	1					167	174		10.1161/HYPERTENSIONAHA.114.04534		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CL6MD	WOS:000357080300025		
J	Tamura, K; Uneda, K; Azushima, K; Wakui, H; Haruhara, K				Tamura, Kouichi; Uneda, Kazushi; Azushima, Kengo; Wakui, Hiromichi; Haruhara, Kotaro			Possible therapeutic impact of the iron chelation on renal fibrosis	HYPERTENSION RESEARCH			English	Editorial Material							CHRONIC KIDNEY-DISEASE; RAT MODEL; RESTRICTION; DAMAGE; HYPERTENSION; INJURY		[Tamura, Kouichi; Uneda, Kazushi; Azushima, Kengo; Wakui, Hiromichi; Haruhara, Kotaro] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan; [Haruhara, Kotaro] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan	Tamura, K (reprint author), Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan.	tamukou@med.yokohama-cu.ac.jp					Mack M, 2015, KIDNEY INT, V87, P297, DOI 10.1038/ki.2014.287; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/01.mnh.0000126791.93346.4a; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Sawada H, 2015, HYPERTENS RES, V38, P317, DOI 10.1038/hr.2015.13; Chen XG, 2013, HYPERTENS RES, V36, P361, DOI 10.1038/hr.2012.204; Cairo G, 2002, FREE RADICAL BIO MED, V32, P1237, DOI 10.1016/S0891-5849(02)00825-0; Charytan DM, 2015, AM J KIDNEY DIS; Haruhara K, 2015, HYPERTENS RES, V38, P116, DOI 10.1038/hr.2014.140; Ikeda Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089355; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; Naito Y, 2013, J HYPERTENS, V31, P1203, DOI 10.1097/HJH.0b013e328360381d; Naito Y, 2015, HYPERTENS RES, V38, P463, DOI 10.1038/hr.2015.14; Sundaram A, 2013, HYPERTENS RES, V36, P213, DOI 10.1038/hr.2012.163	14	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	JUL	2015	38	7					455	456		10.1038/hr.2015.60		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CM3LU	WOS:000357584400002		
J	Otsuka, T; Munakata, R				Otsuka, Toshiaki; Munakata, Ryo			Enlargement of the brachial artery: significance of measurement	HYPERTENSION RESEARCH			English	Editorial Material									[Otsuka, Toshiaki] Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 113, Japan; [Munakata, Ryo] Nippon Med Sch, Chiba Hokusoh Hosp, Cardiovasc Ctr, Chiba, Japan	Otsuka, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.	otsuka@nms.ac.jp					Tomiyama H, 2012, INT HEART J, V53, P170; Atkinson G, 2013, ATHEROSCLEROSIS, V226, P425, DOI 10.1016/j.atherosclerosis.2012.11.027; Montalcini T, 2012, NUTR METAB CARDIOVAS, V22, P8, DOI 10.1016/j.numecd.2011.09.005; Ras RT, 2013, INT J CARDIOL, V168, P344, DOI 10.1016/j.ijcard.2012.09.047; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276; Otsuka T, 2013, HYPERTENS RES, V36, P910, DOI 10.1038/hr.2013.56; Fujii Y, 2013, CIRC J, V77, P1073, DOI 10.1253/circj.CJ-12-1130; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Iguchi T, 2013, HYPERTENS RES, V36, P691, DOI 10.1038/hr.2013.35; Rodriguez-Niedenfuhr M, 2001, J ANAT, V199, P547, DOI 10.1046/j.1469-7580.2001.19950547.x; Strisciuglio T, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0417-1; Tomiyama Y, 2015, HYPERTENS RES, V38, P478, DOI 10.1038/hr.2015.6	12	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	JUL	2015	38	7					459	460		10.1038/hr.2015.59		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CM3LU	WOS:000357584400004		
J	Tanaka, A; Node, K				Tanaka, Atsushi; Node, Koichi			A novel cardioprotective mechanism of exogenous nitric oxide: inhibition of Rho-associated kinase activity	HYPERTENSION RESEARCH			English	Editorial Material							FASUDIL; PATHWAY; ANGINA		[Tanaka, Atsushi; Node, Koichi] Saga Univ, Dept Cardiovasc Med, Saga 840, Japan	Tanaka, A (reprint author), Saga Univ, Dept Cardiovasc Med, Saga 840, Japan.	tanakaa2@cc.saga-u.ac.jp					Hata T, 2011, ATHEROSCLEROSIS, V214, P117, DOI 10.1016/j.atherosclerosis.2010.10.005; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sawada N, 2014, ANTIOXID REDOX SIGN, V20, P1251, DOI 10.1089/ars.2013.5524; Kikuchi Y, 2011, J AM COLL CARDIOL, V58, P1231, DOI 10.1016/j.jacc.2011.05.046; Cao X, 2014, HYPERTENS RES, V37, P803, DOI 10.1038/hr.2014.90; Chitaley K, 2002, HYPERTENSION, V39, P438, DOI 10.1161/hy02t2.102960; Maruhashi T, 2015, HYPERTENS RES, V38, P485, DOI 10.1038/hr.2015.24; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Asanuma H, 2014, HYPERTENS RES, V37, P716, DOI 10.1038/hr.2014.70; Maruhashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109017; Mohri M, 2003, J AM COLL CARDIOL, V41, P15, DOI 10.1016/S0735-1097(02)02632-3	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	JUL	2015	38	7					461	462		10.1038/hr.2015.61		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CM3LU	WOS:000357584400005		
J	Naito, Y; Fujii, A; Sawada, H; Oboshi, M; Iwasaku, T; Okuhara, Y; Morisawa, D; Eguchi, A; Hirotani, S; Masuyama, T				Naito, Yoshiro; Fujii, Aya; Sawada, Hisashi; Oboshi, Makiko; Iwasaku, Toshihiro; Okuhara, Yoshitaka; Morisawa, Daisuke; Eguchi, Akiyo; Hirotani, Shinichi; Masuyama, Tohru			Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease	HYPERTENSION RESEARCH			English	Article						chronic kidney disease; iron; renal fibrosis	N-ACETYLCYSTEINE; OXIDANT STRESS; INJURY; DAMAGE; DEFEROXAMINE; DEFERASIROX; PROGRESSION; NEPHROTOXICITY; HYPERTENSION; INFLAMMATION	Iron accumulation is associated with the pathophysiology of chronic kidney disease (CKD). Renal fibrosis is a final common feature that contributes to the progression of CKD; however, little is known about the association between renal iron accumulation and renal interstitial fibrosis in CKD. Here we investigate the effects of iron chelation on renal interstitial fibrosis in a rat model of CKD. CKD was induced by 5/6 nephrectomy in Sprague-Dawley rats. At 8 weeks after operation, 5/6 nephrectomized rats were administered an oral iron chelator, deferasirox (DFX), in chow for 8 weeks. Other CKD rats were given a normal diet. Sham-operative rats given a normal diet served as a control. CKD rats exhibited hypertension, glomerulosclerosis and renal interstitial fibrosis. Iron chelation with DFX did not change hypertension and glomerulosclerosis; however, renal interstitial fibrosis was attenuated in CKD rats. Consistent with these findings, renal gene expression of collagen type III and transforming growth factor-beta was increased in CKD rats compared with the controls, while iron chelation suppressed these increments. In addition, a decrease in vimentin along an increase in E-cadherin in renal gene expression was observed in CKD rats with iron chelation. CKD rats also showed increased CD68-positive cells in the kidney, whereas its increase was attenuated by iron deprivation. Similarly, increased renal gene expression of CD68, tumor necrosis factor-alpha and monocyte chemoattractant protein-1 was suppressed in CKD rats with iron chelation. Renal iron accumulation seems to be associated with renal interstitial fibrosis in a rat model of CKD.	[Naito, Yoshiro; Fujii, Aya; Sawada, Hisashi; Oboshi, Makiko; Iwasaku, Toshihiro; Okuhara, Yoshitaka; Morisawa, Daisuke; Eguchi, Akiyo; Hirotani, Shinichi; Masuyama, Tohru] Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan	Naito, Y (reprint author), Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ynaito@hyo-med.ac.jp			Hyogo Science and Technology Association	We thank Noriko Kumon, Sachi Ito and Manami Hosokawa for their technical assistance. This study was supported by a grant from Hyogo Science and Technology Association (to Y. Naito).	Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Goraya N, 2012, KIDNEY INT, V81, P86, DOI 10.1038/ki.2011.313; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Martines AMF, 2013, NAT REV NEPHROL, V9, P385, DOI 10.1038/nrneph.2013.98; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Rajapurkar MM, 2013, TOXICOL MECH METHOD, V23, P5, DOI 10.3109/15376516.2012.730558; Chen XG, 2013, HYPERTENS RES, V36, P361, DOI 10.1038/hr.2012.204; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Kontoghiorghes GJ, 2010, EXPERT OPIN DRUG SAF, V9, P633, DOI 10.1517/14740338.2010.497138; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Ritter C, 2004, CRIT CARE MED, V32, P2079, DOI 10.1097/01.CMM.0000142699.54266.D9; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; BOLLI R, 1990, AM J PHYSIOL, V259, pH1901; Breccia M, 2013, ANN HEMATOL, V92, P863, DOI 10.1007/s00277-013-1703-7; Bulucu F, 2008, J NEPHROL, V21, P576; HARRIS DCH, 1994, CLIN EXP PHARMACOL P, V21, P73, DOI 10.1111/j.1440-1681.1994.tb02472.x; Hoskova L, 2014, HYPERTENS RES, V37, P724, DOI 10.1038/hr.2014.79; Ikeda Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089355; Maker GL, 2013, NEPHROLOGY, V18, P188, DOI 10.1111/nep.12035; Molina-Jijon E, 2012, TOXICOLOGY, V291, P93, DOI 10.1016/j.tox.2011.11.003; Murphy Noreen, 2013, WMJ, V112, P177; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; Naito Y, 2011, HYPERTENSION, V57, P497, DOI 10.1161/HYPERTENSIONAHA.110.159681; Naito Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075906; Naito Y, 2013, J HYPERTENS, V31, P1203, DOI 10.1097/HJH.0b013e328360381d; NANKIVELL BJ, 1992, AM J KIDNEY DIS, V20, P580; NANKIVELL BJ, 1994, J AM SOC NEPHROL, V4, P1598; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Pillebout E, 2003, J CLIN INVEST, V112, P843, DOI 10.1172/JCI200317647; REDDY BR, 1989, FREE RADICAL BIO MED, V7, P45; Rodriguez-Iturbe B, 2010, NEPHRON CLIN PRACT, V116, pC81, DOI 10.1159/000314656; Sanchez-Gonzalez PD, 2011, TOXICOL LETT, V203, P154, DOI 10.1016/j.toxlet.2011.03.018; Wang HG, 2001, AM J KIDNEY DIS, V38, P1038, DOI 10.1053/ajkd.2001.28593	34	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	JUL	2015	38	7					463	470		10.1038/hr.2015.14		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CM3LU	WOS:000357584400006		
J	Tomiyama, Y; Yoshinaga, K; Fujii, S; Ochi, N; Inoue, M; Nishida, M; Aziki, K; Horie, T; Katoh, C; Tamaki, N				Tomiyama, Yuuki; Yoshinaga, Keiichiro; Fujii, Satoshi; Ochi, Noriki; Inoue, Mamiko; Nishida, Mutumi; Aziki, Kumi; Horie, Tatsunori; Katoh, Chietsugu; Tamaki, Nagara			Accurate quantitative measurements of brachial artery cross-sectional vascular area and vascular volume elastic modulus using automated oscillometric measurements: comparison with brachial artery ultrasound	HYPERTENSION RESEARCH			English	Article						brachial artery; cross-sectional area; elasticity; oscillometric; ultrasound	CARDIOVASCULAR RISK-FACTORS; YOUNG-ADULTS; TUBE LAW; IN-VIVO; STIFFNESS; INDEX; POPULATION; GUIDELINES; DIAGNOSIS; PRESSURE	Increasing vascular diameter and attenuated vascular elasticity may be reliable markers for atherosclerotic risk assessment. However, previous measurements have been complex, operator-dependent or invasive. Recently, we developed a new automated oscillometric method to measure a brachial artery's estimated area (eA) and volume elastic modulus (V-E). The aim of this study was to investigate the reliability of new automated oscillometric measurement of eA and V-E. Rest eA and V-E were measured using the recently developed automated detector with the oscillometric method. eA was estimated using pressure/volume curves and V-E was defined as follows (V-E = Delta pressure/(100 x Delta area/area) mmHg/%). Sixteen volunteers (age 35.2 +/- 13.1 years) underwent the oscillometric measurements and brachial ultrasound at rest and under nitroglycerin (NTG) administration. Oscillometric measurement was performed twice on different days. The rest eA correlated with ultrasound-measured brachial artery area (r=0.77, P<0.001). Rest eA and V-E measurement showed good reproducibility (eA: intraclass correlation coefficient (ICC)=0.88, V-E: ICC=0.78). Under NTG stress, eA was significantly increased (12.3 +/- 3.0 vs. 17.1 +/- 4.6mm(2), P<0.001), and this was similar to the case with ultrasound evaluation (4.46 +/- 0.72 vs. 4.73 +/- 0.75 mm, P<0.001). V-E was also decreased (0.81 +/- 0.16 vs. 0.65 +/- 0.11mmHg/%, P<0.001) after NTG. Cross-sectional vascular area calculated using this automated oscillometric measurement correlated with ultrasound measurement and showed good reproducibility. Therefore, this is a reliable approach and this modality may have practical application to automatically assess muscular artery diameter and elasticity in clinical or epidemiological settings.	[Tomiyama, Yuuki; Nishida, Mutumi; Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido 060, Japan; [Yoshinaga, Keiichiro; Aziki, Kumi] Hokkaido Univ, Grad Sch Med, Dept Mol Imaging, Sapporo, Hokkaido 060, Japan; [Fujii, Satoshi] Asahikawa Med Univ, Dept Lab Med, Asahikawa, Hokkaido, Japan; [Ochi, Noriki; Katoh, Chietsugu] Hokkaido Univ, Grad Sch Med, Fac Hlth Sci, Sapporo, Hokkaido 060, Japan; [Inoue, Mamiko; Horie, Tatsunori] Hokkaido Univ Hosp, Div Clin Lab & Transfus Med, Sapporo, Hokkaido, Japan	Yoshinaga, K (reprint author), Natl Inst Radiol Sci, Dept Mol Imaging Res, Inage Ku, 4-9-1 Anage, Chiba 2638555, Japan.	kyoshi@nirs.go.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (HOUGA) [24659550]; Adult Vascular Disease Research Foundation [H22 23]; Smoking Research Foundation; A&D Company (Tokyo, Japan); National Institute of Radiological Sciences Human Resources Development Program (Chiba, Japan); Research Assistant Program, Hokkaido University Graduate School of Medicine; Imura Clinical Research Award (Adult Vascular Disease Research Foundation)	This study was supported in part by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (HOUGA Grant No. 24659550), Adult Vascular Disease Research Foundation (#H22 23), Smoking Research Foundation 2011-2014 and A&D Company (Tokyo, Japan). YT was supported by the National Institute of Radiological Sciences Human Resources Development Program (Chiba, Japan) and is supported by the Research Assistant Program, Hokkaido University Graduate School of Medicine. KY is supported by the Imura Clinical Research Award (Adult Vascular Disease Research Foundation). All data were recorded and analyzed by Hokkaido University Graduate School of Medicine.	Hamburg NM, 2011, HYPERTENSION, V57, P390, DOI 10.1161/HYPERTENSIONAHA.110.160812; Weber MA, 2014, J HYPERTENS, V32, P3, DOI 10.1097/HJH.0000000000000065; Liu L, 2007, J OCCUP ENVIRON MED, V49, P258, DOI 10.1097/JOM.0013e31803220ef; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; Marzo A, 2005, J FLUID STRUCT, V20, P817, DOI 10.1016/j.jfluidstructs.2005.03.08; Kozlovsky P, 2014, J BIOMECH, V47, P2378, DOI 10.1016/j.jbiomech.2014.04.033; Wohlfahrt P, 2013, HYPERTENS RES, V36, P718, DOI 10.1038/hr.2013.21; Otsuka T, 2013, HYPERTENS RES, V36, P910, DOI 10.1038/hr.2013.56; Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; Yoshinaga K, 2011, J NUCL CARDIOL, V18, P486, DOI 10.1007/s12350-011-9370-3; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Clairotte C, 2009, DIABETES CARE, V32, P1231, DOI 10.2337/dc08-2230; ZIMMERMAN FH, 1995, J AM COLL CARDIOL, V26, P654, DOI 10.1016/0735-1097(95)00254-2; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Kinlay S, 2001, HYPERTENSION, V38, P1049, DOI 10.1161/hy1101.095329; Doonan RJ, 2013, HYPERTENS RES, V36, P226, DOI 10.1038/hr.2012.158; AlGhatrif M, 2013, HYPERTENSION, V62, P934, DOI 10.1161/HYPERTENSIONAHA.113.01445; Hamburg NM, 2008, CIRCULATION, V117, P2467, DOI 10.1161/CIRCULATIONAHA.107.748574; Bank AJ, 1996, CIRCULATION, V94, P3263; UREN NG, 1995, J NUCL MED, V36, P2032; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Fukui M, 2013, HYPERTENS RES, V36, P645, DOI 10.1038/hr.2013.4; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Green DJ, 2010, ATHEROSCLEROSIS, V210, P525, DOI 10.1016/j.atherosclerosis.2010.01.048; Holewijn S, 2009, EUR J CLIN INVEST, V39, P554, DOI 10.1111/j.1365-2362.2009.02152.x; Hu HQ, 2013, HYPERTENS RES, V36, P334, DOI 10.1038/hr.2012.192; Kaiser DR, 2001, HYPERTENSION, V38, P1440, DOI 10.1161/hy1201.096539; Meirelles Cde M, 2007, ARQ BRAS CARDIOL, V89, P160; Meirelles Cde M, 2007, ARQ BRAS CARDIOL, V9, P176; Rahmani-Cherati T, 2006, J TEH U HEART CTR, V1, P15; Whittaker RJ, 2010, Q J MECH APPL MATH, V63, P465, DOI 10.1093/qjmam/hbq020	32	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	JUL	2015	38	7					478	484		10.1038/hr.2015.6		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CM3LU	WOS:000357584400008		
J	Maruhashi, T; Noma, K; Fujimura, N; Kajikawa, M; Matsumoto, T; Hidaka, T; Nakashima, A; Kihara, Y; Liao, JK; Higashi, Y				Maruhashi, Tatsuya; Noma, Kensuke; Fujimura, Noritaka; Kajikawa, Masato; Matsumoto, Takeshi; Hidaka, Takayuki; Nakashima, Ayumu; Kihara, Yasuki; Liao, James K.; Higashi, Yukihito			Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial	HYPERTENSION RESEARCH			English	Article						atherosclerosis; biologic marker; cardiovascular disease; nitric oxide	ACUTE MYOCARDIAL-INFARCTION; CONGESTIVE-HEART-FAILURE; PROTEIN-KINASE; ENDOTHELIAL FUNCTION; VASOSPASTIC ANGINA; SMOOTH-MUSCLE; OXIDATIVE STRESS; COILED-COIL; HUMANS; DISEASE	The RhoA/Rho-associated kinase (ROCK) pathway has a key physiological role in the pathogenesis of atherosclerosis. Increased ROCK activity is associated with cardiovascular diseases. Endogenous nitric oxide (NO) has an anti-atherosclerotic effect, whereas the exogenous NO-mediated cardiovascular effect still remains controversial. The purpose of this study was to evaluate the effect of exogenous NO on ROCK activity in patients with angina pectoris. This is a prospective, open-label, randomized, controlled study. A total of 30 patients with angina pectoris were randomly assigned to receive 40 mg day(-1) of isosorbide mononitrate (n=15, 12 men and 3 women, mean age of 63 +/- 12 years, isosorbide mononitrate group) or conventional treatment (n=15, 13 men and 2 women, mean age of 64 +/- 13 years, control group) for 12 weeks. ROCK activity in peripheral leukocytes was measured by western blot analysis. ROCK activities at 4 and 12 weeks after treatment were decreased in the isosorbide mononitrate group (0.82 +/- 0.33 at 0 week, 0.62 +/- 0.20 at 4 weeks, 0.61 +/- 0.19 at 12 weeks, n=15 in each group, P<0.05, respectively) but not altered in the control group. ROCK1 and ROCK2 expression levels were similar in all treatment periods in the two groups. These findings suggest that the administration of exogenous NO can inhibit ROCK activity, indicating that the usage of exogenous NO could have a protective effect in patients with angina pectoris.	[Maruhashi, Tatsuya; Fujimura, Noritaka; Kajikawa, Masato; Matsumoto, Takeshi; Hidaka, Takayuki; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima 7348551, Japan; [Noma, Kensuke; Higashi, Yukihito] Hiroshima Univ, RIRBM, Res Ctr Radiat Genome Med, Dept Regenerat & Med, Hiroshima 7348551, Japan; [Nakashima, Ayumu] Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, Dept Regenerat & Med, Hiroshima, Japan; [Liao, James K.] Univ Chicago, Med Ctr, Sect Cardiol, Chicago, IL 60637 USA	Higashi, Y (reprint author), Hiroshima Univ, RIRBM, Res Ctr Radiat Genome Med, Dept Regenerat & Med,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	yhigashi@hiroshima-u.ac.jp			Ministry of Education, Science and Culture of Japan [23591043, 1859081500, 21590898]; Japan Heart Foundation/Novartis Grant and Tsuchiya Foundation Grant, Japan; Japanese Arteriosclerosis Prevention Fund	We thank Naomi Idei, Shinsuke Mikami, Yumiko Iwamoto, Akimichi Iwamoto, Nozomu Oda, Yoshiki Aibara, Chikara Goto, Kazuaki Chayama, Megumi Wakisaka, Miki Kumiji, Ki-ichiro Kawano and Satoko Michiyama for their excellent experimental and secretarial assistance. This work was carried out at the Analysis Center of Life Science, Hiroshima University. Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (23591043), Japan Heart Foundation/Novartis Grant and Tsuchiya Foundation Grant, Japan (to KN) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (1859081500 and 21590898 to YH) and a Grant-in-Aid of Japanese Arteriosclerosis Prevention Fund (to YH).	Abrams J, 2005, NEW ENGL J MED, V352, P2524, DOI 10.1056/NEJMcp042317; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Hata T, 2011, ATHEROSCLEROSIS, V214, P117, DOI 10.1016/j.atherosclerosis.2010.10.005; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Nohria A, 2006, CIRC RES, V99, P1426, DOI 10.1161/01.RES.0000251668.39526.c7; Nakamura Y, 1999, AM HEART J, V138, P577, DOI 10.1016/S0002-8703(99)70163-8; [Anonymous], 1994, LANCET, V19, P343; Hata T, 2011, J HYPERTENS, V29, P373, DOI 10.1097/HJH.0b013e328340902d; Liu PY, 2007, J AM COLL CARDIOL, V49, P1619, DOI 10.1016/j.jacc.2006.12.043; Sato M, 2000, CIRC RES, V87, P195; Dong M, 2012, EUR J HEART FAIL, V14, P965, DOI 10.1093/eurjhf/hfs068; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Nishioka S, 2013, HYPERTENS RES, V36, P934, DOI 10.1038/hr.2013.60; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82; Liu PY, 2009, CIRCULATION, V119, P131, DOI 10.1161/CIRCULATIONAHA.108.813311; Mallat Z, 2003, CIRC RES, V93, P884, DOI 10.1161/01.RES.0000099062.55042.9A; Noma K, 2007, J AM COLL CARDIOL, V49, P698, DOI 10.1016/j.jacc.2006.06.082; Noma K, 2005, ARTERIOSCL THROM VAS, V25, P2630, DOI 10.1161/01.ATV.0000189304.32725.bd; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Sawada N, 2000, CIRCULATION, V101, P2030; Kikuchi Y, 2011, J AM COLL CARDIOL, V58, P1231, DOI 10.1016/j.jacc.2011.05.046; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Soga J, 2011, ARTERIOSCL THROM VAS, V31, P2353, DOI 10.1161/ATVBAHA.111.227892; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; PACKER M, 1987, NEW ENGL J MED, V317, P799, DOI 10.1056/NEJM198709243171304; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1302.105938; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; Mahmarian JJ, 1998, CIRCULATION, V97, P2017; Hung MJ, 2012, ATHEROSCLEROSIS, V221, P521, DOI 10.1016/j.atherosclerosis.2012.01.001; Gori T, 2008, J AM COLL CARDIOL, V52, P251, DOI 10.1016/j.jacc.2008.04.019; COLLINS R, 1995, LANCET, V345, P669; Noma K, 2003, HYPERTENSION, V41, P1102, DOI 10.1161/01.HYP.0000067062.92836.9E; Paulo M, 2013, HYPERTENS RES, V36, P765, DOI 10.1038/hr.2013.49; Shimokawa Hiroaki, 2002, Journal of Cardiovascular Pharmacology, V40, P751, DOI 10.1097/00005344-200211000-00013	35	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	JUL	2015	38	7					485	490		10.1038/hr.2015.24		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CM3LU	WOS:000357584400009		
J	Takeuchi, K				Takeuchi, Keigo			Spatial Modulation Achieves Information-Theoretically Optimal Energy Efficiency	IEEE COMMUNICATIONS LETTERS			English	Article						Spatial modulation; information theory; channel capacity; energy efficiency; low signal-to-noise ratio (SNR)	CHANNELS; REGIME; PERFORMANCE; CAPACITY	Spatial modulation (SM) is investigated for multiple-input single-output channels with perfect channel state information at the receiver. In spite of its low implementation complexity, SM with quadrature phase-shift keying is proved to achieve an information-theoretically achievable rate that is equal to the channel capacity up to second order as the signal-to-noise ratio tends to zero. This implies that SM is second-order optimal in terms of energy efficiency.	Univ Electrocommun, Dept Commun Engn & Informat, Tokyo 1828585, Japan	Takeuchi, K (reprint author), Univ Electrocommun, Dept Commun Engn & Informat, Tokyo 1828585, Japan.	ktakeuchi@uec.ac.jp			MEXT/JSPS KAKENHI, Japan [26709029]; JSPS KAKENHI Grant, Japan [15K13987]	This work was supported in part by the Grant-in-Aid for Young Scientists (A) (MEXT/JSPS KAKENHI Grant Number 26709029), Japan, and by the Grant-in-Aid for Exploratory Research (JSPS KAKENHI Grant Number 15K13987), Japan. The associate editor coordinating the review of this paper and approving it for publication was X. Lei.	An ZC, 2015, IEEE T COMMUN, V63, P826, DOI 10.1109/TCOMM.2014.2387171; Yang P, 2011, IEEE COMMUN LETT, V15, P602, DOI 10.1109/LCOMM.2011.040711.110014; Younis A, 2013, IEEE T COMMUN, V61, P2805, DOI 10.1109/TCOMM.2013.061013.120547; Mesleh RY, 2008, IEEE T VEH TECHNOL, V57, P2228, DOI [10.1109/TVT.2007.912136, 10.1109/TVT.2008.912136]; Sugiura S, 2011, IEEE T COMMUN, V59, P3090, DOI 10.1109/TCOMM.2011.100411.110154; Jeganathan J, 2008, IEEE COMMUN LETT, V12, P545, DOI 10.1109/LCOMM.2008.080739; Verdu S, 2002, IEEE T INFORM THEORY, V48, P1319, DOI 10.1109/TIT.2002.1003824; Yang YL, 2008, IEEE COMMUN LETT, V12, P225, DOI 10.1109/LCOMM.2008.071986; Jeganathan J, 2009, IEEE T WIREL COMMUN, V8, P3692, DOI 10.1109/TWC.2009.080910; Chau YA, 2001, IEEE VTS VEH TECHNOL, P1668, DOI 10.1109/VTC.2001.956483; Lozano A, 2003, IEEE T INFORM THEORY, V49, P2527, DOI 10.1109/TIT.2003.817429; Cover T. M., 2006, ELEMENTS INFORM THEO; Foschini G. J., 1998, Wireless Personal Communications, V6, DOI 10.1023/A:1008889222784; Maleki M, 2014, IEEE T COMMUN, V62, P144, DOI 10.1109/TCOMM.2013.121313.130514; Prelov VV, 2004, IEEE T INFORM THEORY, V50, P1567, DOI 10.1109/TIT.2004.831784; Renzo M. D., 2014, P IEEE, V102, P56, DOI DOI 10.1109/JPROC.2013.2287851; Song S., 2004, PROC IEEE INT CONF C, P229; Stavridis A., 2013, P IEEE VEH TECHN C F, P1; Takeuchi K, 2013, IEEE T INFORM THEORY, V59, P6517, DOI 10.1109/TIT.2013.2268848; Telatar E, 1999, EUR T TELECOMMUN, V10, P585, DOI 10.1002/ett.4460100604; Yang P, 2015, IEEE COMMUN SURV TUT, V17, P6, DOI 10.1109/COMST.2014.2327066; Zheng LZ, 2007, IEEE T INFORM THEORY, V53, P976, DOI 10.1109/TIT.2006.890777	22	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1089-7798	1558-2558		IEEE COMMUN LETT	IEEE Commun. Lett.	JUL	2015	19	7					1133	1136		10.1109/LCOMM.2015.2433271		4	Telecommunications	Telecommunications	CM6JC	WOS:000357793600013		
J	Wang, JQ; Liu, JL; Suguri, KH; Anzai, D				Wang, Jianqing; Liu, Jinlong; Suguri, Kohei; Anzai, Daisuke			An In-Body Impulse Radio Transceiver With Implant Antenna Miniaturization at 30 MHz	IEEE MICROWAVE AND WIRELESS COMPONENTS LETTERS			English	Article						Bit error rate; body area network; implant antenna; implant communication; impulse radio transceiver		For real-time image/video transmission in implant body area networks, we have developed an in-body transceiver at around 30 MHz. The transceiver employs impulse radio (IR) technology with multi-pulse position modulation (MPPM) scheme. The transmit antenna was realized in a dimension of 1 x 2 cm by forming the radiation elements on a flexible magnetic sheet. Experimental results in a biological-equivalent liquid phantom have demonstrated a bit error rate smaller than 10(-3) in a depth of 26 cm with a data rate at least 1.25 Mbps.	[Wang, Jianqing; Liu, Jinlong; Suguri, Kohei; Anzai, Daisuke] Nagoya Inst Technol, Nagoya, Aichi 4668555, Japan	Wang, JQ (reprint author), Nagoya Inst Technol, Nagoya, Aichi 4668555, Japan.	wang@nitech.ac.jp			JSPS KAKENHI [15H04006]	This work was supported in part by JSPS KAKENHI under Grant 15H04006.	Yuce MR, 2012, IEEE MICROW MAG, V13, P90, DOI 10.1109/MMM.2012.2205833; Anzai D, 2014, IEEE T MICROW THEORY, V62, P183, DOI 10.1109/TMTT.2013.2291542; ITOH S, 2006, P IEEE INT S CIRC SY, P3353; Shikada K., 2012, P IEEE CPMT S KYOT J, P283; Wang J., 2013, BODY AREA COMMUNICAT	5	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1531-1309	1558-1764		IEEE MICROW WIREL CO	IEEE Microw. Wirel. Compon. Lett.	JUL	2015	25	7					484	486		10.1109/LMWC.2015.2429112		3	Engineering, Electrical & Electronic	Engineering	CM3XS	WOS:000357619300022		
J	Amft, O; Wahl, F; Ishimaru, S; Kunze, K				Amft, Oliver; Wahl, Florian; Ishimaru, Shoya; Kunze, Kai			Making Regular Eyeglasses Smart	IEEE PERVASIVE COMPUTING			English	Article							EAR-WORN SENSOR; SYSTEM; LIGHT	Software apps running on smart eyeglasses offer unobtrusive universal assistance systems that can support wearers in their daily lives. The authors describe a blueprint of the embedded architecture of smart eyeglasses and discuss findings from using smart eyeglass prototypes.	[Amft, Oliver; Wahl, Florian] Univ Passau, Sensor Technol, Passau, Germany; [Ishimaru, Shoya] Osaka Prefecture Univ, Sakai, Osaka, Japan; [Kunze, Kai] Keio Univ, Grad Sch Media Design, Yokohama, Kanagawa 223, Japan; [Amft, Oliver] Univ Passau, ACTLab Res Grp, Passau, Germany	Amft, O (reprint author), Univ Passau, Sensor Technol, Passau, Germany.	amft@computer.org; wahl@ieee.org; ishimaru@m.cs.osakafu-u.ac.jp; kai.kunze@gmail.com			Dutch Technology Foundation STW [12184]	This research was partly supported by the Dutch Technology Foundation STW under grant numbers 12184, Project OnTime.	Amft O, 2009, IEEE PERVAS COMPUT, V8, P62, DOI 10.1109/MPRV.2009.32; Atallah L, 2014, PHYSIOL MEAS, V35, pN29, DOI 10.1088/0967-3334/35/5/N29; Siegle GJ, 2008, PSYCHOPHYSIOLOGY, V45, P679, DOI 10.1111/j.1469-8986.2008.00681.x; Amft O, 2005, LECT NOTES COMPUT SC, V3660, P56; Bouarfa L, 2014, IEEE T BIO-MED ENG, V61, P566, DOI 10.1109/TBME.2013.2284069; Lin CT, 2014, IEEE T BIOMED CIRC S, V8, P165, DOI 10.1109/TBCAS.2014.2316224; Patterson JAC, 2009, SIXTH INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P286, DOI 10.1109/P3644.15; Duffy JF, 2005, J BIOL RHYTHM, V20, P326, DOI 10.1177/0748730405277983; Stein BE, 2009, HEARING RES, V258, P4, DOI 10.1016/j.heares.2009.03.012; Bulling A., 2012, ACM T APPL PERCEPT, V9, P2; Cinaz B., 2008, P 12 IEEE INT S WEAR, P286, DOI [10.1109/ISWC.2008.4911575, DOI 10.1109/ISWC.2008.4911575]; Costanza E., 2006, PROCEEDINGS OF THE 8, P211, DOI [10.1145/1152215.1152261, DOI 10.1145/1152215.1152261]; DeVaul R.W., 2003, P 2012 16 INT S WEAR, P146; Ishiguro Y., 2010, P 1 AUGM HUM INT C, DOI [10.1145/1785455.1785480, DOI 10.1145/1785455.1785480]; Kourogi M., 2003, Proceedings Second IEEE and ACM International Symposium on Mixed and Augmented Reality; Kunze K, 2013, P 2013 INT S WEAR CO, P113; Kunze K, 2013, PROC INT CONF DOC, P25, DOI 10.1109/ICDAR.2013.14; Manabe H., 2006, HUM FACT COMP SYST C, P1073; McLaughlin C., 2003, SID S, V34, P280; Moore D.W., 2000, STRUGGLING ADOLESCEN; Revell VL, 2005, J BIOL RHYTHM, V20, P353, DOI 10.1177/0748730405277233; Stanovich KE, 2001, J DIRECT INSTRUCTION, V1, P137; Wahl F., 2014, P 2014 ACM INT S WEA, P43, DOI DOI 10.1145/2634317.2634346	23	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1536-1268	1558-2590		IEEE PERVAS COMPUT	IEEE Pervasive Comput.	JUL-SEP	2015	14	3					32	43				12	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Computer Science; Engineering; Telecommunications	CM4YD	WOS:000357691600007		
J	Ali, M; Kohama, T; Ando, M				Ali, Maifuz; Kohama, Takayuki; Ando, Makoto			Modified Edge Representation (MER) Consisting of Keller's Diffraction Coefficients With Weighted Fringe Waves and Its Localization for Evaluation of Corner Diffraction	IEEE TRANSACTIONS ON ANTENNAS AND PROPAGATION			English	Article						Corner diffraction; equivalent edge current (EEC); Fresnel zone; geometrical theory of diffraction (GTD); modified edge representation (MER); uniform theory of diffraction (UTD)	INCREMENTAL THEORY; GEOMETRICAL-THEORY; FLAT PLATES; CURRENTS; FORMULATION; SCATTERING; SURFACE; FIELDS; PLANE; COMPONENTS	Equivalent edge currents (EECs) for high-frequency diffraction analysis are intermediate concepts between ray theory and wave optics [physical optics (PO)]. The methods of EEC present some ambiguity in the definition of currents at general edge points, which do not satisfy the diffraction law. Modified edge representation (MER) is a unique concept for a complete definition of EEC with simple and classical Keller-type knife-edge diffraction coefficients. Although singularities in the definition of EEC exist, the line integration of MER EEC results uniform and accurate fields everywhere including geometrical boundaries except for the case of grazing incidence, where reflection and incidence shadow boundaries (RSB and ISB) are close to each other. In this paper, fringe wave (FW) part of MER EEC is modified by introducing the weighting in terms of Fresnel zone number (FZN) distance from the reflection point to improve the accuracy at and near shadow boundaries even in grazing incidence. Next, the corner diffraction, a contribution coming from edge point which does not satisfy the diffraction law, is extracted in MER by introducing another weighting function using the FZN distance from scattering centers on edge. Its remarkable accuracy fully validates MER EECs at general edge points. The dipole wave scattering from flat square and triangular plates are discussed with numerical examples.	[Ali, Maifuz; Kohama, Takayuki; Ando, Makoto] Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 152, Japan	Ali, M (reprint author), Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 152, Japan.	maifuzali@antenna.ee.titech.ac.jp; kohama.taka@antenna.ee.titech.ac.jp; mando@antenna.ee.titech.ac.jp					AHLUWALI.DS, 1968, SIAM J APPL MATH, V16, P783, DOI 10.1137/0116065; Ali M, 2010, IEEE T ANTENN PROPAG, V58, P969, DOI 10.1109/TAP.2009.2037762; Ando M, 2013, URSI INT SYM ELECT, P1061; Ando M., 1989, Transactions of the Institute of Electronics, Information and Communication Engineers E, VE72; MURASAKI T, 1993, IEICE T ELECTRON, VE76C, P1412; LEE SW, 1976, IEEE T ANTENN PROPAG, V24, P25; Tiberio R, 2004, IEEE T ANTENN PROPAG, V52, P2234, DOI 10.1109/TAP.2004.834142; ANDO M, 1991, IEE PROC-H, V138, P289; MURASAKI T, 1992, IEICE T ELECTRON, VE75C, P617; MICHAELI A, 1984, IEEE T ANTENN PROPAG, V32, P252, DOI 10.1109/TAP.1984.1143303; BURNSIDE WD, 1983, IEEE T ANTENN PROPAG, V31, P104, DOI 10.1109/TAP.1983.1143019; Balanis C. A., 1989, ADV ENG ELECTROMAGNE; BURNSIDE WD, 1974, IEEE T ANTENN PROPAG, VAP22, P620, DOI 10.1109/TAP.1974.1140829; BURNSIDE WD, 1980, IEEE T ANTENN PROPAG, V28, P318, DOI 10.1109/TAP.1980.1142335; Canta SM, 2011, IEEE T ANTENN PROPAG, V59, P1553, DOI 10.1109/TAP.2011.2122291; Clemmow P. C., 1956, IEEE T ANTENN PROPAG, V4, P282, DOI 10.1109/TAP.1956.1144439; DeWitt B. T., 1986, THESIS OHIO STATE U; Ito K., 2011, IEICE T ELECTRON, VE94-C, P77; JOSEPH PJ, 1994, IEEE T ELECTROMAGN C, V36, P372, DOI 10.1109/15.328869; KELLER JB, 1962, J OPT SOC AM, V52, P116, DOI 10.1364/JOSA.52.000116; Kim C. S., 1991, P IEEE INT S ANT PRO, V3, P1350; Kohama T., 2012, IEICE T ELECTRON, VE95-C, P928; Kolundzija B.M., 2000, WIPL D ELECTROMAGNET; KOUYOUMJ.RG, 1974, P IEEE, V62, P1448, DOI 10.1109/PROC.1974.9651; Millar R.F., 1956, Proceedings of the Institution of Electrical Engineers. C. Institution Monographs, V103; RYAN CE, 1969, IEEE T ANTENN PROPAG, VAP17, P292, DOI 10.1109/TAP.1969.1139445; SAHALOS JN, 1983, IEEE T ANTENN PROPAG, V31, P206, DOI 10.1109/TAP.1983.1142987; Sakina K, 2001, IEICE T ELECTRON, VE84C, P74; SATTERWH.R, 1974, IEEE T ANTENN PROPAG, VAP22, P500, DOI 10.1109/TAP.1974.1140803; SIKTA FA, 1983, IEEE T ANTENN PROPAG, V31, P584, DOI 10.1109/TAP.1983.1143116; TIBERIO R, 1994, IEEE T ANTENN PROPAG, V42, P600, DOI 10.1109/8.299558; TIBERIO R, 1995, IEEE T ANTENN PROPAG, V43, P87, DOI 10.1109/8.366356; Toccafondi A, 2013, IEEE T ANTENN PROPAG, V61, P2688, DOI 10.1109/TAP.2013.2244553; TODOROKI A, 1991, IEICE TRANS COMMUN, V74, P4157; Ufimtsev P. Ya., 1971, FTDHC2325971 WRIGHT	35	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-926X	1558-2221		IEEE T ANTENN PROPAG	IEEE Trans. Antennas Propag.	JUL	2015	63	7					3158	3167		10.1109/TAP.2015.2429751		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CM3TF	WOS:000357606500032		
J	Bise, R; Sato, Y				Bise, Ryoma; Sato, Yoichi			Cell Detection From Redundant Candidate Regions Under Nonoverlapping Constraints	IEEE TRANSACTIONS ON MEDICAL IMAGING			English	Article						Bioimage informatics; cell detection; microscopy image	MICROSCOPY IMAGE SEGMENTATION; LINEAGE CONSTRUCTION; ALGORITHM; TRACKING; CONTEXT; OPTICS	Cell detection in microscopy images is essential for automated cell behavior analysis including cell shape analysis and cell tracking. Robust cell detection in high-density and low-contrast images is still challenging since cells often touch and partially overlap, forming a cell cluster with blurry intercellular boundaries. In such cases, current methods tend to detect multiple cells as a cluster. If the control parameters are adjusted to separate the touching cells, other problems often occur: a single cell may be segmented into several regions, and cells in low-intensity regions may not be detected. To solve these problems, we first detect redundant candidate regions, which include many false positives but in turn very few false negatives, by allowing candidate regions to overlap with each other. Next, the score for how likely the candidate region contains the main part of a single cell is computed for each cell candidate using supervised learning. Then we select an optimal set of cell regions from the redundant regions under nonoverlapping constraints, where each selected region looks like a single cell and the selected regions do not overlap. We formulate this problem of optimal region selection as a binary linear programming problem under nonoverlapping constraints. We demonstrated the effectiveness of our method for several types of cells in microscopy images. Our method performed better than five representative methods, achieving an F-measure of over 0.9 for all data sets. Experimental application of the proposed method to 3-D images demonstrated that also works well for 3-D cell detection.	[Bise, Ryoma; Sato, Yoichi] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Bise, Ryoma] Dai Nippon Printing, Tokyo 1158001, Japan	Bise, R (reprint author), Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan.	bise-r@iis.u-tokyo.ac.jp; ysato@iis.u-tokyo.ac.jp					Yin ZZ, 2012, MED IMAGE ANAL, V16, P1047, DOI 10.1016/j.media.2011.12.006; Wood ST, 2013, MED IMAGE ANAL, V17, P337, DOI 10.1016/j.media.2012.12.002; Kachouie NN, 2008, IEEE ENG MED BIO, P375, DOI 10.1109/IEMBS.2008.4649168; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Al-Kofahi O, 2006, CELL CYCLE, V5, P327, DOI 10.4161/cc.5.3.2426; Li K, 2009, LECT NOTES COMPUT SC, V5636, P362; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; Yang FX, 2005, LECT NOTES COMPUT SC, V3749, P302; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Milan A, 2013, IEEE COMPUT SOC CONF, P735, DOI 10.1109/CVPRW.2013.111; Keuper M, 2011, I S BIOMED IMAGING, P973, DOI 10.1109/ISBI.2011.5872565; Wu TF, 2004, J MACH LEARN RES, V5, P975; ROSS GT, 1975, MATH PROGRAM, V8, P91, DOI 10.1007/BF01580430; Li CM, 2010, IEEE T IMAGE PROCESS, V19, P3243, DOI 10.1109/TIP.2010.2069690; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Bise R, 2011, I S BIOMED IMAGING, P1004, DOI 10.1109/ISBI.2011.5872571; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Drish J., 2001, OBTAINING CALIBRATED; House D., 2009, P IEEE C COMP VIS PA, P186; Matas J., 2002, BMVC, V1, P384, DOI DOI 10.1016/J.IMAVIS.2004.02.006; Mattes J., 2002, P BR MACH E VIS C, P384; Mingqiang Y., 2008, PATTERN RECOGNITION; Pan JY, 2010, PROC CVPR IEEE, P2940, DOI 10.1109/CVPR.2010.5540037; Peng J. Y., 2009, TRIIS09008; Praveen S., 2006, P 35 APPL IM PATT RE; Ravin R., CELL STEM CELL, V3, P670; Tcheslavski G. V., 2005, P MICCAI, V3794, P302; Tse S., 2009, P SPIE S MED IM IM P, V7259; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wolsey L. A., 1998, INTEGER PROGRAMMING; Yin ZZ, 2010, LECT NOTES COMPUT SC, V6361, P209; Yu WM, 2008, LECT NOTES COMPUT SC, V5358, P540; Zuiderveld K., 1994, GRAPHICS GEMS, P474	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0062	1558-254X		IEEE T MED IMAGING	IEEE Trans. Med. Imaging	JUL	2015	34	7					1417	1427		10.1109/TMI.2015.2391095		11	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Computer Science; Engineering; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	CM3VX	WOS:000357614300001		
J	Bonnet, V; Venture, G				Bonnet, Vincent; Venture, Gentiane			Fast Determination of the Planar Body Segment Inertial Parameters Using Affordable Sensors	IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING			English	Article						Body segment inertial parameters; identification; inverse dynamics	ADJUSTMENTS; MODELS; GAIT	This study aimed at developing and evaluating a new method for the fast and reliable identification of body segment inertial parameters with a planar model using affordable sensors. A Kinect sensor, with a new marker-based tracking system, and a Wii balance board were used as an affordable and portable motion capture system. A set of optimal exciting motions was used in a biofeedback interface to identify the body segment parameters. The method was validated with 12 subjects performing various standardized motions. The same dynamometric quantities estimated both with the proposed system and, as a reference, with a laboratory grade force-plate were compared. The results showed that the proposed method could successfully estimate the resultant moment and the vertical ground reaction force (rms errors less than 8 Nm and 12 N, respectively). Finally, when local segment values were artificially varied, the proposed method was able to detect and estimate the additional masses accurately and with an error of less than 0.5 Kg, contrary to values generated with commonly used anthropometric tables.	[Bonnet, Vincent; Venture, Gentiane] Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Koganei, Tokyo 1848588, Japan	Bonnet, V (reprint author), Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Koganei, Tokyo 1848588, Japan.	bonnet.vincent@gmail.com	Venture, Gentiane/E-7060-2013		Japan Society for Promotion of Science [PE13559]	This work was supported by the Japan Society for Promotion of Science under Grant PE13559.	Andrews JG, 1996, J BIOMECH, V29, P651, DOI 10.1016/0021-9290(95)00118-2; Conn AR, 1997, MATH COMPUT, V66, P261, DOI 10.1090/S0025-5718-97-00777-1; Viola P, 2001, PROC CVPR IEEE, P511; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Hansen C, 2014, J BIOMECH, V47, P1577, DOI 10.1016/j.jbiomech.2014.03.004; Dumas R, 2007, J BIOMECH, V40, P543, DOI 10.1016/j.jbiomech.2006.02.013; Cheng CK, 2000, CLIN BIOMECH, V15, P559, DOI 10.1016/S0268-0033(00)00016-4; Rao G, 2006, J BIOMECH, V39, P1531, DOI 10.1016/j.jbiomech.2005.04.014; Swevers J, 1997, IEEE T ROBOTIC AUTOM, V13, P730, DOI 10.1109/70.631234; Garrido-Jurado S, 2014, PATTERN RECOGN, V47, P2280, DOI 10.1016/j.patcog.2014.01.005; Bonnet V, 2013, IEEE T BIO-MED ENG, V60, P1920, DOI 10.1109/TBME.2013.2245131; Ayusawa Ko, 2011, IEEE International Conference on Robotics and Automation; Ayusawa K., 2013, INT J ROBOT RES; Baelemans J., 2013, IEEE S SAFT SEC RESC, P1; Barlett H. L., 2014, GAIT POSTURE, V39, P224; Buys K, 2014, J VIS COMMUN IMAGE R, V25, P39, DOI 10.1016/j.jvcir.2013.03.011; Fernandez-Baena A., 2012, P 4 INT C INT NETW C, P656; Khalil W., 2002, MODELING IDENTIFICAT; KHALIL W, 1995, INT J ROBOT RES, V14, P112, DOI 10.1177/027836499501400202; Kingma I, 1996, J BIOMECH, V29, P693, DOI 10.1016/0021-9290(95)00086-0; Lee MK, 2009, J BIOMECH, V42, P217, DOI 10.1016/j.jbiomech.2008.10.036; Millor N, 2014, IEEE T NEUR SYS REH, V22, P926, DOI 10.1109/TNSRE.2014.2331895; Nocedal J., 2006, OPERAT RES; Pham C. M., P 30 IEEE C DEC CONT, P2769; Ren V., 2013, ROBOT AUTOM MAG, V20; Tomasi C., 1991, DETECTION TRACKING P; Varoqui D, 2010, GAIT POSTURE, V32, P34, DOI 10.1016/j.gaitpost.2010.03.004; Venture G., 2008, CISM IFTOMM S ROB DE, P301; Winter D. A., 2005, BIOMECHANICS MOTOR C; Zatsiorsky V. M., 1990, CONT PROBLEMS BIOMEC, P272	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1534-4320	1558-0210		IEEE T NEUR SYS REH	IEEE Trans. Neural Syst. Rehabil. Eng.	JUL	2015	23	4					628	635		10.1109/TNSRE.2015.2405087		8	Engineering, Biomedical; Rehabilitation	Engineering; Rehabilitation	CM3PZ	WOS:000357596500011		
J	Shuto, D; Igarashi, K; Nagasawa, H; Iizuka, A; Inoue, M; Noguchi, M; Yamasaki, A				Shuto, Daiki; Igarashi, Kan; Nagasawa, Hiroki; Iizuka, Atsushi; Inoue, Motoki; Noguchi, Miyuki; Yamasaki, Akihiro			CO2 Fixation Process with Waste Cement Powder via Regeneration of Alkali and Acid by Electrodialysis: Effect of Operation Conditions	INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH			English	Article							AQUEOUS MINERAL CARBONATION; STEELMAKING SLAGS; CALCIUM-CARBONATE; ACETIC-ACID; SEQUESTRATION; SERPENTINITE; DISSOLUTION; CAPTURE; STORAGE	The effect of the operation conditions on the recovery of acid-alkali pairs by electrodialysis was studied to improve the efficiency of the newly developed mineral carbonation process for carbon dioxide fixation. Sodium nitrate (NaOH + HNO3), sodium chloride (NaOH + HCl), and potassium chloride (KOH + HCl) showed almost equal performance in the recovery process for the two fixed membrane configurations. For the same salt, the configuration of anion-exchange membrane bipolar membrane (AEM-BPM) showed higher recovery rate and lower power consumption than the cation-exchange membrane bipolar membrane (CEM-BPM) configuration. Significantly higher recovery rates were observed when potassium acetate was used for the CEM-BPM configuration. A higher recovery rate was observed for a lower initial concentration, but the power consumption was lower for higher initial concentrations. Calcium in waste cement powder can be rapidly leached with acetic acid. The results showed that the process performance would be significantly improved by using acetic acid for calcium leaching, and sodium hydroxide for CO2 capture.	[Shuto, Daiki; Igarashi, Kan; Inoue, Motoki; Noguchi, Miyuki; Yamasaki, Akihiro] Seikei Univ, Grad Sch Sci & Engn, Dept Mat & Life Sci, Musashino, Tokyo 1808633, Japan; [Nagasawa, Hiroki] Hiroshima Univ, Dept Chem Engn, Hiroshima 7398527, Japan; [Iizuka, Atsushi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Res Ctr Sustainable Sci & Engn, Sendai, Miyagi 9808577, Japan	Yamasaki, A (reprint author), Seikei Univ, Grad Sch Sci & Engn, Dept Mat & Life Sci, 3-3-1 Kichijoji Kitamachi, Musashino, Tokyo 1808633, Japan.	akihiro@st.sekieki.ac.jp	Nagasawa, Hiroki/D-7613-2012	Nagasawa, Hiroki/0000-0001-7972-2425			Boot-Handford ME, 2014, ENERG ENVIRON SCI, V7, P130, DOI 10.1039/c3ee42350f; Eloneva S, 2009, STEEL RES INT, V80, P415, DOI 10.2374/SRI09SP028; Eloneva S, 2008, ENERGY, V33, P1461, DOI 10.1016/j.energy.2008.05.003; Alexander G, 2007, FUEL, V86, P273, DOI 10.1016/j.fuel.2006.04.034; Pan SY, 2012, AEROSOL AIR QUAL RES, V12, P770, DOI 10.4209/aaqr.2012.06.0149; Teir S, 2007, INT J MINER PROCESS, V83, P36, DOI 10.1016/j.minpro.2007.04.001; Chen ZY, 2006, ENVIRON PROG, V25, P161, DOI 10.1002/ep.10127; Gerdemann SJ, 2007, ENVIRON SCI TECHNOL, V41, P2587, DOI 10.1021/es0619253; Olajire AA, 2013, J PETROL SCI ENG, V109, P364, DOI 10.1016/j.petrol.2013.03.013; Kakizawa M, 2001, ENERGY, V26, P341, DOI 10.1016/S0360-5442(01)00005-6; Giannoulakis S, 2014, INT J GREENH GAS CON, V21, P140, DOI 10.1016/j.ijggc.2013.12.002; Zevenhoven R, 2011, GREENH GASES, V1, P48, DOI 10.1002/ghg.37; Shuto D, 2014, RSC ADV, V4, P19778, DOI 10.1039/c4ra00130c; Teir S, 2007, ENERGY, V32, P528, DOI 10.1016/j.energy.2006.06.023; Teir S, 2009, APPL ENERG, V86, P214, DOI 10.1016/j.apenergy.2008.03.013; Huijgen WJJ, 2007, ENERG CONVERS MANAGE, V48, P1923, DOI 10.1016/j.enconman.2007.01.035; Bertos MF, 2004, GREEN CHEM, V6, P428, DOI 10.1039/b401872a; Hemmati A, 2014, INT J MINER PROCESS, V130, P20, DOI 10.1016/j.minpro.2014.05.007; Hemmati A, 2014, CHEM ENG J, V252, P210, DOI 10.1016/j.cej.2014.04.112; Iizuka A, 2012, IND ENG CHEM RES, V51, P6099, DOI 10.1021/ie300620u; Iizuka A, 2004, IND ENG CHEM RES, V43, P7880, DOI 10.1021/ie0496176; Jones G, 2006, ENVIRON CHEM, V3, P297, DOI 10.1071/EN06018; Metz B., 2005, IPCC SPECIAL REPORT; O'Connor W. K., 2000, P 25 INT TECHN C COA; Oldham KB, 2012, ELECTROCHEMICAL SCIENCE AND TECHNOLOGY: FUNDAMENTALS AND APPLICATIONS, P1; Sanna A, 2014, CHEM SOC REV, V43, P8049, DOI 10.1039/c4cs00035h; Speight JG, 2005, LANGES HDB CHEM; Strathmann H., 2004, ION EXCHANGE MEMBRAN; Teir S, 2007, INT J MINER PROCESS, V85, P1, DOI 10.1016/j.minpro.2007.08.007; Tokyo Electric Power Company Web site, REP CO2 EM SPEC CO2; Xu TW, 2005, J MEMBRANE SCI, V263, P1, DOI 10.1016/j.memsci.2005.05.002	31	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0888-5885			IND ENG CHEM RES	Ind. Eng. Chem. Res.	JUL 1	2015	54	25					6569	6577		10.1021/acs.iecr.5b00717		9	Engineering, Chemical	Engineering	CM1JG	WOS:000357436600015		
J	Zhou, X; Wang, YH; Ghosh, S; Tang, WF; Pang, BB; Liu, MQ; Peng, JS; Zhou, DJ; Kobayashi, N				Zhou, Xuan; Wang, Yuan-Hong; Ghosh, Souvik; Tang, Wei-Feng; Pang, Bei-Bei; Liu, Man-Qing; Peng, Jin-Song; Zhou, Dun-Jin; Kobayashi, Nobumichi			Genomic characterization of G3P[6], G4P[6] and G4P[8] human rotaviruses from Wuhan, China: Evidence for interspecies transmission and reassortment events	INFECTION GENETICS AND EVOLUTION			English	Article						Human rotavirus; Whole genome analysis; Porcine-like rotavirus; Interspecies transmission; Reassortment	GROUP-A ROTAVIRUSES; PORCINE-LIKE HUMAN; STRAINS; DIARRHEA; CHILDREN; GENOTYPE; REVEALS; ORIGIN; IDENTIFICATION; RARE	We report here the whole genomic analyses of two G4P[6] (RVA/Human-wt/CHN/E931/2008/G4P[6], RVA/Human-wt/CHN/R1954/2013/G4P[6]), one G3P[6] (RVA/Human-wt/CHN/R946/2006/G3P16]) and one G4P[8] (RVA/Human-wt/CHN/E2484/2011/G4P[8]) group A rotavirus (RVA) strains detected in sporadic cases of diarrhea in humans in the city of Wuhan, China. All the four strains displayed a Wa-like genotype constellation. Strains E931 and R1954 shared a G4-P[6]-I1-R1-C1-M1-A8-N1-T1-E1-H1 constellation, whilst the 11 gene segments of strains R946 and E2484 were assigned to G3-P[6]-I1-R1-C1-M1-A1-N1-T1-E1-H1 and G4-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1 genotypes, respectively. Phylogenetically, the VP7 gene of R946, NSP3 gene of E931, and 10 of 11 gene segments of E2484 (except for VP7 gene) belonged to lineages of human RVAs. On the other hand, based on available data, it was difficult to ascertain porcine or human origin of VP3 genes of strains E931 and R946, and NSP2 genes of strains R946 and R1954. The remaining genes of E2484, E931, R946 and R1954 were close to those of porcine RVAs from China, and/or porcine-like human RVAs. Taken together, our observations suggested that strain R1954 might have been derived from porcine RVAs, whilst strains R946 and E931 might be reassortants possessing human RVA-like gene segments on a porcine RVA genetic backbone. Strain E2484 might be derived from reassortment events involving acquisition of a porcine-like VP7 gene by a Wa-like human RVA strain. The present study provided important insights into zoonotic transmission and complex reassortment events involving human and porcine RVAs, reiterating the significance of whole-genomic analysis of RVA strains. (C) 2015 Elsevier B.V. All rights reserved.	[Zhou, Xuan; Wang, Yuan-Hong; Tang, Wei-Feng; Pang, Bei-Bei; Liu, Man-Qing; Peng, Jin-Song; Zhou, Dun-Jin] Wuhan Ctr Dis Prevent & Control, Virol Sect, Wuhan 430015, Hubei, Peoples R China; [Ghosh, Souvik] Ross Univ, Sch Vet Med, Dept Biomed Sci, Basseterre, St Kitts & Nevi; [Ghosh, Souvik; Kobayashi, Nobumichi] Sapporo Med Univ, Sch Med, Dept Hyg, Sapporo, Hokkaido, Japan	Wang, YH (reprint author), Wuhan Ctr Dis Prevent & Control, Virol Sect, 24 Jianghan North Rd, Wuhan 430015, Hubei, Peoples R China.	wyuanh1@hotmail.com; nkobayas@sapmed.ac.jp			National Natural Science Foundation of China [81071352]; Yellow Crane Talents Foundation (Medical and Health Specialty); Japan Society for the Promotion of Science [25305022]	The work was funded by the National Natural Science Foundation of China (Grant No. 81071352) and the Yellow Crane Talents Foundation (Medical and Health Specialty) to Yuan-Hong Wang, and the Grant-in-Aid for Scientific Research (Grant No. 25305022) from the Japan Society for the Promotion of Science to Nobumichi Kobayashi.	Ghosh S, 2012, VET MICROBIOL, V158, P410, DOI 10.1016/j.vetmic.2012.02.037; Mukherjee A, 2009, ARCH VIROL, V154, P733, DOI 10.1007/s00705-009-0363-3; Martel-Paradis O, 2013, VET MICROBIOL, V162, P94, DOI 10.1016/j.vetmic.2012.08.028; Zeller M, 2012, INFECT GENET EVOL, V12, P1492, DOI 10.1016/j.meegid.2012.03.002; Monini M, 2014, INFECT GENET EVOL, V25, P4, DOI 10.1016/j.meegid.2014.03.024; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Wang YH, 2010, J MED VIROL, V82, P1094, DOI 10.1002/jmv.21760; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Mukherjee A, 2011, CLIN MICROBIOL INFEC, V17, P1343, DOI 10.1111/j.1469-0691.2010.03383.x; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Ghosh S, 2012, INFECT GENET EVOL, V12, P471, DOI 10.1016/j.meegid.2011.12.012; Mullick S, 2013, INFECT GENET EVOL, V14, P15, DOI 10.1016/j.meegid.2012.11.010; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Dong HJ, 2013, INFECT GENET EVOL, V20, P155, DOI 10.1016/j.meegid.2013.08.024; Komoto S, 2013, J GEN VIROL, V94, P1568, DOI 10.1099/vir.0.051011-0; Papp H, 2013, INFECT GENET EVOL, V19, P71, DOI 10.1016/j.meegid.2013.06.013; Gentsch JR, 1996, J INFECT DIS, V174, pS30; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Banyai K, 2009, ARCH VIROL, V154, P1823, DOI 10.1007/s00705-009-0499-1; Degiuseppe JI, 2013, CLIN MICROBIOL INFEC, V19, pE367, DOI 10.1111/1469-0691.12216; Do LP, 2014, INFECT GENET EVOL, V21, P334, DOI 10.1016/j.meegid.2013.11.027; Duan ZJ, 2007, J CLIN MICROBIOL, V45, P1614, DOI 10.1128/JCM.00032-07; Esona MD, 2009, EMERG INFECT DIS, V15, P83, DOI 10.3201/eid1501.080899; Estes M, 2007, FIELDS VIROLOGY, V2, P1917; Ghosh S, 2010, VIRUS GENES, V40, P382, DOI 10.1007/s11262-010-0454-y; Guo L., 2013, GENOME ANNOUNC; Hwang KP, 2012, J MED MICROBIOL, V61, P990, DOI 10.1099/jmm.0.042499-0; Kim HH, 2012, INFECT GENET EVOL, V12, P1427, DOI 10.1016/j.meegid.2012.04.028; Lorenzetti E, 2011, VET MICROBIOL, V154, P191, DOI 10.1016/j.vetmic.2011.06.026; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Martella V, 2008, J CLIN MICROBIOL, V46, P3501, DOI 10.1128/JCM.00983-08; Martinez M, 2014, INFECT GENET EVOL, V27, P156, DOI 10.1016/j.meegid.2014.07.020; Mladenova Z, 2012, INFECT GENET EVOL, V12, P1676, DOI 10.1016/j.meegid.2012.07.002; Nguyen TA, 2007, J MED VIROL, V79, P1959, DOI 10.1002/jmv.21030; Okitsu S, 2013, INFECT GENET EVOL, V18, P74, DOI 10.1016/j.meegid.2013.05.005; Park JG, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-88; Shi HY, 2012, ARCH VIROL, V157, P1897, DOI 10.1007/s00705-012-1363-2; Shintani T, 2012, VIRUSES-BASEL, V4, P1289, DOI 10.3390/v4081289; Theuns S, 2015, J VIROL, V89, P1043, DOI [10.1128/JVI.02513-14, 10.1128/JVI02513-14]; Wang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088850; Wang YH, 2009, J MED VIROL, V81, P382, DOI 10.1002/jmv.21387; Wang YH, 2011, ARCH VIROL, V156, P2221, DOI 10.1007/s00705-011-1122-9; Wang YH, 2007, ARCH VIROL, V152, P669, DOI 10.1007/s00705-006-0904-y	45	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	JUL	2015	33						55	71		10.1016/j.meegid.2015.04.010		17	Infectious Diseases	Infectious Diseases	CM1JX	WOS:000357438300009		
